Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
OR4F5		ENSG00000186092	"Olfactory receptor family 4 subfamily F member 5"	Q8NH21	1	65419-71585	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4F29		ENSG00000284733	"Olfactory receptor family 4 subfamily F member 29"	Q6IEY1	1	450703-451697	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain					NA	NA					"HPA047705: AB_2680125"																		0.0	0.0		0.0		0.0	0.2		0.0	0.1	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.2	0.0	0.0			0.0	0.0	0.1		0.0		0.0	0.2		0.2	0.0	0.0	0.2	0.0	0.0		0.0	0.0	1.4			0.0		0.0	0.0		0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.7	0.2	0.2	0.4	0.0	0.5	0.0	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4F16		ENSG00000284662	"Olfactory receptor family 4 subfamily F member 16"	Q6IEY1	1	685679-686673	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain					NA	NA					"HPA047705: AB_2680125"																		0.0	0.0		0.0		0.0	0.2		0.0	0.1	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.2	0.0	0.0			0.0	0.0	0.1		0.0		0.0	0.2		0.2	0.0	0.0	0.2	0.0	0.0		0.0	0.0	1.4			0.0		0.0	0.0		0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.7	0.2	0.2	0.4	0.0	0.5	0.0	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SAMD11	MGC45873	ENSG00000187634	"Sterile alpha motif domain containing 11"	Q96NU1	1	923928-944581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 235.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 4.7"	"Group enriched"	"Detected in many"	4	"HEK 293: 38.7;HeLa: 42.9;SCLC-21H: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA030110			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030110: "	"unprognostic (9.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.18e-1)"	2.1	10.0	2.4	5.0	3.0	1.0	1.6	1.6	4.7	4.4	3.0	7.2	2.5	5.1	9.5	7.4	4.2	13.6	4.5	8.5	5.7	4.0	10.0	2.9	2.4	2.1	6.9	2.0	5.9	1.8	0.6	21.9	0.6	5.9	12.4	1.4	16.9	2.4	22.1	1.4	0.3	5.6	6.0	8.8	11.7	5.5	2.7	5.1	0.3	4.6	0.6	0.5	7.2	22.8	0.3	0.0	0.0	0.2	4.7	0.4	0.0	0.1	2.7	0.0	2.5	0.1	0.0	0.9	4.2	0.2	0.2	0.1	0.1	0.8	0.0	8.1	8.7	2.2	5.5	2.7	0.0	0.0	0.3	38.7	0.0	42.9	0.1	0.7	0.0	0.3	1.6	0.0	0.0	0.0	4.3	0.0	0.1	1.4	0.0	0.0	2.9	0.0	0.0	1.6	0.1	0.3	0.2	0.6	2.2	0.4	0.0	28.0	8.6	8.8	4.2	0.0	2.6	4.9	0.2	0.5	1.4	6.4	0.1	0.9	0.5	0.0	0.1	1.8	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.3	0.2	0.2	0.0	0.1	0.1	0.4	0.0	4.7	0.1	0.0	0.0	0.0	2.4	3.0	1.6	4.7	5.7	4.0	6.9	2.0	5.9	5.1	0.0	2.6	0.0	0.1	0.3	16.4	0.8	0.0	0.0	3.4	3.5	27.5	0.2	0.0	0.5	2.2	0.8	0.0	0.0	0.3	0.6	2.3	2.5	0.0	0.0	0.2	33.4	25.4	6.7	0.3	7.9	0.9	0.0	0.0	0.0	0.0	15.0	2.6	0.2	3.9	0.2	235.2	0.0	1.4	0.9	16.6	0.5	0.1	0.0	0.0	0.3
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944204-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		420000	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	17.7	15.6	13.4	20.5	17.8	23.8	18.2	23.7	27.4	15.0	15.3	15.6	13.5	16.8	19.0	13.5	27.7	18.3	21.8	23.0	15.3	15.3	15.2	36.6	14.0	19.3	18.7	19.0	16.9	26.8	20.8	15.3	15.9	16.7	16.6	11.1	14.0	22.0	16.5	40.0	32.4	14.6	14.7	13.6	17.5	16.4	21.1	18.0	22.7	19.8	29.5	21.8	17.5	18.0	14.3	20.2	11.3	29.0	18.8	18.4	16.0	27.6	27.6	4.9	32.1	9.0	8.0	18.1	20.7	9.7	29.0	15.9	36.6	27.2	31.2	29.4	13.7	24.1	25.4	36.7	30.9	12.3	19.6	41.8	16.5	35.7	31.7	20.3	36.3	16.3	13.1	8.8	31.8	21.3	9.0	14.0	11.1	46.6	14.4	12.8	43.8	23.3	22.0	28.3	20.0	32.8	29.3	20.6	37.8	13.3	11.7	34.7	34.1	27.4	41.5	25.3	7.8	18.5	19.9	16.0	17.3	24.7	18.9	35.3	24.8	26.7	56.4	21.5	51.6	14.4	7.2	17.0	11.3	14.2	25.7	18.4	14.3	13.8	13.6	20.2	11.9	14.3	11.1	1.6	18.8	29.0	13.0	10.9	16.0	13.4	17.8	23.7	27.4	15.3	15.3	18.7	19.0	16.7	18.0	14.9	23.9	46.0	71.4	61.6	53.0	2.8	20.4	20.1	13.6	34.9	58.9	54.4	14.9	44.4	5.6	27.4	17.0	0.0	39.8	56.2	34.7	37.8	12.8	19.8	34.6	42.9	28.8	17.8	23.1	8.1	27.3	24.1	23.6	30.7	23.4	21.7	31.2	17.5	20.1	15.2	68.2	32.3	49.2	36.7	73.9	71.6	49.2	39.9	41.2	60.5
KLHL17		ENSG00000187961	"Kelch like family member 17"	Q6TDP4	1	960587-965715	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031251	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA031251: AB_10601539"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (3.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.73e-2)"	4.7	7.0	9.9	8.7	8.9	8.2	8.8	14.0	10.0	6.2	5.1	4.9	4.1	8.4	6.5	4.8	9.9	4.6	5.8	4.2	8.4	4.2	7.2	6.1	5.6	8.1	6.7	3.4	1.5	9.5	5.4	12.4	5.7	6.3	6.8	2.3	6.0	11.6	5.6	5.2	19.1	6.1	6.6	4.2	9.8	7.7	9.8	8.2	5.6	5.4	4.0	7.6	6.5	6.7	0.4	1.0	0.0	1.2	0.0	1.7	0.4	4.6	5.2	6.5	15.5	2.3	2.4	7.1	9.1	2.5	5.1	5.0	6.8	7.0	1.7	6.4	3.9	4.9	9.9	6.0	3.7	0.8	9.3	14.4	3.0	18.9	9.6	1.5	3.4	9.5	2.0	1.8	5.0	1.4	6.4	3.1	9.7	9.9	3.0	2.2	5.4	5.6	12.0	7.1	1.8	7.7	9.1	2.6	3.2	2.7	1.8	15.8	14.9	2.6	8.2	8.3	2.1	4.5	6.1	5.4	9.8	13.2	8.5	7.5	6.0	2.1	3.9	5.6	7.8	4.5	0.0	1.2	0.0	1.7	0.1	0.4	0.4	0.3	0.4	0.0	0.4	0.7	0.4	0.0	0.0	0.6	1.0	0.0	0.4	9.9	8.9	14.0	10.0	8.4	4.2	6.7	3.4	6.3	8.2	0.0	1.9	2.0	0.9	2.3	4.5	2.5	0.0	0.0	0.0	3.5	2.0	1.1	0.0	0.9	1.1	0.7	0.9	0.0	0.7	1.6	1.1	0.8	0.0	0.6	1.1	6.4	2.9	4.3	1.8	1.5	0.3	1.9	3.3	0.0	1.6	1.0	1.6	0.0	1.4	1.0	6.4	0.0	1.0	3.7	5.5	2.6	0.7	0.9	1.0	1.0
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966497-975865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 17.5;Glandular cells: 28.7;Pancreatic endocrine cells: 24.5;Suprabasal keratinocytes: 15.2;Urothelial cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 11.3;HaCaT: 19.9;SK-BR-3: 13.6"					"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	0.6	0.0	1.8	0.2	0.4	1.4	0.0	0.1	7.7	0.9	0.0	0.0	0.8	1.1	2.7	31.5	0.3	5.0	0.5	0.3	0.0	2.3	0.8	1.1	0.3	0.0	0.0	0.1	0.5	0.3	0.0	1.5	0.0	3.7	0.2	0.3	5.3	1.2	1.5	31.3	0.7	0.6	0.6	0.5	1.7	0.8	0.0	0.2	0.7	20.2	21.2	6.0	10.6	0.0	0.3	2.0	0.9	2.3	1.1	0.2	11.3	1.2	0.0	0.8	0.0	0.6	1.9	5.3	1.3	3.4	0.8	1.5	8.8	0.0	2.5	2.1	4.5	19.9	0.2	3.3	0.5	3.9	0.8	0.0	3.5	2.3	0.5	0.2	0.1	0.1	2.8	2.2	1.2	2.9	0.3	0.0	0.2	3.2	0.2	6.6	0.0	0.2	0.4	1.6	9.1	0.0	0.0	4.2	3.7	3.4	0.1	0.1	5.9	13.6	0.8	0.3	2.6	0.0	2.4	4.3	1.9	0.4	3.5	2.6	0.1	0.1	5.2	1.9	2.4	0.0	0.9	2.0	0.3	0.3	0.0	0.0	0.5	1.1	0.3	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.6	0.9	17.5	4.0	0.1	0.8	0.0	1.4	1.2	0.0	0.0	5.9	0.0	11.4	0.0	0.6	0.0	0.0	12.2	1.5	0.6	28.7	0.0	0.0	1.0	3.2	0.0	0.0	0.8	0.0	0.0	1.4	1.7	1.8	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	15.2	8.2	2.5	0.0	37.9
PERM1	"C1orf170, MGC13275, Perm1, RP11-54O7.8"	ENSG00000187642	"PPARGC1 and ESRR induced regulator, muscle 1"	Q5SV97	1	975204-982093	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"heart muscle: 23.8;skeletal muscle: 68.1;tongue: 24.7"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 18.8;Early spermatids: 5.1;Late spermatids: 5.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.5;HaCaT: 4.4;MCF7: 3.1;SK-BR-3: 4.7"					"Not detected"	"Not detected"			"HPA031711, HPA031712"	Enhanced					NA	NA					"HPA031711: AB_10669636, HPA031712: AB_2674005"	"unprognostic (3.67e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.58e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.96e-2)"	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	23.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.9	0.0	68.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	24.7	0.9	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.5	0.1	0.0	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.5	1.6	0.0	0.5	0.0	1.1	4.4	0.0	0.0	0.0	1.4	0.5	0.0	1.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	3.1	0.0	0.0	0.0	0.7	1.1	0.0	0.0	1.8	0.0	0.9	0.0	0.1	1.3	4.7	1.0	0.3	0.4	0.0	0.9	0.7	0.9	0.0	0.7	0.5	0.0	0.0	1.8	0.4	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	18.8	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	1.4
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 291.1;Glandular cells: 254.1;Paneth cells: 238.4;Smooth muscle cells: 271.9;Urothelial cells: 423.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.4"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 66.9"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: AB_2684771"	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	14.8	4.0	8.3	3.9	15.6	2.8	8.7	2.5	16.9	7.6	10.8	2.9	4.8	5.4	7.8	9.0	7.5	6.8	9.6	13.6	5.9	9.4	5.3	3.2	9.1	2.2	7.3	4.0	4.2	14.8	3.1	5.7	6.1	7.2	10.4	2.6	12.8	5.6	9.4	8.0	7.8	4.2	12.1	3.4	8.6	6.1	3.4	3.1	9.0	3.6	8.4	3.3	10.6	5.6	0.0	0.3	12.4	1.4	0.0	0.0	0.0	4.6	0.5	0.5	0.0	0.0	0.0	5.9	2.8	0.3	1.7	1.8	0.7	1.5	0.0	6.7	0.2	0.8	8.2	0.7	0.1	0.0	0.0	66.9	0.0	0.7	0.9	0.6	0.0	0.5	0.0	0.7	0.1	0.1	0.2	0.2	0.8	1.3	0.1	0.0	2.4	3.7	0.2	0.0	1.0	6.5	0.0	0.6	1.4	0.6	0.0	0.4	1.5	1.9	4.7	8.4	0.2	3.5	0.0	0.3	0.5	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	12.4	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.3	15.6	2.5	7.0	5.9	9.4	7.3	4.0	7.2	3.1	0.0	0.0	0.0	291.1	46.2	3.5	11.8	22.9	0.0	2.3	55.8	0.0	0.9	26.6	14.8	0.8	15.3	10.3	0.0	2.5	35.2	22.6	254.1	55.1	0.0	4.4	0.0	10.3	16.0	3.5	0.8	6.9	13.3	109.6	1.0	10.5	119.5	9.0	238.4	14.5	0.6	10.7	161.7	271.9	2.3	28.1	72.3	2.9	0.7	11.0	423.0
ISG15	"G1P2, IFI15, UCRP"	ENSG00000187608	"ISG15 ubiquitin-like modifier"	P05161	1	1001138-1014541	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 103.3;salivary gland: 116.2"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 427.6;Smooth muscle cells: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 140.4;BJ hTERT+ SV40 Large T+ RasG12V: 141.7;HeLa: 45.8;SK-MEL-30: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004627	Approved				"Secreted to blood"	NA	NA	5000000				"HPA004627: AB_1079152"	"unprognostic (3.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.11e-10)"	"unprognostic (4.55e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.46e-2)"	25.0	5.5	22.6	14.5	14.8	48.5	8.5	2.3	22.7	15.2	11.3	6.2	5.5	17.4	12.8	20.4	7.9	4.3	12.7	12.0	13.2	16.4	29.8	28.9	18.3	13.0	12.0	8.6	6.5	8.2	2.6	10.7	50.1	13.4	9.9	3.5	7.6	116.2	9.0	7.1	3.4	16.8	7.8	17.8	26.9	11.2	4.9	6.4	28.7	16.7	6.2	9.4	9.3	9.1	30.4	22.0	103.3	50.6	31.4	61.3	27.7	5.4	0.8	0.4	3.7	0.5	1.1	3.3	3.8	9.1	140.4	141.7	8.8	8.8	4.8	27.7	3.1	24.5	3.4	0.4	1.6	2.1	5.4	2.4	2.2	45.8	5.9	5.3	1.4	9.3	2.4	0.5	8.9	0.1	0.4	4.3	6.5	1.3	2.6	1.1	25.9	4.6	23.5	0.4	3.4	29.9	8.0	1.1	2.4	1.8	1.6	0.1	0.1	7.4	1.2	44.5	0.2	0.2	2.8	2.4	2.8	2.7	1.2	0.8	3.5	1.8	3.5	2.7	5.5	0.2	55.8	35.9	103.3	30.3	50.6	39.3	30.4	35.1	33.5	22.0	23.5	22.7	26.2	83.7	31.4	42.9	7.3	61.3	27.7	22.6	14.8	2.3	22.7	13.2	16.4	12.0	8.6	13.4	6.4	35.7	20.3	41.2	41.4	39.6	1.5	18.2	35.7	24.1	26.1	43.6	0.0	12.7	5.0	129.5	3.0	180.0	253.7	0.0	242.3	427.6	85.6	41.8	60.0	52.1	238.9	0.0	33.7	74.9	63.0	9.3	30.5	163.4	84.4	57.7	87.1	19.4	135.8	228.0	38.9	17.0	1.4	97.0	303.7	1.7	1.1	32.2	27.0	93.5	15.6	46.9
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020123-1056118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		15000000	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	10.2	2.8	13.0	5.3	12.4	2.9	8.3	2.3	24.0	11.3	8.5	20.5	8.9	9.8	8.2	14.5	8.8	11.4	37.2	8.1	10.9	8.3	36.0	9.3	18.1	2.3	9.3	7.0	7.6	25.2	5.7	5.0	11.0	12.7	8.7	2.5	13.6	26.5	10.8	4.7	18.6	11.2	3.9	7.7	7.2	14.1	7.5	8.1	6.4	27.0	9.5	7.6	13.7	6.2	0.0	0.1	0.0	0.5	0.0	1.1	0.1	27.0	16.8	3.3	10.9	0.5	0.7	29.4	13.7	4.4	9.2	5.6	14.1	46.4	0.5	54.1	2.1	4.5	47.1	1.1	16.9	1.1	1.0	6.4	0.0	22.0	14.8	3.9	0.3	5.5	2.4	7.3	2.9	6.4	12.8	1.6	0.4	5.6	0.1	0.7	22.2	0.2	3.8	7.0	8.7	12.3	4.3	6.4	4.0	16.1	12.1	0.8	6.5	27.8	30.1	26.5	3.3	26.5	2.1	23.9	11.3	40.0	1.5	11.0	0.3	0.2	1.0	7.1	2.5	3.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	13.0	12.4	2.3	22.0	10.9	8.3	9.3	7.0	12.7	8.1	23.8	9.1	2.4	7.5	13.4	0.8	2.2	79.0	5.3	14.8	148.3	7.9	1.1	1.7	85.5	0.1	17.9	18.6	0.0	14.5	4.6	5.6	15.4	2.3	8.9	3.9	4.8	6.4	13.5	2.1	0.8	5.2	3.1	23.6	27.1	10.4	10.0	62.9	14.0	2.5	11.3	5.4	6.5	8.5	0.5	9.6	5.3	1.0	1.0	18.4	13.7
RNF223		ENSG00000237330	"Ring finger protein 223"	E7ERA6	1	1070966-1074307	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 16.4;Urothelial cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 11.9;CAPAN-2: 8.9;HaCaT: 5.6;MCF7: 19.0;OE19: 5.5;SK-BR-3: 13.0;T-47d: 8.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (3.50e-1)"	"unprognostic (6.50e-2)"		"unprognostic (1.43e-3)"	"unprognostic (3.91e-1)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-1)"	"unprognostic (9.52e-3)"	0.0	0.0	0.0	1.4	0.0	0.4	0.8	0.0	0.5	8.3	1.4	0.0	0.0	0.4	1.0	0.3	28.8	0.2	1.9	0.0	0.0	0.0	0.6	0.3	0.9	0.1	0.0	0.0	0.0	1.0	0.1	0.0	6.5	0.0	4.2	0.8	0.0	3.3	0.4	0.7	3.5	0.2	2.6	0.0	0.2	7.8	0.1	0.0	0.0	0.2	14.8	17.1	4.9	9.3	0.6	0.6	1.9	0.4	0.3	0.4	0.0	11.9	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	8.9	0.0	0.1	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.0	0.0	0.1	0.0	5.5	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	13.0	0.2	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.4	0.2	0.3	0.1	0.1	0.3	0.2	0.4	0.0	0.6	0.2	0.4	0.9	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	6.4	0.5	0.0	0.4	0.0	2.7	0.0	1.8	0.0	0.2	0.0	6.7	0.0	0.0	5.1	0.0	2.8	16.4	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.3	0.0	9.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.2	0.0	2.8	31.4
C1orf159	FLJ20584	ENSG00000131591	"Chromosome 1 open reading frame 159"	Q96HA4	1	1081818-1116361	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 48.9;Late spermatids: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA010019, HPA075399"	Approved		Approved	"Nucleoli rim,Mitotic chromosome,Intermediate filaments"		Yes	No			"Nucleoli rim, Mitotic chromosome, Intermediate filaments"		"HPA010019: AB_1078885, HPA075399: "	"unprognostic (2.79e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (1.34e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.62e-4)"	3.7	6.6	8.3	4.9	9.0	5.6	3.1	7.6	10.0	5.5	6.0	11.3	5.4	6.1	6.0	6.9	6.6	4.0	5.9	3.8	8.8	5.8	5.0	5.0	5.6	4.2	6.6	4.9	5.8	5.3	2.2	4.4	5.6	5.0	6.6	1.8	5.8	10.2	6.5	3.6	23.7	5.5	7.5	5.2	7.0	9.0	17.5	5.6	5.2	4.0	5.2	6.4	5.4	4.4	5.0	4.3	9.9	4.9	4.7	5.7	3.9	11.9	9.7	4.5	7.8	1.4	1.4	10.2	6.8	1.6	6.2	4.1	5.2	12.6	3.4	8.4	2.1	5.0	9.9	1.9	6.3	1.8	6.4	14.1	2.3	16.6	5.4	2.9	4.0	5.6	3.1	3.0	3.2	1.2	1.9	3.0	5.5	13.8	2.7	2.2	9.2	7.4	10.2	4.1	4.5	15.6	9.2	5.3	6.2	3.6	4.3	9.4	12.5	5.3	9.5	5.4	1.4	6.6	5.2	5.0	6.7	7.1	9.8	7.0	4.5	6.1	6.0	5.8	10.9	5.4	9.9	4.9	2.6	5.3	4.4	5.4	5.0	4.9	5.7	3.2	4.7	5.3	5.0	1.1	4.7	3.1	4.3	1.7	3.9	8.3	9.0	7.6	10.0	8.8	5.8	6.6	4.9	5.0	5.6	0.0	10.6	1.5	3.4	6.6	6.2	1.8	5.1	9.4	5.7	8.7	3.9	4.7	1.7	7.6	48.9	3.6	5.1	23.3	5.9	11.7	5.0	4.2	5.7	4.7	3.6	12.7	4.1	1.8	1.8	101.9	2.6	2.7	3.3	8.2	7.0	3.0	6.1	2.9	1.4	1.1	7.4	0.0	4.1	11.2	6.6	6.0	4.1	3.8	6.9	4.4
TTLL10	"FLJ36119, TTLL5"	ENSG00000162571	"Tubulin tyrosine ligase like 10"	Q6ZVT0	1	1173884-1197935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"testis: 48.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 234.3;Late spermatids: 619.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Cell type enriched"	"Detected in single"	29	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"NK-cells: 2.9"	"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042712	Uncertain					NA	NA					"HPA042712: AB_10797019"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.66e-3)"	"prognostic favorable (1.61e-5)"	"unprognostic (5.33e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.14e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.00e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.39e-2)"	1.2	0.0	0.1	0.1	0.5	0.0	0.6	0.1	0.2	1.7	0.1	1.0	0.1	0.0	0.2	1.1	0.1	10.9	0.1	0.1	0.3	0.3	0.1	0.1	3.1	0.1	0.1	0.3	0.7	0.1	0.0	1.3	1.5	2.2	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.5	48.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.2	0.3	0.3	0.1	0.3	2.2	0.3	0.0	0.3	0.0	0.5	1.5	0.0	0.6	2.5	54.9	2.3	0.0	2.0	0.0	0.0	0.2	234.3	0.5	0.0	0.0	1.2	0.7	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	619.5	4.9	0.0	0.0	0.0	3.1	0.2	0.9	0.0	4.2	0.0	0.0	6.5	0.0	2.8	2.1	1.8	0.1	0.0	4.1	1.0
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206691	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 46.6;skin 1: 28.9"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 167.9;granulocytes: 46.0;Melanocytes: 47.2;Suprabasal keratinocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 46.6"	"Group enriched"	"Detected in many"	11	"NK-cells: 46.6;T-cells: 19.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 62.6;SCLC-21H: 45.0"									HPA008025	Approved				"Secreted to blood"	NA	NA					"HPA008025: AB_1849696"	"unprognostic (1.20e-3)"	"unprognostic (4.61e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (2.73e-4)"	"prognostic favorable (4.12e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.40e-11)"	"unprognostic (1.02e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.08e-1)"	1.4	0.5	1.0	8.9	1.0	1.9	4.2	4.9	2.5	14.3	8.3	0.3	0.1	5.7	2.1	1.1	4.7	1.0	3.7	0.2	0.5	0.3	1.1	1.7	3.0	9.1	0.4	2.4	0.3	2.7	9.4	3.8	1.3	1.7	1.9	1.2	0.5	9.0	2.6	1.0	28.9	5.0	0.2	0.3	6.7	3.8	0.8	0.1	4.4	0.9	2.7	8.2	1.5	2.2	2.9	0.0	0.2	0.0	46.6	19.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	4.7	0.0	0.0	62.6	0.1	0.0	45.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.6	1.3	8.5	1.2	0.0	2.9	0.3	0.4	0.2	46.6	0.0	0.0	19.0	2.1	1.0	1.0	4.9	2.5	0.5	0.3	0.4	2.4	1.7	0.1	0.0	2.2	7.5	10.8	167.9	0.0	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.5	0.9	11.2	7.3	46.0	0.0	0.8	0.0	3.4	1.3	0.8	0.0	0.0	1.8	47.2	21.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	131.6	0.0	20.8	0.0	3.3
TNFRSF4	"ACT35, CD134, OX40, TXGP1L"	ENSG00000186827	"TNF receptor superfamily member 4"	P43489	1	1211326-1214138	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.5;blood: 18.4;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in some"	19	"Endothelial cells: 15.3;granulocytes: 67.9;monocytes: 30.7;T-cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 15.9;T-reg: 18.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MOLT-4: 8.0;NB-4: 15.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB016128	Enhanced					NA	NA					"CAB016128: AB_626897"	"unprognostic (2.24e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.50e-6)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.91e-2)"	12.5	0.2	0.6	8.8	0.4	0.7	7.3	0.3	1.2	1.1	3.1	0.3	0.3	2.6	0.8	0.7	1.7	0.9	0.8	6.7	0.8	0.1	2.2	0.4	5.3	8.4	0.3	0.6	0.5	0.9	0.0	1.3	5.9	0.6	3.2	0.3	0.6	2.2	1.1	4.4	0.8	4.3	0.3	0.3	13.5	3.5	2.0	0.3	13.6	4.1	0.8	10.9	1.4	0.7	0.0	0.6	4.1	0.0	8.1	18.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	8.0	15.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.0	1.8	0.0	15.9	1.7	0.0	0.0	1.5	0.0	0.2	8.1	0.0	0.6	18.4	1.5	0.6	0.4	0.3	1.2	0.8	0.1	0.3	0.6	0.6	0.3	0.0	0.0	2.2	0.3	8.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.3	0.0	0.0	0.2	0.4	2.8	0.3	67.9	0.0	1.6	0.0	0.0	8.6	1.0	0.0	0.3	5.8	10.1	30.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.2	7.3	0.1	15.8	0.0	0.1
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216908-1232031	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		720000	"Golgi apparatus"		"CAB015227: , HPA011249: AB_2668468, HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	34.7	36.0	17.9	37.3	22.7	19.7	56.3	20.6	33.2	30.3	49.9	21.3	46.6	48.5	35.5	53.4	26.2	26.9	57.5	50.8	18.7	18.5	36.3	73.8	55.8	46.2	19.7	21.3	33.1	56.4	25.9	31.1	47.9	18.2	30.3	25.6	26.5	46.7	52.1	30.7	25.5	56.2	27.6	18.0	33.8	32.9	30.0	18.1	20.5	35.1	28.5	19.6	28.5	44.8	11.5	16.0	20.6	15.9	19.6	22.0	7.0	28.5	26.0	14.3	45.5	70.3	35.5	17.2	56.0	51.3	41.2	34.6	30.6	49.9	18.1	43.5	53.9	29.6	29.4	16.4	24.5	12.6	30.3	27.8	31.6	40.0	42.7	32.3	31.9	42.9	43.6	12.7	31.0	17.6	40.4	32.9	12.1	26.0	48.0	20.2	20.6	15.7	32.2	13.1	32.7	34.9	17.5	18.5	47.9	27.3	13.8	52.2	18.5	37.2	44.4	36.8	13.3	23.0	36.6	41.7	42.6	23.1	32.0	31.8	29.6	28.0	29.7	48.4	60.1	18.4	10.4	14.9	20.6	15.0	9.9	11.6	9.4	21.5	22.0	16.0	11.5	12.4	10.7	12.7	19.6	15.9	10.0	16.5	7.0	17.9	22.7	20.6	33.2	18.7	18.5	19.7	21.3	18.2	18.1	20.8	19.2	50.4	64.0	106.5	33.8	30.8	56.0	16.0	25.0	47.1	17.7	104.0	10.0	70.2	29.0	70.3	256.4	46.7	61.6	264.7	99.3	86.2	35.7	97.8	110.9	36.5	63.0	72.4	62.0	26.3	88.3	73.0	158.6	49.5	146.7	55.9	64.2	189.4	71.5	48.8	31.8	58.2	99.4	77.0	64.5	99.9	140.5	71.0	158.0	55.0
B3GALT6	beta3GalT6	ENSG00000176022	"Beta-1,3-galactosyltransferase 6"	Q96L58	1	1232265-1235041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.76e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-2)"	12.2	9.4	13.4	9.9	11.7	3.0	10.2	10.3	17.2	10.0	7.5	11.1	9.5	7.2	11.9	9.3	7.7	11.9	7.1	12.6	13.7	12.9	9.8	19.5	10.1	12.3	9.4	7.9	11.4	14.7	14.1	10.4	12.3	10.4	9.6	6.0	11.4	9.9	8.7	9.6	13.4	7.0	9.3	8.4	12.9	9.2	8.4	10.8	14.7	10.1	7.0	7.7	8.2	9.0	5.2	5.1	2.9	4.1	6.0	6.6	2.2	10.6	5.4	9.3	9.7	9.4	6.4	7.2	11.4	9.7	9.6	7.8	4.8	10.9	8.0	6.8	6.7	8.3	9.6	4.0	6.1	5.9	14.0	15.2	14.8	5.4	4.5	9.7	9.1	9.4	5.9	4.5	6.3	6.2	5.8	7.2	9.3	10.3	7.2	9.7	6.1	12.4	16.5	12.0	11.2	20.5	11.9	3.7	6.5	9.4	3.3	38.3	15.7	8.4	10.0	5.7	5.7	8.4	13.2	7.7	9.9	4.4	6.2	16.3	4.5	3.8	7.3	7.8	20.6	11.2	2.9	2.8	0.9	3.8	3.5	6.6	3.1	3.9	4.5	3.8	5.2	3.4	4.1	1.4	6.0	4.1	5.1	1.6	2.2	13.4	11.7	10.3	17.2	13.7	12.9	9.4	7.9	10.4	10.8	11.9	6.9	8.3	19.2	7.4	12.1	6.4	7.6	2.7	3.4	12.2	3.9	1.4	6.6	7.4	0.4	9.6	1.6	0.0	10.7	3.0	6.2	12.4	0.0	10.5	6.3	19.1	5.8	7.4	7.5	0.9	2.6	7.2	1.7	1.0	3.9	8.2	9.0	0.0	3.9	9.9	8.3	0.0	6.2	1.4	2.7	11.0	1.1	6.9	4.4	9.5
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 11.0;skin 1: 7.8"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 10.0;Proximal tubular cells: 37.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6;NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"EFO-21: 8.3;U-2 OS: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	38200000		Vesicles		"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.0	0.0	0.5	0.2	0.0	0.0	0.5	0.2	0.2	0.1	3.4			11.0	0.1	0.0	1.2	0.2	0.1	0.2	0.0	1.0	3.1	0.2	0.1	0.0	0.1		0.0	0.0	0.0	0.1	0.3		0.0	1.2		0.4	0.0	0.1	7.8	10.4	0.1	0.2	0.0	0.3	2.4			0.2		0.1	0.0	0.4	0.3	0.6	2.6	0.3	2.2	0.4	0.2	0.3	0.0	0.0	0.6	0.4	0.1	1.6	1.1	0.0	0.1	0.0	0.6	0.4	0.1	8.3	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.1	0.9	0.6	0.1	0.3	0.0	1.3	0.0	0.0	1.2	0.3	0.0	0.0	0.7	0.0	0.6	0.1	0.0	0.0	8.2	0.1	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.6	0.3	0.4	0.0	2.6	2.2	0.3	0.0	0.0	0.2											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.2	0.0	0.0	0.0	0.0	0.7	10.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	37.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
UBE2J2	"NCUBE2, Ubc6p"	ENSG00000160087	"Ubiquitin conjugating enzyme E2 J2"	Q8N2K1	1	1253909-1273885	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 350.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.46e-2)"	24.4	22.2	17.5	21.6	17.1	19.4	33.0	23.8	24.9	17.8	22.0	17.9	19.9	22.0	22.9	21.4	25.2	21.8	20.7	21.2	17.5	17.1	21.6	27.3	17.4	27.4	15.9	15.4	19.4	36.3	14.4	22.8	22.6	15.9	16.9	16.2	18.7	24.2	20.2	29.8	23.2	23.6	19.3	13.1	25.2	22.2	68.3	12.8	26.1	22.8	21.7	23.8	18.3	19.3	24.5	22.3	39.6	23.0	22.0	25.3	17.7	25.7	10.7	15.3	14.6	12.4	12.8	11.9	19.9	15.8	27.2	19.9	19.0	18.8	13.9	21.3	18.4	15.0	18.8	15.5	19.8	21.7	23.5	27.8	20.9	21.0	17.1	24.1	19.1	20.1	12.0	11.1	21.3	15.9	14.9	19.1	19.0	28.8	13.8	15.7	12.8	27.7	21.5	16.5	17.0	26.9	25.8	14.2	22.9	14.1	8.7	56.4	27.9	13.7	29.6	31.4	14.5	15.2	21.8	15.6	16.5	15.8	19.1	20.3	30.4	29.5	38.8	21.2	30.4	13.0	38.2	23.0	39.6	22.0	22.2	20.1	24.5	23.4	22.8	22.3	21.7	21.2	20.9	32.6	22.0	21.3	20.8	25.3	17.7	17.5	17.1	23.8	24.9	17.5	17.1	15.9	15.4	15.9	12.8	8.9	15.9	25.3	40.7	37.9	27.4	16.7	33.1	6.7	21.6	27.9	7.9	59.9	48.0	58.6	187.2	33.6	39.3	0.0	81.4	63.5	40.5	45.1	16.1	24.1	46.5	22.3	16.8	23.9	23.0	350.9	34.8	33.1	38.8	45.1	36.5	29.9	79.3	31.6	35.3	57.4	25.4	32.3	40.3	121.4	83.7	38.1	73.0	44.7	38.2	51.2
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 delta subunit"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 9.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.4"									HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavorable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	3.2	3.8	4.0	1.9	5.1	3.6	1.2	12.8	6.3	1.7	2.0			7.0	3.2	1.1	1.1	3.9	1.5	1.5	4.1	3.3	1.4	3.2	1.5	2.5	3.1		4.6	3.0	0.8	5.9	1.3		2.3	0.2		8.6	2.4	3.9	4.6	5.1	1.0	3.2	3.8	2.4	10.2			1.3		0.7	0.7	1.8	0.5	0.9	0.0	0.2	0.0	0.8	0.2	0.6	5.0	2.0	5.2	1.4	0.8	0.9	3.3	1.0	1.7	1.9	0.9	2.8	3.6	1.8	1.5	2.5	0.8	0.9	0.8	0.3	6.7	3.1	0.4	6.0	1.3	1.4	0.1	3.6	2.3	1.1	2.6	0.0	2.2	0.5	6.5	2.4	8.5	0.4	1.8	1.4	2.4	1.0	0.6	3.7	9.3	0.4	0.8	0.8	0.2	2.7	3.8	1.4	1.5	2.2	0.8	6.6	1.8	1.4	3.2	2.7	5.0	1.1	11.4	0.7	2.9	2.9	6.1	3.6	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.2											3.0	2.9	0.0	0.2	0.7	3.2	4.0	0.0	2.7	2.3	0.0	3.9	0.1	0.0	0.4	9.6	0.0	1.7	0.0	0.4	0.2	1.0	0.1	2.3	2.1	0.3	4.8	1.2	0.6	0.6	3.2	0.9	0.9	0.0	0.0	0.2	2.0	1.2	3.5	1.8	0.6	2.5	0.0	0.9	1.8	2.1	1.4	0.0	0.0	0.6	0.3
ACAP3	"CENTB5, KIAA1716"	ENSG00000131584	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3"	Q96P50	1	1292376-1309609	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 148.4;Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049317, HPA058381"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA049317: AB_2680710, HPA058381: AB_2683699"	"unprognostic (5.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	8.7	7.8	16.4	4.2	24.5	10.4	7.3	42.0	23.6	6.4	6.4	11.5	4.3	7.9	5.9	4.2	10.6	3.7	5.1	7.9	19.5	8.7	4.8	4.9	4.7	4.0	13.0	15.4	5.5	8.2	5.1	11.2	4.3	10.4	5.8	3.4	5.6	14.6	7.7	14.2	26.5	7.7	11.8	8.1	6.0	8.0	3.1	12.8	3.1	2.7	4.5	3.5	5.6	6.4	0.9	1.2	1.5	2.0	0.0	1.4	0.7	5.3	6.0	2.8	4.8	7.1	4.9	3.0	13.5	4.4	3.9	3.0	7.6	4.6	5.9	7.0	7.5	3.9	12.3	2.7	3.6	0.9	6.6	12.0	2.5	22.3	14.3	4.9	5.0	6.2	3.4	2.9	3.3	2.1	3.6	1.8	7.0	6.8	8.2	4.4	7.4	10.5	7.2	2.9	7.2	14.0	10.2	6.4	22.7	2.3	2.9	21.4	15.1	8.1	5.0	12.7	2.6	5.4	3.9	5.9	7.3	5.1	5.8	4.7	6.6	4.7	5.1	10.1	13.3	3.1	0.0	1.4	1.5	1.3	2.0	0.0	0.9	1.0	0.6	1.2	0.8	1.4	1.2	0.2	0.0	1.4	1.0	0.5	0.7	16.4	24.5	42.0	22.1	19.5	8.7	13.0	15.4	10.4	12.8	0.0	6.6	10.0	5.2	28.5	148.4	22.4	17.8	2.7	1.2	1.8	98.2	7.4	3.3	8.2	1.9	6.3	12.4	0.0	4.3	6.8	9.1	4.9	0.0	12.1	6.2	50.9	31.0	14.1	19.0	5.8	14.1	8.3	8.5	1.0	11.9	23.8	9.6	9.5	12.4	5.9	208.8	6.5	14.3	4.2	9.5	29.9	8.5	10.2	10.9	8.1
PUSL1	FLJ90811	ENSG00000169972	"Pseudouridylate synthase-like 1"	Q8N0Z8	1	1308567-1311677	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032057, HPA039999"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA032057: AB_10601251, HPA039999: AB_2676792"	"unprognostic (2.04e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (7.55e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (1.62e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-1)"	7.6	11.7	8.0	8.8	6.8	8.8	9.1	9.4	9.2	13.6	9.2	9.8	15.4	9.9	11.2	14.4	17.1	9.1	10.3	9.2	7.9	6.0	9.5	16.2	7.1	7.8	12.2	6.8	11.4	19.5	6.2	13.2	8.0	6.6	12.4	5.0	9.5	23.3	13.7	11.0	17.0	9.6	7.5	6.5	8.8	11.4	8.3	7.7	9.0	10.6	16.7	11.9	10.9	9.8	9.0	11.3	5.8	16.6	8.1	13.4	7.8	10.1	4.6	4.6	7.9	2.2	3.6	6.3	9.2	5.1	9.1	6.1	15.8	6.7	6.2	7.5	4.5	3.8	8.4	5.1	8.4	1.6	6.9	33.9	8.6	8.3	9.4	8.6	10.2	8.3	3.5	4.4	5.0	3.8	2.5	4.1	8.7	11.0	2.9	4.2	8.3	9.6	13.3	6.3	8.6	20.3	8.9	3.5	14.7	7.0	3.9	21.5	7.9	7.2	21.6	7.3	2.2	6.0	6.8	4.8	5.9	6.1	9.6	8.7	11.4	3.6	26.4	7.3	9.3	3.5	3.6	12.3	5.8	10.6	16.6	10.6	8.9	11.6	8.7	11.3	9.0	7.7	7.7	4.9	8.1	14.0	7.1	13.4	7.8	8.0	6.8	9.4	9.2	7.9	6.0	12.2	6.8	6.6	7.7	0.0	4.0	8.2	8.8	19.6	7.5	1.6	10.2	6.7	6.8	7.0	5.9	21.2	10.0	20.2	7.7	6.7	10.5	0.0	20.2	34.1	10.4	13.7	6.9	8.9	18.2	3.2	5.1	3.1	9.7	11.8	8.1	8.9	6.8	5.4	10.0	3.4	20.9	8.6	10.6	14.0	7.5	0.0	9.5	17.4	16.4	16.8	28.8	12.8	11.3	16.9
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324691	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 66.8;Extravillous trophoblasts: 54.3;monocytes: 63.1;Syncytiotrophoblasts: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	21.4	22.5	22.8	25.4	24.9	23.2	26.9	50.8	30.4	26.5	31.2	32.1	24.1	29.1	33.1	39.8	25.3	39.1	24.8	29.8	23.7	19.8	23.5	26.7	19.7	25.7	25.9	25.8	34.1	33.5	24.1	26.9	25.8	21.0	29.5	19.9	20.4	33.8	28.0	52.8	28.6	25.4	34.0	20.0	27.3	27.9	57.8	25.9	28.5	23.3	23.5	22.5	27.5	25.7	24.6	37.7	22.0	42.2	28.4	35.2	32.4	21.3	22.1	12.5	23.9	21.5	17.5	13.5	11.8	19.8	27.4	20.3	19.9	27.1	24.0	17.1	24.0	16.6	15.7	18.5	26.4	12.2	22.4	24.2	18.4	30.1	26.7	33.1	14.5	20.3	29.5	14.4	25.0	37.6	15.7	28.7	23.6	21.8	21.8	13.5	19.3	28.7	19.8	15.2	20.6	23.8	22.6	11.8	34.4	19.2	10.9	17.6	16.3	11.9	32.2	33.5	10.1	17.3	21.3	20.5	17.1	15.5	19.4	15.0	34.2	36.6	31.1	23.9	25.9	8.4	22.0	32.3	20.8	31.7	37.2	33.8	24.6	28.1	29.3	37.7	20.3	26.5	24.9	15.3	28.4	42.2	24.5	35.2	32.4	22.8	24.9	50.8	30.4	23.7	19.8	25.9	25.8	21.0	25.9	35.7	28.9	0.0	0.0	0.0	0.0	0.0	0.0	26.8	23.9	17.4	0.0	66.8	26.6	47.9	0.0	0.0	0.0	0.0	46.7	54.3	0.0	0.0	9.3	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	63.1	0.0	0.0	47.3	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	64.4	0.0	0.0	0.0
CPTP	"GLTPD1, MGC10334"	ENSG00000224051	"Ceramide-1-phosphate transfer protein"	Q5TA50	1	1324756-1328897	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056832	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA056832: AB_2683251"	"unprognostic (9.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.27e-2)"	9.8	8.7	8.0	9.2	7.6	3.7	8.1	7.2	13.8	10.7	14.9	6.0	12.0	21.4	7.0	21.9	20.5	6.1	9.6	43.1	9.3	5.8	19.1	38.9	6.8	9.0	8.1	7.2	6.4	14.5	9.0	3.7	10.4	9.2	8.4	6.2	5.3	46.4	15.0	51.7	13.9	21.1	4.3	5.7	13.4	15.7	28.2	4.8	12.0	8.8	18.4	13.7	6.6	10.2	4.9	1.8	8.6	1.9	1.8	7.6	1.9	18.8	6.8	3.3	6.0	3.2	2.7	5.4	10.0	5.3	9.4	6.2	9.2	10.6	7.5	11.6	4.5	6.2	14.1	2.6	5.8	3.5	8.9	9.1	5.6	7.3	9.2	8.1	5.3	5.7	5.2	4.6	9.9	2.8	4.7	5.0	4.9	8.2	4.5	3.1	6.9	5.9	6.3	3.0	4.9	30.3	7.4	5.5	21.6	7.6	5.0	7.8	8.2	8.0	25.3	17.0	1.8	9.0	3.7	8.4	10.1	7.1	11.0	8.1	10.0	7.6	7.8	9.7	8.0	3.0	2.9	1.9	8.6	2.6	1.0	1.5	4.9	3.2	2.5	1.3	1.9	1.9	1.5	2.7	1.8	1.8	1.8	7.6	1.9	8.0	7.6	7.2	13.8	9.3	5.8	8.1	7.2	9.2	4.8	0.0	2.7	4.5	8.0	0.0	9.0	20.5	5.1	0.0	2.3	7.0	0.0	16.1	33.2	22.4	50.8	7.5	50.3	0.0	21.2	17.4	2.9	9.5	0.0	25.1	14.5	22.3	5.8	12.3	5.7	124.6	11.2	3.0	0.0	19.8	18.5	16.0	34.5	10.5	9.2	13.5	6.2	12.9	2.0	9.4	5.3	0.0	16.4	6.9	21.5	7.5
TAS1R3	T1R3	ENSG00000169962	"Taste 1 receptor member 3"	Q7RTX0	1	1331314-1335306	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.2;salivary gland: 17.9"	"Group enriched"	"Detected in some"	16	"Cardiomyocytes: 3.1;Muller glia cells: 1.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.9"	"Cell type enriched"	"Detected in single"	37	"memory B-cell: 5.2"	"Lineage enriched"	"Detected in single"	37	"B-cells: 5.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA053439	Uncertain					NA	NA					"HPA053439: AB_2682150"	"unprognostic (1.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.59e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-1)"	0.4	0.4	0.4	1.5	0.4	0.5	0.4	1.9	0.4	0.6	1.4	0.4	1.0	2.0	0.5	35.2	1.9	0.6	0.7	1.4	0.4	0.1	0.5	1.6	0.9	1.6	0.4	0.4	0.4	0.4	0.1	2.6	1.9	0.4	0.4	0.1	0.4	17.9	0.4	1.4	0.2	3.2	0.4	0.4	6.4	0.9	1.6	0.4	0.4	0.8	1.5	2.5	1.0	0.9	5.2	0.1	0.0	0.0	0.0	0.1	0.2	1.4	1.3	0.4	0.5	0.0	0.0	0.7	0.7	0.2	0.2	0.2	0.9	2.9	1.8	0.3	0.0	0.3	0.6	0.0	0.0	0.0	3.7	1.0	0.2	2.6	0.9	0.3	0.0	0.5	0.1	0.2	0.1	0.0	0.3	0.0	0.8	0.5	6.0	0.0	0.9	0.3	0.6	0.8	0.5	3.5	1.0	0.7	0.8	0.0	0.2	2.3	0.4	0.5	2.3	1.9	0.3	2.0	0.4	0.3	0.5	0.2	1.8	0.8	3.7	3.5	0.9	0.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	1.9	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DVL1		ENSG00000107404	"Dishevelled segment polarity protein 1"	O14640	1	1335276-1349350	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"PC-3: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011538, HPA073607"	Approved					NA	NA					"CAB011538: AB_2093326, HPA073607: "	"unprognostic (2.67e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.81e-3)"	"unprognostic (5.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-2)"	13.2	14.1	18.8	7.7	17.1	5.9	12.5	13.9	25.7	8.4	10.4	13.3	12.2	17.9	9.4	8.0	15.4	11.6	8.0	21.4	18.1	11.9	8.0	12.2	9.6	6.2	12.7	17.3	12.5	34.3	10.3	10.6	10.0	13.5	10.8	4.7	7.3	36.5	10.4	120.4	17.0	16.1	12.7	11.8	9.3	18.3	15.0	12.2	2.8	9.0	13.9	6.8	9.8	17.5	2.1	2.0	0.9	2.1	0.8	1.6	0.6	25.7	13.4	5.5	11.7	5.3	6.6	13.6	15.9	7.6	12.6	6.3	10.3	32.7	8.3	24.0	7.0	6.9	16.0	4.3	16.1	1.9	10.0	25.2	4.6	23.9	18.6	11.5	7.1	7.3	5.6	9.9	16.8	11.5	10.7	4.3	11.1	17.9	5.8	5.1	10.4	6.9	11.9	8.7	9.3	51.3	11.8	4.3	14.2	9.2	4.1	21.5	14.7	7.6	20.8	21.0	2.1	11.5	12.1	8.4	7.2	18.5	27.5	26.4	9.3	3.7	10.0	21.1	10.1	4.5	0.9	2.1	0.1	1.6	1.8	1.5	2.1	1.3	1.3	0.7	0.3	1.4	0.7	0.8	0.8	1.2	2.0	0.9	0.6	18.8	17.1	13.9	25.7	18.1	11.9	12.7	17.3	13.5	12.2	17.9	11.3	3.2	4.5	12.2	32.0	19.1	10.2	6.7	7.9	7.0	5.9	9.1	3.3	9.5	0.8	10.3	19.1	0.0	17.4	11.3	7.6	12.8	1.1	17.4	4.4	30.2	11.6	6.7	4.1	1.1	12.0	4.0	6.8	1.8	16.9	20.4	34.3	16.9	9.9	4.4	20.9	12.9	7.8	16.2	12.2	13.6	9.5	3.1	18.7	8.9
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Extravillous trophoblasts: 236.0;Fibroblasts: 92.6;Leydig cells: 163.1;Peritubular cells: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"naive CD8 T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.7;BJ: 50.0;BJ hTERT+: 23.5;fHDF/TERT166: 24.8;HHSteC: 15.7;HSkMC: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		450000	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	45.6	5.3	2.3	11.4	4.6	1.1	25.2	3.9	3.8	34.8	14.3	4.8	6.2	6.5	34.0	16.3	13.7	14.4	20.5	12.7	3.6	1.1	7.6	3.5	13.4	5.6	2.6	2.6	30.4	3.7	1.6	6.0	25.0	5.4	23.4	2.3	36.6	8.4	12.3	15.5	10.9	8.6	22.0	4.5	9.5	8.7	16.4	2.9	0.3	13.9	11.8	4.5	22.3	17.8	0.0	0.0	0.0	0.0	0.0	9.8	0.3	1.3	0.3	0.4	0.3	6.0	16.7	15.1	50.0	23.5	5.9	7.0	2.7	1.1	0.5	0.2	24.8	0.0	1.0	0.3	0.0	1.1	1.0	0.4	0.4	0.9	4.2	15.7	0.0	0.5	19.9	0.0	2.2	0.0	11.1	0.0	0.3	5.8	0.5	7.4	0.1	0.1	0.1	4.9	0.1	1.6	0.2	0.1	0.1	0.0	0.2	1.1	3.1	0.1	0.5	0.0	3.6	3.9	0.2	0.4	0.2	8.3	7.7	0.2	1.1	0.1	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	9.8	0.0	0.0	0.0	0.0	0.0	0.3	2.3	4.6	3.9	2.7	3.6	1.1	2.6	2.6	5.4	2.9	3.0	0.0	0.0	0.8	9.5	0.7	3.2	0.0	0.0	0.0	8.7	0.0	5.9	0.0	4.6	1.4	1.6	0.0	0.0	0.0	236.0	92.6	0.5	0.0	0.0	8.3	0.0	0.0	9.8	0.0	6.1	163.1	1.6	10.1	1.0	0.0	44.6	0.8	0.0	172.5	1.5	1.0	12.9	36.9	0.7	5.2	9.3	24.6	0.0	0.0	0.3
AURKAIP1	"AIP, AKIP, FLJ20608"	ENSG00000175756	"Aurora kinase A interacting protein 1"	Q9NWT8	1	1373730-1375495	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Late spermatids: 2457.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031821	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA031821: AB_10601458"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.31e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.34e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.84e-1)"	26.6	29.3	30.3	19.6	30.5	20.9	16.3	17.8	40.5	14.1	27.9	18.7	18.3	33.5	14.3	18.3	25.0	14.5	22.9	55.2	25.3	23.4	35.0	59.1	14.4	17.6	29.0	23.0	14.8	41.2	16.8	18.7	23.6	21.9	17.2	13.6	20.0	35.8	20.4	115.9	20.2	29.5	15.9	18.5	16.9	24.7	73.8	12.6	16.0	27.1	41.4	20.7	18.2	15.2	53.4	81.9	82.5	67.5	36.1	61.6	59.2	38.9	23.7	13.0	23.3	11.5	14.6	24.0	23.7	15.8	37.6	26.8	41.5	36.2	20.6	35.4	16.0	18.9	28.9	17.8	31.4	10.9	24.7	50.3	16.6	31.0	38.3	22.7	21.4	22.6	19.1	14.2	26.3	10.7	11.0	20.4	19.7	32.7	28.5	21.8	29.7	26.2	76.5	24.6	24.6	67.5	30.7	16.0	44.2	29.7	10.4	41.8	31.3	17.0	59.4	56.3	8.3	25.7	50.1	15.2	23.3	29.9	27.7	34.9	37.3	34.0	43.2	32.5	31.7	15.7	60.8	67.5	70.6	51.1	53.6	48.4	53.1	53.9	53.7	58.0	53.4	50.7	49.3	82.5	36.1	46.0	81.9	61.6	59.2	30.3	30.5	17.8	40.5	25.3	23.4	29.0	23.0	21.9	12.6	44.7	60.9	130.3	137.2	144.1	107.1	195.9	180.9	89.7	56.9	157.1	60.9	351.3	573.6	261.8	1001.4	114.7	553.0	116.8	362.4	394.1	140.0	198.9	86.5	355.2	260.5	98.5	195.6	106.2	140.4	2457.2	126.0	155.3	205.8	225.4	267.9	199.3	331.2	287.5	111.4	527.2	88.0	155.2	136.5	419.6	143.7	172.8	366.4	100.2	314.0	225.6
CCNL2	"ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138"	ENSG00000221978	"Cyclin L2"	Q96S94	1	1385711-1399328	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053137	Supported		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA053137: AB_2682053"	"unprognostic (3.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.61e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (1.46e-7)"	22.2	28.4	26.7	22.2	34.5	22.9	26.7	56.3	32.5	29.1	23.8	28.2	27.9	26.7	33.9	24.0	24.1	30.1	26.4	18.7	30.3	10.7	24.5	35.5	22.6	22.8	38.6	27.1	40.7	36.6	30.9	32.1	26.3	26.9	27.9	16.6	24.1	27.5	29.4	23.4	33.4	27.4	28.2	27.7	27.9	26.8	11.1	32.9	19.5	33.5	16.1	23.3	30.2	28.8	14.9	13.7	14.3	12.4	13.7	14.6	4.9	10.6	10.8	28.6	12.7	16.1	25.1	14.5	25.0	12.7	12.3	12.3	13.7	22.4	12.9	14.6	15.8	10.9	25.6	11.6	15.7	9.2	7.9	27.9	14.3	46.0	17.9	18.9	9.4	17.0	31.3	11.4	12.4	18.5	36.7	13.5	15.7	16.8	12.4	14.3	12.2	10.1	28.6	10.5	8.4	19.7	20.2	7.5	14.8	21.2	13.5	18.5	24.1	15.9	24.6	14.3	17.4	18.9	14.3	23.4	27.9	13.5	12.3	9.7	23.9	5.1	21.6	15.1	20.2	7.6	10.4	12.4	14.3	13.1	10.0	10.3	12.7	12.1	14.6	13.7	14.9	13.3	11.9	10.8	13.7	11.8	13.3	6.8	4.9	26.7	34.5	56.3	32.5	30.3	10.7	38.6	27.1	26.9	32.9	32.8	88.6	26.2	31.6	40.4	25.5	31.1	33.1	56.2	52.4	27.9	45.2	35.8	18.3	26.5	16.2	39.6	34.6	46.7	23.1	28.2	41.7	26.2	41.6	32.0	21.6	57.2	48.6	39.3	29.2	12.1	47.5	27.9	30.4	17.2	36.8	46.4	31.4	27.1	30.8	12.2	40.6	58.2	49.5	44.0	31.9	38.5	53.3	30.5	28.1	33.5
MRPL20	FLJ10024	ENSG00000242485	"Mitochondrial ribosomal protein L20"	Q9BYC9	1	1401908-1407313	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047074	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047074: AB_10964064"	"unprognostic (4.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.64e-1)"	36.7	36.2	44.4	31.0	40.7	22.6	41.2	30.3	46.8	24.8	33.4	24.2	38.8	30.7	28.1	52.3	33.8	32.7	39.9	75.3	37.3	38.6	40.1	48.8	31.5	59.7	39.9	31.4	26.5	72.8	28.4	36.3	27.2	35.6	35.1	33.1	29.1	50.5	47.7	121.8	27.3	28.9	44.5	39.1	30.5	33.6	27.7	29.7	22.8	34.3	54.8	35.9	27.1	26.9	50.6	77.5	37.5	52.1	40.5	59.9	51.7	39.6	38.5	28.9	29.2	22.3	24.3	21.3	35.6	27.3	46.4	33.3	45.7	48.6	42.5	50.0	30.5	21.7	25.4	47.1	38.4	36.1	36.7	66.6	45.9	67.7	44.9	31.0	67.4	29.7	28.3	14.9	35.6	38.4	27.0	34.3	40.7	46.3	25.4	38.9	39.8	51.8	51.5	30.0	46.4	77.9	34.5	26.7	54.1	36.2	26.7	51.4	42.4	33.9	71.0	52.2	25.3	30.4	50.0	29.3	28.4	33.0	42.4	43.9	39.0	55.4	82.8	43.8	54.9	19.7	27.8	52.1	37.5	46.8	49.1	52.4	50.6	52.3	46.4	53.2	47.5	59.9	57.3	24.1	40.5	37.7	77.5	45.0	51.7	44.4	40.7	30.3	46.8	37.3	38.6	39.9	31.4	35.6	29.7	62.5	114.8	142.1	105.7	115.6	77.1	229.7	152.8	116.4	110.3	153.5	33.4	194.5	449.3	166.0	28.9	116.1	135.5	210.2	283.0	213.3	100.7	167.9	100.8	326.9	195.7	47.7	132.8	120.3	122.8	28.2	99.8	123.4	131.6	174.1	154.0	179.7	210.2	161.2	104.3	475.5	87.1	64.7	124.6	122.1	210.0	137.9	189.1	99.7	179.2	143.3
ANKRD65		ENSG00000235098	"Ankyrin repeat domain 65"	E5RJM6	1	1418420-1421769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;fallopian tube: 33.6"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"myeloid DC: 4.8;plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 10.4"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.3;RT4: 20.0;SCLC-21H: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065720	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065720: AB_2685545"	"unprognostic (2.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.64e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.76e-2)"	4.6	1.1	12.4	2.8	20.8	0.4	4.2	8.0	13.3	6.7	4.8	21.0	3.7	2.2	4.0	5.6	6.7	33.6	2.7	2.2	12.0	8.6	1.9	0.9	9.9	7.1	37.8	8.2	6.9	13.3	1.1	0.6	6.3	13.7	8.9	1.8	2.1	14.0	21.2	2.8	4.8	2.1	3.8	16.7	1.4	4.3	3.1	28.0	4.2	1.8	1.0	6.3	13.2	3.3	0.5	10.4	0.3	0.3	0.0	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.5	0.0	2.6	0.2	2.5	0.0	0.3	0.2	0.0	0.0	20.3	0.5	0.0	0.0	0.2	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	2.7	0.0	0.0	20.0	27.7	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	4.8	0.5	0.1	0.4	0.0	0.0	0.0	10.4	0.0	0.2	12.4	20.8	8.0	13.3	12.0	8.6	37.8	8.2	13.7	28.0	20.8	25.3	0.0	11.4	1.9	8.4	0.6	12.7	56.2	20.5	1.8	0.0	21.2	8.3	12.9	0.0	5.0	0.0	0.0	27.8	0.4	3.8	7.3	8.1	0.6	2.0	7.9	1.7	1.8	0.6	0.0	19.2	2.9	3.3	1.8	0.0	16.0	12.0	0.0	27.3	0.3	2.2	0.0	2.6	0.4	0.3	2.8	14.1	0.0	0.0	7.9
TMEM88B		ENSG00000205116	"Transmembrane protein 88B"	A6NKF7	1	1426128-1427787	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 36.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 9.2;SCLC-21H: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065743	Enhanced					NA	NA					"HPA065743: AB_2685552"	"unprognostic (3.17e-2)"	"unprognostic (1.42e-2)"		"unprognostic (1.63e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.30e-5)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"			"unprognostic (3.53e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.95e-2)"	1.1	1.1	10.2	1.4	24.7	1.2	1.1	1.0	23.3	1.1	1.1	34.0	0.0	1.1	1.1	1.1	1.1	1.4	1.3	1.2	19.6	8.3	1.5	1.1	1.4	1.2	30.8	11.2	1.1	1.1	1.1	0.0	1.2	16.1	1.3	1.1	0.0	1.1	1.1	1.1	1.7	1.1	1.1	36.9	1.1	1.3	2.4	28.5	0.0	1.1	0.0	1.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	24.7	1.0	20.6	19.6	8.3	30.8	11.2	16.1	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VWA1	"FLJ22215, VWA-1, WARP"	ENSG00000179403	"Von Willebrand factor A domain containing 1"	Q6PCB0	1	1434861-1442882	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 125.2"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 241.9;Syncytiotrophoblasts: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 16.0;CACO-2: 16.2;CAPAN-2: 48.0;EFO-21: 15.4;Hep G2: 28.6;SCLC-21H: 17.0;T-47d: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		190000				"unprognostic (2.78e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.52e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (6.71e-2)"	13.9	6.4	13.1	17.5	16.2	1.3	9.4	2.7	19.6	12.4	26.3	46.1	34.8	9.4	18.1	13.9	15.7	13.2	15.6	8.9	17.5	9.5	14.0	71.3	13.6	9.0	22.4	12.1	13.9	23.2	5.0	5.1	23.9	15.7	47.0	4.2	11.4	23.9	125.2	6.0	8.6	8.9	34.7	29.8	4.7	17.8	11.8	21.5	0.4	16.6	3.9	4.9	30.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	5.4	0.7	5.5	0.1	0.5	8.7	1.0	0.0	0.8	0.0	16.2	48.0	0.0	15.4	0.4	1.8	4.2	5.6	2.8	0.1	1.0	3.9	0.5	0.0	28.6	1.3	0.0	1.9	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	4.0	0.0	0.3	2.1	5.6	1.5	0.2	0.3	0.7	0.9	2.7	17.0	2.6	0.0	14.8	1.9	1.4	21.6	0.2	0.5	0.0	0.2	0.1	5.2	0.1	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	16.2	2.7	19.6	17.5	9.5	22.4	12.1	15.7	21.5	17.9	29.7	1.4	20.2	5.8	5.1	3.4	17.8	12.0	15.9	50.6	3.9	241.9	6.6	64.8	0.4	55.0	8.6	0.0	57.3	79.4	13.4	33.7	1.1	43.2	19.6	14.3	12.0	7.4	0.6	1.5	31.7	1.4	23.6	4.6	7.2	53.6	40.5	9.0	55.5	5.0	3.9	6.5	13.2	0.5	1.9	7.4	242.8	0.0	6.7	15.4
ATAD3C	FLJ34599	ENSG00000215915	"ATPase family, AAA domain containing 3C"	Q5T2N8	1	1449689-1470158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 17.5;Collecting duct cells: 19.2;Distal tubular cells: 38.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 16.5"									HPA065305			Approved	Mitochondria		NA	NA			Mitochondria		"HPA065305: AB_2685459"	"unprognostic (9.23e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.79e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.12e-3)"	0.7	0.0	2.1	1.7	2.3	0.7	2.7	0.3	1.5	1.3	1.8			0.9	1.4	2.6	0.7	2.5	1.3	0.4	2.8	1.5	3.1	4.9	2.2	0.7	2.6		1.1	5.0	0.1	1.5	0.3		4.0	0.6		5.4	4.5	0.2	1.2	0.5	1.3	4.3	0.5	0.5	0.7			4.1		0.9	2.2	0.9	2.1	0.6	2.9	0.6	1.6	4.3	0.7	0.3	0.0	0.3	0.5	0.5	0.1	0.4	0.1	0.1	0.2	0.1	1.6	3.3	0.3	0.4	0.1	0.1	0.4	1.3	0.5	0.1	0.1	1.3	0.3	0.9	2.0	0.2	0.3	0.3	0.0	0.2	0.2	1.0	0.1	0.0	0.4	0.3	3.9	0.1	0.9	0.5	1.0	0.6	0.1	0.2	0.4	0.1	16.5	1.1	0.4	2.8	1.0	0.0	0.6	0.2	3.0	3.6	0.3	0.3	0.2	0.3	0.5	0.2	1.9	2.7	0.6	0.2	0.4	0.1	2.9	0.6	1.1	1.1	0.4	4.3	2.1	1.5	1.3	0.1	1.3	1.9	1.4	2.5	1.6	0.3	0.6	2.0	0.7											6.0	17.5	0.8	3.2	3.1	4.3	3.3	0.0	1.4	3.4	19.2	15.7	0.7	38.1	4.6	0.3	3.6	0.6	0.0	8.0	0.2	1.0	3.5	3.5	5.9	1.6	6.4	4.1	3.1	2.1	1.1	1.1	1.3	3.3	0.0	1.6	2.8	4.5	0.0	4.6	10.8	8.0	0.0	1.0	0.5	0.9	5.0	0.7	2.9	1.2	2.2
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family, AAA domain containing 3B"	Q5T9A4	1	1471769-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	13.7	7.6	7.5	18.9	9.5	24.3	10.4	11.6	10.8	7.4	9.6	8.7	8.2	12.1	10.0	7.0	11.3	8.1	8.4	6.4	7.5	6.5	9.9	14.5	9.8	17.3	9.5	8.1	10.1	16.5	3.2	13.6	10.3	7.6	11.0	3.8	8.8	16.3	16.5	9.9	15.8	12.3	8.8	6.8	14.5	15.4	9.3	8.2	7.9	9.3	6.6	13.1	5.9	10.0	0.3	0.8	1.4	3.7	0.2	2.0	0.5	6.9	0.0	2.1	11.6	0.6	0.9	15.9	11.2	2.6	11.0	8.4	25.7	20.5	9.8	3.5	4.3	6.6	12.8	14.1	7.0	2.3	8.3	13.3	6.8	16.8	15.7	2.6	11.3	8.0	2.5	0.4	18.1	1.1	0.2	3.8	3.2	20.2	2.2	4.0	3.5	13.4	13.2	22.6	4.6	25.7	10.8	3.4	7.1	3.2	4.6	8.9	7.2	8.3	10.7	9.5	1.4	1.6	4.0	4.7	3.0	6.4	17.4	11.8	6.4	8.8	23.8	9.5	18.8	3.3	0.0	0.7	1.4	1.6	3.7	2.0	0.3	1.0	1.4	0.8	0.0	0.3	0.1	0.0	0.2	1.9	0.5	0.0	0.5	7.5	9.5	11.6	10.8	7.5	6.5	9.5	8.1	7.6	8.2	6.0	26.1	12.0	6.7	23.4	14.1	4.0	10.2	1.4	7.9	8.7	19.6	10.1	1.7	7.4	3.2	6.8	8.4	0.0	6.5	33.5	8.1	6.7	11.5	7.6	10.8	12.7	6.9	4.9	2.8	1.8	4.0	6.3	10.1	3.6	9.1	7.8	9.4	8.0	2.8	1.7	15.6	6.5	8.2	5.1	9.6	20.6	14.9	8.4	10.6	10.2
ATAD3A	FLJ10709	ENSG00000197785	"ATPase family, AAA domain containing 3A"	Q9NVI7	1	1512151-1534687	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (8.42e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (6.62e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.87e-3)"	10.8	13.9	11.2	16.3	11.3	25.0	9.3	9.3	14.8	9.2	11.0	11.1	12.5	16.4	10.4	7.6	16.8	9.3	11.9	15.9	9.2	8.2	12.9	26.7	9.7	13.9	10.5	13.3	8.5	20.4	8.1	16.6	11.3	8.3	10.7	6.2	9.6	19.5	9.5	31.1	13.3	12.2	8.9	8.5	12.4	13.0	12.7	9.1	14.0	12.4	21.1	14.3	9.3	9.4	3.3	4.7	1.3	6.2	5.1	4.0	2.1	21.1	11.9	5.3	13.5	2.7	3.2	12.6	17.5	5.2	15.5	9.4	30.5	14.6	11.7	12.1	6.9	5.7	18.1	7.4	10.3	2.6	11.2	32.0	20.4	29.3	20.4	5.1	29.3	13.1	3.7	3.4	12.5	5.2	2.0	6.7	12.9	31.8	9.0	5.5	14.9	22.0	26.8	10.8	7.1	25.6	24.0	10.0	24.2	4.2	8.9	26.7	10.5	10.8	16.5	13.7	1.9	7.2	14.5	9.1	15.8	12.3	24.1	21.3	13.5	13.2	47.1	15.4	44.0	7.0	0.2	4.0	1.3	3.3	2.9	2.5	3.3	3.8	4.0	4.7	3.0	3.4	1.5	0.1	5.1	6.2	4.4	2.8	2.1	11.2	11.3	9.3	14.8	9.2	8.2	10.5	13.3	8.3	9.1	3.0	7.0	11.9	8.0	18.1	10.3	9.5	7.6	1.4	4.5	7.0	5.9	16.8	6.6	21.0	7.6	11.1	10.0	0.0	18.2	36.3	8.9	11.6	9.2	13.1	19.8	22.3	13.2	4.3	5.0	8.2	5.2	7.7	15.1	5.4	13.0	10.2	20.6	5.8	7.4	9.7	9.0	0.0	10.3	5.4	25.6	21.2	16.5	5.3	20.7	12.2
TMEM240	"C1orf70, SCA21"	ENSG00000205090	"Transmembrane protein 240"	Q5SV17	1	1535174-1540453	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 3.4;Peritubular cells: 2.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.5;HHSteC: 9.1;SCLC-21H: 10.8;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066721	Supported					NA	NA					"HPA066721: AB_2732750"	"unprognostic (2.24e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.52e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (9.13e-2)"	"unprognostic (7.96e-3)"	"unprognostic (9.50e-4)"	"unprognostic (2.64e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.93e-1)"	3.8	4.7	10.8	1.7	17.1	0.8	1.7	24.3	21.8	4.6	5.1	1.8	0.9	1.2	9.1	2.2	1.7	4.2	2.5	3.5	12.2	7.9	1.5	0.8	2.4	1.2	5.6	10.3	10.3	2.1	3.3	3.9	3.7	5.0	4.7	1.5	2.5	4.1	7.9	6.9	2.8	2.9	5.1	2.8	2.6	1.7	2.1	4.9	0.3	1.5	0.2	0.9	2.8	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	1.0	6.7	0.7	1.2	5.0	1.5	4.1	2.2	4.3	2.4	0.0	0.4	0.8	0.8	2.1	0.3	2.4	0.1	0.2	0.7	4.1	9.5	0.5	3.1	1.2	9.1	0.0	0.9	6.2	1.9	1.5	0.3	5.1	4.4	0.6	1.3	0.3	0.1	0.2	0.6	0.8	4.2	0.1	1.5	3.8	1.2	0.9	0.4	0.0	10.8	13.2	1.4	0.5	4.3	0.1	0.6	0.0	2.2	0.6	1.9	0.8	1.9	2.0	0.5	0.5	2.3	2.7	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	17.1	24.3	16.5	12.2	7.9	5.6	10.3	5.0	4.9	0.0	0.0	0.0	0.2	0.0	3.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	3.2	0.0	1.3	0.0	0.0	1.1	0.0	0.0	0.0	0.9	3.4	0.1	0.0	2.1	0.0	0.5	6.5	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.1
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574869	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 520.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	44.1	32.5	48.0	33.6	51.5	29.3	73.9	42.3	51.5	37.2	40.1	25.4	39.3	41.3	32.6	51.8	45.7	46.2	35.3	44.4	40.7	42.5	38.0	50.9	37.5	49.0	39.4	39.0	38.0	61.8	33.9	39.9	35.8	36.9	33.9	35.9	34.1	54.2	35.8	107.1	36.9	40.8	35.4	35.0	41.7	38.5	28.0	28.4	37.0	50.9	45.3	36.3	30.8	42.2	35.5	30.1	62.0	28.8	20.7	46.5	28.1	41.4	26.6	19.2	29.6	33.1	32.0	19.7	36.1	28.2	31.5	32.9	24.9	48.2	42.2	19.8	28.4	30.8	32.4	31.0	29.7	30.8	35.1	36.6	26.5	23.3	39.3	37.5	33.5	23.2	28.5	25.1	33.7	32.2	26.5	29.4	25.7	45.8	32.7	24.9	36.9	38.3	53.8	33.6	40.9	40.4	30.5	31.0	59.0	34.5	12.8	35.6	24.4	24.4	62.7	106.5	34.0	32.7	29.2	22.4	30.4	19.3	34.2	30.9	39.9	47.9	52.7	31.8	53.4	14.7	37.1	28.3	53.6	25.9	28.8	31.9	35.5	34.4	30.7	30.1	33.1	42.2	34.1	62.0	20.7	25.4	19.0	46.5	28.1	48.0	51.5	42.3	51.5	40.7	42.5	39.4	39.0	36.9	28.4	26.8	71.4	136.9	121.9	165.4	98.0	80.5	117.2	36.1	37.5	96.0	19.6	178.0	247.1	62.6	202.0	95.1	177.2	0.0	92.6	189.0	93.0	151.4	60.0	123.8	125.1	106.5	136.4	90.9	152.3	520.2	97.0	118.3	158.6	91.0	137.9	96.8	78.9	168.6	80.6	258.7	57.5	58.2	97.3	81.2	147.4	192.6	205.2	116.7	134.0	129.8
FNDC10	C1orf233	ENSG00000228594	"Fibronectin type III domain containing 10"	F2Z333	1	1598012-1600096	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.9;brain: 17.2"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 1.3;Distal tubular cells: 3.3;Hofbauer cells: 4.5;Pancreatic endocrine cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.76e-2)"	1.6	16.9	10.2	2.6	7.6	4.0	2.7	6.3	17.2	2.2	2.0	2.1	0.0	3.9	1.0	1.3	8.5	1.6	3.9	1.6	10.1	16.3	2.1	0.7	3.8	3.3	9.4	8.6	2.2	1.7	0.4	6.2	2.0	17.1	0.9	1.1	4.5	2.7	1.0	0.6	10.4	2.8	1.2	5.6	3.7	3.1	6.3	1.5	0.1	6.3	2.0	2.0	3.3	1.6	0.1	2.1	4.5	2.4	0.1	1.0	0.6	0.0	2.8	2.7	8.4	5.6	1.3	3.8	6.6	1.3	10.6	0.6	2.5	11.8	0.0	7.9	3.2	0.0	1.7	0.6	1.4	0.9	0.0	2.4	0.1	2.9	6.1	1.3	2.0	19.6	1.8	6.7	0.5	0.0	1.3	0.6	7.6	5.3	0.0	1.2	12.6	1.5	6.1	11.6	3.9	4.1	0.0	0.0	6.4	3.7	0.6	12.6	10.4	7.0	10.5	6.9	1.8	0.0	6.3	1.1	0.0	2.1	4.5	0.0	2.0	0.2	0.1	0.0	4.2	3.0	0.0	2.4	4.5	0.4	1.7	0.5	0.1	0.9	1.0	2.1	0.1	1.0	0.6	0.2	0.1	2.0	0.0	0.7	0.6	10.2	7.6	6.3	17.2	10.1	16.3	9.4	8.6	17.1	1.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	1.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MIB2	"FLJ39787, skeletrophin, ZZANK1, ZZZ5"	ENSG00000197530	"Mindbomb E3 ubiquitin protein ligase 2"	Q96AX9	1	1615415-1630610	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 72.5"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 116.3;Late spermatids: 190.0;Suprabasal keratinocytes: 110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.4;SCLC-21H: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068322	Enhanced					NA	NA					"HPA068322: AB_2685973"	"unprognostic (3.93e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.01e-2)"	6.4	3.9	8.7	6.4	10.0	4.5	4.7	8.8	11.5	4.8	6.9	7.1	4.7	5.3	5.1	5.4	11.4	4.1	3.7	6.1	9.1	7.9	5.5	6.2	5.1	3.7	5.3	7.1	5.8	7.0	3.7	9.4	4.0	5.7	4.7	3.7	6.6	5.4	6.5	72.5	9.6	4.6	5.4	3.4	9.0	8.5	5.2	5.8	7.4	5.9	9.7	4.1	4.5	4.1	2.9	9.2	1.9	0.1	7.3	4.7	1.0	6.6	0.9	0.4	1.5	1.8	0.6	9.3	3.1	1.4	1.0	2.3	1.3	1.7	0.7	4.5	0.9	0.4	13.4	0.5	2.1	0.0	3.5	5.7	0.5	1.9	1.3	2.4	0.8	2.2	1.4	1.4	0.6	0.2	0.6	0.5	3.1	2.7	1.2	0.3	1.0	3.6	8.4	1.2	1.7	10.6	6.2	1.9	9.1	0.1	0.8	14.3	5.2	5.3	0.8	5.1	0.3	1.0	3.3	0.6	1.0	2.2	5.2	0.9	6.9	2.0	1.8	2.4	2.7	1.1	0.0	0.1	1.9	4.3	0.1	4.3	2.6	3.3	4.7	0.0	2.9	3.9	2.9	0.5	7.3	0.0	9.2	2.3	1.0	8.7	10.0	8.8	11.5	9.1	7.9	5.3	7.1	5.7	5.8	0.0	9.6	13.2	14.2	116.3	32.0	9.8	12.7	4.0	7.9	22.7	11.8	8.6	8.3	6.8	52.0	10.0	36.6	0.0	1.1	7.0	10.3	10.7	20.7	9.2	5.8	25.4	14.5	13.5	6.2	190.0	19.5	6.4	16.9	3.6	25.0	25.0	5.9	42.1	14.9	18.1	35.7	0.0	16.8	22.9	43.2	110.2	12.6	52.2	28.9	15.9
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632095-1635263	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 51.8"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 124.0;Leydig cells: 90.9;Peritubular cells: 167.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;HHSteC: 8.3;NTERA-2: 3.6;PC-3: 3.6;U-266/70: 6.5"	"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	4.7	2.4	0.3	3.9	0.3	2.1	2.3	0.5	0.4	19.6	3.2	0.1	4.2	3.9	17.3	20.1	4.7	6.4	28.5	14.4	0.2	0.3	3.6	2.3	11.0	3.3	0.1	0.0	51.8	0.7	0.0	3.1	10.5	0.1	32.1	0.2	1.2	1.4	6.3	0.9	2.5	2.7	11.7	0.2	4.1	4.3	13.5	0.0	0.4	1.2	0.9	2.8	13.9	7.0	0.2	12.3	0.1	0.2	2.2	1.8	1.3	1.0	0.0	0.3	3.4	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.7	1.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.6	1.0	0.3	2.2	8.3	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.3	0.0	0.9	0.0	0.6	3.6	0.0	3.6	1.3	0.1	1.6	0.0	0.1	0.6	0.2	0.5	0.0	0.2	0.1	1.0	0.0	0.7	0.5	0.3	0.7	0.0	6.5	0.3	1.1	0.1	0.4	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.0	0.4	1.1	0.0	0.2	0.1	0.9	0.1	2.2	0.1	12.3	0.2	1.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.9	11.8	1.1	9.0	2.5	0.0	0.0	1.8	0.0	2.7	0.0	0.8	0.8	1.5	1.7	0.0	0.5	1.6	124.0	0.4	0.0	1.0	5.1	3.2	2.9	20.9	1.5	3.2	90.9	1.0	18.6	1.0	1.7	0.8	3.4	0.0	167.3	0.6	5.7	0.0	8.2	1.6	10.7	13.8	8.6	9.2	1.2	0.7
CDK11B	"CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58"	ENSG00000248333	"Cyclin dependent kinase 11B"		1	1635227-1659012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 147.7;Spermatogonia: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA025061, HPA073626"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (7.52e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.75e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (6.52e-3)"	10.5	9.8	10.4	11.7	15.1	24.3	8.6	15.0	14.1	9.0	13.3	11.6	6.7	17.4	11.0	6.1	8.6	7.3	7.5	11.2	12.2	9.3	7.9	8.3	12.8	13.1	11.4	9.7	10.3	11.8	9.1	9.6	8.3	11.0	8.9	7.1	7.0	14.0	9.5	33.7	14.0	18.0	14.0	14.8	12.9	9.6	15.8	13.1	12.2	9.5	8.3	10.3	11.6	11.8	5.2	6.2	16.4	4.2	5.1	8.0	2.1	20.5	16.7	12.8	10.1	12.2	8.1	14.3	20.1	11.1	15.8	13.7	18.7	23.3	19.2	20.0	10.0	10.9	18.8	11.7	11.9	9.3	17.4	20.5	20.2	31.1	16.7	14.2	23.0	24.4	10.0	8.1	14.8	11.7	8.9	12.9	21.1	24.5	13.8	8.2	14.4	22.6	22.3	19.2	8.0	20.6	23.3	21.0	15.3	8.4	8.1	14.5	17.7	19.3	19.9	21.3	7.9	14.9	17.1	17.8	15.5	16.4	10.5	19.3	28.4	25.1	38.8	17.9	27.9	10.7	8.2	4.2	6.3	8.0	3.6	4.1	4.2	5.1	5.4	3.1	5.2	5.9	4.4	16.4	5.1	3.8	6.2	4.1	2.1	10.4	15.1	15.0	14.1	12.2	9.3	11.4	9.7	11.0	13.1	17.9	42.1	36.6	15.2	12.8	30.5	36.0	25.5	42.8	48.9	26.2	19.6	25.0	8.3	26.8	28.9	28.9	89.0	23.3	30.7	26.3	20.4	16.2	52.2	33.4	18.4	14.3	27.6	18.4	25.4	16.7	26.7	23.2	5.0	35.1	53.9	22.7	29.9	56.1	25.1	12.6	42.3	51.8	25.5	147.7	172.1	15.2	37.3	27.7	50.7	12.2
SLC35E2B		ENSG00000189339	"Solute carrier family 35 member E2B"	P0CK96	1	1659529-1692728	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045641, HPA062711"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045641: AB_2679402, HPA062711: AB_2684844"	"unprognostic (9.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.64e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.54e-2)"	"prognostic favorable (5.15e-4)"	7.4	9.7	11.3	5.8	9.3	6.4	14.2	15.5	14.5	8.1	15.4	9.7	15.4	12.5	10.2	10.5	6.8	9.0	9.8	5.0	11.7	7.5	7.7	14.2	8.6	18.8	10.0	8.5	15.0	16.6	6.5	14.4	11.0	9.2	9.7	7.3	8.7	12.1	10.2	10.4	10.5	12.1	13.6	7.1	12.8	8.2	3.9	12.6	8.5	9.8	7.2	10.2	7.3	13.0	4.8	8.7	6.8	3.9	4.5	9.5	5.0	6.1	7.7	27.5	19.4	15.4	14.7	6.9	3.4	8.0	4.0	4.1	3.5	8.4	8.3	12.4	16.4	9.9	4.5	10.9	5.9	3.5	11.7	10.3	12.3	13.7	9.9	15.3	11.6	10.0	13.7	13.8	10.7	12.0	21.4	16.8	16.0	14.6	14.9	9.3	3.8	15.2	13.2	9.5	5.1	9.1	12.7	5.8	14.4	9.9	3.4	18.6	23.8	12.7	11.2	20.1	12.5	9.0	15.8	12.4	11.5	6.1	4.9	4.1	12.5	9.6	17.5	9.1	21.1	8.1	1.7	3.9	3.3	8.3	3.5	8.9	4.3	6.8	9.5	2.8	4.8	8.1	6.7	6.8	4.5	2.5	8.7	6.4	5.0	11.3	9.3	15.5	14.5	11.7	7.5	10.0	8.5	9.2	12.6	11.9	27.0	23.5	6.5	6.5	33.6	15.3	35.7	13.4	27.3	3.5	72.6	11.2	0.0	5.0	0.8	18.6	25.2	0.0	5.3	7.3	19.3	8.4	22.0	18.1	8.9	28.6	24.5	30.1	33.0	1.3	28.1	8.0	11.8	6.4	23.6	12.3	4.8	17.5	25.1	2.2	66.3	6.5	9.5	6.1	15.5	8.4	7.3	30.6	26.7	6.7
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702730-1724324	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	14.3	14.9	17.2	23.7	26.9	39.7	13.0	35.2	32.7	12.5	16.4	14.3	6.1	29.2	16.5	8.5	12.1	12.6	10.2	10.2	19.4	8.4	11.7	12.5	19.0	20.3	22.6	9.0	16.2	12.9	12.2	27.5	12.9	17.1	14.4	14.6	11.6	12.7	10.3	21.5	15.1	34.9	13.1	26.0	24.2	15.7	16.4	25.1	14.9	14.6	7.6	22.4	13.5	15.2	7.4	11.8	33.5	6.3	4.4	5.5	1.4	16.3	9.9	7.1	6.5	9.4	7.5	7.0	16.1	7.2	8.0	9.4	12.3	15.0	17.4	9.9	4.7	10.4	12.2	6.5	8.4	6.4	13.3	10.6	15.5	18.5	11.0	6.2	17.3	22.4	8.7	5.7	7.0	4.6	9.7	13.8	9.4	18.1	14.6	6.7	9.2	8.0	13.6	9.9	10.0	8.4	14.7	10.8	8.4	6.5	7.4	7.9	11.4	14.1	16.6	19.3	3.6	11.1	7.2	14.0	12.6	12.3	5.6	8.9	20.4	14.8	21.9	4.3	14.0	4.0	16.7	6.3	7.7	5.5	3.4	4.2	6.2	4.7	4.2	2.0	7.4	4.7	4.0	33.5	4.4	3.7	11.8	4.5	1.4	17.2	26.9	35.2	32.7	19.4	8.4	22.6	9.0	17.1	25.1	47.6	54.9	22.4	11.6	12.5	31.1	1.2	12.7	53.5	58.0	14.0	25.5	13.8	8.3	17.1	29.6	20.3	32.5	23.3	13.2	19.0	13.9	10.7	79.0	12.3	10.9	38.1	8.7	11.6	8.2	11.1	32.8	22.6	10.1	23.4	23.2	20.4	21.0	46.0	20.1	9.6	39.2	12.9	9.1	104.7	84.3	12.8	25.5	25.5	18.6	12.9
SLC35E2	KIAA0447	ENSG00000215790	"Solute carrier family 35 member E2"	P0CK97	1	1724838-1745999	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006118, HPA062711"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA006118: , HPA062711: AB_2684844"	"unprognostic (3.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-4)"	"unprognostic (9.52e-4)"	"unprognostic (6.57e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.87e-4)"	3.0	4.1	8.0	5.2	5.1	0.6	3.0	9.8	6.2	4.0	3.0	2.9	1.6	4.9	6.0	10.5	4.5	5.8	7.6	3.0	5.0	3.5	2.5	2.4	4.8	11.6	4.4	4.7	5.5	3.5	6.9	5.9	3.5	4.0	3.6	5.4	3.6	9.1	1.6	4.7	6.4	4.8	3.7	3.7	6.8	6.2	6.2	5.5	5.5	3.5	3.8	4.3	4.3	7.7	5.0	5.2	6.4	3.4	3.1	6.5	3.2	1.6	1.6	5.4	11.5	11.2	11.0	3.6	7.4	15.3	7.0	9.0	4.6	15.1	4.9	1.3	1.7	1.7	7.5	1.4	2.9	7.6	6.8	1.7	6.4	7.5	1.2	2.3	1.3	7.2	8.8	3.7	1.2	6.3	5.8	2.1	9.2	2.1	2.2	1.3	1.2	1.9	3.2	1.0	0.9	1.9	3.7	5.0	1.0	7.4	5.3	15.2	3.1	2.2	9.2	8.8	1.3	17.9	3.6	9.6	7.3	1.5	2.2	0.4	3.0	0.4	1.6	5.2	3.9	1.2	6.4	3.4	2.1	5.5	2.6	6.5	4.5	4.8	5.3	1.5	5.0	5.5	4.8	4.0	3.1	1.6	5.2	4.5	3.2	8.0	5.1	9.8	6.2	5.0	3.5	4.4	4.7	4.0	5.5	26.8	22.1	0.0	0.5	0.5	5.1	0.0	2.5	10.7	11.4	0.0	2.0	0.8	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.4	1.0	0.4	2.3	0.8	0.6	12.7	0.0	1.8	0.6	0.0	2.8	0.3	0.0	0.0	0.7	1.2	0.0	0.0	3.2	0.0	3.9	0.0	0.0	0.7	1.3	1.5	0.2	4.9	1.2	0.4
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.4;monocytes: 24.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	24.7	34.3	11.1	19.0	11.9	49.0	25.5	9.9	12.6	12.4	18.2	10.8	14.1	20.3	13.9	14.5	12.5	14.3	17.1	11.9	9.9	7.9	12.7	52.3	17.5	27.0	15.8	8.6	16.9	32.2	8.3	11.9	22.5	10.3	13.7	14.1	13.9	21.4	14.5	10.6	11.7	19.4	14.4	8.3	39.4	22.1	17.3	9.6	10.8	14.0	12.0	19.2	13.7	28.3	1.8	7.2	80.4	24.7	0.5	1.4	10.4	15.1	14.6	13.1	19.2	18.7	13.6	16.9	15.3	13.4	17.5	15.6	15.6	27.9	20.1	11.7	11.3	5.6	12.9	14.0	12.1	7.8	19.5	22.3	16.4	22.9	26.9	18.1	23.0	27.6	15.9	11.0	10.8	15.5	9.5	16.9	16.0	20.1	28.8	13.0	17.3	17.3	20.0	8.9	25.5	16.5	22.0	11.2	41.1	15.1	12.6	17.7	13.5	17.1	37.7	15.7	8.1	12.9	16.1	16.3	12.8	9.2	13.1	13.7	25.7	11.6	45.0	12.6	25.5	6.6	11.8	21.1	49.5	1.2	24.7	1.4	1.8	0.7	0.9	7.2	1.7	0.5	0.7	80.4	0.5	23.8	5.9	1.0	10.4	11.1	11.9	9.9	12.6	9.9	7.9	15.8	8.6	10.3	9.6	11.9	30.7	29.2	12.9	8.8	7.3	5.6	28.1	9.4	18.2	14.0	15.7	22.0	13.3	18.5	13.2	18.0	35.4	23.3	25.3	21.4	15.7	25.2	2.3	80.8	33.4	6.4	21.9	14.7	54.6	20.0	34.8	30.2	8.5	40.5	34.0	5.1	24.7	33.1	32.5	18.2	15.9	12.9	17.0	10.8	20.5	11.2	35.8	13.8	26.2	19.2
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		60000000	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	55.2	42.1	84.7	55.1	82.3	41.7	37.8	78.8	112.5	44.0	52.1	46.4	26.0	55.4	44.3	31.2	41.7	38.8	36.6	39.6	74.7	65.7	43.9	38.7	47.1	47.1	68.5	52.1	45.0	33.9	48.9	36.9	45.3	56.6	40.1	41.0	70.7	37.6	41.7	19.7	35.5	65.3	51.2	61.0	51.0	40.8	31.4	39.2	44.5	37.6	19.5	45.6	42.2	54.1	7.7	18.8	18.4	13.2	10.6	9.9	6.0	54.7	51.8	61.6	42.9	35.2	38.8	23.8	77.8	51.9	70.7	55.6	42.3	54.9	57.2	57.4	78.5	40.1	28.9	61.7	56.4	64.7	87.8	30.3	55.5	49.2	48.0	44.4	33.3	61.0	34.3	39.8	67.5	62.9	47.8	57.3	45.4	34.3	51.8	67.3	34.1	73.0	26.3	35.4	28.2	42.0	71.3	47.6	45.2	48.4	34.1	75.8	86.4	72.1	47.0	63.1	44.3	32.9	45.8	87.3	62.3	41.8	48.4	56.4	35.1	61.2	131.0	53.3	70.4	35.0	7.4	11.1	17.1	8.7	13.2	8.0	7.4	8.7	9.7	10.9	7.7	5.9	6.5	18.4	10.6	13.2	18.8	9.9	6.0	84.7	82.3	78.8	112.5	74.7	65.7	68.5	52.1	56.6	39.2	65.5	41.8	61.1	42.7	76.6	128.2	51.2	58.6	30.8	35.2	71.5	164.9	36.8	39.7	78.1	24.7	107.9	139.4	0.0	86.3	77.4	70.2	78.2	52.0	51.3	89.1	170.0	118.1	93.9	126.8	25.1	70.5	95.3	50.6	74.9	88.7	159.0	130.7	84.2	82.7	56.2	1104.1	77.6	76.5	56.5	67.9	89.0	30.4	48.0	64.7	70.1
CALML6	CAGLP	ENSG00000169885	"Calmodulin like 6"	Q8TD86	1	1914827-1917296	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"skeletal muscle: 51.4;tongue: 73.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.9"					"Not detected"	"Not detected"									NA	NA						"unprognostic (3.85e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.59e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.76e-2)"	"unprognostic (5.21e-10)"	"unprognostic (5.06e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.48e-2)"	0.2	0.0	0.1	0.1	0.6	0.1	0.2	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.2	0.3	2.1	0.0	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.3	0.1	0.1	0.7	0.1	0.1	1.8	0.2	51.4	0.8	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	73.7	0.7	0.1	0.5	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	4.9	1.5	0.9	2.9	1.0	0.0	0.4	0.5	0.0	2.9	1.0	0.1	1.2	0.3	1.5	0.3	0.5	0.0	0.7	0.3	0.0	1.1	0.0	0.4	0.1	0.6	2.1	3.0	0.4	0.3	0.4	0.2	0.2	0.0	1.7	0.1	1.0	0.0	0.1	0.9	0.7	0.8	1.5	0.1	2.5	0.5	0.2	0.2	0.5	0.0	0.3	0.1	2.6	0.8	0.3	0.0	0.1	0.0	2.7	0.1	1.5	0.3	2.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.6	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1
TMEM52		ENSG00000178821	"Transmembrane protein 52"	Q8NDY8	1	1917590-1919273	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 19.1;Hepatocytes: 22.7;Spermatocytes: 23.3;Spermatogonia: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 14.2;OE19: 12.8;RPMI-8226: 25.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (4.39e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.04e-5)"	"unprognostic (1.46e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	1.7	12.5	0.5	0.2	0.5	0.1	1.3	1.5	0.4	0.3	0.9	0.4	0.1	1.0	0.3	1.5	2.0	0.8	0.4	0.4	0.4	0.5	0.6	3.3	1.0	0.1	0.2	0.5	0.5	67.1	0.9	0.3	0.2	0.4	0.5	0.4	0.5	13.8	0.1	77.9	0.8	1.7	0.2	0.3	0.7	1.2	7.9	0.2	0.2	0.9	38.9	2.5	0.3	0.4	0.2	2.3	0.0	0.4	0.0	0.6	0.0	2.3	0.2	0.6	1.3	0.2	0.1	5.5	0.3	0.1	1.6	1.0	3.9	1.6	0.6	1.6	2.5	0.6	0.8	3.9	1.1	0.3	0.2	2.9	0.0	0.6	14.2	0.8	0.0	0.9	0.0	2.3	0.5	0.2	0.1	0.1	2.8	3.5	1.4	0.0	4.5	0.3	1.1	2.1	12.8	7.7	1.0	0.0	25.8	0.8	0.1	2.7	1.8	0.0	2.2	0.3	1.0	1.5	0.3	0.0	0.0	1.1	0.7	0.0	1.8	0.6	0.7	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.5	1.5	0.4	0.4	0.5	0.2	0.5	0.4	0.2	0.0	0.0	1.5	2.5	3.9	0.2	0.6	5.1	4.0	3.4	0.0	0.0	0.9	1.7	1.8	3.4	0.2	9.1	0.0	19.1	5.3	1.7	4.9	0.0	22.7	0.6	0.0	0.0	1.3	0.3	4.5	13.8	0.7	8.5	1.0	7.3	1.2	10.4	2.9	9.2	8.2	1.0	0.0	0.7	23.3	33.4	2.5	3.1	0.0	7.0	2.7
CFAP74	"C1orf222, FLJ45476, KIAA1751"	ENSG00000142609	"Cilia and flagella associated protein 74"	Q9C0B2	1	1921951-2003837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;fallopian tube: 12.1;testis: 26.4"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 33.5;Late spermatids: 12.8;Spermatocytes: 21.5;Spermatogonia: 12.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA028521, HPA029274, HPA030240"	Enhanced					NA	NA					"HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455"	"unprognostic (5.41e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	0.4	2.3	1.3	0.5	4.8	1.6	0.3	11.8	3.8	1.7	0.4	3.9	0.4	0.4	1.0	6.6	1.6	12.1	1.2	0.3	1.9	1.8	0.2	1.7	3.1	1.0	0.8	1.5	2.5	0.1	0.3	2.4	0.5	5.4	0.2	0.4	0.0	0.5	0.7	1.2	5.5	0.3	0.2	0.4	0.4	0.3	26.4	1.0	0.0	1.9	0.0	0.2	0.9	0.1	1.4	1.2	1.5	1.4	1.9	1.1	0.1	1.6	0.0	2.5	1.5	0.0	3.6	2.1	0.3	0.0	0.0	1.2	3.5	0.3	2.1	3.1	0.6	1.6	0.6	0.0	0.6	0.5	1.9	2.9	4.3	5.2	2.3	0.6	3.3	1.4	2.3	2.2	0.0	0.0	1.0	0.0	1.4	6.0	1.6	1.2	0.6	1.6	1.1	1.9	0.2	2.6	1.7	0.7	1.0	0.0	3.4	3.2	1.2	0.6	0.3	0.1	0.7	0.7	0.9	3.6	2.0	2.0	0.9	2.3	2.2	0.8	2.2	0.2	3.3	1.0	0.3	1.4	1.1	0.8	0.6	0.3	1.0	0.6	0.5	0.5	1.4	0.8	1.1	1.5	1.9	0.9	1.2	0.6	0.1	1.3	4.8	11.8	3.8	1.9	1.8	0.8	1.5	5.4	1.0	0.0	2.6	0.0	0.9	0.0	1.4	1.6	0.0	33.5	7.9	0.0	7.9	0.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.8	0.1	0.0	0.0	4.9	1.3	12.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	21.5	12.4	0.0	0.7	0.0	0.0	0.4
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor delta subunit"	O14764	1	2019298-2030758	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"brain: 87.0"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 9.3;Ciliated cells: 8.1;Club cells: 11.4;Horizontal cells: 12.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.0"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;HMC-1: 2.5;MCF7: 8.3;NB-4: 5.3;NTERA-2: 2.1;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA044371: AB_2678916"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	1.2	3.4	8.8	0.9	16.8	1.0	1.0	87.0	40.0	1.0	1.2	1.7	0.0	0.9	1.3	1.2	1.3	1.0	1.5	1.7	6.0	1.7	1.1	0.9	1.4	1.3	3.3	11.1	0.9	0.9	1.4	0.7	1.2	17.1	1.0	1.0	0.0	1.1	0.9	1.3	1.4	1.0	1.4	1.4	1.0	1.0	3.3	1.5	0.0	1.6	0.0	1.0	1.2	0.1	0.0	1.2	0.2	0.1	0.0	0.0	0.8	0.0	0.7	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	5.3	2.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.8	8.8	16.8	87.0	40.0	6.0	1.7	3.3	11.1	17.1	1.5	3.0	5.1	0.0	0.0	0.5	9.3	0.8	0.0	8.1	11.4	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.1	2.3	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	3.1	0.1	13.5	0.0	0.2	0.0	0.0	0.0
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 539.8;Syncytiotrophoblasts: 926.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.3	4.7	1.7	8.7	0.0	0.0	23.0	0.5	0.2	5.5	0.3	11.9	16.0	0.0	14.6	1.8	4.8	12.9	9.9	12.3	3.9	0.5	11.0	0.0	7.6	15.8	1.6	0.0	5.7	0.3	7.4	0.0	4.2	0.0	0.0	1.9	3.2	0.1	0.1	9.0	0.4	0.0	3.3	20.2	11.4	0.0	0.0	2.5	9.4	7.8	12.0	9.7	6.0	13.4	2.5	14.9	9.4	2.0	0.0	0.0	6.9	0.0	0.0	3.5	0.6	0.1	0.6	0.1	8.3	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5	113.2	71.1	0.8	10.2	11.6	22.8	1.2	2.5	21.4	26.1	7.0	3.9	84.1	6.6	10.9	181.6	6.0	56.7	0.0	9.3	48.8	3.1	16.4	8.1	12.5	12.7	58.8	9.8	6.7	1.0	539.8	8.9	3.3	6.8	5.4	22.1	15.6	12.2	31.6	8.1	19.0	21.6	0.0	2.2	15.8	26.8	11.7	926.6	7.7	25.3	11.9
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"Fanconi anemia core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	33.1	18.8	15.4	14.3	12.1	15.2	20.5	15.4	16.4	17.8	19.1	13.8	19.1	14.6	17.8	17.7	20.3	12.6	14.2	17.0	15.4	14.8	27.7	20.9	15.0	22.5	14.9	10.3	16.9	17.2	8.0	26.4	11.7	13.3	21.8	7.3	20.9	21.4	23.9	27.3	28.1	14.9	15.0	14.3	24.4	30.5	20.2	11.5	35.1	30.5	11.4	16.5	17.1	19.3	13.2	22.0	31.0	8.7	5.1	12.6	5.6	10.4	1.6	2.3	2.8	1.4	1.9	13.8	11.8	4.4	3.9	5.1	2.5	6.9	12.2	17.5	1.8	3.5	5.1	1.6	1.7	1.9	26.0	24.0	10.1	2.7	5.3	5.4	7.0	9.8	3.3	3.9	2.3	2.5	2.4	4.7	9.7	13.9	2.9	2.6	4.3	10.2	21.9	8.2	2.0	21.9	13.7	7.2	11.4	1.8	1.6	18.9	25.3	7.7	3.3	20.2	2.2	3.3	2.9	9.9	6.0	14.3	7.4	6.7	27.5	14.6	17.8	11.2	4.4	2.5	3.6	8.7	31.0	10.1	8.1	10.0	13.2	9.2	10.9	8.8	13.1	12.6	10.4	11.2	5.1	7.5	22.0	7.8	5.6	15.4	12.1	15.4	14.1	15.4	14.8	14.9	10.3	13.3	11.5	6.0	11.0	59.7	76.1	0.0	25.1	17.1	50.9	14.7	12.5	92.5	3.9	105.4	144.2	110.3	81.6	33.1	20.8	23.3	96.1	118.9	7.2	104.6	7.0	78.0	115.2	14.3	42.1	73.1	106.0	249.7	79.7	47.3	0.0	185.8	72.9	43.5	131.8	46.3	77.8	221.5	25.4	64.7	14.6	118.4	32.4	0.0	75.1	55.3	55.7	99.4
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228695-2310119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: AB_2685692"	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	12.5	4.7	11.8	7.1	22.5	4.8	8.1	34.5	21.2	9.8	8.2	5.5	3.1	4.6	11.9	4.4	5.9	9.1	8.0	9.0	11.0	4.1	4.4	6.1	11.1	6.9	6.2	10.1	10.4	9.6	4.2	6.2	7.4	8.5	8.4	3.5	4.0	12.0	11.9	6.8	11.7	5.9	9.3	5.3	9.3	6.0	7.2	5.3	3.6	6.9	8.1	5.1	7.6	7.8	0.8	0.3	3.0	0.6	1.3	0.6	0.4	10.3	6.0	14.5	14.1	24.3	14.6	9.6	15.5	8.7	9.7	7.1	9.1	8.0	6.5	11.7	19.9	4.0	12.2	8.1	12.6	9.0	7.2	17.6	16.5	9.1	12.8	16.3	9.2	17.8	15.7	7.0	14.6	10.9	18.0	11.8	2.8	9.3	5.1	11.9	6.6	1.1	10.3	14.7	6.8	11.6	5.1	9.2	5.4	8.2	4.1	20.9	13.6	15.1	13.5	15.0	9.7	4.6	12.0	21.4	16.7	10.5	23.5	12.0	4.0	2.8	6.1	8.9	16.2	6.8	0.6	0.5	0.3	0.5	0.6	0.5	0.3	0.4	0.5	0.3	0.8	0.6	0.5	3.0	1.3	0.3	0.1	0.4	0.4	11.8	22.5	34.5	21.2	11.0	4.1	6.2	10.1	8.5	5.3	8.9	9.3	3.9	12.4	41.8	8.0	12.0	15.3	2.7	6.8	7.0	0.0	6.2	1.7	6.9	0.5	30.3	7.0	23.3	5.9	13.9	21.2	11.5	12.7	18.7	12.5	11.1	5.8	34.4	12.9	2.4	46.1	20.1	15.1	1.0	13.5	10.3	9.7	9.3	51.9	5.0	4.4	45.3	30.6	2.6	13.4	39.4	13.6	13.8	9.3	8.4
MORN1	FLJ13941	ENSG00000116151	"MORN repeat containing 1"	Q5T089	1	2321253-2391707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 34.8;Rod photoreceptor cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005858, HPA070703"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA005858: AB_1848709, HPA070703: AB_2686299"	"unprognostic (1.39e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.21e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.88e-3)"	"unprognostic (2.53e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	4.2	4.0	6.9	5.6	15.1	2.5	4.9	25.8	6.6	7.3	4.4	6.1	14.4	4.5	9.3	13.9	3.7	23.5	7.4	3.0	5.5	5.7	7.8	4.1	5.8	3.5	3.9	8.0	15.2	8.6	4.9	11.6	2.5	11.7	6.7	3.1	8.8	9.1	11.7	4.7	6.4	4.3	6.0	4.9	4.6	5.4	17.3	4.8	5.8	15.0	3.3	3.8	3.5	4.6	2.1	3.7	4.2	4.3	0.8	2.6	1.0	6.4	7.8	5.4	4.9	1.9	0.9	5.6	2.0	1.4	3.2	2.7	3.7	7.3	1.7	4.2	1.2	2.4	8.0	1.1	3.1	3.1	3.9	8.3	1.7	14.3	4.2	1.6	2.1	0.9	1.1	0.7	3.0	2.7	2.4	2.2	3.4	2.7	2.0	1.1	8.9	2.1	0.8	3.2	3.4	6.9	2.2	5.0	2.7	2.5	2.9	8.9	4.3	5.2	9.5	4.1	2.5	5.0	0.6	0.7	3.7	5.3	2.6	2.3	4.8	1.7	1.1	7.4	1.3	2.5	0.0	0.8	0.2	1.4	0.3	0.8	1.0	1.5	1.1	1.0	2.1	2.6	1.2	4.2	0.8	4.3	3.7	0.1	1.0	6.9	15.1	25.8	6.6	5.5	5.7	3.9	8.0	11.7	4.8	3.0	2.7	1.5	3.6	1.4	8.5	3.2	5.1	34.8	4.5	14.0	19.6	3.1	3.3	1.8	16.8	1.0	2.1	0.0	1.2	1.4	2.1	2.7	5.7	1.0	2.3	9.5	5.2	1.8	0.6	19.5	2.3	0.6	1.7	1.0	0.6	8.4	1.4	0.0	2.8	7.9	21.9	0.0	2.0	19.2	5.9	1.9	1.6	0.8	1.9	2.3
RER1		ENSG00000157916	"Retention in endoplasmic reticulum sorting receptor 1"	O15258	1	2391775-2405444	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037240, HPA051400"	Supported		Supported	"Golgi apparatus"		No	No			"Golgi apparatus"		"CAB037240: AB_2179604, HPA051400: AB_2681469"	"unprognostic (2.90e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.23e-8)"	"unprognostic (1.01e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.27e-2)"	31.2	59.8	21.6	26.6	24.8	21.2	40.5	22.6	31.1	30.6	40.2	34.6	34.6	34.1	34.0	39.4	63.0	27.0	44.2	31.3	21.0	18.0	44.9	125.8	28.3	39.6	26.8	24.8	31.3	55.8	29.8	31.8	44.8	23.5	30.0	47.5	29.7	57.7	36.9	36.7	35.5	51.5	32.3	24.6	38.6	34.3	35.7	25.3	26.9	36.6	38.5	41.7	28.3	37.3	40.6	62.3	86.1	63.0	36.3	57.3	65.4	38.6	22.0	26.5	29.7	48.9	58.2	19.7	57.5	52.7	52.1	52.4	31.0	60.2	27.3	48.7	59.1	42.0	41.9	30.6	35.4	66.6	34.1	28.2	30.4	46.6	29.7	52.9	33.6	38.2	47.0	36.1	54.1	48.2	35.9	47.6	31.7	36.3	47.2	60.6	27.5	23.8	24.7	17.3	61.8	53.5	28.0	25.9	35.3	46.6	18.7	21.9	25.2	32.2	76.5	45.3	30.8	30.3	25.1	32.7	40.8	23.0	71.8	42.3	44.9	50.1	49.2	43.0	49.5	20.6	46.5	58.5	66.4	50.3	63.0	46.1	40.6	44.7	53.7	53.9	35.1	33.9	41.6	86.1	36.3	61.8	62.3	57.3	65.4	21.6	24.8	22.6	31.1	21.0	18.0	26.8	24.8	23.5	25.3	59.6	41.3	58.1	71.7	47.3	32.8	32.7	132.5	52.2	29.6	99.5	31.4	203.2	56.3	181.2	360.0	58.9	205.6	23.3	226.7	261.7	88.8	117.1	42.8	225.6	195.4	35.0	35.1	84.1	102.8	329.3	76.5	85.4	59.1	129.8	124.7	70.9	203.8	136.3	71.5	98.0	50.2	109.9	61.4	191.9	119.0	58.6	391.3	76.7	138.8	108.5
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.6	18.7	20.5	6.2	19.9	5.6	16.3	7.6	24.6	9.8	9.2	23.1	6.6	10.1	7.6	13.6	10.6	11.4	8.3	12.9	17.8	15.5	12.0	12.1	8.3	7.6	19.2	13.5	13.0	19.4	12.5	12.2	10.2	16.0	15.4	7.0	11.4	17.4	12.3	22.1	10.8	9.0	6.6	21.3	8.9	10.1	17.3	12.6	6.0	10.5	11.8	9.0	8.1	6.8	7.4	11.5	2.2	10.7	4.5	6.4	4.8	12.2	10.2	8.0	8.9	5.8	6.7	7.4	6.5	7.5	10.8	7.8	16.3	18.5	6.4	17.2	8.5	7.1	9.5	7.3	12.0	5.0	10.3	14.1	4.8	10.5	32.4	11.2	8.6	2.6	6.6	6.3	7.9	10.9	6.8	9.1	7.7	5.9	8.0	9.5	16.0	8.0	4.1	6.8	6.7	20.5	6.6	8.2	13.3	11.6	4.2	12.5	9.6	7.7	11.6	21.1	4.9	10.1	3.4	8.8	9.9	4.4	15.1	8.6	11.7	4.8	5.8	11.4	6.7	7.8	1.9	6.9	2.2	5.2	10.7	6.0	7.4	4.5	6.4	11.5	6.9	5.2	3.9	1.6	4.5	8.7	9.8	2.5	4.8	20.5	19.9	7.6	24.6	17.8	15.5	19.2	13.5	16.0	12.6	3.0	4.1	5.4	10.8	7.8	15.7	0.7	10.2	8.1	4.5	14.0	0.0	22.0	29.9	19.3	42.4	9.2	9.3	0.0	26.3	21.1	10.8	12.5	0.0	8.2	20.4	12.7	12.7	4.9	10.5	144.2	9.8	10.3	21.9	26.2	9.1	39.6	17.3	3.5	12.7	20.2	9.7	0.0	8.5	24.9	16.2	5.4	23.0	4.4	14.9	9.1
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505530	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;retina: 28.6;skin 1: 36.6"	"Cell type enhanced"	"Detected in many"	18	"Bipolar cells: 76.1;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 155.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 2.4"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 50.7;hTCEpi: 23.9;hTERT-HME1: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced					NA	NA					"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.5	1.2	6.4	2.9	9.1	1.4	3.1	32.0	25.1	3.2	0.9	1.6	0.5	1.6	0.3	1.7	9.7	2.5	2.4	0.3	20.2	2.7	0.8	0.8	1.2	4.0	2.6	8.4	0.2	1.7	0.1	3.0	0.4	2.6	6.7	0.7	28.6	8.6	4.9	0.2	36.6	2.0	0.2	6.4	4.0	1.7	0.8	2.0	0.2	1.2	0.2	4.9	8.3	6.4	0.3	0.1	0.0	0.0	2.9	2.4	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	7.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	14.3	0.0	0.0	0.0	0.0	1.2	0.1	0.4	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.1	2.8	5.7	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.3	1.5	1.4	0.0	0.3	1.1	0.7	0.0	2.9	0.0	0.1	2.1	0.9	6.4	9.1	32.0	25.1	20.2	2.7	2.6	8.4	2.6	2.0	0.0	1.7	2.0	13.5	13.7	76.1	3.2	5.1	1.4	4.5	0.0	70.7	0.0	1.7	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	4.9	0.0	0.0	0.1	25.4	1.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	1.4	12.3	0.2	0.0	0.0	16.6	155.3	0.0	0.9	0.1	0.2	12.8	0.0	6.9	0.4	6.7
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4"	Q9NVE7	1	2508533-2526628	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.1"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 9.0;HDLM-2: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	5.3	14.4	10.7	17.8	12.6	4.2	5.4	14.9	12.4	5.5	7.1	6.8	4.9	4.2	7.0	4.2	9.8	5.6	9.2	11.8	8.0	5.2	7.2	7.0	6.7	12.5	9.0	6.8	5.7	5.8	4.2	8.3	6.7	7.4	5.8	6.1	8.9	5.6	5.3	43.1	19.0	7.6	9.1	4.4	8.1	6.3	11.0	9.7	9.4	6.8	6.8	7.2	7.2	5.7	4.5	4.8	11.7	6.9	11.4	8.9	5.3	2.5	6.7	2.3	0.0	0.0	2.7	1.6	9.0	0.0	8.2	7.7	0.0	0.0	1.1	3.1	2.5	0.0	3.9	1.9	0.0	1.8	9.4	5.7	0.0	3.9	5.6	2.6	0.0	4.7	0.0	0.0	0.0	0.0	1.2	1.9	1.3	2.5	0.0	2.2	0.0	1.3	0.3	0.0	0.8	2.8	0.0	0.0	1.8	0.0	0.0	2.0	0.0	5.1	1.9	0.0	0.9	0.0	3.4	0.0	0.0	1.9	4.7	2.2	1.3	4.6	6.1	3.0	0.9	0.0	11.7	4.9	4.5	6.2	6.6	5.1	4.5	3.9	6.4	4.8	3.0	7.4	8.0	6.4	11.4	6.9	0.9	8.9	5.3	10.7	12.6	14.9	12.4	8.0	5.2	9.0	6.8	7.4	9.7	6.0	3.2	5.6	4.9	3.7	7.2	22.5	2.5	0.0	2.3	3.5	9.8	6.5	6.6	5.2	1.1	5.2	4.9	0.0	6.0	4.2	7.0	3.2	1.1	7.6	4.6	3.2	2.9	3.7	5.9	0.4	5.5	5.9	5.0	8.2	4.0	4.5	4.7	7.0	8.5	3.6	13.0	19.4	5.9	4.8	5.2	3.9	8.1	8.5	5.0	3.1
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530245	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enriched"	"Detected in some"	22	"Muller glia cells: 105.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		No	NA			Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: AB_2685492, HPA076164: AB_2732303"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	1.1	0.9	11.1	1.1	12.7	1.4	2.8	3.5	16.7	1.0	1.9	1.2	0.4	1.2	1.9	2.7	1.6	1.1	1.2	2.3	9.7	11.2	1.0	1.0	1.4	1.1	4.1	15.8	1.0	0.9	1.0	2.4	2.2	1.6	1.3	1.4	6.3	1.2	1.1	1.6	6.2	1.2	0.9	0.9	1.0	1.2	2.0	1.9	0.0	1.1	1.9	1.4	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	5.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	12.7	3.5	16.7	9.7	11.2	4.1	15.8	1.6	1.9	0.0	0.0	0.0	0.2	0.1	2.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	105.2	0.0	3.5	0.0	0.0	4.8	0.0	0.7	0.0	0.0	1.3	0.0	0.0	1.1	0.1
TNFRSF14	"ATAR, CD270, HVEA, HVEM, LIGHTR, TR2"	ENSG00000157873	"TNF receptor superfamily member 14"	Q92956	1	2555639-2565382	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.6;HDLM-2: 14.8;HHSteC: 17.3;Karpas-707: 13.6;SK-MEL-30: 28.5"									"HPA006404, CAB026150, CAB030007"	Approved					NA	NA					"CAB026150: , CAB030007: AB_2303380, HPA006404: AB_1851348"	"prognostic favorable (4.39e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (6.83e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (7.79e-6)"	15.9	24.9	4.9	38.9	2.8	11.0	21.9	2.0	4.5	16.8	36.3	3.2	18.5	36.3	15.2	20.5	13.7	12.3	36.7	12.7	4.9	2.5	19.3	20.5	30.3	33.2	3.6	5.7	12.8	7.3	3.5	9.3	8.3	3.9	21.5	8.2	44.1	20.9	22.6	5.2	8.4	41.9	14.6	4.1	36.7	16.7	5.9	2.7	23.5	10.8	10.6	25.0	15.4	17.2	18.2	9.7	30.2	25.8	8.1	25.1	14.2	1.3	0.1	0.1	2.4	5.2	2.8	0.8	0.7	2.4	1.4	1.9	0.2	14.6	0.8	0.1	2.2	1.4	1.3	0.0	0.9	0.2	14.8	0.0	8.5	0.4	2.7	17.3	1.1	10.6	2.7	1.4	0.7	0.1	2.1	3.8	0.8	1.2	13.6	1.3	0.0	4.7	1.3	0.0	4.6	1.3	3.8	0.0	4.2	0.2	2.1	0.4	0.0	0.6	0.1	28.5	0.0	0.4	0.3	9.6	0.2	0.6	0.3	0.1	11.1	2.7	0.4	2.4	1.2	1.0	3.0	15.1	8.2	17.2	25.8	14.9	16.6	18.0	14.8	9.7	18.2	17.3	14.9	30.2	8.1	24.1	8.7	25.1	14.2	4.9	2.8	2.0	4.5	4.9	2.5	3.6	5.7	3.9	2.7	17.9	38.9	54.7	30.5	14.5	1.5	6.7	56.0	26.8	31.8	33.2	0.0	1.0	3.3	16.7	0.3	48.4	116.5	0.0	29.0	0.8	16.0	32.4	50.9	18.3	78.8	0.0	34.7	35.0	60.9	1.3	19.2	62.9	43.9	111.0	60.4	15.8	19.7	86.3	13.1	30.9	0.5	19.4	17.5	0.0	0.3	11.7	1.0	77.3	72.2	38.8
FAM213B	"C1orf93, MGC26818"	ENSG00000157870	"Family with sequence similarity 213 member B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.7;U-2197: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	6.0	9.1	14.7	5.7	14.9	3.8	4.6	7.4	20.0	7.9	15.4	6.2	5.2	22.0	4.5	6.7	5.7	10.5	23.7	3.2	15.0	15.5	7.4	3.5	6.0	5.8	11.7	11.0	7.1	4.6	4.4	4.3	8.4	10.7	5.7	7.4	9.0	5.3	7.7	1.8	6.1	20.2	4.8	6.5	7.4	11.7	3.3	4.7	5.4	5.2	0.9	5.2	6.3	3.5	2.1	2.2	1.5	2.3	7.5	6.3	3.2	7.7	4.3	4.4	4.8	2.1	2.4	0.6	7.0	2.9	6.6	2.9	3.1	9.1	2.0	7.1	4.5	2.7	6.5	3.9	4.9	2.2	5.8	2.0	4.8	3.3	4.9	5.1	2.7	1.4	3.5	2.5	4.6	1.7	3.1	9.3	3.6	6.5	3.1	6.6	5.6	6.3	1.2	5.3	9.0	16.6	6.9	6.5	5.1	6.9	3.9	5.9	9.8	6.0	26.7	8.0	1.1	4.6	1.0	13.5	5.8	6.7	22.9	2.6	2.9	4.3	1.4	5.4	9.2	1.1	1.5	2.0	1.1	3.8	2.3	6.3	2.1	4.2	4.1	2.2	1.5	3.5	5.4	1.5	7.5	2.0	1.0	5.6	3.2	14.7	14.9	7.4	20.0	15.0	15.5	11.7	11.0	10.7	4.7	3.0	1.7	3.9	4.5	3.7	11.0	4.5	12.7	10.7	6.8	33.2	0.0	0.4	6.6	24.6	0.6	11.6	37.6	0.0	8.8	0.4	4.0	3.7	0.0	2.6	8.0	22.3	15.1	12.3	4.9	1.1	4.9	7.6	6.8	8.2	25.7	6.0	31.4	38.2	3.9	11.8	5.2	19.4	8.1	0.9	11.1	4.5	0.6	6.9	32.8	7.0
MMEL1	"MMEL2, NEPII, NL1, NL2, SEP"	ENSG00000142606	"Membrane metalloendopeptidase like 1"	Q495T6	1	2590639-2632990	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.2"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 28.1;Early spermatids: 82.5;Late spermatids: 27.3;Paneth cells: 37.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007876, HPA008205, CAB020786"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011"	"unprognostic (5.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.01e-4)"	1.5	0.5	0.8	1.8	8.5	0.6	1.8	0.4	0.6	4.3	4.2	0.4	1.9	3.2	0.8	10.3	3.0	3.0	9.6	1.3	1.0	2.6	1.4	0.4	1.4	1.4	1.7	0.4	1.1	7.3	0.3	0.4	0.7	0.5	4.2	1.4	0.4	2.0	2.0	0.4	0.3	2.6	0.9	0.7	1.4	7.9	30.2	0.9	0.8	1.1	0.8	0.8	3.7	1.6	0.6	1.1	6.6	5.1	2.3	6.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.5	0.0	17.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.5	6.6	0.5	3.9	0.3	0.6	1.7	0.7	1.1	0.0	4.5	2.2	1.0	2.3	5.1	0.2	6.1	2.2	0.8	8.5	0.4	0.6	1.0	2.6	1.7	0.4	0.5	0.9	0.0	0.0	0.0	4.6	0.0	0.0	0.8	28.1	10.7	2.3	17.4	0.0	0.0	0.0	7.1	82.5	0.6	15.7	0.0	3.1	0.0	0.3	12.4	0.0	0.0	1.3	0.0	1.2	0.6	1.5	27.3	1.7	0.5	0.0	0.0	14.9	0.5	2.7	37.7	1.1	0.0	0.0	0.0	0.4	0.5	0.9	0.0	0.0	0.0	9.7	10.9
TTC34		ENSG00000215912	"Tetratricopeptide repeat domain 34"	A8MYJ7	1	2635976-2801717	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;testis: 4.6"	"Cell type enhanced"	"Detected in some"	12	"Early spermatids: 16.9;Late spermatids: 19.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;JURKAT: 1.7;Karpas-707: 1.9"	"Low region specificity"	"Detected in many"							HPA066832	Uncertain					NA	NA					"HPA066832: AB_2685731"	"unprognostic (1.45e-4)"	"unprognostic (5.00e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.69e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.68e-4)"	0.1	0.2	0.6	0.3	1.2	0.0	0.4	0.2	0.3	0.4	0.0			0.0	0.5	0.6	0.0	3.5	0.0	0.0	0.9	0.7	0.0	0.0	0.4	0.1	0.1		0.6	0.0	0.2	0.3	0.0		0.3	0.0		0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.3	4.6			1.5		0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.1	0.7	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.7	0.2	0.0	0.0	0.4	0.8	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.3	0.2	0.0	0.7	0.5	0.2	0.0	0.0	0.2	0.0	1.7	0.0	1.9	0.0	0.7	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.3	0.0	0.6	0.1	0.0	0.2	0.7	0.7	0.1	0.0	0.6	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0											6.0	0.0	0.0	0.4	0.0	3.6	5.3	2.5	4.0	1.2	0.0	0.0	0.1	0.0	0.5	16.9	0.3	0.0	0.0	0.5	0.0	0.2	0.3	4.6	0.0	0.2	0.0	0.0	0.0	0.3	19.7	0.6	0.0	1.7	0.0	0.2	3.4	0.4	0.0	0.0	0.3	4.1	0.0	0.1	1.8	0.7	0.1	0.0	0.0	0.4	0.0
ACTRT2	"Arp-T2, ARPM2, FLJ25424"	ENSG00000169717	"Actin related protein T2"	Q8TDY3	1	3021483-3022903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	139	"testis: 60.2"	"Group enriched"	"Detected in some"	120	"Early spermatids: 1117.5;Late spermatids: 2561.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;NTERA-2: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006480, HPA025079"	Enhanced					NA	NA					"HPA006480: AB_1845047, HPA025079: AB_1845048"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1117.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2561.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	6.5	0.0	15.3	6.6	0.0	0.0	0.0	0.0	0.0
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 32.8;Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.4"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.5;HEK 293: 2.9;HHSteC: 3.4;hTERT-RPE1: 11.5;MCF7: 2.6;OE19: 5.7"	"Region enriched"	"Detected in many"	5	"basal ganglia: 16.1"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	2.7	0.7	5.3	1.4	5.6	0.5	1.6	0.5	4.7	2.1	6.2	3.3	12.8	14.1	1.5	4.5	1.1	2.0	11.7	5.1	5.2	1.9	7.0	0.6	4.2	1.4	2.9	3.1	3.6	12.7	1.2	1.1	0.6	3.3	1.1	0.9	16.1	1.3	15.0	1.2	0.9	8.0	1.5	2.5	4.2	14.8	1.4	4.8	0.0	10.7	0.0	0.9	1.1	1.5	0.3	0.1	0.0	0.0	5.4	0.4	0.0	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.5	0.0	0.4	0.0	0.4	0.0	2.2	0.0	0.0	0.2	2.9	0.0	0.0	0.5	3.4	0.0	1.2	0.0	0.0	0.0	0.0	11.5	0.0	0.2	0.0	0.0	0.0	2.6	0.2	0.0	0.3	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	5.3	5.6	0.5	4.7	5.2	1.9	2.9	3.1	3.3	4.8	32.8	8.0	0.0	0.2	0.6	0.0	4.8	17.8	2.7	9.1	7.0	0.0	0.0	5.0	7.6	0.0	0.7	0.0	0.0	4.3	2.9	0.0	0.3	0.0	0.0	0.0	1.6	5.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	1.3	5.3	0.0	1.8	0.2	0.0	0.0	5.3	0.2	1.1	0.0	0.0	0.0	1.2	0.1
ARHGEF16	"GEF16, NBR"	ENSG00000130762	"Rho guanine nucleotide exchange factor 16"	Q5VV41	1	3454426-3481113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.6;intestine: 45.9"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 71.7;Extravillous trophoblasts: 39.4;Mucus-secreting cells: 36.4;Paneth cells: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.8;MCF7: 16.2;OE19: 19.3;SK-BR-3: 17.8"	"Region enriched"	"Detected in single"	4	"olfactory region: 5.8"	"Not detected"	"Not detected"			HPA010609	Approved					NA	NA					"HPA010609: AB_1845004"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.39e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (1.24e-10)"	"unprognostic (6.46e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.29e-2)"	1.8	0.1	0.5	7.5	1.0	0.0	2.9	1.1	0.8	2.5	30.4	1.2	11.5	24.8	1.0	4.6	11.4	1.3	28.6	0.5	1.1	0.9	11.7	4.3	3.1	0.5	1.3	0.5	0.9	7.0	4.8	7.7	9.0	2.2	5.7	6.8	1.5	10.1	13.7	0.7	3.4	45.9	1.0	1.9	0.5	15.8	2.3	0.7	0.9	9.0	5.9	5.3	5.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	3.5	0.9	0.1	0.0	0.0	6.2	0.1	0.2	0.2	0.7	10.5	28.8	0.0	6.9	0.0	1.8	9.1	1.5	6.1	0.0	0.0	3.1	0.0	4.3	8.1	0.3	0.0	0.0	0.1	5.9	0.6	0.3	0.6	0.0	0.1	1.1	0.0	0.0	16.2	0.0	0.2	7.0	19.3	0.2	0.0	0.0	1.2	7.3	4.6	4.7	0.9	1.7	17.8	0.4	3.9	7.9	0.3	0.0	0.1	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	1.1	0.8	1.1	0.9	1.3	0.5	2.2	0.7	8.9	4.8	0.0	11.6	2.9	1.0	1.3	12.7	6.7	9.1	15.7	5.9	2.3	13.3	15.0	0.0	0.4	71.7	0.0	11.1	39.4	0.3	4.3	0.0	3.4	1.0	3.2	9.8	0.6	0.0	0.0	0.0	0.7	0.0	1.0	36.4	34.7	20.3	35.7	0.0	8.4	8.1	0.0	0.8	0.4	3.4	0.9	5.6	0.0	24.3	14.8
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3489920-3611495	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted - unknown location"	Yes	No		580000	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	15.0	2.3	0.5	8.5	1.0	9.2	13.4	0.8	2.0	8.1	5.9	1.8	7.5	2.3	5.1	13.1	6.6	14.6	21.0	6.1	1.4	0.5	2.7	1.9	12.6	12.6	0.7	1.9	8.8	4.8	0.8	1.5	2.8	2.3	12.0	0.9	11.0	8.7	5.5	6.1	37.8	4.2	3.0	0.8	5.7	4.2	4.6	1.4	5.0	5.2	12.0	12.0	6.7	10.1	0.8	0.3	4.8	0.1	0.0	1.9	0.2	4.5	7.2	1.6	3.1	0.1	0.1	0.5	22.5	6.3	1.9	0.6	1.5	5.3	0.0	7.2	7.7	1.3	2.8	0.0	0.2	0.2	0.0	0.1	0.0	20.3	1.3	0.0	0.1	0.4	0.0	0.2	0.1	0.2	26.6	2.4	0.0	0.0	0.0	0.0	2.5	0.0	4.1	1.0	1.0	0.4	0.9	0.9	2.7	0.4	1.4	1.6	1.5	8.1	0.5	2.8	2.3	2.2	0.4	1.0	8.2	0.8	20.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	4.8	0.1	0.0	0.4	0.0	0.4	0.4	0.3	0.8	0.8	0.1	2.2	0.0	0.0	0.0	1.9	0.2	0.5	1.0	0.8	2.0	1.4	0.5	0.7	1.9	2.3	1.4	20.8	19.4	0.0	7.5	16.4	0.8	3.0	5.1	0.0	6.8	1.8	0.0	0.1	0.0	3.0	0.2	8.7	0.3	0.0	1.2	1.0	6.4	3.4	1.1	0.9	1.0	0.0	0.0	16.5	0.8	0.0	10.6	2.8	18.6	0.0	1.3	9.5	3.6	0.0	3.2	1.7	1.0	0.0	2.1	0.5	0.6	9.9	0.3	0.0	0.7	3.0
TPRG1L	"FAM79A, FLJ21811, RP11-46F15.3"	ENSG00000158109	"Tumor protein p63 regulated 1 like"	Q5T0D9	1	3625002-3630127	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063163, CAB079051"		Supported	Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB079051: , HPA063163: AB_2684953"	"unprognostic (1.92e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-3)"	"prognostic favorable (1.76e-9)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	18.3	19.1	34.3	9.7	46.6	14.5	17.4	23.1	57.7	19.3	24.0	12.9	17.2	24.5	16.5	21.2	28.7	24.8	19.3	25.0	32.9	32.8	32.1	34.9	16.8	14.6	25.7	41.7	25.9	17.4	11.7	20.5	12.7	41.4	17.1	23.4	19.1	18.7	25.0	29.5	25.4	28.3	18.1	13.2	13.4	17.4	8.7	13.6	8.0	21.9	17.3	18.2	17.1	16.3	5.1	7.9	17.0	3.2	2.6	7.1	3.2	11.3	8.2	5.0	9.0	38.3	26.7	4.7	17.0	23.5	15.8	10.5	15.3	10.5	4.2	15.2	23.1	8.5	18.0	6.0	15.7	13.4	13.3	9.7	5.9	9.5	17.7	23.3	8.5	7.0	20.1	23.2	13.0	13.4	19.3	22.2	7.4	4.2	15.1	22.0	5.2	6.1	8.8	6.8	26.3	19.2	5.1	7.5	10.0	16.3	12.0	14.2	14.0	9.1	18.9	18.0	12.1	11.8	7.4	25.2	13.3	3.9	30.1	4.8	13.7	17.7	4.7	7.8	18.8	1.7	12.8	3.2	4.9	5.6	2.6	7.1	4.2	6.4	5.5	2.8	5.1	5.9	6.8	17.0	2.6	2.5	7.9	3.4	3.2	34.3	46.6	23.1	57.7	32.9	32.8	25.7	41.7	41.4	13.6	14.9	16.2	8.0	8.5	10.6	44.4	33.5	20.4	17.4	5.7	10.4	7.9	8.9	10.0	15.8	2.4	13.0	47.9	0.0	30.6	10.6	9.7	9.0	8.1	49.9	13.0	119.2	18.5	27.0	14.8	3.1	17.3	9.7	6.8	13.6	29.1	57.4	26.8	23.0	20.1	31.6	27.8	6.5	13.8	4.7	13.2	16.6	7.7	10.0	24.1	7.2
WRAP73	WDR8	ENSG00000116213	"WD repeat containing, antisense to TP73"	Q9P2S5	1	3630767-3652761	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026893	Uncertain					NA	NA					"HPA026893: AB_10603459"	"unprognostic (3.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-3)"	11.9	13.4	12.6	22.5	17.3	28.1	16.7	22.4	15.4	11.5	13.4	14.7	12.2	18.2	13.7	11.6	14.2	12.3	12.0	19.3	14.7	10.3	12.0	11.7	22.1	21.1	18.6	10.6	13.9	20.7	11.7	16.8	12.8	15.8	12.4	12.3	11.4	13.9	20.6	13.7	13.1	18.3	11.9	10.2	20.1	13.9	13.5	19.1	14.5	13.7	11.4	18.1	16.5	11.9	12.3	13.0	36.1	16.2	11.5	14.3	9.8	13.4	7.9	7.9	15.3	10.6	6.7	7.8	6.8	6.7	11.5	10.1	12.4	18.0	15.0	12.8	8.6	9.4	10.3	22.8	13.5	6.0	26.3	34.7	8.5	10.6	14.0	11.4	10.0	13.6	6.2	9.6	9.3	11.9	6.4	10.1	18.1	13.9	9.2	8.3	12.2	20.8	15.1	10.8	13.5	17.0	13.0	11.3	8.0	6.1	5.7	20.4	28.6	8.0	10.8	19.1	7.0	10.7	16.1	8.1	8.9	9.0	15.1	9.7	12.7	14.9	29.8	4.6	20.6	4.0	24.7	12.8	36.1	12.5	11.4	12.1	12.3	13.0	12.0	13.0	12.0	11.8	12.2	15.4	11.5	16.2	11.0	14.3	9.8	12.6	17.3	22.4	15.4	14.7	10.3	18.6	10.6	15.8	19.1	3.0	12.0	15.9	9.3	6.3	22.8	6.5	15.3	10.7	6.8	14.0	33.4	18.3	11.6	12.1	9.9	9.2	16.2	0.0	12.4	10.5	10.5	11.2	4.6	6.0	15.9	39.7	9.9	9.2	10.0	18.6	11.5	11.7	11.8	15.4	11.7	15.8	13.2	8.6	9.2	7.8	23.6	6.5	11.9	29.2	14.7	5.9	12.1	17.5	10.9	8.1
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652520-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 17.4;Club cells: 7.9;Early spermatids: 18.5;Late spermatids: 10.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 25.7"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.2;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.4;RH-30: 9.3;SCLC-21H: 14.6;U-698: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.5	0.3	1.1	3.4	2.3	1.0	1.1	25.7	0.4	1.5	0.7	2.4	1.3	0.3	0.4	6.2	4.8	12.8	1.4	0.3	1.9	1.2	0.2	2.1	3.8	2.0	0.5	0.0	2.6	1.5	0.3	0.7	1.7	3.2	3.6	0.4	0.4	5.5	1.4	0.4	11.9	0.5	0.3	0.9	4.2	0.8	9.8	0.3	2.5	0.4	0.8	7.1	0.6	3.9	1.4	0.1	1.2	0.1	0.0	0.6	0.1	2.0	0.1	0.2	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.5	3.2	2.0	1.6	0.0	0.7	3.4	2.1	0.7	0.0	0.6	6.9	0.1	3.2	2.0	0.0	0.0	2.3	0.0	1.4	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.6	1.5	11.4	1.5	0.4	0.0	0.1	0.0	9.3	0.1	0.2	3.0	14.6	6.8	0.3	0.0	0.6	0.0	8.7	7.1	0.0	2.3	6.2	0.0	4.5	2.7	0.5	14.6	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	1.4	0.4	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	2.3	25.7	0.3	1.9	1.2	0.5	0.0	3.2	0.3	0.0	1.0	0.0	3.9	2.7	0.5	1.2	0.0	17.4	7.9	0.0	0.0	0.2	0.0	0.0	18.5	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.0	2.4	0.0	0.0	10.0	0.6	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.2	0.0	0.0	0.1
CCDC27	FLJ32825	ENSG00000162592	"Coiled-coil domain containing 27"	Q2M243	1	3746460-3771645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	81	"testis: 53.3"	"Group enriched"	"Detected in some"	46	"Early spermatids: 60.7;Late spermatids: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"THP-1: 6.2"									HPA044395			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA044395: AB_10962987"	"unprognostic (1.36e-1)"	"unprognostic (6.67e-3)"		"unprognostic (3.23e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.28e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
SMIM1	Vel	ENSG00000235169	"Small integral membrane protein 1 (Vel blood group)"	B2RUZ4	1	3772761-3775982	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Erythroid cells: 607.3;Proximal tubular cells: 216.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	10	"eosinophil: 26.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.7"	"Group enriched"	"Detected in many"	4	"HEL: 37.3;Hep G2: 16.1;K-562: 18.7"	"Low region specificity"	"Detected in all"							HPA069088	Enhanced					NA	NA		420000			"HPA069088: AB_2686080"	"unprognostic (9.50e-3)"	"unprognostic (7.19e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.32e-2)"	1.6	2.2	0.9	0.7	1.3	27.8	2.2	2.2	1.7	6.1	2.9	3.4	9.1	1.0	1.7	7.7	3.7	2.1	3.7	23.5	1.7	1.6	8.4	6.6	2.4	3.4	2.1	1.7	8.0	5.5	2.0	9.3	2.7	3.0	9.0	0.3	5.6	18.5	17.2	1.3	1.1	1.3	4.9	4.0	2.1	3.3	23.5	1.6	0.5	6.9	1.1	1.5	4.6	4.2	2.5	0.3	26.7	1.2	0.1	2.5	1.4	0.1	0.6	0.8	1.6	0.0	0.0	2.8	0.4	0.6	0.0	0.0	1.7	2.0	0.1	3.8	0.0	0.1	0.8	0.3	0.7	0.0	3.4	2.0	37.3	0.0	16.1	1.3	0.0	0.7	1.1	0.5	0.2	0.3	1.6	0.0	0.1	18.7	0.6	0.0	3.6	0.0	1.1	0.2	1.7	3.6	0.0	0.0	5.3	1.9	0.4	0.9	3.6	0.1	3.8	2.7	0.3	3.9	2.1	0.3	0.0	0.5	0.0	0.0	1.6	0.5	0.1	0.0	0.0	0.1	2.6	1.2	26.7	0.7	0.6	0.3	1.6	1.0	0.3	0.3	2.5	2.5	1.1	1.9	0.1	0.2	0.3	0.7	1.4	0.9	1.3	2.2	1.7	1.7	1.6	2.1	1.7	3.0	1.6	6.0	16.1	6.0	9.8	1.4	0.2	48.0	10.2	2.7	11.4	15.7	0.0	20.7	71.3	11.7	8.1	2.3	1.1	607.3	12.4	16.7	7.2	11.2	1.1	43.2	8.2	1.6	5.2	3.1	4.0	18.0	9.2	3.7	40.5	0.0	2.9	20.1	16.0	0.0	9.2	216.9	0.9	0.0	4.2	3.9	15.8	1.0	5.6	4.3	3.5	5.7
LRRC47	"KIAA1185, RP1-286D6.3"	ENSG00000130764	"Leucine rich repeat containing 47"	Q8N1G4	1	3778558-3796504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008512, HPA012018"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		16000	"Nucleoli fibrillar center"		"HPA008512: AB_1853324, HPA012018: AB_1853322"	"unprognostic (2.25e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.25e-1)"	14.4	14.6	14.5	10.3	17.4	14.1	11.9	22.4	28.6	14.9	14.5	15.9	9.2	13.8	16.1	13.0	15.0	15.2	13.7	24.5	13.3	14.9	12.3	22.8	11.2	12.6	12.8	19.2	20.3	23.8	16.5	13.3	16.3	15.0	15.3	9.7	13.6	19.6	17.2	61.2	17.4	12.1	13.8	11.4	13.3	13.9	12.4	12.7	18.3	18.9	16.3	11.7	14.9	14.7	4.9	7.8	6.7	7.2	6.5	8.6	3.5	10.5	12.5	9.1	14.9	9.8	7.9	9.1	9.2	7.1	12.2	9.6	15.4	11.8	11.1	13.6	10.0	9.3	14.9	11.1	11.4	6.7	14.1	20.3	20.4	14.2	16.9	15.2	13.8	7.6	9.3	10.1	12.1	9.8	8.0	8.6	14.5	18.6	3.3	8.8	11.2	15.1	16.0	20.6	10.5	19.2	14.9	9.1	13.2	8.4	7.8	19.1	18.7	11.5	17.5	17.9	9.3	9.5	10.4	11.6	10.2	5.9	15.1	11.9	24.7	22.8	12.7	6.0	18.9	4.0	6.7	6.4	3.2	5.7	7.2	5.9	4.0	6.2	8.6	7.8	4.9	7.0	7.3	4.0	6.5	5.5	6.6	5.6	3.5	14.5	17.4	22.4	28.6	13.3	14.9	12.8	19.2	15.0	12.7	14.9	17.9	20.1	15.7	13.9	30.8	50.4	35.7	10.7	17.0	26.2	13.7	50.0	16.6	10.9	1.3	13.5	22.3	0.0	12.7	34.7	16.0	15.8	11.5	26.0	22.9	36.5	20.7	19.0	14.0	1.9	20.4	11.6	8.5	11.8	22.3	29.8	12.9	25.2	22.3	18.8	15.9	12.9	22.0	15.6	38.4	18.9	40.3	15.4	28.6	11.9
CEP104	"CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4"	ENSG00000116198	"Centrosomal protein 104"	O60308	1	3812081-3857214	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Cone photoreceptor cells: 432.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010126	Approved					NA	NA					"HPA010126: AB_10601583"	"unprognostic (3.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.35e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (7.06e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-1)"	15.9	20.2	15.5	11.3	22.7	8.9	13.2	21.9	18.8	14.0	13.6	28.5	14.6	11.3	14.4	17.7	17.0	15.8	10.5	14.6	17.5	14.9	21.1	17.9	15.6	14.8	26.4	8.8	16.8	19.4	29.6	25.1	12.4	21.6	14.5	13.7	23.5	14.8	19.6	18.4	16.1	14.2	16.6	23.6	13.4	14.3	24.2	23.2	19.8	17.9	7.9	16.9	17.3	15.7	4.6	4.0	8.8	2.6	3.2	4.2	0.8	13.3	13.7	8.0	13.0	21.1	13.8	6.3	11.1	8.9	15.0	10.7	10.5	12.8	13.3	16.0	12.1	11.2	13.1	16.9	14.5	19.1	16.7	16.4	12.3	18.1	17.0	16.6	13.8	13.0	9.5	14.2	17.2	25.2	12.9	14.9	17.5	15.3	16.1	14.2	12.4	18.9	7.4	4.9	18.1	16.7	13.6	13.6	15.4	9.6	9.5	21.4	5.7	17.1	21.0	13.4	9.8	9.4	4.2	11.7	12.0	5.5	22.7	8.9	15.7	17.5	16.9	6.5	14.1	4.4	8.8	2.6	5.2	4.2	2.3	3.3	2.8	3.0	2.9	1.5	4.6	2.6	2.3	3.8	3.2	1.5	4.0	2.9	0.8	15.5	22.7	21.9	18.8	17.5	14.9	26.4	8.8	21.6	23.2	23.8	20.4	15.2	11.9	14.2	18.0	12.7	10.2	34.8	14.8	24.4	432.0	14.6	6.6	21.9	55.2	11.1	13.8	0.0	16.7	20.7	8.4	11.7	10.4	15.3	11.4	55.6	10.9	6.7	14.9	70.0	11.5	15.1	18.6	18.0	12.6	13.5	19.4	10.5	19.4	15.1	54.9	19.4	15.0	43.7	16.2	17.6	9.5	12.9	11.3	12.3
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 43.2;Extravillous trophoblasts: 23.7;Horizontal cells: 14.3;Rod photoreceptor cells: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: AB_2681985"	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.29e-5)"	4.7	4.1	6.0	5.0	7.8	3.8	4.0	13.2	7.8	3.8	4.3	4.2	2.0	12.5	5.9	1.5	3.1	4.9	4.2	4.1	4.1	1.8	2.9	2.0	3.5	2.9	5.4	4.1	6.7	9.3	1.3	8.7	4.8	2.9	3.0	1.6	4.3	3.3	3.3	1.9	2.3	5.6	2.6	3.0	5.6	4.1	1.7	6.3	2.8	3.2	1.0	5.6	4.7	3.4	3.1	6.3	6.9	8.2	2.7	6.4	3.7	3.1	2.9	1.4	4.0	0.9	1.0	0.9	2.7	0.9	3.0	2.9	1.7	1.3	1.2	1.8	0.6	0.3	0.9	0.4	1.7	0.2	7.3	7.5	11.0	1.2	1.6	2.6	6.0	8.6	0.5	0.3	2.7	0.1	0.8	3.3	4.9	6.1	1.3	0.7	0.9	6.6	3.6	2.2	1.1	6.3	5.5	2.3	2.4	0.6	0.4	2.9	5.0	2.0	3.0	8.3	0.0	0.7	3.6	5.0	1.2	1.0	5.8	2.4	2.4	3.6	3.4	1.4	9.4	1.7	5.3	5.5	6.9	4.7	5.1	2.9	3.1	3.0	3.8	6.3	1.2	2.8	4.5	1.7	2.7	8.2	0.1	6.4	3.7	6.0	7.8	13.2	7.8	4.1	1.8	5.4	4.1	2.9	6.3	3.0	5.8	0.0	1.0	0.6	4.4	0.8	2.5	1.4	2.3	1.8	43.2	3.0	1.7	1.9	0.8	2.1	2.0	0.0	1.4	23.7	2.1	0.7	0.0	1.6	2.5	14.3	2.4	3.1	5.3	1.1	1.1	1.9	0.0	0.0	4.1	3.5	1.6	0.0	4.6	2.2	19.3	0.0	0.5	1.8	3.2	0.3	1.1	3.2	3.7	0.7
C1orf174	RP13-531C17.2	ENSG00000198912	"Chromosome 1 open reading frame 174"	Q8IYL3	1	3889125-3900293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008270, HPA065778"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008270: AB_1845633, HPA065778: AB_2685557"	"unprognostic (4.91e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (7.24e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-2)"	17.6	17.4	15.0	18.8	16.5	24.0	17.8	16.3	19.2	15.4	16.9	21.3	11.6	15.6	19.4	20.1	19.3	19.7	21.1	13.4	15.3	15.4	18.1	24.8	14.5	20.2	15.8	17.1	19.6	20.0	5.4	13.3	24.4	16.7	18.9	15.6	16.5	15.9	17.2	22.9	15.6	16.5	20.1	13.7	22.4	16.5	18.9	15.3	26.9	21.9	19.7	22.4	19.5	15.0	16.5	18.7	30.4	28.8	16.1	27.6	13.6	14.3	8.4	13.3	11.2	11.2	7.0	9.4	13.2	7.4	11.8	12.1	12.2	22.8	11.4	14.9	9.7	16.5	13.9	14.0	9.0	13.3	19.3	13.6	29.4	8.6	17.9	6.9	20.9	15.3	7.4	5.9	12.4	10.0	9.2	9.4	14.1	22.9	11.7	8.2	10.7	21.6	16.1	15.1	19.2	17.8	16.4	22.2	10.7	8.0	8.7	12.8	10.6	12.0	18.0	18.1	12.8	7.5	12.8	10.2	17.1	12.8	28.3	12.5	4.5	4.3	21.9	8.3	23.3	5.6	27.7	16.1	30.4	27.6	28.8	24.0	16.5	18.7	20.9	18.7	15.2	17.9	22.7	13.3	16.1	18.8	10.3	19.3	13.6	15.0	16.5	16.3	19.2	15.3	15.4	15.8	17.1	16.7	15.3	8.9	4.8	14.9	10.8	19.5	9.8	3.4	7.6	12.0	14.8	5.2	7.9	52.5	23.2	19.2	104.9	12.3	10.9	0.0	16.9	53.1	17.4	9.5	36.8	11.6	27.7	11.1	10.9	9.8	14.0	14.5	15.8	18.9	13.5	16.2	13.6	11.7	14.8	14.0	18.0	17.2	10.5	12.9	12.3	20.1	26.0	15.4	22.3	24.5	15.6	9.9
AJAP1	"MOT8, SHREW-1, SHREW1"	ENSG00000196581	"Adherens junctions associated protein 1"	Q9UKB5	1	4654732-4792534	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;ovary: 13.1"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 8.7;Early spermatids: 4.6;Peritubular cells: 5.6;Proximal tubular cells: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"eosinophil: 4.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.1;granulocytes: 4.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;EFO-21: 6.2;hTERT-HME1: 3.6;RPTEC TERT1: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.11e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.89e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.49e-2)"	1.4	1.8	18.9	1.1	9.9	0.9	1.1	3.8	18.0	3.0	1.2	4.7	1.6	1.4	2.8	2.5	1.3	2.4	1.2	0.8	10.8	6.0	8.2	1.0	1.2	1.2	6.3	13.4	13.1	3.1	0.9	0.7	1.5	5.5	2.3	1.1	2.2	1.3	6.7	1.3	1.2	1.2	1.6	4.1	3.2	1.3	2.6	7.2	0.0	1.2	0.0	1.2	1.3	1.1	0.0	2.1	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	1.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.7	22.7	0.0	1.1	0.6	0.0	2.1	0.0	2.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	18.9	9.9	3.8	14.9	10.8	6.0	6.3	13.4	5.5	7.2	0.0	0.0	0.0	0.0	3.3	8.7	0.8	2.5	4.0	2.3	1.8	0.0	1.6	0.0	1.0	4.6	0.7	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.3	0.0	1.7	0.0	0.0	1.2	0.2	0.0	5.6	4.9	1.1	0.0	1.9	0.2	0.7	2.0	1.5	0.0	0.0	0.0
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: AB_2685505"	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	5.6	4.7	7.3	4.7	11.2	7.2	4.9	6.3	12.0	5.4	3.5	4.9	8.9	4.4	5.2	11.9	3.7	17.4	5.7	3.7	6.6	3.9	4.5	2.5	6.7	4.6	2.8	6.4	7.0	4.9	7.1	17.8	3.7	5.4	4.5	2.9	8.3	4.1	5.7	3.7	9.6	4.5	5.3	3.5	4.6	4.3	11.4	3.7	5.8	14.9	3.7	2.6	4.3	4.5	0.5	0.4	2.6	1.0	0.5	0.8	0.4	7.6	4.2	5.7	4.4	5.1	7.4	4.4	4.0	4.1	5.6	4.4	4.0	6.7	4.0	10.1	4.5	3.8	7.2	2.8	6.8	2.8	4.9	6.5	3.4	7.7	3.6	3.5	6.6	5.2	6.0	3.4	6.6	4.2	3.4	3.9	9.7	6.1	4.3	2.5	5.6	8.0	6.6	1.0	4.0	4.5	6.9	3.6	6.5	2.5	1.0	18.0	5.5	6.3	4.6	6.6	2.6	6.1	7.2	3.5	8.1	3.4	13.4	4.9	5.2	6.9	4.0	3.4	8.4	2.1	2.6	1.0	0.0	0.5	0.2	0.8	0.3	0.5	0.0	0.4	0.5	0.4	0.0	1.4	0.5	0.8	0.3	0.2	0.4	7.3	11.2	6.3	12.0	6.6	3.9	2.8	6.4	5.4	3.7	0.0	0.6	0.0	1.0	3.5	6.4	2.5	5.1	5.3	5.7	3.5	31.4	0.5	1.7	0.8	1.5	2.2	1.6	0.0	1.6	0.4	1.8	1.5	0.0	1.5	1.7	4.8	3.5	1.3	4.3	1.0	3.7	2.6	10.1	1.0	2.3	5.4	1.9	2.6	2.1	1.4	19.4	6.5	2.1	11.2	6.0	4.5	0.9	0.7	1.2	0.9
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5991466-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.5;brain: 54.3"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 58.5;Kupffer cells: 65.2;Macrophages: 36.4;Melanocytes: 60.8"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 67.4;JURKAT: 36.3;U-937: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA					"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	6.9	4.8	37.8	21.5	34.7	57.5	2.7	13.5	54.3	2.7	4.2	4.2	0.5	3.7	3.4	2.1	4.1	6.2	8.1	8.1	44.6	13.1	10.9	3.8	13.9	31.2	16.1	24.7	3.2	2.2	1.3	6.1	4.5	28.7	2.7	4.1	10.8	3.1	2.5	4.0	9.0	7.4	5.0	5.8	21.9	5.3	3.1	4.7	13.9	2.4	0.5	17.0	9.0	1.7	6.8	19.6	11.4	21.1	9.2	19.8	22.8	2.5	7.0	0.6	0.8	0.3	1.2	2.4	1.3	8.5	1.4	1.7	2.5	1.2	14.9	4.3	0.9	1.3	0.9	0.5	0.1	0.8	17.4	2.4	18.3	7.1	4.2	1.3	67.4	0.5	1.3	0.3	0.9	1.7	1.2	1.1	36.3	0.5	28.4	0.7	2.2	12.9	29.0	0.4	1.1	3.1	2.6	2.1	17.6	0.2	0.0	4.3	1.5	1.0	1.2	22.2	0.6	1.0	26.0	0.2	0.3	2.5	2.6	1.5	21.5	25.1	21.2	2.6	71.8	0.5	2.1	21.1	11.4	19.8	17.6	18.7	6.0	13.0	19.1	19.6	6.8	13.8	14.5	9.0	9.2	15.4	8.1	13.6	22.8	37.8	34.7	13.5	54.3	44.6	13.1	16.1	24.7	28.7	4.7	0.0	10.0	20.6	1.6	4.2	16.5	12.6	7.6	9.4	2.3	1.8	5.9	0.5	0.0	0.3	4.5	3.4	0.0	0.0	1.2	1.7	3.5	0.3	8.1	0.8	58.5	6.4	0.0	4.3	65.2	3.1	3.4	36.4	60.8	5.4	0.2	4.3	0.5	0.0	2.5	35.2	11.0	0.0	3.1	3.8	3.2	2.5	0.7	34.8	0.0	0.8
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 17.0;U-2 OS: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	17.0	0.2	0.2	0.0	0.0	0.0	2.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8	0.0	0.0	0.0	0.0	0.1	60.3	1.7	0.0	0.0	0.0	3.5	11.8	0.0	0.0	0.0	202.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	212.9	0.0	0.0	0.0	67.4	0.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.4	0.0	48.3	0.0	0.9	3.4	17.0	0.4	0.0	0.0	0.0	0.0
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6181269-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068294			Approved	Nucleoplasm,Nucleoli		NA	NA		320000	Nucleoli	Nucleoplasm	"HPA068294: AB_2732781"	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	75.5	71.5	54.3	79.7	42.8	124.7	75.0	46.7	39.5	95.8	73.9	39.2	53.9	66.5	133.6	63.9	103.9	59.1	61.8	50.8	47.4	38.6	58.8	90.2	55.3	142.6	50.6	39.7	163.1	154.8	30.4	57.0	49.8	37.4	90.8	46.4	57.0	140.3	66.8	114.0	79.7	62.6	106.6	58.3	79.1	62.0	38.2	35.0	95.3	91.0	112.8	81.1	101.5	91.9	75.6	62.3	11.0	38.9	42.2	98.8	73.9	89.4	25.5	54.4	55.5	38.3	60.3	43.0	78.2	31.5	28.8	24.6	50.6	77.8	138.9	64.4	28.9	19.9	51.8	40.8	40.6	38.0	68.0	66.5	135.0	58.1	62.8	38.0	178.6	54.2	53.1	33.7	25.6	53.1	59.6	35.9	39.0	111.2	84.2	33.0	39.5	78.0	145.7	33.8	59.9	56.7	75.3	112.8	107.6	42.1	31.1	75.2	69.0	63.6	184.4	143.1	49.3	59.3	141.6	87.7	41.1	45.3	54.2	73.4	67.7	92.9	210.2	27.2	184.7	25.4	11.0	38.9	8.8	38.0	34.3	66.9	75.6	71.1	52.3	59.8	72.4	98.8	78.1	2.9	42.2	27.8	62.3	54.0	73.9	54.3	42.8	46.7	39.5	47.4	38.6	50.6	39.7	37.4	35.0	413.9	647.4	2117.2	1742.6	1617.7	195.0	241.8	1080.3	472.4	833.7	554.8	123.7	1561.4	1614.8	1042.5	368.7	1236.7	707.2	537.3	1569.0	2352.9	1052.3	1320.4	878.8	1234.2	1317.3	133.5	877.3	1218.4	1697.8	247.8	1877.2	1676.9	1020.7	1556.4	1647.3	322.2	1580.5	1090.7	1160.1	1724.2	283.7	763.2	1114.2	317.0	420.5	1692.2	1548.7	1448.0	2302.5	1714.3
RNF207	"C1orf188, FLJ32096, FLJ46380"	ENSG00000158286	"Ring finger protein 207"	Q6ZRF8	1	6205475-6221299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.2"	"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 28.2;Urothelial cells: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.8;HaCaT: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028378, HPA042535"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA028378: AB_10601157, HPA042535: AB_2678042"	"unprognostic (5.53e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	1.6	2.1	0.6	6.6	1.5	0.3	1.9	5.6	1.8	5.7	5.8	0.9	13.3	2.8	3.6	3.8	4.4	4.7	6.6	24.2	0.7	2.1	5.9	4.3	2.0	2.2	0.7	0.2	3.3	5.3	3.3	4.0	9.2	0.9	7.7	2.4	10.6	6.1	16.6	2.5	1.1	8.2	7.6	1.2	1.9	3.5	1.2	0.6	1.4	6.4	2.8	8.7	5.0	5.0	0.0	0.0	0.0	2.7	0.0	0.3	0.1	2.3	4.5	0.4	3.2	0.2	0.4	2.9	1.5	1.1	0.3	0.4	2.3	17.8	0.3	1.2	1.2	0.0	7.6	0.4	1.1	0.1	2.4	1.8	0.1	5.5	2.3	1.5	1.8	0.1	1.3	0.3	0.0	0.0	4.4	0.1	0.4	0.6	3.9	0.1	1.7	0.2	0.3	0.2	0.4	4.1	0.0	0.8	3.2	2.6	4.0	0.5	1.2	2.4	1.6	1.1	0.8	2.9	0.1	0.5	0.0	0.7	0.5	0.0	3.8	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.2	0.1	0.6	1.5	5.6	1.8	0.7	2.1	0.7	0.2	0.9	0.6	8.9	3.8	0.5	28.2	0.2	3.0	14.6	12.7	4.0	15.9	17.4	2.0	11.4	0.0	13.4	0.7	0.7	6.8	0.0	8.6	5.7	3.7	17.2	0.0	3.4	1.0	3.2	3.5	1.8	0.0	0.0	0.0	1.7	0.0	3.6	9.2	6.5	12.5	2.9	1.1	1.9	18.7	6.5	5.0	0.1	2.3	0.4	4.7	0.5	6.0	32.3
ICMT	"HSTE14, PCCMT, PPMT"	ENSG00000116237	"Isoprenylcysteine carboxyl methyltransferase"	O60725	1	6221193-6235972	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 126.5"	"Low region specificity"	"Detected in all"			"HPA032024, HPA032025"	Uncertain					NA	NA					"HPA032024: AB_2674115, HPA032025: AB_10601819"	"unprognostic (1.95e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.99e-3)"	19.0	20.9	11.2	11.4	22.6	3.2	37.4	20.1	19.8	19.8	16.6	12.9	13.3	17.3	18.0	19.7	19.0	15.1	17.7	28.5	11.5	10.3	23.5	14.5	17.2	13.9	13.9	8.4	8.7	20.2	26.2	24.0	20.3	12.7	16.2	16.0	21.5	15.4	18.2	41.3	16.9	22.8	19.8	11.1	11.3	13.5	9.1	7.8	13.0	18.1	30.3	17.2	15.4	13.6	4.1	6.2	4.1	5.1	4.6	7.4	3.9	12.7	11.9	16.4	16.0	50.4	20.1	7.0	30.8	20.8	18.4	14.0	12.7	10.4	14.0	11.9	24.4	15.8	17.4	18.7	13.1	19.6	27.9	18.1	9.6	17.5	9.7	9.8	15.1	13.7	12.8	8.8	19.2	7.3	12.3	14.2	11.7	9.3	11.1	20.7	8.0	15.1	10.5	11.0	23.2	16.6	12.7	23.1	8.1	22.1	9.4	22.3	10.9	15.1	36.0	13.2	19.1	9.4	12.8	17.6	21.0	8.2	24.5	22.1	10.3	20.1	11.3	10.3	35.0	10.8	4.1	4.2	3.6	7.4	5.1	6.5	2.7	6.0	7.3	3.9	4.1	5.4	4.5	1.8	4.6	4.0	6.2	3.4	3.9	11.2	22.6	20.1	19.8	11.5	10.3	13.9	8.4	12.7	7.8	20.8	8.9	6.0	9.0	5.6	15.7	32.2	20.4	24.1	19.4	27.9	29.5	48.9	11.6	19.2	3.3	13.5	31.1	0.0	19.1	66.8	18.8	11.7	4.7	21.7	25.0	46.1	21.9	21.5	8.6	2.9	19.2	7.9	6.8	10.8	18.3	15.1	21.2	7.0	24.8	31.9	55.6	12.9	15.5	13.4	29.6	9.2	26.8	10.0	19.9	12.3
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244192-6245578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 6.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 16.1"	"Region enriched"	"Detected in single"	30	"cerebellum: 39.0"	"Low region specificity"	"Detected in many"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR153	PGR1	ENSG00000158292	"G protein-coupled receptor 153"	Q6NV75	1	6247346-6260975	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 31.4;Horizontal cells: 60.4;Mucus-secreting cells: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 1.3;monocytes: 1.0;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.2;PC-3: 36.4;RH-30: 17.2;SCLC-21H: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007159	Approved					NA	NA					"HPA007159: AB_1849268"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (5.74e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	11.0	2.9	11.9	3.8	5.2	0.5	16.1	1.3	10.6	16.1	19.9	3.7	4.6	5.4	8.3	15.9	7.0	7.1	5.8	7.7	5.8	5.1	2.7	6.3	12.6	2.3	2.0	2.7	14.8	2.1	5.9	10.2	9.2	4.2	6.8	7.1	7.2	2.6	4.9	1.4	8.7	18.3	6.6	1.2	8.8	3.0	2.9	2.5	1.8	1.6	5.5	3.5	6.1	9.6	0.0	0.3	1.3	1.0	0.3	1.7	0.1	3.1	0.5	7.7	9.2	14.2	5.6	0.6	2.1	1.9	0.8	0.9	1.3	1.2	0.0	3.2	2.2	1.8	4.0	0.4	9.0	0.3	2.0	1.9	0.0	1.2	0.2	2.8	0.3	1.2	3.4	2.4	0.6	0.4	1.4	0.6	2.8	0.4	0.0	2.6	3.4	1.0	2.4	0.6	1.8	36.4	3.8	17.2	0.2	0.3	1.7	17.5	6.3	1.4	5.3	4.3	2.2	2.0	1.6	1.8	1.9	1.8	0.2	0.9	0.1	0.1	0.7	0.9	4.1	0.7	1.3	0.0	0.9	1.4	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.3	0.0	0.1	11.9	5.2	1.3	10.6	5.8	5.1	2.0	2.7	4.2	2.5	0.0	0.0	0.0	1.1	3.1	0.6	3.9	5.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.9	1.4	4.5	0.0	0.0	0.2	15.5	0.6	1.1	31.4	0.9	60.4	3.4	1.3	1.0	1.5	4.4	2.8	5.0	3.6	39.4	2.0	0.4	4.8	7.1	1.4	1.8	0.0	3.9	0.0	1.5	6.5	0.3	0.5	1.8	13.5
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.7	20.7	20.4	22.0	4.7	7.8	7.7	20.5	10.6	30.4	18.2	71.4	7.7	29.1	15.1	16.6	23.5	23.5	32.9	54.7	11.4	25.5	28.7	15.3	16.4	25.3	19.3	17.9	12.7	6.9	10.5	25.1	29.8	8.1	17.0	36.5	12.4	6.3	16.0	27.7	37.3	19.0	10.2	23.9	48.0	44.6	23.5	19.7	17.1	9.1	11.2	31.7	18.4	28.3	65.2	10.5	10.1	8.4	27.5	27.7	16.2	27.4	32.3	5.3	21.6	40.9	17.5	31.3	16.8	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9	6.0	25.5	13.7	13.3	28.2	33.6	8.1	12.7	1.4	7.9	8.7	9.8	15.1	13.3	19.1	73.6	15.6	70.9	0.0	6.2	23.1	14.2	7.0	137.0	13.4	26.8	44.5	4.6	5.5	4.0	118.5	3.4	16.9	37.1	25.2	88.8	10.6	16.5	29.1	6.7	214.2	15.6	0.0	6.2	38.2	26.7	25.7	14.4	21.4	48.7	19.5
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;placenta: 60.9"	"Cell type enhanced"	"Detected in many"	11	"Mucus-secreting cells: 46.1;Paneth cells: 29.4;Syncytiotrophoblasts: 83.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.9;HaCaT: 20.3;HBEC3-KT: 17.5;hTCEpi: 10.1;PC-3: 7.3;TIME: 29.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039462	Uncertain					NA	NA					"HPA039462: AB_10673533"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.8	0.0	0.2	0.7	0.2	0.2	0.7	0.2	0.3	6.7	6.0	0.2	0.2	0.1	0.4	0.4	22.6	2.5	0.2	0.2	0.2	0.0	1.0	0.4	3.8	0.2	0.2	0.2	0.5	0.2	0.2	0.4	60.9	0.3	1.2	4.6	0.5	2.9	0.6	0.2	14.5	0.9	0.2	0.2	0.2	0.0	1.8	0.2	0.7	0.2	8.6	6.0	0.3	11.9	0.6	0.6	4.9	0.4	0.5	0.6	0.2	0.9	0.3	0.0	0.1	0.2	0.0	10.9	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.9	0.1	0.1	20.3	0.5	17.5	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.0	10.1	0.0	0.4	0.0	5.3	0.0	0.1	0.2	0.0	1.5	0.0	0.8	0.0	1.1	7.3	0.0	0.0	0.1	0.1	0.3	0.1	0.0	1.0	5.7	0.2	1.1	0.8	0.3	29.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.6	0.5	0.3	0.3	0.4	0.5	0.4	0.1	0.6	0.4	0.6	3.9	0.5	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2	8.9	4.6	0.8	5.2	5.8	1.5	8.1	0.0	16.0	7.9	1.8	3.9	1.5	0.0	0.3	11.3	1.8	8.9	0.0	0.0	3.6	1.9	8.3	1.1	0.0	0.9	0.0	2.9	1.8	0.3	25.8	0.3	1.3	1.7	0.0	46.1	1.2	0.3	29.4	0.7	3.3	5.4	0.0	1.0	5.6	5.7	17.1	83.1	0.0	11.0	21.1
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.4;liver: 54.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 302.8;Late spermatids: 360.4;Muller glia cells: 292.0;Paneth cells: 221.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 6.0"	"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.0;Hep G2: 27.1;SK-BR-3: 55.6;T-47d: 18.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	1.4	0.6	2.5	0.8	6.7	2.9	6.0	0.7	13.3	44.8	0.6	9.2	27.1	1.2	19.7	9.9	6.3	1.2	0.6	1.0	0.1	14.3	54.9	1.6	0.6	0.6	0.6	2.4	0.6	12.9	12.1	1.3	0.6	2.6	1.7	19.5	2.9	4.7	0.6	27.1	70.4	1.0	0.6	0.6	0.4	37.7	0.6	1.2	0.7	2.4	3.2	0.8	5.9	0.0	0.0	0.0	0.0	0.0	3.6	0.3	4.6	0.2	0.2	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	10.1	0.5	0.1	2.3	0.0	0.0	11.1	0.8	0.0	0.0	0.6	0.2	0.1	0.2	27.1	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.3	5.7	0.0	0.0	9.4	0.0	0.3	0.2	1.2	4.2	0.0	0.1	3.6	0.0	0.0	7.3	0.3	1.3	55.6	1.7	0.1	18.5	2.4	5.3	0.0	0.2	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.6	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.6	0.8	6.0	0.7	1.0	0.1	0.6	0.6	0.6	0.6	0.0	1.1	1.4	1.7	6.9	5.5	1.1	5.1	1.4	1.2	8.7	64.8	2.2	11.6	0.3	114.4	0.6	302.8	23.3	2.9	0.4	0.4	1.4	0.0	99.9	0.2	0.0	5.8	3.1	2.9	360.4	3.4	0.3	0.0	0.0	16.1	292.0	0.1	221.0	2.1	91.6	68.8	0.0	0.0	2.6	2.5	19.8	5.5	0.8	19.0	3.2
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.6	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.3	2.2	0.0	3.0	0.0	1.0	3.2	0.4	3.7	0.0	20.2	1.5	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.2	1.9	3.2	0.9	0.0	0.0	0.0	1.6	0.0	8.0	1.0	1.1	5.5	0.6	0.2	19.7	0.8	0.5	3.9	5.4	0.0	1.9	0.1	0.3	1.7	2.2	1.7	1.0	1.5	0.0	1.5	0.0	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8	3.0	5.3	0.5	1.8	21.9	0.8	0.8	2.5	2.7	2.3	1.8	2.0	0.4	0.0	0.1	0.3	5.5	16.9	0.0	0.4	1.6	3.2	1.1	6.9	1.1	3.2	4.8	6.4	9.8	1.6	0.0	2.6	2.1	6.8	1.0	17.6	11.2	0.9	11.5	8.9	0.3	9.3	0.0	0.8	0.5	1.1	25.0	0.1	36.2	28.4	6.7
PLEKHG5	"GEF720, KIAA0720, Syx, Tech"	ENSG00000171680	"Pleckstrin homology and RhoGEF domain containing G5"	O94827	1	6466092-6520061	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.8;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 12.9;Suprabasal keratinocytes: 12.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 17.5"	"Group enriched"	"Detected in many"	4	"amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2"	"Low region specificity"	"Detected in all"			HPA049570	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049570: AB_2680818"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.50e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.85e-2)"	10.6	9.7	8.7	2.9	6.3	0.7	4.1	59.8	11.6	3.9	3.0	1.2	2.5	3.3	3.8	4.5	7.1	3.9	6.5	5.4	7.7	2.9	2.3	0.8	3.6	2.7	1.8	6.7	2.6	3.1	4.0	15.2	7.6	4.4	3.4	2.8	4.9	4.2	5.3	3.4	60.0	4.3	2.7	1.8	16.9	2.6	2.6	1.4	0.0	2.4	6.5	4.8	2.3	4.4	0.5	0.6	2.1	0.5	0.3	1.0	0.4	4.0	1.1	8.1	4.7	0.8	2.8	1.4	5.5	3.1	1.7	1.0	2.3	8.0	0.1	12.6	1.8	3.1	13.7	0.9	12.0	0.9	7.9	1.6	0.0	5.6	1.4	1.2	0.0	0.7	2.9	6.4	5.9	6.9	10.5	12.3	0.9	0.0	1.0	0.4	3.4	0.1	15.6	2.5	1.2	12.2	0.1	1.0	1.1	4.3	1.3	5.2	14.9	0.6	4.1	0.3	4.1	5.4	0.1	17.5	4.2	3.0	0.0	3.3	0.1	0.0	0.9	4.6	0.0	0.3	1.8	0.5	0.3	0.4	0.4	1.0	0.2	0.8	0.7	0.1	0.5	0.5	0.6	2.1	0.3	0.2	0.6	0.2	0.4	8.7	6.3	59.8	11.6	7.7	2.9	1.8	6.7	4.4	1.4	0.0	1.0	0.0	2.1	6.5	0.6	3.2	2.5	1.4	2.3	3.5	2.0	2.2	0.0	1.1	8.6	4.5	3.3	0.0	1.2	3.3	1.8	1.4	0.0	0.0	4.0	1.6	3.4	5.5	1.2	2.6	1.7	0.0	0.0	0.0	5.2	9.2	3.3	5.8	8.1	0.6	1.5	12.9	1.0	1.9	3.2	12.7	1.6	0.0	2.7	5.5
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.4	4.2	12.6	5.6	3.4	4.5	5.1	3.3	5.3	5.6	10.1	7.0	14.3	6.1	5.7	4.6	6.8	8.4	6.9	9.2	5.8	4.5	9.7	11.4	7.9	5.6	8.2	5.4	4.9	2.1	11.3	9.9	3.1	6.2	6.4	11.4	6.0	5.4	8.9	8.0	7.4	5.7	4.0	7.2	10.2	9.8	6.7	4.2	4.8	8.1	3.7	7.9	10.0	6.2	4.5	6.5	3.8	8.1	8.5	6.9	6.0	8.5	5.1	4.8	26.1	7.9	9.2	4.0	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2	17.9	17.9	11.5	5.7	13.7	15.8	12.1	10.2	9.4	7.9	7.0	13.7	13.0	13.3	8.4	4.6	11.3	5.8	0.0	7.4	11.0	11.7	4.8	4.7	11.6	7.8	9.5	6.4	17.2	11.4	13.3	8.9	6.5	1.7	10.0	11.7	7.2	7.8	7.0	12.0	7.8	17.0	0.0	11.1	10.8	19.7	12.9	10.6	15.7	11.8	5.3
TAS1R1	"GPR70, T1R1, TR1"	ENSG00000173662	"Taste 1 receptor member 1"	Q7RTX1	1	6555181-6579757	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"salivary gland: 10.9;testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.0;Late spermatids: 14.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.7;HDLM-2: 4.7;Hep G2: 4.6;LHCN-M2: 3.7;U-698: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034579, HPA034580"	Approved					NA	NA					"HPA034579: AB_2674232, HPA034580: AB_10671504"	"unprognostic (2.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.53e-4)"	"unprognostic (3.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.22e-2)"	0.4	0.8	0.7	0.1	0.8	1.5	0.4	0.6	1.2	0.7	0.9	0.1	0.1	0.4	0.1	0.1	0.4	0.4	1.0	0.1	1.2	0.2	0.1	0.1	0.6	0.2	0.2	0.1	0.9	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.7	10.9	2.1	0.6	1.4	0.5	0.1	0.1	1.3	0.5	8.7	0.1	0.1	0.1	2.2	0.5	0.4	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.5	0.1	0.3	0.1	2.7	0.0	0.0	0.3	0.0	0.0	4.7	0.0	0.0	0.1	4.6	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.7	0.8	0.6	1.2	1.2	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.1	0.0	0.0	0.0	0.0
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6580001-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.8	12.0	9.6	15.1	12.6	13.3	12.3	11.1	16.3	13.5	12.2	12.7	21.4	11.7	13.2	15.1	12.7	14.2	17.6	9.6	8.9	7.5	12.9	21.6	14.3	17.1	7.0	11.3	19.9	15.8	17.1	14.0	10.7	11.4	17.2	13.2	16.9	12.6	11.7	10.9	14.4	17.2	11.3	8.8	17.1	12.9	28.2	10.3	19.9	18.4	7.4	15.9	13.0	14.4	7.5	7.8	26.7	6.8	6.6	6.4	5.3	3.9	4.8	7.6	11.1	8.5	6.6	3.9	4.0	4.8	7.7	8.4	4.9	9.1	13.1	7.2	3.5	5.3	7.4	11.5	8.0	6.2	13.3	10.9	10.6	13.9	4.8	10.1	17.0	28.8	6.6	6.2	7.5	12.1	10.4	5.6	10.0	10.4	8.6	5.7	7.6	8.3	12.2	5.7	7.7	8.3	9.5	7.1	14.4	6.9	3.7	14.9	6.9	6.0	13.8	9.2	8.3	7.9	13.7	6.3	5.3	3.5	5.7	5.0	9.4	8.1	20.3	4.9	13.7	3.0	10.9	6.8	26.7	6.0	4.2	6.0	6.5	4.7	5.7	7.8	7.5	6.4	5.5	10.0	6.6	6.6	5.0	3.8	5.3	9.6	12.6	11.1	16.3	8.9	7.5	7.0	11.3	11.4	10.3	3.0	10.5	6.7	8.5	4.1	7.1	4.5	12.7	13.4	7.9	10.4	5.9	5.1	10.0	4.1	36.3	4.7	15.8	0.0	3.2	4.1	5.8	5.2	26.5	11.6	9.6	9.5	14.9	4.3	6.2	14.2	8.1	9.8	5.0	10.0	12.7	10.4	2.7	14.0	5.3	10.5	7.4	19.4	5.2	17.7	10.4	4.8	4.2	10.1	9.5	5.8
KLHL21	KIAA0469	ENSG00000162413	"Kelch like family member 21"	Q9UJP4	1	6590724-6614607	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 63.3;Cardiomyocytes: 54.0;Suprabasal keratinocytes: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 9.7;neutrophil: 31.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 31.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051364, HPA059307"	Uncertain		Supported	Centrosome		NA	NA			Centrosome		"HPA051364: AB_2681455, HPA059307: "	"unprognostic (6.13e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.33e-3)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.19e-2)"	18.1	11.3	8.7	7.8	16.1	13.6	20.0	7.3	12.7	11.9	14.6	19.1	12.0	4.6	13.7	6.0	17.3	8.5	14.8	20.5	8.6	7.3	11.7	9.1	8.7	7.5	31.2	5.4	18.0	21.0	8.7	11.2	4.4	14.0	15.7	3.5	17.1	20.4	19.4	58.7	15.1	5.4	22.9	9.9	6.5	10.1	6.6	22.4	4.5	10.1	13.8	7.4	19.4	19.5	2.2	1.8	31.2	3.0	1.4	3.8	2.5	9.9	6.0	3.1	9.8	17.2	10.8	7.9	14.1	11.3	9.4	5.6	17.4	6.4	0.4	12.5	8.6	8.4	16.6	6.6	15.5	5.2	21.2	10.7	11.5	10.7	15.6	14.3	6.8	7.1	12.0	5.3	21.2	7.2	8.8	3.9	5.9	12.7	9.3	7.6	3.4	7.0	6.0	5.6	5.1	22.3	10.9	12.7	12.5	5.5	3.1	12.3	3.1	11.0	8.9	24.8	2.8	5.8	8.2	13.2	30.5	3.7	27.9	33.6	10.7	13.2	7.0	29.6	13.0	11.4	3.6	3.0	9.7	3.6	1.2	3.3	2.2	3.4	3.6	1.8	1.4	2.9	2.7	31.2	1.4	1.1	1.7	3.8	2.5	8.7	16.1	7.3	12.7	8.6	7.3	31.2	5.4	14.0	22.4	3.0	3.2	3.4	36.6	63.3	3.8	54.0	7.6	4.0	6.8	8.7	3.9	3.9	6.6	11.1	1.9	7.8	6.7	0.0	11.1	5.9	19.3	38.3	0.0	20.8	4.9	4.8	2.9	6.7	6.0	4.1	10.0	4.2	25.3	6.4	4.7	12.1	14.2	4.9	14.2	5.5	5.3	12.9	35.0	2.1	13.4	63.0	5.4	2.5	4.8	30.6
PHF13	MGC43399	ENSG00000116273	"PHD finger protein 13"	Q86YI8	1	6613685-6624033	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026830	Uncertain					NA	NA					"HPA026830: AB_1855288"	"unprognostic (6.59e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (9.84e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.05e-1)"	11.9	8.8	8.6	6.5	10.0	9.1	23.0	6.8	11.4	17.5	13.7	7.6	11.8	6.2	16.9	12.4	16.8	12.8	12.3	7.7	6.7	7.0	6.5	14.0	10.0	7.6	7.2	8.8	14.7	11.6	9.1	9.7	12.1	10.8	11.3	4.3	5.1	11.1	13.1	11.5	12.5	6.9	14.4	11.5	8.7	9.1	39.6	7.3	10.9	9.3	10.2	6.9	16.1	14.8	3.0	2.3	8.1	3.3	4.6	7.0	3.6	12.2	5.8	17.3	21.2	8.9	12.3	10.1	19.0	14.1	15.1	13.9	11.5	12.0	11.1	7.5	14.5	9.4	10.5	11.3	12.3	15.1	14.6	14.8	16.9	9.5	9.7	9.4	4.5	11.4	13.6	5.3	14.5	6.8	16.9	9.3	10.6	20.1	8.1	12.9	13.7	10.3	12.7	12.7	6.5	10.1	17.8	13.6	6.0	8.2	6.4	12.3	15.3	8.1	14.3	12.4	12.5	11.5	8.6	9.7	26.6	13.0	10.9	9.2	17.0	16.4	18.8	14.7	11.7	5.6	4.2	2.3	8.1	4.8	2.2	7.0	3.0	5.8	4.4	2.3	2.9	3.9	4.6	7.7	4.6	3.3	2.2	4.5	3.6	8.6	10.0	6.8	11.4	6.7	7.0	7.2	8.8	10.8	7.3	3.0	5.3	5.1	17.3	33.3	6.4	4.7	5.1	4.0	3.4	3.5	0.0	10.0	8.3	5.4	4.2	7.0	3.3	0.0	3.3	9.4	10.4	15.1	4.7	8.9	3.6	17.5	7.5	6.7	5.9	6.3	9.8	4.4	15.1	5.4	3.7	10.0	4.8	2.9	7.4	3.6	6.3	25.8	8.3	16.4	33.4	35.1	17.7	5.7	3.1	10.4
THAP3		ENSG00000041988	"THAP domain containing 3"	Q8WTV1	1	6624866-6635586	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067114	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		No	No			Nucleoplasm	"Nucleoli, Mitochondria"	"HPA067114: AB_2685782"	"unprognostic (1.82e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.26e-3)"	14.2	17.2	16.4	11.4	16.8	12.9	31.4	21.5	20.3	16.5	16.6	13.8	11.8	12.0	15.2	13.6	11.8	16.3	11.9	19.0	16.0	14.5	17.2	17.3	10.8	15.5	18.1	14.1	23.7	28.8	12.1	14.2	11.4	17.6	17.0	7.2	11.5	24.8	16.7	20.9	14.2	11.4	12.7	13.0	15.3	12.0	11.9	16.3	11.6	22.6	9.0	12.9	17.2	21.6	22.2	18.0	10.6	14.7	17.0	22.0	15.0	9.9	9.4	8.6	12.4	14.3	12.9	8.3	9.0	11.8	24.0	15.0	12.6	6.3	8.8	12.2	9.9	8.9	7.9	13.6	8.0	8.4	15.1	22.3	10.1	12.6	11.2	17.9	7.1	10.5	12.0	10.3	15.1	13.3	14.7	10.3	15.5	10.2	11.4	8.8	6.9	12.4	16.2	7.4	11.7	16.0	11.9	10.5	12.7	10.7	2.4	11.4	12.9	11.0	15.2	20.8	7.5	9.7	12.9	9.3	12.8	7.7	8.7	14.0	12.9	13.7	11.6	10.8	15.4	7.2	10.2	14.7	10.6	20.1	11.7	20.2	17.1	19.7	20.8	18.0	22.2	22.0	18.5	9.0	17.0	9.1	16.4	19.3	15.0	16.4	16.8	21.5	20.3	16.0	14.5	18.1	14.1	17.6	16.3	0.0	6.9	9.8	10.6	12.5	10.9	5.6	7.6	14.7	3.4	8.7	5.9	12.9	16.6	9.6	5.3	14.0	11.6	23.3	9.0	15.6	14.6	13.0	5.7	10.0	13.4	4.8	7.5	10.4	13.2	2.3	17.3	8.3	10.1	22.6	7.7	9.8	9.8	8.4	21.9	15.1	6.9	12.9	20.6	8.1	16.0	12.9	13.7	9.2	11.5	13.7
DNAJC11	FLJ10737	ENSG00000007923	"DnaJ heat shock protein family (Hsp40) member C11"	Q9NVH1	1	6634168-6701924	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023707, HPA028705"	Uncertain		Supported	Mitochondria		No	No			Mitochondria		"HPA023707: , HPA028705: AB_10603662"	"unprognostic (3.74e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (9.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.38e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.04e-1)"	13.8	24.0	20.5	16.1	25.2	10.2	12.7	19.1	31.3	13.0	23.4	17.3	10.5	22.4	14.6	11.2	19.5	12.7	11.9	26.9	15.7	13.0	33.5	25.8	11.2	14.4	13.9	19.6	16.5	15.3	21.4	13.4	15.5	25.0	12.6	27.4	15.4	13.8	12.4	44.2	16.6	19.5	15.1	14.6	19.6	16.2	12.4	14.2	12.6	12.3	17.2	18.4	14.0	12.6	8.1	12.2	7.2	13.4	10.0	10.1	8.6	16.6	16.3	19.3	17.5	16.9	11.9	17.8	16.7	14.4	33.3	23.6	19.6	24.2	26.8	16.3	19.2	14.2	22.6	33.0	27.0	29.5	15.1	22.7	27.3	31.0	19.7	16.4	32.8	15.0	17.2	7.5	30.0	19.8	11.9	15.6	20.5	34.4	12.0	16.7	13.5	20.3	16.9	19.6	23.4	28.1	22.7	16.7	19.4	21.3	14.6	25.8	18.3	19.1	39.2	20.9	17.0	15.4	17.0	15.3	19.8	10.6	16.3	19.5	13.9	15.1	35.6	19.2	35.7	9.8	7.2	9.6	3.4	9.4	12.5	9.4	8.1	6.9	10.1	12.2	8.1	7.4	5.9	0.3	10.0	13.4	5.3	7.2	8.6	20.5	25.2	19.1	31.3	15.7	13.0	13.9	19.6	25.0	14.2	8.9	10.2	8.3	3.9	17.4	16.6	8.1	2.5	14.7	7.9	12.2	27.5	18.0	29.9	12.1	11.3	7.5	24.2	0.0	11.9	18.8	12.3	3.0	4.7	10.6	14.8	19.1	14.0	5.5	7.6	7.4	7.5	11.1	27.0	8.2	26.0	12.1	9.7	21.0	4.2	25.9	17.5	6.5	14.4	13.3	12.2	15.9	19.9	4.8	33.7	4.8
CAMTA1	KIAA0833	ENSG00000171735	"Calmodulin binding transcription activator 1"	Q9Y6Y1	1	6785324-7769706	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036342, HPA036343"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA036342: AB_2675072, HPA036343: AB_10671839"	"unprognostic (1.11e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (3.90e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.17e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.03e-3)"	18.4	24.3	31.6	12.2	30.7	12.1	21.7	24.4	37.1	16.5	30.2	19.9	13.2	28.3	20.0	46.7	22.7	16.8	17.7	58.1	26.4	27.6	36.7	37.2	16.5	13.3	31.2	26.5	17.1	18.6	22.0	17.6	14.3	47.5	22.2	27.1	25.0	27.1	29.6	48.0	12.9	30.4	38.4	23.9	15.7	21.5	23.0	19.4	14.7	30.8	20.5	17.5	31.3	18.7	19.8	32.3	28.3	32.4	10.3	18.1	18.9	22.0	12.4	34.6	17.5	17.9	27.4	9.7	23.9	18.4	25.8	21.9	15.0	28.0	18.3	18.8	25.0	17.3	13.7	18.0	24.7	36.9	13.7	19.6	20.6	29.4	29.2	29.1	15.6	15.0	18.3	17.2	18.6	28.7	22.3	28.7	26.1	14.4	24.9	29.7	21.3	20.7	42.9	23.9	28.1	14.6	13.9	30.8	40.5	34.8	12.9	35.8	28.9	16.9	25.2	36.8	26.0	13.6	19.6	16.7	18.4	15.6	18.9	14.8	19.0	23.5	49.2	27.5	35.2	10.3	27.5	32.4	28.3	11.5	19.4	12.5	19.8	18.0	14.2	30.6	16.2	14.7	12.8	6.6	10.3	14.7	32.3	18.1	18.9	31.6	30.7	24.4	37.1	26.4	27.6	31.2	26.5	47.5	19.4	50.6	45.6	87.6	306.4	275.2	103.9	495.7	107.0	68.3	46.6	181.5	237.6	60.6	354.8	147.0	138.1	160.0	190.4	46.7	180.4	116.8	142.3	320.6	54.3	215.1	94.9	149.4	125.6	81.6	94.6	111.6	70.8	142.3	226.0	196.6	153.7	60.0	175.4	166.1	120.9	611.1	144.7	135.8	271.7	133.0	213.0	247.2	73.7	58.9	164.9	354.7
VAMP3	CEB	ENSG00000049245	"Vesicle associated membrane protein 3"	Q15836	1	7771269-7781432	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.09e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.15e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.49e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.30e-2)"	52.6	35.6	36.0	20.3	43.9	42.4	35.9	14.8	37.6	37.1	28.8	92.8	19.3	27.0	45.3	30.1	40.5	29.4	28.2	32.8	38.9	30.4	38.3	27.2	39.3	25.8	63.3	26.1	35.9	17.8	31.7	24.9	45.4	50.2	31.4	32.9	41.3	23.1	37.9	34.8	33.6	41.5	37.7	90.6	34.2	26.3	25.4	48.2	14.7	30.0	37.1	26.8	36.4	29.9	5.1	15.8	31.2	26.0	6.8	7.4	9.5	19.1	13.7	14.8	17.6	40.6	45.9	10.4	34.7	39.4	37.4	35.4	14.9	24.9	2.5	19.6	43.6	19.1	16.8	16.1	23.4	48.1	2.0	20.1	12.4	12.8	20.7	26.4	7.3	12.3	37.3	17.6	26.5	21.7	37.0	45.0	5.7	12.7	11.8	52.0	8.6	5.5	6.5	6.5	21.6	24.1	4.6	21.5	7.8	29.2	11.1	4.0	15.5	30.1	14.9	31.0	18.5	15.0	7.8	39.8	33.7	11.6	34.8	16.6	9.8	13.2	7.5	38.5	29.8	26.4	17.4	22.6	22.3	6.3	26.0	6.4	5.1	6.0	5.5	15.8	4.4	4.9	5.2	31.2	6.8	22.5	5.2	7.4	9.5	36.0	43.9	14.8	37.6	38.9	30.4	63.3	26.1	50.2	48.2	44.7	33.7	17.9	51.0	38.7	12.1	38.3	22.9	33.5	28.4	38.4	3.9	70.0	54.7	60.2	19.5	76.7	51.9	0.0	44.0	93.9	39.8	49.7	55.6	30.6	70.0	7.9	30.0	58.9	66.5	9.8	30.0	70.1	54.0	65.9	37.0	79.1	68.1	40.3	44.2	73.6	8.3	45.3	66.3	48.4	39.6	44.8	95.8	20.8	36.2	80.6
PER3		ENSG00000049246	"Period circadian regulator 3"	P56645	1	7784320-7845177	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 194.4;Cone photoreceptor cells: 76.6;Horizontal cells: 117.6;Muller glia cells: 119.7;Rod photoreceptor cells: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019530	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA019530: AB_1855201"	"unprognostic (5.11e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.87e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.62e-1)"	10.2	9.1	10.9	6.0	15.6	0.5	10.4	42.4	17.5	13.5	14.5	22.5	11.2	5.0	16.2	8.9	13.9	10.8	13.5	17.2	10.1	9.4	10.4	20.5	9.6	3.3	11.2	10.7	15.7	13.3	16.0	15.2	2.1	13.4	13.0	5.5	23.2	18.8	17.7	20.4	11.1	7.4	18.5	16.2	6.7	14.0	8.7	10.9	0.9	19.0	15.6	7.1	13.2	9.5	1.3	1.8	1.1	3.3	0.9	5.1	1.6	4.2	1.2	3.8	1.1	0.7	0.3	1.1	1.8	3.3	3.4	4.7	5.1	16.9	1.9	1.0	7.4	5.8	2.0	13.5	0.8	5.2	0.1	0.7	13.5	5.0	0.7	4.3	0.4	4.7	1.9	1.5	3.7	3.8	7.1	1.2	1.0	10.9	3.6	1.4	3.4	7.4	6.0	2.0	9.5	3.6	6.5	1.3	0.1	1.9	0.8	4.9	5.2	15.9	0.0	6.8	4.0	4.1	0.5	2.5	9.3	13.6	2.8	2.4	0.5	0.3	1.6	6.5	21.5	12.9	0.9	1.6	1.1	4.2	2.0	5.1	1.3	2.0	3.8	1.8	0.8	1.7	2.1	0.2	0.9	3.3	1.4	3.1	1.6	10.9	15.6	42.4	17.5	10.1	9.4	11.2	10.7	13.4	10.9	17.9	8.9	1.5	10.8	26.8	194.4	12.3	12.7	12.0	12.5	8.7	76.6	1.4	8.3	2.2	12.3	14.6	4.5	0.0	4.0	0.2	16.4	8.7	25.4	22.2	7.6	117.6	6.3	6.2	4.5	5.0	11.5	7.2	11.8	2.8	2.7	119.7	4.4	1.4	25.8	4.4	141.4	6.5	24.4	17.6	21.8	22.3	0.5	4.4	1.2	6.1
UTS2	"PRO1068, U-II, UCN2, UII"	ENSG00000049247	"Urotensin 2"	O95399	1	7843083-7853512	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 25.4;brain: 19.8"	"Cell type enriched"	"Detected in some"	5	"granulocytes: 40.4"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	19	"hypothalamus: 5.2;pons and medulla: 19.8"	"Cell type enriched"	"Detected in many"	6	"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 25.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.8;HEL: 5.9;HMC-1: 5.0;THP-1: 21.5"									HPA017000	Uncertain				"Secreted to blood"	NA	NA	2590000				"HPA017000: AB_1858656"	"unprognostic (2.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-5)"	"unprognostic (1.09e-4)"	"unprognostic (4.95e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.30e-3)"	1.0	6.3	0.3	0.6	0.3	5.2	0.3	0.3	0.3	0.5	1.2	0.4	1.2	1.1	0.3	0.3	0.3	0.6	0.9	0.3	0.6	5.2	0.3	0.3	0.6	2.9	0.3	0.3	0.4	0.3	0.0	0.3	0.3	19.8	2.0	2.4	0.3	0.3	0.3	0.3	0.5	1.0	2.3	12.7	2.1	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.9	0.3	0.0	0.4	4.1	0.0	3.2	25.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	0.0	0.3	3.0	0.0	4.0	0.0	2.7	2.8	0.4	0.0	0.2	0.8	0.0	3.2	0.0	0.0	25.4	0.9	0.3	0.3	0.3	0.3	0.6	5.2	0.3	0.3	19.8	0.3	0.0	3.4	0.8	0.0	1.3	1.8	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	40.4	0.0	0.1	4.8	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.5	0.8	0.1	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.4	0.1	6.9	8.4	0.0
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915894-7943165	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 13.5;lymphoid tissue: 18.3"	"Group enriched"	"Detected in some"	4	"granulocytes: 62.3;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 47.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071425			Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA071425: AB_2686394"	"unprognostic (7.23e-2)"	"unprognostic (1.72e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-4)"	"unprognostic (9.47e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.69e-8)"	"unprognostic (1.64e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.55e-2)"	0.8	1.0	0.3	11.0	0.3	1.9	0.5	0.2	0.3	0.4	0.5	0.1	0.1	0.6	0.3	0.1	0.6	0.8	1.6	1.8	0.3	1.0	0.7	0.7	2.1	10.8	0.3	0.1	0.3	0.6	0.0	0.5	0.2	0.5	0.4	0.7	0.3	2.1	0.1	0.3	0.5	2.3	0.1	0.3	7.9	0.7	0.5	0.1	18.3	0.7	0.9	17.5	1.4	0.4	0.5	1.1	6.6	1.5	4.1	13.5	1.1	1.2	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	1.0	0.4	0.1	0.4	0.0	0.8	0.2	0.0	0.2	0.5	47.0	0.1	0.2	0.2	0.0	0.9	0.0	0.5	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.2	0.2	0.2	1.6	0.1	0.2	0.1	0.1	0.1	5.8	0.2	0.0	1.1	1.5	0.2	1.5	0.4	0.2	0.2	1.0	8.0	1.1	0.5	0.3	1.6	6.6	4.1	0.1	0.3	13.5	1.1	0.3	0.3	0.2	0.3	0.3	1.0	0.3	0.1	0.5	0.1	0.0	1.7	0.0	0.4	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	1.0	0.0	0.4	0.3	62.3	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	1.8	5.0	53.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.0	12.9	0.0	0.3
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		69000000	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	44.6	67.9	69.3	38.1	64.9	33.7	45.4	57.2	62.7	34.0	36.4	33.4	43.2	27.3	35.8	56.6	40.9	39.0	41.6	71.7	56.9	57.2	60.5	77.1	28.6	46.1	61.6	57.2	45.9	60.4	66.6	48.4	44.6	41.2	44.7	39.5	38.6	46.5	39.4	128.7	19.8	27.5	48.1	52.5	37.5	37.2	38.2	32.2	38.8	71.6	43.3	46.5	41.3	43.4	49.5	141.8	38.8	61.0	52.8	87.2	90.6	68.3	61.6	61.4	70.6	66.1	63.6	30.1	63.7	59.8	62.8	50.7	56.2	75.0	84.8	72.1	68.4	44.1	49.2	66.2	85.2	81.6	75.5	71.6	91.2	92.1	83.3	57.1	87.0	56.2	59.9	36.4	63.9	76.9	49.2	65.7	44.7	88.5	63.2	87.0	64.1	60.5	110.6	50.1	84.9	63.7	46.6	82.5	116.3	98.4	35.2	71.9	60.4	63.7	98.5	99.5	53.8	54.9	64.8	62.3	57.9	46.2	53.4	69.8	61.4	98.5	120.8	76.4	133.2	82.0	22.7	61.0	38.8	52.6	55.4	49.7	49.5	52.7	62.2	73.9	38.6	45.6	52.4	21.0	52.8	44.1	141.8	87.2	90.6	69.3	64.9	57.2	62.7	56.9	57.2	61.6	57.2	41.2	32.2	122.1	136.9	226.3	328.5	185.6	175.5	422.7	221.7	227.5	176.3	235.5	74.6	504.6	721.2	419.3	26.4	207.3	136.6	46.7	416.0	502.3	279.0	413.5	199.9	332.4	385.8	176.4	228.6	156.5	174.9	43.1	331.6	265.8	340.8	806.1	224.5	530.4	359.6	213.9	356.1	742.4	177.0	271.7	346.0	212.8	299.8	125.7	392.7	243.9	261.6	388.0
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026308	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 141.1;pancreas: 133.6"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 1158.6;Basal keratinocytes: 1103.5;Hepatocytes: 716.0;Suprabasal keratinocytes: 640.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 94.3;LHCN-M2: 72.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076543			Supported	Cytosol		NA	NA			Cytosol		"HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	38.6	8.8	4.4	6.3	6.3	0.6	27.8	9.6	7.0	17.5	13.6	5.4	8.4	6.8	15.9	9.6	13.6	12.2	27.3	8.8	4.7	2.5	32.6	141.1	15.5	7.7	7.5	3.7	29.7	133.6	7.7	41.9	33.7	8.1	9.3	5.1	12.0	14.5	5.9	68.3	20.2	26.5	22.9	12.5	2.1	22.3	7.4	5.2	0.6	19.4	4.7	3.8	20.0	19.5	0.4	0.3	0.2	4.9	0.0	1.3	0.2	13.4	7.9	3.4	4.6	32.4	24.3	35.5	13.2	3.8	2.4	2.9	3.5	35.4	0.2	7.9	4.4	16.9	2.9	0.9	23.3	11.3	0.4	2.6	0.2	2.3	41.0	94.3	0.1	0.5	32.9	23.5	8.1	19.7	34.6	6.2	0.5	0.9	0.1	72.0	5.7	0.0	0.8	8.1	10.5	19.8	1.1	38.4	0.2	11.4	4.3	2.3	1.4	2.6	6.0	4.1	25.1	4.1	0.3	8.7	9.6	5.6	8.0	18.5	0.2	0.1	0.2	36.9	0.6	8.8	0.0	0.4	0.0	1.3	0.1	0.2	0.3	1.2	1.3	0.2	0.4	0.9	1.2	0.2	0.0	4.9	0.3	0.6	0.2	4.4	6.3	9.6	7.0	4.7	2.5	7.5	3.7	8.1	5.2	205.4	106.1	3.4	1158.6	1103.5	8.8	38.3	122.3	92.3	168.4	26.2	13.7	65.0	26.6	64.8	18.3	16.0	90.3	0.0	96.3	48.0	90.0	430.0	13.9	716.0	8.9	3.2	104.9	36.8	11.3	51.0	48.1	13.8	67.4	1.0	17.1	35.7	105.2	28.1	36.0	45.8	9.2	6.5	58.9	10.4	22.8	640.6	216.6	5.7	21.0	466.7
SLC45A1	DNB5	ENSG00000162426	"Solute carrier family 45 member 1"	Q9Y2W3	1	8317826-8344167	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0"	"Cell type enhanced"	"Detected in some"	7	"Bipolar cells: 6.7;Horizontal cells: 9.5;Muller glia cells: 5.7;Peritubular cells: 5.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	7	"monocytes: 7.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.9;GAMG: 4.2;HHSteC: 7.8;U-87 MG: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078818	Enhanced					NA	NA					"HPA078818: "	"unprognostic (1.77e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-3)"	5.0	6.6	8.5	2.4	15.3	1.1	2.6	13.8	24.0	6.0	4.4	5.4	2.1	2.5	6.8	3.6	3.9	5.2	4.3	3.1	6.0	7.9	4.3	1.1	2.0	2.1	6.1	12.4	4.4	4.1	4.1	8.1	1.9	13.1	4.9	2.2	3.2	1.5	7.7	4.0	1.7	2.8	4.3	4.6	4.4	2.6	3.8	4.6	0.0	2.4	0.8	1.5	3.6	3.3	0.6	0.2	0.0	7.1	0.0	1.8	0.7	0.0	2.7	0.5	1.1	5.9	3.9	0.1	0.2	1.2	0.4	0.8	0.0	0.4	0.0	0.2	0.8	4.2	0.0	0.1	0.3	0.1	2.3	0.0	0.0	0.2	0.0	7.8	0.0	2.2	2.0	0.2	0.9	0.0	1.4	0.6	0.6	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	1.2	0.0	0.0	0.0	2.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	2.5	0.1	0.5	2.3	0.4	0.0	0.0	0.0	10.1	0.0	0.1	0.0	0.2	0.0	1.3	1.3	1.8	0.6	0.9	0.9	0.2	0.1	0.6	0.6	0.0	0.0	7.1	0.0	0.6	0.7	8.5	15.3	13.8	24.0	6.0	7.9	6.1	12.4	13.1	4.6	0.0	0.0	0.5	1.2	0.3	6.7	0.8	0.0	0.0	0.0	1.8	3.9	0.0	0.0	0.5	1.9	0.9	0.0	0.0	0.2	0.0	0.9	1.0	0.0	0.0	0.1	9.5	0.0	1.3	0.0	4.0	3.1	0.0	0.0	0.0	0.0	5.7	0.1	0.0	5.3	0.6	4.4	6.5	2.9	0.2	0.0	0.3	0.0	0.0	0.0	0.3
RERE	"ARG, ARP, ATN1L, DNB1, KIAA0458"	ENSG00000142599	"Arginine-glutamic acid dipeptide repeats"	Q9P2R6	1	8352397-8817643	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 17.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024093	Uncertain					NA	NA					"HPA024093: AB_1856177"	"unprognostic (4.73e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.94e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.46e-3)"	28.4	24.6	30.2	20.1	28.2	16.5	27.2	54.2	35.6	30.2	29.7	28.9	27.7	23.7	49.4	18.5	19.2	26.6	19.5	30.4	27.6	15.5	26.6	12.1	19.3	20.3	19.5	26.7	24.4	25.0	40.4	30.2	19.8	19.3	33.4	17.1	22.7	23.3	35.4	73.0	17.5	21.3	33.3	17.6	22.9	21.2	23.5	27.8	14.6	26.9	14.4	15.4	32.5	35.2	7.4	4.7	3.6	17.9	2.3	10.2	0.9	12.4	11.0	25.7	19.2	21.1	14.8	13.7	10.3	11.7	8.4	12.1	16.5	11.2	17.9	10.4	12.4	6.4	9.4	8.5	6.7	11.0	14.0	13.9	10.5	9.0	18.4	11.5	6.7	2.8	16.8	9.1	18.1	12.5	17.7	17.6	6.1	12.6	6.0	11.9	8.9	2.6	4.8	18.5	6.8	10.3	13.5	7.3	25.7	9.6	15.1	28.0	19.9	8.2	22.3	17.3	15.7	9.1	2.7	13.5	12.5	11.5	11.9	7.9	10.3	6.0	24.7	8.4	15.7	11.2	1.2	2.1	0.5	2.7	4.8	4.6	3.2	3.9	2.0	2.0	7.4	2.1	1.4	3.6	2.3	17.9	4.7	10.2	0.9	30.2	28.2	54.2	35.6	27.6	15.5	19.5	26.7	19.3	27.8	35.7	38.1	42.3	52.6	20.6	126.9	74.3	48.4	30.8	35.2	62.8	178.7	32.9	29.9	26.8	29.1	42.1	49.2	0.0	21.8	21.9	32.9	74.3	35.7	20.8	22.5	146.2	59.7	69.3	24.5	14.1	45.5	23.3	15.1	10.0	50.7	39.3	28.3	52.6	89.5	30.4	115.2	71.1	34.0	42.9	64.8	16.4	31.8	21.5	46.5	74.4
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879250	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 2408.5;Muller glia cells: 2654.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		490000000	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	68.6	57.7	92.7	94.9	109.6	121.8	73.4	46.6	119.4	47.3	63.8	74.6	21.7	71.3	44.9	24.2	138.2	52.2	55.0	45.2	79.1	70.7	180.4	165.4	64.8	80.3	74.9	62.7	58.2	31.6	52.7	35.5	70.5	88.6	38.6	66.4	62.6	106.1	69.1	45.0	74.6	70.3	84.0	56.4	80.0	44.3	31.7	48.8	98.8	55.4	91.0	119.3	73.5	62.9	38.7	114.1	22.1	105.4	55.5	63.7	159.3	182.3	159.4	76.9	65.8	64.4	71.9	69.7	99.1	109.9	213.7	200.9	102.1	105.9	131.5	132.4	119.3	87.5	90.0	130.6	264.6	218.0	89.7	138.0	111.0	161.9	126.7	96.7	221.2	68.4	74.2	80.3	169.2	257.3	161.8	136.8	67.1	121.6	51.4	138.5	90.3	83.4	118.4	83.9	65.5	160.0	86.4	114.6	214.7	252.9	43.5	104.0	64.2	116.3	169.4	122.3	96.7	84.8	66.3	125.1	148.0	131.1	126.2	168.6	146.8	104.1	199.5	229.8	181.4	124.2	13.9	105.4	20.8	52.3	75.8	59.1	38.7	55.8	53.8	114.1	32.7	45.6	47.8	22.1	55.5	72.4	31.2	63.7	159.3	92.7	109.6	46.6	119.4	79.1	70.7	74.9	62.7	88.6	48.8	259.1	414.8	250.1	443.8	370.0	168.1	63.1	310.8	202.1	440.2	575.7	66.8	1020.4	784.2	1640.5	217.6	199.3	508.9	23.3	1210.7	1855.9	354.5	232.4	289.9	288.6	1045.8	456.1	181.6	141.8	389.1	532.9	158.8	475.7	425.1	2408.5	221.4	2654.1	1226.2	336.6	126.9	717.5	187.6	148.8	217.3	150.6	148.2	305.6	837.7	297.2	410.6	403.0
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, Predicted secreted proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"salivary gland: 1237.9"	"Cell type enriched"	"Detected in single"	404	"Melanocytes: 170.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 15.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 5.5;U-2197: 4.8"					"Not detected"	"Not detected"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	NA	NA		34000000			"HPA028550: AB_10600105, HPA028692: AB_10601883"	"unprognostic (2.54e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.28e-2)"		"unprognostic (2.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.29e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-1)"		0.3	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1237.9	0.0	0.1	24.9	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.6	0.4	1.5	0.3	0.4	15.4	1.6	1.2	0.5	0.9	1.8	0.3	0.3	1.4	0.9	0.1	0.2	0.6	1.0	1.6	5.5	0.6	0.5	1.3	1.6	0.4	0.1	0.8	0.6	0.6	0.8	2.0	1.1	0.4	2.0	2.0	0.0	1.0	0.9	0.1	1.2	0.7	1.4	0.7	3.4	0.1	0.8	1.0	1.5	1.1	1.0	0.8	1.5	0.6	0.3	0.2	1.0	1.0	0.9	0.2	0.9	0.3	0.9	1.5	0.8	0.3	2.8	1.5	4.8	1.2	1.5	0.5	1.7	0.6	1.8	1.4	1.1	0.3	0.2	0.4	0.2	0.4	0.3	0.8	2.8	0.0	0.6	5.6	15.4	1.5	0.4	0.2	0.4	0.3	1.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039931	Uncertain					NA	NA					"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	7.2	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	19.3	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035107-9088478	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.7;intestine: 84.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 42.2;Late spermatids: 12.6;Paneth cells: 28.8;Proximal tubular cells: 18.8;Spermatocytes: 44.4"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 19.7"	"Group enriched"	"Detected in some"	5	"Daudi: 51.3;THP-1: 13.0;U-266/70: 41.3;U-698: 48.2;U-937: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005449, HPA075145"	Enhanced					NA	NA					"HPA005449: AB_1078985, HPA075145: "	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	5.2	2.2	10.3	4.1	15.0	36.7	3.7	1.1	9.9	2.4	50.4	9.2	0.7	44.8	0.8	4.9	2.5	1.5	0.6	1.4	8.6	6.0	16.2	0.6	0.9	8.1	14.1	2.4	1.6	0.6	0.5	1.9	2.1	10.4	6.7	1.6	0.8	1.8	2.4	25.1	3.1	84.1	1.9	17.8	3.1	0.7	30.2	15.4	0.0	0.8	3.7	7.3	1.8	2.5	19.7	0.7	3.0	2.1	0.6	0.3	0.8	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.2	0.0	0.1	0.4	0.0	51.3	0.0	0.1	0.0	0.1	0.4	0.0	0.1	6.6	0.0	0.0	0.9	0.0	0.1	0.8	0.5	0.8	0.7	0.1	0.0	0.8	0.0	0.0	0.1	0.7	0.0	0.0	0.3	2.8	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.0	0.0	13.0	0.0	0.8	0.2	0.1	0.0	41.3	0.0	48.2	0.1	18.5	0.1	3.0	2.1	0.2	0.2	0.5	0.1	3.4	0.2	0.2	0.7	19.7	0.3	0.2	2.2	0.6	0.1	0.4	0.1	0.8	10.3	15.0	1.1	9.9	8.6	6.0	14.1	2.4	10.4	15.4	0.0	0.0	6.7	1.8	1.8	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.1	42.2	0.5	2.6	0.0	0.0	1.0	0.5	0.6	1.1	0.0	4.2	0.0	1.2	0.0	1.2	12.6	2.6	1.8	0.0	1.0	2.2	0.2	0.4	28.8	0.4	18.8	0.0	6.5	0.3	44.4	3.4	0.5	0.5	0.0	2.5	0.1
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129170	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.2"	"Cell type enriched"	"Detected in many"	5	"monocytes: 184.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028697	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoli, Nucleoli rim"	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.5	3.1	0.3	3.7	0.6	0.5	3.5	0.5	0.4	6.2	2.8	0.9	3.9	2.2	2.1	2.1	23.4	2.1	6.9	10.7	0.8	0.4	2.9	6.9	5.5	3.1	0.3	0.1	4.5	4.3	9.8	1.2	19.0	1.4	2.9	1.2	5.2	14.7	7.1	32.2	14.2	3.3	4.0	0.4	2.4	2.2	2.1	0.8	3.6	4.8	25.2	16.2	4.4	8.3	2.4	1.1	4.6	1.5	1.2	2.6	0.7	4.7	2.7	0.8	2.2	0.7	0.7	4.4	1.5	1.0	1.2	1.7	2.1	1.8	0.6	1.9	1.5	1.6	10.1	2.4	1.0	1.8	13.1	4.0	0.0	7.8	3.2	2.7	0.0	1.1	0.7	2.1	2.1	1.3	1.2	1.0	2.0	0.7	17.3	0.5	3.4	1.9	1.0	0.9	2.3	3.4	0.3	0.7	2.3	0.8	3.2	1.2	3.3	5.8	34.0	2.8	1.7	4.8	0.6	7.1	4.3	1.1	11.1	0.7	16.7	2.7	0.0	3.2	6.7	1.8	1.9	1.5	0.4	2.6	1.2	2.0	1.5	1.9	2.3	0.8	2.4	1.9	2.2	4.6	1.2	0.6	1.1	0.8	0.7	0.3	0.6	0.5	0.4	0.8	0.4	0.3	0.1	1.4	0.8	6.0	9.9	0.5	6.4	12.0	0.2	12.1	5.1	2.7	6.8	5.2	2.0	25.6	0.0	3.0	0.0	2.9	5.6	0.0	3.3	9.1	3.8	4.4	0.0	12.9	3.8	1.6	0.0	0.0	1.2	0.0	1.7	4.5	6.8	184.0	4.3	1.4	9.2	4.8	4.9	1.4	1.5	0.0	3.9	0.5	2.5	21.2	40.3	2.1	4.3	13.7
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		91000000	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.9	3.2	2.8	10.5	29.2	33.5	2.7	3.9	9.8	2.9	4.6	0.6	8.1	4.3	4.6	6.1	3.7	4.1	0.7	1.9	4.3	12.9	0.9	0.0	1.0	2.6	16.3	1.4	1.7	32.9	3.8	7.0	4.6	6.5	13.4	2.4	1.1	7.5	5.7	2.3	1.5	3.2	1.5	2.9	1.9	0.5	0.3	3.6	3.8	1.6	0.9	5.0	5.2	4.1	4.9	2.0	3.1	7.0	13.3	10.1	1.7	2.5	1.1	10.0	2.9	1.0	16.9	6.3	6.4	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5	23.8	29.3	11.2	11.1	12.7	18.1	13.0	58.6	10.7	12.5	19.2	25.5	9.0	0.0	15.8	0.8	14.7	15.1	0.0	18.5	6.5	24.0	16.2	3.5	132.8	11.5	15.9	7.5	17.8	18.0	1.5	44.5	10.3	11.8	64.9	15.2	11.2	20.1	17.5	34.6	8.2	11.5	0.0	9.2	4.7	4.6	11.2	4.9	13.8	24.1	11.4
SPSB1	SSB-1	ENSG00000171621	"SplA/ryanodine receptor domain and SOCS box containing 1"	Q96BD6	1	9292880-9369532	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 61.2;Suprabasal keratinocytes: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.23e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (3.95e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-2)"	39.9	7.7	4.4	10.4	14.9	1.2	23.1	1.1	7.7	14.7	24.7	12.9	4.9	14.8	28.5	6.4	18.6	14.0	22.6	12.1	7.9	4.1	16.6	51.5	15.4	8.3	12.7	4.2	15.1	23.0	3.2	6.4	10.0	20.7	10.9	6.9	6.9	9.6	8.2	24.5	14.2	41.9	19.8	19.2	2.7	10.5	6.3	14.0	7.4	12.2	20.6	14.7	18.0	19.8	1.4	0.0	4.0	0.1	1.2	2.7	0.4	6.5	6.0	0.4	1.3	18.2	8.7	11.1	4.4	14.7	8.9	7.0	6.4	9.6	0.2	9.1	6.7	10.5	9.8	2.0	8.0	5.9	23.3	1.5	0.0	8.3	7.0	11.6	0.0	0.6	9.0	16.1	34.2	4.4	8.8	12.8	1.3	0.7	17.6	7.2	2.4	3.5	0.2	1.0	4.5	6.4	1.2	2.6	2.1	7.5	4.4	1.6	0.4	7.0	19.1	28.9	12.5	0.5	2.1	10.6	6.4	8.0	10.0	4.0	7.4	10.5	2.2	11.7	0.8	6.9	4.0	0.1	0.0	0.2	0.0	0.4	1.4	1.2	0.5	0.0	0.3	0.4	0.7	0.0	1.2	0.1	0.0	2.7	0.4	4.4	14.9	1.1	7.7	7.9	4.1	12.7	4.2	20.7	14.0	17.9	4.0	5.1	43.1	61.2	0.6	3.9	35.7	13.4	13.6	3.5	2.0	0.4	3.3	20.3	0.6	10.5	21.0	0.0	27.2	10.1	31.4	25.6	13.9	18.6	3.2	11.1	6.3	8.6	0.0	1.2	10.9	3.6	47.2	5.4	6.3	2.0	32.5	7.0	7.8	2.9	0.5	6.5	36.8	0.4	0.9	61.9	1.8	1.0	9.1	55.9
SLC25A33	"BMSC-MCP, MGC4399, PNC1"	ENSG00000171612	"Solute carrier family 25 member 33"	Q9BSK2	1	9539482-9585179	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 318.7;Late spermatids: 434.0;Spermatocytes: 229.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049982	Uncertain					NA	NA					"HPA049982: AB_2680981"	"unprognostic (1.61e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.55e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.77e-2)"	14.6	5.3	11.3	3.8	15.3	11.0	13.0	8.4	20.6	4.1	6.6	6.5	3.5	3.4	4.6	18.9	4.5	3.5	5.6	6.1	9.4	12.2	13.9	15.1	6.1	4.6	15.1	8.7	3.3	8.5	4.5	6.4	2.3	12.6	6.3	5.6	10.5	7.0	3.8	16.8	2.6	3.4	4.1	10.4	3.3	4.7	16.0	7.0	4.2	7.6	2.8	5.1	4.1	2.5	2.0	1.6	6.1	1.1	1.3	1.9	0.4	4.4	2.1	5.9	9.1	4.8	2.8	3.8	4.3	4.1	7.3	6.5	4.6	3.5	12.9	5.3	3.5	7.7	1.9	14.8	2.9	9.1	9.9	9.3	12.7	3.0	17.9	10.5	12.6	10.1	3.3	5.1	7.3	3.5	1.8	4.3	9.7	12.3	6.8	4.1	4.6	7.9	8.7	7.3	8.2	4.9	10.8	6.2	8.3	4.6	2.5	10.3	6.7	4.9	15.0	12.7	5.4	5.5	9.3	1.9	4.7	6.1	6.2	5.5	8.1	14.9	21.9	3.4	14.1	5.6	6.1	0.9	0.3	1.5	1.1	1.0	2.0	1.1	0.9	1.6	1.0	1.9	1.9	1.3	1.3	1.0	1.5	0.2	0.4	11.3	15.3	8.4	20.6	9.4	12.2	15.1	8.7	12.6	7.0	3.0	12.5	21.1	88.7	45.7	12.9	6.9	28.1	6.7	6.8	8.7	49.1	10.2	169.1	11.4	318.7	15.5	10.2	0.0	13.0	34.4	13.9	74.4	24.1	53.3	18.4	9.5	63.7	9.8	7.2	434.0	9.2	21.8	30.4	10.0	22.0	142.8	9.5	8.6	9.6	19.9	46.4	6.5	36.0	229.6	117.3	31.2	32.8	12.1	24.7	85.3
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588922-9614873	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 37.0"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	6.2	7.3	9.6	5.7	9.4	10.3	4.0	8.7	11.9	4.4	3.9	10.5	4.4	5.4	6.9	5.1	5.9	5.8	4.0	13.2	9.3	7.9	5.7	2.7	4.5	5.0	9.4	8.3	9.0	9.2	5.5	12.6	4.5	7.9	4.9	2.8	12.6	6.7	5.6	37.0	7.1	3.9	4.9	6.7	5.3	4.0	8.2	7.1	6.9	4.5	13.9	5.4	3.8	4.3	1.4	4.3	0.0	0.8	0.4	1.9	1.0	7.7	10.5	6.6	15.5	2.8	1.9	5.9	9.1	2.8	10.9	7.7	19.3	7.1	13.5	11.6	3.1	5.3	16.2	7.3	7.2	3.7	8.9	18.3	9.5	10.0	9.8	5.1	11.5	9.9	3.4	3.3	14.6	2.4	2.3	4.3	6.4	12.1	3.9	4.3	9.2	10.0	8.4	6.7	6.0	9.8	21.2	11.3	11.1	3.9	4.3	15.9	11.9	7.2	17.6	7.9	2.4	5.4	7.3	3.9	13.0	11.3	14.3	17.1	6.6	5.5	12.1	9.0	19.0	11.4	0.0	0.8	0.0	1.1	0.6	0.6	1.4	1.4	1.9	1.1	1.1	1.0	0.7	0.0	0.4	0.4	4.3	1.8	1.0	9.6	9.4	8.7	11.9	9.3	7.9	9.4	8.3	7.9	7.1	3.0	1.3	1.9	1.7	6.3	14.7	10.6	2.5	2.7	2.3	0.0	25.5	2.8	1.7	2.0	1.1	4.5	0.7	0.0	0.8	1.8	2.3	1.4	4.6	1.5	3.0	9.5	6.4	4.3	3.7	1.3	3.7	2.5	3.3	0.0	3.6	4.8	1.3	0.0	4.2	1.9	16.3	0.0	3.8	4.7	5.3	4.8	0.7	1.0	4.0	1.7
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651732-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 20.7;granulocytes: 24.3;Kupffer cells: 28.8;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.7;NB-4: 22.4;REH: 23.3;THP-1: 22.5;U-937: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	4.5	2.1	3.4	34.8	7.1	32.8	2.9	3.3	4.3	3.2	3.3	5.5	0.7	3.1	3.7	3.4	3.5	4.0	6.5	2.9	4.2	3.1	4.6	3.3	8.2	40.3	7.4	1.8	5.3	2.2	2.3	2.2	3.3	4.6	3.2	2.1	3.1	11.2	1.8	0.9	2.0	11.4	2.9	5.3	35.5	3.3	3.0	5.7	23.5	4.1	2.3	36.0	5.8	3.6	8.4	14.5	35.0	15.0	14.5	13.7	16.6	2.7	1.8	0.1	0.5	0.4	0.4	0.2	4.2	8.6	9.2	7.6	0.1	1.1	7.3	1.7	3.3	4.4	0.8	0.7	3.8	5.8	51.7	0.1	0.8	0.4	3.0	1.8	18.8	6.6	1.5	1.6	10.3	3.5	4.0	1.3	5.2	2.6	0.0	5.2	0.2	1.8	22.4	0.8	0.1	0.5	23.3	4.6	0.2	3.9	0.0	0.6	0.5	0.9	1.7	4.1	2.5	0.3	22.5	3.4	2.7	2.8	0.0	3.9	1.7	1.6	10.2	5.9	26.9	1.5	9.6	11.8	21.1	12.9	13.1	13.7	7.8	9.8	11.8	12.5	8.4	12.9	13.4	35.0	14.5	15.0	14.5	7.4	16.6	3.4	7.1	3.3	4.3	4.2	3.1	7.4	1.8	4.6	5.7	8.9	20.7	7.8	1.8	1.3	0.4	2.7	0.0	1.4	1.2	0.0	2.0	0.1	1.7	3.1	2.0	1.6	0.0	0.0	1.8	0.3	1.4	2.5	24.3	0.0	12.5	0.0	0.0	3.7	28.8	1.7	1.1	13.4	3.3	1.0	0.0	2.5	7.7	0.0	1.4	2.9	1.6	6.5	3.8	1.1	2.1	1.0	0.2	30.5	0.1	2.0
CLSTN1	"CDHR12, CSTN1, KIAA0911"	ENSG00000171603	"Calsyntenin 1"	O94985	1	9729026-9824526	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.0"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 412.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012412, HPA077705"	Enhanced					NA	NA		70000000			"HPA012412: AB_1846981, HPA077705: "	"unprognostic (4.63e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.10e-7)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.72e-2)"	13.6	20.1	38.2	15.0	51.2	5.2	15.4	90.5	102.0	24.2	28.6	25.1	11.7	16.7	35.9	14.2	21.0	35.1	25.6	16.3	32.1	31.2	23.3	4.7	16.0	16.4	25.8	53.8	33.6	31.1	27.8	21.0	22.8	32.3	33.6	26.1	29.8	30.0	24.9	10.3	45.6	18.6	28.8	22.0	14.4	15.1	8.1	21.6	15.3	20.9	12.9	16.1	18.0	23.6	2.5	2.7	8.5	1.7	0.9	6.3	2.5	27.7	16.5	23.9	22.1	25.5	16.9	7.9	17.7	19.9	22.7	20.8	11.6	66.9	21.9	46.4	34.9	21.6	39.7	14.0	62.6	18.2	24.8	17.0	6.5	20.7	12.2	35.4	12.2	10.6	17.2	43.2	29.3	19.9	33.3	31.6	12.7	3.0	17.1	11.1	12.9	13.5	6.4	10.0	16.7	13.3	20.4	8.7	10.5	28.1	8.1	25.4	16.0	25.6	49.2	19.8	15.1	10.0	20.9	47.1	26.9	21.4	17.9	29.3	17.4	16.0	31.7	23.0	19.7	30.3	8.5	1.4	4.3	6.3	1.7	3.3	2.3	4.0	4.7	2.7	2.5	2.9	2.6	0.8	0.9	1.7	1.7	3.6	2.5	38.2	51.2	90.5	99.9	32.1	31.2	25.8	53.8	32.3	21.6	26.8	14.9	18.6	53.3	38.9	198.8	10.5	58.6	40.2	38.7	48.8	412.3	27.6	1.7	25.3	3.7	30.8	111.5	23.3	34.1	12.2	32.6	55.8	11.5	2.0	24.2	170.0	29.6	34.4	22.3	3.2	42.8	12.3	30.4	20.8	86.8	156.4	43.0	51.5	47.4	25.6	134.9	84.1	20.6	13.5	37.1	22.8	16.0	25.3	48.3	36.5
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 116.5"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 254.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042617, HPA067089"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane, Cell Junctions, Mitochondria"		"HPA042617: AB_2678081, HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	12.6	4.0	10.1	4.3	8.1	7.7	18.3	21.4	14.8	16.6	5.8	10.1	10.9	7.4	4.8	31.3	49.0	5.2	4.8	13.7	10.1	9.5	5.6	4.8	15.2	4.0	8.4	11.3	5.5	14.1	4.0	6.6	11.0	13.7	9.9	4.2	13.3	15.5	16.5	13.1	116.5	5.8	4.5	9.2	3.3	8.8	11.8	6.5	4.8	7.9	33.9	13.5	5.6	21.7	1.9	6.8	12.9	5.4	8.8	2.9	2.3	26.2	3.9	24.2	18.4	3.6	6.1	7.7	5.2	9.2	7.7	4.9	1.9	33.5	8.1	15.1	6.7	7.9	13.4	2.8	30.9	3.5	20.4	4.3	5.2	1.2	24.4	7.6	3.9	3.1	6.8	30.6	9.8	10.0	6.6	20.7	15.3	9.2	3.8	4.7	16.1	8.7	14.6	12.8	21.2	6.8	10.0	7.1	5.2	3.9	9.0	26.6	16.8	11.8	10.8	15.7	8.6	13.2	9.7	13.5	5.0	6.1	7.5	11.4	8.4	10.9	9.5	1.8	20.0	19.7	2.7	5.4	12.9	2.9	1.9	1.7	1.9	1.5	2.4	6.8	1.6	1.4	1.4	4.0	8.8	1.2	2.1	1.2	2.3	10.1	8.1	21.4	14.8	10.1	9.5	8.4	11.3	13.7	6.5	26.8	11.5	11.8	34.8	91.7	8.4	11.6	22.9	1.4	7.9	17.4	7.9	61.2	28.2	16.0	101.0	18.1	20.6	23.3	16.2	34.6	26.7	52.4	0.0	22.9	49.6	15.9	47.1	16.0	32.6	19.5	13.8	30.5	45.5	5.4	34.9	106.1	27.9	25.8	21.5	23.0	12.2	45.3	22.1	72.3	36.2	254.8	40.5	18.1	24.3	54.7
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 240.8;Spermatocytes: 162.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	13.6	14.2	21.4	12.8	18.0	11.4	17.7	13.6	21.6	18.2	19.2	24.5	15.1	19.5	18.3	13.5	17.6	16.9	14.1	21.0	19.8	16.5	20.0	20.4	11.5	13.6	24.3	10.3	25.5	15.3	26.1	15.9	14.9	20.5	15.8	19.4	13.0	16.6	14.6	21.7	13.9	23.7	21.3	28.2	11.0	12.2	44.3	20.1	20.2	17.2	13.2	15.6	14.9	23.1	13.9	28.1	28.3	22.7	16.8	21.0	12.9	16.1	10.7	20.6	14.6	12.8	21.3	9.2	14.7	12.5	20.8	20.2	13.3	28.4	19.6	16.8	18.5	13.1	12.3	19.4	21.3	31.3	18.1	13.3	28.5	13.9	21.8	12.4	26.0	14.8	13.9	30.6	29.1	27.6	14.9	16.3	26.0	35.3	11.2	19.1	11.4	21.3	12.7	10.4	20.4	17.5	22.8	27.3	15.7	11.2	7.3	10.3	16.3	18.0	7.9	34.6	20.5	13.1	13.4	14.8	14.5	19.8	20.5	15.4	9.2	21.0	33.6	14.8	38.9	19.2	22.0	18.8	28.3	16.0	20.7	14.0	13.9	16.3	15.5	18.1	13.8	16.3	16.9	18.9	16.8	22.7	28.1	21.0	12.9	21.4	18.0	13.6	21.6	19.8	16.5	24.3	10.3	20.5	20.1	6.0	12.9	11.9	18.9	11.3	8.9	52.1	10.2	33.5	11.4	7.0	5.9	24.8	41.4	22.9	240.8	16.9	27.5	0.0	18.4	37.8	16.2	18.9	30.0	19.2	37.4	39.7	8.7	11.6	21.1	51.9	24.5	26.4	13.5	28.9	17.2	47.0	20.3	25.9	25.8	42.9	14.5	19.4	17.6	162.6	67.1	14.6	28.8	17.5	20.6	18.3
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	7.2	13.2	8.1	7.2	9.0	4.0	8.8	4.1	8.1	8.8	12.8	9.3	11.9	8.9	10.1	8.8	8.7	7.4	7.3	13.9	7.6	6.8	11.5	12.6	5.3	5.6	10.3	8.3	5.1	14.1	10.3	9.3	5.6	13.0	7.0	13.6	10.1	17.7	8.4	29.1	8.1	9.2	8.3	9.0	8.6	7.1	10.7	8.3	6.8	10.8	11.5	6.8	6.2	10.4	5.3	4.3	12.8	4.9	3.1	2.7	2.3	3.8	4.7	6.6	6.3	12.6	11.4	1.6	7.5	6.2	8.8	5.7	2.0	6.5	4.1	4.9	11.4	3.7	3.9	8.0	10.8	10.6	8.4	4.1	6.7	2.9	6.2	10.0	5.5	6.6	12.1	12.1	10.6	15.3	8.3	9.2	9.0	7.8	2.7	9.7	6.5	3.1	3.5	0.8	8.6	8.5	3.6	4.0	2.1	10.2	2.1	4.7	2.5	9.9	8.5	8.5	3.6	3.2	5.9	8.6	3.7	3.2	7.4	3.5	3.9	3.7	4.0	6.2	11.6	7.4	6.6	4.9	3.9	2.4	3.3	1.1	5.3	2.3	2.7	4.2	3.6	2.1	2.5	12.8	3.1	4.5	4.3	1.9	2.3	8.1	9.0	4.1	8.1	7.6	6.8	10.3	8.3	13.0	8.3	3.0	4.1	1.7	5.2	2.1	7.7	11.8	5.1	8.1	3.4	7.0	5.9	8.3	19.9	7.9	5.8	6.8	17.0	0.0	6.0	4.2	3.7	4.5	4.6	7.3	11.2	9.5	2.9	6.7	6.9	3.2	6.1	8.6	5.0	11.8	7.7	8.5	6.4	3.5	6.0	11.3	6.3	6.5	4.2	11.1	8.3	1.6	7.6	2.9	12.8	4.1
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016020	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.1;breast: 210.2"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 121.4;Kupffer cells: 402.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6"	"Group enriched"	"Detected in many"	30	"granulocytes: 60.6;monocytes: 54.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.5;SK-MEL-30: 7.1;T-47d: 26.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	68.1	3.7	3.8	3.0	11.4	7.5	210.2	2.1	5.5	4.3	10.9	8.7	2.7	0.5	6.4	4.5	7.2	2.4	14.7	29.7	5.3	2.8	7.6	2.5	2.5	4.5	7.6	3.0	2.6	3.7	14.7	3.5	4.4	6.2	4.7	1.2	3.5	4.8	2.7	5.9	6.6	2.0	4.4	8.9	21.5	3.0	2.6	5.2	1.2	11.3	1.8	1.4	4.5	17.5	0.0	1.8	60.6	54.1	0.0	0.1	15.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.8	1.8	2.4	0.0	10.5	1.0	0.0	0.0	0.0	0.8	3.4	0.0	2.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	1.6	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	4.4	0.0	0.0	0.0	0.5	0.0	0.1	0.4	1.9	0.1	7.1	2.9	26.8	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	54.1	0.4	0.0	23.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	60.6	0.0	11.1	0.3	0.1	15.0	3.8	11.4	2.1	5.5	5.3	2.8	7.6	3.0	6.2	5.2	0.0	2.2	11.2	7.8	18.3	0.0	17.6	10.2	1.4	1.2	1.8	0.0	4.5	19.9	1.3	2.6	121.4	0.0	0.0	2.3	2.2	8.2	19.2	3.5	1.3	54.6	0.0	0.0	49.7	402.1	4.7	5.8	23.1	20.3	0.0	0.0	1.3	3.7	0.0	0.7	0.7	1.1	0.0	5.3	1.2	1.5	15.4	5.1	1.3	0.4	4.3
UBE4B	"E4, KIAA0684, UBOX3, UFD2"	ENSG00000130939	"Ubiquitination factor E4B"	O95155	1	10032832-10181239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019219	Approved					NA	NA					"HPA019219: AB_1858554"	"unprognostic (5.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-3)"	11.8	18.6	16.4	11.5	20.2	16.5	12.7	27.1	24.2	17.5	19.3	26.5	12.6	15.1	16.7	12.8	20.4	14.1	11.3	22.5	18.9	17.3	13.0	13.9	10.5	11.3	18.5	15.0	22.8	20.4	24.3	15.3	18.3	23.6	14.5	12.8	18.2	12.0	12.7	43.5	24.3	14.5	16.6	16.3	13.0	15.1	8.6	21.4	15.7	19.7	11.2	13.6	16.8	12.0	6.0	6.7	9.4	7.9	2.9	9.8	5.3	21.7	13.9	17.1	18.9	22.8	30.1	13.5	14.3	18.1	14.0	14.5	15.0	25.4	18.7	17.4	25.4	11.1	16.1	21.5	16.5	16.7	19.1	12.0	20.2	24.3	17.6	17.3	21.0	14.4	24.7	15.0	18.9	16.1	26.6	20.7	13.7	34.5	24.9	13.0	11.3	13.5	10.3	22.9	14.1	11.6	13.3	17.0	20.1	14.2	9.9	21.0	16.1	22.5	16.1	29.7	19.1	12.3	15.5	17.8	12.6	19.5	15.5	11.7	11.4	15.4	21.7	18.5	24.4	15.9	4.2	7.9	3.6	5.3	6.0	8.8	6.0	8.8	8.5	6.7	5.6	8.0	6.5	9.4	2.9	4.4	3.2	9.8	5.3	16.4	20.2	27.1	24.2	18.9	17.3	18.5	15.0	23.6	21.4	20.8	20.0	17.1	11.5	15.7	13.3	33.5	15.3	13.4	11.4	8.7	23.6	28.0	8.3	10.9	2.4	13.5	13.1	23.3	12.7	11.4	17.5	19.5	5.8	15.3	14.9	15.9	15.6	16.5	22.1	3.1	10.3	14.2	5.0	9.0	16.9	11.3	18.3	13.9	8.1	8.6	34.6	19.4	11.2	6.6	12.4	19.6	17.2	13.1	17.9	12.2
KIF1B	"CMT2, CMT2A, HMSNII, KIAA0591, KLP"	ENSG00000054523	"Kinesin family member 1B"	O60333	1	10210805-10381603	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.9"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 224.2;Cone photoreceptor cells: 545.8;Rod photoreceptor cells: 364.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015177	Approved		Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			Microtubules	"Nucleoli fibrillar center"	"CAB015177: AB_2296564"	"unprognostic (1.30e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.82e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.91e-6)"	"unprognostic (1.51e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	7.8	11.0	32.9	6.2	30.2	10.3	9.0	37.0	43.2	7.4	7.6	31.0	2.0	7.1	10.0	5.7	12.9	7.4	7.8	19.3	28.3	23.7	10.8	7.4	7.4	3.5	29.2	21.5	11.7	8.9	21.2	5.8	7.5	29.9	8.9	7.2	9.5	8.2	7.5	112.9	9.1	7.7	10.9	25.2	5.3	5.4	13.1	25.6	0.3	8.2	13.0	4.2	6.2	5.4	0.8	1.1	8.0	1.8	0.8	1.2	0.7	10.8	7.8	36.7	14.3	10.2	11.4	3.1	10.6	7.4	11.2	11.4	8.5	5.4	1.5	10.7	17.1	6.0	7.9	26.3	8.3	15.7	15.1	8.7	6.4	11.6	10.0	8.2	2.2	2.0	8.8	8.5	19.1	12.2	8.2	13.8	6.8	7.1	6.4	12.4	3.2	2.5	2.2	8.1	4.7	5.8	10.7	21.3	2.8	4.7	5.3	25.2	12.3	14.9	7.2	14.8	15.9	5.1	3.0	16.0	13.3	8.5	14.9	10.1	3.5	5.9	3.4	11.5	6.9	6.6	2.9	1.4	8.0	1.1	1.4	0.5	0.7	1.1	1.2	1.1	0.8	0.7	0.6	7.5	0.8	1.8	0.8	1.2	0.7	32.9	30.2	37.0	29.5	28.3	23.7	29.2	21.5	29.9	25.6	56.6	16.3	5.6	21.4	45.2	224.2	104.1	12.7	16.0	14.8	21.0	545.8	5.7	0.0	16.6	61.9	34.4	23.8	0.0	15.5	5.0	34.2	27.1	6.9	31.1	19.1	131.9	27.6	19.6	23.7	36.2	17.3	22.4	49.0	8.2	18.0	52.7	19.9	20.1	19.4	13.4	364.1	19.4	44.3	19.6	32.1	51.7	5.6	10.1	17.7	17.0
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 204.0;monocytes: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Cell line enhanced"	"Detected in all"		"A549: 181.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		59000000	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	23.1	181.8	45.3	48.7	69.0	42.7	9.8	15.7	27.8	21.8	29.8	26.6	26.7	22.8	19.4	16.1	29.9	19.7	33.1	28.1	14.7	15.7	28.9	30.8	32.7	55.9	21.0	50.8	34.2	30.4	14.1	34.4	8.5	27.8	51.4	32.0	41.0	20.2	27.8	26.3	41.9	25.5	27.2	31.8	16.0	32.5	41.6	41.9	30.4	12.5	24.4	21.3	13.4	21.3	18.5	31.2	23.5	43.6	48.1	11.5	20.4	13.7	17.3	15.3	27.9	40.8	25.1	55.2	10.3	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4	17.9	31.2	16.0	28.9	11.6	7.9	9.5	50.9	17.4	23.9	19.2	17.7	114.8	44.7	45.3	7.1	17.5	32.9	0.0	35.1	31.4	28.8	33.1	24.4	48.2	117.8	1.6	22.4	16.0	204.0	9.8	15.8	88.3	16.9	212.8	23.7	12.9	39.9	25.9	9.9	40.3	16.4	19.4	9.8	33.4	37.9	14.4	68.0	16.0	44.1	66.7
CENPS-CORT	APITD1-CORT	ENSG00000251503	"CENPS-CORT readthrough"		1	10430102-10452153	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"testis: 29.9"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 6.7;Club cells: 1.2;Proximal tubular cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (2.73e-1)"	"unprognostic (8.54e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.97e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.32e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (5.06e-2)"	1.2	1.9	4.5	1.3	6.6	10.6	1.9	1.8	5.1	1.3	2.0	1.0	2.6	3.3	1.2	3.2	2.1	2.1	2.3	1.2	3.5	3.6	4.4	2.2	1.3	2.2	3.4	3.1	1.2	3.4	1.5	5.9	1.0	2.7	1.8	0.8	1.7	3.2	2.7	1.1	1.3	2.4	2.4	1.9	1.6	2.7	29.9	2.0	2.9	4.6	2.5	2.2	1.1	1.4	9.0	2.9	1.9	1.4	3.2	4.5	1.6	8.4	12.2	6.5	0.6	0.9	0.9	1.1	8.4	1.7	13.2	5.3	5.2	2.9	8.0	4.6	1.5	2.7	5.1	4.2	3.4	0.9	7.2	5.8	14.5	3.2	8.9	0.2	19.3	8.1	0.0	1.8	9.1	0.8	2.5	1.6	4.4	3.8	5.0	0.4	4.5	6.6	5.6	2.7	2.0	5.6	7.3	6.7	8.1	2.5	1.7	3.0	4.1	10.1	4.2	2.0	1.8	3.1	4.3	3.5	6.5	13.6	4.0	7.3	1.2	3.5	11.8	5.2	20.9	5.9	0.0	1.0	1.0	0.9	1.4	1.4	6.9	1.7	2.8	1.2	9.0	1.7	1.3	1.9	3.2	0.9	2.9	4.5	1.6	4.5	6.6	1.8	5.1	3.5	3.6	3.4	3.1	2.7	2.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.2	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CENPS	"APITD1, CENP-S, FAAP16, MHF1"	ENSG00000175279	"Centromere protein S"	Q8N2Z9	1	10430443-10442809	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 42.8"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 50.9;Distal tubular cells: 31.5;Proximal tubular cells: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.64e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.06e-3)"	"unprognostic (2.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.72e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.21e-2)"	2.8	7.3	6.5	3.8	12.9	5.5	3.7	3.1	10.3	4.3	4.7	3.2	6.0	8.9	4.0	9.4	6.6	7.2	5.5	3.0	5.5	5.2	20.0	5.8	3.6	4.1	4.5	6.9	3.5	7.5	10.6	11.7	3.1	6.1	5.2	5.5	4.5	7.1	6.1	2.7	3.0	6.4	5.6	3.4	3.5	4.9	42.8	4.9	6.5	9.4	5.8	4.3	4.8	3.6	8.5	6.6	1.0	6.9	2.4	6.5	2.6	19.7	13.1	9.3	13.3	7.5	6.2	4.9	11.2	11.9	14.2	11.5	6.0	14.0	15.1	10.2	9.9	8.4	15.6	8.4	12.4	16.2	12.9	8.8	8.9	11.1	12.5	4.7	29.8	11.7	3.8	6.4	15.9	9.9	5.8	8.7	15.9	12.2	13.4	14.3	14.8	14.0	17.8	13.1	16.9	13.4	15.1	10.8	17.7	17.8	7.0	11.8	10.9	12.1	13.6	12.7	8.1	16.4	16.2	4.9	15.8	19.3	14.2	19.1	3.4	8.4	18.3	14.8	33.7	20.2	0.0	2.0	1.0	4.1	3.1	5.3	8.5	5.8	4.2	2.4	7.6	6.5	5.4	1.0	2.4	6.9	6.6	5.4	2.6	6.5	12.9	3.1	10.3	5.5	5.2	4.5	6.9	6.1	4.9	6.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	50.9	14.8	5.2	0.0	16.2	31.5	14.6	0.0	0.0	0.0	0.0	9.7	8.4	0.0	0.0	3.5	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	7.8	0.0	0.0	72.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0
CORT	MGC32686	ENSG00000241563	Cortistatin	O00230	1	10449719-10451902	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 28.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.5;Late spermatids: 3.6;Spermatocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1"	"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA						"unprognostic (1.25e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-3)"	"unprognostic (7.08e-7)"	"unprognostic (2.01e-1)"	"unprognostic (9.01e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.14e-4)"	1.0	0.7	3.3	0.9	28.8	0.9	0.6	3.2	26.6	0.7	1.0	0.1	0.0	1.3	0.8	1.0	0.5	0.7	1.0	0.6	2.3	2.5	1.2	0.8	0.7	0.7	1.0	6.2	1.0	0.9	1.0	3.2	1.7	0.0	1.1	0.8	0.0	0.7	0.8	0.8	1.1	1.2	0.7	0.7	0.8	0.9	2.1	20.3	0.0	1.1	0.0	0.5	0.8	0.5	0.2	0.4	0.0	0.1	1.2	0.3	0.3	1.2	3.7	1.8	2.3	0.2	0.2	0.8	1.1	0.2	0.4	0.4	3.2	0.5	1.2	0.9	0.0	0.3	1.0	1.1	0.0	0.0	2.1	3.2	1.7	2.8	3.0	0.4	2.4	1.1	0.0	0.3	0.5	0.0	0.2	0.0	1.6	1.1	1.0	0.3	2.5	0.5	2.3	0.3	0.2	4.5	0.9	1.6	0.5	0.2	0.9	1.6	0.8	0.9	1.1	0.7	0.9	0.7	0.0	1.7	0.3	1.8	2.2	0.6	0.9	2.8	1.1	0.7	1.8	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	3.3	28.8	3.2	21.5	2.3	2.5	1.0	6.2	0.0	20.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.4	0.3	0.0	0.0	0.0	0.1
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472526	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	17.8	19.9	22.9	15.6	23.0	7.9	20.9	20.4	20.7	16.6	15.1	22.5	19.1	16.5	18.4	14.4	24.2	18.6	15.3	17.2	20.7	19.9	23.7	18.9	15.5	15.6	26.4	18.9	22.5	19.8	25.7	17.2	27.2	26.1	17.0	17.3	15.0	16.3	18.4	16.8	14.8	14.7	22.4	24.1	14.8	16.8	13.4	21.9	16.7	18.0	13.0	21.4	18.7	26.1	14.1	10.7	7.2	9.9	14.1	14.4	8.9	14.6	14.6	12.6	14.3	10.7	10.2	6.1	20.9	13.5	21.8	16.3	34.9	19.4	31.3	13.5	17.6	12.2	12.1	24.3	24.8	22.1	12.4	16.8	15.6	15.2	13.9	17.5	19.0	10.4	12.7	12.5	34.4	27.8	12.0	16.6	15.7	27.8	7.1	15.4	18.6	18.7	8.6	11.0	11.1	17.1	16.1	15.1	15.8	19.6	11.3	14.9	14.5	19.5	17.0	23.0	11.4	10.9	6.6	17.3	10.3	14.0	18.8	13.8	8.8	12.3	45.6	10.9	18.1	15.5	1.3	9.9	7.2	14.4	8.0	10.9	14.1	9.7	12.4	9.2	13.7	10.2	12.3	1.5	14.1	9.7	10.7	13.5	8.9	22.9	23.0	20.4	20.7	20.7	19.9	26.4	18.9	26.1	21.9	41.7	29.3	39.4	29.8	30.6	18.3	22.1	28.1	32.1	35.2	17.4	102.1	83.5	31.5	40.0	25.0	27.1	15.1	0.0	33.8	52.0	19.4	20.0	24.3	27.7	36.5	19.1	32.8	30.7	19.8	58.1	27.9	18.5	10.1	44.1	12.4	21.1	39.9	7.0	30.4	45.1	30.9	19.4	20.0	31.2	30.4	35.5	55.5	24.9	25.7	31.2
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 60.6;Syncytiotrophoblasts: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	14.9	11.6	14.3	12.2	22.3	8.3	13.1	15.7	35.0	11.8	14.8	18.6	8.3	18.0	14.4	10.4	22.6	14.8	12.2	17.8	14.4	16.2	13.3	25.9	13.6	11.6	13.0	16.1	15.7	15.3	13.6	14.2	17.7	22.4	21.9	10.5	14.8	20.0	31.0	22.1	14.6	20.9	10.7	11.1	11.2	12.8	18.7	11.4	11.4	13.5	11.6	17.3	38.7	13.6	4.2	5.0	7.3	3.8	4.2	8.4	3.6	15.6	14.8	12.6	13.8	9.3	8.8	8.2	18.1	15.3	20.2	19.3	15.6	29.1	11.4	18.1	13.8	12.0	18.7	13.1	17.4	9.7	16.0	21.4	14.0	16.1	21.3	14.0	15.8	20.2	10.6	14.1	15.3	14.1	12.1	12.9	15.1	21.9	11.8	9.1	12.9	15.1	20.8	12.9	12.3	17.4	16.4	10.5	16.3	15.9	10.4	15.0	17.2	17.5	14.7	16.3	10.2	13.5	11.4	12.4	14.8	15.6	14.3	15.3	17.0	13.8	22.3	16.2	21.9	15.7	1.9	3.8	7.3	8.4	2.8	5.3	4.2	4.4	6.2	4.7	3.9	5.8	5.2	0.6	4.2	2.5	5.0	5.2	3.6	14.3	22.3	15.7	35.0	14.4	16.2	13.0	16.1	22.4	11.4	8.9	1.3	7.5	12.5	6.4	14.7	6.1	5.1	21.4	2.3	8.7	25.5	40.0	6.6	15.0	2.2	6.0	18.7	0.0	12.7	15.4	7.1	9.7	5.8	48.3	20.4	17.5	8.6	9.8	7.9	2.4	7.5	5.9	11.8	32.5	8.4	13.8	14.7	10.5	5.3	14.8	60.6	6.5	7.2	5.9	12.1	7.0	54.1	8.5	10.5	11.2
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 573.3;Rod photoreceptor cells: 490.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 9.7;HDLM-2: 10.5;SCLC-21H: 16.3;SK-BR-3: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	3.4	0.9	0.3	2.5	1.5	2.8	6.0	0.3	0.7	6.1	20.7	0.5	14.7	8.8	11.0	2.4	9.9	3.4	13.8	9.9	0.2	0.2	4.5	1.4	7.4	0.8	0.8	0.3	1.7	4.4	0.0	4.0	1.2	0.9	12.1	2.4	19.8	17.0	17.4	29.9	25.3	27.1	8.0	0.2	1.2	9.2	1.0	0.8	0.2	1.9	14.4	6.2	7.2	7.2	0.5	3.5	1.9	2.2	1.6	1.6	0.4	9.7	0.8	1.8	1.7	0.0	0.0	0.4	0.3	0.1	0.3	0.4	2.1	2.2	0.4	2.0	0.4	0.8	8.4	1.9	1.9	0.1	10.5	3.3	0.7	1.6	2.2	0.3	1.1	3.1	0.1	7.2	0.1	0.6	0.0	0.3	1.5	0.0	0.0	0.0	5.2	0.6	7.0	0.2	5.1	0.5	0.8	1.2	0.1	1.6	4.0	16.3	1.5	2.5	15.4	0.2	0.7	8.2	1.0	0.1	0.0	1.4	0.8	0.2	0.0	0.0	1.0	0.0	3.0	0.1	1.9	0.2	1.2	1.6	0.4	0.7	0.4	0.6	1.1	0.6	0.5	0.0	0.5	0.4	1.6	2.2	3.5	0.3	0.4	0.3	1.5	0.3	0.7	0.2	0.2	0.8	0.3	0.9	0.8	26.8	20.0	0.0	17.1	29.3	11.2	21.0	10.2	14.7	7.9	14.0	573.3	0.5	3.3	12.2	0.4	11.7	41.1	0.0	7.7	0.8	2.6	37.9	4.6	4.0	1.0	130.3	39.6	6.7	0.3	0.9	0.0	1.8	1.7	10.8	33.5	24.9	13.7	29.1	6.3	1.0	490.7	0.0	7.1	1.7	2.3	53.4	0.6	3.2	22.9	24.5
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pancreas: 5.1;skeletal muscle: 17.3"	"Cell type enriched"	"Detected in some"	11	"Intestinal endocrine cells: 19.5"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"					"Group enriched"	"Detected in some"	4	"classical monocyte: 1.7;myeloid DC: 4.2"	"Group enriched"	"Detected in many"	30	"dendritic cells: 4.2;monocytes: 1.7"	"Cell line enriched"	"Detected in some"	4	"THP-1: 7.6"									HPA027654	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.1	0.6	0.0	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.2			0.6	0.0	0.0	0.5	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.5	0.8		0.0	5.1	0.0	0.2	0.1		0.0	0.5		0.2	0.0	17.3	0.0	0.2	0.0	0.1	0.5	2.5	0.6			0.1		0.0	0.0	0.0	0.0	4.2	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.4	0.5	0.0	0.0	7.6	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2											0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	19.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11026420	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	36.1	38.1	52.3	43.3	62.9	31.7	42.8	86.2	61.8	38.7	39.8	47.6	37.5	39.8	45.8	47.2	47.8	37.9	32.4	40.8	49.5	36.7	39.3	48.3	40.2	52.8	59.0	45.2	53.0	39.1	60.2	68.1	44.2	46.5	43.3	52.9	38.4	41.7	45.3	57.1	43.0	43.4	50.5	44.7	46.1	38.1	34.5	62.6	52.2	46.7	38.0	63.5	38.1	47.9	29.4	31.7	16.5	24.8	33.6	31.1	17.0	52.6	36.2	62.1	31.8	33.7	28.4	36.7	36.2	32.0	59.6	44.6	42.7	38.9	70.2	26.6	40.2	35.0	37.8	75.2	42.1	78.6	37.6	36.3	53.2	60.1	56.7	27.6	63.7	35.4	23.1	47.9	41.8	34.3	33.5	42.2	27.7	68.3	39.6	50.4	42.5	46.6	51.7	49.5	50.5	32.4	55.3	49.8	44.6	42.9	39.0	42.4	35.0	49.3	39.1	27.9	47.4	39.1	45.0	38.5	40.0	47.0	32.9	52.0	29.6	36.5	74.3	26.2	64.1	42.4	16.3	19.6	16.5	25.4	24.8	31.1	29.4	26.0	24.6	31.7	21.2	25.9	27.7	7.9	33.6	23.6	22.2	26.8	17.0	52.3	62.9	86.2	61.8	49.5	36.7	59.0	45.2	46.5	62.6	29.8	67.3	58.2	67.5	101.8	36.2	65.0	33.1	64.3	60.3	27.9	27.5	55.0	28.2	39.9	5.6	56.1	37.9	46.7	47.0	69.3	45.5	61.8	39.5	45.1	43.8	35.0	63.7	35.6	47.5	7.8	43.7	40.0	33.7	38.7	45.1	35.8	42.4	31.6	48.4	33.2	37.8	32.3	50.6	50.2	31.1	100.1	61.4	41.7	47.8	60.0
AL109811.4		ENSG00000277726			1	11012662-11030528	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 4.2"	"Group enriched"	"Detected in some"	82	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 9.9;Ciliated cells: 9.4;Club cells: 7.9;granulocytes: 4.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 7.1;hTCEpi: 2.3;MCF7: 3.5;RT4: 4.7"															NA	NA						"unprognostic (1.86e-2)"	"unprognostic (1.32e-1)"			"unprognostic (5.30e-2)"			"unprognostic (6.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.80e-2)"		"unprognostic (2.77e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.48e-2)"	0.3	0.0		0.0		2.2	0.1		0.0	0.3	0.2			0.0	0.5	4.2	0.0	0.0	0.1	0.0			0.0	0.0	2.8	1.8			0.0	0.0	1.8		0.0		0.1	2.9		2.6	1.1	1.0	1.9	0.0	0.0		0.6	1.1	0.0			0.0		0.0	0.3		1.5	1.7	1.2	1.3	0.2	2.9	0.0	0.0	0.7	0.0	0.6	1.7	1.3	0.7	1.7	0.0	0.0	0.0	0.7	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	1.0	0.0	0.3	1.2	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.8	3.5	0.6	0.4	0.0	0.0	0.2	0.0	1.3	0.0	0.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.2	0.8	0.7	2.5	0.5	2.7	1.3	1.8	2.6	0.2	1.5	1.6	2.9	0.7	0.2	1.3	1.7	1.1	0.0											8.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	9.4	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell type enriched"	"Detected in some"	68	"Hepatocytes: 541.9"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.5	0.8	0.0	0.0	0.0	1.3	1.1	2.4	0.7	0.0	0.6	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.6	20.5	0.0	2.2	1.7	0.0	0.0	0.1	0.0	2.0	0.0	1.9	0.8	0.5	0.0	0.6	0.6	1.2	0.4	0.2	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	1.8	0.6	1.3	1.2	0.9	0.6	1.0	0.6	0.8	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	3.4	0.2	0.8	0.0	0.4	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	541.9	0.1	0.0	0.0	8.0	7.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060024	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 107.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015746	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	26.7	17.7	20.3	29.0	35.4	15.2	16.9	10.2	30.8	14.3	13.3	14.0	11.5	10.8	18.8	9.8	17.7	15.8	14.2	24.9	19.6	16.9	13.9	45.3	14.0	31.0	15.3	15.0	22.8	107.4	8.0	14.5	14.8	15.6	13.1	11.7	15.0	36.0	17.6	43.6	18.2	9.8	22.9	11.7	21.1	14.5	14.4	14.1	17.9	11.9	21.2	20.8	20.2	19.8	10.7	10.2	0.3	6.0	5.0	10.3	2.0	24.9	36.4	12.1	40.4	24.2	26.2	19.0	38.8	19.9	55.5	29.8	44.8	15.1	48.3	22.9	33.6	17.4	19.6	38.6	31.2	18.5	23.7	58.4	30.4	40.3	50.4	35.6	51.0	27.9	26.2	22.6	53.7	47.2	13.0	23.4	31.6	49.4	40.9	27.0	54.8	43.5	44.5	26.4	23.0	70.5	32.7	12.5	78.8	19.7	9.9	23.3	22.3	20.1	43.3	30.3	9.8	15.1	25.9	19.4	36.3	28.6	62.8	43.5	33.0	33.3	72.3	25.2	68.6	41.7	0.0	5.4	0.3	7.0	6.0	10.3	10.7	7.1	9.1	6.4	9.3	8.4	9.7	0.2	5.0	3.1	10.2	7.5	2.0	20.3	35.4	10.2	30.8	19.6	16.9	15.3	15.0	15.6	14.1	0.0	2.9	57.4	63.7	84.3	27.7	26.4	30.6	2.7	1.2	27.9	19.6	62.5	64.6	20.3	3.4	46.6	5.1	23.3	36.6	175.3	66.1	60.8	27.5	47.6	85.0	28.6	26.4	35.6	21.8	10.5	66.4	35.3	64.1	8.2	27.0	28.1	26.0	7.0	49.8	69.0	12.3	0.0	49.9	12.8	74.2	98.9	30.1	23.5	26.6	92.1
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099881	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	28.2	21.8	30.4	22.1	31.9	30.8	27.9	58.8	34.7	24.8	22.0	31.9	22.4	18.5	27.0	22.9	27.6	22.7	18.3	18.3	27.8	16.2	22.4	18.2	20.8	26.0	31.5	26.3	31.2	24.2	23.1	32.1	23.5	24.3	22.1	25.9	20.4	24.6	20.5	27.3	33.2	22.7	25.6	23.2	26.0	25.2	20.3	32.7	28.2	20.8	12.5	29.9	23.6	24.6	21.0	21.6	24.8	26.4	27.5	25.9	22.3	23.4	15.0	31.5	12.1	16.8	18.6	18.0	23.2	17.1	40.9	37.2	22.1	34.4	23.7	15.1	22.0	18.2	23.4	34.8	25.9	37.6	26.5	34.8	34.4	29.5	22.4	16.5	27.9	27.4	14.6	22.4	40.1	23.7	15.3	25.4	21.2	36.1	21.9	22.5	13.2	27.4	25.8	20.8	18.0	18.0	28.3	26.8	20.7	24.0	12.0	20.3	19.9	25.0	21.7	27.8	23.1	18.9	25.8	23.0	21.9	22.7	19.6	27.1	13.3	20.8	46.9	22.3	41.7	26.2	24.8	18.2	14.6	22.2	23.4	25.9	21.0	23.1	22.1	21.6	19.9	19.8	22.0	3.6	27.5	26.4	11.0	21.8	22.3	30.4	31.9	58.8	34.7	27.8	16.2	31.5	26.3	24.3	32.7	26.8	16.5	14.1	12.2	11.7	15.3	5.6	10.2	32.1	35.2	5.2	45.2	23.7	8.3	21.4	12.5	17.4	11.3	0.0	27.7	27.8	14.3	7.5	18.6	8.1	21.3	20.6	8.6	12.9	13.8	5.4	27.3	19.0	11.8	23.4	14.7	5.6	24.4	11.9	21.5	6.7	34.8	12.9	11.3	20.9	22.8	11.7	19.0	16.2	16.2	8.0
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262507	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 38.8;Spermatocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB069425: , HPA071227: AB_2686367"	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	11.3	13.9	18.7	13.0	22.5	12.3	14.9	25.2	25.2	11.3	14.5	18.2	10.4	11.2	13.8	23.6	13.1	10.5	15.7	14.2	14.5	13.6	15.8	19.4	10.8	14.3	14.0	14.4	10.7	16.6	26.5	16.0	12.5	15.5	15.2	17.1	14.4	14.2	15.2	24.6	16.5	13.6	15.2	10.4	15.4	13.1	38.6	13.1	16.6	13.2	9.9	15.7	11.7	10.2	3.9	4.0	3.0	6.4	2.6	5.6	2.3	15.2	13.9	18.7	14.2	22.7	10.8	9.4	12.9	12.4	17.3	17.0	14.2	14.1	17.0	11.1	15.2	10.7	18.2	25.3	19.8	22.4	13.5	18.5	22.6	28.7	17.9	14.2	21.9	16.8	13.8	15.1	24.7	25.1	8.2	21.8	16.4	25.2	14.6	12.0	17.4	15.1	16.8	14.2	16.0	13.1	15.2	22.1	11.4	15.3	13.9	18.9	13.9	27.6	15.0	16.9	21.5	12.2	13.0	23.3	15.1	13.7	11.5	17.3	14.4	13.4	33.4	10.9	23.8	15.9	0.7	2.9	3.0	5.2	6.4	4.3	3.9	3.0	2.7	4.0	3.4	3.6	3.1	2.0	2.6	3.3	3.1	5.6	2.3	18.7	22.5	25.2	25.2	14.5	13.6	14.0	14.4	15.5	13.1	14.9	10.2	5.2	4.5	3.1	0.0	25.7	2.5	2.7	10.3	8.7	0.0	6.5	1.7	6.3	31.2	7.8	7.9	0.0	5.4	5.9	5.1	7.5	12.7	13.0	6.1	0.0	9.9	5.5	7.3	29.3	7.2	6.0	8.5	5.4	6.8	0.0	8.6	3.5	7.8	4.3	0.0	38.8	6.9	48.4	31.3	5.0	8.2	6.5	9.5	5.5
ANGPTL7	"AngX, CDT6"	ENSG00000171819	"Angiopoietin like 7"	O43827	1	11189341-11195981	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.9"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Cardiomyocytes: 2.2;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Cancer enriched"	"Detected in some"	14	"melanoma: 18.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"SCLC-21H: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted in other tissues"	NA	NA		490000				"unprognostic (3.23e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	12.8	3.7	0.1	2.0	0.2	0.0	4.8	3.2	0.2	5.4	8.0	0.3	9.3	1.3	1.4	4.3	7.0	1.7	5.9	10.4	0.1	0.3	6.5	0.4	2.1	1.0	0.1	0.4	1.9	0.6	0.0	7.8	0.9	0.5	4.7	2.4	5.3	4.2	11.4	22.9	5.9	2.6	16.5	3.5	0.4	2.2	3.9	0.5	0.1	0.7	13.8	1.4	6.2	4.5	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.2	0.2	0.1	0.3	0.1	0.4	0.5	0.5	3.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBIAD1	"SCCD, TERE1"	ENSG00000120942	"UbiA prenyltransferase domain containing 1"	Q9Y5Z9	1	11273206-11296049	"Disease related genes, Predicted membrane proteins"	"Menaquinone biosynthesis, Ubiquinone biosynthesis"	"Prenyltransferase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044862			Approved	Vesicles		NA	NA			Vesicles		"HPA044862: AB_2679117"	"unprognostic (1.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-3)"	"unprognostic (7.55e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.80e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.25e-1)"	12.1	11.8	9.2	10.2	11.8	9.2	12.0	10.2	13.1	9.6	9.8	17.6	5.0	7.8	13.0	9.7	8.8	14.4	11.9	11.6	9.0	8.3	9.9	38.1	8.7	18.6	14.1	6.1	17.5	23.4	14.6	10.0	9.1	11.0	10.6	10.0	11.9	11.2	10.2	24.8	11.3	9.5	11.5	15.5	12.9	10.7	17.7	13.6	17.9	12.2	9.6	17.5	11.7	8.7	22.0	10.7	9.5	8.7	9.6	27.0	11.4	8.5	8.5	6.8	13.0	5.0	4.7	9.1	9.4	7.7	10.2	9.3	9.8	7.9	16.9	9.7	6.7	9.6	11.8	17.1	11.3	12.5	11.8	14.7	11.3	9.1	13.0	9.2	17.2	9.9	7.1	15.4	13.7	16.4	5.4	7.4	15.7	13.4	14.1	6.8	8.7	11.1	8.7	8.1	16.1	12.6	10.6	15.1	20.5	7.8	5.7	8.4	9.0	10.0	10.0	12.7	2.9	7.4	9.1	6.1	9.0	9.7	9.3	12.2	11.5	15.9	31.5	5.7	22.9	11.1	4.8	6.5	9.5	13.1	8.7	14.6	22.0	17.8	13.3	8.6	20.7	27.0	18.3	2.0	9.6	7.3	10.7	16.6	11.4	9.2	11.8	10.2	13.1	9.0	8.3	14.1	6.1	11.0	13.6	8.9	13.4	15.8	11.6	13.7	11.1	8.4	7.6	10.7	23.9	5.2	7.9	8.9	10.0	8.9	26.6	8.4	5.1	23.3	11.2	12.1	10.3	9.4	6.9	18.6	7.9	12.7	4.7	4.3	6.9	17.6	11.5	11.3	5.0	5.4	9.7	9.8	9.3	3.5	10.3	7.9	13.9	0.0	10.3	16.1	13.8	11.0	15.8	12.1	13.1	8.9
DISP3	"KIAA1337, PTCHD2"	ENSG00000204624	"Dispatched RND transporter family member 3"	Q9P2K9	1	11479166-11537584	"Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;testis: 7.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054579	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054579: AB_2682529"	"unprognostic (4.93e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.34e-1)"	0.9	1.9	7.3	1.1	10.0	0.9	0.9	4.1	17.4	0.9	1.0	9.0	0.0	1.3	1.1	0.9	0.8	1.0	0.8	0.8	7.3	5.7	0.9	0.8	0.9	1.2	4.0	6.5	0.9	1.6	0.8	4.2	0.8	5.1	1.6	0.9	5.4	0.9	0.8	0.8	0.8	1.3	1.0	2.1	1.1	1.2	7.5	6.8	0.0	0.9	0.0	1.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	7.9	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.0	0.8	0.0	2.0	0.0	0.2	3.2	11.0	2.4	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	10.0	4.1	12.9	7.3	5.7	4.0	6.5	5.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.7;pancreas: 52.5"	"Cell type enriched"	"Detected in many"	5	"Exocrine glandular cells: 606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 1.4;T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 21.1;HBEC3-KT: 18.5;Hep G2: 44.2;SiHa: 83.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	1.7	21.8	49.7	2.6	39.2	1.2	7.9	21.1	48.3	2.1	1.8	13.2	2.1	13.7	1.5	6.4	3.6	3.6	2.9	2.6	33.1	32.6	6.9	11.0	3.0	2.5	40.0	23.0	2.2	52.5	17.7	20.2	1.3	25.7	5.1	1.3	2.7	21.7	7.6	1.3	6.6	4.9	1.7	31.4	2.2	3.8	4.4	24.3	1.1	3.7	0.0	3.8	2.6	2.9	1.4	0.1	0.0	0.0	0.0	3.1	0.6	6.9	2.1	0.0	6.8	0.1	0.0	1.0	0.3	0.6	0.1	0.0	21.1	2.0	0.0	8.7	0.0	1.8	0.0	0.7	18.5	0.0	0.1	0.2	0.0	0.2	44.2	0.9	0.0	0.0	0.6	3.4	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.0	1.6	0.5	0.7	0.9	83.5	0.0	0.8	0.7	4.1	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	3.1	1.4	1.2	2.9	0.1	1.1	1.8	2.6	0.0	0.0	0.0	0.0	0.8	0.6	49.7	39.2	21.1	30.3	33.1	32.6	40.0	23.0	25.7	24.3	0.0	1.0	6.6	52.3	17.4	10.7	2.4	17.8	5.3	5.7	45.4	2.0	0.6	72.9	20.7	1.7	0.6	0.0	0.0	606.0	3.5	2.4	21.4	4.6	87.3	0.4	27.0	1.2	2.5	1.6	1.8	32.2	1.2	42.2	5.4	0.0	65.1	127.3	0.0	38.2	5.8	10.3	0.0	1.9	11.4	10.4	8.7	0.8	12.9	0.0	22.5
FBXO44	"FBG3, FBX30, Fbx44, Fbxo6a, MGC14140"	ENSG00000132879	"F-box protein 44"	Q9H4M3	1	11654375-11663327	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.7"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003363	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003363: AB_1078831"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (2.63e-4)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.29e-5)"	"unprognostic (1.34e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.02e-3)"	6.6	21.1	26.6	8.3	39.0	5.3	7.0	61.7	45.0	6.5	5.0	12.3	8.9	14.2	8.5	10.3	7.7	12.1	10.5	13.7	28.7	26.4	12.2	7.7	8.1	16.3	20.7	27.4	11.3	17.8	21.7	19.5	2.4	23.1	13.7	3.4	9.9	25.5	15.4	6.4	22.1	7.8	6.2	14.2	13.4	8.1	8.5	15.3	3.2	13.0	3.3	9.9	7.4	7.5	10.9	5.1	1.5	2.5	1.5	11.7	6.1	7.5	12.2	4.5	17.2	6.7	7.0	6.1	6.1	7.4	6.7	5.8	8.9	14.3	0.2	13.6	6.7	11.2	1.9	9.0	20.3	2.8	8.6	11.0	0.2	6.6	14.8	9.3	0.2	1.1	9.0	13.5	6.3	4.8	13.9	5.2	14.1	4.6	1.9	1.7	4.7	12.6	1.4	4.7	6.8	8.7	5.1	0.2	2.5	10.8	2.7	13.7	11.3	16.0	6.2	27.0	5.8	11.1	6.9	6.4	4.9	11.9	6.5	4.8	12.7	7.1	4.6	11.3	3.2	11.6	1.1	2.1	0.6	11.7	2.4	9.0	10.0	8.0	8.9	3.3	10.9	10.9	7.5	1.5	1.5	2.5	5.1	7.1	6.1	26.6	39.0	61.7	45.0	28.7	26.4	20.7	27.4	23.1	15.3	0.0	9.0	9.1	10.8	16.4	20.1	3.6	5.1	2.7	5.7	15.7	13.7	1.3	26.6	8.0	3.6	3.8	0.8	0.0	5.7	2.4	10.1	9.3	3.5	3.9	5.1	38.1	4.1	5.5	6.2	9.9	21.3	5.0	10.1	5.4	2.0	14.8	6.5	1.1	27.3	9.1	6.8	0.0	6.6	11.1	7.2	14.9	0.7	20.0	2.1	4.7
FBXO6	"FBG2, FBS2, FBX6, Fbx6b"	ENSG00000116663	"F-box protein 6"	Q9NRD1	1	11664124-11674354	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 55.4;Late spermatids: 93.4;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051175	Approved					NA	NA					"HPA051175: AB_2681372"	"unprognostic (3.23e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (2.65e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (5.90e-4)"	9.1	11.8	10.8	12.2	17.4	19.7	13.2	9.5	11.6	7.6	11.6	4.4	9.8	14.6	5.4	9.1	14.1	15.7	11.1	14.4	9.5	12.6	8.9	17.5	12.2	17.5	9.4	12.2	6.8	25.9	10.4	6.8	5.0	9.1	11.4	7.5	8.9	13.8	9.9	16.8	9.3	9.9	10.6	6.6	14.9	9.8	9.9	8.5	5.8	13.0	13.2	12.1	10.5	6.9	6.0	25.1	23.5	31.0	14.4	18.7	12.2	6.2	4.7	0.5	0.2	1.4	4.6	3.0	2.7	4.2	13.2	6.1	4.7	5.5	0.2	12.4	4.5	3.7	0.1	4.4	4.8	1.0	16.6	0.7	0.1	0.6	4.8	10.3	5.8	0.0	5.3	10.3	1.6	4.2	2.9	1.8	6.7	14.0	12.3	1.2	12.0	2.1	5.0	0.5	6.4	6.3	1.5	0.1	0.5	4.4	0.9	1.1	1.3	5.9	7.1	8.9	1.2	6.8	6.6	1.3	0.7	0.5	1.8	0.2	6.7	4.5	2.4	0.8	13.7	1.2	5.6	19.1	23.5	18.7	28.0	10.3	6.0	5.0	12.5	25.1	5.2	3.0	10.0	15.6	14.4	31.0	9.9	4.7	12.2	10.8	17.4	9.5	11.6	9.5	12.6	9.4	12.2	9.1	8.5	6.0	5.8	8.5	6.2	6.3	4.6	5.6	5.1	37.5	9.1	8.7	2.0	0.8	0.0	13.8	55.4	3.6	9.8	0.0	33.3	7.8	5.8	8.6	3.5	15.3	24.1	4.8	4.7	7.4	14.5	93.4	7.5	27.2	6.8	52.3	7.8	6.7	12.1	10.7	10.6	9.3	6.7	0.0	3.9	2.8	11.7	8.5	1.5	13.8	6.3	6.7
MAD2L2	"FANCV, MAD2B, POLZ2, REV7"	ENSG00000116670	"Mitotic arrest deficient 2 like 2"	Q9UI95	1	11674480-11691650	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 383.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008110, HPA024176, HPA024612"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.27e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.36e-1)"	12.4	10.1	15.4	15.7	15.6	37.9	13.7	15.5	13.5	10.0	10.5	14.5	11.9	8.6	10.4	11.8	9.8	9.9	10.3	17.3	13.2	11.2	13.2	34.4	12.9	18.3	19.6	9.7	14.6	23.0	5.8	11.1	8.2	12.4	11.8	6.1	8.4	21.0	9.2	23.0	12.0	7.4	11.5	15.0	11.9	12.4	37.0	15.8	42.1	12.0	10.4	19.0	11.9	13.4	19.5	46.9	13.8	31.7	13.2	29.8	27.7	11.7	10.8	18.2	20.5	5.6	11.0	7.3	10.9	12.3	21.5	19.2	14.0	11.4	16.6	13.4	11.4	12.6	5.2	22.5	11.3	12.5	25.0	25.0	7.4	16.7	17.1	9.9	15.0	12.3	7.1	11.6	15.7	13.6	8.4	9.7	22.4	30.5	26.6	10.6	17.4	69.0	70.9	46.8	4.8	17.6	46.9	20.0	20.4	7.8	2.5	33.8	23.7	18.2	7.0	31.6	13.1	10.2	32.6	5.1	17.9	22.7	16.6	15.4	21.4	14.9	43.0	13.2	52.7	13.7	11.9	29.4	13.8	29.8	31.7	23.9	19.5	20.1	23.1	34.0	15.9	13.7	20.3	12.5	13.2	27.2	46.9	22.9	27.7	15.4	15.6	15.5	13.4	13.2	11.2	19.6	9.7	12.4	15.8	0.0	5.3	24.6	22.8	34.3	5.5	13.9	12.7	4.0	5.7	14.0	3.9	14.0	43.1	34.8	122.4	28.4	2.1	70.0	66.1	41.4	31.5	29.1	13.9	52.9	36.0	11.1	32.6	23.9	40.3	383.8	28.7	45.0	45.5	100.0	10.5	7.5	37.7	3.5	15.9	23.1	3.9	38.8	30.9	46.4	40.3	30.4	7.0	38.7	7.5	12.9
DRAXIN	"C1orf187, Draxin, FLJ34999, Neucrin"	ENSG00000162490	"Dorsal inhibitory axon guidance protein"	Q8NBI3	1	11691729-11725857	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 5.6;brain: 9.5"	"Cell type enhanced"	"Detected in some"	6	"Basal glandular cells: 2.5;T-cells: 3.5"	"Group enriched"	"Detected in some"	6	"glioma: 5.1;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 25.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA014302	Uncertain				"Secreted in brain"	NA	NA					"HPA014302: AB_1853084"	"unprognostic (5.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (5.08e-1)"	0.7	0.4	9.5	1.0	4.4	2.8	1.4	4.1	4.7	0.3	0.4	4.9	0.0	0.6	1.0	0.8	0.6	0.7	0.6	0.4	8.9	0.9	0.5	0.2	1.2	1.0	2.7	3.0	0.5	0.7	0.4	0.2	0.4	2.4	0.4	0.5	0.0	3.6	0.7	0.6	1.3	0.7	0.3	1.9	0.9	0.4	1.5	2.5	0.0	0.7	0.8	0.5	0.4	0.2	1.2	0.6	5.6	1.1	0.9	1.9	0.5	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.9	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	5.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	0.3	25.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.1	4.3	0.0	0.1	0.2	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	5.6	1.1	0.7	1.9	0.6	0.7	0.6	0.5	1.1	0.3	1.2	0.8	1.0	2.9	0.9	0.7	0.6	0.8	0.5	9.5	4.4	4.1	4.2	8.9	0.9	2.7	3.0	2.4	2.5	0.0	0.3	0.9	2.5	0.5	0.8	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.6	0.9	0.0	0.0	0.2	0.1	0.7	1.6	1.1	0.0	0.4	0.0	0.0	0.0	0.3	1.8	0.6	1.5	1.7	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.9	0.6	1.9	0.3	0.0	3.5	0.0	2.0
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 96.5"	"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 387.3;Kupffer cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	16.5	19.2	8.7	16.6	10.8	65.5	31.0	3.1	10.0	13.0	9.7	16.7	15.6	6.5	10.3	37.0	19.6	28.4	14.5	22.0	8.9	6.9	29.7	11.0	26.4	35.6	14.2	6.6	15.0	27.2	7.9	12.2	15.2	16.5	33.2	5.6	17.1	22.2	13.5	25.3	13.2	8.4	13.4	12.9	31.0	12.3	15.3	10.7	11.4	25.5	12.6	14.6	15.2	26.0	5.2	35.2	85.3	96.5	7.7	21.7	53.1	15.0	18.7	4.7	10.3	7.9	10.1	8.7	7.9	13.7	9.8	8.6	11.9	36.7	1.6	36.2	9.6	24.7	12.8	7.8	37.7	3.1	0.8	17.1	0.4	11.3	14.1	24.7	7.4	18.3	10.0	29.9	32.0	17.0	12.1	13.1	4.8	19.7	14.9	5.5	12.4	3.6	21.9	8.4	6.5	19.1	1.2	4.2	7.5	16.0	1.4	4.1	6.2	14.6	7.4	13.5	6.6	16.8	15.8	7.4	12.6	8.9	19.8	8.4	5.5	6.5	8.8	32.2	53.7	5.8	45.4	96.5	74.3	21.7	47.6	10.8	5.2	8.2	12.9	35.2	4.0	8.8	11.7	85.3	7.7	39.8	2.9	9.6	53.1	8.7	10.8	3.1	10.0	8.9	6.9	14.2	6.6	16.5	10.7	20.8	27.2	6.9	27.5	10.3	0.3	10.1	30.6	56.2	17.0	34.9	5.9	15.2	8.3	87.9	13.0	31.8	6.4	0.0	387.3	71.9	36.4	56.1	84.5	6.6	107.2	3.2	6.9	45.4	167.4	16.3	35.1	52.2	27.0	8.2	11.0	15.6	91.8	24.6	25.5	44.0	5.5	12.9	6.6	3.3	27.5	11.8	11.0	47.5	19.1	21.8
C1orf167	"DKFZp434E1410, RP11-56N19.2"	ENSG00000215910	"Chromosome 1 open reading frame 167"	Q5SNV9	1	11761787-11789585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	22	"testis: 34.0"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 20.8;Early spermatids: 12.6;Late spermatids: 13.2;Spermatocytes: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	52	"U-698: 26.4"									HPA039114	Enhanced					NA	NA					"HPA039114: AB_10673606"	"unprognostic (2.93e-3)"	"unprognostic (1.34e-2)"		"unprognostic (7.48e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.38e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.55e-3)"	"unprognostic (3.92e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.46e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-2)"	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.1	34.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.9	1.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.8	1.6	0.0	1.1	1.0	0.6	0.4	0.0	0.0	1.2	3.5	0.0	0.5	1.7	0.9	12.6	1.0	0.7	0.0	7.3	0.2	4.1	1.8	0.0	0.0	0.4	4.8	0.0	4.9	0.8	13.2	5.8	0.3	0.0	0.0	0.0	0.3	3.6	2.9	3.5	3.7	0.3	0.0	4.1	14.1	3.4	1.5	0.2	0.0	0.0	3.1
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806920	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	11.7	11.0	8.9	10.3	12.4	24.5	9.7	15.3	15.8	9.0	10.4	13.5	8.3	10.7	10.4	54.5	11.3	12.7	10.9	23.4	9.2	8.6	12.0	12.4	16.2	13.3	9.9	10.7	28.8	11.2	6.7	17.5	6.6	10.7	10.2	9.1	14.1	7.3	7.2	15.3	13.2	13.6	10.9	7.4	18.3	13.6	10.6	10.9	10.2	15.8	9.8	11.7	10.4	17.9	4.9	3.2	4.7	7.4	3.4	4.7	2.3	1.3	5.9	6.8	7.8	6.8	10.5	1.1	4.2	8.8	4.0	3.5	5.4	8.7	11.4	2.3	4.3	9.3	2.6	4.8	4.0	1.7	5.4	4.4	8.4	7.4	1.5	9.1	4.6	10.9	9.2	4.0	3.0	3.3	6.6	6.2	10.8	27.4	7.5	4.1	1.8	5.0	2.2	2.3	5.9	2.1	5.2	3.7	12.6	6.4	7.2	6.8	11.6	5.2	5.1	8.2	4.3	8.1	7.2	5.5	4.0	3.3	4.7	1.0	4.2	5.7	21.3	4.9	10.6	3.6	1.1	3.8	1.9	4.7	7.4	1.8	3.0	1.6	2.5	3.2	4.9	2.4	2.7	4.7	3.4	6.9	1.5	1.0	2.3	8.9	12.4	15.3	15.8	9.2	8.6	9.9	10.7	10.7	10.9	23.8	50.3	12.3	6.7	7.4	0.0	35.5	10.2	5.3	10.3	26.2	0.0	4.1	1.7	7.7	13.8	16.2	32.7	46.7	22.0	2.7	16.0	9.3	8.1	19.5	18.8	0.0	11.6	38.6	38.0	28.3	17.0	26.2	11.8	10.8	15.4	0.0	15.7	17.8	8.5	14.3	0.0	19.4	24.7	6.0	4.7	8.2	2.4	8.7	16.5	8.1
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11843144	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	11.2	14.6	18.9	11.5	18.7	12.2	8.6	18.0	27.9	9.2	8.7	22.4	8.6	9.6	12.8	14.2	6.3	10.7	8.1	15.7	15.0	20.6	10.0	9.1	10.6	11.1	16.4	17.8	21.4	6.6	8.4	14.8	9.6	32.4	11.3	7.8	13.1	6.7	8.7	11.2	10.0	9.1	10.8	15.9	10.6	8.5	16.1	14.5	4.3	10.7	5.0	9.5	7.7	8.2	10.1	3.2	4.2	4.6	2.0	3.2	1.1	5.6	5.3	12.0	10.1	12.9	13.4	3.7	4.7	9.2	6.6	10.3	8.1	13.8	8.1	3.9	4.4	16.4	8.4	7.9	8.8	5.9	3.6	4.2	8.4	10.5	10.7	16.7	4.7	7.9	9.2	5.2	12.4	7.0	8.0	5.9	8.4	10.6	11.7	6.7	3.1	4.8	12.7	8.0	2.7	4.2	6.1	6.6	7.4	8.7	4.7	5.2	8.3	3.2	5.1	11.0	8.8	4.5	8.4	7.1	6.2	7.0	10.5	3.3	7.0	4.3	20.8	7.6	9.4	4.5	4.2	4.6	1.5	2.6	3.7	1.5	8.0	2.1	3.2	2.7	10.1	2.3	2.1	3.9	2.0	4.6	3.2	1.4	1.1	18.9	18.7	18.0	27.9	15.0	20.6	16.4	17.8	32.4	14.5	17.9	20.5	11.3	3.3	3.1	18.5	21.8	10.2	8.1	6.8	3.5	13.7	3.2	0.0	3.6	12.5	5.6	5.4	0.0	3.9	2.2	5.2	4.1	2.3	5.5	6.5	25.4	6.3	8.0	8.2	7.4	6.9	10.1	1.7	5.4	2.9	7.8	4.2	3.5	6.7	3.0	16.0	0.0	4.2	9.7	9.4	2.8	3.4	2.5	3.0	3.5
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"	"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	418	"heart muscle: 1267.7"	"Cell type enriched"	"Detected in some"	14450	"Cardiomyocytes: 19644.9"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.5;SH-SY5Y: 12.0"	"Region enriched"	"Detected in some"	8	"olfactory region: 28.1"	"Not detected"	"Not detected"			"HPA058269, HPA064007"	Enhanced				"Secreted to blood"	NA	NA		190000			"HPA058269: AB_2683660, HPA064007: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	1267.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.3	0.8	0.0	0.5	3.0	1.1	1.7	2.6	2.1	0.0	0.0	1.6	0.9	0.0	0.0	0.0	6.7	2.7	4.3	0.3	0.0	1.5	4.0	0.0	0.0	0.0	1.0	2.6	2.7	1.5	6.6	0.0	1.4	4.6	0.0	0.0	0.0	0.0	0.6	0.0	1.2	5.9	5.1	0.0	0.9	0.5	7.7	1.9	0.1	0.7	0.6	0.8	0.8	0.0	1.8	12.5	12.0	0.7	0.0	2.2	1.2	1.6	0.2	0.4	2.1	4.3	3.4	0.3	1.3	3.2	4.9	0.3	3.5	1.1	0.0	0.4	0.0	0.1	0.8	0.4	1.3	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.5	0.0	0.0	3.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19644.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858931	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"heart muscle: 348.6"	"Group enriched"	"Detected in some"	14	"Cardiomyocytes: 146.6;Ductal cells: 75.3;Pancreatic endocrine cells: 62.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 34.0;CACO-2: 88.4;SuSa: 17.8"					"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	9680								"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	348.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.9	0.5	0.4	0.7	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.5	0.2	88.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.8	0.4	1.0	1.0	0.6	1.0	0.5	0.5	1.1	1.1	0.0	0.7	0.3	0.9	0.7	0.9	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	146.6	0.0	1.4	0.0	0.0	0.0	3.3	0.0	75.3	0.0	0.0	0.0	0.0	6.9	1.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	62.5	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0
KIAA2013	"MGC33867, RP5-1077B9.1"	ENSG00000116685	KIAA2013	Q8IYS2	1	11919591-11926428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052677, HPA060536"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA052677: AB_2681911, HPA060536: AB_2684313"	"unprognostic (3.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.51e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.74e-3)"	13.8	13.9	12.0	10.6	16.7	10.9	12.9	11.9	18.7	13.7	32.0	25.2	16.7	42.6	19.1	24.9	15.4	14.7	19.7	18.9	12.5	10.8	17.1	34.4	12.4	12.6	22.8	10.6	12.2	34.0	9.6	17.7	24.6	16.1	15.1	13.5	14.8	26.2	18.6	24.4	18.6	55.1	14.4	16.0	19.2	16.0	21.7	19.0	15.0	19.8	11.2	14.1	17.4	13.1	7.0	10.8	13.8	6.3	4.6	6.3	3.0	23.7	17.7	8.3	16.4	14.2	9.8	13.8	15.2	16.1	18.5	19.2	21.8	24.8	15.7	23.4	14.4	14.4	27.8	11.2	15.0	9.9	18.0	28.8	10.7	16.4	37.2	16.1	22.2	22.2	12.4	16.8	18.0	8.0	20.1	17.6	12.6	16.4	20.9	11.0	18.0	14.1	31.3	10.9	10.6	24.5	18.1	15.3	37.8	11.7	6.5	31.2	17.6	12.3	13.8	29.0	8.7	11.6	20.8	16.8	15.6	20.5	22.9	20.6	25.3	17.8	17.8	18.6	36.2	16.5	4.2	6.3	6.1	6.2	5.3	4.9	6.1	3.4	4.7	4.3	7.0	3.4	4.5	13.8	4.6	4.2	10.8	6.3	3.0	12.0	16.7	11.9	18.7	12.5	10.8	22.8	10.6	16.1	19.0	20.8	11.2	32.1	8.7	19.7	20.2	16.9	25.5	13.4	9.1	24.4	11.8	15.2	3.3	14.9	19.3	18.7	101.7	23.3	16.5	23.6	14.4	15.6	12.7	63.7	23.1	30.2	39.3	30.1	29.1	27.2	21.0	21.6	18.6	9.0	52.1	20.8	20.2	63.3	21.5	21.4	21.4	19.4	12.0	21.8	10.0	24.6	11.1	17.8	48.7	16.6
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 215.9;Sertoli cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	16.9	14.5	8.0	37.4	54.7	30.6	6.4	50.4	67.0	26.6	45.3	16.5	11.1	9.8	53.4	55.7	19.8	14.3	11.6	17.6	18.3	10.2	12.4	5.3	23.3	20.9	33.9	3.3	25.8	37.1	9.3	32.1	12.9	90.3	47.1	2.2	14.8	4.8	27.7	11.0	0.8	8.9	3.5	17.3	21.6	3.9	16.3	21.3	15.3	3.8	3.0	12.7	22.0	15.1	25.4	13.1	7.6	8.5	46.5	30.4	22.8	38.0	24.7	11.3	18.3	5.8	67.4	11.6	49.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4	0.0	9.3	3.7	7.6	6.3	4.2	16.2	10.2	4.0	5.7	10.4	2.0	34.8	3.3	30.5	1.1	20.4	18.7	0.0	8.4	215.9	28.4	9.2	0.0	29.9	41.8	6.4	8.1	46.6	21.6	1.7	41.1	15.6	10.1	18.0	9.8	10.1	24.0	12.9	23.0	13.7	2.7	103.5	26.2	0.5	3.6	4.4	28.1	4.4	11.0	3.8
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12013514	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.9;skeletal muscle: 111.1"	"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 308.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17.0	17.0	11.2	16.5	12.1	8.7	20.1	9.0	9.0	100.9	17.9	16.0	14.8	20.4	10.6	8.0	18.8	19.3	10.2	9.0	22.0	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14.0	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	26.0	15.9	18.1	23.8	18.3	13.8	21.0	20.6	19.1	28.3	22.1	26.3	17.4	19.1	22.4	24.9	18.6	27.9	29.9	47.8	25.4	69.2	22.7	27.3	25.6	20.4	19.0	27.7	17.2	17.4	36.9	39.8	36.9	12.2	19.9	10.3	28.2	16.8	20.9	13.1	16.8	12.7	12.5	17.5	23.5	19.7	26.4	17.8	17.0	17.4	21.1	13.8	24.2	25.8	23.9	14.2	13.9	16.7	19.9	19.0	19.0	28.8	21.5	20.1	21.1	31.3	22.5	31.2	20.5	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8.0	18.5	5.8	16.9	4.6	8.0	13.4	16.4	20.3	15.9	32.1	17.9	16.0	18.8	19.3	20.8	10.9	20.8	18.6	11.5	8.2	20.3	24.8	308.6	12.7	12.0	14.8	14.0	11.8	12.2	18.3	12.7	3.6	12.0	31.1	23.3	17.3	13.2	9.3	12.5	10.4	39.2	14.2	28.6	17.3	13.5	18.1	4.4	6.6	11.8	16.9	10.0	20.9	11.6	13.9	14.0	14.2	13.3	18.6	12.9	14.4	27.7	16.8	26.3	21.1	9.6	22.1	12.9
MIIP	"FLJ12438, IIp45"	ENSG00000116691	"Migration and invasion inhibitory protein"	Q5JXC2	1	12019466-12032045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044948	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044948: AB_10795887"	"unprognostic (1.36e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (8.02e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	13.2	9.4	12.2	17.0	17.3	53.4	10.8	13.7	15.3	11.1	11.4	11.9	11.6	11.0	16.5	8.8	11.1	13.0	8.9	13.3	12.9	10.1	9.2	11.7	13.3	18.3	15.9	10.6	20.4	13.5	5.8	7.1	14.6	17.0	11.3	4.5	8.5	18.1	14.2	26.3	14.8	12.7	12.3	11.0	20.4	10.0	18.2	15.2	10.5	22.5	9.7	12.5	12.3	11.9	14.8	45.0	18.3	27.1	10.6	19.0	12.5	5.0	3.4	2.7	5.2	1.4	1.6	9.4	2.7	1.4	5.4	4.1	6.6	8.1	6.4	6.6	1.4	3.8	5.3	2.0	3.1	0.7	90.6	7.5	4.0	5.4	7.0	3.1	6.1	12.4	2.2	4.0	4.7	2.1	0.9	3.0	8.8	11.9	5.9	1.6	5.1	6.0	9.1	4.8	3.7	5.1	8.6	3.4	9.8	2.3	1.5	5.0	5.3	4.0	5.1	9.8	1.5	3.4	10.6	3.2	5.0	5.3	9.9	4.2	5.0	6.3	8.6	3.2	10.7	5.0	4.9	23.2	7.1	9.0	25.9	8.4	14.8	9.3	7.8	14.2	13.0	5.8	4.5	18.3	10.6	27.1	45.0	19.0	12.5	12.2	17.3	13.7	15.3	12.9	10.1	15.9	10.6	17.0	15.2	11.9	7.7	14.7	6.9	11.6	14.2	5.0	2.5	6.7	2.3	8.7	7.9	31.4	21.6	13.8	26.0	9.8	14.7	23.3	15.9	82.3	17.4	10.1	17.3	12.5	36.1	7.9	16.0	9.2	17.8	38.7	7.8	20.3	15.1	64.1	9.7	14.2	13.7	14.4	6.3	10.1	14.5	12.9	14.7	14.7	41.9	15.1	27.7	20.8	13.4	5.9
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063377-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.3"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 2.8;Kupffer cells: 6.0;Late spermatids: 7.2"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enriched"	"Detected in single"	14	"basal ganglia: 13.1"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 21.7;non-classical monocyte: 33.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 33.3"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 112.6"					"Low region specificity"	"Detected in many"			"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	10.7	0.2	0.1	7.2	13.1	1.4	5.8	0.2	0.4	1.1	0.8	0.0	1.5	0.2	1.7	1.3	0.9	2.1	1.4	3.8	0.1	0.2	0.9	0.2	3.9	2.9	0.5	0.5	1.2	0.4	0.0	0.1	6.2	0.5	1.0	0.5	0.0	0.7	0.3	3.1	1.6	1.3	1.3	1.4	2.9	6.4	2.5	0.9	3.0	0.7	2.7	5.3	2.6	3.8	0.0	3.2	6.8	33.3	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	112.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	5.2	0.3	0.0	0.0	0.3	0.0	4.5	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.3	0.0	21.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	6.8	0.0	33.3	0.8	0.3	2.7	0.1	13.1	0.2	0.4	0.1	0.2	0.5	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4	0.0	0.0	1.3	6.0	7.2	0.3	1.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.2	0.0	0.0	0.0
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12167003-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.1"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 168.8;Macrophages: 143.1;monocytes: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 70.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;K-562: 21.4;THP-1: 25.1;U-87 MG: 17.2;U-937: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	2500000			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	43.4	4.7	4.6	44.3	13.8	29.2	42.3	2.1	6.1	13.3	13.1	6.6	1.9	11.9	9.7	10.2	6.5	11.3	11.6	21.8	8.5	6.2	6.2	22.2	24.5	60.6	9.1	2.2	9.4	4.2	2.3	4.4	24.9	15.0	7.3	8.2	8.3	5.7	3.7	11.5	6.2	17.3	11.5	22.6	48.3	10.5	6.0	6.1	10.9	6.2	5.6	16.2	18.3	8.4	2.7	13.2	25.7	70.1	2.5	12.7	19.9	0.0	0.1	2.1	0.0	5.6	7.7	4.4	0.5	1.0	2.0	2.2	0.8	17.5	0.1	0.3	1.8	2.9	0.0	0.4	0.0	1.1	6.9	0.0	0.0	0.1	0.0	13.2	0.1	1.9	7.6	0.0	7.0	0.0	3.6	10.6	0.1	21.4	3.2	0.9	0.0	0.0	4.0	0.1	2.7	0.6	0.5	0.2	12.3	0.0	0.4	0.0	0.0	0.3	0.1	0.6	3.3	0.0	25.1	3.7	3.0	0.1	13.3	0.0	1.0	0.0	0.0	17.2	18.1	0.7	0.0	20.7	3.0	9.4	49.3	5.4	2.7	6.6	7.7	13.2	1.7	2.0	3.0	25.7	2.5	70.1	2.8	12.7	19.9	4.6	13.8	2.1	6.1	8.5	6.2	9.1	2.2	15.0	6.1	8.9	22.3	30.3	2.5	14.9	0.1	2.8	7.6	2.7	11.4	3.5	0.0	0.7	0.0	0.4	0.3	40.2	11.8	23.3	0.5	4.3	9.7	4.3	2.3	14.0	63.4	0.0	0.0	22.7	168.8	0.4	2.0	143.1	15.1	73.9	3.1	0.3	0.5	1.4	0.4	0.3	1.0	32.3	13.7	0.0	0.9	9.3	25.2	58.9	3.9	9.8
VPS13D	"FLJ10619, KIAA0453"	ENSG00000048707	"Vacuolar protein sorting 13 homolog D"	Q5THJ4	1	12230032-12512047	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 141.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027332, HPA051621"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA027332: AB_2672223, HPA051621: AB_2681555"	"unprognostic (2.97e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"prognostic favorable (7.42e-12)"	"unprognostic (5.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.31e-2)"	11.7	9.8	16.6	8.5	16.4	8.0	16.6	18.5	19.7	19.9	12.5	17.0	11.7	6.9	12.8	15.3	16.1	10.8	10.2	15.8	15.7	13.2	15.4	11.0	12.3	9.9	16.5	13.8	15.9	11.9	28.1	14.1	9.2	13.3	18.6	11.3	14.0	15.1	16.8	30.3	39.2	9.7	17.3	14.8	10.2	12.8	11.6	13.6	8.6	21.7	11.3	14.4	10.8	17.9	4.1	3.9	6.0	1.9	1.7	3.6	0.9	8.2	4.7	5.3	4.1	14.3	11.4	2.5	4.0	7.0	6.9	6.6	3.1	5.8	7.7	5.1	11.4	5.8	7.5	9.2	7.9	9.7	4.2	3.1	6.6	7.3	2.5	6.0	9.5	3.5	9.6	11.2	8.8	8.7	8.6	10.9	7.5	13.5	4.0	6.3	3.8	5.6	3.7	2.1	4.5	6.0	4.9	6.4	2.3	4.9	4.9	2.6	3.6	11.7	8.7	8.3	5.3	7.4	3.2	11.9	4.3	4.5	11.1	3.3	3.5	2.9	12.3	4.9	6.8	6.5	6.0	1.9	1.4	3.3	1.9	3.5	2.5	3.6	2.3	1.5	4.1	3.2	2.5	2.6	1.7	1.4	3.9	1.7	0.9	16.6	16.4	18.5	19.7	15.7	13.2	16.5	13.8	13.3	13.6	17.9	18.9	9.8	42.5	19.3	35.3	67.8	12.7	20.1	25.0	17.4	68.7	6.1	3.3	7.4	81.4	17.1	17.2	23.3	12.3	6.0	9.9	29.1	11.6	18.1	10.0	44.5	13.8	19.0	16.5	141.6	21.3	14.3	11.8	6.4	14.6	23.4	13.5	10.5	20.5	8.4	33.6	45.3	33.0	16.7	11.3	27.5	12.4	12.5	10.4	35.6
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
AADACL4		ENSG00000204518	"Arylacetamide deacetylase like 4"	Q5VUY2	1	12644547-12667086	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.8;epididymis: 3.5;vagina: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 2.1;REH: 1.0"					"Not detected"	"Not detected"									NA	NA									"unprognostic (3.20e-1)"								"unprognostic (1.89e-2)"						2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8			0.0	0.4	3.5	0.0	0.7	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.7	0.0		0.1	0.2	0.0	0.0	0.7		1.1	0.0		0.0	1.4	0.2	0.0	0.0	0.5	0.0	0.6	0.4	1.4			0.0		0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
AADACL3		ENSG00000188984	"Arylacetamide deacetylase like 3"	Q5VUY0	1	12716115-12728759	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"placenta: 13.4;skin 1: 4.7"	"Cell type enhanced"	"Detected in single"	35	"Extravillous trophoblasts: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA															"unprognostic (3.01e-1)"					"unprognostic (2.54e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746215-12763699	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 23.5;testis: 74.6"	"Group enriched"	"Detected in some"	13	"Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028396			Uncertain	Cytosol		NA	NA			Cytosol		"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	0.7	0.0	2.4	0.3	0.0	0.0	0.2	0.9	0.0	6.2	0.0	0.0	0.4	4.2	0.1	23.5	0.1	0.0	1.0	1.4	0.0	0.0	2.8	0.1	0.2	0.1	4.8	0.1	0.0	0.4	0.1	9.3	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.2	0.1	0.1	74.6	0.9	0.0	0.5	0.0	0.1	0.0	0.0	0.9	0.6	2.3	0.6	1.1	0.8	0.1	0.5	1.3	1.1	0.7	0.6	0.0	1.0	0.1	0.3	0.2	0.2	1.3	0.7	1.1	0.3	0.3	0.4	0.4	0.1	0.1	0.2	0.2	0.7	1.1	1.9	0.5	0.0	0.9	1.0	0.1	0.7	0.3	0.1	0.4	0.1	0.5	0.9	1.4	0.3	0.5	0.2	0.7	1.5	0.3	0.5	0.6	0.3	0.9	0.1	0.5	1.9	0.8	0.5	0.6	0.3	1.4	0.7	0.2	0.5	0.5	0.8	0.4	0.8	0.6	0.5	1.2	1.0	1.1	0.5	1.6	0.6	0.5	0.7	0.5	0.6	0.5	0.5	0.5	0.1	0.9	0.8	0.7	2.3	1.1	0.6	0.6	0.4	0.1	0.7	2.4	0.0	0.2	1.0	1.4	0.2	0.1	9.3	0.9	3.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	105.7	7.9	0.0	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	65.2	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.0	7.9	1.3	0.0	0.0	0.0	0.0	0.1
PRAMEF12		ENSG00000116726	"PRAME family member 12"	O95522	1	12774841-12777906	"Plasma proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.8"									"HPA045286, HPA051704"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045286: AB_10794782, HPA051704: AB_2681581"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.8		0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.1			0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF1		ENSG00000116721	"PRAME family member 1"	O95521	1	12791397-12796628	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.2"	"Group enriched"	"Detected in some"	48	"Early spermatids: 6.8;Late spermatids: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"															NA	NA																				"unprognostic (2.78e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRAMEF11		ENSG00000239810	"PRAME family member 11"		1	12824605-12831410	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	18	"testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNRNPCL1	HNRPCL1	ENSG00000179172	"Heterogeneous nuclear ribonucleoprotein C-like 1"	O60812	1	12847408-12848725	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.8"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.0"															NA	NA						"unprognostic (2.13e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.05e-1)"		"unprognostic (6.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.64e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.43e-3)"	0.1	0.3	0.3	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.1			0.9	0.4	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.5	0.1	0.2	0.3		0.5	0.1	0.0	0.2	0.1		0.2	0.1		0.1	0.0	0.3	0.1	0.2	0.0	0.1	0.3	0.3	1.2			0.1		0.0	0.0	0.2	1.0	1.4	1.2	0.9	0.8	0.9	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.7	0.5	0.8	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.5	0.5	0.3	0.1	0.5	0.3	1.0	0.5	0.8	0.5	0.5	0.9	0.8	0.8	0.9	0.9	1.4	1.0	0.9	0.9	1.2	0.8	0.6	0.5	0.7	1.8											0.0	0.0	0.0	0.8	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.5	0.2	0.0	0.0	0.3
PRAMEF2	FLJ43580	ENSG00000120952	"PRAME family member 2"	O60811	1	12857086-12861909	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"HDLM-2: 1.8"															NA	NA																				"unprognostic (1.91e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF4	RP5-845O24.6	ENSG00000243073	"PRAME family member 4"	O60810	1	12879224-12886201	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"liver: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"liver cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA												"unprognostic (5.41e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF10		ENSG00000187545	"PRAME family member 10"	O60809	1	12892896-12898270	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	67	"liver: 7.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	29	"liver cancer: 1.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	27	"SCLC-21H: 2.7"															NA	NA												"unprognostic (1.20e-1)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF7		ENSG00000204510	"PRAME family member 7"	Q5VXH5	1	12916610-12920482	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049887, HPA051704"	Uncertain					NA	NA					"HPA049887: AB_2680935, HPA051704: AB_2681581"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF6		ENSG00000232423	"PRAME family member 6"	Q5VXH4	1	12938472-12947580	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF27		ENSG00000274764	"PRAME family member 27"	A3QJZ7	1	13049476-13056491	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNRNPCL3		ENSG00000277058	"Heterogeneous nuclear ribonucleoprotein C-like 3"	B7ZW38	1	13060869-13062229	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA										"unprognostic (3.30e-2)"					"unprognostic (3.33e-2)"				"unprognostic (2.90e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.3			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF25		ENSG00000229571	"PRAME family member 25"	A6NGN4	1	13068677-13077884	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.3			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNRNPCL2	HNRNPCP5	ENSG00000275774	"Heterogeneous nuclear ribonucleoprotein C-like 2"	B2RXH8	1	13115496-13116854	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA										"unprognostic (9.41e-2)"					"unprognostic (2.20e-1)"				"unprognostic (7.42e-2)"	"unprognostic (3.84e-1)"			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.9			0.0		0.0	0.0		0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1
PRAMEF26		ENSG00000280267	"PRAME family member 26"		1	13148905-13155961	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNRNPCL4		ENSG00000179412	"Heterogeneous nuclear ribonucleoprotein C-like 4"	P0DMR1	1	13164586-13165467	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA										"unprognostic (1.85e-1)"													0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.4	0.2	0.2	0.3	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.2	0.3	0.3	0.1	0.3	0.1	0.2	0.4	0.4	0.3	0.1	0.2	0.1	0.2	0.4	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF9		ENSG00000204505	"PRAME family member 9"		1	13172455-13179464	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF13		ENSG00000279169	"PRAME family member 13"	Q5VWM6	1	13196330-13201409	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.7"															NA	NA																							0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.1	0.0		0.0	0.1	0.0	0.1	0.0	0.0		0.0	0.2	1.1			0.0		0.0	0.0		0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF18		ENSG00000279804	"PRAME family member 18"	Q5VWM3	1	13222705-13226106	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	4	"bone marrow: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057423	Uncertain					NA	NA					"HPA057423: AB_2683435"																		0.0	0.4		0.0		1.9	0.0		0.0	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.3	0.1	0.4	0.0	0.4	0.5	0.8	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.7	0.1	0.3	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF5	"PRAMEF23, PRAMEF5L"	ENSG00000270601	"PRAME family member 5"	Q5TYX0	1	13254212-13263314	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF8		ENSG00000182330	"PRAME family member 8"	Q5VWM4	1	13281035-13285174	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049887, HPA051704"	Uncertain					NA	NA					"HPA049887: AB_2680935, HPA051704: AB_2681581"															"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF33	PRAMEF33P	ENSG00000237700	"PRAME family member 33"	A0A0G2JMD5	1	13303539-13308907	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"liver cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA												"unprognostic (6.42e-3)"											0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.5	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF15		ENSG00000204501	"PRAME family member 15"	Q5VWM5	1	13315581-13322598	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"liver: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.1"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF14		ENSG00000204481	"PRAME family member 14"		1	13342034-13347134	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"				"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"Early spermatids: 11.1;Late spermatids: 4.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HDLM-2: 2.0;SCLC-21H: 1.2"															NA	NA																				"unprognostic (7.23e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF19		ENSG00000204480	"PRAME family member 19"	Q5SWL8	1	13369067-13371693	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"BEWO: 2.2"									HPA057423	Uncertain					NA	NA					"HPA057423: AB_2683435"															"unprognostic (2.87e-1)"			0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF17		ENSG00000204479	"PRAME family member 17"	Q5VTA0	1	13389632-13392629	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6			0.5		0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF20	"OTTHUMT00000008157, PRAMEF21"	ENSG00000204478	"PRAME family member 20"	Q5VT98	1	13410450-13421328	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SCLC-21H: 3.4"															NA	NA																				"unprognostic (1.02e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6			0.0		0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC38		ENSG00000162494	"Leucine rich repeat containing 38"	Q5VT99	1	13474977-13514048	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 16.0;skeletal muscle: 60.8"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 1.4;Cardiomyocytes: 1.9;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"cerebellum: 4.1;cerebral cortex: 3.0;pons and medulla: 1.1"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.9;MOLT-4: 14.6;PC-3: 10.5;U-138 MG: 17.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038778	Approved					NA	NA					"HPA038778: AB_10673294"	"unprognostic (5.13e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"		"unprognostic (1.72e-1)"		"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.23e-1)"		"unprognostic (7.81e-2)"	"unprognostic (4.47e-2)"		"unprognostic (1.05e-1)"	0.4	16.0	0.1	0.1	0.3	0.2	0.7	4.1	3.0	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.4	0.2	0.2	1.0	0.2	0.1	0.2	0.1	0.2	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.7	1.1	0.4	0.2	0.8	0.5	0.2	60.8	0.8	0.2	0.2	6.8	0.2	0.2	0.5	0.0	5.7	0.2	10.0	0.3	0.2	0.5	0.1	1.8	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	10.5	0.0	0.1	1.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	17.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.3	4.1	3.0	0.2	0.1	0.4	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.8"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3"									"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	27.7	2.0	6.3	29.8	10.9	0.5	30.3	5.0	6.7	21.4	12.8	11.0	4.1	2.5	16.8	15.3	8.9	19.8	23.7	18.6	5.7	6.5	1.9	0.8	17.8	10.4	10.0	2.4	18.4	3.9	0.7	2.3	71.8	13.5	11.3	6.4	26.6	6.0	8.6	21.9	10.0	7.6	18.6	17.5	0.7	15.1	9.7	7.9	3.2	5.7	9.7	9.9	27.3	28.9	0.4	0.2	3.1	0.4	0.3	0.4	0.1	0.0	0.0	30.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	72.6	1.7	0.0	0.1	50.4	9.0	0.0	0.1	9.2	0.0	0.0	0.0	44.7	0.0	0.0	6.1	16.8	3.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.1	48.3	8.5	7.3	0.1	0.0	0.0	0.0	0.1	18.1	0.0	0.0	1.0	0.4	0.6	0.2	0.2	0.2	0.4	0.3	0.3	0.2	0.4	0.4	0.3	3.1	0.3	0.2	0.2	0.2	0.1	6.3	10.9	5.0	4.8	5.7	6.5	10.0	2.4	13.5	7.9	98.3	9.1	0.0	29.7	12.9	1.2	6.9	0.0	6.7	29.6	0.0	3.9	1.8	0.0	0.4	0.5	7.4	0.0	0.0	0.0	1.6	108.5	3.5	1.1	0.0	6.5	0.0	0.0	7.4	0.0	0.4	18.7	4.1	6.8	202.8	0.0	85.7	0.5	0.0	59.1	0.0	2.8	0.0	6.2	0.9	8.6	6.0	2.4	0.0	0.0	3.4
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	15.2	14.5	26.0	17.2	28.1	64.1	17.2	32.3	44.9	16.2	18.1	19.8	12.6	12.4	18.8	16.4	19.6	14.4	16.4	14.3	19.8	14.5	10.8	9.3	15.6	23.4	18.9	27.8	30.7	12.8	16.0	26.7	15.7	18.0	17.7	13.6	10.3	15.8	18.9	45.2	21.6	16.8	16.8	21.6	16.9	14.2	17.1	17.8	14.4	23.3	11.7	22.7	19.8	19.3	16.0	5.4	9.7	5.1	5.7	5.7	2.5	6.9	4.0	14.4	5.5	11.4	8.8	6.9	9.0	5.5	6.2	7.0	6.2	7.9	21.2	8.0	8.7	5.2	8.6	10.7	5.3	6.9	13.1	7.6	14.2	4.6	2.9	6.3	4.7	12.3	9.3	9.4	6.5	5.5	5.9	6.1	8.4	12.6	24.6	7.7	3.5	7.6	7.5	4.3	5.5	5.3	10.6	7.8	6.3	3.5	7.8	12.5	8.1	7.2	4.6	9.9	9.0	6.5	7.7	10.8	7.9	8.7	7.2	4.9	36.1	24.4	30.4	7.1	11.1	10.2	3.9	4.8	6.8	5.7	3.1	3.8	16.0	4.5	5.2	2.9	12.5	5.2	4.5	9.7	5.7	5.1	5.4	4.1	2.5	26.0	28.1	32.3	44.9	19.8	14.5	18.9	27.8	18.0	17.8	35.7	37.8	66.5	49.3	55.2	46.9	34.7	25.5	53.5	40.9	22.7	43.2	19.3	14.9	15.3	8.6	29.3	23.6	46.7	11.9	11.9	42.7	46.2	39.3	16.4	14.7	66.7	36.4	25.2	38.9	11.6	40.9	37.0	28.7	28.9	18.8	23.0	13.7	14.4	42.5	6.6	36.8	25.8	27.0	41.2	51.7	45.7	15.3	50.4	15.2	52.5
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 72.8;Suprabasal keratinocytes: 79.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 40.6;SK-BR-3: 22.0"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: AB_2674146, HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	8.0	1.4	8.8	40.6	3.8	4.0	3.0	3.8	3.2	7.2	5.2	1.8	4.3	0.0	10.1	8.2	1.3	2.9	2.0	6.3	3.6	0.2	3.9	4.6	4.8	12.0	2.8	0.0	2.4	5.6	8.5	1.6	1.1	3.2	0.0	1.1	1.8	9.4	5.7	5.9	0.0	0.4	2.4	3.6	1.2	2.7	0.2	4.9	12.1	2.5	4.7	3.4	0.7	22.0	15.1	5.3	1.3	3.1	0.0	6.0	5.6	9.4	4.6	1.6	1.3	0.0	5.6	8.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9	3.0	2.6	0.9	12.5	44.8	9.3	3.0	5.1	12.0	6.8	47.1	7.9	1.1	14.9	1.8	4.5	8.1	3.0	0.0	1.4	5.8	10.8	8.1	3.5	0.0	0.7	0.0	6.8	40.5	1.2	5.8	17.5	2.1	43.9	0.0	3.7	72.8	1.4	0.0	16.3	11.4	2.4	6.5	21.7	0.1	4.0	79.0	38.8	2.9	2.8	24.0
TMEM51	"C1orf72, FLJ10199"	ENSG00000171729	"Transmembrane protein 51"	Q9NW97	1	15152532-15220480	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Urothelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	23	"dendritic cells: 1.7;monocytes: 2.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014547, HPA019441"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA014547: AB_1858121, HPA019441: AB_2670142"	"unprognostic (1.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (7.81e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.91e-2)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.67e-3)"	4.6	14.1	4.7	7.7	4.4	0.4	7.0	14.2	5.1	9.7	22.4	4.5	14.3	15.9	5.3	7.6	12.0	7.2	25.3	3.7	5.0	2.2	23.5	3.9	10.4	7.4	4.1	3.4	15.4	36.7	14.5	5.2	7.5	4.2	12.3	7.8	16.1	7.5	15.5	1.2	5.3	22.9	8.9	5.7	7.1	18.9	3.4	3.9	2.0	3.8	12.3	8.4	18.5	22.2	0.0	1.7	0.0	2.8	0.0	0.0	0.3	19.1	10.3	5.9	1.4	1.0	2.2	0.0	2.2	9.3	6.8	9.3	13.5	21.6	0.0	7.3	1.4	9.8	18.6	2.0	7.2	3.9	0.0	5.1	0.4	0.5	13.3	8.6	0.0	18.8	0.7	6.4	8.9	9.8	4.4	6.3	0.8	2.9	0.0	3.5	6.6	0.0	0.0	1.0	15.3	3.9	2.7	3.7	3.3	17.3	19.9	0.9	17.5	1.8	7.6	18.4	3.7	1.0	2.0	4.4	7.1	6.3	3.1	6.9	0.2	0.3	0.0	7.0	0.3	8.3	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	4.7	4.4	14.2	5.1	5.0	2.2	4.1	3.4	4.2	3.9	0.0	1.6	2.7	51.9	16.3	0.0	1.8	20.4	6.7	4.5	47.1	0.0	4.2	5.0	64.9	0.4	8.7	12.9	0.0	64.3	0.7	5.6	48.2	0.0	0.4	43.7	0.0	18.4	8.6	24.2	0.0	2.6	18.8	13.5	19.8	16.3	0.0	65.3	25.9	13.1	11.8	0.0	32.3	39.4	0.5	1.9	18.4	1.1	0.0	13.2	98.9
FHAD1	KIAA1937	ENSG00000142621	"Forkhead associated phosphopeptide binding domain 1"	B1AJZ9	1	15247272-15400283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 366.7;Early spermatids: 202.9;Late spermatids: 182.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"pons and medulla: 13.8"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.8;HMC-1: 39.8;K-562: 8.5;U-87 MG: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054284	Enhanced					NA	NA					"HPA054284: AB_2682436"	"unprognostic (3.18e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.36e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-3)"	0.4	0.4	1.4	0.8	2.0	0.0	1.1	0.2	0.9	2.6	0.4	6.7	0.8	1.0	1.0	16.0	0.2	17.9	0.6	0.2	3.0	2.6	0.6	0.3	7.6	0.2	0.5	0.2	8.2	0.9	1.8	1.1	0.5	13.8	1.0	0.3	0.5	0.6	1.3	0.1	0.3	1.1	0.3	0.6	0.2	2.5	28.5	2.8	0.0	1.4	0.1	0.3	0.9	0.3	0.8	0.4	0.0	1.6	1.2	3.6	0.8	0.9	0.2	0.8	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.6	0.3	0.1	0.1	0.2	0.1	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.2	1.2	39.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	3.5	0.1	4.1	0.0	0.0	4.5	0.0	21.4	0.0	0.1	0.0	1.6	0.0	3.6	0.6	0.1	0.8	0.4	1.2	0.4	0.0	0.0	1.5	0.0	1.2	1.2	0.0	0.0	0.8	1.4	2.0	0.2	0.9	3.0	2.6	0.5	0.2	13.8	2.8	0.0	2.1	0.0	0.6	0.1	0.2	1.2	0.0	366.7	45.5	0.0	0.0	0.0	0.0	1.5	202.9	0.7	0.7	0.0	1.2	0.0	0.7	0.4	0.0	0.0	2.3	3.2	1.7	0.0	1.0	182.6	2.0	1.5	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.4	0.0	12.9	1.4	7.9	11.4	0.0	0.1	0.0	0.3	1.1
EFHD2	MGC4342	ENSG00000142634	"EF-hand domain family member D2"	Q96C19	1	15409895-15430343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Pancreatic endocrine cells: 329.7;Urothelial cells: 408.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 45.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 79.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048961	Enhanced		Approved	Cytosol		No	No		35000	Cytosol		"HPA048961: AB_2680572"	"unprognostic (1.37e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (9.11e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.31e-9)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (2.70e-4)"	"prognostic favorable (3.60e-5)"	12.9	21.8	16.1	35.4	15.4	69.3	8.7	13.3	41.2	9.3	24.8	7.0	7.5	39.5	11.8	6.2	18.4	10.3	21.2	7.2	19.6	15.3	7.4	10.4	19.2	31.8	14.2	22.0	9.2	26.8	4.0	10.1	16.4	56.5	14.6	14.8	6.8	11.1	10.3	3.3	10.8	45.0	8.7	8.2	48.9	42.8	28.5	7.1	17.1	14.7	7.5	27.2	20.6	12.9	1.4	9.7	45.0	11.9	9.4	15.6	4.9	79.3	20.2	2.0	5.3	3.2	7.0	10.6	10.1	9.7	9.6	9.2	7.8	21.9	17.3	32.2	7.0	12.4	19.4	5.4	17.9	6.2	21.5	10.6	4.1	4.7	12.3	5.2	21.0	36.2	5.5	6.1	19.6	5.0	4.5	12.4	7.9	9.8	8.4	5.9	7.9	10.8	40.6	2.6	10.9	25.2	14.5	18.5	13.7	5.6	16.7	4.5	3.5	8.9	7.7	16.5	1.6	3.3	22.8	23.2	14.3	15.2	44.3	16.3	5.7	13.4	7.4	19.9	41.9	19.3	4.7	11.9	16.3	15.6	11.1	4.5	1.3	3.6	7.2	9.7	1.4	1.7	6.7	45.0	9.4	9.3	3.4	2.3	4.9	16.1	15.4	13.3	41.2	19.6	15.3	14.2	22.0	56.5	7.1	3.0	16.4	40.3	77.9	58.7	1.0	5.9	28.1	9.4	11.4	21.0	9.8	17.6	16.6	55.1	72.9	39.4	263.4	0.0	225.6	181.1	21.9	96.0	44.9	17.8	193.0	0.0	59.2	29.4	182.4	177.9	9.2	155.3	21.9	97.4	131.4	3.2	329.7	122.8	6.3	27.0	4.2	45.3	23.7	5.9	4.9	59.8	44.6	86.3	90.1	408.3
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438439-15449242	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	417	"pancreas: 1443.7"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 5617.8"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046920	Enhanced				"Secreted to digestive system"	NA	NA					"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1443.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.4	3.4	0.7	1.5	0.6	0.1	3.6	0.6	0.5	0.7	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.7	0.5	1.1	0.0	0.5	0.5	0.0	0.1	0.2	1.1	0.6	0.4	0.3	0.1	0.9	0.2	1.7	0.3	0.0	0.0	0.0	0.6	0.0	0.7	0.1	1.8	0.2	0.5	1.1	1.7	0.5	0.0	0.0	0.5	0.1	0.3	0.0	0.1	0.4	1.0	0.4	0.2	0.2	0.2	0.3	0.1	0.9	0.4	1.4	0.9	0.3	0.8	1.6	0.3	0.8	0.8	0.3	3.4	0.4	0.4	0.4	0.2	0.2	0.3	0.3	0.6	0.1	1.1	0.3	0.4	1.7	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.1	0.0	0.0	5617.8	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	41.5	0.0	0.0	1090.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase family member 2A"	P08217	1	15456728-15472091	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1559	"pancreas: 2376.3"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 6761.1"	"Cancer enriched"	"Detected in single"	3819	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 5.0;K-562: 1.1;U-2 OS: 1.6"														"Secreted to digestive system"	NA	NA						"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	2376.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	1.2	0.0	0.0	0.0	1.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.0	0.0	6761.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.1	0.0	0.0	361.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CELA2B	"ELA2B, RP11-265F14.2"	ENSG00000215704	"Chymotrypsin like elastase family member 2B"	P08218	1	15465909-15491400	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	188	"pancreas: 697.9"	"Cell type enriched"	"Detected in some"	42	"Exocrine glandular cells: 1081.3"	"Cancer enriched"	"Detected in single"	574	"pancreatic cancer: 69.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.7"	"Cell line enriched"	"Detected in some"	5	"U-138 MG: 9.3"														"Secreted to digestive system"	NA	NA						"unprognostic (4.36e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.22e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-2)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	697.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.5	0.0	0.1	1.5	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.7	1.0	1.8	0.7	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.2	1.1	0.0	0.0	0.0	0.0	0.4	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.5	0.4	0.0	0.0	9.3	0.0	0.0	0.0	0.9	0.1	0.3	0.4	0.0	0.0	3.7	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1081.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	7.4	24.1	7.8	8.2	9.3	8.9	5.5	11.1	8.7	8.3	9.3	10.2	18.9	5.2	11.9	16.5	7.5	13.4	29.1	10.2	8.3	7.2	11.6	9.4	10.8	12.6	10.7	4.3	33.4	29.0	15.6	18.5	14.7	8.8	10.2	6.4	8.7	6.6	19.0	8.2	2.8	13.3	7.8	9.0	11.0	6.7	14.4	7.1	6.2	14.8	7.2	14.6	7.3	8.1	11.2	11.7	23.3	11.2	13.0	5.1	6.1	7.2	10.6	4.1	7.2	9.5	4.7	3.8	5.3	7.0	7.9	10.2	7.4	8.8	10.6	12.5	7.2	10.2	2.6	7.0	5.6	9.2	3.7	8.7	7.6	23.6	7.4	8.8	7.3	8.9	6.5	10.4	12.1	3.7	7.8	8.5	9.6	17.0	9.9	4.7	3.7	2.5	8.3	4.1	10.5	5.9	4.9	10.4	12.3	9.8	4.2	3.6	6.9	7.6	1.8	12.6	9.5	4.5	5.3	3.3	10.6	4.8	11.4	3.5	9.6	14.4	12.0	8.1	8.0	3.5	22.7	11.2	23.3	5.1	8.2	3.7	9.6	3.0	3.6	11.7	11.2	1.7	2.6	16.0	13.0	7.9	5.2	2.8	6.1	7.8	9.3	11.1	8.7	8.3	7.2	10.7	4.3	8.8	7.1	3.0	3.0	4.7	7.9	2.6	3.2	6.7	5.1	10.7	9.1	17.4	5.9	15.4	1.7	6.6	9.9	3.0	6.8	0.0	7.8	9.0	5.0	4.5	1.1	4.3	8.5	4.8	2.9	3.7	4.3	4.1	2.0	8.7	0.0	3.6	5.6	6.5	7.9	5.8	3.5	4.2	6.2	0.0	9.9	15.8	5.7	2.0	29.9	4.9	4.5	5.4
DNAJC16	KIAA0962	ENSG00000116138	"DnaJ heat shock protein family (Hsp40) member C16"	Q9Y2G8	1	15526813-15592379	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043643	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043643: AB_10796794"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (4.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.74e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.70e-2)"	9.6	11.5	9.8	9.5	18.7	3.9	12.3	13.2	24.3	10.2	10.9	18.4	14.2	12.0	12.9	14.7	11.5	13.0	11.2	9.1	11.0	10.8	22.1	20.0	8.9	10.5	11.1	10.8	13.1	13.4	20.1	20.3	13.9	17.2	10.8	11.2	12.0	12.1	10.8	19.2	10.2	11.2	11.9	10.7	11.3	9.9	11.1	11.0	11.4	13.9	8.9	12.5	10.3	9.4	6.9	4.1	3.8	4.1	3.2	8.0	3.6	7.5	7.2	6.0	10.9	16.4	13.3	5.6	9.0	9.2	9.1	9.8	6.2	11.1	6.5	6.1	9.0	11.9	9.4	7.3	8.0	12.9	7.7	3.4	6.7	8.3	10.7	16.3	10.3	7.8	9.6	9.5	14.7	8.2	11.4	10.1	5.5	14.1	6.0	10.4	3.0	5.2	5.3	5.7	6.8	5.1	6.2	7.7	7.3	11.2	5.2	6.7	6.3	9.3	8.9	7.6	9.0	5.6	4.2	13.7	16.1	5.8	14.8	4.9	8.2	11.5	5.9	10.0	6.0	7.6	3.8	4.1	3.0	5.6	4.0	8.0	6.8	5.8	5.0	4.1	6.9	7.4	6.3	2.3	3.2	2.9	3.7	5.3	3.6	9.8	18.7	13.2	24.3	11.0	10.8	11.1	10.8	17.2	11.0	0.0	8.3	11.2	4.1	4.5	13.4	12.0	20.4	21.4	11.4	24.4	21.6	10.5	1.7	8.1	7.1	8.7	8.6	0.0	6.0	6.3	8.6	10.7	8.1	15.3	9.4	17.5	11.1	16.5	19.9	5.4	11.5	5.8	6.8	5.4	11.3	12.4	8.2	7.0	10.6	13.8	15.0	6.5	4.6	22.7	14.5	5.1	18.4	4.3	11.5	5.2
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15572353-15585110	"Enzymes, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;kidney: 54.7;liver: 66.1"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 278.6"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.6;T-cells: 10.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.0;Hep G2: 46.0;RPMI-8226: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		250000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.7	0.8	0.7	2.8	0.5	0.1	0.4	0.2	1.0	0.2	14.9	0.3	0.0	7.1	0.3	1.2	0.5	0.2	3.6	0.3	0.6	0.8	54.7	66.1	0.2	1.3	0.7	0.3	0.2	1.1	1.3	0.4	0.2	0.6	0.3	2.8	0.1	9.6	0.0	12.3	0.2	21.3	0.1	0.3	1.0	0.5	0.5	0.1	1.0	0.3	1.7	1.5	0.4	0.2	4.6	0.4	1.4	0.3	0.4	10.5	2.8	4.0	3.2	0.2	0.1	0.0	0.4	0.1	0.7	0.7	0.4	0.2	19.0	2.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	3.9	0.0	2.5	2.7	46.0	0.5	2.0	0.0	0.5	0.2	1.3	0.0	0.3	0.4	0.0	0.0	5.4	1.0	4.3	0.0	1.9	4.3	3.2	1.8	0.0	0.0	11.4	0.1	1.0	0.7	0.6	5.5	0.2	0.6	0.2	0.7	3.8	0.5	0.1	0.1	1.0	0.0	0.1	3.0	2.6	0.2	0.0	0.0	0.9	0.3	0.2	2.4	0.3	3.1	4.6	5.7	3.0	0.2	3.2	10.5	5.9	1.4	0.4	0.2	0.4	7.1	2.8	0.7	0.5	0.2	1.0	0.6	0.8	0.7	0.3	0.6	0.1	0.0	0.0	3.2	1.5	0.2	1.2	0.4	5.1	1.4	0.0	3.5	0.0	0.7	26.6	0.8	6.9	0.1	12.9	0.0	0.8	0.7	0.7	0.9	0.0	38.9	0.9	3.2	1.2	1.8	2.2	3.6	0.3	0.4	1.7	1.0	6.7	0.8	2.0	3.5	0.0	278.6	1.7	0.0	0.4	1.6	2.9	0.5	0.7	5.0	13.8	2.6
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617500-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	14.8	8.1	5.1	10.5	7.1	10.5	15.0	8.7	8.4	8.7	10.8	8.2	9.8	9.0	12.3	9.6	19.4	7.7	8.3	12.5	5.8	4.7	10.4	24.9	10.2	9.1	6.7	5.2	8.3	9.4	14.8	8.0	11.5	7.5	12.1	7.9	11.5	13.5	13.8	54.8	13.3	9.2	8.0	6.5	9.9	6.9	4.3	6.0	11.1	7.6	11.7	16.4	12.1	12.3	3.8	5.4	0.8	2.3	2.0	3.5	1.4	7.5	4.4	8.0	8.3	11.0	8.7	7.8	4.7	3.6	4.2	3.6	10.7	6.9	19.0	5.6	5.2	3.1	8.0	17.4	7.6	7.1	8.7	11.6	14.8	7.4	10.5	4.7	19.6	7.5	8.6	9.1	7.8	8.4	5.2	8.5	12.4	23.8	7.0	5.1	5.1	11.3	6.5	7.6	11.2	3.6	10.7	11.3	11.2	5.9	6.3	9.8	5.4	8.8	14.4	13.1	9.4	7.5	5.1	7.4	6.0	5.2	6.8	5.8	6.6	8.0	15.4	4.7	14.3	4.7	0.7	2.3	0.4	3.3	2.1	2.9	2.6	2.5	2.6	2.3	3.8	2.8	3.5	0.8	2.0	1.6	5.4	2.3	1.4	5.1	7.1	8.7	8.4	5.8	4.7	6.7	5.2	7.5	6.0	8.9	15.2	11.9	12.2	13.6	23.7	23.0	12.7	29.4	22.7	3.5	13.7	17.5	1.7	6.8	1.5	12.1	15.1	46.7	6.6	16.1	13.9	22.6	1.1	54.8	13.2	33.4	14.5	16.0	21.2	0.4	11.8	12.5	15.1	6.4	22.4	8.0	12.5	3.5	6.3	16.5	36.7	6.5	12.3	10.0	7.8	17.7	33.6	12.7	20.1	12.7
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	0.9	0.3	1.7	0.4	2.8	2.6	0.1	0.6	2.2	0.6			0.0	1.2	0.0	3.5	1.2	1.1	2.9	0.3	0.5	4.0	7.7	2.7	2.0	0.4		4.6	0.2	2.1	1.3	2.3		3.9	1.3		0.1	0.8	0.6	2.1	0.6	3.0	0.8	0.1	0.6	4.7			1.7		3.2	1.1	2.2	1.1	2.8	0.5	3.5	1.7	2.3	1.5	3.3	3.9	4.8	3.2	6.0	4.2	6.4	2.8	4.7	7.9	7.4	6.4	5.5	7.4	2.8	6.3	3.9	2.3	12.5	4.0	9.7	4.9	3.1	6.9	7.7	6.8	1.3	10.1	3.5	3.3	0.0	13.6	7.5	1.8	4.9	5.0	19.0	7.0	5.7	3.3	5.3	0.0	5.2	1.9	2.2	4.5	6.8	3.1	1.8	6.2	3.9	1.6	5.3	2.4	4.6	4.3	3.4	0.9	4.8	4.0	7.4	3.6	2.1	2.1	4.0	12.9	1.6	2.7	2.8	0.0	1.2	0.5	0.4	3.5	1.4	1.1	0.5	2.3	2.8	0.2	0.6	0.5	0.0	1.7	0.1	0.7	2.3	1.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLEKHM2	KIAA0842	ENSG00000116786	"Pleckstrin homology and RUN domain containing M2"	Q8IWE5	1	15684332-15734769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032304	Approved					NA	NA					"HPA032304: AB_10670964"	"unprognostic (3.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.36e-8)"	"unprognostic (4.01e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (5.50e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.89e-2)"	16.6	14.0	26.7	14.4	23.3	37.1	11.1	21.2	49.6	10.6	9.4	11.5	6.7	10.7	11.6	6.8	17.7	10.9	14.7	24.6	23.6	13.2	8.7	6.5	14.6	15.5	14.7	21.9	12.6	17.5	14.4	8.9	15.0	13.6	9.5	6.2	11.4	11.9	11.2	50.0	18.1	10.2	11.6	10.6	17.5	11.1	15.9	9.7	9.3	9.4	14.2	11.5	13.6	16.6	4.9	5.2	6.2	6.0	2.1	3.8	2.7	17.8	10.8	10.6	18.4	25.3	20.4	11.6	15.5	25.4	19.7	18.3	14.7	16.2	10.0	16.6	23.6	20.0	10.7	8.2	17.5	7.6	19.3	14.3	12.3	17.8	11.3	26.8	10.3	14.2	23.3	19.7	20.5	23.5	22.8	14.8	17.0	14.7	27.3	10.0	14.0	11.7	10.8	8.0	6.0	9.1	16.1	9.3	13.4	9.6	7.9	11.0	15.1	17.3	10.4	41.3	7.6	7.0	15.9	16.5	27.5	12.9	27.2	11.5	13.9	9.4	12.5	23.7	16.7	16.6	0.6	5.8	3.5	3.8	5.3	3.0	4.5	2.5	1.5	5.2	4.9	3.1	2.6	6.2	2.1	6.0	4.2	1.7	2.7	26.7	23.3	21.2	49.6	23.6	13.2	14.7	21.9	13.6	9.7	14.9	19.4	3.7	9.6	22.0	26.4	27.7	12.7	5.3	6.8	15.7	21.6	6.2	1.7	11.1	25.5	13.8	12.7	0.0	15.3	7.1	19.8	13.9	18.4	9.6	32.2	27.0	10.9	25.2	24.1	13.2	19.0	21.4	8.5	12.6	11.8	20.9	18.1	15.2	17.0	5.6	19.6	0.0	16.3	13.5	6.0	31.6	20.6	7.5	10.3	19.6
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 16.0;Paneth cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.8	0.6	1.4	1.9	0.9	0.8	0.7	1.8	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.1	0.5	0.6	0.4	2.2	0.8	2.7	1.0	0.5	2.2	0.4	4.6	0.6	3.2	0.6	1.8	3.7	2.0	2.9	0.4	1.0	1.9	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.4	3.4	1.9	2.5	1.7	1.7	2.2	2.3	0.6	3.8	3.5	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2	0.0	0.0	0.0	0.3	0.2	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.7	16.0	0.0	0.2	0.2	0.7	0.3	0.0	2.1	1.2	3.2	3.4	2.5	2.6	0.4	0.9	0.1	0.0	1.8	2.4	1.7	0.2	5.3	0.4	3.0	1.4	0.0	0.9	0.5	0.6	0.1	1.1	0.0	4.1	0.4
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742422-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 35.6;liver: 30.1"	"Group enriched"	"Detected in some"	9	"Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"CACO-2: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	7.5	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.1	6.6	0.0	0.0	0.0	86.8	0.0	0.2	1.9	0.0	0.0	0.0	38.2	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	57.5	0.0	47.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.3	0.0
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 180.0;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 54.1;TIME: 84.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	11.6	6.0	1.7	12.8	1.4	0.0	10.1	0.8	1.3	21.5	36.6	1.4	26.8	24.6	30.3	15.8	17.8	16.5	60.2	21.7	1.2	1.0	18.2	3.0	14.7	16.1	1.8	1.6	36.0	13.0	13.9	3.8	21.5	2.3	26.7	15.7	9.0	13.0	26.5	4.1	6.2	62.8	18.7	1.3	22.7	18.9	22.3	0.9	1.3	10.3	7.4	6.3	24.7	16.9	1.8	1.3	4.6	1.2	1.6	1.2	0.3	6.5	3.7	3.3	0.1	0.8	1.7	4.5	11.2	17.9	8.3	6.7	1.2	9.9	0.0	24.3	18.0	14.4	12.7	2.4	25.7	4.1	0.0	1.2	0.0	0.9	6.3	21.6	0.0	0.1	8.5	17.2	6.9	16.5	17.2	54.1	0.4	0.2	1.6	2.8	0.1	0.1	0.1	3.4	10.3	4.8	0.0	0.0	0.2	10.4	4.5	0.0	8.0	5.9	0.7	1.3	7.2	1.4	0.1	84.4	11.0	1.5	0.1	5.1	0.1	0.2	0.1	1.6	0.0	0.1	4.6	1.2	1.0	0.7	0.5	0.6	1.0	0.7	0.7	0.4	1.8	1.1	1.2	3.5	1.6	0.7	1.3	0.4	0.3	1.7	1.4	0.8	1.3	1.2	1.0	1.8	1.6	2.3	0.9	11.9	21.5	5.2	54.8	76.6	3.5	30.9	45.9	12.0	29.6	15.7	5.9	5.8	0.0	80.2	2.4	18.4	138.3	0.0	46.9	102.1	26.9	24.2	17.4	1.8	5.3	1.6	44.1	38.1	0.6	1.8	74.2	10.4	13.5	3.6	47.1	10.0	88.8	84.2	180.0	1.2	5.1	142.3	66.2	2.3	1.8	54.8	16.2	6.1	40.4	47.2
UQCRHL		ENSG00000233954	"Ubiquinol-cytochrome c reductase hinge protein like"	A0A096LP55	1	15807169-15809348	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 418.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042574	Approved					NA	NA					"HPA042574: AB_10960998"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.83e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (9.67e-3)"	"unprognostic (9.76e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.02e-1)"	0.0	0.1		0.2		2.2	0.4		0.4	0.0	0.0			0.2	0.4	1.6	0.1	0.4	0.4	0.1			0.0	0.4	0.2	0.2			0.5	0.0	0.0		0.0		0.1	0.1		0.5	0.0	4.4	2.1	0.4	0.1		0.6	0.0	0.5			0.2		0.0	0.0		1.5	1.2	5.5	1.0	1.3	1.0	0.5	0.7	0.5	3.2	3.3	0.8	0.9	1.2	0.6	0.3	0.1	0.3	0.7	2.5	1.2	0.9	0.5	0.9	1.3	0.6	0.5	0.7	2.2	0.4	1.1	1.9	0.5	0.7	0.9	1.5	0.6	1.0	0.4	0.3	1.2	0.0	1.6	1.1	2.4	0.2	1.9	0.4	1.5	1.6	0.4	1.3	1.1	0.7	1.1	0.0	1.7	2.7	1.8	1.0	2.1	0.8	0.7	0.9	2.7	0.5	2.0	1.1	1.2	0.8	2.3	0.9	1.3	1.0	2.1	0.9	3.6	1.0	0.9	0.8	0.7	0.6	1.1	0.6	0.8	0.6	1.5	1.0	1.0	5.5	1.3	0.7	1.2	0.5	0.5											0.0	0.6	37.2	21.8	0.0	3.8	418.0	28.1	0.0	1.2	8.7	5.9	20.5	19.9	1.0	2.4	12.3	7.7	0.0	0.6	18.0	10.8	25.1	2.3	21.7	18.5	1.6	7.0	17.8	58.5	2.7	10.3	0.8	0.0	0.0	14.1	3.0	0.7	0.0	11.7	6.1	7.3	6.5	1.0	3.2	14.6	0.0	19.7	4.5	17.7	24.4
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15847864-15940460	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015825: AB_1856823, HPA050257: AB_2681065"	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	18.2	11.2	18.2	18.2	22.2	27.2	17.3	38.2	25.9	18.5	13.4	20.7	17.7	11.9	19.0	12.7	16.7	19.4	11.8	13.5	17.6	11.5	14.4	13.2	17.8	16.6	23.4	17.5	31.2	23.9	35.1	17.5	16.2	19.0	14.9	13.3	11.6	16.2	16.2	24.0	22.8	16.0	15.1	22.0	16.5	13.7	13.6	23.3	18.3	20.1	8.7	18.0	17.1	41.9	5.0	2.7	7.7	2.4	1.3	1.7	0.6	12.7	10.8	13.5	10.1	13.6	8.3	7.3	6.6	8.7	7.2	6.1	9.8	10.0	18.0	7.9	13.0	8.5	18.5	12.7	11.8	11.6	16.2	35.2	22.6	9.6	6.2	6.1	18.5	10.8	6.1	8.5	10.7	15.6	6.8	8.2	13.8	23.5	18.6	5.8	7.1	15.3	7.3	6.1	7.4	8.3	14.8	13.2	11.1	4.0	11.5	10.5	10.6	18.6	9.1	7.9	6.4	3.2	9.1	14.7	6.6	8.2	12.8	9.4	11.2	7.3	20.6	6.5	15.0	9.2	7.7	1.5	0.9	1.6	2.4	1.3	1.8	1.7	1.4	0.7	5.0	0.9	1.3	4.2	1.3	1.2	2.7	1.1	0.6	18.2	22.2	38.2	25.9	17.6	11.5	23.4	17.5	19.0	23.3	74.5	74.0	31.3	47.9	93.0	64.6	48.1	20.4	38.8	66.0	5.2	49.1	10.9	3.3	16.9	3.4	55.5	30.7	23.3	15.0	12.0	46.5	43.4	59.1	26.3	13.3	90.6	30.4	13.5	30.8	3.6	25.3	30.1	20.3	25.2	24.4	29.6	18.0	23.2	33.6	6.5	54.5	19.4	54.6	34.9	51.9	88.8	13.2	20.2	18.7	49.2
ZBTB17	"MIZ1, pHZ-67, ZNF151, ZNF60"	ENSG00000116809	"Zinc finger and BTB domain containing 17"	Q13105	1	15941869-15976132	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005789	Approved					NA	NA					"HPA005789: AB_1080633"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (2.08e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.04e-4)"	13.9	17.9	17.4	19.5	23.6	40.8	12.4	16.1	23.9	13.1	12.7	27.8	11.4	15.8	14.7	13.4	18.4	12.4	13.1	15.6	18.6	13.5	14.0	12.0	14.0	19.9	21.4	16.5	17.7	17.7	12.3	12.8	11.3	15.5	14.8	7.3	11.9	19.7	14.0	29.5	18.6	14.4	16.7	13.5	21.6	16.7	31.6	21.9	13.8	15.6	12.1	15.0	15.3	12.5	11.6	6.7	13.7	8.1	11.6	10.3	5.5	7.9	8.6	10.1	19.0	7.8	5.5	8.5	10.8	12.5	11.5	9.8	8.7	12.1	8.2	10.1	9.4	8.9	8.3	5.0	11.1	3.5	16.4	8.8	12.8	13.1	11.3	10.7	9.4	16.6	7.6	9.1	16.4	9.9	8.5	10.0	16.9	12.5	13.6	7.7	11.7	17.0	19.0	8.9	7.0	13.0	17.3	10.0	8.3	6.8	6.4	12.6	17.2	8.8	8.4	14.7	4.5	9.0	15.4	10.5	12.4	13.1	11.0	8.7	17.2	7.9	8.6	16.6	11.3	16.7	1.4	8.1	7.8	9.7	7.2	7.1	11.6	7.7	10.3	6.7	9.1	6.9	6.0	13.7	11.6	6.1	6.3	7.8	5.5	17.4	23.6	16.1	23.9	18.6	13.5	21.4	16.5	15.5	21.9	8.9	2.4	13.7	7.3	12.4	10.1	5.1	12.7	1.4	5.7	8.7	5.9	6.5	5.0	11.8	21.8	9.8	12.7	0.0	8.6	7.8	9.2	6.9	8.1	5.8	8.9	15.9	6.3	6.2	9.5	4.5	11.5	7.4	8.5	45.1	6.9	8.5	9.9	14.0	12.4	6.0	9.6	12.9	9.9	28.4	12.2	9.4	8.9	14.9	7.2	7.7
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.0;breast: 14.7"	"Cell type enriched"	"Detected in single"	763	"Distal tubular cells: 76.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 7.7;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.3"	"Group enriched"	"Detected in some"	12	"Hep G2: 9.2;SK-BR-3: 16.5;T-47d: 5.3"					"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favorable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.9	1.1	12.8	1.2	19.9	2.2	14.7	7.5	19.3	6.6	0.8	3.5	0.0	1.3	3.8	1.2	1.1	0.8	1.1	1.5	14.1	6.4	2.7	0.9	0.9	1.3	12.8	7.2	1.1	1.1	0.6	0.3	1.0	22.0	2.5	0.8	0.0	8.6	0.8	2.2	2.2	0.9	0.6	7.8	1.1	1.4	1.1	16.6	0.0	3.8	0.0	0.7	1.2	0.3	0.8	0.5	5.3	0.4	1.0	0.6	0.1	0.4	0.1	0.4	0.5	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.1	0.5	0.7	9.2	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.7	0.7	0.0	0.5	0.3	0.4	0.1	0.2	0.2	0.2	0.3	0.2	0.0	0.1	0.5	0.8	0.3	16.5	0.3	0.6	5.3	0.5	0.2	0.6	0.4	0.5	0.1	0.3	0.6	0.3	0.2	0.3	0.7	2.0	0.4	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.1	0.8	0.6	0.6	5.3	1.0	0.3	0.5	0.2	0.1	12.8	19.9	7.5	19.3	14.1	6.4	12.8	7.2	22.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 524.6;skeletal muscle: 551.1"	"Cell type enriched"	"Detected in many"	48	"Cardiomyocytes: 2261.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 83.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027639	Approved		Approved	Nucleoplasm		NA	NA		43000	Nucleoplasm		"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (1.26e-4)"	32.3	9.6	0.1	3.3	0.1	0.1	9.0	0.9	0.2	7.0	8.4	0.3	1.3	0.7	12.6	8.0	15.7	4.5	8.2	524.6	0.1	0.0	4.1	0.2	1.2	2.7	0.2	0.3	4.8	1.0	1.1	0.2	0.7	0.9	4.7	0.9	1.7	4.4	2.7	551.1	1.0	2.1	20.1	0.4	0.3	6.1	1.3	0.0	0.0	9.6	70.1	7.2	12.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.6	0.8	0.4	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.3	0.0	0.3	0.0	3.9	0.1	0.4	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.1	2.9	0.2	2261.8	0.0	0.0	0.0	3.5	0.0	2.4	11.6	1.1	29.5	0.7	0.0	0.0	0.2	1.4	11.2	0.3	0.0	0.0	1.4	1.6	0.0	0.0	0.0	47.4	13.3	0.3	0.0	0.0	0.0	3.0	0.0	0.0	6.3	0.0	0.4	0.0	43.4	1.7	1.0	2.3	2.7	0.0	0.0	0.1
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.9;parathyroid gland: 15.4"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 171.7"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 13.0"									HPA057717	Approved					NA	NA					"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.2	0.7	0.2	0.2	0.2	0.0	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	46.9	0.2	0.2	0.2	0.2	0.2	0.2	1.2	15.4	5.8	0.2	0.2	0.2	0.0	0.2	4.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	1.6	1.1	0.2	0.2	6.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.4	3.1	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.3	0.0	0.0	0.1	0.6	3.5	0.0	0.0	1.2	24.4	0.0	0.4	21.6	0.1	38.8	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.1	12.7	1.2	0.0	0.0	171.7	0.3	0.0	1.7	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.7	0.7	0.0	0.6	0.0	0.0	0.1
CLCNKB	hClC-Kb	ENSG00000184908	"Chloride voltage-gated channel Kb"	P51801	1	16043736-16057308	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 58.4;salivary gland: 25.7"	"Group enriched"	"Detected in some"	10	"Collecting duct cells: 22.7;Distal tubular cells: 49.7;Early spermatids: 20.7;Late spermatids: 76.4"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 24.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;CAPAN-2: 2.2;EFO-21: 5.1;HeLa: 3.1;K-562: 2.0;SuSa: 2.1"									HPA057717	Approved					NA	NA					"HPA057717: AB_2683509"	"unprognostic (9.05e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.27e-7)"	"unprognostic (2.04e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.14e-2)"	0.1	0.5	0.2	0.1	0.2	0.0	0.1	2.8	0.2	0.7	0.1	0.1	2.2	0.0	0.5	0.5	0.1	0.1	0.4	1.2	0.1	0.1	58.4	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.9	0.8	0.4	0.3	0.5	0.0	1.2	25.7	0.7	0.1	0.0	0.2	0.3	0.5	0.1	0.1	0.7	0.1	0.1	11.5	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	2.2	0.0	5.1	0.7	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	3.1	0.1	0.6	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.1	2.1	0.4	0.8	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.8	0.2	0.1	0.1	0.1	0.1	0.3	0.1	3.0	1.1	0.0	0.0	0.0	0.5	4.3	0.0	1.4	2.3	22.7	0.0	0.3	49.7	0.5	20.7	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	76.4	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.1	0.2	0.0	0.0	0.1	1.4	0.6	0.0	0.5	0.0	0.6	0.0
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 41.1"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 10.8;HEK 293: 7.0;PC-3: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: AB_2673711"	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.7	7.8	5.6	0.6	4.0	0.5	1.1	41.1	9.1	1.1	1.0	7.7	0.0	0.7	1.0	1.4	1.2	1.1	1.4	5.2	5.0	6.5	10.4	2.2	0.6	0.5	10.7	3.8	1.2	7.1	2.0	5.6	0.7	8.7	0.8	0.6	0.8	6.3	1.6	0.6	3.2	0.8	0.9	17.7	0.6	1.6	1.3	4.9	0.0	1.7	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.3	10.8	0.4	0.6	0.0	0.0	0.0	1.0	0.9	1.2	2.7	0.2	2.4	0.0	0.4	0.5	2.7	1.2	1.4	0.3	0.4	0.0	7.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.9	3.8	0.7	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.5	2.2	8.0	0.0	0.0	4.6	0.8	0.0	1.5	3.1	0.4	1.3	0.3	0.0	0.3	0.0	1.7	0.2	3.8	0.0	0.0	1.7	0.1	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.0	41.1	7.1	5.0	6.5	10.7	3.8	8.7	4.9	0.0	0.0	0.0	0.3	0.2	3.5	1.6	2.5	0.0	0.0	8.7	3.9	0.0	16.6	2.6	1.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	36.5	3.4	0.6	0.0	1.3	0.0	0.0	0.0	4.6	0.0	32.7	0.4	0.0	0.0	0.3	2.0	0.0	0.3	0.6	1.9	1.0	0.0	0.0	0.0	0.4
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.6	31.7	8.8	4.2	0.6	0.7	5.2	9.5	13.4	17.2	10.9	13.2	42.4	0.0	40.9	5.4	21.3	6.4	2.1	21.9	6.0	0.0	1.4	0.0	9.2	8.4	11.3	0.0	0.0	1.0	8.2	9.3	20.7	27.0	18.3	0.0	0.0	0.0	10.9	5.0	0.0	0.0	4.2	11.8	48.6	0.0	8.0	0.0	18.2	8.1	0.0	1.3	18.4	4.5	1.2	4.8	0.6	0.1	22.6	6.1	16.5	0.4	49.8	0.0	0.1	0.1	4.7	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2	50.6	28.9	0.5	100.5	179.7	0.6	5.8	40.8	37.5	33.0	8.7	3.9	8.1	0.0	31.3	5.4	17.5	57.1	0.0	12.5	0.9	7.0	56.8	5.7	19.8	1.6	0.0	2.9	32.5	2.8	0.0	3.1	4.6	25.3	1.8	19.6	5.8	62.9	20.1	0.0	1.4	2.0	32.3	17.6	0.0	0.7	217.2	6.3	0.0	17.7	155.0
ARHGEF19	"FLJ33962, WGEF"	ENSG00000142632	"Rho guanine nucleotide exchange factor 19"	Q8IW93	1	16197854-16212609	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 13.5;T-47d: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068108			Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA068108: AB_2685956"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (4.01e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (3.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.80e-1)"	3.0	7.4	0.6	2.6	1.8	0.7	3.9	1.4	0.8	7.8	4.9	0.9	12.9	2.2	4.7	8.5	22.1	4.4	2.1	2.0	0.7	0.3	3.3	1.0	5.2	1.4	0.8	0.6	5.3	10.6	1.5	1.2	3.1	1.4	7.7	0.8	3.2	19.5	11.6	1.4	17.1	3.2	2.5	0.7	3.1	4.1	2.3	0.5	2.6	15.0	14.6	14.5	5.5	7.5	2.9	2.4	1.6	1.6	2.7	3.7	1.8	13.5	3.9	2.3	4.3	0.3	1.4	0.9	3.8	3.7	2.3	2.9	6.2	2.4	0.0	3.1	3.8	1.6	11.7	0.9	1.4	0.6	2.5	0.4	1.4	9.5	0.5	5.2	0.8	5.2	4.0	0.8	6.1	1.6	0.5	0.7	4.9	2.8	3.6	0.9	3.2	1.7	1.9	0.6	2.3	4.5	6.1	1.9	3.6	0.8	1.0	1.6	2.7	2.9	1.8	0.6	0.3	20.8	2.9	1.7	0.0	7.3	3.6	0.0	3.6	5.5	1.0	0.0	4.0	5.8	0.0	1.6	1.6	3.6	0.9	3.7	2.9	3.0	2.7	2.3	2.3	3.0	1.7	0.2	2.7	0.1	2.4	1.8	1.8	0.6	1.8	1.4	0.8	0.7	0.3	0.8	0.6	1.4	0.5	6.0	5.9	0.8	6.7	4.1	0.0	0.4	2.5	4.0	7.9	0.0	0.0	1.6	0.0	4.6	0.2	3.6	2.0	0.0	5.0	4.4	4.8	1.9	9.2	1.3	2.2	0.0	0.0	7.4	2.4	0.0	7.2	1.5	3.3	1.8	4.0	6.6	4.1	3.5	3.2	1.0	0.2	0.0	2.7	1.4	5.8	6.8	1.0	6.4	3.8	5.0
RSG1	"C1orf89, MGC10731"	ENSG00000132881	"REM2 and RAB like small GTPase 1"	Q9BU20	1	16231700-16237162	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 3.5;granulocytes: 4.6;Spermatocytes: 3.7;Spermatogonia: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028453	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028453: AB_10601692"	"unprognostic (7.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.45e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	3.2	7.5	14.2	3.7	17.1	5.8	3.3	3.7	9.8	6.0	3.7	3.9	12.6	4.2	5.6	3.2	8.9	11.8	3.8	7.9	10.4	12.0	5.3	3.6	3.2	4.5	9.3	10.5	10.1	8.3	7.9	8.0	4.1	10.4	5.4	3.3	5.7	8.0	7.5	2.1	7.4	3.6	6.1	7.9	5.9	6.6	6.7	7.5	1.7	11.6	0.3	4.0	5.9	3.0	3.2	2.2	4.0	3.5	2.9	6.2	1.4	4.0	11.0	3.4	11.1	2.3	4.2	3.1	4.5	2.9	3.7	1.6	4.0	6.2	8.7	9.2	2.5	7.3	3.3	6.1	5.9	0.4	13.1	5.1	4.3	9.6	0.8	5.7	2.9	7.9	2.2	5.1	4.3	3.9	3.7	3.5	6.7	15.6	3.4	3.0	5.0	3.1	2.1	0.8	4.3	4.3	7.8	0.4	7.0	3.3	2.5	8.2	5.5	1.8	2.8	4.1	2.6	8.4	2.7	3.5	1.1	1.8	2.2	1.5	9.4	3.5	5.0	3.0	6.3	6.2	0.0	1.2	4.0	5.0	3.5	6.2	3.0	3.1	1.4	2.2	3.2	3.0	2.4	1.1	2.9	2.2	0.7	3.2	1.4	14.2	17.1	3.7	9.8	10.4	12.0	9.3	10.5	10.4	7.5	0.0	3.5	0.5	1.5	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.7	0.0	0.0	0.8	0.7	2.0	0.0	0.0	2.0	0.7	1.0	4.6	0.8	2.1	0.0	1.2	0.6	1.3	0.9	1.1	0.0	1.7	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	3.7	0.3	0.9	0.0	1.2	0.5
FBXO42	"Fbx42, KIAA1332"	ENSG00000037637	"F-box protein 42"	Q6P3S6	1	16246839-16352454	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025071	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025071: AB_1848461"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (3.22e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.78e-3)"	"unprognostic (3.91e-2)"	18.2	15.0	18.2	13.0	18.7	11.3	16.1	37.3	23.9	19.1	15.8	17.1	16.1	10.4	24.3	18.5	23.0	18.5	16.3	19.7	16.2	15.9	13.4	15.7	15.2	15.3	16.1	13.4	22.2	22.6	21.2	19.6	16.2	19.5	21.6	15.0	19.0	18.2	22.0	24.3	33.6	12.5	24.9	13.1	15.9	14.3	16.5	17.7	20.1	18.2	10.4	18.9	19.9	22.1	12.2	14.4	18.5	16.8	12.4	12.9	7.9	10.6	5.8	14.2	14.3	17.3	11.2	6.2	11.1	16.9	16.1	15.8	5.4	9.9	11.4	10.0	15.4	11.1	9.8	14.3	10.6	13.3	13.1	6.7	10.6	8.8	6.1	20.6	12.5	13.9	12.0	24.4	14.1	20.5	14.7	16.1	14.4	11.3	16.0	11.4	7.3	12.0	11.0	6.1	14.3	6.6	13.7	8.7	10.1	10.6	3.1	13.4	8.8	12.6	10.6	13.1	13.6	8.6	9.9	10.0	8.2	7.2	13.4	8.6	7.9	8.0	11.6	10.8	16.5	11.2	7.1	12.3	18.5	12.9	16.8	9.7	8.2	9.8	8.2	14.4	12.2	11.3	9.6	10.9	12.4	12.5	6.4	12.2	7.9	18.2	18.7	37.3	23.9	16.2	15.9	16.1	13.4	19.5	17.7	11.9	10.2	12.2	5.3	23.0	20.2	17.1	10.2	2.7	4.5	12.2	43.2	9.2	0.0	6.7	7.2	9.2	7.1	0.0	6.6	11.9	12.2	9.8	2.3	8.6	11.8	27.0	10.3	10.4	12.7	7.2	13.8	14.6	1.7	8.2	5.8	12.5	7.7	7.0	10.6	2.8	21.7	12.9	10.5	13.6	8.8	30.4	22.0	14.4	8.2	4.4
SZRD1	"C1orf144, DKFZp566C0424"	ENSG00000055070	"SUZ RNA binding domain containing 1"	Q7Z422	1	16352575-16398145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024221	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024221: AB_10603450"	"unprognostic (3.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.98e-6)"	"unprognostic (2.53e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.60e-2)"	34.9	30.7	23.1	25.0	26.3	37.5	33.1	17.1	20.6	30.7	29.0	20.8	15.4	23.0	38.5	23.2	33.7	26.5	30.5	37.0	23.5	14.3	39.8	41.4	26.2	27.2	27.4	11.8	36.3	25.1	32.2	16.8	46.4	22.4	24.8	20.9	27.9	20.8	23.7	55.2	24.9	39.3	31.3	20.9	40.6	27.1	18.3	25.0	32.1	35.0	27.6	33.6	34.3	35.1	30.4	19.2	34.3	36.7	20.0	25.5	29.6	37.4	28.8	39.9	27.6	34.1	39.4	13.2	38.4	50.0	45.7	35.6	28.8	33.4	32.9	43.1	51.2	25.1	20.7	35.7	42.3	33.9	56.6	30.9	37.7	31.0	22.6	30.8	36.6	37.2	39.7	35.5	49.8	33.4	32.3	39.5	28.6	33.8	31.0	41.7	36.4	35.7	28.0	27.8	27.8	33.0	36.7	42.1	38.7	31.0	17.6	31.7	33.0	33.7	21.8	48.6	17.2	22.5	24.2	44.0	31.2	36.5	48.6	38.1	17.2	18.9	39.6	34.8	50.1	41.2	15.0	24.3	34.3	24.5	33.2	24.2	28.3	21.2	22.8	19.2	30.4	19.6	21.1	27.1	20.0	36.7	14.9	25.5	29.6	23.1	26.3	17.1	20.6	23.5	14.3	27.4	11.8	22.4	25.0	17.9	24.2	44.6	45.3	40.5	19.7	39.9	48.4	8.1	12.5	38.4	2.0	50.0	59.7	57.9	17.5	35.9	61.6	23.3	46.5	67.2	40.6	49.4	36.8	45.6	64.1	41.3	45.9	29.4	42.2	39.0	33.4	33.2	42.2	108.2	41.3	23.4	53.3	42.1	33.6	40.9	17.7	38.8	49.1	20.2	19.8	51.1	70.3	40.6	41.6	56.6
SPATA21	"spergen-2, spergen2"	ENSG00000187144	"Spermatogenesis associated 21"	Q7Z572	1	16387117-16437424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 4.6;testis: 11.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 35.1;Late spermatids: 31.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 11.0"									HPA032080			Approved	Vesicles,Cytosol		No	NA			"Vesicles, Cytosol"		"HPA032080: "	"unprognostic (3.09e-1)"	"unprognostic (8.26e-2)"	"unprognostic (5.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.74e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	0.0	0.2	0.0	0.0	0.1	1.3	0.0	1.1	0.0	0.1	0.0			0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1		0.1	0.7	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.2	0.3	11.3			0.0		0.0	0.3	0.0	1.3	0.6	4.6	0.8	0.9	0.8	0.4	0.2	0.8	0.4	0.7	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	1.5	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	1.5	11.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.2	0.7	0.2	0.1	0.5	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.1	0.3	0.2	0.0	0.0	1.2	0.6	0.3	0.6	0.2	0.3	0.2	0.1	0.4	0.0	0.4	0.4	0.2	0.3	0.3	0.0	4.6	0.5	0.9	0.7	0.8	0.5	1.1	0.7	0.6	0.4	1.3	0.8	0.3	2.3	0.9	0.5	0.6	0.7	0.4											0.0	0.6	0.0	0.2	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	35.1	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.1	4.8	0.0	0.0	1.2	31.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	1.1	0.0	0.3	1.1	0.1	0.4	0.2	0.0	0.0	0.1
NECAP2	FLJ10420	ENSG00000157191	"NECAP endocytosis associated 2"	Q9NVZ3	1	16440672-16460078	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 296.5;monocytes: 288.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028077	Approved		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA028077: AB_10601273"	"unprognostic (6.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.38e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.58e-2)"	23.6	22.0	13.6	25.0	15.0	12.6	19.4	10.2	13.8	15.9	18.6	19.8	12.6	11.9	18.2	15.9	24.1	17.6	18.6	12.5	12.6	11.0	19.3	23.6	26.5	39.4	17.5	12.2	28.0	19.5	12.0	12.4	37.8	14.4	16.9	15.6	15.6	21.1	11.7	9.8	25.7	19.2	15.5	18.1	48.1	15.1	27.4	14.5	43.3	20.8	15.9	36.1	22.1	17.5	25.7	27.5	24.8	57.1	26.7	47.9	54.4	16.7	9.3	9.7	11.4	19.8	21.5	5.7	19.3	26.4	25.0	22.0	10.0	28.3	15.1	23.2	35.1	11.4	11.2	13.6	19.0	20.7	31.4	14.0	14.8	11.1	13.6	25.8	18.4	13.8	23.9	19.8	17.5	14.4	21.3	40.7	17.2	20.5	49.7	21.7	11.0	17.1	19.4	8.6	12.7	13.3	19.3	8.9	24.1	24.6	9.6	6.1	15.9	14.8	8.8	19.0	15.2	10.0	20.4	47.6	16.2	8.8	18.6	12.9	23.6	22.9	14.8	13.7	26.7	15.6	17.3	40.2	24.8	23.8	53.7	23.3	25.7	40.9	28.1	27.5	23.2	42.2	26.7	15.5	26.7	57.1	16.4	47.9	54.4	13.6	15.0	10.2	13.8	12.6	11.0	17.5	12.2	14.4	14.5	20.8	30.2	42.2	31.9	46.4	24.0	6.5	17.8	24.1	14.8	19.2	296.5	43.0	19.9	64.1	42.7	55.5	29.6	23.3	47.5	51.8	39.4	35.2	26.6	11.0	106.9	14.3	18.0	94.5	78.3	29.5	27.6	75.8	23.6	288.6	28.3	23.1	86.4	42.1	31.8	18.6	50.9	38.8	26.5	25.6	26.1	48.9	41.3	67.3	20.6	51.6
NBPF1	"FLJ20719, KIAA1693"	ENSG00000219481	"NBPF member 1"		1	16562319-16613562	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (8.16e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.15e-5)"	"unprognostic (2.16e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-1)"	6.8	23.3	14.2	6.4	18.3	4.5	7.4	32.7	13.1	11.7	11.6	21.5	6.0	7.5	9.5	6.2	6.6	13.9	7.9	5.2	13.4	9.3	8.1	7.7	7.3	3.2	32.8	4.2	18.6	5.5	22.3	12.3	9.7	18.4	9.0	11.3	9.3	6.5	9.6	4.5	5.9	16.6	12.2	21.3	6.7	7.3	22.3	21.5	3.7	9.5	3.3	4.3	10.4	8.5	2.0	0.9	4.3	1.0	0.4	1.7	0.5	5.4	7.8	8.0	4.8	2.2	2.6	1.5	3.8	4.9	7.2	6.5	2.8	2.3	4.3	1.1	10.6	2.9	5.1	3.8	2.3	8.5	2.7	4.2	1.4	2.6	2.7	3.5	2.1	3.4	2.8	2.9	10.4	3.1	3.8	3.2	10.2	4.6	2.5	2.8	4.3	9.3	1.6	1.5	0.9	15.5	8.0	4.3	0.4	2.0	1.1	9.8	9.7	9.7	4.0	5.4	2.4	6.2	1.5	3.8	6.4	3.5	8.6	3.3	1.3	5.9	2.4	1.5	3.2	2.6	0.4	0.7	4.3	1.2	0.8	1.4	1.1	1.1	1.5	0.5	2.0	1.3	1.7	0.2	0.4	1.0	0.9	0.0	0.5	14.2	18.3	32.7	13.1	13.4	9.3	32.8	4.2	18.4	21.5	14.9	11.3	0.0	2.8	7.2	7.6	9.6	12.7	13.4	10.3	10.4	7.9	5.4	3.3	4.7	4.6	7.1	27.6	0.0	2.9	7.4	10.3	5.7	5.8	4.4	10.4	9.5	2.9	4.3	4.5	5.4	6.4	8.1	8.5	2.8	23.2	4.5	4.6	12.9	6.7	7.7	5.7	6.5	17.0	52.6	23.0	6.8	2.6	2.9	10.1	1.8
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	0.3	5.0	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.7	1.6	7.9	0.7	2.8	0.3	3.5	3.3	1.2	11.6	0.9	2.7	3.1	4.2	3.7	0.7	1.2	9.9	10.6	3.2	2.1	9.7	1.0	4.2	1.4	4.4	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.8	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3	0.0	5.8	0.5	4.2	5.6	20.9	3.2	2.5	14.7	3.4	5.2	25.5	1.1	0.0	4.8	3.5	6.8	0.7	0.0	2.0	5.8	4.5	2.1	1.1	2.4	2.0	3.2	3.5	6.7	2.2	1.9	17.8	2.2	5.0	2.8	3.7	11.9	3.2	2.3	12.0	1.3	111.2	0.0	9.2	1.4	13.2	4.4	0.9	3.8	2.5	1.4
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.7"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 148.9;Fibroblasts: 84.5;Leydig cells: 49.8;Peritubular cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.7;ASC TERT1: 50.2;HUVEC TERT2: 51.4;SH-SY5Y: 43.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007354	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	13.1	1.6	0.2	6.0	0.4	0.0	20.8	0.4	0.8	24.8	5.0	0.5	6.7	1.6	28.7	14.0	5.7	6.6	29.7	29.6	0.6	0.3	3.4	0.8	12.5	1.2	0.3	1.0	23.6	33.9	0.0	4.7	51.7	1.8	16.9	1.7	15.4	6.9	5.0	4.6	10.9	4.3	18.3	2.9	1.3	3.5	10.4	0.3	0.7	3.8	7.4	3.3	10.3	13.2	0.3	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.0	19.0	0.0	48.7	50.2	1.2	4.8	20.0	7.5	14.7	4.3	0.2	0.0	16.6	16.7	0.0	0.0	1.3	1.5	3.0	0.0	14.8	0.0	7.0	0.4	4.6	0.0	0.0	20.5	3.7	21.1	8.4	23.3	51.4	0.0	0.0	3.1	3.7	2.3	0.0	0.0	22.1	0.1	0.1	0.2	0.0	0.6	0.2	0.0	1.0	43.1	1.6	7.2	1.8	15.6	2.4	2.5	14.2	13.1	27.4	10.6	0.5	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.8	0.6	0.3	0.3	1.0	1.8	0.3	0.0	1.7	0.0	5.7	6.0	0.0	0.4	2.5	1.4	7.9	3.5	0.0	3.9	0.0	0.9	13.1	0.6	0.0	0.0	0.7	148.9	84.5	1.0	0.0	0.0	6.7	0.0	9.7	1.8	0.0	4.5	49.8	0.9	16.9	0.0	0.3	26.5	3.2	0.0	60.1	0.0	0.8	0.0	4.1	1.1	8.1	5.5	24.3	0.0	0.0	0.8
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 17.9"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 17.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced					NA	NA					"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	9.6	12.3	21.9	16.3	25.8	8.7	6.7	25.5	45.3	6.0	12.5	12.0	4.7	10.4	5.3	6.1	8.9	7.1	7.6	4.5	23.8	34.6	6.5	2.5	9.6	13.2	28.4	20.3	5.3	30.1	7.8	22.2	10.5	52.2	7.2	8.3	9.6	15.6	7.2	7.5	10.0	11.1	7.3	10.9	16.1	10.7	6.2	9.9	5.2	8.6	2.9	8.1	9.2	5.2	2.1	17.9	0.4	2.9	2.2	2.5	1.1	10.2	10.9	6.0	23.1	5.6	4.8	15.8	6.0	5.7	6.6	6.9	19.0	12.0	4.7	25.6	9.9	5.7	16.2	11.9	21.8	2.3	6.2	22.8	15.9	10.2	9.9	7.3	5.8	7.6	3.8	12.1	18.5	13.5	21.4	12.8	12.2	10.2	8.8	26.8	8.4	6.7	3.2	8.8	24.7	7.4	7.4	22.4	18.2	7.4	15.7	16.0	10.3	27.0	35.1	22.7	7.7	11.8	7.1	12.8	7.3	13.8	12.2	12.0	1.8	2.1	4.8	13.8	31.7	11.6	0.0	1.3	0.3	2.4	2.9	2.5	1.2	1.9	2.0	0.4	2.1	1.0	1.4	0.4	2.2	2.7	17.9	1.5	1.1	21.9	25.8	25.5	45.3	23.8	34.6	28.4	20.3	52.2	9.9	0.0	2.1	3.7	6.3	5.8	30.8	3.2	12.7	2.7	1.2	7.0	33.4	5.1	5.0	12.9	0.9	8.4	28.1	0.0	21.6	28.3	4.7	10.7	9.2	3.2	9.2	44.5	7.5	4.3	12.1	0.2	4.9	4.1	5.0	2.8	12.9	37.2	40.5	45.6	6.0	5.7	34.3	0.0	3.8	12.6	14.9	4.5	7.8	8.7	13.3	10.6
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054170	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA			Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	17.8	25.6	19.8	16.6	21.7	17.0	26.4	18.0	29.1	13.9	30.8	12.3	15.1	34.0	14.2	15.7	19.8	13.6	15.1	86.9	18.2	16.4	51.0	75.1	16.8	24.6	20.1	18.9	10.5	30.7	20.0	11.3	15.6	16.7	13.0	31.5	11.7	15.9	19.5	96.2	13.2	31.4	21.3	16.5	17.2	21.7	18.7	15.7	14.2	15.5	52.2	18.0	15.4	17.1	22.2	45.9	48.5	48.7	18.9	26.7	25.0	26.0	25.8	14.7	18.8	28.7	28.5	16.8	22.8	29.3	52.3	47.2	36.3	31.3	35.7	28.5	30.7	33.8	30.7	58.7	45.4	59.0	20.9	48.1	32.1	26.9	27.8	35.1	50.2	23.9	29.3	30.0	45.2	76.6	27.8	36.9	31.4	26.8	41.4	36.3	21.5	33.3	28.7	12.2	41.9	51.9	24.0	28.4	44.2	48.1	14.8	27.8	15.2	30.9	38.7	64.9	16.3	22.7	28.4	18.3	20.1	22.7	36.9	30.0	17.3	21.3	36.5	30.8	76.6	22.2	16.6	38.4	37.4	18.3	48.7	18.3	22.2	21.2	19.5	45.9	18.3	19.3	19.5	48.5	18.9	42.2	21.5	26.7	25.0	19.8	21.7	18.0	29.1	18.2	16.4	20.1	18.9	16.7	15.7	59.6	39.6	77.3	79.1	46.2	28.1	395.8	109.5	78.9	40.9	45.4	13.7	93.2	300.1	104.4	146.0	54.0	212.4	116.8	130.5	121.6	58.6	70.1	65.7	198.8	162.9	35.0	46.7	41.7	81.2	13.8	53.5	90.6	60.8	125.4	89.5	52.1	97.2	192.9	63.6	355.3	35.5	38.8	60.4	85.9	68.4	47.7	101.8	52.3	135.8	97.0
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119435	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.7;skeletal muscle: 126.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 90.3;monocytes: 42.3;Mucus-secreting cells: 71.1;Paneth cells: 95.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.1;neutrophil: 37.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in some"		"A549: 6.9;RPTEC TERT1: 20.3;SK-BR-3: 31.1;T-47d: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA					"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	1.4	16.2	5.0	25.1	10.9	19.2	3.3	25.6	2.7	41.4	76.7	1.3	1.6	1.4	1.3	3.8	2.3	1.8	1.1	21.9	15.6	5.5	1.3	2.2	1.4	36.8	13.6	1.1	1.7	1.3	1.5	1.6	45.6	2.3	43.4	4.6	21.1	1.8	126.4	2.8	3.6	3.9	69.6	4.2	2.1	1.3	26.0	0.0	1.2	14.8	1.6	2.1	0.7	0.0	4.2	37.2	5.1	0.0	0.0	1.7	0.0	6.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	2.9	0.1	0.9	0.3	0.1	0.9	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	2.2	0.3	0.8	1.0	2.3	0.0	0.0	0.0	0.2	20.3	0.0	1.2	0.1	0.0	31.1	0.0	1.8	8.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.4	5.1	15.1	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	37.2	0.0	0.1	0.1	0.0	1.7	16.2	25.1	3.3	22.0	21.9	15.6	36.8	13.6	45.6	26.0	0.0	2.2	0.0	0.2	0.2	2.2	0.3	0.0	0.0	2.3	1.8	90.3	0.1	10.0	0.5	5.7	0.0	25.6	0.0	0.0	0.4	0.4	0.3	16.2	0.0	7.6	0.0	3.5	1.3	6.8	8.5	0.3	4.8	27.0	42.3	71.1	30.6	0.0	95.1	0.7	0.2	29.3	0.0	1.0	0.2	0.3	0.4	0.1	0.0	21.7	0.1
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.5	0.0	4.6	0.4	0.4	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	4.9	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	12.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	3.8
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Urothelial cells: 6.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.5;RT4: 16.2;T-47d: 12.2;U-87 MG: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.5	0.0	1.3	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	16.2	0.0	0.0	0.0	2.4	0.1	0.1	12.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 5.9;granulocytes: 11.6;Kupffer cells: 4.7;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 48.2;monocytes: 18.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;HEL: 4.2;NB-4: 1.7;RPMI-8226: 4.9"	"Not detected"	"Not detected"							"HPA017007, HPA042825"	Enhanced					NA	NA		12000			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.2	0.2	0.3	0.5	0.2	54.8	0.2	0.1	0.8	0.2	0.2	0.5	0.0	0.2	0.2	0.1	0.4	0.9	0.4	9.8	0.6	0.1	0.3	1.2	9.7	5.2	1.8	0.0	0.9	0.3	0.1	0.6	4.1	0.6	0.1	0.2	0.9	0.5	0.1	0.2	0.2	0.2	0.4	0.2	24.2	0.3	1.0	0.3	2.6	0.6	0.2	0.2	0.4	7.5	0.4	3.6	48.2	18.6	1.1	1.2	8.1	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	0.0	4.2	0.1	0.4	0.0	0.4	0.6	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	1.7	0.2	0.0	0.2	0.2	0.0	4.9	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	17.0	18.6	24.6	0.1	1.4	0.0	0.2	0.1	0.2	3.6	0.4	0.7	1.2	48.2	1.1	0.4	1.6	0.1	8.1	0.3	0.2	0.1	0.8	0.6	0.1	1.8	0.0	0.6	0.3	0.0	5.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.6	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.5	0.0	0.0
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"blood: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0		0.1		0.7	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.1	0.0	0.5			0.0		0.0	0.0		0.0	3.5	0.0	0.8	0.0	1.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.9	0.1	0.0	0.0	0.2	1.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RCC2	TD-60	ENSG00000179051	"Regulator of chromosome condensation 2"	Q9P258	1	17406760-17439724	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA072281	Approved					NA	NA					"HPA072281: AB_2686505"	"unprognostic (2.50e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (9.91e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.42e-8)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.03e-8)"	"unprognostic (6.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.41e-2)"	13.6	10.5	9.4	20.5	13.0	27.6	14.0	16.4	12.9	12.3	14.7	13.0	12.5	11.5	12.2	11.2	37.0	12.5	16.6	7.1	11.0	10.1	11.0	9.3	15.6	25.1	13.6	8.2	14.1	16.6	9.4	7.3	20.7	12.0	13.4	18.2	9.7	21.5	10.7	6.1	29.8	15.6	10.6	12.2	24.3	12.9	11.4	12.9	54.0	12.0	15.5	33.7	13.5	17.2	3.4	6.5	1.4	5.5	3.5	3.2	2.2	16.1	9.2	18.6	15.6	7.0	7.2	15.4	6.5	5.6	13.6	11.2	9.8	22.4	35.1	22.1	6.7	3.9	18.1	32.5	18.6	9.4	16.8	16.4	30.8	13.9	9.3	8.8	36.9	21.9	11.3	14.1	15.0	13.4	8.4	14.3	23.8	21.2	51.5	5.9	16.3	30.2	30.1	25.7	19.9	7.0	40.8	18.6	22.6	10.1	7.7	28.2	19.9	16.3	16.1	24.2	16.2	14.4	23.9	11.1	12.4	15.6	4.9	13.4	22.4	18.5	44.1	5.3	41.7	24.5	1.3	4.0	1.4	3.2	5.5	2.7	3.3	2.5	3.1	6.5	3.4	1.9	3.2	0.2	3.5	4.1	5.4	2.0	2.2	9.4	13.0	16.4	12.9	11.0	10.1	13.6	8.2	12.0	12.9	23.8	15.4	23.8	12.0	41.3	5.6	0.8	25.5	16.0	15.9	21.0	9.8	20.9	3.3	21.7	4.6	22.2	9.7	0.0	19.6	42.7	18.3	16.6	16.3	5.8	29.5	6.4	23.2	16.5	24.2	14.4	8.6	31.6	15.1	13.6	25.0	13.8	23.4	11.5	5.6	5.7	4.2	0.0	13.7	11.6	20.7	56.3	13.6	17.5	32.0	15.7
ARHGEF10L	"FLJ10521, KIAA1626"	ENSG00000074964	"Rho guanine nucleotide exchange factor 10 like"	Q9HCE6	1	17539835-17697874	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	40	"classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	46	"dendritic cells: 9.7;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026426, HPA026440, HPA028115"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Cytosol"		"HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285"	"unprognostic (4.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.13e-5)"	"unprognostic (3.61e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.21e-3)"	9.5	6.1	6.2	6.1	6.2	0.7	7.8	31.7	7.5	8.5	13.4	7.1	9.9	9.0	7.7	11.2	14.4	6.4	11.7	16.0	5.7	6.1	16.4	50.7	7.8	2.2	6.3	3.8	5.3	30.2	8.1	2.7	3.3	9.1	6.6	7.4	9.6	13.2	12.3	33.4	13.4	9.7	10.5	5.9	5.4	6.5	3.9	5.9	0.4	10.4	7.4	2.9	9.6	11.9	0.0	9.7	0.2	13.1	0.0	0.0	4.5	5.3	6.1	7.8	2.7	13.3	4.5	5.2	3.6	7.2	4.4	3.7	6.3	16.1	0.0	6.9	6.8	6.1	4.1	1.1	1.9	0.9	0.1	2.0	0.0	6.2	17.7	3.0	0.0	0.0	6.0	3.8	2.7	0.7	8.8	0.8	0.0	0.0	0.1	12.1	5.0	0.0	0.1	3.4	8.1	0.0	0.0	3.1	1.9	9.3	11.1	11.4	8.4	2.8	2.0	8.3	2.3	7.6	6.4	0.0	3.8	4.6	4.5	1.5	0.0	1.6	0.0	5.9	0.1	2.0	0.0	13.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	4.5	6.2	6.2	31.7	7.5	5.7	6.1	6.3	3.8	9.1	5.9	3.0	6.1	0.5	4.6	5.0	12.7	31.1	20.4	1.4	9.1	29.6	2.0	0.4	8.3	12.1	8.9	2.7	18.6	0.0	17.5	0.4	6.2	5.5	0.0	35.4	22.2	9.5	36.2	3.1	5.1	6.9	4.6	15.0	3.3	2.8	41.8	12.8	12.3	21.0	6.3	15.5	5.3	12.9	11.4	2.1	1.5	7.5	0.8	0.0	41.6	8.8
ACTL8	CT57	ENSG00000117148	"Actin like 8"	Q9H568	1	17755313-17827063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 23.6"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 42.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-266/84: 72.4"									HPA027176			Approved	Cytosol		NA	NA			Cytosol		"HPA027176: AB_1844553"	"unprognostic (1.79e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.89e-1)"		"unprognostic (1.43e-1)"	"unprognostic (5.49e-2)"		"unprognostic (4.68e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.2	0.0	0.7	0.0	0.0	2.9	1.8	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	72.4	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	42.7	0.0	0.0	0.0	0.6	0.0
IGSF21	"MGC15730, RP11-121A23.1"	ENSG00000117154	"Immunoglobin superfamily member 21"	Q96ID5	1	18107746-18378483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.5;lymphoid tissue: 16.5"	"Cell type enriched"	"Detected in some"	17	"Bipolar cells: 179.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		7900				"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.85e-4)"	"unprognostic (3.76e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	3.1	9.0	14.1	1.7	12.3	1.6	6.0	48.5	32.7	3.0	1.8	7.2	0.0	0.9	1.9	1.8	2.6	1.8	2.4	1.8	21.1	10.4	1.7	1.7	2.5	1.3	10.9	13.9	2.0	4.1	1.8	1.1	3.3	10.1	4.5	1.5	5.5	1.9	3.0	1.4	1.5	1.2	2.7	6.5	16.5	1.6	1.8	4.5	0.0	1.4	0.0	2.1	4.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	12.3	48.5	27.4	21.1	10.4	10.9	13.9	10.1	4.5	0.0	0.0	0.9	0.0	0.2	179.6	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	1.6	2.9	0.0	10.5	8.3	0.6	1.6	0.0	0.0	0.0	3.7	0.2	0.6	0.0	0.0	10.8	6.5	0.3	0.2	0.4	0.1	0.0	0.0	0.0	0.1
KLHDC7A	FLJ38753	ENSG00000179023	"Kelch domain containing 7A"	Q5VTJ3	1	18480982-18486126	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 36.4"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 7.6;Ciliated cells: 6.7;Collecting duct cells: 8.7;Hepatocytes: 5.7;Proximal tubular cells: 8.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.3;CAPAN-2: 10.4;EFO-21: 5.4;NTERA-2: 5.8;RPTEC TERT1: 11.9;RT4: 9.4;T-47d: 10.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA056616	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA056616: AB_2683193"	"unprognostic (4.63e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.81e-9)"	"unprognostic (4.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.88e-4)"	0.6	0.0	0.0	0.3	0.2	0.0	5.0	0.5	0.5	2.5	0.6	0.7	2.6	0.3	0.0	2.6	1.8	0.8	7.4	0.3	0.0	0.0	36.4	6.9	1.4	0.0	0.1	0.6	0.2	5.7	0.0	0.3	0.3	2.9	0.5	0.7	2.8	2.2	1.2	0.0	0.1	0.4	1.0	0.1	0.0	4.8	0.2	0.0	0.0	1.6	0.3	0.8	5.5	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	5.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.1	10.4	0.0	5.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.1	0.0	0.2	0.0	0.0	11.9	9.4	2.9	0.0	0.0	0.8	0.0	1.1	10.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.5	0.5	0.0	0.0	0.1	0.6	2.9	0.0	0.0	2.7	0.0	0.1	0.1	0.0	1.2	7.6	6.7	1.2	8.7	0.0	0.0	1.7	2.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.9	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18631006-18748866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.9;tongue: 12.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 3.4;CAPAN-2: 3.8;U-2 OS: 8.2"	"Region enriched"	"Detected in single"	17	"midbrain: 5.5"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.4	0.1	0.6	0.0	0.6	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.1	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	3.4	0.3	0.0	0.0	0.1	0.1	12.9	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	3.4	0.8	0.8	2.4	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS1R2	"GPR71, T1R2, TR2"	ENSG00000179002	"Taste 1 receptor member 2"	Q8TE23	1	18839599-18859682	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 313.9;Proximal tubular cells: 167.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6;SK-BR-3: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		40000	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.1	8.0	4.1	12.1	17.4	2.6	10.0	4.9	3.0	5.1	4.1	5.8	3.8	3.4	6.6	6.4	2.4	13.8	6.9	14.7	1.9	1.9	6.1	1.9	1.9	34.6	5.5	1.7	6.2	6.7	8.2	2.8	2.8	3.8	5.7	5.8	7.7	2.5	3.4	13.2	1.7	8.3	2.0	10.6	4.1	10.7	3.4	4.0	5.3	13.0	8.1	3.1	8.7	35.8	6.4	6.5	16.3	2.6	4.7	4.4	5.8	5.3	1.7	2.8	6.6	1.0	1.6	13.5	5.8	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6	0.0	3.2	7.2	14.0	6.6	3.1	18.5	38.2	1.4	0.0	43.6	9.8	61.1	39.7	5.6	0.4	2.7	0.4	0.0	0.8	7.2	2.3	9.5	4.6	313.9	11.9	19.1	2.4	16.5	14.0	0.4	1.1	1.4	3.3	17.2	2.9	10.8	2.9	1.5	2.5	167.5	4.2	6.5	4.3	2.1	3.6	4.6	72.4	2.2	3.3	9.7
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904281-18956686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 76.8"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"									"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: AB_2685296"	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	3.5	5.1	3.8	5.0	7.8	5.7	8.9	22.3	6.4	6.7	4.6	6.2	4.9	1.4	4.7	2.2	28.7	3.6	4.8	2.7	4.4	4.0	4.9	8.9	5.0	5.3	6.8	3.6	2.4	14.5	13.0	4.0	4.7	9.3	6.6	2.0	3.4	7.9	6.5	4.3	76.8	2.5	13.5	8.9	3.9	2.9	1.4	4.6	3.2	4.3	33.2	11.3	6.3	8.8	0.8	0.6	10.6	0.3	0.3	1.0	0.1	8.4	13.8	3.7	10.3	2.4	1.9	6.0	6.4	4.2	3.5	2.4	18.9	9.9	0.1	8.2	4.8	4.0	21.2	2.8	13.5	2.8	50.5	2.5	0.1	2.6	7.4	1.7	1.4	16.2	1.2	13.8	4.7	6.0	5.8	7.4	0.4	0.6	1.7	2.3	1.7	1.4	1.3	1.6	8.7	3.3	4.7	2.3	3.6	2.0	5.4	11.9	0.6	4.8	6.8	4.7	4.0	1.8	0.7	20.2	4.7	6.6	2.7	18.3	3.6	3.9	0.2	3.2	2.1	5.5	10.6	0.3	0.0	0.6	0.3	0.8	0.8	0.5	0.7	0.1	0.3	0.5	1.0	0.1	0.3	0.0	0.6	0.5	0.1	3.8	7.8	22.3	6.4	4.4	4.0	6.8	3.6	9.3	4.6	3.0	4.8	0.9	68.5	107.4	5.7	5.5	15.3	12.0	4.5	1.8	0.0	4.1	1.7	12.7	1.2	7.1	1.0	0.0	15.2	5.8	3.6	12.6	3.5	3.9	2.0	23.8	2.4	6.2	0.8	2.2	1.1	4.0	13.5	2.8	0.6	5.1	13.4	2.9	2.8	8.1	1.6	0.0	8.5	0.7	0.5	87.7	3.3	2.9	1.0	39.7
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.2	22.5	20.4	15.0	38.1	19.7	17.6	17.3	18.4	18.9	17.3	35.9	19.2	13.4	16.3	22.9	16.6	15.3	15.9	17.3	17.7	11.1	14.1	30.7	21.7	23.3	26.9	18.8	20.4	17.6	22.2	38.5	37.2	18.5	20.7	23.9	21.0	12.5	17.9	15.9	8.9	22.9	16.5	45.7	12.7	12.4	15.9	11.2	17.1	13.1	14.4	14.3	20.5	11.8	14.8	19.5	8.2	14.8	32.0	22.2	13.9	26.2	19.4	14.9	9.0	15.6	15.2	29.1	18.8	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6	32.8	42.3	16.3	79.1	240.8	54.0	15.6	40.8	30.8	26.1	29.6	143.3	19.2	11.6	31.4	14.7	21.1	36.4	23.3	35.5	14.1	29.1	39.1	18.5	77.9	54.8	74.7	16.8	28.8	47.4	19.9	28.4	42.8	47.2	36.1	30.4	30.7	51.2	14.0	33.6	88.2	48.0	19.4	26.8	37.4	17.9	220.9	28.4	21.0	19.5	215.5
EMC1	KIAA0090	ENSG00000127463	"ER membrane protein complex subunit 1"	Q8N766	1	19215664-19251552	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048904	Approved					NA	NA		5600			"HPA048904: AB_2680552"	"unprognostic (9.46e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (5.98e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.43e-4)"	18.9	15.2	13.5	12.8	28.3	9.3	14.4	19.7	37.5	15.7	14.6	21.8	9.7	10.0	19.6	16.1	16.1	14.6	13.5	18.2	12.6	15.5	13.5	20.5	14.6	10.1	13.6	15.7	19.0	13.1	24.4	20.0	31.4	22.8	16.1	16.9	14.8	18.7	13.8	27.0	13.5	12.0	22.0	12.4	12.2	13.5	15.2	12.7	12.1	16.6	10.5	13.9	13.4	14.4	5.7	10.9	3.2	10.8	18.3	8.3	7.2	13.8	12.5	14.2	36.8	22.9	17.9	27.6	22.5	21.1	31.2	31.0	13.0	32.1	12.4	29.8	34.4	20.2	15.7	19.7	25.2	36.5	10.4	10.3	14.9	17.0	15.4	16.7	19.0	17.9	19.0	16.4	36.8	30.7	29.2	26.3	10.8	18.3	18.8	24.0	7.9	7.7	9.3	8.5	16.0	11.8	11.6	17.5	21.5	12.7	6.4	17.5	12.0	24.7	12.9	18.6	17.5	14.1	12.0	23.1	28.3	18.6	21.5	25.5	10.5	22.0	16.1	26.9	25.1	37.7	3.2	10.8	2.6	7.5	8.1	8.3	5.6	7.4	8.3	10.9	5.7	7.5	7.5	0.4	18.3	10.0	5.2	5.1	7.2	13.5	28.3	19.7	37.5	12.6	15.5	13.6	15.7	22.8	12.7	14.9	13.4	11.7	9.3	10.3	18.1	14.9	12.7	8.1	5.7	21.0	9.8	32.2	0.0	12.8	0.9	13.4	5.4	0.0	7.4	34.7	11.3	8.0	8.1	23.8	17.2	14.3	18.9	14.7	12.3	1.9	13.8	11.5	10.1	7.2	11.6	20.7	10.2	10.5	13.4	8.1	60.3	6.5	8.6	10.1	21.3	8.2	30.1	7.5	11.5	6.2
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251539-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	17.2	16.5	20.4	16.9	18.5	12.0	21.6	10.7	21.7	12.1	13.8	12.4	10.2	17.5	15.6	15.2	21.6	18.8	11.8	11.7	19.1	15.9	13.6	23.7	10.5	23.0	16.1	19.1	18.7	41.2	10.2	8.8	12.5	15.1	12.2	17.6	10.6	13.2	11.9	22.8	15.3	19.3	17.3	10.0	14.5	13.7	21.6	11.6	14.5	12.9	29.3	22.7	11.4	12.4	14.7	12.8	1.0	8.2	10.6	15.7	7.2	24.3	17.3	14.4	18.8	7.0	11.2	12.7	19.1	10.8	32.7	21.6	24.9	25.3	36.0	16.0	15.8	14.3	19.4	39.7	28.8	33.0	12.8	30.3	26.6	15.5	21.4	8.8	35.1	11.2	9.8	19.1	36.9	19.2	8.7	18.3	16.4	40.2	11.6	19.3	17.8	28.5	25.4	18.4	25.6	26.4	26.8	17.5	27.8	17.8	8.3	23.1	17.0	14.6	20.1	20.1	10.7	14.3	20.7	12.0	17.9	22.2	27.4	32.4	9.5	16.5	47.4	17.4	45.1	28.5	0.7	7.5	0.7	7.9	8.2	15.7	14.7	9.6	10.8	11.4	13.1	13.0	11.6	1.0	10.6	6.2	12.8	6.7	7.2	20.4	18.5	10.7	21.7	19.1	15.9	16.1	19.1	15.1	11.6	6.0	12.6	26.1	38.7	33.2	19.2	9.0	35.7	17.4	23.9	7.0	9.8	42.2	34.9	44.9	14.5	23.3	5.4	0.0	47.2	51.2	28.2	15.4	25.4	14.4	42.9	14.3	20.7	11.6	12.1	27.6	21.3	21.7	18.6	39.7	19.8	19.2	44.4	14.0	19.1	30.1	13.8	19.4	28.8	37.0	43.7	29.4	21.7	14.6	31.2	31.2
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282558-19289250	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5"	"Cell type enhanced"	"Detected in many"	19	"Cholangiocytes: 178.3;Enterocytes: 187.5;Proximal tubular cells: 542.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"OE19: 11.3;SK-BR-3: 18.4"									HPA064638			Approved	Cytosol		NA	NA		1000000	Cytosol		"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	0.7	0.4	0.7	0.7	0.7	0.0	0.7	0.7	0.9	0.7	5.1	0.7	0.7	48.5	0.7	1.3	0.7	0.0	6.9	0.7	0.7	0.2	13.4	27.4	0.7	0.7	0.7	0.7	1.0	59.0	0.0	0.7	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.7	0.2	27.0	0.7	0.7	0.7	35.5	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.3	1.9	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.4	0.4	0.2	1.8	0.1	0.1	0.2	0.1	0.4	1.4	0.2	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.8	0.1	0.1	0.3	0.3	0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.5	0.4	1.4	0.3	11.3	0.6	0.7	0.1	1.4	0.0	0.3	0.9	1.4	0.3	18.4	0.4	0.1	3.3	0.4	0.3	0.3	0.2	1.0	0.3	1.3	0.3	0.3	0.5	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.2	0.7	0.7	0.7	0.7	0.0	0.0	3.5	0.6	0.7	0.4	0.8	178.3	4.0	0.0	27.9	0.0	0.4	101.2	3.8	2.7	0.2	187.5	0.0	28.4	0.2	0.0	1.1	4.6	92.4	0.3	0.0	20.0	5.5	1.9	3.1	0.3	0.3	0.0	0.0	51.4	3.5	17.3	81.8	0.4	542.3	1.1	0.0	0.4	1.1	0.9	0.5	0.5	0.0	99.7	0.3
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312146	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Proximal tubular cells: 516.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	Cytosol		NA	NA		2700000	Cytosol		"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	21.2	39.0	25.2	14.0	26.9	15.2	22.0	19.8	26.2	32.9	38.5	28.1	28.7	56.0	20.2	23.0	25.7	35.1	31.9	31.2	22.0	19.4	49.3	32.4	14.4	21.9	24.9	26.2	31.6	60.8	14.8	19.0	17.2	23.6	19.9	19.5	25.8	21.4	24.9	33.8	18.8	43.1	20.8	20.0	16.3	22.3	21.6	21.4	24.7	22.9	20.2	18.3	16.7	21.6	23.0	40.1	13.7	29.0	22.2	27.1	23.5	24.1	15.3	16.8	15.5	26.6	25.9	11.2	18.1	22.2	25.4	22.9	19.4	20.5	17.5	19.4	24.3	14.3	19.3	18.7	27.2	12.1	13.9	29.7	11.0	14.8	31.0	20.7	12.1	8.9	25.8	21.5	19.5	12.0	24.1	21.5	23.1	16.0	16.5	26.0	24.1	23.5	11.8	4.8	34.0	19.3	24.8	21.0	30.9	24.7	10.7	31.6	11.8	19.7	17.9	30.4	10.0	35.5	42.3	16.8	15.9	16.9	17.1	13.5	20.1	12.6	21.4	34.4	27.9	22.4	0.1	29.0	13.7	23.0	23.7	26.8	23.0	20.7	20.3	40.1	21.4	23.9	20.6	3.4	22.2	17.8	35.0	27.1	23.5	25.2	26.9	19.8	26.2	22.0	19.4	24.9	26.2	23.6	21.4	14.9	21.1	39.8	56.3	21.6	32.8	23.2	94.3	28.1	11.4	73.3	5.9	113.3	215.5	57.4	69.6	30.0	128.4	23.3	32.2	83.3	55.7	48.3	10.3	81.5	89.0	20.6	95.6	38.1	55.4	39.4	71.7	32.8	50.6	63.1	87.2	111.7	40.7	123.6	63.6	516.4	22.5	45.3	39.1	63.0	23.2	29.7	85.8	48.1	129.1	48.9
PQLC2	FLJ20320	ENSG00000040487	"PQ loop repeat containing 2"	Q6ZP29	1	19312326-19329300	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 31.3;Syncytiotrophoblasts: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057810	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA057810: AB_2683535"	"unprognostic (7.84e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (3.77e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.61e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.46e-2)"	10.9	19.9	11.7	8.5	12.3	18.4	9.4	28.8	16.2	12.2	13.1	16.8	8.6	16.9	11.5	15.5	9.2	8.8	11.1	9.3	10.6	11.2	11.9	20.3	12.1	11.1	14.3	9.1	10.9	19.4	10.0	19.4	24.8	14.4	11.7	7.7	18.9	12.1	11.0	10.9	15.3	16.2	9.3	12.2	12.2	13.3	13.8	10.9	6.2	14.0	9.2	10.5	8.0	9.0	5.1	16.7	7.8	10.1	2.9	3.4	3.5	8.1	8.6	8.1	12.9	7.9	7.5	10.3	10.3	14.2	14.4	12.3	12.5	10.4	2.6	13.5	7.5	20.1	6.2	7.9	9.2	6.5	5.5	9.6	2.0	7.4	13.4	22.7	1.7	3.6	12.3	9.7	20.4	6.5	8.1	5.5	4.7	14.7	6.1	13.8	7.3	1.1	5.7	7.8	2.9	7.7	4.5	10.2	4.6	10.9	5.4	10.0	8.4	7.7	5.2	19.7	7.6	8.8	20.3	7.3	12.1	7.0	20.4	9.1	10.7	7.4	1.4	14.8	10.2	9.8	0.9	8.7	7.8	3.2	7.1	2.4	5.1	3.4	2.7	11.1	5.0	1.0	2.1	5.4	2.9	10.1	16.7	3.1	3.5	11.7	12.3	28.8	16.2	10.6	11.2	14.3	9.1	14.4	10.9	3.0	6.5	6.0	2.9	1.6	11.6	2.2	5.1	2.7	5.7	5.2	5.9	23.5	5.0	14.8	0.4	3.7	9.1	0.0	10.2	15.3	6.1	4.3	3.5	9.8	31.3	6.4	9.9	1.8	6.9	2.3	5.8	7.5	3.3	9.0	5.9	9.8	13.8	5.8	3.2	4.3	8.6	0.0	3.6	7.2	4.1	2.6	50.6	4.3	6.6	2.0
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line beta subunit"	P47756	1	19338776-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Late spermatids: 2817.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		35000000	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	29.6	24.8	57.1	38.4	47.3	27.9	28.1	23.0	39.7	34.8	84.1	34.3	19.3	29.2	40.3	28.2	41.8	29.2	29.3	80.3	53.8	40.7	29.3	37.5	29.7	50.4	53.5	33.6	38.6	24.9	23.7	18.1	36.9	29.5	42.2	43.5	30.4	23.7	35.9	160.5	27.0	43.7	49.5	72.0	42.1	32.6	70.5	22.3	51.2	34.2	35.3	54.3	56.9	32.3	39.8	55.6	155.9	96.3	27.1	57.2	78.0	48.6	29.0	52.2	37.5	71.6	92.3	36.7	82.9	86.5	73.5	75.7	36.1	68.7	33.6	36.2	103.6	44.9	41.4	44.8	57.2	82.8	52.9	31.8	65.9	38.9	56.3	73.5	43.6	108.9	85.1	47.7	62.9	59.6	63.2	66.9	39.9	23.4	48.1	73.4	34.6	48.3	50.8	39.2	64.8	31.4	43.7	36.7	44.2	92.7	28.1	31.8	24.5	48.7	40.8	54.8	49.6	44.8	38.2	68.9	49.5	40.7	81.1	39.4	29.8	35.7	42.4	65.0	57.5	53.4	53.8	54.4	155.9	49.1	79.4	41.8	39.8	51.1	52.3	55.6	29.1	43.1	46.1	87.8	27.1	96.3	30.2	57.2	78.0	57.1	47.3	23.0	39.7	53.8	40.7	53.5	33.6	29.5	22.3	92.3	61.8	162.3	259.9	138.7	89.2	77.5	127.4	100.4	63.7	96.0	39.3	284.3	252.0	312.1	989.2	166.8	227.5	23.3	225.6	329.7	194.7	191.6	142.2	80.4	668.4	73.1	135.5	131.3	269.2	2817.9	215.4	313.1	136.7	740.4	212.2	119.4	260.5	192.9	284.2	184.2	70.1	239.3	175.9	100.8	73.9	159.6	286.2	286.6	157.4	234.8
MINOS1	"C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial inner membrane organizing system 1"	Q5TGZ0	1	19596977-19629821	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059930	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA059930: AB_2684167"	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.11e-4)"	10.1	9.7	22.0	8.1	21.3	5.4	12.6	20.4	22.2	17.7	16.3	7.2	7.5	10.6	14.5	13.7	15.1	15.2	13.7	25.4	18.3	21.4	19.8	12.5	9.7	8.3	20.6	15.5	14.0	13.3	14.5	16.6	8.3	17.0	17.2	18.3	9.3	13.8	17.8	25.2	10.1	17.4	18.2	12.1	8.9	11.4	5.0	11.8	7.7	13.7	20.3	11.8	13.9	10.9	7.0	8.4	9.0	10.5	3.7	11.3	8.9	7.6	10.6	6.0	6.6	11.6	11.1	3.7	6.7	7.6	7.9	8.0	7.4	7.1	6.5	5.6	8.8	6.4	5.6	10.5	8.8	12.8	9.8	7.3	5.7	17.0	10.2	5.1	8.8	4.3	9.0	14.5	7.9	9.7	6.0	11.5	4.9	12.1	4.9	11.8	13.6	4.5	11.5	5.1	10.0	13.5	4.5	7.3	8.6	19.3	4.7	12.5	5.6	7.4	6.0	5.8	5.0	5.9	4.9	7.6	6.2	4.8	7.8	6.6	3.1	5.2	6.7	4.8	16.9	5.8	5.6	8.1	9.0	6.4	10.5	5.8	7.0	8.7	7.0	8.2	6.7	11.3	8.1	5.5	3.7	10.5	8.4	7.8	8.9	22.0	21.3	20.4	22.2	18.3	21.4	20.6	15.5	17.0	11.8	157.8	125.9	175.7	110.6	149.9	78.1	411.9	318.5	207.5	112.6	347.2	43.2	260.0	704.6	351.8	112.1	128.1	424.9	46.7	394.4	215.9	199.3	157.4	195.4	297.4	460.5	85.8	231.3	133.8	238.8	184.5	222.6	223.0	214.2	236.3	403.3	76.4	343.8	474.2	207.9	655.8	74.3	64.7	206.0	163.1	143.3	192.6	153.4	121.5	528.4	124.4
NBL1	"D1S1733E, DAN, DAND1, NB, NO3"	ENSG00000158747	"Neuroblastoma 1, DAN family BMP antagonist"	P41271	1	19596979-19658456	"Predicted intracellular proteins, Predicted secreted proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 363.8;Leydig cells: 358.1;Peritubular cells: 335.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 74.3;HSkMC: 52.6;SK-MEL-30: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007394, CAB026132"	Uncertain				"Secreted in other tissues"	NA	NA		10000000			"CAB026132: , HPA007394: AB_10601272"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.26e-2)"	27.5	8.7	20.7	16.8	23.1	1.9	38.7	8.1	31.3	109.5	77.8	8.9	13.5	54.6	45.7	21.7	49.0	41.2	58.0	31.1	22.2	15.1	17.4	8.4	47.5	13.7	14.3	23.6	133.7	10.0	16.2	22.2	8.2	15.8	67.5	31.6	23.6	11.2	35.0	18.3	32.4	86.3	43.1	13.6	8.3	25.2	23.9	11.8	6.3	15.2	25.4	14.0	44.6	65.9	0.2	0.1	0.5	0.2	0.7	3.5	0.5	22.2	7.0	1.2	6.4	74.3	38.7	3.3	32.0	39.9	10.8	11.0	1.9	40.3	0.0	20.5	40.2	7.6	25.1	6.7	29.7	3.3	21.1	3.5	1.1	6.9	11.6	12.0	0.0	0.5	52.6	27.3	15.9	9.8	3.2	8.1	1.3	0.2	0.0	3.4	3.2	0.0	1.8	0.4	23.1	10.5	1.0	0.0	0.7	20.6	2.7	0.5	17.2	5.1	0.2	77.3	1.2	26.7	3.9	11.3	10.6	8.4	30.2	4.9	0.1	0.1	0.1	7.7	0.1	3.1	0.0	0.2	0.5	0.4	0.1	1.7	0.1	3.5	1.8	0.1	0.2	2.5	1.6	0.1	0.7	0.2	0.1	0.0	0.5	20.7	23.1	8.1	31.3	22.2	15.1	14.3	23.6	15.8	11.8	3.0	2.9	2.7	208.3	155.1	16.7	26.2	48.4	6.7	5.7	34.9	5.9	0.6	3.3	40.2	1.6	105.9	363.8	0.0	6.8	1.9	174.7	257.9	13.8	0.5	41.1	6.4	52.4	30.7	1.8	4.5	358.1	6.0	57.3	10.0	184.7	5.7	58.7	179.9	335.6	16.7	8.1	129.4	194.2	1.2	3.6	177.0	1.1	10.7	166.9	177.6
HTR6	"5-HT6, 5-HT6R"	ENSG00000158748	"5-hydroxytryptamine receptor 6"	P50406	1	19665287-19679562	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 24.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 24.6;cerebral cortex: 6.6"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.2;NTERA-2: 2.4;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.5"	HPA068165	Uncertain					NA	NA					"HPA068165: "	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-5)"	"unprognostic (1.38e-4)"	"unprognostic (2.69e-2)"		"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.33e-3)"	"unprognostic (8.63e-2)"	"unprognostic (5.47e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.02e-1)"	0.4	0.5	1.2	1.4	24.6	0.4	0.4	0.2	6.6	0.6	0.4	0.0	0.0	0.6	0.6	0.5	0.5	0.6	0.5	0.4	1.4	1.0	0.3	0.3	0.3	1.4	0.5	2.2	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.3	0.0	0.5	0.3	0.3	0.8	0.5	0.5	0.2	0.4	0.5	0.8	3.2	0.0	0.3	0.0	2.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	2.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	1.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	24.6	0.2	6.6	1.4	1.0	0.5	2.2	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682213-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: AB_2669051"	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favorable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favorable (3.64e-4)"	10.6	8.8	2.4	9.0	3.3	2.5	11.3	0.9	2.3	9.1	6.1	2.8	15.2	11.8	16.9	15.1	8.0	7.3	7.4	4.9	1.6	1.3	9.5	7.9	5.2	12.6	2.6	1.2	8.6	15.3	17.3	10.5	7.3	3.3	12.1	3.9	8.8	25.8	19.0	2.0	5.2	6.4	11.2	2.0	9.1	8.7	3.3	2.4	3.5	10.8	7.6	9.5	11.6	10.0	7.2	9.3	2.7	8.1	4.6	6.7	4.4	5.8	3.6	0.0	0.2	5.0	3.6	4.1	4.4	13.4	8.6	4.8	2.9	27.5	10.2	6.5	12.5	3.8	4.5	1.1	4.4	1.7	8.6	1.1	3.9	4.3	1.4	4.1	0.0	5.4	3.7	4.9	2.9	1.6	3.1	4.1	0.2	0.7	6.9	3.7	4.9	0.0	2.2	0.4	7.8	5.1	1.9	11.5	6.2	7.4	4.6	0.0	0.5	5.8	8.0	9.1	0.6	7.0	6.6	2.5	6.7	3.1	4.6	3.0	0.8	0.3	2.9	7.6	8.8	4.1	0.1	4.8	2.7	6.3	8.1	6.2	5.6	6.7	6.6	9.3	7.2	5.2	4.3	0.3	4.6	4.9	0.2	4.9	4.4	2.4	3.3	0.9	2.3	1.6	1.3	2.6	1.2	3.3	2.4	11.9	8.3	8.2	10.2	2.5	0.1	5.6	2.5	24.1	7.9	10.4	0.0	8.0	8.3	9.0	0.3	4.3	6.7	0.0	14.6	16.0	4.5	12.2	3.5	4.4	8.2	0.0	5.8	5.5	6.3	0.0	5.8	5.7	10.1	12.6	10.8	2.8	10.4	5.8	5.3	6.0	0.6	0.0	7.5	0.2	2.0	2.3	6.1	8.2	12.1	6.5
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815278	"Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5"	"Group enriched"	"Detected in some"	5	"Intestinal endocrine cells: 83.2;Mucus-secreting cells: 32.9;Paneth cells: 108.7;Proximal tubular cells: 98.1;Undifferentiated cells: 113.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034547, HPA035558"	Enhanced					NA	NA					"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.2	0.1	0.1	7.8	0.1	0.0	0.8	0.1	0.1	0.2	38.2	0.0	0.5	47.1	0.2	25.8	0.2	0.2	0.1	0.1	0.1	0.1	44.0	0.7	0.1	0.0	0.1	0.0	0.3	30.5	0.0	0.2	0.0	0.0	0.6	5.4	0.0	0.2	0.0	0.1	0.2	59.0	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.5	6.2	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	4.9	0.0	0.0	17.2	0.0	16.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	83.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	7.1	108.7	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.9	0.1
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882513-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	6.5	11.0	15.0	6.9	19.2	11.4	10.0	19.3	23.2	10.6	8.9	6.6	6.4	10.2	14.2	13.0	6.1	8.2	7.2	5.2	12.6	7.3	7.1	4.8	8.5	7.0	9.9	12.5	11.2	7.2	9.3	20.2	5.4	9.0	9.8	8.3	6.9	6.2	9.2	9.2	13.0	9.6	11.9	8.1	7.7	7.3	28.4	9.7	6.0	6.9	2.9	6.3	7.0	7.6	1.7	0.6	0.8	0.4	0.6	2.2	0.3	5.1	1.9	8.7	10.4	3.8	3.3	8.6	5.5	3.2	2.8	2.8	9.1	4.9	8.1	4.5	12.1	2.0	5.0	8.1	3.2	5.5	5.3	10.8	7.8	10.4	6.3	2.1	5.7	7.2	2.7	3.2	4.4	5.7	6.0	3.7	8.3	5.5	3.5	4.8	2.8	4.3	5.7	4.1	4.1	5.1	10.1	22.3	3.0	4.7	5.6	7.7	5.5	3.9	3.2	4.2	8.9	4.8	4.2	4.5	6.8	8.7	7.5	4.7	4.0	3.4	5.0	4.8	7.6	3.1	0.8	0.4	0.1	1.5	0.3	1.4	1.7	1.7	1.4	0.3	1.3	2.2	1.8	0.7	0.6	0.1	0.6	0.9	0.3	15.0	19.2	19.3	23.2	12.6	7.3	9.9	12.5	9.0	9.7	14.9	6.9	3.0	5.2	12.6	13.5	3.6	0.0	10.7	1.2	8.7	15.7	2.3	0.0	4.5	9.9	4.5	3.8	0.0	4.0	4.7	4.2	8.8	1.1	2.1	1.6	25.4	11.5	9.2	1.6	11.5	5.2	3.3	5.0	2.8	6.7	10.2	3.9	5.9	5.6	3.4	16.0	6.5	3.5	19.1	21.2	7.8	2.1	4.4	5.9	3.0
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;CAPAN-2: 1.2;OE19: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"	NA	NA					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 366.3;Exocrine glandular cells: 945.9;Glandular cells: 937.5;Paneth cells: 354.3;Undifferentiated cells: 591.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Hep G2: 23.4;OE19: 64.1;RT4: 21.5"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	290000			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	25.2	1.0	0.0	13.1	0.0	0.6	14.0	0.0	0.6	1.4	63.9	0.0	0.1	35.0	0.7	22.7	31.5	11.7	2.4	105.4	0.0	0.0	1.6	377.9	3.0	6.5	0.0	0.0	35.6	2.4	0.6	0.5	15.5	0.0	27.1	68.2	6.1	9.5	1.0	30.6	5.0	99.0	39.7	0.0	0.6	4.0	9.8	0.0	0.0	16.0	8.9	19.3	39.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.6	0.0	21.5	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	4.1	6.7	10.0	12.4	0.0	7.2	5.1	2.7	6.8	0.0	0.0	2.8	1.7	0.0	3.0	8.4	366.3	0.0	945.9	3.3	308.9	937.5	4.6	51.6	8.2	0.0	59.8	35.0	6.0	7.5	158.5	4.9	13.5	0.0	270.5	0.0	3.6	354.3	1.1	0.0	0.0	0.0	11.3	0.5	0.1	14.6	5.7	8.4	591.0	9.1
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"	NA	NA					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	3.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3	0.0	0.3	0.0	0.0	0.3	9.3	79.9	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	2.1	1.5	0.0	0.0	0.2	0.0	0.0	8.6	0.8	3.6	75.4	0.0	0.0	0.0	0.0	25.1	0.0	0.0	68.9	0.0	27.8	258.7	2.4	0.5	0.6	0.4	0.2	0.0	0.0	0.0
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	10	"Kupffer cells: 2.2;Melanocytes: 5.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	13.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.3	0.2	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139326-20150386	"Enzymes, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Innate immunity, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.5"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"RT4: 56.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.3"	"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favorable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	7.7	0.0	0.0	0.0	0.0	0.0	13.7	0.1	6.5	0.0	0.0	0.3	0.1	0.0	2.8	0.0	6.3	11.1	19.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.7
PLA2G2C		ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20177424	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;intestine: 4.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.6;Late spermatids: 7.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HL-60: 4.5;NB-4: 1.4;SK-BR-3: 1.3;U-698: 5.0;U-937: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"	NA	NA						"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.1	0.3	0.0	0.3	1.0	0.1	0.2	0.2	0.1	4.7			0.4	0.9	0.3	4.2	0.2	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.3	0.4		0.3	0.0	0.4	0.1	0.0		1.0	0.7		0.2	0.7	0.5	1.2	0.8	0.0	0.2	0.1	1.1	0.9			0.1		0.0	0.9	0.1	0.7	2.4	2.3	1.4	1.3	1.4	0.5	0.2	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.5	0.0	0.1	0.7	1.4	0.4	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.1	0.4	1.3	0.1	0.3	0.3	0.1	0.2	0.6	0.2	0.2	0.2	0.2	0.1	5.0	0.4	4.8	0.1	2.3	1.4	0.5	0.7	0.5	1.4	0.6	0.7	0.9	2.4	0.7	0.6	0.5	2.3	1.3	0.4	0.8	0.3	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
UBXN10	"FLJ25429, UBXD3"	ENSG00000162543	"UBX domain protein 10"	Q96LJ8	1	20186085-20196048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 44.3;testis: 30.4"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 120.5;Early spermatids: 95.0;Late spermatids: 125.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 3.8;HMC-1: 9.9;K-562: 11.0;SCLC-21H: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028555, HPA028564"	Uncertain					NA	NA					"HPA028555: AB_10600417, HPA028564: AB_10601897"	"unprognostic (3.00e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.31e-2)"	"prognostic favorable (2.02e-4)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.60e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	0.9	1.7	2.4	0.8	4.3	1.8	3.1	2.6	8.5	6.8	10.3	6.8	5.3	1.1	6.0	8.4	4.0	44.3	2.1	3.3	3.5	4.2	2.9	6.0	7.6	0.6	2.8	2.7	7.1	1.7	2.8	8.8	1.2	9.0	2.6	4.7	1.7	1.3	2.9	0.5	0.9	2.5	3.4	2.1	0.4	3.8	30.4	1.9	0.0	11.3	0.1	0.8	3.0	0.7	0.8	1.5	0.8	0.9	6.6	4.9	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	2.5	11.0	0.0	0.0	0.0	0.4	0.4	1.1	0.3	0.0	0.0	0.0	0.0	0.8	0.5	7.8	0.0	0.0	0.2	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.8	0.1	4.9	0.8	1.4	1.7	1.5	0.2	1.1	1.6	0.8	6.6	0.0	0.0	0.6	0.8	2.4	4.3	2.6	8.5	3.5	4.2	2.8	2.7	9.0	1.9	0.0	6.7	0.0	0.0	0.1	0.0	4.5	2.5	120.5	15.9	3.5	0.0	0.1	5.0	2.2	95.0	0.3	1.1	0.0	1.6	0.4	0.8	0.2	12.8	3.9	0.8	0.0	1.2	1.3	1.9	125.2	2.6	0.0	0.0	1.0	9.2	1.2	1.1	0.0	1.1	2.2	2.9	0.0	0.4	17.3	1.9	0.0	0.2	0.0	2.9	0.1
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 7.7;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA			Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
CAMK2N1	CaMKIINalpha	ENSG00000162545	"Calcium/calmodulin dependent protein kinase II inhibitor 1"	Q7Z7J9	1	20482391-20486220	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 128.2"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 287.0;Mucus-secreting cells: 362.0;Proximal tubular cells: 363.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.4"	"Group enriched"	"Detected in many"	15	"B-cells: 1.5;T-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 50.5;CAPAN-2: 47.1;Hep G2: 38.1;SK-BR-3: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075200	Approved					NA	NA					"HPA075200: "	"unprognostic (1.67e-1)"	"unprognostic (2.70e-3)"	"unprognostic (9.71e-3)"	"unprognostic (3.13e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (1.37e-7)"	"prognostic unfavorable (5.49e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-2)"	4.9	30.8	128.2	4.8	50.1	1.0	10.7	12.4	120.1	9.1	40.3	26.9	5.9	38.0	11.8	19.7	12.2	5.1	13.8	5.9	76.6	39.3	37.8	25.6	18.7	1.6	42.1	71.0	11.0	4.9	9.3	9.6	6.2	27.6	15.1	37.6	2.2	14.4	21.4	3.7	3.0	40.4	12.0	44.3	6.1	7.3	2.9	28.8	0.0	2.9	0.1	4.0	9.6	5.7	1.5	0.0	0.2	0.0	0.0	4.4	0.2	14.4	4.1	3.6	50.5	7.0	13.0	0.5	12.4	28.2	2.2	1.1	4.6	47.1	1.4	3.5	5.0	1.8	24.3	1.0	21.2	1.4	2.6	0.9	0.3	0.2	38.1	7.7	0.0	1.5	2.0	9.9	1.3	5.1	4.7	3.9	1.0	1.4	0.1	25.1	3.9	0.0	0.1	0.6	25.4	0.9	1.3	2.2	0.0	14.2	21.8	13.9	3.9	6.7	38.2	3.6	2.5	7.3	0.1	1.1	8.5	11.1	11.6	4.9	0.0	0.0	0.6	29.0	3.1	5.2	0.0	0.0	0.0	4.4	0.0	3.2	1.5	1.6	1.2	0.0	0.1	0.8	1.2	0.2	0.0	0.0	0.0	0.0	0.2	128.2	50.1	12.4	120.1	76.6	39.3	42.1	71.0	27.6	28.8	3.0	0.6	3.2	10.1	8.2	245.7	11.4	165.6	0.0	0.0	235.5	5.9	0.2	193.9	19.5	0.6	5.7	254.6	0.0	37.1	1.7	48.3	27.2	1.1	187.5	0.2	81.0	287.0	9.2	1.8	2.1	58.1	2.7	37.1	1.0	362.0	62.5	84.0	239.1	88.4	363.7	31.9	129.4	28.8	0.9	1.9	6.6	1.7	7.5	148.5	23.2
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508161	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	13.3	15.9	10.3	12.9	12.3	20.6	20.4	9.2	22.2	13.1	15.8	19.0	8.0	11.6	18.2	10.7	17.2	17.0	18.5	26.2	11.7	12.5	20.5	20.1	16.3	12.1	16.8	9.5	17.5	26.8	21.9	13.0	21.6	17.6	13.9	13.3	14.3	15.3	18.1	26.7	17.4	19.5	17.0	11.7	13.6	15.2	14.1	11.6	18.5	15.1	14.6	14.0	16.3	13.6	23.2	26.0	31.9	30.4	25.2	32.1	27.5	17.1	16.6	9.6	19.8	20.8	11.7	10.4	17.0	20.4	21.2	20.5	10.2	28.5	12.9	19.1	24.0	16.1	26.1	17.2	24.6	15.5	12.8	13.6	9.9	11.2	14.8	24.5	13.5	17.0	19.1	32.5	21.7	22.6	12.5	13.8	11.7	12.9	15.8	23.0	8.7	8.1	9.1	9.8	14.3	15.9	8.0	12.1	16.7	25.0	9.6	9.8	14.5	15.3	16.4	20.9	8.1	11.5	13.0	15.6	20.7	11.9	18.0	15.2	18.5	16.1	13.9	16.2	18.4	19.1	26.3	26.5	31.9	30.9	30.4	32.1	23.2	23.6	31.4	26.0	21.5	27.1	26.3	24.0	25.2	25.4	20.1	32.1	27.5	10.3	12.3	9.2	22.2	11.7	12.5	16.8	9.5	17.6	11.6	20.8	9.3	11.7	7.8	4.6	12.5	14.6	12.7	9.4	6.8	17.4	5.9	33.7	10.0	21.4	1.6	9.7	12.0	0.0	20.3	20.8	12.1	8.1	3.5	11.9	19.7	12.7	8.2	10.4	11.4	2.8	12.0	7.7	18.6	21.6	11.8	15.6	19.7	11.5	14.5	8.7	10.5	19.4	8.5	10.6	13.4	6.1	31.5	10.8	10.1	9.0
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552439-20555010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"adrenal gland: 21.9;brain: 14.9;epididymis: 8.7"	"Cell type enhanced"	"Detected in some"	19	"Cardiomyocytes: 1.2;Distal tubular cells: 3.3"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;BJ hTERT+: 3.3;fHDF/TERT166: 6.7;Hep G2: 4.9;SCLC-21H: 6.0;SiHa: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050813	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA050813: AB_2681244"	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	3.2	21.9	5.6	1.5	14.9	0.9	1.5	8.8	14.4	1.6	1.3	2.4	0.0	1.1	1.4	8.7	1.3	1.6	1.5	3.3	5.3	12.1	2.6	1.4	1.2	1.0	10.1	6.0	1.0	1.2	0.9	0.7	2.5	11.2	1.4	1.1	0.5	1.2	1.3	2.8	1.0	1.2	2.9	4.0	1.4	0.9	1.3	2.8	0.0	1.3	1.7	0.9	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	4.6	0.2	0.1	0.0	0.5	3.3	0.6	0.0	0.1	0.0	0.0	0.2	6.7	1.2	0.0	0.7	0.0	0.1	0.0	1.0	0.2	0.3	4.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.0	0.7	11.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	14.9	8.8	14.4	5.3	12.1	10.1	6.0	11.2	2.8	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.3	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Cell line enhanced"	"Detected in many"		"A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	42.9	4.2	0.0	0.0	0.0	1.3	0.0	3.3	0.9	0.8	3.4	0.2	28.6	0.0	1.6	6.8	1.8	15.1	0.8	11.2	2.2	0.0	0.8	0.0	40.6	5.4	0.3	0.0	0.0	1.9	1.8	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.0	20.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	51.0	0.0	0.0	0.5	0.0	1.2	0.7	0.0	1.7	3.9	0.2	0.0	0.0	0.0	0.5	18.0	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9	3.0	1.4	0.9	0.2	1.3	0.1	2.8	2.5	0.0	0.0	5.2	0.0	0.2	36.5	2.4	0.6	4.4	120.2	0.0	1.3	2.7	1.0	0.9	0.0	94.4	6.1	0.0	0.0	28.8	118.1	0.8	0.3	3.7	0.0	0.0	12.5	0.0	70.1	48.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.1	1.5	4.9	0.3
PINK1	PARK6	ENSG00000158828	"PTEN induced putative kinase 1"	Q9BXM7	1	20633455-20651511	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.7;monocytes: 4.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Enhanced					NA	NA					"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	17.9	35.9	38.9	6.7	38.0	6.0	10.1	16.8	45.0	9.8	13.0	17.8	10.0	15.2	9.3	9.8	20.7	10.7	11.4	51.4	31.0	28.7	20.2	26.1	10.0	5.1	39.5	27.1	11.6	24.3	16.3	7.1	13.9	31.0	12.4	7.7	10.6	23.9	15.4	142.0	10.8	12.7	10.8	30.2	8.3	10.5	27.2	16.8	3.3	16.0	21.5	4.6	12.7	9.5	1.2	1.4	10.7	4.4	0.7	1.7	0.8	17.7	8.1	3.8	11.0	13.3	12.6	4.0	25.1	25.2	12.2	21.3	2.8	14.5	4.2	19.9	25.5	28.4	8.2	5.5	13.3	6.1	5.0	21.0	2.1	22.7	4.3	10.3	2.2	6.7	11.8	14.4	15.2	5.3	13.7	7.9	3.9	5.1	5.4	8.7	7.5	3.2	5.0	1.7	4.6	26.8	2.8	6.7	3.3	7.6	4.2	14.2	5.5	27.3	9.0	7.6	4.8	3.0	7.8	11.9	11.0	5.7	18.4	3.5	6.3	1.2	1.9	23.9	6.4	5.1	4.8	2.2	4.7	1.1	1.4	1.4	0.3	1.0	1.5	0.7	1.2	0.8	1.1	10.7	0.7	4.4	1.4	1.7	0.8	38.9	38.0	16.8	45.0	31.0	28.7	39.5	27.1	31.0	16.8	20.8	16.3	7.5	31.9	14.0	40.7	0.8	28.1	1.4	6.8	41.8	35.3	21.6	68.0	22.2	58.2	29.5	63.2	23.3	24.0	29.3	21.6	60.4	0.0	92.6	20.3	27.0	19.3	46.6	19.9	102.1	32.8	20.6	20.3	4.6	26.4	52.6	41.8	45.6	53.4	91.3	57.1	84.1	37.3	110.5	24.5	21.0	28.6	13.1	18.0	30.8
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		3300000	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	25.7	42.7	17.0	28.7	21.6	37.1	42.5	13.9	26.7	32.8	35.3	16.4	52.0	27.3	37.1	54.7	33.2	32.7	40.0	53.2	13.9	15.7	36.0	59.8	37.2	84.7	16.5	18.3	42.4	146.9	25.4	37.2	71.6	16.1	24.9	39.1	29.5	51.3	58.3	25.5	25.1	35.6	32.2	12.8	49.8	36.5	35.1	15.0	32.5	51.5	28.7	34.5	26.7	30.0	45.6	80.1	50.1	57.1	49.7	58.9	80.7	46.3	29.8	26.0	77.0	51.8	54.2	54.3	39.1	78.7	63.7	65.8	39.6	97.2	38.6	65.3	63.4	35.0	40.3	35.8	47.9	47.2	30.5	36.8	33.3	19.4	52.0	77.2	51.8	86.3	55.5	53.5	53.3	64.5	76.8	72.7	25.9	16.1	64.3	38.2	35.5	24.5	42.8	26.8	74.4	31.6	21.6	34.9	68.4	52.0	20.5	18.9	33.0	42.2	43.0	58.1	39.2	34.4	80.3	37.3	36.8	38.7	63.4	36.0	76.3	82.0	25.9	60.6	69.2	49.3	44.7	55.7	50.1	55.7	57.1	58.9	45.6	48.2	51.3	80.1	39.6	44.1	46.6	14.2	49.7	48.5	65.4	49.2	80.7	17.0	21.6	13.9	26.7	13.9	15.7	16.5	18.3	16.1	15.0	32.8	59.5	70.0	69.0	44.6	15.7	18.9	58.6	75.0	70.5	33.2	27.5	298.3	33.2	141.7	21.4	50.9	44.9	23.3	130.8	225.3	93.6	64.6	76.3	67.1	126.3	15.9	69.0	62.0	66.8	12.2	69.0	83.0	81.0	115.4	106.2	51.5	92.2	91.2	57.3	44.9	19.3	45.3	41.9	107.7	187.2	46.9	292.5	81.2	128.2	58.0
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;testis: 19.4"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.1	0.4	2.4	0.2	5.2	0.1	0.1	0.0	3.9	0.4	0.2	0.4	0.0	0.3	0.4	0.8	0.1	3.1	0.2	0.2	1.8	3.5	0.2	0.1	0.4	0.1	0.4	0.7	0.6	0.1	0.2	1.5	0.7	0.5	0.4	0.1	0.0	0.1	0.8	0.1	0.1	0.2	0.9	0.3	0.1	0.1	19.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.9	0.0	0.0	0.1	0.2	2.7	3.8	1.5	0.9	0.4	1.0	0.0	1.2	2.0	0.7	0.0	1.3	0.9	1.1	0.0	0.3	0.0	0.0	0.4	1.6	0.0	0.0	0.3	0.8	1.0	8.4	1.0	0.0	0.1	0.6	0.0	1.8	0.1	0.0	0.0	2.5	0.1	1.8	0.0	0.1	0.0	0.6	0.0	0.7	1.5	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.6	5.1	0.5	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	5.2	0.0	3.6	1.8	3.5	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	2.7	0.0	1.8	3.9	0.1	0.0	0.0	35.8	12.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	4.0	0.0	0.0	16.5	1.5	60.3	1.1	3.3	1.7	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	19.4	1.4	1.5	4.2	1.1	1.4	0.0	0.0	0.1
SH2D5		ENSG00000189410	"SH2 domain containing 5"	Q6ZV89	1	20719732-20732837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 19.5;placenta: 14.8;testis: 9.4"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 4.2;Suprabasal keratinocytes: 1.9;Syncytiotrophoblasts: 4.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.3;hTERT-HME1: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030182			Approved	Cytosol		NA	NA			Cytosol		"HPA030182: AB_10670431"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.80e-6)"	"unprognostic (1.11e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-2)"	0.4	0.9	4.5	1.3	19.5	0.4	0.3	0.5	19.2	0.6	0.5	0.3	0.0	1.2	1.4	0.3	0.5	0.5	0.6	0.3	3.9	4.1	0.4	0.3	0.4	0.3	1.5	7.3	1.7	0.3	0.6	0.1	14.8	2.1	0.5	0.3	0.0	0.4	1.8	0.3	0.6	0.5	1.2	0.3	0.4	0.6	9.4	0.7	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.7	3.9	0.8	0.0	0.0	0.0	0.1	4.6	6.6	4.6	3.1	1.6	1.6	0.0	1.2	1.4	10.0	0.4	3.3	25.3	1.9	0.0	1.7	0.0	0.5	1.2	3.8	0.0	0.0	0.2	5.3	8.6	32.4	1.6	0.1	0.8	0.0	0.0	1.9	0.9	0.5	0.0	1.5	0.5	5.0	0.1	0.1	0.2	4.8	0.6	1.5	0.2	0.3	0.1	1.5	0.7	0.0	0.0	0.0	5.6	9.9	8.3	2.2	0.0	0.0	0.4	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	19.5	0.5	12.3	3.9	4.1	1.5	7.3	2.1	0.7	0.0	0.0	0.0	1.0	4.2	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.9	1.9	4.2	0.0	0.0	0.3
HP1BP3	HP1-BP74	ENSG00000127483	"Heterochromatin protein 1 binding protein 3"	Q5SSJ5	1	20742661-20787323	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028215, HPA054295"	Supported		Supported	"Nuclear speckles"		NA	Yes		50000	"Nuclear speckles"		"HPA028215: AB_10601021, HPA054295: AB_2682440"	"unprognostic (3.90e-3)"	"unprognostic (6.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-2)"	40.1	41.4	52.6	41.2	59.0	62.2	39.0	53.3	60.0	52.8	46.8	45.8	41.2	34.1	65.7	32.2	46.9	38.6	36.9	35.9	49.1	33.7	42.4	31.7	39.7	41.4	47.6	41.2	70.8	36.5	54.6	46.7	55.1	46.7	41.6	44.2	32.5	39.5	44.5	48.7	41.7	43.9	49.7	50.1	41.9	39.6	27.9	58.6	58.1	52.7	30.9	42.9	48.0	62.9	21.9	18.9	60.5	17.0	18.3	27.3	14.0	43.8	23.3	59.0	35.5	35.4	42.7	35.3	49.7	41.8	36.7	38.8	21.1	51.0	45.5	25.3	39.7	24.3	37.7	30.7	29.1	47.6	65.5	28.2	64.0	45.6	18.8	23.3	44.0	41.2	32.1	21.6	35.8	48.9	44.6	36.9	55.0	35.5	56.1	41.7	14.0	67.6	20.3	15.5	33.8	28.5	53.7	57.2	47.3	26.1	14.2	39.7	40.9	61.3	25.4	40.4	31.5	26.1	31.1	42.7	40.1	37.1	40.4	30.2	32.1	38.7	51.2	34.4	47.8	45.3	25.5	17.0	60.5	19.4	13.9	20.0	21.9	20.9	20.7	15.5	19.0	27.3	18.6	21.8	18.3	15.8	18.9	21.3	14.0	52.6	59.0	53.3	60.0	49.1	33.7	47.6	41.2	46.7	58.6	140.0	127.5	85.8	101.0	115.9	110.2	129.3	96.8	72.3	125.1	99.5	51.1	70.6	131.0	73.7	29.3	134.9	81.9	186.9	81.3	56.0	120.8	105.9	129.9	89.8	62.7	76.3	99.6	116.0	95.2	11.5	159.9	90.0	108.0	91.0	98.8	111.4	88.9	84.5	152.8	77.4	93.1	155.2	104.6	110.6	94.1	117.6	77.7	103.3	91.3	95.2
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	17.8	19.2	24.8	19.0	28.6	24.1	14.3	24.8	33.8	17.2	17.9	24.5	18.6	12.2	19.7	17.5	16.8	17.1	17.0	16.6	25.9	24.8	14.8	13.6	12.9	14.8	23.1	24.8	15.7	10.6	44.5	30.3	13.8	36.3	16.1	21.0	17.4	11.3	18.5	29.1	17.7	14.0	23.8	25.0	16.1	14.2	67.1	23.1	13.9	30.5	9.7	16.1	18.0	15.7	3.6	5.6	4.2	2.6	1.4	3.7	1.5	11.2	9.2	30.5	12.1	31.9	31.7	6.3	24.5	26.5	17.2	17.8	10.0	12.4	22.7	15.9	26.6	16.2	12.7	18.8	19.9	24.4	19.7	17.7	11.3	18.2	7.0	16.1	18.6	21.0	33.1	16.2	18.1	23.5	27.5	22.2	8.6	8.5	15.9	25.5	10.0	5.8	9.7	8.6	14.1	8.3	11.2	11.2	7.5	19.0	6.1	17.3	13.4	25.5	11.1	14.9	18.6	8.0	21.6	22.6	19.5	7.3	27.7	11.1	7.3	7.8	0.1	25.0	29.7	18.1	2.0	2.6	3.0	3.7	0.5	1.6	2.6	1.5	1.8	3.4	3.6	1.0	2.8	4.2	1.4	1.0	5.6	1.7	1.5	24.8	28.6	24.8	33.8	25.9	24.8	23.1	24.8	36.3	23.1	17.9	26.2	21.5	15.0	18.3	47.5	39.2	10.2	58.9	35.2	15.7	62.8	4.2	0.0	18.6	138.6	31.0	42.3	0.0	16.8	7.4	18.3	16.8	25.5	12.7	20.1	47.7	15.6	39.3	33.2	92.8	41.4	24.3	13.5	2.8	21.4	20.0	22.0	28.8	42.1	8.8	39.4	32.3	21.7	100.5	49.8	23.1	2.9	13.8	23.3	23.7
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345504	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 114.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 103.3;TIME: 91.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		2100000			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	44.0	49.9	10.3	18.7	14.5	17.3	33.7	3.6	15.6	29.5	27.5	19.2	11.2	12.4	24.0	10.5	15.6	19.1	23.0	30.9	12.4	8.0	14.9	41.8	30.1	14.4	13.9	13.4	34.2	42.1	114.4	21.6	27.0	14.6	27.9	14.6	26.5	14.7	11.4	15.2	14.8	23.2	24.1	13.2	23.5	18.9	19.1	14.7	9.5	23.2	10.7	19.1	34.2	37.0	4.6	2.0	21.5	7.5	1.0	6.1	4.2	13.8	9.3	12.0	6.0	17.4	18.6	6.9	20.7	36.1	11.3	10.4	6.7	42.8	5.0	52.1	20.8	24.4	5.9	4.9	9.9	9.9	12.6	4.1	7.2	14.4	5.4	23.2	1.0	1.8	9.7	11.6	17.4	8.7	30.9	103.3	4.1	1.4	2.7	9.5	2.9	2.1	1.6	3.6	3.9	7.3	2.5	6.9	7.2	17.6	2.5	4.1	10.0	20.5	12.1	8.9	6.8	8.7	3.0	91.7	25.5	12.4	11.2	11.9	4.1	7.0	5.8	52.9	2.4	30.7	0.1	5.8	2.2	2.2	7.5	3.3	4.6	4.6	3.5	0.5	3.1	3.1	1.9	21.5	1.0	5.2	2.0	6.1	4.2	10.3	14.5	3.6	15.6	12.4	8.0	13.9	13.4	14.6	14.7	17.9	9.8	18.9	17.1	18.0	1.9	16.1	7.6	10.7	28.4	22.7	0.0	3.6	5.0	21.9	1.1	83.9	51.8	23.3	49.4	26.8	34.3	33.0	18.4	32.5	3.1	0.0	24.2	95.8	8.2	1.7	40.3	5.1	6.8	27.9	10.9	57.2	80.7	84.2	51.9	7.4	4.7	38.8	42.9	1.1	4.7	14.1	8.8	10.7	20.9	38.3
NBPF3	AE2	ENSG00000142794	"NBPF member 3"	Q9H094	1	21440128-21485005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 29.5"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 9.4;Early spermatids: 10.3;Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.4;HHSteC: 14.9"									"HPA042595, HPA043692, HPA044023, HPA046971, HPA058050"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.49e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.31e-5)"	"unprognostic (8.35e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.66e-2)"	3.2	5.1	4.5	2.6	4.6	2.3	6.5	12.7	5.3	4.1	3.5	3.7	4.2	1.5	3.7	4.6	3.7	3.6	2.9	2.8	4.7	3.5	4.0	4.6	3.0	3.0	5.0	3.8	4.7	4.3	2.6	9.4	11.7	4.5	4.5	3.6	3.3	4.9	4.0	2.2	6.2	4.0	5.3	4.6	3.2	4.7	29.5	4.9	2.4	4.8	1.3	4.5	5.1	5.6	1.1	0.3	2.3	0.7	1.1	5.3	1.6	1.8	2.5	0.2	5.7	3.8	1.3	4.8	3.2	15.4	4.5	3.8	3.4	5.8	2.9	1.3	8.4	1.3	0.2	2.7	3.8	0.5	1.5	2.9	2.0	0.1	1.2	14.9	1.2	2.0	1.0	1.1	4.1	0.7	2.2	0.4	0.0	0.8	1.0	1.0	6.4	0.0	2.8	0.8	2.6	3.6	0.0	0.0	2.7	0.7	2.4	3.9	4.1	5.0	1.3	3.9	1.4	1.8	2.4	3.7	1.9	2.2	5.6	1.3	0.0	1.6	4.5	0.4	2.5	2.5	0.0	0.5	2.3	3.8	0.7	5.3	1.1	1.6	3.0	0.3	0.5	2.8	3.5	0.2	1.1	0.0	0.0	1.5	1.6	4.5	4.6	12.7	5.3	4.7	3.5	5.0	3.8	4.5	4.9	0.0	3.0	0.8	2.2	1.1	1.4	2.6	2.5	9.4	1.2	1.8	5.9	2.5	0.0	1.0	10.3	1.4	0.0	0.0	2.2	1.0	3.1	1.5	2.3	1.0	0.8	0.0	0.0	3.7	0.6	1.6	2.6	2.2	0.0	0.0	3.3	1.0	2.0	0.0	1.8	1.6	1.8	0.0	1.0	14.4	7.0	2.6	2.1	1.3	1.2	1.6
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	2.0	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.7	2.3	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.6	0.0	1.1	1.1	0.5	0.0	0.2	53.1	0.0	41.5	0.1	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	12.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	26.4	0.3	0.0	0.0	0.1	14.8	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7	3.0	88.5	0.5	0.5	0.1	2.6	2.0	0.0	1.4	10.3	0.0	0.0	0.0	6.6	0.0	1.2	7.1	0.0	23.3	0.0	0.3	0.3	1.5	7.0	25.3	0.1	1.6	0.0	25.8	1.0	4.4	0.3	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	44.8	28.1	0.0	1.0	0.3	13.6	0.4	1.3	0.0	0.0	0.3
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.3;thyroid gland: 72.5"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 66.1;Distal tubular cells: 61.3;Horizontal cells: 87.4;Mucus-secreting cells: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 16.5;OE19: 57.5;SCLC-21H: 19.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 286.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.9	38.2	30.2	1.9	89.3	1.1	3.1	27.1	40.1	4.7	10.5	5.7	0.0	6.9	1.7	1.8	2.9	3.0	13.4	2.7	17.8	12.9	33.2	10.3	7.8	1.2	8.6	20.6	1.6	49.3	7.1	8.2	5.8	14.6	7.4	9.4	2.4	43.9	1.2	0.7	2.1	11.6	1.1	3.2	0.9	28.4	2.1	14.2	0.0	72.5	0.9	1.6	2.5	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.3	2.1	16.5	0.1	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.3	0.0	1.7	0.0	11.1	2.8	1.6	0.1	0.0	0.3	0.8	0.7	1.5	7.7	0.2	0.0	2.4	0.1	1.1	0.0	0.0	0.0	0.0	8.0	10.2	0.4	0.0	5.5	2.6	0.2	1.0	57.5	2.5	1.5	0.4	0.3	3.8	1.2	19.2	3.4	2.7	10.0	3.2	0.7	1.0	1.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	30.2	89.3	27.1	30.4	17.8	12.9	8.6	20.6	14.6	14.2	8.9	21.1	0.5	0.9	1.1	66.1	3.3	25.5	0.0	6.8	14.0	0.0	0.1	61.3	10.9	0.6	0.0	4.2	23.3	24.6	1.1	0.6	8.3	0.0	5.6	0.2	87.4	6.4	0.0	0.8	0.0	0.0	0.7	15.1	1.0	97.4	10.0	20.3	10.2	0.0	10.2	6.2	0.0	0.4	1.0	3.4	1.0	1.3	0.0	6.9	1.1
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	20.1	38.8	18.6	28.9	30.9	30.9	22.1	48.2	27.5	19.9	18.4	25.6	15.4	17.6	21.3	17.6	19.0	17.4	20.5	17.8	16.9	15.8	15.5	18.3	18.3	26.2	26.6	22.5	27.0	19.8	24.6	35.4	23.1	26.8	21.6	22.0	22.1	24.5	16.3	17.0	23.9	22.2	22.2	19.7	29.1	26.2	15.8	23.6	25.8	23.9	14.0	29.0	19.8	21.0	13.7	10.5	33.7	9.6	5.6	11.2	5.6	14.9	7.1	16.8	12.1	14.6	18.0	16.6	18.8	12.8	12.7	16.8	6.5	15.3	16.8	12.7	17.0	9.9	13.8	20.6	15.2	19.3	16.3	14.1	35.9	26.5	11.8	13.0	18.0	19.2	14.6	13.1	12.8	14.3	17.4	37.2	12.8	28.2	47.5	15.5	7.4	14.9	23.4	10.5	15.3	12.8	21.0	16.9	19.6	14.5	12.6	20.5	12.8	17.7	16.3	42.5	23.5	8.3	21.8	26.4	13.7	11.2	16.7	10.9	38.2	27.1	16.7	13.2	22.3	20.0	33.7	9.6	16.7	6.4	4.6	7.6	13.7	9.5	9.5	10.5	12.8	11.2	7.0	8.9	5.6	5.0	7.7	10.1	5.6	18.6	30.9	48.2	27.5	16.9	15.8	26.6	22.5	26.8	23.6	50.6	38.5	34.3	22.6	19.7	74.8	58.2	22.9	32.1	20.5	19.2	58.9	51.8	21.6	25.0	51.8	24.5	18.7	70.0	17.5	50.1	30.9	20.6	47.5	21.2	26.0	47.7	20.8	28.3	22.2	33.0	32.2	24.7	55.6	47.7	26.9	29.1	20.0	17.5	48.4	16.5	69.2	32.3	25.0	42.9	48.2	22.5	27.2	35.5	30.2	17.1
LDLRAD2		ENSG00000187942	"Low density lipoprotein receptor class A domain containing 2"	Q5SZI1	1	21812265-21825221	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 2: 1.1;Ciliated cells: 1.4;Collecting duct cells: 1.8;Early spermatids: 1.0;Ito cells: 1.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"basophil: 1.9;plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;NTERA-2: 2.5;REH: 3.4;THP-1: 2.9;TIME: 6.3"									HPA030478	Approved				"Secreted - unknown location"	NA	NA					"HPA030478: AB_10601541"	"unprognostic (4.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.35e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.80e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	5.4	1.9	0.2	2.2	0.2	2.7	2.2	0.0	0.1	1.7	3.2			4.7	3.1	0.0	1.3	2.2	1.6	3.6	0.5	1.1	1.5	0.1	1.0	1.8	0.0		0.5	1.1	0.0	0.9	0.2		3.1	0.3		5.7	0.1	2.7	1.3	1.7	0.2	0.0	2.3	3.2	0.8			1.6		0.9	2.2	1.8	0.6	2.5	1.9	0.0	0.7	0.0	0.0	0.5	0.7	0.4	0.6	0.2	0.0	1.3	0.9	0.0	0.0	0.0	0.4	1.5	0.0	2.4	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.4	0.1	0.3	0.0	0.0	0.2	0.0	1.4	2.5	0.3	0.4	3.4	0.5	0.0	0.0	0.4	0.0	0.3	0.5	0.1	0.1	0.7	0.2	2.9	6.3	0.6	0.6	0.8	0.0	0.0	0.1	0.4	0.1	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0											0.0	1.1	0.0	0.0	0.5	0.0	0.5	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.4	0.2	0.0	0.0	0.0
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell type enriched"	"Detected in many"	7	"Ito cells: 621.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	7.0	6.5	2.2	7.7	22.6	17.2	8.6	10.7	2.7	3.1	2.8	7.9	14.5	0.5	46.8	16.5	0.1	4.4	0.5	5.2	0.7	0.1	0.7	2.4	7.0	5.7	4.7	0.0	0.6	10.4	1.6	3.2	0.9	4.7	103.4	0.0	3.1	0.9	4.2	1.9	0.0	3.2	1.9	3.2	2.9	1.0	9.2	0.9	6.0	0.9	0.2	0.6	8.1	3.4	4.7	2.0	1.3	1.2	82.5	6.1	8.0	4.7	0.3	0.0	1.0	0.4	1.6	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7	65.5	28.7	5.2	10.9	23.5	0.7	4.5	40.8	1.4	12.5	87.2	0.0	9.4	0.0	63.1	1.0	75.0	34.2	0.0	21.9	85.1	58.4	6.6	22.0	2.8	6.1	3.2	2.4	621.2	31.6	2.2	69.6	3.5	57.3	2.8	12.8	1.4	55.1	20.7	65.0	0.5	0.5	32.3	38.8	0.4	4.1	15.6	7.8	6.4	13.9	8.3
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase family member 3B"	P08861	1	21977021-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"pancreas: 1614.4"	"Cell type enriched"	"Detected in some"	24	"Exocrine glandular cells: 12399.8"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1614.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.9	5.3	8.2	3.0	2.3	3.2	0.9	0.6	5.0	1.7	1.3	2.5	1.5	2.2	1.2	1.8	1.8	1.7	5.4	2.7	5.5	2.7	1.5	2.2	1.6	1.0	0.5	0.0	2.5	4.1	2.4	4.9	4.0	1.3	1.9	3.2	2.3	2.4	1.5	0.0	2.7	2.5	3.6	2.5	5.6	0.4	2.6	2.2	1.5	1.4	0.9	3.5	3.6	0.9	4.3	0.0	3.6	3.2	1.8	3.5	0.8	0.3	3.7	2.6	2.8	3.7	2.9	1.6	2.3	1.0	4.9	4.8	2.5	1.9	4.8	0.6	5.1	2.5	1.8	3.1	3.0	2.0	3.7	2.2	2.8	1.4	5.9	3.2	3.0	8.2	2.3	1.7	5.3	2.9	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	65.6	0.0	4.9	0.0	12399.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.0	0.9	0.0	0.0	105.6	0.0	0.0	510.5	7.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase family member 3A"	P09093	1	22001656-22012539	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2051	"pancreas: 2541.2"	"Cell type enriched"	"Detected in some"	31	"Exocrine glandular cells: 30160.2"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"MOLT-4: 21.6"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	2541.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	29.3	0.0	0.0	0.0	30160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.8	0.3	0.0	0.0	164.1	0.0	0.0	964.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22052627-22092946	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		42000000	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	76.4	42.0	42.2	45.8	45.9	103.1	44.1	48.8	51.3	46.4	56.1	63.0	27.7	42.1	93.6	33.5	62.0	40.5	42.9	36.3	43.7	56.8	66.3	67.2	55.0	60.3	48.5	33.9	59.0	35.2	30.7	33.0	83.6	55.7	44.1	56.6	40.5	72.9	35.3	38.8	50.1	61.7	52.0	61.7	66.9	45.4	34.6	24.8	60.3	44.4	48.8	60.1	50.8	45.8	25.3	36.0	67.9	71.4	29.4	36.3	48.6	54.9	26.2	46.0	39.8	55.0	58.0	49.3	59.5	56.9	66.3	61.6	31.5	67.0	44.6	46.8	73.4	25.2	35.9	43.0	65.7	79.7	59.0	33.2	77.3	36.0	37.1	48.3	66.3	64.2	53.4	71.8	61.6	36.2	42.2	95.9	27.4	43.2	49.3	77.7	23.1	41.6	53.4	30.4	39.6	32.2	35.0	53.8	41.6	57.5	51.2	33.4	30.5	53.1	41.4	44.0	56.4	43.8	38.3	83.6	48.9	46.3	63.0	35.3	27.4	55.0	51.0	43.0	72.5	49.9	46.3	45.6	52.3	33.9	60.0	33.0	25.3	36.3	34.5	36.0	24.1	26.6	35.0	67.9	29.4	71.4	23.5	33.7	48.6	42.2	45.9	48.8	51.3	43.7	56.8	48.5	33.9	55.7	24.8	56.6	53.3	299.3	307.1	400.2	108.9	75.0	244.5	108.4	77.3	296.6	17.7	318.6	318.3	390.0	31.7	256.2	289.3	163.5	384.6	411.9	258.9	275.0	161.5	189.6	399.8	100.1	288.4	275.0	518.9	30.8	146.2	467.3	401.5	678.1	236.6	81.4	449.7	298.1	166.6	387.6	48.7	232.8	315.6	117.2	101.6	486.6	461.3	388.8	206.6	388.9
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117305-22143969	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 34.3;skin 1: 28.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2"	"Low region specificity"	"Detected in many"							HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA011397: AB_1858854"	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.5	6.5	1.0	0.3	1.0	0.0	1.4	0.6	1.7	4.3	1.7	1.1	1.0	2.0	3.1	6.6	6.9	6.4	6.4	0.6	1.5	3.1	1.1	1.2	1.4	0.3	1.0	1.7	34.3	1.9	0.0	3.7	11.8	1.7	7.7	1.0	1.7	3.0	1.8	2.7	28.6	4.1	1.2	1.5	0.3	2.8	0.9	0.8	1.4	2.2	5.4	2.8	2.0	3.5	0.0	0.0	2.8	0.0	0.0	0.4	0.0	1.5	0.1	3.1	0.1	0.1	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.3	10.2	0.0	0.8	0.0	0.3	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.4	0.2	0.4	0.0	0.0	0.0	1.9	12.5	0.0	0.1	10.6	0.7	0.8	4.2	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.7	1.5	3.1	1.0	1.7	1.7	0.8	3.0	7.5	0.0	3.4	14.8	0.0	0.6	0.0	2.7	6.8	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.9	3.8	0.0	0.4	0.1	0.0	28.3	1.3	0.0	0.0	0.0	0.0	5.0	0.0	10.2	0.0	0.9	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.2	0.0	0.5	2.6
ZBTB40	"KIAA0478, ZNF923"	ENSG00000184677	"Zinc finger and BTB domain containing 40"	Q9NUA8	1	22451851-22531157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042386			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042386: AB_10794649"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.78e-8)"	"unprognostic (8.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.34e-2)"	14.1	21.0	8.3	13.5	12.3	11.2	10.8	18.0	12.6	13.9	11.7	14.1	10.9	10.6	21.5	10.5	8.8	13.1	11.9	8.4	9.6	6.4	11.7	8.2	11.5	17.8	12.9	7.3	15.3	15.5	19.0	31.6	8.5	11.6	13.6	11.6	13.5	14.6	10.6	12.7	11.5	18.1	14.4	12.8	23.2	12.5	9.2	13.0	16.6	14.4	6.8	19.5	12.9	14.8	2.5	1.7	1.6	2.1	7.6	3.0	0.8	7.0	8.0	13.3	14.0	10.0	8.4	12.0	6.1	6.7	9.4	10.3	7.2	8.7	8.2	7.3	7.3	7.7	9.1	13.5	6.5	11.3	10.8	11.3	17.4	15.2	8.5	8.7	10.2	16.9	7.0	9.7	12.5	9.6	7.4	8.1	11.7	18.5	0.1	7.7	5.2	6.9	13.0	8.0	5.9	6.7	11.8	10.4	9.3	4.7	7.6	11.2	9.2	11.5	8.5	4.9	8.6	16.1	8.7	9.9	11.6	9.6	11.9	6.0	5.7	7.5	8.4	7.0	12.8	8.3	1.6	1.0	0.6	2.4	2.1	3.0	1.8	1.9	2.0	1.7	2.5	1.9	2.3	0.4	7.6	1.0	1.1	2.7	0.8	8.3	12.3	18.0	12.6	9.6	6.4	12.9	7.3	11.6	13.0	11.9	14.7	11.3	3.1	5.0	13.1	11.0	10.2	6.7	15.9	1.8	29.5	4.2	1.7	4.9	3.6	6.3	3.4	0.0	6.4	3.7	4.7	4.3	15.1	2.9	4.1	11.1	15.5	4.9	4.5	4.7	5.5	4.5	13.5	0.0	5.2	8.2	5.8	7.0	6.3	1.9	23.1	12.9	5.2	5.9	8.5	3.6	2.4	5.1	5.1	2.4
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563564-22603594	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 5.2;Early spermatids: 2.5;Horizontal cells: 3.2;Late spermatids: 3.9;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 37.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 25.0"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.2	9.4	1.6	0.2	3.1	0.2	0.1	1.8	3.9	0.2	0.2	2.2	0.0	1.7	0.1	0.3	0.2	0.1	0.2	0.2	2.0	2.6	0.1	0.1	0.2	0.2	2.1	4.1	0.1	8.3	0.2	1.7	0.1	5.3	0.2	0.2	1.6	0.8	0.2	0.3	0.4	0.2	0.1	1.3	10.3	0.2	3.5	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	3.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.9	2.0	2.6	2.1	4.1	5.3	0.6	0.0	0.0	0.0	0.0	0.0	5.2	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.0	8.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636506-22639608	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 204.0"	"Cell type enhanced"	"Detected in many"	28	"Hofbauer cells: 1354.3;Kupffer cells: 3186.4;Macrophages: 679.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"intermediate monocyte: 50.3;non-classical monocyte: 37.5"	"Lineage enriched"	"Detected in single"	57	"monocytes: 50.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;NB-4: 2.3;RPMI-8226: 11.7;SCLC-21H: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	NA	NA		1100000000			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	51.4	33.0	12.4	19.3	21.0	5.3	40.6	1.9	10.9	10.8	20.3	8.0	2.1	22.1	8.2	25.9	11.3	15.5	22.6	43.9	9.2	10.4	14.4	27.6	60.7	94.4	17.2	4.6	9.5	11.9	2.4	9.6	33.6	15.8	16.0	15.9	12.2	9.4	7.5	7.9	4.3	24.7	24.8	26.8	204.0	11.6	12.3	16.6	7.5	10.9	5.4	8.4	24.1	12.8	0.0	0.8	0.1	50.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.3	0.5	0.0	0.0	0.8	0.5	11.7	0.0	0.0	5.2	1.6	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.3	0.7	0.2	1.5	0.0	0.1	0.2	0.2	0.1	0.0	1.2	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	37.5	0.0	0.0	2.1	12.4	21.0	1.9	10.9	9.2	10.4	17.2	4.6	15.8	16.6	32.8	68.3	87.4	1.4	16.4	0.4	9.2	53.5	28.1	33.0	0.0	0.0	7.6	0.0	0.0	1.7	7.3	0.0	0.0	0.2	8.7	13.9	1.2	19.8	15.7	1354.3	0.0	1.7	93.3	3186.4	4.5	12.0	679.3	25.3	1.0	0.0	0.0	0.0	0.0	0.4	1.0	0.3	77.6	9.0	0.5	2.0	14.6	15.2	15.8	0.0	1.0
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643630-22648110	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 192.2"	"Group enriched"	"Detected in many"	21	"Hofbauer cells: 1118.0;Kupffer cells: 1266.9;Macrophages: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"intermediate monocyte: 28.4"	"Lineage enriched"	"Detected in single"	284	"monocytes: 28.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.8;NB-4: 2.7;RPMI-8226: 6.7;SH-SY5Y: 2.0;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	NA	NA	513000000	1300000000			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	50.5	35.7	24.2	24.6	39.2	5.9	15.6	2.5	18.3	9.8	21.8	19.9	1.2	30.0	8.5	23.4	9.7	17.0	26.8	22.6	17.5	13.6	14.4	41.2	48.2	75.1	34.8	6.1	8.5	7.8	2.6	10.2	34.8	30.2	15.0	15.7	14.8	13.2	8.3	8.0	4.6	33.1	27.1	34.5	192.2	15.5	10.3	29.1	10.7	8.3	4.0	9.5	28.3	6.0	0.0	0.0	0.0	28.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.7	2.7	0.7	0.0	0.0	1.6	0.9	6.7	0.0	0.0	1.2	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.3	2.9	0.0	0.3	0.3	0.4	0.0	0.0	0.7	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	24.2	39.2	2.5	18.3	17.5	13.6	34.8	6.1	30.2	29.1	6.0	6.9	29.4	1.1	7.9	0.0	1.4	22.9	1.4	5.7	0.0	0.0	4.9	0.0	0.0	2.1	2.1	0.0	0.0	0.2	7.9	5.3	0.4	4.7	5.1	1118.0	0.0	0.0	29.4	1266.9	1.8	5.8	421.7	6.8	40.5	0.0	0.3	0.0	0.0	1.1	0.2	0.4	45.3	1.8	0.3	0.9	5.6	8.2	12.9	0.0	0.6
C1QB		ENSG00000173369	"Complement C1q B chain"	P02746	1	22652762-22661538	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 262.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 1215.3;Kupffer cells: 2993.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	66	"intermediate monocyte: 41.9;non-classical monocyte: 26.9"	"Lineage enriched"	"Detected in single"	83	"monocytes: 41.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 2.8;NB-4: 2.6;SH-SY5Y: 2.9;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	NA	NA		4700000000			"HPA052116: AB_2681735"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	76.7	42.3	30.3	22.0	54.5	7.1	17.6	3.3	27.8	12.1	28.2	27.6	1.4	30.0	9.0	25.5	10.8	21.5	33.2	19.8	19.8	17.0	21.8	51.5	87.9	84.1	45.7	6.8	9.8	11.2	4.2	14.4	41.2	35.7	15.0	24.6	17.2	13.9	9.3	9.2	4.3	30.5	41.9	52.2	262.8	14.4	11.7	38.1	7.4	9.8	3.7	9.5	36.8	6.6	0.0	0.5	0.1	41.9	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.2	2.6	1.6	0.0	0.0	1.6	1.1	1.9	0.0	0.0	1.9	2.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.3	2.9	0.1	0.5	0.5	0.3	0.6	0.0	0.5	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	26.9	0.0	0.0	1.4	30.3	54.5	3.3	27.8	19.8	17.0	45.7	6.8	35.7	38.1	11.9	23.2	50.8	1.6	5.6	1.0	5.0	35.7	6.7	19.4	3.5	0.0	5.3	0.0	0.0	1.5	5.9	0.3	0.0	0.0	7.3	6.4	1.6	10.5	14.4	1215.3	0.0	0.0	59.5	2993.5	4.2	7.8	520.2	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.7	3.4	58.2	1.4	0.2	1.0	4.0	8.0	25.4	0.0	1.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	15.9	6.7	6.5	10.4	0.6	0.6	0.0	3.7	0.2	11.3	2.4	2.3	6.4	0.2	8.0	1.6	34.4	15.1	4.4	21.7	3.0	0.0	1.6	0.0	0.7	0.0	6.8	0.0	1.6	2.2	7.0	20.2	0.1	10.0	29.7	0.9	0.6	0.0	2.2	2.3	0.3	0.1	1.5	17.8	4.4	1.9	6.7	0.3	5.5	1.5	7.1	7.4	6.5	0.2	0.0	0.6	0.4	0.2	29.4	4.5	11.8	11.4	25.5	0.0	0.1	0.0	8.4	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3	3.0	0.0	0.0	1.5	0.7	11.6	1.2	12.7	1.4	3.4	0.0	0.0	0.4	0.0	42.3	2.3	0.5	6.8	0.0	6.8	2.2	1.5	1.4	0.0	0.5	9.1	6.4	46.8	0.6	7.5	0.4	0.9	3.7	0.0	0.0	53.6	20.9	38.4	3.5	0.7	0.0	1.7	0.0	1.7	0.5	2.6	0.4	0.9	0.0	82.9	1.0
LACTBL1		ENSG00000215906	"Lactamase beta like 1"	A8MY62	1	22953043-22965338	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 2.2"	"Cell type enriched"	"Detected in single"	7	"Bipolar cells: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066810			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA066810: "																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX46	C1orf234	ENSG00000227868	"Testis expressed 46"	H3BTG2	1	23010834-23015850	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 39.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HSkMC: 3.9"					"Not detected"	"Not detected"									NA	NA						"unprognostic (3.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.76e-2)"	"unprognostic (8.12e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.29e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-1)"		"unprognostic (7.60e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	39.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	1.4	0.5	3.1	0.8	1.4	0.0	0.6	1.1	0.9	0.0	0.8	0.4	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.5	0.0	1.5	0.0	0.0	0.0	0.3	3.9	1.3	0.6	0.8	0.0	0.7	2.3	0.7	0.4	0.7	1.1	0.0	0.7	1.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.0	1.4	0.5	0.2	0.2	1.4	0.0	1.5	0.3	0.5	0.4	0.0	2.4	0.0	0.2	0.4	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	15.1	19.0	19.7	16.8	23.2	24.9	19.3	28.0	26.6	20.0	20.6	15.1	21.0	16.2	28.9	30.6	20.9	22.0	15.7	18.6	16.4	18.9	15.9	14.8	15.1	19.5	13.8	25.4	27.4	21.4	24.6	28.7	19.3	20.3	20.9	21.6	16.4	21.3	19.9	24.8	23.3	16.9	19.1	10.7	16.2	17.1	78.4	12.1	48.1	20.9	19.1	22.1	18.7	21.9	9.1	9.7	5.7	6.9	3.8	7.4	1.9	30.3	15.7	44.9	39.6	11.9	15.2	32.0	12.9	16.3	26.4	23.6	14.7	29.5	22.6	18.6	21.2	13.4	34.1	41.6	24.6	33.6	20.5	25.2	31.7	26.2	35.7	15.2	24.4	14.0	14.1	17.7	28.0	19.8	23.3	32.9	42.0	34.7	10.7	18.7	18.0	53.2	18.7	29.2	16.9	22.9	51.1	29.6	15.3	22.1	19.6	56.2	42.5	58.3	15.4	19.2	32.9	15.4	18.3	26.6	11.8	19.9	21.8	17.6	13.9	10.9	26.3	12.3	29.0	16.7	2.8	3.7	5.7	5.9	5.9	5.2	9.1	5.4	5.7	4.4	3.3	7.1	7.4	0.3	3.8	6.9	9.7	5.8	1.9	19.7	23.2	28.0	26.6	16.4	18.9	13.8	25.4	20.3	12.1	17.9	26.1	9.0	22.9	16.6	27.5	21.6	15.3	26.8	17.0	22.7	25.5	25.8	14.9	30.7	32.2	12.8	14.4	0.0	21.5	47.0	17.4	18.6	11.5	13.9	13.3	14.3	21.9	14.1	13.9	16.3	19.8	15.0	11.8	28.9	20.5	19.3	25.4	14.0	21.5	12.6	20.0	0.0	15.9	100.4	63.4	11.2	13.8	8.7	24.7	17.5
LUZP1	LUZP	ENSG00000169641	"Leucine zipper protein 1"	Q86V48	1	23084023-23177808	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 318.3;Early spermatids: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028506, HPA028542"	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA028506: AB_10600083, HPA028542: AB_10601986"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.46e-3)"	"unprognostic (9.77e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.50e-1)"	"prognostic favorable (1.46e-7)"	"unprognostic (4.49e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.33e-1)"	9.7	10.3	5.2	6.5	10.7	8.3	7.3	7.8	18.2	7.5	11.7	2.5	4.4	15.7	9.6	4.5	7.5	6.6	9.1	9.2	6.3	6.1	8.1	4.0	9.1	4.0	5.4	9.5	6.6	4.4	21.8	4.9	8.6	21.8	7.0	9.4	4.6	7.1	7.1	4.2	6.8	27.1	8.9	5.0	9.4	5.9	20.4	3.4	5.2	7.9	4.7	5.5	7.9	9.9	4.5	11.9	21.5	7.4	4.8	10.5	2.1	9.6	6.7	9.4	10.9	9.7	12.4	6.9	9.5	15.2	12.0	12.6	3.8	4.5	0.2	8.8	16.1	7.7	13.2	9.3	25.8	14.7	3.5	6.1	13.6	8.3	3.5	6.4	6.7	8.8	10.9	10.2	17.5	13.9	9.9	26.8	3.8	5.0	0.8	9.6	2.6	4.5	2.9	8.0	3.0	7.3	6.9	14.1	1.1	5.4	6.4	1.7	4.5	22.8	6.5	7.8	19.8	3.6	3.6	47.8	14.1	10.7	10.5	9.4	1.2	2.8	3.8	6.3	11.1	12.1	21.5	5.8	6.1	9.3	4.0	10.5	2.4	7.0	5.8	5.6	4.5	5.6	5.5	3.2	4.8	7.4	11.9	3.7	2.1	5.2	10.7	7.8	18.2	6.3	6.1	5.4	9.5	21.8	3.4	8.9	16.8	7.8	318.3	120.2	18.9	43.7	30.6	24.1	25.0	19.2	2.0	22.0	13.3	54.6	217.4	97.6	99.2	0.0	27.1	42.6	62.2	74.9	22.0	10.5	23.5	20.6	20.6	64.4	12.7	34.3	33.6	37.9	32.1	125.4	35.2	15.4	52.9	27.4	41.1	21.0	6.0	32.3	60.4	36.3	33.2	61.9	20.7	26.6	28.7	180.2
HTR1D	"5-HT1D, HT1DA, HTRL, RDC4"	ENSG00000179546	"5-hydroxytryptamine receptor 1D"	P28221	1	23191895-23194729	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.9;intestine: 12.2"	"Cell type enriched"	"Detected in single"	12	"Cholangiocytes: 7.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 8.5;hTERT-RPE1: 8.2;OE19: 11.4;TIME: 21.3;U-2 OS: 7.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 7.6"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.73e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.86e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.87e-3)"	"unprognostic (8.88e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.28e-6)"	"unprognostic (9.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.02e-3)"	0.0	0.0	0.3	0.0	3.9	0.1	0.0	0.0	0.2	0.0	0.1			12.2	0.0	0.0	0.0	0.5	1.9	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2		0.0	0.1	0.0	0.1	0.0		0.1	0.1		0.0	0.0	0.0	0.1	10.4	0.0	0.2	0.0	0.0	0.4			0.0		0.0	0.5	0.0	1.0	0.7	2.2	1.2	1.2	0.9	0.2	2.5	8.5	0.0	0.0	0.0	0.2	0.7	0.0	0.6	0.3	0.3	0.5	6.1	0.0	2.5	0.3	4.3	1.8	1.7	0.0	0.4	0.0	0.7	0.0	5.0	0.1	0.3	0.0	0.0	0.1	0.1	1.0	0.3	8.2	5.0	0.1	0.0	0.0	0.2	1.0	0.0	0.0	2.0	11.4	0.1	0.0	0.0	0.0	0.2	0.0	2.1	0.0	5.7	0.3	0.1	0.7	0.1	0.0	21.3	0.0	7.2	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	1.2	0.5	0.6	0.8	0.4	1.0	0.9	0.6	0.4	1.0	0.6	0.6	2.2	1.2	1.0	0.7	0.4	0.2											0.0	0.0	0.0	0.2	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm		NA	NA		50000	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	27.1	30.4	31.2	36.1	34.7	33.8	31.2	41.0	32.2	32.4	27.4	34.3	29.5	26.5	42.2	23.7	33.2	32.7	20.3	25.6	29.1	27.9	25.1	25.1	28.1	39.6	35.0	27.9	44.3	32.8	40.5	40.9	40.9	27.5	27.3	31.3	26.5	28.1	27.7	31.1	27.8	26.8	41.0	34.1	28.8	24.9	20.3	40.0	68.3	29.9	29.7	40.9	29.0	29.4	21.9	23.6	20.8	23.2	26.1	28.5	19.8	36.7	22.9	47.0	27.8	16.8	16.8	22.2	25.0	25.5	35.3	25.5	15.7	25.5	45.0	12.3	30.3	21.3	21.2	48.5	32.4	46.3	31.2	32.9	43.0	30.3	28.3	17.0	53.2	29.0	18.7	20.0	33.1	26.8	18.0	26.2	34.8	38.6	31.4	27.1	21.1	60.7	15.5	26.5	25.4	21.1	43.5	45.9	31.7	23.8	18.0	30.0	31.3	32.8	27.8	20.2	27.0	22.3	23.8	26.5	23.7	32.4	29.0	29.6	19.9	29.6	60.7	17.9	45.5	25.8	8.7	18.5	20.8	25.4	22.5	27.7	21.9	24.3	25.2	23.6	20.1	26.3	24.4	6.6	26.1	23.2	13.9	28.5	19.8	31.2	34.7	41.0	32.2	29.1	27.9	35.0	27.9	27.5	40.0	110.2	90.3	90.8	156.4	113.3	122.1	64.1	76.5	147.2	144.5	83.7	41.2	198.0	77.9	84.8	12.3	105.1	51.1	23.3	109.3	227.4	125.2	131.2	163.3	64.4	93.4	119.2	111.7	58.3	74.5	13.1	111.9	91.5	79.2	159.7	84.5	155.0	99.5	59.6	109.6	54.2	110.8	84.1	129.6	143.8	153.0	113.4	172.9	111.0	103.7	158.3
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369442	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.2;HSkMC: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	14.5	18.6	10.1	4.7	13.0	2.9	12.9	13.6	15.8	10.7	8.7	11.8	8.6	6.3	15.1	17.5	18.4	10.2	11.2	11.7	9.9	6.1	6.7	4.3	7.8	5.6	12.9	9.6	20.3	8.1	11.6	6.5	8.5	11.3	12.1	6.9	6.3	16.9	13.4	7.2	15.6	6.1	12.7	12.6	8.0	6.8	10.4	10.0	5.7	12.3	9.7	8.0	12.5	11.2	1.6	2.8	1.6	2.1	6.6	2.3	1.6	2.8	1.8	6.5	3.4	7.3	15.2	3.1	2.5	3.5	3.3	3.9	1.0	2.4	1.9	2.9	3.6	2.1	3.5	11.6	4.3	3.6	2.3	2.5	2.0	3.7	1.6	2.9	0.8	1.4	27.7	6.3	2.8	3.3	6.0	4.7	2.3	2.4	1.4	3.5	1.3	2.1	1.6	0.2	1.3	2.8	2.8	2.7	1.8	2.7	7.2	3.0	3.7	7.1	3.6	2.8	2.3	2.0	1.0	3.7	2.8	2.1	2.2	1.4	2.1	2.6	1.6	2.2	1.7	2.2	0.0	1.8	1.6	2.0	2.1	2.0	1.3	1.4	2.1	2.8	1.6	2.3	2.0	1.3	6.6	2.0	0.4	2.2	1.6	10.1	13.0	13.6	15.8	9.9	6.1	12.9	9.6	11.3	10.0	0.0	0.3	0.8	1.0	4.6	3.6	4.8	2.5	2.7	0.0	5.2	5.9	2.9	0.0	2.7	0.9	8.7	2.7	0.0	4.3	1.5	4.6	3.4	0.0	3.0	1.8	9.5	3.5	1.8	2.6	1.1	9.2	0.7	5.0	6.4	3.9	11.8	3.9	5.8	11.0	2.1	2.1	0.0	2.0	4.7	6.0	8.4	2.4	1.0	2.9	1.1
TCEA3	TFIIS.H	ENSG00000204219	"Transcription elongation factor A3"	O75764	1	23381061-23424740	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 114.0"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 307.1;Undifferentiated cells: 204.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.0;Hep G2: 33.2;OE19: 17.1;SiHa: 11.0;T-47d: 17.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044960, HPA055811"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044960: AB_10964053, HPA055811: AB_2682932"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-3)"	"unprognostic (9.18e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.77e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-3)"	"unprognostic (7.37e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.58e-2)"	5.4	17.8	2.5	10.7	1.9	0.1	3.6	1.5	1.5	9.1	12.2	2.2	12.0	4.6	3.8	14.5	12.0	6.2	13.0	20.3	2.4	0.8	12.1	38.0	6.0	1.3	1.2	2.3	19.8	60.4	4.5	3.3	2.5	2.2	16.7	12.5	8.7	32.7	15.9	114.0	8.9	11.9	13.7	2.0	1.6	11.5	2.6	1.3	0.5	8.6	58.3	16.0	8.4	6.9	0.0	2.8	0.0	0.7	0.2	14.3	2.5	0.0	0.1	0.3	0.3	1.7	10.0	5.5	3.9	2.5	2.1	1.2	2.5	0.3	0.1	0.4	4.8	0.6	5.4	0.4	0.0	1.8	0.0	0.0	0.0	4.1	33.2	1.2	0.4	0.0	6.5	1.8	1.8	0.0	4.5	0.2	0.0	0.0	0.0	0.6	0.9	0.2	3.6	0.0	17.1	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	11.0	0.5	0.4	1.0	17.5	1.6	0.2	0.0	0.1	0.4	0.0	0.3	2.9	0.0	0.3	0.3	0.3	0.0	0.1	0.0	0.5	0.7	0.5	0.0	8.5	1.2	2.8	0.0	14.3	6.3	0.0	0.2	0.2	0.9	0.7	2.5	2.5	1.9	1.5	1.5	2.4	0.8	1.2	2.3	2.2	1.3	116.1	83.2	2.2	44.3	24.4	1.5	92.9	68.8	45.5	71.7	40.1	2.0	3.0	169.1	22.0	4.7	12.7	145.7	0.0	86.0	28.5	32.8	62.5	9.2	177.9	1.2	23.8	53.7	9.8	7.3	7.2	15.8	16.2	23.6	2.8	307.1	2.9	40.2	98.2	14.5	173.6	1.5	19.4	20.6	0.5	3.5	47.9	1.8	6.1	204.2	55.5
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 18.6;HSkMC: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA020537: AB_2670467, HPA020546: AB_2670470"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	10.6	15.5	8.7	5.9	9.9	0.7	15.2	2.6	8.3	11.0	8.9	6.6	13.5	2.4	7.9	7.7	12.9	8.7	7.8	20.7	6.9	5.1	10.7	7.4	7.9	2.3	9.2	6.1	29.6	13.7	13.7	7.4	12.4	16.3	12.0	6.8	8.2	14.6	25.5	24.2	32.5	3.7	9.9	15.4	1.9	8.9	9.4	6.7	0.2	12.0	12.0	6.2	7.0	17.7	0.1	0.0	0.0	1.6	0.0	0.4	0.4	1.0	1.0	10.6	6.9	19.6	18.6	13.1	1.9	2.3	3.0	3.8	0.7	0.0	5.4	2.2	3.7	1.7	5.0	7.3	1.7	1.7	0.2	0.9	0.3	2.8	6.8	10.6	0.0	0.5	23.7	2.7	4.7	4.3	8.9	2.3	0.8	3.6	0.0	1.8	2.2	0.7	0.0	1.8	2.9	2.5	2.8	1.1	0.0	2.0	2.1	0.4	3.6	8.3	2.1	2.1	5.5	7.9	0.0	0.8	1.2	3.2	3.6	0.1	2.3	2.3	0.6	0.5	0.0	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.4	8.7	9.9	2.6	8.3	6.9	5.1	9.2	6.1	16.3	6.7	8.9	7.0	0.0	1.7	1.8	1.0	11.6	0.0	2.7	2.3	3.5	0.0	1.6	3.3	4.0	3.5	3.1	2.1	0.0	5.2	32.0	6.7	3.3	1.1	3.4	1.6	0.0	1.2	3.7	0.0	5.6	11.5	0.4	0.0	0.0	7.0	7.5	4.0	0.0	12.7	4.9	0.5	0.0	1.9	6.0	8.1	3.8	1.1	0.0	3.7	1.1
E2F2	E2F-2	ENSG00000007968	"E2F transcription factor 2"	Q14209	1	23506430-23531220	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 22.8;lymphoid tissue: 69.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 45.0;Late spermatids: 84.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9;Karpas-707: 20.5;U-266/84: 18.3;U-698: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016313	Uncertain					NA	Yes					"CAB016313: AB_2096794"	"unprognostic (3.14e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.18e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.43e-6)"	"unprognostic (7.83e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.00e-3)"	"unprognostic (2.82e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.84e-1)"	0.4	0.2	0.1	6.1	0.2	22.8	1.0	0.1	0.2	1.1	3.5	0.2	0.0	1.6	0.1	0.2	11.2	0.1	0.2	1.5	0.0	0.0	0.4	0.7	1.2	3.3	0.2	0.0	0.2	0.6	0.0	0.0	2.2	0.2	0.3	2.3	0.3	1.2	0.0	0.0	4.4	3.4	0.4	0.2	6.8	0.9	4.4	0.1	69.7	0.3	3.9	6.1	0.5	2.3	0.9	1.1	6.7	2.0	0.2	2.8	0.4	2.7	2.0	3.4	5.4	0.1	0.1	2.4	1.3	0.6	1.2	1.6	1.2	1.6	23.9	1.6	0.6	0.6	5.5	6.8	0.3	1.1	6.0	2.2	3.8	5.1	1.4	0.0	2.7	5.0	0.0	0.0	0.9	0.1	0.2	0.4	11.2	2.9	20.5	0.6	1.6	12.2	2.5	0.7	2.9	1.0	13.4	7.3	8.1	0.5	0.7	4.4	6.2	2.2	2.8	0.6	0.4	2.1	2.0	0.2	1.2	3.3	3.7	1.8	15.2	18.3	19.8	1.1	3.0	2.2	6.7	0.6	1.7	0.2	1.5	0.1	0.9	0.7	0.5	1.1	0.6	0.1	0.2	0.4	0.2	2.0	0.9	2.8	0.4	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	7.0	0.1	0.7	0.0	0.5	0.0	0.0	0.0	1.8	0.0	1.0	0.0	0.0	45.0	0.0	2.0	0.0	0.0	4.0	0.2	0.4	0.0	0.0	2.0	0.0	1.2	0.6	4.4	84.0	0.3	0.9	0.0	0.0	5.6	0.0	0.1	7.0	0.4	0.0	0.0	0.0	0.0	1.1	3.3	0.9	0.5	0.0	7.4	1.0
ID3	"bHLHb25, HEIR-1"	ENSG00000117318	"Inhibitor of DNA binding 3, HLH protein"	Q02535	1	23557918-23559794	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Myogenesis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 117.9"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 1041.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 47.4;naive B-cell: 42.9"	"Group enriched"	"Detected in many"	37	"B-cells: 47.4;T-cells: 24.9"	"Cell line enhanced"	"Detected in many"		"U-698: 84.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021353, HPA024677"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB021353: , HPA024677: AB_2671647"	"unprognostic (6.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (5.58e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.37e-3)"	"unprognostic (8.36e-2)"	33.5	12.2	13.3	18.9	15.5	6.0	41.6	2.4	14.4	22.0	25.9	16.6	31.4	18.9	21.7	17.8	20.6	33.8	22.9	42.2	21.1	12.4	21.3	11.1	25.8	15.3	16.6	9.1	27.2	10.2	4.2	31.1	31.3	17.7	38.9	13.0	42.6	9.1	117.9	17.0	14.2	17.0	13.3	16.9	12.4	21.6	6.9	20.7	20.5	82.8	19.3	10.7	35.0	72.1	47.4	0.9	0.5	0.2	0.0	24.9	6.1	3.3	20.4	7.0	24.5	3.2	0.4	8.2	24.6	2.1	13.8	1.7	1.2	0.1	21.8	25.4	9.2	2.9	28.2	8.6	3.2	1.4	0.1	9.0	0.3	26.6	11.0	9.9	0.0	0.0	10.3	17.3	0.3	0.2	12.1	12.2	8.7	0.1	0.2	12.5	8.0	2.9	0.0	6.1	16.3	5.1	27.2	13.0	0.7	0.1	7.7	10.3	8.1	23.5	17.4	1.7	5.5	4.5	0.6	25.3	19.6	10.5	9.7	12.8	6.8	6.2	84.2	4.3	0.2	11.4	0.0	0.2	0.0	0.6	0.2	0.2	47.4	10.9	2.1	0.7	42.9	18.2	7.2	0.5	0.0	0.2	0.9	24.9	6.1	13.3	15.5	2.4	14.4	21.1	12.4	16.6	9.1	17.7	20.7	107.2	66.6	152.0	308.3	182.4	2.9	23.8	20.4	28.1	46.6	198.9	9.8	146.2	19.9	195.6	1.1	558.2	223.7	0.0	376.5	627.5	200.0	250.3	15.0	3.4	67.3	4.8	415.6	1041.7	65.7	1.8	38.0	95.2	236.2	34.3	461.1	365.1	130.9	345.5	0.7	5.7	12.4	511.0	604.0	0.5	0.6	165.7	233.5	45.9	226.0	105.9
RPL11	L11	ENSG00000142676	"Ribosomal protein L11"	P62913	1	23691742-23696835	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA002734, HPA074839"	Approved		Approved	Vesicles		NA	NA		720000	Vesicles		"HPA002734: AB_1079838, HPA074839: AB_2686717"	"prognostic favorable (2.55e-4)"	"unprognostic (3.98e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.70e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (5.93e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.90e-1)"	75.0	46.8	35.1	71.4	74.9	65.8	175.9	33.4	41.1	100.3	69.1	32.9	50.5	30.3	130.0	112.0	87.8	95.9	65.4	79.9	56.0	26.2	56.2	78.8	78.7	222.2	39.5	46.6	148.2	311.5	47.6	43.4	48.3	78.6	85.2	97.7	43.2	204.8	66.6	84.2	92.1	58.0	103.4	47.0	72.3	77.5	52.9	23.2	65.5	91.9	92.2	169.3	73.7	115.4	178.7	93.6	43.4	72.4	79.3	199.1	235.2	38.0	62.3	75.1	38.3	129.0	183.1	26.4	25.6	108.5	98.3	73.5	112.5	43.0	79.4	28.5	87.3	39.9	32.6	94.3	126.9	110.1	28.1	126.3	37.1	213.7	148.6	96.6	62.4	30.5	177.8	188.0	82.8	149.5	121.0	103.9	139.6	42.8	43.0	104.1	118.0	36.2	99.8	18.8	124.7	71.4	46.1	36.5	75.5	110.8	68.1	29.7	36.2	20.1	42.0	74.2	67.9	30.9	77.7	31.1	24.1	33.0	40.5	32.3	39.6	35.8	55.6	30.4	89.3	27.5	43.4	72.4	22.0	73.6	63.2	125.4	178.7	150.1	107.5	93.6	157.3	199.1	146.6	11.6	79.3	49.8	93.2	109.4	235.2	35.1	74.9	33.4	41.1	56.0	26.2	39.5	46.6	78.6	23.2	1095.8	1949.2	5840.5	6304.6	5888.0	338.2	523.0	3003.8	1172.4	1937.0	1067.8	145.3	4113.3	4073.5	2275.3	832.2	3353.1	1873.9	1261.4	5801.9	6645.9	3301.0	4731.7	1987.6	2712.5	3407.9	195.5	2079.9	2711.8	3936.0	1676.5	4261.5	5099.8	3564.8	4184.1	3270.1	600.2	3952.7	3415.8	1958.1	3600.3	474.8	1390.5	3246.9	514.6	525.9	6987.2	3890.4	3666.1	4664.7	6181.0
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 68.1;monocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.6	13.7	10.0	14.2	16.1	22.9	16.3	16.0	17.2	13.7	12.2	15.2	15.1	9.8	15.0	9.0	23.6	13.3	15.7	12.9	9.9	9.8	18.1	41.7	20.3	24.1	10.3	12.5	16.0	41.5	19.1	17.1	19.6	12.7	13.6	13.5	13.0	18.6	13.4	26.0	18.3	14.1	14.0	10.9	20.5	24.6	14.4	10.0	19.3	18.4	22.4	21.8	15.6	14.5	20.7	18.8	18.3	20.9	11.0	14.8	13.2	20.3	11.4	16.5	14.1	19.5	12.2	10.4	21.1	19.1	31.5	27.6	13.9	17.9	10.7	26.0	21.4	17.7	19.6	33.8	22.2	35.3	30.6	16.7	24.1	17.8	16.2	17.3	25.2	14.6	12.9	18.0	34.3	26.3	11.7	18.8	17.7	35.6	18.6	25.1	15.4	13.0	10.3	19.1	22.9	17.3	19.6	21.0	20.3	14.8	13.9	31.5	17.7	19.2	19.4	23.4	19.2	14.0	9.3	19.9	24.8	21.9	43.9	24.8	19.3	21.5	23.6	21.7	25.2	24.7	18.3	19.8	15.4	14.8	20.9	14.6	20.7	12.4	13.3	18.8	16.6	10.2	13.4	5.5	11.0	18.4	15.5	14.0	13.2	10.0	16.1	16.0	17.2	9.9	9.8	10.3	12.5	12.7	10.0	26.8	68.1	0.0	0.0	0.0	0.0	0.0	0.0	30.8	33.0	17.4	0.0	23.2	5.0	34.1	0.0	0.0	0.0	0.0	28.4	28.4	0.0	0.0	12.8	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	61.3	0.0	0.0	32.3	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0
PITHD1	"C1orf128, HT014, TXNL1CL"	ENSG00000057757	"PITH domain containing 1"	Q9GZP4	1	23778405-23788232	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016936	Uncertain					NA	NA		680000			"HPA016936: AB_2067141"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.93e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.38e-1)"	14.7	20.0	40.7	12.5	40.0	40.0	20.8	47.2	51.2	14.9	16.2	27.8	10.3	13.1	16.3	27.4	21.6	16.7	13.7	16.6	39.0	51.9	16.1	24.0	15.0	19.2	44.6	41.6	17.5	20.1	64.4	16.3	17.4	38.2	24.1	19.8	12.3	17.0	19.2	27.1	26.2	12.9	18.2	33.6	16.7	15.3	21.6	23.4	43.5	15.8	21.5	23.7	14.5	17.7	26.7	18.6	25.2	17.3	21.2	29.3	16.6	15.1	8.5	14.1	26.6	21.7	15.8	10.6	21.8	16.1	19.5	15.1	13.5	17.3	40.6	18.7	20.0	8.0	17.4	28.0	17.2	19.8	20.4	21.4	37.9	25.5	18.5	13.1	38.8	14.5	12.7	22.2	15.2	21.6	17.6	16.7	24.9	55.6	21.5	22.7	11.5	24.5	21.6	18.3	24.3	20.9	27.1	15.6	26.5	17.9	10.7	33.4	13.5	15.6	23.6	26.9	15.6	14.4	17.4	14.7	13.5	17.3	27.3	18.4	18.6	19.0	47.2	23.5	43.1	20.6	8.1	11.7	25.2	20.4	14.9	23.0	26.7	24.1	24.0	12.0	24.3	29.3	28.1	11.9	21.2	17.3	18.6	20.0	16.6	40.7	40.0	47.2	51.2	39.0	51.9	44.6	41.6	38.2	23.4	8.9	18.7	49.1	43.5	114.7	59.2	36.6	20.4	8.1	19.4	21.0	21.6	83.5	44.7	29.4	9.2	40.5	27.9	140.2	29.8	51.2	46.8	46.3	24.2	32.6	69.7	98.5	31.6	30.1	27.7	11.7	39.7	44.1	114.7	83.8	37.6	110.0	28.2	28.8	54.1	37.6	32.7	77.6	47.0	97.8	104.4	117.7	97.4	52.3	39.4	29.2
LYPLA2	APT-2	ENSG00000011009	"Lysophospholipase II"	O95372	1	23790970-23795539	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063151			Uncertain	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063151: "	"unprognostic (8.84e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (3.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.24e-1)"	12.4	13.6	14.8	13.3	34.8	20.6	13.5	10.7	17.7	9.9	21.2	12.3	5.6	21.3	10.9	17.2	25.4	19.2	21.6	14.4	9.9	9.5	33.2	34.5	14.3	19.0	7.6	12.8	10.3	18.3	32.0	12.0	31.6	35.4	14.8	12.7	11.3	21.1	11.2	14.2	17.7	24.0	9.5	5.4	22.1	19.1	9.9	6.9	27.7	16.5	9.5	16.5	15.3	13.5	29.5	32.3	50.0	40.6	32.0	48.0	42.4	25.5	15.8	19.3	22.3	9.8	11.9	26.6	15.8	15.1	15.0	12.8	21.8	41.6	13.9	22.3	14.9	10.6	24.3	13.9	41.0	6.4	26.0	19.6	17.5	26.0	35.8	15.2	16.4	23.1	14.7	25.4	22.6	8.6	19.3	35.3	15.9	24.4	14.0	16.4	25.3	22.0	26.7	39.3	21.5	22.3	24.4	11.1	25.6	35.3	19.6	28.0	48.6	17.9	28.7	26.8	14.7	23.3	17.3	30.3	15.1	20.0	18.2	13.1	38.0	32.1	19.4	24.9	37.9	19.0	28.9	40.6	50.0	48.0	39.6	38.7	27.6	40.1	41.6	32.3	29.5	35.2	36.0	48.4	32.0	31.2	24.6	35.6	42.4	14.8	34.8	10.7	17.7	9.9	9.5	7.6	12.8	35.4	6.9	8.9	26.4	19.0	29.7	34.6	31.0	13.7	35.7	37.5	20.5	34.9	17.7	93.7	58.0	104.5	13.5	26.9	80.5	23.3	98.3	88.0	17.6	27.9	36.8	28.8	60.5	22.3	42.6	17.8	16.8	9.9	9.8	20.4	18.6	82.0	39.0	26.1	99.3	53.5	6.0	76.2	20.4	25.8	12.4	6.8	19.0	36.3	96.9	32.4	45.1	36.5
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.3	19.7	7.9	12.5	2.9	4.2	7.7	11.2	15.2	19.9	14.9	18.0	55.1	3.9	15.8	6.5	26.7	18.2	7.0	28.7	15.1	8.3	4.5	11.0	10.0	19.5	30.1	4.7	3.3	8.9	15.1	18.3	46.0	20.1	17.0	8.5	12.2	1.0	14.1	17.5	7.8	5.1	2.2	23.0	19.2	9.3	7.7	4.9	32.2	11.0	3.1	7.0	20.3	18.4	19.9	9.4	13.5	3.9	9.3	14.5	21.7	14.9	13.7	5.1	12.2	5.1	15.4	20.2	7.8	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6	11.9	33.5	8.2	17.9	6.8	14.3	3.1	40.8	12.0	19.4	38.4	15.7	47.8	29.9	42.8	20.5	9.8	92.2	0.0	103.0	85.9	6.3	18.2	10.4	31.8	81.7	7.9	11.6	9.2	3.7	5.1	4.4	12.2	23.6	29.7	119.4	20.6	62.8	84.5	3.2	64.1	13.1	0.0	5.3	14.6	9.7	4.3	80.6	7.5	58.2	38.3
HMGCL	HL	ENSG00000117305	"3-hydroxymethyl-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 147.7;Proximal tubular cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		120000			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	7.4	18.5	6.4	8.2	6.6	1.6	14.3	4.3	7.7	7.6	13.9	9.0	12.0	12.0	6.2	13.2	9.1	9.7	12.8	11.2	5.9	6.0	30.3	81.4	8.8	11.1	7.5	7.1	6.1	15.2	13.1	7.8	8.5	7.9	8.7	14.2	10.0	8.9	11.5	15.2	7.0	15.4	11.7	9.3	8.6	10.8	7.2	6.1	8.3	14.5	8.1	8.3	8.8	6.7	24.1	27.7	40.8	33.8	24.5	21.2	26.8	10.5	6.1	6.9	5.1	28.0	21.4	2.6	8.4	14.7	9.1	11.1	3.8	20.5	5.5	17.3	13.0	7.4	8.5	8.2	13.6	9.9	11.2	6.2	7.4	5.4	8.7	36.2	2.8	4.9	24.8	20.2	11.9	23.0	24.5	12.3	10.5	7.5	7.8	16.6	10.8	4.5	5.7	1.7	28.9	8.5	6.4	5.6	10.2	21.4	5.5	5.8	5.1	10.9	4.1	18.5	9.5	13.0	7.2	9.2	7.5	4.6	13.7	3.6	11.2	5.5	4.9	18.7	10.7	8.8	40.8	32.4	30.1	18.4	30.4	20.1	21.9	20.0	21.2	27.7	24.1	20.3	19.4	12.2	24.5	33.8	20.6	20.8	26.8	6.4	6.6	4.3	7.7	5.9	6.0	7.5	7.1	7.9	6.1	11.9	21.7	21.7	27.4	5.3	24.1	30.3	43.3	28.1	12.5	47.1	17.7	37.1	101.2	42.9	1.5	21.1	59.4	0.0	21.2	21.2	16.6	28.0	17.3	147.7	52.8	33.4	8.6	31.3	25.4	3.2	20.1	21.3	20.3	60.5	44.3	33.5	28.9	49.2	23.0	159.0	20.1	6.5	18.9	4.1	3.3	5.6	34.6	15.2	47.0	22.5
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868294	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 182.1;Paneth cells: 168.7;Syncytiotrophoblasts: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced				"Intracellular and membrane"	NA	NA		65000000			"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	15.8	18.0	4.6	24.1	7.1	0.9	8.9	4.2	8.1	13.1	30.2	6.9	28.4	20.4	9.9	35.7	8.7	12.7	22.6	15.0	4.7	6.4	28.9	39.3	20.7	66.7	4.8	4.7	19.4	15.5	12.2	10.9	31.9	8.0	15.2	33.5	13.8	22.6	18.5	6.9	6.6	42.3	7.4	7.1	32.3	14.8	15.6	2.9	11.6	27.3	8.0	25.1	23.6	7.8	8.3	15.2	16.8	34.8	14.4	9.9	19.0	5.3	3.6	0.7	11.0	1.5	0.1	3.8	5.7	11.9	6.0	11.2	4.9	56.8	8.0	14.4	7.2	6.6	3.2	5.3	12.1	7.9	5.6	8.8	6.6	3.3	10.9	5.1	0.6	22.0	5.5	6.9	2.2	2.9	19.5	2.4	4.6	3.0	0.1	7.1	5.8	1.6	5.9	1.8	16.2	5.8	9.0	0.0	8.7	22.2	13.8	3.8	3.7	16.4	6.4	8.6	6.6	4.7	2.6	0.6	2.0	3.2	13.6	1.9	10.0	10.1	2.9	5.1	19.9	3.2	13.7	34.8	16.8	9.9	34.5	8.5	8.3	7.2	8.4	15.2	4.7	7.0	8.2	4.3	14.4	28.7	8.8	7.0	19.0	4.6	7.1	4.2	8.1	4.7	6.4	4.8	4.7	8.0	2.9	23.8	22.9	10.4	24.6	3.2	3.4	5.7	40.8	24.1	30.7	80.3	0.0	146.1	13.3	48.0	39.6	10.1	182.1	0.0	44.7	19.3	14.8	27.9	8.1	29.4	139.0	0.0	10.4	23.9	89.5	15.5	21.6	35.0	8.5	9.0	39.6	13.3	29.7	168.7	18.4	28.4	4.8	6.5	5.6	78.8	10.6	2.5	167.7	13.8	63.2	33.2
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870526-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 19.2;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 4.6;B-cells: 16.4;T-cells: 5.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 19.2;eosinophil: 16.2;memory B-cell: 14.9;naive B-cell: 15.1;NK-cell: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 15.1;granulocytes: 19.2;NK-cells: 8.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.0;HEL: 4.2;HMC-1: 19.4;U-698: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA					"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.3	0.2	0.2	18.5	0.2	1.8	0.2	0.2	0.2	0.2	0.4	0.0	0.0	0.1	0.2	0.1	1.8	0.2	0.3	0.3	0.2	0.2	0.4	0.3	0.6	27.7	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.4	0.3	0.3	3.1	0.0	1.8	0.2	5.5	0.0	0.2	29.7	0.4	0.4	0.0	3.0	0.6	0.6	31.1	1.5	0.3	15.1	0.8	19.2	0.1	8.7	2.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	13.0	0.0	0.1	0.0	19.2	0.1	16.2	1.7	0.0	2.0	14.9	0.1	1.5	0.2	15.1	0.1	0.9	0.6	8.7	0.1	0.8	0.1	0.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	3.0	4.6	16.4	0.7	0.6	0.7	0.3	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	3.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.8	0.0	0.3	0.3	0.2	0.3	0.2	5.7	0.0	0.6
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23959109-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	35.6	32.8	21.1	39.3	21.4	39.0	36.8	22.3	21.0	38.6	40.6	17.1	25.9	32.0	37.5	24.4	28.7	24.9	32.7	41.9	20.9	19.4	33.3	21.3	37.2	40.6	21.8	20.2	39.7	25.2	29.2	28.5	36.2	18.6	37.1	30.8	23.8	26.2	30.1	32.8	18.7	38.4	37.9	26.1	34.4	29.3	16.9	18.7	44.6	56.0	23.0	34.4	49.1	35.6	46.8	38.9	69.5	40.5	36.6	48.9	52.8	23.9	9.5	41.9	28.9	28.9	26.6	16.0	26.7	23.8	31.1	25.0	27.7	30.4	65.5	26.2	16.9	11.7	21.4	28.0	23.2	34.6	46.5	18.1	62.2	29.2	29.1	24.7	60.2	28.5	20.0	29.4	25.4	23.8	20.4	29.9	34.0	52.6	36.9	18.2	19.6	37.2	23.0	56.6	22.8	17.8	42.3	27.2	27.8	31.2	25.8	25.1	21.9	23.1	19.9	27.1	32.0	21.6	38.0	23.9	20.1	19.5	19.7	16.9	31.2	35.8	44.7	13.7	58.4	20.6	69.5	40.0	44.0	39.6	40.5	41.3	46.8	43.3	42.6	38.9	46.7	48.9	41.2	26.7	36.6	37.1	27.9	44.6	52.8	21.1	21.4	22.3	21.0	20.9	19.4	21.8	20.2	18.6	18.7	172.7	84.5	75.1	213.3	11.7	31.2	75.8	33.1	101.7	112.6	59.3	17.7	106.7	202.2	72.5	5.4	75.4	113.0	116.8	112.0	88.3	60.2	176.8	73.0	27.6	59.3	19.1	96.3	74.3	66.3	11.0	73.1	84.5	1.7	63.1	76.5	50.4	90.7	85.4	76.4	88.9	24.5	45.3	47.6	22.4	23.0	11.0	118.5	109.3	95.0	217.3
SRSF10	"FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2"	ENSG00000188529	"Serine and arginine rich splicing factor 10"	O75494	1	23964804-23980927	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053805, HPA053831"	Uncertain		Supported	Nucleoplasm		NA	Yes		28000	Nucleoplasm		"HPA053805: AB_2682269, HPA053831: AB_2682275"	"unprognostic (2.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.74e-4)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.40e-2)"	34.1	41.8	23.7	34.3	27.1	69.0	34.5	35.5	28.7	35.0	29.2	24.6	35.0	26.8	44.1	34.4	30.6	36.2	24.8	27.1	25.3	21.7	33.0	41.0	32.0	41.6	24.0	22.3	42.8	33.6	29.5	47.9	33.7	24.9	32.5	34.3	23.1	31.1	32.9	30.0	27.1	32.5	30.7	29.8	40.0	31.2	32.4	29.2	73.8	42.9	22.0	41.2	31.4	33.1	51.9	44.1	53.3	50.1	47.7	47.1	41.6	32.1	25.8	44.4	28.1	25.1	21.2	27.8	37.6	16.2	34.9	30.9	26.2	32.2	70.1	24.4	18.0	22.1	28.1	50.5	26.5	44.8	38.2	36.1	42.2	44.6	34.1	19.1	46.2	30.5	13.3	20.5	22.7	22.5	19.7	27.3	25.8	53.9	26.8	29.3	22.8	50.4	33.7	56.7	38.2	25.6	46.3	32.5	35.2	29.2	26.0	32.4	25.3	28.6	25.4	27.6	29.6	27.3	37.3	26.1	29.0	28.3	26.5	36.2	27.1	37.0	56.6	25.0	51.8	31.9	53.3	43.0	44.3	36.4	50.1	45.8	51.9	41.9	42.3	36.4	42.9	47.1	41.6	27.4	47.7	48.9	44.1	46.9	41.6	23.7	27.1	35.5	28.7	25.3	21.7	24.0	22.3	24.9	29.2	104.2	84.9	121.8	101.4	37.8	151.3	50.9	63.7	155.2	142.1	75.0	151.2	94.2	66.3	76.4	85.5	99.4	62.3	23.3	77.4	141.6	73.7	80.8	89.2	54.2	71.8	93.8	117.0	76.1	48.7	91.5	118.2	72.5	25.3	92.0	73.8	132.6	67.9	81.6	104.0	60.5	285.3	103.5	89.5	166.6	159.0	39.6	53.0	96.9	93.0	74.0
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 168.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"A549: 5.2;Hep G2: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		Yes	No		680000	Vesicles	"Golgi apparatus, Cytokinetic bridge"	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	6.3	2.7	0.2	0.0	59.5	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.7	0.0	104.6	0.4	1.5	0.0	0.0	0.0	0.0	1.9	0.1	0.0	2.7	39.7	2.8	0.2	0.1	0.8	0.4	2.3	0.4	0.2	0.4	0.0	0.1	5.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	2.2	0.6	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	19.8	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.1	1.1	0.2	0.6	0.7	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.4	0.1	0.3	0.4	0.1	0.4	0.2	0.2	0.0	0.8	0.3	0.4	2.3	0.2	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	168.2	0.0	0.0	0.0	3.5	0.0	0.0	1.7	0.1	15.5	0.1	4.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.6	0.6	0.0	0.0	0.0	0.0	0.0	1.4	2.9	0.0	25.9	2.8	6.5	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3
IL22RA1	"CRF2-9, IL22R"	ENSG00000142677	"Interleukin 22 receptor subunit alpha 1"	Q8N6P7	1	24119771-24143121	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 123.4"	"Cell type enhanced"	"Detected in some"	20	"Enterocytes: 31.9;Exocrine glandular cells: 10.6;Mucus-secreting cells: 7.9;Pancreatic endocrine cells: 7.7;Paneth cells: 7.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.9;Hep G2: 7.8;OE19: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.68e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.78e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.64e-2)"	0.2	0.1	0.2	1.1	0.3	0.0	0.8	0.6	0.3	1.2	10.9	0.2	0.5	7.8	0.4	0.6	5.2	0.4	3.2	0.2	0.2	0.0	2.8	2.0	0.4	0.1	0.2	0.1	0.4	123.4	0.0	1.0	0.4	0.4	0.4	3.9	0.2	0.9	0.3	0.2	12.9	22.3	0.1	0.2	0.2	1.2	0.3	0.3	0.1	0.7	4.6	3.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.8	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	1.3	1.5	10.9	4.7	0.0	0.9	0.3	4.8	5.0	0.6	2.9	0.5	3.6	0.0	0.0	1.4	7.8	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	0.1	18.1	1.0	0.0	0.0	0.1	0.0	0.6	0.1	0.1	1.4	0.0	1.5	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	4.2	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.6	0.3	0.2	0.0	0.2	0.1	0.4	0.3	0.0	0.0	0.0	0.6	0.8	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	31.9	0.0	10.6	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.0	7.7	7.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.7	0.1
IFNLR1	"CRF2/12, IFNLR, IL-28R1, IL28RA"	ENSG00000185436	"Interferon lambda receptor 1"	Q8IU57	1	24154157-24187959	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 13.9;Urothelial cells: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 11.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 30.2;U-266/84: 10.5;U-698: 22.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017319	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA017319: AB_1851708"	"prognostic favorable (5.12e-4)"	"unprognostic (7.16e-2)"	"unprognostic (8.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.66e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-1)"	3.0	3.0	1.1	9.5	1.9	0.4	2.9	10.2	2.1	2.1	9.9	3.8	3.6	6.5	0.8	6.7	4.7	2.0	2.9	6.4	0.9	2.1	4.3	10.1	9.2	8.2	2.0	1.9	1.5	7.8	5.7	8.2	2.5	2.9	4.1	4.6	1.6	9.3	5.7	3.5	8.3	19.2	0.2	5.3	4.4	3.1	1.2	1.1	1.2	5.3	3.1	10.7	2.0	2.7	6.8	11.9	0.0	0.0	0.0	2.0	0.5	3.7	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.7	0.5	6.3	1.1	8.1	8.8	0.0	3.1	2.8	3.8	6.6	0.5	1.6	2.0	0.0	1.3	1.9	0.0	0.0	0.0	0.0	2.2	0.2	2.0	1.4	0.0	1.6	0.1	0.0	0.0	0.8	0.1	0.2	8.1	0.3	2.4	0.0	0.0	0.6	1.5	1.6	1.2	0.7	2.0	1.1	0.8	1.4	1.5	0.0	0.0	0.0	1.6	0.0	0.0	30.2	10.5	22.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	5.1	0.3	1.5	0.0	6.8	0.6	1.6	0.0	0.0	0.0	11.9	0.3	0.5	1.1	1.9	10.2	2.1	0.9	2.1	2.0	1.9	2.9	1.1	0.0	4.5	2.2	6.8	9.8	2.1	2.9	2.5	5.3	1.2	1.8	0.0	0.3	3.3	2.2	2.0	0.2	13.9	0.0	2.1	1.0	0.4	4.3	0.0	7.8	2.4	0.0	0.0	0.0	0.3	3.4	0.3	2.7	0.0	9.0	3.0	3.3	1.7	4.8	0.0	1.8	2.6	0.0	0.5	0.0	0.6	11.0	0.2	1.3	2.9	12.7
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319322-24364482	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 86.8;Urothelial cells: 72.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 28.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 3.6"	"Group enriched"	"Detected in some"	12	"eosinophil: 1.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;HaCaT: 16.8;MCF7: 25.9;OE19: 9.4;RT4: 29.6;SuSa: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.1	0.1	0.1	0.1	0.9	0.0	1.0	0.2	0.9	9.0	0.1	0.2	0.0	0.2	0.6	0.8	59.0	0.2	0.6	0.1	1.1	0.3	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.1	1.1	3.6	3.6	0.1	0.0	5.9	0.9	0.2	21.7	0.1	0.5	3.0	0.0	0.2	1.1	0.1	0.5	0.1	51.5	60.1	12.3	11.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	1.2	0.4	0.0	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	16.8	0.0	1.5	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	25.9	0.0	0.1	1.1	9.4	0.0	0.0	0.0	0.1	2.1	29.6	0.1	0.0	0.0	2.9	0.0	16.3	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.2	0.1	1.1	0.3	0.1	0.0	3.6	0.1	0.0	1.1	0.0	8.8	12.8	0.0	0.4	0.0	2.7	2.3	1.8	0.0	3.5	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.3	9.1	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	86.8	15.4	0.0	0.0	72.5
STPG1	"C1orf201, FLJ33340, MAPO2"	ENSG00000001460	"Sperm tail PG-rich repeat containing 1"	Q5TH74	1	24356999-24416934	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 225.3;Late spermatids: 476.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA024301			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024301: AB_1845634"	"unprognostic (2.63e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (6.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.42e-1)"	5.5	4.3	6.0	2.6	12.8	1.5	4.2	13.6	23.3	4.7	7.9	12.0	2.4	4.4	4.8	7.1	4.9	20.8	4.2	4.0	6.7	8.7	5.9	1.9	6.2	2.5	6.5	8.0	5.6	4.8	13.0	9.2	1.6	14.2	5.8	6.9	9.9	3.5	4.6	1.5	4.3	5.5	6.4	6.1	2.1	5.1	29.2	7.9	2.5	5.9	1.2	3.4	4.5	3.9	5.2	2.7	1.1	1.4	0.0	4.3	1.9	5.9	3.5	0.5	6.5	4.8	6.9	3.5	8.7	8.4	8.4	8.8	1.5	8.9	0.7	6.0	9.1	7.0	2.4	5.6	6.1	9.7	7.0	5.6	1.0	1.9	1.6	9.8	2.9	1.5	4.1	12.5	12.1	16.0	8.9	6.6	0.0	2.1	0.0	6.3	2.1	0.0	2.4	5.3	6.3	6.0	1.6	0.0	0.2	11.2	2.0	5.4	3.7	4.7	1.8	13.5	5.7	4.8	5.2	4.5	3.0	3.5	1.2	2.5	3.8	3.6	2.1	3.4	0.3	4.8	0.0	0.1	1.1	1.5	1.4	0.2	5.2	1.2	4.3	0.6	3.4	1.4	1.7	0.1	0.0	0.2	2.7	2.5	1.9	6.0	12.8	13.6	23.3	6.7	8.7	6.5	8.0	14.2	7.9	8.9	8.1	2.2	11.4	4.0	12.4	4.8	0.0	65.6	17.0	10.4	13.7	3.8	13.3	6.5	225.3	4.2	16.3	23.3	6.2	7.0	3.8	6.7	11.5	1.3	3.3	9.5	4.6	5.5	1.0	476.4	6.1	4.6	15.1	4.6	5.2	7.4	7.7	10.5	4.2	7.1	16.7	6.5	5.1	14.2	9.4	4.8	3.8	3.9	5.0	51.2
NIPAL3	"DJ462O23.2, NPAL3"	ENSG00000001461	"NIPA like domain containing 3"	Q6P499	1	24415794-24472976	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039978	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039978: AB_10697712"	"unprognostic (9.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (3.03e-7)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.85e-1)"	5.3	5.1	21.4	5.2	21.8	4.9	8.3	41.2	29.4	6.9	8.9	42.4	5.6	7.1	4.2	7.4	10.3	10.4	6.3	9.2	25.5	21.3	9.4	2.3	9.2	7.1	32.9	14.7	5.5	11.3	14.0	6.5	2.8	31.5	38.4	9.3	7.1	9.9	5.7	3.5	7.7	8.5	8.1	34.8	4.8	9.6	3.1	22.5	5.8	20.7	2.3	7.9	7.8	5.4	12.9	8.4	8.9	3.6	9.2	26.0	9.7	12.8	5.2	0.5	1.7	7.9	8.8	1.9	41.7	29.9	15.3	11.3	1.8	14.7	6.0	13.4	23.0	3.1	12.6	5.1	15.5	15.0	12.2	15.9	6.6	8.7	2.1	7.3	5.8	6.0	8.8	14.4	10.1	30.9	13.9	5.2	11.8	3.8	3.8	9.2	2.8	4.7	2.4	3.2	6.2	14.7	2.2	0.0	6.8	16.2	4.1	19.4	1.8	5.6	7.9	11.2	3.6	10.8	4.4	7.5	13.7	2.9	4.5	9.1	11.9	9.7	2.1	9.2	10.6	12.2	8.9	3.6	4.7	10.8	3.4	10.7	12.9	18.2	14.0	6.5	10.9	26.0	16.1	1.6	9.2	2.3	8.4	17.6	9.7	21.4	21.8	41.2	24.6	25.5	21.3	32.9	14.7	31.5	22.5	44.7	28.0	14.5	11.0	8.1	52.0	21.5	17.8	9.4	19.4	38.4	104.1	3.0	3.3	11.5	2.8	8.5	24.1	46.7	13.4	4.0	8.5	26.1	12.7	3.2	4.2	12.7	18.0	7.4	3.8	5.6	3.7	7.1	13.5	6.4	14.9	15.3	17.2	14.4	4.9	3.6	53.0	0.0	6.2	2.4	5.5	14.3	3.5	20.8	16.3	16.1
RCAN3	DSCR1L2	ENSG00000117602	"RCAN family member 3"	Q9UKA8	1	24502351-24541040	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.0"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 73.6;Intestinal endocrine cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 37.0"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 19.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034533, HPA064289"	Enhanced		Approved	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA034533: AB_10601481, HPA064289: AB_2685232"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.41e-3)"	"unprognostic (3.66e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.52e-3)"	"unprognostic (9.83e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.71e-2)"	3.2	1.5	2.7	15.8	4.0	4.7	7.6	37.0	3.7	3.9	5.0	7.6	3.2	5.2	3.2	7.7	12.6	11.2	6.5	3.1	3.3	7.8	5.3	2.1	8.1	27.2	5.5	1.9	2.0	15.0	5.5	15.0	7.0	7.6	27.7	5.2	6.1	17.4	4.8	1.6	10.0	6.7	2.6	7.9	7.9	13.2	2.6	2.9	17.2	11.7	8.6	23.2	6.0	6.3	2.8	1.5	1.4	0.9	1.9	19.2	4.2	10.5	8.3	0.1	2.6	2.3	5.3	9.6	7.2	3.9	5.7	5.4	2.4	14.1	7.9	6.6	12.1	4.2	10.0	7.5	9.1	6.2	7.6	4.5	0.8	2.2	7.2	1.4	2.6	7.0	1.9	6.8	1.9	3.0	5.0	1.2	9.9	1.1	0.3	2.6	3.5	6.9	4.0	11.1	8.2	6.1	2.8	0.1	0.2	4.3	9.1	22.6	5.6	5.7	7.5	22.2	5.2	7.7	5.4	8.2	6.8	8.2	0.4	4.9	10.7	12.8	10.1	2.8	10.8	7.9	1.4	0.9	1.1	0.7	0.5	5.6	2.6	14.0	5.0	1.5	2.8	19.2	9.9	0.3	1.9	0.2	1.1	19.2	4.2	2.7	4.0	37.0	3.7	3.3	7.8	5.5	1.9	7.6	2.9	17.9	14.1	12.6	24.9	12.6	37.2	5.9	15.3	73.6	18.2	19.2	60.9	2.9	11.6	18.2	0.9	7.5	6.5	0.0	24.5	9.2	6.2	52.5	16.1	1.1	8.7	23.8	78.8	7.4	7.9	0.0	1.7	18.6	28.7	34.3	13.5	9.4	32.0	11.2	1.1	0.7	32.8	0.0	8.1	0.5	12.8	19.1	4.5	35.7	11.0	21.8
NCMAP	"C1orf130, FLJ42528, MP11"	ENSG00000184454	"Non-compact myelin associated protein"	Q5T1S8	1	24556111-24609328	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 28.8;placenta: 21.2"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 2: 15.3;Ductal cells: 15.9;Exocrine glandular cells: 41.1;Pancreatic endocrine cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.1;RPTEC TERT1: 3.4;T-47d: 8.1;U-266/70: 6.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013656	Uncertain					NA	NA					"HPA013656: AB_2275006"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.83e-6)"	"unprognostic (3.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.27e-3)"	0.6	0.2	0.6	0.5	0.7	0.6	4.6	0.2	0.7	1.3	7.0	1.3	0.0	6.3	0.5	1.8	0.5	1.1	15.0	0.5	0.8	0.6	2.2	5.8	4.7	0.2	1.0	0.1	0.2	28.8	0.0	9.1	21.2	0.8	2.1	0.2	1.3	13.4	0.0	0.6	0.6	7.5	0.2	2.2	0.3	5.7	0.2	1.1	0.2	5.3	0.7	1.4	0.9	0.3	1.4	1.0	2.7	0.9	0.7	0.8	0.1	0.2	4.1	0.1	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	1.8	0.4	1.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	0.1	0.4	0.3	1.9	0.0	0.2	0.4	0.0	0.2	0.1	0.0	0.3	0.0	0.3	0.2	0.5	0.0	0.4	0.2	0.4	0.2	1.5	0.0	0.4	0.1	1.1	3.4	1.1	0.4	0.3	0.2	0.3	0.0	1.1	8.1	0.2	0.5	0.2	0.3	0.5	0.2	6.4	0.8	0.1	0.1	0.2	0.3	2.7	0.9	0.6	0.5	0.3	0.4	0.8	0.5	0.4	0.2	1.4	0.7	0.8	2.0	0.7	0.4	1.0	0.3	0.1	0.6	0.7	0.2	0.7	0.8	0.6	1.0	0.1	0.8	1.1	3.0	15.3	0.0	1.7	0.0	0.0	1.1	0.0	1.4	2.3	3.5	3.9	1.0	0.0	15.9	0.0	0.0	0.7	0.0	41.1	0.2	0.4	2.8	1.1	1.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	1.8	0.6	3.2	14.2	1.4	0.0	0.7	0.4	0.0	0.3	0.0	0.2	0.1	7.8	0.0	0.8	1.7
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673267	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		12000	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	25.0	22.4	16.6	21.8	29.5	44.5	26.9	38.0	30.0	37.1	27.9	39.7	26.3	20.7	35.6	65.6	21.7	31.7	18.6	23.9	19.5	16.6	24.1	27.7	22.8	27.3	27.2	21.1	49.8	20.3	26.7	35.5	35.2	32.6	33.3	20.8	31.8	24.2	25.5	34.4	30.5	28.6	24.2	32.4	29.8	21.5	23.4	29.8	43.4	24.2	20.3	36.4	28.5	29.8	20.3	19.1	23.9	23.7	27.9	26.2	14.8	17.2	13.9	27.6	24.7	15.6	16.1	27.1	20.2	13.4	20.3	23.3	15.3	29.0	38.6	12.8	17.1	13.5	21.7	27.5	19.8	26.7	13.2	19.1	29.6	27.0	18.1	10.9	34.1	19.7	10.9	12.5	16.4	24.2	23.2	17.5	19.0	28.7	21.2	20.8	14.9	30.9	22.9	45.4	14.1	9.5	27.6	22.1	18.8	17.7	18.0	16.8	15.2	21.8	17.7	15.0	21.7	15.9	16.7	19.4	17.8	18.5	24.1	20.2	19.0	14.5	47.7	19.2	40.1	19.7	23.9	17.8	19.2	21.8	21.7	26.2	20.3	20.7	21.2	19.1	19.7	19.2	21.8	23.6	27.9	23.7	16.6	15.4	14.8	16.6	29.5	38.0	30.0	19.5	16.6	27.2	21.1	32.6	29.8	145.9	144.9	171.3	231.9	268.6	176.0	131.8	137.6	180.7	174.0	115.1	111.9	129.0	169.1	144.9	235.5	146.8	116.3	163.5	128.5	137.4	157.1	230.0	229.3	203.4	133.1	117.6	113.6	127.1	162.6	96.6	155.3	180.0	146.8	260.5	126.0	204.1	128.5	135.3	141.8	117.6	174.7	135.8	173.5	224.9	222.2	258.2	201.7	198.3	147.2	308.0
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745357-24844324	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 13.0;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	Cytosol		NA	NA		20000000	Cytosol		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	45.3	16.9	20.6	26.3	26.7	7.6	35.4	4.5	20.0	52.1	46.4	41.6	23.2	8.9	68.0	27.4	42.0	34.7	29.7	77.4	23.5	16.5	71.2	19.9	40.8	12.9	28.2	13.0	37.6	13.5	10.8	6.1	53.7	22.3	51.9	19.1	29.1	18.2	45.2	20.9	12.6	19.3	87.2	33.6	15.1	33.4	20.9	26.4	7.1	17.7	11.2	15.0	106.7	42.3	13.0	5.3	2.2	5.1	0.0	0.3	3.3	26.4	3.0	26.7	21.2	36.4	79.4	15.4	71.8	67.3	30.4	36.9	5.9	13.9	17.3	41.8	92.7	9.1	9.6	18.2	17.7	76.7	4.3	8.6	6.6	8.2	10.1	51.0	2.2	0.8	36.6	30.7	43.4	44.0	50.2	50.3	9.4	5.1	16.8	87.1	4.4	4.1	3.3	26.1	5.7	13.7	10.4	31.5	6.3	31.1	6.8	5.0	12.8	18.9	8.1	52.4	28.5	7.2	13.4	78.4	56.0	21.4	24.7	27.4	10.2	14.0	14.1	41.2	18.6	16.9	0.7	5.1	2.2	0.3	4.1	0.0	13.0	0.3	0.2	5.3	11.9	0.2	0.2	1.1	0.0	3.3	1.6	0.0	3.3	20.6	26.7	4.5	15.8	23.5	16.5	28.2	13.0	22.3	26.4	14.9	26.2	47.7	48.0	54.7	3.4	162.6	25.5	2.7	13.6	14.0	9.8	55.0	34.9	32.8	34.8	119.6	4.5	0.0	36.5	153.1	125.4	76.4	39.3	31.1	35.9	1.6	9.2	88.4	26.6	20.0	26.4	47.9	123.2	68.5	15.5	9.3	48.8	8.0	82.4	262.2	21.6	45.3	178.4	35.6	29.6	45.5	148.1	6.9	2.9	26.7
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"Runt related transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.5;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"	17	"B-cells: 38.9;granulocytes: 46.0;Macrophages: 35.5;Melanocytes: 43.9;monocytes: 68.5;T-cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.5;Karpas-707: 53.2;SK-MEL-30: 29.5;U-266/70: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.0	1.1	0.9	25.4	1.1	31.5	3.4	0.5	1.0	11.9	8.0	1.2	0.3	2.5	1.7	1.4	3.5	1.7	6.2	1.3	0.9	1.1	2.2	2.3	11.7	28.8	2.8	0.7	1.3	1.0	0.0	1.0	1.3	1.8	2.3	2.3	2.8	6.5	2.2	2.2	9.5	13.7	1.3	1.8	30.6	2.7	2.1	0.8	14.2	1.8	3.1	47.6	8.9	2.2	4.5	1.0	4.3	4.6	18.1	15.1	3.1	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	6.3	6.2	5.4	0.0	0.1	3.7	0.0	0.2	39.5	0.6	0.1	0.6	0.0	0.0	1.4	13.7	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	53.2	0.0	0.0	0.4	12.2	0.2	0.0	1.0	0.0	0.0	7.4	0.0	0.1	1.2	0.0	2.4	0.0	29.5	1.0	0.0	8.5	0.0	0.0	0.6	0.0	0.1	18.4	12.8	6.0	0.0	13.8	1.5	0.4	0.7	4.3	15.1	3.0	8.1	4.5	5.7	13.2	0.9	3.8	2.8	10.3	0.9	18.1	4.6	1.0	5.7	3.1	0.9	1.1	0.5	1.0	0.9	1.1	2.8	0.7	1.8	0.8	0.0	5.1	38.9	0.7	6.8	0.0	2.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.2	0.1	1.2	0.7	46.0	0.8	4.9	0.0	0.0	1.8	17.0	0.8	0.0	35.5	43.9	68.5	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	4.7	0.2	2.7	5.1	0.2	144.9	0.0	0.4
SYF2	"CBPIN, DKFZp564O2082, fSAP29, NTC31, p29"	ENSG00000117614	"SYF2 pre-mRNA splicing factor"	O95926	1	25222679-25232502	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018265, HPA070710"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018265: AB_10962002, HPA070710: AB_2686301"	"unprognostic (4.19e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.98e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (5.72e-4)"	37.5	30.4	31.6	30.8	35.4	67.3	34.4	34.7	30.1	38.2	36.0	15.1	29.3	28.7	34.1	37.8	36.3	28.5	24.5	28.6	30.1	22.0	35.5	24.7	27.7	30.1	30.7	25.3	57.8	32.2	29.5	29.8	37.7	32.9	36.6	31.1	16.3	28.2	31.1	69.8	29.9	40.7	46.8	41.0	34.3	31.3	20.7	32.4	37.2	39.3	28.2	37.1	54.5	50.6	31.5	16.9	85.5	26.5	25.8	29.5	20.1	19.0	8.3	19.9	15.9	32.1	39.2	15.4	21.0	31.8	18.6	17.8	5.5	25.6	18.0	27.8	23.1	14.3	17.1	17.0	15.6	26.5	28.7	17.6	21.6	19.8	13.7	31.7	27.4	19.7	29.3	41.2	20.2	26.7	35.4	26.7	21.4	16.3	25.7	25.7	7.8	27.0	35.4	27.0	26.2	13.3	17.7	17.9	27.7	30.2	9.6	17.1	24.9	19.4	15.8	51.4	17.3	13.9	31.6	24.8	16.4	14.6	31.2	16.3	31.1	29.5	17.3	24.5	28.6	15.8	39.4	21.0	51.4	20.9	22.5	24.3	31.5	26.4	25.5	16.9	28.1	28.7	26.3	85.5	25.8	26.5	16.7	29.5	20.1	31.6	35.4	34.7	30.1	30.1	22.0	30.7	25.3	32.9	32.4	119.1	93.4	144.4	112.2	141.5	75.4	95.6	137.6	139.2	99.0	179.7	78.5	161.9	208.9	133.8	64.9	131.3	194.8	23.3	151.2	112.7	120.4	85.3	224.3	104.6	113.4	55.6	106.9	113.0	226.4	24.6	198.8	166.9	102.9	170.5	145.2	79.4	136.7	221.0	154.9	145.7	79.7	161.7	149.7	96.8	113.4	149.7	234.7	205.6	156.6	123.6
RSRP1	"C1orf63, DJ465N24.2.1"	ENSG00000117616	"Arginine and serine rich protein 1"	Q9BUV0	1	25242237-25338213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 353.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058992, HPA067651"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058992: AB_2683873, HPA067651: AB_2685879"	"unprognostic (1.03e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.81e-2)"	"unprognostic (5.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.73e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.87e-2)"	"prognostic favorable (2.91e-5)"	11.3	55.9	13.2	23.7	20.6	21.3	9.4	18.3	16.7	48.3	13.4	17.8	44.2	10.4	19.2	26.0	15.6	14.7	30.3	16.5	16.8	13.6	19.4	17.5	16.3	11.0	31.0	15.6	20.2	22.8	6.7	25.0	17.0	18.6	21.4	6.4	12.7	36.7	36.6	9.9	16.9	12.6	12.0	25.9	15.0	17.3	14.0	21.5	23.1	17.5	10.5	20.9	12.2	21.1	7.7	18.6	39.2	18.0	10.0	10.5	7.7	3.4	9.7	1.5	1.3	8.4	2.2	3.3	3.4	1.3	4.8	5.1	7.5	4.0	2.8	12.3	0.9	1.5	5.6	7.5	0.8	1.3	6.9	5.1	11.2	10.8	9.0	2.4	4.9	5.7	0.8	4.6	1.9	0.2	2.8	2.9	3.7	8.7	27.6	1.3	4.1	1.3	9.4	5.4	7.0	5.6	4.1	3.8	4.1	3.3	0.2	4.7	1.3	2.5	1.7	2.0	0.8	2.0	5.0	4.0	3.0	2.4	2.8	2.1	15.1	13.5	3.1	2.3	12.4	2.2	36.5	18.0	25.5	7.9	11.4	8.2	7.4	8.2	6.4	18.6	7.7	7.9	5.2	39.2	10.0	14.9	11.8	10.5	7.7	13.2	20.6	18.3	16.7	16.8	13.6	31.0	15.6	18.6	21.5	56.6	75.6	125.0	203.5	0.0	95.1	40.3	40.8	108.4	69.4	89.0	133.5	64.6	18.3	33.2	24.1	69.8	353.7	23.3	18.8	45.9	62.1	147.7	216.6	15.7	55.8	79.4	125.4	61.4	67.3	10.1	129.8	97.5	0.0	83.0	125.1	79.6	32.5	277.0	84.8	7.9	146.7	122.9	31.5	64.2	96.5	0.0	101.4	148.1	107.4	174.4
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.0;bone marrow: 16.5;salivary gland: 7.1"	"Cell type enriched"	"Detected in some"	20	"Erythroid cells: 23.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.0"	"Group enriched"	"Detected in some"	6	"HEL: 28.2;K-562: 8.7"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0.0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2.0	0.6	10.0	1.4	1.4	1.4	1.2	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	28.2	0.7	0.2	0.0	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	8.7	0.7	0.0	0.1	0.2	0.2	3.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.1	0.1	0.2	0.5	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.5	0.2	0.1	4.9	1.4	2.8	1.0	0.6	1.1	1.3	1.3	0.8	0.2	2.0	1.4	1.3	10.0	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	23.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25337917-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA065192: AB_2685429"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favorable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	36.2	45.6	29.2	23.2	39.1	19.4	43.4	30.5	29.4	29.7	32.7	21.5	25.6	26.5	29.4	31.5	36.7	23.5	30.9	32.6	30.9	23.6	39.1	31.8	34.2	36.3	29.3	18.5	22.6	29.7	21.7	13.6	40.4	19.9	32.8	38.6	19.1	56.5	33.0	21.5	25.7	39.6	27.8	38.1	39.4	26.5	17.5	20.4	32.7	39.2	29.6	28.1	37.1	31.0	13.0	14.0	56.5	26.8	19.2	25.0	23.1	8.5	9.8	16.5	8.5	31.0	27.9	5.8	17.4	27.9	33.1	37.1	7.9	21.5	9.9	9.8	61.9	12.4	12.5	12.9	14.2	36.2	26.1	18.5	21.2	10.8	12.0	22.9	16.1	17.2	30.4	20.9	24.5	14.2	15.7	23.8	11.2	14.1	15.6	31.2	6.0	10.5	19.7	19.3	14.1	8.1	9.3	18.1	17.5	33.3	6.3	13.8	8.8	18.0	12.7	13.9	15.6	6.5	10.6	35.2	18.5	7.7	30.2	7.2	10.9	11.8	9.1	24.1	24.2	10.2	56.5	19.1	26.3	24.0	23.0	25.0	13.0	21.1	24.4	14.0	10.1	15.5	21.1	39.7	19.2	26.8	13.0	23.4	23.1	29.2	39.1	30.5	29.4	30.9	23.6	29.3	18.5	19.9	20.4	134.0	76.3	88.7	152.8	225.1	40.2	88.4	119.8	104.4	70.5	160.5	25.5	94.3	43.1	257.7	13.8	175.4	107.8	46.7	188.7	283.9	172.6	238.9	122.5	56.8	203.7	23.8	79.6	140.6	162.8	8.4	140.7	195.1	189.0	268.7	149.5	99.5	250.4	140.3	93.0	82.3	29.5	207.0	211.1	93.4	46.0	277.7	151.8	110.7	95.4	208.9
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"bone marrow: 40.5"	"Cell type enriched"	"Detected in some"	33	"Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"HEL: 44.7"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.6	0.8	2.0	0.6	5.1	40.5	0.9	3.3	4.7	0.8	0.7	3.5	1.0	0.7	0.7	5.2	1.4	1.6	0.8	2.1	2.6	1.5	0.8	2.2	0.7	1.0	2.1	2.5	0.9	9.6	0.5	4.0	1.6	5.9	1.6	0.8	2.2	8.4	0.8	1.9	1.1	0.6	0.5	2.9	2.1	0.8	2.6	1.4	1.2	1.1	1.2	0.8	0.5	0.6	0.1	0.2	2.4	0.2	0.1	0.3	0.9	0.1	0.0	0.1	0.2	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.7	0.3	0.5	0.5	0.0	0.1	0.0	0.1	0.1	0.2	0.0	44.7	0.0	0.0	0.6	0.0	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.3	8.7	0.2	0.2	0.4	0.0	0.3	0.9	0.3	0.2	0.1	0.1	1.2	0.0	0.0	0.3	0.4	0.1	0.1	0.5	0.4	0.2	0.0	0.0	0.1	0.0	0.4	0.0	2.6	0.6	0.5	1.5	0.4	0.2	2.4	0.2	0.6	0.3	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.2	0.0	1.0	0.1	0.0	0.1	0.3	0.9	2.0	5.1	3.3	4.7	2.6	1.5	2.1	2.5	5.9	1.4	0.0	0.0	0.0	0.5	0.5	3.3	0.4	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.8	0.0	0.0	210.2	0.2	0.4	0.2	0.4	4.6	0.4	0.2	6.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.4	0.0	0.7	0.0	2.5	6.5	0.0	2.8	5.1	1.3	0.7	0.0	0.1	0.7
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 25.4;Ductal cells: 30.7;Exocrine glandular cells: 53.7;Pancreatic endocrine cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol		NA	NA			Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	9.8	16.5	12.1	6.9	11.3	26.5	8.9	27.8	13.2	9.2	8.9	11.3	12.7	9.5	9.7	11.9	17.2	7.9	8.8	8.8	8.7	9.4	11.9	33.0	9.4	7.8	12.9	11.5	17.2	28.1	11.4	12.8	8.1	11.3	12.9	9.2	10.4	20.7	13.5	31.2	10.7	9.7	8.5	10.1	9.6	11.5	15.6	13.8	17.9	13.2	12.5	11.1	10.5	10.2	2.6	4.0	6.8	2.5	1.5	3.0	0.7	10.2	3.4	10.5	18.9	12.7	9.7	5.6	11.0	11.5	9.9	10.9	3.1	13.7	20.7	12.8	12.1	6.3	10.6	8.9	10.4	10.4	10.7	8.7	25.7	5.8	8.5	9.0	9.1	18.9	9.6	12.8	14.5	9.7	8.9	11.2	12.7	16.9	7.5	9.7	6.2	22.0	11.8	12.4	9.4	5.6	13.5	11.1	16.3	10.9	5.2	17.8	19.3	8.3	21.1	13.2	9.3	7.7	11.2	13.1	11.8	7.6	14.7	7.1	13.4	8.7	12.0	12.9	12.6	9.2	6.8	1.1	6.2	2.1	0.9	3.0	1.6	2.4	2.7	1.4	2.6	2.5	3.0	0.5	1.5	2.5	4.0	1.4	0.7	12.1	11.3	27.8	13.2	8.7	9.4	12.9	11.5	11.3	13.8	17.9	20.5	0.0	0.0	0.0	0.0	0.0	0.0	25.4	20.5	7.0	0.0	11.1	5.0	30.7	0.0	0.0	0.0	0.0	53.7	16.7	0.0	0.0	9.3	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	12.6	0.0	0.0	38.1	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0
LDLRAP1	"ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705"	ENSG00000157978	"Low density lipoprotein receptor adaptor protein 1"	Q5SW96	1	25543580-25568886	"Disease related genes, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Atherosclerosis, Disease mutation, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 60.6"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 36.7"	"Group enriched"	"Detected in all"	7	"NK-cells: 11.3;T-cells: 36.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003705, HPA050358"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"CAB003705: AB_425923, HPA050358: AB_2681103"	"unprognostic (2.52e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.49e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.96e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.24e-1)"	5.9	10.9	5.4	11.0	16.7	4.7	8.1	60.6	10.4	6.4	11.7	31.8	9.7	7.2	5.9	6.2	10.5	6.2	6.3	6.0	9.3	5.7	8.3	14.0	10.2	21.3	23.4	6.9	6.7	26.1	8.5	11.1	15.8	16.4	11.4	10.8	9.9	22.6	7.6	7.4	13.6	8.8	6.8	34.3	31.1	8.7	3.2	15.8	2.8	11.0	8.0	13.8	6.2	8.3	3.5	2.9	1.0	2.1	11.3	36.7	15.0	13.4	5.3	7.6	8.0	4.8	5.6	6.2	8.6	8.4	13.2	9.2	2.1	11.2	3.0	6.3	11.7	9.2	14.3	5.2	8.7	6.7	3.6	8.0	4.8	6.3	4.1	7.7	5.4	7.2	6.0	12.5	10.6	4.0	3.2	11.3	3.1	6.6	29.7	4.3	7.8	0.1	9.3	9.6	10.9	5.7	0.8	8.6	24.2	4.9	2.8	3.8	2.1	11.9	19.1	13.6	6.5	8.7	9.4	6.7	5.8	8.5	10.9	5.9	28.5	33.2	8.6	19.6	4.6	7.0	0.0	2.1	0.0	7.7	1.7	9.1	3.5	18.2	14.3	2.9	1.8	36.7	29.4	1.0	11.3	1.7	0.4	14.9	15.0	5.4	16.7	60.6	10.4	9.3	5.7	23.4	6.9	16.4	15.8	0.0	14.1	13.7	18.3	7.3	3.3	3.2	7.6	2.7	13.6	7.0	17.7	29.3	3.3	9.2	0.2	9.2	14.7	0.0	15.7	6.3	8.4	16.3	2.3	18.3	9.4	66.7	6.4	13.5	5.7	0.0	9.5	4.6	16.9	0.0	21.5	3.8	11.3	24.6	8.1	4.4	13.2	25.8	7.2	1.2	7.5	5.0	19.8	13.1	17.8	17.1
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25617468-25786207	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 51.1;Ito cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1200000	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	4.6	4.5	4.2	3.0	3.8	0.0	2.2	9.9	8.8	8.6	3.6			1.2	6.6	2.5	2.4	3.9	7.3	3.4	5.2	3.2	10.3	12.1	3.2	4.0	4.2		7.1	0.7	4.4	7.8	8.3		7.2	1.2		1.8	7.5	0.9	2.7	1.9	8.0	6.0	7.0	3.1	1.0			10.7		3.2	4.3	4.0	1.0	0.6	1.1	1.6	0.8	8.3	1.1	0.0	0.1	12.7	2.7	9.5	7.4	3.7	0.1	2.4	0.6	0.2	0.2	0.0	0.1	0.1	0.9	1.7	0.1	1.2	0.1	0.2	4.0	0.5	0.2	0.2	0.0	1.1	2.1	5.3	47.0	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	2.3	3.3	0.0	0.1	0.2	7.8	0.2	0.1	0.2	7.5	0.2	0.3	2.0	0.6	2.4	1.0	1.5	0.0	0.0	0.7	8.6	0.3	14.0	0.0	0.0	1.9	4.5	0.6	0.4	1.6	0.7	0.6	1.0	0.8	0.4	3.6	1.6	0.6	1.0	8.3	4.8	1.1	0.8	1.3	0.4	0.8	1.1											3.0	2.7	1.9	2.9	6.0	19.1	6.4	5.1	2.7	7.9	21.0	51.1	8.3	8.3	0.5	0.3	11.1	0.0	0.0	3.4	1.0	9.9	2.6	2.3	37.6	19.1	20.6	2.9	82.9	16.5	0.9	25.0	3.6	1.7	0.0	0.0	20.6	2.2	0.0	20.8	12.8	4.5	6.5	3.1	0.2	2.0	4.5	35.7	5.3	0.0	1.3
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818224	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 19.2;Ductal cells: 16.8;Exocrine glandular cells: 36.9;Hofbauer cells: 25.2;Pancreatic endocrine cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058076	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA058076: AB_2683598"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favorable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	41.4	27.2	26.3	26.4	24.8	12.4	53.6	22.0	29.7	32.2	21.9	26.5	26.3	14.3	30.7	20.4	25.4	34.3	27.4	29.3	26.3	16.3	33.0	15.1	35.2	47.8	19.2	18.2	35.3	39.9	23.0	23.7	31.6	22.0	37.5	17.8	30.0	29.1	35.0	30.0	18.0	16.5	45.8	21.0	29.1	24.4	11.6	19.1	10.7	31.4	17.6	16.8	26.1	28.0	1.7	2.1	5.9	3.3	0.7	2.6	1.0	12.2	11.7	39.1	33.4	25.5	44.9	13.2	14.8	22.5	16.5	13.2	3.0	13.0	0.0	9.9	22.4	18.3	11.9	10.2	15.7	12.6	12.9	7.8	12.0	4.5	3.7	18.4	2.5	28.5	47.8	10.6	17.3	8.7	19.6	51.5	4.2	4.2	1.7	15.5	6.2	0.5	3.6	14.7	9.6	8.1	10.5	17.1	1.5	6.8	3.5	8.2	13.9	9.3	8.5	12.4	11.0	8.6	8.4	42.8	16.8	11.5	30.7	8.6	1.4	0.0	0.3	23.3	3.7	20.2	5.9	3.3	3.8	1.8	2.6	1.1	1.7	1.7	1.3	2.1	1.1	2.6	1.6	0.5	0.7	2.5	0.3	1.7	1.0	26.3	24.8	22.0	29.7	26.3	16.3	19.2	18.2	22.0	19.1	8.9	9.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.8	19.2	0.0	12.7	0.0	16.8	0.0	0.0	0.0	0.0	36.9	9.5	0.0	0.0	2.3	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	5.4	0.0	0.0	23.6	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0
MTFR1L	FAM54B	ENSG00000117640	"Mitochondrial fission regulator 1 like"	Q9H019	1	25818640-25832942	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 175.3;Late spermatids: 418.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027124, HPA027130"	Approved		Approved	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA027124: AB_10600211, HPA027130: AB_10611251"	"unprognostic (9.90e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-3)"	"unprognostic (5.33e-2)"	"prognostic favorable (5.89e-12)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.33e-1)"	13.2	43.5	17.8	8.1	23.9	6.2	14.0	19.4	26.5	13.8	20.2	17.1	21.6	18.2	16.7	23.3	19.2	17.1	13.4	58.7	16.8	17.6	27.7	25.1	10.7	9.0	17.7	20.7	26.8	14.5	38.7	16.4	15.6	19.2	19.9	14.8	24.2	16.3	28.8	76.9	11.4	15.3	28.0	13.0	13.4	16.4	46.4	15.0	5.8	16.5	23.1	9.9	21.1	16.6	10.1	21.1	41.1	20.3	10.3	10.6	18.1	7.6	10.6	21.5	21.8	27.9	26.4	9.1	17.9	25.6	18.4	20.3	3.5	16.1	2.6	16.0	31.7	16.2	7.0	17.6	15.3	18.1	17.3	15.8	22.0	17.8	13.9	26.8	18.0	22.1	27.1	14.5	19.6	14.7	27.3	15.1	10.8	13.3	11.8	26.2	8.1	10.2	12.8	11.8	10.1	15.6	10.2	19.4	7.7	18.9	7.0	22.0	20.1	13.4	13.0	26.7	15.1	10.9	16.7	15.6	15.2	12.1	35.5	11.2	12.4	7.4	9.2	26.6	24.5	16.9	20.4	19.4	41.1	10.4	18.8	6.2	10.1	9.9	9.3	21.1	10.0	10.6	9.7	5.2	10.3	20.3	8.5	10.3	18.1	17.8	23.9	19.4	26.5	16.8	17.6	17.7	20.7	19.2	15.0	14.9	23.2	21.5	23.3	11.9	0.0	129.8	15.3	8.1	15.9	21.0	0.0	46.0	87.9	28.6	175.3	16.8	19.0	0.0	29.3	32.3	25.4	13.0	34.7	29.4	29.9	0.0	15.0	16.5	13.4	418.5	31.7	18.9	42.2	59.5	13.1	0.0	23.1	14.8	36.7	58.4	0.0	25.8	29.7	84.9	35.7	11.3	49.7	10.2	18.8	11.5
AUNIP	"AIBp, C1orf135, MGC2603"	ENSG00000127423	"Aurora kinase A and ninein interacting protein"	Q9H7T9	1	25831913-25859458	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 35.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 45.3;Late spermatids: 96.4;Spermatocytes: 33.8;Spermatogonia: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028730	Uncertain		Supported	Centrosome		NA	NA			Centrosome		"HPA028730: AB_10670830"	"unprognostic (8.05e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.96e-3)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.70e-6)"	"unprognostic (5.00e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-6)"	"unprognostic (3.61e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.62e-1)"	0.4	1.6	2.5	3.4	1.4	7.2	0.6	2.1	4.0	0.5	1.1	0.2	0.1	1.3	0.5	0.8	2.1	0.5	0.4	0.8	2.8	0.9	0.6	0.8	0.6	1.6	0.9	1.4	0.5	0.5	0.2	0.7	7.0	2.6	0.6	1.3	0.0	0.6	1.7	0.9	0.8	1.1	0.5	0.5	1.2	0.8	35.3	0.0	5.3	0.5	3.2	2.3	0.9	0.9	1.4	2.0	4.4	3.5	1.5	2.3	1.1	11.7	3.4	5.4	6.8	0.3	0.4	5.3	6.8	3.1	13.6	11.1	2.8	9.1	11.7	5.2	2.3	4.7	9.6	14.5	6.6	10.9	6.5	11.7	25.6	5.5	4.3	0.1	12.4	11.2	0.3	3.3	8.3	5.8	1.0	3.0	9.0	15.7	5.8	3.7	6.4	9.0	10.6	9.5	7.7	4.3	7.4	10.5	7.2	4.2	3.9	7.9	3.7	9.4	10.7	7.4	6.2	3.9	6.4	1.3	4.0	6.2	8.3	6.0	2.2	4.6	8.7	2.7	20.9	6.4	4.4	2.5	1.7	0.6	3.5	0.4	0.9	1.0	0.8	2.0	1.4	0.9	1.3	2.2	1.5	2.1	1.6	2.3	1.1	2.5	1.4	2.1	4.0	2.8	0.9	0.9	1.4	2.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.1	0.0	0.0	0.0	0.0	2.0	8.3	0.0	0.5	45.3	0.0	0.0	0.0	0.4	10.2	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.8	96.4	2.0	1.0	0.0	1.8	0.0	0.2	0.5	0.0	0.7	0.0	0.2	0.0	0.0	33.8	40.1	0.4	6.2	0.0	0.3	0.2
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861210-25871253	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"Early spermatids: 346.5;Late spermatids: 1377.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.3;HaCaT: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046936: AB_2679869"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	1.2	9.5	1.8	0.7	2.3	1.0	1.4	1.8	1.8	2.8	1.6			6.7	4.1	10.2	6.1	6.8	2.1	0.6	1.7	2.6	11.9	1.9	1.6	0.6	2.0		13.2	1.8	3.9	2.1	6.9		2.4	0.4		1.5	8.9	0.2	10.7	5.7	2.9	1.4	3.5	2.3	16.2			1.4		1.0	6.3	4.6	3.2	5.5	10.8	11.7	2.4	1.4	0.8	11.7	2.3	2.4	7.8	2.9	6.2	8.4	7.7	6.9	7.8	7.0	3.9	30.3	0.1	5.5	7.6	2.5	24.9	1.3	13.1	4.7	4.6	1.3	10.0	3.3	4.7	4.9	0.1	1.3	6.3	17.5	5.5	4.1	6.9	2.9	1.1	1.0	0.8	5.7	2.7	0.0	0.7	3.7	1.2	4.0	0.8	0.2	1.4	15.8	9.1	1.2	4.7	12.6	16.5	5.7	3.5	4.7	1.8	3.2	1.3	4.0	4.1	2.1	0.1	0.1	0.5	5.9	0.3	2.6	3.1	5.7	10.8	1.1	10.2	1.1	3.2	0.6	0.8	5.5	1.2	1.0	1.4	2.6	2.4	11.7	0.6	0.2	0.8											0.0	1.9	1.9	4.7	16.1	1.9	1.6	17.8	10.7	6.8	73.3	0.0	36.5	18.3	4.9	346.5	4.5	1.3	0.0	12.5	10.0	7.5	1.0	6.9	4.9	9.2	3.2	4.6	10.4	7.3	1377.7	18.4	5.3	20.3	5.4	1.5	2.0	7.0	3.5	14.2	49.2	0.6	12.9	4.0	11.1	9.1	11.4	29.9	0.9	2.9	2.2
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 143.4;lymphoid tissue: 117.1"	"Cell type enhanced"	"Detected in all"	9	"Early spermatids: 782.4;Late spermatids: 1640.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 79.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 79.3;T-cells: 26.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010107, HPA068438"	Enhanced		Approved	Cytosol		NA	NA		210000	Cytosol		"CAB010107: AB_628297, HPA068438: "	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	7.3	13.2	91.7	17.5	47.4	40.7	10.9	54.1	124.8	6.2	16.7	47.0	2.5	12.7	24.7	7.8	13.0	7.3	9.4	9.5	67.9	88.4	13.2	6.4	11.0	42.8	86.5	58.0	33.6	3.5	4.6	12.1	21.7	43.4	5.2	20.7	7.7	5.3	6.3	3.8	9.5	15.9	18.8	143.4	10.9	9.7	58.2	27.1	117.1	6.1	7.2	43.1	13.0	8.1	8.6	79.3	4.0	1.5	10.1	26.2	9.3	68.4	15.4	153.8	61.4	9.2	8.9	15.6	53.4	42.4	76.4	73.9	10.6	70.4	84.3	30.0	38.9	29.9	20.9	42.6	30.9	114.9	25.5	21.1	52.2	27.3	36.8	3.7	65.7	37.4	5.4	4.5	30.8	35.1	28.6	57.4	109.3	70.5	84.1	98.9	17.8	216.1	96.6	94.3	41.6	20.7	127.9	119.9	50.0	36.9	6.1	104.3	90.5	48.5	24.3	42.6	51.3	34.9	83.8	27.6	51.3	60.9	44.4	44.5	49.6	78.7	104.6	25.3	128.5	55.2	2.0	0.7	4.0	10.4	1.5	6.3	6.4	9.3	13.1	4.2	8.6	15.3	13.7	0.3	10.1	0.7	79.3	26.2	9.3	91.7	47.4	54.1	124.8	67.9	88.4	86.5	58.0	43.4	27.1	38.7	43.0	57.6	148.3	179.2	299.1	70.0	30.6	60.2	76.2	165.7	60.9	218.8	192.3	136.4	782.4	74.2	13.5	140.2	17.6	493.5	139.8	37.1	251.1	7.8	436.3	184.3	240.7	76.1	70.3	1640.5	41.4	141.8	254.8	48.7	70.1	201.0	61.7	45.6	44.2	144.1	147.2	38.8	101.9	532.9	205.4	79.0	109.0	151.0	130.1	26.3
PAFAH2	HSD-PLA2	ENSG00000158006	"Platelet activating factor acetylhydrolase 2"	Q99487	1	25959767-25998157	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018157	Approved					NA	NA					"HPA018157: AB_1854928"	"unprognostic (9.89e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.15e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.27e-2)"	6.5	8.8	8.9	6.3	11.0	4.1	7.0	10.7	9.0	7.0	12.3	11.9	7.8	13.2	5.7	7.7	8.7	6.4	10.1	6.7	8.0	4.5	15.5	20.9	6.3	5.5	10.7	5.1	4.7	34.7	14.8	13.6	7.8	9.8	6.8	13.0	9.6	9.0	5.0	19.3	9.5	25.3	5.2	9.8	7.9	11.6	8.4	11.1	4.4	13.6	6.3	11.4	6.5	6.3	2.4	18.9	28.0	3.3	8.3	12.3	3.9	5.2	6.7	4.2	4.8	8.8	7.0	8.7	6.0	3.1	5.4	3.6	2.7	11.2	2.3	7.5	3.5	5.2	4.7	6.3	5.8	7.0	4.7	3.8	3.8	2.9	5.3	5.3	2.0	33.5	4.5	13.2	8.3	5.6	3.0	5.2	5.6	5.3	4.5	7.2	2.3	6.2	1.9	8.4	18.2	3.7	5.1	4.0	5.2	8.7	1.8	5.1	4.3	3.5	4.8	11.0	7.3	8.0	3.6	4.8	3.8	4.7	7.9	4.7	8.3	10.7	3.0	8.0	8.1	12.6	12.7	3.3	28.0	12.3	3.1	7.8	1.8	4.3	7.9	2.4	2.4	5.6	7.9	3.0	8.3	1.1	18.9	4.3	3.9	8.9	11.0	10.7	9.0	8.0	4.5	10.7	5.1	9.8	11.1	14.9	13.8	2.9	1.9	1.3	8.5	6.5	12.7	9.4	14.8	17.4	25.5	9.5	3.3	11.1	0.6	3.6	36.7	0.0	6.4	7.5	3.6	5.1	26.6	19.7	9.8	4.8	7.5	5.5	10.5	1.0	2.3	6.0	8.5	5.4	17.1	5.8	10.2	11.5	2.5	15.7	9.3	6.5	2.1	17.0	9.6	3.3	8.4	12.8	16.5	3.8
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 58.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010726, HPA037749"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		68000	Centrosome	Vesicles	"HPA010726: , HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8	0.0	0.0	0.0	0.0	0.1	6.2	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.4	1.4	0.0	6.8	0.0	0.0	0.6	0.0	0.0	2.5	0.0	1.4	0.0	0.3	0.2	0.2	0.0	0.8	0.0	0.0	0.0
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046133	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 78.0;placenta: 20.0"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	0.7	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	1.3	1.1	0.1	0.1	4.0	2.2	0.1	0.1	10.4	0.1	0.2	0.1	0.1	0.1	0.1	78.0	0.1	0.1	20.0	0.1	0.3	0.0	2.0	1.0	1.4	1.7	0.4	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0.1	12.8	0.2	0.1	0.5	0.1	1.5	1.1	3.1	1.0	1.5	0.9	0.4	0.2	0.2	0.2	1.0	0.3	0.1	4.7	0.4	0.2	0.1	0.1	0.9	1.0	0.2	0.9	0.1	0.2	0.9	0.2	0.3	0.1	0.6	0.3	0.6	0.7	0.1	0.1	0.6	0.7	0.0	0.2	0.1	0.1	0.3	0.0	0.3	0.6	1.5	0.1	0.8	0.5	0.9	0.8	0.4	0.2	0.3	0.7	0.7	10.6	0.4	0.9	0.5	0.6	1.1	0.4	1.6	0.7	0.5	0.6	0.7	1.2	0.6	0.3	1.1	0.6	0.8	0.5	0.6	6.5	3.1	1.0	0.4	0.9	0.4	0.5	0.7	0.6	0.8	0.2	1.5	0.6	0.8	3.1	1.5	0.5	1.1	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.0	4.0	0.0	0.7	0.3	2.4	5.1	15.3	0.0	0.0	8.7	0.0	23.2	5.0	6.8	0.0	0.5	0.4	0.0	18.5	2.4	0.6	0.6	4.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.8	0.1	0.5	5.4	0.0	0.0	27.2	1.8	6.5	0.9	0.2	0.4	0.6	71.2	0.0	0.6	0.7
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051304-26068436	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Muscle protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 271.4"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 236.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"ASC diff: 10.7;SK-MEL-30: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	1.7	0.0	0.6	38.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.0	3.6	1.0	0.0	271.4	0.6	0.1	0.9	0.1	0.0	0.1	0.1	0.0	0.0	1.7	12.7	0.8	1.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.8	0.0	236.2	10.2	0.0	0.0	1.8	0.0	0.4	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.2	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0
PDIK1L	CLIK1L	ENSG00000175087	"PDLIM1 interacting kinase 1 like"	Q8N165	1	26111165-26125543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064157			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064157: "	"unprognostic (1.09e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.99e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.47e-1)"	"unprognostic (1.78e-2)"	7.0	6.0	8.6	6.2	12.3	19.9	11.5	17.8	15.9	8.6	8.9	7.1	7.6	9.5	7.8	6.4	11.4	7.5	5.8	4.8	8.5	10.6	8.5	11.3	6.7	8.0	9.3	9.9	10.2	15.3	10.7	9.9	5.6	11.5	6.8	10.6	6.1	10.2	8.9	7.7	9.4	9.7	6.5	8.3	8.3	10.2	7.8	9.3	19.1	22.2	6.7	8.8	8.8	8.0	6.7	9.3	11.0	6.1	5.6	10.4	5.2	5.5	2.1	5.9	7.4	2.3	3.1	1.9	1.4	2.0	3.8	2.5	1.4	8.0	11.7	4.3	2.1	3.0	4.1	7.8	2.9	3.6	4.2	5.2	10.4	3.3	1.5	3.4	10.9	6.3	1.6	4.2	3.4	6.7	2.6	3.4	11.4	12.3	11.7	1.3	3.1	15.8	4.9	2.7	6.8	3.2	8.4	5.4	14.0	2.5	4.4	9.4	8.0	5.6	7.1	7.2	1.6	4.1	3.7	3.1	4.1	3.6	5.2	4.6	17.5	17.2	8.9	4.3	13.6	3.9	11.0	5.0	4.2	6.7	4.6	6.2	6.7	9.4	7.4	9.3	5.6	10.0	8.0	0.5	5.6	6.1	3.5	10.4	5.2	8.6	12.3	17.8	15.9	8.5	10.6	9.3	9.9	11.5	9.3	8.9	3.4	4.5	1.8	2.9	17.8	1.6	10.2	9.4	7.9	1.8	0.0	3.2	0.0	2.7	0.9	3.5	3.9	0.0	3.5	0.4	2.6	3.1	6.9	9.7	3.4	22.3	12.6	3.1	6.5	0.0	2.3	4.2	3.3	0.0	9.1	10.1	3.0	0.0	2.8	6.0	9.8	0.0	1.4	8.1	4.3	6.5	1.4	4.9	10.0	2.4
FAM110D	"FLJ14050, GRRP1"	ENSG00000197245	"Family with sequence similarity 110 member D"	Q8TAY7	1	26159020-26163962	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Endothelial cells: 29.6;Ito cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"TIME: 4.0;U-2 OS: 5.0;U-937: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA013664	Approved					NA	NA					"HPA013664: AB_1234332"	"unprognostic (7.53e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.16e-3)"	"unprognostic (7.67e-5)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (9.87e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-1)"	17.2	2.2	2.8	2.5	5.4	2.4	14.2	1.2	3.3	10.4	3.8	1.1	3.7	3.3	12.5	5.0	8.6	10.9	6.5	11.6	3.5	2.3	6.3	1.3	8.8	2.9	4.5	0.0	4.8	6.6	3.6	3.7	2.2	5.6	6.9	2.2	4.6	7.9	3.5	9.4	5.3	4.2	8.7	3.4	1.6	4.9	3.3	2.4	0.1	6.9	10.4	2.5	4.2	14.5	1.2	0.9	4.4	0.9	1.6	0.8	0.2	0.4	0.5	1.5	1.0	0.0	0.0	0.7	0.2	0.1	0.3	0.5	0.3	1.0	1.9	2.0	0.0	0.2	0.3	0.6	0.6	0.1	0.6	0.4	0.4	0.9	1.1	0.3	0.5	0.1	0.6	0.4	0.2	0.3	0.2	2.1	0.7	0.3	0.8	0.3	0.5	0.8	0.4	1.7	0.3	0.2	0.3	0.1	0.4	0.1	0.4	1.6	1.5	0.3	0.1	0.3	1.4	0.6	0.7	4.0	0.2	5.0	0.4	0.1	0.1	0.6	0.4	0.0	3.0	0.3	3.8	0.9	0.9	0.8	0.5	0.5	0.7	0.6	0.5	0.3	1.2	0.7	0.7	4.4	1.6	0.7	0.9	0.3	0.2	2.8	5.4	1.2	3.3	3.5	2.3	4.5	0.0	5.6	2.4	0.0	4.3	0.0	0.7	0.9	1.1	1.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	29.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.6	0.0	19.6	1.5	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.1	0.7	0.6	0.2	0.0	0.0	0.2
C1orf232		ENSG00000282872	"Chromosome 1 open reading frame 230"	A0A0U1RR37	1	26164161-26168581	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.4;testis: 2.2;thyroid gland: 1.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 8.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.8"											NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.4	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.8	0.0	0.0	0.0		0.0	0.0	2.2			1.6		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL391650.1		ENSG00000236782			1	26169516-26171821	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"retina: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.3"	"Not detected"	"Not detected"													NA	NA						"unprognostic (4.80e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-3)"	"unprognostic (9.79e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.87e-3)"	"unprognostic (6.44e-4)"	"unprognostic (4.45e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.26e-1)"	0.1	0.5	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.2	0.7	0.1	0.1	0.0	0.1	0.4	0.1		0.1	0.1	0.2	0.3	0.1	0.1	1.1	2.4	0.0	0.1	0.1	0.1	0.2	0.0	18.5	0.3	0.1	3.3	0.3	0.5	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.6	0.2	0.0	0.9	0.0	1.4	0.0	1.0	0.4	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.2	1.0	3.3	0.3	0.0	0.7	0.8	0.0	0.0	0.0	1.0	1.9	0.6	0.4	0.7	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	1.4	0.0	0.2	0.7	0.4	2.6	0.3	0.0	1.3	0.9	0.4	0.0	0.5	2.3	0.6	0.2	0.7	1.9	1.1	0.6	0.0	0.0	0.1	1.8	1.3	0.3	1.2	0.4	2.3	0.0	1.2	1.3	0.0	0.3	0.0	1.0	0.6	0.1	0.4	0.3	0.6	0.2	0.6	1.4	1.0	0.0	0.0	0.9	0.0	1.0	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.1	11.1	3.8	13.4	3.7	4.9	20.2	9.0	4.6	10.5	10.1	17.0	12.2	23.6	16.6	5.6	8.4	13.2	12.9	11.7	3.8	14.1	41.4	16.0	9.1	25.7	16.1	22.1	14.1	8.8	11.5	11.6	12.2	4.4	8.8	5.8	24.0	9.1	6.2	15.4	9.0	41.1	15.1	19.5	39.5	11.3	6.7	23.8	7.5	8.9	10.1	11.0	10.9	27.4	34.2	3.3	11.3	12.5	9.1	10.1	11.9	21.1	16.8	18.0	18.2	25.5	11.8	45.9	12.9	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3	11.9	63.0	48.3	137.4	152.1	16.6	5.9	58.6	21.4	40.9	57.6	2.0	93.3	87.9	89.4	5.0	36.0	55.3	23.3	126.2	135.2	54.6	99.4	51.7	184.5	69.6	3.2	105.3	38.6	55.7	10.0	30.0	42.5	47.2	47.7	71.1	18.5	122.6	60.4	21.9	148.8	11.7	12.9	55.6	33.0	56.3	147.0	186.2	28.8	68.1	152.9
CNKSR1	"CNK, CNK1, KSR"	ENSG00000142675	"Connector enhancer of kinase suppressor of Ras 1"	Q969H4	1	26177403-26189886	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.1;memory CD4 T-cell: 2.4;naive CD4 T-cell: 1.4;T-reg: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 2.1;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A-431: 11.6;BEWO: 10.1;CAPAN-2: 18.0;HaCaT: 13.3;hTCEpi: 11.5;OE19: 10.1;SK-BR-3: 11.6;T-47d: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030847	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030847: AB_10601100"	"unprognostic (2.73e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.91e-4)"	0.7	0.0	1.0	3.5	1.4	0.0	4.5	5.4	1.1	4.4	19.1	0.8	12.8	8.6	1.9	11.9	15.4	6.1	13.3	0.7	1.4	1.2	10.0	2.9	10.2	0.7	0.9	0.7	2.5	27.6	10.2	12.6	32.4	1.2	10.3	5.4	0.7	15.7	18.9	17.7	11.9	22.6	1.0	1.3	1.3	7.3	1.5	0.7	1.9	20.6	11.9	15.9	6.1	5.3	2.1	0.0	0.0	0.0	0.2	2.6	0.5	11.6	0.0	0.2	0.1	0.2	0.0	10.1	0.3	0.0	0.4	0.0	1.8	18.0	1.9	6.0	0.0	0.1	13.3	0.3	8.5	0.3	0.4	0.6	0.3	4.3	5.0	0.1	0.1	0.2	0.0	11.5	0.0	3.3	0.0	0.0	0.4	1.5	0.1	0.0	5.4	0.1	0.6	5.2	10.1	1.1	0.1	0.1	0.0	1.1	6.8	2.5	0.6	0.0	11.6	0.2	4.6	11.0	0.0	0.0	0.0	1.8	0.7	0.1	4.1	0.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.3	1.4	0.1	0.0	0.2	0.0	0.0	2.6	0.5	1.0	1.4	5.4	1.1	1.4	1.2	0.9	0.7	1.2	0.7	14.9	4.5	0.8	13.0	13.1	2.6	0.8	12.7	14.7	6.8	33.2	2.0	27.4	1.7	10.6	0.4	0.7	23.3	0.0	10.9	12.0	1.3	14.9	0.0	0.0	2.3	0.0	17.9	1.3	0.0	0.4	1.1	0.7	1.7	1.8	17.9	1.1	17.6	24.6	0.7	0.3	3.0	0.0	1.9	2.3	4.0	9.9	27.1	0.0	18.3	22.5
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 13.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 36.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.1;hTCEpi: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced					NA	NA					"HPA045257: AB_10968995"	"unprognostic (7.20e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.56e-2)"		"unprognostic (2.69e-2)"		"unprognostic (3.49e-1)"		"unprognostic (3.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.16e-1)"		"unprognostic (3.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.67e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.5	6.7	10.8	11.5	3.0	2.8	21.3	6.9	3.2	9.5	10.2	8.6	12.7	12.9	9.4	2.8	5.2	12.0	12.1	5.7	9.6	9.4	10.5	18.2	13.2	9.1	3.1	16.6	20.2	1.4	5.7	8.0	5.8	4.5	4.2	17.5	24.5	18.0	7.0	4.9	15.9	20.2	10.5	6.7	11.2	16.3	12.6	12.0	4.8	2.1	18.4	8.5	9.7	8.1	8.0	6.2	7.4	11.9	4.9	7.8	13.0	9.1	10.6	14.2	20.7	16.1	4.8	29.3	14.7	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5	0.0	2.1	0.0	4.2	6.2	9.6	26.8	2.5	1.4	4.5	5.2	11.8	2.0	6.6	1.7	0.8	1.8	3.9	0.0	1.1	3.6	2.1	2.2	2.3	2.5	4.3	0.0	1.7	1.8	5.2	2.3	1.4	4.0	1.7	4.6	3.1	1.3	2.1	3.4	0.4	0.8	10.1	0.0	1.0	43.5	37.7	5.4	34.9	3.5	4.7	3.2
SH3BGRL3		ENSG00000142669	"SH3 domain binding glutamate rich protein like 3"	Q9H299	1	26279176-26281522	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 309.8"	"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 2380.9;Urothelial cells: 2379.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030848, HPA076219"	Enhanced		Approved	"Nuclear bodies"		NA	NA		73000000	"Nuclear bodies"		"HPA030848: AB_10602398, HPA076219: AB_2686787"	"unprognostic (4.97e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.17e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.43e-2)"	97.7	26.9	37.3	82.0	37.2	80.9	33.5	11.3	43.2	33.6	65.8	32.3	19.1	31.9	22.9	124.4	84.0	22.9	42.9	31.3	34.6	32.3	36.6	35.1	58.7	98.4	40.5	19.9	26.8	33.6	7.5	22.2	39.9	31.1	23.9	78.2	21.6	36.3	18.3	16.2	51.8	41.3	34.8	32.6	101.4	40.8	13.7	19.3	80.5	26.6	66.0	95.0	41.1	41.5	75.1	184.4	237.0	211.4	68.2	155.1	309.8	28.8	11.2	11.9	15.8	37.8	94.2	1.8	49.5	58.7	44.2	29.2	8.4	26.2	6.0	18.2	92.5	16.5	10.8	5.5	47.2	33.3	10.3	4.1	51.0	10.7	8.7	28.7	15.9	87.2	38.9	27.4	45.7	36.3	67.9	52.9	13.4	5.3	25.6	80.4	13.0	11.1	25.8	13.2	25.0	73.5	19.7	13.4	9.2	35.9	9.8	7.2	11.3	18.2	20.3	21.9	13.6	3.7	26.6	79.5	62.9	22.6	91.7	24.1	8.1	12.4	5.7	134.9	42.2	31.3	107.5	211.4	188.4	143.1	191.7	106.2	75.1	127.2	140.7	184.4	66.0	55.5	108.8	237.0	68.2	180.6	96.8	155.1	309.8	37.3	37.2	11.3	43.2	34.6	32.3	40.5	19.9	31.1	19.3	89.3	227.2	487.6	666.7	874.2	12.9	5.3	206.4	127.2	135.4	349.0	3.9	99.7	265.2	1062.3	13.2	348.4	756.2	70.0	895.1	379.2	363.5	911.1	977.5	102.7	2380.9	15.9	325.9	311.8	2032.0	36.2	128.9	1759.5	738.9	502.3	1235.8	41.9	1651.6	517.4	152.4	317.2	12.4	148.8	259.2	6.6	24.7	925.4	189.9	897.8	380.7	2379.6
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 103.4;Late spermatids: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.6;monocytes: 32.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: AB_2673840"	"unprognostic (1.78e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.90e-4)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	5.4	7.6	16.6	10.2	25.7	18.9	5.6	7.0	21.5	8.6	4.6	7.9	9.0	4.2	6.7	23.8	4.3	35.4	8.4	5.9	17.0	15.0	9.3	3.7	12.0	8.2	9.8	12.3	9.7	8.2	8.4	18.3	5.2	12.7	5.4	3.5	13.6	8.3	8.3	6.2	6.0	4.4	5.0	5.6	11.7	4.8	27.4	8.5	6.2	15.7	2.7	5.7	6.1	3.9	5.3	16.6	2.4	32.4	1.9	5.7	13.2	17.4	7.9	3.9	7.9	2.9	2.2	13.7	3.9	6.1	10.8	7.9	3.1	15.5	10.2	5.9	2.4	7.2	9.5	2.4	6.3	2.8	5.1	9.3	1.7	11.2	7.5	5.1	7.4	3.5	3.3	6.8	18.2	4.6	3.4	3.0	7.5	6.6	7.1	3.6	7.8	4.2	3.6	7.9	4.9	6.1	8.7	2.9	9.2	6.0	2.6	18.7	4.4	9.6	9.1	6.7	2.1	7.0	7.2	2.8	6.3	9.5	9.3	5.7	6.7	19.0	11.6	7.7	10.3	5.1	0.7	32.4	1.5	3.4	28.1	4.1	4.4	5.0	3.9	16.6	5.3	5.7	3.6	2.4	1.9	22.5	2.5	4.1	13.2	16.6	25.7	7.0	21.5	17.0	15.0	9.8	12.3	12.7	8.5	0.0	1.4	9.1	13.3	19.1	9.8	1.1	7.6	17.4	7.9	22.7	21.6	7.5	11.6	11.5	103.4	4.4	1.7	0.0	7.5	17.4	10.8	8.6	10.3	2.4	19.7	22.3	8.6	7.4	69.6	252.6	11.8	30.3	10.1	3.6	4.3	12.1	6.8	2.9	9.6	21.2	50.8	19.4	7.8	13.9	22.6	11.7	6.1	13.1	5.6	11.0
CD52	"CDW52, EDDM5, HE5"	ENSG00000169442	"CD52 molecule"	P31358	1	26317957-26320523	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 495.7;epididymis: 978.9"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 1214.9;granulocytes: 550.2;Hofbauer cells: 593.7;Macrophages: 676.6;T-cells: 760.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Daudi: 76.1;REH: 111.3;U-266/84: 111.2;U-698: 123.2"															NA	NA						"prognostic favorable (1.85e-5)"	"unprognostic (3.28e-3)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (4.18e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (9.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.73e-3)"	"unprognostic (6.27e-2)"	"unprognostic (4.58e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.64e-1)"	"unprognostic (6.14e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.26e-1)"	9.5	0.9	0.8	23.0	1.4	5.7	4.7	0.3	0.8	0.9	3.7	0.3	93.2	1.0	1.1	978.9	2.9	1.5	2.2	1.5	0.6	0.2	3.5	3.2	43.4	54.6	0.8	0.6	0.8	1.0	0.0	0.7	0.7	0.7	1.7	2.5	1.3	5.7	2.9	0.4	1.9	39.6	1.1	1.2	98.7	2.7	5.3	0.4	24.7	3.2	2.1	30.4	4.3	1.7	292.0	87.6	258.4	194.6	94.3	308.1	495.7	0.2	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	76.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.7	11.9	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.5	0.1	0.0	0.5	0.8	6.8	0.3	0.0	0.0	111.3	0.1	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.1	1.0	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.3	111.2	123.2	0.0	1.9	0.0	12.4	126.8	258.4	194.7	194.6	155.1	292.0	244.1	190.3	87.6	273.7	166.6	171.2	9.6	94.3	167.6	28.6	308.1	495.7	0.8	1.4	0.3	0.8	0.6	0.2	0.8	0.6	0.7	0.4	62.5	287.6	1214.9	0.7	40.3	0.0	6.0	2.5	32.1	92.1	47.1	0.0	2.7	0.0	0.2	0.7	22.7	0.7	0.0	0.2	4.3	18.8	0.4	550.2	1.5	593.7	0.0	0.0	17.8	203.9	1.3	0.0	676.6	101.3	2.8	1.9	0.0	0.1	2.9	0.0	7.6	0.0	0.0	3.3	0.2	0.2	27.5	4.7	760.6	0.2	0.8
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.9;placenta: 55.0"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 40.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	8.0	4.4	0.0	0.0	4.9	0.9	0.6	43.9	0.2	2.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	55.0	0.0	0.8	1.4	0.1	5.1	0.0	0.0	13.8	10.4	0.0	0.0	0.0	0.9	1.2	0.0	0.1	0.0	22.0	19.8	4.9	16.1	0.7	0.0	2.4	0.1	0.2	1.7	0.3	7.1	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.1	25.1	16.9	0.1	5.1	0.0	0.1	6.3	0.0	4.5	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.2	4.0	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.0	0.0	3.0	0.0	1.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.5	0.7	1.7	0.7	0.0	0.6	0.5	0.5	2.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	4.9	1.7	1.8	0.0	0.0	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.7;testis: 39.4"	"Group enriched"	"Detected in some"	134	"Early spermatids: 495.3;Late spermatids: 367.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 47.7;memory CD8 T-cell: 30.6"	"Lineage enriched"	"Detected in many"	18	"T-cells: 47.7"	"Group enriched"	"Detected in some"	8	"NB-4: 4.5;OE19: 10.0"					"Not detected"	"Not detected"			HPA023865	Uncertain					NA	NA					"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (3.45e-5)"	0.3	0.2	0.3	0.2	0.3	1.0	0.5	0.2	0.5	1.7	0.3	0.3	0.0	0.0	2.0	1.0	1.2	1.0	1.0	0.6	0.3	0.3	0.4	0.4	4.8	1.0	0.4	0.6	1.2	1.1	0.0	0.4	0.7	0.6	1.2	0.2	0.9	8.2	1.6	0.2	0.4	0.4	1.3	1.2	1.2	2.1	39.4	0.2	7.1	0.8	1.1	1.4	0.6	0.6	0.0	0.1	0.3	0.8	2.7	47.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.5	0.3	10.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	47.7	0.0	0.1	0.0	10.3	30.6	0.0	0.0	4.0	18.1	0.3	2.7	0.8	0.1	0.2	4.9	0.3	0.3	0.2	0.5	0.3	0.3	0.4	0.6	0.6	0.2	3.0	1.1	0.0	0.0	0.5	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	495.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	367.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.2	2.0	0.0	0.0	3.2	0.0	0.0
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410778-26429722	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.8"	"Group enriched"	"Detected in some"	42	"Early spermatids: 24.2;Late spermatids: 49.8"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NTERA-2: 136.8;SuSa: 50.5"	"Not detected"	"Not detected"							"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.5	0.1	0.1	0.1	0.2	0.3	9.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.6	2.3	0.5	1.0	0.8	0.1	0.0	0.0	13.5	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.7	0.7	0.3	0.4	1.0	0.5	0.6	0.2	1.3	0.8	0.7	2.2	1.0	0.3	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.4	0.1	0.0	0.0	0.0	0.1
DHDDS	"DS, FLJ13102, HDS, RP59"	ENSG00000117682	"Dehydrodolichyl diphosphate synthase subunit"	Q86SQ9	1	26432282-26471294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Transferase	"Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 241.5;Rod photoreceptor cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026721, HPA026727"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA026721: AB_1847643, HPA026727: AB_1847644"	"unprognostic (1.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (9.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.95e-1)"	31.8	14.4	11.2	10.8	15.9	6.4	15.0	45.9	18.8	10.4	23.1	12.5	8.3	12.2	15.4	21.9	18.9	9.2	10.9	14.8	9.7	10.7	16.2	15.3	9.5	10.3	12.1	15.8	9.8	14.7	23.2	15.5	13.1	20.6	9.6	23.9	22.0	56.9	9.1	10.3	13.1	12.2	11.3	7.6	10.5	14.2	12.9	8.9	9.7	12.1	11.1	16.9	10.6	9.8	11.1	11.2	11.8	19.5	8.1	11.6	8.2	14.9	12.2	8.1	11.1	16.8	14.1	14.0	25.6	16.0	19.8	19.8	18.8	16.5	16.9	15.7	23.9	14.5	10.9	10.9	20.0	19.0	10.3	5.8	16.8	30.3	13.8	15.8	18.3	24.8	19.3	11.9	27.3	15.4	13.3	24.9	11.1	12.0	18.6	18.1	10.2	9.3	7.7	12.8	21.0	16.4	11.2	14.4	14.4	10.7	14.1	11.4	9.1	17.2	19.0	11.3	11.7	14.3	10.3	31.7	13.8	13.4	25.9	14.6	22.7	30.4	18.2	21.7	23.0	13.4	6.5	13.4	7.1	11.6	19.5	8.4	11.1	7.7	7.5	11.2	9.3	6.5	9.0	11.8	8.1	18.0	9.1	7.3	8.2	11.2	15.9	45.9	18.8	9.7	10.7	12.1	15.8	20.6	8.9	8.9	5.6	17.5	7.9	4.0	31.4	13.7	12.7	8.1	10.3	14.0	241.5	15.5	10.0	17.0	55.9	9.0	44.5	0.0	12.6	19.4	8.2	11.0	18.5	11.5	21.3	14.3	20.1	11.1	7.3	16.4	9.8	9.7	10.1	48.7	32.2	15.3	14.8	42.1	7.1	20.3	101.1	0.0	10.3	9.3	13.5	4.4	21.3	10.0	14.0	11.1
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472450-26475972	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	30.6	34.9	36.0	52.4	32.3	169.1	37.6	30.8	39.1	51.3	43.4	30.3	53.6	30.0	46.1	60.6	44.1	50.1	51.6	37.6	30.5	32.0	35.9	37.1	62.9	100.2	32.7	30.5	64.7	59.4	16.7	52.7	49.6	26.0	48.0	49.9	42.5	58.9	51.9	41.1	33.9	41.3	68.1	40.4	50.0	33.2	29.9	31.1	104.6	48.6	52.5	83.2	43.7	38.7	60.4	81.4	157.4	73.6	38.6	83.4	103.5	83.3	28.9	83.9	35.2	7.8	18.1	32.8	41.3	23.8	80.9	62.5	29.8	78.2	93.9	39.5	33.6	23.6	48.2	105.8	41.0	68.9	57.8	74.9	100.8	34.3	29.1	14.7	213.4	58.9	19.0	21.6	44.2	26.2	16.9	37.6	62.7	79.7	45.1	42.4	61.6	152.1	97.0	70.3	96.0	53.8	105.9	131.8	57.5	25.4	22.9	83.7	51.9	124.1	34.9	45.7	21.8	57.2	101.2	27.9	40.4	75.5	77.3	68.8	55.2	74.8	104.6	25.9	224.6	80.0	30.3	59.9	157.4	34.2	69.0	32.0	60.4	46.8	41.4	60.9	59.1	51.5	41.7	53.1	38.6	73.6	81.4	83.4	103.5	36.0	32.3	30.8	39.1	30.5	32.0	32.7	30.5	26.0	31.1	318.6	348.4	323.5	270.1	256.3	146.9	79.2	191.1	714.7	343.5	247.7	133.5	686.4	315.0	197.4	143.3	140.8	163.3	537.3	235.1	491.1	459.0	285.8	361.7	123.4	660.0	89.0	554.4	172.5	336.2	26.8	172.0	473.8	215.9	762.9	372.7	230.4	94.5	305.1	142.8	214.8	300.1	122.9	297.7	273.8	419.4	186.6	772.2	318.1	517.4	227.4
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 85.8;monocytes: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.9;U-937: 32.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.9	3.5	2.8	3.7	0.1	0.0	3.8	0.8	1.6	4.2	4.1	4.0	8.2	18.5	4.6	0.5	5.1	11.7	6.4	22.9	3.0	15.3	4.1	20.3	8.6	7.1	1.3	23.9	29.9	0.7	8.4	3.9	7.0	1.9	1.8	7.4	3.4	6.7	0.2	5.5	0.8	23.6	7.3	19.3	11.1	12.8	3.6	8.1	12.1	2.7	4.1	1.6	7.0	6.6	3.2	3.1	4.2	20.6	1.2	0.2	5.4	0.7	3.3	4.2	4.9	10.1	2.5	32.2	4.1	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0	14.9	23.5	13.7	7.4	16.6	1.3	1.2	10.2	10.7	5.7	8.7	3.9	1.2	6.6	15.5	1.8	4.2	85.8	0.0	16.3	14.5	1.9	13.9	32.2	3.8	43.9	0.0	15.6	12.3	57.1	0.5	0.0	36.8	1.7	68.5	34.3	0.4	21.8	41.9	0.0	13.6	1.7	6.5	2.1	1.1	2.7	10.2	3.4	41.5	32.9	6.8
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782110	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	18.6	18.4	17.4	24.9	17.0	33.8	27.8	23.6	19.1	20.3	23.7	21.7	23.9	15.8	24.1	17.3	23.2	20.6	21.9	15.5	14.8	12.8	13.7	15.9	18.8	35.6	20.3	19.2	24.1	23.9	27.5	15.8	19.3	17.2	16.5	16.4	18.9	21.4	23.1	22.6	20.6	20.7	18.4	15.4	25.9	19.5	16.5	19.8	57.3	24.8	14.2	24.5	24.4	20.4	4.3	5.3	7.4	3.3	4.7	5.1	3.5	19.2	18.3	25.9	27.0	7.5	7.2	12.2	9.0	7.9	12.4	8.8	13.3	13.0	27.2	7.9	11.7	7.8	11.7	22.5	10.0	14.5	33.6	8.8	23.1	11.9	8.9	6.2	34.2	7.4	8.3	7.1	14.6	10.5	6.9	10.6	19.7	27.6	30.5	8.0	9.1	28.8	13.3	27.4	12.5	8.5	30.1	17.1	15.4	7.7	13.0	24.3	20.0	15.8	13.4	10.9	15.0	3.9	19.4	18.7	13.3	12.9	12.4	14.6	14.5	19.1	12.5	8.1	21.9	11.7	0.4	3.3	2.9	4.0	2.9	5.1	4.3	3.2	4.9	3.1	4.3	4.0	4.4	7.4	4.7	2.8	5.3	1.5	3.5	17.4	17.0	23.6	19.1	14.8	12.8	20.3	19.2	17.2	19.8	56.6	36.8	33.6	18.1	65.3	60.2	31.1	28.1	25.4	28.4	36.6	49.1	31.8	1.7	31.8	14.2	37.2	28.4	0.0	32.5	32.1	42.6	39.3	56.9	53.9	43.0	69.9	45.7	51.0	93.5	7.5	35.6	45.4	38.8	34.3	56.1	31.2	40.3	31.6	39.3	14.5	37.1	51.8	27.2	46.0	55.3	82.4	30.7	41.2	46.0	27.7
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787472-26798398	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 65.1;Spermatocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.2	14.6	8.1	5.3	8.9	4.6	9.2	6.1	10.3	10.5	7.5	9.9	9.3	7.3	8.3	14.7	8.7	10.6	8.9	4.4	7.2	6.6	10.6	24.6	6.8	5.1	11.6	6.8	9.0	13.5	15.8	13.5	9.3	9.7	11.5	8.4	6.6	9.9	10.6	5.0	10.1	10.7	7.1	7.5	7.2	7.7	31.3	10.0	7.2	20.0	8.2	7.8	9.3	7.6	8.3	9.7	23.5	12.9	18.0	19.1	9.2	9.4	5.7	4.6	4.0	8.9	11.0	3.9	6.5	15.4	6.2	7.6	3.1	19.6	5.6	5.9	8.1	6.9	16.9	2.4	7.6	7.7	9.5	4.0	4.9	7.6	7.8	10.0	8.9	12.1	11.4	31.6	8.5	10.4	13.2	4.7	9.1	8.9	9.0	11.1	5.3	4.4	5.0	6.9	13.9	4.6	3.2	5.3	10.6	9.8	2.4	6.6	3.5	6.4	3.2	6.3	8.3	11.0	4.4	7.8	11.2	4.8	5.4	2.2	3.2	2.1	3.0	9.2	9.5	6.6	23.5	10.3	7.7	13.3	10.1	19.1	7.4	9.0	13.0	9.7	8.3	9.1	11.1	12.5	18.0	12.9	3.8	7.7	9.2	8.1	8.9	6.1	10.3	7.2	6.6	11.6	6.8	9.7	10.0	3.0	5.9	6.7	10.3	3.8	2.9	1.8	2.5	8.1	1.2	7.0	7.9	22.6	6.6	6.3	40.4	5.0	6.1	23.3	4.0	12.3	8.7	6.7	0.0	14.1	8.1	7.9	3.4	7.4	4.7	65.1	6.6	4.0	6.8	10.0	6.5	10.3	4.6	2.9	9.2	7.9	2.7	0.0	5.1	82.9	13.9	3.6	11.8	6.1	9.8	5.8
ZDHHC18	DKFZp667O2416	ENSG00000204160	"Zinc finger DHHC-type containing 18"	Q9NUE0	1	26826710-26857602	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 86.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 27.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040234	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA040234: AB_10805709"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (1.36e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	20.5	8.2	13.3	22.7	18.9	86.2	39.0	21.4	18.4	10.2	13.0	11.9	7.5	11.7	12.4	6.4	19.3	9.9	13.5	9.8	13.5	20.0	7.8	14.5	16.2	23.5	16.3	12.8	9.6	10.8	7.1	10.5	20.3	15.2	10.7	13.9	11.2	14.1	9.8	8.7	16.3	12.2	16.6	10.4	27.1	10.8	7.0	9.5	11.7	14.6	10.1	23.3	16.5	24.7	0.2	0.4	27.0	0.6	0.5	1.3	0.2	18.5	8.3	13.5	9.3	11.3	7.9	13.3	11.2	13.3	19.7	14.7	7.6	11.9	8.6	7.2	14.8	10.3	13.1	14.3	6.7	17.0	54.3	12.2	8.3	6.1	10.5	9.7	7.3	7.3	6.8	9.1	18.1	12.0	7.1	11.0	13.3	8.6	17.9	7.8	9.0	13.9	5.9	12.9	11.6	8.0	11.6	11.6	9.1	8.3	4.7	6.3	7.6	7.5	5.7	8.1	10.8	5.1	7.3	9.3	13.7	10.5	22.3	12.8	21.3	15.3	7.4	7.7	13.4	9.3	0.0	0.2	5.1	0.9	0.6	0.7	0.2	0.6	0.6	0.4	0.1	0.4	0.4	27.0	0.5	0.4	0.2	1.3	0.2	13.3	18.9	21.4	18.4	13.5	20.0	16.3	12.8	15.2	9.5	8.9	9.3	9.8	7.5	22.8	39.0	4.8	12.7	0.0	6.8	1.8	25.5	8.9	0.0	3.2	2.9	8.0	12.3	23.3	2.5	6.3	7.1	12.5	1.1	10.4	6.6	17.5	2.9	6.7	6.9	1.4	5.8	8.9	10.1	36.9	4.3	4.8	6.7	9.5	3.5	2.2	33.0	0.0	5.5	2.2	11.1	31.7	5.1	8.7	5.2	13.2
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	"Nucleoli rim,Cytosol"	"Secreted in other tissues"	NA	NA		54000000	Cytosol	"Nucleoli rim"	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	70.1	11.8	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.3	37.1	0.6	3.1	0.0	0.0	110.7	0.0	170.4	0.0	16.7	0.5	0.0	11.8	12.5	0.0	0.0	0.1	0.0	114.4	0.0	29.9	0.0	0.0	0.0	0.1	0.4	0.0	15.0	0.0	0.0	0.2	12.2	19.7	0.0	0.0	3.9	26.5	16.2	0.0	0.0	16.9	3.0	0.1	0.2	7.9	0.1	0.0	0.0	32.4	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4	166.7	216.2	0.5	1339.8	6884.3	0.0	0.3	33.1	30.8	122.8	15.7	0.0	6.7	3.3	52.1	0.0	0.6	409.5	0.0	68.0	45.3	37.0	487.4	31.2	0.0	1.6	0.0	64.7	0.6	0.3	0.0	0.0	15.6	506.2	1.8	78.2	0.0	315.2	136.8	0.0	0.0	0.0	0.0	110.7	0.0	0.2	9365.4	5.0	0.0	146.1	2426.4
GPN2	"ATPBD1B, FLJ10349"	ENSG00000142751	"GPN-loop GTPase 2"	Q9H9Y4	1	26876133-26890297	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028059	Uncertain					NA	NA					"HPA028059: AB_10612113"	"unprognostic (2.14e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (3.56e-8)"	"unprognostic (1.17e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.18e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-2)"	18.2	27.6	16.0	15.6	19.5	26.9	19.4	22.1	26.7	17.9	21.9	21.3	21.6	21.4	20.3	23.9	26.2	16.4	19.9	18.8	14.3	14.2	21.2	26.1	17.3	24.9	18.3	18.1	18.4	23.0	22.4	18.7	23.8	18.5	21.6	24.8	19.0	18.5	24.1	27.5	23.5	21.5	22.2	13.3	23.2	19.7	16.1	18.8	21.4	22.4	15.9	27.0	20.7	18.4	19.1	18.7	20.4	21.7	13.1	19.5	10.9	18.1	8.7	10.8	10.3	11.6	11.2	8.4	13.7	18.5	21.6	22.7	14.2	20.2	8.7	18.2	19.5	17.2	17.9	23.1	31.9	28.1	10.3	15.2	15.2	15.2	15.2	19.9	20.1	16.5	13.9	12.5	34.9	24.9	12.5	21.2	10.9	15.2	10.2	18.4	15.1	10.0	17.8	19.6	19.7	18.6	13.6	16.0	14.6	16.2	10.2	14.6	9.9	18.3	12.3	21.9	12.0	14.6	8.4	12.7	16.1	16.9	13.7	14.1	21.3	10.7	13.1	12.5	18.7	14.2	5.0	19.7	20.4	16.7	21.7	19.0	19.1	16.5	16.0	18.3	17.9	12.8	12.3	6.2	13.1	21.4	18.7	19.5	10.9	16.0	19.5	22.1	26.7	14.3	14.2	18.3	18.1	18.5	18.8	14.9	10.2	15.2	12.9	16.7	9.2	3.9	25.5	6.7	15.9	15.7	7.9	29.7	11.6	19.8	4.9	9.8	21.1	0.0	16.7	22.8	13.8	15.3	17.3	13.0	20.0	12.7	17.7	12.3	10.7	4.5	8.9	12.0	8.5	30.7	15.3	8.7	16.8	17.5	11.0	13.9	8.6	6.5	11.3	16.6	10.9	19.6	36.2	8.6	15.5	26.9
GPATCH3	"FLJ12455, GPATC3"	ENSG00000198746	"G-patch domain containing 3"	Q96I76	1	26890488-26900466	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032078, HPA054973"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA032078: AB_10603671, HPA054973: AB_2682656"	"unprognostic (2.93e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (4.37e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.46e-2)"	"prognostic favorable (6.42e-4)"	"unprognostic (3.77e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.82e-2)"	11.7	14.5	13.1	10.2	13.6	31.8	13.0	19.5	20.9	9.4	11.7	15.8	11.8	13.0	11.8	14.5	11.6	10.3	12.0	9.6	11.6	10.9	10.9	14.8	10.5	12.4	12.6	10.8	11.8	11.8	12.0	10.1	13.3	13.6	10.3	10.1	10.1	10.4	10.5	21.5	16.0	11.7	10.4	12.1	15.4	12.0	17.2	16.2	16.9	10.1	10.5	11.7	10.5	12.2	12.4	17.4	22.4	16.8	8.1	16.0	12.8	8.9	7.4	7.0	11.1	6.7	6.5	9.5	7.0	8.0	14.1	12.3	9.8	10.7	8.3	7.8	6.9	7.4	9.4	11.6	12.9	7.4	9.3	17.5	16.0	16.2	20.8	9.5	11.1	11.2	10.0	12.0	14.1	7.5	6.1	9.1	11.3	18.8	11.0	5.8	8.2	9.4	21.6	16.3	10.4	11.2	12.0	9.9	13.2	7.1	4.9	9.2	11.3	13.6	12.0	20.9	7.9	10.6	11.6	9.3	9.1	10.5	12.2	7.9	14.2	19.4	11.0	8.2	16.0	7.9	22.4	16.8	19.7	16.0	13.7	12.9	12.4	13.3	14.0	17.4	12.1	14.0	13.2	7.1	8.1	15.8	13.3	11.4	12.8	13.1	13.6	19.5	20.9	11.6	10.9	12.6	10.8	13.6	16.2	3.0	4.6	13.4	4.8	8.7	5.6	3.1	2.5	2.7	2.3	0.0	11.8	13.7	5.0	9.3	0.6	6.8	9.9	0.0	10.7	8.1	6.2	3.7	5.7	5.1	9.5	4.8	10.9	8.0	7.6	1.0	4.9	7.3	8.5	18.0	4.7	5.6	8.3	7.0	6.7	6.7	4.8	6.5	7.1	8.9	22.9	8.5	25.2	10.2	5.2	4.2
NUDC	NudC	ENSG00000090273	"Nuclear distribution C, dynein complex regulator"	Q9Y266	1	26900238-26946862	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027183, HPA028105"	Enhanced		Enhanced	Cytosol		NA	NA		18000	Cytosol		"HPA027183: AB_10600086, HPA028105: AB_10601988"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.10e-2)"	30.7	57.9	49.9	25.8	44.9	31.8	30.9	40.1	59.0	30.5	35.7	32.0	31.7	25.8	30.0	53.0	26.6	69.2	28.2	41.8	39.3	41.0	28.2	46.8	26.4	27.3	39.6	49.7	34.5	44.7	36.7	32.3	29.2	38.6	34.2	23.7	25.0	35.0	43.9	65.6	30.8	22.9	39.0	32.9	29.2	36.6	41.4	35.9	30.0	36.8	24.8	29.5	37.6	84.4	73.7	69.0	63.1	62.8	57.9	71.8	64.8	42.6	44.7	23.5	32.6	18.8	16.9	26.7	34.3	21.2	46.3	34.2	41.0	29.9	35.9	30.4	23.4	34.1	33.6	49.9	45.2	35.8	27.8	51.7	44.6	45.5	70.1	33.2	47.0	33.0	18.1	29.6	55.6	36.0	20.2	33.9	42.2	63.5	20.2	31.1	37.1	47.2	60.9	61.7	56.1	58.1	49.5	29.8	36.6	39.4	16.9	39.2	29.4	37.3	23.8	30.2	23.1	23.2	29.0	33.4	33.1	39.5	41.3	43.9	40.7	63.9	43.3	35.7	66.5	37.1	63.1	60.3	57.5	69.1	62.8	69.7	72.0	70.4	65.3	59.8	73.7	70.0	71.8	41.0	57.9	60.0	69.0	66.5	64.8	49.9	44.9	40.1	59.0	39.3	41.0	39.6	49.7	38.6	35.9	125.0	96.1	101.3	254.2	136.9	88.8	139.6	127.4	592.9	157.0	104.7	49.1	182.7	222.2	232.6	46.2	119.1	64.9	0.0	274.8	170.3	125.0	214.5	143.3	551.3	129.0	104.9	125.9	76.1	61.3	97.3	125.7	95.2	143.4	146.1	65.8	130.4	273.1	71.9	143.9	157.8	81.0	109.9	158.4	185.6	247.7	129.7	136.0	118.6	82.6	183.4
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913966	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 47.2;liver: 49.4;pancreas: 52.8"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 56.0;Distal tubular cells: 44.7;Exocrine glandular cells: 37.2;Hepatocytes: 149.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 52.3;stomach cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	32	"Hep G2: 41.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.9"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.1	7.5	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	11.8	0.3	0.1	32.6	0.1	0.8	0.1	0.0	18.5	16.6	0.1	0.0	9.3	49.4	2.4	0.1	0.1	0.1	0.1	52.8	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	3.5	0.0	47.2	0.1	0.1	5.3	8.5	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.6	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	3.0	12.0	1.5	0.0	0.0	0.0	7.4	56.0	0.0	1.2	12.2	0.0	0.0	44.7	17.4	0.4	0.0	1.7	23.3	37.2	0.0	0.0	0.0	0.0	149.9	0.1	27.0	23.4	1.8	2.2	0.0	0.0	0.0	0.0	0.0	5.8	0.2	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	5.7	0.0
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960406	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	36	"B-cells: 3.7;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028639, HPA068312"	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitotic spindle"		NA	NA			"Cell Junctions"	"Nucleoplasm, Mitotic spindle"	"HPA028639: AB_10599191, HPA068312: AB_2685972"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.2	1.1	0.6	3.8	0.7	0.0	7.9	1.5	3.6	2.9	11.9	0.4	13.6	9.3	1.0	17.3	16.1	5.5	4.2	0.5	0.8	0.1	7.9	3.5	7.5	6.7	0.2	0.6	1.0	23.8	6.6	9.0	12.4	0.8	6.0	5.1	2.0	14.3	11.5	0.2	13.3	12.5	0.2	0.2	1.0	7.7	5.8	0.5	1.6	14.5	7.2	8.6	5.2	6.0	3.7	0.1	0.0	0.0	0.0	8.6	2.4	13.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	6.6	12.5	0.0	0.5	0.0	0.0	11.8	0.0	16.2	0.0	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	21.3	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	7.9	0.0	0.0	0.9	20.5	0.1	0.0	0.0	1.9	2.9	6.3	8.2	0.0	0.1	13.9	0.0	1.5	9.0	0.2	0.1	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.5	3.5	5.9	4.2	0.1	3.7	8.6	5.1	0.0	0.0	0.0	0.0	0.3	2.4	0.6	0.7	1.5	3.6	0.8	0.1	0.2	0.6	0.8	0.5	11.9	9.1	0.5	10.7	0.0	0.4	0.3	12.7	9.4	4.5	14.0	0.0	28.2	21.6	24.5	0.3	0.1	17.1	0.0	20.6	20.1	0.8	11.8	0.0	2.9	2.4	0.0	7.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.1	1.0	18.2	22.9	0.0	7.3	2.1	0.0	0.2	5.8	7.0	0.0	24.8	1.5	17.2	16.2
TRNP1	"C1orf225, LOC388610"	ENSG00000253368	"TMF1-regulated nuclear protein 1"	Q6NT89	1	26993707-27000898	"Predicted intracellular proteins"	"Cell cycle, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 81.1"	"Cell type enriched"	"Detected in many"	12	"Bipolar cells: 375.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.8;non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	12	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.9;BJ hTERT+: 44.5;EFO-21: 37.6;RPTEC TERT1: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.41e-1)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.88e-3)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.53e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.90e-1)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.55e-2)"	4.1	4.3	11.3	2.0	11.7	0.9	8.5	12.3	22.0	6.3	5.3	1.8	0.5	3.7	6.8	3.7	32.0	7.9	20.9	11.6	9.7	10.2	9.3	2.6	5.1	2.3	10.1	9.2	3.6	13.2	12.9	5.3	5.8	18.4	5.9	2.6	9.6	6.0	8.1	1.6	4.2	3.7	7.8	2.8	3.0	81.1	2.1	1.7	0.1	2.8	2.4	16.2	9.1	9.3	0.0	0.2	0.0	2.8	0.0	0.0	0.0	6.3	18.7	4.6	2.9	36.2	46.9	0.0	32.7	44.5	3.0	1.4	2.5	3.1	0.0	37.6	30.4	1.2	6.6	2.4	13.2	3.7	0.1	1.9	0.0	0.4	13.0	26.2	0.0	0.0	26.8	28.1	1.5	28.9	2.9	2.9	0.2	0.4	0.0	7.2	0.9	0.0	0.4	6.0	28.7	31.0	1.8	0.0	0.5	37.5	1.9	7.7	0.5	6.3	1.3	14.9	3.0	0.6	0.1	15.3	1.0	7.5	16.0	1.4	0.0	0.1	0.1	1.0	0.1	1.8	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	11.3	11.7	12.3	22.0	9.7	10.2	10.1	9.2	18.4	1.7	17.9	1.1	0.0	10.1	6.5	375.7	21.9	30.6	2.7	3.4	8.7	7.9	0.1	26.6	6.9	0.4	1.0	0.0	0.0	27.2	0.1	1.4	4.0	0.0	0.2	0.2	7.9	11.5	1.8	1.9	0.0	8.9	0.8	3.3	1.8	0.5	27.5	20.3	0.0	2.8	0.0	31.8	25.8	13.3	1.4	0.5	7.8	0.0	0.0	0.2	9.5
FAM46B	MGC16491	ENSG00000158246	"Family with sequence similarity 46 member B"	Q96A09	1	27005020-27012836	"Predicted secreted proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.8;tongue: 42.0"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 59.6;Basal keratinocytes: 91.9;Suprabasal keratinocytes: 129.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 32.4;hTERT-HME1: 16.7;NTERA-2: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"	NA	NA						"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	3.3	0.6	0.6	3.9	0.3	0.1	10.4	0.3	0.4	20.6	13.4	0.4	3.6	0.8	8.0	2.8	55.8	5.5	4.0	9.1	0.2	0.0	3.8	0.5	11.6	0.7	0.4	0.9	3.8	1.2	1.0	0.7	7.4	0.9	6.8	1.2	1.5	23.5	11.1	0.9	36.3	3.5	21.5	0.3	0.4	6.8	4.6	0.1	0.6	3.1	42.0	18.7	23.0	13.6	0.0	0.4	1.3	2.5	0.0	0.0	0.0	1.9	0.3	4.0	1.2	0.5	0.6	1.0	2.8	0.9	11.3	4.5	7.7	2.6	0.0	4.8	1.5	2.5	6.3	0.7	10.3	3.0	0.0	0.6	0.1	1.5	1.3	5.7	0.0	0.2	2.6	32.4	3.4	16.7	0.0	0.1	0.0	0.2	0.0	1.4	1.5	0.0	0.6	17.0	1.4	0.8	0.2	0.0	0.1	11.0	0.0	0.4	0.3	5.4	12.2	7.1	8.7	9.6	0.1	0.2	2.7	9.4	0.3	0.6	0.1	0.4	0.0	0.5	0.0	1.7	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.4	0.2	0.0	0.4	0.9	0.9	0.1	59.6	1.9	0.0	24.5	91.9	0.1	0.0	0.0	2.7	0.0	0.0	0.0	1.7	0.0	0.0	1.4	0.5	1.1	0.0	0.0	2.6	2.4	12.8	0.0	0.0	0.5	0.0	7.0	1.8	0.0	1.4	4.6	0.8	6.8	0.0	1.2	5.0	0.0	0.0	1.8	0.0	0.6	0.0	17.8	5.8	3.9	129.2	4.5	0.0	0.9	10.6
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.7	4.7	4.5	4.5	10.2	7.4	27.6	11.3	17.3	9.9	10.8	5.7	9.0	6.2	9.7	14.7	4.8	17.2	4.4	28.0	6.2	7.4	4.1	9.5	3.1	2.4	31.1	5.5	7.2	9.2	13.6	16.7	23.3	7.2	16.4	4.4	2.6	6.1	14.5	8.2	2.8	2.9	6.2	17.0	9.8	5.1	4.0	2.9	5.2	20.8	5.2	1.6	9.5	13.0	5.7	4.8	6.0	3.5	17.6	10.6	4.2	9.8	6.2	5.5	3.5	1.8	11.3	6.2	6.1	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9	6.0	17.9	5.2	16.2	27.7	6.3	11.3	10.2	0.0	3.4	10.4	0.0	30.0	0.0	8.5	26.9	7.1	52.0	0.0	10.9	16.2	11.0	8.8	26.5	1.0	11.5	19.1	12.0	8.0	4.9	9.7	8.6	6.6	6.8	1.8	12.3	10.8	19.4	22.0	12.4	1.3	3.6	6.5	8.7	1.4	3.4	22.0	44.3	6.7	14.3	16.3
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234516-27308633	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	14.7	17.5	20.2	11.1	22.0	13.2	12.1	21.8	28.4	15.0	15.3	20.7	14.1	13.3	14.5	9.1	12.4	21.1	11.0	29.1	18.0	15.0	13.6	13.0	14.3	13.3	15.8	16.1	15.8	22.3	49.3	12.3	10.9	19.7	14.3	10.1	29.6	20.6	16.5	51.1	20.9	14.2	12.8	15.1	13.2	15.2	28.3	16.5	21.0	19.4	12.1	14.0	15.0	12.3	1.3	1.5	5.6	0.8	0.8	3.3	1.2	13.0	5.7	9.3	0.9	13.3	11.1	3.9	8.1	13.6	8.7	10.6	1.9	13.2	11.1	9.8	16.1	6.5	6.8	8.7	12.3	7.5	15.3	15.0	11.5	6.6	5.2	12.0	5.9	15.6	10.5	20.2	10.8	9.9	15.9	11.8	3.7	11.7	11.9	9.1	7.2	9.6	14.5	4.4	8.7	12.5	4.8	7.0	12.3	10.2	2.9	13.7	11.8	10.5	4.5	9.5	7.3	6.7	10.4	10.0	7.1	4.4	10.1	3.9	17.2	9.2	5.4	14.6	11.4	8.5	0.3	0.5	5.6	3.3	0.8	1.3	1.3	0.8	1.4	1.5	0.8	0.6	1.5	4.8	0.8	0.6	1.0	0.9	1.2	20.2	22.0	21.8	28.4	18.0	15.0	15.8	16.1	19.7	16.5	8.9	12.5	5.1	9.7	11.4	24.2	12.2	7.6	6.7	5.7	29.6	51.1	10.4	8.3	13.9	22.7	7.1	16.7	0.0	12.2	4.0	7.2	12.5	1.1	15.5	11.3	20.6	16.0	17.8	18.9	50.8	15.8	9.7	10.1	14.4	19.3	16.1	13.2	5.8	15.6	14.3	68.8	6.5	8.1	34.9	5.7	15.2	13.7	13.8	15.5	12.8
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	18.4	22.0	28.0	12.0	31.4	19.5	17.8	23.2	45.4	18.1	17.1	32.1	13.2	14.4	16.5	25.0	22.8	29.8	21.3	27.5	28.9	30.8	20.6	35.0	18.8	15.0	26.0	20.8	22.3	24.6	19.9	22.4	20.0	26.7	22.9	14.3	26.4	21.7	25.2	19.9	15.6	21.3	18.6	21.5	15.2	16.7	20.7	16.4	19.4	24.0	14.9	19.1	17.8	13.3	22.8	19.9	36.5	21.0	19.2	23.2	15.7	12.2	14.9	12.5	20.5	19.6	14.2	10.1	19.0	21.9	26.0	22.2	6.1	25.8	7.8	14.9	20.2	12.1	17.0	13.7	18.5	10.9	10.3	26.3	13.0	12.4	14.0	29.1	12.9	13.0	24.8	10.5	24.9	14.2	12.0	17.3	15.6	9.8	18.1	16.2	10.9	18.5	13.6	23.5	12.7	18.7	15.4	8.7	15.7	25.2	7.2	27.0	23.8	14.7	20.8	18.3	4.7	20.5	20.9	15.8	15.4	13.0	24.7	17.9	19.5	17.3	8.1	23.3	25.1	22.1	19.3	13.7	17.0	22.3	20.3	17.0	22.8	20.7	17.0	12.0	18.9	20.9	21.4	36.5	19.2	21.0	19.9	23.2	15.7	28.0	31.4	23.2	45.4	28.9	30.8	26.0	20.8	26.7	16.4	8.9	15.7	15.7	11.9	10.4	39.6	7.7	10.2	5.3	5.7	12.2	13.7	26.0	33.2	33.2	19.8	15.4	22.2	23.3	35.0	28.5	23.5	15.6	16.2	11.3	24.4	41.3	28.7	9.2	9.1	60.6	18.7	11.4	25.3	29.7	17.4	52.7	36.4	17.5	18.7	17.0	17.1	12.9	14.6	18.9	17.7	11.8	25.7	22.3	19.1	10.1
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 70.0;Basal glandular cells: 70.0;Urothelial cells: 73.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 8.8;cerebellum: 30.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 20.2;CAPAN-2: 23.1;NB-4: 32.8;U-266/70: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA					"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	0.6	0.1	8.8	20.8	0.5	19.2	5.6	30.2	0.7	9.1	3.7	0.4	15.7	3.4	2.5	5.1	38.1	7.2	15.3	0.9	1.1	0.4	1.7	0.7	8.6	13.5	0.7	0.7	2.3	50.8	2.5	7.2	3.6	1.8	20.6	1.4	0.9	42.6	20.5	0.4	26.2	5.7	3.0	0.4	14.5	15.4	0.7	0.5	20.3	4.7	26.4	47.4	12.5	15.7	14.5	15.9	52.3	28.9	14.5	21.6	11.2	4.5	0.0	0.0	0.1	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.4	23.1	3.4	4.6	0.0	0.1	14.4	0.0	8.6	0.0	0.0	0.8	0.4	0.3	6.0	0.3	8.8	0.0	0.0	16.0	0.0	3.3	0.0	0.0	11.7	0.3	4.0	0.0	5.9	5.1	32.8	0.2	7.7	2.3	6.0	0.0	16.0	3.6	3.8	6.8	0.3	0.0	6.7	0.2	0.2	17.0	9.5	0.0	0.0	2.2	0.0	0.0	18.8	4.5	3.0	0.6	11.3	0.0	11.8	6.0	52.3	21.6	14.8	19.4	14.5	17.1	17.5	15.9	11.2	10.4	12.4	10.7	14.5	28.9	0.9	19.2	11.2	8.8	0.5	30.2	0.7	1.1	0.4	0.7	0.7	1.8	0.5	20.8	12.8	70.0	70.0	36.6	0.5	3.4	7.6	28.1	40.9	0.0	0.0	29.4	6.6	3.8	0.5	2.6	2.8	0.0	21.6	7.6	3.5	47.6	1.1	0.6	2.8	0.0	10.9	3.1	7.6	0.4	0.3	6.1	10.1	0.0	26.9	1.0	12.9	2.9	0.7	3.8	0.7	0.0	1.7	12.5	13.6	48.3	11.8	47.9	7.4	73.2
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.5	7.0	6.3	7.0	8.8	15.4	1.6	9.4	5.4	7.1	5.4	2.1	10.2	0.1	8.4	14.2	2.8	11.9	2.1	6.5	3.6	6.2	5.2	0.5	16.2	3.1	2.7	0.5	0.6	12.4	16.1	7.4	2.6	7.9	4.8	0.5	2.3	4.1	11.3	18.7	0.3	8.6	2.0	7.5	5.8	2.7	4.2	1.7	10.6	7.9	2.3	3.5	9.9	8.7	7.4	2.7	4.6	6.4	9.9	17.9	7.5	19.9	4.9	3.4	4.2	0.1	15.8	6.1	5.2	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0	17.9	16.2	4.7	10.4	11.1	0.5	8.9	10.2	1.4	11.4	3.5	0.0	0.9	3.3	2.3	0.4	15.8	1.7	0.0	3.8	1.7	7.7	7.3	2.3	0.8	2.5	4.8	0.0	28.8	12.5	1.1	15.0	5.1	5.0	13.6	4.9	5.2	8.9	0.0	14.2	1.5	0.4	6.5	10.5	8.7	2.1	12.9	0.1	10.2	4.3	14.4
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369112-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 83.2;lung: 153.7"	"Cell type enriched"	"Detected in many"	14	"Ito cells: 3886.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.8;MCF7: 2.2;U-2197: 2.2"									CAB025945	Approved				"Secreted to blood"	NA	NA	22800000000	33000000000			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	7.2	5.0	0.1	1.7	0.2	0.0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1.0	0.5	0.5	25.0	0.4	0.0	13.0	83.2	153.7	1.0	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1.0	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.8	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.8	0.4	0.6	0.0	1.0	1.1	0.0	0.4	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.3	0.2	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.6	0.0	0.0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	1.1	0.2	0.0	15.2	66.2	0.3	0.7	0.0	2.0	81.5	4.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	99.1	0.0	93.5	0.0	0.0	0.2	0.4	3.5	6.8	0.3	0.0	0.0	3886.1	270.1	2.2	3.1	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.4	0.6	1.0	0.0	8.6	0.0	0.3
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.8"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA062915: AB_2684903"	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.2	0.1	0.5	0.0	2.3	0.1	0.4	3.2	0.4	0.7	1.2	0.0	0.4	12.6	13.4	26.8	0.1	0.1	0.4	0.4	0.4	0.3	7.4	0.1	0.1	0.6	3.3	0.3	0.4	5.8	0.1	1.1	2.4	0.2	1.0	12.9	0.3	0.1	8.1	0.1	0.1	0.1	0.1	0.2	1.0	0.4	0.1	0.9	5.9	6.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.7	2.0	0.1	0.0	0.0	0.1	1.0	0.0	1.0	0.0	0.0	4.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.4	0.4	0.4	0.1	0.6	1.1	0.4	0.0	3.0	0.0	8.0	2.6	0.0	0.6	0.0	62.9	4.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.5	0.0	0.0	0.0	3.1
GPR3	ACCA	ENSG00000181773	"G protein-coupled receptor 3"	P46089	1	27392644-27395814	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.9"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 1.8;Cardiomyocytes: 3.2;Horizontal cells: 4.8;Intestinal endocrine cells: 4.6;Smooth muscle cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB006254	Uncertain					NA	NA					"CAB006254: AB_425462"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.30e-3)"	"unprognostic (6.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-2)"	3.5	1.5	4.0	2.8	7.5	3.2	1.5	5.5	12.3	1.2	1.1	2.1	0.2	1.0	2.3	0.5	2.0	1.1	2.9	7.1	5.0	6.3	1.9	2.0	2.7	1.0	4.4	1.7	1.2	2.6	2.8	6.1	1.8	13.9	1.8	1.1	1.1	0.7	1.0	0.6	0.6	0.9	2.5	6.5	0.7	1.3	0.8	0.5	0.0	3.0	0.8	0.7	1.6	0.5	0.7	0.4	0.0	0.1	0.0	0.1	0.0	1.6	0.9	4.8	5.4	0.2	0.6	0.6	3.1	3.6	4.8	3.5	1.4	1.0	0.3	0.7	1.4	4.9	1.2	1.3	3.8	3.7	0.1	0.2	1.3	0.3	3.0	0.6	3.0	4.1	0.7	0.0	6.7	1.5	0.5	1.5	2.1	3.7	5.3	5.8	2.4	0.6	4.2	7.1	2.4	7.6	8.1	3.8	2.2	2.0	0.4	0.9	2.3	1.5	0.6	5.7	2.2	0.1	0.6	0.9	3.6	6.5	21.0	3.7	0.7	3.6	0.4	5.4	1.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.0	7.5	5.5	12.3	5.0	6.3	4.4	1.7	13.9	0.5	0.0	0.0	0.0	1.8	0.1	1.4	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.2	4.8	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.3	0.1
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WAS protein family member 2"	Q9Y6W5	1	27404226-27490158	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		470000	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: AB_2679287"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	36.9	23.3	22.0	23.8	30.0	30.0	28.6	13.6	24.0	31.9	28.8	33.2	13.2	15.7	36.9	16.0	55.3	28.8	22.3	20.5	22.8	13.1	20.2	11.6	29.4	31.1	32.5	12.6	38.8	24.0	21.3	14.8	29.7	23.2	26.4	23.3	22.2	25.6	26.1	11.4	35.1	26.7	42.9	31.5	34.0	26.4	20.7	32.7	32.3	21.6	22.2	35.2	39.1	30.3	18.9	21.8	36.9	38.4	8.5	12.9	16.8	24.4	11.7	27.3	24.8	19.9	26.1	15.8	20.0	18.6	22.1	19.9	10.1	26.5	17.0	19.4	31.2	15.0	19.7	21.9	32.8	26.5	23.8	13.8	37.1	20.8	11.9	26.8	29.6	21.4	23.8	35.8	24.0	45.0	24.0	27.6	19.0	29.5	8.9	29.9	8.8	22.0	13.6	21.9	12.5	18.1	46.1	33.5	17.4	15.8	13.9	13.6	15.0	34.9	15.6	26.1	17.3	13.0	18.0	36.2	18.4	19.1	38.0	15.7	18.3	24.1	22.8	21.7	36.8	20.6	14.8	23.3	18.5	12.9	29.1	10.5	14.1	10.2	8.9	14.8	18.9	10.7	8.1	36.9	8.5	38.4	21.8	10.2	16.8	22.0	30.0	13.6	24.0	22.8	13.1	32.5	12.6	23.2	32.7	62.5	51.0	92.0	173.5	131.5	24.5	30.1	86.6	64.3	69.4	85.5	13.7	174.6	53.0	89.1	42.3	188.8	120.0	46.7	88.6	107.9	114.2	242.5	56.7	41.4	133.0	19.1	104.2	120.3	180.2	47.6	152.8	97.4	72.6	162.3	79.4	56.5	119.6	91.2	171.5	37.6	19.4	135.8	119.5	121.8	114.1	170.0	120.0	87.1	89.2	299.4
AHDC1	"DJ159A19.3, RP1-159A19.1"	ENSG00000126705	"AT-hook DNA binding motif containing 1"	Q5TGY3	1	27534035-27604431	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028648, HPA028685, HPA028691"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781"	"unprognostic (1.96e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.43e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (5.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	10.2	17.6	16.9	6.7	12.9	4.6	7.7	40.3	21.7	15.3	8.7	5.8	6.7	5.2	16.8	6.6	20.4	13.5	7.5	9.9	15.2	7.4	7.2	5.6	6.6	5.7	8.2	12.7	19.0	7.5	4.3	16.0	8.4	13.7	8.0	3.0	8.8	15.4	13.1	41.5	21.3	5.6	11.0	14.6	18.2	9.3	8.9	12.9	9.1	12.8	10.9	10.6	9.8	14.0	0.6	1.6	0.9	0.7	2.0	1.4	0.7	7.6	7.0	9.9	5.3	3.2	5.3	10.1	7.2	5.2	5.0	4.2	2.7	7.2	1.1	5.3	4.8	3.0	7.7	1.0	9.4	1.4	2.8	3.8	6.0	6.3	3.6	3.0	1.6	3.1	5.0	3.9	3.5	2.2	5.1	2.6	3.6	7.2	0.9	8.3	3.7	5.1	8.6	7.3	1.9	8.7	22.9	11.9	0.6	3.3	1.0	17.1	6.5	5.0	8.3	2.0	3.5	4.1	1.3	4.8	8.7	7.2	6.4	2.2	2.5	1.7	1.2	7.4	4.8	4.9	0.9	0.4	0.5	1.2	0.6	0.7	0.5	1.0	1.2	0.4	0.6	1.4	1.0	0.7	2.0	0.7	1.6	1.1	0.7	16.9	12.9	40.3	21.7	15.2	7.4	8.2	12.7	13.7	12.9	6.0	6.9	8.2	7.7	44.0	32.7	14.2	2.5	5.3	9.1	17.4	0.0	9.1	3.3	9.3	0.6	11.9	5.6	0.0	11.8	4.0	19.6	9.7	0.0	9.7	11.2	33.4	9.4	14.7	2.1	1.9	48.1	4.1	15.1	2.8	6.1	11.7	12.9	5.8	59.8	4.4	1.8	38.8	15.6	2.6	4.3	49.1	4.7	4.5	6.3	11.3
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 30.1;U-266/70: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	55.9	0.7	2.3	0.0	6.8	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1	6.0	30.7	12.5	0.5	2.5	0.0	1.6	2.5	2.7	10.3	1.8	0.0	0.4	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.5	1.4	0.3	12.7	0.9	58.9	0.0	0.0	4.3	187.9	0.4	0.3	86.1	1.7	7.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.2	0.5	1.0	0.8	45.8	0.0	0.9
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666061-27672218	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 225.6"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5"					"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	32.3	27.5	24.9	13.5	28.2	37.3	10.9	14.2	36.1	11.4	13.8	22.9	6.5	16.5	26.8	68.0	8.6	11.9	113.9	19.3	23.0	42.3	44.8	23.5	31.6	5.8	20.0	17.0	14.1	21.3	5.9	60.1	225.6	34.3	13.9	10.1	31.6	111.4	10.1	7.4	5.4	12.5	17.0	26.0	27.3	35.4	15.4	6.8	24.8	35.2	7.9	9.7	7.8	7.6	9.7	19.4	84.9	58.6	15.8	27.5	16.8	1.4	0.4	2.2	1.4	7.3	4.0	9.0	4.7	21.7	134.5	157.3	0.7	5.7	0.5	54.1	2.1	35.6	0.5	0.5	1.0	4.4	11.1	1.8	3.4	1.1	0.4	1.9	1.1	4.5	4.3	0.1	8.1	0.1	2.1	1.2	3.1	0.2	9.5	1.5	0.4	4.1	14.5	0.4	2.7	4.5	2.8	1.2	1.3	1.1	0.0	3.2	2.9	5.8	1.3	95.5	0.7	0.6	4.4	2.1	1.2	1.9	0.9	0.8	11.3	6.4	0.3	2.4	10.1	3.5	29.3	44.4	39.4	22.7	58.6	22.4	9.7	23.0	20.7	19.4	8.0	24.3	23.6	84.9	15.8	38.8	2.0	27.5	16.8	24.9	28.2	14.2	36.1	23.0	42.3	20.0	17.0	34.3	6.8	131.0	105.4	20.9	17.6	20.8	10.1	13.4	73.9	88.3	37.5	61.1	9.8	3308.6	16.6	186.8	2.9	139.0	7.0	0.0	304.1	1015.8	142.9	71.5	60.2	43.3	628.8	3.2	56.0	68.2	47.6	8.5	102.4	129.6	67.4	56.9	22.2	79.9	144.2	8.7	192.3	28.3	5.5	109.9	38.2	1.7	0.9	19.6	3573.6	51.2	8.0	13.6
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725979-27763122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 122.7;Late spermatids: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	22.1	8.6	10.6	12.2	17.2	14.3	14.1	17.9	18.3	14.7	12.8	17.4	8.4	10.2	15.9	16.6	13.9	13.8	15.3	13.8	11.3	11.4	13.7	13.8	13.1	11.3	9.5	16.1	14.6	14.4	11.7	19.5	12.8	14.3	12.9	16.2	15.7	12.4	16.8	39.7	15.4	12.1	17.8	11.9	12.1	13.8	28.5	10.9	13.6	18.7	17.8	13.8	14.0	14.1	13.6	14.6	13.7	12.2	12.0	16.0	6.4	8.8	7.1	8.1	8.4	10.3	9.0	14.7	8.3	8.7	12.3	12.1	8.1	11.9	16.1	5.4	9.2	11.6	11.7	10.2	9.1	9.6	8.3	7.7	5.0	10.0	9.5	8.3	7.9	7.8	9.1	9.9	13.4	13.6	6.2	6.1	8.7	9.4	15.2	8.8	8.5	18.7	7.3	12.8	8.5	7.1	11.4	9.7	9.1	9.7	12.7	11.8	5.3	9.5	10.3	9.9	10.4	7.4	3.1	6.5	14.6	6.3	16.8	5.7	13.9	15.1	13.2	9.0	10.4	6.2	10.0	12.2	13.7	14.7	12.1	15.6	12.2	15.3	14.0	10.4	13.6	14.5	16.0	8.3	12.0	12.1	14.6	11.3	6.4	10.6	17.2	17.9	18.3	11.3	11.4	9.5	16.1	14.3	10.9	26.8	17.1	25.3	8.5	16.9	27.1	13.2	7.6	26.8	9.1	22.7	25.5	23.1	18.3	9.7	122.7	11.3	8.6	23.3	8.5	9.5	13.4	4.4	10.5	15.3	10.5	27.0	4.1	20.9	15.6	84.8	15.5	14.5	37.1	7.2	9.5	20.5	8.4	8.5	35.0	12.4	35.8	19.4	17.9	20.0	49.8	23.6	38.0	17.8	8.5	3.9
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773183-27824452	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		No	No			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: AB_2682778"	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	38.5	20.2	32.2	16.3	29.6	6.3	22.9	25.8	35.9	20.3	19.4	27.3	23.5	22.9	20.4	42.1	25.7	15.0	25.9	15.3	31.2	31.9	23.2	18.5	31.2	16.3	35.5	29.0	15.2	19.5	16.7	19.6	21.1	32.3	20.8	21.4	11.6	17.7	22.2	14.2	17.1	20.9	23.1	36.9	20.0	38.7	9.0	19.9	6.3	67.0	11.0	13.9	19.4	14.8	7.6	14.2	10.1	21.7	5.2	6.4	8.3	8.8	4.2	11.5	7.5	21.9	26.7	5.9	18.7	27.6	17.2	19.6	5.2	11.5	9.6	20.1	25.0	7.4	7.4	7.5	9.3	17.3	8.5	9.0	5.5	4.7	5.2	17.2	6.0	11.6	25.0	11.4	24.2	13.9	14.2	27.6	5.6	7.2	9.7	18.7	3.2	5.2	4.6	4.8	13.1	6.0	3.3	9.2	5.8	15.2	14.6	12.9	7.0	8.8	7.6	13.5	9.7	5.2	5.4	29.6	8.8	5.0	19.9	6.4	5.8	4.2	5.6	14.2	9.3	12.3	10.1	19.6	7.5	3.7	21.7	6.4	7.6	4.4	5.7	14.2	6.5	4.9	4.1	9.3	5.2	21.0	7.0	4.4	8.3	32.2	29.6	25.8	31.8	31.2	31.9	35.5	29.0	32.3	19.9	50.6	27.6	22.7	84.1	97.1	42.7	15.9	28.1	17.4	38.7	54.1	29.5	25.5	31.5	43.8	1.6	48.9	48.7	0.0	51.3	28.6	42.2	58.3	22.0	15.5	45.8	25.4	39.6	55.3	69.4	1.5	33.4	58.6	50.6	19.8	27.1	61.7	52.7	46.0	44.6	44.7	48.6	38.8	58.4	14.9	17.5	86.7	65.2	22.3	26.7	83.3
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830778-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	18.0	14.5	28.6	15.5	37.0	23.2	19.4	23.1	29.7	18.9	16.0	18.2	12.0	13.3	24.0	15.6	19.6	19.4	14.6	16.2	23.4	17.7	13.9	14.8	17.6	28.6	24.6	25.7	24.6	18.5	14.2	18.9	17.4	24.4	15.3	18.0	11.7	15.1	19.5	17.8	17.8	15.1	21.8	24.6	16.9	14.3	21.4	25.6	20.7	17.9	9.4	24.6	18.6	16.0	11.9	9.7	17.0	11.4	14.0	16.5	14.9	21.1	15.0	32.7	21.2	20.6	21.6	18.8	22.8	24.0	39.1	31.7	16.8	24.4	30.3	16.1	25.9	15.2	19.1	38.4	21.3	28.4	25.4	23.4	39.5	20.4	24.7	20.8	36.3	28.1	18.8	23.3	35.4	31.7	17.6	23.1	26.0	33.4	20.7	23.2	13.8	39.6	21.4	40.4	18.7	17.5	32.5	27.1	28.8	21.0	19.5	22.9	20.9	28.0	21.9	27.0	17.5	19.2	22.9	19.0	19.3	17.6	30.2	21.1	19.2	29.3	38.3	18.8	47.4	24.6	17.0	10.0	9.1	14.0	10.0	16.5	11.6	11.6	15.8	9.7	11.9	12.8	12.1	5.9	14.0	11.4	7.3	11.4	14.9	28.6	37.0	23.1	29.7	23.4	17.7	24.6	25.7	24.4	25.6	14.9	7.7	28.1	17.4	15.3	22.6	11.5	7.6	18.7	20.5	5.2	2.0	41.6	26.6	24.8	26.4	14.6	12.6	0.0	22.4	34.1	19.0	13.0	25.4	15.8	23.1	7.9	11.1	20.3	14.3	18.7	22.2	16.9	10.1	40.5	14.5	19.8	24.7	16.1	15.9	19.9	13.9	25.8	16.4	27.9	40.2	12.3	36.7	24.5	15.3	17.4
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 60.6;Kupffer cells: 120.5;Macrophages: 117.1;monocytes: 154.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 48.2;U-266/70: 37.4;U-937: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	13.4	5.2	4.3	27.2	7.2	72.3	5.8	0.9	4.6	3.6	7.2	10.7	0.3	4.1	3.0	6.6	4.6	5.4	9.5	6.5	7.1	4.6	5.9	7.5	22.1	39.0	11.5	2.7	3.8	2.7	1.0	2.7	7.1	7.8	2.8	4.2	6.0	6.0	1.8	2.3	2.3	12.7	6.0	16.4	73.0	4.8	9.9	6.7	12.5	5.3	1.1	25.2	7.8	3.3	6.5	43.6	72.0	62.6	8.5	11.3	40.5	3.2	0.1	1.2	0.2	4.1	5.7	0.5	0.6	7.0	10.3	14.6	0.4	0.8	4.5	0.4	2.2	5.7	0.4	1.8	0.4	1.6	0.6	0.4	6.3	0.1	0.9	8.2	7.8	10.3	2.9	0.1	5.3	0.0	0.5	3.9	0.3	8.8	48.2	0.7	2.1	0.3	6.8	4.1	0.1	0.7	1.4	4.6	7.9	3.0	0.1	0.0	1.8	0.0	0.2	9.0	0.7	0.1	6.9	2.4	0.6	0.0	2.0	0.1	37.4	2.1	0.3	11.6	21.9	0.1	4.4	54.1	47.1	11.3	62.6	10.3	6.5	8.2	9.1	43.6	2.9	7.1	7.3	72.0	8.5	60.9	17.7	7.9	40.5	4.3	7.2	0.9	4.6	7.1	4.6	11.5	2.7	7.8	6.7	3.0	30.7	30.5	1.4	2.9	0.3	0.5	5.1	1.4	5.7	0.0	0.0	0.6	0.0	0.5	0.9	2.2	0.0	0.0	7.5	1.0	1.8	2.2	12.7	0.8	60.6	0.0	10.3	5.5	120.5	3.6	0.6	117.1	16.9	154.1	0.1	0.0	7.4	0.0	0.4	0.3	0.2	0.0	0.5	0.7	1.9	1.0	2.1	49.0	0.0	3.8
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	18.6	17.1	33.6	24.3	38.8	20.5	26.6	23.6	30.5	20.0	15.4	17.2	17.6	9.9	19.5	26.3	18.7	28.8	19.2	22.5	31.4	22.1	19.5	18.4	19.3	37.1	22.0	26.7	32.6	15.3	16.4	27.0	17.2	25.4	17.2	19.0	18.0	16.2	19.8	45.0	22.6	16.8	18.6	22.1	28.4	15.3	34.6	27.7	25.4	30.7	17.2	37.9	20.3	17.1	46.2	31.5	48.4	18.1	49.3	55.9	65.9	13.2	12.6	21.2	16.0	14.4	13.4	12.9	24.6	16.7	31.5	27.4	17.9	16.4	33.7	15.8	9.7	11.3	12.3	30.0	13.9	30.8	25.0	27.8	39.2	17.1	15.4	7.3	52.0	27.6	5.7	7.8	30.4	15.7	9.8	13.6	30.6	40.9	29.4	18.2	13.4	37.0	22.7	41.6	26.0	27.1	24.7	31.5	15.7	11.3	14.4	18.1	17.6	27.2	11.0	21.5	17.6	11.3	15.4	8.7	7.8	16.9	42.1	16.1	23.9	53.2	29.3	19.3	46.1	14.0	42.8	18.1	48.4	51.6	14.0	55.9	46.2	48.8	47.3	20.4	39.0	55.8	53.9	18.1	49.3	18.1	31.5	42.5	65.9	33.6	38.8	23.6	30.5	31.4	22.1	22.0	26.7	25.4	27.7	20.8	14.9	53.6	28.2	18.7	26.4	26.0	28.1	30.8	25.0	21.0	2.0	71.3	29.9	26.8	35.0	27.8	9.3	23.3	18.1	52.7	29.0	16.7	60.0	13.5	44.9	7.9	13.3	26.4	35.6	17.1	38.3	36.5	35.4	118.2	13.1	96.8	21.4	7.0	43.5	17.7	30.1	32.3	27.8	118.9	183.5	19.6	46.6	91.4	17.8	15.7
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 24.4;Enterocytes: 33.4;Pancreatic endocrine cells: 24.8;Paneth cells: 43.2;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.1;CAPAN-2: 17.8;NTERA-2: 13.7;RPMI-8226: 14.3;SK-BR-3: 23.0;T-47d: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		330000	Cytosol	"Golgi apparatus"	"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.6	1.2	0.0	0.1	0.0	0.0	23.1	0.0	0.5	0.3	1.7	5.9	17.8	0.8	4.2	0.0	0.3	2.9	1.9	1.6	0.3	0.0	11.8	3.8	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.5	0.2	0.5	0.5	0.1	0.5	0.2	0.0	9.3	0.0	0.4	13.7	2.0	2.1	0.2	0.1	14.3	12.4	4.6	11.9	0.2	0.0	23.0	0.6	2.5	16.6	0.7	0.0	0.0	3.9	0.0	0.0	0.1	6.0	0.3	0.4	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3	8.9	13.2	2.2	2.4	0.1	0.0	0.3	2.5	4.0	15.9	8.7	0.0	2.2	0.0	24.4	0.2	0.1	33.4	0.0	19.9	0.1	0.0	5.5	0.0	0.0	0.3	0.0	19.7	0.6	0.0	0.0	0.0	0.8	0.0	0.0	23.2	0.0	24.8	43.2	0.0	6.7	0.0	0.0	0.8	0.0	0.1	0.1	6.4	1.3	29.8	2.5
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959462-27968096	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 47.1"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 47.7;monocytes: 27.9"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in all"	10	"eosinophil: 47.1;neutrophil: 24.3"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA049984: AB_2680982, HPA053529: AB_2682179"	"prognostic favorable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	2.6	2.3	2.8	4.2	3.8	10.3	1.8	8.3	1.8	2.3	2.5			4.1	3.3	2.9	2.4	3.2	2.9	3.2	2.8	1.9	3.3	8.6	3.1	3.0	3.0		3.6	8.7	3.5	2.4	7.8		3.5	2.4		5.6	3.7	2.9	2.0	3.1	3.5	4.9	5.6	4.7	1.6			3.5		2.4	2.8	2.4	1.3	2.6	47.1	2.5	2.8	3.0	1.9	4.6	2.5	3.0	2.9	3.3	6.2	7.6	6.9	7.5	8.8	9.0	6.6	3.7	0.0	5.7	7.6	1.9	2.6	5.5	3.3	3.1	7.5	10.0	6.1	2.0	4.5	5.4	0.0	0.0	6.5	5.5	9.5	2.7	9.4	8.6	4.6	0.0	1.8	5.0	2.2	3.3	2.2	13.9	4.4	5.7	5.4	0.0	3.3	5.7	2.4	2.1	0.0	2.0	2.8	0.1	6.6	2.0	4.7	3.6	7.0	0.2	13.1	2.2	7.3	7.0	0.8	17.3	0.0	0.3	3.5	2.5	47.1	3.0	2.4	2.9	1.3	3.0	2.6	2.6	1.3	2.6	2.6	24.3	2.8	1.7	1.2	2.9	1.9											3.0	0.6	8.8	3.3	1.6	3.9	2.4	2.5	0.0	4.5	3.5	0.0	47.7	3.3	6.8	0.4	5.2	4.5	0.0	9.9	12.2	4.8	4.7	1.1	4.3	12.1	3.2	1.7	6.2	6.6	0.5	3.1	5.4	1.7	27.9	5.2	15.4	6.3	0.0	3.5	3.6	0.9	6.5	2.5	0.6	5.9	2.6	18.8	8.7	4.5	3.4
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088696	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	12.8	10.0	14.9	24.0	12.9	8.6	13.3	21.9	13.8	14.7	10.2	14.4	12.8	10.7	14.4	12.4	19.4	11.8	8.1	11.7	10.6	11.8	21.6	11.3	12.5	15.6	11.1	8.8	12.4	12.9	20.9	29.2	13.8	12.9	11.8	11.7	16.4	11.8	13.1	14.5	16.3	12.2	10.5	10.1	14.2	10.0	20.6	13.7	17.4	17.3	12.2	25.0	10.7	13.8	8.6	12.4	10.5	11.2	10.4	12.1	2.6	10.5	4.4	9.0	6.7	10.6	8.2	5.1	7.7	7.4	9.1	9.0	4.3	6.5	16.7	8.6	5.2	3.4	10.4	16.6	6.4	10.8	8.8	9.3	19.0	9.0	7.7	6.3	18.3	17.5	5.0	5.8	10.0	6.8	7.9	11.6	6.2	17.4	6.5	8.1	4.6	11.7	12.3	18.9	8.4	5.9	8.9	16.6	10.6	10.7	5.9	10.4	5.7	8.3	5.2	7.4	7.6	4.3	4.9	11.1	11.0	5.9	10.1	6.3	9.7	9.7	15.5	7.9	17.9	4.8	7.5	11.2	10.5	12.1	10.4	10.8	8.6	9.5	8.7	12.4	7.6	8.3	9.4	9.7	10.4	8.3	7.7	8.2	2.6	14.9	12.9	21.9	13.8	10.6	11.8	11.1	8.8	12.9	13.7	8.9	9.6	18.4	9.6	15.9	17.4	7.5	2.5	1.4	5.7	24.4	15.7	11.8	13.3	9.9	72.6	10.8	8.6	0.0	7.9	11.4	10.4	8.5	11.5	6.8	8.8	17.5	19.7	15.4	12.3	29.7	9.5	14.3	11.8	10.0	9.2	9.1	11.2	10.2	5.6	11.6	18.9	12.9	8.5	40.6	26.0	19.9	9.2	25.4	8.9	9.9
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 98.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 98.3;monocytes: 28.2"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 14.7;HMC-1: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	5.6	2.3	2.4	16.2	1.9	20.3	2.4	0.6	2.0	6.9	3.4	1.6	3.5	1.8	2.8	1.4	16.8	2.8	7.5	3.5	2.1	2.3	6.4	1.8	9.2	6.1	4.1	1.0	1.5	2.7	0.9	0.7	3.5	1.8	2.6	3.4	0.6	3.4	2.6	1.1	2.8	5.0	3.8	5.1	15.4	2.3	2.2	1.1	2.3	1.4	22.2	21.7	5.9	3.6	1.5	13.2	98.3	28.2	0.0	0.1	10.1	7.7	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	2.2	0.5	0.0	0.0	0.1	5.3	0.2	14.7	0.3	0.1	0.2	2.9	0.0	0.3	0.0	0.7	53.6	0.0	2.4	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	7.2	0.2	0.2	0.1	0.1	0.0	0.0	3.6	0.8	0.1	0.0	0.0	7.3	0.0	0.2	0.1	2.0	0.0	0.1	0.3	0.0	0.0	0.5	0.4	2.1	0.0	0.9	0.2	5.9	28.2	98.3	0.0	8.9	0.1	1.5	0.0	0.0	13.2	0.7	0.0	0.0	85.7	0.0	3.5	0.1	0.1	10.1	2.4	1.9	0.6	2.0	2.1	2.3	4.1	1.0	1.8	1.1	6.0	7.9	4.3	1.5	5.8	1.2	2.0	2.5	6.7	2.3	1.8	2.0	0.5	0.0	8.8	0.0	5.9	0.2	0.0	4.6	0.4	2.2	0.4	73.9	0.8	62.8	0.0	0.0	1.8	70.6	0.0	0.6	55.7	0.0	4.6	0.0	0.2	55.1	0.0	0.0	0.0	0.8	0.0	0.9	2.1	0.5	2.5	1.3	1.0	0.0	8.6
DNAJC8	SPF31	ENSG00000126698	"DnaJ heat shock protein family (Hsp40) member C8"	O75937	1	28199456-28233025	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026275, HPA026283"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026275: AB_2671823, HPA026283: AB_10600907"	"unprognostic (1.42e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.95e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.07e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (4.84e-2)"	27.3	26.9	35.9	27.8	40.1	27.5	27.7	33.6	40.7	26.3	27.2	33.6	15.8	22.6	33.1	25.9	24.5	23.6	22.5	30.5	31.2	31.7	29.0	29.1	23.4	38.5	34.2	32.5	32.0	15.0	20.0	23.8	32.4	38.2	30.0	25.4	21.4	20.7	26.1	26.4	21.8	21.8	36.0	33.0	30.3	22.3	15.7	36.0	30.8	35.1	19.9	42.8	29.6	27.7	31.9	34.8	29.6	30.8	29.6	37.0	44.0	24.9	12.9	20.4	23.4	24.7	20.3	18.2	20.8	26.0	42.0	38.6	13.5	20.4	28.7	21.6	23.1	20.8	15.5	29.9	20.4	44.6	22.5	22.2	36.8	19.8	23.9	22.3	36.2	30.4	15.5	18.3	26.5	14.0	19.8	27.8	23.9	34.3	20.2	30.6	14.5	27.5	25.4	36.9	15.6	15.0	31.3	30.2	27.5	26.7	20.6	7.4	19.1	27.3	11.7	24.6	15.8	16.8	29.6	21.3	18.8	20.4	41.9	30.9	19.2	25.1	45.1	25.2	44.3	25.4	29.6	30.5	27.8	37.0	29.3	37.0	31.9	33.5	36.1	33.1	30.7	33.6	34.1	16.2	29.6	30.8	34.8	35.1	44.0	35.9	40.1	33.6	40.7	31.2	31.7	34.2	32.5	38.2	36.0	71.5	77.9	119.9	114.0	115.2	95.1	130.7	76.5	89.7	100.1	101.2	23.6	164.5	228.8	122.3	29.6	126.6	51.6	70.0	85.7	129.7	132.6	93.6	134.3	64.5	156.1	65.2	44.2	86.5	68.5	31.5	111.7	136.1	97.8	171.3	45.8	156.0	94.7	57.5	135.4	133.6	90.4	84.1	106.1	126.5	83.5	96.4	187.4	117.7	62.3	94.7
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1141.6;Distal tubular cells: 877.0;Exocrine glandular cells: 585.4;Proximal tubular cells: 988.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria		NA	NA		1800000	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favorable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	17.1	35.1	65.9	32.1	64.0	58.5	20.9	41.8	71.7	24.6	54.5	15.7	33.8	78.2	18.6	24.1	26.4	31.9	38.4	135.2	51.8	60.7	60.2	55.4	20.1	28.7	46.8	58.7	20.5	33.8	20.7	37.6	19.4	53.0	30.4	30.5	24.8	34.5	34.4	135.2	26.3	58.7	15.4	31.0	25.9	45.0	72.4	26.2	24.3	25.0	44.6	23.5	17.9	18.6	56.5	64.2	35.7	35.2	39.1	64.8	55.2	45.6	23.7	13.9	13.2	10.5	11.5	16.6	20.5	10.2	17.6	17.3	22.8	33.5	32.3	30.9	12.4	6.6	27.9	15.9	20.4	13.9	24.1	53.6	27.6	102.7	30.7	11.4	21.0	28.0	13.3	33.9	15.6	12.6	17.2	16.8	38.6	48.8	29.5	12.5	30.3	31.2	38.9	46.3	17.2	29.3	29.9	15.4	45.6	34.2	30.4	28.2	20.3	25.4	26.5	26.1	14.2	39.3	23.3	17.3	5.7	15.7	22.2	24.1	76.4	46.0	44.6	27.0	57.7	6.6	30.3	35.2	35.7	46.5	31.7	46.2	56.5	49.6	49.1	42.3	43.7	46.7	45.0	30.9	39.1	28.3	64.2	64.8	55.2	65.9	64.0	41.8	71.7	51.8	60.7	46.8	58.7	53.0	26.2	190.6	249.0	0.0	0.0	0.0	0.0	0.0	0.0	1141.6	276.4	518.2	0.0	390.3	877.0	342.1	0.0	0.0	0.0	0.0	585.4	173.6	0.0	0.0	159.3	0.0	316.5	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	214.6	0.0	0.0	472.8	0.0	0.0	988.7	0.0	0.0	0.0	0.0	0.0	0.0	210.5	0.0	0.0	0.0
SESN2	"DKFZp761M0212, HI95, SES2, SEST2"	ENSG00000130766	"Sestrin 2"	P58004	1	28259527-28282491	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 23.1;SK-MEL-30: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018191	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA018191: AB_1856750"	"unprognostic (7.05e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (8.97e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	9.2	7.7	7.0	6.8	6.7	32.0	7.6	6.1	11.1	6.1	9.6	3.5	4.6	14.3	7.2	4.0	15.2	6.2	7.6	4.3	4.5	6.1	12.5	18.4	7.7	4.1	8.4	4.5	22.4	10.4	7.5	5.4	9.3	7.6	5.2	8.3	6.9	14.5	4.6	5.8	4.9	12.6	6.2	10.9	5.8	7.2	9.2	4.3	4.8	7.0	4.2	9.7	7.3	14.9	1.9	2.8	6.2	2.7	3.9	9.6	2.5	2.6	1.4	3.5	5.8	5.7	4.5	19.2	5.1	4.7	3.1	3.7	2.0	1.9	3.0	2.1	2.3	3.5	2.6	4.1	3.6	2.2	2.7	3.8	1.2	2.0	3.4	18.8	4.5	6.8	14.3	23.1	8.4	20.1	1.4	3.4	7.1	7.1	14.5	2.9	1.5	1.6	1.2	2.8	1.2	2.9	2.5	0.9	6.6	2.1	4.5	1.2	1.3	1.4	1.2	27.9	4.0	3.2	6.4	1.9	1.6	4.9	3.6	3.1	18.8	4.7	4.7	3.7	4.6	3.5	0.0	2.3	1.9	9.6	1.9	4.7	1.9	3.4	4.6	2.4	1.4	2.1	4.3	6.2	3.9	2.7	2.8	3.9	2.5	7.0	6.7	6.1	11.1	4.5	6.1	8.4	4.5	7.6	4.3	0.0	5.3	7.3	16.1	15.0	12.1	6.1	7.6	1.4	1.2	7.0	7.9	25.1	3.3	20.3	2.0	5.8	23.8	0.0	14.6	17.0	10.4	12.6	4.6	18.8	11.7	0.0	12.6	8.0	3.3	2.7	2.3	10.9	6.8	7.2	10.7	5.8	23.7	11.5	3.2	20.7	7.4	0.0	21.9	4.7	3.3	10.9	56.0	12.8	11.5	19.1
MED18	"FLJ20045, p28b, SRB5"	ENSG00000130772	"Mediator complex subunit 18"	Q9BUE0	1	28329002-28335967	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027429	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027429: AB_10610137"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.78e-3)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.38e-5)"	"prognostic favorable (6.72e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.69e-2)"	9.8	11.2	6.2	9.2	6.7	5.9	7.9	5.5	12.1	7.7	11.4	7.1	8.9	9.7	8.1	9.1	13.3	9.9	9.5	8.4	6.6	6.7	11.6	19.2	6.7	11.8	8.5	6.6	7.0	12.3	5.7	7.1	12.4	8.6	8.6	10.3	7.8	10.2	7.3	10.9	9.1	13.0	6.9	6.0	14.3	9.9	8.5	6.9	17.0	11.0	6.1	18.5	8.4	6.6	8.3	8.3	11.6	8.3	5.4	7.5	7.1	13.2	6.6	6.6	5.6	8.9	8.6	7.4	7.9	9.5	10.4	9.0	3.7	12.5	16.5	8.2	8.1	6.3	8.3	10.5	9.8	8.1	11.2	7.4	12.7	6.0	8.2	12.3	7.6	13.6	9.2	12.1	8.1	12.5	6.2	8.9	8.3	12.0	4.4	9.6	6.4	9.6	9.7	7.8	7.4	3.8	7.0	9.5	8.7	9.1	6.7	6.7	6.7	8.0	8.1	11.0	7.3	6.9	7.3	10.7	6.3	7.2	10.4	8.2	7.6	10.1	9.2	9.3	16.2	4.5	6.2	7.5	10.4	7.5	7.4	5.5	8.3	5.9	6.2	6.2	6.7	7.4	7.3	11.6	5.4	8.3	8.3	7.5	7.1	6.2	6.7	5.5	12.1	6.6	6.7	8.5	6.6	8.6	6.9	8.9	4.5	6.0	3.4	0.7	3.2	4.1	2.5	4.0	5.7	1.8	11.8	9.8	6.6	6.2	0.4	2.3	6.3	23.3	5.2	11.1	2.1	2.5	1.1	3.4	6.8	9.5	3.4	4.3	3.2	0.7	4.4	3.3	1.7	6.4	4.8	4.6	5.0	6.8	4.9	6.4	4.6	19.4	3.1	7.2	6.3	1.1	12.4	5.1	4.1	5.3
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500369	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	11.0	12.3	10.0	17.2	17.4	11.5	11.6	18.7	15.2	17.2	14.2	16.5	11.7	9.9	22.7	12.1	37.0	15.1	12.6	10.7	11.4	7.9	16.4	18.7	13.8	10.4	15.3	8.9	15.3	15.4	22.3	18.1	11.6	12.1	13.7	15.8	15.4	18.1	10.3	14.9	19.1	15.4	15.7	13.6	14.4	12.1	15.7	18.5	17.8	15.2	18.1	30.0	12.1	20.6	5.3	5.6	4.0	6.3	4.8	7.7	3.4	12.4	8.6	19.3	13.9	4.9	5.5	2.9	9.0	9.2	19.7	20.5	8.2	14.2	12.0	8.2	10.7	12.4	8.9	13.3	9.0	17.7	9.0	7.4	25.0	14.7	12.7	7.4	14.9	28.9	4.9	8.4	12.6	22.3	7.3	25.9	9.3	12.6	8.3	12.5	3.9	10.5	3.7	14.6	6.8	5.9	11.1	18.4	8.9	10.2	11.3	10.2	12.8	20.1	8.3	10.4	8.0	11.2	5.5	16.8	9.6	18.0	6.7	17.3	6.4	9.1	10.1	9.3	12.6	10.1	3.4	4.6	4.0	7.7	4.1	6.8	3.3	5.9	7.2	4.5	5.3	4.0	5.4	3.5	4.8	6.3	5.6	2.7	3.4	10.0	17.4	18.7	15.2	11.4	7.9	15.3	8.9	12.1	18.5	65.5	49.1	30.2	22.5	34.3	33.3	35.0	28.1	81.7	67.1	22.7	19.6	15.0	14.9	29.8	4.7	40.9	48.1	23.3	31.5	14.3	20.1	21.0	45.2	50.0	20.2	22.3	47.4	41.1	23.6	5.9	17.8	29.3	16.9	19.0	49.8	18.4	39.7	31.6	28.0	40.8	37.3	38.8	26.8	48.3	31.1	47.3	12.7	29.4	44.9	29.8
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 181.3;Late spermatids: 634.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	12.3	11.2	7.5	21.1	10.9	32.0	13.9	5.8	10.4	11.6	17.9	5.0	8.0	17.5	12.1	10.1	30.1	12.6	8.6	6.9	8.0	4.6	9.5	23.0	15.3	22.7	14.8	4.0	16.3	21.0	4.7	12.4	17.0	9.8	10.2	19.0	6.0	20.6	7.8	13.6	11.7	14.7	12.7	17.7	23.0	11.8	46.7	10.2	34.2	47.9	28.4	34.2	16.4	16.7	8.4	16.0	4.6	8.7	6.2	11.5	6.9	48.3	21.0	18.2	21.5	13.0	16.9	20.4	19.0	11.6	30.9	24.2	20.8	38.9	62.1	11.7	18.2	12.8	29.1	59.4	30.2	24.3	25.1	35.4	54.8	25.6	27.4	9.8	59.7	32.9	21.3	20.1	29.7	24.5	18.6	21.0	37.5	40.8	19.2	12.5	26.2	47.6	21.7	39.2	22.3	20.5	47.2	32.2	30.3	11.5	22.7	29.3	14.9	20.6	32.7	15.8	10.3	13.8	18.7	16.1	15.9	31.5	19.5	36.8	11.7	16.5	47.5	15.5	88.4	17.1	4.6	8.7	3.2	6.2	8.7	11.5	8.4	9.2	9.6	16.0	7.7	8.3	9.1	1.9	6.2	6.2	9.1	8.4	6.9	7.5	10.9	5.8	10.4	8.0	4.6	14.8	4.0	9.8	10.2	0.0	9.3	16.4	8.8	32.5	0.8	4.0	7.6	9.4	9.1	7.0	2.0	18.6	3.3	28.4	181.3	8.7	7.4	23.3	20.5	31.6	11.8	10.1	1.1	5.3	18.6	12.7	5.2	4.3	10.5	634.1	15.8	9.7	13.5	16.2	15.5	0.2	34.0	3.5	9.9	3.5	0.3	6.5	13.3	11.4	18.1	29.5	20.5	12.9	23.4	16.3
TRNAU1AP	"FLJ20503, SECP43, TRSPAP1"	ENSG00000180098	"TRNA selenocysteine 1 associated protein 1"	Q9NX07	1	28553085-28578545	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032068, HPA032069"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA032068: AB_2674135, HPA032069: AB_10603998"	"unprognostic (4.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.93e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (5.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.76e-1)"	11.4	10.5	12.6	11.3	14.7	9.3	13.4	19.6	14.1	12.4	10.9	15.4	12.0	7.0	11.7	14.8	10.8	13.2	8.7	12.3	11.7	12.1	11.4	8.7	13.2	15.7	19.3	13.3	12.8	11.6	14.0	9.2	10.8	13.6	10.3	11.6	10.7	10.5	14.0	7.9	17.3	9.4	14.0	12.8	11.1	10.2	7.2	17.1	15.4	8.4	9.0	16.9	12.9	9.5	4.8	4.3	9.1	5.9	12.9	7.5	2.7	4.5	2.7	8.0	5.4	7.4	14.1	3.8	6.2	12.5	11.5	10.3	4.2	7.2	7.0	2.4	6.8	5.4	3.5	8.7	9.8	11.5	6.1	9.9	5.2	9.6	2.8	6.8	4.0	4.5	15.1	8.5	8.9	7.0	8.1	16.2	7.2	6.1	5.7	11.1	3.1	6.8	4.7	5.7	4.9	6.0	4.9	5.6	4.9	12.4	4.6	4.7	6.2	7.3	6.5	6.7	9.0	7.1	4.9	4.6	3.0	2.9	4.6	5.5	7.5	9.4	4.3	7.2	8.8	8.4	6.9	3.5	9.1	5.7	5.9	6.0	4.8	6.2	7.2	4.3	4.7	7.5	4.8	2.2	12.9	3.5	2.8	4.0	2.7	12.6	14.7	19.6	14.1	11.7	12.1	19.3	13.3	13.6	17.1	32.8	33.0	23.2	18.6	15.7	33.7	18.5	22.9	54.9	35.2	17.4	33.4	27.7	14.9	32.7	9.3	19.6	14.6	23.3	28.3	39.5	19.7	18.5	33.6	7.8	29.5	22.3	9.9	25.2	25.4	3.2	26.7	27.0	13.5	36.1	13.0	23.6	32.8	13.6	21.2	15.0	33.0	32.3	25.7	15.4	24.9	17.9	57.2	30.0	15.1	26.0
TAF12	"TAF2J, TAFII20"	ENSG00000120656	"TATA-box binding protein associated factor 12"	Q16514	1	28589323-28643085	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 179.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008519	Approved					NA	NA					"HPA008519: AB_1080181"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (4.02e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-2)"	21.6	20.0	18.2	22.3	22.5	20.9	22.2	18.3	22.2	20.3	18.4	17.7	18.7	17.0	20.6	24.7	23.8	18.6	18.3	22.8	20.9	18.6	20.9	24.7	18.5	28.6	26.5	14.2	22.1	22.5	19.5	27.1	20.5	24.6	15.7	20.3	17.7	17.8	23.6	28.8	22.9	17.0	20.6	24.4	20.8	17.3	27.5	26.3	32.1	19.9	23.8	32.5	21.1	21.2	14.5	14.6	41.3	17.1	17.3	19.9	14.0	16.9	8.6	12.4	8.1	29.7	33.7	7.5	21.0	13.4	13.6	17.8	4.6	15.1	22.0	20.1	19.5	10.5	13.9	20.5	17.7	22.3	12.6	7.5	21.7	9.5	7.6	19.7	16.8	9.6	19.2	19.4	24.2	23.1	14.4	14.1	19.2	18.6	16.8	21.9	16.6	19.7	14.1	17.1	19.9	14.9	20.3	12.2	13.9	19.0	6.9	4.7	11.8	27.5	14.5	29.5	15.2	11.6	20.3	12.4	5.6	9.8	22.2	21.1	20.1	18.1	17.6	13.1	28.5	15.5	31.6	17.0	41.3	15.4	16.7	16.0	14.5	15.2	17.1	14.6	12.9	13.1	16.4	40.1	17.3	17.1	11.6	19.9	14.0	18.2	22.5	18.3	22.2	20.9	18.6	26.5	14.2	24.6	26.3	29.8	16.8	43.2	28.0	26.2	13.2	26.4	28.1	6.7	7.9	22.7	5.9	58.5	49.7	29.8	30.6	32.2	16.2	0.0	34.6	68.8	43.2	22.7	25.3	30.9	70.5	3.2	7.5	20.3	49.8	11.0	46.3	49.7	28.7	64.9	20.0	19.7	32.8	25.9	31.5	51.9	23.2	32.3	34.0	101.7	179.1	29.1	97.9	47.9	22.3	24.3
RAB42	MGC45806	ENSG00000188060	"RAB42, member RAS oncogene family"	Q8N4Z0	1	28592200-28595443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Cell type enriched"	"Detected in some"	7	"Hofbauer cells: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.6;Hep G2: 15.5;HSkMC: 11.0;REH: 8.5"									HPA050290			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050290: AB_2681075"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.00e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.07e-3)"	4.3	1.2	0.8	1.8	1.6	0.4	3.2	0.8	1.6	3.7	2.3	0.8	0.8	1.8	3.1	4.1	1.5	1.4	2.4	1.3	1.6	0.5	1.5	3.2	3.4	14.3	1.2	0.8	1.4	0.8	5.0	0.8	6.2	1.2	3.3	2.5	1.7	4.2	0.8	1.5	0.9	2.3	1.8	5.5	5.9	1.6	3.0	0.8	3.4	1.0	0.8	4.4	4.1	1.8	0.7	0.7	1.2	0.9	2.4	0.5	0.1	0.1	1.2	1.0	0.0	4.6	10.6	0.0	0.7	4.4	4.6	6.1	2.2	1.5	0.2	2.9	5.0	0.4	0.1	4.5	0.0	3.0	0.1	0.1	0.4	7.1	15.5	1.8	1.2	0.0	11.0	0.2	2.8	0.0	0.4	1.4	0.1	0.2	0.1	0.9	0.0	0.2	2.4	5.4	0.1	0.0	8.5	0.0	1.8	1.8	0.0	0.3	2.1	4.2	0.1	0.0	0.7	0.1	2.0	0.7	0.0	1.4	4.6	0.1	0.4	2.8	0.2	0.2	4.5	0.1	1.2	0.9	0.2	0.3	0.4	0.3	0.6	0.2	0.2	0.7	0.7	0.5	0.4	0.9	2.4	0.8	0.4	0.1	0.1	0.8	1.6	0.8	1.6	1.6	0.5	1.2	0.8	1.2	0.8	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	6.9	4.0	0.1	0.0	0.0	0.0	0.6	2.3	0.2	0.0	0.0	74.2	0.0	0.0	2.5	2.9	10.0	1.4	4.4	0.0	1.8	0.0	0.9	1.9	0.3	0.0	0.3	0.9	0.0	0.9	1.5	1.9	0.4	0.3	0.0	0.0	0.1
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668732-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044811: AB_10959666, HPA052975: AB_2682003"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	8.3	6.6	8.0	14.0	6.5	21.1	8.7	13.5	9.0	8.8	8.0	8.4	6.4	5.4	10.9	8.0	10.4	8.5	8.0	6.8	7.8	4.9	6.6	7.3	8.7	11.3	5.8	7.0	12.1	7.5	8.6	8.8	16.4	5.8	7.2	8.4	8.0	7.4	6.8	10.3	9.3	8.6	9.1	6.3	11.5	7.4	11.4	6.4	25.3	7.5	7.0	14.1	7.9	12.4	10.8	9.7	14.4	12.7	10.6	12.8	6.3	9.3	6.8	11.6	10.4	3.8	7.1	8.2	10.0	7.3	6.5	9.7	2.1	7.6	17.3	5.3	9.3	3.9	3.7	10.3	7.8	8.5	19.7	6.3	16.1	7.1	4.1	5.8	13.3	8.3	5.7	5.6	15.7	10.2	5.7	8.9	8.7	9.6	13.9	7.8	8.2	8.3	4.4	15.4	6.3	4.6	5.6	7.9	8.0	4.9	7.7	8.5	7.0	9.5	6.5	6.5	8.1	4.9	6.9	9.0	4.5	10.8	7.6	13.5	6.2	10.5	9.7	5.4	12.5	7.0	10.0	8.2	14.4	11.1	10.2	8.4	6.6	10.6	12.8	9.7	10.8	8.8	9.3	11.8	10.6	12.7	7.2	8.9	6.3	8.0	6.5	13.5	9.0	7.8	4.9	5.8	7.0	5.8	6.4	6.0	24.8	13.5	13.9	15.0	22.8	4.2	5.1	5.3	12.5	14.0	11.8	11.6	5.0	9.2	8.0	10.6	9.6	23.3	9.5	13.6	7.3	9.8	27.7	5.6	9.4	23.8	7.5	17.8	12.9	2.2	8.9	11.7	1.7	8.2	11.1	17.5	9.5	10.4	7.4	4.9	23.9	19.4	7.6	14.4	27.4	14.6	27.0	15.9	9.2	15.6
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Cytoplasmic bodies"	"HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	31.1	33.0	18.2	27.0	19.9	42.0	52.4	21.5	28.3	23.7	23.6	20.4	31.5	22.1	26.6	35.1	36.0	26.1	21.7	23.3	18.5	19.4	26.8	35.8	30.0	42.5	18.1	21.3	25.5	37.2	29.7	18.4	32.6	20.2	21.7	26.2	22.1	34.4	31.3	39.6	36.5	24.4	25.1	15.1	29.8	24.8	28.0	17.0	44.2	26.4	30.4	31.7	24.7	31.0	36.5	42.2	33.3	39.9	39.0	40.4	41.8	21.7	15.2	33.3	32.3	26.0	20.0	38.3	21.2	26.6	26.6	27.1	13.8	25.8	37.4	21.3	27.2	16.1	20.4	38.5	34.5	31.8	23.5	28.0	31.4	20.9	25.4	30.7	33.0	24.8	26.8	35.8	28.6	41.0	23.6	32.5	22.5	31.5	18.7	29.8	17.1	34.9	26.0	53.5	19.7	19.4	30.3	24.6	30.8	37.3	31.3	28.5	30.3	22.1	34.1	57.3	29.0	22.5	31.3	22.2	18.8	19.4	17.5	30.0	22.5	14.4	42.9	21.5	26.1	29.8	33.3	32.4	32.6	28.9	39.9	40.0	36.5	33.9	36.4	42.2	25.5	36.1	34.1	11.5	39.0	38.0	25.9	40.4	41.8	18.2	19.9	21.5	28.3	18.5	19.4	18.1	21.3	20.2	17.0	47.6	50.4	61.8	85.7	135.7	43.7	41.5	81.5	32.1	59.1	41.8	29.5	127.2	56.3	89.8	9.8	76.8	37.5	0.0	60.6	91.0	73.1	49.8	71.5	91.0	67.2	55.6	72.6	69.3	64.2	12.7	65.9	55.7	35.4	71.3	55.9	65.9	70.7	38.6	70.7	74.9	41.0	90.5	54.6	103.5	109.1	141.3	217.6	64.7	53.3	104.3
OPRD1		ENSG00000116329	"Opioid receptor delta 1"	P41143	1	28812142-28871267	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.7"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 3.4;Urothelial cells: 1.1"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"RH-30: 14.9;SCLC-21H: 5.9;SH-SY5Y: 5.9;WM-115: 19.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070831	Approved					NA	NA					"HPA070831: AB_2732167"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-3)"	"unprognostic (6.28e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.95e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-7)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-3)"	0.4	2.4	5.5	0.6	3.9	1.9	0.4	0.4	8.7	0.4	0.6	0.0	0.0	0.5	0.4	0.4	0.4	0.4	0.6	0.4	3.0	1.3	0.4	0.4	0.5	0.7	0.6	5.9	0.5	1.3	0.2	0.5	0.5	4.7	0.4	0.5	0.1	1.0	0.2	3.2	1.0	0.6	0.4	0.4	0.7	0.8	0.8	0.2	0.0	0.6	0.0	0.2	0.4	0.4	1.2	1.1	3.1	0.5	1.1	0.7	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	14.9	0.1	0.0	0.0	5.9	5.9	0.0	0.1	1.0	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.3	19.8	3.1	0.5	0.6	0.6	0.3	0.4	0.6	0.6	0.5	0.1	1.2	0.6	0.7	2.5	1.1	0.3	1.1	0.3	0.1	5.5	3.9	0.4	8.7	3.0	1.3	0.6	5.9	4.7	0.2	0.0	0.0	0.0	0.8	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.1
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
TMEM200B	TTMB	ENSG00000253304	"Transmembrane protein 200B"	Q69YZ2	1	29119428-29123935	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 11.8;Melanocytes: 8.5;Peritubular cells: 14.2;Sertoli cells: 6.5;Smooth muscle cells: 8.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.8;ASC TERT1: 13.2;BJ hTERT+ SV40 Large T+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 16.3;fHDF/TERT166: 15.4;HBF TERT88: 14.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 14.0;cerebellum: 23.9"					HPA055254	Uncertain					NA	NA					"HPA055254: AB_2682760"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-3)"	9.1	2.0	1.4	2.9	3.7	0.0	15.7	9.7	1.3	33.3	10.9	1.2	7.4	1.1	32.8	7.7	6.0	7.0	7.3	2.4	0.5	0.2	3.5	3.0	3.7	1.2	1.3	0.9	21.6	0.7	15.4	1.2	3.5	2.5	17.2	2.3	6.0	1.5	23.9	2.9	2.1	3.4	20.6	1.4	2.4	2.3	13.6	0.6	0.7	2.1	3.5	1.5	13.1	12.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	10.9	0.0	1.8	0.0	15.8	13.2	0.6	7.7	12.2	14.6	16.3	0.6	1.2	0.0	1.9	15.4	5.3	0.2	1.2	0.0	14.0	0.0	0.5	0.0	2.8	0.9	11.0	0.0	0.0	7.0	1.4	11.0	2.2	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	11.0	0.0	0.0	5.4	0.0	0.0	0.0	5.2	0.2	10.8	0.2	0.0	0.0	0.0	6.4	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.4	3.7	9.7	1.3	0.5	0.2	1.3	0.9	2.5	0.6	3.0	1.1	0.0	0.2	1.6	0.8	1.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	5.4	0.2	0.0	1.0	0.1	0.0	0.0	1.3	0.0	0.9	11.8	0.0	8.5	0.0	0.0	0.1	0.0	0.0	14.2	3.8	1.7	6.5	8.3	0.2	0.7	0.5	0.5	0.0	0.0	0.3
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA050975: AB_2681296"	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (4.26e-4)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	42.5	26.5	26.8	31.7	34.6	46.6	38.7	37.5	28.3	33.9	35.8	27.9	30.7	35.1	39.0	29.1	35.9	30.7	26.3	28.7	26.0	22.3	27.8	40.7	36.7	37.1	35.0	24.1	43.0	30.4	28.5	27.0	40.7	27.9	35.2	26.2	27.8	33.6	34.8	47.0	38.0	34.0	52.6	30.7	38.7	29.9	23.4	33.8	46.9	35.1	23.6	30.0	55.6	70.2	23.8	25.6	44.8	26.1	20.0	35.0	20.7	31.4	18.9	35.3	12.9	25.9	19.7	22.1	26.6	19.6	31.4	27.0	17.2	19.3	36.2	24.9	21.9	20.5	29.6	29.8	24.1	32.0	43.9	35.7	55.3	27.8	26.8	27.1	36.9	35.1	15.8	30.7	26.5	34.2	25.6	25.8	21.0	44.7	28.8	21.2	15.6	47.1	31.9	38.1	18.8	18.0	44.0	38.9	24.4	21.3	32.3	21.7	25.0	32.7	18.6	30.3	32.8	12.3	22.3	25.1	25.4	20.5	27.6	43.2	27.1	20.4	40.0	24.4	47.5	27.6	26.2	20.8	44.8	31.8	24.7	30.9	23.4	29.3	34.0	25.6	23.8	25.6	27.1	41.2	20.0	26.1	19.7	35.0	20.7	26.8	34.6	37.5	28.3	26.0	22.3	35.0	24.1	27.9	33.8	74.5	113.4	61.1	138.0	88.7	64.2	46.2	30.6	103.1	109.2	48.8	80.5	110.3	46.4	56.7	5.5	100.5	64.2	46.7	40.9	106.4	70.9	133.4	86.9	64.4	60.8	54.0	37.5	92.7	69.0	6.8	79.4	75.8	52.3	69.5	66.4	76.0	49.2	66.8	83.8	49.4	95.7	71.1	62.8	58.8	51.7	90.3	119.5	97.5	68.5	198.5
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192873-29230942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.29e-4)"	16.4	11.9	16.0	6.6	17.0	6.0	12.3	7.8	17.7	13.0	9.7	8.6	7.1	7.8	10.5	8.4	9.4	10.9	8.5	24.8	15.7	11.5	11.0	13.7	8.3	10.0	14.7	16.3	11.7	14.3	8.1	10.0	10.8	12.8	7.5	8.9	10.8	12.6	10.0	45.5	11.3	5.9	10.2	10.7	5.4	8.1	8.2	10.5	4.4	8.3	12.8	7.6	8.0	7.2	8.3	14.7	0.3	11.5	11.6	13.1	6.5	10.2	9.8	4.8	22.2	4.9	8.7	17.6	7.8	8.8	10.2	9.9	7.4	21.0	13.5	15.6	7.6	3.2	12.8	6.0	15.8	6.3	9.2	12.4	11.7	6.3	9.4	15.2	12.9	6.0	8.6	14.1	5.4	19.9	8.5	11.2	17.3	10.0	14.0	12.7	11.5	10.9	7.1	12.9	19.5	12.5	6.7	8.1	23.7	10.8	5.9	7.3	11.3	11.5	16.4	14.4	9.8	6.0	12.5	11.3	7.4	8.0	11.5	11.4	13.4	5.5	10.0	20.0	17.2	14.0	0.1	7.0	0.0	8.3	11.5	13.1	8.3	7.8	6.7	14.7	7.4	8.4	8.5	0.3	11.6	7.0	8.6	6.3	6.5	16.0	17.0	7.8	17.7	15.7	11.5	14.7	16.3	12.8	10.5	11.9	3.8	8.2	13.8	4.9	12.0	17.1	15.3	2.7	11.4	19.2	9.8	41.0	34.9	18.9	31.2	8.0	7.8	0.0	17.2	32.6	12.7	8.1	5.7	18.3	18.3	7.9	7.5	4.9	4.9	60.9	12.7	6.0	15.1	12.6	9.8	10.9	14.2	7.0	10.3	32.7	62.2	12.9	8.9	6.7	15.0	6.5	23.3	4.9	19.9	15.6
PTPRU	"FMI, hPTP-J, PCP-2, PTP, PTPRO"	ENSG00000060656	"Protein tyrosine phosphatase, receptor type U"	Q92729	1	29236516-29326813	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011476, HPA039832"	Approved					NA	NA					"CAB011476: AB_442989, HPA039832: AB_10793923"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (7.92e-4)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-1)"	6.0	3.2	3.1	1.7	5.8	0.6	16.0	6.7	12.7	24.8	3.7	2.6	6.1	1.3	9.5	4.7	3.9	14.5	7.0	8.9	4.5	5.1	3.9	7.0	11.4	1.2	5.2	5.3	12.2	12.0	12.1	8.1	14.3	21.4	11.0	2.3	18.7	11.3	17.9	14.7	7.3	1.7	6.5	6.6	2.4	4.5	4.4	0.9	0.3	4.9	2.1	2.0	12.2	17.6	0.4	0.0	0.0	0.5	0.0	0.2	0.0	3.2	4.4	0.2	0.6	12.4	0.4	40.5	3.4	3.1	0.1	0.2	3.8	14.4	0.5	6.9	0.6	0.4	17.5	16.1	11.2	0.0	0.2	8.1	0.6	5.0	16.0	5.2	0.0	0.7	5.7	6.1	0.0	1.0	4.8	0.1	2.0	0.1	0.5	3.2	5.3	0.2	0.1	6.6	6.4	2.0	0.0	4.7	0.2	5.0	16.2	13.7	17.8	3.5	11.0	2.4	2.9	6.5	0.7	2.9	0.6	4.0	1.1	0.4	0.3	0.4	0.0	8.0	0.7	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	5.8	6.7	12.7	4.5	5.1	5.2	5.3	21.4	0.9	8.9	12.8	0.0	6.2	1.3	3.6	3.4	0.0	6.7	11.4	5.2	11.8	16.4	0.0	5.6	0.5	0.7	0.0	0.0	2.3	9.3	5.1	5.4	1.1	4.5	2.1	0.0	0.0	1.8	1.2	1.1	4.4	0.3	8.5	0.0	0.0	17.4	5.3	0.0	6.7	0.2	40.7	6.5	3.8	1.2	6.1	0.5	7.6	0.0	0.0	8.6
MATN1	"CMP, CRTM"	ENSG00000162510	"Matrilin 1, cartilage matrix protein"	P21941	1	30711277-30723587	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 6.6"	"Cell type enhanced"	"Detected in some"	14	"B-cells: 2.7;Club cells: 1.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.0;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;Karpas-707: 3.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA028580	Supported				"Secreted to extracellular matrix"	NA	NA					"HPA028580: AB_10601913"	"unprognostic (4.71e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.75e-6)"	"unprognostic (9.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.01e-13)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.42e-2)"	0.4	0.4	1.1	1.0	0.7	2.6	0.4	0.4	1.7	2.0	0.4	0.4	0.4	0.3	1.7	0.6	0.4	0.9	0.7	0.4	1.2	1.1	0.4	0.4	6.6	2.0	1.1	0.4	2.9	0.6	0.0	1.1	1.1	0.4	0.5	0.0	0.4	1.4	0.4	0.4	0.9	0.5	0.4	1.4	1.4	0.5	1.0	0.4	0.4	1.4	0.4	0.4	0.5	1.2	3.0	0.1	0.2	0.1	0.0	2.3	0.6	0.9	0.5	0.2	1.0	0.2	0.0	0.3	0.5	0.2	0.1	0.0	0.1	1.5	0.7	3.5	0.1	0.7	1.3	0.2	0.1	0.2	1.5	0.4	1.3	1.0	0.1	0.0	0.4	1.0	0.0	0.0	0.0	0.9	0.6	0.0	0.4	2.0	3.5	0.0	1.4	0.1	0.2	0.2	0.3	1.0	0.5	1.4	0.5	0.0	0.4	0.4	0.6	0.5	0.4	0.8	0.6	0.4	1.2	0.6	0.3	0.8	0.2	0.8	0.9	0.1	0.3	0.0	0.6	2.1	0.0	0.1	0.0	0.5	0.0	0.9	0.9	0.6	0.5	0.0	3.0	2.3	1.2	0.2	0.0	0.0	0.1	0.8	0.6	1.1	0.7	0.4	1.7	1.2	1.1	1.1	0.4	0.4	0.4	0.0	0.3	2.7	0.5	0.1	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.1	0.2	0.0	0.0	0.1
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757820	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5"	"Group enriched"	"Detected in many"	5	"B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	56.0	15.5	11.5	59.1	17.8	157.5	15.0	2.2	10.4	8.2	11.2	20.7	1.8	9.5	7.5	6.8	8.3	13.7	19.9	9.2	11.2	12.7	14.0	18.2	60.8	144.5	19.0	3.3	7.7	6.3	2.0	6.8	20.1	14.6	8.2	13.2	7.4	11.7	4.7	4.0	5.5	37.1	12.9	33.8	130.9	9.5	6.7	15.8	75.2	10.1	5.2	91.2	21.4	6.4	98.2	69.1	145.1	109.3	26.0	55.4	166.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.1	4.9	0.1	0.1	0.1	0.0	0.0	0.0	5.2	0.0	89.3	0.0	0.1	0.0	56.6	211.5	0.0	0.1	0.0	0.3	0.0	10.8	6.1	1.1	2.9	0.7	0.0	9.7	11.9	0.0	0.0	0.0	66.3	8.7	32.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	36.0	12.5	0.0	0.2	0.0	0.2	0.2	0.0	76.8	0.2	46.2	0.1	73.5	109.3	115.3	47.7	87.9	55.4	70.2	43.7	44.6	69.1	98.2	44.2	43.1	145.1	26.0	83.9	33.2	53.7	166.6	11.5	17.8	2.2	10.1	11.2	12.7	19.0	3.3	14.6	15.8	23.8	148.6	749.7	1.1	21.2	0.0	5.6	10.2	18.7	25.0	3.5	0.0	5.6	0.0	0.4	1.5	31.3	0.7	0.0	0.6	5.1	16.6	0.8	621.6	4.2	1099.3	0.0	1.2	36.2	831.6	1.7	1.4	787.9	47.2	70.3	0.6	0.2	0.9	0.0	0.4	2.2	1.3	0.0	6.8	0.3	0.3	17.6	7.4	409.7	0.3	1.6
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869467-30908761	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 52.5;WM-115: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	17.9	48.8	35.4	11.6	44.7	1.9	9.2	10.4	53.1	20.4	20.8	21.7	10.9	6.9	25.6	7.1	9.8	13.7	15.9	11.1	26.8	32.2	4.7	11.5	12.0	15.4	36.1	16.4	6.2	4.4	6.1	5.4	9.7	34.1	14.8	8.1	8.2	8.6	29.2	17.7	5.7	9.1	33.1	28.3	45.3	9.3	2.4	15.5	2.6	5.5	1.7	4.2	14.4	6.0	1.2	1.0	3.2	2.5	2.1	1.2	0.9	2.7	2.0	16.3	7.6	12.6	3.0	3.2	6.8	9.7	3.2	2.0	0.3	2.5	0.2	17.3	19.0	4.6	3.7	1.7	1.5	2.1	1.4	1.4	0.0	0.8	0.4	12.1	0.0	1.8	7.3	7.5	0.2	3.2	17.9	4.0	0.7	1.3	0.2	6.2	2.9	0.1	0.1	8.3	1.9	2.4	0.1	15.6	0.6	4.0	2.9	6.4	4.1	8.6	1.2	52.5	10.9	1.2	1.2	4.4	4.0	6.9	0.5	1.5	0.0	0.1	0.2	0.4	0.0	73.1	3.2	1.3	1.0	0.8	2.5	1.2	0.8	0.8	0.9	0.9	1.2	1.0	1.0	2.5	2.1	1.8	1.0	0.9	0.9	35.4	44.7	10.4	29.5	26.8	32.2	36.1	16.4	34.1	15.5	0.0	2.1	0.8	2.8	2.3	8.1	3.2	15.3	0.0	2.3	45.4	0.0	2.1	0.0	9.0	17.7	8.7	0.0	0.0	2.6	2.8	10.0	6.9	0.0	0.2	13.2	0.0	2.9	28.8	157.7	63.3	2.0	2.2	18.6	5.4	0.9	1.5	6.1	0.6	7.4	0.3	25.6	0.0	5.6	0.7	0.4	1.9	3.0	0.0	1.2	3.7
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	25.1	26.3	30.1	17.1	35.0	36.3	27.0	38.1	35.9	24.0	20.8	28.1	16.5	17.6	27.6	24.5	22.6	29.1	18.3	22.0	24.2	29.7	23.6	20.3	20.4	18.8	22.8	25.5	33.9	21.8	38.1	31.7	31.4	33.1	22.8	24.0	25.8	25.4	23.9	40.7	29.7	22.8	25.9	20.1	19.1	20.6	15.9	22.1	27.9	28.3	15.6	27.1	23.4	24.1	18.9	25.2	27.6	24.8	28.5	27.1	22.0	16.4	22.1	36.0	22.8	28.4	24.6	24.7	19.8	24.2	20.6	23.5	23.2	28.6	19.5	20.9	26.7	12.9	24.3	29.5	21.8	26.7	16.1	25.7	21.0	25.9	27.5	19.9	25.6	20.2	26.2	27.7	27.3	29.0	27.3	28.1	18.6	28.9	18.4	23.5	13.8	25.0	18.5	36.8	20.6	15.5	26.0	24.6	20.7	30.1	25.1	29.8	22.7	27.3	21.2	23.4	41.7	21.4	19.5	29.2	17.2	15.6	22.8	19.6	14.8	13.6	21.5	15.4	19.0	21.7	27.6	24.8	18.5	25.7	23.8	26.3	18.9	23.2	25.0	25.2	18.8	26.6	26.9	14.8	28.5	24.6	14.6	27.1	22.0	30.1	35.0	38.1	35.9	24.2	29.7	22.8	25.5	33.1	22.1	68.5	50.4	39.5	44.5	80.1	52.6	70.4	76.5	18.7	44.3	34.9	74.6	42.5	19.9	36.8	23.3	48.8	36.7	70.0	31.4	36.3	46.0	63.4	17.4	50.5	29.7	31.8	100.5	44.2	71.5	13.3	66.7	39.7	16.9	15.4	66.5	44.7	48.2	31.6	75.7	38.8	56.7	32.3	42.2	36.3	19.1	81.9	65.2	34.6	58.4	78.2
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239554	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2"	"Cell type enhanced"	"Detected in some"	12	"Distal tubular cells: 1.7;Suprabasal keratinocytes: 1.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.4;AN3-CA: 17.2;NTERA-2: 44.3;SCLC-21H: 13.2;SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA					"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.7	15.5	4.2	0.8	13.3	0.5	1.2	23.2	11.8	0.6	0.7	10.7	0.0	0.7	1.5	5.8	1.4	0.8	0.6	0.6	6.3	4.3	0.6	0.5	0.5	0.5	4.7	7.2	0.6	0.7	0.7	0.3	0.9	18.2	2.2	0.7	0.0	0.7	1.1	26.2	1.9	0.7	0.8	3.3	0.5	0.6	0.9	9.0	0.0	0.5	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	17.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	44.3	0.0	0.4	0.0	0.1	0.0	0.0	1.5	13.2	21.0	0.4	0.1	1.1	1.2	4.6	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.3	23.2	9.5	6.3	4.3	4.7	7.2	18.2	9.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	0.1
SNRNP40	"HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57"	ENSG00000060688	"Small nuclear ribonucleoprotein U5 subunit 40"	Q96DI7	1	31259568-31296782	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026527, HPA027345"	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026527: AB_1858814, HPA027345: AB_2239703"	"unprognostic (2.31e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.24e-2)"	20.2	23.1	13.2	19.6	20.2	25.2	21.2	24.1	21.8	20.9	20.1	30.0	20.9	16.2	25.6	23.0	23.4	23.0	15.4	17.8	14.3	15.4	18.8	19.1	17.4	31.6	31.5	14.0	26.7	15.8	15.0	20.2	21.9	23.5	20.8	22.8	20.2	17.9	22.4	22.6	20.8	19.9	22.0	22.3	27.3	18.7	31.3	21.3	44.0	24.4	17.0	38.2	20.0	19.4	33.7	32.8	27.5	33.8	36.7	44.3	47.8	20.8	15.7	29.6	24.3	14.8	12.3	20.3	17.6	17.5	32.3	32.1	22.6	21.4	27.3	17.4	13.9	16.6	20.1	44.5	21.1	33.5	29.0	32.8	40.3	22.7	24.7	18.4	44.1	18.4	11.4	16.9	31.5	23.8	10.8	26.1	24.2	37.4	16.3	18.6	15.0	32.5	26.0	52.9	21.2	22.9	25.9	41.7	21.1	13.8	17.3	20.2	19.8	28.0	14.7	33.2	28.7	14.5	28.3	18.0	18.2	26.6	25.1	33.4	13.3	16.3	37.7	14.8	41.5	29.5	26.0	26.7	27.5	37.2	33.8	42.6	33.7	36.4	36.6	32.8	30.9	39.2	44.3	5.9	36.7	30.3	27.9	37.4	47.8	13.2	20.2	24.1	21.8	14.3	15.4	31.5	14.0	23.5	21.3	3.0	6.7	41.0	44.7	47.2	13.7	11.8	20.4	10.7	6.8	15.7	17.7	100.1	36.5	28.8	5.4	33.3	13.5	0.0	31.5	71.3	44.7	26.1	34.5	20.3	49.1	9.5	33.5	29.4	20.6	3.6	24.7	27.9	40.5	47.7	16.9	22.6	27.7	21.0	32.2	34.6	19.3	32.3	34.3	68.7	67.1	47.9	51.3	42.4	31.1	33.6
ZCCHC17	"HSPC251, pNO40, PS1D"	ENSG00000121766	"Zinc finger CCHC-type containing 17"	Q9NP64	1	31296982-31364953	"Predicted intracellular proteins"		Ribonucleoprotein		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053727	Approved					NA	NA					"HPA053727: AB_2732581"	"unprognostic (1.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.17e-1)"	12.8	18.8	38.2	11.0	29.6	11.2	20.4	22.4	34.6	15.7	12.3	23.0	11.5	8.4	13.8	40.3	10.7	13.5	10.4	25.9	32.5	33.5	17.2	11.2	10.9	13.0	33.9	25.1	14.2	10.7	13.1	15.4	14.2	30.8	14.5	14.0	14.1	13.3	19.1	18.8	10.9	8.5	15.9	57.6	11.5	10.2	31.2	17.7	9.0	14.8	10.1	16.7	12.7	9.7	24.8	22.8	35.9	21.4	19.9	27.8	27.6	13.9	11.4	19.9	13.1	18.7	16.1	11.9	21.4	18.5	23.9	21.8	18.8	12.8	14.6	16.9	15.7	10.7	10.2	22.3	19.8	27.4	10.1	14.8	19.9	18.5	21.0	16.0	17.8	8.4	11.7	20.3	27.3	28.6	17.4	25.4	16.2	20.5	9.0	21.6	11.2	15.5	18.7	35.2	16.6	20.5	14.9	27.6	13.7	25.9	13.7	14.7	9.2	18.2	14.7	64.8	30.9	11.0	11.4	17.3	12.2	13.6	28.2	21.7	9.0	14.8	18.2	16.6	22.8	34.3	35.9	20.6	33.3	25.0	21.4	22.4	21.6	25.2	25.9	20.3	24.8	23.7	27.8	7.0	19.9	20.1	22.8	23.2	27.6	38.2	29.6	22.4	34.6	32.5	33.5	33.9	25.1	30.8	17.7	17.9	21.3	26.0	31.8	27.5	51.0	60.2	30.6	29.4	27.3	26.2	25.5	75.6	61.3	47.4	53.0	42.5	19.0	0.0	45.7	59.7	36.9	34.6	40.5	21.2	47.2	81.0	23.7	30.7	19.9	92.4	39.7	30.0	33.7	69.5	26.1	55.0	43.9	31.6	50.5	53.5	52.0	45.3	36.3	132.7	130.1	29.9	70.1	43.1	26.0	39.2
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365625-31376850	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 420.9;skeletal muscle: 129.4"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2447.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"ASC TERT1: 120.7"	"Low region specificity"	"Detected in all"							"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	4400000	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	2.3	5.2	8.1	0.7	6.0	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11.0	5.3	21.3	1.9	4.3	1.3	9.8	6.0	2.2	0.4	0.3	0.7	1.1	13.7	5.0	1.5	3.0	4.4	14.0	129.4	0.9	0.6	13.0	3.4	3.9	3.6	2.0	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0.0	0.9	0.2	0.9	0.6	0.1	0.0	3.3	0.2	23.1	120.7	1.1	0.9	8.9	0.1	3.2	0.2	0.9	0.2	12.8	2.5	0.0	0.3	0.9	0.0	0.1	0.1	0.5	0.4	1.1	2.4	1.5	0.2	0.0	10.7	0.0	2.4	0.0	0.3	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.2	6.1	0.0	0.4	0.1	1.2	0.0	2.9	0.0	0.3	0.0	0.5	0.0	13.9	7.1	0.1	1.4	0.3	0.2	0.1	2.1	0.2	0.1	0.4	0.1	0.5	0.1	0.3	0.0	0.4	0.0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0.0	0.9	0.0	0.2	0.1	0.4	0.6	0.6	8.1	6.0	1.4	13.3	11.0	5.3	9.8	6.0	13.7	1.3	0.0	1.7	0.8	1.0	3.2	3.1	2447.6	5.1	2.7	2.3	26.2	2.0	2.1	383.0	0.3	2.1	0.8	0.0	0.0	0.3	1.3	14.9	3.8	1.1	0.0	96.1	7.9	0.0	3.7	20.0	4.2	6.4	17.6	8.5	0.0	0.0	2.7	0.5	3.6	7.4	399.5	8.1	0.0	32.3	0.3	0.1	2.6	1.4	1.0	0.1	5.2
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.9"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 12.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favorable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (2.11e-4)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	2.0	6.6	0.6	13.5	1.2	1.1	12.1	0.8	0.8	17.3	32.9	0.8	52.1	27.4	3.7	26.5	32.5	4.3	34.4	2.0	1.0	0.6	57.5	113.9	10.3	7.1	1.8	0.5	1.7	12.9	5.7	5.1	33.9	1.4	17.0	12.8	5.0	58.6	74.4	20.2	14.2	73.0	6.7	1.2	1.7	20.7	3.5	0.8	5.7	13.1	12.7	19.1	31.1	19.9	0.2	12.0	2.3	2.7	0.0	0.0	0.5	13.0	3.1	2.7	8.9	6.0	8.1	7.6	25.2	18.7	1.6	2.0	4.7	47.3	8.6	33.2	23.6	2.0	53.9	0.3	85.2	0.3	0.8	2.0	0.0	2.7	2.4	6.8	0.0	10.1	7.4	48.5	10.4	22.9	7.2	1.0	1.0	0.3	0.0	2.8	2.1	0.3	0.3	2.8	26.1	6.6	0.0	5.4	2.9	9.0	58.3	1.2	6.7	6.4	48.8	1.0	1.4	28.5	1.5	6.2	0.4	2.1	0.2	0.5	0.4	0.3	0.4	0.2	0.2	2.1	0.0	2.7	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.5	0.6	1.2	0.8	0.8	1.0	0.6	1.8	0.5	1.4	0.8	14.9	6.2	0.5	97.8	11.0	0.0	0.6	127.4	8.1	21.6	111.7	0.0	323.0	61.3	546.6	3.9	4.4	427.6	0.0	288.5	86.2	3.3	137.4	0.0	45.6	43.7	0.0	111.9	8.6	7.6	6.6	2.0	6.8	38.8	83.8	168.4	0.6	386.0	170.9	0.0	57.4	0.0	0.0	1.4	0.6	3.6	18.4	373.5	0.0	116.2	257.8
TINAGL1	"ARG1, LCN7, LIECG3, P3ECSL, TINAGRP"	ENSG00000142910	"Tubulointerstitial nephritis antigen like 1"	Q9GZM7	1	31576485-31587686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.4"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 1103.3;Syncytiotrophoblasts: 1627.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 58.8;CAPAN-2: 32.1;EFO-21: 74.1;HaCaT: 32.2;HBEC3-KT: 37.9;HUVEC TERT2: 31.4;TIME: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048695	Approved				"Secreted to extracellular matrix"	NA	NA		170000			"HPA048695: AB_2680497"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.29e-3)"	"unprognostic (6.02e-3)"	"unprognostic (4.18e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (7.42e-2)"	"unprognostic (6.64e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.43e-2)"	43.0	8.4	2.2	11.6	3.4	0.8	60.0	0.8	4.4	30.2	22.0	2.9	14.2	12.0	25.7	23.4	23.7	17.0	36.1	52.6	3.4	2.3	53.3	14.7	24.4	12.8	3.9	3.3	15.5	7.4	3.2	5.6	128.4	5.0	19.4	7.9	12.0	24.2	20.0	19.6	7.6	15.9	22.5	2.7	34.3	16.3	10.3	2.1	0.8	30.7	11.0	6.4	39.8	20.0	1.1	0.6	4.8	0.5	1.5	0.8	0.0	16.7	0.0	0.0	0.1	0.1	0.0	58.8	2.6	0.3	0.1	0.0	7.9	32.1	0.0	74.1	2.3	1.2	32.2	0.0	37.9	0.0	0.1	0.0	0.0	1.4	2.0	0.8	0.0	0.1	0.0	6.9	0.0	1.4	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	9.1	1.0	0.0	0.0	0.0	10.2	12.9	0.0	0.1	6.8	22.7	0.7	3.6	1.3	0.0	67.1	0.0	17.0	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.6	4.8	0.5	0.5	0.8	0.3	0.5	0.4	0.6	0.5	0.1	1.1	0.8	0.8	2.7	1.5	0.5	0.6	0.5	0.0	2.2	3.4	0.8	4.4	3.4	2.3	3.9	3.3	5.0	2.1	8.9	7.2	5.3	91.5	9.7	0.0	41.9	38.2	1.4	7.9	125.6	0.0	1103.3	1.7	361.6	1.2	133.2	75.1	0.0	83.6	184.7	19.9	41.9	14.9	1.1	78.0	0.0	10.9	249.8	10.8	0.4	6.9	5.7	21.9	3.6	27.7	0.3	206.9	37.7	3.9	67.7	0.4	420.4	356.4	0.2	0.9	5.6	1627.5	6.4	49.2	157.0
HCRTR1	OX1R	ENSG00000121764	"Hypocretin receptor 1"	O43613	1	31617686-31632518	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.0"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 1.1;Late spermatids: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;HUVEC TERT2: 3.0;TIME: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014018	Approved					NA	NA					"HPA014018: AB_1854810"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.54e-5)"	"unprognostic (3.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	3.3	4.3	0.9	0.3	1.4	1.6	2.7	0.7	4.5	0.1	0.3	0.0	0.0	0.2	0.6	0.3	0.7	0.5	0.8	1.8	0.8	4.6	0.5	0.1	0.2	0.6	1.1	0.0	0.5	0.3	0.0	1.7	2.3	8.0	0.5	0.2	0.7	0.5	0.0	2.4	1.1	0.5	0.0	0.5	0.6	0.4	0.4	0.0	0.0	2.9	0.8	0.2	0.6	0.1	1.1	0.2	0.0	0.2	0.2	0.5	0.1	0.4	0.0	0.4	0.1	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	0.0	0.0	1.0	0.4	0.0	0.0	0.5	0.0	0.5	3.0	0.5	0.4	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.4	0.3	0.2	0.0	0.8	0.2	0.0	1.7	0.1	0.2	0.3	0.4	0.5	0.1	0.2	0.0	0.6	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.1	0.2	0.0	0.1	1.1	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.9	1.4	0.7	4.5	0.8	4.6	1.1	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0
PEF1	PEF1A	ENSG00000162517	"Penta-EF-hand domain containing 1"	Q9UBV8	1	31629862-31644896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061608			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		660000	"Nucleoplasm, Cytosol"	Vesicles	"HPA061608: AB_2684567"	"unprognostic (2.92e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-3)"	34.0	27.0	26.9	15.3	28.7	17.0	27.1	22.5	40.8	26.6	23.4	25.9	21.1	16.2	27.1	46.5	29.7	29.0	26.1	26.4	24.3	23.8	28.3	38.7	24.9	20.8	25.0	17.3	31.1	20.8	31.6	21.6	44.2	28.6	29.8	24.2	25.7	24.8	33.4	25.5	32.5	20.7	31.9	22.4	23.6	20.5	17.8	16.5	27.4	85.9	20.3	30.7	23.7	21.9	39.1	40.4	60.9	39.5	42.0	49.2	48.7	17.7	20.8	17.4	13.4	20.6	21.6	16.7	16.9	29.1	41.0	36.2	12.2	26.9	19.0	23.7	37.7	21.1	18.7	33.6	43.2	33.3	23.8	36.4	15.7	16.8	24.6	36.3	15.3	14.9	22.2	50.0	40.0	37.6	26.2	39.6	23.5	16.2	19.7	29.3	20.9	23.3	14.9	24.1	22.0	23.7	22.7	16.9	20.7	32.0	19.3	24.9	14.4	19.3	18.2	25.2	28.6	16.2	11.2	20.9	17.8	15.3	30.2	22.3	12.7	12.8	20.4	22.4	22.6	21.3	60.9	39.5	46.2	49.2	35.3	47.5	37.8	42.1	44.6	40.4	39.1	39.9	40.0	40.1	42.0	32.7	37.4	41.9	48.7	26.9	28.7	22.5	40.8	24.3	23.8	25.0	17.3	28.6	16.5	38.7	33.6	34.3	57.8	32.2	37.2	14.6	20.4	20.1	21.6	66.3	11.8	131.6	96.2	58.8	67.1	60.4	35.8	0.0	54.4	80.4	36.6	45.7	71.5	20.5	54.6	50.9	42.5	31.9	17.0	60.2	41.7	26.1	47.2	124.4	29.6	55.3	47.2	34.8	55.2	41.2	20.3	19.4	42.2	34.5	41.5	44.9	152.9	34.6	33.2	48.8
COL16A1		ENSG00000084636	"Collagen type XVI alpha 1 chain"	Q07092	1	31652247-31704319	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 46.4;Leydig cells: 40.6;Muller glia cells: 43.8;Peritubular cells: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.8;ASC TERT1: 30.0;BJ hTERT+: 32.9;fHDF/TERT166: 30.0;HSkMC: 28.4;U-2197: 27.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027237			Uncertain	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		530000	Cytosol	"Plasma membrane"	"HPA027237: AB_10600699"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (4.00e-9)"	"unprognostic (9.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.15e-2)"	18.0	7.3	7.0	12.7	9.0	0.2	10.8	2.8	8.2	63.1	17.3	10.2	12.5	6.1	31.0	15.2	9.3	8.3	15.9	9.1	9.6	6.2	3.4	1.0	7.2	3.1	9.9	10.2	62.6	2.6	1.3	7.3	8.2	8.8	29.3	4.6	12.5	15.3	38.1	4.2	26.9	8.6	45.2	15.7	3.9	10.5	10.0	10.3	1.5	11.8	7.9	5.0	26.1	28.3	0.2	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	38.8	30.0	4.1	17.8	32.9	4.3	4.5	0.1	3.1	0.0	0.5	30.0	0.6	13.9	0.0	18.3	1.0	0.0	0.0	0.0	2.0	6.0	12.9	0.0	0.1	28.4	12.6	12.3	6.7	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.4	0.7	2.1	0.3	2.6	0.1	0.3	0.0	0.0	16.0	16.0	27.5	0.3	0.0	0.0	0.0	10.9	0.0	1.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.0	0.0	0.0	7.0	9.0	2.8	7.1	9.6	6.2	9.9	10.2	8.8	10.3	8.9	3.8	0.0	13.1	27.2	2.6	7.0	0.0	8.1	4.5	17.4	2.0	1.4	0.0	4.5	10.5	2.2	4.5	0.0	0.6	3.1	46.4	3.8	6.9	0.0	1.1	0.0	26.6	6.7	0.8	17.8	40.6	1.5	13.5	0.0	14.2	43.8	1.2	2.5	85.9	0.8	1.9	0.0	25.8	8.8	1.8	18.4	1.8	0.0	4.5	10.6
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 52.0"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 18.3;Horizontal cells: 7.9;Late spermatids: 10.3;Muller glia cells: 10.1"	"Cancer enhanced"	"Detected in many"		"glioma: 20.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.7;SH-SY5Y: 15.2;T-47d: 17.5;U-2 OS: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069175			Supported	"Plasma membrane"		NA	NA		49000	"Plasma membrane"		"HPA069175: "	"prognostic favorable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	2.2	5.4	15.9	1.3	26.8	1.1	1.4	7.9	52.0	2.4	1.4	7.3	0.0	5.2	2.4	1.2	1.6	2.2	2.1	2.8	18.9	8.0	1.4	0.9	1.3	1.3	7.4	16.5	1.8	1.4	1.3	2.7	3.8	8.4	2.4	1.1	1.3	1.4	3.1	1.1	1.5	5.0	2.4	2.9	1.8	1.8	3.2	6.3	1.5	3.2	0.0	1.1	2.0	0.5	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.6	4.4	4.2	12.0	1.2	0.7	2.0	2.8	4.5	2.8	4.9	0.2	1.3	0.0	2.8	1.2	4.6	0.4	1.8	0.2	0.4	3.1	1.9	0.0	20.7	0.0	0.1	0.0	1.6	0.7	0.3	3.8	0.0	8.8	0.4	8.8	0.4	0.1	3.1	0.4	7.9	0.1	5.2	0.1	1.3	12.1	0.4	0.4	0.0	5.7	3.2	15.2	6.5	0.4	0.5	1.5	17.5	0.0	0.1	2.1	17.0	0.3	0.7	0.0	0.0	0.4	6.7	0.0	5.1	0.0	0.0	0.0	0.9	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	15.9	26.8	7.9	37.6	18.9	8.0	7.4	16.5	8.4	6.3	0.0	0.0	0.0	0.5	0.0	18.3	4.1	0.0	0.0	0.0	0.0	5.9	0.7	0.0	0.1	2.9	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0	0.4	7.9	1.2	0.0	0.0	10.3	1.1	0.0	0.0	0.0	0.0	10.1	0.1	0.0	1.8	1.9	4.1	0.0	0.3	0.7	4.5	0.0	0.2	0.0	0.1	0.9
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell type enhanced"	"Detected in some"	19	"Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008"	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.7	0.3	0.0	0.0	0.2	1.5	0.5	14.1	18.9	13.7	9.2	0.2	0.6	0.1	1.9	15.9	5.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.9	0.2	19.7	0.6	11.1	9.3	0.7	0.2	0.2	8.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	1.4	0.0	0.0	33.2	0.0	0.0	0.3	0.0	0.9	0.4	8.2	0.0	17.3	14.5	1.4	9.3	5.3	0.0	0.1	0.0	32.7	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6	0.0	5.9	0.0	4.0	0.1	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	9.9	0.2	0.1	0.0	0.0	8.9	0.5	0.4	1.7	1.1	0.0	13.9	0.0	1.7	0.6	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.2	0.0	0.0	44.4
PTP4A2	"HU-PP-1, OV-1, PRL-2, PRL2, ptp-IV1a, PTP4A, PTPCAAX2"	ENSG00000184007	"Protein tyrosine phosphatase type IVA, member 2"	Q12974	1	31906421-31944856	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Urothelial cells: 819.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003281, CAB011204"	Uncertain					NA	NA		440000			"CAB011204: AB_532271, HPA003281: AB_1855903"	"unprognostic (2.67e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (6.90e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.10e-11)"	"unprognostic (1.16e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.72e-5)"	51.6	22.4	41.1	39.6	57.3	74.6	48.8	12.0	34.6	26.3	37.1	68.9	24.9	31.9	23.4	20.8	25.3	23.9	31.6	64.8	50.6	31.4	26.7	36.3	34.6	44.0	56.3	29.5	34.6	28.5	17.1	19.2	25.8	40.9	28.6	36.9	21.1	28.0	27.5	82.8	16.5	29.1	32.7	58.5	40.9	31.3	44.6	48.7	110.5	48.0	20.0	47.2	49.0	40.3	14.7	14.8	50.0	44.6	18.2	29.0	18.2	42.3	24.7	24.2	45.2	48.6	52.1	16.6	41.6	58.1	34.2	35.6	21.7	61.4	75.3	32.8	56.5	38.5	17.3	24.7	24.2	63.5	67.7	14.0	52.3	43.8	22.5	52.2	42.4	53.0	47.8	20.2	48.2	47.6	34.2	34.6	60.6	67.2	30.9	43.8	20.6	135.8	20.8	32.4	32.5	36.1	23.6	40.7	31.3	22.9	78.4	23.8	17.1	44.3	28.9	47.1	44.1	82.5	23.5	35.7	40.3	34.0	60.0	45.8	32.2	50.2	38.4	39.0	34.8	39.1	50.0	17.2	27.4	25.4	32.6	20.3	14.7	22.6	29.0	14.8	11.3	14.5	24.9	18.0	18.2	44.6	10.7	17.8	18.2	41.1	57.3	12.0	34.6	50.6	31.4	56.3	29.5	40.9	48.7	113.2	107.0	105.7	413.0	172.4	53.2	156.4	145.2	36.1	85.3	191.9	56.9	42.6	162.5	131.4	33.4	86.3	153.7	46.7	159.0	99.5	130.0	535.6	85.4	139.5	112.1	93.8	123.2	81.0	165.5	29.0	163.7	193.7	109.6	162.3	177.6	142.6	155.3	178.2	164.8	128.3	51.1	129.4	116.1	95.6	88.0	171.8	133.9	143.0	162.7	819.0
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013829-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		20000	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	34.5	31.7	31.1	49.7	34.2	42.0	35.9	56.6	41.5	42.0	38.8	35.1	30.1	33.3	51.5	37.8	37.0	39.5	51.2	34.9	29.7	30.1	30.0	30.9	38.3	52.5	27.3	35.9	63.2	31.3	40.4	29.5	33.9	25.9	36.5	31.7	32.2	31.1	35.5	39.0	30.6	32.4	44.2	31.4	36.0	31.0	42.7	23.7	69.9	35.1	41.0	50.0	40.2	34.4	11.4	10.2	6.4	10.2	8.2	14.4	3.5	44.4	27.1	62.1	45.6	21.6	27.2	36.5	27.0	34.4	50.8	42.9	30.1	40.0	66.7	30.3	34.1	29.5	31.2	50.0	37.0	52.1	39.7	42.7	42.0	26.7	41.0	28.5	55.6	28.3	29.8	21.2	38.6	30.7	33.4	47.9	41.1	54.1	30.6	38.9	29.0	81.8	47.6	63.0	28.1	32.6	65.7	52.6	56.3	35.4	45.2	42.5	55.6	39.3	33.7	33.9	46.2	40.1	40.5	35.9	33.1	35.9	35.3	45.1	32.2	34.8	65.6	34.4	44.5	25.2	4.6	6.7	6.4	9.6	10.2	14.4	11.4	11.5	9.9	9.0	9.3	12.5	11.8	5.9	8.2	8.2	10.2	10.3	3.5	31.1	34.2	56.6	41.5	29.7	30.1	27.3	35.9	25.9	23.7	35.7	61.9	121.1	181.3	131.1	88.3	92.4	79.0	108.4	116.0	66.3	47.1	161.4	71.3	89.2	18.7	98.3	69.3	23.3	88.7	198.7	113.7	105.9	126.8	57.1	105.8	60.4	113.1	87.8	125.1	11.5	102.9	123.6	102.9	84.8	92.4	126.7	86.6	57.5	116.7	98.2	71.0	90.5	113.7	152.3	117.7	114.2	145.1	101.2	124.2	156.2
TMEM39B	FLJ10315	ENSG00000121775	"Transmembrane protein 39B"	Q9GZU3	1	32072031-32102866	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040191, HPA040224"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA040191: AB_10805706, HPA040224: AB_10795274"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (2.82e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (5.11e-9)"	"unprognostic (2.20e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.10e-1)"	13.4	10.2	6.2	7.4	10.1	6.1	10.8	6.2	14.3	18.2	10.7	11.5	8.2	7.1	18.8	11.9	8.2	11.8	9.4	10.0	5.8	7.9	6.7	13.7	9.3	13.5	7.2	11.7	16.1	6.6	7.8	9.9	16.9	8.3	9.7	8.1	10.8	8.5	13.7	9.9	13.0	8.4	12.6	7.0	9.5	9.0	18.3	7.1	22.9	10.8	10.3	13.1	12.7	11.3	11.5	21.6	5.1	14.1	4.4	10.6	8.3	8.1	2.4	2.9	7.8	10.0	6.0	4.1	7.7	11.8	9.3	9.0	4.2	12.0	8.7	11.6	5.3	5.7	9.3	2.3	11.4	2.6	4.8	7.5	5.7	5.2	2.2	12.1	10.1	5.8	8.8	4.2	14.2	10.3	5.1	5.6	5.0	7.4	7.8	8.0	3.8	6.5	3.0	10.4	9.2	5.8	12.0	11.2	12.3	4.1	4.4	7.2	4.3	10.5	5.4	8.2	1.1	4.2	4.8	8.4	14.6	9.7	5.3	7.5	3.9	5.9	9.5	8.9	8.7	11.1	2.5	14.1	5.1	5.3	12.0	7.2	11.5	7.9	6.6	14.4	11.5	10.6	8.6	3.7	4.4	8.7	21.6	8.2	8.3	6.2	10.1	6.2	14.3	5.8	7.9	7.2	11.7	8.3	7.1	8.9	0.6	14.5	14.4	9.8	7.7	2.2	7.6	2.7	7.9	3.5	17.7	28.7	1.7	7.4	2.4	17.5	4.7	0.0	13.8	18.0	17.0	4.9	15.0	5.5	13.5	6.4	5.2	12.3	15.7	0.9	11.2	12.6	10.1	19.8	7.6	4.3	5.3	2.9	13.1	3.4	5.6	6.5	12.2	10.3	15.1	8.9	34.1	10.1	9.3	3.5
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108038-32176568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 204.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	16.1	18.7	24.6	14.6	19.0	22.9	18.1	23.9	25.2	16.3	18.8	15.7	23.0	11.5	21.3	17.5	21.4	15.9	12.1	23.4	22.7	18.2	18.3	18.0	17.3	13.2	15.4	19.8	16.9	17.1	40.9	18.0	23.5	29.7	17.6	17.3	14.1	16.2	19.8	54.0	20.5	14.2	23.1	29.2	14.8	17.4	22.2	17.6	12.6	17.8	14.5	18.3	17.9	17.8	9.1	9.3	9.5	12.5	5.0	11.2	6.4	17.0	13.5	12.1	15.5	18.6	16.4	14.2	13.8	16.3	20.2	19.6	15.0	18.7	14.3	16.4	24.8	12.2	14.8	18.5	21.1	25.9	14.4	10.2	14.7	20.8	12.1	16.5	16.1	12.1	16.5	20.1	25.0	24.0	17.1	21.0	11.3	14.2	13.2	19.1	9.4	13.0	9.2	28.1	11.1	10.1	13.1	17.4	11.7	17.6	15.7	11.6	9.8	25.1	15.1	13.4	30.9	10.6	8.6	24.4	18.8	13.0	24.4	19.8	9.5	10.8	11.3	20.5	15.1	17.9	4.0	10.2	9.5	11.2	12.5	11.0	7.8	9.7	8.7	8.3	9.1	11.2	10.8	6.0	5.0	12.5	9.3	9.6	6.4	24.6	19.0	23.9	25.2	22.7	18.2	15.4	19.8	29.7	17.6	38.7	37.4	43.4	31.3	56.4	47.6	28.5	33.1	40.2	21.6	27.9	55.0	38.1	14.9	32.5	204.0	37.9	20.6	0.0	27.4	36.4	38.2	41.3	12.8	56.3	26.8	49.3	44.3	35.6	32.3	48.0	31.7	26.8	23.6	28.9	37.1	29.8	38.9	17.5	38.2	28.3	40.5	32.3	29.9	55.9	52.6	74.4	113.5	32.6	29.2	51.1
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179686-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: AB_2686525"	"prognostic favorable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (5.53e-4)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	22.5	29.4	20.2	19.4	27.5	14.0	17.9	23.2	26.4	20.3	23.7	17.0	23.4	16.6	30.4	24.7	24.2	25.0	24.6	16.4	18.5	13.9	20.9	44.8	19.0	19.9	25.6	13.4	26.5	23.6	31.5	35.9	19.3	21.8	24.6	18.5	20.8	23.9	23.3	16.5	31.0	18.9	28.3	19.9	23.5	21.2	38.4	22.9	17.0	22.8	18.8	26.0	19.3	23.5	8.0	14.3	8.4	12.2	14.2	13.9	9.0	19.5	16.8	17.5	19.7	22.8	30.0	14.2	28.1	22.4	27.2	26.1	18.7	21.3	22.4	11.5	27.2	8.9	22.2	23.9	18.4	24.8	25.6	18.5	35.5	24.4	24.4	24.2	25.7	28.2	30.0	24.8	28.7	13.6	20.1	21.4	27.3	14.4	23.2	22.2	10.9	18.8	16.6	25.5	14.0	15.5	22.2	26.6	19.7	18.6	25.1	18.4	18.9	29.1	18.5	29.8	22.5	17.1	15.7	22.2	28.8	24.9	37.9	35.8	34.7	26.8	20.4	29.8	35.1	26.5	8.4	9.0	4.5	13.9	9.7	11.9	7.3	9.6	10.3	6.9	8.0	8.4	9.1	1.3	14.2	12.2	14.3	7.0	9.0	20.2	27.5	23.2	26.4	18.5	13.9	25.6	13.4	21.8	22.9	20.8	21.3	7.7	9.2	7.8	13.9	7.7	10.2	28.1	19.4	14.0	37.3	8.8	1.7	15.8	11.5	15.8	11.9	0.0	14.2	12.0	17.1	10.3	12.7	28.6	15.9	25.4	25.2	16.0	12.4	13.3	22.2	11.7	5.0	20.8	15.4	13.8	18.6	2.9	19.4	11.8	24.5	12.9	21.1	21.8	24.5	10.7	5.7	10.2	12.1	6.7
CCDC28B	"MGC1203, RP4-622L5.5"	ENSG00000160050	"Coiled-coil domain containing 28B"	Q9BUN5	1	32200386-32205387	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 66.7"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 86.5;monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 140.1"	"Low region specificity"	"Detected in all"			HPA028589	Uncertain					NA	NA					"HPA028589: AB_10602175"	"prognostic favorable (2.92e-4)"	"unprognostic (6.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.87e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.07e-2)"	2.0	6.5	7.0	4.1	7.2	3.4	1.6	12.4	6.5	2.2	3.1	2.0	1.4	2.4	3.1	3.2	3.2	2.7	3.9	8.6	6.3	4.6	2.9	1.1	2.0	6.8	5.0	6.0	3.4	3.5	4.4	10.1	3.0	4.3	2.7	1.7	4.7	4.0	2.6	66.7	2.6	1.9	3.8	3.6	3.4	2.8	11.7	5.2	4.5	3.2	11.7	4.7	3.2	1.9	9.3	14.2	3.1	4.3	15.8	15.6	8.4	4.6	1.5	10.3	9.9	3.0	3.8	0.8	3.3	4.8	5.8	3.9	3.0	5.3	10.2	5.4	3.9	0.9	1.3	8.3	3.9	1.1	11.6	11.7	13.2	7.1	1.8	4.2	0.3	4.5	4.7	1.8	6.6	0.1	5.5	7.9	17.0	8.5	1.3	3.8	0.6	17.2	2.6	10.4	1.3	2.5	18.3	5.0	8.2	5.3	0.7	19.9	8.8	4.8	1.0	5.8	6.2	3.2	3.9	4.7	3.3	4.4	4.5	2.1	2.8	0.7	0.6	5.6	17.8	3.1	3.1	4.3	0.9	15.6	2.0	7.8	7.8	7.4	13.2	9.8	9.3	12.4	12.3	0.4	15.8	0.5	14.2	9.6	8.4	7.0	7.2	12.4	6.5	6.3	4.6	5.0	6.0	4.3	5.2	0.0	6.7	6.7	5.3	8.0	29.4	12.8	10.2	2.7	1.2	12.2	21.6	1.7	29.9	17.1	11.4	9.0	0.5	23.3	6.6	3.2	31.7	3.0	3.5	0.8	9.8	22.3	86.5	8.6	3.4	22.6	18.7	4.8	16.9	107.4	5.3	16.1	9.1	1.7	15.9	3.3	43.3	0.0	21.7	2.7	11.9	6.8	1.8	22.9	3.3	1.3
IQCC	FLJ10547	ENSG00000160051	"IQ motif containing C"	Q4KMZ1	1	32205661-32208687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.6"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 23.3;Spermatocytes: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA028602, HPA028686"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA028602: AB_10600298, HPA028686: AB_10601985"	"unprognostic (1.45e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (7.81e-6)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.97e-2)"	"unprognostic (2.97e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.12e-3)"	"prognostic favorable (3.79e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.66e-1)"	2.2	4.2	5.0	3.3	8.2	4.4	5.0	9.7	11.7	3.8	3.5	5.1	4.4	2.5	5.5	10.2	3.1	8.3	3.4	2.8	4.0	4.3	4.3	1.9	2.9	3.5	3.1	5.9	5.4	8.1	5.6	9.5	2.7	3.4	4.3	3.5	4.7	4.8	5.7	4.1	4.9	3.1	3.0	3.1	3.2	4.4	26.6	4.6	4.4	8.3	1.0	3.7	2.8	2.9	5.1	2.8	3.4	1.1	3.9	3.8	1.2	7.5	2.5	6.2	5.8	1.1	2.3	3.9	4.3	5.0	9.1	8.5	6.1	6.8	2.7	4.8	1.3	1.6	6.4	6.2	3.8	7.7	4.1	7.0	4.8	5.8	2.6	1.5	5.1	3.3	1.6	4.0	8.1	3.6	3.7	1.9	10.5	8.4	0.7	4.1	5.2	8.4	5.3	3.9	4.1	5.7	11.9	3.7	6.2	3.4	2.9	8.7	3.4	8.6	5.0	4.6	5.9	6.0	5.4	2.6	3.4	6.3	4.9	7.3	3.4	2.4	2.4	4.8	4.9	6.9	1.6	1.0	0.4	3.3	1.0	3.1	5.1	3.4	2.5	1.8	2.5	3.8	2.2	3.4	3.9	1.1	2.8	3.7	1.2	5.0	8.2	9.7	11.7	4.0	4.3	3.1	5.9	3.4	4.6	0.0	2.9	0.0	0.8	0.2	4.8	1.6	2.5	4.0	0.0	3.5	5.9	1.4	3.3	1.2	0.6	1.1	0.9	23.3	1.2	1.6	1.6	0.5	1.1	0.5	0.8	6.4	2.9	0.0	0.0	1.1	1.1	0.2	0.0	1.8	2.7	2.3	1.0	1.5	2.5	0.4	8.4	0.0	0.5	18.9	9.8	0.6	0.8	1.9	1.7	0.2
DCDC2B		ENSG00000222046	"Doublecortin domain containing 2B"	A2VCK2	1	32209094-32216196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 11.1;fallopian tube: 26.6;lung: 10.1"	"Cell type enriched"	"Detected in some"	13	"Ciliated cells: 115.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;hTERT-RPE1: 2.9;TIME: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045832	Uncertain					NA	NA					"HPA045832: AB_10962048"	"unprognostic (6.45e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.66e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.71e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.18e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	11.1	0.0	26.6	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	5.5	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.0	0.6	0.1	0.2	0.3	0.0	0.1	0.8	1.6	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	2.9	0.0	0.9	0.1	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.2	0.4	0.0	0.0	0.6	0.2	0.5	0.8	0.1	3.6	0.1	0.7	1.0	0.7	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	115.1	9.1	1.8	3.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	3.2	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0
TMEM234	"C1orf91, dJ622L5.7, FLJ90779, RP4-622L5"	ENSG00000160055	"Transmembrane protein 234"	Q8WY98	1	32214472-32222359	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015049	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA015049: AB_1856409"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.37e-2)"	7.9	9.2	7.0	9.5	9.2	5.7	8.6	9.5	12.2	9.4	9.4	9.9	21.9	5.0	9.6	22.2	10.4	11.8	12.3	11.0	7.4	8.4	11.5	7.3	9.8	9.9	6.0	7.6	12.6	10.8	14.5	14.9	12.5	6.6	10.2	9.3	14.8	8.8	25.0	6.3	5.3	7.4	9.6	5.8	9.0	9.4	15.9	4.7	8.6	15.3	4.0	9.4	6.8	9.0	5.2	7.5	23.2	8.3	7.0	6.4	4.1	8.2	6.8	3.6	3.9	10.5	8.3	4.0	12.2	9.0	6.3	4.8	4.5	8.8	2.5	14.2	11.6	4.9	6.9	4.6	9.0	5.6	5.3	5.4	5.2	10.0	5.1	8.0	6.1	3.5	10.7	9.6	6.8	5.0	11.7	9.3	2.7	4.7	1.8	11.0	2.4	2.4	4.9	6.9	2.1	5.0	3.3	2.9	2.9	14.3	4.0	4.7	4.8	9.2	5.2	4.0	12.3	2.4	2.0	11.0	2.4	3.8	9.1	8.7	3.1	1.5	1.2	7.2	2.3	8.4	11.7	8.0	11.9	4.1	8.3	6.4	4.5	3.3	4.4	7.5	5.2	2.4	3.0	23.2	7.0	5.9	5.6	1.9	4.1	7.0	9.2	9.5	12.2	7.4	8.4	6.0	7.6	6.6	4.7	8.9	1.0	5.8	6.2	2.4	5.6	2.8	2.5	22.7	6.8	22.7	2.0	22.7	1.7	18.9	18.4	7.7	12.9	0.0	13.5	19.1	7.5	6.4	3.5	5.8	16.7	1.6	5.8	9.2	7.5	41.2	8.6	6.3	13.5	15.4	10.8	8.0	15.1	11.5	7.4	9.8	11.5	6.5	6.9	26.5	15.3	2.8	17.8	5.7	8.4	5.8
EIF3I	"eIF3-beta, eIF3-p36, eIF3i, EIF3S2, TRIP-1"	ENSG00000084623	"Eukaryotic translation initiation factor 3 subunit I"	Q13347	1	32221928-32231604	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029939, HPA029940"	Enhanced		Approved	Cytosol		NA	NA		16000	Cytosol		"HPA029939: AB_10611109, HPA029940: AB_10600878"	"unprognostic (4.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.82e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (9.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.81e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.47e-2)"	46.3	45.9	26.1	28.9	27.6	32.2	44.8	21.2	28.7	36.6	39.1	25.3	41.0	24.5	33.5	50.4	61.0	37.9	42.7	44.4	25.2	25.0	47.6	89.7	33.9	42.7	27.1	21.9	50.5	72.0	27.0	25.0	45.4	22.8	38.7	45.5	26.5	59.6	40.6	79.1	35.0	39.5	38.5	25.9	36.1	34.8	31.3	17.0	55.8	67.9	75.4	46.6	43.3	34.5	44.4	56.6	23.8	50.3	42.4	52.9	61.6	49.6	39.2	31.8	59.0	48.2	60.7	30.5	39.5	73.8	76.2	60.4	45.7	55.0	75.5	40.1	70.0	52.8	35.0	68.2	77.6	93.5	27.8	64.6	45.9	35.1	50.7	54.8	75.9	39.0	58.4	69.7	73.6	83.2	59.1	66.2	52.6	88.2	30.3	68.9	39.0	56.7	59.4	83.3	68.9	61.6	41.3	53.0	64.0	75.2	34.9	42.8	47.6	43.1	46.5	77.0	63.1	35.7	38.3	40.7	44.0	46.4	67.4	82.8	51.1	55.1	63.8	49.6	61.8	57.4	23.8	47.3	21.7	42.1	50.3	47.7	44.4	45.1	41.9	56.6	39.7	40.2	38.3	6.1	42.4	36.8	43.5	52.9	61.6	26.1	27.6	21.2	28.7	25.2	25.0	27.1	21.9	22.8	17.0	47.6	67.3	128.8	178.4	121.3	38.5	37.7	81.5	91.0	78.5	48.8	9.8	263.3	112.7	251.4	51.4	121.5	96.3	0.0	237.9	288.5	128.5	125.4	112.0	70.0	199.5	12.7	132.9	70.0	89.1	20.4	159.6	124.5	136.7	223.6	124.0	53.3	233.6	105.2	130.8	144.9	32.3	90.5	209.4	67.7	73.9	123.6	286.3	137.0	158.7	187.7
FAM167B	"C1orf90, MGC10820"	ENSG00000183615	"Family with sequence similarity 167 member B"	Q9BTA0	1	32247233-32248856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"vagina: 91.1"	"Cell type enriched"	"Detected in some"	10	"Ito cells: 188.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 46.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 7.0;EFO-21: 8.9;SK-MEL-30: 21.5;U-2197: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029398, HPA062074"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA029398: AB_10602807, HPA062074: AB_2684677"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.03e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-3)"	"unprognostic (7.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.04e-2)"	"unprognostic (5.08e-2)"	17.2	10.5	1.4	5.0	1.7	0.1	20.1	1.7	1.9	6.1	3.1	1.1	7.4	3.6	7.8	2.2	4.5	3.4	5.5	11.3	1.8	1.7	20.3	18.4	22.4	6.2	3.2	0.6	3.8	6.6	5.2	8.5	5.8	3.3	9.2	2.7	5.2	2.6	8.2	3.3	1.1	4.1	7.5	2.6	1.4	4.0	1.8	2.7	1.2	11.8	1.5	1.9	7.2	91.1	1.0	0.0	0.8	0.0	0.3	4.5	0.7	0.6	1.3	0.4	0.0	0.9	0.8	0.0	3.1	7.0	1.4	1.9	0.0	0.6	0.1	8.9	5.2	1.6	1.0	0.2	0.0	0.4	0.1	0.0	0.0	2.8	0.4	0.3	0.0	0.1	0.8	0.5	1.0	0.3	1.8	2.6	0.4	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.1	3.0	0.6	0.0	0.8	0.9	0.3	1.3	0.3	2.0	0.1	21.5	0.5	0.3	0.0	2.3	0.6	0.7	22.0	0.0	0.1	0.2	0.5	0.2	0.1	0.3	0.0	0.0	0.8	2.6	0.0	0.7	0.5	0.8	0.8	0.0	1.0	0.5	1.6	0.0	0.3	0.0	0.0	4.5	0.7	1.4	1.7	1.7	1.9	1.8	1.7	3.2	0.6	3.3	2.7	0.0	1.4	3.9	0.4	0.2	0.2	0.4	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.4	0.0	19.1	0.0	0.0	0.7	0.3	0.9	0.6	0.0	1.0	0.5	0.0	0.0	188.4	11.9	0.0	2.6	0.4	1.7	0.0	1.0	0.0	0.2	0.2	1.1	0.0	0.6	0.0	1.2	0.0	0.2	0.9	0.2	3.3	0.4	0.3
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 112.2;lymphoid tissue: 153.0"	"Cell type enriched"	"Detected in many"	10	"T-cells: 207.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"gdT-cell: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2"	"Group enriched"	"Detected in many"	13	"NK-cells: 42.8;T-cells: 112.2"	"Group enriched"	"Detected in some"	6	"JURKAT: 66.9;MOLT-4: 93.9;U-698: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	2.6	0.7	0.4	28.2	0.5	3.8	1.3	0.3	0.5	1.7	3.9	0.5	0.9	2.2	1.1	4.5	2.3	1.6	3.8	1.0	0.4	0.4	3.0	2.3	6.6	34.9	0.9	0.5	1.2	0.8	0.0	0.8	0.7	0.6	2.2	1.9	1.3	8.4	1.3	0.9	1.0	16.5	0.7	1.0	28.9	3.5	0.7	0.5	153.0	2.9	1.5	27.1	5.8	2.1	6.1	0.5	2.5	0.3	42.8	112.2	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	93.9	0.0	1.0	0.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	54.1	0.0	0.0	0.0	0.6	0.3	0.4	83.4	0.3	77.5	4.0	86.1	90.2	0.3	6.1	97.0	91.3	2.5	42.8	0.3	0.5	112.2	109.3	0.4	0.5	0.3	0.5	0.4	0.4	0.9	0.5	0.6	0.5	0.0	16.0	20.4	0.9	4.0	0.0	1.1	2.5	2.7	2.3	3.5	0.0	0.2	0.0	0.3	0.1	1.6	0.0	0.0	0.4	0.1	2.0	0.8	4.7	1.0	0.3	0.0	2.4	3.7	4.9	0.0	0.0	0.6	3.3	0.0	0.0	0.0	2.7	0.0	0.4	1.1	0.0	0.0	0.9	3.7	1.9	2.8	0.3	207.5	0.4	1.0
HDAC1	"GON-10, HD1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292086-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	13.8	22.8	12.8	33.5	14.8	15.0	21.1	5.1	13.0	21.9	35.7	16.0	34.8	22.2	24.6	17.5	40.6	21.0	43.8	12.4	12.5	8.5	21.1	21.5	17.2	33.3	14.7	8.6	27.7	20.5	17.2	27.1	24.4	12.2	25.2	33.9	18.0	27.8	31.3	6.6	16.9	32.7	22.1	13.3	32.6	27.8	20.0	16.7	59.4	36.8	21.2	51.1	26.0	25.1	47.7	32.1	59.8	44.6	42.4	49.2	54.7	29.4	18.0	11.6	23.0	6.8	8.1	24.1	20.9	23.4	28.0	25.9	32.9	53.1	45.4	38.8	23.0	28.5	34.4	35.5	28.4	31.1	42.4	35.3	31.3	21.6	25.2	16.0	55.4	45.4	14.6	15.6	21.7	14.4	22.0	21.2	59.5	41.0	18.1	12.3	22.4	63.1	31.2	26.8	35.2	46.1	43.6	27.5	20.2	30.3	42.6	9.1	11.5	34.8	23.5	43.8	47.7	27.7	43.1	24.5	18.7	21.9	5.7	50.8	11.0	23.7	62.3	15.4	46.0	24.2	37.0	27.7	59.8	43.2	35.5	35.4	47.7	42.4	46.1	32.1	44.3	49.2	45.7	19.9	42.4	44.6	20.1	42.5	54.7	12.8	14.8	5.1	13.0	12.5	8.5	14.7	8.6	12.2	16.7	23.8	38.4	50.1	48.1	22.0	15.5	18.2	56.0	80.3	48.9	64.6	15.7	81.3	81.2	57.2	10.0	40.9	97.1	0.0	65.1	93.0	21.5	29.1	29.0	28.2	38.0	11.1	82.9	63.8	40.8	5.9	38.0	31.0	27.0	42.3	101.3	32.1	65.7	108.7	41.8	25.9	13.9	58.2	37.7	45.1	76.2	22.2	78.1	50.7	115.8	49.8
MARCKSL1	"F52, MacMARCKS, MLP, MLP1"	ENSG00000175130	"MARCKS like 1"	P49006	1	32333832-32336379	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.5"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 1596.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 54.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 54.9"	"Cell line enhanced"	"Detected in many"		"AF22: 108.3;NTERA-2: 104.4"	"Low region specificity"	"Detected in all"							"CAB020787, HPA030528"	Enhanced		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	Yes		120000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB020787: , HPA030528: AB_2673514"	"unprognostic (8.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.16e-3)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (3.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-2)"	9.9	12.7	59.9	22.1	45.4	10.9	27.7	22.0	58.0	22.3	27.5	126.3	5.3	15.9	25.8	42.3	3.6	15.9	24.9	10.7	64.2	47.2	6.4	9.7	9.0	41.5	83.6	35.4	74.1	4.8	1.3	4.9	11.0	56.6	22.5	30.7	5.2	19.9	14.2	2.0	5.3	13.9	11.3	166.5	12.5	34.8	30.3	52.3	41.4	29.0	2.2	49.2	17.0	5.5	6.4	2.2	54.9	6.7	0.2	3.9	1.2	8.4	7.6	108.3	44.2	2.4	0.9	19.2	3.5	2.2	10.6	7.0	18.0	6.2	19.0	13.3	2.4	0.0	4.5	34.9	0.4	7.8	0.4	25.8	1.0	2.9	39.7	7.5	4.9	0.1	12.4	1.4	7.9	0.2	16.5	30.9	32.8	29.1	0.2	14.2	20.0	61.7	20.9	104.4	27.4	17.6	77.1	11.6	9.0	15.9	16.8	67.2	63.9	18.6	20.6	58.5	46.0	14.3	8.8	9.1	4.5	26.3	0.4	6.7	2.9	0.2	49.9	0.5	7.5	23.7	0.7	1.0	54.9	0.9	5.4	0.3	4.6	1.9	1.2	1.5	6.4	3.9	1.6	4.4	0.2	6.7	2.2	1.0	1.2	59.9	45.4	22.0	54.9	64.2	47.2	83.6	35.4	56.6	52.3	0.0	2.2	147.6	95.4	83.2	17.7	7.3	163.1	2.7	4.5	57.6	5.9	9.9	69.6	353.9	21.7	181.6	54.0	0.0	269.1	98.8	68.7	341.5	23.0	3.8	20.1	9.5	716.9	486.2	57.0	35.8	567.8	77.4	285.1	1596.0	443.0	406.9	517.8	228.0	602.9	1.2	12.4	129.4	72.9	6.2	129.4	72.6	11.2	47.2	387.2	506.2
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 68.1"	"Group enriched"	"Detected in some"	52	"Early spermatids: 242.3;Late spermatids: 839.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: AB_2675517"	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	1.1	2.0	0.8	1.7	0.8	8.2	1.1	3.9	0.8	1.3	0.9	0.8	1.4	2.5	1.8	2.9	0.8	1.3	1.0	0.9	0.8	0.0	0.9	1.3	1.4	2.4	0.8	0.8	2.0	1.2	0.0	0.8	0.8	1.0	1.0	0.0	0.8	1.4	0.8	1.7	3.4	2.9	0.8	0.8	3.4	1.2	68.1	0.8	0.8	1.3	0.8	0.8	0.9	1.1	0.6	0.1	0.1	0.7	0.3	2.3	0.1	2.3	2.3	6.0	3.5	0.0	1.2	5.4	0.7	1.1	0.0	0.0	0.5	1.2	1.2	0.9	0.0	1.0	3.7	0.0	0.0	0.0	3.5	7.2	2.7	9.8	3.7	4.4	1.1	3.4	0.1	0.9	0.0	1.3	6.3	0.0	4.6	3.1	5.8	0.0	0.6	1.4	1.5	1.5	0.4	1.2	1.9	1.7	4.4	0.0	1.9	1.8	3.8	0.8	2.8	4.1	4.4	1.9	2.7	2.9	2.1	3.4	3.0	2.4	8.5	2.8	1.8	3.7	3.9	0.5	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.2	0.0	0.1	0.6	2.3	0.9	0.1	0.3	0.5	0.0	0.0	0.1	0.8	0.8	3.9	0.8	0.8	0.0	0.8	0.8	1.0	0.8	0.0	0.3	0.0	0.4	0.1	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	242.3	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	839.4	8.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	8.9	0.6	1.4	6.5	0.0	10.3	3.8	0.0	0.2	0.0	0.2	0.2
FAM229A		ENSG00000225828	"Family with sequence similarity 229 member A"	H3BQW9	1	32361270-32364278	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	17	"testis: 71.8"	"Group enriched"	"Detected in many"	83	"Early spermatids: 2788.2;Late spermatids: 3116.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 12.8;U-2 OS: 4.0;U-266/70: 5.7"	"Not detected"	"Not detected"													NA	NA						"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.82e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.03e-2)"	"prognostic favorable (2.33e-4)"	1.7	1.0	1.3	0.6	1.3	4.1	0.5	1.4	2.1	1.0	1.4	1.0	0.5	1.1	1.0	1.6	0.5	1.2	0.7	0.5	0.9	0.8	1.5	1.8	0.9	0.5	0.8	1.5	2.3	0.5	0.2	0.6	0.6	1.0	1.3	0.3	1.0	0.5	0.6	2.2	3.5	1.5	0.5	1.1	3.2	0.9	71.8	1.1	0.6	1.3	0.8	0.6	0.6	0.6	0.6	0.0	0.9	0.1	0.0	1.8	0.4	0.6	0.3	0.2	0.5	0.0	0.0	3.4	0.5	0.0	0.0	0.0	0.4	0.0	0.3	1.1	0.0	0.1	0.6	0.0	0.0	0.0	0.8	12.8	0.7	0.7	0.2	0.0	0.4	1.1	0.3	0.0	0.0	0.2	0.4	0.0	1.0	0.8	0.9	0.0	1.2	0.4	3.4	1.5	0.1	0.1	3.2	0.4	1.9	0.1	0.0	0.8	3.1	0.0	0.3	1.4	0.0	0.4	0.7	1.0	0.6	4.0	0.7	1.5	5.7	1.7	0.0	0.9	0.5	0.0	0.0	0.1	0.8	0.4	0.0	1.5	0.0	0.0	0.1	0.0	0.6	1.8	0.6	0.9	0.0	0.0	0.0	0.0	0.4	1.3	1.3	1.4	2.1	0.9	0.8	0.8	1.5	1.0	1.1	3.0	1.9	0.0	1.9	2.1	4.3	3.1	5.1	0.0	0.0	8.7	0.0	0.7	18.3	2.5	2788.2	3.6	5.6	0.0	2.9	0.4	3.3	4.5	0.0	2.4	0.7	4.8	13.3	6.2	1.2	3116.7	35.6	0.7	0.0	1.0	6.6	7.5	4.2	6.0	30.8	2.4	6.2	19.4	1.3	33.5	14.3	1.3	0.2	2.5	4.3	2.5
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32365103-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	21.9	34.7	30.5	16.8	33.9	45.6	22.8	44.0	41.2	20.7	20.5	34.4	30.8	20.7	25.9	36.8	19.9	22.5	23.4	19.6	27.7	27.1	20.1	41.4	19.6	16.6	27.8	27.2	32.0	37.1	44.5	26.4	28.1	32.5	24.8	24.3	22.2	30.4	21.2	19.0	25.1	23.9	22.8	28.9	20.1	21.4	40.4	27.3	16.2	23.9	16.1	20.3	19.5	19.8	8.4	6.8	36.4	5.8	5.2	6.8	5.4	17.5	9.5	19.6	18.2	28.0	23.5	15.9	20.1	27.4	25.6	25.8	13.9	16.2	12.7	23.1	29.1	18.7	16.2	15.4	15.1	20.5	24.2	19.5	10.2	17.9	15.8	26.1	12.8	17.6	23.7	33.8	23.3	16.2	31.3	22.0	17.4	27.4	21.9	18.4	9.2	14.9	11.5	17.2	13.2	15.4	12.3	14.8	17.1	18.7	13.6	28.7	15.8	18.8	19.6	19.2	30.9	15.8	11.3	21.9	16.1	13.6	22.3	16.9	24.8	29.4	9.3	20.7	14.0	12.0	36.4	4.9	17.2	6.5	5.8	6.8	5.9	5.8	5.4	4.6	8.4	6.8	5.9	8.1	5.2	5.1	6.8	6.1	5.4	30.5	33.9	44.0	41.2	27.7	27.1	27.8	27.2	32.5	27.3	29.8	15.2	36.9	49.2	25.2	48.7	17.1	35.7	14.7	10.3	24.4	78.5	42.9	16.6	31.5	87.7	26.6	52.4	70.0	38.4	26.0	26.1	51.5	20.7	49.0	18.0	81.0	38.5	52.8	18.7	78.5	50.6	15.3	30.4	26.2	43.0	35.7	38.9	31.6	44.6	22.6	66.5	38.8	25.9	28.6	41.1	22.6	80.7	37.0	35.7	42.7
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465069-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 10.8"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 5.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 3.6;SCLC-21H: 3.6"									HPA055553	Enhanced					NA	NA					"HPA055553: AB_2682848"	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.4	1.3	5.1	0.6	2.8	2.5	0.6	2.2	5.0	0.4	0.3	1.3	0.7	0.5	1.2	1.3	0.7	0.7	0.6	0.4	3.3	4.7	0.6	0.6	0.5	0.9	2.6	2.7	1.0	0.8	1.0	10.8	0.7	4.1	0.8	0.4	0.2	1.7	0.5	3.4	1.7	0.5	0.5	1.6	0.8	0.5	3.1	1.6	0.0	0.8	0.0	0.6	1.0	0.4	1.4	1.2	3.2	0.8	1.3	0.7	0.2	0.2	0.1	2.0	1.5	0.2	0.5	0.6	0.2	0.1	0.7	0.6	0.2	0.5	0.4	0.7	0.1	1.1	0.7	2.3	0.2	0.5	0.7	2.4	0.3	0.7	0.4	0.0	0.3	0.4	0.2	0.2	0.5	0.0	0.4	0.2	0.2	0.2	0.9	0.1	0.3	0.3	0.6	2.1	0.1	0.9	0.3	0.2	0.3	0.4	3.6	3.6	2.1	1.3	0.5	0.2	2.9	0.4	0.3	0.9	0.5	0.4	0.6	0.3	0.7	0.7	0.4	0.5	0.4	0.4	3.2	0.8	1.0	0.6	0.5	0.6	0.8	0.6	0.5	0.3	1.4	0.7	0.7	2.9	1.3	0.7	1.2	0.5	0.2	5.1	2.8	2.2	5.0	3.3	4.7	2.6	2.7	4.1	1.6	0.0	2.6	0.0	0.8	1.4	2.9	0.6	0.0	2.7	1.2	0.0	5.9	1.5	0.0	0.0	1.5	0.7	0.0	0.0	0.0	1.0	0.8	0.7	3.5	0.2	0.3	3.2	0.0	1.3	0.3	1.0	0.6	1.5	1.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.3	1.9	1.2	0.5	0.2	1.0	0.0	0.7
ZBTB8A	"BOZF1, FLJ90065, ZBTB8, ZNF916A"	ENSG00000160062	"Zinc finger and BTB domain containing 8A"	Q96BR9	1	32539427-32605939	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 33.2;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031768, HPA031769, HPA031770"	Approved		Approved	"Nuclear speckles,Focal adhesion sites"		NA	NA			"Nuclear speckles, Focal adhesion sites"		"HPA031768: AB_10610568, HPA031769: AB_2674036, HPA031770: AB_2674037"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.45e-5)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.15e-2)"	8.8	4.9	4.4	3.2	5.0	2.3	19.1	11.1	5.9	13.6	6.2	4.8	12.2	3.8	12.7	8.6	7.2	7.8	5.7	6.9	4.4	3.4	5.7	4.4	14.0	1.9	3.3	4.5	8.6	10.9	10.7	8.9	5.5	7.9	7.8	6.2	6.9	9.9	11.4	10.3	4.8	4.2	15.4	5.2	2.7	6.4	6.2	3.5	1.8	11.2	6.6	3.0	9.1	7.6	1.6	2.1	4.1	1.0	2.6	1.0	0.5	6.6	1.9	7.8	8.4	5.6	7.5	5.9	6.7	5.3	6.3	6.4	0.8	5.4	5.4	4.6	7.2	2.8	5.2	7.7	5.3	5.6	1.4	5.2	0.3	6.6	2.9	7.2	1.2	0.4	5.0	7.6	4.6	12.1	6.3	7.0	4.9	1.1	3.9	6.3	6.8	3.6	0.6	7.1	3.3	2.8	6.6	11.4	4.3	3.9	6.9	6.6	6.0	9.3	4.7	8.9	4.3	6.1	3.1	7.2	8.4	6.9	11.5	4.8	7.1	3.4	4.2	5.8	1.4	3.5	4.1	1.0	0.8	0.8	0.6	1.0	0.8	0.7	0.7	0.7	1.6	0.8	0.9	3.8	2.6	0.8	2.1	0.6	0.5	4.4	5.0	11.1	5.9	4.4	3.4	3.3	4.5	7.9	3.5	14.9	14.4	1.5	6.3	3.7	10.5	3.6	5.1	4.0	4.5	7.0	21.6	2.5	1.7	5.7	3.8	12.8	3.5	0.0	4.5	5.1	10.1	7.2	2.3	3.6	1.4	6.4	4.7	20.3	4.0	3.9	18.4	4.8	3.3	1.0	4.5	4.1	5.0	3.5	33.2	2.4	8.7	32.3	11.3	0.9	4.3	3.3	1.3	2.5	8.7	5.4
ZBTB8OS	ARCH	ENSG00000176261	"Zinc finger and BTB domain containing 8 opposite strand"	Q8IWT0	1	32600172-32650903	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046315	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA046315: AB_2679623"	"unprognostic (3.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (5.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.11e-8)"	"unprognostic (1.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.42e-1)"	16.1	18.8	20.9	21.2	22.3	14.5	16.7	21.7	21.1	13.1	25.6	11.9	21.4	24.9	13.9	29.5	20.6	15.5	12.2	20.7	16.9	15.8	23.2	26.6	15.5	25.9	23.5	18.6	10.4	20.3	9.2	36.6	13.6	20.9	15.9	26.8	15.3	19.0	18.5	29.5	13.4	28.6	16.2	18.0	22.3	20.6	11.1	23.0	8.4	18.7	20.3	32.5	14.8	13.5	36.0	26.1	33.8	35.4	22.4	40.1	18.0	18.4	10.7	9.5	16.1	16.8	15.4	13.1	21.0	21.2	16.8	17.1	25.2	20.7	20.6	19.4	15.3	18.6	13.9	16.6	16.4	22.5	27.4	15.3	16.7	22.2	41.9	13.9	23.9	15.5	15.3	18.0	14.7	17.8	10.5	18.2	25.3	16.4	28.0	21.4	14.5	18.2	14.0	29.6	28.8	16.6	14.7	20.6	20.0	19.9	22.0	19.3	14.9	17.0	17.1	26.3	27.1	11.7	19.9	12.9	23.4	14.2	18.8	26.1	42.6	41.7	58.0	16.8	29.9	23.1	15.8	29.2	33.8	24.4	33.9	23.5	36.0	27.0	28.9	20.4	23.1	22.5	24.2	32.5	22.4	35.4	26.1	40.1	18.0	20.9	22.3	21.7	21.1	16.9	15.8	23.5	18.6	20.9	23.0	20.8	53.8	37.9	26.7	15.2	44.5	57.6	33.1	40.2	31.8	36.6	41.2	44.3	76.3	54.3	27.3	35.0	79.9	23.3	46.1	51.1	32.5	30.0	41.7	75.0	66.3	15.9	36.1	34.4	66.8	24.3	33.9	58.6	49.0	83.8	44.2	24.2	63.5	46.3	43.5	103.7	51.5	32.3	36.3	42.1	29.1	13.7	54.5	49.8	48.8	32.5
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		27000	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	23.8	33.6	28.2	34.3	27.8	23.4	29.1	30.5	35.1	32.2	24.1	32.0	42.3	20.5	36.0	29.2	26.0	35.4	21.3	24.0	27.9	24.8	25.2	25.4	23.0	43.9	30.6	29.0	37.6	31.3	27.0	32.9	26.2	26.9	24.2	35.5	31.2	30.1	43.1	31.8	24.9	26.8	32.6	26.9	27.6	28.8	53.4	31.4	73.3	35.8	20.5	65.2	32.5	26.6	33.7	45.4	26.7	39.4	33.1	32.4	48.4	15.6	13.7	39.2	28.6	12.1	11.5	15.9	11.9	10.4	24.4	23.8	19.6	32.2	47.5	13.2	14.1	14.1	10.1	42.9	12.4	26.3	18.5	20.6	44.3	27.7	25.7	17.5	41.8	19.2	12.6	15.8	18.4	12.0	19.0	18.0	32.9	31.1	34.1	20.8	10.9	53.5	13.1	43.6	15.5	16.0	52.0	41.3	41.2	17.1	33.5	37.5	22.3	28.2	10.1	19.3	40.4	17.3	19.3	14.9	14.8	15.1	18.7	16.0	27.0	28.3	53.3	17.7	33.8	22.7	26.4	38.8	26.7	31.1	39.4	32.4	33.7	29.7	31.4	45.4	26.6	26.7	28.8	10.2	33.1	35.3	38.3	30.3	48.4	28.2	27.8	30.5	35.1	27.9	24.8	30.6	29.0	26.9	31.4	38.7	41.4	104.6	60.7	63.4	104.9	19.4	79.0	50.9	46.6	69.8	135.5	102.1	71.3	72.0	18.9	58.2	40.2	23.3	50.7	69.8	69.6	53.3	47.4	69.1	71.5	100.1	93.2	70.6	73.4	13.7	73.6	63.2	47.2	72.1	69.7	74.5	62.2	28.8	83.1	53.7	104.1	97.0	47.5	120.2	77.3	67.8	71.5	85.3	75.6	47.1
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32680360-32703596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 51.0"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 69.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.8;fHDF/TERT166: 38.9;hTERT-RPE1: 23.8;U-138 MG: 34.1;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028311, HPA063549"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA028311: AB_2672554, HPA063549: "	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	4.2	3.2	3.7	5.8	3.9	0.1	6.8	1.1	4.2	5.9	7.2	3.7	1.2	1.5	7.7	7.7	15.6	5.3	4.8	7.9	3.5	3.9	1.4	1.1	4.6	0.6	3.6	2.6	7.9	0.9	2.7	2.8	1.1	3.5	6.1	4.8	4.6	4.1	8.4	51.0	1.6	4.0	28.5	4.5	1.9	6.5	5.4	1.9	0.0	1.9	23.6	2.3	7.8	2.5	0.0	0.3	0.0	1.8	0.0	0.3	0.0	0.0	1.3	0.1	0.0	6.5	10.2	0.0	10.5	26.8	9.1	6.6	0.1	0.1	0.0	0.5	38.9	11.0	0.4	0.3	0.2	5.5	0.0	0.0	0.2	4.4	0.9	5.2	0.0	0.0	15.7	0.9	10.1	0.3	23.8	2.9	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.1	0.9	0.0	2.0	0.0	10.6	0.0	0.1	0.1	10.6	2.2	0.0	2.1	0.6	0.0	1.7	34.1	1.5	18.1	2.7	0.0	0.0	0.0	9.5	0.1	22.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.7	3.9	1.1	4.2	3.5	3.9	3.6	2.6	3.5	1.9	8.9	6.0	18.0	11.4	19.6	44.6	0.8	17.8	5.3	13.6	8.7	37.3	7.3	5.0	10.7	8.6	8.7	7.8	23.3	4.7	7.6	12.4	10.4	21.9	16.1	4.8	69.9	7.0	20.3	20.5	12.4	38.6	9.9	32.1	4.6	7.0	16.9	6.8	8.0	60.5	7.8	52.5	19.4	12.0	30.1	26.0	19.4	4.2	21.3	8.9	8.5
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741885-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	3.7	39.4	12.1	8.6	8.7	0.7	14.1	1.6	15.8	8.7	25.9	2.7	27.8	28.1	5.4	8.7	33.8	13.5	28.8	2.3	6.4	4.5	23.1	5.9	13.4	0.8	2.4	6.6	18.0	32.8	21.7	4.8	19.3	7.3	18.5	17.4	10.0	36.9	44.6	1.8	33.4	36.0	6.8	1.6	1.1	25.5	2.9	3.0	3.1	19.2	17.9	20.3	15.0	22.3	0.0	2.1	0.0	1.0	0.0	0.4	0.2	19.4	10.2	1.6	2.8	0.7	1.5	7.6	2.4	4.7	2.8	2.7	11.1	38.4	0.0	10.1	3.5	8.2	29.0	3.1	20.6	1.4	0.0	4.1	4.0	14.5	9.0	1.2	0.0	10.4	0.5	32.0	7.3	8.8	12.5	5.7	0.8	5.8	0.1	1.3	16.1	0.1	0.1	3.4	16.8	6.4	2.6	2.1	4.9	26.5	35.5	1.4	1.4	15.0	21.6	2.9	10.9	23.0	1.3	5.3	4.6	12.6	4.2	5.1	0.2	0.1	0.1	4.7	0.7	5.3	0.0	0.6	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	12.1	8.7	1.6	15.8	6.4	4.5	2.4	6.6	7.3	3.0	11.9	49.9	0.5	31.7	65.7	0.5	3.3	76.5	20.1	23.9	26.2	2.0	12.1	8.3	38.3	3.6	6.7	90.1	0.0	57.6	3.7	5.6	56.0	26.6	8.6	2.5	0.0	27.9	1.3	0.3	3.6	8.1	2.5	6.8	3.6	55.5	0.8	52.7	49.1	4.6	12.5	0.0	6.5	5.0	1.8	2.5	72.6	6.6	1.9	54.5	60.9
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.8	15.1	15.9	38.3	19.8	22.8	17.0	29.8	24.7	24.5	31.3	17.9	19.9	52.5	11.8	30.9	20.0	17.0	48.4	35.1	38.8	22.1	19.2	48.1	22.9	16.8	65.2	37.9	29.1	22.6	43.7	38.7	98.6	17.7	24.8	42.5	52.9	55.6	21.0	14.9	42.5	20.8	29.0	29.5	20.9	37.2	15.2	44.1	17.6	14.5	30.7	18.9	16.2	19.1	55.0	19.0	19.1	41.3	20.1	14.9	26.6	30.2	24.6	44.9	47.9	49.1	37.3	52.9	40.9	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0	20.8	45.6	14.5	22.1	22.2	19.3	14.9	5.1	34.8	34.2	8.7	25.5	36.7	3.3	30.4	14.4	19.0	12.8	0.0	71.3	38.8	20.0	22.9	12.8	23.3	35.7	30.2	16.7	7.4	22.2	12.4	11.8	21.1	13.5	35.1	12.7	10.8	50.1	3.5	10.6	9.8	19.8	12.9	24.5	26.7	19.4	21.3	31.5	33.0	17.5	30.1
S100PBP	"FLJ12903, S100PBPR"	ENSG00000116497	"S100P binding protein"	Q96BU1	1	32816767-32858879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027242, HPA027328"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA027242: AB_2672174, HPA027328: AB_2672221"	"unprognostic (4.29e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.44e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	8.5	11.0	9.6	13.2	15.9	13.9	10.5	18.1	12.4	13.0	9.0	18.9	12.2	6.8	19.8	11.9	8.5	11.1	11.4	6.5	9.0	12.0	7.2	7.5	8.7	15.6	14.9	8.7	20.1	6.5	8.7	13.4	12.1	12.0	12.6	8.9	11.0	8.6	10.3	6.3	9.2	10.0	13.7	11.0	14.6	7.7	35.2	16.1	14.2	11.3	6.5	15.9	10.2	12.1	7.7	10.3	5.7	3.5	16.9	8.3	3.4	6.0	7.3	17.6	8.7	8.3	11.9	8.8	12.0	8.3	11.4	12.5	4.6	9.5	18.1	9.3	7.9	11.3	9.6	17.6	7.3	13.9	10.1	4.5	24.2	13.8	6.1	9.9	10.5	9.5	8.4	6.9	11.1	13.4	15.5	11.8	16.0	13.5	14.0	13.6	2.8	16.8	9.1	19.3	4.1	5.7	13.7	18.2	16.1	5.0	3.9	7.1	6.9	11.8	3.4	13.1	28.7	6.7	6.6	5.8	14.2	10.5	12.8	7.3	21.8	19.5	18.6	7.1	11.8	7.2	5.4	3.5	5.7	6.3	1.9	8.3	7.7	5.3	6.9	3.7	4.9	3.6	5.1	3.9	16.9	1.6	10.3	5.1	3.4	9.6	15.9	18.1	12.4	9.0	12.0	14.9	8.7	12.0	16.1	11.9	18.9	15.2	10.0	9.3	20.9	5.3	17.8	5.3	14.8	19.2	33.4	12.4	11.6	9.2	5.4	12.4	6.7	0.0	4.4	13.9	12.4	7.4	13.9	10.4	12.9	17.5	8.1	21.5	19.3	4.9	17.5	9.6	5.0	1.0	6.6	15.2	7.0	2.9	16.6	3.8	23.4	25.8	9.6	99.8	55.3	6.1	5.1	20.8	10.0	4.8
FNDC5	FRCP2	ENSG00000160097	"Fibronectin type III domain containing 5"	Q8NAU1	1	32862268-32872482	"Predicted membrane proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.0;tongue: 33.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 68.2;Cardiomyocytes: 56.9;Early spermatids: 25.8;Muller glia cells: 40.4"	"Group enriched"	"Detected in many"	7	"glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051290	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051290: AB_2681422"	"unprognostic (4.36e-2)"	"unprognostic (9.08e-3)"	"unprognostic (7.62e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.07e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.33e-2)"	1.2	6.3	3.4	0.6	5.1	0.6	0.9	26.7	13.6	1.0	0.8	1.7	0.0	0.9	2.1	1.5	4.9	2.6	1.4	15.9	3.6	4.1	0.9	8.6	1.0	0.6	5.0	3.7	3.0	0.8	2.5	2.3	0.8	9.5	2.0	0.7	8.2	12.3	1.0	110.0	0.6	1.0	1.5	2.8	0.6	2.3	1.3	1.7	0.0	1.0	33.3	1.3	0.9	0.4	0.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.9	0.2	0.0	1.3	0.1	0.4	0.1	0.5	0.1	0.9	0.2	0.1	0.6	0.3	0.2	0.0	3.9	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	2.4	0.0	0.3	0.0	0.5	0.0	0.2	0.7	0.1	0.9	0.1	0.1	0.1	1.4	0.0	0.1	0.4	32.7	0.2	0.0	0.0	5.6	0.9	0.3	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.6	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.1	26.7	13.6	3.6	4.1	5.0	3.7	9.5	1.7	0.0	0.0	0.0	0.1	0.1	68.2	56.9	0.0	0.0	0.0	1.8	3.9	0.0	1.7	0.0	25.8	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	1.0	0.7	0.0	0.0	0.0	0.0	2.6	4.9	0.0	0.0	0.0	0.0	40.4	0.2	0.0	5.3	0.1	7.3	0.0	1.0	0.5	0.9	0.0	0.2	0.0	0.3	0.1
HPCA		ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"brain: 118.9"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 146.4;Early spermatids: 133.0;Late spermatids: 89.6"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 118.9;cerebral cortex: 40.4;hippocampal formation: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 10.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 1321.6;hippocampal formation: 1344.5"	"CAB012340, HPA043245"	Enhanced					NA	NA					"CAB012340: AB_2120209, HPA043245: AB_2678385"	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	1.2	1.5	13.5	1.2	118.9	1.1	1.2	4.8	82.2	1.4	1.5	2.2	0.0	1.2	1.4	1.2	1.1	1.4	1.3	1.2	42.5	2.8	1.3	1.1	1.1	1.2	3.7	14.5	1.5	1.2	1.1	0.0	1.2	0.0	1.3	1.5	0.6	1.3	1.3	1.1	1.2	1.4	1.3	0.8	1.2	1.2	2.5	12.2	0.0	1.3	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.4	0.3	0.4	0.0	0.1	0.1	0.2	0.3	0.9	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.6	0.1	0.0	0.1	0.7	0.0	0.0	10.2	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.2	0.0	1.0	0.8	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13.5	118.9	4.8	40.4	42.5	2.8	3.7	14.5	0.0	12.2	0.0	0.0	0.0	1.0	0.0	146.4	0.4	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.3	133.0	0.1	1.0	0.0	0.4	0.3	0.2	1.3	0.0	0.0	0.1	12.7	17.2	0.0	0.0	89.6	1.1	0.0	0.0	0.0	2.5	5.0	0.5	2.9	0.4	0.6	18.2	0.0	0.1	3.1	7.8	0.3	0.1	0.0	2.1	0.9
TMEM54	CAC-1	ENSG00000121900	"Transmembrane protein 54"	Q969K7	1	32894594-32901438	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 673.9;Mucus-secreting cells: 310.3;Paneth cells: 422.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 48.3;OE19: 57.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061992			Approved	Vesicles		NA	NA			Vesicles		"HPA061992: AB_2684652"	"unprognostic (2.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.40e-2)"	3.2	3.3	16.1	21.5	10.7	0.0	8.5	2.7	10.6	10.0	70.0	8.2	7.0	37.9	8.5	9.4	28.8	5.0	24.2	4.5	9.7	9.4	11.4	4.4	7.2	2.4	10.9	5.7	6.2	12.4	9.0	4.7	47.3	6.8	14.7	37.4	7.4	11.8	8.4	1.9	26.9	76.7	7.3	7.3	3.1	35.0	3.7	6.0	1.1	23.6	16.9	14.2	12.5	15.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	29.9	8.1	0.0	7.8	14.9	9.0	29.3	4.4	7.2	10.7	13.8	20.2	48.3	0.0	13.1	5.9	13.6	18.4	7.0	25.9	3.2	34.8	1.4	0.0	2.9	1.0	10.8	0.1	0.4	7.7	23.7	16.3	4.5	7.2	4.7	3.1	4.1	0.0	5.5	32.1	0.0	0.6	2.5	57.6	14.1	4.0	12.2	0.1	3.9	38.5	0.4	4.0	3.1	20.1	10.1	5.0	21.8	5.8	8.9	10.5	11.2	23.5	9.4	1.1	2.5	3.5	7.5	0.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	10.7	2.7	10.6	9.7	9.4	10.9	5.7	6.8	6.0	17.9	25.1	9.7	74.9	18.1	5.9	2.8	76.5	6.7	6.8	45.4	3.9	34.8	23.2	128.9	43.4	11.3	673.9	0.0	180.9	127.1	10.8	130.2	5.7	1.5	7.4	0.0	58.3	12.9	1.8	20.3	18.4	3.7	13.5	5.4	310.3	13.7	137.0	422.1	23.0	38.7	8.7	6.5	11.3	11.1	8.9	55.7	53.8	0.0	231.5	148.6
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964685	"Enzymes, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in all"		"Daudi: 39.3;Karpas-707: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049587, HPA063640"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049587: AB_2680826, HPA063640: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.39e-4)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	8.6	11.3	8.0	13.1	10.5	36.4	12.0	14.1	14.1	9.9	13.2	10.1	4.8	14.1	10.8	6.9	23.3	7.9	10.1	8.5	6.0	7.2	12.0	6.5	13.8	12.9	9.6	9.3	7.1	7.0	6.4	5.7	9.4	10.2	7.4	15.3	9.0	10.8	5.7	10.2	13.6	15.5	10.6	8.0	9.0	7.4	54.7	8.3	6.8	8.2	11.1	16.7	11.3	12.8	1.3	1.3	16.1	2.0	0.8	1.6	0.7	6.7	5.2	4.5	4.1	2.7	3.9	30.0	3.1	3.8	5.7	6.1	6.1	20.3	39.3	5.5	4.1	7.0	9.7	5.5	7.5	5.2	14.4	3.6	3.4	4.1	6.1	8.8	5.2	7.2	3.1	14.0	12.5	15.4	6.6	11.9	3.9	4.2	47.3	5.5	2.2	3.4	6.4	7.2	7.7	5.9	4.6	6.4	4.0	4.4	9.8	7.1	3.6	10.0	3.4	22.4	11.5	2.9	7.6	13.0	3.1	4.3	7.8	5.4	11.3	5.7	13.9	4.5	5.3	4.6	5.3	2.0	3.5	1.6	1.8	1.2	1.2	1.4	0.8	1.3	1.3	0.4	0.6	16.1	0.8	1.5	0.6	1.5	0.7	8.0	10.5	14.1	14.1	6.0	7.2	9.6	9.3	10.2	8.3	11.9	4.1	1.9	20.3	41.0	4.4	12.0	15.3	6.7	2.3	7.0	2.0	11.0	1.7	9.3	30.1	8.7	34.3	0.0	9.9	5.4	7.1	22.8	4.6	3.4	12.6	3.2	10.9	3.7	20.2	18.4	2.0	28.7	5.0	43.3	16.5	2.0	19.2	17.5	3.5	7.1	7.4	0.0	5.4	29.3	12.6	28.4	6.2	3.2	10.5	35.3
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		5500000	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	24.9	27.1	16.0	27.6	20.3	18.3	24.2	19.1	17.6	21.4	31.3	24.6	22.4	36.6	20.6	22.8	31.6	17.6	25.0	33.9	15.1	14.5	51.2	46.5	17.9	18.2	23.1	9.9	24.3	23.2	27.2	16.2	18.6	19.7	22.4	31.8	20.4	31.4	21.5	73.8	20.6	37.1	18.7	25.9	24.7	24.0	29.3	25.0	40.2	37.4	34.4	28.7	26.7	23.3	31.7	51.9	50.9	41.2	27.4	24.4	43.1	45.7	20.3	19.2	22.3	13.3	16.7	19.5	25.8	20.0	38.9	40.9	39.0	41.5	85.2	30.7	19.1	27.9	33.2	44.6	43.9	41.9	37.2	32.6	56.4	39.1	29.7	31.2	100.3	32.0	16.5	33.2	33.3	67.3	21.7	26.5	36.0	59.9	32.1	23.1	23.0	37.9	55.5	26.8	44.1	31.2	44.3	32.7	56.1	38.3	27.6	28.3	16.6	29.5	32.8	82.3	23.8	26.6	71.4	19.4	23.6	28.5	36.3	48.3	33.5	43.8	79.4	32.0	95.0	27.2	11.0	41.2	50.9	22.0	37.4	23.0	31.7	20.6	20.6	51.9	27.7	21.2	19.8	11.3	27.4	31.5	39.1	24.4	43.1	16.0	20.3	19.1	17.6	15.1	14.5	23.1	9.9	19.7	25.0	47.6	66.5	38.7	80.7	111.2	21.1	86.7	71.4	46.8	83.0	106.4	78.5	137.4	217.2	94.6	81.6	64.2	135.8	0.0	107.9	138.4	58.1	76.3	39.3	127.8	84.9	7.9	48.5	31.9	41.6	29.1	43.4	51.1	82.7	58.7	70.5	20.1	99.6	51.8	41.4	362.4	38.8	51.8	59.5	97.9	21.1	107.3	181.1	37.4	94.5	113.8
AZIN2	"ADC, KIAA1945, ODC-p, ODC1L, ODCp"	ENSG00000142920	"Antizyme inhibitor 2"	Q96A70	1	33081104-33120530	"Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 23.1;testis: 22.9"	"Group enriched"	"Detected in many"	23	"Early spermatids: 190.6;Late spermatids: 686.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 17.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 17.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.3;SK-MEL-30: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028527			Approved	Cytosol		NA	NA			Cytosol		"HPA028527: AB_10602077"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.15e-4)"	"unprognostic (9.19e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.41e-1)"	1.5	5.3	7.8	3.1	11.9	0.2	3.6	5.8	14.6	5.1	4.4	23.1	0.5	1.4	3.8	3.4	1.7	7.0	4.1	5.7	10.1	7.8	3.5	0.9	2.5	1.9	10.2	12.2	9.9	3.0	4.4	2.9	1.4	13.6	3.9	3.0	3.4	3.5	3.6	0.9	1.8	1.3	3.4	18.1	1.9	1.8	22.9	10.1	0.7	4.3	0.0	3.0	2.3	1.9	0.2	17.9	3.5	0.0	0.0	1.6	0.7	0.5	0.6	2.0	1.2	1.0	4.5	0.6	0.7	3.1	3.2	2.6	0.3	2.6	0.0	0.9	0.5	1.7	1.4	1.4	0.6	0.9	0.0	0.0	0.1	0.1	0.5	4.9	0.0	0.2	4.4	2.8	2.6	1.0	14.3	0.4	0.7	0.1	0.2	2.3	0.0	0.2	0.9	1.0	0.3	0.4	1.4	1.9	0.1	2.2	0.1	0.4	2.1	0.5	0.0	18.4	1.9	0.8	0.3	0.1	0.7	1.4	2.2	0.4	1.1	0.0	0.0	4.9	0.0	0.8	3.5	0.0	0.0	1.3	0.0	1.4	0.2	1.4	1.4	0.0	0.0	1.6	1.6	0.0	0.0	0.0	17.9	0.0	0.7	7.8	11.9	5.8	12.8	10.1	7.8	10.2	12.2	13.6	10.1	0.0	4.8	2.0	2.4	0.0	7.1	0.8	0.0	4.0	1.2	1.8	17.7	0.4	0.0	1.3	190.6	1.1	4.2	0.0	1.2	0.4	1.2	1.5	0.0	0.0	1.1	6.4	1.2	1.8	0.3	686.4	5.8	0.4	0.0	2.8	1.2	9.9	1.2	4.8	7.1	2.6	7.6	6.5	0.9	18.8	5.9	0.0	0.2	1.5	2.5	0.8
TRIM62	"DEAR1, FLJ10759"	ENSG00000116525	"Tripartite motif containing 62"	Q9BVG3	1	33145402-33182059	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050061			Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Vesicles, Focal adhesion sites"		"HPA050061: AB_2681001"	"unprognostic (1.57e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-3)"	4.8	11.8	10.1	6.4	19.2	9.3	6.2	19.0	13.9	5.6	4.9	31.8	1.6	5.6	4.9	6.9	6.9	5.1	4.9	5.3	12.3	10.5	5.3	2.7	5.6	9.6	28.1	9.1	6.7	4.8	7.5	9.2	19.6	15.4	8.7	5.4	5.0	10.8	7.5	6.7	20.5	5.8	6.9	12.8	8.3	6.5	4.0	23.7	8.7	6.3	5.1	10.4	9.8	7.3	3.0	1.8	6.0	3.5	1.7	8.5	2.1	2.9	2.3	20.7	3.4	5.2	2.3	6.3	2.9	8.7	5.4	4.8	2.4	3.0	4.7	3.2	2.6	2.6	6.0	4.1	3.8	5.2	4.5	3.2	5.4	2.5	1.9	5.0	1.7	13.5	4.5	3.5	7.2	1.8	8.9	5.4	4.3	0.8	3.1	5.5	7.8	5.3	1.7	4.9	3.7	2.9	6.7	10.8	2.2	3.5	7.7	5.0	3.1	3.2	12.2	13.8	12.1	3.4	1.2	5.2	2.3	3.2	6.6	2.2	5.8	2.5	2.3	4.2	3.2	2.8	2.2	2.0	6.0	2.7	3.5	4.6	2.2	4.1	3.7	1.8	3.0	2.8	2.7	4.4	1.7	2.2	0.8	8.5	2.1	10.1	19.2	19.0	13.9	12.3	10.5	28.1	9.1	15.4	23.7	3.0	2.1	0.9	0.7	2.4	2.4	0.6	0.0	0.0	0.0	1.8	0.0	0.8	0.0	1.4	0.5	1.0	1.1	0.0	1.7	1.6	1.3	2.2	1.1	0.6	1.0	9.5	1.7	1.3	1.2	0.0	2.3	1.2	0.0	1.0	2.0	1.4	2.1	0.0	4.6	0.6	0.8	6.5	2.0	1.1	0.4	4.1	1.1	1.9	0.9	1.7
ZNF362	"FLJ25476, lin-29, RN"	ENSG00000160094	"Zinc finger protein 362"	Q5T0B9	1	33256545-33300719	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059239	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA059239: AB_2683955"	"unprognostic (8.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.66e-1)"	21.6	14.0	18.1	12.0	17.2	8.9	21.7	24.5	30.5	18.6	17.3	13.8	9.6	11.0	23.7	23.8	14.2	20.1	20.7	28.0	15.4	13.8	16.8	8.8	18.7	26.3	12.8	15.6	23.3	19.9	16.4	19.1	17.9	12.3	20.4	8.8	27.4	22.8	21.7	26.1	23.5	11.6	28.1	13.1	22.6	14.0	8.5	10.3	17.9	17.4	14.1	15.3	20.1	15.4	6.0	8.3	6.0	4.6	4.2	4.7	2.5	3.3	5.4	23.7	9.4	6.3	4.4	15.6	4.7	5.5	5.8	6.2	5.6	11.4	1.7	10.3	5.9	1.8	11.3	5.5	2.6	2.4	10.0	5.0	8.5	3.3	6.8	5.6	4.0	6.9	9.4	6.6	2.5	2.2	5.9	7.9	11.3	0.9	2.9	4.4	8.1	13.0	6.7	14.1	2.0	5.1	21.3	5.6	0.7	4.6	5.4	8.4	25.4	13.3	4.2	20.9	10.6	4.1	10.4	11.4	3.5	4.8	8.3	3.1	8.9	8.2	1.8	2.8	3.6	10.4	3.8	4.6	6.0	4.7	4.1	3.4	3.0	3.5	4.1	3.3	6.0	3.1	2.9	3.5	4.2	4.5	8.3	2.6	2.5	18.1	17.2	24.5	30.5	15.4	13.8	12.8	15.6	12.3	10.3	8.9	11.3	1.9	4.0	9.0	12.3	19.4	7.6	1.4	9.1	10.4	0.0	9.4	1.7	5.5	0.9	10.5	3.1	0.0	6.5	5.7	9.7	2.2	9.3	6.6	8.7	7.9	1.7	19.6	14.5	5.4	12.7	6.1	8.5	1.0	4.0	7.7	3.7	8.5	20.1	9.9	4.5	6.5	11.3	0.9	2.5	8.3	3.0	4.9	6.9	1.3
A3GALT2	"A3GALT2P, IGB3S, IGBS3S"	ENSG00000184389	"Alpha 1,3-galactosyltransferase 2"	U3KPV4	1	33306766-33321098	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.1"	"Group enriched"	"Detected in some"	4	"HeLa: 5.2;SiHa: 3.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.86e-2)"	"unprognostic (2.36e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-3)"		"unprognostic (4.96e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-8)"	"unprognostic (1.17e-1)"		"unprognostic (1.12e-2)"	"unprognostic (7.87e-2)"	0.7	0.1	0.1	1.2	0.2	1.3	0.4	1.3	0.9	0.4	0.2			0.0	0.5	0.0	0.2	0.2	1.4	0.1	0.2	0.1	0.4	0.1	0.5	0.1	0.0		0.4	0.1	0.0	0.4	0.1		0.6	0.0		0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.8	0.3	2.1			0.4		0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	5.2	0.0	0.2	0.0	0.0	0.7	0.2	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHC2	"EDR2, HPH2"	ENSG00000134686	"Polyhomeotic homolog 2"	Q8IXK0	1	33323623-33431052	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"neutrophil: 37.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 37.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047403	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047403: AB_10964220"	"unprognostic (8.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	58.8	32.6	16.9	32.5	30.5	27.9	38.7	22.8	25.6	28.4	31.0	32.4	20.0	16.6	31.5	19.4	27.9	27.9	32.1	49.8	19.3	16.7	46.5	52.6	46.3	45.5	36.6	13.5	32.4	32.9	18.4	24.0	29.5	28.0	25.4	18.5	37.9	23.7	31.1	90.9	21.8	20.0	39.4	28.1	47.9	30.7	25.9	31.9	24.3	43.6	12.3	17.8	45.3	25.6	0.6	1.5	37.3	2.9	0.7	1.1	0.8	11.2	7.4	32.3	12.3	34.0	39.1	9.6	11.2	24.5	15.6	17.2	4.6	25.3	10.1	9.5	17.6	12.7	6.0	6.4	19.2	15.2	4.8	5.8	6.7	3.6	11.6	52.5	8.2	6.5	63.7	11.9	28.1	22.3	29.9	20.6	9.8	5.9	7.7	40.7	4.6	17.8	8.4	7.3	19.2	21.6	20.3	13.4	5.6	28.6	8.5	19.7	18.1	8.7	8.8	44.2	14.2	4.4	10.6	20.4	15.6	7.9	13.3	21.0	5.4	3.7	7.6	37.3	8.7	42.9	3.1	2.6	1.2	0.8	2.5	0.7	0.6	0.9	0.7	1.3	0.5	1.1	0.6	37.3	0.7	2.9	1.5	0.6	0.8	16.9	30.5	22.8	25.6	19.3	16.7	36.6	13.5	28.0	31.9	14.9	11.5	7.5	25.5	12.6	66.5	26.6	7.6	9.4	11.4	33.2	64.8	9.4	14.9	29.6	50.7	26.3	10.9	0.0	37.8	7.7	14.4	19.3	5.8	45.0	19.5	58.8	36.1	56.4	64.7	50.1	27.0	29.7	20.3	3.6	21.9	52.1	60.6	14.4	28.0	23.7	74.9	12.9	21.3	10.7	7.0	9.5	9.6	8.7	15.7	26.5
ZSCAN20	"KOX29, ZNF31, ZNF360"	ENSG00000121903	"Zinc finger and SCAN domain containing 20"	P17040	1	33472645-33496507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017933	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017933: AB_1859028"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-3)"	"unprognostic (9.28e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.77e-6)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.74e-2)"	3.8	4.2	4.7	2.5	7.1	1.0	4.4	6.1	8.2	4.4	4.1	7.7	4.5	8.4	7.4	3.2	3.6	4.4	3.6	6.1	4.3	2.9	3.9	3.0	3.2	2.1	4.3	5.7	7.8	4.0	11.2	8.6	4.0	5.7	4.2	4.4	5.1	5.0	5.5	3.4	2.9	6.6	5.9	4.2	3.1	4.3	6.1	7.6	3.9	4.4	2.7	3.2	4.9	8.5	0.8	1.7	0.7	2.2	1.0	3.0	0.6	3.7	2.8	6.5	4.5	5.2	5.4	4.4	4.7	4.7	6.3	5.1	2.9	4.9	2.8	2.6	4.9	3.8	4.7	5.4	2.5	6.6	0.0	6.1	5.7	6.2	2.4	5.0	3.2	2.1	3.8	4.5	6.7	5.5	5.8	4.9	4.7	3.8	3.6	5.6	1.3	2.4	2.0	5.4	3.5	1.6	2.7	7.6	1.1	3.5	3.2	2.6	3.8	3.5	3.9	5.1	9.1	2.6	3.6	4.4	5.6	4.0	5.0	6.6	4.8	3.0	1.3	5.8	1.0	3.7	0.2	2.2	0.0	1.3	1.0	2.1	0.3	0.4	0.9	1.7	0.8	1.9	3.0	0.7	1.0	1.0	1.2	0.8	0.6	4.7	7.1	6.1	8.2	4.3	2.9	4.3	5.7	5.7	7.6	0.0	2.2	0.0	0.5	0.0	1.5	1.6	2.5	1.4	0.0	0.0	3.9	0.7	0.0	0.9	15.3	0.6	0.4	0.0	0.2	0.7	0.7	0.5	1.1	0.0	0.6	0.0	1.2	1.3	0.3	1.3	1.1	0.0	0.0	1.8	0.5	0.6	0.7	0.9	1.8	0.4	2.0	0.0	1.0	2.5	1.1	0.0	0.2	0.0	0.4	0.4
CSMD2	KIAA1884	ENSG00000121904	"CUB and Sushi multiple domains 2"	Q7Z408	1	33513999-34165842	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 4.8;Bipolar cells: 10.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 4.9;fHDF/TERT166: 6.0;HEL: 9.0;NTERA-2: 7.2;PC-3: 7.4;U-87 MG: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008622	Uncertain					NA	NA					"HPA008622: AB_1078579"	"unprognostic (1.33e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.25e-5)"	"unprognostic (1.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-2)"	2.1	2.3	9.0	2.0	10.6	0.7	0.9	5.9	15.8	1.2	1.1	6.2	1.6	1.7	1.4	1.3	1.1	0.9	6.6	1.5	10.4	7.5	1.0	0.9	1.0	1.9	4.7	9.3	0.9	1.9	0.8	0.8	0.9	10.4	1.4	1.4	2.7	0.9	1.8	0.8	1.6	1.4	2.5	7.4	1.5	1.2	3.4	5.2	0.0	1.3	0.0	2.9	2.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	1.3	0.0	2.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	10.6	5.9	15.8	10.4	7.5	4.7	9.3	10.4	5.2	6.0	4.8	0.0	0.3	0.2	10.5	4.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	3.6	2.8	1.2	0.0	0.0	2.5	0.1	0.6	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.0	1.4	0.4	0.0	0.0	0.0	0.2	0.9	0.0	3.5	0.0	1.6	0.0	0.5	0.3	1.8	0.4	0.0	0.0	0.0	0.2
HMGB4	FLJ40388	ENSG00000176256	"High mobility group box 4"	Q8WW32	1	33860475-33864791	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	346	"testis: 34.6"	"Group enriched"	"Detected in some"	143	"Early spermatids: 10561.9;Late spermatids: 15960.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035699	Enhanced					NA	NA					"HPA035699: AB_10960531"															"unprognostic (1.33e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10561.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15960.0	92.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	45.3	0.0	90.7	44.3	0.0	0.0	0.0	0.0	0.0
C1orf94	MGC15882	ENSG00000142698	"Chromosome 1 open reading frame 94"	Q6P1W5	1	34166883-34219131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 24.6"	"Cell type enhanced"	"Detected in some"	29	"Early spermatids: 53.5;Late spermatids: 24.4;Spermatocytes: 12.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 11.4;U-87 MG: 33.0"	"Low region specificity"	"Detected in many"							HPA045805			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045805: AB_10969626"					"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"				"unprognostic (9.77e-2)"	"unprognostic (4.09e-2)"			"unprognostic (1.65e-2)"	"unprognostic (2.31e-1)"			0.0	0.1	0.6	0.0	0.8	0.0	0.0	1.2	1.8	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.2	1.8	0.5	0.7	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	53.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	12.2	0.5	0.0	0.0	0.0	0.0	0.0
SMIM12	"C1orf212, FLJ90372"	ENSG00000163866	"Small integral membrane protein 12"	Q96EX1	1	34712737-34859816	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065331	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA065331: AB_2685470"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (7.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.52e-2)"	26.6	28.8	16.4	19.0	21.9	16.0	21.0	14.2	27.1	12.2	22.6	14.2	12.4	22.6	14.8	15.5	22.4	13.9	15.7	25.5	15.6	21.7	31.7	61.5	17.1	21.4	19.0	18.7	13.3	25.5	10.9	15.3	19.3	19.8	11.3	21.8	15.4	17.3	16.8	32.2	15.7	23.1	23.9	13.8	19.2	17.0	13.7	13.1	20.3	18.1	20.1	20.1	15.7	16.8	25.7	38.5	54.4	35.1	25.5	36.6	35.3	21.7	16.7	18.8	13.6	24.6	19.4	13.0	23.7	20.7	30.7	26.6	16.8	27.8	22.9	21.4	24.3	24.2	22.0	23.8	31.8	23.6	27.8	16.7	40.7	26.8	20.0	22.9	44.3	24.1	29.4	31.2	33.2	27.0	11.1	31.2	20.0	28.9	31.3	27.0	15.8	21.4	22.9	30.3	17.1	21.8	18.3	18.4	29.8	27.1	22.9	18.0	14.2	22.0	20.8	33.3	24.7	14.1	12.6	29.3	21.1	21.6	32.2	27.8	17.6	24.2	23.2	19.8	26.5	13.8	36.4	34.7	54.4	31.1	35.1	36.6	25.4	29.2	33.9	38.5	25.7	24.4	31.4	22.8	25.5	28.0	27.6	32.5	35.3	16.4	21.9	14.2	27.1	15.6	21.7	19.0	18.7	19.8	13.1	23.8	12.5	54.1	17.0	60.7	14.8	28.3	56.0	26.8	17.0	21.0	9.8	43.4	72.9	68.9	51.5	46.6	46.3	70.0	73.0	49.7	30.1	24.0	23.1	74.6	73.0	19.1	20.9	44.2	34.6	23.8	13.8	47.4	37.1	111.8	21.6	21.4	68.8	33.2	21.9	69.5	14.5	12.9	67.9	35.2	22.7	66.0	48.5	47.4	34.9	38.3
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0"	"Group enriched"	"Detected in some"	16	"Basal glandular cells: 21.6;Basal keratinocytes: 43.0;Suprabasal keratinocytes: 73.0;Urothelial cells: 70.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.9;HaCaT: 31.8;HBEC3-KT: 14.2;hTCEpi: 52.7;hTERT-HME1: 8.4;RT4: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain					NA	NA					"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.0	0.1	0.7	0.0	0.5	0.1	2.6	0.6	2.3	7.5	0.1	0.0	0.5	0.0	0.1	2.1	39.0	0.4	3.3	0.1	0.8	0.1	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.6	0.0	0.4	7.0	0.2	3.0	0.1	0.0	5.6	2.1	0.2	37.7	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.6	0.6	28.0	26.1	3.4	11.7	0.0	0.0	0.0	0.8	0.0	0.1	0.8	9.9	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	31.8	0.0	14.2	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	52.7	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	17.7	0.0	0.0	1.2	0.5	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.7	0.5	0.6	2.3	0.8	0.1	0.2	0.5	0.2	0.0	0.0	0.6	0.0	21.6	43.0	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	73.0	0.3	0.0	0.0	70.5
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759741-34763724	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.1;skin 1: 26.2"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 91.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;HaCaT: 9.9;HBEC3-KT: 6.4;hTCEpi: 4.2;OE19: 3.7;RPTEC TERT1: 3.9;RT4: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.1	0.1	0.1	1.2	0.1	0.0	1.5	0.1	0.1	1.7	0.3	0.0	2.9	0.0	0.1	11.1	2.9	0.1	8.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	3.4	0.0	2.0	0.2	0.0	0.8	2.0	0.1	26.2	0.3	1.2	0.1	0.1	0.2	0.7	0.0	0.1	0.1	1.6	2.4	3.2	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	6.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	0.1	9.9	0.0	6.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.9	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.7	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	21.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	91.2
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	3.6	0.0	0.0	30.4	0.0	26.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.7	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	16.3	6.8	0.0	0.0	0.0	12.7	10.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0	3.0	0.0	0.0	49.4	123.0	0.0	0.3	2.5	1.4	2.3	5.2	0.0	0.0	0.0	15.7	0.0	0.1	3.1	0.0	6.3	0.1	3.1	16.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.9	0.0	70.6	7.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	149.2	0.1	0.0	16.1	169.4
GJA4	CX37	ENSG00000187513	"Gap junction protein alpha 4"	P35212	1	34792998-34795747	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Ito cells: 227.8;Sertoli cells: 653.2;Smooth muscle cells: 352.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047981	Approved					NA	NA					"HPA047981: AB_2680228"	"unprognostic (2.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.48e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (3.28e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.17e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.82e-3)"	"unprognostic (7.96e-3)"	36.1	7.9	2.9	6.7	6.8	0.6	35.9	2.4	3.6	16.2	8.1	2.8	2.0	2.4	18.8	9.7	13.8	23.1	12.7	33.6	4.2	2.8	10.9	17.4	15.3	15.9	4.9	1.8	17.0	3.0	5.7	2.7	45.6	6.3	10.8	3.2	13.3	6.5	9.0	19.4	5.7	5.2	12.0	3.0	7.3	5.3	10.3	3.2	1.5	16.5	10.8	5.8	13.5	13.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.9	6.8	2.4	3.6	4.2	2.8	4.9	1.8	6.3	3.2	0.0	0.0	0.0	1.4	8.7	0.0	2.0	0.0	1.4	1.2	3.5	0.0	0.1	0.0	5.8	0.0	63.9	0.0	0.0	0.0	0.1	5.9	2.3	0.0	0.8	0.2	0.0	15.0	227.8	7.5	0.4	0.9	4.7	18.6	1.0	0.0	0.0	1.6	0.0	12.0	0.0	0.6	653.2	352.3	0.2	0.7	7.5	0.0	0.0	0.0	2.6
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.7"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 11.5;Hofbauer cells: 7.8;Horizontal cells: 20.6;Late spermatids: 13.7"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.6;NTERA-2: 5.2;SCLC-21H: 15.5;SH-SY5Y: 3.0"	"Group enriched"	"Detected in all"	4	"amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9"	"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		NA	NA			"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	1.3	1.5	17.4	1.8	20.0	2.8	1.1	14.6	28.7	0.9	1.2	3.3	0.0	1.4	1.0	1.0	0.9	1.0	1.1	1.0	17.7	5.5	1.3	1.0	1.1	1.4	5.4	9.6	1.0	2.2	1.0	1.9	1.0	2.3	1.0	1.0	0.7	1.1	1.5	1.0	1.1	1.3	1.0	1.1	2.5	1.3	6.7	5.0	0.0	1.0	0.0	1.2	1.0	0.0	0.3	3.2	0.4	2.3	0.1	0.8	0.9	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	9.6	0.2	0.0	1.2	0.0	1.6	0.0	0.0	0.2	0.2	0.7	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.6	0.0	0.0	5.2	0.0	0.0	0.5	0.0	0.2	0.0	0.5	15.5	3.0	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.1	1.7	0.0	0.0	0.2	0.3	1.9	0.1	0.1	0.1	0.4	2.3	0.0	0.2	1.4	0.8	0.3	0.5	0.5	3.2	0.3	0.2	0.8	0.0	0.1	0.1	0.9	0.7	0.9	17.4	20.0	14.6	22.4	17.7	5.5	5.4	9.6	2.3	5.0	0.0	0.0	0.0	0.6	0.2	4.0	1.1	0.0	0.0	0.0	1.8	3.9	0.1	3.3	0.4	11.5	0.1	0.8	0.0	0.5	0.2	0.2	0.2	0.0	0.0	7.8	20.6	1.2	0.0	7.3	13.7	0.9	1.0	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.7	2.2	0.0	0.1	2.7	3.4	0.3	0.0	0.8	0.7	0.1
AC114490.3		ENSG00000284773			1	34974356-34985313	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 1.4;Collecting duct cells: 5.2;Ductal cells: 1.0;monocytes: 1.8;Pancreatic endocrine cells: 1.1"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																	NA	NA																							6.3	2.1	0.8	3.2	1.3	2.9	6.8	0.5	2.0	6.5	3.2	1.7	2.8	2.5	6.1	5.1	3.7	3.8	7.3	1.9	0.6		7.8	6.8	7.1	8.0	2.0	1.2	5.3	5.5	1.6	3.5	8.5	1.8	8.5	3.3	7.5	3.2	4.1	2.1	3.9	4.0	4.8	1.4	5.2	1.6	5.8	1.2	4.6	14.9	1.9	4.8	6.0	1.9	1.8	1.1	1.0	0.5	2.4	2.8	0.1	0.7	0.6	0.7	0.8	2.3	4.4	0.4	1.1	4.4	0.6	0.6	0.0	2.7	1.5	0.6	1.3	0.3	1.6	0.2	0.7	0.5	2.4	0.7	1.1	0.7	0.6	3.8	1.7	3.2	3.7	1.4	0.6	2.6	2.3	1.1	3.4	0.4	2.5	1.4	0.8	0.8	2.1	1.0	0.1	0.1	1.7	0.2	0.0	1.3	1.3	0.6	1.5	1.2	0.1	0.4	1.3	0.2	1.3	1.8	1.1	0.8	1.5	0.5	2.6	0.6	0.3	1.0	1.8	0.5	0.4	0.5	0.2	1.5	0.1	1.8	0.5	2.8	2.0	0.4	1.8	1.2	1.3	1.0	2.4	0.5	1.1	0.4	0.1											0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM35B	ZMYM6NB	ENSG00000243749	"Transmembrane protein 35B"	Q8NCS4	1	34981535-34985353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.3;Ciliated cells: 28.1;Club cells: 11.4;granulocytes: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;CAPAN-2: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051024	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051024: AB_2681316"	"unprognostic (3.34e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.07e-1)"	23.1	20.6	6.4	10.7	8.0	5.3	24.4	5.7	7.9	23.7	13.8	9.3	12.6	7.4	22.3	19.0	15.2	19.7	26.1	17.6	6.4	5.8	27.5	24.4	25.3	28.0	9.9	7.6	20.0	20.5	9.2	14.6	29.5	9.6	29.6	12.6	26.6	14.2	17.4	10.5	7.2	16.0	18.3	10.2	19.0	12.9	21.4	7.8	17.9	48.7	9.8	18.4	22.0	19.1	24.9	37.3	29.4	26.8	36.4	53.1	38.4	9.1	7.0	1.7	2.8	43.0	25.5	3.5	10.0	16.8	7.2	9.8	6.9	40.6	4.7	15.6	10.3	11.1	9.9	3.1	8.5	5.8	17.3	4.7	9.8	3.7	8.2	23.6	6.5	10.3	25.3	8.0	6.4	13.6	14.5	14.0	9.7	6.3	13.4	12.5	5.6	4.7	6.5	7.6	0.0	4.9	6.4	13.8	1.5	19.2	9.1	4.2	1.4	15.2	0.2	13.4	8.3	3.8	9.9	14.2	9.6	9.0	8.4	5.7	7.8	4.4	3.2	9.7	10.6	8.0	29.4	24.5	25.4	47.3	26.8	50.7	24.9	52.3	51.9	16.8	21.0	46.1	46.3	7.6	36.4	21.9	37.3	53.1	38.4	6.4	8.0	5.7	7.9	6.4	5.8	9.9	7.6	9.6	7.8	20.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	28.1	11.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	8.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ZMYM6	"Buster2, MYM, ZBED7, ZNF198L4, ZNF258"	ENSG00000163867	"Zinc finger MYM-type containing 6"	O95789	1	34986165-35031968	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011004, HPA071865"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011004: AB_1859075, HPA071865: AB_2686464"	"prognostic favorable (1.30e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.11e-6)"	"unprognostic (1.77e-3)"	"unprognostic (4.83e-3)"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.29e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.84e-3)"	12.8	14.7	9.4	13.3	15.9	21.3	11.6	16.3	16.0	10.7	10.9	14.6	9.8	11.0	13.3	13.6	12.8	11.7	10.7	10.8	8.6	8.3	11.7	9.7	12.2	14.9	13.8	10.2	15.9	11.5	13.7	33.7	7.9	17.0	11.0	12.9	12.5	12.9	11.0	8.0	13.6	15.3	11.9	16.7	20.1	11.6	14.9	10.1	16.2	15.4	8.4	14.7	12.5	11.2	10.1	12.3	9.0	9.3	6.5	9.3	4.3	9.3	5.1	9.4	8.9	10.7	13.5	5.8	7.8	11.7	9.5	10.3	4.0	10.3	13.0	8.4	11.5	6.4	9.2	10.4	8.3	11.6	8.9	6.1	11.4	7.4	5.4	9.4	15.8	13.4	11.3	11.9	10.4	8.7	7.2	10.5	10.3	17.5	14.2	9.4	3.1	7.3	10.7	9.4	5.3	8.3	10.3	12.4	7.3	7.8	7.3	9.8	9.1	9.1	8.6	10.7	9.7	5.7	8.8	10.7	11.8	8.7	12.4	11.5	8.8	13.4	9.5	12.0	15.2	9.4	4.6	9.3	9.0	9.3	7.5	8.1	8.1	6.4	5.3	8.3	10.1	9.1	6.1	4.9	6.5	9.1	12.3	6.8	4.3	9.4	15.9	16.3	16.0	8.6	8.3	13.8	10.2	17.0	10.1	11.9	13.9	8.8	4.6	5.4	12.2	13.7	10.2	6.7	6.8	15.7	19.6	3.1	5.0	5.1	1.3	5.2	7.3	0.0	4.7	2.8	5.4	3.5	9.3	6.8	6.8	12.7	3.5	6.7	21.1	1.1	7.8	15.2	1.7	11.8	7.1	7.7	4.7	6.8	10.6	5.8	18.2	12.9	8.2	13.4	17.7	5.6	4.5	6.9	7.9	5.4
ZMYM1	"FLJ23151, MYM"	ENSG00000197056	"Zinc finger MYM-type containing 1"	Q5SVZ6	1	35059786-35115859	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064019			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA064019: AB_2685178"	"unprognostic (7.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-1)"	7.6	6.2	6.5	6.1	5.9	1.8	9.9	5.4	6.0	10.7	7.0	6.7	6.6	5.1	8.6	10.5	8.8	8.0	5.5	5.7	5.4	3.6	6.8	5.0	6.4	6.4	8.3	4.0	12.0	11.1	7.4	13.0	7.5	7.3	8.7	6.1	6.6	8.3	8.0	4.7	7.6	6.4	8.1	8.9	6.8	6.1	11.4	7.8	10.6	9.0	4.1	6.1	10.3	9.1	2.0	2.3	7.1	4.3	6.0	4.4	1.6	10.0	5.3	8.2	7.1	9.0	10.4	4.6	9.1	6.9	7.9	8.6	5.6	10.9	6.4	4.0	5.0	4.4	10.1	7.6	6.9	14.2	1.8	3.2	6.8	5.1	4.8	5.2	4.7	3.1	7.6	6.0	12.4	11.8	6.0	12.1	6.4	6.1	2.4	8.8	5.0	6.7	1.8	12.8	3.9	4.7	4.3	9.0	0.0	3.9	5.8	4.1	5.1	8.7	6.8	8.3	12.2	5.6	2.8	5.9	6.7	7.9	5.0	9.2	0.0	0.5	0.9	3.7	3.5	5.3	7.1	1.4	2.3	3.8	1.9	4.4	2.0	3.2	2.8	1.7	1.7	2.8	3.2	0.5	6.0	4.3	2.3	2.8	1.6	6.5	5.9	5.4	6.0	5.4	3.6	8.3	4.0	7.3	7.8	11.9	6.2	4.2	9.3	1.4	6.0	4.3	2.5	8.1	5.7	14.0	0.0	5.0	8.3	5.7	3.7	5.1	2.1	0.0	3.1	5.3	5.0	6.1	5.8	3.2	3.8	11.1	1.7	3.7	5.9	4.4	6.9	2.3	1.7	4.6	3.5	6.9	3.2	0.0	7.4	4.4	4.3	12.9	4.3	19.4	14.7	1.3	3.1	4.3	3.8	5.8
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193148	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		280000	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	40.5	35.7	31.5	39.4	31.4	122.5	48.3	53.0	38.5	39.0	31.4	37.8	32.9	30.0	45.3	36.5	45.5	43.0	28.1	34.0	29.1	24.6	36.4	34.2	47.6	48.8	26.3	32.6	59.9	40.2	45.8	46.3	35.5	31.9	35.5	38.0	35.7	39.6	38.0	44.9	42.9	34.1	36.5	32.8	42.4	35.5	37.5	32.9	95.2	35.3	24.1	60.6	35.9	38.6	6.9	11.2	4.4	8.8	4.9	8.9	3.3	36.4	30.5	53.2	30.1	13.1	19.7	49.9	20.0	20.3	34.2	25.0	33.1	26.4	66.6	27.8	23.1	21.4	33.4	57.8	39.1	46.6	35.5	38.4	50.0	32.9	39.3	17.7	52.0	29.8	15.7	15.2	29.6	14.4	15.2	29.7	35.3	56.5	31.8	33.2	31.7	60.8	44.6	63.4	22.0	29.5	61.9	36.1	43.3	33.0	44.3	38.4	42.7	28.8	22.5	28.9	38.9	26.3	37.1	31.6	27.4	40.3	17.9	42.7	36.5	31.0	67.8	19.5	34.5	38.9	2.6	6.5	4.4	7.7	8.8	8.9	6.2	7.6	6.1	5.8	6.9	7.2	7.9	3.4	4.9	6.4	11.2	8.2	3.3	31.5	31.4	53.0	38.5	29.1	24.6	26.3	32.6	31.9	32.9	157.8	233.8	123.2	218.3	317.6	223.2	127.3	68.8	123.1	187.7	104.7	180.6	178.4	69.6	106.2	101.7	173.0	92.7	46.7	119.2	185.7	204.4	133.7	151.3	95.2	121.1	162.1	210.6	114.8	123.3	250.0	132.3	139.5	133.3	108.2	106.4	182.5	126.2	101.2	109.6	66.5	219.0	51.8	200.9	192.3	171.1	286.1	255.5	127.5	133.5	143.0
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268967-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: AB_2681431, HPA054802: AB_2682605"	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	16.6	15.9	17.9	17.3	22.1	13.6	19.7	28.1	24.7	22.0	14.8	17.1	18.3	10.2	19.8	18.2	15.0	17.9	15.7	13.1	17.6	19.0	15.8	14.4	14.1	15.0	15.8	14.6	27.0	15.7	26.1	22.6	19.6	22.2	21.0	13.6	18.2	18.0	26.8	15.9	12.9	12.5	16.6	15.2	16.0	15.4	36.3	13.6	26.7	21.6	13.0	18.8	17.2	14.7	4.2	9.8	3.5	8.2	9.6	4.4	2.5	12.8	10.4	32.1	16.2	9.4	20.4	11.8	15.3	23.1	18.7	24.4	11.2	12.9	23.9	9.4	19.1	9.1	8.3	22.2	11.3	27.0	13.5	15.4	29.2	12.2	9.5	17.0	25.0	13.2	15.4	10.1	18.1	17.2	15.6	20.7	13.3	31.8	6.6	22.6	7.7	21.1	13.9	26.7	6.7	10.0	23.7	20.6	11.6	13.4	17.0	18.5	18.0	18.4	13.5	20.9	21.1	10.9	19.0	24.9	17.4	18.1	7.6	16.4	7.2	13.4	18.4	12.6	19.1	16.6	2.4	5.0	3.5	4.3	7.1	4.4	4.2	4.2	3.8	4.8	3.7	4.1	3.9	1.0	9.6	8.2	9.8	3.1	2.5	17.9	22.1	28.1	24.7	17.6	19.0	15.8	14.6	22.2	13.6	11.9	15.0	11.0	16.2	10.2	27.2	29.5	35.7	22.7	22.7	26.2	29.5	12.4	5.0	19.4	48.6	21.1	5.3	0.0	20.5	10.2	15.8	19.3	13.9	16.1	11.2	22.3	21.5	17.2	18.4	69.6	24.5	13.7	5.0	13.6	13.8	20.1	18.6	9.0	21.5	9.1	33.8	19.4	15.5	22.9	10.4	9.9	11.8	11.7	12.2	24.5
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433490-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"		NA	NA		870000	"Golgi apparatus"	Nucleoli	"HPA072692: AB_2686549"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	10.6	23.5	20.3	10.6	29.0	9.9	20.1	21.9	37.2	19.2	17.7	24.1	17.0	18.1	19.7	19.2	14.4	25.1	15.7	30.7	19.4	20.0	27.5	32.1	21.3	11.0	19.4	20.1	13.0	32.8	38.5	28.1	21.1	23.0	25.3	21.3	24.5	33.9	20.5	27.4	13.8	19.8	12.7	16.6	17.1	23.3	14.0	17.5	11.9	29.3	11.9	17.4	12.9	12.0	2.3	3.2	27.1	11.0	5.5	3.5	4.5	5.4	8.1	16.9	13.3	23.0	16.2	16.1	7.4	15.9	10.9	16.2	8.7	22.2	6.1	20.6	8.1	16.3	10.9	12.5	12.0	12.5	9.7	9.1	8.3	9.9	9.6	18.0	6.8	11.4	22.8	15.5	12.5	16.4	36.2	17.7	7.6	10.8	8.9	14.7	5.5	4.0	5.8	19.2	15.3	4.9	4.6	14.4	7.6	18.0	13.4	3.7	10.5	10.8	13.0	22.2	38.9	13.6	9.7	18.1	7.5	8.1	6.3	11.5	13.3	10.6	4.0	19.1	9.0	7.4	4.5	11.0	5.0	3.0	3.6	2.9	2.0	2.5	2.8	3.2	2.3	3.5	2.5	27.1	5.5	2.2	2.1	2.3	4.5	20.3	29.0	21.9	37.2	19.4	20.0	19.4	20.1	23.0	17.5	68.5	67.8	11.2	13.5	7.0	71.9	47.3	48.4	52.2	52.4	33.2	102.1	26.5	3.3	15.2	7.8	22.2	31.6	0.0	28.2	18.9	16.7	25.7	20.8	40.4	16.3	60.4	20.7	21.5	29.5	4.9	16.1	17.1	13.5	11.8	53.3	28.9	26.4	24.6	16.3	17.3	62.2	6.5	8.2	21.2	17.7	8.2	26.1	17.3	28.1	10.8
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 144.3"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 21.4;Club cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol		NA	NA			Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	5.2	11.3	33.4	6.0	144.3	3.4	3.6	28.7	104.9	9.9	3.5	8.7	1.2	3.9	6.2	4.8	4.5	8.1	6.5	12.0	45.4	25.0	4.0	2.5	4.5	5.9	15.8	32.3	9.2	6.1	6.2	5.5	4.7	26.4	7.1	2.9	3.6	6.7	8.0	5.3	5.6	3.2	6.5	10.7	5.0	4.7	5.8	15.6	0.8	6.5	0.6	4.6	6.0	2.4	5.9	2.7	0.8	4.5	3.0	6.5	5.5	8.8	10.7	9.0	14.1	13.1	16.2	6.2	11.7	12.2	12.3	9.9	10.7	13.1	10.1	11.4	10.8	8.9	13.6	8.8	14.2	4.5	9.8	18.2	12.5	15.7	5.5	18.1	11.3	14.5	15.5	12.0	21.8	8.8	10.2	6.5	6.1	13.5	16.2	10.0	15.9	10.3	7.3	40.3	9.8	18.9	8.5	5.0	13.0	8.3	9.9	11.2	16.1	13.3	12.3	16.5	7.5	11.8	7.4	8.9	15.8	11.3	11.5	16.0	22.8	16.1	7.5	19.6	18.2	14.3	0.0	4.5	0.8	3.1	2.6	3.8	5.9	4.8	4.8	2.7	2.7	6.5	5.3	0.7	3.0	4.2	1.6	2.7	5.5	33.4	144.3	28.7	61.4	45.4	25.0	15.8	32.3	26.4	15.6	3.0	11.8	0.8	0.5	3.1	3.4	12.0	5.1	21.4	15.9	7.0	0.0	5.0	1.7	3.2	2.2	2.8	1.0	0.0	3.7	2.2	5.0	0.4	3.5	3.6	3.3	6.4	3.5	3.1	7.0	0.7	6.1	1.9	5.0	1.0	2.8	1.6	3.5	2.8	3.9	3.0	2.4	0.0	4.1	3.2	2.2	2.6	4.7	3.2	2.1	0.4
TFAP2E	AP2E	ENSG00000116819	"Transcription factor AP-2 epsilon"	Q6VUC0	1	35573370-35595328	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 22.0;skin 1: 11.4"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 3.3;Bipolar cells: 9.1;Rod photoreceptor cells: 5.1;Suprabasal keratinocytes: 3.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 22.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 10.5;SK-MEL-30: 5.7;THP-1: 5.0;U-937: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (7.06e-4)"	"unprognostic (1.96e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.27e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.67e-15)"	"unprognostic (2.03e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.40e-2)"	0.6	0.5	2.5	2.6	4.3	4.7	1.3	22.0	3.4	1.2	1.3	1.1	0.6	0.3	1.3	1.8	0.7	1.3	0.7	0.6	4.8	2.9	0.6	0.6	8.2	3.0	2.2	0.6	1.7	0.6	0.2	1.5	0.7	4.7	1.2	0.4	2.2	1.1	0.7	0.6	11.4	0.6	0.7	4.3	1.9	1.0	1.7	2.9	0.6	0.6	0.6	1.6	0.6	1.3	1.4	1.2	5.2	3.1	3.5	3.1	1.6	0.4	0.4	0.6	0.3	0.5	0.9	1.8	0.3	0.3	0.2	0.1	1.2	1.0	0.2	0.8	0.3	0.1	0.4	0.1	0.0	0.3	0.5	1.2	4.3	0.8	1.1	1.3	0.7	0.3	0.3	0.9	0.6	0.4	1.8	0.0	0.9	0.1	1.3	0.0	0.7	0.9	10.5	0.9	0.0	0.6	0.4	0.3	0.3	0.0	0.1	0.4	0.8	1.2	0.5	5.7	0.6	1.6	5.0	0.5	0.3	1.8	2.6	0.7	2.2	1.1	0.1	0.3	8.8	1.6	1.6	3.1	5.2	3.1	1.1	1.5	1.4	1.8	2.5	1.2	1.3	0.8	2.5	0.0	3.5	1.4	1.0	2.1	1.6	2.5	4.3	22.0	3.4	4.8	2.9	2.2	0.6	4.7	2.9	0.0	2.2	0.0	0.1	3.3	9.1	0.3	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.6	0.6	1.0	2.0	0.6	1.7	0.0	0.0	0.2	0.2	0.0	0.7	0.0	5.1	0.0	0.3	1.1	0.3	3.9	0.1	0.0	0.5	0.1
PSMB2	HC7-I	ENSG00000126067	"Proteasome subunit beta 2"	P49721	1	35599544-35641844	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		15000000	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.5	30.5	29.4	28.0	35.1	37.2	25.3	20.1	50.9	23.2	26.1	35.9	15.4	27.5	27.8	25.0	30.4	26.5	20.7	23.8	30.6	33.4	27.9	63.8	24.6	30.4	30.6	24.8	22.7	24.6	22.0	21.8	37.5	32.6	23.1	27.8	22.8	23.0	24.9	54.7	28.2	27.0	28.7	32.5	29.3	22.8	23.5	21.5	42.8	22.7	29.1	34.0	23.9	22.4	24.6	30.2	19.4	35.3	25.1	28.1	25.4	40.9	25.7	28.1	19.1	14.9	17.9	35.5	19.4	22.9	40.1	32.7	30.4	49.3	40.9	45.7	22.9	24.5	25.5	36.1	32.2	33.8	33.3	33.5	37.1	28.1	29.7	26.9	38.9	21.9	19.5	20.4	47.9	23.2	16.4	31.5	33.9	44.2	23.4	25.8	18.8	50.6	29.1	37.5	18.2	27.4	31.4	28.6	28.8	27.8	22.2	24.9	18.3	22.3	21.1	30.1	33.5	15.5	17.7	21.6	20.1	23.7	18.9	45.9	20.2	32.4	41.5	29.7	41.0	34.8	17.4	27.0	19.4	23.1	33.0	23.4	24.6	23.1	24.2	29.7	19.3	16.7	20.9	9.7	25.1	35.3	30.2	28.1	25.4	29.4	35.1	20.1	50.9	30.6	33.4	30.6	24.8	32.6	21.5	59.6	61.8	70.7	120.5	98.8	48.7	51.8	71.4	68.3	47.8	62.8	15.7	342.2	122.7	240.6	77.0	88.7	69.5	23.3	197.3	290.1	75.1	97.6	33.6	136.0	195.7	55.6	94.4	84.7	99.4	12.8	93.2	93.1	72.6	231.8	76.2	58.8	222.8	74.6	85.9	183.0	36.4	90.5	72.1	168.5	124.8	97.5	369.7	82.8	96.1	159.8
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713875-35719472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 22.3;Rod photoreceptor cells: 26.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: AB_2673834"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	4.3	4.4	12.5	2.1	10.5	1.1	2.4	5.0	22.1	4.7	3.5			1.0	4.1	5.0	2.1	2.5	3.0	4.0	12.1	9.7	0.7	1.8	3.1	2.4	7.0		3.5	1.2	2.0	1.8	1.6		3.1	2.0		1.1	4.4	5.1	2.9	1.2	7.0	5.2	2.2	1.2	3.4			1.4		2.5	2.4	1.4	2.5	3.2	0.1	3.7	0.8	7.3	3.0	3.4	8.0	4.4	5.7	20.1	14.8	2.9	9.8	11.5	14.5	13.9	4.7	7.3	4.3	7.1	14.3	11.9	3.3	10.9	6.4	12.5	14.0	5.2	25.7	11.7	1.3	7.6	12.7	17.0	15.1	8.2	10.4	3.3	10.7	9.4	3.2	10.2	11.6	15.5	5.6	5.1	10.9	6.4	3.7	6.8	3.4	5.8	3.5	5.0	4.0	5.9	5.9	9.3	1.9	19.0	2.7	3.6	5.7	11.2	11.8	9.4	8.8	10.1	3.5	8.7	3.2	11.8	12.3	18.4	0.0	3.2	0.1	5.9	3.7	1.9	2.5	4.7	7.3	3.2	1.4	1.1	4.4	0.1	0.8	2.7	0.7	1.6	3.0											0.0	2.1	0.0	2.9	5.4	18.4	6.4	0.0	0.0	1.2	1.8	13.7	2.0	0.0	5.5	10.2	6.0	0.0	0.0	2.4	1.2	4.7	1.8	4.6	1.7	6.9	22.3	1.7	5.5	4.0	6.8	7.8	5.4	15.1	8.2	0.0	16.2	2.2	0.0	19.4	0.7	26.6	0.0	6.9	2.8	2.2	4.0	0.9	5.0	0.3	1.4
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.7	7.3	15.9	8.4	1.1	2.1	5.9	18.0	5.0	13.2	17.7	11.5	8.2	18.7	5.8	4.8	9.6	8.8	15.5	6.2	20.7	12.8	7.0	26.3	15.9	5.1	0.0	21.5	15.5	0.4	0.2	22.7	1.6	1.5	7.1	11.2	17.7	13.0	12.6	5.7	22.6	4.9	15.0	6.0	5.2	14.4	24.1	5.6	2.7	14.5	5.9	6.9	15.6	4.8	3.1	11.2	4.1	8.5	5.1	19.0	14.4	11.6	20.0	4.7	11.4	19.7	6.0	15.4	15.3	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5	0.0	0.3	1.5	4.6	4.9	7.9	1.1	2.5	0.0	3.4	0.0	11.8	5.5	0.0	1.3	6.2	1.9	0.4	0.0	0.6	33.9	3.9	1.4	1.1	0.0	14.0	1.6	1.2	3.7	3.2	4.9	2.3	6.5	3.3	15.4	1.6	6.6	0.9	1.9	0.4	0.0	96.1	6.5	2.5	71.5	133.3	1.8	8.7	5.1	4.1	2.6
AGO4	"EIF2C4, FLJ20033, hAGO4, KIAA1567"	ENSG00000134698	"Argonaute 4, RISC catalytic component"	Q9HCK5	1	35808172-35857890	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 21.6"	"Low region specificity"	"Detected in all"							"CAB012179, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Cytosol	"CAB012179: , HPA067849: "	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.70e-5)"	"unprognostic (3.92e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-3)"	"unprognostic (4.91e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.58e-2)"	10.8	6.3	8.4	11.5	9.5	24.2	10.2	16.2	12.7	11.1	11.8	16.4	9.9	6.5	16.2	11.1	10.0	9.2	10.8	14.7	8.8	7.9	6.5	9.0	14.4	18.1	9.6	11.1	9.7	11.2	13.0	7.8	12.1	7.9	12.6	9.0	12.4	10.8	9.0	16.0	26.8	10.6	13.6	7.6	18.7	11.8	16.1	12.0	9.6	7.4	9.1	9.1	13.2	13.6	0.8	2.9	10.7	3.7	0.8	2.1	1.1	5.2	1.3	10.2	5.8	5.4	6.2	5.2	4.0	4.0	4.2	4.8	0.7	8.0	8.4	5.5	5.8	4.3	2.1	4.4	3.2	4.0	9.2	4.0	4.2	3.5	2.4	5.1	4.8	6.6	3.9	6.9	2.3	3.5	8.0	7.1	10.2	3.2	3.4	5.5	0.8	7.7	5.4	3.3	3.3	2.4	7.8	9.2	1.0	4.1	6.6	4.5	6.6	3.6	3.3	11.2	9.2	2.7	21.6	8.4	3.2	1.6	3.2	3.0	4.9	1.6	1.3	3.9	6.2	2.8	1.8	3.7	4.1	1.4	2.1	2.1	0.8	1.1	1.6	2.9	0.7	0.5	0.7	10.7	0.8	1.9	0.6	0.3	1.1	8.4	9.5	16.2	12.7	8.8	7.9	9.6	11.1	7.9	12.0	17.9	20.0	7.3	3.9	8.8	25.1	19.3	20.4	8.1	10.3	10.4	21.6	3.5	1.7	5.4	1.7	8.7	6.7	0.0	4.9	4.0	5.4	7.4	2.3	9.7	11.6	6.4	12.1	19.6	49.2	1.0	4.6	18.3	3.3	5.4	9.7	6.7	10.6	9.1	5.3	1.2	33.7	19.4	4.2	6.6	1.6	11.2	3.4	9.6	6.0	3.8
AGO1	"EIF2C1, hAGO1"	ENSG00000092847	"Argonaute 1, RISC catalytic component"	Q9UL18	1	35869808-35930528	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067849			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Cytosol	"HPA067849: "	"unprognostic (2.35e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.61e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.77e-3)"	12.3	15.9	16.6	14.4	19.0	11.3	11.2	23.3	21.3	15.7	12.1	22.2	19.0	13.2	14.3	9.3	11.7	13.8	11.3	14.0	15.7	13.8	11.7	8.6	11.8	14.3	14.5	20.0	17.2	12.6	21.6	13.5	9.8	16.3	15.4	12.8	13.0	11.7	22.3	14.8	16.3	13.8	15.7	13.7	15.7	12.2	10.7	16.4	13.1	12.2	8.3	14.4	12.4	11.5	2.3	2.5	3.7	7.1	2.1	3.1	4.9	8.2	5.4	13.2	11.6	8.2	5.0	13.6	4.5	6.8	8.0	7.4	9.9	5.4	9.0	5.6	8.9	5.5	4.0	18.9	7.1	9.4	8.9	5.9	19.6	8.8	7.6	3.2	11.6	7.9	4.2	2.5	13.3	6.9	4.6	11.3	8.4	13.2	5.6	5.7	4.5	12.1	5.0	28.3	9.9	4.5	9.0	9.9	3.9	2.6	10.8	16.2	6.7	14.5	5.7	4.8	14.7	4.8	3.9	7.8	5.9	12.9	8.0	8.2	5.6	4.5	4.6	6.4	6.5	7.6	2.7	5.6	2.6	3.1	7.1	3.0	2.3	2.6	2.9	2.4	2.3	2.8	2.9	3.7	2.1	5.6	2.5	2.4	4.9	16.6	19.0	23.3	21.3	15.7	13.8	14.5	20.0	16.3	16.4	3.0	9.4	14.9	5.9	12.4	32.3	11.5	12.7	8.1	9.1	14.0	37.3	4.4	1.7	9.9	4.5	11.7	12.6	0.0	11.4	4.2	7.4	8.4	16.1	11.3	12.2	33.4	24.9	9.8	20.4	5.5	13.8	12.5	5.0	7.2	16.1	12.5	9.8	10.5	19.4	9.2	31.5	12.9	10.4	9.2	15.6	12.7	1.9	8.6	15.2	6.0
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute 3, RISC catalytic component"	Q9H9G7	1	35930718-36072500	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	9.8	8.1	8.8	16.2	11.7	20.6	9.6	12.8	9.6	9.4	7.4	13.8	10.4	4.6	9.5	10.9	7.8	7.4	8.8	9.5	8.0	7.4	8.2	11.3	9.6	9.3	11.5	6.1	10.8	9.7	13.3	28.0	11.0	9.1	9.8	7.1	8.7	7.7	14.1	8.3	12.5	7.3	12.0	10.9	8.3	8.0	21.4	13.5	14.4	9.7	4.7	10.1	8.4	13.9	6.5	5.1	14.0	6.0	6.0	5.5	2.3	6.6	4.6	5.9	4.6	8.3	5.0	7.1	5.5	5.8	8.5	9.1	5.0	7.5	7.4	6.8	5.6	9.8	5.6	6.3	4.0	11.4	10.2	3.9	9.0	8.0	3.8	4.4	8.7	7.6	2.4	3.6	12.2	7.7	3.4	7.2	7.8	9.7	10.8	7.4	2.5	6.3	4.7	10.2	3.5	8.1	7.7	7.9	7.3	2.7	6.5	7.2	4.5	9.8	2.5	3.4	9.4	3.7	3.6	5.6	5.9	15.1	5.2	5.9	6.0	10.3	10.3	3.0	5.6	5.7	8.5	4.7	13.2	5.5	4.2	3.5	6.2	3.6	3.9	5.1	6.5	5.0	5.0	14.0	6.0	6.0	4.5	3.4	2.3	8.8	11.7	12.8	9.6	8.0	7.4	11.5	6.1	9.1	13.5	80.4	42.9	19.0	30.7	34.5	67.6	16.7	7.6	12.0	26.1	24.4	106.0	9.2	0.0	13.1	43.3	29.9	12.7	0.0	10.6	11.0	30.1	30.9	56.4	20.3	14.3	39.7	44.9	31.3	28.4	54.4	35.1	34.5	21.9	14.4	14.3	46.3	13.7	7.0	38.9	6.7	82.2	19.4	33.0	33.1	19.8	29.4	10.8	27.7	16.3	25.0
TEKT2	TEKTB1	ENSG00000092850	"Tektin 2"	Q9UIF3	1	36084075-36088275	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 41.4;testis: 33.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 414.8;Late spermatids: 228.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	45	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.4"	"Cell line enriched"	"Detected in some"	7	"NB-4: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA027248, HPA027461"	Approved		Uncertain	Microtubules		NA	NA			Microtubules		"HPA027248: AB_1857884, HPA027461: AB_10600912"	"unprognostic (1.02e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-3)"	"unprognostic (5.28e-4)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (9.78e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.68e-2)"	0.2	0.5	1.9	0.2	3.8	0.9	0.8	0.8	1.1	2.3	0.2	3.1	0.5	0.2	1.1	6.1	0.2	41.4	0.2	0.2	2.3	2.5	1.0	0.1	4.0	0.2	0.5	0.8	3.3	1.1	1.2	2.0	0.2	6.4	0.3	0.1	0.1	0.4	1.1	0.1	0.1	0.1	0.4	0.7	0.1	0.3	33.3	1.2	0.3	1.9	0.3	0.2	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	28.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	1.9	3.8	0.8	1.1	2.3	2.5	0.5	0.8	6.4	1.2	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	44.2	4.5	1.8	0.0	0.1	0.0	0.5	414.8	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.1	0.0	1.7	0.0	0.0	228.6	4.6	0.0	0.0	0.0	0.0	0.9	0.1	0.0	3.5	1.6	0.0	0.0	0.0	6.2	3.8	0.0	0.0	0.0	0.0	0.1
ADPRHL2	"ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylhydrolase like 2"	Q9NX46	1	36088875-36093932	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	15.5	27.6	17.4	15.2	17.4	16.9	20.0	16.5	22.7	15.9	17.3	30.3	17.7	15.6	14.3	17.8	26.3	28.4	13.5	15.1	19.1	18.9	19.8	16.5	20.7	19.1	25.8	18.5	19.7	27.6	15.1	14.0	20.9	19.7	16.6	12.9	12.2	21.9	20.2	26.4	24.4	17.7	22.2	23.5	18.0	14.1	25.1	20.0	21.2	21.2	22.3	19.7	16.1	15.9	27.7	38.9	34.1	38.8	23.5	29.3	29.2	25.7	10.9	13.0	18.3	12.0	8.8	18.6	19.2	16.2	31.1	30.7	12.9	23.4	18.4	18.8	19.1	16.1	16.1	16.4	29.5	18.7	13.1	20.6	16.7	13.2	17.3	22.7	19.0	9.9	10.3	22.6	28.1	12.3	23.7	19.6	17.8	14.4	15.3	14.5	12.4	19.2	28.8	28.0	15.3	22.7	15.7	13.7	18.5	27.8	21.2	16.0	25.4	14.1	14.8	31.3	18.0	15.2	16.5	13.4	18.0	18.6	24.9	25.4	19.9	19.0	16.3	26.0	18.9	11.0	18.2	32.4	34.1	25.5	38.7	24.0	23.6	27.9	29.3	38.9	27.7	28.3	24.0	31.4	23.5	38.8	24.6	22.8	29.2	17.4	17.4	16.5	22.7	19.1	18.9	25.8	18.5	19.7	20.0	29.8	10.0	22.9	24.4	34.9	17.7	7.3	15.3	30.8	14.8	21.0	5.9	67.9	29.9	47.4	6.6	17.1	20.1	0.0	30.7	33.5	19.7	18.0	14.9	6.0	46.0	9.5	16.7	11.1	11.2	7.9	15.3	22.0	25.3	45.1	12.5	24.3	38.3	15.0	17.0	36.1	15.8	25.8	17.9	24.4	46.2	35.8	59.0	19.2	19.8	22.7
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095236-36125220	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.4"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 9.8;Fibroblasts: 13.4;Hofbauer cells: 6.5;Melanocytes: 6.8;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 4.1;HHSteC: 14.2;hTERT-RPE1: 18.1;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	4.4	1.2	1.7	8.1	3.4	0.3	7.2	6.0	1.3	9.6	4.8	4.5	1.0	1.4	5.2	3.1	6.4	3.4	6.3	11.1	1.7	1.4	1.1	0.4	4.8	2.9	3.8	0.9	4.2	1.8	0.1	3.7	13.7	7.6	5.5	2.1	39.4	6.5	13.4	1.4	4.6	1.8	16.3	4.8	7.5	9.6	1.9	2.5	1.9	7.7	4.7	3.5	10.1	5.5	0.0	2.8	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	5.6	1.6	1.5	0.9	0.2	0.1	0.0	0.8	4.1	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	14.2	0.0	0.0	1.7	0.1	0.7	0.0	18.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.5	0.5	0.0	0.2	0.4	0.0	4.5	0.1	2.3	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.2	2.4	0.0	0.2	1.7	3.4	6.0	1.3	1.7	1.4	3.8	0.9	7.6	2.5	0.0	2.6	0.0	1.6	1.9	0.0	9.8	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.2	13.4	0.7	2.3	0.0	6.5	0.0	0.0	0.6	1.9	0.0	2.8	5.1	6.8	0.0	0.0	0.3	0.4	0.0	5.6	0.0	0.0	6.5	2.3	0.0	0.1	1.1	0.7	0.0	0.0	0.4
TRAPPC3	BET3	ENSG00000054116	"Trafficking protein particle complex 3"	O43617	1	36136570-36156053	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028408	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA028408: AB_10601826"	"unprognostic (3.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (7.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.10e-3)"	"unprognostic (6.53e-2)"	28.7	53.5	31.9	29.4	31.9	17.8	41.0	27.3	33.6	28.4	33.6	21.9	33.6	24.3	28.9	46.3	39.7	27.8	33.4	39.4	26.3	29.4	39.7	36.6	26.0	24.4	28.7	26.1	19.9	37.0	29.0	32.4	42.8	30.2	29.9	31.7	28.8	30.8	35.6	34.2	32.4	27.2	36.6	26.8	28.3	31.1	33.7	23.3	28.0	48.4	35.6	37.4	32.4	38.6	37.6	52.6	56.9	55.4	35.9	51.6	55.6	32.7	23.8	16.1	24.9	42.0	33.9	31.6	30.2	38.7	36.2	35.2	19.6	31.7	14.0	28.7	33.1	28.7	24.4	24.6	40.4	41.3	27.3	37.8	26.1	27.7	28.4	49.2	27.3	27.8	28.9	35.5	33.7	33.2	37.6	45.1	36.9	31.5	23.7	43.4	25.3	32.1	25.6	21.4	27.5	35.2	22.6	22.8	31.3	45.7	27.1	24.5	17.9	24.6	27.8	47.8	43.4	17.9	20.6	33.5	21.3	24.2	41.5	40.0	29.0	29.2	22.9	36.5	30.9	21.4	54.0	53.1	56.9	36.3	55.4	37.5	37.6	43.2	38.1	52.6	33.9	41.9	37.8	53.9	35.9	43.6	43.3	51.6	55.6	31.9	31.9	27.3	33.6	26.3	29.4	28.7	26.1	30.2	23.3	23.8	28.8	54.4	94.1	89.8	39.6	51.3	50.9	22.7	23.9	36.6	15.7	128.6	144.2	122.4	210.9	67.3	56.3	23.3	162.6	126.4	66.1	106.5	45.0	39.5	127.5	50.9	46.3	27.6	50.2	99.5	39.7	66.2	91.1	134.3	44.1	49.9	150.1	66.2	48.8	80.1	23.0	32.3	57.1	95.6	83.7	108.0	160.1	47.9	48.6	103.8
MAP7D1	"FLJ10350, FLJ39022, PARCC1, RPRC1"	ENSG00000116871	"MAP7 domain containing 1"	Q3KQU3	1	36155579-36180849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028075	Approved		Approved	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA028075: AB_10603778"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (6.00e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.32e-3)"	39.4	12.8	25.4	24.4	27.8	19.4	17.4	26.4	44.7	11.2	24.0	32.4	4.6	12.4	16.6	5.5	25.9	10.6	18.4	51.7	25.1	22.5	7.4	4.9	21.3	14.7	31.2	24.1	10.2	10.0	8.3	12.2	15.4	30.8	18.4	7.1	10.2	11.0	19.5	144.7	20.9	10.9	21.1	40.7	17.8	14.2	6.7	22.8	14.9	10.5	18.6	11.5	22.8	12.4	0.4	0.8	4.7	1.4	0.4	1.9	0.2	29.2	17.2	27.1	17.1	16.6	12.6	20.0	29.4	29.9	31.0	27.4	9.6	30.2	12.3	25.3	26.6	17.0	32.2	11.1	39.9	10.2	20.9	9.9	8.3	12.9	3.6	26.2	12.3	21.5	22.0	11.4	41.8	26.0	24.1	21.1	17.3	8.0	19.0	17.1	5.9	22.6	10.4	24.7	4.1	9.7	23.5	20.0	11.6	15.7	10.1	10.5	20.2	16.9	9.4	22.8	15.3	6.2	8.7	39.6	36.6	27.9	30.9	39.7	18.9	5.6	14.3	31.4	8.4	21.9	0.5	1.4	1.4	1.1	0.7	1.5	0.1	1.0	0.8	0.6	0.4	1.9	0.6	4.7	0.4	0.5	0.8	0.3	0.2	25.4	27.8	26.4	43.8	25.1	22.5	31.2	24.1	30.8	22.8	41.7	15.6	16.1	127.0	127.2	31.7	140.8	17.8	0.0	13.6	22.7	9.8	41.0	14.9	35.7	29.9	48.9	40.4	0.0	23.7	93.6	61.5	85.8	12.7	8.6	62.7	46.1	9.7	27.0	38.3	58.1	28.4	52.1	30.4	27.9	12.4	29.4	46.9	17.5	44.9	9.2	38.5	19.4	64.5	7.6	15.3	124.0	108.9	52.3	17.2	165.9
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224416-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		22000	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	33.9	30.5	19.8	27.2	28.5	26.8	27.0	30.7	33.7	25.5	26.6	28.4	24.8	20.2	30.2	23.6	29.7	25.1	21.5	28.1	19.7	20.2	25.2	37.1	24.6	32.4	21.2	20.1	29.6	24.8	38.6	32.6	35.6	28.5	32.1	24.1	26.3	27.4	23.7	79.1	27.0	29.3	27.6	20.7	32.6	26.5	23.8	22.2	57.4	29.0	28.6	38.8	27.4	26.1	36.2	23.1	49.3	24.0	25.2	29.8	22.2	31.3	20.3	35.0	29.8	28.0	22.8	29.3	33.8	34.1	34.1	35.2	23.8	28.9	58.5	12.8	34.8	24.1	29.1	39.0	32.8	42.7	30.1	21.9	48.5	31.4	25.1	30.5	49.2	32.7	34.9	20.7	34.6	29.4	23.5	37.4	35.5	40.1	30.4	24.4	17.8	52.9	27.3	41.4	19.5	16.0	50.7	41.5	31.2	24.4	44.5	22.2	26.5	38.6	25.0	28.0	35.4	23.1	21.1	39.4	28.4	33.0	26.4	35.4	18.2	32.0	53.2	26.7	33.7	29.5	36.6	20.1	36.7	29.8	24.0	25.2	32.2	25.3	26.0	22.7	36.2	26.8	23.3	49.3	25.2	23.8	23.1	21.3	22.2	19.8	28.5	30.7	33.7	19.7	20.2	21.2	20.1	28.5	22.2	107.2	81.4	114.8	82.1	50.5	89.2	98.7	56.0	99.0	85.3	45.4	29.5	126.9	82.9	123.3	5.3	83.5	50.1	46.7	91.4	130.0	82.0	97.4	88.1	63.2	88.9	82.6	69.5	65.1	67.8	7.8	74.2	78.2	69.2	174.1	63.3	132.3	90.9	52.6	78.5	58.7	85.1	90.5	82.4	132.9	116.0	59.8	120.5	106.5	79.1	64.3
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306387-36324886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 26.2"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 13.1;Late spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2"									"HPA042212, HPA042456, HPA066168"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.6	1.1	11.6	3.4	9.5	1.9	10.1	12.2	11.3	4.4	5.3	1.1	1.4	16.6	2.8	2.7	7.1	1.9	3.0	2.2	5.2	2.2	8.6	1.4	4.5	2.8	1.9	7.0	4.0	1.0	1.3	2.2	19.4	7.4	7.0	6.0	12.4	12.7	2.6	1.0	16.2	24.3	2.0	2.4	1.6	2.3	6.6	1.9	0.0	26.2	4.1	4.5	3.7	6.7	0.1	0.3	2.0	0.5	2.7	0.6	0.0	8.3	0.2	1.6	1.9	0.5	1.0	9.1	4.0	0.8	3.0	1.3	4.7	3.4	1.5	4.4	1.7	0.3	13.5	1.4	3.0	2.5	0.4	0.6	1.3	2.9	3.7	1.3	0.7	2.0	0.5	2.5	2.0	1.5	22.0	1.1	4.1	0.2	2.6	1.4	4.9	1.4	0.7	1.0	2.2	1.6	2.0	0.1	1.0	3.4	1.0	3.4	1.7	0.9	10.1	3.1	11.2	0.3	0.3	2.3	1.2	0.7	4.0	0.4	3.0	0.9	1.7	3.4	0.7	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	11.6	9.5	12.2	11.3	5.2	2.2	1.9	7.0	7.4	1.9	0.0	1.3	0.8	1.5	2.7	5.2	0.9	0.0	0.0	0.0	5.2	0.0	2.5	1.7	0.5	13.1	0.9	11.8	0.0	0.3	2.1	1.4	2.0	1.1	0.0	7.0	11.1	0.0	0.6	3.2	38.8	1.1	4.7	3.3	3.6	2.0	1.0	2.7	0.8	2.5	0.8	1.1	0.0	1.7	2.1	1.5	2.8	4.8	0.0	1.6	1.1
EVA1B	"C1orf78, FAM176B, FLJ10647"	ENSG00000142694	"Eva-1 homolog B"	Q9NVM1	1	36322031-36324154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 229.9;Ito cells: 91.4;Syncytiotrophoblasts: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 20.0;NB-4: 24.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041928, HPA043537"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041928: AB_2677752, HPA043537: AB_2678538"	"prognostic favorable (4.58e-4)"	"unprognostic (5.66e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.87e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	7.2	5.9	3.3	5.0	2.6	3.1	10.6	1.7	3.7	9.4	4.4	2.5	4.1	8.9	9.8	3.8	4.1	5.1	4.2	7.7	2.4	1.1	10.5	2.8	6.3	8.1	3.4	1.7	8.9	1.9	1.3	2.0	23.3	3.2	7.4	0.5	2.9	7.8	4.3	3.6	6.9	8.1	6.4	3.4	10.4	3.9	5.1	2.9	2.6	9.2	1.7	2.5	5.4	8.3	0.0	1.1	5.8	2.1	3.5	2.2	0.3	2.8	1.7	1.4	2.6	5.2	14.7	7.6	20.0	13.6	3.4	3.8	2.9	2.0	0.4	6.6	5.8	0.7	4.4	0.1	0.7	0.7	2.3	4.9	2.6	1.8	2.3	11.1	0.1	1.5	13.1	0.0	4.2	0.4	5.3	5.2	0.7	0.9	1.0	2.2	3.3	0.1	24.7	1.6	0.2	7.7	1.6	0.3	4.2	2.7	0.6	1.1	3.4	2.0	2.2	7.9	2.2	0.3	1.8	8.8	5.4	0.6	7.9	2.2	1.1	0.3	0.6	3.2	1.6	4.4	5.8	2.1	0.0	0.4	0.8	1.4	0.0	0.8	1.2	1.1	0.0	0.0	0.1	3.7	3.5	0.3	0.0	2.2	0.3	3.3	2.6	1.7	3.7	2.4	1.1	3.4	1.7	3.2	2.9	0.0	0.0	6.9	16.7	14.3	0.0	1.6	2.5	0.0	1.2	7.0	0.0	44.7	1.7	17.7	5.6	44.2	0.2	0.0	12.8	229.9	52.8	37.6	4.6	0.4	40.9	0.0	0.0	91.4	28.8	20.1	46.9	15.6	11.8	6.4	0.0	10.9	23.2	0.0	45.6	6.3	0.5	25.8	41.1	9.3	2.4	10.8	134.9	9.5	0.2	17.8
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385896	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 181.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 19.2;monocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	22.9	7.2	9.8	15.3	9.4	9.2	26.5	8.9	11.1	10.2	19.1	7.4	16.7	9.4	11.8	12.2	22.3	11.3	18.2	25.6	10.0	7.1	14.3	23.5	16.6	15.4	13.1	7.4	22.2	34.4	9.2	14.7	19.2	12.1	15.7	9.1	9.0	25.1	17.7	53.9	17.2	10.8	26.0	10.3	17.2	17.0	32.0	8.9	9.2	14.6	20.7	16.6	19.5	26.6	2.4	2.7	19.2	8.5	1.6	2.9	2.4	7.1	3.1	15.7	16.3	11.1	6.5	8.8	7.2	9.8	8.8	9.5	17.2	10.3	30.2	5.9	6.7	9.3	7.2	14.3	3.1	6.5	13.1	11.2	19.7	2.9	21.9	11.1	11.5	26.3	5.8	11.9	6.7	3.5	4.7	5.5	23.4	24.2	11.0	5.4	11.2	11.9	15.2	10.1	12.9	4.3	13.7	10.7	20.0	5.5	8.0	19.3	9.8	5.5	8.7	24.1	10.4	5.9	13.6	9.1	5.5	11.6	16.2	15.9	11.5	6.4	25.5	28.9	10.1	18.1	1.0	3.0	4.9	2.6	6.7	2.9	2.3	1.7	1.7	2.7	2.4	1.0	1.5	19.2	1.6	8.5	2.6	1.0	2.4	9.8	9.4	8.9	11.1	10.0	7.1	13.1	7.4	12.1	8.9	11.9	18.3	19.8	48.5	54.5	12.0	21.1	2.5	6.7	7.9	10.4	3.9	4.7	14.9	14.5	92.4	11.0	27.7	0.0	27.1	8.3	15.3	55.1	12.7	19.5	21.4	9.5	22.4	12.9	20.3	181.6	21.3	21.3	28.7	14.4	12.9	4.5	23.4	14.4	31.5	10.5	9.5	25.8	30.9	12.6	8.7	65.9	47.8	14.6	10.8	43.7
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397892	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	15.0	11.9	19.8	17.7	20.2	12.6	21.1	11.1	20.9	12.3	20.8	9.5	16.7	11.9	14.2	19.1	15.0	11.4	15.7	28.2	18.6	19.7	17.3	21.3	11.8	27.3	17.7	14.4	14.6	18.6	12.1	16.4	13.2	17.0	16.2	11.0	13.8	16.9	19.5	82.0	10.1	13.0	17.8	12.5	21.1	14.5	12.1	10.3	10.3	18.9	22.0	26.8	19.1	25.0	73.8	45.9	66.7	50.5	19.1	31.0	49.9	18.9	29.0	10.9	29.2	25.8	25.3	11.3	17.1	25.1	27.5	21.1	12.9	18.2	44.9	23.7	23.1	20.4	10.5	18.5	22.2	18.3	30.4	22.1	22.5	17.2	30.3	31.4	16.9	33.1	21.2	19.8	24.7	17.6	15.0	28.1	25.8	20.7	22.0	19.3	33.7	18.8	19.3	28.1	23.6	30.1	14.3	10.5	30.3	26.5	11.6	14.0	10.5	13.9	17.8	41.5	18.4	9.2	14.6	18.6	12.6	17.4	32.7	26.6	29.1	39.1	35.1	25.2	26.0	28.3	35.7	50.5	61.4	25.6	48.7	27.8	70.6	25.5	26.5	36.0	73.8	23.1	25.0	66.7	19.1	44.9	45.9	31.0	49.9	19.8	20.2	11.1	20.9	18.6	19.7	17.7	14.4	17.0	10.3	11.9	15.6	88.7	31.6	28.6	15.4	45.2	15.3	5.3	11.4	43.6	5.9	48.1	119.3	34.9	7.6	35.4	23.8	46.7	41.3	51.7	42.8	37.2	40.4	54.6	93.0	17.5	27.1	30.1	72.9	16.5	35.9	85.7	49.0	44.1	20.4	20.9	37.9	34.5	44.2	91.1	12.7	12.9	49.5	8.4	23.0	35.0	33.4	57.3	25.4	24.3
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 35.8;testis: 49.9"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	3.9	5.3	6.2	1.5	14.0	1.2	6.0	3.6	12.7	6.2	3.6	6.5	7.5	1.8	6.3	14.1	3.2	35.8	5.5	4.7	6.5	8.9	11.9	1.8	6.7	1.3	4.9	5.3	5.9	6.2	15.7	15.7	8.9	7.8	6.4	2.5	6.7	5.3	6.8	2.4	3.4	1.3	5.0	3.2	0.9	3.5	49.9	3.2	1.3	11.1	3.5	2.4	3.2	2.6	0.8	3.8	0.3	1.7	0.3	3.1	0.8	5.2	5.0	6.2	7.1	7.4	7.2	1.1	3.2	7.8	7.9	5.4	0.1	4.6	1.1	6.0	5.7	5.8	4.1	0.2	6.0	5.1	0.9	4.7	0.0	3.3	0.5	9.1	0.6	0.9	8.1	9.8	11.1	4.9	11.5	5.4	5.0	0.1	1.3	6.2	3.7	2.7	1.9	6.3	2.0	2.1	2.9	2.5	0.9	12.9	1.8	16.6	7.3	5.9	2.8	4.1	6.1	6.1	0.9	4.6	5.7	2.1	10.3	5.3	2.3	2.3	0.5	11.0	0.1	3.8	0.0	0.7	0.0	0.9	1.7	0.0	0.4	0.9	0.7	1.8	0.8	2.2	3.1	0.3	0.3	0.2	3.8	2.2	0.8	6.2	14.0	3.6	12.7	6.5	8.9	4.9	5.3	7.8	3.2	8.9	7.5	0.5	6.7	1.3	5.3	4.7	5.1	144.6	19.4	12.2	15.7	9.8	19.9	11.2	336.5	2.4	0.7	0.0	8.1	2.6	4.1	4.3	0.0	1.9	3.8	4.8	4.7	2.5	0.6	35.1	11.5	1.2	3.3	0.0	2.6	12.3	7.9	4.0	8.5	18.1	18.9	0.0	3.3	91.2	18.9	2.8	16.8	0.7	2.6	3.3
MRPS15	FLJ11564	ENSG00000116898	"Mitochondrial ribosomal protein S15"	P82914	1	36455718-36464437	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 621.9;Late spermatids: 1487.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028100, HPA028134, HPA067137"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787"	"unprognostic (2.05e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.39e-1)"	22.6	20.7	17.8	16.9	17.3	24.0	23.8	9.5	16.0	13.2	19.9	9.3	13.7	14.3	13.3	23.0	23.0	10.4	16.6	43.2	15.0	15.2	30.6	61.7	16.6	23.3	17.5	10.6	13.8	23.3	14.3	14.3	23.7	18.3	15.0	18.2	13.8	24.0	14.7	89.5	14.1	18.4	15.7	12.3	17.3	18.8	65.5	10.6	20.3	19.1	41.3	19.3	16.0	12.9	24.5	40.7	7.0	28.7	20.3	28.1	28.6	40.5	22.6	24.7	30.1	24.6	35.7	61.5	22.7	32.6	56.3	51.8	39.9	43.8	37.6	37.1	29.8	33.9	35.8	36.0	57.3	50.8	24.4	45.7	38.4	29.3	43.6	46.1	47.5	27.2	32.9	51.2	50.1	40.6	21.8	45.9	28.3	41.5	29.7	34.7	27.9	45.7	50.9	44.4	34.8	39.9	35.4	43.5	55.0	49.7	34.2	36.7	20.3	31.4	40.2	58.2	38.5	24.8	32.7	21.6	31.7	33.7	39.1	47.8	29.9	41.0	52.5	36.1	32.3	44.2	4.9	26.7	7.0	22.0	28.7	27.2	24.5	25.2	25.0	40.7	21.6	23.9	23.2	1.8	20.3	18.9	27.7	28.1	28.6	17.8	17.3	9.5	16.0	15.0	15.2	17.5	10.6	18.3	10.6	35.7	41.7	43.3	52.5	58.2	23.2	120.0	53.5	38.8	28.4	68.0	13.7	219.1	273.5	113.2	621.9	59.7	89.2	116.8	140.3	210.6	61.7	96.5	41.5	122.3	137.3	12.7	63.4	52.8	79.0	1487.0	58.1	81.5	54.0	95.6	78.7	16.2	134.3	66.6	70.0	248.1	19.2	64.7	69.1	202.9	79.7	70.3	235.5	61.8	99.8	87.6
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7"	"Cell type enhanced"	"Detected in many"	27	"Alveolar cells type 2: 228.0;Cytotrophoblasts: 271.6;Syncytiotrophoblasts: 999.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 167.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 167.3"	"Group enriched"	"Detected in some"	18	"BEWO: 34.9;NB-4: 9.4;THP-1: 22.9;U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB017116: , HPA048086: AB_2680257"	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	8.5	1.5	2.9	39.5	3.2	88.9	2.4	0.7	2.9	1.1	1.1	4.2	0.4	0.6	0.7	1.1	1.2	6.9	4.3	5.6	2.6	2.0	1.7	4.5	26.9	27.5	7.2	1.1	1.1	1.3	0.3	1.1	152.7	3.8	1.3	0.5	2.1	1.6	0.5	0.6	0.3	1.6	3.1	7.1	71.4	2.2	1.4	3.3	1.1	1.0	0.4	0.9	4.6	3.9	0.0	8.2	167.3	22.1	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.0	22.1	0.6	0.0	4.8	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	167.3	0.2	1.8	0.2	0.0	10.3	2.9	3.2	0.7	2.9	2.6	2.0	7.2	1.1	3.8	3.3	23.8	228.0	2.4	0.6	0.9	0.0	1.4	0.0	12.0	18.2	0.0	0.0	271.6	0.0	0.0	0.4	1.9	0.0	0.0	0.0	49.1	3.0	0.2	17.4	0.8	60.8	0.0	0.0	3.7	146.3	0.4	0.3	62.6	0.0	3.6	0.0	0.2	0.1	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.2	0.1	999.2	0.5	0.0	2.2
GRIK3	"GluK3, GLUR7"	ENSG00000163873	"Glutamate ionotropic receptor kainate type subunit 3"	Q13003	1	36795527-37034129	"Plasma proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;pituitary gland: 13.1"	"Group enriched"	"Detected in some"	5	"Late spermatids: 5.1;Muller glia cells: 14.3"	"Cancer enhanced"	"Detected in some"		"glioma: 13.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.60e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.08e-2)"	1.7	4.6	5.4	1.8	9.4	0.6	5.4	5.7	24.7	2.1	8.4	3.3	1.5	2.1	0.8	4.5	3.1	1.2	2.2	1.9	3.8	9.6	0.8	0.7	0.9	0.9	9.1	10.4	1.3	1.6	1.5	13.1	0.6	13.1	1.9	3.3	9.0	2.2	5.8	0.7	1.1	2.9	1.8	3.6	1.0	2.1	2.0	2.7	0.0	1.0	0.2	1.4	1.1	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.4	5.7	14.2	3.8	9.6	9.1	10.4	13.1	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.3	0.0	1.7	0.0	0.0	14.3	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZC3H12A	"FLJ23231, MCPIP1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474552-37484379	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.7;tongue: 56.9"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 174.0;Suprabasal keratinocytes: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;RT4: 30.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		No	No			"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	11.7	8.4	0.8	15.0	2.9	58.7	8.2	1.3	1.3	6.4	13.3	2.9	5.6	7.0	5.0	6.9	25.2	8.1	22.6	6.3	2.1	0.7	6.7	10.7	21.0	11.3	1.8	0.7	7.1	6.8	1.0	4.6	8.1	3.8	16.1	4.2	3.0	10.9	6.3	11.8	23.1	14.1	8.5	2.6	10.9	11.0	3.4	1.1	8.3	4.0	56.9	34.8	17.0	22.2	6.1	2.6	8.9	2.1	5.5	5.5	2.3	3.7	2.7	0.3	1.7	1.4	2.0	3.1	2.7	24.3	1.7	2.3	3.0	8.5	4.2	11.6	2.6	19.2	8.2	1.1	17.5	1.0	8.5	1.6	1.1	8.9	4.7	2.0	2.2	1.8	4.4	9.0	15.2	2.7	4.0	1.9	2.2	2.1	7.0	1.6	4.5	1.7	3.9	2.1	5.0	2.4	2.5	1.1	2.5	4.4	30.1	0.8	0.5	5.4	8.6	0.6	2.8	3.0	2.5	2.0	5.2	2.9	3.8	4.1	5.6	2.0	3.1	11.9	4.6	1.0	1.8	2.1	5.8	5.4	2.1	5.5	5.2	2.2	3.3	2.6	6.1	1.3	2.5	8.9	5.5	1.9	2.5	2.8	2.3	0.8	2.9	1.3	1.3	2.1	0.7	1.8	0.7	3.8	1.1	14.9	39.3	19.1	112.5	174.0	0.0	3.9	38.2	8.1	21.6	10.4	0.0	3.1	0.0	64.4	17.4	11.7	60.6	0.0	65.3	7.5	22.6	104.0	42.6	11.6	9.3	0.0	61.3	1.8	10.8	2.4	0.9	50.4	45.5	20.8	50.6	0.8	44.4	38.4	1.1	0.3	4.3	6.5	45.7	1.4	0.9	196.9	9.8	17.3	33.3	73.7
MEAF6	"C1orf149, CENP-28, Eaf6, FLJ11730, NY-SAR-91"	ENSG00000163875	"MYST/Esa1 associated factor 6"	Q9HAF1	1	37492575-37514774	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.95e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.41e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.87e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.68e-3)"	"unprognostic (3.57e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.19e-1)"	22.9	23.6	34.5	18.8	42.4	25.5	35.4	28.3	42.5	28.5	25.6	22.4	37.4	19.8	29.0	42.1	25.0	31.5	25.0	18.0	29.7	46.7	21.3	30.2	23.6	24.4	30.3	35.7	37.9	26.2	29.3	46.9	22.6	36.2	56.6	22.7	16.6	28.0	39.2	25.5	27.0	20.3	30.7	22.8	21.6	21.8	33.6	24.1	24.7	26.2	18.9	27.9	31.2	28.3	48.6	32.4	54.0	31.0	33.1	50.0	43.1	27.6	6.4	25.8	21.0	21.5	30.9	16.3	23.0	22.2	24.7	20.8	11.7	25.0	22.0	25.5	20.2	21.0	17.0	21.6	19.0	25.5	32.8	25.0	30.8	10.7	23.0	23.2	31.2	24.0	18.4	34.3	25.4	39.1	20.8	21.9	28.7	39.3	19.7	28.0	12.4	30.1	34.9	38.9	20.7	22.1	31.1	26.8	29.6	24.6	13.8	29.4	19.0	30.2	19.7	43.0	17.2	23.3	24.3	17.7	24.9	19.9	30.5	19.9	29.4	36.9	39.2	23.3	38.5	17.6	40.2	31.0	54.0	46.8	27.3	48.1	48.6	44.0	45.1	32.4	43.4	44.2	42.6	16.5	33.1	29.2	28.8	50.0	43.1	34.5	42.4	28.3	42.5	29.7	46.7	30.3	35.7	36.2	24.1	59.6	38.0	80.8	147.6	188.1	43.9	26.0	86.6	125.8	70.5	102.9	21.6	78.7	189.0	84.7	38.1	46.6	27.0	46.7	55.1	46.7	66.1	254.3	51.0	47.0	78.0	19.1	67.4	57.7	71.4	81.4	70.2	68.7	124.9	54.1	53.7	61.0	58.0	37.4	76.7	133.8	37.3	45.3	68.7	126.7	195.0	215.7	45.0	102.2	46.0	115.4
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554344	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	10.6	13.4	10.6	13.3	12.4	15.9	15.0	18.4	14.4	12.8	10.8	10.0	14.2	8.5	14.2	11.9	13.5	11.9	10.0	8.5	11.1	9.0	9.9	20.6	10.2	11.7	10.8	10.5	12.7	15.3	9.8	13.1	13.2	9.9	13.3	9.0	12.3	11.7	11.5	13.5	13.2	12.3	11.6	7.9	14.9	11.8	21.7	11.6	16.9	10.5	11.1	14.0	11.7	17.0	3.7	4.3	4.6	3.5	3.1	5.5	1.8	6.2	3.5	7.0	6.9	8.4	8.0	4.8	8.0	9.1	7.7	6.7	3.4	5.7	8.6	6.3	8.5	5.0	6.6	6.5	7.3	6.4	7.7	9.4	13.2	6.2	6.9	9.6	12.2	7.5	7.7	8.6	7.6	9.7	8.3	7.4	6.7	9.3	8.0	5.4	4.7	7.2	9.5	11.3	5.2	8.1	7.6	11.8	7.2	5.6	6.0	5.6	11.3	8.5	5.5	10.4	7.6	4.9	6.7	12.2	6.1	6.8	7.5	7.9	9.5	11.0	7.1	7.2	8.7	5.4	4.1	3.1	3.9	5.5	2.8	5.4	3.7	3.7	5.3	2.6	3.6	5.1	4.5	4.6	3.1	3.5	4.3	4.2	1.8	10.6	12.4	18.4	14.4	11.1	9.0	10.8	10.5	9.9	11.6	17.9	14.8	3.4	10.6	14.3	10.1	4.8	5.1	10.7	19.4	5.2	7.9	4.7	1.7	6.3	4.6	6.5	7.3	0.0	6.2	4.0	8.4	7.8	11.5	10.0	3.9	9.5	8.1	12.3	8.1	7.9	7.5	5.2	8.5	7.2	8.6	11.3	6.5	6.0	7.4	3.5	15.4	0.0	7.5	10.2	13.2	15.7	8.5	10.2	6.6	11.2
DNALI1	"dJ423B22.5, hp28, P28"	ENSG00000163879	"Dynein axonemal light intermediate chain 1"	O14645	1	37556919-37566857	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 50.5;testis: 59.5"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 307.9;Early spermatids: 530.7;Late spermatids: 878.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;ASC TERT1: 9.0;hTERT-RPE1: 13.5;RPTEC TERT1: 12.1;SH-SY5Y: 8.4;T-47d: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028305, HPA031633"	Enhanced					NA	NA					"HPA028305: AB_10601807, HPA031633: "	"unprognostic (1.21e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.52e-2)"	2.4	6.3	9.7	1.3	10.8	0.6	7.7	2.6	7.2	9.2	3.9	17.2	10.5	1.7	8.4	20.6	3.2	50.5	8.8	2.9	10.1	13.2	11.9	11.3	9.9	1.3	8.5	6.2	13.9	8.7	8.5	19.2	2.1	23.9	6.9	2.8	7.5	4.1	8.7	1.5	0.9	1.9	5.2	9.1	1.5	6.0	59.5	8.1	0.0	12.1	1.1	1.2	3.3	1.8	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.1	0.9	2.1	9.0	0.1	1.3	2.8	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.0	0.0	6.6	0.0	13.5	1.1	0.0	0.7	0.0	5.4	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.7	0.0	12.1	0.0	1.2	8.4	0.0	0.0	0.0	1.7	21.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.8	2.6	7.2	10.1	13.2	8.5	6.2	23.9	8.1	17.9	25.9	0.0	16.8	0.8	2.6	3.9	17.8	307.9	42.1	19.2	7.9	2.6	24.9	24.8	530.7	3.4	0.0	0.0	8.9	6.5	7.1	30.3	2.3	8.5	2.2	3.2	20.1	4.3	0.3	878.1	12.7	1.8	0.0	0.0	9.8	15.1	16.1	0.0	11.3	26.7	18.7	6.5	4.8	82.2	15.6	0.5	2.9	1.3	3.7	7.4
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595935	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	24.1	17.4	13.8	24.1	15.0	30.7	21.9	11.2	14.2	15.9	15.7	11.7	16.8	12.4	20.2	18.3	21.8	16.4	14.8	17.9	12.5	11.3	18.0	26.9	18.7	19.6	21.2	11.5	19.6	17.4	15.2	21.6	24.5	15.8	16.4	18.7	10.1	19.4	18.9	40.3	22.2	16.3	17.4	15.0	21.8	17.8	21.4	15.2	24.3	17.1	27.5	22.2	20.5	19.8	18.4	25.2	14.4	22.7	20.7	17.4	12.2	19.3	10.0	19.4	20.3	15.6	18.0	31.6	29.5	20.5	27.3	27.9	27.3	22.9	31.8	19.3	21.7	15.4	18.3	31.7	24.0	37.7	18.0	24.8	31.9	20.1	21.9	20.9	41.8	22.9	11.3	22.1	37.2	44.6	13.0	19.6	13.9	42.3	22.9	26.4	17.1	22.5	25.3	50.9	14.0	19.6	24.1	35.3	36.1	22.8	21.2	23.8	21.9	22.3	22.5	21.9	30.2	16.1	24.4	15.7	18.5	26.1	39.1	40.9	21.5	19.3	55.3	21.3	33.7	23.5	10.3	17.1	14.4	15.3	22.7	17.4	18.4	14.3	16.5	25.2	13.5	15.1	14.5	1.8	20.7	20.7	18.5	16.9	12.2	13.8	15.0	11.2	14.2	12.5	11.3	21.2	11.5	15.8	15.2	14.9	47.4	26.7	52.5	56.2	7.6	18.2	5.1	73.6	79.6	7.0	9.8	32.5	23.2	37.6	45.3	20.2	13.4	0.0	54.2	43.6	26.3	29.5	46.2	16.2	28.9	6.4	16.6	11.6	17.1	7.8	22.2	29.8	8.5	36.1	16.0	19.1	39.6	17.8	18.0	12.9	8.6	0.0	33.0	50.5	54.9	46.2	38.6	26.7	19.7	42.6
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634923	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 17.3;endometrium 1: 26.6"	"Cell type enhanced"	"Detected in some"	18	"Fibroblasts: 4.7;Melanocytes: 1.7;Smooth muscle cells: 4.1"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 1.8;NTERA-2: 4.6;THP-1: 4.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046154, HPA062923"	Uncertain		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA046154: AB_10964912, HPA062923: "	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	5.0	0.1	0.2	1.9	0.3	0.0	5.8	0.5	0.6	17.3	2.1	0.2	0.2	0.6	26.6	3.0	1.8	15.8	12.2	0.4	0.2	0.0	0.7	0.2	4.5	1.9	0.2	0.2	7.5	1.6	0.0	0.2	1.3	0.4	3.0	0.2	2.3	1.5	1.4	0.2	4.0	3.1	10.9	0.2	0.7	2.0	1.0	0.2	0.2	0.2	1.3	6.1	1.3	8.8	0.4	0.3	0.7	0.5	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	4.7	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.7	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.7	0.0	0.5	0.3	0.3	0.0	0.2	0.3	0.5	0.6	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 44.6;Suprabasal keratinocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavorable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	13.8	15.1	12.0	9.3	15.0	9.3	14.5	17.9	20.5	12.9	11.1	11.4	16.2	11.0	15.9	14.3	13.7	13.9	10.5	11.1	13.1	12.9	12.8	12.0	8.8	14.1	13.6	15.0	19.7	19.6	20.5	10.9	14.6	15.9	15.0	7.8	12.9	20.3	14.8	15.2	14.9	8.5	11.6	9.9	10.1	11.1	11.2	12.2	13.1	15.7	9.1	12.6	13.7	12.8	11.4	27.5	3.3	5.0	12.2	16.2	7.5	8.3	9.6	8.3	13.6	7.3	5.2	18.9	10.0	7.1	15.2	11.2	14.6	10.1	11.9	12.1	4.4	7.0	12.2	15.3	10.2	15.6	18.9	17.2	13.5	9.7	9.1	14.1	14.7	8.9	7.1	12.6	14.9	19.5	6.6	7.6	10.5	26.5	14.5	8.6	5.7	14.2	6.5	25.8	8.6	18.5	14.2	17.4	32.5	8.0	7.2	25.1	12.1	8.8	13.7	20.3	8.7	7.7	6.6	5.1	15.3	9.6	12.3	20.3	11.8	13.1	24.3	7.6	14.4	16.0	1.7	5.0	3.3	10.3	3.9	16.1	11.4	12.4	9.9	5.9	10.3	16.2	13.8	0.9	12.2	4.2	27.5	6.2	7.5	12.0	15.0	17.9	20.5	13.1	12.9	13.6	15.0	15.9	12.2	6.0	6.4	16.6	16.0	44.6	9.7	4.5	7.6	6.7	15.9	3.5	9.8	11.8	11.6	8.2	1.2	10.5	4.0	23.3	6.3	11.6	13.5	9.8	11.5	4.9	4.9	15.9	4.1	5.5	4.3	0.2	9.2	4.9	11.8	7.2	4.5	10.1	8.1	7.0	13.1	6.8	12.2	0.0	10.3	10.1	26.6	54.3	6.6	13.8	7.3	9.6
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.4	12.4	23.5	17.0	1.0	2.0	15.8	21.5	10.8	38.0	27.0	19.4	21.3	34.6	8.7	13.7	15.3	16.2	27.0	14.2	40.4	23.0	12.1	31.1	13.3	15.3	0.2	29.9	16.1	0.8	1.0	21.4	19.0	4.3	16.8	24.9	26.2	37.2	27.4	12.7	27.5	18.4	27.2	16.6	17.2	26.9	32.1	19.8	8.6	11.9	20.9	9.2	23.6	11.1	14.5	21.1	16.3	11.4	10.1	18.7	19.9	10.7	33.5	25.3	32.9	47.2	8.8	27.8	21.4	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7	0.0	0.3	9.3	0.8	3.0	1.1	0.4	5.1	8.1	0.0	0.0	0.0	2.2	0.0	1.1	0.8	0.2	4.2	0.0	0.6	20.9	0.9	0.6	0.0	1.0	9.5	1.6	3.5	1.8	3.1	2.2	1.4	4.6	1.7	2.8	5.1	0.0	1.6	4.9	1.1	0.5	0.8	19.4	0.0	82.1	41.4	2.4	2.4	3.2	6.3	0.9
EPHA10	"FLJ16103, FLJ33655"	ENSG00000183317	"EPH receptor A10"	Q5JZY3	1	37713880-37765133	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.6;intestine: 12.6;testis: 24.8"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 86.4;Early spermatids: 49.4;Late spermatids: 147.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.2;HDLM-2: 19.6;SCLC-21H: 9.1"									HPA027497	Uncertain				"Intracellular and membrane"	NA	NA					"HPA027497: AB_10601158"	"unprognostic (9.27e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.24e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (8.81e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	0.4	1.1	5.8	1.7	15.6	0.7	1.9	1.3	10.5	0.6	12.6	3.6	0.2	5.8	0.5	6.8	0.8	1.8	2.1	0.4	4.6	7.4	0.5	0.4	0.5	0.6	3.5	5.0	0.4	5.1	1.1	10.8	0.4	6.4	1.4	10.3	1.6	2.4	0.7	0.4	0.6	7.3	1.0	2.3	0.5	5.3	24.8	2.1	0.0	1.0	0.0	0.5	0.6	0.3	0.4	0.3	1.5	0.3	0.8	0.7	0.1	1.5	1.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.7	2.8	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.0	19.6	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.7	0.0	1.1	0.0	0.2	0.7	2.1	0.6	0.0	0.0	0.4	0.3	1.7	9.1	0.4	1.1	0.0	0.0	0.2	2.9	0.1	0.0	0.0	1.0	0.1	0.0	1.8	1.2	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.7	0.1	0.4	0.4	0.3	0.3	0.1	0.4	0.6	0.7	1.5	0.8	0.3	0.3	0.2	0.1	5.8	15.6	1.3	10.5	4.6	7.4	3.5	5.0	6.4	2.1	0.0	0.3	0.0	0.0	0.1	5.0	1.4	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.4	49.4	0.0	9.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	11.1	18.0	0.0	0.0	147.5	1.7	0.0	0.0	0.0	9.3	0.3	2.1	23.5	0.4	0.0	3.0	0.0	0.0	8.2	2.5	0.0	0.0	0.0	8.3	0.1
MANEAL	FLJ31434	ENSG00000185090	"Mannosidase endo-alpha like"	Q5VSG8	1	37793802-37801137	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.6;Horizontal cells: 25.4;Intestinal endocrine cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063423			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		24000	"Golgi apparatus"		"HPA063423: AB_2685011"	"unprognostic (8.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.92e-2)"	"prognostic favorable (5.28e-4)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.26e-1)"	1.6	9.5	12.3	2.6	15.2	0.4	6.4	11.2	21.7	4.1	7.6	6.6	2.4	4.5	2.6	8.8	4.8	3.8	2.4	1.5	12.0	20.3	3.8	11.4	3.9	1.5	10.4	9.6	1.8	12.8	6.2	16.2	1.3	15.4	5.6	8.2	4.1	4.4	3.8	4.6	5.2	4.4	3.1	6.2	1.9	6.3	3.5	3.8	0.8	7.3	1.8	2.4	2.7	2.1	0.6	0.3	0.1	0.4	0.0	3.6	0.6	8.1	10.4	1.9	20.1	2.6	0.9	18.2	1.5	9.0	7.8	3.4	17.2	19.3	13.5	6.7	1.0	9.3	1.8	3.8	2.0	2.8	16.0	8.2	10.0	9.4	13.7	0.2	14.2	8.3	0.3	10.8	0.4	0.3	11.0	0.2	2.4	5.8	10.8	1.2	16.0	3.9	0.0	6.3	19.4	11.0	6.2	13.8	15.8	4.6	21.6	50.0	15.1	21.9	0.7	8.1	0.4	9.6	1.5	1.2	11.1	6.8	10.7	13.9	15.6	14.7	4.5	1.8	4.7	8.2	0.0	0.0	0.0	1.5	0.1	3.6	0.6	0.7	0.8	0.0	0.6	0.0	1.2	0.1	0.0	0.4	0.3	0.6	0.6	12.3	15.2	11.2	21.7	12.0	20.3	10.4	9.6	15.4	3.8	3.0	2.4	0.8	0.9	0.5	15.6	0.7	2.5	0.0	0.0	3.5	3.9	0.1	0.0	1.5	0.2	0.4	1.1	0.0	5.0	1.3	0.3	1.2	0.0	2.9	0.8	25.4	29.2	0.0	0.3	0.0	0.3	0.2	3.3	0.0	4.5	4.1	3.2	0.0	0.0	0.2	8.4	0.0	0.4	0.0	1.4	0.0	0.1	0.0	3.0	1.1
YRDC	"FLJ23476, IRIP, SUA5"	ENSG00000196449	"YrdC N6-threonylcarbamoyltransferase domain containing"	Q86U90	1	37802944-37808185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 58.4;Urothelial cells: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 9.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030147	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030147: AB_10603327"	"unprognostic (2.98e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.43e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-2)"	10.8	10.0	7.7	9.3	8.0	41.6	13.0	10.6	13.1	8.2	9.6	9.8	7.2	8.2	8.3	8.8	16.3	8.8	13.5	9.0	8.6	9.0	11.7	22.5	9.3	16.2	8.1	7.4	8.1	19.7	7.5	11.3	22.2	8.5	9.2	12.2	8.7	12.5	6.6	13.0	14.6	11.9	9.5	7.5	11.2	10.2	20.6	7.0	13.5	9.3	11.5	12.0	9.1	9.2	1.6	1.6	9.6	1.1	0.9	2.1	0.7	10.5	7.6	8.2	10.4	5.7	6.6	23.7	8.8	7.1	13.9	8.8	10.1	10.2	25.5	14.4	8.7	16.0	8.6	15.4	14.1	13.0	15.3	15.4	17.8	9.3	10.5	12.6	23.1	18.5	6.8	21.2	15.4	22.4	9.1	9.7	19.7	27.6	11.5	11.0	7.5	13.4	13.7	30.8	15.4	16.2	13.6	13.3	16.6	11.4	10.8	21.4	22.1	9.5	12.3	30.0	15.3	6.7	10.3	9.0	12.0	12.5	13.1	28.9	23.7	33.2	21.2	10.5	15.1	19.1	9.6	1.1	0.9	1.2	1.1	1.1	1.0	1.7	0.9	0.9	1.6	1.9	2.1	1.3	0.9	0.7	1.6	1.7	0.7	7.7	8.0	10.6	13.1	8.6	9.0	8.1	7.4	8.5	7.0	0.0	8.6	8.3	58.4	45.0	10.7	3.4	15.3	4.0	4.5	5.2	5.9	21.5	19.9	5.2	2.7	12.0	6.4	0.0	7.9	42.6	12.4	31.3	6.9	9.8	11.4	20.6	15.0	7.4	6.7	1.8	3.7	9.6	5.0	3.6	9.8	9.4	12.2	5.8	3.9	11.7	8.0	6.5	18.9	15.1	35.7	43.2	34.0	10.0	9.6	71.6
C1orf122	FLJ45459	ENSG00000197982	"Chromosome 1 open reading frame 122"	Q6ZSJ8	1	37806979-37809454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.83e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.58e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.81e-4)"	16.1	26.2	26.4	10.6	21.3	7.0	15.1	8.5	27.8	16.4	13.7	27.0	20.7	11.5	9.6	25.7	22.4	9.6	18.7	19.8	22.3	17.5	21.0	31.0	9.3	7.0	26.3	21.0	7.6	31.3	14.7	22.8	12.1	22.0	17.2	9.9	11.3	23.0	22.1	30.2	10.3	9.5	13.3	25.5	8.2	15.5	15.3	18.3	4.3	13.0	11.4	8.0	10.9	10.0	4.2	6.4	9.4	9.6	5.0	6.8	5.0	15.6	10.6	11.6	13.4	20.5	23.3	36.4	18.4	12.9	15.9	14.3	17.0	17.3	8.5	38.3	15.1	11.6	14.5	7.8	15.5	9.9	17.0	23.1	6.2	12.6	11.0	28.4	7.9	11.1	28.2	36.6	12.9	15.2	18.5	11.4	8.7	14.7	11.0	15.3	18.1	8.4	14.3	26.3	16.0	23.8	12.5	10.3	18.9	17.3	10.3	17.8	30.1	13.9	15.4	16.5	22.1	19.0	5.7	11.4	19.4	15.2	10.2	18.2	22.4	11.1	10.1	17.6	9.5	14.2	2.7	9.4	9.4	6.8	9.6	3.3	2.3	4.7	4.2	6.4	4.2	2.8	4.6	5.4	5.0	9.4	4.4	4.7	5.0	26.4	21.3	8.5	27.4	22.3	17.5	26.3	21.0	22.0	18.3	3.0	12.3	41.0	72.6	49.2	134.8	71.8	53.5	6.7	5.7	78.5	39.3	69.3	225.5	50.7	9.0	56.4	79.4	0.0	95.4	105.4	87.4	164.1	34.5	109.5	129.5	65.2	109.0	59.5	47.2	20.9	45.5	45.9	79.2	137.9	43.3	149.1	61.0	45.6	69.3	185.5	115.1	32.3	58.5	22.6	15.6	52.6	89.2	36.3	39.9	139.9
MTF1		ENSG00000188786	"Metal regulatory transcription factor 1"	Q14872	1	37809567-37859620	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028604, HPA028689"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028604: AB_10600304, HPA028689: AB_10611384"	"unprognostic (5.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.19e-1)"	7.8	7.1	9.9	8.1	11.8	28.4	6.9	12.4	10.8	8.4	7.2	10.0	6.7	4.8	9.6	4.8	16.1	9.5	6.0	4.9	9.4	6.5	6.5	5.3	7.3	8.2	10.7	7.0	9.5	8.6	12.7	12.1	10.5	8.3	6.4	7.7	5.3	7.1	8.3	10.5	7.7	6.2	7.8	8.9	8.4	6.4	10.5	13.4	4.9	6.5	7.1	10.0	6.8	7.8	2.9	3.9	6.3	9.1	1.6	3.1	2.7	6.6	4.1	4.1	3.6	10.5	7.3	7.8	6.6	6.8	7.9	7.5	4.4	3.8	7.1	5.1	7.4	5.1	6.2	6.9	5.5	9.2	24.4	4.3	6.7	5.6	3.4	6.0	7.8	7.5	6.7	9.7	11.1	11.3	5.6	5.0	5.1	4.3	5.8	5.8	3.8	3.9	4.0	5.8	3.5	4.0	4.2	9.7	4.3	5.2	6.6	6.3	4.6	7.9	6.4	5.7	5.9	3.9	6.6	7.0	4.9	5.6	5.6	8.6	10.6	12.0	4.1	6.7	8.2	4.3	4.4	6.1	3.9	3.1	5.9	2.7	2.4	2.7	2.4	3.9	2.9	2.9	2.4	6.3	1.6	9.1	1.4	1.8	2.7	9.9	11.8	12.4	10.8	9.4	6.5	10.7	7.0	8.3	13.4	8.9	9.3	12.9	9.3	18.3	0.0	10.9	5.1	25.4	3.4	7.0	0.0	8.4	1.7	9.7	42.8	11.7	10.2	0.0	13.7	20.3	7.8	10.8	16.1	5.5	9.3	0.0	22.8	12.3	17.3	15.0	8.9	16.2	6.8	11.8	7.8	0.0	10.7	7.0	11.0	5.6	0.0	6.5	7.6	28.7	21.3	26.0	14.3	12.5	8.1	12.7
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	14.5	10.2	11.7	15.9	18.2	22.3	12.8	25.4	16.1	15.3	18.3	21.0	9.4	9.3	19.5	13.7	9.9	15.0	13.7	14.3	12.2	9.0	11.7	16.2	18.7	21.1	23.2	11.4	28.7	11.4	13.1	14.4	14.3	15.9	12.0	13.7	18.9	9.4	16.0	9.7	12.0	13.9	17.5	18.5	19.0	14.7	8.6	21.8	17.4	13.8	4.7	22.3	17.4	13.2	6.7	5.3	19.1	4.7	5.3	9.1	3.8	3.7	2.8	6.7	10.7	8.4	10.8	11.8	4.7	8.3	6.0	8.6	4.4	5.7	14.0	2.2	8.6	3.0	5.2	8.8	3.4	7.8	9.0	3.8	21.3	9.2	2.9	12.2	11.3	31.1	12.6	2.1	6.2	4.0	6.2	7.1	9.4	7.3	18.3	8.1	3.2	9.1	12.0	9.4	5.7	2.2	11.1	13.2	6.6	3.5	3.5	2.6	4.5	5.0	2.4	12.2	9.9	3.0	10.0	7.1	6.0	5.6	5.6	4.3	14.9	7.2	11.3	7.1	10.6	5.1	19.1	2.5	13.2	6.3	2.0	9.1	6.5	4.5	6.1	5.3	6.7	5.8	5.3	3.4	5.3	4.7	4.8	5.6	3.8	11.7	18.2	25.4	16.1	12.2	9.0	23.2	11.4	15.9	21.8	26.8	22.9	10.2	5.0	1.9	15.6	2.4	0.0	5.3	9.1	1.8	23.6	3.4	0.0	1.9	8.1	4.3	3.1	0.0	3.7	12.1	4.3	3.5	8.1	6.4	4.3	22.3	3.4	6.2	6.5	12.4	7.8	6.7	6.8	10.0	4.1	4.5	2.4	3.7	8.5	2.2	20.1	6.5	5.3	4.1	7.5	2.9	3.9	10.7	4.3	3.4
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990921	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	7.0	6.4	5.3	6.3	5.9	13.6	7.6	7.4	5.5	6.3	6.5			4.3	9.4	8.7	6.8	7.7	4.1	4.3	4.8	4.9	5.9	6.2	6.1	8.4	5.3		8.7	6.7	6.4	5.7	5.6		6.1	7.2		5.9	7.2	15.3	7.7	5.9	7.7	4.3	7.9	6.2	5.8			6.3		10.3	6.2	6.1	23.6	19.0	10.6	20.6	18.7	27.8	20.6	15.9	12.2	22.1	18.8	13.8	12.8	26.7	15.6	14.3	27.5	22.3	20.0	17.0	30.4	13.7	15.2	10.7	13.8	28.0	22.8	33.8	13.9	27.3	38.6	19.5	17.3	12.7	46.9	18.7	12.1	16.0	28.4	18.8	12.6	19.0	23.7	34.0	12.0	19.8	10.7	24.7	27.1	54.5	16.6	19.0	29.5	37.9	21.9	12.6	16.7	19.3	14.3	20.0	9.3	16.5	20.6	11.0	18.6	17.0	14.4	15.8	13.2	30.9	11.5	16.3	31.0	13.9	43.2	17.9	10.6	15.3	9.8	21.8	18.9	21.2	20.4	25.8	22.0	19.0	23.6	27.8	23.6	2.0	18.7	20.6	11.8	26.3	20.6											47.6	31.2	43.1	32.7	42.0	34.1	19.8	7.6	28.1	44.3	21.0	21.6	48.1	33.2	40.0	18.5	30.6	15.5	0.0	33.5	56.8	32.4	19.1	40.5	20.8	45.1	25.4	15.0	21.5	25.3	10.0	36.8	36.9	37.1	107.4	22.3	37.9	31.9	7.0	50.9	23.7	34.2	38.8	34.7	116.5	59.6	36.5	27.6	38.9	28.3	25.9
FHL3	SLIM2	ENSG00000183386	"Four and a half LIM domains 3"	Q13643	1	37996770-38005606	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"blood: 67.9;skeletal muscle: 247.1;tongue: 100.1"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 67.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 67.9"	"Cell line enhanced"	"Detected in many"		"HEL: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA045723			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045723: AB_10966278"	"prognostic favorable (5.62e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (4.20e-11)"	"unprognostic (8.88e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.77e-2)"	7.0	2.0	1.2	3.3	2.1	3.9	4.5	0.6	1.4	5.5	6.4	1.3	2.4	1.1	7.5	8.1	6.9	4.4	3.6	2.3	1.6	1.1	1.7	1.3	2.9	5.0	2.4	0.9	7.6	2.0	1.4	1.1	2.1	2.1	4.8	1.6	2.2	5.5	3.6	247.1	2.6	1.9	12.0	2.2	2.5	2.7	1.7	1.0	0.3	1.8	100.1	4.0	15.5	5.7	0.1	3.8	67.9	5.7	3.0	3.4	2.3	6.2	2.3	6.2	6.3	5.8	23.6	3.9	5.0	9.8	9.4	7.0	5.2	5.0	0.0	8.4	11.2	4.5	2.4	4.0	6.0	4.7	2.3	7.2	29.5	5.1	5.9	22.8	2.3	21.7	20.8	6.9	10.8	6.1	20.1	13.2	3.1	24.8	0.1	17.6	3.3	0.8	10.0	8.1	0.4	1.6	4.0	5.2	0.4	6.2	1.1	0.7	3.2	4.5	0.4	7.2	12.1	1.9	2.0	9.3	4.2	9.5	1.1	4.5	1.6	5.7	0.7	1.9	13.8	4.3	1.3	5.7	67.9	3.2	3.7	3.4	0.0	0.7	1.6	3.8	0.1	0.5	0.7	7.4	3.0	2.4	0.1	1.6	2.3	1.2	2.1	0.6	1.3	1.6	1.1	2.4	0.9	2.1	1.0	0.0	4.0	0.5	16.0	18.5	0.3	3.9	5.1	0.0	4.5	7.0	0.0	7.1	1.7	16.8	0.6	9.3	0.0	0.0	24.2	26.2	19.0	5.1	73.7	0.9	25.9	0.0	0.0	15.4	14.3	0.9	20.8	24.2	5.0	8.2	0.0	2.4	24.2	0.0	30.1	2.5	0.3	25.8	30.6	1.1	14.7	14.2	8.1	12.2	0.0	8.4
UTP11	"CGI-94, UTP11L"	ENSG00000183520	"UTP11, small subunit processome component"	Q9Y3A2	1	38009258-38024824	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.7"	"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 54.9;Exocrine glandular cells: 58.5;Pancreatic endocrine cells: 60.3;Syncytiotrophoblasts: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045830	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045830: AB_10969917"	"unprognostic (1.95e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.44e-8)"	"unprognostic (3.51e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (1.42e-8)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	11.3	12.4	9.1	9.6	8.4	9.3	9.7	7.5	11.3	10.6	12.1	6.0	6.9	7.3	11.4	9.1	13.8	9.8	8.6	11.5	12.9	9.5	9.1	13.1	7.4	8.6	9.3	8.7	10.7	11.5	6.6	10.2	11.4	11.2	12.9	8.7	6.7	10.0	8.8	74.7	9.4	7.6	19.7	10.9	10.2	10.4	9.3	5.7	10.5	8.1	26.1	10.6	22.6	10.9	12.9	18.7	9.6	22.5	21.9	17.7	12.3	15.0	9.1	16.0	15.6	12.0	16.4	14.6	17.1	16.3	23.2	21.4	13.4	18.9	25.2	16.1	13.8	11.4	13.2	18.1	15.0	29.1	18.9	16.6	29.3	12.3	11.7	16.2	29.2	19.3	15.1	9.7	25.6	22.4	14.5	18.5	19.3	33.5	13.7	26.2	10.7	22.6	30.2	38.9	16.9	12.2	20.1	34.2	23.4	15.2	14.7	21.2	17.6	15.0	13.0	27.5	17.6	11.8	18.0	13.6	15.9	19.2	17.3	32.5	13.1	25.6	21.3	21.3	32.1	19.5	8.4	18.9	9.6	16.9	20.5	17.7	10.5	13.5	14.0	18.7	12.9	12.4	15.0	5.7	21.9	22.5	18.0	15.6	12.3	9.1	8.4	7.5	11.3	12.9	9.5	9.3	8.7	11.2	5.7	32.8	35.8	0.0	0.0	0.0	0.0	0.0	0.0	46.8	38.7	24.4	0.0	47.4	33.2	54.9	0.0	0.0	0.0	0.0	58.5	41.6	0.0	0.0	23.3	0.0	47.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	33.3	0.0	0.0	60.3	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	65.1	0.0	0.0	0.0
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38044611-38046794	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.5;skin 1: 31.0"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 24.3;Cone photoreceptor cells: 21.6;Muller glia cells: 14.6;Rod photoreceptor cells: 19.3;Suprabasal keratinocytes: 48.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.1;HDLM-2: 19.2;NTERA-2: 5.3;SCLC-21H: 3.8;SK-MEL-30: 15.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7"	"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.8	2.1	4.0	0.9	10.5	0.7	0.8	1.2	6.8	0.6	0.7	1.1	0.0	0.6	0.7	0.8	3.4	0.7	0.7	0.7	7.7	0.9	0.7	0.6	0.6	1.7	3.9	2.9	0.7	0.8	0.6	0.0	0.6	1.4	3.6	0.6	1.6	0.6	0.7	1.3	31.0	0.7	2.5	0.6	0.7	0.7	1.5	2.6	0.0	0.7	1.3	1.7	1.5	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	11.1	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	19.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.1	0.0	0.7	3.8	0.0	0.0	0.0	15.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	10.5	1.2	6.8	7.7	0.9	3.9	2.9	1.4	2.6	0.0	0.0	0.0	1.7	24.3	7.4	4.3	0.0	0.0	0.0	0.0	21.6	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.1	0.9	0.8	0.0	0.0	0.2	1.6	1.7	0.0	0.0	0.0	0.3	0.0	6.8	0.0	0.6	14.6	0.0	0.0	0.0	0.0	19.3	0.0	2.0	0.2	1.7	48.8	0.1	0.0	0.4	2.1
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859823	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	27.8	14.0	18.6	11.9	24.1	20.1	36.5	15.9	22.3	13.4	19.4	13.3	11.0	14.1	14.9	11.1	20.7	11.8	13.6	19.0	16.7	13.8	18.8	13.9	15.0	14.2	18.9	14.1	17.6	12.9	13.9	8.9	27.6	21.4	12.6	13.3	11.9	12.7	13.8	15.5	24.6	13.0	17.0	15.6	12.8	12.9	12.7	15.9	11.2	12.9	8.2	16.0	16.0	14.9	4.9	11.3	7.7	3.3	2.0	4.0	2.0	12.1	5.5	7.3	7.9	39.0	26.5	11.3	11.3	23.3	15.5	16.4	4.2	8.1	7.6	6.5	17.6	24.9	7.3	13.6	7.5	12.8	12.3	9.6	7.3	6.8	4.8	47.9	8.5	8.3	23.5	19.0	16.5	21.5	12.3	16.1	8.3	7.4	15.4	22.3	3.3	6.1	4.8	9.3	5.3	9.5	5.9	12.9	5.1	10.9	14.2	3.8	5.7	9.0	6.8	23.6	17.2	6.2	6.5	14.2	18.9	7.8	20.6	9.6	12.1	19.4	9.0	17.6	9.6	9.7	0.5	3.3	6.7	2.5	3.0	4.0	4.6	3.7	3.0	3.1	4.9	3.3	3.1	7.7	2.0	2.3	11.3	3.3	2.0	18.6	24.1	15.9	22.3	16.7	13.8	18.9	14.1	21.4	15.9	29.8	28.3	36.0	36.3	99.5	18.7	21.2	22.9	10.7	11.4	12.2	11.8	70.5	10.0	46.2	51.6	21.1	19.1	23.3	41.7	49.6	38.6	38.8	16.1	10.2	61.8	36.5	13.8	38.1	28.2	37.2	28.4	37.6	50.6	80.2	9.7	40.2	38.6	14.4	35.0	23.7	21.1	19.4	41.2	23.3	25.2	122.8	187.4	20.3	13.0	38.8
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862964-38874105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	8.6	10.5	4.8	13.6	7.4	9.0	14.5	4.6	4.9	11.6	14.9	3.6	21.3	10.5	9.6	18.2	23.4	17.7	15.6	16.8	5.2	4.9	26.5	21.1	16.1	20.7	4.6	3.1	9.3	20.0	13.9	12.5	24.8	11.2	13.6	15.6	6.6	22.9	17.3	11.8	12.0	24.4	14.6	4.9	16.8	13.1	28.9	5.2	16.8	24.3	18.1	19.6	13.0	11.9	9.0	21.7	32.1	15.1	11.0	12.9	8.1	18.5	8.1	7.2	5.2	4.2	7.4	28.7	14.9	4.9	15.1	11.9	9.5	22.3	15.3	16.6	6.8	2.4	13.9	11.2	19.4	18.3	19.2	18.6	16.3	11.6	10.0	1.1	40.4	14.8	6.6	15.5	12.5	7.9	5.8	11.0	17.6	23.6	14.2	15.8	10.9	12.9	19.4	18.2	28.1	20.4	12.4	21.2	21.4	19.7	15.7	13.6	9.3	14.3	19.0	9.6	17.2	13.0	19.5	8.7	7.9	13.3	12.1	17.0	9.5	17.0	16.9	7.9	23.8	10.3	14.8	12.6	32.1	7.8	15.1	8.9	9.0	9.7	9.3	16.0	6.4	8.4	9.3	25.1	11.0	13.5	21.7	12.9	8.1	4.8	7.4	4.6	4.9	5.2	4.9	4.6	3.1	11.2	5.2	8.9	13.3	18.6	14.6	9.4	0.6	7.3	22.9	163.3	36.4	26.2	0.0	96.0	54.7	19.6	63.4	10.8	26.5	23.3	23.9	75.4	7.3	14.2	26.4	13.4	19.0	9.5	9.2	6.2	15.1	16.8	6.6	15.9	18.6	23.4	25.1	3.8	23.0	38.6	8.5	34.2	4.5	6.5	12.2	22.9	68.8	15.6	73.7	21.5	26.9	20.0
AL139260.3		ENSG00000274944			1	38864501-38881617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 7.3;testis: 15.5"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 8.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA041188, HPA078331"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (8.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-3)"	"unprognostic (4.27e-4)"	"unprognostic (4.64e-7)"	"unprognostic (2.59e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.09e-6)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-3)"	1.2	0.0	0.4	1.3	0.9	0.0	0.4	0.4	1.0	0.4	3.3	0.6	0.4	2.0	0.4	0.4	3.0	0.0	0.4	0.4	0.4		0.5	1.5	0.4	2.7	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.6	0.4	2.3	1.8	2.3	0.4	0.4	1.5	2.1	0.4	0.4	0.4	2.4	15.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.0	7.3	2.8	4.0	0.0	1.7	0.0	12.4	1.3	3.3	0.0	0.6	0.0	3.6	0.4	0.0	0.0	0.5	6.7	13.3	2.4	11.3	0.2	0.5	9.2	0.0	0.9	0.0	7.9	2.1	2.8	2.5	2.2	0.0	17.0	5.0	0.0	0.0	1.6	1.1	1.5	2.0	0.5	6.4	4.6	1.7	3.3	6.8	16.1	6.5	9.8	7.7	7.9	8.0	12.6	0.0	7.0	6.3	3.4	7.7	7.3	1.5	3.6	4.2	5.2	5.8	2.3	6.5	6.3	11.5	1.5	11.7	9.4	5.7	7.4	2.6	0.0	1.3	0.2	0.5	1.9	1.1	3.0	0.2	0.5	4.2	2.0	0.4	0.4	2.8	0.0	4.0	7.3	1.7	0.0											0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GJA9	"CX58, CX59, GJA10"	ENSG00000131233	"Gap junction protein alpha 9"	P57773	1	38874451-38881587	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3"					"Low region specificity"	"Detected in all"			HPA067850	Uncertain					NA	NA					"HPA067850: AB_2685910"	"unprognostic (2.00e-1)"	"unprognostic (8.78e-2)"			"unprognostic (4.55e-2)"	"unprognostic (2.66e-1)"		"unprognostic (4.79e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"		"unprognostic (4.11e-3)"	"unprognostic (2.32e-2)"	1.1	0.1	0.7	0.4	0.9	0.2	0.4	0.9	1.0	0.4	0.7	0.7	0.4	0.9	0.4	0.4	1.4	0.6	0.8	2.3	1.2	0.6	0.4	0.4	0.4	0.4	1.2	0.4	0.4	0.4	0.0	0.9	0.4	0.7	0.5	1.3	1.8	0.8	0.4	0.6	1.9	0.5	0.4	1.8	0.4	1.2	15.8	0.4	0.4	1.1	0.4	0.4	1.2	0.7	1.5	1.0	1.8	1.2	0.4	1.5	0.4	0.5	0.8	0.7	0.5	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.2	1.7	0.4	0.1	0.0	4.3	0.2	0.0	0.3	0.2	0.7	0.7	0.3	0.6	1.1	0.0	0.8	0.6	0.0	0.4	0.3	0.0	0.2	0.0	0.9	0.3	1.2	0.1	0.2	0.4	0.1	0.3	0.3	0.4	0.6	0.2	0.1	0.0	1.3	0.7	0.7	0.0	0.5	1.4	1.1	0.3	0.4	1.8	1.6	0.4	0.4	0.1	0.3	0.6	0.4	1.6	0.5	0.7	0.0	1.1	0.0	0.6	1.2	0.4	0.9	0.5	0.3	1.0	1.5	1.1	0.6	1.8	0.4	0.3	0.3	1.5	0.4	0.7	0.9	0.9	1.0	1.2	0.6	1.2	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHBDL2	FLJ20435	ENSG00000158315	"Rhomboid like 2"	Q9NX52	1	38885807-38941799	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.9"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 26.3;Pancreatic endocrine cells: 31.9;Suprabasal keratinocytes: 24.8;Undifferentiated cells: 31.4;Urothelial cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 8.2;CAPAN-2: 26.6;HaCaT: 13.8;RT4: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043807	Approved					NA	NA					"HPA043807: AB_10961118"	"unprognostic (3.34e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.57e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.23e-1)"	"unprognostic (7.47e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.20e-2)"	1.4	0.0	2.9	6.7	2.7	0.0	1.5	0.4	4.0	5.5	14.9	1.7	0.4	0.7	1.9	0.7	18.9	0.7	6.9	4.9	4.2	2.1	0.5	0.4	2.1	1.5	4.9	0.7	1.2	2.4	0.0	0.4	1.0	1.6	3.1	14.7	0.8	8.2	0.4	0.4	13.4	0.9	0.9	7.9	0.6	12.3	8.4	0.4	1.3	0.4	12.2	16.4	6.9	8.2	1.7	2.1	5.3	1.7	0.9	0.9	0.7	8.2	3.3	0.2	0.1	0.1	1.0	0.9	0.4	0.1	0.6	0.1	0.5	26.6	0.2	1.9	3.8	2.4	13.8	0.0	4.9	0.3	0.1	0.1	0.1	2.0	1.8	0.5	0.0	0.3	0.6	0.6	4.0	0.0	2.5	0.8	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.9	0.7	0.1	0.1	0.0	0.0	26.8	0.2	0.1	2.8	6.8	0.2	0.3	3.5	0.2	0.5	3.0	0.3	0.2	0.2	0.2	0.3	0.3	2.6	0.4	0.1	3.6	1.7	1.1	0.8	1.1	0.4	1.7	0.6	0.5	1.9	1.1	0.7	0.7	5.3	0.9	0.7	2.1	0.9	0.7	2.9	2.7	0.4	1.5	4.2	2.1	4.9	0.7	1.6	0.4	0.0	0.3	0.0	6.7	15.8	2.4	0.4	2.5	9.4	6.8	3.5	0.0	0.4	0.0	11.2	2.8	1.1	26.3	0.0	14.2	0.2	2.3	11.4	4.6	0.0	0.2	1.6	2.4	1.3	0.0	0.4	0.6	0.0	1.7	1.0	21.0	1.5	31.9	23.0	0.0	0.0	1.6	6.5	2.0	0.0	0.0	24.8	0.6	0.0	31.4	36.7
AKIRIN1	"C1orf108, FLJ12666"	ENSG00000174574	"Akirin 1"	Q9H9L7	1	38991223-39006059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 1447.5;Late spermatids: 943.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051871	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA051871: AB_2681646"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.77e-3)"	"unprognostic (5.17e-2)"	30.2	20.8	28.3	21.1	29.4	43.1	16.8	17.6	30.3	16.2	23.3	35.0	20.4	15.9	20.6	29.5	19.8	19.5	28.6	40.8	30.1	34.0	29.2	35.0	19.8	25.5	32.1	21.0	17.0	18.2	25.9	34.5	19.5	31.3	25.5	25.0	20.3	18.2	25.7	20.7	12.0	19.2	28.2	41.8	20.5	24.3	68.0	23.6	25.6	24.5	11.2	27.1	22.6	22.4	14.8	22.7	43.1	15.8	29.3	28.6	20.1	16.4	7.7	33.2	27.0	16.2	19.3	23.5	19.4	20.4	19.6	20.1	19.6	13.8	13.1	18.1	18.4	14.1	11.6	32.0	17.4	31.7	19.5	16.0	38.8	11.7	24.9	21.5	36.8	21.3	19.8	22.8	25.5	21.1	17.6	18.1	17.2	26.3	13.1	24.5	6.7	15.6	15.9	69.9	12.5	12.9	25.0	24.1	13.0	21.8	20.3	22.9	15.7	21.5	11.4	42.0	54.3	10.6	19.1	16.0	12.0	19.5	13.0	19.6	19.0	24.4	28.1	20.7	21.9	20.4	12.2	15.8	33.2	14.6	13.5	22.4	14.8	24.1	22.6	22.7	13.0	28.6	18.3	43.1	29.3	15.0	17.1	21.7	20.1	28.3	29.4	17.6	30.3	30.1	34.0	32.1	21.0	31.3	23.6	59.6	44.0	57.9	73.6	122.5	43.4	42.7	28.1	25.4	40.9	36.6	45.2	66.3	79.6	41.6	1447.5	35.9	34.6	46.7	35.5	58.5	56.4	57.9	47.3	31.4	40.1	52.4	90.8	28.8	40.3	943.7	40.9	47.8	40.5	101.0	32.3	47.2	39.9	31.7	42.8	28.4	42.1	51.8	47.4	71.1	89.7	121.1	140.1	47.3	28.1	70.7
NDUFS5	CI-15k	ENSG00000168653	"NADH:ubiquinone oxidoreductase subunit S5"	O43920	1	39026318-39034636	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 1936.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042582	Supported					NA	NA					"HPA042582: AB_2678062"	"unprognostic (1.49e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.97e-3)"	"unprognostic (8.96e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.52e-3)"	"unprognostic (8.08e-2)"	56.0	62.1	98.7	34.3	84.4	44.5	55.4	48.6	83.7	36.6	62.0	33.7	49.0	42.8	49.4	114.5	59.2	40.9	40.3	166.0	76.3	69.5	61.5	71.3	30.3	35.4	71.6	65.5	49.1	45.8	36.8	46.3	33.0	49.3	44.8	66.9	35.7	72.6	62.9	150.9	36.9	38.2	64.4	46.9	25.1	44.6	22.4	31.9	30.2	47.2	85.8	43.9	55.3	35.1	38.7	64.7	28.4	53.2	36.4	74.4	59.0	42.8	74.8	56.6	68.3	62.4	66.5	74.8	51.2	42.0	50.7	51.6	89.6	57.9	48.1	70.5	54.7	25.2	30.0	72.3	70.0	56.4	52.8	85.1	47.4	134.8	148.5	43.4	95.6	36.5	66.3	80.3	53.6	48.1	50.5	86.1	50.5	75.7	43.9	24.2	95.5	45.4	123.6	98.3	64.9	77.5	61.5	81.1	76.5	99.9	139.1	79.2	73.1	60.0	75.9	66.1	128.0	51.0	77.5	53.2	41.0	48.5	42.0	86.0	35.4	69.2	68.2	45.1	106.9	55.1	26.1	50.8	28.4	46.1	53.2	52.9	38.7	71.9	53.5	51.7	30.0	74.4	63.5	9.7	36.4	48.9	64.7	66.1	59.0	98.7	84.4	48.6	83.7	76.3	69.5	71.6	65.5	49.3	31.9	154.9	172.8	250.2	316.5	409.4	120.7	1936.4	387.3	269.0	202.4	523.4	35.3	556.6	1158.9	487.9	110.4	342.3	536.4	46.7	470.4	522.0	402.8	334.4	205.5	539.4	482.2	93.8	391.7	255.9	289.3	92.4	326.0	334.5	433.6	373.3	534.7	142.1	537.4	534.4	397.4	1154.8	128.4	278.1	523.5	118.9	99.2	402.4	439.3	231.2	642.6	409.2
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule-actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	Actin-binding	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 734.3;Rod photoreceptor cells: 425.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	24.1	22.6	41.4	21.4	44.0	21.2	25.2	62.6	54.0	37.1	42.2	35.3	22.7	11.9	66.5	33.6	20.3	28.0	31.5	39.0	35.9	32.7	27.2	24.4	53.5	21.2	41.1	28.6	41.5	25.0	46.2	37.1	22.8	40.5	26.3	18.2	23.3	26.0	32.0	40.8	59.2	18.4	56.7	37.0	29.7	22.9	17.7	39.0	13.3	34.5	17.9	16.0	28.0	34.8	4.8	2.6	4.9	2.8	6.4	13.7	2.0	12.6	15.4	19.0	8.6	16.8	17.4	8.2	17.4	23.6	10.8	10.8	9.2	15.3	6.6	18.4	24.7	18.1	8.4	3.4	12.5	15.1	12.7	9.4	11.7	11.5	14.9	19.2	10.8	5.0	11.8	12.9	29.9	16.1	24.8	38.2	23.1	17.2	9.0	42.4	4.2	6.1	14.1	26.2	5.3	9.1	11.5	29.1	1.2	56.4	13.7	10.5	10.7	6.9	4.7	16.6	23.9	2.0	10.7	43.0	17.7	14.2	8.4	30.4	5.4	5.2	7.9	29.0	10.3	16.2	4.9	1.5	3.8	13.7	2.7	6.7	2.3	6.8	8.6	1.9	4.8	5.4	6.8	1.3	6.4	2.8	2.6	2.9	2.0	41.4	44.0	62.6	54.0	35.9	32.7	41.1	28.6	40.5	39.0	140.0	115.4	34.3	51.5	137.1	376.9	222.7	76.5	60.2	85.3	76.8	734.3	41.1	0.0	105.2	8.2	146.8	21.9	0.0	98.3	49.9	58.2	60.0	73.1	41.2	44.1	111.2	34.7	127.1	56.4	6.8	40.6	41.9	67.4	45.1	23.8	104.0	136.1	16.9	105.7	7.9	425.5	103.5	69.7	34.4	25.0	167.4	58.5	78.3	17.8	61.3
BMP8A		ENSG00000183682	"Bone morphogenetic protein 8a"	Q7Z5Y6	1	39491646-39525935	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"thyroid gland: 45.6"	"Group enriched"	"Detected in some"	74	"Early spermatids: 42.2;Late spermatids: 125.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2197: 16.2;U-266/70: 7.9;U-266/84: 7.1"														"Secreted to blood"	NA	NA						"unprognostic (9.62e-3)"	"unprognostic (2.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.95e-9)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	0.7	1.0	1.7	1.2	2.0	0.9	0.5	0.8	3.6	3.3	1.0	8.5	0.0	1.4	3.7	1.2	0.7	2.0	2.6	1.2	1.9	1.3	0.6	0.5	0.7	5.6	4.6	1.1	8.9	3.8	0.5	0.9	1.0	4.8	1.0	0.6	0.4	1.3	1.8	1.4	1.6	2.2	1.9	8.3	1.4	1.0	4.0	2.3	1.7	45.6	0.0	0.6	0.9	0.9	0.7	0.0	0.0	0.6	0.0	0.1	0.4	0.4	0.8	0.4	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.4	1.9	0.0	1.7	0.3	3.9	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	0.2	2.9	0.0	1.7	0.0	2.1	1.1	0.2	0.1	0.5	0.3	2.4	0.1	0.1	1.5	0.4	0.1	0.2	1.2	0.3	0.7	2.9	0.1	0.0	0.7	16.2	0.0	7.9	7.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	2.0	0.8	3.6	1.9	1.3	4.6	1.1	4.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560816-39576790	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 137.3;skeletal muscle: 117.8"	"Cell type enhanced"	"Detected in all"	6	"Kupffer cells: 414.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"HPA027301: AB_2672208, HPA056496: AB_2683153"	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	30.0	19.2	9.0	23.0	7.9	20.8	19.6	7.2	9.6	19.1	26.0	14.0	22.0	12.4	22.2	21.1	20.3	13.7	20.2	32.0	8.6	7.2	12.3	28.8	24.9	38.2	8.3	7.3	28.6	137.3	9.1	8.2	16.2	8.6	20.7	11.5	15.4	16.4	22.9	117.8	12.9	21.1	22.4	16.4	27.5	28.0	29.2	6.4	21.5	18.1	51.1	21.0	25.3	20.3	13.9	13.7	6.7	21.2	8.2	21.4	5.5	57.5	15.7	16.7	27.7	41.8	83.0	54.9	34.1	23.9	26.5	19.7	31.4	30.2	49.8	33.9	42.8	12.6	30.8	31.8	38.1	34.3	25.4	26.2	41.9	17.9	31.2	41.9	27.7	28.2	71.9	45.1	32.2	49.1	37.4	33.2	39.6	44.4	27.6	42.5	22.5	28.7	35.8	51.6	19.4	18.0	22.1	53.5	37.7	25.5	56.9	15.8	24.0	23.8	22.7	51.5	31.7	24.2	82.2	29.9	25.8	35.8	62.4	43.0	71.2	78.1	38.7	38.3	28.1	14.7	6.7	13.9	3.5	9.9	18.0	10.6	13.8	16.1	10.3	13.7	13.9	21.4	15.1	1.4	8.2	21.2	13.5	11.2	5.5	9.0	7.9	7.2	9.6	8.6	7.2	8.3	7.3	8.6	6.4	17.9	49.3	108.2	65.3	49.6	24.0	117.4	112.1	8.1	54.6	45.4	76.6	73.5	34.9	38.4	37.3	38.0	79.4	70.0	78.6	128.3	61.8	38.6	51.9	117.5	95.8	31.8	56.9	82.3	414.4	19.0	63.9	76.1	54.0	32.5	56.2	26.4	58.7	46.3	43.5	34.2	89.3	6.5	60.6	30.6	120.1	36.5	89.6	43.3	61.7	91.4
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif-like"	Q9NQ87	1	39624153-39639945	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 66.3"	"Cell type enhanced"	"Detected in many"	13	"Leydig cells: 24.2;Peritubular cells: 53.4;Sertoli cells: 51.8;Smooth muscle cells: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 6.5;LHCN-M2: 17.6;RH-30: 21.7;THP-1: 5.0;U-266/84: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA001438: AB_1079052, HPA076960: AB_2732326"	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.26e-6)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.63e-5)"	10.0	8.3	2.9	4.7	6.2	0.5	6.5	1.8	4.0	14.7	4.4	2.9	5.1	1.9	21.7	13.2	4.0	11.2	13.9	28.2	3.2	4.8	12.3	3.3	12.5	2.0	6.8	2.9	14.4	66.3	1.7	8.2	22.1	7.1	8.1	2.9	10.9	2.3	11.4	8.9	1.9	2.7	18.9	2.4	4.5	3.4	25.4	4.4	0.0	11.0	6.8	1.9	6.0	8.8	1.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	2.4	4.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	1.6	0.2	0.0	1.4	0.4	0.0	0.0	2.2	0.0	0.2	0.0	2.6	4.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.5	17.6	1.4	0.0	0.0	0.0	0.2	0.1	1.1	21.7	0.1	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.9	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.2	1.8	4.0	3.2	4.8	6.8	2.9	7.1	4.4	0.0	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	0.7	0.0	0.0	3.1	0.2	3.8	0.2	0.0	0.0	0.3	1.6	0.0	1.3	0.0	11.8	24.2	1.1	5.0	0.0	0.0	0.2	4.5	0.0	53.4	0.0	3.7	51.8	35.4	0.1	1.7	0.1	0.2	0.0	0.4	0.1
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 51.9;tongue: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"SH-SY5Y: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA050283, HPA054158"	Supported					NA	NA					"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.7	2.8	1.2	0.8	3.0	0.5	0.5	5.6	7.6	0.7	0.5	1.0	0.0	0.5	0.6	2.9	3.0	0.7	0.5	9.8	1.7	1.7	0.9	0.5	0.5	0.5	1.8	4.9	0.7	6.0	0.5	0.5	0.5	6.9	0.9	0.5	0.0	0.7	0.7	51.9	0.5	0.6	0.6	5.2	0.5	0.6	0.7	1.0	0.0	0.5	13.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	20.4	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	5.6	7.6	1.7	1.7	1.8	4.9	6.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HPCAL4	"DKFZp761G122, HLP4"	ENSG00000116983	"Hippocalcin like 4"	Q9UM19	1	39678648-39691689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 80.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 36.4;Distal tubular cells: 10.0"	"Group enriched"	"Detected in some"	11	"glioma: 5.4;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.0;SH-SY5Y: 13.4;SK-MEL-30: 4.2;U-2 OS: 2.8;U-266/70: 3.5;U-266/84: 4.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4"	HPA053808			Approved	Cytosol		NA	NA			Cytosol		"HPA053808: AB_2682270"	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.56e-4)"	"unprognostic (4.73e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.63e-1)"	1.2	10.2	35.8	1.8	46.0	1.5	1.2	31.1	80.4	1.2	1.2	3.7	0.0	1.3	1.2	1.5	5.5	1.2	1.3	1.4	28.3	17.0	3.5	1.2	1.7	1.9	7.5	32.7	3.7	4.7	1.2	0.4	1.2	6.8	1.4	1.3	0.0	1.2	1.3	2.1	1.2	1.3	1.2	4.4	1.4	1.3	4.1	3.0	0.0	1.2	0.0	1.8	1.3	0.0	0.0	0.1	0.0	0.0	0.0	5.6	1.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	2.1	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	1.2	13.4	0.4	0.0	4.2	0.3	0.0	0.1	0.0	0.0	2.8	0.0	0.0	3.5	4.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.0	5.6	1.0	0.1	0.0	5.0	1.8	0.0	0.0	0.0	0.0	3.8	1.8	35.8	46.0	31.1	40.4	28.3	17.0	7.5	32.7	6.8	3.0	0.0	0.0	0.0	0.1	0.0	36.4	0.8	0.0	0.0	1.2	1.8	0.0	0.0	10.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	5.0	0.1	0.0	1.4	0.0	1.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA019357: AB_2670131, HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	19.3	23.8	23.7	24.3	22.5	18.6	25.7	25.9	36.1	25.5	28.1	35.6	22.2	19.7	30.6	26.5	26.0	34.7	21.1	27.1	22.3	22.1	25.2	29.8	20.6	25.9	26.3	20.5	35.5	42.1	27.4	23.6	21.9	24.9	26.1	22.7	26.9	30.7	28.9	29.6	21.7	23.2	34.2	25.6	25.7	23.9	38.8	20.2	22.8	33.7	21.9	33.9	31.5	22.6	43.3	31.6	14.1	27.2	49.0	46.9	44.2	9.8	17.1	15.7	12.6	17.5	15.6	8.3	17.0	17.1	26.0	24.5	21.3	29.2	28.0	24.1	19.0	16.7	15.1	21.5	25.2	24.8	18.1	23.2	30.9	19.8	6.4	24.0	27.8	16.9	14.1	23.1	24.4	9.0	18.9	23.3	25.0	31.3	19.6	18.9	17.7	12.8	22.6	18.8	23.3	19.1	19.0	11.8	15.9	19.6	18.4	22.4	17.9	17.8	14.5	12.3	19.4	18.2	73.1	15.1	16.3	18.1	20.2	26.0	26.9	26.9	19.4	11.3	35.9	25.6	11.6	27.1	14.1	38.3	27.0	37.0	43.3	39.7	38.2	31.6	39.8	46.9	38.9	2.2	49.0	27.2	28.5	40.0	44.2	23.7	22.5	25.9	36.1	22.3	22.1	26.3	20.5	24.9	20.2	29.8	27.1	41.2	35.7	22.0	24.9	29.6	17.8	64.3	56.9	31.4	13.7	54.2	56.3	49.6	25.8	24.5	23.9	0.0	42.1	51.6	34.0	28.9	54.3	27.6	48.7	22.3	27.6	25.8	36.1	47.7	27.6	34.0	37.1	53.3	28.0	35.4	38.6	28.1	42.5	54.9	25.9	58.2	41.0	62.7	44.8	23.1	29.1	40.6	33.0	29.5
BMP8B	"BMP8, OP-2"	ENSG00000116985	"Bone morphogenetic protein 8b"	P34820	1	39757182-39788861	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"intestine: 21.9;thyroid gland: 26.8"	"Group enriched"	"Detected in some"	15	"Early spermatids: 74.8;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 47.4;U-266/70: 14.3;U-266/84: 20.5;WM-115: 22.9"														"Secreted to blood"	NA	NA						"unprognostic (1.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.79e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.67e-2)"	"unprognostic (8.68e-3)"	"unprognostic (4.82e-1)"	2.8	8.1	5.5	2.4	6.7	1.4	1.6	2.5	4.1	3.8	13.2	6.9	8.2	7.5	2.6	14.2	3.5	2.3	2.1	1.6	5.0	3.3	1.6	1.0	3.1	3.6	6.1	5.5	1.4	9.9	6.6	5.8	2.3	2.8	5.1	4.0	3.6	3.6	4.7	1.2	3.2	21.9	2.1	3.6	2.4	3.0	3.1	6.2	0.4	26.8	3.4	3.1	2.1	3.3	1.7	0.2	0.8	0.7	2.6	1.9	0.3	1.0	1.9	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	2.2	0.0	0.7	0.0	0.3	0.2	1.7	0.0	0.0	0.4	2.3	1.9	1.6	0.1	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	7.6	0.1	1.5	0.0	1.0	0.3	1.1	0.7	1.1	6.5	2.5	1.6	1.1	5.4	1.4	1.7	0.1	5.3	0.4	1.3	47.4	0.0	0.0	0.1	1.7	0.1	14.3	20.5	0.8	0.0	1.5	22.9	0.8	0.7	0.1	0.5	0.3	0.6	1.7	0.2	1.9	0.1	0.7	0.3	0.4	0.6	2.6	0.3	0.2	0.1	0.3	5.5	6.7	2.5	4.1	5.0	3.3	6.1	5.5	2.8	6.2	0.0	2.6	0.0	0.5	0.3	0.2	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	74.8	0.0	3.5	0.0	3.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	1.2	0.0	0.0	77.6	1.1	0.3	5.0	0.0	2.0	0.1	3.1	2.9	0.7	0.0	0.4	0.0	2.2	0.5	0.3	0.0	0.0	0.0	0.7	0.7
OXCT2	"FKSG25, FLJ00030, SCOT-T"	ENSG00000198754	"3-oxoacid CoA-transferase 2"	Q9BYC2	1	39769523-39771348	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.8"	"Group enriched"	"Detected in some"	89	"Early spermatids: 428.2;Late spermatids: 642.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	9	"memory B-cell: 3.3;naive B-cell: 1.9;NK-cell: 1.4"	"Group enriched"	"Detected in many"	9	"B-cells: 3.3;NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 9.9;THP-1: 10.6;U-266/70: 8.2"									HPA075423	Enhanced					NA	NA					"HPA075423: AB_2732292"	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.16e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.39e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.85e-1)"	0.0	0.6	0.2	0.2	0.2	0.1	0.0	0.8	0.5	0.3	0.3			0.4	0.5	0.7	0.4	0.2	0.5	3.9	0.4	0.1	0.0	0.1	0.0	0.3	0.3		1.5	0.4	0.2	0.3	0.0		0.8	0.2		0.0	1.2	0.0	1.4	0.5	0.4	0.4	0.3	0.2	31.8			1.6		0.0	0.1	0.0	3.3	0.0	0.0	0.2	1.4	0.0	0.1	0.5	0.3	0.0	1.2	0.4	1.5	0.0	1.5	0.0	1.4	0.7	5.0	0.6	0.0	1.0	2.0	0.2	0.5	1.5	0.1	0.7	0.0	3.3	0.9	3.3	0.2	2.4	0.0	0.5	0.7	0.4	0.2	0.1	0.0	1.1	0.4	0.3	9.9	0.2	1.4	0.0	1.5	0.1	0.0	1.3	1.3	1.6	1.5	0.4	1.0	1.7	0.9	4.3	0.3	1.5	0.1	0.5	10.6	1.2	0.0	0.3	4.8	0.0	8.2	4.3	0.6	0.1	0.6	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1											0.0	1.1	0.8	0.2	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	428.2	0.5	0.5	0.0	0.6	0.1	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	642.7	3.7	0.8	1.7	1.0	0.6	0.3	0.6	0.0	6.0	0.0	0.0	0.0	5.6	2.7	2.2	0.4	0.0	0.0	0.3	0.1
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39841022-39883511	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.5	10.3	12.9	10.4	19.1	8.0	19.8	25.8	18.4	15.1	13.4	15.9	22.7	11.4	19.3	21.3	19.8	18.4	9.1	15.9	12.5	12.0	14.6	13.2	11.9	14.8	13.9	10.4	16.7	27.7	14.1	26.7	17.6	14.4	21.4	15.8	13.5	15.1	23.9	10.1	22.9	11.7	18.0	9.8	14.0	12.9	17.3	17.9	15.4	19.2	9.4	14.7	17.2	17.5	3.9	13.4	0.9	6.6	2.4	5.2	2.8	14.7	6.8	14.8	15.1	7.4	11.2	22.4	9.8	13.2	15.8	17.8	13.1	19.5	8.6	13.0	8.4	9.5	15.1	21.3	16.9	22.2	10.4	10.8	18.3	15.8	8.1	17.1	17.7	10.0	9.4	15.3	19.8	19.6	16.2	12.7	18.9	24.7	10.3	9.9	7.2	13.5	19.1	19.9	11.2	6.2	14.4	18.6	19.6	15.0	19.0	16.8	11.2	14.1	9.6	10.8	16.4	10.7	30.4	9.1	10.6	13.0	18.2	16.2	14.0	11.0	17.3	13.4	18.1	9.1	0.0	6.6	0.9	2.7	4.9	5.2	3.9	2.6	2.9	13.4	3.2	3.4	3.5	0.1	2.4	5.8	11.6	2.7	2.8	12.9	19.1	25.8	18.4	12.5	12.0	13.9	10.4	14.4	17.9	20.8	5.6	4.4	14.1	13.2	3.1	8.9	7.6	20.1	10.3	7.0	2.0	27.7	6.6	9.5	3.6	5.1	3.2	0.0	8.1	30.0	8.3	6.6	2.3	5.8	7.2	14.3	9.8	8.6	6.2	2.0	8.9	6.8	5.0	7.2	8.2	5.2	9.2	7.0	10.6	7.0	7.3	0.0	5.2	18.6	16.7	14.9	13.8	3.5	8.9	9.0
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 46.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 21.7;Hepatocytes: 21.9;Mucus-secreting cells: 22.7;Urothelial cells: 22.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	75	"dendritic cells: 15.4;monocytes: 11.5"	"Group enriched"	"Detected in some"	7	"U-266/70: 96.4;U-266/84: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		NA	NA			Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.3	0.3	1.2	4.4	2.1	0.1	1.7	0.8	1.7	3.6	7.5	1.8	8.5	2.6	1.0	4.0	17.8	1.6	2.3	0.7	1.1	0.9	0.8	6.4	1.9	2.9	0.6	1.4	0.5	46.4	0.0	2.1	11.2	1.8	5.3	3.6	1.8	4.6	16.6	0.6	26.0	7.3	1.2	1.1	4.0	3.3	1.5	0.6	6.4	4.2	3.1	6.0	18.4	7.3	0.0	15.4	0.1	11.5	0.0	0.1	3.8	0.2	0.0	2.9	0.7	0.0	0.0	7.1	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.7	2.0	0.5	0.1	0.4	1.1	0.1	0.0	0.1	0.0	0.0	1.7	0.2	2.4	0.0	0.2	0.0	0.2	1.1	0.7	0.0	0.1	0.2	0.0	0.0	2.8	0.4	0.1	0.2	3.4	0.6	0.2	11.6	0.5	0.7	0.2	0.4	0.1	1.1	0.7	3.7	0.0	0.0	1.1	1.3	0.1	96.4	70.7	0.2	0.0	0.4	0.0	0.0	11.5	0.0	0.0	5.5	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	0.1	0.0	2.3	15.4	0.0	3.8	1.2	2.1	0.8	1.7	1.1	0.9	0.6	1.4	1.8	0.6	0.0	0.6	0.0	9.0	6.0	0.2	3.3	0.0	1.4	4.5	8.7	0.0	21.7	0.0	1.1	0.1	0.5	9.5	0.0	5.1	11.3	0.7	4.8	0.0	21.9	4.9	0.0	16.6	2.5	6.9	0.2	0.0	9.6	1.7	0.0	22.7	1.1	2.4	8.5	0.0	0.0	0.0	0.0	0.3	0.0	0.7	10.3	14.6	0.0	10.5	22.1
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.9;THP-1: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.5	6.8	3.2	0.6	0.0	2.0	4.0	4.6	5.5	0.2	1.2	13.3	1.2	1.0	3.2	5.3	4.4	7.7	3.6	1.7	2.1	1.6	0.0	0.0	10.7	2.3	7.9	3.6	4.8	18.9	7.8	0.8	1.1	4.1	0.0	3.4	2.0	0.2	3.6	3.6	3.6	7.4	1.6	2.5	6.6	3.0	0.7	6.3	1.6	2.4	1.6	11.4	1.1	0.4	0.5	59.5	0.7	1.0	2.0	3.4	8.7	0.6	1.2	2.9	10.6	9.0	3.3	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3	17.9	112.2	11.5	13.4	46.9	1.9	0.6	12.7	12.0	31.8	15.7	0.0	0.3	0.0	3.2	0.6	6.7	112.9	0.0	22.5	6.5	9.7	5.7	17.3	268.3	6.4	0.0	1.2	10.4	12.4	0.9	0.6	11.4	0.0	2.8	16.4	41.8	16.3	3.5	0.4	3.7	1.8	0.0	3.4	1.1	1.0	47.9	43.9	2.2	10.0	23.0
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 201.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 203.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Approved	Cytosol		NA	NA		270000000	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	70.0	31.8	33.3	68.7	41.0	74.6	42.4	16.6	37.4	40.1	58.2	42.7	25.2	37.9	69.4	28.9	60.9	44.6	36.9	27.2	28.6	26.6	56.6	52.0	58.2	63.7	37.2	26.9	44.5	22.6	29.7	22.5	74.4	39.5	42.0	57.7	31.3	39.8	39.7	20.6	37.1	58.9	62.9	42.7	79.9	44.6	39.0	30.0	62.4	40.2	32.6	83.1	53.3	40.8	27.4	70.6	201.2	106.1	37.2	57.6	115.5	44.9	19.5	24.7	14.6	35.1	32.9	36.8	79.7	48.2	45.0	45.4	28.1	47.8	35.0	32.5	65.6	30.8	28.3	29.6	58.4	62.1	46.7	17.5	54.8	21.5	22.1	32.3	33.8	156.3	33.6	30.1	68.7	38.9	50.7	37.9	20.3	20.4	23.5	67.3	13.3	26.8	18.5	40.0	33.0	21.9	20.3	32.8	21.4	47.6	47.6	11.7	24.6	33.9	39.3	54.2	51.1	18.2	203.6	67.5	38.5	35.0	20.1	67.5	19.2	37.6	32.1	50.6	37.7	50.4	95.4	60.2	201.2	57.6	88.9	45.3	27.4	41.7	55.1	70.6	26.3	35.4	47.9	128.3	37.2	106.1	27.7	55.1	115.5	33.3	41.0	16.6	37.4	28.6	26.6	37.2	26.9	39.5	30.0	113.2	90.0	165.3	126.1	99.7	40.3	13.7	86.6	73.6	78.5	108.2	25.5	179.9	94.5	335.8	422.5	137.1	167.8	0.0	239.7	381.4	126.1	105.8	219.9	66.5	383.8	39.7	73.1	171.2	376.6	351.4	81.4	395.6	94.5	634.8	120.1	147.6	544.5	150.5	166.2	105.9	41.2	161.7	157.2	125.6	45.8	116.1	198.9	232.9	110.6	183.3
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 247.2;Kupffer cells: 246.8;Macrophages: 282.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.0;THP-1: 163.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.3	7.0	11.3	6.3	13.6	11.6	22.1	5.8	10.4	13.9	17.2	40.1	17.3	11.8	11.3	6.0	11.5	18.1	17.5	10.3	19.1	14.8	18.0	6.2	17.2	19.8	15.4	13.8	14.9	10.9	11.3	11.1	10.3	7.8	18.7	10.1	14.3	17.1	7.8	20.6	7.9	10.3	21.2	15.8	10.8	8.9	15.2	20.5	9.7	18.4	9.0	9.6	11.3	88.0	35.0	11.1	12.7	163.5	6.6	6.8	14.6	6.3	17.1	15.4	32.3	11.3	8.7	33.8	12.3	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1	26.8	50.8	34.5	72.3	35.1	45.4	13.0	38.2	38.8	47.8	36.6	15.7	48.8	5.0	52.1	40.9	45.0	3.0	23.3	36.9	52.5	46.0	47.6	82.1	8.3	247.2	23.8	19.1	48.5	246.8	54.3	29.1	282.7	64.1	155.1	8.2	108.8	23.0	7.0	37.1	15.4	24.1	19.4	53.3	13.7	37.9	23.8	34.4	40.8	10.3	29.4
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"Rearranged L-myc fusion"	Q13129	1	40161373-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	14.8	8.1	12.6	11.3	12.6	44.5	13.9	20.8	17.1	12.4	11.1	11.6	7.1	8.6	14.1	8.6	12.4	9.9	11.2	12.3	11.0	8.3	8.7	12.7	12.8	11.8	12.8	11.8	14.6	9.4	12.5	15.1	11.9	15.4	13.2	9.2	10.2	9.4	9.9	13.4	17.7	9.9	14.3	14.1	10.1	9.3	15.9	11.8	14.9	10.0	8.4	13.5	18.1	14.8	4.1	3.5	10.1	4.1	4.1	4.9	2.4	12.4	4.8	9.5	9.9	8.5	6.9	11.3	4.7	7.0	8.1	10.8	9.7	6.6	12.4	6.2	6.0	6.1	11.8	11.9	8.2	14.8	5.8	8.1	10.2	5.9	5.9	6.7	8.4	6.2	6.8	8.7	8.6	9.8	9.7	5.5	6.9	15.5	7.7	7.4	3.9	7.1	5.1	12.6	4.6	5.6	5.6	15.6	7.2	5.2	12.6	6.8	9.5	8.7	11.7	8.3	15.4	5.5	30.8	4.7	9.6	10.2	7.8	8.7	7.0	6.6	11.7	8.3	7.9	5.9	10.1	2.8	5.5	3.7	3.9	4.9	4.1	3.7	3.8	3.5	4.1	4.8	4.0	6.3	4.1	4.1	1.6	3.3	2.4	12.6	12.6	20.8	17.1	11.0	8.3	12.8	11.8	15.4	11.8	29.8	10.8	22.4	42.2	58.3	17.2	13.4	5.1	30.8	30.7	3.5	15.7	6.9	5.0	10.9	32.9	23.3	8.4	0.0	5.9	8.0	34.2	25.7	26.5	8.3	8.5	25.4	19.4	16.0	13.9	4.9	8.3	16.8	16.9	10.0	7.8	17.0	9.3	14.0	7.4	5.7	15.8	12.9	27.8	26.5	20.0	53.3	14.4	14.1	6.7	27.2
TMCO2	dJ39G22.2	ENSG00000188800	"Transmembrane and coiled-coil domains 2"	Q7Z6W1	1	40245947-40251691	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 74.7"	"Group enriched"	"Detected in some"	81	"Early spermatids: 2374.6;Late spermatids: 756.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;NB-4: 1.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.30e-2)"	"unprognostic (2.71e-1)"			"unprognostic (3.26e-2)"		"unprognostic (3.58e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.93e-2)"			"unprognostic (2.70e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.62e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2374.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	756.1	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	19.4	0.0	13.0	5.8	0.0	0.1	0.0	0.0	0.0
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258107-40294184	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		13000			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	21.6	24.2	17.6	15.4	19.6	6.5	18.6	10.7	21.3	20.9	20.6	14.9	27.0	17.9	29.7	19.7	21.4	19.9	20.7	20.8	17.1	16.9	34.2	48.7	16.2	23.1	21.9	17.0	16.0	20.4	39.8	17.0	23.0	23.5	21.7	23.3	15.6	18.9	19.0	19.1	14.7	20.9	25.2	19.2	17.7	19.0	10.7	17.9	20.9	20.6	14.7	18.4	19.1	16.7	15.1	25.8	15.1	23.9	24.2	22.5	20.3	20.9	14.0	10.9	8.1	29.0	23.3	21.2	22.0	18.4	24.9	22.8	15.3	36.4	18.1	15.3	26.9	9.7	21.8	22.3	20.3	28.7	17.0	14.3	17.4	15.0	14.0	16.6	28.1	21.9	16.8	20.8	21.2	9.2	14.0	17.4	9.0	18.5	18.2	23.5	9.8	17.0	8.4	21.0	13.9	14.6	14.8	19.4	22.4	22.0	20.3	11.4	13.5	20.3	45.3	27.3	17.6	16.7	77.7	17.3	22.5	16.5	20.9	26.7	11.2	30.0	15.8	24.7	19.8	23.8	15.1	20.0	13.6	17.9	23.9	21.5	15.1	19.1	18.9	25.8	11.6	17.0	22.5	11.8	24.2	22.7	16.9	22.3	20.3	17.6	19.6	10.7	21.3	17.1	16.9	21.9	17.0	23.5	17.9	35.7	23.7	17.1	19.8	28.4	5.7	18.7	50.9	49.5	28.4	69.8	0.0	33.1	26.6	47.9	2.1	31.5	34.1	0.0	31.7	32.0	28.1	33.2	20.7	56.7	30.7	9.5	26.5	20.3	28.9	0.5	26.4	29.6	23.6	31.5	26.3	29.0	37.5	25.9	30.8	33.7	6.3	0.0	21.5	7.0	5.5	23.7	32.6	17.5	28.0	19.9
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300487-40317813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;pituitary gland: 32.1;retina: 40.8"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 280.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.4;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 6.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10.0	3.6	32.0	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1.0	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2.0	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4.0	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.3	0.1	0.7	0.3	1.0	0.5	2.9	0.0	0.0	0.2	0.5	0.1	2.5	1.2	3.8	0.1	0.0	0.7	0.0	0.0	0.1	35.4	0.5	0.7	0.3	9.9	0.6	0.3	34.1	1.8	0.0	0.0	0.0	0.2	0.0	0.5	0.0	7.4	0.0	0.9	0.4	0.7	0.8	0.0	0.4	0.8	0.0	2.4	0.0	5.2	0.5	0.8	0.0	4.4	0.4	2.6	5.6	38.3	0.0	0.0	4.5	0.0	0.1	0.5	0.0	1.2	0.3	4.5	0.2	0.0	0.2	6.4	0.0	0.5	0.0	0.5	0.2	0.0	2.7	0.7	0.1	0.0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7	0.0	3.5	4.5	2.6	0.9	1.8	0.8	7.6	1.4	3.4	24.4	0.0	2.3	0.0	6.3	0.0	0.0	3.3	0.0	0.7	0.4	1.4	7.8	26.4	0.0	3.3	0.0	12.2	1.3	0.3	0.8	2.0	6.5	1.7	30.7	5.5	280.3	3.6	7.0	0.0	0.1	7.8	0.0	0.9	2.6	2.6	0.5	1.1	2.2	12.2	11.1
SMAP2	SMAP1L	ENSG00000084070	"Small ArfGAP2"	Q8WU79	1	40344850-40423326	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.9"	"Cell type enhanced"	"Detected in all"	7	"B-cells: 177.5;Kupffer cells: 237.9;Macrophages: 148.9;monocytes: 250.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021466, HPA024424"	Approved					NA	NA					"HPA021466: AB_2239737, HPA024424: AB_1857259"	"unprognostic (1.65e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.32e-1)"	"prognostic favorable (5.34e-5)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.24e-1)"	24.3	9.4	21.3	47.3	25.9	26.1	12.7	17.0	35.1	17.8	12.2	12.4	2.7	6.6	6.8	5.8	10.0	11.8	17.7	6.6	20.0	19.1	8.2	26.3	21.6	90.9	15.7	15.6	6.9	8.9	9.5	16.0	13.9	18.2	7.2	12.5	9.1	11.4	7.7	12.0	11.4	34.3	15.0	14.2	79.2	15.0	6.2	13.8	35.1	7.0	4.3	70.0	16.7	6.9	14.4	11.7	47.4	42.7	6.9	8.4	10.5	6.1	2.3	5.6	5.6	8.2	15.8	3.1	9.6	8.7	10.0	9.8	2.9	4.2	22.9	4.7	8.5	4.1	2.5	10.3	7.3	13.8	43.2	8.6	12.7	3.6	6.2	7.4	13.1	39.4	13.5	6.2	12.9	5.6	4.9	5.6	18.0	22.8	24.2	11.8	4.1	19.0	12.5	3.4	6.0	21.0	7.3	5.2	23.4	4.8	7.2	9.4	4.3	4.5	11.7	7.3	4.5	3.7	74.7	3.1	11.0	4.5	10.2	7.3	7.9	8.8	18.8	10.0	13.1	7.1	2.7	21.1	23.2	3.7	36.8	4.6	10.6	5.9	5.5	11.7	14.4	8.4	7.7	47.4	6.9	42.7	2.2	8.1	10.5	21.3	25.9	17.0	35.1	20.0	19.1	15.7	15.6	18.2	13.8	23.8	34.5	177.5	8.3	16.0	30.6	9.0	17.8	87.0	30.7	7.0	21.6	4.7	5.0	9.9	11.7	9.2	9.6	46.7	16.2	8.4	16.8	13.3	26.7	55.0	37.0	25.4	9.1	46.6	237.9	16.5	4.9	148.9	27.0	250.7	9.1	13.0	14.0	3.5	4.6	6.9	23.7	32.3	18.4	11.8	8.7	15.6	3.4	91.2	8.6	10.8
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 2.9;Spermatogonia: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	1.6	1.7	7.8	4.6	11.1	1.1	2.8	8.2	12.8	3.1	2.5	1.8	0.1	2.6	4.3	2.4	2.2	1.6	3.3	1.8	6.3	4.9	1.6	2.4	1.6	3.7	3.6	5.8	2.0	3.5	3.2	3.6	1.1	4.7	2.0	3.1	1.2	1.9	1.8	1.2	1.4	1.8	3.0	3.2	2.3	2.5	4.0	3.8	5.0	2.7	0.9	5.5	3.8	1.7	2.1	1.2	0.9	2.1	1.3	4.1	1.0	3.3	1.3	5.7	14.0	2.1	5.7	1.6	3.2	3.1	1.5	2.8	1.6	2.2	6.3	3.2	2.8	2.9	1.2	2.9	2.8	3.3	5.5	1.2	2.6	3.2	4.8	1.5	0.4	4.2	1.3	4.7	5.2	6.9	1.5	2.0	8.5	6.8	6.4	4.4	2.3	8.5	0.6	7.7	1.2	1.4	4.8	5.6	3.0	2.9	3.3	7.7	8.0	5.1	4.4	2.2	3.4	2.3	7.4	4.3	4.8	10.1	4.4	4.6	9.8	9.3	13.8	6.3	0.9	4.9	0.0	0.3	0.9	2.6	2.1	3.5	2.0	1.8	1.4	1.2	2.1	3.4	3.0	0.2	1.3	0.7	0.5	4.1	1.0	7.8	11.1	8.2	12.8	6.3	4.9	3.6	5.8	4.7	3.8	0.0	0.0	0.0	0.6	0.2	2.9	0.4	0.0	0.0	0.0	1.8	0.0	0.4	0.0	1.0	0.0	0.3	0.0	0.0	0.2	1.3	0.4	0.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.8	0.9	0.0	0.4	0.0	1.7	0.0	0.3	1.5	5.9	0.1	0.0	0.8	0.1	0.3
ZFP69	"FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A"	ENSG00000187815	"ZFP69 zinc finger protein"	Q49AA0	1	40477215-40496343	"Predicted intracellular proteins, Transcription factors"	"Lipid metabolism, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 6.0;Early spermatids: 5.9;Spermatogonia: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"THP-1: 36.3"	"Low region specificity"	"Detected in many"							"HPA027808, HPA054942"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027808: AB_10601031, HPA054942: AB_2682644"	"unprognostic (1.07e-2)"	"unprognostic (6.00e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (7.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.81e-1)"	5.1	3.4	8.3	5.8	8.5	4.1	5.1	6.8	5.8	4.7	5.3	7.5	5.1	4.4	5.6	5.6	4.4	5.2	8.9	7.3	6.7	5.6	3.7	4.7	5.6	6.3	9.0	2.4	6.8	6.7	8.1	3.1	5.3	8.6	5.6	4.9	3.9	4.9	6.0	1.2	6.7	4.9	9.7	8.7	6.9	4.8	8.4	8.4	9.4	5.2	2.9	6.8	6.1	14.3	1.1	0.6	0.1	0.5	4.8	2.0	0.6	3.3	0.0	2.0	2.6	2.5	2.6	3.4	1.8	2.1	2.8	3.3	1.8	2.6	6.0	2.4	2.9	3.7	2.7	3.8	1.6	3.3	5.4	2.6	4.4	3.0	2.9	2.0	0.1	4.8	2.6	4.0	1.9	2.9	0.9	1.6	0.1	2.5	0.0	1.6	1.7	4.5	5.6	3.8	0.3	0.0	2.5	7.1	2.8	1.5	2.5	2.6	4.2	3.1	2.9	5.1	3.2	0.0	36.3	0.7	1.3	2.6	3.6	0.2	0.1	4.6	3.8	2.4	0.9	3.5	0.0	0.5	0.1	1.6	0.2	2.0	1.1	1.2	1.9	0.6	0.6	0.6	2.0	0.1	4.8	0.4	0.0	0.6	0.6	8.3	8.5	6.8	5.8	6.7	5.6	9.0	2.4	8.6	8.4	6.0	0.0	0.9	0.3	0.9	1.3	1.2	0.0	1.4	0.0	0.0	0.0	1.0	1.7	1.3	5.9	1.8	0.3	0.0	1.2	1.2	0.7	0.2	0.0	0.9	1.1	0.0	0.0	0.6	1.5	2.5	1.1	1.4	1.7	1.8	1.4	1.6	0.8	0.0	1.8	0.5	0.8	0.0	0.5	2.7	4.6	0.4	0.2	0.7	1.4	0.1
EXO5	"C1orf176, DEM1, FLJ21144"	ENSG00000164002	"Exonuclease 5"	Q9H790	1	40508741-40516556	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028429			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028429: AB_2092105"	"unprognostic (9.44e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (9.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.91e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (9.95e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.53e-1)"	8.6	9.1	9.9	8.6	12.4	6.5	16.9	13.9	10.4	8.6	8.4	5.5	11.1	6.9	11.7	8.9	8.5	8.4	7.5	10.3	8.5	5.9	9.9	10.7	8.3	12.3	6.4	10.2	7.5	8.1	8.4	6.9	8.1	6.5	8.9	8.4	7.3	9.0	11.8	6.2	8.2	10.0	12.5	6.1	13.8	7.2	10.1	7.5	15.7	7.3	5.8	16.9	8.6	10.8	11.8	7.9	16.4	9.8	8.6	14.9	7.0	5.5	2.0	5.0	8.3	3.3	3.0	3.4	7.5	1.9	6.8	8.2	3.5	6.7	7.5	4.7	4.8	7.7	6.9	4.8	5.0	8.2	2.5	3.1	6.5	9.4	4.9	4.1	0.0	6.5	3.1	3.2	9.4	3.5	2.0	4.3	5.3	7.5	0.0	9.7	2.3	10.2	5.1	7.5	0.9	0.8	7.8	16.9	2.9	3.4	8.6	6.0	5.3	9.7	3.5	6.2	7.9	4.9	57.6	4.7	4.7	14.1	10.5	7.3	2.2	6.9	0.0	0.6	2.0	9.3	7.5	6.6	16.4	14.9	9.8	12.3	11.8	10.4	10.7	7.9	9.8	12.8	12.4	11.3	8.6	7.2	6.4	13.4	7.0	9.9	12.4	13.9	10.4	8.5	5.9	6.4	10.2	6.5	7.5	0.0	1.7	1.4	0.9	0.8	3.0	0.8	2.5	2.7	2.3	7.0	3.9	3.8	0.0	4.1	0.9	2.5	1.7	0.0	2.1	4.4	2.5	0.7	5.7	1.8	4.4	3.2	1.2	1.8	1.5	0.8	3.1	2.1	1.7	5.4	3.0	4.3	2.6	2.0	1.8	2.1	3.2	6.5	2.3	3.9	3.2	0.9	1.6	2.2	3.7	0.3
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531561-40548169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 28.0"					"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA059153: AB_2683932"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favorable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	3.6	6.4	4.1	2.9	8.9	8.2	4.2	5.8	7.4	3.6	3.8	2.3	5.4	3.2	3.6	4.3	3.2	3.1	3.4	10.6	4.4	3.3	18.3	20.8	3.4	4.4	9.8	3.6	3.8	5.4	2.5	4.6	2.1	5.4	5.1	4.8	1.6	3.5	4.1	4.4	4.1	3.4	3.2	5.9	5.1	4.2	4.3	7.8	6.4	5.6	4.1	3.5	3.1	2.7	6.0	3.9	7.0	7.7	3.5	5.9	2.4	2.2	0.7	2.8	3.8	2.6	3.8	1.7	2.0	2.0	2.4	4.1	1.4	2.9	3.8	1.7	1.3	1.6	2.7	2.8	2.0	3.8	3.3	4.7	4.1	2.6	3.6	1.3	4.4	4.5	2.5	0.8	2.9	1.1	1.4	3.7	3.0	2.1	5.7	3.4	0.6	6.4	5.1	6.8	0.9	2.3	3.0	8.4	2.6	3.6	1.9	2.1	3.6	3.7	3.7	4.1	3.6	1.6	28.0	2.1	2.5	5.2	2.4	3.9	4.8	3.4	4.4	2.2	4.7	3.8	7.0	4.0	1.9	5.9	7.7	3.2	6.0	4.2	3.6	2.4	3.5	2.8	5.5	2.3	3.5	4.1	3.9	4.7	2.4	4.1	8.9	5.8	7.4	4.4	3.3	9.8	3.6	5.4	7.8	6.0	2.7	3.7	1.7	2.1	3.0	9.9	2.5	5.3	3.4	7.0	0.0	1.0	14.9	4.4	1.8	3.5	1.3	0.0	12.9	2.1	2.8	1.0	2.3	14.5	4.2	3.2	1.2	4.3	4.3	2.6	2.3	4.3	8.5	7.2	1.7	3.5	4.9	2.0	2.8	12.4	2.3	0.0	4.7	6.1	3.2	1.1	0.0	4.8	3.8	0.9
RIMS3	"NIM3, RIM3"	ENSG00000117016	"Regulating synaptic membrane exocytosis 3"	Q9UJD0	1	40620679-40665657	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.7"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 1.8;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 4.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055285			Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA055285: AB_2682771"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-4)"	"unprognostic (3.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.19e-2)"	1.3	7.2	13.6	2.2	19.2	3.7	3.1	21.5	47.7	1.4	3.4	3.4	0.0	1.1	3.0	2.2	2.9	2.1	1.3	1.5	7.8	17.4	1.4	0.7	3.1	2.0	7.4	22.3	2.5	1.1	4.0	0.5	3.8	4.9	3.2	3.8	2.0	2.0	4.1	0.6	2.7	1.7	4.8	3.4	1.7	2.5	3.1	4.4	0.7	2.8	0.0	2.8	1.7	1.0	0.1	4.6	0.1	0.3	0.1	1.8	0.1	1.9	0.7	2.9	3.1	0.1	0.0	0.4	0.0	0.0	0.5	0.6	0.3	0.6	37.3	0.0	0.0	1.4	0.3	1.9	0.3	0.3	6.4	0.9	2.1	0.2	1.0	0.1	0.3	1.7	0.0	1.5	0.1	0.1	0.1	0.1	13.2	1.8	1.4	0.0	3.4	5.5	0.2	1.8	0.3	0.2	2.5	2.6	6.9	0.5	0.5	10.0	17.7	0.4	1.8	1.2	4.0	0.4	10.4	0.0	0.3	3.0	0.0	0.5	0.3	2.7	8.2	16.3	0.6	0.3	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.5	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	4.6	0.4	0.1	13.6	19.2	21.5	47.7	7.8	17.4	7.4	22.3	4.9	4.4	6.0	0.0	0.0	0.2	0.5	6.3	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	10.7	0.1	1.7	0.0	1.3	0.1	0.3	0.4	1.1	0.0	2.4	4.8	0.0	0.0	2.1	23.5	0.0	1.1	0.0	1.0	1.9	12.8	2.3	0.8	0.7	0.3	0.6	0.0	2.2	3.3	1.1	0.1	0.2	0.0	0.6	0.1
NFYC	"CBF-C, NF-YC"	ENSG00000066136	"Nuclear transcription factor Y subunit gamma"	Q13952	1	40691648-40771603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055011			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055011: AB_2682671"	"unprognostic (1.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (1.47e-2)"	"unprognostic (5.66e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.12e-1)"	"unprognostic (7.75e-3)"	25.5	22.1	18.8	32.5	24.0	27.8	23.1	35.8	39.7	23.3	22.0	24.1	22.2	22.0	27.8	22.9	25.8	23.7	20.1	45.4	18.7	15.9	25.2	24.8	19.8	25.7	15.9	22.5	33.0	31.3	26.1	18.0	35.1	18.6	23.7	18.5	30.5	35.3	22.8	49.2	30.7	23.5	23.5	17.1	32.2	22.8	33.4	16.6	37.2	27.7	33.3	33.9	23.0	23.3	20.7	25.3	43.8	31.2	16.8	18.7	15.6	9.0	12.2	18.2	13.7	7.3	6.8	18.2	7.5	8.4	13.4	12.7	17.2	22.8	21.7	11.8	7.1	11.9	10.9	14.6	11.2	13.9	13.1	15.4	23.4	9.4	15.5	8.8	12.4	20.1	7.4	12.2	13.2	14.0	10.4	8.7	16.6	10.3	13.9	6.3	12.3	22.1	12.2	15.7	10.8	9.6	16.6	19.4	19.4	12.5	11.0	12.4	11.5	9.0	19.8	20.4	22.0	8.9	90.8	7.9	6.3	21.5	10.9	11.0	12.9	20.7	17.8	14.6	15.9	16.7	20.2	26.1	26.2	12.9	29.0	13.1	20.7	17.2	14.5	25.3	19.0	18.7	14.0	43.8	16.8	31.2	19.5	17.8	15.6	18.8	24.0	35.8	39.7	18.7	15.9	15.9	22.5	18.6	16.6	17.9	17.6	27.3	24.3	26.0	17.2	30.7	7.6	9.4	18.2	10.4	9.8	62.7	31.5	24.9	6.0	25.1	20.3	0.0	32.8	41.1	20.4	17.2	36.9	21.5	46.7	23.8	15.6	22.1	25.7	4.9	25.6	29.2	16.9	42.3	22.2	26.2	23.2	14.0	20.1	18.3	11.5	19.4	30.0	28.6	34.1	28.2	63.6	25.4	26.0	20.2
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783814-40840452	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 40.1;retina: 23.0"	"Cell type enhanced"	"Detected in some"	12	"Muller glia cells: 4.1;Sertoli cells: 6.5;Smooth muscle cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;HEK 293: 5.9;K-562: 5.9;MCF7: 3.5;REH: 3.1;THP-1: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA					"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	2.5	0.9	1.1	1.5	2.9	0.4	1.3	3.8	3.6	2.5	9.1	0.9	1.5	1.5	5.8	0.9	3.5	4.6	2.8	2.1	1.6	0.7	0.4	0.4	1.4	0.4	1.4	2.1	1.6	40.1	0.5	0.6	2.1	1.3	3.3	1.7	23.0	5.4	5.3	5.9	1.1	2.3	7.5	2.0	0.4	2.9	1.2	1.4	0.5	0.6	0.9	0.4	5.3	2.5	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.3	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	1.6	0.4	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.1	5.9	2.0	0.3	0.0	0.4	0.4	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.9	5.9	0.1	0.0	3.5	0.7	0.0	0.4	0.0	0.1	3.1	0.0	0.0	0.7	0.0	2.6	0.5	0.0	1.5	0.6	0.4	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.1	2.9	3.8	3.6	1.6	0.7	1.4	2.1	1.3	1.4	0.0	0.0	0.0	0.0	0.1	0.3	1.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	0.3	0.0	0.7	0.0	0.3	6.5	2.7	0.2	0.5	0.4	0.0	0.0	0.4	0.1
CITED4		ENSG00000179862	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4"	Q96RK1	1	40861051-40862366	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 152.3;Cholangiocytes: 76.5;Urothelial cells: 122.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 25.8;THP-1: 74.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056434	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA056434: AB_2683132"	"unprognostic (5.39e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.38e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.13e-2)"	17.3	10.1	2.9	2.5	5.2	21.5	22.1	3.2	9.4	18.3	12.3	8.0	13.8	3.0	11.3	14.4	14.9	7.1	15.7	10.4	2.4	5.5	12.9	27.8	8.6	4.8	5.5	2.8	12.2	39.4	4.0	2.3	12.9	6.0	11.0	1.5	26.1	15.9	19.1	37.1	22.6	3.7	8.0	2.7	33.4	7.4	12.3	2.7	1.5	8.1	16.0	11.4	8.5	10.1	0.0	1.3	2.2	1.0	0.0	1.5	0.4	8.1	1.6	0.4	9.9	0.2	0.4	10.0	0.5	0.6	0.2	0.2	0.8	11.0	0.0	1.3	0.1	0.3	12.5	0.6	6.8	0.2	0.0	0.1	0.0	0.8	1.3	1.7	0.2	0.1	1.2	2.9	0.6	2.2	0.8	0.5	0.1	0.0	0.0	0.3	0.2	0.1	5.4	3.2	0.2	1.1	0.0	0.0	0.0	25.8	4.7	1.9	0.5	0.4	10.3	0.5	1.1	5.0	74.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	3.8	0.2	0.0	1.0	0.4	0.1	0.5	0.3	0.0	0.3	0.0	1.3	0.0	1.1	1.5	2.2	0.0	0.3	0.0	0.0	0.4	2.9	5.2	3.2	9.4	2.4	5.5	5.5	2.8	6.0	2.7	8.9	0.6	0.5	152.3	16.9	3.5	9.0	76.5	4.0	4.5	21.0	0.0	0.5	36.5	11.8	34.8	3.8	0.5	0.0	37.1	0.8	3.1	48.3	0.0	28.7	1.1	1.6	7.5	3.7	7.1	46.4	4.6	2.2	18.6	1.0	3.1	41.7	27.0	3.1	5.3	65.0	1.9	19.4	3.9	0.5	0.6	21.2	0.1	0.0	2.1	122.5
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979335-41012565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes			Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	7.1	10.0	4.5	10.8	7.8	9.7	5.1	5.9	9.8	14.4	23.6	5.8	16.3	4.3	25.9	8.4	11.3	21.9	13.4	6.7	4.7	5.1	8.6	26.4	7.0	9.4	7.9	4.7	10.1	6.3	16.8	5.4	7.7	6.2	14.4	9.8	9.1	56.5	19.6	13.2	5.8	13.5	35.8	5.1	7.5	9.0	11.8	6.7	14.6	4.5	11.3	13.2	21.3	9.5	6.0	12.8	0.0	7.3	6.6	7.0	3.8	21.2	19.5	27.6	22.2	7.6	9.5	43.4	37.4	16.1	41.1	27.7	38.3	18.9	39.9	17.0	17.1	11.3	15.0	29.5	27.9	41.1	16.7	22.4	24.4	26.0	12.1	25.0	32.5	19.2	10.4	15.1	42.5	30.6	7.2	18.6	29.3	24.5	17.6	28.7	11.9	35.1	12.1	37.7	17.8	23.2	27.1	33.5	25.8	20.7	19.4	37.1	18.1	23.3	25.1	9.3	28.3	8.7	45.0	15.2	27.2	35.6	18.3	46.4	11.4	13.3	35.5	17.8	25.9	28.3	0.0	4.0	0.0	4.6	7.3	6.6	6.0	5.3	4.8	12.0	3.9	4.4	7.0	0.0	6.6	6.1	12.8	6.6	3.8	4.5	7.8	5.9	9.8	4.7	5.1	7.9	4.7	6.2	6.7	6.0	20.2	17.3	10.5	7.1	9.9	4.2	20.4	2.7	5.7	5.2	5.9	14.6	1.7	15.2	22.6	7.3	2.8	0.0	15.1	21.5	6.6	4.3	1.1	24.5	9.6	11.1	2.9	2.5	2.4	21.2	10.0	6.0	1.7	12.6	2.6	5.2	14.2	0.0	23.3	9.6	4.2	38.8	14.4	9.3	42.5	6.5	4.7	5.7	5.2	5.8
SLFNL1	FLJ23878	ENSG00000171790	"Schlafen like 1"	Q499Z3	1	41015597-41023237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.7"	"Group enriched"	"Detected in some"	83	"Early spermatids: 200.0;Late spermatids: 500.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054956			Approved	Cytosol		NA	NA			Cytosol		"HPA054956: AB_2682649"	"unprognostic (7.01e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.11e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.40e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-4)"	"unprognostic (2.70e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.43e-1)"	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.3	0.2	0.4	0.2	0.2	0.2	0.5	2.6	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.8	1.9	0.2	0.2	0.2	0.6	0.3	0.1	0.3	0.2	0.2	0.6	0.0	0.2	3.4	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.1	49.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	1.3	0.0	0.0	0.7	0.0	1.0	1.6	0.7	1.1	0.0	0.3	4.9	2.1	0.1	0.0	0.1	10.2	1.0	1.8	1.8	0.1	0.3	1.8	0.1	0.0	0.0	1.3	3.0	1.3	2.4	1.3	0.7	1.9	1.2	0.2	0.2	0.1	0.0	0.5	0.2	1.5	1.1	2.2	0.1	0.9	1.1	2.0	1.9	0.2	2.6	2.5	1.3	1.1	0.0	2.8	1.3	0.6	0.4	0.9	0.8	0.9	0.6	1.2	0.8	2.0	2.4	1.0	1.5	1.1	0.6	2.3	0.3	2.2	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.4	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	3.2	0.0	0.1	0.2	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	200.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	500.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.2	2.4	0.1	0.0	0.0	0.0	0.0
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: AB_2797246"	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (5.80e-4)"	12.5	13.1	14.7	18.2	15.3	11.2	21.3	15.9	13.9	15.8	27.9	6.7	23.4	9.0	21.4	16.7	11.1	16.5	17.2	27.2	12.6	8.8	14.8	9.5	11.4	10.5	7.6	12.5	24.8	30.2	26.5	23.0	7.8	10.7	22.7	12.6	16.8	19.2	23.8	28.4	8.4	12.7	36.9	7.4	8.7	18.5	26.6	6.7	11.3	14.3	11.1	8.3	22.7	25.7	4.3	7.6	2.2	2.2	2.9	4.2	1.7	9.0	6.1	14.5	13.3	6.7	12.7	0.0	7.3	12.8	12.3	12.8	5.8	11.7	16.6	5.6	13.2	10.3	2.3	11.2	9.8	10.6	11.4	8.5	7.7	8.2	14.4	29.0	16.5	12.8	13.8	10.0	8.1	19.8	14.9	12.3	20.7	7.2	12.9	12.0	4.9	16.5	14.3	13.3	7.7	6.5	18.3	15.2	9.8	9.8	11.4	10.2	11.0	12.7	10.2	10.5	10.3	9.0	42.5	9.0	12.9	10.1	7.9	13.3	13.2	7.4	18.1	8.1	14.8	11.7	1.3	1.2	2.2	3.3	2.2	4.2	4.3	3.9	3.1	3.7	2.1	2.9	2.4	0.0	2.9	0.5	7.6	2.7	1.7	14.7	15.3	15.9	13.9	12.6	8.8	7.6	12.5	10.7	6.7	8.9	6.7	8.0	23.8	6.0	13.8	13.5	10.2	4.0	7.9	12.2	15.7	6.7	1.7	8.8	7.2	6.8	7.8	0.0	18.3	2.6	8.0	20.7	4.7	4.7	5.2	7.9	8.1	6.7	4.8	9.4	15.3	3.1	8.5	2.8	6.2	6.0	11.3	3.5	17.0	11.5	13.5	19.4	8.0	50.0	28.6	3.1	4.0	4.8	11.7	11.9
FOXO6		ENSG00000204060	"Forkhead box O6"	A8MYZ6	1	41361922-41383590	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.2;placenta: 8.4"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 5.1;Muller glia cells: 7.2"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.35e-2)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (5.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.55e-9)"	"unprognostic (4.35e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.10e-2)"	1.1	0.6	0.7	0.6	3.0	0.7	1.0	0.1	4.5	1.0	0.6	1.9	0.0	1.4	0.6	0.6	0.6	0.6	0.9	0.6	4.9		0.7	0.8	0.9	0.7	0.1	1.9	4.8	2.3	0.6	3.6	8.4	0.7	0.6	0.6	1.3	0.6	0.6	1.3	0.6	0.6	0.6	0.0	1.0	0.6	1.2	1.6	7.2	0.6	3.5	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	2.5	0.2	4.2	3.1	5.1	0.0	0.0	1.8	0.0	2.4	0.0	0.8	3.6	0.4	0.0	0.0	0.2	1.6	1.1	1.3	0.0	0.0	0.3	0.0	1.2	0.6	0.0	4.3	3.7	0.0	0.0	0.0	0.8	7.2	0.2	0.0	3.9	0.7	0.8	0.0	1.4	0.2	0.4	0.0	3.7	0.0	0.4	1.2
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.6	0.0	21.7	0.0	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.8	5.1	5.8	0.4	10.4	0.0	0.2	25.8	0.0	0.5	0.5	0.0	0.0	0.0	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1	6.0	1.0	0.0	145.6	27.0	0.0	0.4	5.1	1.4	0.0	66.3	0.0	0.0	0.0	6.2	0.0	0.0	10.9	0.0	0.9	0.0	0.5	63.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	6.7	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.5	0.0	0.0	3.3	23.3
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"Human immunodeficiency virus type I enhancer binding protein 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3;lymphoid tissue: 16.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.9;hTEC/SVTERT24-B: 9.3;Karpas-707: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	4.2	1.5	7.5	5.4	5.7	3.8	3.6	20.3	11.7	1.2	1.4	5.1	0.0	1.2	1.1	1.1	3.2	1.3	2.0	2.1	6.1	3.0	1.4	1.2	4.6	4.1	4.8	4.7	1.6	2.4	2.3	8.3	1.8	6.5	2.2	1.5	0.5	3.7	1.1	1.6	11.7	1.3	2.2	5.0	2.9	1.9	1.4	5.1	16.6	2.9	1.8	5.4	1.9	1.6	1.0	1.5	0.1	3.7	0.2	2.1	1.1	1.8	0.6	0.2	1.7	2.3	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	3.8	0.6	0.9	1.4	2.6	0.4	0.4	3.1	17.9	0.5	0.2	0.8	0.0	0.4	0.3	0.3	5.6	0.4	9.3	1.1	0.6	0.5	1.3	0.0	10.8	1.7	1.1	2.8	0.8	0.6	0.6	2.2	1.9	2.8	2.0	1.5	0.3	2.0	0.6	2.5	0.7	0.5	1.1	0.8	3.2	3.3	2.0	2.2	0.6	4.4	3.2	1.3	2.6	8.1	0.2	7.3	0.1	1.7	0.0	2.1	3.7	0.5	0.6	0.9	1.0	1.5	1.0	0.2	0.8	0.1	0.2	3.1	0.3	0.3	1.1	7.5	5.7	20.3	11.7	6.1	3.0	4.8	4.7	6.5	5.1	6.0	8.0	2.2	24.6	21.1	15.2	5.1	0.0	1.4	12.5	1.8	2.0	0.3	1.7	3.1	7.6	4.3	2.1	23.3	2.4	2.8	11.6	16.0	1.1	2.8	6.1	23.8	3.5	13.5	5.1	18.7	8.1	10.5	5.0	0.0	1.1	15.6	2.3	0.0	3.9	2.2	3.5	6.5	9.0	8.6	8.3	7.5	0.7	17.0	0.8	7.3
AC119676.1		ENSG00000284895			1	41585306-41628816	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	16	"blood: 1.9;lung: 3.2;smooth muscle: 1.3"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 3.2;ASC diff: 11.5;U-266/70: 1.8;WM-115: 2.9"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	3.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	1.3		0.0	0.0	0.0			0.0		0.0	0.0		1.9	0.7	0.0	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153421-42155824	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"intestine: 92.4"	"Group enriched"	"Detected in some"	27	"Enterocytes: 716.3;Paneth cells: 2864.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Group enriched"	"Detected in some"	6	"A549: 3.3;CACO-2: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		740000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.1	55.2	0.1	0.1	13.5	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	8.7	0.1	0.1	0.1	0.1	0.0	92.4	0.1	0.1	0.2	5.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	9.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	716.3	0.0	43.1	0.1	0.0	0.0	23.0	2.6	0.1	0.0	21.9	0.6	0.0	1.1	0.0	0.0	0.0	0.0	67.1	0.0	3.8	2864.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	33.2	0.0
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162691-42164718	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"intestine: 265.7"	"Group enriched"	"Detected in some"	16	"Enterocytes: 4125.7;Paneth cells: 4082.4"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 34.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018215	Enhanced				"Secreted to blood"	NA	NA		26000000			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.2	0.1	0.2	8.0	0.2	0.0	0.2	0.2	0.2	0.2	87.3	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.7	0.0	0.2	3.5	0.2	0.2	91.9	0.2	0.2	0.2	0.2	0.1	265.7	2.1	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	4125.7	0.0	1.0	2.7	0.0	0.0	23.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	263.8	0.0	0.1	4082.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	76.4	0.1
FOXJ3	KIAA1041	ENSG00000198815	"Forkhead box J3"	Q9UPW0	1	42176539-42335877	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067284			Approved	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA067284: AB_2685817"	"unprognostic (5.60e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.24e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (3.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (4.51e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (5.43e-2)"	24.8	15.1	21.2	20.1	31.3	31.6	25.6	38.2	30.9	22.3	18.4	22.9	15.4	18.8	24.9	18.9	17.4	19.8	16.2	23.5	21.5	20.2	16.8	17.6	20.4	19.6	22.9	19.2	29.5	22.6	31.6	28.7	33.5	21.2	21.7	22.5	18.4	19.0	23.7	44.3	24.3	20.0	22.0	20.7	19.6	20.8	19.0	22.6	29.0	23.7	15.2	22.2	22.8	21.4	12.3	9.7	10.9	9.4	11.6	13.1	4.3	13.8	11.7	12.9	13.4	14.0	17.2	18.6	10.5	15.6	14.2	15.9	10.8	16.7	21.3	11.3	14.7	12.2	13.3	18.0	17.3	24.2	16.0	10.1	23.5	14.9	9.1	12.1	21.5	16.2	12.8	17.2	21.2	26.4	15.2	15.4	17.1	14.1	15.5	16.9	7.9	21.7	12.3	20.1	11.1	10.7	20.4	33.9	14.5	12.1	20.2	18.0	16.9	19.0	22.0	19.1	19.3	11.0	32.1	14.3	14.9	20.0	15.0	17.4	15.4	18.9	17.4	13.5	18.0	11.9	6.0	5.7	6.1	9.0	4.8	10.9	8.0	11.0	9.5	4.6	12.3	11.8	13.1	10.9	11.6	9.4	9.7	7.0	4.3	21.2	31.3	38.2	30.9	21.5	20.2	22.9	19.2	21.2	22.6	11.9	17.6	20.1	9.7	31.5	18.4	37.6	7.6	12.0	15.9	15.7	17.7	11.1	14.9	9.7	14.9	23.2	22.8	46.7	12.6	26.0	14.6	16.6	12.7	14.9	10.3	20.6	25.9	14.1	19.0	14.2	20.8	12.7	10.1	6.4	26.0	14.1	13.7	17.3	18.7	11.0	32.9	6.5	12.3	22.8	22.7	29.2	23.3	12.5	17.9	19.2
RIMKLA	"FAM80A, MGC47816, NAAGS-II, RP11-157D18.1"	ENSG00000177181	"Ribosomal modification protein rimK like family member A"	Q8IXN7	1	42380795-42422578	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 41.2;Horizontal cells: 33.4;Rod photoreceptor cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;JURKAT: 6.3;Karpas-707: 9.1;SCLC-21H: 11.9;U-266/70: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027826	Uncertain		Uncertain	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA027826: AB_10603992"	"unprognostic (4.04e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.68e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.63e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	0.9	1.2	6.2	1.5	10.4	0.8	1.3	7.8	18.4	1.0	7.9	1.7	0.0	1.4	1.0	0.8	1.0	0.9	1.8	8.5	7.5	5.9	2.5	0.7	5.4	0.8	7.9	8.5	0.7	2.5	6.6	2.0	1.3	20.1	2.2	9.0	3.3	1.1	1.2	1.4	1.1	1.3	2.4	3.6	1.1	2.1	2.3	1.2	0.0	2.2	0.0	0.8	1.1	0.4	0.3	1.6	1.3	0.2	0.4	2.0	0.1	0.0	0.8	0.1	7.8	0.1	0.0	1.5	0.0	0.0	0.2	0.5	0.4	0.2	0.0	1.6	0.0	1.3	0.0	4.6	0.0	0.4	4.1	3.1	0.3	0.1	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	9.1	0.0	0.3	2.1	0.0	4.0	0.6	5.5	0.0	0.3	0.4	0.7	2.1	11.9	5.1	0.4	0.3	0.1	0.9	0.4	2.0	0.0	0.0	0.4	0.0	0.8	8.3	4.7	5.5	0.1	0.0	0.0	1.1	0.2	1.3	0.2	0.2	2.0	0.2	0.1	1.0	0.0	0.3	0.1	0.2	1.0	0.4	0.1	1.6	0.1	0.1	6.2	10.4	7.8	18.4	7.5	5.9	7.9	8.5	20.1	1.2	14.9	4.6	0.0	0.8	0.6	13.2	13.0	0.0	0.0	1.2	1.8	41.2	1.0	1.7	3.2	4.7	0.9	7.8	0.0	4.2	11.6	0.3	2.9	0.0	0.0	0.8	33.4	10.9	1.3	0.0	6.4	0.3	0.8	5.0	0.0	7.5	4.5	6.8	5.9	0.0	2.4	23.9	0.0	0.5	1.0	2.5	0.1	1.4	0.0	5.5	0.7
ZMYND12	DKFZp434N2435	ENSG00000066185	"Zinc finger MYND-type containing 12"	Q9H0C1	1	42430329-42456267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.8"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 30.8;Early spermatids: 110.7;Late spermatids: 52.1;Spermatocytes: 31.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 6.0;SK-MEL-30: 5.0;WM-115: 3.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.43e-3)"	"unprognostic (2.53e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.23e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	1.0	2.6	3.4	0.3	4.7	0.4	2.2	1.1	3.3	1.9	1.0	4.7	3.3	0.9	1.3	7.8	0.5	15.3	1.8	2.1	3.3	4.8	6.9	5.4	2.1	0.5	2.7	4.0	2.0	3.0	3.0	6.1	0.5	9.7	2.2	1.0	2.7	1.3	3.1	1.8	0.7	0.6	1.0	2.8	0.8	1.5	51.8	2.5	0.2	4.9	0.2	0.4	1.2	0.7	0.6	2.0	0.1	1.6	3.0	0.8	1.0	0.0	0.0	0.4	1.6	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	1.2	0.0	0.0	6.0	0.4	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.9	0.1	1.5	0.0	0.8	0.0	0.0	0.4	0.0	1.5	0.9	0.0	0.8	5.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	2.0	1.8	0.0	0.0	0.7	3.6	0.0	1.6	0.1	0.1	1.2	0.7	0.2	0.8	0.0	2.0	0.6	0.7	0.4	0.1	3.0	1.1	0.7	0.0	1.0	3.4	4.7	1.1	3.3	3.3	4.8	2.7	4.0	9.7	2.5	3.0	2.4	0.0	0.6	0.0	0.4	3.5	7.6	30.8	4.5	7.0	0.0	1.0	13.3	0.4	110.7	0.1	0.7	0.0	0.4	1.0	0.8	0.9	0.0	3.4	2.2	0.0	0.0	0.6	2.2	52.1	2.3	0.0	3.3	1.0	1.7	3.1	0.1	0.0	2.1	11.1	2.9	0.0	0.2	31.6	3.4	0.3	0.6	0.0	0.6	0.7
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Enzymes, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		16000	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	23.4	36.3	18.9	20.5	21.9	10.7	30.7	12.0	26.0	23.2	32.0	12.4	27.3	25.5	18.2	34.4	31.6	14.5	30.9	22.1	17.8	16.4	41.4	43.9	26.5	28.1	19.3	14.9	19.6	47.0	22.8	16.1	37.6	17.2	27.2	27.3	19.6	36.6	35.0	19.6	21.9	41.0	27.6	18.9	24.4	27.2	13.5	13.4	22.6	31.3	26.0	20.5	24.0	19.4	41.9	44.4	76.1	55.7	42.0	41.0	52.0	22.9	9.6	5.6	8.7	17.4	18.1	20.9	11.6	13.4	15.7	13.9	8.1	28.1	6.9	22.9	14.7	9.1	13.5	3.7	17.6	13.2	18.3	11.1	11.6	10.6	9.6	23.9	11.9	20.6	15.9	31.9	11.0	20.4	19.3	14.5	8.6	4.7	5.0	16.0	13.7	5.8	11.8	6.4	21.2	14.9	6.6	5.7	12.3	34.3	21.7	6.6	7.3	14.2	34.8	36.0	17.0	16.4	52.7	9.1	8.6	11.5	13.1	13.2	16.5	10.3	5.0	3.6	13.8	17.6	58.1	55.7	76.1	30.7	55.1	35.7	41.9	37.0	33.0	44.4	39.9	41.0	34.9	41.2	42.0	51.8	33.2	36.4	52.0	18.9	21.9	12.0	26.0	17.8	16.4	19.3	14.9	17.2	13.4	53.6	69.7	61.9	43.1	20.7	9.2	94.6	86.6	54.9	59.1	61.1	5.9	137.5	336.5	81.6	2.8	50.7	119.1	0.0	120.2	108.8	45.6	37.4	54.4	103.6	97.2	11.1	30.1	43.0	68.9	3.4	56.1	87.5	77.6	111.0	116.6	40.7	82.5	122.6	59.8	254.9	21.8	25.8	44.7	8.4	19.2	31.7	112.6	52.4	93.7	42.7
CCDC30	"FLJ20972, LOC728621, PFD6L"	ENSG00000186409	"Coiled-coil domain containing 30"	Q5VVM6	1	42463330-42654664	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.1"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 140.5;Club cells: 35.2;Early spermatids: 48.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	18	"HMC-1: 16.5"									"HPA036344, HPA036345"	Approved					NA	NA					"HPA036344: AB_10795572, HPA036345: AB_10796213"	"unprognostic (3.21e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.70e-3)"	"unprognostic (6.95e-3)"	1.4	1.7	5.5	1.2	11.1	1.1	2.5	4.1	7.9	3.2	1.4	1.9	9.2	1.1	2.1	14.3	1.1	8.0	1.9	1.2	4.9	3.7	5.5	1.2	6.5	1.1	2.2	6.0	3.2	2.1	6.8	27.1	1.4	13.7	2.3	1.1	1.7	1.5	9.5	1.1	1.3	1.3	1.3	2.0	1.8	1.2	12.4	2.2	0.0	5.3	0.0	1.2	1.4	1.4	0.6	0.5	2.9	0.3	0.4	0.8	0.2	0.2	0.1	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	16.5	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.2	0.0	0.1	0.1	0.2	0.2	0.9	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.2	0.2	0.3	2.9	0.3	0.9	0.4	0.1	0.4	0.4	0.3	0.1	0.4	0.6	0.8	0.4	1.6	0.4	0.2	0.5	0.6	0.2	5.5	11.1	4.1	7.9	4.9	3.7	2.2	6.0	13.7	2.2	6.0	14.6	0.0	2.4	1.1	4.7	2.4	5.1	140.5	35.2	7.0	7.9	1.1	1.7	4.4	48.5	2.9	2.2	0.0	2.1	0.9	2.0	2.0	9.2	0.8	1.1	6.4	2.9	2.5	3.2	30.7	5.5	2.7	1.7	3.6	1.6	5.7	1.4	1.1	6.7	6.3	8.7	6.5	3.6	20.9	4.3	0.9	1.5	1.8	1.2	2.2
PPIH	"CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP"	ENSG00000171960	"Peptidylprolyl isomerase H"	O43447	1	42658425-42676758	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059019	Approved					NA	NA					"HPA059019: AB_2683885"	"unprognostic (7.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (6.59e-3)"	"unprognostic (4.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	17.5	19.7	20.4	35.7	19.6	40.7	21.4	23.9	23.3	19.5	24.0	20.9	14.7	18.0	29.8	24.2	29.6	19.2	14.4	21.2	18.0	16.1	17.5	13.6	17.8	31.0	15.8	19.9	22.0	17.7	7.0	15.2	24.6	17.2	17.1	26.5	19.2	24.4	18.8	18.4	20.9	20.7	20.8	15.0	27.2	18.0	21.1	18.6	39.7	26.9	28.1	36.8	15.3	20.3	20.0	14.9	16.8	12.3	18.5	26.3	14.0	19.3	12.5	15.8	22.1	5.2	9.9	21.3	13.2	9.3	24.7	22.6	19.7	22.1	32.0	16.6	9.7	12.0	15.7	28.7	20.2	26.0	26.9	23.2	30.4	23.0	18.2	4.5	58.2	17.8	6.4	10.7	23.0	18.0	9.6	11.5	31.0	37.6	18.2	12.1	16.2	45.1	82.0	38.8	18.6	15.0	25.3	29.4	28.4	11.8	12.6	12.4	22.5	11.6	19.3	14.5	20.5	10.6	85.3	9.5	10.9	27.9	14.9	31.5	11.8	27.5	58.2	12.2	54.5	17.8	12.6	8.8	16.8	21.0	12.3	19.8	20.0	21.7	23.9	11.7	19.2	22.3	26.3	1.8	18.5	11.2	14.9	20.2	14.0	20.4	19.6	23.9	23.3	18.0	16.1	15.8	19.9	17.2	18.6	17.9	20.2	42.4	37.9	25.6	8.9	12.2	15.3	16.0	14.8	21.0	3.9	53.8	38.1	23.6	19.6	18.3	12.3	0.0	23.0	87.1	17.1	22.2	30.1	9.6	45.9	4.8	20.6	18.4	15.3	7.6	27.0	26.9	15.1	27.9	25.8	14.3	22.0	17.5	20.1	25.0	11.8	19.4	16.9	16.3	29.6	18.7	31.7	41.5	31.9	30.1
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682427-42702349	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 128.1;testis: 426.5"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 6931.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Supported		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		870000	Cytosol	Vesicles	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavorable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	47.5	20.6	15.6	36.4	18.4	57.6	35.2	13.7	14.4	27.9	44.5	21.2	20.1	25.6	35.1	36.4	40.0	25.6	32.5	57.8	15.2	12.3	33.1	38.1	35.3	49.8	17.6	13.2	30.2	36.7	9.4	12.2	26.1	15.5	32.0	33.1	31.1	26.6	23.0	128.1	22.5	27.1	50.0	21.0	47.9	33.2	426.5	15.9	53.2	31.4	64.1	37.2	39.4	41.0	23.5	26.9	21.8	40.5	11.6	23.0	10.6	92.5	54.6	87.4	87.6	85.2	77.1	77.9	68.3	63.6	95.0	74.6	74.7	86.5	117.5	71.7	68.6	40.6	56.0	98.4	103.6	94.4	62.7	91.3	119.8	108.4	95.9	68.7	160.8	89.8	70.9	89.3	94.8	117.4	52.1	78.5	98.4	124.6	51.2	88.4	58.3	181.7	156.6	197.1	59.5	73.8	110.0	157.1	126.9	94.0	68.5	120.9	85.2	67.0	90.7	127.6	97.4	30.2	320.5	61.2	67.5	115.2	91.4	138.9	75.1	94.1	133.7	63.9	120.6	71.6	4.3	18.1	21.8	16.3	37.8	19.9	23.5	19.5	15.8	26.9	20.1	16.8	17.2	3.3	11.6	40.5	20.9	23.0	10.6	15.6	18.4	13.7	14.4	15.2	12.3	17.6	13.2	15.5	15.9	160.8	193.6	710.2	1008.1	1241.5	227.0	1010.1	351.6	187.4	286.6	308.8	141.4	639.1	1235.1	944.3	6931.7	600.7	713.3	817.7	771.6	1697.6	856.8	736.8	377.2	465.4	1556.8	114.4	564.5	393.5	1134.6	2234.4	695.5	1494.6	858.7	964.0	841.6	220.6	737.9	799.5	757.7	816.8	432.4	459.2	1265.4	2608.0	287.2	1138.5	402.6	588.8	1140.5	1354.3
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Cell type enriched"	"Detected in some"	7	"Extravillous trophoblasts: 192.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4"	"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	1.2	12.2	0.0	9.1	28.2	0.0	0.0	0.0	0.0	0.0	0.0	192.3	0.2	0.1	0.0	0.0	4.4	0.0	0.0	0.6	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 37.3;Extravillous trophoblasts: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"	NA	NA		13000	Vesicles	Nucleoli	"HPA012113: AB_2668626, HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	11.9	11.2	7.1	8.6	6.3	5.2	9.7	6.4	5.3	14.0	7.1	6.0	7.7	2.6	13.8	11.1	6.4	8.8	12.1	8.8	3.8	2.9	7.9	19.9	10.8	10.1	6.1	3.3	13.1	6.8	5.8	15.2	36.1	4.6	7.8	5.7	10.5	6.4	6.5	4.3	7.2	6.6	19.7	3.4	13.3	6.6	13.1	4.7	10.2	7.4	5.3	7.8	11.4	8.5	3.1	16.2	11.0	16.2	11.7	7.9	6.1	2.2	5.8	13.1	30.6	30.9	23.7	5.4	26.9	35.1	19.5	33.3	2.9	4.9	3.3	21.6	50.7	7.8	2.0	5.5	6.8	13.4	5.0	7.0	7.9	9.2	8.4	17.9	7.8	9.1	20.1	4.6	19.6	8.4	27.7	27.4	4.8	4.4	4.3	13.0	1.2	5.1	4.5	14.3	1.2	4.2	5.0	19.3	4.5	10.2	1.2	2.7	4.6	16.4	0.4	11.6	23.9	0.9	33.0	22.3	14.6	12.9	11.6	10.6	3.8	4.3	3.0	16.7	10.6	20.2	3.5	13.2	11.0	6.0	14.0	6.4	3.1	4.6	5.1	16.2	2.6	3.9	3.9	1.2	11.7	16.2	7.6	7.9	6.1	7.1	6.3	6.4	5.3	3.8	2.9	6.1	3.3	4.6	4.7	3.0	2.9	4.8	5.7	0.0	10.0	4.2	5.1	1.4	1.2	10.4	23.6	37.3	0.0	10.4	16.8	15.7	0.4	0.0	6.6	47.0	22.9	3.0	1.1	10.6	15.4	14.3	5.8	17.8	6.7	7.5	17.8	8.7	0.0	10.0	2.8	2.6	6.7	2.0	15.2	1.7	20.0	0.0	7.6	21.8	11.1	0.0	14.6	12.5	1.7	3.5
C1orf50	MGC955	ENSG00000164008	"Chromosome 1 open reading frame 50"	Q9BV19	1	42767269-42779488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030236	Uncertain					NA	NA					"HPA030236: AB_10602110"	"unprognostic (1.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (5.63e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.72e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.53e-1)"	8.4	9.9	15.8	6.4	14.6	13.4	11.2	8.6	13.8	7.3	7.7	10.5	3.2	8.0	8.4	9.4	9.2	8.2	7.4	12.6	12.9	14.0	10.7	14.4	7.3	7.9	12.8	14.8	11.8	9.7	12.4	10.7	8.4	10.8	9.1	8.6	7.9	8.8	7.8	26.5	8.3	9.1	7.6	11.3	7.7	8.0	15.9	10.5	8.2	8.4	6.2	7.7	7.2	7.1	5.2	7.2	6.8	6.8	4.5	5.4	3.8	2.8	1.8	7.6	6.5	5.5	6.2	4.6	4.3	4.2	4.4	4.3	2.6	3.4	6.6	4.8	6.1	2.6	3.6	6.6	3.4	4.0	7.9	4.1	6.0	4.1	4.0	4.9	7.1	5.3	5.1	5.4	4.8	7.8	4.8	4.6	8.1	7.0	4.1	4.3	3.0	7.0	4.2	6.2	4.1	3.7	7.2	7.3	5.3	5.3	4.9	8.4	5.6	6.3	3.9	6.0	7.9	3.5	8.5	4.4	3.2	3.5	5.6	3.8	5.7	5.2	5.4	3.5	5.8	3.2	4.1	4.0	6.8	4.3	4.0	3.6	5.2	4.7	4.7	3.6	4.5	5.4	5.4	4.1	4.5	6.8	7.2	5.1	3.8	15.8	14.6	8.6	11.9	12.9	14.0	12.8	14.8	10.8	10.5	0.0	3.0	16.9	8.4	8.1	2.8	19.6	5.1	5.3	5.7	10.4	2.0	23.0	19.9	8.5	51.6	11.1	15.2	0.0	3.4	22.8	11.3	11.9	10.3	26.9	24.1	0.0	18.4	20.3	19.2	132.6	12.7	9.8	13.5	13.6	14.6	6.5	7.4	11.4	6.3	13.6	6.4	6.5	10.5	36.7	32.6	6.8	28.3	19.5	14.0	8.2
TMEM269		ENSG00000274386	"Transmembrane protein 269"	A0A1B0GVZ9	1	42785007-42816619	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;skin 1: 2.1"	"Cell type enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.03e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-9)"	"unprognostic (2.23e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.77e-2)"	0.1	0.0		0.0		1.5	0.6		0.6	0.0	0.0			0.0	0.1	1.3	0.0	0.0	0.0	0.0			0.0	0.5	0.0	0.3			0.0	0.6	0.4		0.0		0.2	0.3		0.0	0.0	1.8	2.1	0.1	0.0		0.5	0.1	1.4			0.0		0.4	0.0		0.9	1.8	3.4	0.6	1.5	0.9	0.1	0.3	1.7	1.2	2.6	1.1	0.1	1.2	0.2	0.2	0.6	0.8	1.4	0.6	2.4	0.4	0.1	0.2	0.3	0.7	0.1	0.2	2.2	0.6	2.5	0.5	0.7	0.1	1.0	0.5	0.7	0.5	0.0	2.1	0.2	0.0	1.7	0.8	2.0	0.0	0.7	0.4	2.7	2.0	0.2	1.1	0.8	1.2	0.3	0.0	0.3	1.6	1.6	0.7	0.7	1.1	1.0	1.1	1.2	0.3	0.6	1.3	2.3	0.5	3.8	6.3	2.7	0.4	0.9	0.6	2.1	0.6	0.4	0.3	0.4	0.3	0.4	0.4	0.3	0.2	0.9	0.9	0.4	3.4	1.5	0.4	1.8	0.3	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817252	"Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 164.4;Spermatogonia: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	20.1	14.1	25.6	11.1	18.9	32.3	20.1	24.0	20.4	16.2	15.7	17.6	10.4	9.7	20.5	23.9	13.0	20.1	15.5	19.6	21.8	19.7	16.0	15.9	13.8	17.8	23.5	22.3	34.4	9.1	10.7	20.0	23.5	20.4	16.8	14.5	13.6	11.6	14.5	21.1	10.1	11.8	17.1	26.9	14.3	11.5	38.2	18.7	29.2	15.5	16.1	19.4	16.2	15.1	24.5	16.0	30.2	16.8	14.3	44.8	9.7	10.2	4.9	32.3	11.6	13.1	20.9	15.7	8.8	7.3	12.0	12.4	9.0	8.2	11.1	9.7	11.8	9.4	7.1	5.7	9.4	16.2	19.7	9.8	22.3	4.9	17.9	10.6	16.7	14.6	13.1	15.1	6.7	6.9	13.0	12.1	22.4	17.3	6.0	15.3	4.8	16.7	20.0	17.7	9.8	6.0	12.2	24.6	7.8	12.7	11.2	19.3	17.3	10.5	6.1	12.6	35.9	4.8	47.3	9.2	10.6	12.0	8.5	14.2	5.8	7.1	8.0	6.8	11.4	10.0	20.8	16.6	30.2	11.4	15.9	10.3	22.1	20.4	14.0	16.0	24.5	19.2	16.4	29.3	14.3	16.8	13.4	44.8	9.7	25.6	18.9	24.0	20.4	21.8	19.7	23.5	22.3	20.4	18.7	8.9	4.6	32.1	27.2	0.0	5.5	0.0	28.1	13.4	17.0	19.2	2.0	47.5	46.4	41.3	113.1	20.3	12.5	93.5	21.4	53.4	17.5	19.3	10.5	31.8	64.1	6.4	17.5	31.3	40.5	49.2	39.7	28.7	0.0	64.1	23.7	13.2	34.6	28.5	50.5	34.8	13.5	58.2	0.0	164.4	149.9	0.0	51.5	20.0	30.2	25.4
ERMAP	"BTN5, RD, SC"	ENSG00000164010	"Erythroblast membrane associated protein (Scianna blood group)"	Q96PL5	1	42817088-42844993	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 21.6;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 24.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042573, HPA054672"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA042573: AB_10794282, HPA054672: "	"unprognostic (9.46e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.48e-2)"	10.0	14.1	9.3	6.7	10.4	25.7	8.4	2.5	9.3	9.3	7.9	12.4	12.2	6.4	9.4	16.7	8.3	10.2	7.4	4.7	9.3	6.3	7.8	13.1	9.8	4.4	10.4	8.3	6.2	11.7	9.8	12.3	12.0	10.8	9.4	8.3	11.8	10.2	8.0	4.0	9.2	9.4	6.5	14.6	8.6	7.8	4.2	11.9	4.8	13.1	3.2	8.1	9.7	8.0	2.4	8.1	3.0	7.1	3.5	5.0	2.9	3.5	4.7	1.5	4.7	5.3	15.5	1.3	7.0	11.7	6.2	6.2	1.9	6.4	3.1	2.5	7.3	2.9	4.4	1.6	2.1	5.7	5.1	5.6	24.9	3.4	1.5	6.6	3.6	12.9	9.4	7.9	2.9	6.8	11.4	4.0	3.8	16.9	3.1	5.7	2.3	1.7	1.3	3.6	2.2	2.6	1.7	2.1	2.9	5.3	5.4	3.3	2.4	6.0	2.2	2.6	2.6	4.4	13.3	6.3	4.7	2.8	3.9	3.2	1.4	2.7	1.3	3.8	3.8	3.0	0.5	6.8	3.0	2.1	7.1	1.2	2.4	2.3	2.2	8.1	1.3	2.0	2.3	2.1	3.5	4.5	2.3	5.0	2.9	9.3	10.4	2.5	9.3	9.3	6.3	10.4	8.3	10.8	11.9	11.9	10.4	0.8	3.1	3.4	1.2	1.7	7.6	6.7	7.9	3.5	21.6	2.5	1.7	3.0	3.2	3.5	2.6	23.3	6.2	1.1	3.6	2.6	2.3	11.6	7.0	11.1	5.2	2.5	11.9	18.9	2.6	6.6	5.0	1.8	5.6	5.0	4.1	3.5	3.9	2.9	3.8	0.0	1.9	0.0	0.9	3.3	2.4	0.9	6.6	0.9
ZNF691	Zfp691	ENSG00000164011	"Zinc finger protein 691"	Q5VV52	1	42846573-42852477	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062527	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA062527: AB_2684791"	"unprognostic (4.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (7.33e-6)"	"unprognostic (1.40e-3)"	"unprognostic (2.65e-3)"	"unprognostic (5.12e-2)"	"prognostic favorable (6.25e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	7.8	14.6	13.6	11.2	15.5	2.9	15.6	10.8	14.4	12.9	12.6	18.3	14.1	8.8	16.9	21.8	9.1	14.2	8.4	11.4	11.9	9.8	14.2	24.1	9.9	16.0	12.2	12.1	18.6	13.4	19.2	17.3	12.7	12.3	16.8	10.2	12.3	15.2	18.5	10.9	12.8	10.6	13.5	11.9	17.7	10.8	13.9	14.8	17.9	19.3	6.4	16.8	11.8	10.0	20.5	12.5	18.2	11.2	18.4	19.3	12.8	4.5	6.3	12.8	10.5	11.6	8.9	1.6	5.4	6.5	8.8	8.8	4.4	6.6	11.1	8.4	5.0	4.4	8.0	12.3	7.1	7.6	19.8	12.4	11.6	17.3	7.9	8.6	4.4	2.5	7.7	8.7	11.0	9.1	10.8	8.9	11.0	11.2	4.8	8.6	3.6	13.2	5.9	19.1	4.9	4.7	9.0	16.1	7.6	8.2	4.3	9.2	9.2	5.5	10.0	9.3	20.0	5.5	15.2	4.6	8.8	9.3	4.9	5.8	11.7	9.2	3.2	6.2	5.4	7.4	18.2	11.2	16.0	12.2	9.7	15.7	15.9	16.4	16.4	11.1	20.5	15.8	15.7	6.3	18.4	10.0	12.5	19.3	12.8	13.6	15.5	10.8	14.4	11.9	9.8	12.2	12.1	12.3	14.8	6.0	2.4	3.0	2.1	1.5	2.4	5.7	5.1	4.0	2.3	5.2	3.9	5.4	6.6	3.9	3.0	3.6	1.7	0.0	3.3	4.4	4.0	2.4	4.7	6.4	6.4	1.6	2.9	6.2	3.3	2.5	6.6	3.5	1.7	3.6	2.7	5.2	2.4	2.9	6.7	6.8	4.2	0.0	3.9	9.1	6.4	0.6	2.7	6.4	2.3	1.0
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell type enhanced"	"Detected in many"	20	"Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		36000000	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.7	15.6	12.8	3.2	1.5	0.5	44.8	7.1	15.4	8.8	12.9	72.7	30.1	4.1	21.2	2.1	6.2	10.1	2.8	16.5	3.9	2.4	2.6	6.7	9.0	49.6	4.5	3.6	1.9	1.9	12.7	5.5	5.9	26.0	1.4	3.5	15.0	0.9	3.9	19.2	1.7	2.5	8.2	5.3	3.9	1.6	4.1	5.7	8.0	5.2	6.8	4.8	8.3	26.3	3.1	19.2	1.1	4.6	3.2	8.0	5.8	1.4	16.0	0.7	1.5	2.5	15.8	2.6	6.5	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5	0.0	2.6	23.8	35.5	254.3	8.1	23.0	25.5	28.1	9.1	26.2	62.8	686.5	5.0	47.8	4.0	9.9	16.8	303.7	10.3	412.9	42.1	25.5	5.8	1.3	74.8	4.8	17.6	0.6	1.3	0.0	7.2	3.2	20.3	61.3	13.7	394.9	72.4	18.7	13.8	1.6	31.1	0.0	20.2	0.0	1.7	208.3	2076.2	17.3	9.0	98.7
FAM183A	"hCG23177, LOC440585"	ENSG00000186973	"Family with sequence similarity 183 member A"	A6NL82	1	43145153-43156396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.5;fallopian tube: 55.8"	"Cell type enriched"	"Detected in many"	7	"Ciliated cells: 1011.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 19.3"	"Region enhanced"	"Detected in many"		"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.9;hTCEpi: 4.4;NTERA-2: 5.4;SCLC-21H: 4.6;SuSa: 9.1"	"Low region specificity"	"Detected in many"							"HPA043382, HPA049120"	Approved					NA	NA					"HPA043382: AB_2678456, HPA049120: AB_2680640"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.42e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.73e-2)"	0.1	0.1	3.6	0.1	9.8	0.1	0.8	0.0	0.5	2.6	0.3	6.5	0.0	0.2	1.3	16.5	0.5	55.8	0.2	0.1	4.6	4.7	0.3	0.2	14.5	0.2	0.1	0.2	10.1	0.3	1.0	5.5	0.5	25.5	1.4	0.3	0.0	0.9	0.3	0.1	5.5	0.1	0.3	0.6	0.2	0.2	6.7	1.7	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.6	0.6	0.6	1.0	5.9	0.0	0.8	0.4	0.6	0.7	0.0	0.4	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	2.3	1.1	4.6	0.0	0.0	0.3	0.0	9.1	1.3	0.0	0.9	0.0	0.7	0.2	0.1	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	9.8	0.0	0.5	4.6	4.7	0.1	0.2	25.5	1.7	0.0	6.1	0.0	12.9	1.6	0.0	0.1	0.0	1011.8	135.4	3.5	0.0	1.5	3.3	0.0	89.9	0.1	0.0	0.0	0.0	0.2	0.4	3.8	3.5	0.0	0.1	0.0	4.1	0.0	0.0	153.7	1.7	0.0	3.3	0.0	0.1	0.4	0.2	0.0	0.7	1.3	0.0	0.0	0.0	1.9	2.8	2.3	1.7	0.0	0.4	10.2
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	18.9	24.8	30.2	22.8	41.1	19.3	27.6	17.7	35.7	18.1	23.6	19.0	15.6	15.4	22.4	40.6	27.8	30.4	15.6	24.9	26.3	25.2	34.0	66.0	18.5	21.9	25.1	29.8	21.8	30.7	24.5	30.0	26.0	29.2	20.3	26.0	16.6	22.3	22.3	28.4	22.8	16.9	24.3	21.6	18.4	19.7	24.8	27.4	18.2	28.8	31.3	25.8	21.5	19.8	26.9	29.6	10.2	22.8	24.1	25.1	17.8	61.7	36.1	13.5	39.1	10.9	12.3	28.0	43.1	21.6	68.9	43.4	40.3	38.6	41.1	34.2	31.3	32.5	44.0	29.2	39.9	75.4	19.4	28.8	28.0	32.5	35.4	19.8	48.5	21.6	9.8	40.4	50.6	41.0	13.2	37.7	28.3	42.3	13.9	33.5	34.0	36.8	29.0	58.7	41.5	33.5	27.0	30.7	46.3	25.3	27.0	26.9	28.9	24.9	46.6	43.2	22.9	19.1	26.5	29.0	26.7	50.3	42.6	70.0	20.6	40.6	50.8	22.1	50.3	53.6	7.5	20.1	10.2	24.0	22.8	25.1	26.9	24.5	24.9	29.6	26.7	22.8	22.8	1.8	24.1	21.6	28.3	24.6	17.8	30.2	41.1	17.7	35.7	26.3	25.2	25.1	29.8	29.2	27.4	32.8	33.2	26.8	68.9	109.3	25.1	28.5	56.0	87.0	48.9	29.6	5.9	95.0	76.3	100.0	109.6	36.8	23.0	70.0	107.4	112.0	52.9	58.1	49.7	127.1	57.6	14.3	23.2	32.5	23.4	70.9	30.8	30.6	52.3	54.1	37.8	44.2	101.2	11.5	36.0	100.9	22.3	38.8	54.7	79.6	103.6	86.9	70.5	23.5	59.7	77.3
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172149-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.6;testis: 29.2"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 156.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 6.9;HDLM-2: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002736, HPA028623"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0.0	0.3	1.0	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0.0	1.9	0.0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1.0	0.8	0.6	0.2	0.2	0.9	1.1	1.8	1.4	1.4	0.9	1.2	0.3	1.3	2.4	0.8	6.9	0.4	0.9	2.6	4.5	0.2	0.4	0.6	0.6	0.5	0.0	0.3	0.2	1.2	1.1	0.4	1.9	2.0	0.4	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.2	0.1	0.4	1.0	0.2	3.0	0.5	1.2	0.5	1.4	0.2	1.1	0.8	1.7	0.5	3.9	0.2	1.5	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.9	0.5	1.1	0.7	1.4	2.0	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0.0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4	6.0	0.3	0.0	0.1	0.0	0.4	0.4	0.0	156.6	10.3	0.0	5.9	0.8	0.0	0.3	22.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.1	1.6	0.0	0.6	0.0	21.6	0.9	0.0	0.0	3.6	0.0	0.5	0.2	0.0	0.7	1.4	0.8	0.0	0.0	18.7	3.3	0.0	0.0	0.0	0.0	0.1
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269994-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 73.6;salivary gland: 47.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 113.2;Alveolar cells type 2: 120.0;Enterocytes: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 13.4;BEWO: 11.5;CACO-2: 10.5;CAPAN-2: 25.1;OE19: 16.0;SK-BR-3: 21.6;T-47d: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		NA	NA			"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.8	0.0	5.3	4.6	7.1	0.0	4.9	0.9	5.0	7.4	14.4	1.0	20.7	15.1	1.8	12.5	3.3	6.6	18.9	1.0	8.9	4.3	9.4	1.4	42.5	0.8	10.7	0.8	2.0	73.6	9.6	15.7	5.6	1.1	8.8	9.1	1.5	47.8	19.0	0.8	3.7	29.4	0.8	21.1	0.8	11.6	1.2	0.8	1.1	33.6	3.8	5.0	1.4	3.5	0.0	0.8	0.0	0.0	1.8	0.9	0.2	13.4	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	10.5	25.1	0.0	0.6	0.0	0.0	6.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.5	16.0	0.0	0.0	0.0	0.3	0.2	4.3	6.5	0.0	0.0	21.6	0.0	2.0	17.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.2	0.0	1.8	0.0	0.8	0.0	0.2	5.3	7.1	0.9	1.9	8.9	4.3	10.7	0.8	1.1	0.8	113.2	120.0	0.5	1.7	0.0	0.0	0.4	43.3	29.4	47.8	15.7	0.0	26.1	14.9	32.4	3.1	0.0	84.2	0.0	34.1	1.2	0.2	16.8	1.1	0.0	2.0	0.0	20.8	0.0	0.0	6.0	0.3	0.8	0.0	1.0	59.6	1.7	27.0	37.4	1.1	23.1	0.0	0.0	0.2	1.0	0.2	0.4	6.1	0.0	32.2	5.4
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281883-43285617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 105.5;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"A-431: 7.4;BEWO: 8.3;CACO-2: 7.8;CAPAN-2: 25.2;OE19: 20.3;SK-BR-3: 8.8;T-47d: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA013788	Uncertain		Uncertain	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.3	0.1	0.3	6.5	0.3	0.0	7.4	0.3	0.3	3.9	28.6	0.4	7.4	20.6	1.0	10.9	11.2	2.6	20.7	0.3	0.3	0.1	25.2	3.3	13.5	0.3	0.3	0.3	1.0	29.8	3.0	9.6	6.1	0.4	4.4	14.4	0.4	25.8	7.2	0.3	10.6	64.0	0.5	0.3	0.3	14.6	1.1	0.3	1.0	32.1	7.8	7.7	3.4	5.2	0.1	0.3	5.4	0.3	0.4	0.2	0.0	7.4	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	7.8	25.2	0.0	0.1	0.0	0.0	5.7	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.2	0.6	4.8	3.0	0.2	0.0	8.8	0.0	1.4	9.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.3	0.4	0.3	0.2	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.4	0.3	20.8	10.7	0.8	5.9	1.0	0.0	0.0	22.9	4.0	4.5	21.0	0.0	11.1	24.9	17.9	0.1	0.0	105.5	0.0	29.5	2.9	0.2	10.4	0.0	0.9	0.6	0.0	32.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	34.2	0.0	16.3	49.1	0.0	39.3	0.0	0.0	0.2	0.1	0.0	2.3	3.9	0.0	31.2	7.8
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300993-43323108	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 81.7;Ito cells: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 3.4;NK-cell: 5.4"	"Group enriched"	"Detected in many"	22	"granulocytes: 3.4;NK-cells: 5.4"	"Group enriched"	"Detected in some"	5	"EFO-21: 28.5;HUVEC TERT2: 63.1;TIME: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		75000000				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	39.4	5.4	3.9	6.6	6.0	1.0	43.6	2.5	6.0	10.8	8.4	4.5	4.2	4.5	18.6	10.9	7.8	10.2	11.1	15.1	4.9	4.2	9.4	10.8	22.0	13.1	6.4	3.1	7.0	3.0	2.7	5.1	39.9	5.5	8.6	3.0	6.9	6.0	6.9	17.8	4.2	5.8	12.1	5.3	14.8	5.1	5.1	3.8	1.1	13.9	10.2	3.1	9.0	14.7	0.0	0.2	3.4	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	2.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	54.8	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	3.9	6.0	2.5	6.0	4.9	4.2	6.4	3.1	5.5	3.8	0.0	6.2	0.0	0.6	1.9	0.3	3.4	0.0	6.7	3.4	0.0	0.0	0.1	0.0	0.0	1.5	81.7	0.0	0.0	0.2	0.1	1.4	0.6	19.7	0.9	0.4	0.0	0.0	106.2	8.6	1.5	2.0	1.6	1.7	0.0	0.0	0.2	0.0	0.0	0.7	0.8	0.7	0.0	0.9	0.7	0.1	1.3	0.2	6.9	0.0	0.6
MPL	"CD110, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337849-43352772	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enriched"	"Detected in single"	78	"HEL: 41.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Low region specificity"	"Detected in all"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane"	"HPA007619: AB_1854080"	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	1.1	0.3	0.9	0.5	0.8	2.0	0.9	0.5	2.2	0.6	0.6	0.5	0.5	0.3	0.9	1.7	0.9	2.1	0.5	3.9	0.8	0.6	0.5	0.5	2.0	0.5	0.9	0.5	6.6	1.1	0.6	0.6	2.2	0.5	1.5	0.7	0.5	0.5	0.7	0.6	0.4	1.2	2.1	2.5	8.6	0.5	2.1	0.5	0.5	2.2	2.4	0.5	0.9	0.5	0.0	0.0	1.6	0.3	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	41.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.0	0.9	0.8	0.5	2.2	0.8	0.6	0.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	52.6	25.7	35.9	23.4	1.2	3.2	34.4	24.4	21.9	71.2	38.0	40.3	43.8	30.5	14.3	22.4	25.1	37.1	39.2	46.6	59.5	23.9	29.0	44.6	25.4	24.9	0.3	31.1	16.3	1.0	2.2	49.4	44.8	6.2	30.1	29.3	20.1	21.0	32.2	20.4	29.9	19.1	45.4	25.1	34.6	43.5	49.3	19.3	17.3	14.0	21.2	10.4	43.1	29.2	13.5	28.8	20.5	39.4	15.6	21.3	50.0	23.6	75.6	16.1	14.3	31.6	15.3	38.8	31.7	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7	0.0	0.6	16.2	2.0	9.3	0.0	0.7	0.0	2.7	1.2	0.0	0.0	13.4	0.0	2.1	97.6	0.7	3.2	70.0	0.3	127.9	4.1	2.0	0.0	1.0	30.9	0.0	0.0	8.0	5.0	7.0	2.6	5.2	0.0	2.8	2.9	0.2	0.7	0.0	1.8	2.1	2.6	0.0	1.4	74.9	48.1	7.3	8.9	1.3	15.5	2.6
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363397-43368074	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	21.2	15.6	16.2	15.3	25.3	18.3	24.1	6.8	32.5	16.1	23.6	101.5	11.7	20.7	14.1	13.0	46.6	15.1	17.3	11.5	30.3	18.3	26.6	23.8	22.9	22.7	51.4	14.1	9.3	18.3	16.7	8.4	20.9	45.6	21.6	20.1	8.6	20.6	21.6	6.8	54.0	21.7	20.7	99.5	17.2	22.8	8.4	37.2	7.2	23.9	15.6	21.7	20.4	22.6	30.9	61.1	46.9	54.8	30.5	32.3	48.8	23.8	26.9	5.2	10.3	35.6	33.5	16.3	28.3	35.7	36.1	29.1	23.8	41.9	16.5	22.0	44.3	31.2	27.5	18.4	34.8	22.2	21.2	12.4	21.4	18.6	17.2	30.9	18.4	22.9	25.6	39.6	42.6	47.1	27.1	36.1	6.5	14.8	12.6	41.3	17.6	4.3	15.5	7.6	31.1	27.9	9.7	13.9	20.1	45.5	29.1	6.4	6.7	16.7	59.7	23.8	16.2	28.1	18.4	29.8	30.6	19.4	37.0	35.8	6.3	6.8	7.9	29.8	18.9	27.5	29.0	54.8	46.9	32.3	50.6	28.6	30.9	30.7	31.4	61.1	25.5	20.1	28.1	38.2	30.5	48.1	42.9	31.4	48.8	16.2	25.3	6.8	32.5	30.3	18.3	51.4	14.1	45.6	37.2	17.9	8.4	18.1	20.4	13.9	5.4	3.6	45.9	5.3	7.9	38.4	9.8	79.2	6.6	86.7	2.5	28.7	74.3	70.0	86.6	103.3	20.2	33.0	20.7	13.7	66.2	3.2	18.4	23.4	47.0	3.4	18.7	37.1	11.8	129.8	30.5	12.4	99.9	40.7	24.1	21.3	8.4	19.4	15.3	6.7	8.6	27.0	80.2	24.6	36.9	43.7
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	22.7	21.9	19.0	18.3	22.0	22.0	22.9	30.0	25.8	20.4	21.1	21.9	19.0	21.7	18.4	24.8	33.4	15.0	16.1	15.9	18.5	19.0	22.1	34.6	19.4	18.3	21.0	17.2	19.2	25.6	17.7	34.5	26.8	20.3	19.3	24.5	19.2	25.0	21.1	16.5	27.3	21.2	23.5	21.3	20.9	22.5	18.5	20.6	14.2	27.0	19.3	25.9	24.9	20.6	27.0	34.6	32.5	35.0	18.4	25.5	22.1	22.2	14.0	13.2	15.7	20.4	20.5	17.4	22.4	20.6	27.0	28.6	26.6	16.4	13.5	16.1	28.1	17.8	14.2	20.7	19.0	26.3	18.7	20.3	22.2	24.3	33.3	34.8	19.5	23.6	20.0	25.2	28.5	35.1	16.2	21.5	12.5	19.6	23.1	17.3	14.3	10.2	16.0	12.6	20.9	16.3	12.0	15.2	20.7	18.0	14.6	13.9	10.4	13.3	21.8	44.0	19.1	14.8	39.3	15.9	11.8	21.5	23.1	31.7	27.6	31.8	15.8	25.1	24.4	15.7	25.3	35.0	32.5	22.0	31.3	20.9	27.0	20.2	24.8	34.6	21.1	20.7	21.5	28.0	18.4	27.3	16.0	25.5	22.1	19.0	22.0	30.0	25.8	18.5	19.0	21.0	17.2	20.3	20.6	14.9	8.0	15.6	20.0	16.7	28.3	11.8	25.5	8.1	11.4	14.0	13.7	44.7	28.2	39.6	9.7	21.0	24.2	93.5	65.5	56.4	27.8	21.2	31.1	23.1	52.8	15.9	18.6	18.4	20.8	18.1	22.7	29.1	18.6	38.7	19.9	27.7	46.2	19.3	20.5	41.8	47.9	25.8	17.9	66.2	30.9	22.2	73.9	24.9	19.6	25.5
SZT2	"C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B"	ENSG00000198198	"SZT2, KICSTOR complex subunit"	Q5T011	1	43389882-43454247	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029012	Approved		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			"Nucleoplasm, Vesicles, Actin filaments"		"HPA029012: AB_10600817"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.47e-7)"	"prognostic unfavorable (2.53e-4)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (8.28e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.61e-2)"	10.0	8.4	9.0	15.9	12.8	13.5	10.3	16.1	12.9	10.2	10.2	21.7	12.8	8.8	13.7	8.3	9.4	11.3	8.2	8.6	8.7	6.8	7.9	6.1	10.3	11.1	12.4	9.1	14.9	10.8	23.6	16.1	8.1	10.9	10.9	8.9	13.5	11.4	11.6	10.9	17.4	11.6	12.1	9.9	11.0	10.0	12.2	11.1	13.9	16.3	5.9	12.6	12.3	9.6	1.8	3.0	4.9	1.8	1.3	3.0	1.2	6.3	5.9	6.0	5.3	15.4	9.2	8.4	4.9	7.0	6.8	6.7	2.0	7.8	5.9	6.5	8.6	4.4	7.7	5.0	9.0	5.2	7.5	5.0	10.7	11.4	3.7	6.1	8.5	8.8	8.2	7.2	11.2	10.3	8.0	7.4	7.0	4.7	9.3	5.1	3.2	5.8	3.0	4.9	4.3	6.4	7.4	6.5	7.9	4.3	8.0	5.8	5.4	9.8	9.0	6.7	7.7	5.4	13.1	9.6	7.4	9.3	10.3	8.5	9.7	3.8	4.7	7.7	5.9	5.4	3.8	1.8	4.9	1.5	1.5	3.0	1.4	0.8	0.8	1.5	1.8	1.7	1.3	3.7	1.3	1.7	3.0	1.7	1.2	9.0	12.8	16.1	12.9	8.7	6.8	12.4	9.1	10.9	11.1	23.8	20.0	9.3	3.1	1.6	15.1	4.4	5.1	6.7	7.9	5.2	58.9	5.4	0.0	5.2	11.0	6.0	8.5	0.0	5.7	4.3	5.1	3.8	13.9	9.5	4.8	12.7	3.5	9.8	7.8	11.5	8.6	6.9	5.0	9.0	5.7	7.8	5.7	3.5	5.6	7.1	22.6	19.4	4.3	7.0	6.6	1.6	4.6	12.8	6.4	3.2
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 39.2;WM-115: 33.2"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.4	2.2	0.7	1.2	3.4	6.4	0.0	15.2	13.7	19.2	12.9	8.9	30.5	0.0	1.1	9.8	7.7	3.2	0.0	16.1	7.9	4.3	6.3	2.8	8.0	0.0	22.7	0.0	0.0	3.8	4.6	21.8	0.0	19.4	39.2	0.1	0.2	0.0	12.9	0.3	2.6	2.9	3.2	1.6	4.5	13.5	0.0	0.1	13.3	0.6	8.3	6.1	17.1	9.6	3.8	2.8	2.5	21.9	18.1	1.2	0.0	3.4	29.7	0.0	0.0	0.0	1.0	4.0	33.2	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1	17.9	66.3	11.9	39.0	24.8	15.2	0.3	68.8	10.7	20.5	54.1	9.8	14.0	38.1	94.3	0.9	20.2	81.2	23.3	74.3	97.6	32.9	36.0	43.7	49.7	24.9	7.9	66.7	21.5	7.0	3.1	29.4	17.5	38.8	23.4	57.1	28.8	107.8	112.2	28.7	115.0	14.1	25.8	53.4	0.9	2.1	19.3	10.1	10.0	43.0	29.2
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase, receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 261.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.6;SK-BR-3: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		95000000	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	37.1	5.5	22.4	10.4	18.1	0.9	30.7	6.8	19.5	14.2	34.3	16.8	34.4	30.7	12.3	33.4	41.4	32.2	20.0	6.3	17.2	15.0	12.0	45.6	15.7	5.8	17.2	18.5	10.4	25.3	17.5	10.3	38.1	16.1	30.9	23.1	5.9	41.9	23.6	2.9	46.8	35.5	16.8	11.2	2.0	21.8	4.3	15.8	4.6	12.5	11.7	14.9	21.4	21.3	0.9	0.0	0.2	0.0	0.0	0.0	0.7	31.0	14.9	9.7	11.5	2.2	0.1	54.6	17.8	7.1	14.7	12.6	15.8	42.3	0.0	5.0	7.8	11.9	24.3	11.3	39.2	17.9	0.3	14.1	0.1	10.2	14.3	6.9	0.2	0.2	2.3	22.6	21.2	35.2	18.6	21.9	1.5	4.7	1.4	5.4	17.9	0.2	0.2	14.8	17.2	4.1	10.8	17.3	0.7	5.7	46.9	14.6	5.4	17.7	62.4	2.3	26.9	18.1	3.3	17.1	0.3	23.6	1.5	23.7	0.6	0.5	0.0	1.4	0.7	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	22.4	18.1	6.8	19.5	17.2	15.0	17.2	18.5	16.1	15.8	145.9	89.7	2.2	43.9	55.8	11.0	4.0	152.8	81.7	63.7	82.0	41.2	48.4	0.0	138.1	4.0	7.0	185.3	0.0	104.8	261.2	17.9	82.4	4.7	141.8	12.4	174.8	96.9	9.2	4.3	6.9	6.4	5.4	11.8	4.6	152.5	28.3	148.7	95.1	6.7	13.9	28.0	0.0	11.0	8.0	34.8	79.8	55.4	2.2	124.5	65.3
KDM4A	"JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A"	ENSG00000066135	"Lysine demethylase 4A"	O75164	1	43650158-43705515	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA007610	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA007610: AB_1852006"	"unprognostic (7.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	12.8	29.5	12.7	15.4	19.7	11.2	14.5	23.4	22.3	17.5	18.8	20.7	17.6	29.0	18.2	14.6	19.1	19.7	15.4	10.7	11.9	11.5	13.9	18.5	15.3	14.8	14.8	16.3	22.1	15.1	22.3	22.4	13.8	19.1	15.3	20.0	21.6	17.9	12.9	13.2	23.4	23.3	16.1	13.8	18.6	15.2	6.9	14.1	29.7	18.5	11.3	22.3	17.2	15.5	6.7	5.9	12.8	7.2	6.2	7.7	4.6	10.6	9.9	16.0	28.4	15.8	15.0	11.4	10.1	11.6	15.5	15.4	11.3	9.6	14.0	10.5	10.1	11.8	11.2	19.8	12.0	16.1	9.8	16.3	19.8	14.9	9.1	15.1	14.2	16.0	16.3	19.5	15.2	19.2	11.9	16.1	12.2	9.8	20.1	11.2	8.4	11.1	12.1	26.7	9.2	10.0	14.9	18.8	9.9	11.0	21.4	14.4	13.0	22.1	15.3	27.8	24.9	8.9	48.2	12.3	9.3	15.0	8.3	13.7	9.2	11.0	12.6	9.7	12.0	17.5	11.1	6.8	12.8	6.9	5.6	7.7	6.7	6.7	5.6	5.9	5.1	4.6	4.0	4.5	6.2	7.2	5.3	7.1	4.6	12.7	19.7	23.4	22.3	11.9	11.5	14.8	16.3	19.1	14.1	8.9	21.1	2.2	4.2	8.1	20.8	6.8	7.6	26.8	4.5	1.8	35.3	7.1	5.0	7.9	9.2	7.1	13.8	0.0	5.9	4.7	8.3	4.8	12.7	8.6	7.5	30.2	11.5	9.8	6.4	4.4	11.5	7.7	1.7	10.0	19.3	10.6	8.9	10.5	13.8	5.7	23.4	6.5	6.2	0.7	1.0	4.1	6.8	5.7	14.0	5.0
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"	NA	NA					"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	11.6	9.0	13.0	8.9	16.5	9.9	12.8	15.5	20.4	9.0	10.3	9.0	8.0	3.2	10.8	10.7	8.7	8.3	7.2	16.9	12.8	13.9	6.7	9.1	7.2	7.6	12.0	10.4	13.3	7.5	6.9	10.9	6.7	11.6	8.8	5.1	9.0	8.0	13.9	71.5	7.4	3.8	15.9	7.7	6.0	5.9	14.5	10.3	3.2	8.1	17.8	4.8	8.1	7.0	7.1	7.0	5.8	4.2	4.7	7.6	6.1	2.4	1.9	14.2	6.7	11.2	14.2	1.8	9.3	19.4	8.7	8.4	1.6	4.0	4.5	4.8	11.9	4.8	2.3	1.2	6.1	10.5	5.3	3.2	8.6	6.0	4.6	9.4	3.9	4.3	7.5	4.6	6.4	14.0	16.7	6.8	11.2	5.1	8.4	16.1	1.6	4.0	7.4	5.6	0.6	5.0	6.7	1.9	3.0	7.0	1.6	5.8	8.5	3.7	1.4	8.1	6.0	2.1	18.8	6.5	5.2	2.4	8.5	9.4	6.7	3.8	4.2	7.7	9.4	9.6	2.9	4.2	2.5	6.8	2.5	6.1	4.5	4.4	5.1	3.0	7.1	7.6	5.7	5.8	4.7	3.7	7.0	5.2	6.1	13.0	16.5	15.5	20.4	12.8	13.9	12.0	10.4	11.6	10.3	6.0	20.0	0.9	2.8	3.0	8.5	22.8	2.5	6.7	3.4	3.5	0.0	2.1	5.0	2.6	16.4	7.4	0.2	0.0	2.1	1.2	7.4	2.0	23.1	9.0	2.6	17.5	2.4	4.3	2.4	10.2	3.4	4.6	3.3	3.6	1.2	3.9	2.3	0.0	11.0	5.6	16.1	19.4	7.2	5.2	3.8	1.1	0.8	3.5	1.6	7.9
ARTN	"ENOVIN, EVN, NBN"	ENSG00000117407	Artemin	Q5T4W7	1	43933320-43937241	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 18.3"	"Cell type enriched"	"Detected in some"	10	"Urothelial cells: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 29.8;HaCaT: 31.5;HBEC3-KT: 28.0;hTCEpi: 11.8;hTERT-HME1: 9.0"	"Region enriched"	"Detected in single"	9	"olfactory region: 4.0"	"Region enhanced"	"Detected in single"		"olfactory region: 1.0"						"Secreted in other tissues"	NA	NA						"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.59e-6)"	"unprognostic (2.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.53e-1)"	2.4	1.1	0.7	2.2	2.5	1.2	2.1	4.3	1.7	3.9	3.7	0.5	7.6	0.6	3.6	5.6	4.1	2.0	5.1	2.0	0.6	1.6	6.2	0.4	2.1	0.5	1.0	0.1	2.4	14.4	18.3	8.0	10.4	4.8	10.0	2.5	0.7	5.3	12.4	1.0	1.2	1.1	2.0	2.0	0.6	1.7	2.2	0.7	0.6	1.8	4.4	1.5	4.7	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.8	0.7	0.5	0.4	0.1	0.1	0.1	1.2	0.2	1.2	1.2	0.1	0.7	0.3	0.1	0.4	0.3	31.5	0.0	28.0	0.2	0.1	0.9	0.4	3.0	0.0	0.0	0.1	0.6	0.0	11.8	0.5	9.0	5.4	0.0	0.4	0.3	0.9	0.1	2.1	0.1	1.7	2.6	0.0	1.1	0.5	0.0	0.4	0.1	0.5	0.6	0.2	0.1	0.0	0.6	0.5	5.0	4.5	0.3	0.5	0.2	0.2	1.2	3.0	2.2	0.3	4.0	1.4	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	4.3	1.7	0.6	1.6	1.0	0.1	4.8	0.7	0.0	0.0	0.0	2.6	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.1	5.6	0.0	0.8	0.0	0.2	0.0	0.2	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.8	4.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	56.7
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946939-43968022	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 80.5"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 39.4;Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain					NA	NA					"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	8.1	10.7	21.8	7.3	28.5	6.7	6.8	17.6	27.6	8.4	7.4	42.1	4.5	7.2	8.5	11.1	12.2	10.7	7.4	17.4	27.6	16.6	16.0	9.2	7.2	7.0	27.8	18.4	7.6	8.0	21.6	10.8	8.0	18.4	10.4	8.2	7.4	10.5	13.1	80.5	11.1	6.1	12.1	35.8	7.7	7.3	25.1	27.6	6.3	13.8	13.0	7.9	8.1	5.8	2.8	5.5	2.6	3.7	4.5	4.9	2.2	13.6	11.1	11.2	17.7	30.6	15.9	9.4	13.1	12.2	19.7	15.1	8.5	6.9	14.3	13.6	17.1	12.5	15.3	20.1	23.1	13.1	14.5	17.2	14.9	20.1	11.6	21.6	9.9	13.9	16.2	23.6	25.5	16.0	14.8	13.0	11.2	14.9	13.2	15.6	9.5	10.0	13.1	10.3	11.7	18.7	13.9	14.1	15.0	14.5	13.2	18.0	8.3	12.3	20.8	17.0	15.4	13.0	13.8	10.6	19.7	11.9	17.1	14.7	14.8	18.1	6.9	12.6	21.5	17.1	0.0	3.3	2.6	4.9	3.7	4.4	2.8	3.2	4.9	5.5	2.2	2.9	3.6	1.1	4.5	3.7	5.3	3.8	2.2	21.8	28.5	17.6	27.6	27.6	16.6	27.8	18.4	18.4	27.6	0.0	1.3	6.5	2.5	3.0	14.7	21.7	10.2	5.3	3.4	10.4	7.9	5.2	1.7	5.8	39.4	5.2	7.5	0.0	3.7	3.3	4.2	3.3	0.0	10.2	14.0	27.0	2.9	4.9	9.1	63.2	7.8	2.8	8.5	8.2	4.6	11.2	5.2	0.0	14.9	14.7	7.3	0.0	4.7	19.1	11.9	3.8	3.4	5.0	4.7	3.4
DPH2	DPH2L2	ENSG00000132768	"DPH2 homolog"	Q9BQC3	1	43970000-43973369	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045796	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA045796: AB_2679456"	"unprognostic (2.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.17e-8)"	"unprognostic (1.38e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.37e-2)"	9.6	12.7	13.5	12.4	14.1	7.5	9.8	7.9	18.8	8.3	12.0	12.4	5.9	8.9	9.4	7.5	15.2	10.8	11.5	11.6	11.6	6.3	11.5	21.7	8.5	14.1	13.6	9.3	9.1	21.1	10.4	10.6	8.3	9.7	9.8	11.9	5.8	11.6	9.2	33.4	13.1	9.9	11.2	7.6	13.7	10.6	14.7	12.3	10.8	8.9	14.6	13.5	10.3	7.8	9.0	10.2	0.5	9.2	9.8	10.1	5.8	9.9	11.5	5.2	11.0	3.9	4.1	17.5	5.3	5.8	13.9	11.4	14.6	9.8	16.8	9.1	5.5	7.2	11.5	17.4	15.1	7.5	11.5	15.2	17.3	14.4	15.1	10.3	19.9	9.8	6.3	16.9	16.4	9.1	4.2	9.6	13.4	21.8	9.5	6.9	11.6	17.6	11.0	35.9	16.7	13.2	15.2	11.9	27.2	8.7	8.0	17.9	20.7	7.0	17.8	12.9	7.3	7.5	13.8	6.2	6.7	15.4	11.8	21.1	23.3	38.5	17.2	6.0	22.2	9.8	0.0	6.6	0.3	6.7	9.2	9.9	9.0	6.8	6.9	10.2	8.8	7.0	10.1	0.5	9.8	4.7	8.5	6.6	5.8	13.5	14.1	7.9	18.8	11.6	6.3	13.6	9.3	9.7	12.3	0.0	3.7	17.1	9.7	20.4	6.3	8.5	10.2	6.7	3.4	1.8	9.8	12.3	5.0	14.8	0.3	6.0	2.5	0.0	16.3	12.3	7.0	9.4	4.6	4.2	7.7	3.2	11.5	3.1	1.8	0.9	7.8	5.0	5.0	10.8	6.5	4.5	11.7	0.0	3.5	7.3	5.5	0.0	11.2	8.6	27.1	23.7	7.2	6.9	11.8	8.0
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 173.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol		NA	NA			Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.87e-4)"	20.4	35.7	35.4	21.8	35.3	84.2	28.5	29.1	56.4	23.3	28.3	32.2	26.7	19.2	13.9	35.6	21.9	20.0	22.0	24.8	41.2	44.7	47.6	56.3	25.8	28.5	43.6	31.5	12.9	87.0	32.5	36.3	35.0	33.9	27.0	32.0	32.4	34.8	22.2	27.9	20.1	20.2	19.1	34.8	33.2	25.2	15.3	24.8	16.3	38.7	19.5	24.7	23.2	16.5	23.7	58.0	173.6	78.0	8.8	14.2	87.6	23.7	23.2	19.3	24.2	29.7	15.7	23.6	21.4	31.8	41.6	36.0	24.9	26.0	22.1	19.8	22.6	49.4	19.7	45.0	32.2	19.6	20.7	46.9	27.6	40.1	35.8	47.1	42.9	53.7	19.3	42.5	45.8	40.6	26.7	20.0	31.0	27.5	48.5	34.0	25.1	17.7	71.5	31.8	34.5	49.6	25.1	18.5	60.2	43.3	29.3	45.5	22.5	14.4	57.1	53.6	22.8	23.4	77.2	10.1	21.5	18.3	38.7	51.4	39.3	57.7	24.5	29.2	61.2	33.5	31.9	78.0	64.2	13.2	48.1	13.0	23.7	14.2	12.7	48.1	19.1	10.8	10.9	173.6	8.8	44.0	58.0	13.7	87.6	35.4	35.3	29.1	56.4	41.2	44.7	43.6	31.5	33.9	24.8	74.5	137.9	144.5	130.3	298.3	238.3	92.4	122.3	100.4	66.0	268.7	96.2	165.0	170.8	307.8	2.7	147.4	174.0	23.3	286.0	191.3	151.0	308.8	203.1	213.0	743.7	122.3	214.8	101.3	356.6	8.6	73.1	420.3	266.6	357.1	190.7	203.9	311.9	371.7	61.5	175.0	164.2	77.6	135.2	133.6	224.9	313.3	415.2	116.5	165.6	262.4
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		12000	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	20.1	14.7	15.3	26.1	20.9	18.7	15.4	22.8	18.8	18.2	16.7	9.7	17.7	13.2	11.7	36.4	16.7	14.0	13.7	23.3	8.5	13.3	26.0	8.8	10.2	22.1	16.9	8.4	0.3	16.3	27.3	13.0	26.7	19.2	21.0	5.3	16.6	8.6	14.2	14.5	4.4	8.4	21.4	14.4	18.4	15.7	20.6	20.7	12.9	9.4	27.9	23.2	10.0	31.6	15.3	8.0	13.7	10.0	16.5	31.7	40.6	21.9	25.4	3.1	6.0	5.6	14.2	6.4	21.1	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3	0.0	12.0	0.8	8.4	6.9	13.5	12.2	7.6	2.7	4.5	14.0	3.9	1.6	1.7	12.6	14.0	7.4	5.8	0.0	17.4	6.6	10.6	10.5	0.0	17.8	2.1	17.5	15.6	4.3	0.6	5.4	15.3	1.8	3.3	2.8	19.7	7.5	21.8	7.0	11.7	8.6	12.0	6.5	6.1	3.5	13.0	11.0	0.5	1.3	13.3	14.9
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 52.2;Intestinal endocrine cells: 34.9;Spermatocytes: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: AB_2684591"	"prognostic favorable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (3.18e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.8	5.5	9.3	2.6	9.8	1.1	5.1	3.0	9.8	7.2	5.0	3.2	18.9	3.7	4.9	6.6	2.6	20.3	13.1	1.5	6.4	8.0	8.9	3.0	3.2	2.6	5.5	9.6	3.4	6.0	9.6	14.5	2.4	5.2	7.2	4.1	6.5	8.4	14.7	1.5	0.9	3.3	3.4	3.3	3.0	4.9	15.4	1.7	0.6	8.8	1.0	2.5	4.7	2.1	6.8	0.8	1.4	4.0	0.5	0.6	0.5	5.1	3.1	1.4	1.6	1.4	1.0	3.1	0.2	2.2	1.6	2.8	2.0	15.0	4.2	5.9	0.6	4.6	5.3	0.8	7.4	1.5	4.4	1.8	2.1	1.9	0.6	1.6	0.7	3.7	0.3	0.7	5.2	0.5	5.0	1.3	1.6	0.9	1.6	2.2	4.5	0.3	1.6	3.1	4.7	2.6	1.3	0.0	0.8	6.2	2.0	3.4	3.0	4.6	2.6	2.9	3.1	7.8	0.1	0.4	2.4	7.0	1.8	0.7	0.6	2.0	0.9	6.3	0.6	2.0	0.0	0.7	1.4	0.6	4.0	0.3	6.8	0.2	0.2	0.8	3.0	0.0	0.0	0.6	0.5	3.1	0.6	0.0	0.5	9.3	9.8	3.0	9.8	6.4	8.0	5.5	9.6	5.2	1.7	3.0	7.4	0.5	8.2	1.0	8.8	0.8	12.7	52.2	19.4	8.7	5.9	4.7	18.3	7.1	16.4	0.7	6.3	0.0	6.4	1.7	3.3	6.8	2.3	2.1	2.9	3.2	34.9	1.8	3.2	8.5	2.0	1.8	3.3	4.6	12.1	9.5	5.4	8.6	2.8	8.0	14.2	0.0	2.4	48.8	19.5	0.6	2.1	0.0	13.0	8.4
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 26.6;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.9;hTCEpi: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.3	5.5	2.7	7.0	4.4	1.5	6.2	5.9	15.9	9.6	11.9	1.8	2.9	0.1	0.6	16.3	0.0	23.9	4.2	4.7	1.9	0.0	0.7	6.5	13.1	2.1	20.2	1.4	0.3	4.5	41.9	4.7	11.2	6.0	0.2	4.7	5.0	18.8	0.4	4.0	1.0	0.0	2.1	2.8	7.4	0.8	0.0	8.4	0.9	0.8	1.7	1.6	3.0	13.7	2.7	0.7	3.6	3.9	0.1	1.1	4.5	0.9	3.0	20.8	14.3	1.6	3.6	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3	0.0	1.3	0.9	0.7	6.6	26.6	0.6	5.1	8.1	0.0	1.8	15.7	0.4	0.0	3.2	5.8	0.4	9.8	70.0	7.9	0.7	0.9	1.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.4	1.4	0.0	3.3	1.8	2.9	1.2	4.2	2.0	1.4	1.0	10.2	6.5	6.3	0.0	0.4	11.3	0.5	0.0	1.3	2.5
KLF17	"FLJ40160, Zfp393, ZNF393"	ENSG00000171872	"Kruppel like factor 17"	Q5JT82	1	44118850-44135140	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 31.5"	"Group enriched"	"Detected in some"	73	"Early spermatids: 110.1;Late spermatids: 32.3"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 4.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 3.2;HBF TERT88: 4.0;U-138 MG: 6.6"									HPA024629	Enhanced					NA	NA					"HPA024629: AB_1668927"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-4)"	"unprognostic (4.02e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (5.17e-2)"		"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.70e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.35e-2)"		"unprognostic (5.54e-2)"	"unprognostic (6.60e-2)"		"unprognostic (8.04e-3)"	0.1	0.8	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	1.6	0.1	1.2	0.3	0.4	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	2.5	0.2	0.1	0.1	31.5	0.1	0.1	0.1	0.1	0.1	1.8	0.1	0.3	0.3	2.5	0.4	0.8	0.9	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.9	2.1	3.8	3.2	0.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	4.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	1.1	0.1	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.7	0.1	0.1	0.0	6.6	0.8	0.2	1.9	0.0	0.0	0.1	0.6	0.2	0.2	1.2	0.4	0.9	0.3	0.3	0.2	0.3	0.4	0.4	0.0	0.3	0.9	0.6	2.5	0.8	0.3	0.3	0.8	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.1
KLF18		ENSG00000283039	"Kruppel like factor 18"		1	44137821-44141631	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	19	"testis: 1.9"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597"	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	12.7	31.7	21.5	17.6	22.4	12.5	12.6	21.3	31.5	12.8	13.8	20.4	15.6	13.5	14.0	14.9	12.9	19.8	11.7	20.3	20.7	18.3	14.9	16.1	12.9	17.2	18.0	19.4	23.3	19.9	25.3	15.7	14.3	17.9	13.9	11.9	19.2	21.1	15.2	30.5	18.0	12.7	17.0	15.8	16.7	13.8	13.8	17.0	15.2	18.1	14.3	13.6	12.7	11.4	18.6	15.4	23.2	14.8	26.5	23.1	15.0	12.4	13.2	18.7	9.8	9.7	9.2	21.6	11.0	14.8	26.7	23.1	21.6	15.6	18.7	15.0	17.7	10.5	10.2	16.6	14.2	14.2	14.9	26.9	17.1	23.6	21.3	17.6	16.8	13.1	14.4	15.8	22.0	12.7	17.2	17.2	17.9	11.9	17.2	15.5	14.4	23.4	21.1	26.6	6.4	16.9	23.8	18.9	20.3	14.0	15.8	17.4	14.4	20.7	14.9	21.0	18.9	12.3	19.4	16.5	7.6	22.9	17.4	22.2	20.9	12.5	14.9	14.3	16.7	12.4	23.2	14.8	14.1	21.2	13.1	21.6	18.6	21.4	21.8	15.4	18.6	19.6	19.3	6.4	26.5	10.5	12.4	23.1	15.0	21.5	22.4	21.3	31.5	20.7	18.3	18.0	19.4	17.9	17.0	29.8	27.9	19.5	20.8	17.1	38.2	20.9	20.4	26.8	14.8	10.4	23.6	62.4	24.9	28.1	32.9	20.7	35.1	46.7	36.4	27.8	20.5	10.0	26.5	17.4	28.6	22.3	52.2	18.4	21.5	52.0	16.7	14.0	16.9	27.1	25.6	36.1	20.7	25.9	16.6	28.1	52.1	6.5	19.6	25.4	33.4	15.6	43.8	20.0	24.0	11.9
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 823.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	12.6	15.4	30.7	8.3	32.0	12.4	15.2	19.7	43.7	15.1	13.4	23.2	10.8	12.3	14.7	22.2	13.4	23.4	12.7	21.1	28.9	25.1	25.3	15.5	11.7	10.0	23.9	26.8	18.6	15.7	24.0	17.2	13.5	22.9	16.7	14.1	14.8	14.7	16.9	35.7	13.3	8.6	17.7	17.9	9.5	10.6	24.4	21.9	9.7	17.6	11.9	11.0	12.5	12.1	18.8	25.3	9.6	22.2	14.8	18.2	15.2	28.6	22.2	28.2	31.2	18.5	23.3	17.7	18.8	25.0	33.4	31.2	14.3	30.7	20.5	31.8	23.1	17.1	16.6	25.2	32.0	23.6	22.9	48.6	22.9	37.5	20.2	27.1	23.1	13.2	23.7	30.1	25.3	34.8	24.8	22.9	22.9	22.3	16.7	21.9	19.3	25.6	21.6	33.4	25.5	35.2	24.7	25.9	30.0	25.9	15.1	48.1	22.7	20.5	28.1	33.2	23.3	18.4	19.1	13.9	22.1	23.1	24.0	28.4	15.9	18.5	22.0	27.4	20.1	27.8	9.4	16.3	9.6	16.7	22.2	18.2	18.8	14.0	16.2	25.3	18.3	16.7	17.2	1.5	14.8	21.3	18.9	18.1	15.2	30.7	32.0	19.7	43.7	28.9	25.1	23.9	26.8	22.9	21.9	23.8	16.8	23.4	29.6	28.0	20.9	13.7	10.2	10.7	9.1	27.9	2.0	80.0	82.9	48.6	192.5	20.2	20.0	0.0	54.5	67.1	42.9	35.8	15.0	21.3	39.5	23.8	113.7	19.6	24.3	823.2	33.6	22.4	45.5	35.1	48.9	30.3	33.0	25.9	34.3	131.8	13.5	6.5	31.1	46.2	48.7	30.2	51.5	15.4	35.1	23.5
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 37.2"	"Low region specificity"	"Detected in all"							"HPA027577, HPA027578"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA027577: AB_2672339, HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	9.8	7.4	20.9	9.6	38.5	12.7	6.7	12.6	40.1	5.4	9.2	40.7	2.7	10.7	8.0	8.8	6.0	9.3	4.5	9.2	33.4	20.9	7.4	5.1	7.4	7.6	49.8	19.8	9.5	8.1	7.0	5.7	8.7	25.8	7.7	5.9	4.2	9.3	7.1	28.4	8.7	8.8	8.0	57.4	7.9	7.6	7.0	49.6	5.0	7.3	4.6	8.0	7.9	5.6	3.6	6.6	2.8	2.3	1.9	4.3	1.4	6.1	2.9	12.6	4.2	4.9	4.5	9.4	7.2	6.7	5.6	8.3	5.0	6.1	11.9	6.4	5.8	8.0	4.0	14.0	5.9	7.6	14.7	12.5	16.3	9.1	8.4	7.9	11.5	8.4	4.9	13.6	6.2	10.0	4.6	3.2	6.3	12.0	5.9	3.5	4.2	11.3	8.7	13.7	6.7	6.6	9.6	7.4	8.5	3.6	3.8	5.7	7.0	6.1	4.3	8.7	4.6	3.2	20.4	4.9	6.0	6.4	5.6	13.3	13.5	12.9	8.5	4.9	37.2	3.5	2.4	2.3	2.8	3.2	1.8	2.4	2.4	1.0	4.3	3.4	3.6	1.9	1.7	1.5	1.9	1.3	6.6	3.2	1.4	20.9	38.5	12.6	30.8	33.4	20.9	49.8	19.8	25.8	49.6	8.9	12.0	15.9	12.3	13.5	23.6	19.4	25.5	4.0	9.1	22.7	23.6	15.6	14.9	16.5	7.9	16.1	22.2	46.7	24.8	20.6	12.8	18.6	10.4	25.9	22.1	22.3	17.3	15.4	25.1	11.8	17.8	12.8	11.8	15.4	22.6	13.2	19.6	20.1	13.1	27.9	17.0	6.5	9.9	27.4	27.9	15.3	8.5	20.0	25.2	12.7
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674555	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7;liver: 44.7"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 845.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 38.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 38.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	8.3	9.0	6.0	4.4	8.7	6.0	7.0	2.4	11.8	4.9	11.0	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8.0	5.2	7.2	13.9	6.0	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4.0	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8.0	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.2	2.4	7.3	2.1	17.0	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.3	9.3	7.3	8.8	1.9	4.8	2.4	5.5	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.9	5.2	4.0	1.1	23.6	13.1	8.0	5.6	5.4	2.4	9.6	12.4	5.9	3.0	5.8	1.0	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3.0	8.6	2.6	5.3	3.1	2.5	2.6	5.0	1.5	2.0	0.5	2.8	6.0	38.7	3.0	2.8	6.0	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8.0	4.4	6.0	11.8	2.4	6.7	1.4	5.6	24.6	10.2	18.7	9.1	19.2	3.9	11.6	38.1	14.3	155.5	8.7	50.1	23.3	22.5	13.2	5.6	7.8	5.8	81.3	29.8	17.5	13.8	8.0	8.3	845.8	8.3	7.2	8.5	1.8	18.4	12.9	16.0	56.1	11.7	39.8	12.4	25.8	7.3	5.1	8.3	1.9	7.8	4.1	15.4	10.3
C1orf228	"MGC33556, NCRNA00082, p40"	ENSG00000198520	"Chromosome 1 open reading frame 228"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.0;testis: 17.9"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 46.8;Early spermatids: 45.0;granulocytes: 81.7;Late spermatids: 39.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 8.6;MOLT-4: 7.1;NB-4: 10.1;U-937: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favorable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.9	2.2	6.3	0.7	11.2	4.3	1.5	3.2	6.8	1.7	1.0	5.6	3.9	0.7	3.1	6.8	1.3	14.0	1.5	0.6	6.5	2.4	1.4	7.0	2.0	1.5	1.4	7.5	4.5	1.4	3.0	5.4	0.8	7.7	1.8	0.9	3.3	1.6	1.4	0.5	1.7	0.8	0.9	2.4	0.8	1.4	17.9	5.4	0.2	1.3	0.0	1.0	0.8	0.8	1.4	6.2	10.4	2.7	0.5	2.3	1.8	0.2	0.3	2.0	0.1	0.7	2.6	0.5	0.0	0.3	0.5	0.3	0.5	4.3	0.3	0.3	0.9	1.0	0.5	0.0	0.0	0.0	1.1	0.2	1.0	2.6	0.6	0.2	8.6	5.1	2.0	0.3	0.8	0.0	1.5	0.2	0.3	0.1	0.8	0.2	0.1	7.1	10.1	0.1	0.6	0.1	3.7	0.2	2.4	0.9	0.0	1.4	0.9	0.0	1.4	1.1	1.4	0.4	4.5	0.0	0.3	0.3	0.4	0.0	0.3	0.3	0.2	0.3	13.7	0.4	10.4	2.7	7.5	0.3	0.8	0.1	0.7	1.5	1.0	1.3	1.4	2.2	2.3	1.2	0.5	0.1	6.2	0.1	1.8	6.3	11.2	3.2	6.8	6.5	2.4	1.4	7.5	7.7	5.4	6.0	5.0	14.5	0.4	0.7	1.1	0.0	0.0	46.8	9.1	0.0	11.8	0.3	0.0	0.0	45.0	0.0	0.3	0.0	0.0	0.1	0.7	0.4	81.7	3.2	10.7	1.6	9.8	0.0	15.0	39.8	0.3	6.1	0.0	0.0	0.6	6.1	0.0	0.0	0.7	0.0	4.3	6.5	0.3	2.3	14.3	0.6	0.1	1.0	0.6	0.1
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Group enriched"	"Detected in many"	18	"Early spermatids: 430.2;Late spermatids: 1559.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	29.0	11.3	25.3	20.2	1.4	2.9	17.0	21.8	15.6	44.7	39.0	19.1	21.1	33.5	10.5	10.7	30.9	13.9	25.7	14.7	40.9	21.6	11.1	39.6	20.0	15.9	0.1	29.2	18.4	0.7	1.4	31.8	15.6	4.1	14.4	23.8	31.2	28.8	28.2	11.3	30.7	17.7	24.7	14.3	14.2	24.7	38.2	21.0	7.5	10.6	17.4	12.4	29.0	20.7	18.3	19.1	11.9	22.2	8.5	16.2	32.3	17.6	38.2	15.2	15.5	48.3	10.4	28.5	31.2	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2	0.0	0.3	0.8	0.5	1.5	1.0	0.8	0.0	0.0	2.3	1.8	2.0	1.1	1.7	0.3	430.2	0.1	0.0	23.3	0.3	20.1	0.7	0.6	0.0	0.0	7.4	0.0	0.0	4.3	1.0	1559.3	8.6	1.3	0.0	7.2	0.9	0.3	0.1	0.0	6.3	0.0	0.2	6.5	0.3	55.1	28.0	0.4	3.1	0.7	1.6	0.4
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		52000	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	55.7	60.7	44.8	44.4	46.3	100.1	82.0	50.1	65.5	69.6	47.8	33.8	37.0	40.7	61.9	48.4	78.0	66.7	43.9	36.8	34.6	23.7	41.6	74.1	36.5	77.7	34.8	34.6	195.0	98.3	13.1	37.2	45.4	36.8	53.5	42.5	32.3	61.0	72.7	53.7	91.2	45.6	39.4	35.6	57.0	47.4	71.9	29.0	64.8	40.9	97.3	72.0	52.7	71.2	146.1	98.0	15.3	50.2	61.2	128.4	168.5	102.3	51.3	82.4	108.5	143.3	225.6	134.8	75.3	119.5	106.5	85.7	87.9	112.1	194.1	83.1	91.2	68.6	70.3	105.6	131.1	78.8	70.2	184.5	72.3	73.0	116.8	203.7	143.7	71.0	179.4	217.6	70.9	190.6	153.6	127.2	117.8	107.4	136.5	99.0	81.0	157.9	153.8	180.0	86.4	88.8	127.3	100.9	216.6	119.5	88.1	88.2	101.8	40.7	228.4	298.5	83.3	79.8	289.3	86.7	53.0	92.9	81.2	127.8	107.8	105.6	146.7	64.8	172.7	63.4	10.3	50.2	15.3	55.1	49.1	94.1	146.1	101.4	76.7	79.2	124.5	128.4	106.7	5.0	61.2	38.1	98.0	84.2	168.5	44.8	46.3	50.1	65.5	34.6	23.7	34.8	34.6	36.8	29.0	1316.1	1723.1	6218.3	8263.7	7023.7	212.5	618.5	2667.5	1619.4	2842.4	1036.4	86.4	4856.6	3516.4	2080.0	402.3	3276.6	1407.7	2826.7	5263.3	6516.1	3553.3	5089.6	1744.1	1895.9	3113.3	57.2	2060.2	2974.6	3941.2	529.4	5688.8	4066.1	2795.5	3230.1	3644.2	416.1	4072.9	3794.5	2586.4	2671.8	154.0	1481.1	4301.1	393.8	413.6	9798.1	4485.5	3459.3	5777.2	7011.6
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44787705	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 34.3"	"Cell type enriched"	"Detected in some"	35	"Paneth cells: 745.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 7.4;U-698: 5.3"					"Low region specificity"	"Detected in all"			HPA058564	Uncertain					NA	NA					"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.5	1.1	0.6	1.4	2.5	0.4	0.5	2.1	0.7	1.2	32.7	0.5	0.5	8.8	0.7	2.6	0.5	7.2	0.5	0.5	1.0	3.2	0.5	0.5	1.1	0.5	0.5	0.5	0.5	0.5	0.4	1.8	0.5	0.5	0.5	15.9	0.5	0.5	0.5	0.5	1.8	34.3	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	3.0	0.9	0.7	0.1	0.9	2.8	0.4	0.2	0.6	1.1	1.2	0.4	0.4	3.5	0.8	0.4	0.3	0.1	0.4	1.5	0.3	1.5	0.4	0.8	1.6	0.3	0.2	0.4	0.8	0.7	0.2	1.9	7.4	0.4	0.0	0.9	0.7	0.9	0.4	0.7	1.8	1.0	1.3	0.2	0.6	0.2	0.2	0.0	0.5	2.4	0.2	0.2	0.4	0.3	0.7	0.5	0.1	2.5	0.9	0.3	0.2	0.3	0.8	1.2	0.1	1.7	0.5	0.5	0.5	0.5	1.2	0.3	5.3	1.2	0.3	0.2	0.1	0.1	0.5	1.1	0.1	2.7	3.0	1.9	2.8	0.0	2.0	1.0	1.8	0.7	0.9	0.0	0.9	2.2	0.4	0.6	2.5	2.1	0.7	1.0	3.2	0.5	0.5	0.5	0.5	0.0	0.0	0.8	0.7	0.2	0.7	0.4	0.0	21.4	3.4	5.2	0.0	0.3	1.7	0.5	0.0	0.3	15.8	0.0	0.7	0.1	0.2	0.4	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.9	0.3	0.0	0.0	3.4	1.0	0.4	745.7	0.4	0.6	0.1	0.0	0.3	0.5	0.7	0.5	0.2	1.3	5.0	0.4
PLK3	"CNK, FNK, PRK"	ENSG00000173846	"Polo like kinase 3"	Q9H4B4	1	44800225-44805990	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060318	Enhanced					NA	NA					"HPA060318: AB_2684252"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.78e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	14.8	7.6	4.4	16.3	18.8	8.6	10.0	2.4	6.4	8.6	5.3	13.9	3.2	4.0	9.9	5.8	23.9	8.5	21.6	6.8	10.5	6.0	6.7	9.0	14.9	10.0	9.9	2.5	7.8	10.7	15.6	9.0	29.6	14.8	6.4	4.0	7.6	8.2	6.8	7.0	16.6	7.0	6.0	15.2	9.1	6.1	4.5	5.6	4.6	8.4	25.0	18.2	9.9	9.5	1.3	4.2	2.8	5.1	0.6	11.0	3.5	4.1	2.7	4.2	1.9	3.1	10.1	7.8	9.7	13.7	3.7	3.7	1.6	5.8	5.0	4.1	7.9	12.0	3.7	2.3	13.2	2.1	8.1	0.7	5.6	1.5	3.6	15.2	1.8	7.2	7.9	8.0	11.0	10.8	12.9	11.6	1.8	2.8	2.1	8.3	2.7	3.7	1.6	2.8	2.5	3.3	4.4	2.8	7.3	13.2	1.5	3.2	2.0	2.6	4.5	10.7	6.7	0.4	1.7	14.8	2.3	5.7	4.5	5.7	5.8	2.7	1.3	4.9	2.9	4.5	0.0	2.9	0.8	1.7	5.0	2.1	1.3	9.9	4.2	4.2	1.1	11.0	4.9	2.8	0.6	5.1	1.8	10.5	3.5	4.4	18.8	2.4	6.4	10.5	6.0	9.9	2.5	14.8	5.6	11.9	41.5	19.3	51.6	39.2	5.3	2.2	12.7	9.4	12.5	5.2	2.0	13.1	0.0	17.7	0.6	29.7	73.5	0.0	11.3	19.2	25.9	18.8	78.3	5.4	35.4	6.4	50.8	24.5	18.9	0.4	9.2	52.8	11.8	10.8	21.9	5.4	18.2	66.6	4.9	2.3	9.6	25.8	26.8	1.7	4.9	29.4	49.5	24.5	28.1	55.0
TCTEX1D4		ENSG00000188396	"Tctex1 domain containing 4"	Q5JR98	1	44805913-44806675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 7.9;epididymis: 3.1;fallopian tube: 12.4"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 45.5"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 7.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;EFO-21: 2.4;HDLM-2: 2.7;SK-MEL-30: 2.2;TIME: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062652	Enhanced					NA	NA					"HPA062652: AB_2684818"	"unprognostic (3.12e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.58e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.83e-3)"	0.0	1.1	0.2	0.4	0.2	0.8	0.2	0.0	0.1	1.0	0.2			0.5	0.8	3.1	0.2	12.4	0.7	0.2	0.3	0.4	0.3	0.5	1.8	0.0	0.0		0.0	0.7	0.0	0.3	0.0		0.1	0.0		0.6	0.3	0.1	0.2	0.5	0.0	0.1	0.0	1.2	0.1			0.5		0.0	0.2	0.0	0.0	0.0	7.9	0.6	0.0	0.2	0.3	1.4	1.2	0.3	0.0	0.0	0.0	3.4	1.5	0.0	0.0	0.2	0.0	1.2	0.0	2.4	0.0	0.5	1.9	0.0	0.0	0.0	2.7	0.0	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.6	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.6	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	2.2	0.2	0.0	0.0	3.4	0.2	1.9	0.2	0.7	1.4	1.2	0.0	0.2	0.4	0.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3											0.0	0.3	0.0	0.5	0.2	0.0	0.2	2.5	45.5	5.7	1.8	0.0	0.1	0.0	0.9	0.0	0.0	1.4	0.0	3.5	0.2	0.2	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	1.0	1.2	0.0	1.3	2.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.6	0.5
BTBD19		ENSG00000222009	"BTB domain containing 19"	C9JJ37	1	44808482-44815585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 7.0;HUVEC TERT2: 6.4;TIME: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042633, HPA076404"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA042633: AB_2678091, HPA076404: AB_2686796"	"unprognostic (4.69e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.18e-8)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.70e-1)"	6.7	8.7	3.5	3.6	1.9	2.7	4.9	0.6	2.8	13.5	2.0	2.4	6.2	1.6	13.9	21.4	2.1	6.4	4.2	3.8	1.3	1.4	4.2	2.2	4.1	1.8	1.4	4.0	8.4	1.5	3.2	11.9	7.9	6.3	5.6	1.8	7.6	1.7	8.3	1.8	1.2	2.2	5.6	1.9	2.3	2.2	3.5	0.6	0.1	6.0	2.0	1.4	2.1	4.3	0.0	0.2	2.3	0.1	0.0	0.2	0.0	0.1	1.1	1.0	1.1	2.3	2.6	0.7	2.1	1.3	1.0	2.0	0.0	0.8	0.1	1.0	3.7	0.5	0.3	0.0	1.1	0.4	0.9	0.2	2.0	0.3	1.1	2.3	0.0	1.6	3.9	0.1	3.7	0.7	7.0	6.4	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.3	0.1	1.2	1.3	0.0	0.0	14.9	3.8	3.0	1.8	1.6	0.5	0.1	0.0	2.3	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	3.5	1.9	0.6	2.8	1.3	1.4	1.4	4.0	6.3	0.6	3.0	3.4	0.0	1.6	1.8	0.0	1.0	2.5	1.4	4.5	1.8	0.0	0.2	0.0	0.9	0.4	3.5	2.1	0.0	0.5	0.2	3.8	0.9	2.3	2.8	2.7	0.0	0.0	3.7	6.0	0.0	2.8	4.6	3.3	0.0	1.3	1.5	0.8	0.8	1.1	2.7	0.0	0.0	4.6	0.7	0.2	1.9	1.0	0.0	0.7	1.3
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843063	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.4;salivary gland: 44.3;testis: 32.0"	"Cell type enhanced"	"Detected in many"	15	"Leydig cells: 99.8;Peritubular cells: 64.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	2.5	1.9	8.0	2.4	5.2	6.0	2.2	9.7	7.2	2.5	2.0	1.2	1.3	1.5	6.7	1.9	1.3	2.7	2.4	3.3	6.2	6.1	1.0	1.2	1.2	2.2	2.5	5.8	19.1	1.1	82.4	6.8	1.0	6.0	1.8	1.4	4.6	44.3	1.7	2.0	2.3	1.3	6.6	5.5	1.8	1.2	32.0	5.2	0.0	3.1	2.4	1.3	2.2	2.3	3.4	7.6	3.3	3.8	2.0	2.4	0.5	0.3	0.4	1.6	3.7	1.3	1.4	1.4	1.2	2.4	0.8	0.7	0.4	0.5	1.5	0.7	0.6	0.8	0.1	1.6	0.1	0.3	3.2	2.8	0.9	1.2	1.1	0.4	0.9	1.8	0.5	0.6	1.5	0.1	2.5	0.2	1.5	1.0	1.6	0.1	0.8	1.8	3.0	0.5	0.1	0.6	1.4	0.3	0.7	0.3	0.1	2.2	0.9	0.4	0.6	1.0	0.9	0.3	1.8	0.2	0.3	0.9	1.9	0.7	2.7	15.3	4.5	0.9	4.4	0.5	3.3	3.8	0.3	1.1	2.0	2.4	2.2	1.4	1.4	2.5	3.4	1.7	1.3	1.3	2.0	1.8	7.6	0.7	0.5	8.0	5.2	9.7	7.2	6.2	6.1	2.5	5.8	6.0	5.2	0.0	1.4	20.6	0.4	0.5	0.6	0.9	7.6	1.4	1.2	1.8	2.0	1.9	0.0	3.2	1.4	1.6	8.4	0.0	1.6	1.4	3.4	0.5	0.0	5.9	6.3	7.9	11.1	1.3	23.6	4.3	99.8	3.4	0.0	2.8	4.9	1.9	2.6	0.0	64.0	0.0	1.0	12.9	3.3	3.4	2.7	1.4	1.9	3.8	5.6	0.1
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	16.5	18.3	12.9	9.2	14.6	7.1	16.1	22.2	16.5	11.6	10.1	13.1	11.2	6.6	13.1	10.1	11.8	9.6	7.5	22.5	10.7	11.1	11.9	20.7	8.8	9.9	13.7	11.1	12.3	18.5	23.3	26.7	7.3	16.0	10.6	10.6	12.3	17.9	11.9	52.1	10.5	6.6	14.8	12.1	9.8	9.1	13.7	12.3	11.1	9.8	13.7	12.4	12.2	10.9	11.3	21.9	2.3	21.4	14.1	15.4	12.5	14.0	11.5	12.7	10.8	15.6	18.7	15.2	22.8	17.4	23.4	22.2	16.6	8.4	36.8	16.8	17.1	18.7	8.3	26.8	19.3	28.7	12.7	24.6	18.2	12.7	15.9	19.8	27.9	10.4	12.9	10.5	25.6	29.2	11.1	21.5	12.3	41.8	12.8	25.3	9.7	26.8	12.2	17.7	16.0	22.9	21.7	21.3	26.2	12.0	6.6	23.0	8.4	23.0	26.5	14.5	17.5	10.3	13.0	11.5	15.2	18.2	22.3	29.5	13.3	15.0	27.5	11.8	23.5	18.1	1.0	14.3	2.3	12.2	21.4	14.4	9.5	12.0	13.5	21.9	11.3	15.2	15.4	1.2	14.1	18.5	15.4	9.9	12.5	12.9	14.6	22.2	16.5	10.7	11.1	13.7	11.1	16.0	12.3	6.0	19.5	8.2	17.8	12.2	13.2	75.1	12.7	46.8	21.6	5.2	19.6	21.5	24.9	16.9	18.8	15.6	5.1	0.0	13.7	17.9	16.5	14.5	24.4	19.1	22.1	20.6	3.5	3.7	11.6	7.7	24.5	15.7	16.9	41.5	6.1	17.0	12.9	5.8	23.7	17.7	20.5	25.8	39.1	38.7	23.0	13.0	12.5	10.0	7.9	13.1
HECTD3	FLJ21156	ENSG00000126107	"HECT domain E3 ubiquitin protein ligase 3"	Q5T447	1	45002540-45011329	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027467	Approved					NA	NA		34000			"HPA027467: AB_10600710"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (3.19e-1)"	18.4	16.9	9.6	16.7	11.1	9.2	25.9	12.4	14.8	11.2	38.0	14.8	11.7	34.1	12.4	12.4	16.7	9.1	14.6	8.7	9.9	8.4	16.4	22.9	10.5	11.3	10.9	7.9	14.1	24.1	22.9	8.0	11.8	10.8	10.4	19.5	9.7	27.0	15.4	24.2	20.1	59.3	12.0	9.9	14.0	13.9	11.7	9.7	11.9	13.3	14.8	12.5	13.8	12.0	8.7	9.9	10.4	15.1	5.0	10.9	7.5	11.1	10.1	6.5	10.5	22.9	14.4	12.9	10.7	16.2	11.8	13.4	14.4	3.5	5.2	9.1	17.5	26.5	10.5	15.4	11.1	10.6	9.8	11.9	8.4	14.7	12.6	20.1	6.5	14.2	15.5	19.1	20.1	7.9	12.3	26.3	9.2	18.8	5.9	15.0	9.5	8.2	5.3	8.9	12.6	15.5	9.9	11.8	7.5	17.3	13.2	15.7	6.5	14.4	25.0	12.7	17.2	8.1	6.1	19.6	13.7	11.0	16.9	12.1	7.6	8.9	2.9	21.9	7.1	6.7	9.4	10.4	10.4	10.9	15.1	9.1	8.7	8.9	9.3	9.9	5.1	7.5	8.9	4.0	5.0	8.2	7.5	9.0	7.5	9.6	11.1	12.4	14.8	9.9	8.4	10.9	7.9	10.8	9.7	3.0	8.0	3.0	2.3	3.4	5.3	5.5	7.6	0.0	6.8	5.2	5.9	6.1	1.7	8.5	1.0	4.6	34.5	23.3	13.5	12.8	6.0	2.1	5.8	10.5	12.1	6.4	2.4	5.5	16.5	1.3	13.6	5.4	3.3	8.2	13.7	3.9	11.3	23.0	9.2	5.5	5.9	6.5	4.1	4.5	7.7	5.4	5.0	5.0	11.5	2.0
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Erythroid cells: 607.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.7	8.4	13.4	17.7	23.3	21.9	6.5	15.6	40.4	33.0	25.4	12.1	6.8	9.1	16.6	23.7	23.3	6.6	25.6	30.5	23.0	8.1	26.9	47.0	19.4	39.9	27.1	14.3	8.7	22.7	19.4	31.4	25.5	24.4	42.3	17.6	81.5	10.0	31.4	10.7	9.7	12.4	20.9	10.2	29.7	14.7	20.0	13.1	28.7	10.9	14.4	11.3	17.1	12.9	26.4	15.9	10.1	15.0	27.3	18.8	14.7	6.5	25.2	10.4	11.1	7.6	29.4	21.7	9.4	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5	41.7	38.9	45.2	26.1	20.4	23.6	60.9	40.8	22.7	18.2	26.2	15.7	83.3	76.3	62.1	7.2	47.7	22.7	607.3	55.7	45.2	63.6	19.5	50.8	86.0	88.6	12.7	17.2	30.7	34.3	12.5	73.6	37.9	45.5	163.3	18.4	80.8	47.4	21.8	52.6	99.3	21.8	38.8	41.5	35.1	38.5	21.7	41.6	21.8	17.4	22.2
ZSWIM5	KIAA1511	ENSG00000162415	"Zinc finger SWIM-type containing 5"	Q9P217	1	45016399-45306209	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 7.6;Cone photoreceptor cells: 9.8;Horizontal cells: 7.9;Intestinal endocrine cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.0;Hep G2: 7.9;SCLC-21H: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018211	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018211: AB_1859502"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.12e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.16e-1)"	1.8	18.5	5.9	4.4	6.5	0.7	3.2	17.3	6.6	3.8	7.2	6.6	3.8	7.5	5.2	4.5	2.2	4.5	5.4	2.5	6.4	4.6	5.2	1.3	3.8	2.0	4.9	4.0	14.0	5.4	16.9	16.0	1.8	6.1	5.6	8.5	6.2	6.3	4.4	2.0	2.7	11.7	5.4	3.2	2.9	3.2	6.6	7.1	0.0	7.1	1.3	1.9	4.4	3.7	0.1	0.5	0.0	0.0	0.7	2.4	0.3	0.6	1.8	4.2	7.0	0.6	0.2	1.0	0.2	5.6	1.0	0.9	0.5	0.7	0.4	0.1	0.1	3.2	0.2	2.9	0.1	1.3	2.9	5.3	0.3	5.8	7.9	0.0	0.8	0.9	0.1	0.2	0.3	0.0	0.6	1.2	1.4	0.3	0.3	0.1	2.3	0.5	0.3	3.8	4.8	2.1	1.9	0.1	0.2	0.1	1.3	9.9	5.1	2.7	1.0	0.5	1.2	2.0	0.2	0.3	1.0	0.6	0.3	1.1	1.9	0.3	0.1	3.9	0.2	0.8	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.5	0.8	0.0	0.0	2.4	0.3	0.0	0.7	0.0	0.5	0.9	0.3	5.9	6.5	17.3	6.6	6.4	4.6	4.9	4.0	6.1	7.1	0.0	1.9	0.0	0.5	0.5	7.6	1.1	2.5	1.4	2.3	0.0	9.8	0.1	1.7	0.2	1.1	1.0	3.8	0.0	1.2	0.0	0.4	0.3	0.0	0.2	0.1	7.9	6.4	1.8	0.0	0.8	0.3	0.0	0.0	1.0	2.3	2.0	1.0	3.5	1.4	1.4	4.7	0.0	0.4	0.9	2.3	0.6	0.1	0.0	3.7	0.1
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326905-45328533	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 38.4"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	35	"hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8"	"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.9	0.7	2.7	3.1	4.2	3.6	1.0	7.6	3.4	2.0	8.4	2.4	0.0	5.4	1.0	1.3	3.6	1.0	1.8	3.0	2.7	2.4	0.7	0.2	0.8	2.6	2.5	1.8	1.0	0.3	0.2	0.4	5.1	3.1	1.7	7.1	38.4	1.3	0.6	3.3	1.1	4.7	0.9	2.2	2.8	7.8	1.4	0.6	6.4	1.0	4.2	2.3	0.8	1.6	3.1	0.7	0.0	0.3	2.1	1.5	0.8	0.0	0.4	0.1	0.0	0.0	0.1	47.2	0.6	0.0	0.8	0.2	11.7	3.1	2.4	0.1	0.6	0.0	2.8	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.0	0.3	13.3	0.3	0.5	0.1	0.5	0.0	0.0	0.9	0.0	0.0	2.2	0.1	5.8	8.6	16.6	0.2	9.1	0.0	2.6	0.0	7.7	0.1	0.1	9.3	0.6	6.0	29.8	4.6	0.6	0.0	2.5	0.4	0.0	0.1	0.4	0.0	0.3	0.1	8.3	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	1.5	3.1	0.7	1.2	0.7	0.3	0.9	0.8	0.0	2.1	0.0	0.0	0.4	0.8	2.7	4.2	7.6	3.4	2.7	2.4	2.5	1.8	3.1	0.6	0.0	0.0	1.9	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.6	3.3	0.5	0.1	0.3	0.7	0.0	0.0	1.7	0.4	0.9	0.0	0.0	2.1	0.0	1.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	2.1	1.0	4.2	0.0	6.6	1.0
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340470	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	7.7	8.4	10.3	12.7	14.8	11.1	8.3	31.6	12.4	10.5	10.1	15.1	11.0	11.1	11.5	9.8	8.3	11.0	10.0	6.1	10.9	7.3	9.7	9.0	7.2	14.0	13.6	10.1	12.9	8.4	7.5	12.5	12.5	11.6	9.1	11.0	12.6	9.5	11.7	8.5	11.1	9.8	7.5	12.6	12.8	11.8	4.9	16.6	14.1	11.9	7.4	12.0	9.3	9.2	7.2	6.5	1.9	8.9	6.6	15.4	6.3	4.9	4.3	10.1	6.9	7.2	5.4	17.6	3.4	4.7	7.4	6.1	9.1	7.0	13.9	6.1	2.3	5.9	7.6	5.3	6.3	3.4	11.5	4.0	6.8	6.9	6.5	6.7	5.8	5.0	3.6	6.5	9.9	16.6	1.9	5.3	18.3	10.5	5.4	3.1	8.0	15.9	5.5	25.5	11.7	5.3	21.6	7.8	7.5	3.8	9.3	9.2	7.2	7.4	5.8	11.5	13.6	4.6	6.7	3.3	6.5	4.0	5.0	5.4	8.2	9.4	8.5	5.6	8.8	4.9	1.5	5.6	1.9	9.8	8.9	15.4	7.2	10.2	9.9	6.5	7.2	11.3	11.0	0.9	6.6	6.8	5.5	10.3	6.3	10.3	14.8	31.6	12.4	10.9	7.3	13.6	10.1	11.6	16.6	0.0	6.4	7.0	10.7	6.2	14.7	3.1	0.0	9.4	6.8	7.0	2.0	33.3	3.3	5.7	0.8	5.2	13.7	0.0	4.6	11.1	7.0	7.0	10.4	3.9	8.7	4.8	7.5	6.7	6.4	0.6	10.0	6.9	6.8	9.0	12.3	11.8	3.3	14.0	11.3	7.0	18.5	12.9	7.1	7.1	11.1	4.6	18.5	12.9	12.5	6.4
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45339670-45343975	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	7.4	9.2	8.9	8.0	10.6	9.7	8.1	11.6	9.4	7.4	8.9	8.7	11.2	9.8	10.8	11.0	8.3	8.9	8.7	7.5	6.4	5.6	7.1	7.9	9.4	8.7	5.1	7.4	9.4	7.4	10.8	7.8	8.2	7.7	8.8	9.2	10.0	9.9	7.7	4.3	6.9	9.4	10.0	9.4	11.0	9.4	18.7	5.0	14.6	10.3	6.1	8.8	9.1	7.3	8.7	6.0	13.8	6.8	3.2	9.6	4.7	8.2	4.5	6.4	7.6	3.8	3.1	11.5	6.7	6.0	12.4	11.8	5.6	4.4	14.5	6.8	7.9	11.0	7.5	10.0	11.6	8.7	9.2	8.2	15.3	8.8	6.2	3.3	9.2	8.4	4.5	2.0	12.5	8.0	4.3	9.9	12.0	12.0	8.0	8.5	6.4	16.4	7.8	14.2	9.2	6.2	11.8	11.3	6.3	4.9	11.0	6.8	7.0	6.8	17.5	13.0	11.0	4.4	14.7	6.7	5.3	11.2	9.6	11.9	5.7	7.6	9.2	7.9	12.1	6.8	13.8	5.7	5.7	7.9	6.8	9.6	6.2	7.7	8.4	5.5	8.7	6.9	8.3	0.8	3.2	5.9	6.0	8.5	4.7	8.9	10.6	11.6	9.4	6.4	5.6	5.1	7.4	7.7	5.0	6.0	3.7	9.5	5.0	1.5	9.9	1.4	7.6	4.0	9.1	7.0	11.8	33.5	6.6	4.8	8.9	9.0	6.7	0.0	5.5	10.3	5.2	5.5	11.5	4.5	8.0	7.9	2.9	7.4	3.5	6.5	6.4	4.9	3.3	13.6	5.9	12.3	2.8	10.5	6.0	5.8	17.6	12.9	7.2	31.0	18.1	1.3	19.0	7.0	5.7	3.7
TESK2		ENSG00000070759	"Testis-specific kinase 2"	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;RT4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4.0	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6.0	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2.0	15.9	5.9	1.1	3.7	2.6	1.6	0.0	0.8	0.0	3.2	1.7	13.1	0.6	4.3	1.9	3.2	3.6	1.5	5.3	0.6	1.6	4.9	2.0	3.4	2.7	1.5	3.7	4.3	3.6	1.8	2.7	1.7	1.2	9.9	1.8	2.9	2.1	3.0	2.9	1.5	7.1	0.6	10.9	1.3	0.6	3.0	2.4	3.4	1.5	1.5	4.4	0.1	1.4	1.7	12.8	0.3	1.4	3.4	6.4	12.2	8.1	10.0	1.5	0.0	0.2	2.0	1.6	1.1	7.2	4.2	1.0	1.0	0.0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2.0	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8	0.0	3.2	2.4	6.5	6.9	2.3	1.1	5.1	1.4	3.4	0.0	13.7	6.5	0.0	1.0	18.1	2.9	12.4	0.0	2.3	2.5	2.2	12.9	6.9	5.5	5.9	0.0	4.1	1.3	4.6	5.2	2.6	4.5	3.3	2.8	5.3	1.1	1.0	7.4	1.8	0.6	2.8	6.5	4.7	26.8	5.7	7.4	12.4	4.4	4.9	7.3
CCDC163	"C1orf231, CCDC163P, LOC126661"	ENSG00000280670	"Coiled-coil domain containing 163"		1	45493866-45500079	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	11	"Cytotrophoblasts: 2.8;Distal tubular cells: 1.7;Ductal cells: 1.2;Exocrine glandular cells: 1.8;Extravillous trophoblasts: 1.6;Hofbauer cells: 1.0;Syncytiotrophoblasts: 1.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 7.0;U-266/70: 11.0"															NA	NA						"unprognostic (5.25e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.50e-8)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.38e-6)"	"unprognostic (4.73e-3)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (1.61e-1)"	1.6	1.3	3.2	2.5	4.7	3.4	2.0	2.9	4.2	2.5	1.6	4.0	9.0	1.5	1.7	0.7	1.2	1.4	1.2	0.9	3.2		0.6	1.2	1.6	3.3	5.5	0.1	1.9	2.0	7.1	4.7	0.9	3.4	0.5	1.5	3.1	5.9	5.8	0.7	2.0	2.2	1.4	7.6	1.5	0.7	1.2	5.4	1.8	4.4	0.0	1.8	2.1	0.0	1.0	1.0	3.0	0.5	0.4	1.8	1.7	2.3	0.0	0.0	0.6	0.3	0.0	0.9	0.3	0.1	2.3	1.4	2.7	1.3	0.4	1.3	0.5	0.1	1.7	0.4	2.5	1.3	3.8	1.5	1.2	1.3	1.9	1.7	1.2	0.7	0.1	0.5	1.5	3.2	0.1	0.9	2.3	1.1	7.0	0.5	1.9	2.6	0.3	1.7	1.3	1.5	2.6	0.1	1.9	0.4	0.2	0.6	1.1	0.5	4.5	1.2	0.9	0.7	0.0	0.0	1.4	1.1	1.8	0.9	11.0	5.0	2.0	0.7	1.3	0.4	3.0	0.5	2.6	1.2	0.1	1.8	1.0	1.1	1.0	0.2	0.5	1.2	1.7	1.4	0.4	0.1	1.0	0.3	1.7											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.7	1.2	0.0	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria"	Q9Y4U1	1	45500053-45513382	"Disease related genes, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.1"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	3.5	7.4	5.8	3.3	10.2	2.2	6.1	3.6	12.2	5.4	6.3	11.8	3.2	5.6	4.1	5.6	4.0	6.2	2.9	11.1	6.2	5.1	7.6	30.1	2.7	3.1	7.3	6.9	6.4	9.8	9.5	5.4	2.9	8.5	3.9	7.6	4.0	11.9	7.5	14.7	3.8	4.1	4.2	6.7	3.6	4.5	7.3	5.7	4.1	4.4	3.7	3.6	3.9	3.1	2.1	3.6	5.0	6.1	2.6	3.9	1.1	6.8	3.5	6.1	9.2	5.8	3.5	7.6	5.3	3.5	9.7	8.8	7.3	4.2	10.7	6.9	4.4	1.8	5.7	11.2	12.7	8.9	2.9	10.2	8.3	5.9	8.2	5.5	11.8	3.0	5.0	7.2	10.7	11.8	3.5	4.6	11.3	9.4	6.1	7.4	7.3	7.9	3.8	10.0	7.8	8.3	9.8	2.5	11.9	5.6	5.4	9.8	5.0	8.0	13.3	17.3	4.8	7.6	4.3	2.1	6.8	9.3	7.6	2.8	9.2	7.4	6.2	4.9	5.7	6.3	5.0	1.6	1.6	1.7	2.4	2.8	2.0	2.0	1.4	1.7	2.1	3.9	2.0	3.5	2.6	6.1	3.6	1.4	1.1	5.8	10.2	3.6	12.2	6.2	5.1	7.3	6.9	8.5	5.7	3.0	5.6	1.5	1.7	0.1	0.9	8.7	2.5	1.4	3.4	1.8	0.0	3.1	5.0	1.1	0.6	0.7	1.6	0.0	1.2	3.7	1.8	1.3	2.3	21.9	2.9	3.2	4.1	2.5	3.1	0.0	1.7	0.9	0.0	0.0	2.6	1.0	1.8	0.0	1.4	3.2	4.4	0.0	1.7	8.1	2.0	0.1	2.3	1.3	6.0	1.6
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45511036-45523047	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	43.3	58.2	71.0	43.8	57.4	12.0	75.5	31.6	60.0	46.9	51.1	72.2	42.6	78.5	40.8	75.7	136.1	49.7	46.9	84.2	56.5	73.0	121.7	136.5	52.9	51.0	99.1	51.2	43.0	20.4	34.1	34.3	58.3	87.8	42.2	53.0	48.8	53.5	52.2	78.9	46.9	77.6	52.4	98.3	46.5	52.5	25.7	72.6	29.7	130.1	114.3	91.0	49.1	56.3	44.7	50.3	64.4	64.5	20.4	72.3	58.7	64.7	119.4	49.2	62.6	55.9	47.8	105.4	73.7	76.7	80.1	66.6	59.4	28.1	57.2	77.8	79.1	97.3	67.2	106.9	71.3	79.2	44.0	82.6	43.3	168.6	166.0	24.3	50.0	56.7	41.0	53.3	79.4	18.8	44.0	91.7	68.2	79.1	19.8	79.4	52.0	67.1	48.9	154.3	144.4	125.2	118.3	62.1	75.4	143.8	55.9	65.5	32.9	67.6	183.7	4.7	150.5	49.9	40.5	77.9	32.0	72.4	68.4	98.1	13.8	77.4	109.1	52.9	34.8	18.7	64.4	55.6	18.4	28.5	60.6	37.5	44.7	45.5	37.9	50.3	36.2	28.3	31.0	2.4	20.4	64.5	33.5	72.3	58.7	71.0	57.4	31.6	60.0	56.5	73.0	99.1	51.2	87.8	72.6	485.3	206.7	314.1	835.1	539.4	156.1	25.5	438.2	477.8	340.1	586.2	98.2	1056.6	802.4	878.0	14.3	395.3	667.0	116.8	386.1	1465.8	343.6	670.3	319.6	809.1	1307.1	195.5	167.4	307.6	343.8	26.3	461.7	625.9	551.7	763.8	204.7	292.0	608.7	403.3	386.1	1911.4	290.8	304.0	372.5	90.5	393.1	462.1	932.4	124.6	344.7	1354.4
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 344.6;Spermatogonia: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	20.7	15.2	19.3	33.4	32.0	64.0	21.2	20.1	24.0	22.8	21.9	30.2	26.4	15.9	22.3	19.8	20.1	23.0	12.5	18.1	22.4	17.3	17.5	21.0	17.6	39.0	40.2	17.8	28.3	17.4	21.9	22.9	28.5	24.2	18.9	24.7	12.6	17.8	21.8	14.3	16.1	20.5	21.3	30.3	31.7	17.5	35.8	40.2	49.1	17.7	28.2	43.0	18.5	19.6	16.9	11.8	8.1	9.7	7.3	17.5	6.9	24.6	14.6	70.1	24.8	11.8	6.2	33.0	20.0	14.9	31.1	39.1	26.9	17.9	46.5	14.1	8.6	34.2	23.9	46.7	21.3	39.9	21.2	29.6	60.1	26.3	42.1	4.1	62.7	25.3	7.2	5.2	34.3	11.9	8.1	21.2	39.2	50.5	27.5	21.0	16.8	71.4	57.5	101.9	24.6	12.4	90.3	61.5	44.7	15.4	24.9	26.9	32.6	32.9	18.8	20.3	55.3	13.5	49.1	11.4	14.4	44.2	27.6	32.5	16.9	31.8	80.7	14.7	40.1	14.3	4.9	7.3	8.1	12.3	9.7	14.2	13.5	13.9	14.0	11.5	16.9	12.3	11.8	3.1	7.3	5.7	11.8	17.5	6.9	19.3	32.0	20.1	24.0	22.4	17.3	40.2	17.8	24.2	40.2	53.6	89.6	88.0	115.5	69.4	46.4	46.2	35.7	160.6	146.7	34.9	35.3	265.5	26.6	48.1	12.2	85.7	26.9	23.3	32.6	179.3	75.1	49.2	111.0	32.6	90.0	41.3	49.2	76.1	37.0	19.1	87.8	52.1	38.8	54.1	39.4	64.0	29.7	41.2	73.6	27.1	77.6	84.1	71.5	344.6	575.6	49.8	224.3	87.3	90.3	75.0
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6"	"Cell type enriched"	"Detected in many"	12	"Ciliated cells: 291.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA028338	Enhanced					NA	NA					"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	3.2	0.1	0.4	0.0	0.2	0.5	24.5	0.0	31.0	0.0	0.0	0.2	0.1	0.0	0.1	23.0	0.1	0.0	0.0	9.6	0.1	0.0	1.6	0.2	1.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.1	1.1	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	2.3	0.1	0.4	1.0	1.3	0.3	0.0	0.1	0.0	0.4	0.3	2.3	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.8	0.1	1.0	0.2	0.0	0.1	0.0	3.0	1.1	0.0	0.2	0.4	0.0	0.0	0.2	0.3	0.9	0.0	0.0	2.0	1.2	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.3	3.0	2.6	0.0	0.2	1.0	0.0	1.6	0.0	291.7	25.0	0.0	0.0	0.3	5.0	0.4	0.0	0.7	3.2	0.0	0.8	0.1	0.4	0.4	1.1	0.9	0.6	0.0	1.2	0.6	0.8	0.2	1.1	1.4	0.0	1.0	1.6	0.3	0.9	1.9	2.1	0.6	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.0	1.5	0.3
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Focal adhesion sites, Cytosol"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	29.9	20.5	16.9	21.2	23.7	24.9	25.2	24.4	18.6	27.4	36.9	33.3	29.7	31.6	26.3	23.8	34.8	22.5	19.7	23.9	17.3	17.0	30.2	38.9	28.3	29.1	33.2	12.4	24.7	46.9	24.4	36.6	25.7	22.1	26.4	37.2	29.8	33.5	35.3	29.6	31.0	58.0	25.7	28.2	30.6	26.2	33.2	27.2	40.5	37.7	30.3	35.4	32.5	27.5	13.5	17.8	29.8	22.1	20.0	20.0	15.4	15.8	9.8	17.1	18.1	20.2	19.7	23.4	12.6	21.0	18.3	23.1	9.8	17.8	22.0	16.5	17.3	19.3	16.6	18.7	19.0	23.3	25.1	13.3	28.5	11.4	15.2	27.8	28.4	26.5	14.3	41.6	14.3	41.0	24.7	23.1	28.3	24.3	19.6	20.8	8.5	25.2	25.6	24.3	21.4	11.2	16.6	22.2	16.1	21.0	15.7	21.1	14.1	20.8	30.8	32.1	34.8	14.0	33.6	19.6	13.2	13.9	14.2	19.1	19.2	17.8	16.2	13.9	23.8	13.8	16.4	16.6	29.8	17.8	21.2	18.9	13.5	17.6	17.4	17.8	11.5	19.4	18.9	17.7	20.0	22.1	10.2	20.0	15.4	16.9	23.7	24.4	18.6	17.3	17.0	33.2	12.4	22.1	27.2	56.6	19.5	31.8	35.2	57.7	23.3	41.7	45.9	16.0	29.6	57.6	33.4	23.0	43.1	29.6	10.8	38.3	66.9	46.7	33.6	29.3	24.3	50.8	58.8	72.6	22.6	35.0	36.8	31.9	45.9	13.4	19.0	33.1	21.9	23.4	66.9	16.0	42.8	46.0	20.1	45.1	32.3	19.4	35.3	70.7	75.4	59.2	38.0	35.1	54.0	53.8
TMEM69	"C1orf154, FLJ21029"	ENSG00000159596	"Transmembrane protein 69"	Q5SWH9	1	45687214-45694443	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026993	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026993: AB_10601824"	"prognostic favorable (2.24e-4)"	"unprognostic (2.47e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.66e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.41e-3)"	"unprognostic (3.65e-2)"	6.0	9.0	7.0	5.8	11.0	2.6	12.2	6.8	13.8	5.3	7.5	7.3	2.9	8.3	5.6	9.9	12.1	6.0	5.6	11.6	6.3	6.2	8.4	7.6	8.3	8.8	6.9	5.0	8.9	7.8	10.7	5.5	6.8	10.8	7.0	8.4	4.7	7.9	5.7	8.2	7.7	8.2	6.2	9.1	7.8	5.7	12.1	9.4	10.1	7.5	8.8	9.3	8.4	11.1	8.7	10.9	5.4	15.6	4.6	8.2	6.1	13.1	3.2	9.1	7.4	7.0	9.0	22.4	8.6	10.2	14.6	14.2	9.0	6.9	16.0	6.0	8.2	10.8	17.8	7.3	19.6	15.0	11.1	8.5	32.6	8.0	9.7	12.4	15.6	16.1	10.5	20.4	13.4	8.5	9.4	11.9	15.4	19.5	11.1	9.1	4.8	8.6	11.2	21.7	8.0	8.8	13.5	8.3	16.2	15.4	14.0	10.6	9.5	9.1	24.6	14.7	16.6	12.8	16.0	8.9	6.7	11.5	14.8	10.3	8.9	11.0	12.2	9.4	11.7	9.8	5.0	12.2	5.0	5.1	12.7	6.4	8.7	7.2	5.7	10.9	8.3	8.2	6.3	5.4	4.6	15.6	6.8	6.8	6.1	7.0	11.0	6.8	13.8	6.3	6.2	6.9	5.0	10.8	9.4	0.0	12.2	15.7	21.6	17.9	11.2	7.9	7.6	13.4	17.0	17.4	0.0	53.1	36.5	19.2	1.5	11.6	17.1	0.0	15.4	28.9	13.5	20.5	5.8	12.5	33.1	6.4	23.1	14.1	39.0	3.0	17.3	26.0	16.9	12.6	21.0	12.4	13.5	10.5	12.0	27.2	10.5	12.9	8.6	18.4	14.9	22.7	49.9	14.9	23.6	18.4
IPP	KLHL27	ENSG00000197429	"Intracisternal A particle-promoted polypeptide"	Q9Y573	1	45694324-45750650	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075545	Approved					NA	NA					"HPA075545: "	"unprognostic (8.45e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.03e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-1)"	6.6	8.7	7.2	5.1	10.1	3.5	7.9	5.8	11.3	6.8	7.1	13.8	7.6	6.1	15.0	7.2	8.2	8.7	7.6	8.6	7.7	7.4	9.4	8.7	5.3	7.8	7.8	8.3	10.2	8.5	16.5	12.7	5.5	10.7	10.1	7.4	10.5	10.7	8.8	17.7	7.2	8.4	11.4	9.2	4.5	7.2	14.8	6.7	16.0	12.7	5.8	9.3	8.9	6.6	4.7	1.0	5.1	1.2	5.0	7.5	3.5	8.3	8.0	7.2	10.6	9.2	16.9	5.8	9.0	6.4	6.2	6.4	4.9	6.1	4.6	9.5	10.9	7.2	6.2	7.8	6.6	9.0	10.5	5.0	6.5	7.2	6.0	9.3	1.8	5.8	14.3	7.6	13.5	7.4	7.5	6.0	8.7	7.9	9.3	10.9	5.5	6.2	0.5	4.5	6.1	4.6	2.6	13.3	3.7	5.1	9.1	10.6	6.8	17.0	9.2	8.4	8.6	9.0	1.7	7.2	6.8	8.6	4.7	6.9	7.7	8.8	8.4	11.0	2.8	10.7	4.5	0.9	5.1	7.5	0.6	5.6	4.7	4.6	6.0	1.0	4.4	5.8	6.7	4.2	5.0	1.2	1.0	6.8	3.5	7.2	10.1	5.8	11.3	7.7	7.4	7.8	8.3	10.7	6.7	11.9	10.6	3.4	5.8	2.3	11.9	14.8	5.1	10.7	7.9	5.2	11.8	6.8	3.3	5.2	12.7	3.6	7.0	0.0	6.5	5.8	4.1	4.3	12.7	5.1	1.3	17.5	5.2	3.7	1.5	4.9	6.6	0.9	1.7	4.6	6.2	19.3	4.8	3.5	6.0	7.1	15.8	0.0	3.3	33.9	13.6	4.1	6.4	7.2	5.6	3.7
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036124	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.3;Cone photoreceptor cells: 51.1;Enterocytes: 45.1;Late spermatids: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	8.9	4.3	7.0	9.9	8.1	3.7	7.1	7.1	11.8	13.6	15.2	8.4	6.6	11.2	16.7	7.7	8.8	9.5	9.9	25.5	5.0	7.6	4.8	6.1	5.9	4.4	8.9	7.3	19.8	3.6	9.1	10.5	5.5	10.1	13.9	13.9	7.2	8.3	8.6	83.3	5.5	21.3	14.9	5.8	2.5	9.0	24.8	4.8	3.5	5.7	27.4	7.5	16.3	10.6	0.5	1.9	1.4	4.3	1.4	1.4	0.5	14.9	12.1	12.3	9.4	16.1	23.1	13.6	16.0	11.6	14.8	16.5	13.9	4.9	23.4	7.5	19.5	30.0	7.4	14.8	9.1	15.7	11.2	8.0	10.6	13.7	12.7	14.0	5.6	13.6	17.7	11.8	24.8	19.8	18.6	13.8	6.1	8.1	7.2	17.6	10.2	8.2	5.8	10.1	10.1	13.9	12.2	20.6	4.4	7.7	8.1	17.1	10.1	18.8	24.6	8.0	14.1	11.2	5.6	13.4	28.7	18.5	14.9	15.8	9.7	8.7	8.5	19.1	7.7	11.8	0.0	1.1	1.4	1.4	0.6	1.4	0.2	0.7	1.4	1.9	0.5	0.5	1.0	0.0	1.4	4.3	0.1	0.0	0.5	7.0	8.1	7.1	11.8	5.0	7.6	8.9	7.3	10.1	4.8	0.0	1.3	0.0	4.2	3.8	14.9	43.3	2.5	1.4	7.9	3.5	51.1	4.4	1.7	4.2	27.6	5.3	45.1	0.0	5.4	4.0	6.6	7.8	0.0	5.6	5.5	4.8	11.6	3.1	1.6	44.9	8.3	6.4	6.8	1.0	18.3	3.0	6.7	26.6	9.6	4.2	12.7	6.5	6.1	28.4	11.7	2.4	4.6	1.9	18.1	6.0
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 44.0;Cone photoreceptor cells: 43.2;Endothelial cells: 43.8;Rod photoreceptor cells: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"RT4: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	33.7	10.9	7.4	7.0	8.2	0.8	24.7	36.4	11.0	16.9	6.3	3.5	9.1	3.3	15.8	11.0	8.4	7.6	10.9	28.7	6.8	8.5	10.4	4.1	20.0	6.0	8.7	3.1	4.6	4.0	18.7	10.2	13.4	10.4	9.0	5.3	13.6	9.4	8.0	14.8	4.6	6.0	12.3	7.1	10.9	7.4	24.0	4.5	5.9	12.7	6.2	5.3	12.3	8.7	0.5	0.6	8.6	3.1	0.1	3.5	0.9	4.7	1.6	21.6	10.9	2.1	0.9	6.9	2.8	2.0	3.7	4.6	0.9	1.4	6.2	8.6	1.1	4.5	2.8	7.5	2.6	2.4	4.8	6.7	3.9	19.4	0.7	0.7	3.5	5.4	2.7	1.5	3.9	1.4	3.6	7.7	14.5	1.4	4.5	5.2	7.2	14.1	2.2	7.6	1.3	4.3	18.2	5.7	7.4	9.3	33.6	15.6	11.3	9.1	24.1	2.6	13.5	6.7	3.2	14.3	4.0	3.7	0.6	2.7	6.4	6.6	3.8	3.1	4.7	2.0	0.0	0.3	8.6	3.3	0.5	3.0	0.5	0.8	2.9	0.0	0.0	0.3	1.9	0.1	0.1	3.1	0.6	3.5	0.9	7.4	8.2	36.4	8.9	6.8	8.5	8.7	3.1	10.4	4.5	0.0	9.6	0.0	3.0	2.3	44.0	17.3	0.0	17.4	5.7	17.4	43.2	4.0	0.0	0.4	8.7	43.8	5.1	0.0	1.0	1.0	4.5	7.4	9.2	0.0	1.4	3.2	7.5	0.0	0.0	12.1	1.1	1.8	5.0	1.0	1.5	30.4	1.3	1.1	7.4	3.4	44.4	0.0	12.5	29.2	28.5	1.6	1.1	1.5	1.7	3.3
AL358075.4		ENSG00000278139			1	46043661-46176488	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	27	"testis: 43.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HeLa: 4.6;RT4: 15.1"	"Not detected"	"Not detected"							HPA005751	Uncertain					NA	NA					"HPA005751: AB_1855350"																		0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	43.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	1.8	0.6	0.0	0.0	0.5	0.0	1.1	0.2	0.0	0.0	2.1	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185958	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.0;testis: 119.0"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1113.5;Collecting duct cells: 549.6;Enterocytes: 573.6;Late spermatids: 654.5;Paneth cells: 587.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	90	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in some"		"A-431: 21.3;CAPAN-2: 36.8;HaCaT: 25.7;hTCEpi: 29.8;OE19: 42.8;RPTEC TERT1: 107.8;RT4: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.7	0.6	1.7	4.8	2.4	0.0	1.5	11.4	3.5	9.0	59.9	1.8	1.5	2.2	1.8	4.6	1.9	13.9	2.6	2.6	2.2	0.0	46.0	1.9	5.7	2.1	2.4	1.7	1.5	1.5	15.4	3.3	1.5	2.1	22.7	70.0	3.3	16.1	7.8	1.5	0.1	18.3	1.9	1.8	1.6	24.6	119.0	1.9	1.6	13.9	1.8	1.9	21.0	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	21.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	36.8	0.0	6.9	0.0	0.0	25.7	0.0	18.8	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	29.8	0.1	10.6	0.6	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.0	0.0	42.8	1.3	0.0	0.0	0.2	107.8	51.7	0.3	0.0	0.0	2.2	0.1	0.1	1.5	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	1.7	2.4	11.4	3.5	2.2	0.0	2.4	1.7	2.1	1.9	23.8	19.0	15.7	180.5	0.9	0.0	0.6	15.3	1113.5	208.1	549.6	0.0	0.1	39.7	40.8	130.9	1.2	573.6	0.0	480.2	0.1	1.0	212.2	11.5	2.6	0.2	0.0	193.7	2.5	0.3	654.5	4.6	4.0	5.0	2.8	525.2	0.0	292.8	587.5	1.8	400.8	0.0	0.0	0.3	4.2	1.9	1.1	0.0	0.8	136.2	439.3
AL672043.1		ENSG00000250719	"Homo sapiens uncharacterized LOC110117498 (LOC110117498), mRNA."		1	46175486-46176478	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	64	"testis: 42.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POMGNT1	"FLJ20277, LGMD2O, MEB, MGAT1.2"	ENSG00000085998	"Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)"	Q8WZA1	1	46188682-46220305	"Disease related genes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044518	Approved					NA	NA		6300000			"HPA044518: AB_10795985"	"unprognostic (4.59e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.74e-2)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (5.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	12.8	17.8	17.9	8.2	26.7	2.8	14.3	12.9	21.6	13.9	9.7	29.5	11.1	12.4	11.7	19.1	9.2	15.8	12.4	43.6	18.8	16.7	19.1	19.2	13.8	7.1	39.4	18.0	10.0	17.2	47.1	19.4	16.6	24.7	21.1	10.7	13.0	13.8	17.2	29.7	13.3	11.3	16.3	36.3	11.7	12.5	16.1	25.0	7.7	22.4	7.5	9.1	11.3	9.0	3.2	6.4	1.6	5.2	9.4	6.2	1.9	12.3	13.3	16.3	15.7	18.0	19.7	21.1	16.7	28.2	22.8	18.0	7.5	10.4	11.5	27.7	27.7	39.0	7.1	11.6	23.9	13.7	15.0	13.2	9.1	11.9	11.3	15.8	7.0	8.9	19.8	31.3	25.5	23.8	41.1	23.2	15.9	10.7	7.5	37.2	8.6	12.3	5.0	13.5	7.1	18.7	9.0	16.7	10.7	20.1	15.4	6.2	22.2	15.4	17.9	23.3	24.5	11.9	9.9	16.8	17.2	15.3	19.4	31.9	18.9	21.0	5.3	26.2	6.9	18.2	0.0	1.6	1.6	5.1	2.8	3.5	2.1	3.4	4.0	2.2	3.2	6.2	4.8	0.0	9.4	5.2	6.4	3.3	1.9	17.9	26.7	12.9	21.6	18.8	16.7	39.4	18.0	24.7	25.0	11.9	45.5	9.8	35.8	7.4	40.4	36.8	20.4	21.4	33.0	33.2	47.1	21.1	11.6	38.1	28.2	13.4	14.6	0.0	34.5	23.8	14.1	34.3	25.5	18.4	13.6	25.4	25.9	8.6	11.0	10.4	18.7	11.0	23.6	25.2	11.8	23.2	31.7	14.4	12.4	17.7	36.4	12.9	15.5	5.0	11.0	6.6	19.6	13.1	15.8	26.0
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Early spermatids: 111.8;Late spermatids: 227.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 7.8;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 110.5"	"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	3.0	7.3	7.1	2.2	13.2	3.4	3.9	12.7	12.7	5.8	3.8	15.2	2.2	2.0	5.5	4.9	4.0	4.0	3.7	8.7	6.7	5.8	7.4	1.1	3.2	1.6	18.8	6.0	7.2	1.1	21.5	3.2	2.3	11.2	7.5	2.5	4.7	5.2	9.8	2.5	4.2	1.9	5.6	17.5	3.5	3.7	10.8	13.6	0.0	19.6	0.0	2.1	5.6	5.3	1.0	0.7	6.2	1.1	1.9	0.8	0.3	0.2	0.2	3.0	0.2	4.0	5.5	3.1	2.0	5.3	2.8	3.4	0.1	0.2	0.2	0.1	5.0	1.0	0.3	3.2	6.7	2.4	0.6	1.5	0.2	0.6	0.3	1.2	0.2	0.1	2.8	4.5	5.6	2.6	7.8	4.2	0.8	2.5	0.5	1.6	0.3	0.3	0.3	1.1	0.0	0.5	1.0	1.5	0.0	7.5	0.1	0.4	1.2	0.1	0.2	4.8	1.3	1.5	0.2	0.2	1.8	2.3	1.4	0.4	0.3	0.1	0.3	1.7	0.3	0.4	1.3	1.1	0.4	0.3	0.5	0.8	0.5	0.4	0.3	0.4	1.0	0.8	0.6	6.2	1.9	0.5	0.7	0.1	0.3	7.1	13.2	12.7	12.7	6.7	5.8	18.8	6.0	11.2	13.6	0.0	0.0	0.0	13.1	4.4	0.0	2.2	0.0	0.0	0.0	10.4	0.0	1.9	13.3	0.0	111.8	2.8	0.0	0.0	0.4	1.9	2.3	7.3	0.0	0.0	3.6	0.0	1.2	0.0	0.3	227.3	8.6	1.5	13.5	1.0	0.0	1.6	0.0	0.0	9.2	2.6	0.0	6.5	6.2	8.2	2.0	3.0	6.4	0.0	0.0	4.8
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46247688-46278473	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 41.9;testis: 56.6"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	1.9	0.6	1.5	12.9	4.7	9.4	1.3	3.0	1.9	1.1	4.8	0.7	0.5	2.8	1.2	2.1	5.2	0.3	1.2	1.5	1.8	1.5	1.4	0.5	1.5	6.0	1.9	0.7	0.8	1.4	0.6	0.5	4.2	0.9	1.1	5.8	0.6	1.4	1.0	1.4	3.0	3.6	1.8	3.2	4.1	1.7	56.6	0.6	41.9	1.7	3.8	9.6	1.0	1.7	0.5	0.3	0.0	0.1	0.9	4.1	0.7	9.0	6.8	20.5	12.5	1.5	1.0	19.1	10.7	4.7	18.1	18.6	14.5	6.0	17.8	8.2	4.5	16.5	9.4	18.9	6.0	16.0	9.7	19.1	21.8	18.2	14.4	0.0	21.8	12.8	0.6	0.5	18.0	5.3	3.0	5.6	20.7	15.6	18.2	9.9	8.6	27.1	24.2	18.3	8.0	11.2	21.7	11.4	7.8	4.4	7.8	9.8	7.0	7.8	10.8	2.6	17.4	3.8	15.9	2.4	19.5	11.6	10.0	18.0	7.7	4.4	19.2	5.2	14.5	7.8	0.0	0.1	0.0	1.2	0.1	0.2	0.5	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.9	0.1	0.0	4.1	0.7	1.5	4.7	3.0	1.9	1.8	1.5	1.9	0.7	0.9	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	1.8	0.1	0.2	0.0	0.0	7.8	0.4	0.3	4.6	0.0	2.2	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.2	0.3	1.4	0.0	1.2	0.4
LRRC41	MUF1	ENSG00000132128	"Leucine rich repeat containing 41"	Q15345	1	46261196-46303608	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051941	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA051941: AB_2681669"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.66e-9)"	"unprognostic (6.09e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-2)"	24.2	27.6	19.7	14.6	20.3	14.1	23.3	26.0	31.9	29.9	23.6	25.7	32.6	18.4	35.0	25.1	29.1	36.2	25.2	25.7	19.5	17.3	21.8	27.6	21.5	16.4	17.5	20.2	38.3	30.6	37.4	29.4	45.2	17.7	28.8	16.6	25.4	27.0	36.7	32.2	26.3	25.1	29.4	15.3	19.1	22.6	26.1	17.9	30.4	31.7	21.8	24.1	29.5	25.1	14.8	29.1	16.4	20.1	19.4	16.9	17.0	14.3	10.5	18.2	19.7	24.6	30.9	17.1	14.9	27.7	21.7	14.6	8.8	4.8	9.1	19.9	35.3	29.1	11.2	17.7	21.1	11.1	11.0	19.2	14.8	12.1	12.8	34.6	9.1	7.9	37.8	28.5	20.3	24.5	31.3	27.7	17.3	14.7	9.4	23.7	9.1	12.1	12.2	27.2	9.4	10.3	10.1	9.4	14.7	24.3	17.6	17.0	19.3	20.1	20.0	24.0	29.3	11.8	27.8	18.2	19.1	8.7	15.9	14.2	15.5	7.2	4.0	17.9	7.0	13.2	16.4	20.1	9.2	14.3	19.0	15.1	12.7	15.4	15.9	29.1	14.8	16.9	13.0	2.0	19.4	12.7	16.6	14.9	17.0	19.7	20.3	26.0	31.9	19.5	17.3	17.5	20.2	17.7	17.9	17.9	24.3	13.3	31.1	25.2	23.2	10.9	17.8	14.7	14.8	33.2	23.6	74.9	33.2	37.3	20.8	17.5	29.6	23.3	26.2	40.3	30.1	28.8	6.9	25.6	31.5	44.5	35.2	27.0	17.7	13.8	32.2	15.8	10.1	23.4	26.7	27.3	26.9	20.1	31.1	24.0	26.3	38.8	32.0	27.4	33.6	25.3	119.2	19.8	26.6	28.1
UQCRH	"QCR6, UQCR8"	ENSG00000173660	"Ubiquinol-cytochrome c reductase hinge protein"	P07919	1	46303631-46316776	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042574	Supported					NA	NA					"HPA042574: AB_10960998"	"unprognostic (2.24e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.04e-1)"	31.3	25.8	57.4	29.5	56.6	52.2	36.7	59.1	73.9	28.4	63.4	11.6	37.1	61.3	23.6	32.8	48.5	18.3	28.9	140.9	48.8	48.6	52.5	38.8	22.2	37.0	55.9	57.0	36.5	66.4	33.4	25.3	21.2	52.9	23.1	64.2	18.9	60.5	40.4	132.5	26.3	44.2	38.4	42.7	24.6	37.3	14.0	26.7	23.9	20.5	76.0	49.4	29.6	30.1	82.4	72.4	35.8	56.4	30.5	57.7	82.4	49.1	28.8	34.4	61.4	35.2	47.9	71.4	32.7	19.5	28.2	24.2	55.6	27.2	48.4	43.5	30.3	52.8	35.4	47.6	50.0	42.0	36.2	82.0	120.2	83.2	74.2	20.7	118.2	34.4	54.1	28.6	46.7	23.5	43.2	39.5	60.5	113.1	54.0	42.8	37.9	53.1	120.6	205.3	61.1	59.0	56.0	56.4	150.6	61.7	105.1	66.8	79.4	53.6	100.9	100.5	95.0	33.5	146.3	35.5	27.5	36.0	39.4	60.7	37.0	73.3	76.2	39.9	92.0	41.1	20.4	56.4	35.8	35.2	47.9	45.1	82.4	50.8	46.2	72.4	61.5	57.7	51.5	10.7	30.5	40.8	49.6	50.5	82.4	57.4	56.6	59.1	73.9	48.8	48.6	55.9	57.0	52.9	26.7	98.3	125.7	583.3	503.9	406.7	272.2	1846.1	557.9	152.6	193.3	373.4	157.1	587.0	1779.0	451.3	50.7	322.9	766.9	210.2	303.5	704.1	295.5	485.5	281.3	508.0	631.3	96.9	482.7	305.1	657.1	51.7	286.0	422.8	464.0	348.9	986.2	177.1	370.2	653.5	267.3	1048.7	322.7	323.4	420.5	100.7	334.1	460.6	543.7	320.4	1157.3	702.1
NSUN4	"MGC22960, SHTAP"	ENSG00000117481	"NOP2/Sun RNA methyltransferase family member 4"	Q96CB9	1	46340177-46365152	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 18.4;testis: 55.1"	"Group enriched"	"Detected in many"	9	"Early spermatids: 122.0;Late spermatids: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028489	Approved					NA	NA					"HPA028489: AB_10601444"	"unprognostic (3.28e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (5.53e-2)"	"prognostic favorable (8.99e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.28e-1)"	5.0	8.2	3.3	4.5	4.6	6.2	5.3	4.4	6.0	3.2	3.4	5.5	5.4	3.5	4.8	4.1	5.5	4.2	4.5	5.0	2.8	2.8	5.0	5.1	4.6	3.5	5.3	3.3	5.7	4.8	5.2	5.2	4.2	5.1	4.9	3.9	4.7	5.3	6.2	4.7	5.0	4.2	3.8	4.0	4.9	4.0	55.1	4.1	4.3	5.0	3.9	4.7	5.0	4.9	7.2	7.7	18.4	6.8	4.0	4.5	3.3	3.9	8.2	6.4	7.6	7.7	5.7	9.1	4.0	5.2	8.4	9.2	9.7	3.7	9.9	11.7	6.1	11.8	5.8	5.5	8.9	6.4	11.8	9.5	10.0	9.1	13.2	9.0	7.7	7.6	7.5	9.2	11.6	13.1	3.6	9.2	7.9	14.8	10.4	8.6	12.1	6.5	4.1	7.5	5.7	3.8	8.9	4.3	13.2	14.4	12.8	9.7	3.6	6.6	8.0	8.5	6.7	5.4	9.6	7.3	5.7	6.3	4.5	5.0	6.1	5.1	8.6	3.2	9.5	6.4	1.3	6.8	7.0	3.1	4.6	4.5	7.2	3.5	4.2	6.3	5.7	4.2	3.0	18.4	4.0	3.2	7.7	1.8	3.3	3.3	4.6	4.4	6.0	2.8	2.8	5.3	3.3	5.1	4.1	17.9	13.7	5.2	11.9	4.9	8.8	13.2	15.3	5.3	13.6	8.7	7.9	9.4	1.7	8.0	122.0	13.7	5.4	0.0	6.1	9.3	5.4	12.3	28.9	10.6	8.0	4.8	7.5	9.8	10.4	421.7	11.5	9.2	3.3	5.4	8.8	5.2	7.7	3.5	10.3	9.3	10.8	0.0	9.2	6.6	10.0	5.1	12.7	5.3	9.2	12.0
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394265-46413848	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 68.0;Late spermatids: 88.3;Spermatocytes: 73.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 19.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;OE19: 10.7;RT4: 23.9;SK-BR-3: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favorable (4.25e-5)"	"prognostic favorable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	6.1	7.7	11.2	2.5	22.0	7.9	7.9	20.4	21.9	6.9	15.0	40.7	10.1	18.0	3.1	8.2	4.9	10.6	4.6	2.9	14.7	11.7	12.0	18.3	6.7	2.1	19.1	19.3	2.7	18.2	15.1	10.6	3.5	17.6	33.3	12.8	7.4	12.8	8.6	7.1	10.1	17.8	2.3	23.6	2.0	14.3	30.9	18.8	5.6	24.9	3.5	3.5	5.7	4.2	0.1	6.0	19.1	4.7	0.3	0.4	0.9	2.8	0.7	0.4	0.5	0.7	0.5	22.2	0.6	0.3	0.3	0.5	4.1	6.6	0.2	2.3	0.4	0.2	9.4	0.4	1.3	0.1	1.2	3.1	0.0	0.1	1.9	0.5	0.8	1.6	0.4	6.4	0.2	0.8	0.2	0.0	0.5	0.1	0.5	0.0	5.9	0.4	1.2	1.8	10.7	0.2	0.5	0.2	0.1	5.2	23.9	2.8	2.1	3.2	12.4	0.1	0.6	8.5	8.2	0.0	0.0	0.3	0.6	0.4	1.2	0.5	0.3	0.1	7.6	0.2	0.0	4.7	19.1	0.3	1.2	0.1	0.0	0.3	0.1	5.7	0.1	0.4	0.4	0.2	0.3	0.6	6.0	0.1	0.9	11.2	22.0	20.4	21.9	14.7	11.7	19.1	19.3	17.6	18.8	20.8	10.4	4.2	27.1	4.6	12.6	2.2	25.5	4.0	10.3	21.0	41.2	14.4	0.0	12.8	35.5	1.8	68.0	0.0	5.6	6.3	2.4	27.0	0.0	29.2	2.6	1.6	14.9	0.6	3.2	88.3	6.9	2.9	5.0	0.0	33.1	6.3	5.0	40.4	4.2	19.5	11.4	0.0	2.7	73.1	7.7	5.3	10.4	0.0	48.5	12.3
DMBX1	"OTX3, PAXB"	ENSG00000197587	"Diencephalon/mesencephalon homeobox 1"	Q8NFW5	1	46506996-46514226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.7;testis: 3.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 1.5;Cone photoreceptor cells: 2.0;Spermatogonia: 1.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"hypothalamus: 1.2;midbrain: 1.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.7;CAPAN-2: 5.0;GAMG: 4.0;K-562: 5.1;SiHa: 5.1;T-47d: 4.4"	"Group enriched"	"Detected in some"	7	"midbrain: 1.8;pons and medulla: 1.0"	"Region enhanced"	"Detected in some"		"thalamus: 5.1"	HPA026811	Uncertain					NA	NA					"HPA026811: AB_10603660"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.13e-5)"	"unprognostic (2.33e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.00e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.12e-12)"	"unprognostic (7.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.35e-2)"	0.3	1.8	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	3.5	0.1	0.1	1.4	0.1	0.1	0.9	0.1	0.6	0.3	1.9	0.2	0.0	0.1	0.0	2.2	1.5	0.0	15.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.8	0.0	4.0	1.4	3.0	0.0	0.0	1.1	1.8	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	5.1	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.2	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.7	0.3	0.0	0.0	0.0	0.1
AL136373.1		ENSG00000282881	"Uncharacterized protein LOC105378696 "		1	46532166-46533614	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"brain: 1.9;testis: 1.2"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	16	"BEWO: 3.4"	"Group enriched"	"Detected in some"	5	"amygdala: 1.2;basal ganglia: 1.6;hypothalamus: 1.4"											NA	NA																							0.0	0.0		0.0		0.0	0.0		1.9	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KNCN	"FLJ32011, KINO, L5"	ENSG00000162456	Kinocilin	A6PVL3	1	46545644-46551527	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.9;pituitary gland: 1.0;testis: 2.5"	"Group enriched"	"Detected in some"	41	"Early spermatids: 10.4;Late spermatids: 26.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA									"unprognostic (6.99e-3)"	"unprognostic (2.28e-2)"					"unprognostic (2.80e-2)"								0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	2.1	0.3	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	1.6		0.0	0.0	0.0	1.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
MKNK1	MNK1	ENSG00000079277	"MAP kinase interacting serine/threonine kinase 1"	Q9BUB5	1	46557408-46616843	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.3"	"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favorable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	17.6	12.0	10.7	16.2	10.5	16.8	12.1	13.7	12.3	9.2	12.6	11.0	9.6	9.7	11.9	13.3	12.2	11.1	11.4	12.3	10.8	7.0	9.4	10.8	16.1	16.3	9.9	9.8	10.7	72.3	8.6	11.3	15.4	11.0	9.9	13.3	11.9	10.6	7.7	12.8	10.2	12.7	13.3	8.1	25.6	11.7	7.6	8.7	12.5	8.8	15.8	10.9	10.9	14.5	4.9	6.0	33.3	12.1	5.0	22.0	6.1	19.5	13.2	8.8	9.7	7.9	11.7	11.7	9.9	9.9	12.0	16.4	15.3	8.0	12.9	12.2	9.9	13.5	23.7	14.7	16.2	12.9	22.2	13.0	27.3	15.2	13.0	12.3	14.6	22.2	15.4	11.2	15.6	8.6	6.5	14.0	15.9	14.2	9.5	6.5	12.8	10.4	13.0	6.0	11.3	15.7	9.6	18.4	12.9	12.9	20.5	6.2	5.5	19.1	17.3	16.0	18.3	11.7	16.3	11.4	4.4	0.9	13.6	11.0	8.1	13.5	11.0	8.5	18.8	8.0	3.9	12.1	14.3	7.5	11.5	22.0	4.6	6.6	6.8	6.0	4.9	4.8	7.0	33.3	5.0	8.1	4.4	4.4	6.1	10.7	10.5	13.7	12.3	10.8	7.0	9.9	9.8	11.0	8.7	11.9	22.1	17.5	15.7	12.4	17.9	15.5	15.3	10.7	18.2	21.0	2.0	19.4	6.6	16.1	13.0	14.3	23.5	23.3	32.1	29.7	19.5	15.8	11.5	20.2	113.5	17.5	16.1	18.4	71.2	17.5	19.8	58.2	10.1	16.2	11.9	6.5	28.0	14.0	34.3	10.2	4.6	6.5	14.4	16.8	15.5	9.7	15.4	24.9	14.7	19.5
MOB3C	"MOB1E, MOBKL2C"	ENSG00000142961	"MOB kinase activator 3C"	Q70IA8	1	46607715-46616891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (1.76e-3)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.61e-3)"	16.9	9.0	8.8	8.0	14.7	4.1	12.1	19.7	7.5	10.7	11.2	9.3	11.8	8.8	8.4	12.9	12.6	9.6	10.8	12.3	10.1	5.6	9.1	8.8	13.3	7.8	13.2	6.8	12.6	29.8	10.4	10.9	12.8	12.5	12.2	9.3	9.5	16.8	12.5	20.2	6.0	12.5	9.8	5.5	14.7	10.9	4.2	9.4	3.1	11.1	19.1	11.4	10.8	16.0	9.3	7.1	15.1	9.0	16.1	21.5	11.4	7.4	3.0	1.5	4.5	14.9	11.7	0.6	4.2	10.7	7.7	7.5	0.9	5.3	0.6	4.6	7.2	11.1	10.8	1.6	5.4	4.1	11.1	0.2	17.5	4.0	1.1	7.8	1.5	6.6	9.5	8.4	7.3	2.0	10.2	5.0	1.9	2.6	4.4	3.2	3.1	0.7	2.3	0.5	4.7	9.0	1.9	5.0	3.2	4.3	13.5	0.6	1.8	6.5	4.6	5.2	1.8	2.8	5.9	3.7	3.9	2.7	6.4	3.7	4.1	0.9	0.5	5.8	2.6	3.2	2.1	8.4	15.1	12.2	9.0	21.5	6.9	12.0	12.3	5.8	9.3	10.7	10.8	6.0	16.1	5.7	7.1	8.1	11.4	8.8	14.7	19.7	7.5	10.1	5.6	13.2	6.8	12.5	9.4	6.0	5.8	3.7	9.1	9.8	2.1	3.9	2.5	5.3	4.5	7.0	0.0	1.6	5.0	2.4	7.1	5.1	6.0	0.0	5.5	0.8	8.0	8.1	5.7	2.6	10.5	4.8	8.1	7.4	8.5	0.4	5.8	10.4	3.3	4.6	7.9	1.5	4.0	2.9	6.3	2.6	0.6	6.5	9.8	0.0	0.2	5.6	1.1	7.9	5.2	13.3
ATPAF1	"ATP11, Atp11p, FLJ22351"	ENSG00000123472	"ATP synthase mitochondrial F1 complex assembly factor 1"	Q5TC12	1	46632737-46673867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 73.4"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 236.9;Early spermatids: 241.4;Late spermatids: 261.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028382, HPA044950"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA028382: AB_2672574, HPA044950: AB_2679151"	"unprognostic (1.34e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.33e-7)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.62e-1)"	20.6	32.0	32.9	7.5	34.5	7.9	14.0	15.9	31.0	11.1	15.2	16.1	9.3	12.0	7.8	10.8	10.6	9.8	9.0	73.4	22.3	20.8	33.3	31.9	7.5	8.6	28.2	24.9	10.6	18.8	39.5	14.6	11.0	28.5	11.6	16.9	11.9	15.9	10.8	66.9	5.7	11.7	12.7	18.6	6.9	12.8	13.4	18.2	10.8	13.0	13.1	9.4	9.8	6.1	3.1	2.4	5.8	4.2	9.2	6.6	1.8	20.8	17.0	23.0	20.5	25.2	20.4	19.3	15.6	19.6	23.5	19.0	13.6	9.1	12.4	21.0	19.7	20.9	16.2	36.2	20.3	31.8	27.1	28.6	21.9	21.2	23.6	20.3	21.6	1.3	19.9	24.4	25.1	22.0	18.8	14.7	23.3	10.0	24.6	17.9	18.9	31.8	12.0	36.2	18.1	25.7	13.8	6.2	26.9	26.8	16.6	27.3	20.4	26.5	28.2	40.7	27.8	26.0	30.5	12.7	8.1	20.0	16.2	21.2	30.6	27.7	8.5	13.3	8.4	15.1	0.0	2.5	5.8	3.5	4.2	4.6	3.1	3.7	4.0	2.4	1.7	5.2	2.4	2.1	9.2	1.7	1.8	6.6	1.8	32.9	34.5	15.9	31.0	22.3	20.8	28.2	24.9	28.5	18.2	3.0	15.2	20.4	17.4	8.4	34.1	236.9	22.9	8.1	12.5	29.6	25.5	54.8	145.9	19.3	241.4	11.3	22.6	0.0	17.5	23.1	16.9	15.2	16.1	37.5	32.6	44.5	18.5	8.0	16.4	261.4	17.5	11.1	23.6	10.8	33.8	29.9	12.2	10.5	25.1	85.7	23.3	25.8	29.3	25.6	40.1	11.8	39.2	12.5	43.6	16.1
TEX38	"ATPAF1-AS1, C1orf223, LOC374973, THEG4"	ENSG00000186118	"Testis expressed 38"	Q6PEX7	1	46668855-46673594	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"testis: 109.8"	"Group enriched"	"Detected in some"	114	"Early spermatids: 1833.7;Late spermatids: 4115.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.0;SK-BR-3: 2.2;TIME: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA073711			Uncertain	Vesicles		NA	NA			Vesicles		"HPA073711: "	"unprognostic (8.46e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.21e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.93e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.48e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	2.5	0.3	0.1	1.6	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	1.3	0.6	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.8	0.3	0.0	0.5	0.4	0.0	0.6	0.6	0.5	0.1	0.0	0.4	0.1	0.9	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.9	0.0	0.6	0.6	2.0	1.4	1.0	2.2	0.0	1.8	0.8	0.0	2.5	0.3	0.0	1.0	0.2	0.9	0.3	0.6	0.2	0.0	0.2	0.0	0.3	2.5	1.2	0.2	1.6	0.9	0.1	0.9	0.4	0.4	0.9	0.2	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1833.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4115.3	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.4	6.5	0.0	24.7	13.3	0.0	0.0	0.0	0.0	0.0
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46675159-46719064	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA		58000	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	29.4	17.4	29.4	14.3	29.5	6.7	22.5	16.2	24.8	25.3	26.0	40.6	15.6	17.2	23.7	27.3	30.0	22.0	19.7	20.2	27.2	20.5	27.8	24.9	24.0	16.4	31.0	15.2	25.2	16.0	107.1	17.2	25.2	27.3	24.4	24.0	23.0	19.9	24.9	24.7	20.4	26.9	22.5	36.1	24.0	36.4	21.9	30.6	28.7	30.1	13.2	20.2	25.7	20.0	16.6	16.0	30.3	21.1	17.1	28.5	18.3	14.5	8.3	7.1	11.2	34.0	21.4	16.3	15.8	23.3	17.5	18.1	9.9	9.9	11.7	16.5	21.4	23.7	17.6	12.1	17.4	23.8	22.2	7.8	14.6	9.2	4.0	11.7	18.8	28.8	18.9	29.2	13.9	11.6	16.8	21.3	11.4	9.0	16.7	18.0	5.7	12.4	8.5	10.1	17.2	9.4	9.5	19.9	10.2	18.5	29.6	3.7	5.1	19.5	27.6	14.8	20.1	12.3	16.5	19.6	15.0	7.3	17.4	16.0	17.2	23.8	9.4	19.2	16.2	11.0	15.6	18.6	30.3	23.6	21.1	28.5	16.6	20.6	20.2	16.0	16.2	18.0	19.5	12.5	17.1	18.3	12.9	17.8	18.3	29.4	29.5	16.2	24.8	27.2	20.5	31.0	15.2	27.3	30.6	68.5	69.2	34.6	40.1	28.2	30.1	33.2	45.9	45.5	45.5	108.2	29.5	31.8	26.6	31.3	50.1	52.8	51.8	0.0	33.7	27.6	35.0	57.4	96.2	51.2	37.0	44.5	36.2	46.1	67.7	14.4	43.7	41.1	25.3	34.3	62.6	50.2	37.9	57.5	46.7	30.6	17.7	25.8	28.8	37.2	23.3	38.0	49.3	41.5	41.9	98.2
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enriched"	"Detected in some"	8	"RT4: 81.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1	1140.4	70.0	0.0	114.6	0.5	0.0	4.8	0.0	602.3	304.8	0.0	0.0	0.9	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.2	4.7	3.9	5.8	0.0	0.6	0.0	0.0	2.5	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.6	0.7	0.0	0.0	142.5
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	78	"kidney: 36.5;liver: 141.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 433.3;Proximal tubular cells: 109.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HL-60: 1.2;RH-30: 1.3;SiHa: 1.6;U-698: 2.3;U-937: 1.6"															NA	NA						"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.0	36.5	141.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	0.0	0.3	0.4	0.0	0.2	0.1	1.1	0.0	1.4	0.0	0.4	0.0	1.2	0.5	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	1.3	0.6	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.0	1.6	0.1	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.2	0.0	0.2	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	43.3	0.0	0.0	7.0	0.0	0.0	14.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.3	0.0	0.0	0.0	6.2	6.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023568-47050751	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 38.1"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 156.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5"	"Low region specificity"	"Detected in all"							HPA017661	Approved					NA	NA					"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	7.9	3.6	9.0	1.1	14.9	0.5	16.0	7.1	16.9	38.1	2.0	1.6	2.5	2.1	3.6	3.2	12.0	9.7	2.0	6.7	4.8	10.6	6.3	10.0	8.9	2.0	3.3	13.5	1.7	2.0	2.0	4.1	1.5	7.8	8.0	2.3	17.6	23.7	3.4	4.5	5.0	1.8	2.4	2.0	1.0	14.3	4.2	0.9	0.0	4.0	6.9	8.8	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.9	1.0	0.0	0.0	0.5	0.0	0.6	0.2	3.8	0.0	0.0	0.3	0.0	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9	20.8	10.5	0.0	23.5	2.3	0.9	1.0	0.0	156.6	27.3	0.0	0.0	0.0	0.0	0.3	6.0	2.3	0.0	0.0	0.6	0.0	1.9	10.7	0.0	2.5	2.9	0.0	0.0	0.6	0.3	5.6	9.8	0.6	5.0	0.0	0.0	0.0	0.2	0.0	19.4	1.3	0.7	0.0	14.5	0.0	1.5	1.3	0.1	0.0	0.6	26.2
CYP4Z1	CYP4A20	ENSG00000186160	"Cytochrome P450 family 4 subfamily Z member 1"	Q86W10	1	47067488-47118319	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"breast: 23.1"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9"	"Cancer enriched"	"Detected in some"	50	"breast cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	39	"HDLM-2: 13.7;SK-BR-3: 5.9"															NA	NA						"unprognostic (4.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-3)"		"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (5.09e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.46e-2)"	"unprognostic (3.49e-3)"	2.5	0.2	0.4	0.4	0.9	0.0	23.1	0.4	2.0	1.0	0.4	0.4	0.4	0.0	0.4	0.8	0.8	0.7	0.4	0.4	0.4	1.8	0.4	1.5	2.1	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.7	1.3	0.0	0.4	1.5	0.8	0.5	2.2	0.4	0.4	0.4	0.4	0.2	1.0	0.4	0.6	0.4	0.4	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	2.0	0.4	1.8	0.4	0.4	0.7	0.4	8.9	0.6	0.0	0.4	0.1	0.0	0.2	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
CYP4A22		ENSG00000162365	"Cytochrome P450 family 4 subfamily A member 22"	Q5TCH4	1	47137435-47149741	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 71.0"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 99.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 5.1;SuSa: 2.6"															NA	NA						"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.19e-2)"			"unprognostic (2.88e-3)"	"unprognostic (2.76e-3)"		"unprognostic (1.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.59e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.0	14.4	71.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.4	0.2	0.1	0.6	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.5	0.5	0.2	0.1	0.0	0.2	0.3	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.0	0.6	0.6	0.2	0.0	0.1	0.2	0.0	0.1	0.3	0.2	0.5	0.1	0.1	0.4	0.4	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.4	0.5	0.2	0.3	0.1	0.0	2.6	0.4	0.6	0.7	0.2	0.1	0.2	0.0	0.0	0.5	0.6	0.2	1.1	0.0	0.0	0.2	0.4	0.5	0.0	0.4	0.5	0.5	0.6	0.1	0.6	0.5	0.6	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.2	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183593-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 281.3"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 4006.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 31.5;RPTEC TERT1: 104.5"	"Not detected"	"Not detected"							HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	2.7	1.2	0.6	2.4	0.6	3.9	4.1	0.6	0.6	9.2	9.1	0.6	0.6	2.2	1.3	4.8	30.4	2.9	23.9	0.7	0.5	0.0	281.3	1.6	7.2	0.5	0.6	0.5	2.3	16.8	0.0	0.6	3.2	0.6	2.1	3.4	0.8	33.9	12.4	0.7	19.9	9.5	0.5	0.5	0.7	9.0	1.4	0.6	1.1	1.0	18.3	18.5	4.1	8.3	0.1	0.5	2.1	1.1	0.2	0.3	42.4	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.6	0.0	31.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	104.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.1	0.2	0.0	0.5	0.3	42.4	0.6	0.6	0.6	0.6	0.5	0.0	0.6	0.5	0.6	0.6	71.5	39.6	6.7	11.1	12.6	0.0	0.0	359.2	6.7	34.2	221.6	0.0	0.0	351.5	818.0	0.0	1.6	60.9	140.2	656.9	0.0	0.9	37.3	10.4	1.0	0.2	0.0	38.1	2.5	0.3	0.0	3.1	1.5	8.5	21.6	123.8	0.5	959.8	81.8	0.0	4006.8	0.0	0.0	2.3	0.0	0.1	47.2	0.7	1.5	119.5	16.8
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.1"	"Cell type enhanced"	"Detected in some"	22	"Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0"	"Region enriched"	"Detected in some"	5	"midbrain: 17.1"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	9.1	2.7	7.0	1.8	5.7	33.1	7.1	1.6	6.9	3.3	2.4	12.0	2.3	1.6	3.7	3.3	2.5	4.1	4.2	3.9	8.8	3.5	4.5	2.4	14.6	2.2	11.1	4.4	1.5	1.3	2.2	2.1	9.8	7.3	2.4	2.4	2.1	1.4	3.0	3.1	2.0	3.3	4.4	9.4	8.5	2.1	1.8	9.2	0.0	6.7	4.1	1.5	2.5	5.5	0.3	0.1	3.2	0.3	0.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	11.0	21.1	16.5	0.0	0.0	0.0	8.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	1.2	0.4	0.1	0.1	0.1	2.2	7.0	5.7	1.6	6.9	8.8	3.5	11.1	4.4	7.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	1.7	2.5	0.0	2.3	1.8	0.0	0.1	0.0	0.0	4.8	18.0	0.0	93.5	0.0	0.1	0.9	0.0	35.8	0.0	7.9	0.0	0.0	30.7	2.1	10.2	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.4	0.9	0.0	0.0	0.0	0.0
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL, centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.0;testis: 23.8"	"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 18.6;Spermatogonia: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046543			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.2	1.4	1.3	10.8	2.4	11.0	2.9	1.4	2.2	1.2	4.1	0.9	2.5	3.6	1.5	2.2	5.8	0.9	1.7	2.0	1.4	1.2	1.5	1.6	1.7	5.0	1.3	1.5	1.2	1.5	0.9	0.9	5.5	1.1	1.7	6.4	0.8	3.6	0.5	0.8	4.2	4.0	1.3	1.2	3.4	2.2	23.8	1.0	36.0	1.1	3.5	7.1	1.3	2.1	1.9	1.6	5.4	0.7	3.3	1.2	0.5	16.9	9.1	13.1	11.7	0.9	2.3	8.4	15.0	7.2	16.8	17.7	9.8	8.4	20.0	7.1	7.5	17.3	11.3	15.3	7.9	18.1	14.9	6.9	22.5	11.3	8.6	0.5	18.2	11.5	0.8	1.3	14.4	9.4	2.1	11.1	15.3	15.9	19.1	12.6	7.7	17.6	5.7	15.9	9.4	7.5	11.5	21.4	9.6	4.7	10.2	11.7	7.0	16.1	11.9	7.8	16.3	7.7	10.4	6.5	15.9	16.1	11.4	20.3	6.3	13.1	19.7	7.4	13.9	14.7	4.3	0.7	1.1	1.1	0.4	0.5	1.7	1.2	1.0	0.5	1.9	0.8	0.8	5.4	3.3	0.3	1.6	1.1	0.5	1.3	2.4	1.4	2.2	1.4	1.2	1.3	1.5	1.1	1.0	3.0	0.3	2.2	0.5	0.8	1.2	0.5	0.0	6.7	2.3	0.0	3.9	1.2	0.0	1.2	0.7	0.9	1.8	0.0	0.4	3.8	0.8	1.2	2.3	0.5	2.3	0.0	1.7	1.8	1.9	1.3	0.3	1.2	0.0	4.6	4.3	0.8	1.8	1.5	0.7	0.3	0.7	0.0	0.0	18.6	17.8	2.0	0.7	0.8	3.4	1.4
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		2100000	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	35.0	17.0	28.5	30.4	24.4	14.8	72.2	18.0	35.8	26.8	44.8	17.8	20.9	53.7	16.5	19.3	42.2	13.5	39.2	28.6	28.0	31.4	26.2	88.2	36.8	46.2	35.1	16.8	16.2	42.3	19.3	16.6	16.0	25.4	32.8	48.1	16.2	50.8	18.3	30.4	22.2	64.9	46.9	33.1	21.6	35.9	8.6	18.2	25.6	31.7	26.7	28.0	34.0	39.0	11.2	10.6	23.1	12.4	15.0	17.5	12.1	30.8	17.3	22.4	20.0	40.9	47.9	31.7	54.9	33.1	33.4	34.0	15.4	21.4	45.7	28.3	37.2	31.4	21.0	16.5	28.4	45.8	69.1	13.5	35.5	23.9	26.5	26.7	50.6	26.0	26.8	34.4	27.8	31.3	31.6	34.5	17.1	33.5	36.9	43.5	11.3	41.0	23.9	14.2	40.6	24.0	25.6	38.8	34.3	32.5	34.0	20.3	10.7	39.3	45.7	31.5	30.9	11.3	30.2	32.3	41.8	24.2	39.9	45.1	26.9	37.2	31.2	33.0	31.3	28.5	23.1	10.2	18.2	13.6	10.7	17.5	11.2	15.5	16.7	10.6	10.2	14.7	14.0	4.2	15.0	12.4	8.9	16.0	12.1	28.5	24.4	18.0	35.8	28.0	31.4	35.1	16.8	25.4	18.2	65.5	42.5	120.7	103.0	155.9	32.3	44.9	101.9	57.6	33.0	71.5	15.7	70.1	147.6	156.9	1.2	74.2	219.2	46.7	158.3	115.0	53.6	209.9	94.4	215.9	69.9	41.3	112.9	68.2	97.0	4.1	55.0	98.6	241.3	77.5	273.0	40.6	127.4	150.8	65.7	149.9	26.0	84.1	148.0	8.2	27.2	170.5	99.0	139.5	184.6	187.9
FOXE3	"FKHL12, FREAC8"	ENSG00000186790	"Forkhead box E3"	Q13461	1	47416072-47418052	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cataract, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.9;lymphoid tissue: 4.6;testis: 2.9"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 4.2;Spermatogonia: 1.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.9;cerebellum: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"SuSa: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.11e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-7)"	"unprognostic (2.41e-1)"	"unprognostic (5.46e-2)"		"unprognostic (3.60e-1)"	0.2	0.1	0.2	0.1	2.9	0.1	0.1	1.6	0.4	0.8	0.7	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.0	2.9	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	14.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	1.6	0.4	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0
FOXD2	"FKHL17, FREAC9"	ENSG00000186564	"Forkhead box D2"	O60548	1	47436017-47440691	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7"	"Cell type enhanced"	"Detected in some"	11	"Enterocytes: 14.4;Intestinal endocrine cells: 8.7;Mucus-secreting cells: 13.7;Paneth cells: 8.6;Sertoli cells: 6.5;Undifferentiated cells: 16.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AN3-CA: 12.8;WM-115: 18.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.79e-12)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (5.91e-2)"	0.5	1.2	0.0	0.9	0.0	0.0	0.3	0.0	0.1	2.1	7.7			0.8	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.1	3.2	0.9	0.4	0.3	0.0		0.0	0.2	0.0	2.0	0.1		2.4	5.7		0.3	0.2	0.1	0.2	0.6	0.0	0.1	1.1	1.1	0.5			0.2		0.0	0.2	0.8	0.8	0.2	1.5	0.6	0.3	2.1	0.2	0.9	0.4	0.0	12.8	0.0	0.1	1.1	0.5	0.1	0.0	0.1	1.2	0.2	1.1	0.7	0.0	1.5	0.6	0.3	0.0	0.0	2.0	2.0	0.7	0.8	0.3	0.0	0.7	1.5	0.0	0.4	0.0	0.0	0.3	0.0	1.5	0.9	1.0	0.0	0.6	0.7	0.7	0.0	0.3	0.6	2.6	1.9	0.6	0.0	0.9	2.2	0.0	0.8	0.6	1.3	0.6	2.6	0.8	0.5	0.7	3.3	0.3	1.0	1.3	0.9	1.2	0.5	1.7	18.4	0.6	0.5	1.4	2.1	0.6	1.5	0.8	0.8	1.6	0.2	0.6	0.6	1.3	1.5	0.3	0.5	0.2	0.5	0.2											0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	14.4	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	8.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	13.7	3.7	0.2	8.6	0.7	0.0	0.1	6.5	0.9	0.5	0.7	0.1	0.0	0.0	16.6	0.0
TRABD2B	TIKI2	ENSG00000269113	"TraB domain containing 2B"	A6NFA1	1	47760528-47996895	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 34.3"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 7.4;Cholangiocytes: 10.2;Hepatocytes: 10.4;Proximal tubular cells: 20.3;Smooth muscle cells: 7.6"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.8"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 8.0;U-2197: 17.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045817	Approved				"Intracellular and membrane"	NA	NA		22000			"HPA045817: AB_2679460"	"unprognostic (2.38e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	3.6	1.5	0.5	2.2	0.3	0.1	3.3	2.7	0.5	4.8	3.0	0.5	1.5	0.9	1.8	9.3	4.7	2.2	9.5	8.2	0.1	0.1	34.3	7.1	1.8	1.9	0.4	0.5	2.5	7.0	0.3	2.3	0.9	0.8	4.9	1.6	2.7	2.3	8.5	1.7	1.7	1.8	7.1	0.7	1.5	1.9	1.8	0.0	0.6	1.1	1.0	0.8	6.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.5	0.0	8.0	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	17.1	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.7	0.5	0.1	0.1	0.4	0.5	0.8	0.0	0.0	0.3	0.0	1.4	0.7	0.0	7.4	10.2	0.0	0.0	1.8	0.0	0.0	5.0	3.3	0.1	0.8	0.0	0.0	1.8	0.0	2.1	0.2	0.0	10.4	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	2.1	20.3	0.0	0.0	7.6	0.0	2.2	0.3	0.0	0.0	0.0	0.1
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 77.3"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	33.0	0.1	0.8	26.0	0.1	7.2	0.1	0.2	2.2	0.1	0.0	0.0	3.1	4.9	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	1.0	77.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	1.0	0.0	0.0	0.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	1.7	0.4	5.8	0.0	0.7	0.0	0.2	0.0	0.0	0.1	4.6	4.5	0.1	0.0	0.0	0.0	1.2	7.9	0.3	0.0	0.0	0.0	0.6	0.0	0.1	1.1	0.4	3.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0
SPATA6	"FLJ10007, SRF-1, SRF1"	ENSG00000132122	"Spermatogenesis associated 6"	Q9NWH7	1	48295372-48472208	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 61.8"	"Group enriched"	"Detected in many"	31	"Early spermatids: 1331.5;Late spermatids: 2941.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.5;ASC TERT1: 17.7;HSkMC: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028234			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA028234: AB_2672532"	"unprognostic (1.36e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.89e-2)"	"unprognostic (5.71e-3)"	5.8	8.9	6.2	3.0	12.9	1.5	8.4	2.4	8.9	7.5	5.0	12.9	10.1	3.3	6.9	7.9	4.1	16.2	5.9	4.7	7.8	5.6	6.9	2.4	7.5	7.0	14.9	3.9	9.0	5.2	12.8	21.5	5.3	8.5	6.4	4.6	6.6	6.9	12.2	3.8	5.0	3.7	8.3	10.0	4.1	7.3	61.8	13.4	1.1	10.3	2.4	2.2	6.5	12.2	0.2	1.7	5.2	8.2	0.3	0.6	0.7	0.1	0.9	9.5	10.5	8.8	17.7	1.3	1.0	4.0	0.8	0.7	0.1	0.7	0.0	0.6	1.7	5.1	0.2	0.8	2.3	0.7	0.7	1.3	0.1	0.4	0.4	1.8	0.0	0.7	12.6	1.8	1.5	0.5	5.2	3.8	1.5	0.1	0.0	4.0	0.3	0.1	0.1	4.0	0.7	1.0	2.9	0.0	0.9	5.8	1.6	2.3	5.2	3.8	0.4	9.1	8.2	2.3	0.5	1.1	1.4	1.4	2.2	1.5	0.0	0.0	0.0	5.8	0.1	6.3	0.0	1.8	5.2	0.1	4.3	0.0	0.2	0.4	0.0	1.7	0.1	0.6	0.5	0.3	0.3	8.2	0.8	0.0	0.7	6.2	12.9	2.4	8.9	7.8	5.6	14.9	3.9	8.5	13.4	3.0	7.7	0.0	15.5	4.9	17.1	2.8	15.3	68.3	17.0	15.7	43.2	0.3	14.9	7.4	1331.5	8.1	2.1	0.0	9.1	0.6	10.3	7.2	16.1	2.1	4.2	30.2	9.2	9.2	17.5	2941.6	33.9	13.4	18.6	1.8	5.2	21.5	4.5	3.4	23.7	7.7	44.9	19.4	9.2	58.1	20.0	4.5	0.2	0.9	5.2	8.8
AGBL4	"CCP6, FLJ14442"	ENSG00000186094	"ATP/GTP binding protein like 4"	Q5VU57	1	48532855-50023913	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 20.4;pituitary gland: 31.5"	"Cell type enhanced"	"Detected in some"	23	"Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.7;SCLC-21H: 5.3;SH-SY5Y: 2.0;SuSa: 1.8;U-937: 2.2"	"Low region specificity"	"Detected in many"							HPA037994	Approved					NA	NA					"HPA037994: AB_10673036"	"unprognostic (3.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.31e-4)"	"unprognostic (3.42e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.51e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.85e-1)"	1.4	4.5	7.8	0.8	13.6	1.1	1.5	1.3	20.4	1.0	0.8	3.0	0.1	0.7	1.0	4.5	0.9	7.8	1.0	3.7	7.1	7.2	10.2	4.6	1.6	0.8	3.2	11.6	1.3	2.7	3.6	31.5	2.7	6.7	1.0	0.7	4.6	0.8	1.5	0.9	1.5	0.8	0.7	1.5	1.3	1.1	10.7	1.9	0.0	3.4	0.0	0.8	0.7	0.7	0.8	0.5	2.2	0.3	0.6	1.8	0.2	0.0	0.5	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.9	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.3	0.1	0.4	3.7	0.0	0.4	0.1	0.1	0.1	0.1	0.3	5.3	2.0	0.0	0.2	0.0	1.8	0.0	0.3	0.0	0.0	1.4	0.2	0.0	0.2	0.0	0.1	0.1	2.2	0.5	2.2	0.3	0.4	0.3	0.3	1.8	0.5	0.2	0.1	0.2	0.8	0.4	0.2	1.0	0.6	0.2	0.5	0.3	0.2	7.8	13.6	1.3	20.4	7.1	7.2	3.2	11.6	6.7	1.9	0.0	0.0	0.0	0.6	0.2	2.3	1.0	0.0	9.4	1.2	3.5	80.5	0.1	1.7	0.1	9.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	4.8	5.8	0.6	0.0	6.5	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	3.8	22.3	0.0	0.0	13.6	3.6	0.0	0.1	0.0	0.0	0.1
BEND5	"C1orf165, FLJ11588"	ENSG00000162373	"BEN domain containing 5"	Q7L4P6	1	48727523-48776969	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 7.1;naive B-cell: 10.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 4.2;HDLM-2: 13.6;JURKAT: 5.4;MOLT-4: 5.6;NTERA-2: 3.2;REH: 7.8;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in many"							"HPA054347, HPA058007"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA054347: AB_2682456, HPA058007: AB_2683577"	"prognostic favorable (2.50e-5)"	"unprognostic (1.36e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.68e-2)"	"prognostic favorable (8.30e-6)"	2.7	5.4	6.5	5.6	7.7	3.0	3.1	2.1	15.5	4.8	5.0	2.8	3.5	1.6	5.0	4.9	2.3	4.3	6.0	4.0	6.0	5.1	6.5	0.8	3.0	5.9	5.4	9.7	12.8	2.8	1.9	5.9	1.4	14.7	3.9	1.6	3.3	2.5	4.3	6.6	1.9	2.6	2.6	3.2	6.4	2.9	2.6	1.9	11.3	4.3	0.5	4.1	4.4	2.9	10.1	1.9	0.2	0.0	1.1	2.0	0.6	0.0	0.0	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	5.6	0.2	3.2	0.0	0.0	7.8	1.4	0.0	0.1	1.5	1.4	3.8	0.0	0.0	0.3	1.6	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.2	1.9	10.1	2.0	1.2	0.2	1.1	0.0	1.9	0.0	0.6	6.5	7.7	2.1	15.5	6.0	5.1	5.4	9.7	14.7	1.9	6.0	1.9	5.9	4.6	1.6	12.3	5.3	12.7	9.4	7.9	5.2	15.7	0.3	46.4	4.6	7.5	6.3	0.0	0.0	1.6	0.4	5.4	0.9	1.1	0.0	0.2	7.9	11.6	1.8	0.0	3.6	12.0	0.5	3.3	0.0	0.6	18.0	2.4	5.5	20.1	19.2	14.9	6.5	3.4	3.2	8.1	1.9	0.1	0.0	1.5	1.4
ELAVL4	"HUD, PNEM"	ENSG00000162374	"ELAV like RNA binding protein 4"	P26378	1	50048014-50203786	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.1"	"Group enriched"	"Detected in some"	11	"Early spermatids: 111.8;Intestinal endocrine cells: 31.6;Late spermatids: 117.9"	"Group enriched"	"Detected in some"	10	"glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.1"	"Cell line enriched"	"Detected in some"	19	"SH-SY5Y: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004442, HPA043047"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB004442: AB_627765, HPA043047: AB_2732502"	"unprognostic (1.25e-1)"	"unprognostic (6.63e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.83e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.43e-2)"	0.9	11.4	11.5	3.3	12.8	0.8	1.0	11.6	43.1	0.9	3.0	0.9	0.0	2.3	0.9	0.8	1.1	0.9	1.0	1.0	12.3	16.5	0.9	1.0	1.0	0.9	10.6	30.7	0.8	2.8	0.8	7.1	0.9	37.0	1.0	3.8	0.0	0.9	0.9	0.8	1.2	3.1	2.0	8.5	1.0	1.9	7.8	1.4	0.1	0.8	0.0	1.0	0.9	0.5	0.0	0.6	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.6	0.0	0.0	11.5	12.8	11.6	40.4	12.3	16.5	10.6	30.7	37.0	1.4	0.0	0.0	0.0	0.0	0.7	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	31.6	0.0	4.5	117.9	1.4	2.3	1.7	0.0	0.0	1.0	0.5	0.0	0.4	0.0	3.0	0.0	0.0	7.5	7.9	0.6	0.1	0.0	0.0	0.0
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423500	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 3.7;Intestinal endocrine cells: 1.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.2	0.1	0.4	0.1	1.5	0.2	0.2	0.4	2.1	0.3	0.3	8.5	0.0	0.4	0.2	0.1	3.8	0.2	0.1	0.1	1.2	0.7	0.2	0.2	0.2	0.2	1.2	0.0	0.2	0.1	0.4	5.4	0.2	2.1	0.2	0.3	0.0	0.5	0.2	0.3	0.1	0.2	0.1	2.0	0.3	0.2	4.0	3.7	0.3	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	1.9	0.0	1.3	4.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	3.3	3.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.4	1.8	1.2	0.7	1.2	0.0	2.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	16.0	13.6	11.6	18.0	13.4	17.4	16.7	20.0	16.3	14.1	14.6	19.1	14.5	12.2	17.2	12.9	16.9	13.3	12.2	22.3	11.1	10.8	13.2	14.7	13.3	14.9	16.4	13.3	17.0	21.3	22.8	21.5	12.0	13.1	13.9	13.0	12.5	18.0	17.3	58.4	19.0	15.8	17.3	13.1	10.6	14.5	29.7	15.7	29.6	15.6	19.6	17.8	19.4	14.0	5.6	5.4	7.3	5.0	6.1	9.1	2.4	14.5	10.8	9.4	15.9	9.4	8.9	13.9	14.3	12.9	22.2	20.3	12.0	10.5	23.7	10.6	12.1	19.6	10.9	15.1	13.3	19.0	15.7	13.6	19.6	14.3	12.4	15.3	21.1	11.7	8.3	12.0	23.4	28.8	11.5	11.9	18.0	22.8	0.0	11.4	5.8	21.8	16.8	12.5	19.5	7.8	20.4	20.7	0.0	22.4	13.2	0.1	11.7	12.9	26.5	21.7	13.7	8.3	25.3	7.2	12.6	15.4	15.4	0.1	18.5	19.3	27.5	0.0	30.8	14.4	1.4	3.4	7.3	6.6	4.1	8.7	4.0	5.9	6.4	5.4	5.6	7.0	4.7	1.2	6.1	5.0	4.5	9.1	2.4	11.6	13.4	20.0	16.3	11.1	10.8	16.4	13.3	13.1	15.7	6.0	12.8	13.6	31.6	19.1	19.0	40.5	5.1	21.4	29.6	15.7	25.5	12.7	24.9	7.5	59.2	12.6	15.8	23.3	9.8	23.2	11.1	17.4	5.7	15.1	10.0	15.9	10.9	8.0	9.4	92.2	10.3	9.9	15.1	5.4	16.2	18.8	7.4	8.6	10.3	23.7	31.5	6.5	12.9	31.6	13.9	24.6	12.8	19.5	18.0	32.0
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974633	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 53.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	42.1	12.6	5.9	10.7	7.9	14.9	31.7	4.3	5.7	13.1	13.0	8.7	7.7	6.6	17.1	13.9	11.5	8.4	13.7	20.1	5.7	3.1	7.4	3.3	7.9	11.0	13.7	5.3	22.5	9.4	23.1	5.7	3.1	3.9	10.3	5.7	6.0	5.4	12.2	9.2	8.5	7.9	15.1	7.5	8.5	5.3	5.3	8.9	54.2	8.0	4.9	9.8	17.4	21.7	3.4	7.4	12.2	2.5	6.0	14.1	3.8	14.0	5.8	1.1	19.4	20.0	2.9	0.2	13.4	13.6	22.5	19.8	0.3	4.8	27.6	12.1	11.4	8.2	1.7	13.0	1.7	11.1	16.7	17.5	20.9	44.3	3.5	1.0	14.5	9.6	1.0	0.3	6.1	2.6	8.5	5.9	22.9	9.4	0.0	13.0	3.5	18.7	7.0	0.0	5.3	14.2	22.3	18.3	0.0	7.1	5.9	9.8	23.0	18.3	12.8	4.3	0.1	6.3	49.3	4.7	25.8	10.0	15.6	0.2	28.3	26.9	22.7	0.0	53.0	22.8	12.2	2.5	11.0	5.2	1.4	6.0	3.4	7.7	6.8	6.1	1.9	4.3	4.1	0.2	6.0	0.6	7.4	14.1	3.8	5.9	7.9	4.3	5.7	5.7	3.1	13.7	5.3	3.9	8.9	0.0	4.6	5.3	2.5	9.0	4.2	12.5	2.5	2.7	2.3	3.5	15.7	1.1	14.9	3.3	3.6	5.3	3.9	70.0	3.1	11.0	20.6	2.5	16.1	6.0	22.5	4.8	8.1	17.2	19.7	5.3	36.5	11.2	6.8	24.4	4.8	27.8	4.0	4.0	44.9	26.6	9.7	84.1	18.6	5.1	6.8	9.8	1.6	33.8	3.9	1.0
C1orf185	FLJ27485	ENSG00000204006	"Chromosome 1 open reading frame 185"	Q5T7R7	1	51102234-51148086	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 23.8"	"Cell type enriched"	"Detected in some"	14	"Early spermatids: 474.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.1;THP-1: 1.2"					"Not detected"	"Not detected"									NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	474.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	3.0	1.8	0.0	0.0	0.0	0.0	0.0
RNF11	"CGI-123, MGC51169, Sid1669p"	ENSG00000123091	"Ring finger protein 11"	Q9Y3C5	1	51236271-51273455	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045781	Uncertain					NA	NA					"HPA045781: AB_2679450"	"unprognostic (2.66e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.92e-2)"	35.0	39.5	61.8	12.7	49.8	32.3	31.8	36.7	67.0	29.2	20.2	23.2	14.8	18.4	27.1	29.7	37.0	18.5	22.3	36.3	54.6	50.0	35.7	32.3	23.0	10.0	48.6	35.8	44.2	14.9	35.7	26.5	30.8	39.3	29.0	17.1	22.8	18.5	28.5	51.2	19.0	18.3	26.6	36.5	20.1	18.2	16.1	19.1	13.0	39.6	18.7	13.5	33.4	29.8	0.9	6.8	15.2	2.3	3.4	4.3	3.8	18.6	4.5	9.6	13.1	34.6	28.1	14.7	20.9	24.4	18.5	22.9	5.2	7.1	0.1	21.5	38.4	23.0	6.4	10.6	15.6	31.6	35.2	11.8	12.2	7.5	8.1	23.9	5.7	33.6	20.5	25.9	20.2	21.4	29.1	23.4	6.8	4.1	7.7	38.2	6.8	6.9	4.8	13.7	9.4	11.9	5.4	17.7	8.3	32.8	17.7	9.4	10.2	15.6	18.2	21.8	24.2	10.5	8.2	24.8	29.2	15.5	22.5	23.5	17.5	17.3	1.8	15.3	11.6	17.7	15.2	1.6	6.6	2.8	2.3	4.3	0.9	2.9	3.8	1.7	0.7	3.1	3.9	6.3	3.4	2.0	6.8	3.1	3.8	61.8	49.8	36.7	67.0	54.6	50.0	48.6	35.8	39.3	19.1	53.6	34.5	32.1	98.1	121.6	35.3	104.9	30.6	16.0	28.4	38.4	23.6	31.4	89.5	48.0	116.4	57.3	47.6	0.0	52.8	35.4	50.6	118.8	55.2	52.9	27.9	33.4	73.9	49.7	42.4	111.4	53.2	28.7	62.4	35.1	35.0	57.3	54.4	34.2	81.7	105.6	31.6	38.8	59.0	46.5	29.0	147.5	164.7	32.4	23.3	126.1
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 357.0;Late spermatids: 452.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 23.4"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 23.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.9;MCF7: 17.2;SK-BR-3: 53.6;T-47d: 38.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028098, HPA043440"	Uncertain		Enhanced	Centrosome		NA	NA			Centrosome		"HPA028098: AB_10601705, HPA043440: AB_2678483"	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.2	4.9	3.2	6.0	5.5	0.6	23.4	0.7	4.3	8.5	18.0	0.2	8.1	3.3	1.4	10.4	10.4	4.5	17.9	8.3	3.3	7.4	40.4	3.1	12.4	0.5	4.2	2.4	0.9	22.3	6.1	12.1	0.9	10.1	12.3	20.2	3.1	10.1	10.7	2.2	5.6	4.5	0.8	4.9	0.3	18.7	28.2	2.0	0.2	5.5	8.5	6.2	5.0	5.0	0.1	23.4	0.5	0.0	0.0	0.0	0.2	2.2	1.3	0.2	0.1	0.1	0.2	9.5	0.1	0.0	0.0	0.0	5.8	0.9	0.0	4.2	0.1	0.1	0.0	1.2	0.0	0.0	21.9	4.4	0.1	0.5	1.1	0.4	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	17.2	0.2	0.0	1.6	11.9	0.2	0.0	0.0	1.4	9.4	2.9	7.9	0.7	0.1	53.6	0.5	0.7	38.8	0.2	0.2	0.1	1.0	0.1	0.1	2.2	2.9	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	23.4	0.0	0.2	3.2	5.5	0.7	4.3	3.3	7.4	4.2	2.4	10.1	2.0	3.0	25.1	1.5	3.8	1.3	1.3	11.3	7.6	10.7	4.5	8.7	0.0	0.4	10.0	31.3	357.0	1.4	9.5	23.3	46.7	4.0	0.6	16.7	3.5	0.6	1.6	0.0	39.7	0.6	0.3	452.0	2.3	0.8	0.0	4.6	53.2	1.7	28.2	8.6	2.5	21.6	6.2	6.5	1.4	6.0	5.9	5.6	2.9	1.3	17.1	11.4
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519328	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		67000	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	39.0	26.9	35.5	25.3	27.8	13.2	19.3	22.2	41.0	25.7	16.7	35.7	16.2	11.4	21.8	21.3	19.6	14.1	19.3	18.9	40.7	26.0	21.0	19.1	24.4	30.7	36.2	11.2	22.4	10.9	17.0	14.6	22.8	20.3	22.5	15.5	25.7	24.3	16.4	30.9	18.1	19.3	18.2	36.8	33.8	15.2	32.4	33.1	25.0	20.3	23.4	32.1	25.3	17.0	16.1	10.8	14.9	12.2	10.7	18.7	8.0	14.8	4.4	9.6	9.0	22.3	22.3	24.0	10.4	16.4	8.5	12.6	6.1	8.3	30.3	10.7	16.2	17.4	14.1	12.4	9.9	12.9	34.2	7.8	26.9	7.6	7.2	21.0	15.3	24.9	18.1	9.2	14.9	20.3	14.8	15.8	10.8	16.7	13.8	12.9	7.3	12.3	8.3	13.2	10.4	7.2	10.1	14.6	6.6	11.2	18.4	6.6	9.2	12.3	22.0	17.9	27.7	8.9	10.9	21.9	7.9	8.6	15.9	8.6	16.5	16.7	20.4	11.8	17.4	7.0	14.9	10.1	11.6	10.1	10.7	15.3	16.1	12.2	15.6	10.8	10.0	7.3	10.5	7.8	10.7	12.2	7.1	18.7	8.0	35.5	27.8	22.2	41.0	40.7	26.0	36.2	11.2	20.3	33.1	32.8	43.7	52.2	25.1	38.1	16.1	53.7	20.4	26.8	21.6	41.8	29.5	17.7	16.6	12.4	21.7	42.7	20.1	0.0	16.4	15.6	33.6	48.2	23.2	33.7	65.6	27.0	27.6	74.9	76.1	45.1	60.9	39.3	97.8	33.3	31.1	41.6	19.4	24.1	45.3	22.7	26.0	38.8	31.5	70.5	36.4	44.5	23.8	47.5	19.5	42.3
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	35.7	28.8	12.6	19.0	20.7	20.3	27.4	30.3	17.6	29.4	15.4	29.8	20.0	13.1	36.3	29.7	18.8	19.4	15.0	27.2	13.5	16.1	35.4	52.6	25.7	18.2	25.1	14.0	29.4	26.9	43.2	27.6	20.8	22.2	37.1	16.6	29.9	18.2	22.4	55.6	15.2	16.4	25.3	28.2	22.5	22.5	20.0	24.8	19.4	28.2	18.5	24.6	27.7	31.6	23.4	19.9	28.7	13.6	12.8	23.2	12.6	20.5	10.6	21.4	4.7	15.3	7.6	38.5	10.5	17.7	17.1	20.4	15.3	15.4	29.9	18.4	11.6	37.9	9.5	18.1	18.3	24.3	21.3	13.2	23.6	20.6	31.6	14.9	24.3	12.2	15.4	17.7	19.3	12.7	22.5	22.4	16.1	44.7	9.8	9.5	14.6	6.9	26.3	29.2	8.5	4.9	17.6	31.2	31.8	22.8	16.0	10.7	14.1	9.0	24.6	29.2	54.5	11.9	24.5	13.4	4.9	16.4	6.1	18.8	24.0	15.2	34.9	12.0	11.3	7.6	28.7	13.6	25.0	16.1	11.4	23.2	23.4	16.0	16.6	19.9	16.4	17.1	18.1	15.9	12.8	8.6	15.7	15.3	12.6	12.6	20.7	30.3	17.6	13.5	16.1	25.1	14.0	22.2	24.8	74.5	49.1	18.6	29.9	15.8	56.5	40.9	33.1	34.8	64.8	43.6	39.3	73.6	106.1	38.4	33.8	24.8	19.8	23.3	41.8	42.1	39.1	43.6	32.4	52.3	33.4	25.4	28.6	20.3	22.4	30.8	57.8	20.0	62.4	63.1	19.4	41.4	33.7	8.6	47.0	45.4	31.9	45.3	36.4	30.9	17.6	16.6	63.2	23.5	21.4	23.0
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 492.5;Late spermatids: 1318.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	16.4	15.9	13.4	15.8	17.5	14.5	11.7	14.7	16.9	12.2	13.7	11.0	9.9	11.2	11.8	12.1	14.4	10.9	10.9	25.7	13.1	13.3	12.4	28.5	12.0	13.6	16.2	10.6	11.7	15.9	19.3	21.4	14.2	15.7	13.8	12.1	9.8	11.9	11.3	96.4	19.1	10.3	13.3	14.0	13.6	11.9	32.3	14.5	19.4	11.7	21.5	15.1	13.0	16.0	13.8	18.5	36.3	19.1	15.8	15.1	16.2	46.9	26.5	26.6	38.1	28.0	43.3	30.9	47.5	41.1	34.6	36.7	18.5	18.6	31.0	25.4	35.7	46.4	27.4	39.0	36.8	43.8	36.7	19.2	37.0	36.0	16.1	28.7	32.3	28.2	34.4	28.2	50.4	46.8	29.8	35.9	33.0	48.7	20.8	43.2	17.2	29.2	11.2	47.2	19.4	28.5	28.6	31.8	34.2	25.5	27.3	25.5	19.2	43.3	34.9	25.7	53.9	23.3	39.3	29.8	30.4	28.2	33.1	40.3	31.1	46.9	29.0	35.9	40.7	34.8	19.3	18.1	26.0	13.7	19.1	13.7	13.8	12.7	15.1	18.5	9.3	12.5	13.4	36.3	15.8	14.5	15.0	14.4	16.2	13.4	17.5	14.7	16.9	13.1	13.3	16.2	10.6	15.7	14.5	32.8	55.9	17.8	35.3	0.0	67.0	0.0	17.8	108.4	63.7	26.2	76.6	47.3	26.6	38.1	492.5	33.3	18.8	70.0	55.1	37.0	33.6	42.0	32.5	52.9	39.9	58.8	17.5	28.3	38.2	1318.0	61.2	53.3	0.0	60.5	26.4	53.0	45.7	14.0	55.5	15.1	68.3	58.2	0.0	37.6	20.9	0.0	69.0	40.6	27.9	33.4
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990764	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;placenta: 37.6;prostate: 20.0"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 137.0;Alveolar cells type 2: 101.3;Intestinal endocrine cells: 282.2"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 17.3;fHDF/TERT166: 16.1;HBF TERT88: 15.3;TIME: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.4	5.8	16.6	1.4	8.5	0.8	1.8	2.0	13.8	0.4	3.1	0.9	0.0	1.6	0.5	0.8	0.5	0.7	2.7	0.4	9.9	15.8	1.4	1.3	0.5	0.5	4.5	9.3	3.2	2.1	0.4	13.7	37.6	18.2	20.0	4.4	0.1	0.8	0.6	1.0	3.7	1.9	0.9	1.4	0.5	2.7	0.8	1.3	0.0	0.5	0.0	0.6	0.6	0.4	1.1	0.8	2.1	0.5	0.5	0.4	0.0	0.6	3.0	0.4	0.5	0.1	0.8	0.0	44.6	17.3	9.0	4.4	3.6	1.3	0.2	0.7	16.1	1.3	0.0	5.5	4.6	15.3	0.0	0.4	0.0	0.2	1.2	0.7	0.0	0.0	0.4	0.1	14.9	3.4	5.6	2.8	0.4	0.1	0.1	9.9	0.1	0.0	0.0	7.2	0.8	0.4	0.1	0.0	0.0	1.4	0.2	1.5	0.4	0.0	0.1	0.0	9.3	0.0	0.1	34.6	8.8	3.2	0.1	14.5	0.0	0.2	0.1	8.0	0.0	0.3	1.1	0.5	0.3	0.4	0.3	0.3	0.6	0.3	0.4	0.1	1.1	0.4	0.4	2.1	0.5	0.5	0.8	0.2	0.0	16.6	8.5	2.0	13.8	9.9	15.8	4.5	9.3	18.2	1.3	137.0	101.3	0.9	5.2	2.2	2.4	0.6	15.3	52.2	51.2	0.0	2.0	0.6	3.3	4.0	1.9	0.5	1.3	0.0	15.3	0.2	0.9	19.1	7.0	0.4	0.3	0.0	282.2	0.0	2.6	1.0	0.6	0.9	1.7	1.0	6.1	24.2	59.3	0.3	1.1	0.0	3.5	0.0	0.4	1.9	4.8	1.3	3.3	0.7	1.5	2.6
TXNDC12	"AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19"	ENSG00000117862	"Thioredoxin domain containing 12"	O95881	1	52020131-52056171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		95000				"unprognostic (6.54e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.61e-4)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.40e-12)"	"unprognostic (2.13e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.17e-1)"	30.5	24.6	20.4	19.8	20.1	19.5	22.7	19.2	20.4	23.1	25.6	15.3	20.9	20.4	18.6	28.5	18.9	25.1	20.2	21.6	18.2	22.1	30.7	60.3	24.5	20.6	23.5	12.5	28.0	51.9	14.0	29.4	32.4	18.5	19.7	29.1	15.4	30.3	22.0	15.5	17.2	35.0	17.7	21.0	35.1	24.3	16.7	18.3	31.8	38.6	18.3	26.6	20.8	21.6	24.2	28.6	62.8	36.4	22.3	33.3	36.7	18.1	16.7	18.9	26.9	31.3	16.7	15.0	28.0	27.6	25.4	29.4	18.6	15.0	14.1	18.4	22.0	28.4	24.4	26.2	21.3	34.1	18.5	23.8	18.0	15.4	29.8	37.7	33.2	36.2	24.3	29.1	26.3	42.4	19.6	25.4	19.3	16.0	10.8	20.9	16.6	18.5	43.3	41.7	26.3	16.3	18.9	27.9	38.8	33.7	15.7	15.0	19.6	27.6	24.4	26.5	38.3	13.7	43.7	16.2	18.3	20.2	20.9	31.5	22.0	33.1	15.9	26.6	31.2	20.7	46.7	36.4	54.6	23.2	33.2	29.0	24.2	28.5	24.8	26.9	20.9	27.4	26.3	62.8	22.3	34.4	28.6	33.3	36.7	20.4	20.1	19.2	20.4	18.2	22.1	23.5	12.5	18.5	18.3	8.9	10.5	52.4	53.7	39.2	18.1	12.7	45.9	25.4	9.1	41.8	13.7	96.2	14.9	64.8	5.6	58.2	36.0	0.0	78.0	136.0	41.8	60.0	33.4	29.0	107.7	20.6	46.6	43.6	52.6	4.5	51.8	56.6	49.0	71.3	56.4	36.1	65.7	59.6	29.0	25.4	12.5	32.3	36.0	49.4	9.6	39.6	99.1	50.0	68.5	55.2
KTI12	"MGC20419, SBBI81, TOT4"	ENSG00000198841	"KTI12 chromatin associated homolog"	Q96EK9	1	52032103-52033816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031203, HPA031204, HPA031205"	Approved		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles, Cytoplasmic bodies"		"HPA031203: AB_2732464, HPA031204: AB_10600110, HPA031205: AB_10611380"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.36e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.08e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.64e-2)"	14.9	14.6	5.9	9.9	7.4	22.1	9.7	8.1	9.3	7.8	8.4	6.7	7.2	7.4	10.5	7.6	8.1	10.6	10.9	8.1	5.6	7.6	14.1	14.1	6.4	11.9	5.4	5.9	16.1	10.7	4.3	11.0	15.5	5.5	9.6	6.3	9.1	6.4	7.7	9.4	7.3	10.0	8.9	3.9	12.2	9.5	10.6	4.8	15.4	14.5	9.2	11.3	9.7	10.5	19.4	27.7	9.7	15.2	13.4	19.9	11.7	9.2	9.2	3.6	8.7	12.6	10.6	11.6	9.4	11.7	13.9	11.9	10.2	4.6	10.7	10.7	9.8	20.8	10.6	12.8	11.2	9.7	10.8	14.3	11.0	10.4	9.9	8.8	15.8	11.0	10.0	8.6	11.1	6.0	6.1	9.4	9.5	16.4	5.7	11.6	7.3	11.5	17.6	7.2	8.1	10.4	11.1	10.1	14.3	13.2	6.7	6.6	9.5	9.1	16.2	16.9	8.7	3.1	24.9	7.0	11.4	7.0	13.6	17.7	19.9	16.5	16.6	12.5	16.8	8.2	7.8	13.9	9.7	14.8	15.2	16.3	19.4	16.7	17.9	18.4	15.2	19.9	14.0	2.9	13.4	11.4	27.7	16.2	11.7	5.9	7.4	8.1	9.3	5.6	7.6	5.4	5.9	5.5	4.8	3.0	6.1	10.0	11.8	6.4	6.0	2.4	10.2	2.7	3.4	3.5	0.0	10.5	5.0	10.1	0.8	6.9	2.0	0.0	9.4	16.1	9.3	5.5	5.8	5.3	8.7	9.5	2.4	10.4	3.8	0.5	10.6	6.0	5.0	12.6	3.4	8.0	9.5	3.5	9.6	8.3	4.4	19.4	12.3	16.8	7.0	6.5	15.3	10.0	4.7	11.2
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056125-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA067026: AB_2685765"	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	22.3	29.1	20.6	14.8	22.1	26.7	26.2	25.5	52.3	17.5	12.8	17.2	8.4	7.1	19.5	16.7	20.3	19.6	12.5	28.4	23.7	22.4	18.5	20.8	19.6	38.8	20.4	23.8	29.2	47.6	21.0	24.3	19.1	16.7	15.7	12.6	16.5	26.4	13.5	36.9	19.3	9.8	22.4	23.1	14.1	14.2	19.2	14.6	20.7	22.9	13.6	20.4	19.0	16.2	23.2	34.1	32.2	36.0	21.3	28.2	27.9	28.0	6.8	33.5	17.5	18.1	23.3	34.7	27.8	28.0	31.9	34.4	12.4	14.7	26.2	28.0	19.5	37.7	16.4	32.3	21.7	40.9	18.1	22.6	30.0	12.5	18.5	49.6	33.2	20.8	23.9	30.0	29.5	41.7	26.5	25.2	21.7	22.6	16.7	28.6	12.0	22.9	19.7	59.6	21.8	15.0	15.2	39.0	30.8	30.8	22.6	26.4	29.9	32.5	30.1	40.0	38.8	27.2	35.6	18.4	18.0	19.5	23.2	32.7	29.3	48.3	25.6	15.6	25.9	22.6	24.1	35.4	32.2	15.0	36.0	20.1	23.2	21.7	15.4	34.1	22.1	25.4	19.4	15.1	21.3	31.0	16.1	28.2	27.9	20.6	22.1	25.5	52.3	23.7	22.4	20.4	23.8	16.7	14.6	32.8	18.2	57.0	77.6	95.7	41.1	40.3	43.3	40.2	31.8	66.3	31.4	99.7	142.6	93.1	81.2	49.3	16.0	93.5	69.0	113.3	65.9	74.4	22.0	66.1	115.8	36.5	50.2	45.4	117.9	13.6	67.0	77.6	74.2	55.9	28.5	42.6	74.2	28.1	52.3	110.7	28.6	58.2	77.3	111.6	14.3	140.0	122.0	50.7	33.3	87.5
ZFYVE9	"MADHIP, PPP1R173, SARA, SMADIP"	ENSG00000157077	"Zinc finger FYVE-type containing 9"	O95405	1	52142094-52346686	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017702, HPA065852, HPA065862"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570"	"unprognostic (5.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.73e-2)"	10.2	10.0	13.6	3.8	18.4	1.0	13.0	28.4	27.7	15.5	8.0	9.5	10.1	6.8	14.1	9.1	10.8	12.2	8.1	10.4	13.8	15.7	15.2	10.7	11.3	4.1	13.8	15.8	19.5	16.9	32.3	14.6	7.4	18.7	13.6	9.9	9.6	9.8	13.8	25.5	12.3	7.4	13.3	11.6	4.2	8.6	14.9	8.0	1.5	19.5	8.8	4.2	10.9	13.8	0.4	0.0	0.0	0.0	0.2	2.1	0.4	9.8	4.7	6.8	8.7	16.7	15.0	11.1	8.1	11.1	9.7	11.1	5.5	0.8	0.0	5.0	11.5	13.4	3.6	12.0	13.0	14.9	0.0	8.2	2.8	5.4	6.5	11.1	2.5	1.7	10.1	14.8	8.4	19.2	12.0	14.0	6.7	4.3	1.8	12.9	2.2	3.5	1.8	8.8	2.7	8.3	3.1	11.6	0.9	5.5	22.2	5.7	5.9	9.0	7.8	10.4	14.3	3.6	3.3	12.9	9.8	3.9	7.4	4.8	2.5	1.5	1.2	6.9	3.1	3.9	0.0	0.0	0.0	0.3	0.0	2.1	0.3	1.6	0.4	0.0	0.4	1.3	0.7	0.0	0.2	0.0	0.0	0.0	0.4	13.6	18.4	28.4	27.7	13.8	15.7	13.8	15.8	18.7	8.0	8.9	5.1	0.0	9.7	4.5	19.7	10.9	5.1	2.7	14.8	1.8	3.9	3.5	6.6	5.2	12.6	7.9	5.6	0.0	6.4	4.8	5.2	6.5	1.1	6.8	0.4	22.3	16.8	3.7	1.2	10.3	14.1	0.5	6.8	0.0	8.1	12.2	4.3	8.2	15.6	8.2	14.1	12.9	5.8	27.1	53.7	6.5	2.4	2.1	5.2	5.7
CC2D1B	KIAA1836	ENSG00000154222	"Coiled-coil and C2 domain containing 1B"	Q5T0F9	1	52345723-52366193	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027500, HPA031426"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA		140000	Nucleoplasm	Vesicles	"HPA027500: AB_10600693, HPA031426: AB_2673876"	"unprognostic (1.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (3.39e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.87e-1)"	14.6	16.0	12.6	14.5	20.0	7.4	11.5	12.9	18.8	9.6	13.0	22.5	10.8	14.3	11.1	15.2	16.5	9.6	13.6	14.9	14.3	14.9	17.7	15.5	17.9	18.7	21.0	17.2	14.1	17.2	15.3	20.0	16.2	20.6	12.7	11.0	17.3	16.1	14.0	25.6	15.6	14.9	11.3	29.2	16.9	14.4	24.3	19.2	17.9	17.1	17.1	15.7	12.8	10.8	2.9	1.7	11.2	1.8	2.7	4.0	1.9	9.3	13.3	5.9	8.7	20.5	7.6	14.5	12.4	18.8	15.0	11.9	9.2	7.3	6.7	10.6	13.0	31.9	6.7	7.3	14.6	6.3	11.0	8.6	7.4	11.2	7.1	15.2	8.4	16.4	11.9	13.6	17.1	12.2	14.0	9.4	9.2	11.3	6.7	15.0	7.1	9.2	6.8	10.9	7.8	13.0	6.2	12.0	7.8	13.9	13.7	7.1	6.1	11.5	17.1	15.6	14.3	6.2	11.1	12.7	19.2	10.7	10.2	13.7	9.8	9.2	7.3	21.4	9.7	19.3	11.2	1.8	4.0	4.0	1.0	3.0	2.9	3.2	2.9	1.7	2.2	2.5	3.4	2.6	2.7	0.8	1.7	2.3	1.9	12.6	20.0	12.9	18.8	14.3	14.9	21.0	17.2	20.6	19.2	8.9	14.9	7.4	3.3	2.9	4.4	4.9	5.1	5.3	9.1	10.4	0.0	7.8	3.3	8.9	2.9	5.8	7.8	0.0	11.0	8.6	4.1	3.9	15.1	6.7	9.9	1.6	5.8	8.6	4.8	1.3	3.1	4.2	1.7	6.4	4.8	6.3	9.9	5.8	6.0	3.7	4.0	0.0	2.1	12.7	5.1	2.8	13.2	7.0	3.6	2.7
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404459	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.9;lymphoid tissue: 29.1"	"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 4.6;Extravillous trophoblasts: 8.3;Spermatogonia: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favorable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.9	1.2	0.2	9.9	0.4	22.9	0.8	1.4	1.1	1.1	3.4	0.4	0.1	1.4	0.6	1.5	5.3	0.5	0.8	0.9	0.3	0.4	1.0	1.1	1.4	5.7	0.3	0.4	1.0	0.7	0.2	0.9	1.6	0.9	0.8	3.8	0.5	1.4	0.8	0.9	2.0	3.0	0.7	0.4	4.2	1.2	8.7	0.5	29.1	0.5	8.0	11.3	1.0	1.7	1.0	1.3	0.7	0.4	7.5	2.3	0.7	7.4	8.2	13.3	8.7	0.3	1.1	12.8	5.3	4.9	15.8	16.4	10.1	4.2	17.2	4.7	3.3	7.2	10.3	19.5	6.7	13.8	7.3	11.2	20.6	12.2	10.0	0.0	27.6	11.8	0.6	0.3	15.4	1.7	1.1	4.6	10.9	23.9	8.4	5.1	5.5	21.6	13.1	29.4	4.5	11.8	23.3	20.7	16.8	2.7	9.8	7.5	6.3	12.3	7.5	4.2	13.0	4.1	11.1	2.1	6.4	9.3	10.0	13.2	4.4	11.7	21.3	6.3	20.6	7.8	0.1	0.2	0.0	0.5	0.3	0.6	0.4	0.8	0.8	1.3	1.0	0.3	0.7	0.7	7.5	0.4	0.1	2.3	0.7	0.2	0.4	1.4	1.1	0.3	0.4	0.3	0.4	0.9	0.5	0.0	0.0	0.8	0.2	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.2	4.6	0.1	0.0	0.0	0.2	8.3	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.8	0.6	0.2	0.0	0.0	0.7	0.2	0.1	0.0	0.4	3.3	0.9	0.0	0.1	3.2	7.3	1.0	1.5	0.5	1.9	0.1
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404564-52420839	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053099: AB_2682044, HPA058407: AB_2683709"	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	13.5	13.2	21.5	16.9	19.2	25.4	20.6	30.5	18.5	17.3	17.2	20.7	12.9	12.9	22.1	16.0	15.0	18.0	11.3	11.5	19.1	16.8	15.4	12.1	15.1	22.1	20.3	14.0	28.1	12.6	19.2	19.9	15.9	16.6	17.6	19.1	17.2	13.4	15.1	10.0	17.4	16.2	14.5	19.3	17.8	12.9	18.8	22.1	36.4	19.3	13.7	22.1	14.1	20.1	9.1	9.7	12.5	8.8	13.3	15.3	6.6	8.3	4.1	14.7	7.0	5.9	5.8	8.8	5.7	3.9	9.5	9.2	7.5	4.2	17.3	6.0	3.9	7.4	6.2	20.9	6.2	12.4	9.4	16.0	23.2	15.4	7.7	7.2	25.8	8.6	4.4	5.6	10.4	10.1	7.2	8.0	12.6	21.3	4.5	5.6	4.7	19.9	15.5	18.1	8.9	9.7	19.6	22.3	14.5	8.4	5.0	9.8	12.0	11.6	9.6	11.2	10.4	6.7	21.0	6.2	5.4	8.1	8.0	11.2	8.7	12.4	17.5	8.0	22.6	6.8	12.5	7.5	10.5	9.8	8.8	13.3	9.1	11.0	11.8	9.7	8.5	15.3	11.6	6.0	13.3	8.6	5.4	10.7	6.6	21.5	19.2	30.5	18.5	19.1	16.8	20.3	14.0	16.6	22.1	38.7	27.2	33.7	76.8	47.2	31.2	23.5	15.3	17.4	30.7	15.7	88.4	53.1	29.9	28.6	65.9	47.2	52.0	23.3	25.7	65.9	30.1	36.9	57.8	15.5	35.1	23.8	34.3	22.7	35.1	11.0	23.9	30.8	28.7	23.4	38.6	45.7	21.8	45.6	31.5	26.9	42.6	51.8	41.1	111.6	55.6	48.9	86.5	62.3	47.3	64.1
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 229.7;Horizontal cells: 198.6;Rod photoreceptor cells: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.3	9.8	24.2	16.3	9.5	12.2	16.8	9.2	13.5	13.4	15.6	10.1	5.4	22.1	10.9	12.8	21.8	8.6	18.1	9.8	17.2	18.0	16.5	23.3	12.7	21.0	15.8	25.2	13.3	14.4	21.7	14.4	17.9	17.1	9.3	15.5	18.9	11.1	11.2	0.1	25.1	18.0	17.5	5.3	12.5	22.3	24.6	17.3	14.5	8.6	13.0	12.9	14.2	6.1	13.8	28.7	8.4	13.2	7.8	10.5	14.2	9.6	11.2	24.3	31.9	31.8	6.9	13.8	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1	56.6	47.0	71.8	47.7	40.9	133.4	0.0	45.9	66.9	56.9	0.0	229.7	39.6	0.0	0.0	48.0	31.6	5.9	0.0	0.0	15.9	34.0	45.0	55.6	29.2	14.9	198.6	35.3	38.1	14.9	22.9	59.2	16.4	16.9	0.0	15.8	50.0	0.0	12.2	57.3	0.0	193.4	19.4	28.8	108.0	77.6	44.5	30.9	55.4	16.1	36.0
GPX7	"FLJ14777, GPX6, NPGPx"	ENSG00000116157	"Glutathione peroxidase 7"	Q96SL4	1	52602372-52609051	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.8;HEL: 21.0;REH: 25.0;RPMI-8226: 42.2;THP-1: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (5.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.17e-1)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (1.14e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.44e-2)"	8.6	9.4	6.9	10.1	7.5	13.8	10.4	5.8	5.8	13.7	9.6	6.6	6.2	2.8	14.8	6.8	5.5	11.1	12.0	11.0	5.2	4.9	9.9	5.5	7.3	12.8	5.5	4.2	14.1	18.3	9.9	15.4	32.9	6.8	11.1	5.1	10.0	7.7	9.2	9.3	5.7	6.5	9.7	5.2	9.3	6.0	7.8	5.2	22.6	20.5	7.9	14.1	14.0	8.2	13.6	29.8	2.0	0.6	12.0	19.8	9.3	0.0	0.0	6.2	11.5	2.3	6.7	0.0	4.2	0.2	5.1	5.3	4.0	0.0	0.0	3.4	22.8	0.0	0.0	9.8	0.0	2.8	0.0	0.0	21.0	1.2	3.7	8.4	0.0	0.0	15.5	0.0	0.8	0.0	0.0	7.7	0.1	0.0	0.0	9.5	0.0	1.0	10.9	10.7	0.0	0.0	25.0	0.0	42.2	0.4	0.0	4.7	9.3	11.1	0.0	7.2	1.0	0.0	33.4	0.4	0.0	1.3	1.3	0.0	0.0	0.0	15.6	0.0	0.0	3.8	0.0	0.6	2.0	9.9	0.1	13.6	13.6	15.1	11.6	2.2	13.3	19.8	12.8	0.3	12.0	0.0	29.8	10.8	9.3	6.9	7.5	5.8	5.8	5.2	4.9	5.5	4.2	6.8	5.2	3.0	5.6	19.2	9.6	1.9	0.9	3.7	10.2	10.7	9.1	3.5	0.0	18.6	5.0	11.2	5.0	4.4	0.0	0.0	13.7	18.3	24.5	4.9	1.1	3.4	10.3	4.8	1.2	20.9	1.8	4.9	14.1	5.2	6.8	4.6	0.7	7.7	6.1	0.0	12.7	2.6	0.5	12.9	4.1	10.0	8.1	2.9	13.0	7.9	0.0	3.3
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633344-52669683	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 10.8;lymphoid tissue: 25.4"	"Cell type enhanced"	"Detected in single"	26	"Hofbauer cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.4;Karpas-707: 13.0;NB-4: 3.7;RPMI-8226: 17.1"	"Region enhanced"	"Detected in single"		"hypothalamus: 4.7"	"Low region specificity"	"Detected in many"			HPA030744	Uncertain					NA	NA					"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"	0.6	0.4	1.0	25.4	1.4	3.5	0.5	1.3	2.0	1.3	1.2	1.2	0.0	1.0	1.1	1.9	1.0	0.9	1.3	0.3	0.9	8.8	0.8	0.4	1.2	20.4	2.8	0.2	0.2	0.7	0.0	3.2	0.5	1.2	0.7	0.9	0.6	3.7	1.0	0.7	0.2	5.7	0.6	2.1	12.1	1.2	1.2	0.7	3.5	1.3	0.3	24.0	3.2	0.4	10.8	0.1	1.9	0.0	5.7	7.9	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	3.7	2.2	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.5	0.0	1.1	0.0	0.0	0.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	7.9	0.0	4.5	10.7	7.2	6.4	0.1	10.8	5.0	3.1	0.0	5.7	0.0	0.1	2.2	1.8	1.0	1.4	1.3	2.0	0.9	8.8	2.8	0.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
COA7	"C1orf163, FLJ12439, RESA1, SELRC1"	ENSG00000162377	"Cytochrome c oxidase assembly factor 7 (putative)"	Q96BR5	1	52684451-52698366	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028154, HPA029926"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA028154: AB_10600656, HPA029926: AB_10602173"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	8.8	8.5	9.0	6.9	10.6	4.6	9.7	7.9	16.6	6.6	10.1	7.0	4.1	10.1	8.5	6.0	9.5	6.6	5.2	8.6	7.6	9.2	12.8	15.7	5.5	4.9	8.4	12.4	6.7	19.1	7.2	7.7	7.4	10.0	4.9	10.3	4.2	6.7	5.2	26.3	8.6	7.2	8.0	7.6	6.1	7.0	4.3	7.8	2.3	9.6	9.9	5.8	6.9	7.9	3.7	5.9	3.3	8.4	2.3	3.4	2.7	12.3	7.1	6.5	10.7	10.6	9.2	14.3	9.4	7.8	11.7	9.9	8.7	4.4	28.5	6.4	5.5	14.8	9.6	15.7	13.2	15.3	8.8	15.8	24.0	11.2	10.1	13.0	23.5	8.2	10.1	11.7	13.3	16.7	5.2	8.0	8.2	21.8	5.1	8.8	8.2	7.9	12.1	28.7	13.3	20.2	15.7	22.3	20.7	10.3	12.6	14.6	7.7	13.6	17.5	17.3	9.6	10.2	16.1	8.8	9.3	12.2	12.7	12.9	10.6	26.6	13.3	4.3	17.1	7.5	3.1	5.9	1.8	2.5	8.4	3.4	3.7	2.6	2.5	5.9	1.8	2.4	2.6	3.3	2.3	4.0	2.8	1.5	2.7	9.0	10.6	7.9	16.6	7.6	9.2	8.4	12.4	10.0	7.8	6.0	11.3	4.5	15.2	10.2	7.3	12.6	5.1	2.7	7.9	3.5	3.9	14.1	23.2	9.6	0.1	8.2	8.5	0.0	11.5	12.9	7.2	10.1	0.0	11.5	12.1	15.9	2.4	4.9	4.9	0.4	6.9	8.2	1.7	9.0	5.5	7.0	9.0	5.8	7.1	14.4	9.6	6.5	7.6	3.7	12.5	11.3	13.8	4.5	9.6	10.7
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726467-52827342	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.9"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 97.3;Horizontal cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	8.9	9.1	10.8	5.6	15.6	7.1	7.7	22.3	21.7	9.9	10.4	9.1	5.6	4.7	11.0	6.5	9.7	7.3	6.8	15.9	10.7	15.4	12.9	17.7	7.7	5.0	10.1	11.6	11.3	6.5	12.7	9.1	7.2	16.4	9.8	7.9	10.1	6.1	9.2	63.9	6.5	5.8	12.3	8.4	5.7	6.3	8.4	7.7	6.9	12.7	11.4	5.7	9.2	7.0	2.2	2.2	5.7	2.4	2.1	3.8	1.0	8.1	7.4	9.4	11.7	17.3	15.1	8.2	9.2	11.8	7.3	6.8	6.3	2.7	7.8	9.3	17.8	9.9	4.2	10.7	8.0	11.7	6.5	7.0	10.0	8.5	3.9	9.2	7.5	6.2	10.7	8.8	10.5	7.4	10.3	12.7	1.8	8.9	1.6	13.2	3.4	2.9	4.7	9.7	4.0	7.7	5.0	17.8	7.1	7.5	12.9	4.3	8.7	16.0	10.0	8.5	12.5	6.0	5.8	14.5	11.4	6.7	11.2	5.7	6.8	8.2	6.0	7.8	5.1	7.3	1.0	2.4	2.7	2.1	1.3	2.3	2.2	2.6	1.6	2.2	2.1	3.8	2.7	5.7	2.1	2.0	1.7	3.0	1.0	10.8	15.6	22.3	21.7	10.7	15.4	10.1	11.6	16.4	7.7	23.8	24.5	6.9	9.4	10.1	48.7	78.7	17.8	6.7	12.5	14.0	19.6	20.1	6.6	10.4	4.6	18.0	13.5	0.0	9.5	9.4	18.4	19.6	8.1	97.3	18.3	92.2	9.8	35.6	30.1	6.4	22.7	14.5	20.3	4.6	10.9	21.7	13.8	15.6	29.0	25.4	23.0	25.8	19.4	9.4	26.9	12.8	29.1	5.7	13.6	13.9
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.2;thyroid gland: 8.1"	"Cell type enhanced"	"Detected in some"	18	"Glandular cells: 1.7;Spermatocytes: 3.4;Spermatogonia: 6.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.6;hTEC/SVTERT24-B: 10.3;K-562: 9.9;SiHa: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.3	0.1	0.2	3.0	0.2	0.4	1.4	0.7	0.1	0.6	0.2	0.1	0.8	0.4	0.1	3.0	1.7	0.1	0.4	0.9	0.1	0.3	6.4	3.1	0.1	1.0	0.1	0.0	0.6	0.3	0.6	0.5	1.0	2.2	1.7	0.2	1.0	0.5	0.0	0.3	0.6	0.3	0.5	1.3	0.3	0.1	21.2	0.0	0.9	8.1	1.3	5.6	0.5	1.1	1.0	0.8	3.1	0.6	0.9	0.7	0.2	0.0	1.9	0.3	0.0	0.0	0.0	4.4	1.2	1.3	5.7	4.6	0.1	0.1	0.0	3.0	1.7	0.0	0.1	3.8	0.1	6.8	0.3	7.3	0.0	10.6	0.0	2.8	0.0	0.9	0.0	0.3	10.3	0.1	0.3	1.3	0.1	9.9	5.5	0.2	5.3	0.0	5.3	1.4	0.0	1.0	0.0	1.3	4.7	3.6	0.2	1.5	2.2	10.3	0.5	0.0	4.6	5.8	2.9	0.1	0.0	0.1	0.0	0.0	2.8	4.5	0.1	0.0	0.1	0.8	1.8	0.6	0.8	0.5	0.3	0.3	0.7	0.5	0.5	0.1	1.0	0.6	0.7	3.1	0.9	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	1.7	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	1.3	0.0	0.0	3.4	6.9	0.1	0.2	0.0	0.0	0.3
ECHDC2	FLJ10948	ENSG00000121310	"Enoyl-CoA hydratase domain containing 2"	Q86YB7	1	52895910-52927212	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.9"	"Cell type enhanced"	"Detected in all"	8	"Hepatocytes: 663.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.4;HHSteC: 11.1;THP-1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026731, HPA026768"	Enhanced		Approved	Mitochondria		NA	NA		410000	Mitochondria		"HPA026731: AB_1847969, HPA026768: AB_1847970"	"unprognostic (2.73e-3)"	"unprognostic (1.52e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.67e-2)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.11e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.62e-1)"	"prognostic favorable (2.70e-4)"	10.2	13.3	4.8	9.3	7.4	3.1	10.3	12.3	2.9	10.0	11.2	2.6	20.3	14.5	10.4	20.5	10.2	9.1	20.7	11.1	4.8	2.6	21.3	74.9	9.2	2.5	2.9	3.6	11.8	9.9	8.4	18.1	4.4	5.3	10.9	3.8	15.9	11.2	25.6	22.2	6.0	13.3	16.2	4.6	3.8	10.2	3.8	4.2	1.8	16.4	11.1	8.1	8.0	10.7	5.2	8.2	1.7	1.8	4.8	11.0	3.8	0.0	1.5	0.0	0.0	1.1	0.5	15.4	1.2	7.1	1.5	2.4	0.0	1.1	0.0	7.1	1.2	0.0	0.8	0.0	1.2	0.3	0.0	7.2	0.0	2.6	3.2	11.1	0.0	2.1	1.6	3.2	1.0	1.1	2.1	4.4	0.0	1.1	0.2	0.0	3.8	0.0	0.8	0.1	6.2	1.6	0.0	0.1	0.6	4.9	6.0	0.7	0.3	2.1	5.6	0.1	0.8	1.1	9.3	1.7	0.0	0.0	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.3	0.0	1.8	1.7	11.0	1.4	8.2	5.2	9.0	10.3	8.2	2.6	10.2	6.2	0.4	4.8	0.7	2.0	10.8	3.8	4.8	7.4	12.3	2.9	4.8	2.6	2.9	3.6	5.3	4.2	50.6	72.4	17.1	77.5	27.2	30.8	55.4	119.8	60.2	70.5	82.0	308.3	162.8	150.9	46.2	111.4	19.6	107.0	46.7	52.0	12.3	46.8	90.9	28.9	663.7	26.8	39.7	50.1	25.8	25.9	134.0	142.6	17.0	38.8	10.0	59.3	58.0	41.0	123.8	105.7	257.8	155.8	19.4	46.6	14.2	12.8	25.7	103.7	39.2	56.8	67.7
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		370000	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.6	14.1	19.0	34.8	62.4	53.4	20.6	30.6	45.9	20.1	29.2	12.6	27.8	24.4	33.1	44.8	23.5	18.0	13.0	28.6	30.8	35.5	18.9	26.2	20.3	25.9	41.6	37.7	44.2	43.3	39.0	23.8	11.9	44.1	56.9	28.9	23.3	12.7	40.6	14.8	42.0	32.8	20.8	65.1	27.7	22.0	33.5	33.3	55.8	43.6	15.7	19.0	26.7	54.2	25.6	44.1	27.7	43.2	44.0	27.4	14.2	47.7	24.4	21.3	27.0	28.5	35.5	37.5	25.3	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4	125.0	163.3	99.5	107.7	133.6	35.0	136.8	201.2	147.2	103.5	176.2	29.5	158.8	401.3	140.3	42.8	125.8	592.0	70.0	143.6	134.4	129.4	170.2	138.2	1150.9	181.7	39.7	225.9	115.4	211.6	39.0	170.6	166.5	182.2	152.3	388.8	98.9	131.8	498.1	161.5	617.2	27.0	77.6	119.7	10.6	19.8	149.3	112.0	172.0	297.8	155.6
PODN	"MGC24995, PCAN, PODOCAN, SLRR5A"	ENSG00000174348	Podocan	Q7Z5L7	1	53062052-53085502	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Leydig cells: 248.8;Peritubular cells: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"gdT-cell: 8.5;memory CD8 T-cell: 2.4;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	85	"T-cells: 8.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 10.5;BJ: 17.4;fHDF/TERT166: 10.3;HHSteC: 43.1;HSkMC: 6.8;U-2197: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		190000				"unprognostic (8.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (5.91e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-2)"	39.0	4.1	2.1	15.2	1.5	0.0	48.1	1.1	1.3	33.4	23.5	1.0	21.5	4.6	29.1	57.8	28.4	29.0	96.8	32.3	1.7	1.2	3.3	4.0	18.5	4.0	2.6	0.7	65.7	8.4	1.4	5.2	7.2	3.0	47.1	3.4	6.1	10.9	15.0	14.0	10.9	7.5	46.5	3.4	1.0	20.4	35.5	1.6	4.4	19.6	19.4	4.3	50.5	55.1	0.0	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.0	0.0	10.5	1.4	0.0	17.4	2.3	0.2	0.1	0.0	0.0	0.0	0.3	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	6.8	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.6	2.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.1	2.1	1.5	1.1	1.3	1.7	1.2	2.6	0.7	3.0	1.6	0.0	3.5	0.0	0.4	5.7	0.1	1.2	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.4	42.1	0.4	0.0	0.0	0.5	0.0	0.0	7.4	0.0	4.0	248.8	1.1	5.0	0.0	0.0	0.2	0.0	0.0	245.4	0.0	0.5	0.0	13.2	0.6	0.6	5.3	0.5	0.0	0.0	0.1
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142632	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"retina: 70.1"	"Group enriched"	"Detected in some"	17	"Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	58	"T-cells: 5.7"	"Cell line enriched"	"Detected in some"	9	"HHSteC: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049124	Enhanced					NA	NA					"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	2.0	0.2	1.1	0.6	0.6	0.0	1.2	0.6	0.7	0.9	1.0	0.7	0.6	4.1	1.3	1.2	2.1	2.2	9.6	2.9	1.7	1.1	0.7	2.8	0.9	0.6	1.2	0.6	3.8	0.6	0.0	0.6	0.6	1.1	0.9	0.0	70.1	0.6	0.6	2.1	1.2	5.3	0.6	1.3	0.6	1.1	0.9	0.6	0.6	0.6	0.6	0.6	2.5	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.6	0.6	0.7	1.7	1.1	1.2	0.6	1.1	0.6	0.0	0.6	0.0	0.0	0.0	228.0	0.4	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.0	0.0	7.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.2	0.0	2.9	1.1	0.2	66.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 64.6;Hepatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.7	3.2	7.5	7.3	6.5	3.8	8.5	4.8	4.9	6.9	6.4	1.6	6.5	13.2	7.3	2.2	7.8	7.7	14.0	11.0	5.9	7.3	8.2	7.5	4.3	1.3	9.5	7.1	7.3	8.2	9.4	5.0	4.2	7.7	4.7	11.7	9.6	4.7	4.2	4.5	5.5	5.8	14.0	14.4	8.6	6.4	7.2	13.9	8.6	7.2	11.2	7.6	9.6	12.2	18.1	18.1	14.2	15.2	4.5	3.9	3.1	6.8	3.9	14.5	8.9	8.1	5.0	8.2	5.7	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7	11.9	20.8	8.9	5.1	1.5	3.1	12.4	15.3	4.0	3.4	10.4	13.7	64.6	21.6	10.7	1.1	3.6	39.8	0.0	9.3	16.0	2.8	4.8	2.3	80.0	23.6	14.3	13.9	6.7	13.5	2.1	6.4	8.2	6.8	26.2	26.9	10.5	9.8	21.0	4.9	28.3	9.9	6.5	3.2	29.8	16.3	2.3	45.7	7.1	25.3	4.6
C1orf123	FLJ20580	ENSG00000162384	"Chromosome 1 open reading frame 123"	Q9NWV4	1	53214099-53220617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		380000	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	32.6	21.4	27.8	19.1	29.4	12.9	26.3	16.4	25.4	29.2	33.2	25.0	22.7	15.4	34.0	28.9	25.7	32.2	22.7	28.8	24.3	22.3	26.9	29.3	20.3	18.3	24.7	26.3	33.5	17.5	21.0	20.1	22.5	23.7	31.7	24.7	24.0	16.6	33.5	44.4	14.3	16.9	48.4	22.5	18.4	23.4	26.0	23.8	18.9	26.0	18.0	19.4	28.9	26.0	25.5	38.4	31.5	39.1	30.5	36.5	26.4	11.7	12.8	16.9	15.4	39.3	50.5	15.0	17.7	18.9	18.0	19.5	10.9	10.2	18.3	14.9	21.4	17.5	4.7	10.4	17.4	21.9	23.5	17.7	18.6	9.9	16.3	38.8	21.4	12.3	32.7	19.0	19.2	20.4	27.3	29.3	22.7	19.2	5.1	22.5	19.8	26.2	20.1	28.2	14.5	20.4	19.2	21.5	14.4	20.8	12.0	14.3	13.8	16.7	15.4	16.7	28.7	11.0	21.9	18.3	20.9	12.3	14.4	17.2	7.5	10.8	20.6	16.8	21.4	16.0	28.3	32.1	31.5	30.4	39.1	27.7	25.5	30.2	31.7	38.4	23.6	33.7	33.4	13.0	30.5	31.8	25.9	36.5	26.4	27.8	29.4	16.4	25.4	24.3	22.3	24.7	26.3	23.7	23.8	11.9	22.3	30.6	23.2	14.7	32.1	41.2	20.4	42.8	25.0	36.6	2.0	51.1	86.2	35.5	86.3	45.6	23.9	0.0	31.5	63.6	57.4	21.8	30.1	40.4	58.2	17.5	27.0	35.6	28.2	159.2	74.5	32.0	33.7	43.3	31.3	44.6	30.1	36.6	92.6	79.1	28.3	64.7	60.5	49.3	36.1	13.7	39.0	20.8	32.6	18.0
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex core component"	P61326	1	53226892-53238610	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148"	"prognostic favorable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	31.5	31.3	25.7	32.9	28.9	70.7	33.8	23.0	36.8	26.9	33.9	17.4	33.5	30.2	37.5	33.7	37.5	31.4	25.6	27.6	30.3	25.6	35.9	42.5	33.2	43.2	23.5	28.8	36.7	35.6	18.9	46.6	43.4	31.4	24.6	31.9	22.8	31.2	31.1	40.9	30.7	35.7	35.3	32.6	36.9	28.5	28.1	24.3	50.3	37.4	37.2	46.0	28.0	30.0	29.8	35.2	31.3	30.9	29.8	33.0	18.2	33.1	16.0	28.2	24.5	14.6	9.4	32.6	24.9	14.6	32.9	33.4	36.5	15.9	47.4	29.1	14.5	41.7	20.5	36.8	21.8	39.3	31.4	40.9	43.2	20.9	39.4	23.4	74.9	24.2	10.1	15.7	29.9	24.6	12.9	21.7	43.8	43.3	10.9	17.8	25.8	61.4	52.0	52.1	27.3	35.2	42.0	53.9	25.1	17.5	33.2	24.2	19.6	33.3	27.1	39.0	35.3	14.0	53.9	19.9	20.5	28.1	28.9	56.9	16.0	28.6	74.0	18.6	47.7	20.9	17.0	21.6	31.3	32.3	30.9	31.1	29.8	31.2	33.0	30.5	29.0	28.8	29.5	26.0	29.8	28.1	35.2	32.3	18.2	25.7	28.9	23.0	36.8	30.3	25.6	23.5	28.8	31.4	24.3	47.6	37.5	73.4	102.0	128.2	31.7	45.8	56.0	76.3	62.6	54.1	13.7	170.1	150.9	70.5	11.4	70.8	46.6	0.0	74.0	157.5	82.2	60.3	80.9	46.1	101.6	22.3	52.2	54.6	49.1	8.4	69.9	77.4	77.6	102.8	70.6	51.5	72.6	70.2	64.0	112.9	28.8	58.2	90.6	80.9	69.2	105.6	202.3	78.8	80.9	86.6
LRP8	"APOER2, HSZ75190, LRP-8, MCI1"	ENSG00000157193	"LDL receptor related protein 8"	Q14114	1	53242364-53328070	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5;thyroid gland: 48.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 39.8;Ciliated cells: 14.7;Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;T-cells: 1.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073031	Enhanced				"Secreted in other tissues"	NA	NA		240000			"HPA073031: AB_2732217"	"unprognostic (3.83e-2)"	"unprognostic (6.06e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (3.46e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.03e-3)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.88e-16)"	"unprognostic (7.73e-3)"	"unprognostic (5.47e-2)"	"unprognostic (6.98e-2)"	"unprognostic (3.00e-2)"	2.6	1.9	7.0	5.5	7.1	5.8	1.9	13.0	15.1	1.8	1.8	2.7	0.3	1.4	2.0	2.8	6.1	3.6	2.3	1.9	7.6	8.0	1.4	0.8	3.2	5.6	5.8	7.9	1.3	0.9	0.8	4.2	5.0	6.6	1.5	2.4	11.9	1.4	1.6	0.8	1.5	1.5	2.9	3.8	2.3	1.3	22.5	3.4	1.7	48.7	2.4	4.9	1.7	2.0	0.3	3.2	0.0	0.4	0.0	1.6	0.2	10.0	21.4	8.4	12.1	5.8	5.6	10.8	12.4	10.3	18.8	13.1	5.8	12.0	16.4	14.4	8.3	27.9	17.1	6.6	14.2	8.9	12.0	6.5	9.2	24.4	10.2	6.0	16.6	16.6	1.6	1.6	20.5	11.2	2.9	14.7	12.7	3.6	7.2	2.7	12.5	10.2	7.8	15.6	9.8	15.6	18.2	12.3	14.2	7.3	8.5	19.2	7.3	5.9	33.5	7.9	5.3	4.0	11.3	11.8	4.9	7.9	10.7	24.7	11.5	17.8	6.8	24.5	23.1	28.1	0.0	0.4	0.0	1.0	0.0	1.6	0.3	0.6	0.4	0.5	0.2	0.2	0.2	0.0	0.0	0.0	3.2	1.4	0.2	7.0	7.1	13.0	12.7	7.6	8.0	5.8	7.9	6.6	3.4	0.0	6.7	3.0	1.7	1.3	39.8	2.3	0.0	14.7	6.8	0.0	0.0	2.0	0.0	2.3	2.1	1.9	0.0	0.0	2.1	1.6	0.9	5.1	1.1	0.0	1.7	25.4	2.4	0.0	6.2	3.8	0.6	2.0	0.0	10.0	1.2	1.4	2.9	0.0	2.5	0.0	1.8	0.0	2.7	3.2	0.9	1.3	8.1	2.5	0.5	4.6
DMRTB1		ENSG00000143006	"DMRT like family B with proline rich C-terminal 1"	Q96MA1	1	53459399-53467488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	104	"testis: 78.1"	"Group enriched"	"Detected in some"	17	"Early spermatids: 42.1;Late spermatids: 90.9;Spermatocytes: 144.5;Spermatogonia: 150.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.3"					"Low region specificity"	"Detected in single"			"HPA036490, HPA058553"	Enhanced					NA	NA					"HPA036490: AB_10671844, HPA058553: AB_2683753"										"unprognostic (2.20e-3)"					"unprognostic (1.36e-1)"	"unprognostic (1.67e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.5	0.0	144.5	150.6	0.0	0.0	0.0	0.0	0.0
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.9;seminal vesicle: 14.7"	"Cell type enhanced"	"Detected in some"	10	"Basal keratinocytes: 6.0;Early spermatids: 2.7;Late spermatids: 2.5;Melanocytes: 3.3;Proximal tubular cells: 5.0;Spermatogonia: 2.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;BJ hTERT+: 5.9;GAMG: 7.8;hTERT-RPE1: 6.3;PC-3: 9.5;U-138 MG: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001409	Uncertain					NA	NA					"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.1	0.1	0.5	0.6	1.2	0.0	0.9	3.9	1.6	4.2	0.5	0.5	0.5	0.6	1.4	1.0	0.6	0.8	1.0	1.0	2.3	0.7	3.3	0.5	0.5	0.5	0.5	0.5	1.0	0.5	0.0	0.5	1.2	0.8	8.9	0.1	5.5	0.5	14.7	0.5	1.7	0.6	0.5	0.5	0.5	0.9	4.1	0.5	0.5	0.5	0.5	1.0	2.7	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	3.8	5.0	0.0	2.6	5.9	2.3	1.7	0.0	0.0	0.0	0.1	2.7	7.8	0.0	0.0	0.0	0.7	0.0	1.7	0.0	1.7	0.1	1.3	0.0	0.0	3.5	0.2	2.8	2.6	6.3	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	1.2	0.1	1.7	0.0	0.0	4.2	0.5	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	3.9	1.6	2.3	0.7	0.5	0.5	0.8	0.5	0.0	0.0	0.0	0.0	6.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.1	5.0	0.0	0.0	1.4	1.9	2.8	1.5	0.1	0.0	0.0	0.0
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	20.0	10.6	14.4	14.7	5.3	5.4	17.0	13.8	10.3	21.6	17.5	15.6	13.5	39.6	9.0	6.1	17.5	24.2	24.3	14.3	30.6	9.8	17.5	19.3	15.5	13.2	5.0	30.9	11.0	3.2	5.7	21.3	12.7	6.3	13.0	14.8	22.0	5.7	11.8	7.2	15.1	12.3	34.3	17.0	16.9	17.1	23.3	21.6	10.1	13.8	8.7	11.1	12.3	24.0	11.8	16.0	18.6	16.4	7.6	11.3	11.3	15.5	24.7	6.3	15.6	28.2	9.4	23.5	14.1	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5	6.0	4.6	3.7	6.1	9.0	4.1	7.6	2.5	2.7	2.3	5.2	2.0	8.2	0.0	5.9	1.7	4.8	3.3	0.0	7.7	16.4	5.9	5.0	7.0	5.9	10.3	3.2	0.0	4.3	9.1	1.7	2.6	6.7	6.8	2.8	8.4	4.1	6.1	2.9	3.2	4.5	3.2	6.5	4.7	9.3	13.1	7.4	5.7	4.1	15.1	5.4
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889834	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	10.1	15.6	12.8	9.1	13.9	8.0	18.2	6.9	12.8	11.2	12.1	8.8	11.5	11.0	6.6	12.2	14.0	10.2	10.8	13.4	10.6	12.1	16.1	31.8	11.9	14.1	12.4	9.1	11.8	13.7	7.2	15.5	15.4	14.4	17.8	14.4	10.2	17.1	14.3	18.7	13.9	10.6	9.4	10.6	13.3	13.0	10.8	11.1	10.3	33.5	9.8	15.7	12.9	16.2	8.1	11.4	26.7	14.5	6.9	16.0	10.2	6.9	4.2	6.7	4.7	7.9	8.9	6.0	5.0	7.9	9.3	12.2	4.8	2.1	2.3	8.5	6.0	14.3	8.3	8.8	11.1	9.6	17.6	7.0	5.8	4.7	7.2	10.9	6.4	5.5	8.9	10.5	7.4	9.0	7.9	10.0	8.7	6.0	6.7	9.0	5.9	6.5	9.3	4.9	8.2	7.0	4.1	6.3	9.9	7.9	3.6	3.0	3.8	4.7	9.0	23.0	22.1	13.9	7.2	4.5	3.8	3.9	6.7	4.3	13.5	15.4	4.3	5.8	5.3	3.3	12.5	12.5	13.2	8.5	11.3	8.0	8.1	7.3	8.5	11.4	7.7	7.1	6.7	26.7	6.9	14.5	7.8	16.0	10.2	12.8	13.9	6.9	12.8	10.6	12.1	12.4	9.1	14.4	11.1	6.0	13.0	10.7	15.1	7.6	6.5	8.5	28.1	14.7	15.9	8.7	0.0	65.7	10.0	23.6	22.9	8.7	11.7	0.0	28.3	23.0	8.3	37.4	9.2	17.4	34.5	9.5	9.2	13.5	19.9	41.4	5.5	15.8	10.1	16.2	23.0	16.2	25.6	12.9	8.9	13.5	5.4	0.0	6.2	12.7	18.3	9.5	108.4	13.8	9.5	22.0
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"kidney: 36.1;liver: 50.8;thyroid gland: 67.7"	"Cell type enhanced"	"Detected in some"	22	"Cholangiocytes: 17.8;Hepatocytes: 52.9;Proximal tubular cells: 83.0"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	26	"Hep G2: 17.0;SK-BR-3: 41.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	36.1	50.8	0.4	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	67.7	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	41.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	13.7	17.8	0.0	0.0	0.0	0.0	0.2	10.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	52.9	0.4	0.0	0.0	0.6	2.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0
HSPB11	"C1orf41, HSPCO34, IFT25, PP25"	ENSG00000081870	"Heat shock protein family B (small) member 11"	Q9Y547	1	53916574-53945929	"Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Stress response, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030140	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		18000	Nucleoplasm	Cytosol	"HPA030140: AB_10600713"	"unprognostic (5.73e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (9.58e-7)"	"unprognostic (5.12e-1)"	"unprognostic (6.70e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.84e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-2)"	12.2	19.7	21.5	20.1	19.5	22.6	19.5	13.1	18.6	17.4	15.6	9.5	19.4	11.0	19.1	30.6	19.0	31.9	11.0	12.9	15.4	16.0	16.0	20.0	19.9	24.0	15.0	18.7	20.8	13.4	9.5	31.3	18.2	16.8	15.1	14.6	22.4	13.3	25.1	5.6	16.0	13.1	17.8	17.3	16.0	15.6	19.6	10.0	27.1	40.4	15.0	24.2	23.5	14.3	28.6	35.9	37.5	20.0	31.1	35.0	16.8	20.7	8.9	27.5	6.5	9.5	12.6	11.1	18.6	15.9	25.8	30.5	20.5	11.7	25.1	14.5	12.6	46.9	16.9	11.3	17.7	30.9	20.3	16.3	30.8	19.3	27.5	10.3	15.4	21.6	13.1	13.5	24.4	6.9	17.0	13.5	15.4	18.0	6.0	32.1	4.3	34.3	23.8	11.1	16.4	19.3	23.3	34.9	12.9	20.9	23.1	14.0	11.5	26.3	12.1	16.7	27.5	75.5	22.4	10.0	18.1	22.2	20.2	19.5	10.9	16.2	24.8	28.6	14.5	15.5	35.4	14.8	37.5	28.0	19.0	25.1	28.6	27.8	33.0	16.8	22.9	21.9	28.0	10.3	31.1	20.0	35.9	35.0	16.8	21.5	19.5	13.1	18.6	15.4	16.0	15.0	18.7	16.8	10.0	29.8	26.1	55.8	65.1	94.4	20.9	30.8	43.3	235.5	68.2	48.8	7.9	156.8	99.5	53.0	36.0	40.6	41.8	0.0	57.6	83.4	59.6	60.9	60.0	64.4	99.0	12.7	74.2	30.1	40.7	11.5	57.0	60.6	74.2	95.6	37.1	67.6	70.4	49.1	59.8	97.6	16.4	38.8	75.1	103.5	92.0	72.4	97.7	63.3	38.8	99.6
LRRC42	MGC8974	ENSG00000116212	"Leucine rich repeat containing 42"	Q9Y546	1	53946077-53968168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047458, HPA050537, HPA064581"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.88e-5)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.67e-2)"	12.0	27.1	11.8	9.8	14.7	8.7	20.3	8.8	10.5	15.1	13.1	7.9	18.5	10.7	17.5	19.4	18.8	15.1	16.6	14.0	9.1	8.3	16.1	23.1	13.1	12.9	7.7	10.0	17.9	11.5	12.4	23.1	32.3	10.5	15.8	11.9	17.9	15.0	21.2	14.9	18.0	10.2	16.1	13.6	10.2	14.4	24.0	9.9	16.6	21.8	14.9	13.1	18.3	17.8	6.5	10.5	7.6	4.5	6.4	8.9	4.1	25.3	9.5	24.0	14.1	12.6	17.2	16.3	20.1	28.2	26.9	36.8	31.2	17.2	14.2	16.2	24.7	32.0	22.5	20.3	28.8	31.5	11.3	12.2	13.2	15.2	20.2	23.0	8.2	12.7	15.5	40.1	23.2	25.7	19.9	17.1	13.4	16.5	3.9	26.1	8.8	15.1	11.5	20.4	18.8	14.8	26.2	25.4	10.0	19.4	19.2	14.4	15.4	26.9	15.4	22.1	39.6	22.7	9.9	13.8	20.6	26.3	18.2	12.5	10.7	12.3	21.4	20.0	8.6	10.9	0.1	4.5	7.6	7.6	4.4	6.4	6.5	6.5	8.9	5.6	4.1	6.9	5.0	6.8	6.4	3.3	10.5	7.0	4.1	11.8	14.7	8.8	10.5	9.1	8.3	7.7	10.0	10.5	9.9	11.9	4.3	5.6	28.2	45.8	3.6	8.3	20.4	12.0	11.4	10.4	3.9	38.1	16.6	32.6	2.2	8.7	8.5	0.0	14.7	26.4	20.6	35.2	0.0	11.9	15.2	9.5	65.5	8.6	5.6	2.7	22.2	8.6	10.1	10.8	8.5	20.7	26.6	13.5	16.6	12.2	3.2	12.9	14.1	24.6	45.1	34.3	48.1	6.5	13.6	35.8
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007299-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 64.2;lung: 16.1;ovary: 20.5"	"Cell type enriched"	"Detected in some"	15	"Ciliated cells: 499.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 3.7;Hep G2: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.1	0.1	0.0	0.0	0.6	2.1	0.4	64.2	1.1	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	20.5	0.1	0.0	1.5	0.1	0.2	0.5	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.8	4.8	0.0	0.0	0.7	0.5	2.1	0.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	3.7	0.0	1.9	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.3	0.8	15.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.6	0.3	0.0	0.1	1.0	0.0	0.1	0.8	0.1	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.0	7.4	0.0	0.2	0.0	0.0	0.0	0.0	499.2	34.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	4.7	0.0	0.1	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
TMEM59	"C1orf8, HSPC001"	ENSG00000116209	"Transmembrane protein 59"	Q9BXS4	1	54026681-54053504	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075447	Approved					NA	NA					"HPA075447: "	"unprognostic (2.63e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.49e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.38e-2)"	45.1	68.7	41.1	29.8	42.9	36.4	58.8	31.6	47.5	61.8	79.7	68.4	72.3	59.5	47.5	73.1	53.3	68.9	55.5	63.2	43.8	44.5	80.6	85.4	47.8	35.5	62.8	49.2	48.0	96.2	58.8	65.4	78.6	56.9	60.5	82.3	58.9	85.3	58.2	44.5	42.5	77.8	42.7	111.0	41.1	71.6	43.3	55.6	26.4	84.4	36.1	35.5	53.5	58.6	52.4	63.8	146.1	78.9	48.2	67.2	115.3	25.7	17.0	20.5	26.3	124.4	55.2	26.2	48.8	71.0	30.5	40.2	13.6	55.4	13.3	46.7	83.4	37.3	39.7	23.6	33.4	32.3	32.6	24.9	18.2	41.5	22.7	46.9	22.5	38.8	60.1	59.4	29.9	31.9	82.4	35.0	18.1	21.3	46.7	34.9	12.4	13.2	18.8	28.5	73.3	31.9	12.9	35.7	54.8	37.5	34.5	29.9	24.8	53.4	55.1	54.3	40.2	26.4	48.3	36.3	37.7	13.3	27.6	25.8	41.6	45.2	15.8	50.8	38.1	31.4	115.5	78.9	96.7	56.7	63.1	59.6	52.4	61.2	61.7	63.4	46.9	57.3	56.9	146.1	48.2	67.3	63.8	67.2	115.3	41.1	42.9	31.6	47.5	43.8	44.5	62.8	49.2	56.9	55.6	217.4	154.8	203.9	559.3	359.0	145.7	125.5	443.3	431.0	210.4	415.2	111.9	422.4	135.9	388.3	250.3	265.0	704.5	163.5	312.7	461.3	462.7	771.4	151.3	356.8	292.7	125.5	391.8	308.7	279.1	144.4	400.7	261.8	654.6	140.7	617.9	435.3	300.5	929.3	332.7	375.5	125.4	362.2	279.1	321.0	124.1	362.2	574.6	211.6	510.6	638.1
TCEANC2	"C1orf83, FLJ32112"	ENSG00000116205	"Transcription elongation factor A N-terminal and central domain containing 2"	Q96MN5	1	54053587-54112519	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 24.1;Early spermatids: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046918	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046918: AB_2679864"	"unprognostic (2.80e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.73e-5)"	"unprognostic (8.64e-2)"	"unprognostic (7.93e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.57e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.08e-1)"	5.9	5.9	7.9	7.6	11.1	6.5	5.9	3.0	7.9	6.1	5.4	13.4	6.6	6.8	5.3	6.2	7.9	5.2	4.4	4.4	8.3	6.4	7.2	4.7	4.8	9.4	10.2	4.5	4.3	6.4	6.6	6.2	6.0	8.8	5.1	8.1	6.5	5.5	4.1	9.4	6.8	6.4	6.3	14.1	8.2	5.2	15.4	8.8	15.7	5.7	3.0	10.8	7.3	5.1	7.8	7.6	10.1	8.9	10.2	6.3	3.8	5.2	2.3	5.9	4.9	4.0	6.3	5.7	5.6	4.3	6.3	5.6	1.4	3.3	4.6	4.9	2.4	6.3	5.3	7.8	4.3	8.0	10.2	4.2	6.8	5.5	2.7	2.5	5.0	6.9	4.7	3.7	5.5	3.2	2.8	8.1	10.6	6.7	4.3	5.2	1.9	10.0	3.7	13.7	5.8	3.9	10.0	10.8	6.8	2.3	3.1	5.1	5.4	3.6	5.6	6.7	8.7	5.5	9.5	4.2	5.7	3.6	5.5	6.8	10.0	14.3	6.4	4.8	6.9	7.1	5.9	7.3	10.1	4.7	8.9	4.6	7.3	5.4	5.8	7.6	7.8	6.3	6.2	9.4	10.2	6.5	6.9	4.1	3.8	7.9	11.1	3.0	7.9	8.3	6.4	10.2	4.5	8.8	8.8	8.9	9.1	0.8	1.5	0.6	3.0	7.5	10.2	24.1	7.9	10.4	11.8	4.9	1.7	2.9	22.3	4.4	3.3	0.0	1.6	5.2	3.1	1.7	2.3	4.0	4.2	7.9	3.5	2.5	6.3	18.0	2.8	3.7	1.7	6.4	4.4	3.1	3.2	3.5	2.8	3.4	3.1	0.0	2.5	12.7	2.6	0.9	3.3	5.1	4.4	1.4
CDCP2		ENSG00000157211	"CUB domain containing protein 2"	Q5VXM1	1	54132968-54153770	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.4"	HPA031143	Uncertain				"Secreted - unknown location"	NA	NA					"HPA031143: AB_10611819"	"unprognostic (1.08e-1)"	"unprognostic (5.16e-2)"		"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-2)"	"unprognostic (7.67e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.21e-2)"	0.5	0.3	0.1	0.1	0.5	0.3	0.9	0.1	0.6	1.1	0.2			0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.4	0.3	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.5	0.0	0.6	0.3	0.2	0.0	2.2	0.2	0.1			0.6		0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.7	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 9.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	1.7	4.9	1.9	0.8	1.9	1.6	2.4	1.3	1.7	2.5	2.2			2.6	2.5	2.3	2.1	2.9	2.0	3.5	2.1	1.7	2.7	2.6	1.5	2.1	2.3		5.0	4.1	1.8	4.2	1.1		2.1	2.7		3.2	1.4	3.7	3.9	1.5	2.4	1.8	2.5	2.8	1.2			3.1		2.2	2.8	1.8	1.4	1.8	2.6	3.5	3.1	1.5	1.2	3.9	5.3	7.3	7.5	5.9	5.7	2.5	3.1	4.5	6.1	6.6	4.9	4.3	6.6	3.7	2.1	13.9	3.6	11.3	3.3	6.9	7.4	4.6	7.5	8.5	5.0	4.4	6.3	3.8	3.0	4.4	7.2	3.3	4.3	5.3	6.0	8.0	3.1	4.4	4.8	6.3	3.5	7.2	4.5	4.2	10.2	8.9	6.0	2.7	4.5	10.7	5.3	2.1	7.2	6.3	6.1	5.0	4.9	2.4	4.7	3.8	6.9	5.5	4.7	7.5	9.7	5.2	13.6	7.1	2.2	1.8	1.6	1.0	3.5	0.8	1.1	1.5	0.6	1.6	1.4	1.2	1.2	2.6	3.1	0.8	1.8	0.5	1.2											0.0	7.4	0.9	1.0	0.1	3.7	4.2	0.0	9.4	4.5	3.5	3.9	1.5	6.6	2.4	0.0	3.6	0.9	0.0	3.6	1.7	1.5	1.1	2.3	2.1	4.6	0.0	2.4	3.1	1.0	0.6	1.4	1.4	0.0	1.0	0.7	2.0	1.3	0.0	1.8	2.2	3.1	0.0	1.4	0.9	5.3	0.6	0.2	0.5	2.4	0.8
MRPL37	"MRP-L2, RPML2"	ENSG00000116221	"Mitochondrial ribosomal protein L37"	Q9BZE1	1	54184041-54225464	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025767, HPA025826, HPA025951"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107"	"unprognostic (2.00e-1)"	"unprognostic (6.81e-2)"	"prognostic favorable (6.99e-4)"	"unprognostic (1.71e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.67e-3)"	21.3	35.0	16.2	15.8	24.0	26.0	18.0	16.9	34.8	15.8	22.9	18.0	13.9	23.5	17.6	13.7	29.0	18.2	18.6	32.0	15.4	14.0	25.1	65.2	13.8	20.6	16.0	14.6	21.2	30.8	15.4	10.9	19.4	23.0	16.2	25.2	20.1	33.5	15.3	68.0	24.0	25.0	19.3	11.9	17.9	20.9	20.0	9.0	31.4	18.1	39.9	28.1	16.2	17.5	39.0	40.8	14.8	35.3	29.1	37.4	38.5	39.4	22.8	20.8	28.0	21.1	28.3	37.2	26.9	25.3	48.1	41.9	45.6	18.3	53.8	24.4	30.1	45.9	31.9	40.9	39.8	37.7	26.2	51.6	46.2	48.3	46.0	36.2	54.6	21.6	31.1	34.2	49.8	39.1	27.0	42.9	42.3	51.0	16.2	34.2	29.1	37.6	53.3	42.6	32.0	50.9	41.4	42.4	45.3	27.4	29.6	41.2	19.2	37.2	64.1	49.4	28.7	27.7	62.0	21.3	30.9	28.1	38.8	53.9	20.6	28.9	41.9	40.2	55.8	29.2	14.8	35.3	14.6	24.1	29.9	28.2	39.0	29.8	27.2	40.8	32.8	30.3	27.0	1.9	29.1	27.9	34.1	37.4	38.5	16.2	24.0	16.9	34.8	15.4	14.0	16.0	14.6	23.0	9.0	20.8	18.9	20.8	36.7	30.8	8.2	68.7	48.4	18.7	17.0	17.4	2.0	102.8	68.0	71.3	25.7	28.2	48.4	46.7	83.7	118.7	37.0	38.0	13.9	148.6	76.9	6.4	31.9	38.1	35.8	43.5	24.2	28.1	21.9	58.7	48.4	9.1	62.0	31.6	26.9	83.4	6.9	12.9	26.2	21.7	38.3	32.6	61.8	25.9	80.6	43.8
SSBP3	"CSDP, FLJ10355, SSDP, SSDP1"	ENSG00000157216	"Single stranded DNA binding protein 3"	Q9BWW4	1	54225432-54413479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071780			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071780: "	"unprognostic (1.44e-2)"	"prognostic favorable (2.48e-9)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.96e-1)"	12.3	19.9	17.4	11.1	18.8	21.3	12.2	27.8	35.8	24.7	15.7	11.2	12.0	14.5	26.1	7.3	17.2	21.9	17.2	13.1	15.3	13.5	10.6	14.7	10.7	9.6	13.7	21.1	51.9	13.5	6.1	7.8	13.9	11.0	16.4	10.7	12.5	13.6	21.1	13.9	16.7	14.9	16.5	15.1	12.1	26.2	12.8	9.6	40.7	9.9	8.5	9.3	15.4	18.9	0.5	0.7	1.1	0.4	0.3	6.6	1.3	3.9	2.5	22.8	14.4	9.0	5.8	52.8	7.7	6.6	3.2	2.5	4.5	3.5	2.7	14.7	6.8	3.3	12.5	11.3	5.3	3.2	20.3	5.3	26.4	8.3	5.1	8.2	6.9	13.1	10.1	3.9	5.6	1.6	5.6	15.9	16.2	25.8	4.9	3.8	3.7	41.4	8.3	43.6	15.3	11.4	29.6	6.3	10.7	4.4	3.0	34.5	19.5	9.2	18.7	5.0	20.2	9.8	8.0	13.3	6.6	11.6	8.2	5.4	11.1	8.9	6.2	11.0	24.0	2.7	0.0	0.4	1.1	2.3	0.2	2.1	0.5	3.7	3.0	0.7	0.3	6.6	5.2	0.1	0.3	0.4	0.6	0.2	1.3	17.4	18.8	27.8	35.8	15.3	13.5	13.7	21.1	11.0	9.6	11.9	8.9	3.0	36.3	26.4	85.6	15.1	45.9	21.4	13.6	22.7	7.9	45.2	8.3	27.5	29.8	31.7	34.9	46.7	22.5	38.4	36.8	27.8	7.0	84.4	22.8	39.7	107.4	44.2	31.0	27.5	84.8	16.2	21.9	6.4	73.5	53.9	41.6	34.5	128.7	8.9	45.8	25.8	41.2	2.5	14.3	22.6	19.8	9.5	46.0	25.7
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 80.9;Late spermatids: 73.7;Muller glia cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 12.6;OE19: 17.6;RT4: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA041047: AB_2677273"	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.3	4.1	5.7	1.9	7.3	3.0	1.2	3.7	8.6	3.7	10.9	9.6	10.0	28.2	3.6	5.2	14.8	2.7	4.0	22.2	5.9	2.6	15.1	1.2	1.7	1.5	3.1	9.5	4.6	3.0	9.4	18.8	1.4	11.1	3.9	9.5	22.0	9.4	4.5	6.8	2.6	22.5	14.6	6.2	1.3	9.0	6.6	3.9	0.0	10.1	5.7	2.7	9.1	5.5	1.3	1.3	8.3	1.3	0.9	0.9	0.6	4.3	2.8	1.4	0.9	0.6	1.3	2.2	2.5	0.2	0.9	0.6	4.2	11.1	1.0	4.2	2.1	2.7	12.6	0.6	2.2	0.5	2.6	1.0	10.3	4.0	1.8	0.2	1.2	1.7	1.4	2.5	0.4	1.1	1.2	2.3	0.8	0.6	1.5	2.9	1.4	0.5	1.7	2.3	17.6	0.6	0.9	7.5	1.0	1.0	26.2	2.9	2.9	1.2	0.9	0.5	4.9	1.1	3.3	2.4	2.0	1.7	1.3	1.0	1.7	0.8	1.1	0.9	7.7	0.9	2.0	1.3	8.3	0.8	0.7	0.7	0.7	0.7	0.5	1.3	1.3	0.9	0.9	2.8	0.9	0.9	0.9	0.6	0.6	5.7	7.3	3.7	8.6	5.9	2.6	3.1	9.5	11.1	3.9	0.0	8.5	2.7	14.4	4.2	46.5	21.5	12.7	12.0	10.3	24.4	0.0	1.8	10.0	4.7	13.0	1.8	80.9	0.0	2.2	5.4	3.5	4.9	15.0	0.0	7.6	14.3	45.7	1.8	5.6	73.7	12.7	9.1	8.5	2.8	31.3	81.2	3.9	34.5	16.6	31.2	4.0	0.0	3.8	0.5	0.2	2.5	2.1	0.0	34.5	20.9
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609182-54623556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 45.8;kidney: 59.3"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 116.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Cell line enriched"	"Detected in single"	45	"CACO-2: 41.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved					NA	NA					"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.6	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.0	59.3	5.6	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	45.8	0.1	0.1	0.5	0.0	0.3	0.1	0.3	0.1	0.1	0.9	0.1	0.1	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	41.7	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	7.0	0.0	0.0	11.6	0.0	4.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	116.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0
MROH7	"C1orf175, FLJ46354, HEATR8"	ENSG00000184313	"Maestro heat like repeat family member 7"	Q68CQ1	1	54641754-54710266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 54.2"	"Group enriched"	"Detected in many"	59	"Early spermatids: 146.5;Late spermatids: 448.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	29	"eosinophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;SH-SY5Y: 1.6"									HPA071840	Enhanced					NA	NA					"HPA071840: AB_2732187"	"unprognostic (1.52e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.15e-2)"	0.3	0.0	0.5	0.3	0.4	0.5	0.3	0.3	0.4	0.3	1.0	0.3	0.8	0.1	0.3	0.9	0.5	0.4	0.3	0.7	0.3	0.4	0.7	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.7	1.8	0.3	0.3	0.8	0.3	0.3	1.4	0.6	0.6	0.9	0.4	0.3	0.3	0.3	0.5	54.2	0.3	0.3	2.3	0.3	0.3	0.8	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.0	2.2	0.0	0.6	0.8	1.7	1.8	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	146.5	0.1	3.9	0.0	0.3	0.0	0.4	0.2	4.7	0.4	0.4	0.0	2.4	0.6	1.0	448.4	4.0	0.0	0.0	1.0	2.6	4.3	0.1	3.1	4.2	0.0	0.2	0.0	0.0	5.0	2.5	0.4	0.1	0.0	1.7	0.5
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715822-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	10.9	10.6	14.5	13.4	17.6	3.5	17.1	13.7	14.0	18.2	10.9	12.8	12.7	9.1	14.9	14.1	11.9	15.7	8.0	13.4	14.6	14.0	13.2	16.4	8.9	13.0	13.5	9.3	18.5	16.6	15.6	14.6	12.5	12.9	13.5	10.8	9.2	13.1	14.7	33.3	14.7	8.5	12.8	20.4	10.3	11.2	13.3	12.0	11.7	11.5	15.1	14.0	11.4	13.6	11.5	11.3	8.6	11.7	15.0	14.9	10.5	9.9	7.5	8.9	4.5	14.4	7.3	7.8	13.7	6.8	17.8	10.7	9.4	2.8	18.4	7.4	9.2	19.5	5.8	19.9	13.5	18.0	15.6	15.7	17.7	3.4	5.3	12.6	13.4	4.3	6.5	13.8	25.9	15.9	7.7	7.3	14.5	18.9	2.3	9.6	4.7	11.9	8.1	18.7	13.1	14.4	11.0	18.9	8.3	8.7	2.8	5.8	4.1	11.6	6.2	11.5	15.3	5.6	7.3	7.0	8.7	9.6	8.8	18.4	6.6	11.7	14.6	11.2	15.3	8.8	5.9	10.3	8.6	12.5	11.7	13.3	11.5	10.3	11.8	11.3	11.0	14.9	13.2	0.2	15.0	11.3	9.6	9.3	10.5	14.5	17.6	13.7	14.0	14.6	14.0	13.5	9.3	12.9	12.0	8.9	1.6	4.5	2.5	1.0	4.1	2.8	2.5	4.0	7.9	0.0	0.0	3.1	0.0	2.9	0.4	2.1	1.3	0.0	3.6	2.0	1.7	1.5	6.9	2.4	1.2	4.8	1.2	3.7	1.2	0.0	3.7	1.6	1.7	8.2	1.3	3.3	3.2	1.1	2.5	2.5	3.1	0.0	0.8	7.2	8.7	1.4	1.1	2.2	2.3	1.7
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764514	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	6.8	8.4	4.7	4.0	8.2	0.5	6.2	5.2	7.9	6.5	9.0	9.5	8.3	6.0	7.9	7.5	7.0	10.4	4.1	6.6	6.5	4.4	9.6	11.3	4.1	5.8	4.5	5.3	11.5	13.6	7.0	6.6	5.6	4.9	7.1	8.3	5.0	7.2	6.9	8.7	6.7	5.1	4.9	4.3	4.9	6.2	11.5	9.4	8.7	6.7	5.9	5.2	6.0	5.2	7.3	8.9	5.3	11.6	8.1	10.5	6.0	4.7	7.8	5.1	6.7	6.3	5.4	11.5	4.0	5.0	7.2	5.2	9.0	3.1	8.3	6.4	3.6	10.5	7.6	9.2	6.4	5.4	5.3	8.3	8.0	4.8	6.6	9.8	4.6	2.8	5.8	9.8	9.3	8.4	6.2	5.3	9.2	14.0	1.1	5.4	5.0	6.4	6.1	11.8	9.0	10.1	5.0	10.1	9.6	6.1	3.4	5.3	5.4	5.8	7.7	10.5	10.3	4.4	5.9	2.8	5.4	5.6	7.6	5.0	8.2	6.9	3.3	4.0	5.5	3.1	1.5	6.6	5.3	6.4	9.7	7.6	6.1	7.0	6.8	8.9	7.3	10.5	7.0	0.6	8.1	11.6	7.1	9.3	6.0	4.7	8.2	5.2	7.9	6.5	4.4	4.5	5.3	4.9	9.4	0.0	0.6	0.5	0.9	0.6	2.1	1.0	2.5	0.0	1.2	0.0	0.0	5.8	8.3	3.9	6.5	0.0	1.7	0.0	2.4	4.0	0.6	1.1	0.0	1.9	2.6	4.8	0.0	0.0	1.2	5.3	3.4	0.7	0.0	1.0	2.5	2.8	2.1	0.0	2.8	4.5	1.3	0.0	0.4	8.1	10.4	0.9	2.7	0.0	4.3	0.6
TTC22	FLJ20619	ENSG00000006555	"Tetratricopeptide repeat domain 22"	Q5TAA0	1	54779712-54801267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 46.8"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 45.7;Mucus-secreting cells: 19.6;Paneth cells: 38.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 8.4;CAPAN-2: 10.4;HaCaT: 11.9;hTCEpi: 6.8;OE19: 14.0;RPMI-8226: 7.6"	"Low region specificity"	"Detected in single"							HPA035072	Uncertain					NA	NA					"HPA035072: AB_10602252"	"prognostic favorable (2.06e-4)"	"unprognostic (8.52e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.08e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.21e-1)"	0.3	0.4	1.0	4.2	3.5	0.6	1.5	0.2	0.4	12.1	11.8	0.2	5.1	10.1	1.6	2.4	46.8	2.1	7.7	0.2	1.1	0.6	6.6	6.4	5.0	1.5	0.3	0.5	0.6	5.7	8.2	5.7	0.5	0.6	3.6	7.3	1.0	9.5	3.9	0.1	12.2	27.7	0.3	0.3	1.1	8.7	0.5	0.7	3.0	5.3	18.4	21.0	1.8	18.8	1.2	0.1	4.0	0.1	2.9	6.5	0.7	8.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	10.4	0.1	0.4	0.0	0.0	11.9	0.0	3.5	0.0	3.7	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.1	0.1	14.0	1.1	0.1	0.0	7.6	0.4	2.1	0.3	0.2	0.7	0.1	0.0	0.2	0.3	0.2	0.1	0.2	0.0	0.2	0.1	0.8	2.0	0.1	0.1	0.1	0.0	1.4	0.1	4.0	6.0	0.0	3.6	1.2	2.9	6.5	0.1	0.9	2.5	3.1	2.3	2.9	0.1	0.1	3.9	0.7	1.0	3.5	0.2	0.4	1.1	0.6	0.3	0.5	0.6	0.7	0.0	1.9	0.0	5.9	1.1	0.0	1.8	12.7	2.7	2.3	3.5	0.0	0.2	6.6	4.5	3.0	0.0	45.7	0.0	7.9	0.4	0.2	5.1	0.0	1.8	0.0	0.0	2.4	0.0	0.0	0.4	0.3	0.0	1.7	0.0	19.6	0.0	7.9	38.5	0.0	7.4	0.0	0.0	0.0	0.2	0.6	4.0	0.0	3.5	11.9	11.7
LEXM	"C1orf177, FLJ40201, LEM"	ENSG00000162398	"Lymphocyte expansion molecule"	Q3ZCV2	1	54806063-54842252	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 7.0;esophagus: 14.2;testis: 5.2"	"Group enriched"	"Detected in some"	22	"Early spermatids: 34.6;Late spermatids: 32.5"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.5;HaCaT: 1.6;Karpas-707: 1.9;U-266/84: 2.0;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035889, HPA035890"	Uncertain					NA	NA					"HPA035889: AB_2674844, HPA035890: AB_10669535"	"unprognostic (1.61e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.69e-2)"		"unprognostic (1.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.5			2.3	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.5		0.6	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.2	5.2			0.0		0.6	0.0	3.8	0.0	0.2	1.6	0.0	3.0	7.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	0.1	0.2	0.0	0.2	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.2	0.0	0.2	0.8	1.1	0.2	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	0.0	1.0	2.0	0.0	1.2	0.3	0.1	0.0	0.0	1.6	7.0	0.0	0.4	0.0	1.5	3.4	0.0	0.0	0.3	4.6	0.0	3.0	0.0	0.2	0.3	1.4											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.6	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849633-54887218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 164.5;liver: 119.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 733.4;Hepatocytes: 888.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA					"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	10.6	164.5	6.6	3.9	22.1	0.7	22.0	6.5	27.5	7.7	11.1	43.8	1.2	11.9	2.2	1.1	40.8	12.3	8.6	3.7	12.0	9.2	6.4	119.6	40.9	2.0	36.2	13.0	7.8	4.6	28.4	2.6	4.4	47.9	26.1	8.3	4.8	20.2	2.1	24.6	47.6	7.3	2.7	71.7	24.3	17.6	14.1	31.1	1.7	4.3	17.1	14.3	2.5	13.0	5.4	7.0	7.3	3.1	3.7	9.0	5.5	40.5	7.5	26.5	32.0	132.8	28.6	6.2	11.7	20.3	16.9	34.9	41.6	25.7	6.5	23.6	10.2	53.9	39.0	31.7	61.7	15.1	0.9	19.9	36.1	17.7	49.7	21.6	15.0	8.4	20.8	53.9	52.2	9.7	8.3	8.3	15.3	26.3	0.0	6.2	17.0	3.2	13.2	73.3	11.0	20.5	0.0	6.7	19.9	92.9	32.9	18.3	6.7	22.2	42.0	15.3	29.3	54.7	17.5	7.6	5.6	16.5	8.1	22.1	2.8	6.4	11.2	4.1	25.9	7.3	7.3	2.4	1.1	9.0	3.1	0.5	5.4	4.0	4.2	7.0	2.4	3.9	4.7	0.1	3.7	1.0	4.2	0.7	5.5	6.6	22.1	6.5	27.5	12.0	9.2	36.2	13.0	47.9	31.1	276.9	733.4	19.9	13.4	27.9	4.4	9.0	165.6	95.0	154.7	64.6	0.0	33.0	3.3	46.7	12.8	10.6	64.2	93.5	65.4	27.5	19.8	70.0	30.2	888.0	22.6	4.8	23.1	154.7	70.4	40.3	13.0	6.1	13.5	10.8	30.6	3.7	38.4	26.0	7.4	11.2	4.4	0.0	4.7	1.7	14.0	70.3	25.6	7.0	24.8	34.0
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980792-54992293	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 41.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 52.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.2;pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 22.6"					"Low region specificity"	"Detected in many"			HPA030614	Uncertain					NA	NA					"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favorable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.2	3.9	0.4	0.7	1.0	0.0	2.7	5.2	0.5	0.9	3.7	0.2	4.9	2.4	0.2	3.8	2.9	2.0	1.7	0.0	0.5	0.6	22.1	0.0	2.4	0.0	1.1	0.7	1.1	4.2	7.8	29.1	0.5	5.2	2.4	2.3	0.5	34.1	6.7	0.4	1.8	3.5	5.3	0.8	0.4	2.2	0.2	0.1	0.1	0.6	0.8	1.8	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	22.6	2.4	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	5.2	0.5	0.5	0.6	1.1	0.7	5.2	0.1	0.0	1.9	0.0	6.7	0.8	0.7	0.0	0.0	10.7	2.3	7.0	2.0	0.1	41.4	4.0	0.1	0.0	1.7	0.0	3.0	0.1	0.2	3.1	0.0	0.0	0.1	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	52.9	0.1	4.2	5.8	0.7	0.0	0.8	0.0	0.1	0.1	0.7	2.0	0.2	0.0	2.0	2.6
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory beta subunit"	Q8WZ55	1	54998193-55011784	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 3.9;kidney: 12.3;salivary gland: 4.2"	"Group enriched"	"Detected in some"	37	"Collecting duct cells: 8.7;Distal tubular cells: 21.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"					"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.9"	"Cell line enriched"	"Detected in single"	20	"RPMI-8226: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced					NA	NA					"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.3	0.0		0.0	0.0		4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.4	0.2	3.9	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.3	0.2	0.5	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.9	0.1	0.4	0.2	0.1	0.1											0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	8.7	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 15.3;Hepatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 29.1;CACO-2: 13.5;HaCaT: 38.9;HeLa: 33.9;RPTEC TERT1: 19.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	143000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	6.5	0.9	0.0	2.1	1.5	0.1	0.0	0.0	0.0	0.0	13.5	4.6	0.0	5.3	2.5	0.1	38.9	1.1	11.8	0.0	0.0	0.0	0.0	33.9	9.4	0.7	0.0	0.0	2.3	8.8	8.5	6.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	5.5	0.5	0.7	0.0	0.0	0.3	19.2	0.0	0.5	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0	14.9	15.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	1.3	0.0	0.4	0.1	0.0	17.0	0.1	0.0	4.1	1.8	1.6	0.2	0.0	0.0	1.7	0.0	2.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	2.9	0.2
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215113	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	12.3	7.6	7.5	12.1	8.8	30.1	10.6	20.1	8.5	7.8	10.2	6.8	10.6	5.0	10.1	7.0	7.7	6.9	7.0	14.7	7.9	6.4	10.4	9.3	7.6	12.7	8.0	5.6	10.9	7.3	15.5	16.9	5.8	6.9	7.6	8.5	5.1	9.7	10.7	46.0	8.9	8.7	7.3	6.2	10.9	7.8	4.9	8.7	16.4	7.4	11.5	12.7	9.7	13.7	6.0	10.5	5.9	2.2	3.8	4.5	1.1	17.7	9.8	12.3	6.6	16.0	14.1	14.2	7.9	9.9	11.4	11.9	13.9	6.3	14.3	8.7	14.6	23.4	14.4	16.3	13.3	17.9	14.9	9.8	28.6	21.4	16.3	9.5	19.7	22.2	12.3	11.8	17.2	19.6	11.0	10.3	14.6	26.3	6.0	15.1	4.2	11.8	10.5	18.0	8.6	11.9	12.3	15.7	6.2	19.8	12.0	10.8	7.6	13.4	9.6	11.7	19.5	6.7	9.8	13.9	10.4	10.1	12.5	12.5	7.6	5.6	18.8	9.9	16.4	9.3	5.9	2.0	2.5	4.5	1.8	2.8	4.8	3.5	3.5	1.8	6.0	3.2	4.2	2.3	3.8	2.2	10.5	1.9	1.1	7.5	8.8	20.1	8.5	7.9	6.4	8.0	5.6	6.9	8.7	14.9	18.3	14.2	7.0	13.3	12.9	28.1	10.2	8.1	15.9	12.2	68.7	3.6	0.0	8.8	0.4	13.1	6.8	0.0	8.7	6.5	9.6	9.6	12.7	10.9	8.4	36.5	16.6	10.4	17.5	1.3	10.9	12.2	10.1	12.6	16.4	7.1	9.9	11.5	7.4	4.5	16.7	6.5	10.5	8.6	5.8	15.1	1.3	17.1	14.9	8.6
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	105.3	52.6	5.0	5.5	5.6	5.1	2.5	4.4	0.8	0.7	0.6	8.3	5.7	0.8	0.3	0.1	1.0	0.0	1.3	0.1	0.6	6.1	2.5	0.0	0.0	65.0	0.4	4.9	4.1	3.6	4.8	0.0	0.4	0.0	5.5	0.4	0.0	0.0	6.2	1.2	6.1	0.0	0.0	0.2	0.8	4.6	0.0	4.1	1.7	2.3	0.5	6.4	0.7	0.0	3.0	25.8	2.1	95.5	0.2	0.0	0.0	0.0	4.5	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7	23.8	20.5	11.5	20.0	0.0	3.2	0.0	56.0	8.1	23.9	21.0	0.0	102.0	18.3	16.0	5.7	50.7	10.7	23.3	7.9	10.3	54.5	13.7	3.5	84.4	36.2	0.0	2.4	854.4	45.1	12.0	1011.7	10.2	0.0	1.0	10.3	146.0	8.7	7.0	374.8	18.2	2.5	135.8	0.0	4.3	2.5	0.0	179.8	4.3	7.8	16.5
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 309.5;Rod photoreceptor cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.4	4.2	3.7	4.7	0.0	0.6	0.6	7.4	0.0	7.7	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.7	0.8	1.9	0.0	0.0	1.0	0.1	0.0	0.0	5.5	0.0	5.4	0.0	0.0	0.0	13.9	1.2	2.0	5.4	5.7	0.1	0.0	6.2	3.2	0.0	0.0	1.5	2.3	2.7	6.2	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8	8.9	3.7	0.0	5.9	0.8	39.3	309.5	22.9	10.7	15.9	47.1	47.1	0.8	46.4	9.1	2.3	11.7	1.0	0.0	4.1	0.3	3.5	15.6	2.3	6.4	0.1	25.4	13.8	3.7	0.0	1.9	6.4	0.9	5.0	0.0	7.7	16.8	6.7	0.0	27.6	74.2	106.6	6.5	21.2	7.2	2.8	0.4	0.3	0.0	5.2	11.2
FYB2	"ARAP, C1orf168, FLJ43208, RP4-758N20.2"	ENSG00000187889	"FYN binding protein 2"	Q5VWT5	1	56718804-56819696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.5;liver: 22.6;retina: 16.7"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 20.8;Ciliated cells: 89.7;Collecting duct cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 1.6;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"T-47d: 10.9"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (6.12e-5)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.19e-3)"	"unprognostic (4.77e-3)"		"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-3)"	0.2	0.2	0.2	0.0	0.2	0.0	0.7	0.7	0.7	4.1	0.9	2.0	7.5	0.3	3.7	7.7	0.6	15.5	0.0	3.7	1.6	0.2	10.0	22.6	3.2	0.0	0.2	0.8	4.3	1.2	0.0	12.4	0.2	5.7	2.1	0.5	16.7	3.0	2.1	2.8	0.2	3.0	0.1	0.2	0.2	0.5	2.1	0.0	2.5	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.4	10.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.3	1.6	0.2	0.2	0.8	5.7	0.0	20.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	89.7	12.5	29.6	0.0	0.4	3.3	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854806-56918221	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	305	"liver: 210.3"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 254.8"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		3400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	210.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	4.3	0.0	0.0	0.0	0.0	254.8	0.0	0.0	0.0	6.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929210-56966140	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"liver: 240.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 251.9"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	47	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		3600000000			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	240.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	5.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.3	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	251.9	0.1	0.0	0.0	6.2	5.3	8.9	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
DAB1		ENSG00000173406	"DAB1, reelin adaptor protein"	O75553	1	56994778-58546734	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4;intestine: 20.8"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 20.8;Early spermatids: 6.5;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 31.4"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.5"	"Group enriched"	"Detected in many"	16	"granulocytes: 1.4;T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;fHDF/TERT166: 30.0;HeLa: 10.8;NTERA-2: 13.3;RT4: 17.7;WM-115: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	1.8	1.7	5.8	0.3	3.8	0.0	0.7	31.4	6.2	1.7	1.0	1.8	0.5	15.0	1.0	1.0	0.6	1.6	0.8	1.8	5.3	1.4	0.7	7.5	0.8	0.2	1.1	4.2	1.2	0.7	0.0	0.7	0.0	2.0	4.0	0.3	2.9	5.2	10.2	0.6	0.6	20.8	0.3	1.1	0.6	1.0	0.9	0.7	0.0	0.8	0.0	0.1	1.9	1.0	0.0	0.0	1.4	0.0	0.2	5.5	0.1	0.0	0.0	6.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	13.3	0.0	0.0	3.2	0.0	0.1	0.0	17.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	1.4	0.5	0.0	5.5	0.0	2.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	5.8	3.8	31.4	6.2	5.3	1.4	1.1	4.2	2.0	0.7	0.0	0.0	0.0	0.0	0.0	20.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.1	20.6	0.0	1.3	0.0	4.3	3.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.0	0.0
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	10.2	22.4	13.8	21.5	18.1	9.2	15.8	10.6	14.6	14.5	16.4	14.1	20.1	12.1	15.4	15.1	17.1	15.9	12.1	15.8	12.6	10.0	23.0	23.8	19.1	17.9	16.7	9.6	15.0	18.2	15.7	20.9	8.9	13.0	17.8	16.1	11.3	20.6	22.7	20.9	10.2	16.1	24.2	18.2	17.2	13.9	6.9	19.4	18.4	18.3	14.5	16.4	17.0	20.6	22.5	9.5	18.6	19.5	18.6	22.8	10.2	13.5	5.7	3.8	3.5	19.2	18.0	10.9	5.6	6.1	4.9	6.2	1.6	8.2	30.6	11.9	5.8	17.2	13.9	13.4	13.6	5.8	23.4	7.5	9.5	4.4	6.6	9.5	23.3	6.7	16.9	15.3	4.8	10.0	11.1	4.3	15.3	18.0	9.2	13.4	8.3	7.9	8.3	5.6	20.5	12.4	9.9	12.5	12.8	10.7	9.1	4.0	1.9	11.4	18.8	15.8	18.3	8.5	9.0	2.5	2.5	5.1	12.6	5.8	7.5	9.8	20.1	7.8	18.3	6.2	10.8	9.2	18.6	12.8	14.5	16.5	22.5	15.7	15.0	9.5	21.4	22.8	20.8	10.6	18.6	19.5	5.0	13.9	10.2	13.8	18.1	10.6	14.6	12.6	10.0	16.7	9.6	13.0	19.4	17.9	11.5	14.7	15.7	5.4	7.2	25.0	10.2	54.9	11.4	24.4	11.8	19.1	21.6	7.7	5.0	4.9	6.9	0.0	4.8	7.8	8.6	15.0	5.8	15.5	13.6	1.6	5.8	8.6	10.7	9.7	9.2	10.4	6.8	7.2	15.0	10.0	5.2	10.4	8.1	20.7	19.6	6.5	4.4	11.7	12.1	5.9	15.3	13.8	13.0	17.5
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575423-58577773	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;salivary gland: 56.4"	"Cell type enhanced"	"Detected in many"	15	"Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 12.4"	"Group enriched"	"Detected in many"	65	"dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	17.1	0.0	0.0	23.1	0.0			0.0	1.7	2.6	103.9	2.7	0.9	0.0	0.0	0.0	10.4	0.0	8.0	0.0	0.0		0.0	9.0	0.0	0.0	1.5		15.7	0.0		56.4	12.6	0.0	42.1	0.0	0.0	0.0	0.0	7.3	0.0			0.1		20.6	17.7	36.1	0.0	3.7	12.4	3.2	0.0	0.0	1.8	75.7	0.0	0.0	0.1	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	102.7	0.0	9.9	6.4	0.0	102.9	0.0	18.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	1.1	0.0	4.3	0.0	0.0	0.1	0.0	16.3	0.0	0.1	0.0	16.7	0.1	0.0	0.0	0.0	13.8	35.5	0.0	0.0	3.3	27.4	0.1	0.3	17.9	0.1	4.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	12.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.8											321.6	110.2	1.3	5162.0	1324.0	0.0	0.3	287.9	277.1	312.8	1212.6	0.0	74.9	36.5	1546.3	0.0	14.3	0.4	0.0	1122.5	4.7	23.0	2977.4	8.1	0.6	7.6	0.0	0.0	0.6	0.3	0.0	0.0	32.3	108.0	54.1	2.9	0.0	1294.2	4.0	0.0	3.3	0.0	0.0	47.2	0.5	0.9	1339.0	65.6	0.0	0.9	7434.9
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58654739-58700092	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	13.2	12.3	14.1	14.4	15.7	24.4	17.3	16.9	24.3	14.3	13.7	11.4	11.9	12.5	17.5	14.3	13.5	13.0	9.9	14.1	11.7	8.1	11.0	11.0	12.9	14.3	14.0	13.3	18.1	14.0	16.5	19.2	11.3	18.0	14.4	11.6	9.3	15.5	15.2	23.2	20.4	14.6	13.7	15.2	14.2	11.5	8.3	14.7	11.9	15.5	10.6	12.9	13.3	14.7	1.1	0.7	2.2	2.1	0.2	2.3	0.5	8.3	2.4	6.2	6.6	5.7	7.3	8.9	5.0	5.6	5.0	4.3	4.2	3.7	8.7	1.5	3.8	5.9	6.4	6.8	2.9	9.6	5.8	4.6	10.5	1.1	4.6	6.9	15.8	8.0	5.2	5.0	6.4	3.3	6.6	1.2	5.6	11.1	5.6	5.7	2.8	7.7	13.2	9.8	3.4	4.5	6.6	14.9	5.3	4.1	3.2	5.1	5.0	4.2	8.3	11.7	11.7	2.5	9.0	4.0	8.9	4.0	6.8	9.5	10.2	4.8	11.6	5.2	11.5	9.7	0.8	0.7	0.5	2.0	1.0	1.4	0.9	1.4	1.6	0.6	1.1	2.3	1.1	2.2	0.2	2.1	0.7	1.4	0.5	14.1	15.7	16.9	24.3	11.7	8.1	14.0	13.3	18.0	14.7	20.8	28.9	12.6	19.3	16.9	20.3	24.6	10.2	22.7	48.9	10.4	23.6	7.0	13.3	7.0	3.2	17.3	18.0	0.0	8.1	4.8	11.6	20.1	54.4	12.4	9.7	17.5	15.5	31.3	13.2	4.0	11.8	14.6	8.5	15.4	16.2	12.0	10.3	14.4	16.3	6.3	26.3	25.8	14.1	13.0	20.4	16.2	9.5	25.5	13.6	22.6
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58780788-58784327	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 71.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	64.5	29.4	26.7	33.7	17.2	68.4	61.7	19.5	20.6	60.0	32.7	30.8	28.4	13.3	40.5	21.8	34.1	72.6	48.5	31.3	20.2	12.4	21.2	39.3	55.1	14.3	15.3	12.0	49.8	48.7	15.0	16.7	21.6	24.1	48.6	16.7	40.5	59.4	39.3	32.2	51.3	28.6	40.7	17.6	22.9	47.0	18.2	18.1	9.0	61.0	35.2	23.3	41.5	33.1	7.4	1.3	4.0	5.1	3.2	2.5	1.2	16.1	2.3	5.2	1.0	8.3	9.5	0.1	20.6	7.5	14.6	8.9	4.2	1.2	0.6	9.9	12.8	31.6	5.6	0.4	6.7	9.3	12.8	37.5	0.2	0.9	4.7	6.9	1.1	3.7	10.2	17.3	18.8	7.9	6.6	10.9	0.7	5.7	9.4	5.6	3.0	1.0	9.0	4.2	7.8	14.7	0.4	71.6	3.2	13.7	1.5	14.5	4.2	14.3	15.0	6.0	5.9	5.3	0.6	19.1	33.3	15.1	12.0	25.8	20.9	3.3	1.2	34.8	2.1	9.5	1.2	5.1	2.0	2.4	1.1	1.3	4.1	1.2	2.5	1.3	7.4	0.3	1.7	4.0	3.2	0.4	0.2	0.9	1.2	26.7	17.2	19.5	20.6	20.2	12.4	15.3	12.0	24.1	18.1	500.2	627.8	505.0	717.3	1097.5	107.5	1349.5	494.3	76.3	282.1	99.5	247.4	529.1	43.1	569.2	40.2	960.8	1411.6	46.7	449.9	86.5	867.7	1920.0	529.9	118.4	560.4	82.6	1440.1	352.4	430.2	18.1	1136.5	481.3	718.7	237.2	1907.1	688.6	543.7	1520.1	243.3	25.0	400.6	1513.4	1714.3	15.6	13.8	843.0	347.6	518.9	938.7	449.9
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;RH-30: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054971			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		110000	"Nucleoplasm, Nuclear bodies"		"HPA054971: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.5	10.3	5.4	6.5	5.7	1.4	4.6	23.2	5.5	4.9	5.1	4.4	10.1	4.9	9.6	26.1	4.5	7.0	8.6	7.6	3.7	5.0	13.0	45.4	7.8	5.2	6.2	3.3	3.8	8.4	9.9	7.4	2.7	4.4	5.7	4.7	6.8	7.6	8.8	26.0	3.7	7.6	6.3	3.0	3.4	3.8	2.9	3.4	4.5	5.4	4.3	6.9	6.2	3.7	8.2	3.6	3.9	4.8	4.7	8.0	3.0	2.8	0.9	6.1	2.5	3.0	10.8	0.5	2.5	4.3	1.5	2.2	0.0	2.2	3.4	8.3	6.8	2.7	1.2	1.0	7.6	3.1	26.8	0.7	2.3	2.0	5.4	8.0	1.3	1.5	15.2	6.4	3.1	5.0	6.4	2.9	3.9	1.6	2.1	9.7	3.3	1.8	2.0	3.8	8.3	3.3	4.0	18.6	1.3	8.1	5.5	4.7	2.0	3.5	2.1	7.3	5.4	1.7	1.4	2.8	2.5	1.9	2.9	1.7	4.9	1.7	2.9	8.3	5.6	2.3	2.6	2.2	2.2	5.4	2.3	5.0	8.2	2.6	6.6	3.6	6.8	4.8	8.0	3.9	4.7	4.8	1.8	4.5	3.0	5.4	5.7	23.2	5.5	3.7	5.0	6.2	3.3	4.4	3.4	50.6	181.0	3.7	19.6	18.5	9.2	20.3	349.1	56.2	27.3	12.2	11.8	7.6	14.9	35.1	12.9	6.3	8.8	0.0	38.7	3.8	4.5	19.5	9.3	122.9	10.8	7.9	2.4	6.7	8.0	8.9	1.7	8.5	33.7	16.2	9.9	11.7	15.0	7.8	2.8	34.0	15.5	0.0	4.4	3.9	7.9	27.6	3.8	2.9	16.3	26.4
HOOK1	HK1	ENSG00000134709	"Hook microtubule tethering protein 1"	Q9UJC3	1	59814786-59876378	"Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 575.1;Late spermatids: 758.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 19.6;RPTEC TERT1: 18.1;SK-BR-3: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018537, HPA018820"	Enhanced					NA	NA					"HPA018537: AB_1850907, HPA018820: AB_1850910"	"unprognostic (9.82e-3)"	"unprognostic (4.29e-1)"	"prognostic favorable (4.53e-6)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.79e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-1)"	1.0	4.5	3.6	3.6	8.3	1.9	7.6	11.6	8.0	3.3	9.9	0.6	7.5	7.7	2.0	6.0	12.8	4.5	2.4	2.4	6.8	2.9	20.9	35.9	3.8	3.2	1.3	5.5	1.4	16.7	24.6	18.4	2.3	3.6	4.1	9.0	8.4	18.1	7.6	0.4	9.3	13.0	0.2	0.7	1.9	6.6	10.4	1.4	2.7	9.2	4.0	3.2	1.9	4.9	3.5	0.0	1.5	0.0	2.1	9.9	1.1	8.7	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	7.7	0.0	19.6	0.0	0.0	5.1	1.9	3.9	0.0	0.3	8.6	0.1	2.5	9.3	0.0	0.0	2.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	3.7	0.0	0.0	7.4	12.9	3.6	0.0	0.0	9.7	18.1	9.1	7.4	3.0	0.1	17.5	0.2	7.9	10.3	0.1	0.0	0.0	0.0	0.0	0.0	11.9	8.8	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.4	0.0	2.5	1.7	2.7	0.6	0.0	3.5	9.9	2.9	0.1	2.1	0.0	0.0	0.4	1.1	3.6	8.3	11.6	8.0	6.8	2.9	1.3	5.5	3.6	1.4	14.9	25.1	9.0	13.8	35.1	119.7	15.6	38.2	62.9	75.1	19.2	74.6	18.4	26.6	23.9	575.1	1.5	39.3	0.0	29.8	1.6	1.3	21.3	0.0	45.7	1.4	74.7	35.1	1.8	0.8	758.0	4.6	1.9	15.1	1.0	32.4	94.4	19.8	35.1	3.2	51.9	91.1	0.0	1.0	27.7	7.8	43.4	30.0	2.5	39.5	17.1
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926790	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.9;intestine: 46.6;liver: 74.6"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 84.7;Cytotrophoblasts: 107.4;Syncytiotrophoblasts: 201.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"OE19: 9.9;RT4: 36.0;SK-BR-3: 9.7"					"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	0.8	0.9	8.8	1.2	12.0	0.7	5.8	7.9	8.5	1.2	13.1	22.1	0.0	17.9	1.2	1.1	7.2	1.1	1.7	44.9	9.1	6.9	2.2	74.6	1.4	0.8	13.2	6.3	0.7	1.8	0.6	0.7	11.9	12.3	2.4	12.0	0.5	7.2	1.0	12.2	5.3	46.6	1.6	10.1	0.7	3.0	0.9	15.5	0.0	0.7	0.5	2.3	5.8	1.8	1.8	1.2	0.0	0.0	0.7	6.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.7	0.2	1.6	0.0	0.5	0.0	2.1	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	1.8	0.0	0.0	0.9	9.9	1.6	0.0	3.8	0.0	2.0	36.0	0.5	2.3	0.0	9.7	0.3	0.1	2.4	0.0	0.0	1.2	1.5	0.0	0.5	1.1	0.1	0.0	0.4	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.2	1.8	0.7	0.4	0.1	0.9	6.0	5.2	0.0	0.7	0.0	1.2	0.0	1.0	8.8	12.0	7.9	8.5	9.1	6.9	13.2	6.3	12.3	15.5	3.0	2.6	0.5	1.2	0.3	0.0	84.7	12.7	29.4	35.2	0.0	0.0	107.4	0.0	9.1	16.8	0.0	23.8	0.0	0.8	7.3	1.0	0.8	0.0	44.3	6.1	0.0	8.6	0.0	0.6	19.0	0.0	0.0	0.0	1.0	21.4	11.9	1.8	21.0	0.0	2.9	1.0	0.0	0.0	0.3	0.1	1.9	201.5	0.0	23.6	0.9
C1orf87	"CREF, MGC34837"	ENSG00000162598	"Chromosome 1 open reading frame 87"	Q8N0U7	1	59987269-60073770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;fallopian tube: 33.4"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 156.6;Early spermatids: 60.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 19.1;pons and medulla: 17.7"	"Cell type enriched"	"Detected in single"	19	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;HSkMC: 3.3;SCLC-21H: 1.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA031366, HPA031368"	Enhanced					NA	NA					"HPA031366: AB_2673847, HPA031368: AB_10600795"				"unprognostic (1.16e-2)"	"unprognostic (9.87e-2)"			"unprognostic (3.83e-2)"		"unprognostic (1.92e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.11e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"			0.3	0.3	3.2	0.3	19.1	0.3	0.3	0.0	0.9	1.7	0.3	3.4	0.0	0.3	0.9	4.8	0.3	33.4	0.3	0.3	3.8	4.5	0.5	0.3	6.8	0.3	1.3	0.7	5.1	0.4	0.7	0.8	0.3	17.7	0.4	0.3	2.5	3.4	0.6	0.3	0.3	0.3	0.3	0.9	0.3	0.3	1.2	3.6	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.2	19.1	0.0	0.9	3.8	4.5	1.3	0.7	17.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	156.6	19.4	1.8	0.0	0.0	0.0	0.0	60.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.0
NFIA	"KIAA1439, NFI-L"	ENSG00000162599	"Nuclear factor I A"	Q12857	1	60865259-61462793	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Leydig cells: 378.6;Peritubular cells: 412.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.8;T-47d: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006111, HPA008884"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006111: AB_1854422, HPA008884: AB_1854421"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.20e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (2.03e-4)"	29.1	17.7	21.9	17.0	19.1	15.9	28.5	42.1	16.9	23.1	20.1	17.1	19.2	9.1	17.1	16.3	27.9	20.4	18.7	25.7	18.2	13.7	13.7	48.4	11.3	8.7	16.9	13.0	22.1	17.2	24.5	14.1	6.5	21.9	26.0	12.8	16.4	25.3	26.5	30.8	11.6	12.3	44.0	25.8	11.7	14.9	11.1	15.9	2.9	36.6	14.9	8.8	35.6	30.9	1.3	2.4	5.2	5.0	0.7	5.6	2.8	3.4	3.3	0.4	37.8	15.9	10.5	0.1	0.8	2.6	0.8	1.6	0.2	2.6	5.8	2.7	1.6	0.8	4.5	1.4	9.3	0.4	13.4	3.0	0.3	8.5	2.7	3.6	0.7	1.2	13.2	7.6	3.7	15.4	2.8	9.9	1.8	3.6	10.9	0.7	1.7	0.1	0.1	1.7	3.5	3.3	0.5	3.9	9.6	2.0	6.9	3.7	2.8	2.0	15.9	5.2	0.5	20.1	0.2	9.4	0.6	5.4	8.7	1.6	0.9	1.6	0.0	0.9	0.0	0.8	5.2	5.0	2.3	3.7	3.4	5.5	1.3	4.5	5.6	2.4	0.5	4.4	5.3	0.2	0.7	4.3	1.7	0.1	2.8	21.9	19.1	42.1	16.9	18.2	13.7	16.9	13.0	21.9	15.9	32.8	33.6	5.4	59.0	75.6	33.8	159.5	142.7	66.9	62.6	45.4	2.0	4.7	23.2	26.4	20.8	92.6	15.2	140.2	42.1	1.3	154.1	78.8	26.5	273.8	12.6	39.7	24.2	171.2	52.2	9.9	378.6	13.7	43.9	16.2	43.1	155.3	21.3	31.6	412.3	88.5	5.8	142.3	149.4	6.0	8.1	66.7	1.4	11.4	64.6	44.8
TM2D1	BBP	ENSG00000162604	"TM2 domain containing 1"	Q9BX74	1	61681046-61725423	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046058, HPA055621"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046058: AB_2679519, HPA055621: AB_2682865"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.79e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	24.2	30.7	32.5	20.0	42.8	16.2	30.1	24.7	50.1	26.2	22.1	25.3	21.2	16.6	26.3	38.9	19.3	25.1	23.7	36.5	27.9	28.3	32.3	23.5	35.9	27.0	32.7	22.2	31.4	27.6	25.9	24.0	28.8	33.6	28.3	23.9	24.4	23.1	25.6	29.6	16.0	20.1	24.2	45.6	20.3	23.4	27.0	22.3	20.2	33.7	16.6	16.0	21.9	20.5	15.3	22.6	27.2	15.7	14.7	15.2	12.5	11.7	5.8	9.0	7.1	27.5	27.0	11.5	21.1	21.6	10.4	14.0	3.7	15.1	9.6	28.2	17.6	20.9	13.5	11.4	15.3	16.2	15.6	13.4	10.6	9.5	8.2	27.0	15.3	19.0	30.0	26.5	12.0	15.2	25.6	19.7	13.0	12.2	18.7	25.2	3.8	7.7	12.1	9.8	10.5	8.3	6.7	17.0	11.8	30.8	9.3	10.1	12.3	12.6	25.1	37.9	12.6	13.7	16.6	17.4	14.1	7.1	7.8	15.9	15.8	14.5	11.8	24.5	15.0	12.4	26.6	12.6	27.2	11.2	14.6	11.1	15.3	13.0	13.5	11.8	13.0	12.3	14.1	7.6	14.7	15.7	22.6	15.2	12.5	32.5	42.8	24.7	50.1	27.9	28.3	32.7	22.2	33.6	22.3	38.7	38.1	38.9	83.1	69.5	54.4	36.2	38.2	58.9	37.5	75.0	56.9	45.4	33.2	46.4	4.1	53.0	41.7	23.3	39.6	53.3	78.6	77.5	60.0	45.7	45.3	65.2	42.2	74.3	58.7	6.8	73.9	51.2	86.0	39.7	38.7	80.4	42.9	56.0	49.8	58.8	62.9	38.8	59.7	165.1	61.8	66.9	44.7	47.9	41.6	90.1
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ, crumbs cell polarity complex component"	Q8NI35	1	61742406-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4"	"Group enriched"	"Detected in some"	9	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1"	"Low region specificity"	"Detected in many"							"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	2.6	4.6	3.4	6.3	4.4	1.9	11.6	66.4	3.2	5.7	9.6	2.0	17.9	5.5	4.4	17.7	11.6	5.3	10.3	27.8	2.3	5.1	19.8	7.7	12.5	6.1	4.6	2.0	4.7	17.9	15.2	21.4	2.8	14.2	8.4	7.0	4.4	24.8	24.3	25.4	13.9	15.7	5.2	15.8	2.2	6.3	2.7	3.0	1.3	17.0	11.1	9.6	7.4	7.5	1.8	0.3	9.9	0.2	3.2	4.1	0.8	19.2	3.9	1.3	1.7	0.7	1.9	16.3	1.1	1.5	1.2	1.6	6.7	7.3	0.1	5.2	2.4	10.5	11.6	2.8	10.2	2.1	1.9	4.8	0.1	5.6	5.9	1.6	0.0	0.1	0.7	10.9	2.0	4.6	3.0	0.6	0.0	0.0	0.0	1.0	6.7	0.0	0.0	6.7	8.7	1.0	0.0	1.4	2.7	16.9	18.1	3.3	1.1	4.9	16.0	4.2	13.8	12.7	0.2	0.1	1.0	2.4	0.1	2.2	0.8	1.4	2.5	0.9	0.0	0.2	0.4	0.1	9.9	1.9	0.1	3.5	1.8	3.1	2.6	0.1	1.5	4.1	2.6	0.9	3.2	0.2	0.3	2.7	0.8	3.4	4.4	66.4	3.2	2.3	5.1	4.6	2.0	14.2	3.0	80.4	49.2	0.0	0.0	0.0	0.0	0.0	0.0	49.5	71.7	54.1	0.0	2.5	5.0	30.3	0.0	0.0	0.0	0.0	23.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194831-62212328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.2;placenta: 34.0"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 82.1;Syncytiotrophoblasts: 23.6"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 8.1"	"Lineage enriched"	"Detected in single"	17	"monocytes: 8.1"	"Group enriched"	"Detected in some"	22	"NTERA-2: 68.4;SuSa: 53.8"									"HPA028501, HPA030064"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA028501: AB_10599287, HPA030064: AB_10600538"	"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.6	0.8	0.2	18.2	0.4	0.0	0.7	0.4	0.2	1.6	6.9	0.0	0.3	0.1	0.3	0.4	0.4	0.4	0.3	0.3	0.2	0.2	0.4	0.2	3.1	1.6	0.2	0.1	1.3	0.3	0.0	0.4	34.0	0.7	2.4	1.6	1.5	0.7	0.1	0.6	0.3	0.6	0.5	0.2	2.9	0.4	8.5	0.0	0.4	2.4	0.1	0.1	1.6	1.3	0.4	0.3	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.1	0.7	0.0	6.0	15.4	0.0	0.5	0.3	2.5	0.3	0.0	10.7	13.6	0.0	5.9	82.1	0.0	0.0	0.3	0.7	0.2	0.0	0.3	20.0	2.1	0.3	1.1	0.0	6.6	3.2	10.2	0.0	0.8	0.4	1.7	2.0	0.0	0.0	4.4	0.3	0.4	0.9	17.3	0.0	3.9	0.0	0.9	0.7	13.2	0.1	23.6	1.9	0.6	0.2
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell type enhanced"	"Detected in some"	18	"Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	23.5	0.1	0.0	0.1	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	9.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.7	0.4	0.0	21.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9	0.0	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.2	0.0	0.0	0.0	7.3	14.9	0.8	0.0	0.0	0.5	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.3	0.0	3.5	0.2	0.3	0.0	1.7	0.0	0.1	0.0	4.6	0.0	0.6	0.0
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 281.4;Spermatogonia: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	11.6	9.0	11.3	17.2	10.7	29.3	15.9	20.6	14.2	19.2	13.3	7.8	8.0	10.8	15.1	12.0	15.6	13.8	8.9	9.0	11.5	9.6	11.8	9.3	11.7	19.2	14.2	9.6	26.7	12.7	14.8	18.4	13.6	10.9	14.8	13.9	7.6	12.7	13.5	11.7	12.3	13.3	15.8	15.5	18.1	11.6	31.6	11.8	70.6	15.0	13.3	20.1	16.5	16.5	14.7	11.8	23.4	12.4	15.5	16.3	9.2	22.3	6.6	27.8	15.0	6.2	7.5	15.4	21.5	14.7	26.8	29.3	11.1	10.9	40.4	15.6	12.0	24.0	13.0	22.7	14.8	37.5	20.2	16.4	33.2	22.9	11.6	6.8	35.5	16.8	4.0	9.7	24.2	18.3	7.3	12.6	27.5	24.0	35.3	18.8	10.0	36.3	13.7	24.4	13.4	13.7	34.5	47.1	25.0	10.0	16.7	28.7	16.1	24.3	19.9	23.5	19.4	11.4	21.7	8.7	20.7	22.5	30.2	30.1	14.0	19.5	46.4	14.0	28.4	18.5	17.4	9.5	23.4	12.6	9.6	16.3	14.7	15.0	12.7	11.4	10.7	14.3	11.9	16.9	15.5	12.4	11.8	13.6	9.2	11.3	10.7	20.6	14.2	11.5	9.6	14.2	9.6	10.9	11.8	44.7	25.6	45.4	30.6	55.3	44.0	29.7	20.4	56.2	43.3	15.7	21.6	30.6	16.6	26.4	117.0	37.9	12.9	0.0	29.7	56.2	38.1	45.1	26.6	15.8	26.9	33.4	8.1	23.4	28.2	52.6	46.3	31.1	25.3	53.3	29.2	47.5	22.4	7.0	38.5	13.5	78.0	51.8	47.7	281.4	214.8	56.2	27.6	46.5	30.4	28.8
DOCK7	"KIAA1771, ZIR2"	ENSG00000116641	"Dedicator of cytokinesis 7"	Q96N67	1	62454298-62688368	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 4.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.07e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (4.90e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-2)"	12.1	8.0	24.4	8.2	24.2	3.5	16.7	18.6	21.7	14.2	12.5	12.4	4.5	8.9	14.0	10.4	8.6	12.5	10.8	7.6	22.6	12.4	11.8	10.3	8.2	8.8	13.7	14.9	20.7	7.3	24.4	17.9	12.5	17.6	13.8	14.9	19.4	11.9	10.9	4.7	10.2	8.9	14.3	20.0	7.5	13.3	19.9	20.9	7.3	8.4	5.3	6.0	11.7	10.8	1.7	4.5	0.0	2.3	0.5	2.0	0.5	12.6	5.1	20.7	4.6	19.9	21.8	9.7	18.3	15.7	15.2	14.4	5.5	4.0	5.7	4.2	23.5	18.1	6.8	10.0	14.3	25.0	6.8	8.0	9.8	5.2	10.2	9.1	4.3	3.8	13.1	6.7	18.5	16.5	18.4	7.4	5.3	4.8	2.1	18.2	3.7	3.6	0.3	11.3	2.7	6.3	4.5	22.8	1.5	12.3	10.9	6.8	21.2	9.8	10.4	21.3	19.2	3.3	3.5	13.1	16.2	9.5	15.8	13.2	4.0	5.1	3.0	13.8	1.0	16.8	0.0	1.4	0.0	0.6	2.3	2.0	1.7	0.4	1.2	4.5	0.7	0.5	1.3	0.0	0.5	0.7	1.0	0.4	0.5	24.4	24.2	18.6	21.7	22.6	12.4	13.7	14.9	17.6	20.9	8.9	8.5	13.1	11.2	10.5	12.9	9.7	5.1	10.7	6.8	22.7	21.6	9.5	1.7	19.2	1.9	5.0	9.1	0.0	13.8	14.0	12.1	14.5	5.7	13.9	13.0	19.1	12.6	6.7	10.1	3.6	21.3	8.9	11.8	5.4	11.5	27.9	21.5	14.4	21.5	7.9	18.8	6.5	12.3	40.7	46.9	6.8	9.7	2.2	13.0	11.6
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597487-62606159	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 276.6"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 523.1;Proximal tubular cells: 240.8"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.1;HL-60: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038097	Approved				"Secreted to blood"	NA	NA	225000000	45000000			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	276.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	1.1	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.9	0.3	7.6	0.0	0.0	5.2	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	523.1	0.1	0.0	0.0	7.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	240.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784135-62865513	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	8.8	9.8	19.4	11.3	32.8	6.0	9.2	16.7	23.4	10.6	9.5	29.8	7.2	7.7	9.6	7.2	8.6	8.0	10.4	7.2	23.7	15.5	13.5	12.6	9.2	13.7	42.6	16.5	10.3	11.2	15.5	11.3	15.0	22.4	8.0	10.6	4.9	10.8	8.0	6.4	6.3	7.8	11.2	26.5	13.3	8.6	8.9	40.4	11.0	12.0	3.7	12.4	13.4	6.8	20.6	19.4	16.0	10.9	7.0	9.4	6.7	7.6	6.1	9.5	8.3	12.5	13.5	9.5	11.5	7.8	11.1	12.5	4.5	6.1	16.3	8.9	5.8	13.0	5.9	11.3	8.7	16.1	12.2	10.4	18.3	6.5	5.8	8.9	14.8	12.3	11.1	6.2	11.8	5.6	10.8	13.3	18.0	15.5	13.3	9.3	3.6	14.9	5.7	13.9	11.0	10.1	17.9	22.8	11.5	8.0	5.6	12.9	6.5	7.6	14.4	14.8	17.2	7.0	7.0	5.2	8.9	8.7	15.0	12.6	11.6	15.6	13.3	10.2	14.7	10.7	16.0	10.9	8.5	4.8	8.8	6.6	20.6	6.6	5.6	19.4	19.1	9.4	7.7	1.6	7.0	5.0	11.6	5.7	6.7	19.4	32.8	16.7	23.4	23.7	15.5	42.6	16.5	22.4	40.4	6.0	8.8	28.4	6.2	4.4	5.1	8.1	10.2	1.4	9.1	7.0	2.0	33.2	16.6	6.4	1.3	11.6	3.6	0.0	7.3	24.5	8.4	4.1	11.5	8.9	31.5	4.8	5.8	13.5	18.6	1.4	8.1	20.5	8.5	30.7	4.4	9.7	4.5	4.5	9.2	19.9	5.1	6.5	7.6	30.5	13.3	3.4	24.3	9.6	6.6	2.7
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63323041-63325126	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"Melanocytes: 5.0"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Group enriched"	"Detected in some"	11	"midbrain: 1.9;pons and medulla: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 13.8;SK-MEL-30: 11.2;WM-115: 17.2"	"Region enriched"	"Detected in single"	13	"olfactory region: 2.1"	"Region enriched"	"Detected in single"	22	"olfactory region: 18.3"	CAB022455	Uncertain					NA	NA					"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	1.1	2.0	0.0	2.9	0.0	0.2	1.6	0.0	0.1	4.2	9.3	0.0	1.8	1.3	0.7	3.1	8.7	0.8	7.3	3.3	0.1	0.0	0.3	0.2	0.1	0.1	1.9	0.0	1.1	0.3	0.0	0.2	0.0	1.9	4.6	1.2	7.7	2.2	3.9	5.9	2.0	2.7	1.7	0.5	0.1	2.3	2.7	0.0	0.0	0.4	2.0	0.4	5.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.2	0.0	0.0	0.3	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	11.2	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.7	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	14.6	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	6.1	12.5	14.2	11.3	11.2	7.7	7.0	12.2	10.7	26.0	14.6	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	16.3	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7	8.9	3.7	7.5	8.0	9.7	5.6	2.8	10.2	4.0	7.9	3.5	3.9	39.5	1.7	10.5	1.9	5.8	5.8	0.0	7.8	23.6	8.2	5.4	9.2	9.2	13.7	6.4	4.1	8.0	5.9	1.7	6.4	7.5	15.1	0.0	7.8	4.9	6.5	0.0	4.6	5.9	5.1	6.5	5.1	12.1	15.9	9.7	22.4	13.8	9.3	6.4
ITGB3BP	"CENPR, HSU37139, NRIF3, TAP20"	ENSG00000142856	"Integrin subunit beta 3 binding protein"	Q13352	1	63440770-63593721	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA028463	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028463: AB_10601435"	"unprognostic (4.98e-2)"	"unprognostic (5.88e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.58e-1)"	"prognostic favorable (4.32e-4)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.68e-2)"	"unprognostic (7.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.97e-3)"	"prognostic unfavorable (8.45e-6)"	"unprognostic (1.34e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.34e-3)"	"unprognostic (6.14e-2)"	8.3	11.3	10.9	11.2	14.2	8.3	12.8	17.6	16.3	11.8	8.6	3.1	4.4	6.5	10.1	13.8	13.6	11.3	9.0	6.5	12.5	3.6	13.2	7.1	8.1	13.8	17.6	3.6	15.5	12.6	15.1	29.4	8.3	13.7	10.7	8.9	4.5	12.5	6.4	6.1	8.6	8.7	9.6	16.5	12.0	9.6	17.1	15.0	17.6	11.6	9.0	13.6	11.0	11.5	13.5	6.8	7.1	3.3	11.6	10.2	5.7	24.2	11.6	13.7	11.3	3.3	10.5	12.8	11.8	7.1	20.6	25.3	6.5	11.2	22.1	9.1	2.9	10.3	17.5	10.9	11.3	25.3	16.4	26.1	16.8	16.4	13.1	3.6	23.0	11.1	2.5	8.9	11.5	9.4	9.6	10.5	12.9	19.4	29.5	2.7	10.1	24.7	21.3	18.0	9.2	13.1	16.1	24.7	32.7	13.5	7.0	18.3	11.0	13.5	7.7	18.7	21.5	7.8	7.7	6.4	7.0	10.4	14.5	17.7	14.9	24.0	20.8	11.5	28.9	10.8	7.1	3.3	0.9	5.8	2.4	9.5	13.5	9.0	8.7	4.0	12.8	10.2	8.7	1.0	11.6	2.9	6.8	9.5	5.7	10.9	14.2	17.6	16.3	12.5	3.6	17.6	3.6	13.7	15.0	8.9	8.6	52.6	43.2	30.1	9.4	9.9	28.1	37.5	35.2	24.4	9.8	31.6	24.9	34.7	65.0	20.2	5.0	70.0	29.7	49.0	20.3	18.0	23.1	7.9	25.3	6.4	16.7	20.3	24.1	95.1	19.8	17.0	20.3	27.1	16.7	21.1	28.9	0.0	24.4	21.0	14.0	32.3	21.7	117.9	61.4	28.5	16.0	26.2	24.8	25.4
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 25.4;Sertoli cells: 25.8;Spermatocytes: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	4.3	8.4	12.7	3.5	16.7	3.1	9.3	24.5	19.5	9.4	5.1	3.7	6.4	3.2	9.6	9.8	5.7	12.6	7.2	9.7	11.4	11.8	8.8	2.8	6.2	5.2	8.1	10.8	12.8	4.9	16.3	31.6	5.1	13.7	8.7	5.0	3.5	5.3	8.2	10.8	4.9	3.4	7.5	9.4	4.2	5.0	20.0	10.2	11.5	9.1	2.4	5.2	7.3	12.9	3.3	1.7	9.8	3.3	1.8	2.9	1.1	6.0	5.1	6.7	4.3	7.1	10.6	3.4	3.9	4.3	6.8	8.4	1.6	4.8	4.3	9.4	2.2	13.9	5.6	5.7	3.7	8.2	7.9	4.0	3.4	9.5	3.5	4.5	4.7	3.1	5.7	9.2	8.0	5.4	10.8	5.7	7.9	4.3	7.0	4.4	1.3	9.0	3.2	2.9	4.2	5.1	5.8	10.1	4.2	10.4	3.2	14.4	5.5	7.5	4.2	9.6	9.4	4.3	3.4	1.5	3.8	3.4	11.4	3.7	4.7	8.1	4.9	7.0	3.4	5.6	9.8	0.7	0.2	2.1	0.4	2.9	3.3	2.4	2.5	1.3	2.8	2.5	2.4	0.1	1.8	3.3	1.7	2.7	1.1	12.7	16.7	24.5	19.5	11.4	11.8	8.1	10.8	13.7	10.2	11.9	2.6	2.9	5.2	2.7	8.3	6.2	0.0	25.4	4.5	5.2	3.9	2.9	6.6	2.9	17.3	2.1	0.5	0.0	0.6	1.6	3.0	1.5	2.3	0.8	2.1	0.0	1.7	2.5	2.4	3.2	10.0	1.1	1.7	1.8	1.4	5.8	1.1	0.0	12.7	4.6	10.5	25.8	2.3	58.1	17.7	1.9	1.0	1.3	1.7	0.7
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 209.3;Hepatocytes: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		NA	NA		20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	29.8	12.5	4.7	15.5	31.2	23.1	38.3	12.3	16.7	13.4	22.0	10.3	13.9	9.4	25.8	19.0	29.7	7.1	6.5	25.9	15.8	11.5	8.7	19.9	21.2	10.6	25.8	17.4	1.1	29.1	16.7	15.6	24.8	36.0	8.0	9.8	0.0	12.6	21.5	1.8	5.0	9.6	21.4	0.9	20.1	7.1	22.0	3.0	19.5	9.4	2.8	18.4	26.9	28.2	41.0	22.9	8.8	6.6	0.7	19.9	10.2	17.6	10.4	8.0	11.7	15.4	32.5	15.3	8.5	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5	86.4	31.4	19.9	24.0	15.9	8.1	140.8	50.9	14.7	10.3	15.7	9.8	71.5	74.6	42.0	24.0	10.7	74.3	0.0	209.3	136.9	28.0	18.3	4.7	186.6	22.2	0.0	12.6	16.0	18.3	5.2	20.4	10.7	25.3	32.5	40.1	54.2	92.3	23.0	35.7	59.8	10.7	12.9	17.9	4.7	7.5	15.8	49.2	21.8	71.1	13.6
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 31.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 47.6;Intestinal endocrine cells: 20.6;Leydig cells: 25.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 13.0"	"Group enriched"	"Detected in some"	5	"NK-cell: 3.3;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.8;ASC TERT1: 24.8;CACO-2: 16.9;HHSteC: 18.8;HSkMC: 20.3;NTERA-2: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057016			Approved	Microtubules	"Intracellular and membrane"	NA	NA		2800000	Microtubules		"HPA057016: "	"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13.0	2.8	16.7	8.8	2.2	4.4	2.0	14.2	5.0	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1.0	2.4	8.3	9.8	31.2	3.6	2.9	3.0	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0.0	7.1	5.6	2.8	0.4	19.8	24.8	1.9	1.4	3.9	0.8	2.0	16.9	2.3	0.1	3.2	3.3	1.4	1.5	0.0	1.3	0.5	0.0	1.8	0.0	0.7	0.2	18.8	0.0	0.0	20.3	5.2	10.4	12.2	4.0	0.3	0.2	0.0	0.1	5.2	0.1	0.1	0.0	20.6	5.2	2.8	0.1	0.1	4.4	4.1	0.1	1.6	6.6	0.4	0.1	2.9	10.0	0.0	0.0	3.9	1.6	2.9	11.0	2.9	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	3.3	0.1	1.1	0.0	0.0	1.3	2.7	13.0	2.8	1.3	1.1	1.0	2.4	3.0	0.9	47.6	8.0	0.0	1.8	3.4	1.7	8.5	2.5	1.4	2.3	1.8	0.0	0.2	0.0	5.3	7.8	1.3	0.0	0.0	13.4	0.7	7.6	1.5	0.0	0.0	5.8	0.0	20.6	1.3	0.0	4.7	25.6	0.0	3.3	0.0	2.3	4.9	10.7	0.0	13.8	2.8	0.0	6.5	12.0	0.7	1.2	4.0	0.2	0.0	2.6	0.9
UBE2U	MGC35130	ENSG00000177414	"Ubiquitin conjugating enzyme E2 U (putative)"	Q5VVX9	1	64203627-64267368	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"testis: 31.8"	"Group enriched"	"Detected in some"	12	"Early spermatids: 118.4;Late spermatids: 169.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;U-266/84: 1.3"					"Region enhanced"	"Detected in many"		"midbrain: 19.5"							NA	NA									"unprognostic (9.44e-4)"				"unprognostic (5.52e-2)"		"unprognostic (1.81e-1)"	"unprognostic (2.37e-1)"		"unprognostic (4.01e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.69e-2)"			0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	118.4	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	169.4	1.7	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.0	11.9	1.8	0.0	0.2	0.0	0.0	0.0
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"		1	64470792-64693058	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 37.5;Club cells: 18.2"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	11	"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"AF22: 21.4;NTERA-2: 29.3;SuSa: 19.1;U-2197: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	5.4	7.6	6.5	0.5	8.4	0.0	4.7	1.2	4.3	7.3	0.8			0.2	6.1	5.2	1.6	8.5	2.1	1.2	3.5	4.2	3.3	0.4	4.7	0.4	2.3		14.2	3.7	5.5	4.5	5.5		4.0	1.0		4.4	4.3	0.8	3.0	0.9	5.3	0.6	1.7	3.3	0.5			2.4		0.2	2.1	4.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.8	21.4	3.1	8.5	3.0	0.0	3.0	3.9	5.1	4.9	12.4	0.1	0.0	8.8	4.8	3.7	1.5	11.9	2.5	5.2	2.3	6.4	4.4	1.3	0.0	0.0	1.9	0.0	2.6	1.7	0.6	3.2	2.9	2.7	3.0	0.0	0.0	0.0	0.3	0.3	0.0	29.3	0.1	2.2	2.3	2.1	0.0	0.0	0.6	0.5	11.2	6.5	0.0	2.6	19.1	0.8	0.2	1.9	0.5	3.8	15.0	2.6	0.0	0.0	0.0	0.4	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0											6.0	37.5	0.0	6.1	15.3	12.7	1.4	0.0	13.4	18.2	3.5	0.0	0.0	0.0	2.0	7.7	11.8	0.0	0.0	2.5	0.1	4.1	1.2	2.3	0.9	0.2	0.0	0.0	3.1	0.3	2.3	13.3	1.8	1.7	0.0	0.0	5.2	1.3	0.0	2.8	3.1	1.1	6.5	5.7	0.4	0.4	12.9	0.0	0.0	0.1	4.8
RAVER2	"FLJ10770, KIAA1579"	ENSG00000162437	"Ribonucleoprotein, PTB binding 2"	Q9HCJ3	1	64745095-64833232	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 31.0;Mucus-secreting cells: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045785	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045785: AB_10964058"	"unprognostic (8.02e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.14e-6)"	"unprognostic (1.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-2)"	5.2	9.6	13.2	9.2	14.0	7.8	9.0	17.4	9.3	11.5	21.8	7.2	13.9	22.3	9.1	5.9	10.8	7.5	15.2	17.1	13.4	8.1	7.5	1.7	7.9	1.9	8.6	6.1	8.2	7.3	15.2	27.7	6.9	9.1	12.0	25.7	12.6	15.3	15.1	18.5	6.5	41.4	9.1	9.5	4.6	11.8	2.6	7.4	7.0	7.2	10.7	6.8	8.4	8.4	0.2	0.9	7.8	0.1	0.2	0.4	0.0	10.3	3.2	9.9	10.7	1.8	1.5	2.7	2.3	4.2	4.8	5.4	8.5	4.6	0.0	5.4	2.4	10.8	7.9	10.0	6.9	5.8	0.0	11.1	12.6	8.6	7.6	3.4	16.9	0.1	4.5	6.4	0.3	4.9	11.1	7.8	10.6	2.7	10.5	0.4	3.8	5.6	3.5	12.2	8.2	8.6	19.3	15.5	4.2	5.1	7.8	7.4	16.7	10.4	0.0	10.1	9.7	8.1	2.7	2.9	4.4	7.2	4.4	8.1	8.0	9.0	4.4	2.7	0.0	4.1	7.8	0.1	0.1	0.2	0.0	0.4	0.2	0.2	0.1	0.9	0.1	0.1	0.1	0.0	0.2	0.0	0.4	0.1	0.0	13.2	14.0	17.4	9.3	13.4	8.1	8.6	6.1	9.1	7.4	6.0	9.1	0.0	5.5	7.1	5.8	21.8	10.2	5.3	11.4	1.8	13.7	0.1	0.0	2.5	6.3	6.9	31.0	0.0	4.5	0.3	5.3	5.9	1.1	0.0	0.5	0.0	17.3	4.3	4.0	10.7	6.1	0.7	3.3	0.0	30.2	24.7	3.0	14.4	7.8	1.6	3.5	0.0	8.1	1.2	0.9	5.1	0.2	1.5	25.1	6.3
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833229-64966504	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved					NA	NA					"CAB013088: "	"prognostic favorable (9.63e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.66e-2)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.51e-1)"	46.7	20.4	15.5	31.1	16.5	21.2	56.6	24.3	20.4	27.3	27.1	16.3	16.5	13.8	28.2	22.0	27.0	20.7	27.7	27.3	15.3	16.5	31.4	38.3	36.5	61.4	15.6	14.1	33.3	29.1	28.3	39.8	22.9	25.1	26.0	22.2	18.1	19.8	21.3	45.1	29.7	29.3	30.7	16.3	52.7	20.9	17.3	15.0	62.7	29.0	17.9	42.5	37.2	29.3	20.2	15.4	34.9	17.1	68.1	27.5	25.8	11.2	14.6	6.1	0.6	70.7	40.1	7.9	17.5	25.9	14.6	17.2	4.8	6.2	17.1	13.6	31.1	27.2	6.3	4.1	13.5	20.8	22.5	6.6	23.1	7.7	10.4	26.1	8.8	16.1	35.1	18.8	22.0	23.0	17.4	45.4	8.5	8.4	18.3	16.1	6.4	4.8	5.9	4.2	12.9	8.8	6.9	17.6	6.3	37.6	19.8	4.3	12.9	24.0	11.3	10.3	12.7	24.0	5.5	41.2	17.5	7.8	39.6	9.3	11.5	5.2	13.5	16.3	11.7	7.9	31.2	10.9	31.5	22.8	15.2	27.5	20.2	22.0	25.7	15.4	16.1	24.3	20.7	34.9	68.1	17.1	10.5	26.5	25.8	15.5	16.5	24.3	20.4	15.3	16.5	15.6	14.1	25.1	15.0	47.6	79.3	120.3	114.0	103.6	35.7	98.8	79.0	41.5	63.7	106.4	21.6	5.5	36.5	152.3	100.2	130.9	49.5	23.3	184.7	94.8	76.6	173.3	55.4	77.3	52.1	20.6	63.8	178.0	138.0	72.8	88.9	109.3	47.2	252.5	54.9	54.4	180.7	49.2	79.5	61.6	35.1	161.7	144.2	30.5	50.9	145.2	10.2	159.2	38.1	188.3
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 89.7;liver: 50.7"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 223.0;Proximal tubular cells: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4"	"Low region specificity"	"Detected in all"							"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		18000	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	12.4	1.6	11.7	3.7	11.2	2.7	13.4	12.0	9.9	4.0	9.5	4.0	4.7	2.7	3.9	4.4	12.3	4.2	8.6	26.0	9.3	7.1	89.7	50.7	1.6	1.4	6.3	9.1	5.8	1.8	8.2	2.6	4.5	7.2	8.9	7.7	4.4	9.4	7.3	2.2	14.0	3.5	13.6	8.1	1.2	7.8	6.0	5.0	0.4	1.9	5.7	3.2	12.4	7.4	0.5	5.3	1.6	6.1	0.6	0.5	1.4	20.6	1.4	1.6	7.0	15.6	14.9	3.5	3.5	4.4	7.6	21.2	31.0	2.5	11.1	9.2	5.4	9.5	13.4	5.5	26.1	30.6	9.3	6.3	10.8	7.0	59.4	0.7	8.3	1.3	8.2	14.7	7.4	21.9	12.6	0.2	3.5	13.4	0.2	11.6	8.8	0.3	0.3	7.2	0.3	12.4	0.0	12.1	2.0	11.2	0.9	6.1	4.5	6.2	0.4	4.9	8.0	8.7	3.7	1.2	12.7	10.9	0.9	5.9	11.7	5.2	0.6	20.5	3.1	0.7	1.6	6.1	0.0	0.2	1.4	0.4	0.5	0.2	0.5	5.3	0.4	0.2	0.2	1.0	0.6	0.2	0.8	0.1	1.4	11.7	11.2	12.0	9.9	9.3	7.1	6.3	9.1	7.2	5.0	0.0	0.3	4.9	19.8	44.2	14.7	91.5	61.1	5.3	6.8	29.6	2.0	1.2	48.0	16.1	1.6	17.5	13.5	0.0	11.0	13.9	10.3	33.2	0.0	223.0	3.3	15.9	5.2	5.5	5.6	4.2	3.7	2.7	23.6	7.2	6.7	27.4	22.8	3.5	8.9	422.4	6.2	6.5	27.4	2.1	5.1	65.0	4.1	1.0	22.9	16.6
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.2;HEL: 56.7;K-562: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	1.0	0.0	1.6	0.8	0.2	8.4	7.1	11.6	11.7	11.5	0.9	0.1	3.4	0.6	2.9	2.9	0.9	5.1	1.1	9.2	21.2	2.4	56.7	1.9	0.2	0.0	1.9	1.4	1.0	0.8	1.1	5.0	2.2	0.2	2.8	22.0	0.4	2.4	0.6	0.7	0.0	2.3	0.0	0.8	0.0	1.7	0.1	8.9	0.0	14.2	9.7	4.1	5.6	1.9	14.1	2.7	0.1	2.2	1.7	1.2	0.2	2.0	2.1	1.4	1.0	4.8	1.4	2.9	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1	0.0	0.3	0.0	0.2	1.1	29.6	26.1	0.0	0.0	0.0	0.0	13.7	4.8	1.7	0.8	1.8	0.7	0.0	23.3	0.6	1.9	1.7	1.3	0.0	0.0	1.1	49.3	6.9	0.0	0.0	1.4	0.0	0.8	6.8	1.8	1.3	3.1	0.4	0.0	0.0	5.9	21.6	0.0	2.3	1.0	2.3	0.3	6.2	0.0	0.5	0.1
LEPROT	"FLJ90360, OB-RGRP, OBRGRP, VPS55"	ENSG00000213625	"Leptin receptor overlapping transcript"	O15243	1	65420587-65436007	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069444			Approved	Centrosome		NA	NA			Centrosome		"HPA069444: AB_2686137"	"unprognostic (3.64e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	37.3	30.0	13.9	12.6	14.0	17.1	37.8	9.2	13.3	25.4	20.5	18.0	16.1	12.5	42.6	18.4	25.5	20.7	20.8	22.1	11.4	11.0	50.7	31.1	26.3	24.5	16.5	10.1	28.7	30.8	22.5	21.7	44.3	18.9	25.4	16.9	30.4	21.4	20.5	13.6	16.2	23.5	26.2	20.0	24.3	18.1	17.4	11.7	6.5	34.2	14.0	14.7	28.5	19.5	2.2	8.1	15.3	18.0	4.1	4.9	8.4	10.7	4.5	4.7	2.0	41.7	28.2	15.0	16.6	23.3	13.5	13.7	3.8	6.8	2.5	9.6	16.6	16.0	6.7	2.5	6.9	17.3	11.5	2.6	12.3	5.8	6.9	11.5	2.4	6.6	38.6	17.6	10.8	8.5	17.9	15.4	1.7	7.3	6.1	24.2	2.7	0.9	2.8	7.5	3.7	4.9	0.5	10.4	3.8	60.6	8.0	4.8	6.4	10.1	9.0	9.6	18.9	6.9	4.6	18.0	13.7	10.1	10.5	6.2	7.5	6.6	1.1	11.0	6.3	8.7	15.3	12.7	10.7	4.1	12.7	4.9	2.2	3.9	3.7	8.1	1.5	3.9	3.8	11.8	4.1	18.0	6.7	3.0	8.4	13.9	14.0	9.2	13.3	11.4	11.0	16.5	10.1	18.9	11.7	154.9	49.4	25.7	74.0	51.2	17.8	51.3	89.2	85.6	66.0	169.3	21.6	193.8	69.6	117.2	5.0	175.0	47.0	46.7	125.5	93.2	138.0	69.9	60.2	71.7	95.6	36.5	53.6	190.3	110.3	5.1	184.1	107.1	69.2	63.1	58.2	82.8	129.1	63.0	140.0	131.1	26.2	187.5	142.2	17.1	17.5	58.5	307.6	40.3	43.3	74.9
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.8"	"Cell type enhanced"	"Detected in many"	18	"Endothelial cells: 59.1;Hepatocytes: 196.4"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7;K-562: 46.5;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Secreted to blood"	NA	NA	8240000	8300000			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	15.9	5.5	3.8	3.7	4.3	3.3	23.5	2.5	3.9	15.0	9.2	5.6	5.4	3.2	20.6	7.3	10.9	11.7	10.1	9.2	4.3	4.9	14.6	82.8	20.3	9.0	4.9	3.3	18.4	16.7	3.9	13.1	12.8	8.2	10.8	4.1	18.1	12.0	5.7	5.6	10.2	7.3	12.9	7.0	6.4	11.9	6.6	3.1	1.9	13.1	11.2	6.9	13.6	8.6	0.6	1.8	6.9	1.9	1.1	2.3	1.8	1.3	0.8	1.1	1.2	5.0	4.7	3.9	5.9	3.4	2.0	1.9	0.6	3.2	0.5	4.4	7.5	0.5	1.1	0.9	5.2	5.5	7.0	1.5	7.7	3.6	0.1	3.0	0.5	0.6	13.2	3.0	1.2	4.7	15.7	5.9	0.6	46.5	0.9	9.5	0.3	0.6	0.1	1.8	0.8	0.1	0.1	0.9	0.3	22.5	0.6	0.7	11.4	1.4	0.6	1.6	6.7	2.1	2.1	2.2	2.1	4.4	0.4	3.2	1.3	0.9	0.2	4.5	2.2	2.0	6.9	1.9	2.8	1.3	1.5	1.3	0.6	1.1	1.1	1.8	0.3	0.9	1.5	1.1	1.1	1.7	1.2	2.3	1.8	3.8	4.3	2.5	3.9	4.3	4.9	4.9	3.3	8.2	3.1	0.0	16.5	3.0	1.9	31.4	4.9	3.5	10.2	2.7	4.5	8.7	0.0	1.2	3.3	1.5	1.0	59.1	0.4	0.0	0.9	2.3	20.2	3.3	1.1	196.4	1.9	1.6	0.0	27.6	6.5	1.5	31.9	5.8	33.7	2.8	0.9	0.0	1.6	1.7	7.1	6.8	0.9	0.0	17.7	1.1	0.6	25.7	2.2	0.5	0.8	1.4
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 81.5;Horizontal cells: 108.1;monocytes: 104.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 36.6"	"Group enriched"	"Detected in all"	5	"B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.4;HUVEC TERT2: 36.6;NTERA-2: 22.2;SK-MEL-30: 22.0;TIME: 20.4;U-266/84: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	14.9	2.9	21.5	28.4	29.0	48.2	15.0	12.7	31.9	6.4	6.6	39.2	0.7	3.9	6.7	2.1	3.9	3.5	8.1	16.1	20.7	18.8	3.7	8.7	10.0	15.9	36.3	14.2	2.0	1.7	1.7	3.4	13.1	32.2	18.3	8.6	6.6	15.9	10.3	28.2	6.2	8.5	9.5	37.4	18.5	4.2	3.2	36.9	2.3	5.5	5.5	14.7	16.1	3.9	16.1	2.6	36.6	2.8	4.4	13.3	3.7	0.1	7.0	13.8	24.4	0.7	0.7	0.0	4.5	5.3	4.2	5.6	0.0	0.0	2.0	0.1	8.4	0.1	0.0	0.1	0.0	4.2	5.9	0.0	0.1	2.0	0.0	0.5	4.9	0.0	1.4	0.2	2.1	0.1	0.6	36.6	0.0	0.0	1.3	1.8	0.1	0.0	2.8	22.2	0.0	0.3	1.0	2.4	1.3	3.4	0.0	0.1	10.6	0.0	1.2	22.0	1.2	0.1	1.7	20.4	3.3	0.8	1.8	0.7	0.6	19.1	7.5	3.4	5.1	1.4	2.7	2.8	8.4	4.4	2.4	8.4	15.4	8.3	6.2	2.4	16.1	9.4	6.5	36.6	4.4	2.1	2.6	13.3	3.7	21.5	29.0	12.7	24.6	20.7	18.8	36.3	14.2	32.2	36.9	8.9	16.4	50.2	24.5	18.0	35.4	29.1	0.0	2.7	12.5	5.2	0.0	5.2	0.0	0.5	7.9	23.2	0.0	0.0	0.8	1.6	9.3	81.5	14.0	1.6	12.6	108.1	4.1	12.3	25.8	5.6	0.3	42.5	49.0	104.6	1.2	12.2	0.1	0.0	2.5	1.6	3.3	0.0	10.3	0.1	0.7	7.0	4.7	36.2	1.1	5.7
SGIP1	DKFZp761D221	ENSG00000118473	"SH3 domain GRB2 like endophilin interacting protein 1"	Q9BQI5	1	66533383-66748299	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 91.2;Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.0;BJ hTERT+: 22.0;fHDF/TERT166: 13.9;hTERT-RPE1: 9.2;RPTEC TERT1: 16.2;SH-SY5Y: 8.8;U-138 MG: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017963	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017963: AB_10964882"	"unprognostic (1.74e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.48e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.63e-2)"	6.2	7.5	19.6	3.8	30.2	1.3	2.7	26.2	36.5	7.5	2.7	11.4	1.3	3.4	17.1	8.0	5.2	4.7	8.1	6.8	22.9	12.4	14.0	1.7	9.6	2.0	10.8	26.3	3.6	1.2	1.9	7.0	3.9	26.4	5.4	3.4	5.8	3.5	9.1	3.2	1.7	3.2	7.0	11.3	1.4	5.1	7.4	14.9	0.0	8.0	0.8	1.5	6.1	5.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.0	17.0	22.0	1.3	2.0	0.0	0.0	0.0	0.0	13.9	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	3.9	0.0	0.0	2.4	0.0	1.3	0.0	9.2	6.4	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.4	8.8	0.0	0.0	0.0	0.3	0.0	0.6	1.1	16.1	0.0	0.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	19.6	30.2	26.2	35.0	22.9	12.4	10.8	26.3	26.4	14.9	0.0	0.0	0.0	0.2	0.9	91.2	1.6	2.5	0.0	0.0	8.7	329.9	0.0	6.6	0.3	0.5	11.1	0.0	0.0	0.0	0.0	4.1	0.4	9.3	0.0	0.2	69.9	0.0	0.6	0.0	0.5	2.0	0.0	10.1	0.0	0.0	55.4	0.0	0.0	10.6	0.0	347.4	12.9	52.6	0.0	0.0	0.9	0.2	0.0	0.0	0.3
TCTEX1D1	FLJ40873	ENSG00000152760	"Tctex1 domain containing 1"	Q8N7M0	1	66752459-66778787	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;fallopian tube: 18.2;liver: 13.5"	"Cell type enriched"	"Detected in some"	4	"Ciliated cells: 97.7"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 14.1;HUVEC TERT2: 14.2;THP-1: 15.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028420	Uncertain					NA	NA					"HPA028420: AB_10603995"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.72e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.53e-6)"	"unprognostic (9.28e-4)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.65e-2)"	1.8	1.1	5.3	1.2	7.2	7.4	1.1	2.1	3.7	1.5	1.0	9.5	0.0	0.8	0.8	7.5	0.8	18.2	1.1	1.9	8.2	10.4	0.7	13.5	4.0	0.4	3.3	2.4	3.4	0.8	0.7	0.9	11.5	28.4	0.8	1.1	0.7	0.5	1.7	1.9	1.3	1.1	1.3	2.6	0.4	0.8	0.5	2.2	0.0	0.6	0.2	0.6	1.5	0.8	0.0	0.1	0.9	0.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	2.5	0.0	0.3	0.7	0.3	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	14.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.6	5.3	7.2	2.1	3.7	8.2	10.4	3.3	2.4	28.4	2.2	0.0	2.7	0.0	0.0	1.1	0.0	0.4	0.0	97.7	15.9	0.0	0.0	0.0	1.7	0.0	0.2	6.7	0.0	0.0	0.0	0.0	0.5	0.3	24.4	3.4	2.3	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	5.7	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"intestine: 52.9"	"Cell type enriched"	"Detected in some"	577	"Intestinal endocrine cells: 8520.8"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;hTCEpi: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030100, CAB033849"	Enhanced				"Secreted to blood"	NA	NA	38500000				"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.1	1.0	0.0	30.8			0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	1.8	0.4	0.0	0.0	0.0	0.5		0.0	0.0	0.0	0.5	0.0		0.2	52.9		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8520.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0
WDR78	"DIC4, FLJ23129"	ENSG00000152763	"WD repeat domain 78"	Q5VTH9	1	66812885-66924887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.7;testis: 29.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 310.5;Early spermatids: 118.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.8;RPTEC TERT1: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.26e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (9.60e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.79e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.69e-1)"	1.6	2.0	3.1	2.7	7.5	0.3	3.0	0.9	3.9	4.2	5.1	4.0	4.0	0.9	3.1	16.0	0.9	25.7	2.5	1.7	4.2	4.1	6.8	1.3	5.6	1.0	2.0	4.0	7.6	2.0	6.3	7.0	2.1	16.8	2.4	4.0	2.4	2.1	5.8	0.9	1.3	1.2	1.5	2.4	1.2	1.2	29.8	3.3	1.6	6.2	1.1	0.9	1.7	1.5	1.6	0.0	0.2	0.0	7.6	1.0	0.2	3.3	1.4	1.8	2.5	5.8	8.8	0.6	1.5	2.6	2.0	2.0	0.3	2.9	1.7	0.3	1.5	5.9	0.3	1.4	0.3	3.0	0.2	0.4	0.5	0.7	0.3	2.0	0.1	0.1	4.0	4.2	7.2	1.5	6.9	0.7	1.8	0.5	0.1	3.2	1.2	0.7	0.5	2.4	1.1	0.7	0.8	0.0	0.0	13.6	0.0	2.3	1.1	1.5	0.6	1.2	2.0	0.6	1.2	0.3	0.8	0.0	5.5	0.7	0.5	0.0	3.8	1.6	0.4	2.0	0.0	0.0	0.0	0.3	0.0	0.3	0.7	0.6	0.3	0.0	1.6	1.0	0.4	0.2	7.6	0.0	0.0	0.1	0.2	3.1	7.5	0.9	3.9	4.2	4.1	2.0	4.0	16.8	3.3	6.0	4.6	0.0	1.7	1.1	3.1	6.5	0.0	310.5	40.9	15.7	17.7	1.4	13.3	2.7	118.7	1.4	2.1	0.0	1.4	0.4	1.8	0.8	3.5	1.0	0.6	1.6	4.1	3.1	0.3	19.1	9.8	0.1	0.0	1.8	3.8	3.8	1.8	5.1	9.2	8.4	11.9	0.0	3.3	21.7	1.3	0.6	0.6	0.0	2.6	0.9
MIER1	"hMI-ER1, KIAA1610, MI-ER1"	ENSG00000198160	"MIER1 transcriptional regulator"	Q8N108	1	66924895-66988619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019589, HPA050306"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA019589: AB_1853953, HPA050306: AB_2681080"	"unprognostic (3.38e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.44e-8)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.45e-2)"	23.5	20.0	13.9	23.2	14.8	70.3	19.9	15.9	14.9	22.2	22.9	10.8	18.8	13.2	19.3	17.9	16.0	15.0	19.0	12.5	13.3	12.9	16.0	20.7	19.4	22.2	14.8	10.9	22.9	11.8	11.2	20.2	18.5	13.3	19.9	20.7	10.8	12.6	22.5	14.0	14.1	22.3	25.6	15.0	23.0	16.1	15.9	13.9	30.4	17.4	13.9	16.3	23.9	34.3	8.5	7.6	24.3	12.2	9.6	14.9	5.3	14.1	8.4	10.3	18.4	21.2	14.6	11.5	15.0	17.0	15.4	16.7	6.8	8.9	14.3	5.7	16.9	13.7	9.5	12.7	16.2	22.0	16.8	9.8	31.4	22.5	10.5	17.2	24.7	18.7	14.5	12.3	17.1	17.8	17.6	16.5	17.9	16.5	13.0	17.6	4.4	35.8	9.0	14.4	6.5	5.4	15.7	24.8	9.9	12.8	16.3	6.2	11.9	22.4	13.8	14.6	10.4	7.4	16.4	19.3	17.6	12.5	17.2	13.8	16.1	14.9	20.9	14.3	10.9	10.6	21.6	7.4	16.6	12.8	8.0	14.9	7.5	11.6	11.3	5.5	8.5	12.0	11.7	24.3	9.6	12.2	7.6	9.5	5.3	13.9	14.8	15.9	14.9	13.3	12.9	14.8	10.9	13.3	13.9	14.9	43.7	34.7	30.9	42.8	36.6	29.9	20.4	36.1	34.2	26.2	23.6	32.0	38.1	31.5	37.6	46.8	73.5	0.0	35.1	21.8	47.2	42.0	89.1	45.1	20.1	38.1	40.5	35.0	36.9	40.6	75.4	43.8	13.5	51.3	46.9	62.0	40.3	63.2	87.7	24.9	46.9	77.6	49.2	49.7	56.8	30.4	28.7	56.8	35.4	56.7
SLC35D1	"KIAA0260, UGTREL7"	ENSG00000116704	"Solute carrier family 35 member D1"	Q9NTN3	1	66999332-67054099	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.91e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.63e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (2.12e-3)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.20e-1)"	4.0	6.3	5.1	7.5	7.0	4.7	4.7	6.6	5.5	6.2	16.2	7.5	4.8	9.9	5.4	3.8	5.3	4.4	4.4	3.8	4.7	3.8	8.1	50.4	3.8	5.7	7.4	4.0	6.4	7.2	6.4	8.7	6.0	5.4	5.6	17.3	7.1	3.9	4.0	6.9	6.2	14.3	5.4	4.0	4.0	8.0	4.1	5.6	11.1	5.1	4.0	6.4	5.8	6.5	2.3	1.8	9.7	2.4	5.1	4.3	1.4	5.0	2.9	8.9	7.5	9.3	10.8	10.6	11.3	15.0	8.2	5.8	6.2	1.2	15.6	5.0	8.9	9.7	7.7	6.1	7.2	10.4	15.5	2.8	11.6	6.1	12.2	7.8	13.1	7.7	10.5	16.1	9.7	6.9	13.3	3.1	6.6	7.0	8.3	19.9	1.7	8.0	4.1	3.7	13.6	4.0	6.2	18.4	1.7	3.8	9.6	1.1	4.0	17.1	5.3	7.2	5.2	4.4	9.8	3.4	15.4	3.6	9.4	10.8	17.4	9.0	8.7	11.0	2.0	6.5	9.7	1.5	4.0	3.4	1.1	4.2	2.3	2.6	2.7	1.8	1.7	3.7	3.3	0.3	5.1	2.4	1.0	4.3	1.4	5.1	7.0	6.6	5.5	4.7	3.8	7.4	4.0	5.4	5.6	6.0	2.1	4.3	4.7	4.8	6.9	2.6	33.1	6.7	2.3	5.2	11.8	30.4	0.0	2.8	37.3	4.2	36.7	23.3	8.6	4.0	7.2	5.6	4.6	84.4	6.2	6.4	14.5	6.7	9.2	6.6	5.8	3.8	1.7	1.0	14.9	21.0	7.2	14.4	4.2	8.4	8.7	0.0	3.9	7.6	6.7	6.8	13.6	6.9	13.4	7.4
C1orf141		ENSG00000203963	"Chromosome 1 open reading frame 141"	Q5JVX7	1	67092165-67231853	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 14.9;fallopian tube: 12.8;testis: 18.7"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 84.3;Early spermatids: 83.3;Late spermatids: 78.9;Muller glia cells: 34.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 14.9"	"Group enriched"	"Detected in some"	5	"basophil: 2.5;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"	"Cell line enriched"	"Detected in single"	37	"HEL: 18.1"					"Low region specificity"	"Detected in all"			HPA035316			Uncertain	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA035316: AB_10600886"					"unprognostic (1.48e-1)"			"unprognostic (8.09e-2)"		"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"			"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"			0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.1	1.3	0.3	0.1	1.9	0.0	0.0	0.1	1.1	0.0	12.8	0.2	0.0	2.6	1.8	0.1	0.1	2.0	0.1	0.3	0.7	1.8	0.0	0.0	1.0	0.0	14.9	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.2	18.7	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	2.5	0.1	0.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	18.1	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	0.1	0.0	0.5	1.1	2.6	0.1	1.3	2.6	1.8	0.3	0.7	14.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	84.3	15.9	0.0	0.0	0.0	0.0	0.0	83.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	78.9	1.7	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.7	0.0	1.3	0.0	0.0	6.0	0.7	0.0	0.1	0.0	0.0	0.0
IL23R	IL-23R	ENSG00000162594	"Interleukin 23 receptor"	Q5VWK5	1	67138907-67259979	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 18.1;lymphoid tissue: 11.0"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 8.3;Intestinal endocrine cells: 2.9;Late spermatids: 5.1;monocytes: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 18.1"	"Lineage enriched"	"Detected in single"	35	"T-cells: 18.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.7;HMC-1: 10.7;K-562: 4.0;U-2197: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056427	Uncertain					NA	NA					"HPA056427: AB_2683129"	"unprognostic (4.01e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.41e-3)"	0.2	4.8	0.2	11.0	0.3	0.0	0.2	0.2	0.2	0.2	2.4	0.2	0.0	0.9	0.3	1.0	0.3	0.2	0.6	0.2	0.2	0.2	0.3	0.5	0.5	4.8	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.2	2.6	0.6	2.3	0.0	0.2	0.2	2.7	0.0	0.2	3.3	1.3	4.1	0.0	1.2	0.2	1.4	7.6	0.9	0.3	0.0	0.0	0.0	0.0	0.5	18.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	2.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	16.2	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	18.1	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	5.1	0.0	0.0	0.0	2.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.2	0.1
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67396900	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.2;pancreas: 15.0"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 2.9;Hofbauer cells: 2.9;Melanocytes: 1.7;T-cells: 6.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 18.2"	"Group enriched"	"Detected in many"	42	"NK-cells: 18.2;T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.5;SCLC-21H: 8.9;SK-MEL-30: 22.4;THP-1: 13.0"	"Region enhanced"	"Detected in single"		"olfactory region: 1.8"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	3.8	1.0	1.8	3.1	3.6	1.5	3.7	0.6	7.7	2.4	1.0	0.0	0.0	0.7	0.8	1.1	3.2	0.9	1.1	5.2	9.6	1.1	1.5	1.4	1.8	4.3	1.0	6.0	0.8	15.0	0.9	0.8	14.1	1.6	1.2	0.9	1.3	7.2	1.7	11.4	2.1	1.4	1.0	1.0	2.5	1.0	2.3	0.0	1.1	1.1	3.2	1.6	1.4	1.2	0.0	0.0	0.2	0.0	18.2	6.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	2.1	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.0	22.4	0.0	0.0	13.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	2.7	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.2	18.2	0.0	0.0	3.9	1.0	1.8	3.6	0.6	7.7	9.6	1.1	1.0	6.0	1.6	0.0	0.0	2.9	0.0	0.2	0.5	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.6	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.4	0.0	0.1
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol		NA	NA		430000	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	38.3	30.4	22.5	35.7	30.0	33.8	36.9	25.4	27.7	35.4	32.8	25.5	28.6	30.9	36.4	35.2	68.4	25.9	39.4	32.6	22.3	19.1	30.6	48.4	27.5	47.9	29.7	18.6	33.5	56.1	52.2	21.8	28.7	25.0	34.8	27.1	23.2	41.8	28.5	87.5	50.5	29.9	42.0	26.8	31.9	31.5	35.8	28.7	48.9	42.6	54.1	41.3	36.0	40.7	34.3	35.4	16.8	30.2	46.7	44.4	33.9	59.2	36.2	38.9	38.7	34.7	31.9	57.7	62.6	24.6	43.5	36.9	69.8	26.5	114.7	46.9	33.7	40.4	45.7	61.0	58.6	47.2	51.2	73.4	105.6	68.0	61.8	30.4	85.5	40.5	32.5	39.5	55.8	51.0	28.8	47.1	37.5	117.6	40.5	34.7	41.3	64.3	51.9	135.3	39.5	47.9	74.3	85.4	57.3	33.7	49.4	65.7	46.1	48.6	52.9	56.6	33.9	28.9	52.3	49.1	40.0	48.6	57.6	84.1	37.7	48.2	102.9	32.9	81.2	44.6	9.8	27.4	16.8	35.0	30.2	44.4	34.3	35.2	35.3	35.4	33.4	41.4	37.4	9.0	46.7	27.4	32.3	41.7	33.9	22.5	30.0	25.4	27.7	22.3	19.1	29.7	18.6	25.0	28.7	232.3	185.1	214.5	341.9	609.6	146.7	119.8	186.0	238.3	320.8	111.7	86.4	217.4	205.6	253.5	407.2	294.6	134.6	186.9	310.6	429.9	231.1	212.2	213.7	301.4	265.1	135.1	220.8	148.0	205.2	164.8	204.8	212.7	182.2	266.1	277.0	146.7	292.1	133.3	262.0	212.1	123.4	135.8	315.9	477.7	288.9	629.1	191.8	235.2	341.4	442.1
GADD45A	"DDIT1, GADD45"	ENSG00000116717	"Growth arrest and DNA damage inducible alpha"	P24522	1	67685061-67688338	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 86.7;skeletal muscle: 102.1"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 2362.0;Urothelial cells: 1859.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;T-cells: 9.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 60.1;hTERT-HME1: 92.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053420			Supported	"Nuclear speckles"		NA	Yes			"Nuclear speckles"		"HPA053420: AB_2682144"	"unprognostic (1.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.76e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.21e-2)"	"prognostic favorable (8.06e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.93e-1)"	29.6	6.8	10.7	8.2	20.9	46.2	20.9	1.7	15.8	11.7	10.8	5.8	18.8	10.1	23.3	13.8	12.2	8.8	16.7	12.9	18.1	9.8	86.7	66.9	17.1	4.9	11.4	4.1	13.8	8.3	4.1	5.1	10.8	21.2	16.5	9.0	9.4	9.5	15.6	102.1	14.8	20.4	16.1	15.5	7.4	14.1	9.2	7.5	9.2	26.2	10.1	10.9	23.9	11.1	1.1	2.2	24.9	3.2	3.1	9.3	4.8	22.2	1.4	3.8	1.1	6.8	7.1	35.9	39.6	18.5	13.2	14.4	7.8	3.8	9.6	12.1	6.4	33.1	13.4	0.4	33.9	24.9	7.0	3.8	12.0	3.5	7.8	60.1	3.5	1.1	12.0	17.2	16.7	92.9	6.6	9.4	2.3	25.6	17.1	15.5	0.7	1.0	4.2	4.8	2.9	15.7	2.6	29.5	9.8	6.8	16.8	16.4	2.9	8.3	2.3	23.7	13.5	0.4	3.7	9.7	13.8	18.6	14.5	27.7	43.8	8.5	17.5	6.1	1.7	13.4	7.2	3.2	24.9	3.7	1.5	3.0	1.1	2.5	3.0	1.4	0.7	0.7	1.2	4.1	3.1	1.0	2.2	9.3	4.8	10.7	20.9	1.7	15.8	18.1	9.8	11.4	4.1	21.2	7.5	59.6	21.3	30.0	2362.0	763.0	34.8	176.4	48.4	136.5	91.0	97.7	9.8	17.5	200.6	253.6	0.6	85.9	120.7	93.5	224.9	94.3	192.2	631.8	44.9	99.0	16.2	25.4	126.2	49.1	19.7	2.2	35.4	33.2	150.1	467.1	44.4	25.0	252.2	49.1	60.8	290.2	70.0	51.8	190.0	2.7	12.4	341.6	14.8	38.8	37.5	1859.7
GNG12		ENSG00000172380	"G protein subunit gamma 12"	Q9UBI6	1	67701466-67833467	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA057790, HPA062208"	Enhanced	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA057790: AB_2683527, HPA062208: AB_2684711"	"unprognostic (5.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.46e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.46e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-3)"	28.7	23.8	10.3	13.8	9.4	0.0	49.4	5.1	7.7	28.3	34.5	10.9	16.6	40.1	41.5	20.7	34.0	21.2	27.2	14.2	11.8	9.3	36.1	15.4	16.4	12.4	9.1	6.3	24.9	16.0	23.9	17.1	40.1	14.3	21.4	22.2	14.6	16.4	19.3	9.0	33.0	86.2	51.8	22.9	17.5	19.5	11.6	9.6	3.6	23.1	20.5	16.5	31.5	26.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.0	9.4	10.0	5.4	42.8	37.2	10.3	31.1	40.6	27.5	24.8	4.4	9.9	0.0	13.3	43.5	17.2	7.5	6.2	25.5	48.5	0.0	4.8	0.1	8.4	0.0	17.1	0.0	0.5	22.3	15.3	29.3	38.9	38.7	43.1	0.0	0.5	0.0	30.1	1.7	0.0	0.0	7.6	11.0	11.7	0.0	20.7	0.1	26.4	9.0	2.3	4.6	21.5	9.0	41.7	8.9	4.6	0.1	55.4	32.0	20.9	57.5	19.1	0.5	0.0	0.0	20.2	1.2	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	10.3	9.4	5.1	7.7	11.8	9.3	9.1	6.3	14.3	9.6	50.6	25.1	2.4	66.8	178.8	1.5	25.9	48.4	69.6	34.2	55.8	5.9	52.0	63.0	84.4	7.6	66.7	171.8	0.0	120.2	89.1	65.8	79.6	3.5	38.9	22.5	3.2	33.4	86.0	16.9	10.4	66.2	12.4	74.2	6.4	58.8	1.3	115.9	90.3	71.1	129.0	17.2	51.8	74.6	1.7	24.7	189.6	147.1	4.3	51.3	91.1
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045896-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 33.2;pituitary gland: 35.2"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 16.7;Distal tubular cells: 54.7;Exocrine glandular cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 49.9"	"Group enriched"	"Detected in some"	18	"plasmacytoid DC: 2.1;T-reg: 1.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.5;HSkMC: 15.7;TIME: 9.7;U-251 MG: 7.9;U-87 MG: 15.2"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favorable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.0	10.2	2.0	0.2	49.9	0.0	2.4	0.9	2.9	2.3	1.6	1.0	0.0	3.4	1.2	5.4	1.3	1.3	5.9	5.7	1.3	8.7	3.2	4.5	2.3	0.0	1.3	1.1	33.2	9.9	8.8	35.2	0.0	17.3	2.3	0.1	2.4	1.3	1.1	1.0	1.1	1.2	0.3	1.7	1.2	1.9	2.4	0.5	0.0	1.6	0.3	0.1	1.2	1.9	0.0	2.1	0.0	0.0	0.0	1.8	0.0	0.0	1.3	1.4	0.0	4.8	3.6	0.5	4.0	1.4	0.3	1.1	0.0	0.7	0.0	0.2	4.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.6	0.0	7.5	0.0	0.0	15.7	0.1	0.6	0.0	0.0	0.9	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.1	0.5	0.1	0.0	9.7	0.0	0.4	0.2	7.9	2.5	0.0	0.0	15.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	0.0	2.0	49.9	0.9	2.9	1.3	8.7	1.3	1.1	17.3	0.5	0.0	2.6	0.0	16.7	2.9	0.6	4.8	10.2	1.4	3.4	3.5	9.8	0.7	54.7	2.0	0.0	0.6	0.0	0.0	17.0	0.1	10.6	3.2	0.0	2.6	0.1	0.0	15.5	1.8	0.0	0.0	6.4	0.2	5.0	0.0	0.3	0.7	3.6	0.0	1.4	5.0	5.6	0.0	2.6	0.0	0.2	2.5	0.3	0.0	0.6	2.1
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls"	ENSG00000116729	"Wntless Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 10.0;neutrophil: 29.1"	"Group enriched"	"Detected in many"	46	"granulocytes: 29.1;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AF22: 70.0;ASC TERT1: 54.2;SuSa: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	13.7	17.2	33.5	14.3	39.0	1.5	14.5	6.8	26.6	20.0	28.3	25.8	51.6	9.1	19.5	55.1	26.7	19.9	37.1	24.1	23.1	25.4	36.8	8.9	20.3	6.9	27.0	18.6	31.4	34.7	12.1	9.8	29.2	44.5	29.0	22.8	37.8	14.5	47.4	5.3	19.3	14.1	46.2	30.5	10.8	24.4	12.2	22.3	1.9	8.9	13.5	8.2	29.6	17.0	0.0	0.4	29.1	10.0	0.0	0.0	1.9	1.9	2.9	70.0	0.0	38.8	54.2	40.6	9.7	23.9	13.5	18.8	4.2	4.6	0.0	9.8	2.7	12.6	20.3	15.7	15.9	11.5	0.1	11.7	0.0	8.4	0.0	33.9	0.0	0.1	38.7	10.7	33.1	10.9	13.7	31.7	3.7	0.0	0.1	19.9	0.3	0.0	0.2	3.1	4.2	4.7	0.0	14.7	0.0	2.3	10.5	3.9	8.2	8.9	0.4	11.6	66.2	1.9	0.2	36.7	13.0	10.4	20.8	13.1	4.7	0.1	0.0	29.9	0.3	23.7	0.0	10.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.1	0.0	0.3	0.1	0.0	1.9	33.5	39.0	6.8	23.8	23.1	25.4	27.0	18.6	44.5	22.3	44.7	28.8	2.4	56.2	37.7	7.2	27.1	35.7	115.1	44.3	26.2	131.6	119.4	8.3	69.5	13.0	20.8	38.0	0.0	52.3	3.0	31.4	26.5	5.7	10.2	20.8	12.7	9.2	34.4	10.2	7.0	30.2	10.7	18.6	12.6	24.7	7.3	63.3	28.8	51.9	30.0	160.2	38.8	20.8	0.5	0.7	26.2	46.1	1.8	33.6	39.6
RPE65	"BCO3, LCA2, rd12, RP20"	ENSG00000116745	"RPE65, retinoid isomerohydrolase"	Q16518	1	68428822-68449959	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Isomerase"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"retina: 268.3"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 17.3"	"Group enriched"	"Detected in some"	10	"glioma: 5.8;head and neck cancer: 1.5"	"Group enriched"	"Detected in many"	5	"hypothalamus: 6.0;midbrain: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.2;PC-3: 10.6;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.15e-1)"		"prognostic favorable (9.75e-4)"	"unprognostic (4.55e-2)"		"unprognostic (5.91e-2)"	"unprognostic (6.59e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.48e-2)"	"unprognostic (8.40e-3)"	0.0	0.0	0.9	0.1	0.7	0.0	1.0	0.1	3.8	0.2	0.1	1.3	1.4	0.4	1.4	0.7	0.8	0.6	0.2	0.0	1.5	6.0	0.0	0.0	0.0	0.1	8.8	0.1	0.1	0.0	0.0	0.0	0.0	1.2	4.2	0.2	268.3	0.2	10.5	0.0	0.0	0.1	0.5	1.4	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.6	1.5	6.0	8.8	0.1	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"GTPase activation, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6;testis: 19.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 29.0;Erythroid cells: 70.0;Extravillous trophoblasts: 29.4;Late spermatids: 57.0;Spermatocytes: 71.4;Spermatogonia: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			Nucleoplasm	"Nucleoli fibrillar center"	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	1.3	0.8	0.7	12.1	0.5	5.1	1.9	0.3	0.7	1.2	3.3	0.1	0.5	2.9	0.5	0.7	6.5	0.6	0.3	1.3	2.1	0.6	0.7	0.8	2.0	5.5	0.5	0.2	0.6	0.5	0.3	0.4	7.4	0.3	2.5	4.3	0.5	1.3	0.0	0.4	1.7	3.7	1.5	0.4	3.1	1.4	19.5	0.0	28.6	0.5	5.4	5.7	1.5	2.0	0.3	0.0	0.0	0.0	0.8	2.6	0.3	15.5	7.2	13.8	6.3	0.9	2.0	10.8	20.0	9.2	17.1	14.8	6.0	6.5	0.0	14.9	8.2	27.4	10.5	20.0	10.4	29.0	13.6	13.1	12.7	12.8	3.4	0.2	10.9	0.0	0.7	0.5	19.5	10.9	3.5	12.3	5.6	8.7	12.4	30.3	3.5	0.0	4.1	11.9	6.5	9.9	0.0	41.2	5.1	6.9	4.2	15.5	7.2	20.0	8.5	10.4	9.3	7.7	5.5	7.2	11.0	12.6	19.4	23.1	7.8	16.7	0.1	10.4	3.8	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.6	0.3	0.7	0.5	0.3	0.7	2.1	0.6	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.2	3.0	0.4	0.5	0.0	0.0	0.0	1.8	0.0	3.1	0.0	0.1	29.0	0.0	0.7	70.0	0.0	29.4	1.9	1.8	0.0	0.0	6.9	0.0	0.0	0.6	1.9	57.0	0.3	1.3	0.0	0.0	1.9	0.0	0.1	0.0	0.4	0.0	0.2	0.0	1.0	71.4	20.2	1.1	2.4	1.3	2.5	1.4
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 37.9;Early spermatids: 20.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.5;HEL: 31.3"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.5	31.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6	0.0	0.0	5.1	0.5	0.7	37.9	5.8	2.5	0.0	0.0	0.0	2.0	0.4	0.0	0.0	20.2	1.4	0.0	0.0	0.0	0.4	2.1	0.7	0.0	5.5	0.3	6.4	0.0	1.8	1.5	4.6	0.6	0.7	5.0	0.0	0.0	0.5	0.0	0.0	2.8	1.3	7.9	0.0	1.4	7.4	2.7	1.1	0.1	2.5	0.0	0.1
LRRC40	FLJ20331	ENSG00000066557	"Leucine rich repeat containing 40"	Q9H9A6	1	70144805-70205620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026564	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA026564: AB_2250054"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.54e-4)"	"unprognostic (6.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.94e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	14.3	10.4	15.7	10.0	18.5	16.4	13.2	22.0	27.4	13.4	10.7	10.4	8.0	17.0	12.6	10.2	11.5	9.0	10.1	13.5	16.5	16.6	20.4	27.2	9.6	14.2	13.7	15.7	11.3	8.8	7.9	13.8	13.9	19.8	10.6	11.8	7.5	9.0	8.8	13.6	9.0	18.0	13.3	15.6	13.2	9.0	13.4	11.0	23.0	9.9	10.0	14.2	11.1	9.6	10.4	8.4	7.4	8.2	9.8	10.9	6.5	11.3	4.7	18.9	14.8	6.9	7.7	11.4	11.0	8.0	16.7	20.6	6.9	6.4	15.3	9.7	8.5	16.5	8.4	44.3	9.8	22.8	12.2	8.9	11.5	8.7	11.1	8.7	15.0	2.8	6.4	5.7	11.1	11.2	7.7	9.6	9.8	14.2	7.4	14.0	2.9	18.1	11.8	24.8	7.5	10.0	14.5	19.5	9.9	15.2	7.0	9.7	9.8	13.2	13.3	12.2	14.0	6.3	8.6	11.9	11.8	9.5	17.8	12.4	6.3	6.0	24.8	9.5	15.9	12.1	6.8	6.6	7.4	8.5	8.2	10.9	10.4	9.0	7.9	8.4	9.2	10.6	8.8	0.9	9.8	7.6	6.5	10.8	6.5	15.7	18.5	22.0	27.4	16.5	16.6	13.7	15.7	19.8	11.0	11.9	9.3	7.5	7.2	11.4	14.9	9.2	5.1	6.7	6.8	14.0	5.9	14.2	10.0	11.9	0.9	8.9	6.7	23.3	7.6	11.1	13.9	5.2	15.0	17.4	10.1	14.3	22.3	12.3	11.7	1.9	9.5	8.0	5.0	10.8	5.8	6.6	7.9	3.5	9.6	20.3	11.9	19.4	12.3	19.1	25.5	9.7	6.1	12.9	7.7	5.0
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	36.1	42.7	38.3	36.9	41.3	80.1	42.2	68.2	43.6	38.6	32.6	34.8	38.4	30.7	41.4	51.2	31.2	39.0	31.6	25.9	33.4	26.6	30.7	42.5	33.9	47.6	47.7	34.4	51.1	42.5	39.0	53.4	38.4	39.9	37.1	32.4	32.3	34.4	41.8	31.3	51.8	40.6	36.8	37.8	45.9	34.5	35.1	41.7	46.6	44.6	25.5	43.3	32.8	36.7	34.7	42.1	45.4	29.7	36.0	36.4	22.2	24.9	12.7	33.4	21.3	17.2	23.2	46.0	30.9	16.0	25.3	23.0	22.3	18.9	42.6	21.2	15.5	16.6	21.4	42.2	17.0	34.6	28.5	33.0	43.1	28.6	26.6	20.6	59.2	17.9	18.6	21.5	23.3	23.9	31.7	22.4	21.9	42.4	27.0	24.8	9.8	35.4	44.0	53.7	19.7	21.5	42.2	37.0	26.9	29.4	18.1	28.2	23.3	26.1	28.4	36.9	32.4	22.7	26.7	26.4	27.9	20.1	20.1	27.8	31.3	25.0	46.8	20.0	44.1	24.4	39.6	29.7	45.4	32.6	23.1	36.4	34.7	32.9	31.4	30.1	34.1	36.1	33.4	15.0	36.0	27.1	42.1	35.5	22.2	38.3	41.3	68.2	43.6	33.4	26.6	47.7	34.4	39.9	41.7	196.5	200.1	139.7	263.5	314.4	155.0	102.3	104.4	147.2	159.3	184.9	111.9	207.5	97.8	131.8	35.2	175.9	101.9	93.5	118.0	224.3	226.0	265.6	185.3	117.5	131.7	151.0	166.7	144.2	126.7	37.3	236.8	155.2	160.3	181.3	121.4	114.0	119.2	94.7	248.6	77.4	151.4	168.1	201.8	223.9	131.7	309.1	254.0	175.7	130.9	285.4
ANKRD13C	"dJ677H15.3, DKFZP566D1346"	ENSG00000118454	"Ankyrin repeat domain 13C"	Q8N6S4	1	70260588-70354734	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.38e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.42e-2)"	16.4	16.2	16.9	13.5	18.6	8.5	14.9	33.0	23.0	16.2	15.3	18.9	10.6	13.0	16.6	11.5	13.7	12.3	13.0	11.4	17.0	15.7	16.7	13.1	13.4	15.2	15.3	16.8	17.9	14.8	21.5	14.8	12.9	17.2	15.6	15.9	15.9	13.0	12.6	18.2	17.4	14.3	15.3	17.6	15.1	14.2	8.1	13.9	22.5	15.5	9.6	14.3	14.0	13.4	10.5	11.2	13.1	9.6	8.3	14.2	9.3	12.7	6.1	10.6	10.6	13.6	18.3	4.1	12.0	14.4	10.7	10.8	8.2	7.3	11.2	11.7	14.8	10.7	8.7	10.6	7.4	13.1	15.8	11.8	11.9	14.4	7.6	14.0	12.9	6.5	15.2	8.6	12.9	11.6	9.9	10.5	6.0	9.9	16.0	10.8	5.8	7.6	6.3	11.0	6.1	12.0	8.0	13.0	7.6	16.1	8.4	8.0	8.1	15.8	19.6	16.7	10.6	10.1	8.7	12.9	16.8	10.6	25.4	14.6	15.6	19.8	9.2	14.5	10.4	13.9	13.1	7.6	8.8	10.1	9.6	13.8	10.5	12.7	12.3	11.2	8.5	12.0	11.2	0.8	8.3	8.1	5.9	14.2	9.3	16.9	18.6	33.0	23.0	17.0	15.7	15.3	16.8	17.2	13.9	26.8	10.8	7.0	10.6	14.3	16.0	12.6	5.1	20.1	18.2	10.4	29.5	7.5	11.6	9.3	1.1	10.5	8.4	0.0	9.2	8.9	15.5	15.6	3.5	6.6	8.9	6.4	12.0	12.9	16.2	1.3	10.9	8.7	16.9	8.2	12.0	10.8	10.1	10.5	10.6	8.6	22.1	0.0	22.8	7.5	5.5	10.7	11.0	15.7	8.0	14.0
HHLA3		ENSG00000197568	"HERV-H LTR-associating 3"	Q9XRX5	1	70354805-70385339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 51.4;Proximal tubular cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031323	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031323: AB_10601477"	"unprognostic (2.31e-3)"	"unprognostic (8.35e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.60e-2)"	6.9	20.0	18.2	4.1	19.5	7.6	8.5	6.9	19.3	8.9	6.4	20.1	7.2	4.6	8.2	25.7	8.0	15.8	6.8	5.1	15.8	16.5	16.8	17.6	4.6	9.7	17.5	14.6	18.0	15.5	15.8	14.1	6.8	13.4	11.4	6.1	13.1	14.4	8.6	2.8	11.0	4.3	7.9	17.0	7.3	5.2	8.9	15.4	5.8	13.6	3.2	9.0	7.6	13.2	13.4	8.5	4.5	3.0	5.2	11.2	3.9	7.8	3.6	14.0	7.9	12.1	9.9	2.0	2.2	5.1	3.7	4.8	1.2	9.0	7.4	9.7	9.3	16.8	4.9	13.7	6.3	6.6	21.1	7.9	5.0	7.5	3.5	11.8	2.4	4.0	12.8	7.5	7.9	9.3	8.4	1.2	9.9	9.1	21.1	5.4	5.8	4.9	8.5	13.8	5.6	4.8	10.3	1.0	3.6	17.1	1.2	5.1	4.0	16.8	5.3	9.9	17.6	3.1	5.5	3.1	4.0	2.3	8.3	2.7	10.6	8.5	20.2	8.1	7.5	7.7	4.5	2.5	1.4	6.5	3.0	6.5	10.5	6.7	7.0	3.7	13.4	11.2	9.9	0.7	5.2	2.2	8.5	10.8	3.9	18.2	19.5	6.9	19.3	15.8	16.5	17.5	14.6	13.4	15.4	0.0	3.2	6.0	11.4	4.5	2.8	1.2	20.4	8.1	5.7	21.0	0.0	12.7	51.4	5.7	0.6	4.6	2.6	0.0	6.6	11.5	5.4	10.3	6.9	17.4	6.9	6.4	4.1	11.1	8.6	1.0	6.9	2.7	1.7	12.6	3.9	18.6	6.4	5.8	14.2	35.6	2.8	0.0	5.1	3.7	13.4	7.4	13.3	4.9	5.0	8.3
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 104.5"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 130.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 20.2;Karpas-707: 31.3;SK-MEL-30: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		25000			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	2.2	8.3	2.3	1.0	3.2	2.2	2.0	3.7	3.6	1.9	3.3	2.2	1.8	3.3	1.7	1.4	2.7	2.3	1.5	1.6	2.1	2.7	8.2	104.5	2.2	1.0	2.4	2.2	18.3	11.6	1.5	1.7	1.0	3.2	2.9	4.1	11.2	4.8	2.8	2.1	1.0	3.2	1.2	2.4	0.8	3.7	5.4	1.3	0.0	11.4	1.2	1.5	2.7	1.2	4.5	1.3	1.1	0.6	0.6	6.4	1.1	5.1	0.7	3.5	4.9	4.3	2.4	7.8	2.1	1.9	1.8	7.8	1.4	3.2	2.8	1.6	1.5	4.6	2.4	13.5	1.4	3.6	8.6	3.0	3.3	2.6	4.4	20.2	3.7	0.8	3.7	12.2	3.7	4.3	0.7	1.6	5.6	6.5	31.3	1.1	1.4	1.3	0.8	3.6	1.9	2.7	1.3	1.9	7.8	3.6	0.0	1.9	1.6	3.2	3.8	40.8	6.9	1.3	2.1	0.5	0.6	4.0	2.8	1.9	12.1	7.1	1.5	4.8	7.7	1.4	1.1	0.6	0.2	2.5	0.4	4.6	4.5	2.3	3.5	1.0	2.9	6.4	3.1	0.9	0.6	0.5	1.3	0.7	1.1	2.3	3.2	3.7	3.6	2.1	2.7	2.4	2.2	3.2	1.3	6.0	3.5	5.6	6.2	2.3	6.8	1.6	5.1	0.0	1.2	5.2	9.8	0.6	10.0	1.6	14.9	2.0	11.9	0.0	3.5	1.3	2.8	5.2	0.0	130.7	1.0	0.0	2.9	4.3	2.9	3.4	1.1	1.3	18.6	0.0	5.9	4.3	6.4	11.0	3.9	22.0	10.1	0.0	5.5	1.6	0.5	1.8	0.7	4.3	4.3	2.8
PTGER3	EP3	ENSG00000050628	"Prostaglandin E receptor 3"	P43115	1	70852353-71047808	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 71.2;endometrium 1: 65.2"	"Cell type enriched"	"Detected in many"	10	"Distal tubular cells: 190.6"	"Group enriched"	"Detected in some"	7	"breast cancer: 4.1;renal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	49	"basophil: 22.4"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 22.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.2;HAP1: 10.8;HDLM-2: 16.3;HEL: 7.8;T-47d: 37.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010689	Uncertain					NA	NA					"HPA010689: AB_1855883"	"unprognostic (1.53e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-4)"	32.5	3.0	3.9	6.8	0.7	0.0	71.2	0.2	1.7	7.8	6.3	0.1	3.0	0.5	65.2	16.6	1.7	4.8	11.3	2.6	0.6	2.0	41.5	0.3	0.6	2.2	0.4	1.4	2.4	10.7	0.0	0.4	0.5	1.6	3.3	1.0	0.1	15.5	3.7	0.5	6.2	1.8	31.9	0.5	0.3	9.1	4.0	0.0	0.0	0.7	3.2	0.7	4.4	5.7	0.0	0.4	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.2	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.8	0.0	0.0	16.3	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.1	0.0	0.1	37.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	22.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.2	1.7	0.6	2.0	0.4	1.4	1.6	0.0	0.0	0.3	0.0	0.2	4.4	1.1	0.8	0.0	0.0	0.0	19.2	0.0	0.0	190.6	2.3	0.8	0.9	0.0	0.0	0.0	2.2	2.0	1.5	9.2	0.0	0.1	3.2	2.4	1.3	0.0	0.4	1.1	2.8	8.5	1.0	0.0	0.2	0.0	0.0	0.0	3.3	0.0	6.5	5.1	0.1	0.0	6.6	0.1	0.0	0.0	0.1
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081297	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	26.4	27.4	39.8	31.1	42.2	35.1	34.4	54.1	48.6	39.3	28.8	19.6	33.3	23.4	48.3	45.6	20.2	30.6	20.3	27.5	33.5	30.6	20.1	19.5	26.7	37.8	34.1	40.5	39.5	23.9	23.1	77.5	24.6	32.0	30.5	29.3	17.5	25.1	33.2	54.4	27.9	24.9	35.1	42.2	26.2	23.6	31.6	38.0	40.0	32.8	24.3	30.9	32.8	25.6	31.4	34.0	32.1	16.3	20.9	30.8	13.8	23.7	8.6	35.6	20.5	13.9	24.0	20.3	29.1	16.0	25.6	32.7	16.1	15.4	49.3	25.8	17.9	24.1	15.0	30.1	18.1	38.4	34.8	21.7	42.8	33.8	13.4	20.7	46.6	17.5	18.2	22.7	24.9	21.5	29.0	21.5	25.5	44.7	26.4	19.5	8.1	38.1	15.1	36.3	14.2	16.9	43.4	26.6	28.9	16.5	20.3	26.5	16.8	24.8	16.7	24.8	19.4	20.5	20.5	28.8	18.9	18.1	14.8	28.7	21.8	27.0	54.2	27.9	43.5	26.5	32.1	16.3	14.2	22.2	15.0	25.1	30.6	23.6	21.3	12.4	31.4	30.8	24.2	14.6	20.9	14.8	34.0	22.0	13.8	39.8	42.2	54.1	48.6	33.5	30.6	34.1	40.5	32.0	38.0	92.3	128.7	70.6	66.5	45.0	171.8	89.9	58.6	91.0	72.8	47.1	121.7	45.9	41.4	45.1	111.6	51.1	53.4	23.3	58.7	46.6	56.3	44.1	84.4	36.4	38.8	201.8	70.2	51.0	27.2	20.7	171.7	52.0	45.5	50.5	41.0	144.1	55.6	45.6	108.5	30.6	205.0	116.4	59.5	149.3	96.0	40.7	53.1	60.9	36.0	49.3
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395940-72282734	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.5"	"Cell type enhanced"	"Detected in many"	20	"Bipolar cells: 41.5;Leydig cells: 194.8;Peritubular cells: 42.1;Rod photoreceptor cells: 57.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;TIME: 16.3;U-2 OS: 13.6;U-251 MG: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		390000000	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	17.5	7.8	18.1	7.6	16.3	2.2	7.3	24.1	41.5	8.0	14.7	2.6	2.4	3.8	7.1	5.9	13.6	5.9	13.5	10.7	11.2	14.8	8.8	1.1	5.4	2.4	8.7	26.3	8.4	6.0	1.5	4.6	4.1	5.9	9.9	10.3	3.2	3.6	7.6	5.9	5.5	6.3	25.5	10.2	1.5	7.6	4.4	3.0	0.3	3.8	1.5	1.6	20.1	9.1	0.5	3.3	1.1	0.4	0.4	0.4	0.1	0.2	0.1	0.5	0.2	16.0	12.7	0.1	11.1	4.2	6.1	7.5	0.1	0.1	0.2	0.1	12.2	0.2	0.3	0.0	0.0	13.3	0.2	0.1	0.1	2.2	0.1	1.3	0.2	0.3	6.1	0.0	5.2	0.9	9.1	7.2	0.2	0.1	0.5	11.3	0.1	0.1	0.2	1.8	0.2	6.4	7.7	11.9	0.2	1.0	0.2	0.9	1.0	3.9	0.1	0.1	0.3	0.1	0.2	16.3	1.4	13.6	0.6	13.8	0.3	0.2	0.1	3.1	7.4	4.8	1.1	0.4	0.3	0.4	0.2	0.3	0.3	0.3	0.3	3.1	0.5	0.3	0.3	0.8	0.4	0.4	3.3	0.2	0.1	18.1	16.3	24.1	31.8	11.2	14.8	8.7	26.3	5.9	3.0	0.0	0.3	0.0	0.5	4.4	41.5	4.0	0.0	12.0	4.5	0.0	25.5	0.0	0.0	1.5	4.9	2.9	0.0	0.0	0.0	0.0	29.4	1.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	7.1	194.8	2.2	8.5	0.0	0.0	10.8	0.6	0.0	42.1	1.4	57.5	32.3	6.6	0.7	1.5	3.0	0.0	0.0	0.0	0.7
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 34.1"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 144.3;Late spermatids: 74.3;Spermatocytes: 156.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;JURKAT: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.8	1.3	0.9	0.9	2.7	0.2	0.9	0.3	1.5	0.8	0.4	1.1	0.1	0.3	0.4	1.2	0.6	2.8	0.6	0.6	1.0	1.1	3.5	1.7	1.6	0.9	2.5	1.4	2.5	0.6	2.1	7.2	0.3	2.4	0.6	0.3	0.6	0.8	0.6	0.4	0.3	0.4	0.2	1.3	1.6	0.5	34.1	1.0	1.4	1.9	0.0	0.8	0.5	0.4	3.9	1.1	1.9	1.1	1.1	4.0	0.9	0.3	1.5	0.2	0.6	1.6	0.6	1.0	0.9	0.6	1.3	1.4	0.2	2.1	2.1	1.9	0.2	12.2	0.2	3.3	3.0	1.6	5.2	0.0	1.9	0.5	1.0	0.2	3.4	1.1	1.1	1.6	2.2	0.8	0.5	0.6	7.3	1.6	3.0	2.1	0.0	1.3	0.5	1.7	3.7	1.0	1.6	1.2	2.1	1.9	0.2	1.6	1.1	0.2	0.2	4.6	0.3	1.3	1.9	0.2	0.2	1.1	0.8	1.8	3.1	1.1	1.7	2.3	0.3	1.6	0.0	0.2	1.9	2.3	1.1	2.9	3.9	2.6	2.9	0.3	2.0	2.5	3.5	0.0	1.1	0.3	1.1	4.0	0.9	0.9	2.7	0.3	1.5	1.0	1.1	2.5	1.4	2.4	1.0	0.0	1.0	0.0	1.0	1.0	0.8	0.4	0.0	36.1	1.2	0.0	3.9	1.4	11.6	1.4	144.3	0.1	0.0	0.0	1.6	1.5	0.2	1.2	0.0	1.0	1.1	0.0	2.9	0.0	0.6	74.3	1.7	0.4	0.0	1.0	0.9	1.1	0.7	0.0	1.4	4.2	0.6	0.0	0.4	156.8	22.6	0.1	0.2	0.7	0.6	0.7
FPGT	GFPP	ENSG00000254685	"Fucose-1-phosphate guanylyltransferase"	O14772	1	74198212-74234086	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072331			Uncertain	Vesicles		NA	NA			Vesicles		"HPA072331: "	"unprognostic (1.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.18e-3)"	"unprognostic (4.32e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.86e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.91e-1)"	14.6	11.6	10.9	9.1	12.6	3.4	13.0	19.0	15.8	15.9	11.7	13.0	7.5	11.5	17.7	11.1	15.7	15.4	13.3	12.8	10.9	7.1	15.9	13.7	10.8	8.0	15.5	10.6	14.1	10.2	14.2	27.7	10.6	14.4	11.1	11.3	10.6	11.7	9.1	15.7	12.0	12.0	11.8	16.3	11.0	12.3	8.7	13.9	6.6	20.0	6.8	9.2	17.9	12.9	4.3	9.2	15.2	14.9	3.8	5.4	7.4	9.3	7.7	5.8	8.5	13.5	12.7	8.7	12.2	8.2	8.5	10.0	4.3	7.0	5.7	15.1	7.2	9.6	7.8	10.4	11.2	13.5	11.5	4.4	12.9	9.4	7.3	11.3	9.8	10.0	10.4	14.5	8.4	4.0	5.8	8.7	8.0	13.3	6.9	13.2	2.5	5.4	2.0	6.3	12.0	7.0	5.8	13.7	8.0	7.4	6.8	6.1	6.1	9.0	13.3	14.0	1.9	16.0	11.2	7.8	3.7	7.1	20.2	9.2	7.5	5.4	7.6	15.0	9.7	12.5	12.0	14.9	15.2	4.3	14.5	5.0	3.6	4.4	3.9	9.2	4.3	4.9	4.4	4.4	3.8	12.5	0.9	5.4	7.4	10.9	12.6	19.0	15.8	10.9	7.1	15.5	10.6	14.4	13.9	6.0	2.7	0.5	3.7	6.1	7.0	8.7	10.2	9.4	2.3	10.4	2.0	11.0	16.6	5.0	6.1	5.2	9.3	0.0	6.3	9.1	5.8	2.7	4.7	7.9	13.3	3.2	5.8	6.7	9.8	5.7	9.5	10.6	5.0	3.6	7.6	8.4	5.6	7.0	5.3	12.4	4.5	25.8	5.2	8.1	10.6	5.6	5.1	1.8	7.2	1.7
FPGT-TNNI3K		ENSG00000259030	"FPGT-TNNI3K readthrough"		1	74198235-74543982	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"heart muscle: 28.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 7.9;Cone photoreceptor cells: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 5.0;CAPAN-2: 4.6;SiHa: 6.5"									HPA072331			Approved	Vesicles		NA	NA			Vesicles		"HPA072331: "	"unprognostic (6.29e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.87e-3)"	8.5	5.5	5.4	3.1	6.3	2.7	6.1	16.1	8.2	6.4	6.3	6.6	3.4	2.5	9.3	4.2	6.0	5.7	4.2	28.0	5.4	4.9	6.3	3.7	6.1	3.5	8.0	5.2	5.6	3.1	4.7	15.0	3.8	7.4	5.5	3.7	5.2	5.4	6.0	11.2	8.0	5.1	6.3	8.5	5.9	4.9	4.1	7.1	2.9	5.1	3.0	3.5	5.5	4.9	2.4	2.4	4.9	4.7	0.8	4.9	3.5	0.0	1.1	0.7	1.5	0.8	5.0	0.1	2.1	1.0	0.2	0.4	1.1	4.6	0.1	3.3	0.2	0.0	0.0	0.3	3.1	0.4	0.1	0.2	1.7	0.1	0.1	0.8	0.4	0.3	2.1	2.1	0.2	0.2	0.6	0.2	0.2	0.0	1.7	1.0	0.0	0.1	0.2	0.1	1.7	0.9	2.3	3.9	0.0	0.4	0.0	1.1	3.4	6.5	0.3	0.3	0.0	0.0	2.3	0.1	0.7	0.2	0.2	0.8	0.2	0.1	1.7	1.0	1.0	1.1	3.6	4.1	3.5	1.1	4.7	3.5	2.1	3.9	2.2	2.4	2.4	4.9	2.5	4.9	0.8	1.2	2.1	3.8	3.5	5.4	6.3	16.1	8.2	5.4	4.9	8.0	5.2	7.4	7.1	3.0	0.6	0.0	0.4	0.1	4.9	7.9	2.5	1.4	1.2	0.0	9.8	0.1	0.0	0.1	0.9	0.5	0.0	0.0	0.9	0.1	0.5	0.3	2.3	0.4	0.2	4.8	2.9	2.5	1.9	0.2	2.6	0.1	1.7	0.0	0.0	1.2	0.9	1.4	0.7	0.5	2.7	0.0	0.5	1.8	1.4	0.1	0.0	0.0	0.2	0.2
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235401-74544428	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 44.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 23.4;Early spermatids: 20.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;HSkMC: 2.6;OE19: 2.8;RPTEC TERT1: 2.6"															NA	NA						"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	0.7	0.6	1.1	0.5	1.5	0.0	1.0	6.0	1.7	0.5	0.5	0.5	0.5	0.2	0.5	1.7	0.5	0.7	0.5	44.6	1.1	1.3	2.2	0.5	0.5	0.5	0.6	0.5	0.7	0.5	0.3	0.6	0.5	0.9	0.5	0.3	0.5	0.5	1.2	0.5	0.9	0.5	0.6	0.5	0.5	0.1	1.8	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.3	1.9	0.0	2.3	0.0	1.0	0.1	0.0	0.6	0.7	0.0	0.5	1.5	0.0	0.0	1.3	0.3	1.0	0.0	3.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.5	2.6	1.5	0.2	0.0	0.0	0.5	0.3	0.0	0.8	1.1	0.0	0.2	0.2	1.1	2.8	0.0	0.2	0.0	0.0	2.6	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.8	1.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.0	0.0	0.2	1.9	0.0	0.1	1.1	1.5	6.0	1.7	1.1	1.3	0.6	0.5	0.9	0.5	0.0	0.0	0.0	0.1	0.8	1.2	23.4	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.1	20.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	5.4	0.9	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	3.3	0.2	0.0	1.7	0.4	1.1	0.3	0.1	0.0	0.0	0.1
LRRC53		ENSG00000162621	"Leucine rich repeat containing 53"	A6NM62	1	74469878-74512614	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"brain: 2.9"	"Cell type enriched"	"Detected in single"	11	"Intestinal endocrine cells: 6.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"SCLC-21H: 3.6"									HPA054062	Uncertain					NA	NA					"HPA054062: AB_2682364"					"unprognostic (3.67e-1)"													0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.6	2.9	0.0	0.2			0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.5	0.3	0.0	0.0	0.1	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.7		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERICH3	"C1orf173, DKFZp547I048, RP11-653A5.1"	ENSG00000178965	"Glutamate rich 3"	Q5RHP9	1	74568111-74673738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 21.1;testis: 26.4"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 431.0;Early spermatids: 257.5;Late spermatids: 256.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.2;SCLC-21H: 3.3"									"HPA028655, HPA072916"	Approved					NA	NA					"HPA028655: AB_10961002, HPA072916: "	"unprognostic (4.49e-4)"	"unprognostic (1.02e-2)"		"prognostic favorable (1.56e-5)"	"unprognostic (1.71e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-4)"	"unprognostic (9.21e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	0.4	3.5	12.7	0.5	10.7	0.4	1.4	7.0	14.5	7.6	0.5	0.5	0.0	0.5	1.7	3.0	0.4	21.1	0.5	0.5	12.0	4.2	0.5	0.6	3.7	0.7	1.0	10.3	1.2	0.4	0.4	6.3	0.5	2.4	0.5	0.6	0.0	0.7	0.5	0.4	0.5	0.5	0.5	0.7	0.6	0.6	26.4	1.6	0.0	0.5	0.0	0.7	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.5	0.0	3.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	10.7	7.0	12.0	12.0	4.2	1.0	10.3	2.4	1.6	3.0	1.9	0.0	0.0	0.0	4.0	0.5	0.0	431.0	52.4	0.0	0.0	0.0	0.0	0.0	257.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.0	0.0	3.4	0.0	0.0	256.2	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.3	6.5	0.0	35.8	1.4	0.0	0.1	0.0	0.0	0.3
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.0;liver: 79.8"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 151.8;Distal tubular cells: 192.3;Hepatocytes: 184.9;Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 98.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		NA	NA		7200000	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	6.0	13.4	7.5	4.6	5.4	0.2	8.8	4.2	5.9	19.8	12.6	3.9	27.1	11.3	11.9	29.1	9.7	11.5	15.7	10.4	6.0	9.0	100.0	79.8	7.1	4.8	6.5	3.5	9.4	26.1	13.2	17.2	3.7	11.1	13.8	4.9	9.4	5.9	21.9	5.6	5.6	19.8	14.1	6.8	5.4	9.5	4.9	5.9	7.1	17.1	7.9	5.8	14.8	15.8	18.2	8.9	4.7	8.6	14.4	21.7	9.0	2.5	24.8	12.8	3.6	14.8	16.2	8.7	8.0	12.7	11.6	13.1	19.4	10.3	13.9	14.1	15.5	20.4	6.9	10.4	10.1	19.0	16.0	4.2	5.8	7.7	38.8	7.8	4.9	11.9	7.5	9.0	18.6	3.4	10.9	9.7	7.7	18.2	5.0	24.2	5.8	8.9	8.3	9.6	20.2	16.2	5.7	12.1	5.1	98.3	7.9	3.5	6.3	1.8	13.5	8.7	15.0	12.1	1.6	4.7	2.8	7.0	8.7	12.0	3.6	6.9	6.8	22.8	1.9	7.9	4.7	5.2	0.9	18.2	7.7	14.7	18.2	17.9	16.7	8.9	13.7	15.7	16.7	0.8	14.4	8.6	7.5	21.7	9.0	7.5	5.4	4.2	5.9	6.0	9.0	6.5	3.5	11.1	5.9	26.8	16.9	14.3	23.5	15.9	2.5	25.7	89.2	16.0	12.5	151.8	2.0	12.7	192.3	42.4	0.3	8.0	12.3	0.0	28.1	14.2	21.7	10.3	13.9	184.9	15.3	0.0	6.4	11.6	12.5	1.1	19.2	10.6	10.1	10.0	13.2	6.8	30.1	9.1	19.4	384.2	2.6	0.0	15.9	1.4	6.8	18.4	6.1	15.2	13.3	12.7
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	16.5	19.7	13.7	13.5	17.7	11.9	18.3	15.0	19.9	20.4	17.7	7.5	13.7	9.5	21.0	15.2	20.6	16.4	10.0	21.1	11.1	12.9	20.4	17.0	11.3	14.3	16.2	17.2	30.0	14.4	22.2	34.3	13.5	17.0	20.7	12.3	8.6	13.8	15.7	12.3	10.5	10.9	24.7	15.6	16.0	14.8	12.3	18.1	12.3	23.5	14.3	16.9	23.5	33.3	9.7	9.0	6.0	8.0	13.6	13.9	5.2	8.6	7.3	12.6	8.9	14.3	15.7	19.1	14.9	13.7	14.3	12.6	15.4	7.4	22.7	13.7	12.8	21.0	7.1	14.4	17.2	17.9	14.1	12.4	17.8	22.3	29.8	9.4	35.6	11.6	11.9	17.4	18.2	17.6	11.5	12.7	15.8	30.8	17.5	18.3	7.3	17.3	11.9	33.5	13.0	17.0	16.4	26.3	10.2	12.2	11.3	9.8	8.3	7.1	19.4	22.9	14.3	10.6	13.1	8.2	6.3	17.3	17.1	17.8	10.1	18.3	15.9	14.2	12.9	18.2	6.0	6.0	1.6	10.3	8.0	9.9	9.7	9.1	9.3	9.0	8.8	13.2	13.9	0.5	13.6	5.9	8.7	8.4	5.2	13.7	17.7	15.0	19.9	11.1	12.9	16.2	17.2	17.0	18.1	14.9	22.9	32.0	34.6	22.8	31.3	26.5	17.8	24.1	36.4	15.7	3.9	37.5	66.3	29.4	14.9	24.8	8.0	0.0	51.1	41.5	28.2	34.8	20.7	29.2	29.0	47.7	13.3	17.8	27.2	18.5	40.3	22.8	20.3	29.7	17.0	18.0	31.2	7.0	57.7	43.8	19.9	12.9	38.0	31.8	45.3	19.8	18.7	27.7	24.9	23.3
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Cell type enhanced"	"Detected in single"	26	"Spermatogonia: 2.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.8;U-266/70: 8.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	8.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 63.4;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA047455: AB_2680054, HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	1.0	0.4	2.4	1.0	1.5	0.0	6.3	1.0	3.6	1.0	1.8	1.0	1.0	0.9	1.0	1.0	7.7	3.7	1.0	2.2	2.8	2.8	2.0	1.0	1.0	1.0	2.3	1.0	1.0	1.8	5.6	3.7	3.8	1.0	1.0	2.9	1.0	1.6	1.0	1.5	11.3	1.0	1.0	1.0	1.0	1.3	32.6	1.0	1.0	1.0	1.0	1.8	2.2	1.9	3.2	0.3	0.6	0.3	0.5	1.1	0.3	0.2	0.2	4.5	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	2.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.5	0.6	1.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.4	2.4	2.6	0.0	0.0	1.7	0.0	4.5	2.9	0.6	0.0	0.0	2.1	7.1	4.8	1.0	11.1	0.0	4.6	0.0	11.8	0.2	0.0	13.7	0.4	1.2	0.0	1.4	2.0	1.9	3.0	0.2	0.0	0.7	0.4	0.3	0.2	0.4	0.1	0.9	3.2	0.8	1.1	0.1	2.4	0.6	0.4	0.6	0.5	0.2	0.3	0.6	0.3	2.4	1.5	1.0	3.4	2.8	2.8	2.3	1.0	1.0	1.0	0.0	0.6	0.0	0.6	1.6	3.7	0.6	0.0	2.7	1.2	0.0	0.0	6.8	0.0	0.1	63.4	0.4	0.4	0.0	0.8	3.2	0.2	0.8	0.0	0.0	1.0	0.0	2.4	3.1	0.0	27.3	0.9	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	5.8	3.2	0.0	0.2	3.1
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	7.0	5.6	17.7	7.8	15.3	12.6	5.0	13.3	10.9	13.0	11.0	10.5	11.3	77.6	11.8	9.5	11.2	6.6	15.1	11.3	16.3	30.0	7.4	25.4	17.3	16.2	10.7	21.7	7.1	14.5	6.5	11.4	6.8	10.1	10.2	16.9	25.9	17.5	14.0	2.6	25.4	10.2	14.3	21.5	13.6	33.2	23.4	8.1	21.6	18.7	9.6	12.1	10.8	32.1	27.7	12.8	9.5	27.5	5.5	8.9	8.8	7.6	21.7	11.4	16.3	34.5	7.5	17.7	10.1	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0	53.6	43.4	62.8	34.2	24.3	36.0	330.8	53.5	152.6	51.2	55.8	23.6	30.2	291.8	28.7	45.7	27.1	38.4	23.3	23.5	17.3	29.9	27.0	42.8	232.4	67.1	28.6	39.0	43.6	39.4	18.0	43.4	40.9	49.0	30.7	34.0	51.0	23.3	33.6	42.8	350.1	27.0	0.0	32.5	64.2	67.3	23.6	12.8	30.5	42.5	35.5
RABGGTB		ENSG00000137955	"Rab geranylgeranyltransferase beta subunit"	P53611	1	75786197-75795079	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026585, HPA027167, HPA030793"	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: "	"unprognostic (4.83e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (9.80e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.05e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.89e-1)"	19.4	31.8	20.2	25.3	20.1	8.7	23.5	25.8	24.2	19.4	18.8	16.8	14.8	18.6	20.9	14.1	15.7	15.6	12.0	27.2	19.1	20.4	40.7	35.8	17.4	13.1	26.3	14.8	18.5	33.2	12.3	26.4	17.3	20.5	15.6	16.2	13.7	25.0	15.8	33.5	9.5	14.5	13.1	29.4	19.0	14.3	11.9	18.0	21.3	17.3	21.6	34.4	12.4	13.3	10.6	12.8	7.6	11.5	6.3	10.7	4.4	17.1	9.8	17.8	6.9	22.3	25.7	10.3	23.4	17.4	22.5	18.0	22.1	4.2	14.4	23.9	12.9	38.2	10.6	43.3	18.8	31.7	14.9	11.6	12.4	16.4	37.3	27.7	16.6	7.6	17.1	42.6	20.0	23.2	33.3	18.3	15.4	20.7	15.0	25.1	7.4	14.0	19.8	14.1	12.9	16.8	11.5	26.2	6.6	17.1	9.4	9.6	9.3	5.3	30.2	54.2	15.8	5.9	17.1	17.6	14.2	16.1	33.3	44.7	10.1	29.5	10.3	16.4	13.5	6.2	7.6	7.7	4.5	8.8	11.5	10.3	10.6	8.9	8.1	12.8	7.1	10.5	10.7	1.3	6.3	8.0	12.0	8.0	4.4	20.2	20.1	25.8	24.2	19.1	20.4	26.3	14.8	20.5	18.0	32.8	40.6	61.9	46.8	113.4	22.5	59.6	66.2	22.7	33.0	26.2	19.6	39.2	87.9	38.3	1.3	35.0	39.3	0.0	44.7	50.2	57.6	54.1	71.3	68.3	56.4	30.2	86.2	29.4	47.6	3.6	30.0	61.3	55.6	48.7	49.0	26.6	40.5	35.1	31.5	127.1	22.2	6.5	65.0	15.4	14.3	125.0	44.7	48.9	56.6	68.1
MSH4		ENSG00000057468	"MutS homolog 4"	O15457	1	75796882-75913238	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"testis: 33.0"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 19.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.7;HDLM-2: 2.7;JURKAT: 3.0"	"Not detected"	"Not detected"													NA	NA						"unprognostic (6.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.58e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.88e-8)"	"unprognostic (5.33e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.63e-2)"	0.3	0.2	0.3	0.3	0.6	0.1	0.5	2.6	0.4	0.3	0.8	0.3	0.3	0.1	0.6	4.8	0.3	0.6	0.3	0.6	0.3	0.0	0.3	0.3	0.4	0.3	0.3	0.3	1.0	0.3	0.0	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.5	0.4	0.7	0.7	1.2	0.2	33.0	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.7	0.4	0.0	0.1	0.0	0.5	0.0	0.8	0.1	0.0	5.7	1.1	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.2	0.0	0.3	0.0	2.7	0.6	0.2	0.2	0.0	0.0	0.1	0.4	1.1	1.7	0.5	0.0	0.7	0.1	3.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.3	0.9	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.7	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	2.6	0.4	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	1.2	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.3	0.0	0.0	19.1	1.3	0.0	0.0	0.0	0.0	0.0
ASB17		ENSG00000154007	"Ankyrin repeat and SOCS box containing 17"	Q8WXJ9	1	75918873-75932431	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 33.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 933.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																		"unprognostic (7.27e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	933.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.7	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074719-76634601	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	20.7	2.9	7.0	3.6	13.0	5.3	13.9	3.8	9.7	4.3	4.0	13.4	2.0	1.8	10.7	2.1	3.8	4.2	4.7	7.8	8.8	6.0	14.9	3.9	7.5	5.1	16.3	3.6	4.7	2.2	12.6	4.3	5.7	12.9	2.5	4.7	2.8	2.3	3.5	3.3	1.9	2.7	8.3	19.0	3.0	3.0	1.2	12.5	0.0	23.2	1.5	1.7	5.5	5.2	5.9	3.0	5.2	8.3	0.4	1.9	2.6	0.1	0.0	18.6	0.0	0.3	0.0	0.0	0.0	2.2	0.3	0.2	6.0	0.0	0.3	1.2	0.1	1.2	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.9	0.8	0.0	0.0	0.0	1.4	4.6	0.0	0.0	32.2	4.5	0.0	0.1	10.4	0.1	1.5	0.0	1.7	0.0	0.0	0.0	0.0	4.2	2.8	0.0	8.3	3.7	0.0	2.9	0.0	3.3	0.5	0.8	3.0	5.9	1.9	1.9	5.2	0.4	5.3	0.0	0.0	2.6	7.0	13.0	3.8	9.7	8.8	6.0	16.3	3.6	12.9	12.5	3.0	1.0	1.3	0.1	0.2	3.0	1.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.8	0.0	0.0	57.1	11.7	0.4	0.0	1.5	5.0	0.0	0.3	11.0	0.2	3.2	0.0	0.0	0.5	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.1
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867441-77065711	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enriched"	"Detected in some"	7	"Alveolar cells type 1: 50.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Group enriched"	"Detected in many"	4	"amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0.0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3.0	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1.0	2.1	10.2	0.8	1.0	3.7	1.2	0.2	0.0	0.6	0.0	1.4	4.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	9.1	0.0	0.0	0.0	0.0	0.8	3.2	2.6	0.8	0.0	0.2	0.0	0.0	10.9	0.0	5.2	0.0	0.1	2.8	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.7	0.6	0.0	0.1	2.5	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	9.0	0.0	5.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3.0	14.2	4.7	0.2	50.6	0.3	0.0	0.0	0.0	7.3	0.4	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1
PIGK	"GPI8, hGPI8"	ENSG00000142892	"Phosphatidylinositol glycan anchor biosynthesis class K"	Q92643	1	77088990-77219430	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056383, HPA057040"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA056383: AB_2683109, HPA057040: AB_2683319"	"unprognostic (2.43e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.12e-3)"	14.5	17.4	13.8	8.0	20.4	10.2	17.1	14.8	22.9	14.2	11.4	17.4	9.6	9.2	14.6	13.8	10.7	13.0	13.6	20.0	15.4	17.7	25.4	19.0	12.3	10.6	17.7	11.7	13.7	14.1	24.9	23.1	11.2	23.8	15.9	12.9	11.2	11.9	12.9	11.9	7.6	11.6	14.5	19.9	14.7	11.6	9.6	17.2	14.6	22.3	8.1	9.8	12.9	9.4	5.2	7.6	7.6	4.4	8.9	12.8	6.3	5.7	6.8	5.6	7.1	32.4	24.4	9.1	11.7	16.1	12.3	17.7	5.6	5.9	5.0	12.1	20.7	14.7	5.2	7.1	10.0	22.5	10.4	7.3	6.8	7.3	5.2	7.2	15.1	6.1	14.7	5.4	13.1	11.4	14.8	18.1	6.3	8.3	17.4	18.9	3.9	4.7	6.1	5.0	6.5	11.3	5.6	16.5	6.4	15.7	4.2	4.8	4.5	11.1	10.1	12.7	9.7	4.8	8.7	10.3	19.9	7.8	10.7	11.9	7.9	11.0	5.1	14.8	19.2	7.8	6.9	4.1	7.6	8.3	4.4	8.4	5.2	8.5	7.0	7.6	4.1	10.7	9.5	2.0	8.9	4.2	5.2	12.8	6.3	13.8	20.4	14.8	22.9	15.4	17.7	17.7	11.7	23.8	17.2	8.9	7.8	11.5	13.1	8.5	13.1	18.9	22.9	20.1	9.1	38.4	2.0	16.1	3.3	18.9	1.5	17.3	6.5	0.0	18.7	28.7	19.2	13.7	17.3	24.6	18.1	7.9	10.4	16.5	14.3	2.2	18.1	11.1	18.6	8.2	11.9	15.7	11.7	7.0	25.8	18.8	7.2	51.8	21.2	56.1	20.2	10.5	12.7	18.1	11.2	10.8
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282051-77559969	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.5"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 137.0;Extravillous trophoblasts: 30.0;Spermatogonia: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 10.9;naive CD4 T-cell: 14.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.9;T-cells: 14.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.3;BJ: 20.7;fHDF/TERT166: 23.6;LHCN-M2: 59.3;U-2 OS: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.8	2.1	43.8	1.9	35.7	3.7	14.1	1.3	95.5	2.0	1.8	20.4	0.0	1.8	1.6	1.5	1.8	1.8	1.7	1.5	35.8	11.8	2.0	1.2	1.4	2.5	13.0	41.1	1.5	2.1	2.4	1.4	1.8	11.4	2.7	1.8	0.0	3.1	2.7	1.3	2.4	1.7	1.7	14.2	2.4	2.9	7.3	13.9	0.0	1.7	0.0	2.1	1.5	0.4	0.8	10.9	0.7	0.7	0.1	14.2	1.9	0.0	1.1	0.9	0.0	11.2	30.3	0.4	20.7	4.4	3.4	1.4	0.1	0.5	0.1	0.1	23.6	1.3	0.1	0.0	0.0	1.7	0.7	0.2	0.1	0.1	0.0	0.5	0.1	0.0	3.7	0.1	0.6	1.3	12.0	9.7	0.1	0.2	0.2	59.3	0.2	0.0	0.1	1.2	5.5	7.5	0.5	2.2	0.3	9.2	0.3	4.6	1.1	0.0	0.0	1.3	0.1	0.1	0.1	2.4	8.2	18.6	0.4	0.6	4.8	4.3	0.0	1.6	1.0	3.0	0.7	0.7	0.0	3.4	0.1	0.5	0.8	3.2	1.6	10.9	0.8	14.2	7.8	0.5	0.1	0.2	1.2	1.4	1.9	43.8	35.7	1.3	47.1	35.8	11.8	13.0	41.1	11.4	13.9	0.0	0.0	0.0	0.5	0.2	0.5	1.2	0.0	0.0	0.0	1.8	0.0	0.9	6.6	0.2	137.0	1.1	0.0	0.0	0.6	30.0	1.2	2.2	0.0	0.0	2.2	12.7	11.5	0.6	0.0	16.1	1.1	0.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	4.5	0.2	0.0	3.1	6.5	72.5	0.3	2.4	1.5	0.0	0.1
AC118549.1		ENSG00000036549	"ZZ-type zinc finger-containing protein 3 "	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	17.8	17.4	20.8	14.1	23.6	11.6	21.6	20.4	20.3	18.1	16.2	16.1	18.3	12.1	18.3	14.3	14.5	15.3	12.1	13.7	16.9	11.7	18.8	20.0	12.3	15.8	24.1	17.8	24.1	14.5	19.0	28.2	13.9	14.4	16.0	13.0	10.5	15.2	16.8	19.0	16.9	12.4	17.0	16.2	11.5	13.5	9.9	23.6	17.9	26.5	8.6	16.0	20.1	14.9	7.9	7.4	5.6	5.1	7.4	10.4	5.0	13.4	6.9	12.7	9.7	11.1	17.7	13.4	17.2	15.9	15.9	17.5	7.7	7.2	17.6	15.5	14.4	18.0	12.4	16.7	11.1	24.1	13.8	13.2	21.8	13.9	9.5	17.1	22.5	6.2	13.5	17.2	17.6	34.4	15.4	16.1	12.2	21.1	13.7	15.4	6.3	11.2	7.0	18.8	7.4	15.7	13.2	21.7	9.0	11.1	14.3	15.9	13.4	10.3	11.8	30.3	9.1	7.1	12.4	13.2	13.8	17.0	22.3	22.1	10.3	14.4	18.7	13.6	19.7	10.5	0.1	4.6	5.6	6.9	5.1	10.4	7.9	8.2	8.1	7.4	7.9	10.2	9.2	0.9	7.4	4.7	5.0	10.4	5.0	20.8	23.6	20.4	20.3	16.9	11.7	24.1	17.8	14.4	23.6	11.9	19.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	12.5	10.4	0.0	11.4	10.0	13.1	0.0	0.0	0.0	0.0	11.1	10.1	0.0	0.0	5.8	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	13.6	0.0	0.0	11.8	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	30.8	27.1	28.1	18.8	32.1	24.6	28.6	55.3	37.5	21.6	20.4	20.6	18.5	20.2	23.3	23.0	17.8	19.2	21.7	17.0	30.7	30.6	26.0	20.3	21.0	20.7	26.0	25.4	25.3	17.0	28.8	23.4	34.6	38.7	24.6	21.0	21.4	19.5	19.8	16.3	19.4	23.8	19.8	21.4	22.3	19.5	19.9	21.6	27.8	25.1	12.9	20.3	21.0	20.0	15.7	12.2	33.2	18.4	12.3	17.8	10.6	16.1	7.4	25.6	17.7	36.9	32.3	22.0	17.7	16.9	21.6	24.3	9.8	14.0	12.1	16.8	17.2	35.5	12.8	18.6	12.1	26.6	11.1	14.5	42.7	18.1	8.5	23.0	14.5	10.8	23.7	9.5	20.9	15.4	20.9	19.2	11.1	16.6	10.6	16.2	6.2	13.1	14.5	24.7	12.6	14.7	12.6	27.0	8.5	20.4	16.6	21.5	16.6	12.4	16.5	24.7	22.8	9.2	15.8	16.1	20.0	14.2	20.1	16.7	8.7	11.0	11.8	15.1	17.2	10.1	33.2	15.4	20.0	15.1	15.0	15.3	13.4	14.7	15.2	11.5	15.7	17.8	15.6	20.9	12.3	18.4	12.2	13.2	10.6	28.1	32.1	55.3	37.5	30.7	30.6	26.0	25.4	38.7	21.6	41.7	36.3	21.6	16.5	15.2	50.9	31.5	20.4	36.1	25.0	33.2	55.0	21.0	8.3	16.9	2.8	26.4	26.8	0.0	13.4	15.9	21.2	23.9	22.0	18.1	16.5	58.8	34.1	28.8	33.6	3.6	33.1	22.3	21.9	19.8	26.0	34.5	15.7	28.6	30.1	19.2	40.3	19.4	17.5	36.1	26.3	14.3	10.0	27.5	22.9	20.0
MIGA1	"FAM73A, FLJ35093"	ENSG00000180488	"Mitoguardin 1"	Q8NAN2	1	77779624-77879539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 27.0;Collecting duct cells: 22.7;Proximal tubular cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017589	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA017589: AB_1848409"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.31e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.75e-2)"	11.7	11.0	12.2	6.9	23.7	8.1	19.2	18.1	25.4	10.5	8.2	20.3	7.2	9.7	12.0	7.5	8.7	9.1	10.3	8.6	15.7	16.1	20.2	11.2	8.3	6.6	19.2	19.7	12.7	8.9	28.0	13.9	10.1	26.4	13.3	8.0	7.6	12.1	9.6	15.7	7.6	10.6	10.1	29.9	7.5	9.8	7.6	18.8	5.9	21.8	5.1	5.9	10.5	8.1	6.2	3.7	7.3	6.8	5.8	6.7	3.2	8.6	5.6	3.5	4.5	8.7	11.4	9.3	12.5	5.9	7.4	7.6	6.2	6.0	3.8	13.9	8.6	8.9	6.0	4.7	7.4	14.1	5.5	4.8	4.4	6.9	2.9	8.9	4.1	3.4	8.1	8.1	15.1	11.0	10.6	7.4	3.4	2.4	5.2	11.2	1.4	3.9	2.3	3.0	4.3	7.0	2.1	8.6	1.9	9.0	9.4	7.1	5.8	5.8	8.8	16.0	6.1	3.3	2.7	11.8	10.6	4.9	16.0	13.1	3.1	4.3	2.4	9.4	3.6	4.6	7.3	5.5	6.6	5.9	6.8	6.2	4.6	4.7	4.7	3.7	6.2	6.7	5.9	3.5	5.8	4.3	3.0	4.3	3.2	12.2	23.7	18.1	25.4	15.7	16.1	19.2	19.7	26.4	18.8	32.8	27.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	19.4	22.7	0.0	13.4	5.0	13.8	0.0	0.0	0.0	0.0	12.6	10.5	0.0	0.0	11.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	4.6	0.0	0.0	15.3	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 110.8;skeletal muscle: 198.5"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2090.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 43.5;LHCN-M2: 40.0;RH-30: 31.7"	"Low region specificity"	"Detected in many"							"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		12000000	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	8.9	4.3	0.4	10.4	0.8	0.0	5.0	0.5	0.4	14.1	17.0	0.2	12.5	1.9	16.6	12.5	24.1	9.9	8.7	110.8	0.4	0.5	4.0	1.2	6.2	3.8	0.6	0.5	8.2	2.0	0.3	0.5	2.6	0.7	13.1	3.2	0.9	4.1	14.8	198.5	1.4	5.5	45.8	0.8	3.9	10.6	4.2	1.2	0.0	5.1	40.1	1.0	29.7	10.3	1.4	1.7	2.9	3.4	0.6	0.6	7.0	7.1	0.4	1.3	0.0	23.5	22.8	3.5	43.5	19.3	8.9	6.0	1.2	0.0	0.0	2.5	15.8	10.1	0.9	0.9	4.1	16.0	0.2	0.9	1.7	2.2	0.4	17.6	0.3	0.0	17.0	0.9	12.3	6.9	19.0	6.7	1.7	0.0	0.0	40.0	0.0	8.1	0.5	6.9	0.0	5.3	6.8	31.7	0.0	10.4	0.3	0.0	0.3	3.8	0.0	0.2	9.1	0.0	0.9	6.8	21.3	15.6	9.0	21.6	0.0	0.0	0.0	1.2	0.8	0.0	0.0	3.4	0.0	0.4	2.0	0.1	1.4	0.3	0.4	1.7	1.1	0.6	0.2	2.9	0.6	1.4	1.2	0.0	7.0	0.4	0.8	0.5	0.4	0.4	0.5	0.6	0.5	0.7	1.2	98.3	8.2	0.0	0.8	1.5	2.8	2090.8	0.0	0.0	9.1	0.0	3.9	0.3	1.7	15.9	15.1	11.3	0.9	0.0	27.4	2.8	19.0	0.9	1.1	0.8	1.1	1.6	0.0	53.4	2.6	5.4	67.9	5.3	0.0	0.0	0.0	0.2	23.5	0.0	325.3	0.5	2.6	213.4	98.6	0.7	2.1	0.6	0.2	2.2	0.3	0.2
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm		NA	NA		200000	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	23.9	35.5	21.8	42.4	26.9	56.8	27.0	34.0	31.8	24.3	19.6	18.1	23.0	21.8	29.4	35.0	23.5	25.2	18.4	27.5	22.0	22.3	26.6	16.3	27.2	37.6	17.5	28.8	44.4	31.6	36.0	41.5	27.3	26.3	22.4	28.3	22.0	28.2	35.6	27.4	21.3	24.0	22.7	31.3	28.6	22.6	17.6	19.9	64.9	35.0	26.2	40.3	24.0	29.1	16.1	11.3	10.8	16.1	23.5	22.2	12.8	22.3	19.7	46.6	18.5	7.2	9.1	38.2	23.1	13.8	22.2	16.2	19.9	25.0	40.0	10.8	17.1	26.3	22.3	31.2	25.4	29.7	44.0	15.9	25.6	32.7	29.2	15.7	43.8	10.8	11.9	21.0	23.7	18.9	18.2	17.7	27.0	29.3	17.8	17.5	22.5	34.7	21.2	36.4	22.0	14.1	42.7	36.9	15.3	23.0	22.0	24.6	23.2	21.5	20.4	18.2	26.0	24.8	15.9	22.7	21.5	31.3	6.1	27.6	17.1	18.4	51.9	9.3	19.3	21.9	3.8	9.6	10.8	18.7	15.7	22.2	16.1	18.3	19.4	8.7	13.1	17.9	20.9	4.0	23.5	16.1	11.3	21.3	12.8	21.8	26.9	34.0	31.8	22.0	22.3	17.5	28.8	26.3	19.9	68.5	47.3	43.1	67.8	75.3	41.1	65.5	30.6	96.4	89.9	31.4	39.3	42.2	36.5	50.0	27.8	42.8	20.6	0.0	62.7	54.9	40.0	39.3	75.2	20.7	29.1	17.5	52.9	33.7	27.2	15.1	44.5	34.8	37.1	55.9	32.7	36.4	54.2	30.6	28.3	19.7	37.0	32.3	42.4	33.8	40.6	55.2	29.9	54.8	35.4	54.0
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 89.8"	"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.6;HUVEC TERT2: 43.5;LHCN-M2: 73.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	23.3	39.0	19.2	8.4	20.7	4.9	16.6	22.7	24.1	21.3	12.7	7.2	9.3	5.4	20.8	10.1	25.0	11.7	25.2	42.0	18.0	16.8	16.0	15.5	21.7	7.0	25.7	9.1	15.3	18.5	16.4	19.1	19.5	23.8	19.4	9.4	5.1	7.0	12.2	33.3	7.6	8.8	23.0	29.5	30.3	11.9	7.8	22.5	2.8	35.1	29.4	5.1	22.1	89.8	3.6	5.0	4.5	1.9	3.1	7.2	2.6	1.4	2.8	3.5	2.1	15.3	28.6	1.6	27.8	7.1	12.4	14.0	0.9	1.8	2.1	4.7	13.2	5.1	2.1	4.5	2.4	21.2	2.3	1.2	1.0	8.3	6.7	20.8	0.5	0.5	11.8	6.7	16.0	4.6	6.9	43.5	0.7	4.5	1.5	73.8	0.1	0.6	1.5	2.2	0.4	1.3	1.1	6.2	1.3	2.9	0.7	2.5	0.8	3.2	2.3	2.6	3.8	0.9	0.9	20.7	17.5	4.3	12.4	3.6	1.3	0.4	1.8	2.3	1.2	3.0	4.5	1.7	2.7	2.6	1.7	4.4	3.6	3.2	3.1	1.7	3.0	7.2	5.1	0.4	3.1	1.9	5.0	4.2	2.6	19.2	20.7	22.7	24.1	18.0	16.8	25.7	9.1	23.8	22.5	56.6	4.6	13.3	77.1	37.1	28.0	82.6	10.2	30.8	20.5	17.4	64.8	46.9	31.5	10.5	126.4	66.1	19.8	23.3	12.8	18.9	83.6	23.4	57.5	18.1	15.9	28.6	20.5	33.2	21.3	48.4	22.7	19.0	62.4	6.4	4.0	35.7	14.8	17.5	32.9	22.8	56.8	25.8	119.1	21.1	13.2	34.4	151.4	15.2	6.5	27.1
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 48.7;Proximal tubular cells: 149.4;Undifferentiated cells: 50.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.9;naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;HaCaT: 4.9;Hep G2: 18.3;HUVEC TERT2: 19.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	6.4	17.0	0.8	3.2	0.9	0.0	4.0	0.4	1.0	2.6	27.0	0.3	0.2	19.6	5.4	4.5	5.7	1.4	8.1	3.1	0.5	0.5	21.3	10.4	3.2	2.2	0.5	0.3	3.7	24.7	3.3	2.5	1.6	1.3	2.1	7.8	1.5	6.9	1.0	1.8	2.7	64.0	1.4	0.6	22.7	3.0	2.2	0.4	0.1	1.5	4.9	1.4	2.5	5.1	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	5.2	0.0	0.8	0.0	0.4	0.9	4.1	2.7	1.2	0.0	0.4	0.0	4.9	0.0	0.0	2.7	0.1	0.0	0.6	0.0	18.3	1.0	0.0	0.0	0.8	0.0	2.9	0.1	0.0	19.3	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	1.0	0.6	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	0.5	0.5	0.5	0.3	1.3	0.4	0.0	2.2	1.3	2.0	11.4	0.4	2.6	25.5	12.0	3.4	8.7	2.0	5.2	28.2	9.6	1.7	13.7	48.7	0.0	29.0	1.9	1.6	0.5	0.0	39.9	10.0	0.0	2.9	11.1	0.6	0.5	1.1	0.2	0.0	1.8	34.6	0.0	18.0	31.7	0.0	149.4	0.5	0.0	1.3	0.5	0.2	19.1	1.4	0.5	50.7	5.6
PTGFR	FP	ENSG00000122420	"Prostaglandin F receptor"	P43088	1	78303884-78539749	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 10.1;Club cells: 23.9;Fibroblasts: 9.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 10.1"	"Cell type enriched"	"Detected in single"	13	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 79.7;HSkMC: 24.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.89e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.61e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.46e-4)"	"unprognostic (2.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.21e-4)"	"unprognostic (8.48e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.21e-3)"	13.0	4.1	1.1	5.2	1.8	0.0	8.7	0.3	1.0	8.3	3.8	0.3	2.1	0.9	27.2	7.0	6.1	5.3	8.8	7.7	10.1	3.3	5.6	3.6	2.3	1.1	0.5	0.3	14.5	1.5	0.0	0.5	7.7	0.6	12.9	2.7	1.8	6.5	2.1	6.9	7.3	3.0	21.3	0.7	0.8	2.7	4.0	0.0	0.0	2.1	13.4	4.3	20.3	15.9	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	7.6	79.7	0.0	5.7	5.5	2.0	0.7	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	24.9	0.0	0.5	5.0	5.2	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.4	1.4	0.6	0.4	0.3	0.0	0.0	0.1	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	1.8	0.3	1.0	10.1	3.3	0.5	0.3	0.6	0.0	0.0	10.1	0.0	0.0	5.7	0.8	0.4	5.1	6.7	23.9	8.7	0.0	0.0	3.3	3.3	5.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	5.1	5.2	0.2	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	1.0	0.6	0.0	4.1	0.2	0.0	0.0	0.0
IFI44L	"C1orf29, GS3686"	ENSG00000137959	"Interferon induced protein 44 like"	Q53G44	1	78619922-78646145	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 70.0;Peritubular cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 25.6;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;GAMG: 9.2;HSkMC: 14.9;SK-MEL-30: 11.7"					"Low region specificity"	"Detected in all"			"HPA053247, HPA060372"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053247: AB_2682088, HPA060372: AB_2684267"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (2.95e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.03e-2)"	33.6	5.3	9.4	6.2	10.6	36.2	7.6	3.3	10.4	3.8	4.0	12.3	2.7	3.5	10.6	19.7	3.8	4.9	15.0	7.4	9.2	11.0	15.7	4.9	9.5	5.1	10.6	9.4	6.6	2.2	1.9	5.6	8.6	21.6	5.4	3.1	14.4	26.3	5.2	3.5	2.7	3.8	7.0	17.2	23.1	3.7	5.0	12.2	21.6	10.0	4.9	5.2	10.4	3.2	3.6	2.2	2.3	5.6	4.4	2.2	1.5	0.0	0.0	1.0	0.0	0.5	6.9	0.0	0.2	5.3	25.6	27.8	0.0	0.3	5.7	3.1	0.1	9.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.6	0.1	0.1	14.9	0.1	1.9	0.3	4.8	0.2	0.0	0.0	0.8	0.5	0.0	0.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	1.3	0.1	0.0	0.0	6.9	0.0	11.7	0.0	0.0	0.1	0.2	0.2	0.4	0.5	0.7	1.2	0.2	0.0	4.2	0.0	0.0	0.1	5.0	0.3	0.5	5.6	1.6	3.6	2.2	1.7	1.6	1.6	0.8	0.8	2.3	4.4	2.1	2.2	0.5	1.5	9.4	10.6	3.3	10.4	9.2	11.0	10.6	9.4	21.6	12.2	0.0	9.0	7.2	2.5	3.5	0.0	1.7	2.5	17.4	9.1	7.0	0.0	0.1	0.0	4.0	0.6	70.0	0.0	0.0	7.5	0.1	6.1	1.5	2.3	0.0	22.8	0.0	0.0	22.1	13.0	1.8	21.9	14.1	3.3	2.8	0.0	1.2	1.6	0.0	45.3	0.6	0.2	6.5	4.2	0.3	0.0	1.8	0.2	6.2	0.0	3.1
IFI44	"MTAP44, p44, TLDC5"	ENSG00000137965	"Interferon induced protein 44"	Q8TCB0	1	78649796-78664078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 36.8;Ito cells: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 46.1;BJ hTERT+ SV40 Large T+ RasG12V: 57.0;GAMG: 46.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA027148, HPA043858"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027148: AB_1851411, HPA043858: AB_2678702"	"unprognostic (1.20e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.90e-2)"	35.2	12.6	10.2	16.2	11.7	47.8	13.0	4.3	8.2	10.0	8.1	6.6	10.5	10.5	13.6	29.9	15.2	8.3	24.9	10.7	10.8	9.8	26.9	11.2	18.6	16.5	11.9	10.5	10.9	5.2	3.0	19.6	11.4	10.5	11.0	5.3	11.3	35.4	13.2	7.5	5.5	8.8	10.2	15.1	32.3	11.2	4.8	11.0	22.3	13.8	11.3	8.1	13.6	8.0	2.2	5.9	3.7	13.0	6.1	12.4	5.5	1.9	0.0	0.3	0.0	1.4	9.6	0.0	1.2	16.8	46.1	57.0	0.0	5.6	2.6	13.1	1.2	46.6	1.0	0.0	0.7	7.5	5.6	0.0	6.7	4.9	0.0	1.9	0.0	0.0	6.0	0.0	19.9	0.2	3.6	8.6	1.7	0.0	9.0	10.9	0.0	5.5	0.4	0.0	0.0	3.7	4.3	13.9	0.3	1.3	1.2	0.1	0.3	0.4	0.1	19.7	0.0	0.0	0.2	10.5	8.5	3.6	0.9	8.4	0.7	0.9	0.0	13.1	7.6	2.3	0.3	13.0	0.1	6.2	12.3	12.4	2.2	9.1	5.9	5.9	1.6	3.9	5.0	3.7	6.1	6.3	1.7	4.3	5.5	10.2	11.7	4.3	8.2	10.8	9.8	11.9	10.5	10.5	11.0	26.8	23.9	0.5	8.9	3.2	0.0	4.5	5.1	21.4	15.9	8.7	0.0	0.2	0.0	9.9	0.4	36.8	0.8	0.0	10.8	0.2	9.8	3.6	17.4	2.4	27.7	0.0	6.4	48.5	34.5	0.5	12.4	26.5	5.0	4.6	1.5	0.8	8.5	0.0	16.3	2.1	0.2	19.4	9.5	0.0	0.4	4.0	0.0	12.5	1.5	11.7
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79006718	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.9"	"Group enriched"	"Detected in some"	7	"Endothelial cells: 232.9;Ito cells: 348.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 19.6;HUVEC TERT2: 64.3;RPTEC TERT1: 14.0;TIME: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		1800000			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	98.9	4.7	3.6	5.6	5.7	0.0	43.8	3.2	6.1	14.6	7.8	1.5	6.6	2.8	12.9	7.1	12.4	6.8	12.3	12.3	4.3	3.7	11.3	8.8	16.2	8.5	5.4	1.4	9.3	3.0	5.7	7.8	12.8	6.2	12.2	3.6	5.9	4.8	5.7	16.1	5.3	4.8	16.0	4.7	34.8	4.9	6.8	4.3	1.1	13.9	8.0	3.9	16.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.6	5.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	3.8	0.0	11.1	0.0	19.6	64.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	78.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.7	3.2	6.1	4.3	3.7	5.4	1.4	6.2	4.3	0.0	8.9	2.2	0.3	0.0	0.0	4.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	232.9	0.0	0.0	0.2	0.0	0.3	1.1	0.0	2.0	0.5	1.6	0.0	348.0	29.4	42.9	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	1.2	1.4	1.1	0.0	0.0	0.0	0.0	0.6
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306160-81992436	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 51.9;Cardiomyocytes: 43.9;Hepatocytes: 33.8;Horizontal cells: 31.8;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 63.8;hTEC/SVTERT24-B: 31.7;NTERA-2: 26.8;SH-SY5Y: 42.7;U-2197: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane,Cell Junctions"		NA	NA		280000	"Plasma membrane, Cell Junctions"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	8.9	10.5	21.1	3.6	20.9	0.0	8.8	1.5	45.8	7.5	7.0	1.4	1.2	2.7	6.1	8.6	12.0	12.0	11.5	17.6	12.2	6.6	10.9	18.7	32.7	3.5	3.5	22.8	18.8	4.9	20.3	11.8	24.4	6.2	15.6	5.4	9.4	19.1	10.1	2.0	6.3	6.1	6.0	3.2	10.0	7.6	2.0	3.3	0.6	22.4	15.0	5.0	6.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.4	63.8	0.0	7.9	9.1	0.8	1.5	3.5	0.6	0.7	0.0	0.0	0.0	17.5	8.1	1.8	2.5	5.0	6.7	0.5	0.1	10.4	0.0	1.8	4.4	3.0	0.0	0.1	7.7	0.4	31.7	3.2	4.4	10.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	26.8	0.0	1.9	0.0	8.8	0.0	14.5	0.9	3.2	42.7	0.0	1.8	0.0	18.9	0.1	18.8	6.8	6.5	7.4	29.2	2.2	0.0	0.0	0.0	3.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	20.9	1.5	45.8	12.2	6.6	3.5	22.8	6.2	3.3	3.0	2.1	0.0	6.5	0.0	51.9	43.9	10.2	0.0	5.7	5.2	5.9	0.3	0.0	3.7	1.0	27.2	0.0	0.0	1.5	0.2	9.1	8.9	0.0	33.8	0.7	31.8	0.0	40.5	6.0	1.3	21.6	0.9	0.0	0.0	1.1	20.6	1.0	0.0	16.6	7.0	2.4	19.4	3.7	0.5	3.0	0.0	0.3	0.0	0.7	2.4
TTLL7	FLJ23033	ENSG00000137941	"Tubulin tyrosine ligase like 7"	Q6ZT98	1	83865028-83999150	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.8"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 124.4;Early spermatids: 135.0;Rod photoreceptor cells: 112.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"basophil: 3.3"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.7;RH-30: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052249	Uncertain					NA	NA					"HPA052249: AB_2681773"	"unprognostic (9.68e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.93e-4)"	"unprognostic (4.34e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.04e-3)"	7.4	3.7	20.6	3.1	33.6	1.4	2.8	12.4	47.8	4.1	4.3	24.7	0.7	3.9	7.0	3.6	6.4	8.0	7.6	5.2	19.4	11.7	2.5	3.1	6.0	1.5	33.1	17.2	2.7	4.9	7.8	11.3	1.4	24.2	10.2	4.9	2.8	5.1	5.8	4.0	1.7	3.9	12.9	24.9	2.0	4.9	8.7	41.3	0.0	3.8	0.5	1.6	6.9	3.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	2.4	0.1	1.9	3.4	1.7	3.9	0.0	5.3	2.1	1.9	3.6	0.0	0.4	0.0	1.6	4.9	7.8	0.0	3.7	1.9	2.9	20.7	2.7	3.0	3.9	0.1	0.9	0.1	0.4	1.2	0.1	3.0	0.1	5.7	2.1	0.1	0.0	7.8	7.8	0.0	0.0	0.0	1.5	0.0	2.6	0.0	16.8	0.0	0.3	1.3	10.7	6.8	2.8	1.6	1.7	3.7	2.3	0.1	0.2	2.9	1.2	0.4	5.6	2.7	4.7	0.1	4.0	0.0	4.2	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	33.6	12.4	26.8	19.4	11.7	33.1	17.2	24.2	41.3	62.5	9.8	1.9	17.3	2.9	124.4	15.1	15.3	37.5	12.5	7.0	68.7	0.5	1.7	14.6	135.0	5.5	0.7	0.0	6.4	0.2	6.5	31.5	24.3	2.6	0.5	90.6	26.5	4.9	0.0	21.5	10.0	2.5	16.9	0.0	3.0	17.1	6.9	3.5	79.5	5.8	112.3	19.4	54.6	75.3	33.1	1.8	0.6	1.9	0.8	22.5
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1500000	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	7.0	21.5	40.0	10.5	57.0	6.2	8.0	54.7	85.5	9.4	23.6	16.9	3.9	4.8	8.7	17.6	8.1	5.2	11.5	10.1	43.1	52.1	10.6	9.0	6.9	16.2	38.3	33.5	8.3	11.9	12.2	18.3	5.1	35.5	13.8	22.6	4.9	32.9	12.7	3.2	2.6	6.3	12.6	47.7	14.6	14.2	3.6	25.9	25.5	11.1	1.8	15.3	13.5	4.6	13.5	7.1	17.1	5.4	25.9	27.6	22.0	3.1	6.3	10.1	12.1	11.7	10.3	4.7	15.6	11.9	8.0	7.5	0.1	2.8	16.6	10.8	12.2	14.6	2.2	4.7	5.1	8.5	16.1	2.6	36.5	8.6	1.2	11.5	14.4	0.8	6.1	2.3	7.7	4.3	11.6	36.6	6.2	1.1	9.6	12.9	0.6	18.7	7.6	9.9	0.0	4.4	14.5	15.7	10.0	19.4	11.2	3.3	12.9	8.6	3.3	9.5	7.9	3.0	3.0	32.4	11.1	8.6	11.2	11.8	7.1	8.5	16.7	5.3	15.4	13.8	17.1	2.7	5.8	23.3	3.6	18.7	13.5	17.3	20.6	7.1	10.2	26.4	27.6	1.5	25.9	5.4	4.1	15.9	22.0	40.0	57.0	54.7	58.2	43.1	52.1	38.3	33.5	35.5	25.9	0.0	1.0	20.3	6.7	4.5	44.0	38.9	15.3	4.0	5.7	14.0	33.4	1.4	28.2	6.9	2.4	8.4	61.7	0.0	10.3	1.0	11.0	15.2	57.7	14.8	23.2	44.5	20.8	26.4	52.7	2.6	13.8	32.7	15.1	1.0	61.1	36.9	13.3	28.8	20.5	15.6	30.0	12.9	13.7	5.9	6.9	2.5	0.6	69.2	52.4	6.5
SAMD13		ENSG00000203943	"Sterile alpha motif domain containing 13"	Q5VXD3	1	84298366-84389957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell type enhanced"	"Detected in many"	10	"Mucus-secreting cells: 19.6;Paneth cells: 35.1;Spermatocytes: 20.4;Undifferentiated cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 11.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058929	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA058929: AB_2683855"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.55e-2)"	"prognostic favorable (1.14e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.98e-7)"	"unprognostic (3.99e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.56e-3)"	1.2	5.2	4.9	1.0	12.9	2.1	2.0	9.1	5.8	1.5	16.6	7.4	0.6	2.6	1.8	4.5	1.1	3.7	1.4	1.7	4.8	2.3	1.7	0.4	0.7	0.8	7.9	6.5	0.5	2.3	1.0	2.3	0.5	4.5	3.4	19.4	0.4	13.6	1.9	7.6	1.2	3.0	2.1	5.1	1.5	5.6	12.4	8.5	3.5	8.6	2.0	0.4	2.7	0.7	0.6	1.4	11.2	0.8	0.7	0.5	0.3	0.7	2.5	1.2	4.0	4.3	4.3	2.7	0.3	0.3	0.3	0.3	0.2	4.0	4.2	7.5	0.2	0.8	0.8	0.4	1.3	0.6	2.2	2.1	1.5	1.8	0.3	1.1	4.8	0.1	1.5	1.9	0.1	1.2	3.0	10.1	9.5	0.6	1.2	1.2	1.2	6.2	0.6	4.0	3.2	2.6	0.7	3.1	1.6	7.9	2.7	1.6	6.2	0.1	0.2	9.2	1.7	1.2	4.5	1.6	1.4	0.4	0.4	1.1	3.2	0.6	7.2	0.5	4.3	1.2	11.2	0.4	0.0	0.1	0.8	0.3	0.2	0.1	0.1	0.9	0.6	0.5	0.5	0.2	0.7	0.3	1.4	0.0	0.3	4.9	12.9	9.1	5.8	4.8	2.3	7.9	6.5	4.5	8.5	0.0	1.1	0.0	0.6	0.3	1.0	1.2	5.1	1.4	1.2	1.8	0.0	3.4	5.0	1.3	3.9	1.3	6.2	0.0	0.6	0.6	2.0	2.8	5.7	0.0	1.4	0.0	10.9	1.8	1.6	3.1	1.7	0.9	8.5	0.0	19.6	2.6	0.9	35.1	2.5	2.2	0.0	0.0	0.1	20.4	2.0	0.3	0.7	0.0	16.6	1.3
DNASE2B	DLAD	ENSG00000137976	"Deoxyribonuclease 2 beta"	Q8WZ79	1	84398532-84415018	"Enzymes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"salivary gland: 98.7"	"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 1.4;Early spermatids: 1.6;Glandular cells: 2.3;Hofbauer cells: 5.7;Late spermatids: 2.4;Paneth cells: 1.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.6;U-266/70: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (2.24e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.62e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	16.2	0.1	0.2	0.1	2.2	0.1	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.6	0.1	0.2	13.0	1.2	0.3	0.0	0.3	0.4	0.0	0.4	0.1	0.2	2.9	0.3	0.0	98.7	0.1	1.8	0.0	0.1	0.1	1.7	0.5	0.6	0.3	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.6	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.3	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	5.7	0.0	1.2	0.0	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84497790	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	20.9	20.4	21.3	25.1	36.2	42.7	26.3	14.8	24.7	21.3	24.8	12.8	18.8	18.8	25.5	27.4	26.0	20.8	18.2	39.8	17.9	16.5	33.1	33.8	21.3	27.2	16.7	15.1	23.9	21.3	16.8	25.7	19.8	16.0	23.7	24.0	14.1	20.8	26.2	56.8	22.1	22.7	20.8	16.6	33.9	22.8	31.0	20.3	31.8	29.3	27.9	30.2	30.0	23.1	36.9	23.1	29.2	26.0	31.8	33.9	26.1	18.9	13.4	17.0	14.1	13.3	17.7	19.2	19.6	17.3	25.6	22.8	10.1	8.2	14.6	22.1	15.4	42.0	14.4	25.4	20.1	28.3	21.0	26.7	36.8	15.1	17.4	18.4	35.3	12.1	14.0	30.0	26.7	19.0	14.6	20.4	27.7	35.5	18.8	22.3	9.9	33.2	23.8	42.3	19.5	29.9	21.4	27.2	11.8	24.3	22.3	21.4	19.9	11.4	24.4	46.7	16.3	13.8	24.2	14.0	19.3	19.2	30.4	40.4	13.0	15.3	32.3	9.0	31.9	17.2	29.2	21.3	19.6	26.6	24.6	29.3	36.9	30.4	26.9	22.5	31.0	33.8	33.9	8.9	31.8	26.0	23.1	31.3	26.1	21.3	36.2	14.8	24.7	17.9	16.5	16.7	15.1	16.0	20.3	35.7	39.9	29.5	37.1	30.8	16.6	33.9	28.1	56.2	31.8	15.7	15.7	30.8	63.0	50.8	38.7	32.2	14.2	0.0	55.7	26.7	25.8	24.7	62.5	32.6	39.0	7.9	32.1	25.2	28.4	6.4	30.2	41.3	27.0	25.2	25.0	24.4	43.8	28.1	32.9	47.6	20.8	45.3	26.9	66.1	60.2	28.5	23.0	49.8	33.6	38.2
GNG5		ENSG00000174021	"G protein subunit gamma 5"	P63218	1	84498325-84506565	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032623, HPA043651"	Approved					NA	NA		1400000			"CAB032623: AB_2109919, HPA043651: AB_2678600"	"unprognostic (1.82e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.75e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.59e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (4.22e-2)"	37.8	24.8	17.0	32.2	19.6	50.3	55.4	5.1	13.3	29.7	46.5	14.2	28.3	36.0	28.0	33.6	41.8	25.6	38.3	78.2	14.4	11.6	55.1	72.3	45.9	53.3	22.6	11.5	28.9	52.1	9.0	20.6	44.7	18.6	27.5	34.3	20.9	52.6	32.2	90.8	25.7	63.6	28.4	18.5	51.5	35.6	40.7	17.5	50.5	58.7	51.6	40.2	35.4	37.3	37.5	61.5	118.4	80.8	27.1	34.9	46.9	40.2	16.7	46.3	38.8	30.9	34.9	54.5	39.3	26.9	47.9	50.7	21.6	25.1	25.5	37.4	37.5	72.9	21.2	26.0	37.2	41.5	32.6	41.1	52.5	18.1	43.4	52.2	36.2	20.1	31.5	46.6	47.3	29.5	28.5	50.8	30.0	48.5	40.0	45.6	11.0	52.3	80.0	59.1	28.9	52.2	33.7	56.0	29.9	62.0	20.7	13.7	44.2	28.6	38.2	74.7	37.9	27.3	48.0	39.0	37.4	44.3	54.5	49.6	44.0	30.0	38.3	21.8	48.1	34.4	54.3	61.0	54.0	27.5	73.7	21.9	37.5	29.5	26.9	57.1	30.0	24.0	25.8	118.4	27.1	80.8	61.5	34.9	46.9	17.0	19.6	5.1	13.3	14.4	11.6	22.6	11.5	18.6	17.5	247.1	181.0	147.5	257.8	247.5	2.2	1004.3	298.1	239.6	207.0	263.5	5.9	342.3	606.8	360.3	657.2	281.7	490.0	116.8	425.1	404.5	244.1	387.6	169.9	348.4	532.4	17.5	201.6	238.1	320.0	60.9	167.7	396.4	236.2	663.7	332.1	261.0	480.0	401.2	183.9	470.3	12.7	129.4	168.8	164.4	122.6	228.2	260.6	155.3	372.2	420.6
SPATA1	SP-2	ENSG00000122432	"Spermatogenesis associated 1"		1	84506300-84566194	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.6;testis: 6.9"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.7;Cardiomyocytes: 2.9;Club cells: 4.5;Collecting duct cells: 5.2;monocytes: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.8;REH: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.00e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-2)"	"unprognostic (8.84e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.77e-3)"	"unprognostic (5.52e-4)"	"unprognostic (2.03e-1)"	"unprognostic (5.81e-8)"	"unprognostic (1.63e-1)"	"unprognostic (5.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.79e-4)"	0.0	0.0	0.7	4.6	3.5	0.9	0.1	0.0	0.6	1.2	0.0	0.7	0.0	0.0	0.6	0.9	0.0	0.1	0.0	0.5	0.0		2.0	0.9	1.9	0.3	0.0	0.9	0.8	0.8	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.2	6.9	0.0	0.9	0.8	0.0	0.8	0.5	0.0	0.7	0.3	2.6	0.3	0.0	0.4	0.1	0.3	0.0	0.6	0.6	0.3	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.0	0.9	0.1	1.3	0.2	1.2	0.1	0.3	0.4	0.4	0.2	0.3	0.4	1.8	0.7	0.2	0.1	1.0	0.3	0.1	0.6	2.3	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.8	0.6	0.5	0.1	0.5	1.2	1.0	0.0	0.6	0.3	0.0	0.0	0.0	0.4	1.1	0.1	0.6	0.3	0.0	0.1	0.3	0.0	0.7	0.1	0.0	0.1	0.5	0.1	0.1	2.6	0.0	0.0	0.3	0.4	0.1											6.0	3.7	2.2	0.0	0.0	0.0	2.9	0.0	1.4	4.5	5.2	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.8	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTBS	CTB	ENSG00000117151	Chitobiase	Q01459	1	84549606-84574480	"Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"basal ganglia: 7.6"	"CAB017043, HPA023594, HPA048810"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		380000000	Cytosol		"CAB017043: , HPA023594: AB_1847311, HPA048810: "	"unprognostic (7.76e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-2)"	6.4	6.9	4.0	8.8	4.4	9.7	15.3	4.4	3.5	5.3	5.8	3.3	8.1	3.7	6.2	16.4	4.8	5.2	8.0	13.1	4.5	4.4	10.4	22.3	15.6	28.1	5.8	2.3	5.1	15.0	6.5	10.4	6.9	8.1	8.1	5.1	4.7	18.5	12.5	4.3	8.4	7.2	6.7	10.0	12.6	6.1	3.5	4.4	5.5	5.9	4.9	5.1	5.5	5.2	0.8	0.4	3.2	1.6	0.7	0.6	0.2	1.8	0.6	0.4	0.4	5.6	6.7	1.4	1.3	4.5	0.6	1.7	0.2	2.2	2.4	0.5	2.8	0.7	0.8	0.1	1.7	1.9	2.2	0.6	1.5	0.3	0.3	3.4	1.6	0.8	4.9	3.3	1.6	2.5	4.0	1.9	1.0	1.4	4.4	1.3	0.1	1.0	1.8	0.4	0.4	0.6	0.5	0.7	1.6	4.0	0.9	0.3	0.8	0.5	1.8	2.1	1.1	1.0	1.7	2.9	2.3	0.2	3.1	1.4	1.3	0.4	0.7	1.6	2.2	1.6	1.8	0.8	1.5	0.2	0.9	0.4	0.5	0.4	0.3	0.4	0.8	0.3	0.6	3.2	0.7	1.6	0.4	0.4	0.2	4.0	4.4	4.4	3.5	4.5	4.4	5.8	2.3	8.1	4.4	8.9	16.0	29.6	25.9	27.0	5.8	5.1	30.6	26.8	20.5	22.7	39.3	20.5	36.5	15.7	2.6	28.2	17.1	0.0	16.9	19.2	19.6	41.9	43.8	58.7	42.5	3.2	22.2	45.4	70.4	3.0	19.5	43.1	6.8	23.4	21.5	19.9	17.2	21.0	23.0	38.3	40.1	12.9	14.4	7.5	9.8	21.7	21.4	17.5	16.9	25.3
SSX2IP	hMsd1	ENSG00000117155	"SSX family member 2 interacting protein"	Q9Y2D8	1	84643707-84690803	"Predicted intracellular proteins"	"Cell adhesion, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.4"	"Cell type enhanced"	"Detected in many"	16	"Cone photoreceptor cells: 245.4;Early spermatids: 718.3;Late spermatids: 850.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075946	Supported		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA075946: "	"unprognostic (5.18e-3)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.45e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.46e-2)"	1.8	2.0	10.6	2.8	25.2	6.5	2.7	17.7	25.7	3.9	7.9	1.6	3.0	22.2	5.1	12.4	3.8	3.8	4.6	4.9	9.8	5.0	9.0	7.5	2.2	3.1	3.8	12.4	1.6	3.7	5.6	10.2	3.2	6.9	7.0	4.2	5.2	3.8	6.6	3.1	3.3	13.3	5.6	3.1	2.7	3.7	51.4	5.1	4.8	4.4	1.7	3.2	3.1	3.0	1.5	5.8	4.8	3.2	5.4	11.0	5.0	16.2	8.1	6.5	11.9	2.2	7.0	8.0	27.9	14.3	12.3	10.0	5.7	3.6	16.1	4.9	23.5	15.9	9.1	11.5	9.0	17.4	3.2	9.7	15.2	9.8	4.9	4.6	13.2	1.2	3.0	14.8	13.9	8.8	8.3	4.1	6.2	31.3	6.1	7.8	6.2	9.2	5.2	9.6	3.1	12.7	6.2	28.6	7.1	12.9	9.4	12.8	16.0	7.8	12.8	14.0	4.3	7.4	6.9	1.2	11.8	17.3	16.0	27.5	6.4	7.5	17.6	9.8	11.9	7.2	1.1	1.1	4.8	11.0	2.4	6.2	1.4	3.7	4.5	4.4	1.5	4.6	6.9	1.5	5.4	3.2	5.8	2.0	5.0	10.6	25.2	17.7	25.7	9.8	5.0	3.8	12.4	6.9	5.1	3.0	4.0	3.7	6.9	9.3	28.4	19.4	17.8	17.4	10.3	10.4	245.4	3.2	6.6	5.7	718.3	3.6	10.2	46.7	10.4	1.7	6.6	5.7	4.6	12.5	2.3	19.1	8.1	3.7	1.3	850.2	14.7	4.7	5.0	2.8	7.3	174.8	7.0	3.5	10.6	33.8	147.0	0.0	4.1	42.7	52.8	8.5	0.5	5.3	7.4	2.5
LPAR3	"Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3"	ENSG00000171517	"Lysophosphatidic acid receptor 3"	Q9UBY5	1	84811602-84893213	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 32.0"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 13.1;Cardiomyocytes: 24.9;Ciliated cells: 25.4;Glandular cells: 15.0;Urothelial cells: 10.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 24.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 13.3;HBEC3-KT: 16.3;hTCEpi: 17.6;NTERA-2: 14.8;PC-3: 16.6;SK-MEL-30: 15.6"	"Region enhanced"	"Detected in some"		"olfactory region: 3.5"	"Low region specificity"	"Detected in some"			HPA013421			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA013421: AB_1847990"	"unprognostic (2.85e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.31e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.13e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	0.0	1.2	2.4	0.5	1.9	0.3	0.7	0.2	3.5	8.8	0.4	2.2	2.9	0.1	2.4	11.8	7.2	32.0	0.5	12.4	3.7	0.9	0.0	0.1	4.2	0.1	0.1	2.6	5.1	8.6	0.3	0.4	1.1	6.8	11.5	0.5	0.7	5.0	4.7	0.3	4.0	0.5	0.5	0.3	0.1	0.2	14.7	0.2	0.7	0.2	3.3	4.3	4.8	6.9	0.6	0.4	1.1	0.1	1.8	0.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.2	1.2	1.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	13.3	16.3	1.0	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.1	17.6	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	16.6	0.0	0.0	0.0	0.0	3.8	0.9	0.7	0.0	0.3	15.6	1.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.2	0.3	0.0	0.2	0.4	0.5	0.5	0.3	0.6	0.4	0.3	1.1	1.8	0.1	0.4	0.1	0.1	2.4	1.9	0.2	3.5	3.7	0.9	0.1	2.6	6.8	0.2	0.0	0.3	0.0	13.1	3.1	0.0	24.9	0.0	25.4	7.9	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	15.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.6	0.6	1.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	4.4	8.0	0.1	0.0	0.0	10.8
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			HPA019114	Uncertain					NA	NA					"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	3.0	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	14.1	0.4	0.0	1.8	0.1	10.1	1.2	1.1	16.8	7.5	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.1	3.7	0.0	0.3	0.2	0.4	0.2	0.1	1.1	0.0	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.2	0.2	1.8	20.1	0.1	1.0	1.6	0.1	2.6	0.1	0.0	12.5	0.9	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4	0.0	1.1	9.8	0.5	3.9	0.0	0.5	0.0	2.7	2.3	1.8	0.0	0.1	0.0	0.0	34.6	0.1	6.0	0.0	1.2	0.1	2.1	0.7	0.0	0.0	0.7	0.0	2.4	1.3	0.6	14.2	0.0	15.1	8.5	53.3	4.1	0.0	0.4	5.8	0.0	0.3	0.0	0.0	0.1	0.2	3.7	2.9	0.2	8.2	2.3	0.1
WDR63	"DIC3, FLJ30067, NYD-SP29"	ENSG00000162643	"WD repeat domain 63"	Q8IWG1	1	84999147-85133138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 21.3;brain: 39.7;testis: 31.0"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 167.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 39.7"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.9;HBEC3-KT: 5.4;HSkMC: 7.2;hTCEpi: 8.7;LHCN-M2: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038526	Enhanced					NA	NA					"HPA038526: AB_2676063"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-4)"	"unprognostic (1.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.14e-5)"	"unprognostic (8.57e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	0.3	21.3	2.0	0.4	4.6	0.1	0.9	0.1	0.9	1.3	0.6	4.2	1.0	0.3	0.7	11.7	0.6	14.0	0.4	0.9	3.0	2.9	2.5	0.1	3.7	0.3	0.4	0.9	4.9	0.5	3.9	14.6	0.5	39.7	0.3	0.6	0.3	1.8	0.3	0.3	1.9	0.2	0.4	0.9	0.2	0.2	31.0	1.9	0.0	1.1	1.0	0.2	0.7	0.3	0.0	0.5	0.0	0.0	0.0	2.2	0.4	0.2	0.5	0.1	0.4	3.9	10.9	2.0	2.1	4.3	0.7	1.1	0.0	0.6	0.5	0.0	0.4	2.6	0.0	0.4	5.4	0.9	0.1	0.4	0.3	0.0	0.0	0.6	0.0	0.0	7.2	8.7	3.6	0.2	0.4	0.1	0.6	0.0	0.0	7.8	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.2	0.2	0.0	0.0	0.2	1.3	2.2	0.0	3.4	0.0	0.6	0.3	0.0	0.5	0.0	0.0	0.4	4.2	0.2	1.4	0.0	0.0	0.0	2.2	0.0	1.3	0.0	1.2	0.9	0.1	0.0	0.8	1.9	0.0	0.0	0.0	0.5	0.0	0.4	2.0	4.6	0.1	0.9	3.0	2.9	0.4	0.9	39.7	1.9	0.0	1.7	0.0	0.4	0.9	0.0	0.7	0.0	167.3	18.2	0.0	3.9	0.1	3.3	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	5.1	0.0	0.0	3.6	1.7	0.0	18.6	4.6	0.0	0.5	0.0	0.0	0.0	0.7	0.4	0.0	0.0	36.6	2.9	0.1	0.1	0.0	0.0	0.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Group enriched"	"Detected in many"	8	"Intestinal endocrine cells: 109.0;Melanocytes: 143.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.5	1.5	0.0	0.0	5.3	4.8	1.7	0.1	10.1	2.5	7.0	0.5	1.2	0.0	0.7	0.1	2.3	0.0	10.0	3.2	1.6	2.6	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.2	2.6	0.0	0.0	0.0	0.0	4.9	0.6	0.0	0.0	0.7	0.0	0.6	0.0	12.2	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.6	0.8	4.1	5.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3	14.9	1.7	0.0	3.6	7.7	0.0	6.9	10.2	0.0	1.2	3.5	0.0	6.4	0.0	1.9	0.3	0.5	1.3	0.0	8.4	0.1	5.1	1.1	0.0	0.0	3.4	0.0	109.0	0.0	0.0	0.0	1.7	0.8	143.4	2.8	0.6	0.0	4.9	7.8	0.0	2.2	0.0	6.5	1.2	0.9	1.6	3.0	2.2	0.0	0.6	0.3
SYDE2	FLJ13815	ENSG00000097096	"Synapse defective Rho GTPase homolog 2"	Q5VT97	1	85156873-85201046	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 47.6;Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 133.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.4;SK-BR-3: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027138, HPA058378"	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus"		No	No			"Nucleoli, Nucleoli rim, Golgi apparatus"		"HPA027138: AB_1857686, HPA058378: AB_2683696"	"unprognostic (1.68e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.84e-3)"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.69e-2)"	2.5	1.8	1.1	2.6	1.7	0.6	3.8	0.6	2.2	3.5	11.4	0.5	2.0	2.5	3.8	2.6	5.6	2.3	7.7	5.4	2.8	0.9	4.7	6.4	9.1	3.4	0.9	2.4	3.3	9.9	8.4	5.1	5.0	0.9	5.0	2.6	7.2	3.9	2.5	2.4	1.9	9.2	13.3	0.9	1.0	6.0	3.3	1.0	0.6	5.2	1.0	0.8	6.0	9.6	0.3	0.1	1.4	0.1	0.3	0.7	0.2	2.2	0.7	0.7	0.8	2.5	0.8	16.4	2.5	1.6	1.5	2.4	4.3	0.8	0.0	0.8	1.6	3.0	4.3	8.1	1.1	2.4	0.9	2.3	2.0	1.7	1.5	3.0	1.3	0.5	1.1	1.3	1.2	1.1	1.0	0.3	1.5	2.5	0.0	1.2	3.1	1.3	0.2	4.2	1.7	0.9	0.0	4.4	0.5	1.2	5.7	0.1	0.0	1.8	8.9	2.6	3.9	2.0	1.8	0.3	1.9	4.3	0.0	2.5	0.0	0.3	0.9	0.2	0.9	1.7	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.3	0.7	0.3	1.4	0.3	0.0	0.1	0.0	0.2	1.1	1.7	0.6	2.2	2.8	0.9	0.9	2.4	0.9	1.0	47.6	7.7	0.0	8.1	7.3	4.6	21.2	2.5	2.7	10.3	1.8	51.1	7.9	6.6	1.6	2.4	1.8	3.3	0.0	4.0	3.8	5.4	4.5	1.1	6.0	1.3	0.0	18.5	3.1	0.3	0.9	2.0	1.4	18.6	2.8	3.3	6.4	3.2	0.0	2.5	4.6	133.9	0.0	2.0	11.5	7.2	4.0	2.2	2.2	3.7	3.8
C1orf52	"FLJ44982, gm117"	ENSG00000162642	"Chromosome 1 open reading frame 52"	Q8N6N3	1	85249953-85259672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036072, HPA061790"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036072: AB_10602696, HPA061790: AB_2684610"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.37e-5)"	"unprognostic (6.67e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.93e-4)"	"prognostic unfavorable (1.17e-7)"	"unprognostic (8.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.05e-2)"	14.4	13.5	22.4	13.4	30.1	42.9	17.4	13.8	25.8	11.8	12.3	19.1	9.4	11.3	14.2	16.9	12.0	11.3	12.2	13.0	25.4	19.3	9.9	13.3	14.6	20.3	20.6	19.9	13.9	14.2	11.0	15.6	21.0	17.9	13.1	11.9	8.8	11.5	11.8	18.0	19.8	10.7	12.0	18.7	14.1	12.0	17.0	20.3	12.4	11.4	8.8	14.3	11.2	12.3	27.3	20.8	25.6	21.4	15.5	23.6	16.7	13.4	6.1	11.9	9.9	13.0	9.9	20.7	13.7	8.3	15.1	14.8	8.7	7.2	12.4	12.9	12.0	13.5	9.0	24.0	7.8	15.2	12.8	15.0	16.7	10.7	10.9	11.5	17.2	7.8	7.9	11.1	13.2	10.1	10.6	9.5	18.7	19.7	13.7	8.8	3.7	13.1	14.0	36.7	6.5	8.8	14.5	13.8	5.3	15.0	8.4	7.3	11.4	3.8	10.7	20.2	15.7	6.1	28.0	9.1	8.3	12.4	15.2	16.8	13.0	21.7	18.9	4.9	13.2	9.3	25.6	15.1	22.8	16.4	21.4	17.6	27.3	15.6	14.2	19.4	16.7	23.6	22.9	23.6	15.5	17.6	20.8	12.9	16.7	22.4	30.1	13.8	25.8	25.4	19.3	20.6	19.9	17.9	20.3	41.7	26.4	35.3	50.1	129.1	22.6	21.3	7.6	30.8	33.0	15.7	21.6	54.0	16.6	32.5	28.7	43.0	21.5	23.3	24.1	49.7	56.0	31.9	49.7	14.7	32.0	14.3	37.2	25.8	27.0	8.0	33.9	37.1	30.4	16.2	18.9	25.6	27.3	23.5	23.0	17.3	25.6	38.8	54.2	91.6	55.3	112.7	56.8	36.3	22.0	60.4
BCL10	"c-E10, CARMEN, CIPER, CLAP, mE10"	ENSG00000142867	"B cell CLL/lymphoma 10"	O95999	1	85266248-85277090	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Immunity"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 172.4;Urothelial cells: 313.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001944, HPA017925"	Approved					NA	NA					"CAB001944: , HPA017925: AB_1845312"	"unprognostic (3.78e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (7.06e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.92e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-1)"	17.2	10.7	5.8	16.4	6.0	19.6	20.7	5.8	8.6	14.7	21.5	7.5	9.5	12.2	14.8	10.0	29.0	8.5	16.7	7.5	5.9	5.4	11.9	11.4	20.4	21.5	6.5	5.2	11.6	9.1	5.4	6.3	11.8	5.9	11.6	20.4	6.4	11.8	12.4	5.0	14.6	27.6	9.9	6.1	18.5	13.0	8.5	5.1	18.3	11.3	12.7	22.1	14.3	17.6	22.4	14.2	37.5	18.2	10.4	13.3	9.0	16.0	3.4	4.6	5.0	6.7	10.0	7.9	12.3	11.2	8.9	12.4	4.0	6.5	7.2	8.7	9.6	16.9	8.7	5.3	13.1	13.0	6.1	4.0	7.6	3.3	5.6	10.5	7.4	7.1	7.9	14.5	13.3	11.9	10.8	40.6	4.2	5.3	6.5	14.9	3.0	7.1	6.1	8.2	9.0	11.3	5.1	10.7	4.6	31.0	12.4	3.1	4.2	3.7	12.7	11.7	6.7	4.3	5.0	20.2	9.2	6.5	11.2	12.2	5.3	2.9	7.0	4.6	6.5	6.3	25.2	15.1	20.1	10.0	18.2	11.1	22.4	13.1	11.3	14.2	20.3	12.4	11.4	37.5	10.4	13.5	12.0	13.3	9.0	5.8	6.0	5.8	8.6	5.9	5.4	6.5	5.2	5.9	5.1	20.8	18.6	32.1	121.5	172.4	5.3	3.6	15.3	24.1	36.4	22.7	0.0	13.1	14.9	59.3	42.4	34.3	75.1	0.0	39.3	23.1	20.1	72.2	39.2	15.3	19.5	9.5	47.0	20.9	28.8	8.6	10.3	35.3	15.1	19.0	59.4	9.9	56.0	60.3	10.6	16.3	5.4	0.0	22.0	7.6	12.4	149.7	19.8	24.9	40.5	313.8
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 36.9;SH-SY5Y: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.3	2.3	6.5	1.2	10.9	9.2	0.8	21.7	13.2	7.7	8.2	26.1	4.9	0.0	9.1	24.6	7.6	5.3	23.5	4.5	9.9	0.0	9.0	0.0	6.2	9.1	3.9	16.7	1.0	7.7	0.4	6.5	4.1	9.8	12.3	0.0	0.0	1.8	19.8	1.5	0.8	0.0	7.8	36.9	6.8	0.0	15.2	0.2	33.0	13.7	18.3	35.6	2.8	16.5	2.6	9.7	8.9	1.2	24.0	6.8	5.5	1.6	15.1	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0	32.8	31.3	4.2	4.0	12.2	2.7	11.4	68.8	30.8	13.6	66.3	3.9	1.7	106.1	15.6	17.1	4.5	78.7	0.0	26.7	0.8	23.5	37.8	0.0	94.3	0.9	0.0	32.8	9.2	2.2	18.4	14.7	1.5	11.8	1.0	77.8	59.7	34.2	73.6	70.4	219.6	8.0	12.9	18.9	5.0	5.6	12.5	0.7	3.3	85.4	6.5
CYR61	"CCN1, GIG1, IGFBP10"	ENSG00000142871	"Cysteine rich angiogenic inducer 61"	O00622	1	85580761-85583962	"Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 678.9;Basal glandular cells: 1529.5;Basal keratinocytes: 745.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 99.0;U-138 MG: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029853	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA029853: AB_10611822"	"unprognostic (6.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-3)"	79.6	23.6	3.5	106.4	6.4	0.0	47.8	0.8	4.8	110.6	27.4	13.1	20.3	3.0	73.4	64.4	26.3	76.5	108.4	60.1	4.7	4.0	30.8	41.7	98.8	59.9	2.9	4.4	66.8	17.2	5.1	8.8	64.7	7.2	60.8	16.5	23.6	14.6	49.3	55.3	28.2	15.6	102.4	6.1	58.9	35.0	26.6	3.7	1.9	56.4	23.6	16.3	101.6	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	2.2	6.3	1.3	41.6	38.6	9.5	68.1	51.1	99.0	75.9	16.4	2.4	0.0	43.6	67.0	66.5	4.5	6.4	16.2	82.3	0.1	0.8	0.0	10.3	2.3	64.0	0.4	0.0	20.9	10.7	44.6	30.2	69.8	73.6	0.0	0.1	0.0	51.4	2.0	0.0	0.1	4.1	0.6	4.3	0.0	18.8	0.0	75.5	2.8	0.0	0.4	76.3	15.5	10.3	23.7	5.0	0.3	79.3	99.2	31.0	14.2	95.9	0.0	0.1	0.1	1.2	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.4	0.8	4.8	4.7	4.0	2.9	4.4	7.2	3.7	678.9	102.9	2.4	1529.5	745.3	1.5	85.3	73.9	29.4	76.2	36.6	2.0	128.7	1.7	489.8	1.5	159.3	2.6	0.0	263.1	474.2	526.6	216.8	12.8	32.1	36.5	0.0	0.0	244.9	3.2	1.1	103.6	25.2	99.5	4.6	4.4	75.3	290.4	34.5	86.7	11.3	6.0	291.1	529.9	0.7	0.8	212.2	109.8	9.6	10.4	81.8
ZNHIT6	"BCD1, C1orf181, FLJ20729, NY-BR-75"	ENSG00000117174	"Zinc finger HIT-type containing 6"	Q9NWK9	1	85649423-85708433	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018132	Uncertain		Approved	"Nuclear speckles,Vesicles"		No	No			"Nuclear speckles, Vesicles"		"HPA018132: AB_1848789"	"unprognostic (1.37e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.08e-6)"	"unprognostic (1.11e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.37e-2)"	18.5	12.6	20.7	15.9	28.0	15.5	21.5	19.2	25.6	23.5	13.8	21.4	14.2	9.0	20.4	14.9	19.9	14.6	12.0	12.4	22.5	18.8	12.9	10.3	12.9	19.4	21.5	20.5	21.9	11.5	17.4	20.3	15.1	19.5	17.4	14.0	8.1	15.3	15.1	15.7	17.1	12.0	19.8	26.1	14.5	11.0	11.0	26.6	14.8	17.4	13.8	18.9	19.5	25.7	7.6	6.0	1.3	2.3	5.7	6.4	2.5	13.0	9.5	9.0	8.2	19.6	18.4	11.5	17.4	16.9	11.9	11.7	9.4	6.9	10.2	20.9	10.6	26.4	11.1	15.4	10.8	19.4	14.5	13.4	21.0	10.7	10.7	17.2	33.9	8.4	17.7	9.9	16.1	14.0	11.8	13.9	16.5	19.8	13.9	17.9	5.3	19.6	8.3	13.0	10.3	16.8	16.2	19.7	11.6	18.0	25.9	8.7	5.6	13.7	18.8	18.5	9.9	9.0	8.7	15.9	15.2	10.3	12.9	24.6	8.9	9.2	29.4	3.3	21.0	13.5	1.3	2.1	0.2	5.7	2.3	6.4	5.6	5.1	6.4	3.6	7.6	6.4	6.3	0.3	5.7	1.9	6.0	5.4	2.5	20.7	28.0	19.2	25.6	22.5	18.8	21.5	20.5	19.5	26.6	14.9	22.7	11.5	9.5	14.3	29.6	17.3	10.2	21.4	36.4	29.6	31.4	7.6	3.3	10.5	3.2	13.2	7.8	0.0	7.7	11.9	14.3	7.1	26.6	8.7	6.8	14.3	9.1	15.4	12.6	2.2	12.4	10.5	6.8	9.0	11.8	23.0	9.0	7.0	12.0	3.9	39.4	19.4	9.5	24.2	14.9	14.3	2.3	14.6	14.0	10.1
COL24A1		ENSG00000171502	"Collagen type XXIV alpha 1 chain"	Q17RW2	1	85729233-86156943	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 59.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;HSkMC: 3.2;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;SuSa: 4.6;U-266/70: 11.2"	"Low region specificity"	"Detected in some"												"Secreted to extracellular matrix"	NA	NA		12000				"unprognostic (3.00e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.44e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.48e-6)"	"unprognostic (2.79e-5)"	"unprognostic (5.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.90e-2)"	1.1	0.4	6.2	3.4	7.1	2.3	1.1	1.7	18.0	7.0	9.5	0.3	0.0	4.1	3.6	2.4	2.2	0.6	4.4	4.1	12.1	1.2	1.5	0.3	1.7	1.0	1.1	5.2	6.9	0.3	0.2	2.0	0.3	1.7	2.3	2.4	2.4	1.2	4.3	1.4	1.6	3.7	2.8	1.0	0.8	3.4	1.9	2.9	0.0	0.8	2.6	0.8	8.3	4.9	0.0	6.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	1.5	0.0	3.4	0.6	0.0	0.6	0.1	0.2	0.5	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.9	0.0	1.4	0.0	0.8	0.0	1.0	0.1	0.1	0.0	0.0	3.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	6.0	0.9	0.0	0.0	0.2	3.1	0.0	0.0	0.0	4.4	0.5	0.6	1.1	0.1	0.0	0.0	0.2	0.5	4.6	0.0	0.9	0.0	2.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	6.2	0.0	0.0	6.2	7.1	1.7	18.0	12.1	1.2	1.1	5.2	1.7	2.9	0.0	1.1	1.9	0.0	0.3	2.2	1.6	0.0	2.7	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.3	10.1	0.0	0.0	59.8	0.0	0.0	0.7	0.0	1.1	0.0	0.0	1.1	0.4	0.1	0.0	0.0	0.0	0.0
ODF2L	KIAA1229	ENSG00000122417	"Outer dense fiber of sperm tails 2 like"	Q9ULJ1	1	86346824-86396342	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 455.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028020, HPA028095, HPA028333"	Uncertain					NA	NA					"HPA028020: AB_10601670, HPA028095: AB_10611385, HPA028333: AB_10601007"	"unprognostic (4.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (4.69e-7)"	"unprognostic (2.40e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.04e-3)"	16.1	15.7	14.9	13.8	16.7	15.4	22.3	16.6	23.0	18.1	14.4	10.6	14.8	8.6	19.1	26.0	13.8	22.6	16.2	10.2	12.2	15.6	14.1	6.6	19.2	15.4	9.6	16.9	16.7	9.5	6.3	37.8	10.5	15.9	15.7	15.9	13.5	14.4	13.6	4.1	12.4	17.4	10.3	15.3	29.0	7.2	10.9	12.6	36.5	18.5	9.5	13.4	12.3	13.9	11.0	6.1	6.3	2.0	6.7	27.2	2.5	14.2	3.9	9.8	7.5	10.7	18.4	10.3	14.0	8.6	14.0	16.1	3.0	8.0	0.3	13.2	7.4	17.7	7.4	4.0	8.2	11.9	6.7	6.3	3.5	11.7	0.3	8.1	6.2	4.7	8.6	10.1	20.8	5.7	10.1	22.2	9.7	4.8	3.4	8.1	2.0	7.4	6.6	11.9	3.1	7.1	10.0	7.4	1.5	14.5	19.4	9.7	7.1	12.6	12.9	25.8	16.1	4.2	6.1	20.3	11.6	10.8	15.8	14.1	1.0	0.5	5.9	2.7	3.2	13.0	2.2	1.2	6.3	13.8	1.6	27.2	10.2	16.1	10.9	1.1	11.0	10.4	9.9	3.2	6.7	2.0	6.1	14.9	2.5	14.9	16.7	16.6	23.0	12.2	15.6	9.6	16.9	15.9	12.6	86.4	63.3	68.6	42.7	22.1	90.4	8.5	20.4	455.0	182.0	76.8	133.5	7.0	19.9	48.6	23.9	74.5	12.0	0.0	23.7	30.1	39.8	14.4	34.8	2.6	12.9	54.0	39.6	62.0	16.8	5.0	23.0	16.5	54.0	22.6	51.0	32.7	46.9	31.6	26.9	15.9	124.7	19.4	19.3	58.1	26.0	15.2	2.4	71.4	24.7	59.5
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 68.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		66000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	12.6	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	68.6	0.3	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	6.0	42.1	0.0	0.3	0.0	10.7	22.7	0.0	0.0	0.2	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	47.9	0.1	0.0	0.0	35.8
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500289	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 242.9"	"Cell type enriched"	"Detected in some"	56	"Mucus-secreting cells: 1736.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;K-562: 1.7;NB-4: 5.3;RPMI-8226: 5.7;SH-SY5Y: 4.1;U-2197: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	NA	NA		70000			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favorable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			0.2	0.2	0.2	41.7	0.2	0.0	0.2	0.2	0.2	0.2	100.0	0.1	0.1	80.7	0.2	0.1	0.2	0.3	4.4	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.2	98.0	0.2	0.2	0.1	0.2	0.2	242.9	1.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1736.8	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.9	0.0
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 182.1;intestine: 64.2"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 115.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	988	"RT4: 98.7"									"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		210000	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.2	0.1	2.2	8.8	3.0	0.1	0.6	0.0	2.0	12.3	64.2	2.0	0.0	0.1	0.3	0.1	182.1	0.1	0.1	0.1	2.2	0.6	0.1	0.1	0.1	0.1	3.2	1.6	0.1	0.0	0.1	0.0	0.1	3.0	1.8	38.4	0.0	5.9	0.1	0.1	4.5	6.1	0.8	2.4	0.1	0.1	0.1	5.0	0.0	0.1	8.6	21.5	9.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	2.0	2.2	0.6	3.2	1.6	3.0	5.0	0.0	0.0	0.0	13.3	3.0	0.0	0.2	0.0	2.7	5.7	1.8	0.0	0.0	0.0	0.0	0.3	0.0	18.6	0.0	0.0	0.0	0.0	3.9	9.2	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.0	4.1	115.2
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 468.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 69.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		18000	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	42.3	19.9	15.0	22.1	18.8	23.7	50.5	13.7	16.9	20.1	24.1	17.8	25.7	20.0	19.9	25.6	42.4	15.2	20.0	48.1	15.4	12.6	22.4	24.0	27.6	40.2	18.2	14.8	18.0	28.5	18.2	18.4	23.7	20.3	19.7	24.8	11.7	30.2	24.5	89.7	19.4	24.4	26.6	24.5	33.6	16.1	45.4	16.2	19.0	20.0	29.7	20.8	28.5	35.6	8.9	10.4	69.7	16.3	13.9	14.5	10.0	19.3	7.1	11.4	10.4	47.9	41.6	18.8	29.3	29.4	27.9	29.6	20.5	16.2	9.9	18.9	36.3	34.8	11.3	10.1	19.1	26.6	21.4	7.2	23.6	10.9	21.7	29.0	12.7	24.1	29.7	22.2	30.7	33.8	30.0	43.9	10.6	8.8	28.0	37.3	5.7	11.4	8.1	11.1	14.2	12.2	13.2	48.0	7.3	24.0	33.4	12.5	9.1	16.5	21.3	34.9	17.8	8.4	13.0	38.4	26.9	16.3	33.5	24.1	14.8	13.6	14.6	13.3	13.1	16.2	29.4	13.7	14.7	10.6	14.5	10.4	8.9	9.9	10.6	10.4	8.1	4.8	8.5	69.7	13.9	16.3	10.2	14.5	10.0	15.0	18.8	13.7	16.9	15.4	12.6	18.2	14.8	20.3	16.2	77.4	64.0	67.1	96.1	79.6	31.2	138.8	43.3	80.3	58.0	52.4	49.1	72.5	72.9	127.2	468.5	101.4	103.4	46.7	149.1	181.7	92.1	83.8	111.9	70.0	131.7	15.9	83.1	143.6	150.6	144.3	65.0	116.4	77.6	140.7	120.2	67.6	162.6	110.1	79.9	93.5	53.0	77.6	110.4	217.9	73.1	103.3	85.2	73.9	68.5	158.5
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"		1	86862445-86914424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 217.7;Extravillous trophoblasts: 290.7;Hofbauer cells: 216.8;Syncytiotrophoblasts: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			Nucleoli	Cytosol	"HPA054937: AB_2682642"	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favorable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	41.5	48.9	34.7	32.4	33.2	27.1	41.4	20.4	33.9	44.3	37.0	28.9	42.7	32.9	34.9	62.0	36.9	36.8	36.1	31.4	33.4	35.8	68.4	85.3	47.8	45.4	36.0	25.1	47.6	38.5	20.6	46.9	65.6	34.3	41.5	37.4	30.8	35.8	33.7	22.0	21.7	51.1	30.2	45.0	58.7	32.3	36.4	29.0	57.0	100.7	22.8	33.7	40.0	29.7	68.9	57.5	44.3	41.8	26.8	41.3	51.1	39.1	26.9	22.5	24.8	73.7	87.7	36.8	49.4	56.6	46.5	47.4	38.0	47.7	48.4	63.4	43.8	40.3	24.7	25.4	27.5	54.9	45.1	35.9	49.2	25.7	35.9	46.6	64.3	33.6	56.3	43.6	30.9	46.7	37.9	39.1	40.2	45.5	50.6	45.1	17.6	46.7	43.3	33.0	40.7	37.2	39.1	41.6	47.2	64.5	40.5	29.2	24.2	49.2	44.9	65.1	21.5	19.6	56.1	40.8	34.1	25.4	65.6	53.9	30.5	30.9	49.5	19.9	53.2	39.9	44.3	40.0	36.8	32.8	38.4	41.3	56.7	35.8	34.7	39.0	68.9	37.1	37.5	36.7	26.8	41.8	57.5	38.3	51.1	34.7	33.2	20.4	33.9	33.4	35.8	36.0	25.1	34.3	29.0	110.2	143.1	0.0	0.0	0.0	0.0	0.0	0.0	128.5	137.6	102.9	0.0	217.7	63.0	187.2	0.0	0.0	0.0	0.0	170.1	290.7	0.0	0.0	59.3	0.0	216.8	0.0	0.0	0.0	0.0	0.0	0.0	83.2	0.0	111.8	0.0	0.0	167.0	0.0	0.0	129.7	0.0	0.0	0.0	0.0	0.0	0.0	263.6	0.0	0.0	0.0
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914648-87109998	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.8	28.7	15.5	9.6	25.2	2.8	7.3	8.9	15.1	10.3	9.5	6.2	5.4	8.6	9.0	9.4	6.4	6.5	9.6	6.8	14.7	10.2	12.8	15.5	8.0	9.7	9.2	13.8	12.3	9.0	15.9	12.1	7.5	10.1	8.9	8.3	8.2	8.3	9.7	5.3	7.2	8.0	7.1	7.6	18.6	7.2	8.0	7.7	16.5	11.8	4.3	10.0	9.2	7.1	5.6	1.3	9.0	4.3	1.8	3.0	1.8	9.9	8.5	25.0	16.3	13.9	40.6	8.7	9.7	12.8	8.2	9.1	32.4	12.8	21.9	9.5	6.7	14.2	6.1	11.4	8.1	13.3	17.1	9.5	26.3	9.4	25.8	5.8	13.5	13.2	16.7	7.2	13.2	11.0	13.0	12.1	12.4	17.9	11.6	11.8	3.5	13.5	8.2	8.7	10.9	5.6	16.8	23.7	4.7	10.0	20.9	5.4	8.1	12.9	11.1	11.2	6.8	7.3	6.2	10.6	10.3	12.8	18.0	12.2	10.7	7.9	20.6	6.3	9.8	10.5	9.0	2.0	1.7	2.6	1.2	3.0	2.0	2.8	2.8	1.3	5.6	2.8	1.8	2.1	1.8	4.3	1.3	1.5	1.8	15.5	25.2	8.9	15.1	14.7	10.2	9.2	13.8	10.1	7.7	14.9	11.3	8.0	7.0	14.7	8.7	11.5	15.3	9.4	19.4	19.2	3.9	8.0	11.6	13.0	3.6	12.6	10.5	0.0	10.0	7.5	16.7	8.7	18.5	24.1	29.9	7.9	22.4	17.2	12.6	3.0	6.4	11.8	11.8	5.4	13.5	26.9	11.0	3.5	19.1	14.7	16.3	0.0	14.2	7.4	13.9	13.8	3.7	7.5	13.0	6.8
AC093155.3		ENSG00000267561			1	86993009-87169204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.8"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 4.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.0;HEL: 13.2;HMC-1: 16.8;THP-1: 11.4"									"HPA043069, HPA043603"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432"	"unprognostic (4.41e-1)"				"unprognostic (3.13e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.14e-1)"			"unprognostic (2.54e-1)"	10.8	3.2	0.6	0.9	0.8	0.0	3.7	0.8	0.6	2.1	1.3			0.6	0.8	0.5	1.1	0.5	2.1	4.1	0.6	0.6	0.8	4.3	2.5	0.3	0.7		3.7	0.6	0.0	0.5	2.7		0.6	1.2		0.9	0.7	1.6	0.6	1.0	2.0	0.8	0.8	0.7	2.4			0.6		0.0	2.2	0.6	0.1	0.9	4.6	0.1	0.4	0.2	0.1	0.0	0.1	0.8	2.0	2.4	9.0	0.2	0.0	0.1	0.0	0.3	0.6	0.8	0.0	0.2	0.0	0.2	0.2	0.3	0.1	0.4	0.1	0.5	13.2	0.4	0.1	0.1	0.3	16.8	1.5	0.3	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.0	0.2	0.2	0.3	1.1	0.0	0.2	0.3	0.0	0.4	0.4	0.1	0.4	0.3	0.0	0.4	0.9	0.2	11.4	0.0	0.3	0.7	0.1	1.3	0.9	3.5	0.0	0.6	0.0	0.4	2.0	0.1	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.4	0.0	0.9	0.0	0.1											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328468-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 105.3;T-47d: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	19.3	7.5	39.8	11.7	36.4	8.0	13.9	10.3	102.4	22.7	16.2	9.8	10.9	11.5	19.4	18.1	22.2	13.7	21.0	17.2	62.3	18.0	12.8	14.5	16.6	11.5	21.0	50.9	18.4	10.4	11.6	13.3	27.5	13.0	26.0	14.3	11.2	36.2	37.9	18.4	17.1	21.1	15.3	16.5	15.8	38.6	12.0	11.0	4.4	14.2	12.5	36.3	15.4	21.4	7.8	7.2	18.9	8.2	15.3	6.9	3.6	9.4	7.4	5.8	105.3	17.9	21.3	14.8	8.6	6.8	8.1	9.1	18.2	6.0	22.2	11.0	10.0	13.2	7.9	2.3	6.0	8.1	11.8	5.8	20.2	16.2	5.6	17.2	10.9	27.5	11.1	13.9	12.6	7.2	14.7	5.5	8.6	4.5	19.7	4.3	3.8	0.3	7.1	21.3	10.2	7.0	12.6	8.1	4.8	10.0	36.4	4.8	0.3	34.6	5.1	25.5	11.6	67.0	30.0	3.5	38.2	7.2	9.1	28.1	18.1	11.9	5.0	4.7	2.4	5.4	18.9	6.8	13.0	6.0	8.2	6.9	7.8	5.4	6.1	5.0	4.4	1.4	3.5	10.9	15.3	7.7	7.2	1.4	3.6	39.8	36.4	10.3	102.4	62.3	18.0	21.0	50.9	13.0	11.0	41.7	27.4	50.6	46.8	87.3	192.0	49.2	163.1	29.4	48.9	34.9	68.7	270.0	53.0	48.7	1.6	54.7	57.7	23.3	112.7	251.2	186.2	38.4	292.9	75.1	64.5	104.9	29.9	81.6	115.9	4.5	88.1	61.6	62.4	25.2	66.7	78.4	77.9	34.8	221.3	42.6	34.0	32.3	148.3	3.9	34.7	81.2	214.1	67.1	38.3	32.9
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.7	9.3	18.5	11.1	12.4	14.1	12.0	14.1	13.0	15.8	16.5	9.9	17.1	9.4	16.8	13.4	19.5	18.8	18.0	10.7	21.7	3.3	13.1	6.9	19.4	8.4	10.9	6.8	2.1	11.6	11.1	12.4	15.0	12.6	18.0	7.5	11.5	6.9	17.0	4.8	7.8	5.9	9.3	9.0	10.9	7.5	28.2	3.8	14.0	46.8	9.0	5.9	21.1	12.2	18.1	14.6	9.1	6.2	16.8	13.5	12.1	17.2	14.7	3.8	3.2	6.4	5.6	6.7	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2	38.7	52.6	24.5	42.6	42.9	83.6	41.1	40.8	45.5	39.8	66.3	84.4	37.5	10.0	51.4	2.1	51.2	79.8	70.0	52.5	29.4	35.1	52.3	15.1	32.6	20.4	62.0	42.5	51.0	34.3	2.9	50.3	29.0	30.4	41.5	55.9	64.3	62.0	87.7	45.3	22.4	151.6	38.8	29.8	35.8	18.8	45.8	31.2	21.0	50.9	118.4
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852932-88891944	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	23.7	27.0	22.2	27.1	29.8	54.9	30.2	25.7	30.0	24.2	21.9	12.5	19.2	18.8	23.4	32.9	26.4	23.0	24.6	16.0	22.0	21.7	23.7	34.8	22.8	30.6	24.3	17.9	28.2	23.8	21.6	25.9	30.2	23.8	19.2	24.7	13.8	24.9	20.8	21.6	26.4	29.3	21.6	20.6	30.0	22.5	15.2	23.5	44.4	27.6	24.0	30.8	22.6	22.7	28.6	31.6	51.1	28.2	25.8	34.4	23.8	19.7	7.4	19.0	9.4	28.9	20.3	23.0	16.7	22.2	25.1	26.8	9.8	13.7	22.9	19.1	15.7	30.0	11.9	20.2	17.9	22.1	22.6	18.9	24.1	12.3	16.4	18.8	27.8	14.8	17.8	18.3	22.0	12.8	18.7	13.2	22.8	21.5	19.8	26.3	7.0	28.3	25.3	14.6	19.1	16.3	18.1	23.4	17.4	26.7	22.1	14.4	12.6	15.9	19.9	29.2	18.2	8.5	27.6	11.7	10.7	13.1	18.6	20.0	19.4	13.4	30.4	7.1	23.6	9.0	37.9	25.5	39.3	25.6	28.2	29.1	28.6	28.5	27.2	31.6	24.2	34.4	29.5	51.1	25.8	28.1	21.3	34.2	23.8	22.2	29.8	25.7	30.0	22.0	21.7	24.3	17.9	23.8	23.5	6.0	30.1	29.7	68.6	41.1	13.1	8.1	12.7	40.2	23.9	10.4	2.0	67.5	33.2	42.9	11.6	26.6	28.2	23.3	34.0	50.4	30.8	22.8	48.4	15.3	36.1	17.5	19.4	13.5	28.9	5.6	33.6	39.2	27.0	35.1	21.2	24.1	41.2	59.6	27.6	32.3	17.3	12.9	41.6	21.4	28.5	43.7	125.5	54.6	17.7	77.4
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	22.2	26.8	16.6	13.2	19.3	10.6	27.5	14.9	23.5	23.7	17.5	20.0	13.0	19.4	24.1	21.2	27.2	18.9	17.8	13.2	18.6	14.2	27.3	23.8	17.1	17.6	16.9	22.2	27.4	28.6	27.0	19.5	21.9	23.4	19.0	19.6	19.5	21.0	20.7	10.4	22.0	17.2	22.1	14.8	20.7	23.5	15.6	17.2	15.5	24.5	13.4	20.2	25.2	17.7	9.6	17.0	9.2	12.7	11.5	16.7	8.2	20.8	4.4	21.4	7.1	7.7	21.5	18.6	12.8	24.2	16.5	21.5	6.4	7.3	13.8	9.8	9.5	11.0	5.9	6.0	9.9	25.2	8.1	8.6	12.3	4.2	10.5	25.1	17.2	3.4	18.1	10.0	11.3	20.4	10.5	15.9	16.2	15.9	7.3	15.5	6.9	18.4	8.4	12.7	16.1	3.8	18.8	15.0	7.3	34.6	21.3	15.6	19.1	17.0	22.8	11.1	14.3	12.6	4.2	10.6	6.9	4.6	22.1	9.3	9.9	4.9	9.2	3.4	7.7	5.9	5.6	12.7	7.1	9.1	7.9	12.6	9.6	11.8	10.5	17.0	9.3	12.4	10.4	9.2	11.5	10.2	6.3	16.7	8.2	16.6	19.3	14.9	23.5	18.6	14.2	16.9	22.2	23.4	17.2	11.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.8	12.2	0.0	59.0	21.6	29.8	0.0	0.0	0.0	0.0	33.6	33.1	0.0	0.0	4.7	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	55.9	0.0	0.0	21.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0
RBMXL1	KAT3	ENSG00000213516	"RNA binding motif protein, X-linked like 1"	Q96E39	1	88979456-88992960	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057707	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057707: AB_2683508"	"prognostic favorable (7.60e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	13.3	9.8	18.5	11.7	15.3	23.8	13.4	12.0	18.0	18.2	12.2	15.3	9.7	9.8	18.5	16.2	20.9	16.7	11.5	14.0	17.1	15.2	17.4	18.3	13.0	13.5	17.1	17.0	22.8	14.5	25.0	14.1	16.7	17.9	16.3	9.5	14.8	11.8	14.3	8.9	12.1	12.2	16.9	17.4	14.4	13.9	14.2	13.0	11.7	16.2	10.1	14.0	19.3	12.4	8.8	8.6	12.3	10.1	6.3	10.8	8.4	10.7	3.2	9.2	12.0	10.9	11.1	17.6	4.6	10.7	9.4	11.1	5.3	7.3	9.1	9.2	5.5	21.9	6.3	17.4	11.5	10.5	8.3	7.7	10.8	11.2	7.0	6.3	8.5	5.9	6.4	6.7	8.4	7.5	4.1	6.0	6.5	15.0	6.0	5.6	4.0	9.0	4.4	16.9	7.0	7.3	8.3	22.6	4.5	6.2	12.5	6.7	10.3	5.0	11.3	11.6	12.9	8.2	8.9	4.4	6.1	12.5	7.1	7.8	9.5	8.9	9.4	4.3	5.2	5.6	2.5	6.6	5.9	6.9	8.9	9.3	6.7	9.7	7.3	8.6	8.8	10.8	6.6	12.3	6.3	10.1	4.4	7.6	8.4	18.5	15.3	12.0	18.0	17.1	15.2	17.1	17.0	17.9	13.0	32.8	34.6	13.7	48.3	27.2	18.9	17.1	20.4	24.1	29.6	12.2	13.7	25.6	3.3	7.6	1.2	18.0	9.7	0.0	7.6	24.9	16.5	19.0	33.5	28.7	10.2	23.8	27.6	14.1	21.3	1.5	15.8	13.8	20.3	19.0	9.4	26.1	8.1	5.8	14.2	4.3	16.8	6.5	23.1	10.1	15.4	21.2	28.5	20.8	10.5	30.8
GBP3	FLJ10961	ENSG00000117226	"Guanylate binding protein 3"	Q9H0R5	1	89006666-89022894	"Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 63.1"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 83.0;Enterocytes: 83.4;Paneth cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.9;BJ hTERT+ SV40 Large T+ RasG12V: 22.2;LHCN-M2: 27.4"									HPA045657	Approved					NA	NA					"HPA045657: AB_10961631"	"unprognostic (1.14e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.06e-3)"	7.5	10.9	3.0	10.5	6.5	0.4	6.1	3.4	4.1	10.5	20.6	2.8	9.8	35.9	4.9	14.3	7.1	7.2	16.4	5.4	4.2	3.5	16.5	6.8	11.8	5.6	6.9	0.8	10.4	3.9	1.9	6.1	14.1	8.0	8.8	13.0	4.6	8.2	10.0	1.9	3.1	63.1	5.9	9.5	8.6	14.6	3.2	6.4	4.9	15.0	4.3	5.1	12.6	16.8	3.5	5.7	3.0	10.1	5.8	11.5	4.4	9.8	0.6	0.0	0.0	9.7	11.4	1.7	17.0	30.9	16.2	22.2	0.0	0.8	0.7	3.2	15.3	9.2	4.1	0.0	11.2	15.9	0.2	0.0	0.9	1.6	0.2	8.2	3.3	0.0	8.8	2.2	12.0	4.3	11.1	5.3	1.6	0.0	2.0	27.4	0.0	2.3	0.4	0.0	5.4	7.7	0.7	1.8	1.1	16.2	18.7	0.0	0.0	5.2	3.0	0.0	0.3	0.0	1.0	6.4	17.4	1.1	0.1	1.7	2.9	0.9	0.0	0.1	0.0	4.3	0.0	5.8	0.3	11.5	6.3	10.0	3.5	10.2	9.2	5.7	2.7	6.5	9.6	3.0	5.8	10.1	0.4	7.2	4.4	3.0	6.5	3.4	4.1	4.2	3.5	6.9	0.8	8.0	6.4	6.0	14.9	5.7	22.4	6.2	0.0	0.8	43.3	83.0	26.1	21.0	0.0	5.3	11.6	49.6	0.0	21.0	83.4	0.0	54.2	5.7	8.7	22.6	4.6	9.2	5.0	0.0	8.7	22.1	13.9	0.0	9.2	17.4	0.0	19.8	22.7	0.9	69.5	73.7	14.5	26.9	0.0	19.4	2.6	0.5	0.2	4.3	1.8	28.8	17.8	33.6
GBP1		ENSG00000117228	"Guanylate binding protein 1"	P32455	1	89052319-89065360	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 125.8;monocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.7;BJ hTERT+ SV40 Large T+ RasG12V: 48.7;GAMG: 38.4"									CAB015450	Approved				"Intracellular and membrane"	NA	NA					"CAB015450: AB_2109333"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.36e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.01e-3)"	32.2	4.9	4.2	30.8	8.8	2.1	12.5	3.1	4.3	18.3	14.7	5.9	4.8	7.3	17.3	11.5	9.4	11.0	19.7	7.1	4.2	4.6	15.5	35.4	38.6	21.6	6.7	3.0	16.5	2.3	8.4	4.2	20.9	20.1	21.4	7.2	5.4	5.9	9.3	17.0	6.3	21.4	18.0	9.0	32.3	9.4	4.6	4.5	12.5	51.3	7.7	12.6	19.2	9.8	4.0	10.8	26.0	30.6	14.1	39.1	18.7	3.5	0.0	0.0	0.0	3.4	6.2	10.6	9.8	19.6	35.7	48.7	1.0	2.5	3.4	6.1	11.5	38.4	0.8	0.0	4.5	16.5	10.6	0.0	0.7	3.3	0.1	21.2	0.0	0.5	15.0	1.8	15.7	2.8	9.7	8.7	5.1	0.0	3.2	11.9	0.0	8.1	0.0	0.1	0.0	0.4	12.0	11.3	0.2	2.3	5.9	0.2	0.0	10.7	2.6	0.9	0.0	0.3	0.0	11.4	10.6	0.4	3.2	7.9	0.1	0.0	0.0	4.1	0.0	1.1	0.1	9.3	1.2	23.4	30.6	22.3	4.0	23.7	24.9	10.8	2.7	18.1	20.8	26.0	14.1	29.3	0.0	39.1	18.7	4.2	8.8	3.1	4.3	4.2	4.6	6.7	3.0	20.1	4.5	68.5	20.8	5.4	125.8	35.1	0.2	2.0	15.3	73.6	33.0	8.7	0.0	34.9	0.0	35.8	0.0	44.3	10.7	0.0	63.6	65.0	39.3	13.4	13.9	65.5	33.4	0.0	8.6	20.9	30.1	0.2	9.2	52.4	5.0	99.2	3.4	9.1	33.3	7.0	24.1	12.8	0.0	12.9	17.0	0.0	0.0	18.7	29.2	17.5	6.1	24.5
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.9;HDLM-2: 26.3;RT4: 33.0"									"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	40.1	39.4	4.7	24.4	14.3	8.9	31.9	2.3	11.0	38.2	35.7	3.3	9.5	11.0	29.0	20.6	39.0	17.5	18.5	12.6	4.6	4.1	21.6	17.9	42.8	21.3	14.3	2.9	35.5	4.9	39.8	5.9	17.3	12.2	48.7	13.8	12.4	14.2	15.4	20.1	19.5	39.6	48.1	26.7	27.5	20.2	13.0	6.0	7.7	22.0	18.2	15.3	63.1	40.3	3.1	8.5	78.9	44.2	20.1	61.2	22.2	6.1	0.5	0.0	0.0	17.7	15.4	4.6	1.6	15.9	2.6	6.1	0.1	9.7	0.0	23.9	10.6	12.0	1.2	0.0	0.2	1.4	26.3	0.0	0.1	4.5	1.3	4.7	0.7	1.1	16.1	0.1	3.9	0.0	8.9	18.0	0.0	0.3	1.0	7.3	0.0	0.0	5.8	0.0	5.6	0.4	0.1	6.8	0.0	5.0	33.0	0.0	0.2	7.8	2.2	0.2	0.5	0.2	1.0	12.2	2.0	0.4	2.8	1.7	19.1	0.0	0.0	6.1	0.1	0.3	12.2	20.5	6.6	24.6	31.2	32.6	3.1	26.3	27.1	8.5	2.7	18.0	18.9	78.9	20.1	44.2	0.5	61.2	22.2	4.7	14.3	2.3	11.0	4.6	4.1	14.3	2.9	12.2	6.0	23.8	30.1	5.9	100.6	41.3	0.1	2.8	28.1	24.1	17.0	17.4	0.0	26.1	0.0	75.3	22.8	54.8	48.0	23.3	62.4	50.9	30.1	66.0	44.1	22.2	33.3	0.0	9.8	22.1	68.8	22.5	4.4	82.4	8.5	45.9	9.7	0.6	67.5	28.1	8.1	7.7	0.0	19.4	69.6	0.7	2.1	54.1	48.3	77.8	8.6	78.8
GBP7	"FLJ38822, GBP4L"	ENSG00000213512	"Guanylate binding protein 7"	Q8N8V2	1	89131751-89176040	"Predicted intracellular proteins"		Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 48.1"	"Cell type enhanced"	"Detected in some"	20	"Endothelial cells: 6.0;Hepatocytes: 14.3;Ito cells: 3.7"	"Cancer enriched"	"Detected in single"	58	"liver cancer: 10.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											HPA051245	Uncertain					NA	NA					"HPA051245: AB_2681404"	"unprognostic (4.22e-5)"	"unprognostic (7.32e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.35e-2)"	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.3	1.3	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.0	0.2	0.9	0.2	0.1	0.3	0.2	0.1	0.1	0.3	0.2	0.2	1.3	1.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	14.3	1.0	0.0	0.0	3.7	0.6	0.0	0.6	0.8	0.0	0.0	0.0	2.8	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.4
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181148-89198932	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 56.2;Endothelial cells: 79.8;Ito cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.0;HDLM-2: 8.0;HEL: 10.7;REH: 9.0;RT4: 15.1;U-266/70: 13.6"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	25.4	4.4	3.9	18.4	5.9	3.6	9.4	2.1	5.0	7.8	5.8	4.4	2.9	8.0	10.5	7.4	7.9	6.3	5.7	9.2	4.6	4.4	8.5	9.8	34.7	20.5	5.8	4.4	12.8	2.4	9.3	4.8	9.1	6.9	12.7	4.8	17.4	4.8	4.8	12.0	3.2	11.0	5.1	7.4	23.4	7.4	2.6	2.7	8.1	23.3	5.7	15.2	9.3	7.7	3.3	2.0	5.1	12.6	12.2	7.6	4.4	0.7	0.0	0.1	0.3	0.1	0.1	0.6	1.5	6.4	6.8	6.2	0.1	10.0	0.5	0.9	1.9	0.6	0.8	0.0	0.3	0.3	8.0	0.1	10.7	0.3	0.3	0.9	0.2	0.3	0.3	0.0	0.1	0.0	1.0	1.6	0.2	0.3	2.0	0.0	0.1	5.3	0.3	0.4	0.0	0.1	9.0	0.2	0.3	0.1	15.1	0.2	0.5	0.2	0.5	0.3	0.7	0.5	1.1	0.4	0.2	1.4	0.2	0.1	13.6	0.2	0.3	0.3	0.1	1.9	0.4	3.8	0.4	6.6	12.6	5.8	2.3	7.3	7.3	2.0	3.3	5.5	5.1	5.1	12.2	11.5	0.7	7.6	4.4	3.9	5.9	2.1	5.0	4.6	4.4	5.8	4.4	6.9	2.7	29.8	44.9	10.0	7.8	4.0	2.1	2.8	10.2	56.2	37.5	5.2	7.9	0.7	0.0	1.9	1.5	79.8	2.5	23.3	2.9	1.1	5.6	14.8	20.8	6.4	8.7	0.0	0.0	89.0	20.0	0.5	3.4	22.5	5.0	29.7	2.8	16.2	21.4	1.9	1.8	0.7	10.6	0.0	5.7	2.6	4.5	2.6	1.3	21.3	0.5	12.5
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 29.1"	"Cell type enhanced"	"Detected in some"	13	"granulocytes: 10.4;Kupffer cells: 15.1;Macrophages: 11.7;T-cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.1;NB-4: 7.5;U-266/70: 16.3;U-937: 23.9"	"Low region specificity"	"Detected in all"							HPA028656	Supported					NA	NA					"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.3	1.5	1.0	29.1	1.5	12.1	1.7	0.7	0.8	2.3	4.4	0.7	0.2	2.0	2.4	3.0	2.6	3.3	4.5	1.5	1.0	1.0	2.6	4.0	14.0	26.2	2.8	0.8	3.4	1.3	0.0	1.5	2.6	1.9	3.8	3.0	3.3	2.4	1.2	0.9	1.2	7.6	2.0	2.9	27.6	3.2	4.5	1.0	7.8	3.6	1.3	24.9	6.8	1.7	1.5	1.5	23.0	9.4	11.6	54.6	7.3	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.9	1.0	0.0	0.1	0.1	5.1	4.1	2.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.4	2.4	0.2	0.0	0.0	7.5	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.5	1.5	0.1	0.0	0.0	3.0	0.1	0.4	0.4	0.0	1.7	16.3	0.3	0.1	0.2	23.9	0.0	0.1	3.5	0.2	23.5	8.7	36.8	1.1	15.5	21.4	1.5	1.5	5.8	9.0	23.0	11.6	9.4	0.1	54.6	7.3	1.0	1.5	0.7	0.8	1.0	1.0	2.8	0.8	1.9	1.0	6.0	6.1	3.7	0.1	0.0	0.0	0.6	2.5	8.1	6.8	0.0	3.9	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.0	0.0	0.4	0.2	10.4	0.6	4.2	0.0	0.0	4.3	15.1	0.0	0.0	11.7	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.1	1.5	0.0	0.1	33.2	0.0	0.1
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364058-89386461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 106.5;lymphoid tissue: 60.5;tongue: 61.3"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 16.0;Club cells: 4.5"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;T-cells: 2.7"	"Group enriched"	"Detected in some"	9	"A-431: 8.0;HaCaT: 17.7"									HPA027744	Enhanced					NA	NA					"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	106.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	15.6	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	61.3	60.5	0.1	6.8	0.6	0.6	3.4	0.6	0.3	2.7	0.4	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	17.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.4	0.7	0.2	1.2	0.6	0.9	1.2	0.4	0.4	0.7	0.7	3.4	0.3	0.4	0.6	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	16.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3
LRRC8B	"KIAA0231, TA-LRRP"	ENSG00000197147	"Leucine rich repeat containing 8 VRAC subunit B"	Q6P9F7	1	89524836-89597864	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 81.5;Late spermatids: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017950	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA017950: AB_1853346"	"unprognostic (2.50e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.15e-4)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	8.1	18.0	13.0	4.4	19.3	3.0	6.6	2.5	27.8	3.8	5.6	15.4	0.5	7.4	2.6	6.9	5.0	4.3	6.2	3.3	15.3	6.5	4.9	4.8	5.8	4.9	8.8	17.1	2.6	8.5	12.4	5.1	2.4	8.3	5.6	6.8	4.4	5.0	1.6	5.9	6.9	4.9	3.6	16.2	4.3	6.4	17.4	8.2	3.1	6.1	2.7	5.9	3.3	3.3	3.0	2.4	1.5	2.2	0.9	3.7	1.6	8.5	3.3	2.4	8.4	12.2	7.3	9.7	0.2	2.5	1.1	1.6	5.2	5.2	0.7	3.5	1.2	3.3	4.5	22.3	1.9	1.4	4.1	4.5	16.6	2.2	4.5	1.2	7.9	11.8	4.0	7.1	0.9	3.7	0.4	11.9	6.7	18.5	5.7	1.3	4.6	3.9	3.8	13.8	3.5	4.8	8.8	1.1	3.0	2.7	10.7	7.0	11.2	4.7	11.4	8.1	3.0	6.9	3.8	3.9	1.0	5.7	2.6	2.7	4.2	3.4	4.2	1.4	2.0	2.0	1.4	2.2	1.5	1.1	1.1	1.7	3.0	2.1	1.7	2.4	2.3	3.7	2.9	0.7	0.9	1.2	2.1	3.4	1.6	13.0	19.3	2.5	27.5	15.3	6.5	8.8	17.1	8.3	8.2	14.9	11.5	5.6	11.4	29.3	34.9	3.4	12.7	20.1	14.8	7.0	45.2	2.6	1.7	12.0	81.5	8.4	5.1	0.0	16.2	9.6	1.5	17.3	2.3	6.7	6.1	0.0	25.8	19.6	13.2	55.3	2.3	7.7	1.7	3.6	13.0	5.5	12.8	3.5	2.5	4.5	21.5	6.5	14.7	6.9	4.1	24.1	2.1	2.5	11.0	8.9
LRRC8C	AD158	ENSG00000171488	"Leucine rich repeat containing 8 VRAC subunit C"	Q8TDW0	1	89633072-89769903	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 40.3;Endothelial cells: 39.4;Suprabasal keratinocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 9.1;monocytes: 6.1;T-cells: 11.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029347	Uncertain		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA029347: AB_10601544"	"unprognostic (2.61e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.76e-3)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.78e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.38e-2)"	19.8	12.6	8.3	11.7	11.4	9.2	27.8	2.0	11.0	6.6	4.8	12.9	1.4	4.5	11.9	7.3	4.4	6.0	9.2	8.2	7.8	7.4	4.5	4.8	10.4	14.8	13.0	7.6	7.8	3.0	5.8	6.9	9.0	9.0	4.5	5.5	6.4	5.0	3.2	5.9	8.3	7.7	21.3	10.8	12.1	4.5	6.4	10.2	3.4	7.6	6.1	10.3	7.5	7.5	0.8	9.1	0.9	6.1	1.9	11.3	3.3	0.1	2.0	1.7	1.5	5.1	5.8	0.8	10.6	11.9	4.8	4.5	0.0	0.7	3.2	3.0	4.6	8.3	7.2	5.5	15.8	11.8	7.9	3.3	3.1	1.7	0.1	4.2	14.1	1.0	2.5	3.2	10.5	5.6	3.2	19.5	5.1	2.0	4.4	4.1	0.3	2.0	13.9	1.8	0.0	4.3	14.1	0.8	1.1	1.0	1.7	1.3	6.0	3.9	0.3	8.8	2.7	0.1	22.2	16.3	8.6	4.1	2.9	8.0	1.6	1.3	1.7	2.7	10.6	1.4	0.4	6.1	0.0	4.2	5.5	3.7	0.8	6.7	5.5	9.1	0.5	5.4	5.0	0.9	1.9	6.1	0.7	11.3	3.3	8.3	11.4	2.0	11.0	7.8	7.4	13.0	7.6	9.0	10.2	3.0	5.1	4.7	3.0	40.3	2.5	5.2	5.1	4.0	3.4	0.0	0.0	0.1	0.0	1.5	29.1	39.4	0.0	0.0	2.2	0.4	4.0	0.9	0.0	0.0	12.1	1.6	1.2	31.3	28.6	17.3	0.0	24.5	25.3	16.2	0.2	0.4	7.7	1.9	0.7	0.6	1.3	0.0	16.5	1.4	1.7	39.3	0.2	17.5	0.2	1.7
LRRC8D	"FLJ10470, LRRC5"	ENSG00000171492	"Leucine rich repeat containing 8 VRAC subunit D"	Q7L1W4	1	89821014-89936611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No						"unprognostic (2.92e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (4.98e-2)"	"unprognostic (7.03e-2)"	"unprognostic (7.71e-3)"	"unprognostic (7.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.91e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.61e-2)"	4.4	26.3	15.7	11.0	24.0	9.6	9.7	8.8	21.3	9.7	13.1	46.2	4.3	14.1	7.7	8.1	6.7	5.9	6.0	5.5	24.5	16.9	19.8	17.6	7.1	17.0	34.7	20.3	4.6	9.6	6.8	16.2	7.5	24.5	4.3	14.0	7.5	17.8	4.6	7.8	5.0	13.6	8.6	38.5	16.8	8.3	7.5	31.6	11.8	12.1	4.3	14.8	8.9	3.4	5.8	7.8	3.0	8.8	10.5	14.3	8.4	24.7	16.2	6.6	15.6	11.9	10.1	22.5	17.0	25.7	9.7	12.2	6.9	6.3	19.6	19.4	28.2	11.0	32.7	15.2	20.4	12.3	15.3	8.4	23.0	14.7	14.6	23.3	26.2	7.3	6.3	17.0	8.2	18.0	13.4	16.4	11.4	12.5	6.2	10.5	7.4	10.8	17.0	11.5	5.6	14.9	14.7	9.6	14.0	24.4	8.8	12.4	8.7	21.1	21.9	47.0	12.0	5.2	26.1	7.2	10.4	3.5	21.1	12.8	7.6	12.9	11.8	4.0	33.1	9.1	0.0	7.1	1.2	6.2	8.8	10.3	5.8	14.3	7.4	6.8	5.3	13.8	10.2	3.0	10.5	6.6	7.8	13.8	8.4	15.7	24.0	8.8	21.3	24.5	16.9	34.7	20.3	24.5	31.6	3.0	1.7	6.5	1.5	5.4	6.1	2.1	10.2	6.7	4.5	12.2	2.0	3.5	6.6	5.0	0.6	5.8	17.1	23.3	7.4	7.9	1.8	2.0	5.7	26.3	10.8	3.2	7.5	9.2	20.6	0.0	1.1	16.3	10.1	20.8	11.2	6.5	5.7	10.5	3.5	9.7	7.1	6.5	1.4	0.1	0.6	1.0	1.5	8.7	9.8	1.4
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995112-90035531	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 134.9;Cone photoreceptor cells: 351.5;Rod photoreceptor cells: 448.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favorable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.84e-4)"	12.7	13.4	18.4	12.7	27.8	45.2	17.7	20.2	18.5	11.8	14.1	23.2	16.3	18.5	18.3	17.1	17.5	11.9	13.9	12.5	19.2	15.2	13.4	15.2	11.5	15.3	26.1	14.1	21.8	20.2	14.4	18.0	14.5	22.8	13.3	20.7	23.9	15.7	9.4	19.2	14.5	18.9	17.8	31.3	11.0	14.6	10.6	27.8	17.3	14.1	10.5	15.1	11.9	17.2	6.8	8.4	3.6	6.1	7.8	4.3	2.2	17.2	15.8	24.6	11.7	11.0	5.2	26.0	17.5	6.8	14.5	9.1	14.6	12.6	21.6	12.5	9.0	16.0	15.6	25.6	11.4	20.0	12.6	12.3	19.5	15.4	13.3	3.7	22.9	9.6	4.6	5.4	14.4	9.2	10.2	8.4	10.1	26.0	9.4	11.7	8.2	23.6	13.0	23.1	14.6	18.0	16.8	24.9	5.8	12.0	19.4	21.6	14.0	20.1	18.7	8.5	18.2	10.3	6.0	11.4	17.1	17.2	14.4	17.3	8.0	7.9	21.6	4.1	18.1	10.9	2.1	5.1	3.6	4.0	6.1	3.2	4.2	3.2	3.4	4.0	6.8	3.2	4.3	2.5	7.8	4.6	8.4	2.8	2.2	18.4	27.8	20.2	18.5	19.2	15.2	26.1	14.1	22.8	27.8	20.8	44.0	32.0	53.5	57.9	134.9	34.4	15.3	45.5	44.3	22.7	351.5	36.5	16.6	45.3	3.4	38.7	63.7	0.0	48.0	73.0	29.8	46.9	48.7	28.0	22.6	65.2	67.4	24.5	16.4	4.2	40.0	32.7	37.1	46.9	33.4	49.5	37.7	66.6	31.8	14.7	448.1	25.8	38.7	58.0	40.9	39.5	41.3	22.4	36.2	68.1
BARHL2		ENSG00000143032	"BarH like homeobox 2"	Q9NY43	1	90711539-90717237	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 29.3"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 22.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	42	"cerebellum: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;HEK 293: 8.9;HEL: 1.3;HMC-1: 2.5;JURKAT: 1.5"	"Region enriched"	"Detected in some"	5	"cerebellum: 14.5"	"Region enriched"	"Detected in many"	20	"cerebellum: 48.3"							NA	NA										"unprognostic (1.83e-1)"				"unprognostic (1.73e-1)"	"unprognostic (6.80e-2)"				"unprognostic (3.10e-1)"	"unprognostic (1.60e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	8.9	1.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	3.6	0.0	0.0	0.0	0.0	0.0
ZNF644	"BM-005, KIAA1221, MGC60165, MGC70410"	ENSG00000122482	"Zinc finger protein 644"	Q9H582	1	90915298-91022272	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057795	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA057795: AB_2683529"	"unprognostic (8.20e-2)"	"unprognostic (5.86e-3)"	"prognostic favorable (4.27e-4)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (3.19e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-1)"	22.2	14.1	20.7	19.0	20.0	19.4	23.9	34.9	25.1	24.7	17.6	17.8	17.1	11.2	23.8	16.7	17.6	14.4	14.2	14.9	21.7	16.6	15.2	26.2	15.1	19.5	23.7	18.9	21.3	14.4	22.4	24.2	18.2	23.3	18.3	18.7	12.0	20.6	15.3	20.3	14.4	19.1	19.2	25.3	21.6	14.6	17.1	26.5	35.3	26.1	14.9	19.7	19.9	18.3	8.1	7.0	5.0	4.8	12.5	8.6	3.2	13.0	6.3	18.4	10.1	8.6	10.1	10.6	11.4	12.1	13.1	14.0	8.3	4.8	16.0	12.7	8.7	17.2	10.4	18.3	13.3	19.4	11.4	10.3	20.7	12.4	11.9	12.3	18.7	6.9	9.5	15.7	12.9	17.6	12.1	13.6	12.0	14.4	18.5	13.6	4.7	15.3	16.7	16.7	6.9	11.8	15.1	30.1	9.0	13.5	12.1	15.1	11.8	14.1	11.0	29.2	13.1	7.2	19.0	10.7	14.4	11.9	11.7	17.5	13.2	8.9	21.4	5.8	14.4	7.4	5.0	4.5	5.0	6.2	4.8	7.0	8.1	7.0	7.0	5.8	7.2	8.6	7.5	1.3	12.5	4.7	7.0	5.5	3.2	20.7	20.0	34.9	25.1	21.7	16.6	23.7	18.9	23.3	26.5	65.5	23.0	38.4	82.6	48.1	32.9	41.2	22.9	36.1	45.5	10.4	23.6	21.1	26.6	28.4	7.0	36.5	26.5	0.0	19.7	15.1	32.9	51.0	43.7	23.2	19.0	52.4	52.8	20.3	24.0	11.7	43.1	27.4	33.7	20.8	24.3	37.9	25.0	28.1	32.5	22.1	34.8	51.8	64.6	45.3	49.0	41.5	10.1	34.6	31.0	62.6
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"HFM1, ATP dependent DNA helicase homolog"	A2PYH4	1	91260766-91404869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;testis: 19.9"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 10.1;Spermatocytes: 40.0;Spermatogonia: 7.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 4.9;K-562: 5.0;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.8	0.7	2.6	0.3	4.1	0.4	0.8	11.3	4.4	1.7	0.9	1.5	2.7	0.6	3.7	2.5	0.4	1.2	0.6	1.0	2.3	0.9	1.3	0.4	0.5	1.6	0.7	1.4	6.4	1.2	0.1	7.8	0.9	3.9	1.1	0.7	2.7	1.0	2.0	2.3	0.4	0.5	1.7	4.7	0.7	0.6	19.9	1.5	0.0	2.7	0.5	0.4	0.7	2.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.3	4.9	0.0	0.2	0.1	0.5	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.9	1.0	0.0	0.1	0.2	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.6	0.2	2.4	0.0	0.0	0.3	1.4	0.1	0.0	0.0	3.1	3.8	0.0	0.0	1.3	2.6	0.0	0.8	0.1	0.0	1.0	0.9	0.1	4.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	4.1	11.3	4.4	2.3	0.9	0.7	1.4	3.9	1.5	0.0	0.6	0.0	0.0	0.0	3.7	2.6	0.0	0.0	0.0	0.0	5.9	0.4	0.0	0.2	10.1	0.3	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	3.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	2.1	0.0	6.4	0.0	0.3	40.0	7.8	0.0	0.0	0.0	0.0	0.0
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500893-91525764	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	2.5	3.7	5.7	7.6	8.9	15.4	4.3	19.4	10.3	2.5	4.2	1.4	0.9	4.2	2.8	2.6	4.7	1.7	2.6	1.9	6.8	5.2	3.6	2.3	5.1	11.7	4.0	4.7	3.7	2.4	2.2	12.3	7.9	5.2	2.7	6.8	2.3	2.5	2.3	1.0	6.8	4.9	3.3	5.9	15.1	2.6	21.2	4.7	18.7	2.5	4.5	12.0	4.2	3.0	1.6	3.5	0.1	1.6	2.4	6.5	2.1	14.2	4.2	27.6	7.8	0.6	3.7	8.8	5.4	4.3	10.7	11.7	8.9	5.1	9.9	7.6	3.4	9.3	6.2	18.1	6.1	14.8	16.4	15.5	15.0	12.2	4.1	1.0	16.3	5.5	1.9	1.8	9.8	5.6	1.9	4.1	13.9	19.8	14.5	7.3	5.2	14.0	14.6	22.9	7.8	10.1	17.3	22.9	6.3	4.6	10.7	21.9	8.6	17.1	4.7	9.6	7.1	4.4	8.0	3.4	12.1	10.7	9.4	8.1	5.3	6.7	26.5	4.3	15.9	4.4	0.0	1.6	0.0	5.9	1.2	5.2	1.5	4.5	5.6	3.5	1.6	2.5	5.1	0.1	2.4	0.3	2.1	6.5	2.1	5.7	8.9	19.4	10.3	6.8	5.2	4.0	4.7	5.2	4.7	0.0	0.6	2.2	1.1	5.3	7.6	1.3	0.0	1.4	1.2	1.8	0.0	5.3	3.3	1.1	28.3	2.8	0.2	0.0	2.2	5.1	4.6	0.7	4.6	0.0	2.2	3.2	0.0	3.1	1.8	12.9	0.9	1.0	3.3	1.0	1.3	1.3	1.0	1.1	0.7	0.1	4.7	6.5	3.1	28.4	20.6	3.1	1.8	5.1	2.9	0.9
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	22	"NK-cells: 9.0;T-cells: 21.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA		29000000	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favorable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.08e-2)"	40.1	15.9	3.2	6.8	3.1	1.6	63.5	1.8	4.4	30.1	15.2	3.5	30.0	3.4	17.6	21.0	22.2	17.6	23.3	16.3	3.9	1.9	12.5	11.9	18.4	18.1	2.6	2.0	62.4	8.9	4.4	4.4	25.1	4.5	21.7	5.6	8.8	14.7	46.5	19.2	13.4	9.8	34.4	4.1	27.1	11.1	14.0	3.0	1.1	7.5	6.5	3.1	39.2	42.1	0.0	0.6	0.6	0.6	9.0	21.3	3.9	2.7	2.7	4.1	0.7	67.2	32.8	13.0	2.0	10.2	2.4	2.9	1.2	0.4	0.0	0.5	3.7	1.9	0.4	1.0	0.3	1.8	9.5	2.2	0.0	3.4	11.3	1.4	0.1	0.0	7.9	1.3	5.2	1.2	0.3	1.2	0.0	6.5	0.2	0.7	0.0	0.0	0.0	1.7	1.2	0.9	0.1	1.4	0.5	0.9	16.4	0.1	0.0	1.0	0.0	5.7	1.7	0.3	1.0	3.6	4.0	1.0	22.8	0.4	10.1	0.9	0.0	0.8	0.5	0.5	0.6	0.0	0.0	21.3	0.1	11.6	0.0	5.4	11.4	0.0	0.0	1.7	8.0	0.3	9.0	0.6	0.6	2.4	3.9	3.2	3.1	1.8	4.4	3.9	1.9	2.6	2.0	4.5	3.0	8.9	11.9	3.0	10.4	33.4	0.2	17.3	28.1	6.7	6.8	29.6	2.0	23.5	3.3	1.7	48.3	64.2	0.7	23.3	4.2	9.3	105.0	7.3	2.3	17.8	9.7	0.0	23.1	311.2	19.6	18.5	135.4	3.8	33.7	0.0	0.5	2.2	3.5	0.0	70.0	15.9	0.2	12.9	35.4	0.7	1.7	29.7	48.5	30.5	2.3	5.4
BRDT	"BRD6, CT9"	ENSG00000137948	"Bromodomain testis associated"	Q58F21	1	91949371-92014426	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 66.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 993.1;Spermatocytes: 377.5"	"Group enriched"	"Detected in some"	10	"lung cancer: 1.3;testis cancer: 6.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	28	"BEWO: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012237	Approved					NA	NA					"CAB012237: AB_304756"	"unprognostic (5.00e-2)"	"unprognostic (2.86e-1)"		"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"		"unprognostic (5.25e-2)"		"unprognostic (2.53e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.22e-13)"	"unprognostic (2.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.00e-3)"	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	3.9	1.4	1.0	1.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	21.5	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.7	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.1	3.9	1.4	0.9	1.0	0.4	0.9	0.5	0.4	0.6	0.2	1.1	0.9	0.6	2.9	1.0	0.4	0.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	993.1	0.1	0.0	0.0	0.0	19.8	0.4	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	130.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	377.5	18.3	0.0	16.2	0.5	0.0	0.0
EPHX4	"ABHD7, EPHXRP, FLJ90341"	ENSG00000172031	"Epoxide hydrolase 4"	Q8IUS5	1	92029982-92063536	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 13.3;brain: 20.7"	"Cell type enhanced"	"Detected in some"	11	"Endothelial cells: 2.9;Melanocytes: 3.3;Muller glia cells: 8.1;Pancreatic endocrine cells: 3.0;Spermatocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 13.3"	"Lineage enriched"	"Detected in single"	24	"T-cells: 13.3"	"Cell line enhanced"	"Detected in some"		"A-431: 10.0;CAPAN-2: 8.8;EFO-21: 17.9;RPTEC TERT1: 24.8;U-251 MG: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035067	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035067: AB_10601465"	"unprognostic (1.27e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (6.10e-8)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (5.36e-3)"	"unprognostic (2.72e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.44e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.36e-6)"	"unprognostic (6.93e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	1.0	1.3	5.8	1.3	14.1	0.3	3.2	1.7	20.7	2.4	1.0	0.3	0.1	1.6	1.7	1.3	2.1	1.3	1.2	1.2	3.3	2.4	0.9	0.4	1.5	0.7	3.1	9.8	0.6	0.3	0.5	1.3	1.9	4.4	2.2	1.4	1.5	0.4	4.1	0.4	0.6	0.9	2.5	1.1	0.4	0.5	2.6	2.1	0.0	3.9	0.0	0.7	1.9	0.4	0.1	0.0	0.0	0.0	0.5	13.3	1.4	10.0	0.3	2.0	0.0	0.0	0.0	0.5	0.2	3.7	0.3	0.2	0.0	8.8	0.0	17.9	0.0	2.7	0.1	0.3	0.8	0.3	0.0	5.4	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.4	0.0	0.0	6.5	3.1	0.0	0.0	0.0	0.3	0.6	1.4	0.3	1.9	0.0	3.5	0.3	0.2	0.0	24.8	2.0	1.2	1.5	6.1	0.0	1.8	0.1	0.0	1.4	0.1	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	2.3	0.1	1.7	3.3	0.0	0.0	0.4	3.4	0.0	0.5	0.0	0.0	0.0	1.4	5.8	14.1	1.7	20.7	3.3	2.4	3.1	9.8	4.4	2.1	0.0	0.0	0.0	0.1	0.1	0.8	1.2	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.3	1.3	2.9	0.0	0.0	0.7	0.6	0.5	0.2	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	8.1	3.0	0.0	0.0	0.0	1.8	0.0	0.8	3.8	0.7	0.4	0.0	0.0	0.0	0.3
SETSIP	SETP18	ENSG00000230667	"SET-like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.8"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 3.1;granulocytes: 3.5"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.3"									HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA			Nucleoplasm	"Lipid droplets"	"HPA063683: AB_2685088"	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0		0.1		0.3	0.0		0.8	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.1			0.2	0.0	0.2	0.0			0.2	0.0	0.0		0.3		0.0	0.0		0.3	0.0	0.7	0.0	0.0	0.0		0.0	0.0	1.8			0.0		0.0	0.0		0.3	0.2	0.6	0.3	0.1	0.2	0.1	0.6	0.7	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	1.3	0.5	0.4	0.0	0.1	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.9	1.2	0.0	0.0	2.3	0.0	1.6	0.4	0.5	1.2	1.0	1.4	0.0	0.6	1.5	0.6	1.3	0.9	0.5	0.1	0.7	0.3	0.0	0.7	0.4	0.2	0.2	0.7	0.6	1.3	0.0	0.1	1.9	0.0	0.0	0.6	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1											0.0	1.1	0.0	0.8	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	1.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.5	0.0	0.0	0.9
BTBD8		ENSG00000189195	"BTB domain containing 8"	Q5XKL5	1	92080305-92184725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 42.3"	"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.2"					"Low region specificity"	"Detected in all"			"HPA024216, HPA035311"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024216: AB_1852385, HPA035311: AB_10671933"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.04e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.15e-1)"	3.4	4.6	11.7	1.2	27.3	0.7	3.3	20.3	42.3	2.3	2.4	4.0	0.6	1.7	3.4	4.7	2.0	3.3	2.3	2.8	7.8	2.1	2.4	1.9	2.5	1.4	4.5	23.3	5.0	2.7	5.1	6.0	2.5	16.4	3.3	2.5	1.2	2.8	2.7	2.3	1.8	2.1	2.0	6.6	1.8	2.4	8.3	9.9	0.2	3.7	0.0	1.1	4.7	2.7	0.5	0.8	0.6	0.7	0.9	2.3	0.4	2.7	2.2	1.6	0.0	5.0	10.2	5.5	1.8	2.5	1.5	1.8	0.5	3.2	1.2	6.5	1.6	6.0	0.8	1.2	3.2	2.3	2.8	1.8	2.1	0.6	0.9	1.1	1.1	1.2	6.0	2.7	0.9	1.8	6.8	1.5	2.9	2.5	0.8	2.8	1.7	0.8	2.1	1.7	3.8	1.7	1.8	1.6	0.2	3.2	2.0	0.9	1.5	2.9	1.4	1.4	3.0	2.3	1.6	1.0	1.9	1.2	1.1	0.7	2.1	0.9	0.0	1.5	0.2	0.4	0.0	0.6	0.0	2.3	0.1	0.5	0.5	1.0	0.9	0.0	0.5	1.8	1.4	0.6	0.9	0.7	0.8	0.9	0.4	11.7	27.3	20.3	42.3	7.8	2.1	4.5	23.3	16.4	9.9	0.0	2.6	0.0	1.0	0.3	8.7	0.7	5.1	5.3	5.7	5.2	5.9	1.9	1.7	3.1	4.5	0.6	1.7	0.0	2.5	0.9	1.1	1.8	0.0	0.8	0.6	3.2	0.0	1.3	2.4	0.5	5.5	1.3	1.7	1.8	2.3	6.5	3.2	2.9	3.5	1.1	16.7	0.0	0.5	3.7	8.2	0.5	1.1	0.5	2.3	0.9
C1orf146		ENSG00000203910	"Chromosome 1 open reading frame 146"	Q5VVC0	1	92217940-92245813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 12.7"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 58.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"													NA	NA						"unprognostic (2.89e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-3)"	"unprognostic (8.77e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.78e-7)"	"unprognostic (3.36e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.19e-3)"	0.1	0.0	0.1	0.4	0.2	0.1	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	1.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.1	12.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.5	0.5	2.6	0.1	0.7	0.5	0.0	0.4	0.0	0.9	2.3	0.0	0.5	1.1	0.3	0.0	0.6	0.7	0.0	1.2	2.1	0.3	0.0	0.1	0.8	0.3	0.0	0.0	0.5	1.0	0.9	0.7	0.0	0.0	0.7	1.9	0.5	0.3	0.9	0.0	0.6	0.3	1.7	0.0	0.8	0.0	1.3	1.1	1.7	0.7	0.1	0.0	0.6	0.2	0.3	0.0	1.6	0.7	0.1	0.4	1.2	0.0	1.4	0.2	1.2	1.0	1.2	0.9	1.0	0.9	1.9	0.4	0.9	0.5	1.0	0.5	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.2	0.4	0.1	0.5	0.3	0.2	2.6	0.7	0.1	0.5	0.0	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	7.5	0.0	0.0	0.0	0.0	0.0
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	4.9	6.6	12.5	8.1	14.8	9.0	10.3	21.3	19.5	7.4	6.8	6.6	5.1	5.1	11.5	8.6	10.1	6.3	5.7	7.2	9.4	6.9	6.4	5.2	5.3	10.6	6.8	13.2	8.3	4.7	8.5	13.6	7.9	8.6	7.6	7.3	13.9	4.9	6.9	7.5	13.5	6.6	6.9	8.0	7.6	5.8	11.2	5.7	13.3	9.0	4.8	12.1	7.9	6.9	2.5	2.0	1.4	1.4	9.0	5.5	1.9	12.2	4.7	15.8	8.7	5.6	8.9	14.6	8.5	7.1	10.7	9.6	9.7	4.9	12.4	13.8	5.1	15.3	9.3	8.3	7.8	15.5	8.8	11.7	16.6	9.4	9.6	5.6	20.9	8.7	6.9	4.5	12.5	5.7	4.2	11.5	10.8	13.7	7.6	14.0	2.8	12.8	15.9	24.1	5.8	8.6	11.1	21.7	8.6	12.1	11.9	14.6	7.6	14.9	14.1	8.9	9.2	6.7	20.2	7.2	7.8	7.5	13.3	12.8	6.7	9.2	15.7	2.9	21.1	4.5	0.0	0.7	1.4	3.2	1.4	5.5	2.5	3.5	3.9	2.0	1.5	3.1	3.6	0.2	9.0	0.8	1.4	2.7	1.9	12.5	14.8	21.3	19.5	9.4	6.9	6.8	13.2	8.6	5.7	8.9	8.8	10.0	10.8	7.9	25.7	7.5	5.1	1.4	4.5	12.2	96.2	13.1	1.7	5.2	1.5	6.8	2.0	0.0	4.5	9.1	10.4	6.7	8.1	2.0	7.2	25.4	10.3	4.9	2.4	1.0	11.5	5.3	8.5	4.6	4.2	13.3	4.5	2.9	7.4	6.8	128.0	6.5	8.1	13.0	28.1	7.9	13.2	20.1	3.9	6.3
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.3	3.9	6.8	6.3	5.6	7.2	5.8	5.0	3.5	3.3	2.7	2.8	2.9	9.5	8.7	3.7	4.5	4.4	5.6	3.2	5.1	6.5	4.0	5.8	7.0	3.7	3.3	10.0	5.8	3.7	4.0	4.2	4.1	4.9	3.5	5.9	5.9	6.4	5.0	3.3	8.4	6.3	5.3	3.6	4.4	6.3	9.0	4.1	4.3	5.7	6.4	4.7	8.1	7.5	4.0	5.3	3.9	7.7	6.1	5.0	6.4	5.7	7.1	6.2	7.1	5.0	3.5	6.3	3.4	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7	59.6	66.2	8.2	15.1	8.1	55.5	21.2	5.1	75.0	68.2	7.0	104.1	17.6	10.0	16.4	39.3	17.1	7.7	23.3	11.9	12.3	13.6	12.8	59.1	7.4	8.5	33.4	12.1	8.0	10.8	4.7	17.5	8.8	1.7	15.4	11.9	39.3	12.8	10.7	20.1	13.0	87.8	25.8	12.0	18.9	18.8	8.5	19.8	24.2	11.1	9.8
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92474762-92486876	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.9;lymphoid tissue: 56.1"	"Group enriched"	"Detected in some"	6	"Mucus-secreting cells: 10.4;T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 16.7;HMC-1: 13.4;NB-4: 17.3;THP-1: 34.8;U-937: 71.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA					"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.2	0.4	0.1	3.6	0.3	31.9	0.7	0.2	0.3	1.1	3.9	0.1	0.1	3.0	0.7	0.7	1.2	1.0	2.6	0.6	0.2	0.1	1.0	0.9	3.4	5.4	0.5	0.3	0.5	12.4	0.0	0.7	0.7	0.5	1.1	3.1	0.9	1.2	1.3	0.7	0.4	6.8	0.6	0.8	8.9	1.8	1.1	0.2	56.1	1.2	0.5	5.0	1.9	0.8	0.0	1.6	0.8	0.0	0.3	4.9	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	1.4	0.0	16.7	13.4	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	4.3	0.0	0.5	10.5	17.3	0.0	0.0	0.0	2.1	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.4	0.0	0.0	6.2	0.4	1.1	0.0	71.9	0.0	0.0	0.0	0.8	4.9	0.0	2.2	0.0	2.1	3.0	0.0	0.0	0.8	4.5	0.1	0.3	0.0	1.6	0.7	0.5	0.1	0.3	0.2	0.3	0.2	0.1	0.5	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	13.1	0.2	0.0
EVI5	NB4S	ENSG00000067208	"Ecotropic viral integration site 5"	O60447	1	92508696-92792404	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027339	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027339: AB_1848308"	"unprognostic (1.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.04e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.35e-2)"	4.5	8.5	27.5	3.4	13.4	1.6	3.6	5.1	35.7	5.4	4.1	2.3	1.7	3.4	5.6	3.9	3.2	4.4	5.0	6.0	12.5	5.5	4.2	14.5	5.9	2.1	5.6	23.1	3.5	4.4	8.8	4.5	10.4	3.7	4.6	4.6	1.7	4.2	5.0	3.1	4.0	3.3	6.1	5.7	3.3	5.3	8.0	2.4	1.7	5.6	1.7	2.4	4.2	3.9	2.3	2.2	6.0	4.8	0.2	0.2	0.7	3.7	4.1	6.5	6.3	10.7	13.5	6.2	8.6	13.1	5.9	6.8	7.2	1.0	1.6	12.2	9.8	11.0	4.3	6.1	6.3	10.6	0.1	2.4	3.0	4.2	4.3	10.5	2.1	3.5	8.4	5.2	10.2	6.2	17.3	12.7	0.1	5.2	2.7	9.8	1.8	0.2	2.5	1.9	2.4	3.4	1.5	15.6	2.1	4.5	10.8	2.4	5.1	10.1	5.3	11.5	7.4	2.6	4.9	8.3	6.6	4.9	8.7	5.6	3.9	2.3	2.7	4.3	3.5	5.4	1.3	4.8	4.4	0.2	3.3	0.1	2.0	0.2	0.0	2.2	2.3	0.1	0.1	6.0	0.2	4.7	1.5	0.1	0.7	27.5	13.4	5.1	35.7	12.5	5.5	5.6	23.1	3.7	2.4	56.6	25.1	12.7	21.7	38.6	23.4	46.0	22.9	36.1	35.2	15.7	23.6	42.6	14.9	25.8	2.6	27.4	18.8	23.3	25.8	20.4	35.1	27.0	12.7	46.1	26.8	28.6	21.2	46.1	51.1	3.1	26.2	36.2	25.3	13.6	24.7	27.6	47.1	17.3	50.9	15.5	24.8	12.9	30.0	35.6	42.8	43.7	54.8	3.2	18.7	31.6
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nucleoli rim"	"HPA043717: AB_10964719, HPA054444: AB_2732584"	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	118.8	51.1	91.0	76.7	118.4	239.2	146.0	71.1	95.2	88.5	63.5	135.2	52.0	224.2	114.2	79.8	84.0	76.0	104.3	133.2	113.2	71.0	142.8	116.3	85.0	124.4	142.0	178.1	49.1	195.6	210.2	78.6	173.1	160.6	122.3	118.5	144.0	118.2	101.4	67.4	141.8	201.9	140.6	90.4	96.5	130.3	176.3	144.8	107.4	99.0	77.6	92.9	46.3	129.2	206.7	78.2	71.2	245.0	74.2	44.7	81.8	84.6	128.1	73.2	69.5	151.7	30.3	153.6	30.3	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7	607.4	848.7	2690.4	3540.6	2525.4	316.8	352.2	1200.0	674.6	1189.7	390.8	84.4	2237.8	1689.4	1278.7	1159.8	1643.6	564.1	537.3	2338.5	3530.6	1572.9	2535.7	1002.7	856.3	1297.7	138.2	1189.1	1198.2	1468.3	888.7	2620.2	1565.9	1334.5	1646.5	1585.6	343.0	1936.2	1164.3	2027.0	1766.3	226.7	1034.8	1885.9	531.9	457.4	2528.9	2185.2	1965.9	2487.8	3230.9
FAM69A	FLJ23493	ENSG00000154511	"Family with sequence similarity 69 member A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 25.6;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	13.3	3.4	20.7	10.4	22.5	7.0	7.8	19.4	22.2	7.3	13.2	15.9	4.2	8.8	15.7	3.8	9.3	8.3	11.1	5.3	22.6	18.0	6.1	24.7	4.5	10.1	25.0	12.2	6.0	3.5	20.5	4.1	12.8	17.7	9.5	12.4	5.4	5.5	11.3	7.5	5.6	8.2	19.4	24.7	7.6	8.8	6.4	24.4	9.6	6.2	3.6	8.8	12.2	6.0	22.5	7.1	0.2	0.9	11.8	14.2	6.7	4.3	4.8	2.0	4.8	7.5	14.1	2.4	13.6	28.1	7.7	15.7	2.7	0.9	14.8	2.5	25.0	15.4	5.6	0.3	10.2	12.8	5.9	4.8	0.5	3.8	6.9	2.7	1.3	0.9	8.4	8.2	17.0	3.9	13.1	0.1	9.1	5.2	15.7	9.7	1.6	4.9	1.2	3.5	7.3	1.9	4.4	14.5	4.5	1.1	4.5	4.9	3.8	3.8	3.8	5.0	4.6	1.8	0.4	0.5	9.1	7.0	17.7	4.8	23.8	22.7	17.3	4.3	0.9	0.8	0.0	0.9	0.0	10.5	0.4	8.1	22.5	12.1	8.2	4.3	13.6	14.2	12.1	0.2	11.8	0.2	7.1	10.7	6.7	20.7	22.5	19.4	22.0	22.6	18.0	25.0	12.2	17.7	24.4	0.0	2.4	9.3	3.5	10.1	1.3	3.6	7.6	10.7	1.2	5.2	2.0	25.6	3.3	1.6	1.5	3.0	1.3	0.0	2.1	4.9	9.9	3.7	0.0	13.2	3.7	7.9	0.0	4.9	3.7	2.3	0.9	2.2	6.8	16.2	3.2	0.7	2.8	0.0	7.1	4.4	1.3	0.0	9.2	0.7	1.6	8.2	21.2	5.7	2.5	1.8
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139081	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.4"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.05e-4)"	"prognostic unfavorable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	6.8	8.0	8.5	19.7	18.4	21.9	10.3	24.3	12.2	9.8	8.0	8.6	4.9	8.0	9.0	8.5	7.2	7.6	7.4	5.3	9.0	8.2	7.6	7.3	8.6	19.9	8.1	9.8	12.0	7.0	6.7	13.9	13.0	9.2	7.0	8.4	6.7	6.7	6.8	7.1	8.1	9.5	6.8	8.5	12.7	7.2	17.3	9.2	43.4	9.6	7.1	19.4	7.9	8.3	11.7	12.0	14.7	10.6	13.0	14.3	6.2	7.4	3.6	12.5	8.2	2.2	2.1	14.5	4.8	3.8	8.3	10.4	6.1	4.1	24.1	8.8	3.0	7.1	4.0	11.5	5.0	12.3	9.3	8.4	16.6	5.5	8.2	3.3	21.6	7.1	2.6	2.7	7.8	4.7	3.8	7.9	18.8	18.7	7.6	5.1	3.1	31.0	18.0	21.3	3.3	4.8	25.2	15.4	6.5	7.7	8.1	7.8	9.5	7.9	9.4	9.6	13.8	5.6	15.3	4.5	5.5	8.2	5.2	7.1	5.9	6.7	42.8	1.1	12.9	3.5	9.4	9.4	14.7	11.3	10.6	12.9	10.0	11.7	14.3	12.0	11.7	13.9	12.4	7.2	13.0	6.3	11.4	12.9	6.2	8.5	18.4	24.3	12.2	9.0	8.2	8.1	9.8	9.2	9.2	26.8	27.2	56.4	25.5	41.3	0.0	11.7	7.6	17.4	28.4	36.6	0.0	60.2	6.6	29.9	3.7	39.3	25.4	23.3	16.9	56.8	29.0	28.2	57.8	13.4	30.0	0.0	30.9	35.0	26.7	5.0	30.2	40.6	16.9	42.3	29.2	0.0	27.2	31.6	22.3	12.9	0.0	38.8	23.6	122.6	74.3	37.8	50.8	48.4	30.8	32.0
TMED5	"CGI-100, p24g2, p24gamma2"	ENSG00000117500	"Transmembrane p24 trafficking protein 5"	Q9Y3A6	1	93149742-93180728	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050289	Approved					NA	NA					"HPA050289: AB_2681074"	"unprognostic (3.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.02e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.37e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.38e-1)"	16.5	22.2	9.4	13.9	11.8	21.0	22.7	7.6	11.1	8.8	11.4	8.5	10.9	12.8	8.6	12.2	10.2	8.1	12.1	20.2	9.5	6.3	30.4	57.4	15.8	11.3	16.5	6.4	9.9	13.6	9.4	15.6	17.3	13.8	9.1	10.8	6.0	14.6	9.2	22.7	6.2	12.5	6.6	17.9	15.2	11.4	7.7	12.4	8.4	19.0	8.4	10.2	12.5	19.2	14.8	15.9	30.2	20.2	8.9	16.8	15.3	21.6	9.3	10.3	10.3	29.7	18.0	22.9	17.3	17.2	14.0	20.8	15.7	17.2	10.5	17.9	14.9	30.1	11.8	11.8	10.5	15.7	12.1	14.5	9.7	10.0	16.0	17.8	11.4	15.1	21.4	15.2	21.8	19.8	15.9	16.4	8.8	16.5	30.2	13.4	3.5	12.8	8.6	6.8	11.7	12.7	9.7	17.4	17.0	17.6	12.2	6.0	6.9	20.9	18.9	19.9	8.9	9.0	9.8	16.3	14.8	15.0	18.8	17.6	21.0	26.3	12.9	9.7	10.8	6.6	30.2	19.5	26.2	14.3	19.3	16.8	14.8	14.7	16.4	15.9	10.6	11.3	13.1	9.7	8.9	20.2	11.0	16.2	15.3	9.4	11.8	7.6	11.1	9.5	6.3	16.5	6.4	13.8	12.4	68.5	41.6	39.4	55.9	63.7	6.1	40.3	25.5	17.4	33.0	55.8	19.6	31.4	10.0	28.6	61.5	30.2	44.4	0.0	35.1	66.7	30.5	83.9	39.3	97.8	63.8	7.9	19.5	17.2	63.2	97.4	21.9	73.1	32.1	42.3	29.1	12.4	33.9	42.1	15.2	56.5	8.1	58.2	41.4	29.0	13.4	56.7	71.4	41.5	29.9	101.7
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 128.6;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	3.8	2.3	2.7	20.0	4.3	13.4	4.6	3.7	2.7	2.2	3.2	0.4	2.9	2.5	1.8	4.0	3.2	1.8	1.7	2.6	3.4	1.9	2.0	3.0	3.8	11.9	1.7	1.8	2.8	1.5	0.7	4.8	1.9	2.6	1.9	4.1	1.3	2.0	3.1	6.2	3.1	3.4	2.3	3.8	6.0	2.3	12.6	2.5	15.8	2.1	2.8	8.2	2.9	3.3	12.2	11.9	6.0	3.9	1.1	2.7	0.5	15.7	5.3	12.4	3.9	3.0	3.2	6.5	9.8	5.2	10.1	10.3	2.7	5.4	20.4	5.5	5.2	9.9	7.5	5.4	7.7	14.7	10.1	7.1	14.0	11.3	4.8	1.1	14.5	6.5	2.1	0.6	7.6	7.5	2.8	6.5	9.2	14.9	15.8	13.4	2.2	6.9	5.9	11.3	4.3	6.6	9.0	14.8	6.0	4.9	7.1	5.5	3.5	13.9	7.1	4.1	5.8	3.4	8.5	5.0	11.9	8.4	7.6	11.1	6.8	8.8	12.3	2.5	13.0	3.1	3.4	3.8	5.3	2.4	3.9	2.7	8.8	2.2	2.1	1.6	12.2	1.7	2.0	6.0	1.1	3.5	11.9	2.2	0.5	2.7	4.3	3.7	2.7	3.4	1.9	1.7	1.8	2.6	2.5	17.9	11.1	17.6	6.5	3.7	2.4	8.1	0.0	6.7	4.5	3.5	3.9	2.6	0.0	1.9	17.7	3.7	1.7	0.0	2.6	5.8	6.8	3.3	18.5	2.9	7.2	1.6	0.0	4.3	12.4	8.5	5.8	19.5	3.3	9.0	2.5	1.1	1.8	3.5	6.0	1.0	0.6	6.5	5.7	128.6	37.7	6.4	2.4	14.1	3.1	6.4
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345888-93369498	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	18.5	15.2	14.6	19.4	17.9	37.2	16.9	20.1	18.7	19.2	19.0	17.5	12.6	19.4	20.7	9.7	26.7	13.6	17.0	19.0	14.5	13.9	17.0	17.8	19.0	28.2	15.0	10.1	17.1	14.3	14.4	17.6	25.9	14.2	17.6	12.2	16.7	18.2	10.9	32.2	27.0	21.4	15.4	15.9	21.8	21.8	44.4	14.9	63.4	17.8	17.8	25.4	20.5	22.1	19.0	28.0	39.8	26.0	16.5	27.9	18.7	33.0	10.4	16.7	21.5	15.5	17.7	20.6	26.8	16.5	18.3	19.6	12.0	12.0	35.1	31.1	19.7	24.9	17.6	20.0	18.5	27.0	29.5	18.8	29.5	21.9	13.1	24.7	34.6	21.8	12.3	22.4	25.4	37.0	19.1	16.2	21.1	30.3	34.0	21.6	10.2	32.8	10.9	27.8	11.5	25.5	28.6	36.9	35.8	12.9	20.2	16.2	20.7	22.8	21.2	28.1	15.8	15.0	27.4	25.1	33.1	26.4	32.3	40.0	19.7	21.8	36.3	9.5	27.7	13.4	36.8	22.8	39.8	19.0	26.0	21.1	19.0	21.0	21.6	28.0	16.1	21.2	20.6	31.9	16.5	22.1	22.9	27.9	18.7	14.6	17.9	20.1	18.7	14.5	13.9	15.0	10.1	14.2	14.9	26.8	23.2	41.0	28.2	152.1	30.2	28.2	22.9	12.0	25.0	34.9	23.6	62.2	38.1	30.0	119.9	35.9	27.5	46.7	24.1	58.0	36.2	39.6	48.4	24.3	46.8	47.7	20.0	32.5	46.7	83.6	26.2	41.6	42.2	63.1	37.3	14.2	36.5	23.0	24.8	31.0	24.1	32.3	43.2	95.6	40.9	140.4	91.9	44.7	23.4	63.0
FNBP1L	"C1orf39, FLJ20275, TOCA1"	ENSG00000137942	"Formin binding protein 1 like"	Q5T0N5	1	93448131-93554661	"Predicted intracellular proteins"	"Autophagy, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"SuSa: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065273	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA065273: AB_2685452"	"unprognostic (1.83e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.72e-7)"	"unprognostic (3.59e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.78e-1)"	22.8	6.8	17.8	8.3	36.0	1.7	27.0	20.3	11.3	15.7	24.3	5.4	27.3	16.5	14.2	15.9	7.6	11.4	11.9	16.3	13.0	13.7	29.9	10.9	18.0	3.3	10.5	10.3	12.2	15.0	16.0	15.6	13.7	14.0	14.5	14.5	5.6	32.2	23.2	23.4	10.3	27.5	10.3	13.9	2.6	19.0	12.0	16.1	2.5	26.3	7.1	3.3	15.2	24.2	0.9	2.2	11.1	0.1	0.1	0.4	0.2	9.9	5.5	29.1	16.2	6.3	4.6	32.5	5.0	3.4	3.8	5.3	6.9	3.1	0.0	10.4	4.8	10.2	5.1	7.0	5.7	5.4	6.4	5.2	5.3	8.1	10.0	3.1	0.9	0.1	8.2	9.5	3.5	5.2	9.9	17.9	6.3	2.0	0.0	8.9	4.6	3.8	0.4	22.1	17.0	5.6	8.4	22.2	2.6	16.6	16.0	11.7	16.5	15.6	30.6	8.7	36.1	11.6	1.3	17.7	8.9	11.3	0.2	3.4	3.1	2.5	0.1	0.8	0.1	6.0	11.1	0.1	1.1	0.0	0.0	0.1	0.6	0.4	0.0	0.5	0.9	0.0	0.4	0.1	0.1	0.0	2.2	0.4	0.2	17.8	36.0	20.3	11.3	13.0	13.7	10.5	10.3	14.0	16.1	101.3	29.0	3.7	34.3	23.6	13.4	37.0	50.9	60.2	73.9	59.3	3.9	29.1	48.0	67.0	9.4	31.9	31.6	0.0	42.3	30.4	14.6	55.7	15.1	18.3	9.5	65.2	64.3	16.0	5.6	13.7	7.5	10.6	37.1	10.8	30.8	17.3	48.1	38.4	3.5	42.3	9.3	25.8	12.2	20.7	37.1	22.5	14.3	2.6	31.4	72.9
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavorable (8.41e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic unfavorable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.3	6.6	12.4	0.9	5.4	4.2	10.7	15.9	27.8	13.1	8.1	1.1	11.5	2.5	5.5	24.5	17.1	9.6	0.3	20.6	11.5	1.1	0.3	0.0	4.8	2.8	9.7	0.1	0.0	5.0	22.8	13.6	46.2	12.7	14.4	0.3	0.4	0.1	35.5	2.3	0.3	0.0	3.9	6.7	22.9	1.0	17.9	0.3	34.4	19.5	0.4	1.0	7.7	8.3	9.9	5.0	9.3	0.6	16.9	19.6	5.0	8.3	21.0	1.3	0.5	0.3	2.9	0.0	7.1	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0	3.0	7.4	7.4	102.8	8.8	1.0	6.7	7.6	10.7	9.1	14.0	0.0	23.0	23.2	11.1	8.4	17.3	20.2	0.0	5.6	70.7	9.3	24.4	3.5	9.4	10.3	20.6	14.3	5.5	4.3	11.2	9.5	8.1	18.6	16.2	20.7	4.3	17.7	20.7	1.1	15.6	0.4	71.1	19.3	3.2	2.9	8.9	15.8	0.0	10.0	114.7
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866283-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	14.0	8.5	10.7	7.3	11.4	27.6	10.9	12.0	12.5	12.4	9.4	5.8	7.9	6.1	9.4	14.1	15.1	9.7	9.7	11.4	9.4	10.3	14.5	15.1	12.1	10.7	10.4	10.5	15.9	8.3	9.9	12.1	15.5	17.7	13.0	8.1	4.6	9.0	7.3	24.6	11.7	11.7	11.0	13.2	16.2	9.0	12.0	10.9	15.9	16.2	12.6	10.7	17.3	15.5	11.1	7.2	15.8	11.6	11.9	11.6	8.0	12.4	6.0	6.8	7.1	6.5	5.8	10.3	8.4	6.0	10.1	8.7	6.6	5.6	16.7	11.3	8.8	12.7	7.1	10.8	10.1	14.4	10.1	6.1	13.7	9.9	9.6	6.8	15.3	4.9	6.4	11.0	10.8	9.1	5.1	7.2	5.5	16.1	5.8	13.7	5.4	10.7	10.0	13.0	5.6	9.7	6.2	14.4	6.4	10.3	9.7	8.1	7.3	8.8	13.2	9.2	9.0	5.7	11.1	6.8	8.2	8.6	9.4	14.1	6.1	8.1	13.7	4.8	12.1	5.4	10.9	7.9	15.8	9.6	11.6	11.6	11.1	8.9	8.7	7.2	10.5	8.2	10.4	12.1	11.9	10.7	5.0	8.8	8.0	10.7	11.4	12.0	12.5	9.4	10.3	10.4	10.5	17.7	10.9	53.6	74.1	43.3	98.3	48.3	31.6	69.0	10.2	117.8	117.2	12.2	55.0	44.4	18.3	60.2	28.9	60.6	13.1	23.3	52.7	36.6	31.7	61.4	112.5	16.6	33.8	19.1	8.1	20.9	24.1	7.4	23.9	59.5	21.9	64.1	12.1	30.7	68.6	15.3	24.4	14.7	29.6	19.4	106.0	54.0	70.5	44.3	46.7	46.5	19.7	80.3
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885205-93909456	"Cancer-related genes, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 210.2;Glandular cells: 272.8;Urothelial cells: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	10.3	17.5	7.0	6.0	7.7	11.3	23.9	5.7	8.9	4.5	22.8	4.2	11.5	16.6	3.5	6.5	8.8	12.8	12.5	7.7	6.8	8.9	17.8	41.7	8.4	10.4	9.2	5.7	4.6	6.9	6.3	5.1	10.3	8.7	5.3	5.2	6.4	6.7	6.4	19.2	3.4	20.0	3.4	7.7	6.9	6.1	3.2	2.8	5.6	15.0	23.0	8.6	8.9	8.0	3.2	1.9	3.3	0.7	4.6	6.7	1.2	13.1	20.9	2.3	4.5	7.8	4.9	8.9	15.8	9.8	12.0	9.0	3.5	7.8	5.0	31.6	10.2	39.2	13.3	3.4	6.4	9.7	13.5	4.6	34.9	14.2	15.0	14.6	12.8	5.6	6.0	2.4	24.4	3.9	4.8	13.1	5.7	13.8	7.4	8.6	2.5	9.2	3.0	7.9	12.6	10.0	4.3	7.0	7.3	8.5	15.4	5.4	2.2	14.8	11.7	5.5	27.5	2.6	8.0	13.7	12.6	7.4	23.6	23.6	6.7	8.5	5.2	10.4	7.2	4.4	3.3	0.7	1.3	5.3	0.4	3.1	2.6	5.0	6.7	0.6	3.2	3.2	3.2	2.9	4.6	0.5	1.9	1.3	1.2	7.0	7.7	5.7	8.9	6.8	8.9	9.2	5.7	8.7	2.8	38.7	18.4	13.3	119.7	10.2	23.7	13.5	53.5	49.5	19.4	27.9	5.9	60.1	21.6	24.6	3.0	14.5	25.6	210.2	10.7	16.4	25.0	272.8	19.6	71.6	16.8	31.8	50.4	41.7	17.7	1.9	19.8	15.4	8.5	10.8	9.3	19.3	22.5	7.0	11.7	45.8	12.6	0.0	44.3	22.8	40.4	8.2	37.6	34.6	13.2	201.0
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	0.2	1.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.0	0.2	0.3	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	5.1	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2	0.0	0.6	0.0	0.2	0.1	14.3	0.8	0.0	2.7	0.0	7.0	424.1	0.1	0.0	0.0	8.5	0.8	0.0	0.0	0.0	1.1	0.2	1.5	0.0	0.0	0.1	9.5	0.0	0.6	0.0	15.5	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.4	0.0	455.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 271.0;Glandular cells: 419.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	38	"monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"A-431: 48.5;hTERT-HME1: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	28.1	3.2	7.2	6.8	10.6	0.3	24.4	34.9	11.5	11.9	7.4	2.3	9.0	2.8	10.3	8.1	6.9	8.2	9.1	15.9	7.8	5.2	27.7	21.1	23.0	8.2	6.7	3.6	11.5	6.5	12.8	7.4	22.9	10.0	12.2	4.7	11.7	20.7	10.4	10.3	13.5	5.4	8.0	6.4	26.0	8.8	7.7	7.0	2.2	22.7	8.9	3.8	10.6	14.8	0.0	0.0	0.0	3.7	0.0	0.0	0.3	48.5	2.0	3.0	0.0	10.6	25.2	10.8	16.3	26.5	13.8	20.2	5.8	2.4	0.0	36.7	32.6	15.8	10.4	0.1	11.1	28.5	0.0	1.6	0.2	2.8	2.6	1.0	0.0	0.0	4.9	2.0	10.5	43.7	16.3	37.2	0.0	0.0	0.0	13.7	1.6	0.9	0.0	3.9	0.2	33.4	0.6	2.5	0.0	29.1	4.3	0.0	0.6	10.0	7.8	0.7	12.2	2.3	0.1	33.3	8.4	11.5	12.9	12.5	0.0	0.0	0.0	1.6	0.0	0.4	0.0	1.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	7.2	10.6	34.9	11.5	7.8	5.2	6.7	3.6	10.0	7.0	47.6	17.3	2.9	135.8	20.8	9.7	19.9	25.5	9.4	33.0	123.9	17.7	21.9	46.4	71.3	49.8	271.0	0.0	0.0	14.7	90.4	34.4	419.1	3.5	51.3	2.6	87.4	0.0	176.8	18.6	16.2	22.7	5.6	25.3	0.0	0.9	95.2	37.1	0.0	20.5	47.5	80.7	187.5	197.8	66.2	123.5	15.1	11.8	4.3	0.4	45.2
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418455-94518666	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA			Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	8.9	14.2	13.1	9.5	13.3	10.3	16.8	11.2	12.8	11.8	21.2	14.9	24.9	21.4	9.8	14.6	15.4	10.0	17.3	16.0	12.7	10.3	29.3	60.6	11.2	9.9	13.2	10.4	8.1	16.7	18.3	14.6	11.2	14.3	11.0	20.1	21.4	13.2	24.0	12.9	17.1	21.7	10.8	16.5	7.6	20.8	10.2	12.7	46.5	13.7	10.8	9.9	11.8	11.1	3.1	8.4	3.9	6.2	8.0	7.4	4.2	28.2	13.3	13.7	13.1	10.6	11.7	20.4	14.8	11.5	17.0	19.0	41.4	8.9	17.5	19.2	18.7	18.3	20.8	15.8	19.1	24.0	14.0	13.6	19.9	19.6	35.9	10.3	17.6	6.2	9.8	10.8	19.8	7.6	11.1	10.4	16.7	8.8	10.5	17.6	3.9	29.6	9.3	15.8	21.7	18.9	16.7	28.6	6.8	16.9	43.3	10.4	17.1	25.6	27.2	19.2	10.9	10.0	14.7	10.3	12.7	18.4	22.2	19.6	6.0	5.6	17.1	9.9	9.0	5.9	0.3	5.3	3.9	6.5	6.2	6.1	2.8	5.9	7.4	8.4	3.1	7.1	6.9	1.3	8.0	5.2	2.2	6.5	4.2	13.1	13.3	11.2	12.8	12.7	10.3	13.2	10.4	14.3	12.7	32.8	39.0	10.4	16.3	20.7	25.9	36.4	63.7	30.8	25.0	40.1	21.6	22.7	19.9	19.9	5.4	12.0	62.4	0.0	38.4	9.6	17.3	22.1	27.6	99.9	10.1	31.8	38.2	20.3	21.6	6.2	12.7	12.6	15.1	2.8	38.1	85.8	29.7	28.1	23.0	56.2	22.8	19.4	12.3	10.4	23.7	29.6	12.8	10.5	32.8	20.0
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529225-94541800	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 636.0;Exocrine glandular cells: 410.4;Muller glia cells: 389.7;Pancreatic endocrine cells: 1078.7;Peritubular cells: 498.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 117.4;HaCaT: 55.6;HBEC3-KT: 144.4;U-2197: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	45.5	9.8	27.0	14.1	42.9	2.1	55.1	3.4	27.9	14.8	18.7	20.9	18.7	18.3	30.5	23.7	21.3	25.4	30.9	18.8	26.9	14.5	6.6	2.8	31.4	5.8	14.1	20.3	41.6	35.0	6.1	28.8	65.4	39.2	29.7	22.2	49.9	29.2	33.0	2.4	17.7	19.2	5.9	46.3	2.9	18.2	16.4	16.0	0.0	21.8	17.3	11.9	24.7	22.3	0.5	0.9	2.8	0.8	0.7	0.4	0.2	117.4	0.2	0.2	0.0	12.8	6.3	6.6	16.7	10.0	18.1	19.7	2.1	25.2	0.0	8.6	20.7	3.9	55.6	1.5	144.4	29.9	0.1	0.1	0.0	3.6	0.3	4.2	0.0	0.0	10.9	3.2	8.5	41.9	34.4	0.1	0.1	0.1	0.1	12.6	0.2	0.1	2.4	1.1	0.7	0.2	0.1	1.2	0.0	2.2	0.3	0.1	0.3	13.3	5.5	0.4	3.6	0.1	1.6	0.0	11.0	0.3	54.8	5.0	0.1	0.1	0.1	8.4	0.6	0.4	1.7	0.8	0.1	0.3	0.3	0.4	0.2	0.3	0.2	0.2	0.5	0.3	0.3	2.8	0.7	0.2	0.9	0.2	0.2	27.0	42.9	3.4	27.1	26.9	14.5	14.1	20.3	39.2	16.0	122.1	188.9	0.5	636.0	14.4	1.5	21.1	7.6	72.3	238.8	14.0	0.0	13.6	0.0	120.9	5.6	10.5	10.3	0.0	410.4	4.8	48.3	85.3	2.3	0.6	5.4	3.2	12.6	12.3	4.0	9.8	260.4	4.9	3.3	3.6	40.9	389.7	1078.7	11.0	498.9	0.3	13.3	6.5	7.2	1.1	3.4	6.6	6.4	0.8	9.5	358.5
SLC44A3	"CTL3, MGC45474"	ENSG00000143036	"Solute carrier family 44 member 3"	Q8N4M1	1	94820342-94895246	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 14.8;RPTEC TERT1: 43.5;RT4: 29.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047433	Enhanced					NA	NA					"HPA047433: AB_2680046"	"unprognostic (8.06e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.63e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (9.09e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.31e-3)"	1.8	7.3	9.1	6.1	8.3	0.0	5.3	6.6	5.6	5.9	19.8	3.9	4.5	16.5	4.8	5.1	6.6	5.1	16.3	4.5	6.3	5.0	21.4	3.9	6.7	0.4	6.1	3.6	2.7	22.2	5.3	22.2	3.9	5.8	7.2	22.9	9.5	16.0	8.5	1.6	3.7	17.2	2.9	5.4	0.5	17.9	1.6	4.2	2.6	5.4	0.9	4.1	11.0	6.3	0.0	0.0	0.0	0.0	0.0	5.2	0.1	9.5	1.3	0.3	0.0	1.1	1.4	6.7	0.1	1.4	0.3	1.6	8.9	2.4	0.0	6.6	0.1	3.0	3.2	1.4	2.3	0.6	0.0	1.7	0.0	0.5	0.7	0.4	0.0	0.0	4.3	2.1	0.7	0.0	2.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	0.1	0.4	14.8	0.3	0.7	0.3	0.5	43.5	29.0	4.5	7.3	0.4	4.6	3.2	3.3	2.6	0.3	0.0	0.2	1.5	0.6	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	8.3	6.6	5.6	6.3	5.0	6.1	3.6	5.8	4.2	23.8	7.9	0.0	27.4	2.7	0.5	6.5	33.1	4.0	3.4	12.2	0.0	13.2	13.3	27.9	20.6	1.0	14.8	0.0	24.6	0.5	5.2	16.6	1.1	1.6	1.1	0.0	15.6	0.6	0.3	2.5	4.6	0.7	5.0	1.8	32.8	14.5	30.4	31.6	10.3	28.4	0.2	0.0	2.1	0.1	0.2	3.3	5.6	0.0	40.5	25.0
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927278	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.7;naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	14	"B-cells: 9.7;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"		NA	NA		320000	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: AB_2681399"	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.99e-4)"	49.3	78.5	53.4	27.9	53.9	1.2	82.7	25.3	44.7	55.1	36.3	30.8	20.8	45.4	74.0	31.4	53.6	39.4	55.3	33.0	46.8	40.3	74.2	50.6	59.0	28.6	45.3	27.0	61.5	28.0	21.6	33.5	88.5	67.8	38.8	30.2	47.5	32.9	48.9	16.1	16.6	33.4	68.6	78.2	30.8	30.6	21.1	41.9	9.3	44.3	18.4	17.2	48.7	74.5	9.7	0.1	0.4	0.1	0.7	11.1	2.6	44.9	8.7	49.6	43.7	35.5	31.9	22.0	21.7	43.0	36.6	58.1	40.2	4.0	0.0	50.1	28.0	36.3	12.9	36.2	19.3	53.0	0.1	12.8	2.0	6.1	30.4	66.0	0.0	0.0	29.8	3.0	45.2	10.5	64.1	32.8	2.9	0.4	4.1	95.4	0.0	2.1	0.1	38.1	0.0	4.7	0.0	59.2	0.2	47.7	18.7	3.0	30.4	18.1	7.7	30.7	38.7	13.9	4.5	20.1	24.5	42.0	9.0	70.6	5.0	2.9	0.1	5.3	0.0	36.7	0.1	0.0	0.0	1.9	0.1	3.1	3.9	2.0	1.1	0.1	9.7	11.1	7.6	0.4	0.7	0.1	0.0	0.0	2.6	53.4	53.9	25.3	43.6	46.8	40.3	45.3	27.0	67.8	41.9	140.0	65.4	13.7	201.6	69.5	9.8	33.1	81.5	65.6	75.1	120.4	19.6	195.8	369.7	231.6	114.0	306.3	50.5	23.3	214.4	29.9	297.7	266.3	13.9	115.7	19.8	1.6	69.5	399.0	29.8	108.9	254.3	14.6	187.3	8.2	41.2	367.2	119.5	39.1	359.2	359.0	12.3	258.7	319.2	10.3	37.5	68.0	172.1	10.1	89.1	330.4
ALG14	MGC19780	ENSG00000172339	"ALG14, UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974407-95072945	"Disease related genes, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA031829: AB_2674062"	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	5.8	13.2	6.8	4.1	8.5	4.6	6.8	5.6	8.0	5.5	7.5	8.5	7.0	8.5	5.4	11.3	5.7	4.8	6.1	6.3	7.0	7.2	8.9	15.1	5.3	7.5	8.2	4.7	5.3	12.6	5.8	6.6	6.3	8.4	5.1	8.7	6.9	14.5	9.8	7.2	5.0	9.2	4.4	9.4	5.8	6.0	10.0	4.2	3.7	8.5	6.2	5.3	4.8	4.2	4.9	5.8	3.1	3.9	2.8	3.8	1.9	5.2	3.3	2.8	2.5	2.2	3.8	2.5	3.8	4.1	3.9	3.3	3.9	1.8	2.7	4.0	4.7	4.7	3.6	3.2	3.6	4.7	5.7	5.5	1.5	3.6	5.9	3.6	3.6	1.0	4.1	3.7	2.9	2.9	3.2	3.3	3.6	2.9	3.6	3.7	2.5	3.8	2.3	1.7	5.2	4.8	2.4	5.7	2.9	4.4	3.0	2.5	3.2	2.1	7.2	6.3	2.2	3.2	3.1	2.6	2.5	2.8	4.4	7.9	2.3	2.2	2.4	1.8	1.8	2.0	3.1	3.2	1.1	2.5	3.9	2.4	4.9	3.1	3.1	4.5	4.4	2.9	3.0	2.7	2.8	1.9	5.8	3.8	1.9	6.8	8.5	5.6	8.0	7.0	7.2	8.2	4.7	8.4	4.2	0.0	12.6	5.2	10.9	10.4	14.8	7.3	10.2	8.1	11.4	15.7	5.9	28.7	16.6	21.4	5.4	8.0	19.2	23.3	46.6	23.6	21.1	9.2	1.1	30.6	17.2	7.9	4.1	14.7	6.3	6.5	13.3	10.8	30.4	11.8	11.1	28.5	21.0	25.9	9.6	34.3	12.9	32.3	12.5	33.6	22.6	7.5	21.1	4.4	24.9	9.1
TMEM56	FLJ31842	ENSG00000152078	"Transmembrane protein 56"	Q96MV1	1	95117338-95197607	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 68.8;Erythroid cells: 186.9;Hepatocytes: 246.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.3;naive B-cell: 1.6;neutrophil: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A-431: 13.9;GAMG: 13.1;RH-30: 23.2"									HPA046762			Approved	"Nuclear speckles"		No	No			"Nuclear speckles"		"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	3.3	6.6	6.1	1.6	6.5	10.4	2.0	10.9	10.6	2.0	8.2	3.8	2.8	3.6	2.5	2.1	1.9	2.2	4.5	15.1	4.2	3.2	3.9	74.2	2.6	0.7	3.5	5.7	1.5	6.5	5.4	6.8	3.1	4.7	3.8	6.6	28.1	4.8	2.7	7.2	1.7	6.6	8.1	4.1	1.0	3.9	3.2	3.2	0.0	4.8	1.7	0.8	4.8	3.1	3.3	0.1	1.0	0.1	0.0	0.3	0.1	13.9	8.0	1.1	1.7	0.5	0.0	1.9	0.5	0.3	1.8	4.3	5.8	6.7	0.0	7.0	0.2	13.1	0.1	4.7	0.7	3.2	9.7	2.6	0.3	6.8	1.2	0.5	0.2	0.4	0.8	0.2	1.4	0.0	2.9	0.0	0.8	12.2	0.7	0.4	1.1	0.8	0.0	1.1	0.4	4.4	0.0	23.2	0.3	7.8	9.1	2.9	2.3	9.9	7.0	4.1	1.2	7.6	0.2	0.1	0.2	6.0	0.7	4.9	2.5	4.8	0.0	1.0	0.0	1.4	0.3	0.1	0.1	0.1	0.0	0.0	3.3	0.2	0.2	0.0	1.6	0.3	0.1	1.0	0.0	0.0	0.1	0.1	0.1	6.1	6.5	10.9	10.6	4.2	3.2	3.5	5.7	4.7	3.2	6.0	22.6	10.7	4.2	1.0	3.2	68.8	25.5	4.0	3.4	14.0	0.0	6.6	1.7	13.6	13.9	1.0	39.2	186.9	21.0	1.3	5.1	21.2	0.0	246.3	0.5	0.0	15.6	17.2	5.0	36.7	2.6	0.0	1.7	0.0	18.7	37.5	10.3	13.6	2.1	12.4	1.0	6.5	4.2	3.3	6.0	0.4	3.8	1.0	13.3	4.2
TMEM56-RWDD3		ENSG00000271092	"TMEM56-RWDD3 readthrough"		1	95117923-95247225	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 42.6;retina: 25.5"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 2.7;granulocytes: 4.6;Intestinal endocrine cells: 1.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.1"															NA	NA						"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.42e-2)"	3.1	3.9	4.6	1.8	5.8	2.8	3.9	7.5	9.2	2.9	3.6	3.3	2.3	4.1	3.2	4.9	2.1	3.1	3.7	14.2	3.8	2.4	2.8	42.6	2.7	3.3	2.5	4.9	3.5	6.2	4.1	6.1	4.5	4.1	3.7	3.9	25.5	3.9	2.2	4.7	4.6	5.8	7.0	2.9	2.3	3.9	3.4	2.8	0.0	4.5	1.6	2.6	3.6	2.9	2.7	1.3	1.1	0.8	0.7	2.4	1.0	7.2	4.3	4.0	5.3	1.7	3.2	4.6	1.4	0.9	2.8	3.2	6.6	3.0	2.6	5.0	1.6	7.7	1.8	3.8	1.9	3.0	1.9	2.4	3.2	4.2	1.6	1.5	1.0	1.0	1.9	2.1	2.5	0.7	3.2	1.2	2.4	5.3	1.7	1.5	2.0	2.2	2.5	2.0	1.2	2.2	1.9	15.1	0.4	3.8	7.4	4.0	4.5	5.3	4.2	5.2	3.0	3.0	2.4	2.6	3.0	4.1	2.8	3.9	2.4	1.6	1.6	1.4	0.6	2.1	0.6	0.7	1.1	1.3	0.8	0.7	2.7	2.0	0.8	1.3	2.6	2.4	0.9	0.0	0.7	0.7	0.6	1.6	1.0	4.6	5.8	7.5	9.2	3.8	2.4	2.5	4.9	4.1	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	2.7	1.2	0.0	0.0	1.2	0.0	0.8	0.1	0.0	0.7	0.0	0.4	0.4	0.0	0.1	4.6	0.8	0.7	0.0	1.7	0.6	0.0	1.3	1.1	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0
RWDD3	DKFZP566K023	ENSG00000122481	"RWD domain containing 3"	Q9Y3V2	1	95234155-95247225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 14.7;Club cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.87e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.54e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.48e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.46e-8)"	"unprognostic (2.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.37e-3)"	"prognostic favorable (2.06e-4)"	11.7	13.9	17.3	14.8	21.5	9.3	16.6	18.1	17.0	14.3	13.0	12.3	14.9	10.3	18.1	18.8	9.8	18.7	14.9	23.0	17.2	11.7	13.3	14.0	9.3	14.6	13.2	16.5	17.3	14.2	8.7	16.8	12.2	14.0	16.7	12.3	22.0	13.4	14.8	16.1	10.1	11.1	19.5	13.3	12.8	12.3	7.8	16.4	15.6	13.7	10.0	11.8	16.6	13.8	20.1	11.2	15.3	9.9	11.8	17.8	7.2	10.1	3.7	13.4	3.9	8.9	11.5	7.5	5.8	7.9	7.1	8.2	6.1	3.3	9.4	9.6	7.8	16.2	6.3	4.7	6.7	7.6	6.9	5.1	5.6	4.7	7.4	10.6	5.0	3.5	12.0	7.1	3.5	5.5	11.7	10.4	10.5	7.0	4.6	9.4	1.7	5.5	5.8	6.0	4.1	5.7	7.5	19.0	2.5	8.6	5.4	3.9	7.7	5.5	8.6	12.7	8.5	2.2	9.3	6.6	4.8	5.1	3.5	5.2	4.5	4.1	5.8	2.4	4.8	4.6	15.3	9.6	14.3	11.3	9.9	13.8	20.1	14.6	10.5	11.2	19.3	15.5	13.8	6.3	11.8	6.9	9.8	17.8	7.2	17.3	21.5	18.1	17.0	17.2	11.7	13.2	16.5	14.0	16.4	6.0	6.7	0.8	0.4	0.8	0.8	3.6	2.5	14.7	9.1	1.8	2.0	1.0	0.0	1.3	1.0	1.3	0.7	0.0	1.0	0.6	1.6	0.2	7.0	2.6	0.8	0.0	0.0	3.7	3.0	1.6	1.7	1.3	0.0	1.0	0.1	6.0	1.2	0.0	1.8	1.1	1.6	0.0	0.9	0.9	1.3	1.4	0.3	2.1	0.7	0.5
PTBP2	"brPTB, nPTB, PTB, PTBLP"	ENSG00000117569	"Polypyrimidine tract binding protein 2"	Q9UKA9	1	96721665-96823738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 48.7;Spermatocytes: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047420	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047420: AB_10962353"	"unprognostic (2.14e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.26e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.31e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	12.5	10.5	17.1	9.9	21.2	34.4	15.3	22.0	25.8	16.7	26.6	20.0	11.3	7.6	23.6	11.2	12.8	11.9	10.7	7.8	18.8	18.4	12.0	8.1	7.3	9.8	17.9	18.9	14.6	7.3	6.1	22.0	8.1	21.7	16.3	13.0	9.0	7.4	17.3	15.4	8.3	11.0	28.1	18.6	10.3	11.6	35.4	19.9	16.6	14.7	6.8	8.4	21.1	12.8	3.6	1.6	1.4	1.8	4.1	4.2	0.7	3.5	1.9	16.7	8.8	4.0	4.9	9.4	3.2	3.5	5.5	5.1	2.4	3.5	12.2	3.7	2.1	12.1	2.3	10.0	2.6	8.0	2.0	3.0	6.7	5.6	3.1	2.3	3.4	3.5	2.7	1.6	6.9	2.9	4.4	2.7	5.9	4.9	3.3	7.2	1.2	11.0	11.1	10.2	1.4	4.4	6.5	39.6	1.8	5.6	2.0	9.6	9.9	4.1	2.7	4.7	8.7	2.6	7.0	2.6	3.8	7.5	3.1	4.1	2.7	2.0	14.2	1.8	5.5	1.6	0.9	1.4	0.9	2.7	1.7	2.0	3.5	3.5	2.5	0.8	3.6	4.2	2.9	1.4	4.1	1.8	1.6	3.2	0.7	17.1	21.2	22.0	24.7	18.8	18.4	17.9	18.9	21.7	19.9	8.9	11.5	10.8	8.8	12.4	26.4	10.8	5.1	8.1	5.7	19.2	13.7	4.6	11.6	5.9	3.7	14.6	4.0	0.0	4.4	3.6	9.3	8.6	7.0	8.2	2.9	28.6	23.5	8.0	11.3	5.3	8.3	7.7	13.5	6.4	6.2	48.7	4.2	3.5	7.4	6.2	21.7	6.5	27.8	71.4	31.7	6.1	1.7	8.7	4.7	4.8
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 50.8;Kupffer cells: 129.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1300000			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	24.9	15.4	8.8	17.0	20.9	7.4	18.4	2.0	11.2	17.9	15.6	20.3	6.4	17.0	13.7	10.8	19.0	13.5	20.5	13.3	8.3	6.1	10.5	52.2	26.0	25.7	25.3	7.1	20.4	9.7	15.5	18.4	8.0	13.9	11.6	8.4	6.2	16.7	11.6	6.7	7.7	22.4	15.5	15.0	27.7	12.0	6.0	22.2	27.4	13.5	10.0	10.4	16.3	19.6	2.6	14.3	28.3	28.1	5.7	7.3	8.0	7.7	2.2	2.8	0.0	15.9	27.4	0.0	12.7	11.6	11.8	8.8	0.0	3.3	4.1	18.7	11.7	1.8	1.9	0.0	2.9	21.8	4.0	2.6	3.5	4.2	0.0	7.1	1.5	0.2	21.6	1.1	9.4	10.8	25.1	9.6	2.4	0.1	13.2	6.1	0.0	8.1	2.2	0.3	0.0	2.7	0.0	13.6	6.4	14.5	0.0	4.1	3.2	10.8	0.9	0.1	0.3	0.0	3.5	11.0	25.7	1.8	20.6	25.0	1.1	0.0	0.0	3.7	4.5	20.3	6.3	28.1	1.7	5.5	13.0	7.3	0.9	6.5	5.3	14.3	2.6	6.2	5.4	28.3	5.7	10.7	0.4	7.0	8.0	8.8	20.9	2.0	11.2	8.3	6.1	25.3	7.1	13.9	22.2	14.9	33.7	3.0	8.0	6.8	1.9	3.1	30.6	6.7	12.5	7.0	0.0	0.2	5.0	2.1	5.8	11.7	4.0	0.0	5.5	0.1	11.7	5.8	9.2	50.8	17.3	0.0	2.9	17.8	129.0	2.0	31.1	44.1	3.3	10.0	3.7	4.8	3.9	2.3	17.7	5.6	0.0	12.9	9.5	1.2	1.7	4.8	0.1	10.8	3.0	8.8
SNX7		ENSG00000162627	"Sorting nexin 7"	Q9UNH6	1	98661701-98760500	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037419, HPA054338"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA037419: AB_10671754, HPA054338: AB_2682454"	"unprognostic (3.19e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.10e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (9.59e-7)"	"unprognostic (1.53e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.77e-1)"	19.2	13.6	12.0	8.2	11.3	0.2	22.4	3.1	9.8	18.6	24.7	9.7	12.5	19.4	18.7	18.7	17.7	13.5	15.4	18.0	12.0	15.6	22.1	13.0	9.6	4.7	13.6	9.3	13.8	13.7	14.7	13.2	13.9	15.6	17.7	25.4	6.6	15.0	14.8	5.8	11.5	27.2	21.8	17.3	6.4	13.9	14.7	12.7	2.0	13.9	10.3	7.4	18.7	21.9	0.6	0.3	0.0	1.4	0.0	0.3	0.3	16.3	8.9	5.4	7.3	19.2	30.4	3.0	10.4	19.1	15.7	20.5	5.1	6.2	0.0	13.6	25.6	12.9	4.7	5.6	14.8	15.7	0.0	10.9	0.0	14.1	8.8	11.3	0.0	0.0	15.2	16.0	12.9	5.7	17.8	21.8	0.2	0.0	0.0	24.7	3.3	0.1	0.0	5.1	6.5	12.8	0.0	12.1	0.0	15.6	13.2	2.7	32.1	13.9	13.2	7.5	9.4	0.0	0.6	14.9	15.4	8.6	11.9	21.0	0.0	0.0	0.0	21.8	0.0	7.4	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	12.0	11.3	3.1	9.8	12.0	15.6	13.6	9.3	15.6	12.7	17.9	4.1	0.5	35.3	13.1	0.2	45.7	12.7	20.1	4.5	22.7	0.0	25.2	31.5	40.0	13.7	15.7	27.6	0.0	71.6	28.2	36.3	18.9	1.1	10.6	10.1	3.2	20.2	8.6	1.6	16.0	31.7	10.8	33.7	64.9	25.3	10.1	46.0	20.1	49.5	51.2	0.2	32.3	47.5	3.3	10.5	14.3	11.8	0.0	44.8	39.6
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 18.6;testis: 5.5"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.2;Horizontal cells: 3.2"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 12.3;SH-SY5Y: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.5	1.8	7.8	0.7	8.7	0.5	0.5	0.8	18.6	1.4	0.6	2.1	0.0	0.7	0.7	0.5	0.6	0.5	0.6	0.5	8.0	6.6	0.7	0.5	0.7	0.5	2.5	4.5	0.6	1.6	0.5	0.3	0.5	3.6	0.6	0.8	1.8	0.5	1.0	0.9	0.6	0.7	0.6	1.0	0.5	0.7	5.5	1.8	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	12.3	0.0	0.0	0.0	0.5	0.1	0.4	22.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	8.7	0.8	11.6	8.0	6.6	2.5	4.5	3.6	1.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.7	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
PLPPR4	"KIAA0455, LPPR4, PHP1, PRG-1"	ENSG00000117600	"Phospholipid phosphatase related 4"	Q7Z2D5	1	99263953-99309590	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 55.3"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 28.6;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"non-classical monocyte: 2.1"	"Lineage enriched"	"Detected in single"	22	"monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 20.3;BJ hTERT+ SV40 Large T+ RasG12V: 7.9;fHDF/TERT166: 6.8;SH-SY5Y: 15.3;U-138 MG: 7.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.32e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-12)"	"unprognostic (1.67e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.16e-3)"	3.0	1.7	25.1	1.2	25.8	0.8	1.8	2.0	55.3	4.6	1.5	2.6	0.0	1.2	1.7	1.7	3.2	1.3	6.0	1.4	39.2	10.8	1.4	0.8	3.5	1.5	5.2	16.7	0.8	1.5	1.7	9.0	1.9	6.1	1.1	1.9	0.6	1.4	1.3	1.2	4.6	1.5	2.1	2.2	1.3	1.1	5.2	2.7	0.0	1.5	0.4	1.7	7.0	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	3.9	20.3	4.5	7.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	25.1	25.8	2.0	33.8	39.2	10.8	5.2	16.7	6.1	2.7	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	25.5	0.0	0.0	1.4	0.6	4.3	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99645943-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.9;skeletal muscle: 106.9"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 153.8;Ciliated cells: 174.0;Endothelial cells: 169.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 43.5;LHCN-M2: 14.0;TIME: 60.9;U-87 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	84.9	18.6	8.3	6.2	4.3	0.0	46.4	1.1	3.7	17.1	6.5	3.9	4.0	1.3	18.6	10.1	16.2	8.7	5.3	59.0	5.6	3.4	5.1	20.9	10.6	3.4	3.9	3.8	17.4	2.2	4.4	4.7	16.8	19.0	8.1	2.6	7.9	34.0	4.4	106.9	18.0	3.5	12.2	4.1	2.3	2.8	7.5	2.2	2.1	3.4	48.2	6.2	6.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.7	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	7.3	0.0	0.0	0.0	1.1	0.5	0.0	0.0	1.2	43.5	0.0	6.1	0.0	14.0	0.1	0.0	0.0	0.0	0.4	1.9	0.0	10.9	0.0	0.0	2.2	0.2	0.1	0.0	2.8	0.0	0.3	0.6	0.0	60.9	0.0	0.1	4.7	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	4.3	1.1	3.7	5.6	3.4	3.9	3.8	19.0	2.2	6.0	9.3	0.0	9.8	34.2	0.2	153.8	35.7	174.0	45.5	3.5	0.0	0.2	5.0	7.1	73.5	169.5	0.0	0.0	0.2	0.4	4.8	4.7	1.1	55.2	0.5	3.2	1.7	58.9	1.3	7.9	8.6	1.7	23.6	0.0	0.0	54.8	2.5	0.0	22.6	0.0	2.1	0.0	6.1	0.5	0.2	40.7	0.2	0.0	0.0	0.7
FRRS1	"SDFR2, SDR2"	ENSG00000156869	"Ferric chelate reductase 1"	Q6ZNA5	1	99708632-99766631	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.1"	"Cell type enhanced"	"Detected in some"	5	"Syncytiotrophoblasts: 3.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"HEL: 27.8;K-562: 18.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017883	Approved					NA	NA					"HPA017883: AB_2294223"	"unprognostic (3.97e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.54e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.54e-2)"	10.3	6.2	0.6	2.7	1.2	1.5	5.1	0.5	1.2	6.4	6.1	1.2	14.5	2.6	10.7	6.5	11.2	2.0	3.4	2.9	0.6	0.6	1.9	27.1	3.8	1.7	2.1	0.0	5.3	2.0	1.5	2.3	9.8	0.9	4.4	4.0	1.6	8.4	13.4	2.0	7.2	8.0	3.3	3.1	1.5	4.2	2.9	1.3	1.4	5.6	5.4	6.0	5.1	7.0	0.3	0.5	5.5	0.8	0.0	0.1	0.1	5.5	1.0	2.4	2.1	7.7	4.1	12.3	1.4	2.7	1.7	6.5	6.7	7.3	3.2	5.8	1.6	2.3	12.8	3.8	5.9	2.2	6.5	2.5	27.8	2.7	7.3	1.1	3.1	7.5	6.1	7.6	3.4	1.3	0.4	0.3	2.1	18.6	0.2	1.4	1.7	1.0	1.2	1.7	12.5	5.1	0.0	9.1	1.3	1.1	13.9	0.5	0.1	2.3	10.5	5.4	1.9	3.8	4.0	0.6	3.0	4.1	2.6	1.5	2.3	0.0	5.5	6.7	1.3	1.4	0.5	0.4	5.5	0.0	0.8	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.6	1.2	0.5	1.2	0.6	0.6	2.1	0.0	0.9	1.3	0.0	0.0	0.0	1.7	1.6	0.0	0.7	0.0	2.7	0.0	1.8	0.0	2.1	0.0	0.2	0.1	0.1	1.3	0.0	0.0	1.6	1.3	1.0	0.0	2.5	1.0	0.0	0.0	0.0	2.2	0.0	0.9	0.0	0.0	1.0	0.0	0.8	0.3	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.3	2.4	3.1	0.0	0.2	2.2
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 151.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		16000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	12.1	3.6	4.3	7.0	7.1	6.8	14.5	3.8	5.7	3.4	6.0	13.5	4.1	15.9	7.4	6.5	3.0	6.9	25.1	7.5	6.4	8.4	7.9	9.2	12.4	7.5	4.7	8.2	5.6	8.2	4.9	4.7	3.9	4.8	5.3	5.6	15.2	1.1	3.5	3.8	9.6	2.6	6.8	5.4	4.6	0.0	1.4	0.8	10.3	16.4	10.7	7.4	11.1	10.7	6.0	8.4	7.7	5.5	5.4	4.1	5.9	5.5	3.7	4.5	3.6	18.4	7.2	2.2	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2	20.8	23.2	15.3	15.5	9.4	36.9	94.9	20.4	29.4	29.6	15.7	51.1	77.6	19.9	11.9	1.1	10.8	15.8	23.3	11.2	17.2	13.6	9.9	10.4	84.7	15.8	49.3	16.1	16.0	16.2	1.1	9.5	9.2	15.1	10.8	18.2	151.6	14.2	10.5	20.1	16.3	47.8	6.5	14.2	8.1	11.7	8.2	24.4	15.0	17.4	16.6
SLC35A3		ENSG00000117620	"Solute carrier family 35 member A3"	Q9Y2D2	1	99969351-100035637	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015253	Uncertain					NA	NA					"HPA015253: AB_1857106"	"unprognostic (1.05e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.34e-2)"	10.7	9.4	6.5	16.7	6.8	5.9	16.2	7.4	8.9	12.4	31.4	5.5	16.2	29.1	10.5	10.8	14.9	9.5	12.5	7.1	5.4	4.8	13.2	21.9	18.0	10.9	7.0	6.3	7.9	13.8	12.8	8.6	12.2	9.6	14.4	32.7	6.0	22.3	21.9	7.5	10.0	41.0	15.3	7.6	6.3	19.9	5.1	5.6	24.7	15.3	7.9	8.1	13.9	13.0	4.3	9.0	6.4	3.7	7.7	5.2	3.2	17.4	4.7	4.3	4.5	9.8	8.6	17.3	15.6	9.5	6.2	9.0	3.1	9.5	9.4	19.6	9.0	8.7	10.1	8.1	7.0	14.2	11.5	5.9	8.5	6.7	7.4	6.2	13.5	1.0	4.6	7.9	7.4	14.6	7.4	7.1	7.5	14.0	14.1	12.5	4.3	8.9	7.1	5.3	10.0	15.9	2.8	13.2	5.9	11.3	10.1	5.6	3.1	10.8	20.9	8.2	4.2	12.7	10.3	8.2	9.4	8.5	20.7	8.3	8.4	9.8	7.0	15.0	8.5	3.9	6.4	3.6	2.0	4.2	3.7	4.7	4.3	4.2	4.9	3.1	3.4	5.2	4.4	1.2	7.7	2.9	9.0	4.8	3.2	6.5	6.8	7.4	8.9	5.4	4.8	7.0	6.3	9.6	5.6	74.5	25.8	14.7	19.1	22.1	16.3	7.4	22.9	64.3	35.2	52.4	19.6	15.3	6.6	14.1	3.5	17.5	139.9	0.0	13.4	24.2	13.2	46.0	16.2	42.7	12.4	9.5	19.0	23.9	17.4	0.0	12.4	12.9	8.5	9.0	96.8	16.0	18.6	71.9	12.4	28.5	22.5	6.5	15.1	11.9	5.7	26.0	19.5	21.8	78.5	31.8
AC118553.2		ENSG00000283761			1	99970011-100083321	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.6;Ciliated cells: 9.4;Club cells: 2.3"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073681			Approved	Vesicles		NA	NA			Vesicles		"HPA073681: AB_2686625"																		2.5	1.9	1.9	6.5	2.0	3.0	6.3	2.3	4.0	3.1	8.2	1.4	6.3	3.3	3.1	3.9	5.9	3.1	4.6	2.1	1.4		3.8	6.1	7.1	3.9	2.1	1.8	4.2	5.2	3.0	2.8	4.4	3.3	3.5	4.2	1.6	5.8	8.9	2.2	1.5	17.6	5.9	2.1	1.8	2.8	4.6	1.5	10.2	2.9	2.5	3.1	3.5	3.8	4.4	8.7	9.1	7.8	9.1	8.6	6.7	0.9	1.2	1.6	0.5	0.0	1.1	1.5	2.4	1.0	2.4	5.0	0.8	3.5	0.2	6.0	3.6	5.0	3.9	4.7	1.7	3.1	1.6	2.4	3.9	6.9	0.2	0.5	0.8	0.8	0.0	1.6	4.6	4.1	1.3	2.9	0.7	3.1	2.2	1.4	2.1	3.9	0.2	0.1	3.6	2.0	0.9	3.8	1.7	1.4	1.9	1.1	1.4	1.9	1.2	1.0	1.6	1.0	0.1	0.9	1.5	2.6	1.4	2.6	1.3	5.0	0.7	1.9	1.9	0.6	9.1	7.5	5.0	6.9	7.8	7.9	4.4	7.2	8.2	8.7	2.9	6.9	5.9	1.1	9.1	4.5	6.7	8.6	6.7											6.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	9.4	2.3	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MFSD14A	"DKFZP564L0864, HIAT1"	ENSG00000156875	"Major facilitator superfamily domain containing 14A"	Q96MC6	1	100038097-100083377	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 248.4;Late spermatids: 274.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA073127, HPA073681"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA073127: , HPA073681: AB_2686625"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	24.3	23.7	21.8	23.9	23.5	55.7	34.7	16.3	28.3	22.0	23.5	30.2	21.2	14.7	29.4	20.6	24.5	22.9	19.3	17.0	19.9	20.8	22.7	21.7	27.1	24.1	24.5	16.8	27.0	29.2	92.6	19.4	25.0	23.6	26.0	17.1	20.5	23.0	32.0	18.8	22.4	18.5	29.3	33.9	20.6	21.7	28.3	22.3	24.4	21.3	15.9	21.0	23.0	22.9	24.1	27.0	47.1	28.1	26.9	29.8	30.8	23.5	9.8	22.2	11.4	26.0	24.7	18.7	17.3	29.6	23.5	27.5	8.3	16.5	17.7	28.3	22.4	15.5	22.7	19.7	19.0	22.6	15.4	15.6	17.4	15.0	12.4	23.0	28.0	22.9	20.1	29.2	20.7	26.6	20.8	18.0	20.1	21.3	34.8	21.6	6.9	21.0	16.5	25.5	11.5	14.5	14.8	27.1	17.3	25.1	20.7	23.1	20.6	19.5	28.5	28.5	14.7	11.0	28.6	19.7	19.4	13.7	20.3	17.8	33.2	34.9	24.7	21.1	20.5	8.3	32.8	28.1	26.1	25.9	25.2	29.2	24.1	26.5	28.3	27.0	19.4	29.8	27.6	47.1	26.9	20.7	12.6	28.6	30.8	21.8	23.5	16.3	28.3	19.9	20.8	24.5	16.8	23.6	22.3	6.0	8.6	16.2	37.8	0.0	16.3	0.0	25.5	10.7	6.8	3.5	9.8	31.3	1.7	8.7	248.4	19.6	4.3	46.7	6.2	26.8	8.2	35.5	2.3	14.3	20.0	12.7	12.9	17.2	28.9	274.7	21.0	4.2	0.0	7.2	13.2	20.5	5.7	19.3	28.7	0.6	10.5	12.9	0.0	16.3	20.7	0.0	48.7	13.8	13.6	47.7
SASS6	"DKFZp761A078, FLJ22097, SAS-6, SAS6"	ENSG00000156876	"SAS-6 centriolar assembly protein"	Q6UVJ0	1	100083563-100132955	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 71.0;Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028187	Uncertain		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA028187: AB_10602220"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.76e-8)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.54e-1)"	6.2	3.8	3.8	6.1	5.4	10.9	5.9	17.8	6.9	6.4	6.1	5.0	8.3	6.4	4.8	5.5	6.2	4.3	2.5	3.2	5.4	3.5	3.3	3.5	3.3	8.5	5.5	3.3	5.3	4.2	10.2	12.0	5.9	5.8	6.9	6.4	3.1	5.1	4.8	3.8	4.5	7.0	4.9	6.2	7.3	4.6	15.0	6.9	17.1	4.6	5.0	7.7	4.5	4.8	5.1	1.4	8.1	2.3	2.3	3.6	1.4	11.4	3.9	9.4	9.1	1.1	2.0	13.7	7.2	3.5	9.6	11.4	6.0	6.2	12.3	6.3	2.9	5.5	10.6	12.7	4.4	12.9	6.8	12.8	10.4	8.3	7.7	0.6	17.6	10.6	1.0	2.1	7.9	7.0	2.0	5.0	9.1	16.8	12.1	4.4	3.4	15.7	8.5	12.2	7.8	7.8	11.3	18.4	6.4	4.5	5.3	6.7	10.0	7.2	11.7	6.0	6.9	5.8	10.7	2.4	6.6	8.4	7.7	10.2	6.1	12.4	17.2	5.5	11.7	3.7	8.1	1.2	4.8	3.5	2.3	3.6	5.1	3.4	2.9	1.4	3.9	3.1	3.0	3.5	2.3	1.7	1.4	3.1	1.4	3.8	5.4	17.8	6.9	5.4	3.5	5.5	3.3	5.8	6.9	0.0	2.9	10.4	2.1	3.5	17.2	2.4	5.1	6.7	5.7	1.8	15.7	8.3	1.7	6.0	11.7	4.7	1.6	0.0	4.9	17.1	5.2	3.5	5.7	2.9	8.1	7.9	4.1	6.7	5.0	4.0	7.5	4.9	1.7	5.4	4.1	10.9	5.1	2.9	10.3	3.7	21.0	0.0	4.7	71.0	34.5	3.6	4.2	6.4	6.3	1.7
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150497	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	13.0	12.2	13.9	21.7	24.1	5.9	18.3	26.5	22.5	17.4	13.1	18.2	24.2	13.6	17.4	15.4	13.7	13.9	9.6	12.0	14.4	9.0	12.1	13.0	9.6	20.9	23.1	12.8	21.4	18.1	23.8	26.8	13.2	15.6	14.9	14.4	10.8	14.3	17.4	16.9	17.9	14.2	14.3	19.4	16.5	12.6	11.1	25.8	17.8	16.5	12.0	17.6	13.9	15.8	15.1	9.6	2.2	4.5	5.4	13.6	3.9	10.7	6.3	10.6	7.4	5.7	11.3	11.7	11.4	4.5	8.7	7.3	7.5	4.5	17.8	14.2	9.0	5.8	9.8	19.5	8.8	15.1	17.9	15.5	10.6	13.9	7.2	10.4	18.3	10.0	7.8	10.1	16.4	21.7	5.5	7.9	13.3	22.2	11.5	8.7	4.1	14.9	9.7	14.8	10.4	12.7	16.0	16.1	9.7	7.1	8.6	6.9	11.6	10.5	10.1	13.4	10.9	5.9	16.3	8.2	11.6	7.8	9.7	15.1	14.8	11.9	21.1	13.1	14.7	4.4	0.1	4.5	2.2	8.5	4.4	10.4	14.8	9.0	8.3	5.2	15.1	13.6	11.1	1.9	5.4	3.5	9.6	6.2	3.9	13.9	24.1	26.5	22.5	14.4	9.0	23.1	12.8	15.6	25.8	23.8	13.4	31.3	12.1	8.7	36.7	10.0	17.8	25.4	28.4	14.0	27.5	11.7	11.6	9.2	7.7	11.7	9.1	0.0	5.2	8.8	10.8	10.7	20.8	9.9	6.7	27.0	19.5	17.2	6.1	4.3	23.0	9.9	10.1	8.2	8.1	19.7	7.8	12.5	17.3	8.4	45.1	19.4	12.2	36.3	22.8	10.5	6.1	19.7	13.2	8.4
LRRC39	MGC14816	ENSG00000122477	"Leucine rich repeat containing 39"	Q96DD0	1	100148449-100178273	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 30.7;skeletal muscle: 113.7;tongue: 28.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 83.0;Cone photoreceptor cells: 56.9;Early spermatids: 72.5;Hofbauer cells: 57.5;Rod photoreceptor cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 12.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA077159	Enhanced					NA	NA					"HPA077159: AB_2732333"	"unprognostic (7.68e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.38e-4)"	1.8	3.2	1.6	0.4	1.3	0.4	0.5	0.6	3.0	0.2	0.3	0.5	0.0	0.3	0.4	2.6	1.3	0.3	0.4	30.7	0.8	0.5	0.3	0.5	0.3	0.6	0.8	1.3	0.3	0.3	0.3	0.5	1.3	0.5	1.3	0.3	9.5	1.1	0.3	113.7	1.1	0.3	0.3	0.7	0.5	0.3	1.7	0.6	0.1	0.5	28.5	1.2	0.3	0.1	1.1	0.4	0.2	0.6	0.2	0.9	0.0	0.6	0.9	3.1	4.3	0.7	1.8	2.5	1.3	0.6	0.6	1.5	0.2	1.9	3.4	1.5	0.6	0.6	1.9	0.3	0.4	1.4	0.4	2.8	1.5	3.2	0.6	0.5	1.0	1.8	3.3	0.7	0.7	0.3	0.9	0.7	2.6	1.5	2.9	1.1	0.6	1.7	4.1	1.3	0.8	1.1	1.5	1.4	1.4	0.6	1.1	1.3	4.3	1.1	1.1	12.0	1.1	1.0	2.2	0.9	1.6	1.7	2.5	2.7	5.8	2.8	1.1	3.1	2.2	0.4	0.0	0.4	0.2	0.4	0.6	0.6	0.9	0.4	0.4	0.1	1.1	0.9	0.9	0.2	0.2	0.3	0.4	0.4	0.0	1.6	1.3	0.6	3.0	0.8	0.5	0.8	1.3	0.5	0.6	0.0	2.2	0.0	0.1	0.1	11.4	83.0	0.0	1.4	0.0	0.0	56.9	0.3	0.0	0.1	72.5	0.3	0.0	0.0	0.5	0.4	0.2	0.0	1.1	0.0	57.5	17.5	0.0	1.3	0.8	5.0	2.0	0.7	0.0	1.0	0.0	5.5	0.2	0.0	0.4	0.0	63.1	0.0	0.9	1.7	1.1	0.1	0.6	0.0	0.0	0.0
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.7	5.8	5.3	10.8	11.7	10.3	12.4	8.0	6.5	7.2	8.7	12.0	4.5	10.7	11.7	4.8	4.6	10.5	11.8	8.5	9.0	11.2	6.8	7.7	11.1	5.9	10.1	10.1	3.7	10.0	9.4	5.9	9.3	6.5	6.7	10.0	12.4	11.7	5.7	2.7	8.4	3.3	11.2	7.8	11.5	8.2	19.4	8.0	7.9	10.6	9.4	5.8	17.8	15.9	13.4	9.8	12.5	6.3	7.7	7.1	4.7	9.1	7.2	8.2	8.3	5.5	8.4	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2	20.8	28.4	16.7	5.9	6.1	21.3	62.5	20.4	16.0	9.1	12.2	37.3	16.0	43.1	8.1	0.6	6.7	8.1	0.0	7.2	10.3	7.5	7.4	2.3	43.1	7.4	14.3	8.7	10.4	7.5	0.9	14.1	7.8	3.3	6.4	12.5	15.6	6.7	3.5	19.8	26.5	20.8	6.5	8.1	2.4	5.5	6.4	6.9	10.0	12.7	4.6
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266207-100292769	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		8700	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	20.9	25.0	19.4	17.8	24.9	25.5	20.0	22.6	31.7	14.7	22.9	20.3	19.9	31.7	14.2	26.0	27.0	13.4	19.9	25.5	20.0	21.0	31.7	23.0	16.1	21.8	21.5	20.7	13.3	27.7	21.1	17.2	21.2	33.1	20.9	22.2	14.1	18.5	17.4	35.4	14.6	37.8	15.4	20.5	24.2	21.8	12.2	12.4	25.0	18.3	20.2	20.8	18.7	17.5	9.6	8.0	8.2	19.6	11.0	20.1	7.7	22.0	11.4	11.3	15.2	14.3	23.3	30.9	26.2	12.8	17.1	14.8	18.6	11.1	22.6	19.9	16.6	21.1	11.2	13.8	12.4	20.7	22.6	11.5	14.9	13.0	23.4	22.1	27.1	23.6	18.9	19.6	22.3	29.9	17.0	21.2	16.5	25.6	34.5	25.8	7.3	13.9	21.1	17.3	15.7	22.1	10.0	20.2	9.9	21.0	18.1	9.1	11.4	16.9	24.5	35.8	18.5	5.3	34.8	18.4	16.2	11.3	25.2	31.4	20.0	20.1	18.1	34.0	23.6	9.6	8.2	9.1	7.5	10.8	11.3	13.8	9.6	10.0	12.8	8.0	7.1	9.3	10.5	4.4	11.0	19.6	7.6	20.1	7.7	19.4	24.9	22.6	31.7	20.0	21.0	21.5	20.7	33.1	12.4	6.0	14.4	26.1	13.0	12.0	22.2	49.6	7.6	13.4	10.3	17.4	11.8	48.9	21.6	37.0	11.5	17.5	35.4	0.0	30.2	65.3	13.9	14.2	12.7	15.3	69.5	20.6	18.5	22.7	41.9	6.4	17.8	28.9	15.1	50.5	26.6	20.6	46.7	37.1	12.0	49.6	26.8	6.5	12.3	27.2	14.7	12.8	38.8	32.0	29.7	15.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 165.7;Late spermatids: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.9	6.7	2.2	1.6	4.1	2.9	1.9	2.9	2.3	6.2	1.9	1.1	2.1	1.7	2.3	1.7	4.0	1.6	2.9	2.3	9.9	4.0	1.7	2.0	0.8	5.4	7.1	1.3	0.4	3.1	1.0	1.4	5.1	2.4	30.6	3.5	4.2	1.0	4.3	6.0	3.6	1.4	2.3	4.7	7.6	1.1	2.0	5.1	1.1	1.9	3.0	2.9	4.0	3.0	1.3	7.0	2.2	1.6	3.6	2.7	1.7	1.7	0.6	1.7	1.9	5.0	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7	3.0	5.6	2.2	4.2	3.3	0.2	5.3	0.0	28.1	5.7	1.8	3.9	1.7	0.0	2.7	165.7	9.3	12.8	0.0	1.7	0.8	4.7	6.6	14.0	1.5	2.3	0.0	4.6	6.2	4.6	161.3	4.6	4.3	5.0	5.4	4.7	9.1	2.5	8.7	0.7	1.7	3.6	0.0	2.8	1.9	3.0	2.0	1.8	10.2	2.7	2.3
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538137-100542018	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 62.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Group enriched"	"Detected in many"	7	"basal ganglia: 62.7;thalamus: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HSkMC: 4.9;SCLC-21H: 6.1"	"Region enriched"	"Detected in many"	11	"basal ganglia: 643.5"	"Region enriched"	"Detected in some"	34	"basal ganglia: 223.4"	HPA007488		Approved				NA	NA					"HPA007488: AB_2667844"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.7	0.6	1.2	0.5	62.7	0.2	10.9	0.0	6.8	0.1	0.3	0.8	0.0	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.9	0.8	0.3	13.1	0.2	0.3	0.7	1.1	3.8	0.1	4.6	0.5	0.2	7.0	0.6	0.5	0.3	0.7	0.1	0.3	0.1	0.5	0.3	0.5	13.7	0.4	0.2	32.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	62.7	0.0	6.8	0.9	0.8	0.7	1.1	7.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 69.6;lymphoid tissue: 129.2"	"Cell type enhanced"	"Detected in many"	21	"Ductal cells: 130.8;Ito cells: 82.3;Kupffer cells: 410.3;Proximal tubular cells: 200.7"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.9"	"Group enriched"	"Detected in some"	5	"HHSteC: 58.3;HSkMC: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Supported	"Cell Junctions"		NA	NA	624000000	960000000	"Cell Junctions"		"CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215"	"unprognostic (2.96e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	10.9	18.1	1.5	20.2	3.2	1.3	5.2	0.9	1.1	3.7	5.0	3.3	1.4	3.3	4.9	4.5	5.3	4.9	6.8	7.2	1.7	2.3	69.6	11.8	9.8	26.8	2.8	1.7	11.1	6.6	10.6	3.5	10.9	4.2	8.3	5.5	15.3	4.9	1.1	4.7	1.8	6.3	4.2	3.7	129.2	3.0	2.5	1.6	13.3	3.5	2.8	20.9	8.2	2.8	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.3	0.1	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	58.3	0.0	0.0	38.9	0.0	10.2	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	3.2	0.9	1.1	1.7	2.3	2.8	1.7	4.2	1.6	0.0	6.4	2.4	0.1	8.9	0.0	2.0	0.0	2.7	0.0	3.5	0.0	0.9	8.3	130.8	0.1	16.1	0.0	0.0	2.7	0.8	67.5	0.6	1.1	2.5	3.0	0.0	0.0	82.3	410.3	0.0	15.8	1.9	1.7	0.0	0.0	3.0	2.6	0.0	7.1	200.7	0.0	0.0	14.0	0.0	0.0	6.5	2.3	1.5	0.0	0.0
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895998	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 175.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		83000000	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	7.5	23.0	9.8	4.1	19.9	1.7	10.4	14.7	22.8	13.4	8.7	8.1	9.9	4.5	16.7	13.1	6.0	10.1	10.3	8.2	9.5	13.3	11.2	10.0	7.6	3.4	14.0	12.0	18.8	7.7	17.5	18.7	21.8	20.1	12.3	7.1	8.6	6.0	11.4	5.3	5.9	4.6	15.4	11.4	5.4	6.2	9.7	16.3	6.4	9.3	5.0	3.4	9.0	6.2	2.1	7.4	3.3	1.1	5.3	5.6	1.9	5.2	2.7	20.1	21.0	22.3	16.5	12.8	9.0	14.9	7.1	15.9	2.6	4.0	5.8	8.8	8.3	5.6	5.1	7.3	7.7	14.4	11.8	5.1	7.1	9.7	7.2	7.3	11.0	3.8	19.5	2.7	14.2	2.8	15.0	25.9	7.4	8.9	0.7	17.9	2.7	5.8	6.1	25.3	4.7	6.1	4.2	20.7	4.7	7.6	4.0	8.3	23.6	6.9	1.8	16.2	15.3	4.3	5.0	10.8	17.8	10.5	11.4	9.5	6.2	5.5	3.6	28.3	11.4	5.8	3.3	0.8	0.0	5.6	1.1	2.8	1.9	1.9	3.7	2.5	2.1	2.1	4.8	0.2	5.3	0.9	7.4	0.0	1.9	9.8	19.9	14.7	22.8	9.5	13.3	14.0	12.0	20.1	16.3	11.9	5.9	2.2	11.4	7.6	20.3	9.7	10.2	29.4	14.8	14.0	33.4	175.5	10.0	5.2	19.7	10.8	2.0	0.0	1.8	25.1	33.5	5.4	17.3	14.7	21.3	3.2	9.1	15.4	7.0	27.2	23.3	3.6	21.9	10.0	3.9	18.6	2.5	2.9	32.5	10.8	17.8	12.9	16.5	29.8	8.1	7.0	62.1	6.9	6.3	3.0
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	15.6	14.2	5.0	13.1	6.4	10.3	12.7	7.4	7.6	13.3	10.8	6.2	17.2	10.8	13.3	13.7	10.8	9.4	13.2	9.3	5.9	5.6	13.0	43.1	18.1	25.6	7.7	4.6	10.5	19.1	17.1	17.7	25.2	9.2	11.9	14.7	10.8	17.5	18.1	5.7	12.6	15.8	9.0	8.1	16.2	13.3	7.5	6.4	24.7	13.2	10.9	17.4	10.5	11.1	5.5	8.2	13.9	14.9	8.4	10.7	5.9	10.9	5.7	6.2	13.6	13.2	13.5	15.7	7.2	19.3	8.8	11.6	5.8	7.9	4.4	15.7	14.7	7.0	10.9	7.2	10.7	13.5	6.9	4.5	8.6	9.7	10.4	14.8	11.3	9.2	15.4	6.9	14.8	18.1	8.5	14.2	8.4	5.2	19.3	11.9	4.9	8.2	5.7	6.6	5.5	7.1	4.1	11.1	5.7	7.8	12.8	3.4	6.7	12.9	14.5	9.3	4.9	7.2	6.3	15.3	20.8	8.0	19.2	11.5	13.1	6.9	4.9	21.2	9.3	5.5	13.9	10.7	7.4	10.7	10.4	9.2	5.3	9.9	8.4	8.2	5.5	8.9	9.6	5.3	8.4	14.9	7.7	7.2	5.9	5.0	6.4	7.4	7.6	5.9	5.6	7.7	4.6	9.2	6.4	29.8	16.3	25.1	16.5	50.9	8.9	3.2	15.3	10.7	12.5	22.7	5.9	26.3	1.7	20.8	0.6	24.6	16.0	0.0	23.0	19.6	25.5	36.1	36.9	38.5	19.8	4.8	21.9	35.0	29.4	0.9	15.8	29.5	30.4	14.4	32.0	7.8	29.1	24.6	15.6	16.2	12.4	6.5	22.3	6.2	7.6	55.8	34.9	29.8	20.1	24.8
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.6	21.5	11.2	9.1	19.0	7.9	21.4	10.4	11.9	17.3	12.8	11.5	13.2	6.8	20.6	19.0	16.1	19.3	10.0	19.2	11.2	11.9	14.1	18.1	8.5	15.2	11.9	11.4	39.0	28.4	15.5	31.7	9.3	12.3	15.3	13.7	10.8	16.1	12.7	16.8	11.5	9.2	15.4	16.7	13.6	11.5	9.2	11.3	22.2	18.4	15.5	17.7	14.4	14.7	12.1	8.4	3.3	6.2	14.9	16.2	6.7	9.6	8.8	13.1	12.8	16.2	46.2	11.3	8.5	14.0	12.5	10.6	10.5	2.4	17.0	11.4	7.2	7.8	6.3	14.6	13.0	18.4	7.1	10.7	8.9	8.5	19.9	25.3	10.8	4.7	31.0	18.9	11.7	38.0	24.1	18.6	11.8	19.9	5.4	18.8	8.3	13.2	10.6	10.6	5.2	13.8	12.2	19.1	9.8	14.1	7.4	15.2	7.4	4.7	13.1	37.7	10.4	8.5	6.4	9.4	7.4	10.4	10.7	11.2	6.4	7.4	10.4	10.1	10.2	2.7	3.3	5.1	2.6	11.1	5.5	15.1	12.1	12.3	12.1	8.4	9.6	16.2	14.8	1.9	14.9	6.2	6.2	8.2	6.7	11.2	19.0	10.4	11.9	11.2	11.9	11.9	11.4	12.3	11.3	6.0	10.5	39.8	17.8	14.1	5.0	21.8	17.8	20.1	7.9	7.0	0.0	22.0	19.9	12.0	1.2	11.3	3.4	0.0	15.9	23.6	15.8	9.8	25.3	25.4	17.0	1.6	9.8	13.5	29.4	1.5	25.0	11.3	11.8	26.2	11.4	15.8	10.5	17.5	13.1	22.8	6.2	6.5	10.3	16.4	16.4	15.7	10.9	20.0	23.2	6.3
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236888-101241518	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.9"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 89.9;Ito cells: 114.2;Muller glia cells: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 19.4;HUVEC TERT2: 54.9;TIME: 30.5;U-251 MG: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	72.3	8.4	24.7	16.6	26.2	9.7	46.3	21.6	21.8	13.3	10.5	9.5	2.5	5.7	12.1	5.0	14.7	11.5	17.6	43.5	22.9	15.4	8.9	20.5	35.7	24.5	23.2	14.0	7.9	11.0	13.4	4.7	29.6	21.2	8.9	7.0	9.3	7.5	5.6	21.7	8.2	9.8	19.0	11.0	35.2	8.0	5.8	13.9	4.4	17.0	8.7	15.7	15.2	18.5	27.4	0.2	88.9	0.2	33.4	49.8	30.8	3.6	0.0	3.9	0.0	0.4	9.3	0.0	19.4	3.5	11.8	4.2	0.0	0.1	0.0	4.8	6.7	0.0	0.0	0.5	0.2	7.9	1.3	0.4	1.3	0.1	0.0	1.8	0.0	0.8	12.5	0.0	0.0	0.9	0.5	54.9	1.1	0.0	4.0	3.7	0.0	4.6	0.0	1.0	0.1	1.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	30.5	2.0	0.7	0.4	37.6	0.3	0.0	0.2	0.2	0.0	0.1	88.9	0.1	4.9	49.8	0.1	40.2	25.1	45.3	44.1	0.2	27.4	35.7	36.2	1.4	33.4	0.2	0.2	26.8	30.8	24.7	26.2	21.6	16.8	22.9	15.4	23.2	14.0	21.2	13.9	0.0	12.8	17.1	0.1	6.8	0.0	16.9	2.5	0.0	2.3	0.0	0.0	5.5	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.3	8.4	0.5	7.0	6.0	7.6	0.0	0.0	114.2	6.9	0.0	0.9	1.5	5.0	14.4	0.0	38.0	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.4	0.7	4.4	2.2	9.2	0.0	0.4
OLFM3	NOE3	ENSG00000118733	"Olfactomedin 3"	Q96PB7	1	101802574-101997030	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.0"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 25.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050297			Uncertain	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA050297: "			"unprognostic (4.19e-1)"	"unprognostic (4.19e-4)"	"unprognostic (1.26e-1)"				"unprognostic (4.61e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.47e-2)"			"unprognostic (3.58e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.68e-2)"		0.7	3.2	5.0	1.4	13.7	0.7	0.8	24.2	30.0	0.9	1.8	0.4	0.0	1.0	0.9	1.2	0.7	0.8	0.8	0.7	4.8	7.4	1.5	0.8	0.7	0.7	6.0	11.9	0.8	0.7	0.7	2.4	0.8	16.6	0.7	1.7	0.3	0.8	0.7	0.7	0.7	2.1	1.3	1.5	0.9	1.0	0.9	0.7	0.0	1.2	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	3.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	13.7	24.2	26.7	4.8	7.4	6.0	11.9	16.6	0.7	0.0	0.0	0.0	0.0	0.0	25.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COL11A1	"CO11A1, COLL6, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 33.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		270000	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	1.2	1.8	8.6	1.3	9.1	0.8	1.5	2.0	7.9	2.3	1.1	4.1	0.0	1.0	1.8	1.0	0.8	0.8	5.9	0.8	8.3	8.6	1.0	0.8	1.2	0.9	8.1	5.9	1.2	1.9	1.0	5.5	33.3	11.1	1.1	1.4	5.9	3.3	2.2	0.9	2.4	0.9	1.3	9.0	2.2	0.9	4.7	5.8	0.0	0.9	0.6	0.8	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	38.5	0.0	1.5	2.1	0.0	13.5	5.2	7.8	28.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	48.5	0.0	0.3	0.0	5.9	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.2	9.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	9.1	2.0	7.9	8.3	8.6	8.1	5.9	11.1	5.8	0.0	2.1	0.0	0.0	1.5	0.6	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.5	2.1	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.1	0.6	10.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	1.7	0.0	1.9	0.5	0.4	1.0	0.2	0.0	0.0	0.0
RNPC3	"FLJ20008, KIAA1839, RBM40, SNRNP65"	ENSG00000185946	"RNA binding region (RNP1, RRM) containing 3"	Q96LT9	1	103525691-103555239	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 95.4;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052434			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052434: AB_2681832"	"unprognostic (1.87e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-5)"	"unprognostic (9.00e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (7.82e-4)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.25e-4)"	19.8	18.5	42.1	16.7	52.4	15.3	20.7	53.4	41.2	22.3	17.8	19.1	22.2	16.4	24.2	40.7	11.9	25.8	15.4	20.1	33.5	12.7	19.4	10.9	17.0	22.4	25.6	28.6	27.2	29.6	25.1	42.5	9.0	24.4	17.5	16.3	17.2	26.9	18.2	28.9	26.6	19.3	13.8	24.5	20.3	16.1	11.0	33.0	15.5	37.9	14.0	18.3	18.7	18.4	33.6	26.3	61.3	23.1	9.3	19.2	3.2	7.0	5.7	12.3	6.1	7.6	13.5	8.2	9.8	6.5	7.9	11.8	6.1	12.0	13.4	15.7	4.8	4.7	14.3	7.5	7.7	9.3	8.7	14.2	14.0	29.9	6.1	5.4	18.5	12.1	12.4	11.8	6.7	4.7	11.6	7.2	11.7	8.7	15.6	9.0	3.9	10.5	9.4	8.0	6.8	8.7	14.6	11.4	10.5	10.4	7.6	13.1	6.4	6.6	9.2	9.8	7.1	6.2	8.6	9.6	8.6	8.5	4.6	6.3	11.7	3.9	11.8	15.1	14.4	4.3	42.7	23.1	15.3	13.5	10.7	9.8	24.6	16.1	12.2	6.7	33.6	19.2	17.5	61.3	9.3	12.1	26.3	10.7	3.2	42.1	52.4	53.4	41.2	33.5	12.7	25.6	28.6	24.4	33.0	26.8	37.9	11.5	17.0	6.6	95.4	16.9	12.7	62.9	43.3	26.2	125.7	6.4	13.3	8.2	22.1	16.6	19.7	0.0	9.0	3.6	9.1	9.5	19.7	8.6	6.7	58.8	16.3	14.1	21.9	3.6	23.0	16.8	15.1	15.4	16.3	53.0	9.0	12.5	20.1	4.3	145.9	25.8	11.2	18.2	8.1	7.9	9.2	17.5	12.1	11.7
AMY2B	AMY2	ENSG00000240038	"Amylase, alpha 2B (pancreatic)"	P19961	1	103553815-103579534	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 939.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 31.4;Exocrine glandular cells: 124.1"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.5;EFO-21: 11.8;HSkMC: 7.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		75000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	1.7	0.5	0.8	0.8	1.5	0.4	1.0	2.6	0.8	0.9	0.9	0.8	0.8	0.5	0.8	1.0	0.8	1.5	0.9	1.1	0.8	0.5	1.5	1.1	1.0	1.1	1.0	0.9	1.2	939.9	0.8	1.1	0.8	0.8	0.9	0.4	0.9	145.7	1.0	1.7	1.3	0.9	0.8	0.8	1.0	0.4	0.8	0.8	0.8	2.4	1.1	0.8	0.8	0.8	1.8	2.6	1.9	8.5	0.1	1.1	1.9	0.0	0.6	1.3	0.0	6.4	11.5	1.2	0.9	0.9	0.7	1.7	0.0	0.2	1.1	11.8	0.3	0.0	1.4	0.1	1.4	1.6	1.4	1.8	2.1	4.4	0.9	1.0	2.6	2.8	7.8	7.7	0.8	1.3	2.0	0.2	3.3	0.0	3.5	0.9	0.0	2.1	0.5	0.1	0.1	1.6	0.6	0.0	5.1	6.6	2.1	3.2	0.6	2.7	1.3	0.8	2.1	0.1	1.5	0.9	0.4	1.0	0.5	0.7	4.0	0.1	0.3	2.2	2.0	0.2	0.0	8.5	1.7	0.8	3.9	0.6	1.7	0.3	0.4	2.6	1.8	1.1	0.4	1.9	0.1	3.6	0.8	0.3	1.9	0.8	1.5	2.6	0.8	0.8	0.5	1.0	0.9	0.8	0.8	11.9	16.1	3.2	2.8	4.1	10.0	6.9	5.1	17.4	18.2	1.8	31.4	0.3	0.0	0.7	4.8	1.5	3.6	0.0	124.1	0.2	1.4	1.2	3.5	5.9	1.5	9.5	4.7	1.8	7.0	2.3	2.3	3.1	5.0	1.8	2.5	2.4	1.3	1.4	1.8	0.4	16.2	0.0	2.2	1.7	0.6	2.6	0.2	0.8	2.5	0.9
AMY2A	AMY2	ENSG00000243480	"Amylase, alpha 2A (pancreatic)"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"pancreas: 1849.4"	"Cell type enriched"	"Detected in some"	68	"Exocrine glandular cells: 849.6"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.0;U-2 OS: 1.3"									"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		77000000			"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.9	1849.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	59.9	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	849.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4
AMY1A	AMY1	ENSG00000237763	"Amylase, alpha 1A (salivary)"	P04745	1	103655290-103664554	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	100	"salivary gland: 654.0"	"Cell type enriched"	"Detected in some"	11	"Ciliated cells: 38.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;SH-SY5Y: 2.4"									"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		68000000			"CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0			0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	3.7	0.0	0.0	0.0		0.0	0.0		654.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.1	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7											3.0	2.1	0.0	0.8	0.6	0.0	2.4	0.0	38.8	3.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3
AMY1B	AMY1	ENSG00000174876	"Amylase, alpha 1B (salivary)"	P04745	1	103687415-103696680	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"salivary gland: 302.4"	"Cell type enriched"	"Detected in some"	10	"Ciliated cells: 34.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.0	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	302.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	3.2	0.0	0.1	0.2	0.0	0.7	0.0	34.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
AMY1C	AMY1	ENSG00000187733	"Amylase, alpha 1C (salivary)"	P04745	1	103750406-103758690	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 34.3;salivary gland: 62.5"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 33.4;Ciliated cells: 95.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 3.7"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0			0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0		0.0	34.3	0.0	0.0	0.0		0.0	0.0		62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5			9.6		4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											3.0	33.4	0.0	0.0	0.0	0.0	0.4	0.0	95.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.6	0.0	7.3	3.2	4.8	5.4	2.0	4.9	3.7	4.8	4.9	4.7	2.5	9.0	6.8	4.5	2.6	5.2	6.6	7.2	3.8	0.0	7.1	5.4	10.2	6.7	4.8	11.2	3.4	5.0	4.0	4.3	4.4	3.2	4.1	5.2	7.2	1.4	4.3	83.6	6.5	3.9	3.1	2.9	6.9	8.3	15.9	3.4	11.5	7.4	13.6	16.6	6.7	9.7	3.2	4.6	6.7	8.4	4.7	3.5	7.3	7.4	7.3	1.5	1.0	1.5	5.3	5.3	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6	0.0	4.1	8.2	6.2	3.9	12.5	2.2	0.0	8.1	2.3	14.0	0.0	16.1	23.2	9.0	0.9	4.2	3.5	0.0	6.5	11.9	3.9	3.6	1.1	0.0	8.5	14.3	16.8	4.9	7.0	2.3	8.1	3.6	1.7	1.8	8.7	6.9	4.9	7.0	8.5	15.2	4.3	12.9	8.4	8.4	8.8	5.4	5.9	5.4	9.5	5.8
NTNG1	"KIAA0976, Lmnt1"	ENSG00000162631	"Netrin G1"	Q9Y2I2	1	107140007-107483458	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4"	"Cell type enhanced"	"Detected in some"	16	"Basal glandular cells: 6.0;Bipolar cells: 23.3;Collecting duct cells: 7.0;Early spermatids: 7.6;Leydig cells: 7.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 28.6;fHDF/TERT166: 13.9;RPTEC TERT1: 15.6;U-138 MG: 13.1;U-251 MG: 9.4;U-87 MG: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065954			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA065954: AB_2685585"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.38e-5)"	"unprognostic (1.93e-3)"	"unprognostic (9.87e-3)"		"unprognostic (3.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-5)"	4.2	11.0	6.8	1.3	6.4	0.9	1.1	7.3	12.8	7.0	2.9	9.6	0.3	0.8	2.2	0.9	1.2	1.3	2.1	0.9	9.8	16.4	13.0	0.8	9.2	1.7	5.0	5.3	1.9	1.1	0.7	7.4	3.2	10.0	9.0	1.7	6.4	2.8	12.1	1.1	1.9	1.7	7.5	7.4	1.3	1.4	1.7	6.1	0.0	0.8	0.0	2.0	5.3	3.0	4.4	0.8	1.4	0.7	0.8	0.6	0.3	0.0	0.0	1.7	0.0	2.9	28.6	0.0	7.8	1.1	0.7	0.6	0.0	0.0	0.0	0.3	13.9	0.0	0.0	0.0	0.8	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	8.2	0.2	2.0	1.1	8.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	3.6	0.0	1.9	0.0	15.6	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.1	2.5	4.8	9.4	0.0	0.0	0.0	14.6	0.0	1.4	1.4	0.3	0.4	0.3	0.4	0.5	4.4	0.4	0.3	0.4	1.0	0.6	0.5	0.9	0.8	0.7	0.8	0.4	0.3	6.8	6.4	7.3	12.3	9.8	16.4	5.0	5.3	10.0	6.1	0.0	0.0	0.5	6.0	0.5	23.3	0.8	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	7.5	0.0	1.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	2.1	6.5	1.4	0.2	0.4	0.5	0.0	0.0	0.0	4.3
VAV3		ENSG00000134215	"Vav guanine nucleotide exchange factor 3"	Q9UKW4	1	107571160-107965144	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.5;placenta: 54.4"	"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 99.5;Syncytiotrophoblasts: 205.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 19.1;RH-30: 23.5;RPTEC TERT1: 33.0;T-47d: 40.3"	"Low region specificity"	"Detected in all"							CAB002012	Uncertain					NA	NA					"CAB002012: "	"unprognostic (4.80e-3)"	"unprognostic (7.99e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.67e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.23e-2)"	2.3	1.2	1.8	12.2	2.4	7.1	15.2	2.7	3.0	11.4	17.5	0.8	6.4	3.8	3.3	4.8	32.6	1.6	1.7	2.0	1.2	1.9	47.5	1.1	7.1	8.6	3.8	0.8	1.0	7.3	0.5	2.0	54.4	3.1	6.2	22.2	6.9	6.3	5.3	0.8	27.1	7.6	2.1	1.0	13.1	3.7	2.5	0.4	8.9	4.2	17.6	17.6	7.3	11.5	4.4	4.8	6.8	1.1	3.8	4.6	1.1	0.0	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.3	0.2	0.0	0.0	0.0	1.7	6.4	2.3	3.7	0.0	5.9	2.5	0.0	13.9	0.0	0.4	0.0	0.0	3.2	0.0	5.0	0.0	2.0	12.2	1.5	1.9	0.0	0.4	19.1	23.5	0.1	33.0	10.9	1.1	1.0	6.1	2.7	0.1	0.6	40.3	10.9	0.4	0.2	0.0	0.0	0.2	3.0	1.1	0.2	5.0	9.6	0.4	6.8	1.1	1.4	4.1	1.0	2.3	2.9	1.2	2.0	4.8	4.4	0.3	2.9	3.3	3.8	0.4	3.1	4.6	1.1	1.8	2.4	2.7	3.0	1.2	1.9	3.8	0.8	3.1	0.4	0.0	1.7	22.9	10.8	10.4	14.6	1.7	2.5	13.4	19.4	48.8	2.0	73.5	99.5	3.9	44.5	6.3	29.0	0.0	0.0	24.7	2.6	1.9	7.0	0.0	20.4	0.0	20.3	12.9	16.3	31.8	0.3	12.8	3.3	0.0	25.9	1.8	0.1	43.2	0.4	39.3	28.4	6.5	1.0	0.6	0.5	18.3	205.7	14.1	47.7	1.3
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134036-108200849	"Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		8900	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	19.8	10.8	3.0	13.1	3.3	3.8	25.2	2.3	4.5	15.9	26.6	3.9	9.6	13.6	12.4	11.8	11.4	9.0	16.1	12.4	2.8	3.3	15.3	2.9	17.8	10.8	3.0	2.7	13.5	7.2	13.2	7.7	10.4	5.3	12.4	18.2	9.8	11.2	9.7	7.4	6.9	42.4	9.7	4.0	17.0	9.0	5.1	1.5	10.3	13.7	10.8	9.4	10.8	18.2	2.9	4.8	4.4	7.1	1.7	4.3	2.1	24.2	5.4	16.6	5.1	11.4	15.1	8.3	8.5	10.0	15.1	16.7	6.6	8.1	0.0	7.8	15.6	6.7	9.5	4.9	13.7	20.5	6.0	2.5	1.5	8.1	3.2	9.5	3.9	3.2	11.2	9.7	8.8	11.3	9.8	11.5	3.5	4.1	8.2	19.1	15.9	2.2	0.8	9.8	10.0	6.2	4.1	21.7	7.2	10.2	12.5	3.2	5.5	12.0	8.6	11.2	16.4	8.3	6.9	7.8	8.6	4.4	15.3	9.1	2.3	1.3	0.0	2.9	7.1	5.1	2.8	4.9	4.4	2.3	5.7	2.9	2.9	2.7	2.3	4.8	2.3	1.3	2.3	0.6	1.7	7.1	1.4	4.3	2.1	3.0	3.3	2.3	4.5	2.8	3.3	3.0	2.7	5.3	1.5	50.6	26.7	15.9	17.7	13.9	14.1	12.9	20.4	57.6	36.4	17.4	7.9	5.8	18.3	29.1	2.2	20.4	70.3	0.0	32.1	55.2	18.8	10.7	21.9	0.4	48.5	9.5	17.4	36.8	51.2	2.1	18.1	43.2	21.9	26.2	43.1	8.9	48.3	51.2	17.0	19.3	31.4	51.8	17.9	4.3	1.3	13.0	5.1	13.1	47.4	29.8
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.1;testis: 8.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 8.2;K-562: 11.8;Karpas-707: 3.5;MCF7: 13.9;THP-1: 4.2"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.6			0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.5	1.4		0.0	0.8		0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	3.5	0.0	13.9	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	1.7	0.0	0.2	4.2	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.9;testis: 7.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;K-562: 14.0;SK-BR-3: 3.3;SK-MEL-30: 2.5"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.1			0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.6	1.4		0.0	0.9		0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	1.5	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	11.6	5.2	11.8	10.4	11.4	19.0	11.3	23.3	20.0	8.5	13.8	3.8	6.6	11.4	7.5	8.2	6.5	6.7	15.7	9.2	15.6	14.3	4.6	5.1	8.1	8.8	12.6	19.0	10.5	5.8	12.1	7.3	6.0	11.4	8.5	15.7	5.5	13.5	9.6	2.3	4.2	11.5	11.4	10.2	8.6	7.9	8.8	5.0	9.4	6.7	4.3	8.4	16.4	18.0	0.9	2.7	5.7	2.3	0.7	1.4	0.5	3.6	2.6	5.4	2.8	9.7	5.9	3.5	2.2	2.9	3.4	5.8	0.9	3.7	4.0	2.0	5.6	3.5	7.2	18.2	0.7	4.4	2.6	2.6	5.7	20.5	0.4	2.5	7.3	11.0	3.1	0.8	5.0	0.3	6.9	2.2	6.8	13.8	22.8	7.9	15.1	4.7	5.3	4.2	8.7	13.4	10.8	13.6	0.8	0.9	4.3	17.5	5.1	8.7	15.2	4.5	4.0	3.2	12.1	0.4	5.5	10.4	4.7	8.2	4.1	1.0	3.8	8.1	5.8	2.9	5.7	1.1	1.0	1.0	2.3	0.6	0.9	1.0	1.4	2.7	0.9	0.7	0.5	1.0	0.7	0.9	0.5	0.8	0.5	11.8	11.4	23.3	20.0	15.6	14.3	12.6	19.0	11.4	5.0	0.0	2.1	0.0	2.1	5.5	4.6	1.2	10.2	2.7	2.3	1.8	0.0	2.1	1.7	1.7	9.2	5.8	7.1	0.0	5.3	2.1	7.3	2.6	7.0	0.8	8.9	0.0	6.9	6.7	22.2	4.5	13.3	16.8	5.0	10.0	10.0	1.2	4.3	10.5	19.4	0.4	0.9	0.0	3.9	1.7	6.0	3.1	2.9	5.0	13.0	4.6
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.8;testis: 45.2"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	15	"cerebellum: 18.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	3.5	2.2	6.7	5.1	10.2	7.7	5.5	3.6	11.6	6.1	4.4	4.2	1.4	3.4	2.8	3.4	1.9	1.8	4.5	3.1	9.5	10.1	1.8	1.4	4.9	9.8	8.2	5.6	3.8	1.5	0.6	3.9	3.8	10.7	2.7	6.6	1.3	2.4	2.6	2.0	2.6	5.2	2.5	6.9	8.0	3.2	45.2	2.5	10.3	1.7	1.2	7.3	5.5	1.6	5.4	10.6	18.2	12.0	22.9	28.8	15.9	5.8	3.0	0.2	0.0	0.2	0.2	0.0	1.4	0.5	3.5	0.5	8.8	9.3	0.0	3.2	2.6	0.0	0.0	0.0	0.0	2.2	1.9	0.0	15.0	11.3	0.0	3.0	8.8	13.4	2.9	0.1	0.7	0.0	0.0	0.7	25.7	0.0	6.7	0.1	14.9	23.6	26.4	8.7	4.7	1.3	10.3	0.0	0.5	0.0	6.4	14.7	0.0	12.6	3.5	0.0	0.9	0.0	19.8	0.1	0.0	11.7	6.4	0.0	4.1	5.1	0.0	0.0	34.8	0.1	16.0	8.8	18.2	28.8	10.1	26.0	5.4	14.2	26.0	10.6	2.9	11.8	21.7	8.6	22.9	12.0	8.5	13.1	15.9	6.7	10.2	3.6	11.6	9.5	10.1	8.2	5.6	10.7	2.5	0.0	0.6	0.0	1.4	1.4	3.8	1.5	17.8	1.4	1.2	5.2	0.0	10.4	3.3	2.8	8.7	2.6	3.9	0.0	1.2	16.4	3.1	0.6	6.9	0.4	14.0	0.0	4.7	6.7	11.7	17.0	4.6	8.5	1.7	7.2	2.5	2.0	1.9	6.8	2.8	0.7	2.6	6.5	2.8	118.4	74.4	1.4	4.3	38.3	5.6	2.5
PRPF38B	"FLJ10330, NET1"	ENSG00000134186	"Pre-mRNA processing factor 38B"	Q5VTL8	1	108692323-108701803	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053255	Approved					NA	NA					"HPA053255: AB_2682093"	"unprognostic (2.13e-3)"	"unprognostic (9.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (3.28e-3)"	"unprognostic (3.77e-3)"	"unprognostic (9.49e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.44e-3)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (6.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-1)"	18.4	18.3	17.2	36.4	21.3	47.6	37.4	46.3	21.7	19.7	23.3	12.0	19.8	19.8	19.2	22.8	19.9	16.2	19.0	14.7	16.9	13.9	15.1	17.9	27.0	34.5	23.0	12.2	19.0	23.0	17.9	24.9	19.7	18.6	22.7	19.6	9.9	20.0	31.6	21.0	19.5	24.7	15.6	26.6	33.1	18.9	12.9	21.4	44.1	19.9	15.6	26.2	23.0	29.8	19.1	21.9	24.1	15.9	26.0	21.2	9.7	21.8	8.9	19.7	13.6	12.7	10.9	17.5	21.8	10.0	11.2	12.7	16.5	10.3	30.6	12.2	7.4	7.7	19.4	19.4	12.3	17.3	16.9	19.2	23.5	26.9	16.5	12.5	31.6	19.5	6.7	17.7	11.3	23.8	15.2	9.4	13.9	28.8	22.9	12.7	16.5	23.5	26.6	22.8	10.6	14.9	22.7	42.0	12.6	11.7	18.9	19.4	14.4	16.3	18.7	23.1	13.5	9.4	21.5	15.3	21.3	16.0	16.9	19.5	20.4	13.7	29.0	18.8	24.2	22.1	16.1	15.9	20.0	20.3	15.6	21.2	16.3	18.6	16.1	17.9	19.1	17.2	17.3	24.1	26.0	13.2	21.9	18.5	9.7	17.2	21.3	46.3	21.7	16.9	13.9	23.0	12.2	18.6	21.4	98.3	141.8	125.3	169.8	219.1	73.8	60.0	94.3	91.0	151.2	57.6	127.6	72.8	11.6	62.1	9.6	101.8	68.8	46.7	57.6	89.7	89.7	128.1	98.4	47.3	69.8	35.0	91.2	89.0	101.6	8.5	91.7	178.5	99.5	108.2	70.4	62.1	59.5	75.9	79.9	12.4	73.8	45.3	105.0	97.9	61.8	231.6	73.3	173.0	79.4	196.2
FNDC7	FLJ35838	ENSG00000143107	"Fibronectin type III domain containing 7"	Q5VTL7	1	108712657-108742740	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.0;testis: 5.2"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 1.1;Early spermatids: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.1;Karpas-707: 1.2;U-87 MG: 1.8"	"Not detected"	"Not detected"							"HPA028079, HPA054297"	Enhanced		Approved	"Nucleoplasm,Actin filaments"	"Secreted in male reproductive system"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA028079: AB_10602501, HPA054297: AB_2682441"	"unprognostic (2.35e-2)"	"unprognostic (2.65e-2)"			"unprognostic (3.74e-1)"			"unprognostic (8.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-4)"		"unprognostic (1.90e-10)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.31e-1)"	0.1	0.1	0.6	0.1	0.8	0.6	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.7	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.5	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.1	0.9	0.5	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.6	0.2	0.3	0.1	0.0	1.1	0.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.5	0.3	0.3	0.1	0.4	0.2	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.4	1.1	1.7	0.7	0.1	0.1	3.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809526	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	18.3	18.4	29.8	18.7	42.1	15.2	20.9	21.9	27.1	19.4	20.5	26.3	15.6	18.7	20.3	19.9	18.8	16.0	20.8	14.3	30.4	22.1	30.2	17.8	16.8	18.2	48.0	28.0	16.2	20.5	31.9	18.0	20.3	31.4	18.1	21.9	9.8	17.5	21.3	15.4	19.7	23.8	18.4	56.6	19.8	18.0	11.3	42.5	20.0	27.8	14.6	17.8	20.2	18.3	5.9	8.3	26.2	11.6	8.7	10.2	5.9	22.3	8.9	15.3	8.0	18.7	18.1	21.6	20.8	19.3	14.1	14.4	8.2	9.0	19.9	14.2	16.8	12.8	13.5	10.3	12.3	19.8	22.1	14.3	16.4	12.1	10.6	14.8	25.5	28.2	14.0	17.4	15.7	17.3	17.4	17.3	12.8	12.1	19.6	19.4	15.2	16.1	20.6	16.3	14.8	14.1	13.5	22.3	10.9	22.8	18.7	9.2	8.5	25.5	24.7	30.2	14.6	9.9	24.3	19.4	18.4	10.8	25.5	17.8	13.2	11.4	16.5	33.1	19.7	27.9	26.2	8.8	20.8	7.8	10.6	9.9	5.9	9.2	7.8	8.3	5.4	7.9	7.5	24.3	8.7	11.6	3.9	10.2	5.9	29.8	42.1	21.9	27.1	30.4	22.1	48.0	28.0	31.4	42.5	11.9	25.1	16.6	33.8	39.0	22.8	30.7	25.5	28.1	34.2	19.2	19.6	36.5	38.1	31.9	4.1	26.9	28.6	0.0	24.1	27.4	24.9	28.7	68.1	15.3	28.0	25.4	20.2	14.7	42.9	2.5	31.1	37.2	37.1	42.3	29.5	38.2	25.3	23.0	29.7	42.3	18.4	19.4	27.8	20.9	24.3	35.3	79.9	26.1	24.1	35.8
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108858228	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	57	"testis: 12.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 58.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HBEC3-KT: 1.3;hTCEpi: 4.0;hTERT-HME1: 2.2;LHCN-M2: 1.2"									"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.9	0.6	0.0	0.9	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	3.5	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	58.5	1.0	0.0	0.0	0.2	0.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.6	2.3	0.0	1.7	0.0	0.3	0.6	0.3	0.0	1.1	0.0	0.0	0.0	0.7	0.5	0.7	0.1	0.6	0.0	0.4	0.0
AL449266.1		ENSG00000274068			1	108837660-108963484	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	19	"Club cells: 2.3;Collecting duct cells: 3.5;granulocytes: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 5.1"															NA	NA						"unprognostic (1.60e-1)"		"unprognostic (2.63e-2)"		"unprognostic (1.21e-1)"					"unprognostic (2.12e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.00e-1)"	"unprognostic (2.03e-1)"		3.7	8.2	3.5	3.6	5.6	2.8	2.0	5.0	6.8	4.4	2.8	6.7	5.1	3.9	3.9	4.6	2.9	2.9	3.1	2.8	4.1		3.2	5.3	3.6	2.8	5.5	3.2	3.8	6.6	10.4	5.5	3.3	4.4	3.1	3.4	3.6	4.3	4.8	7.1	2.2	4.7	4.0	4.7	2.6	3.1	3.3	5.5	0.0	3.2	1.5	2.2	2.9	1.5	3.6	4.6	3.5	4.3	2.3	3.9	1.8	3.1	1.7	2.4	0.5	0.7	2.5	1.3	2.4	1.1	0.4	0.0	0.0	0.0	0.0	3.1	0.5	1.3	0.6	0.5	0.5	0.0	5.1	0.6	3.1	0.3	0.6	0.0	1.4	0.8	0.0	0.0	0.4	0.0	0.9	1.8	0.6	1.0	1.4	0.4	0.0	0.0	0.0	0.6	0.2	0.0	0.6	0.6	0.7	0.0	1.9	0.6	1.1	2.9	0.9	0.9	0.0	0.0	1.5	1.1	0.8	1.1	1.2	0.7	2.0	3.0	0.2	1.2	0.3	2.0	0.6	3.8	3.5	3.6	3.3	2.5	3.6	2.3	2.5	2.5	2.6	3.3	3.9	0.6	2.3	4.3	4.6	2.3	1.8											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 35.6"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 125.7;Syncytiotrophoblasts: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol		NA	Yes			Cytosol		"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	3.8	4.0	16.6	4.4	17.9	13.9	8.5	10.1	20.6	7.5	13.6	17.9	2.5	8.0	6.9	4.3	30.4	2.9	3.1	3.0	15.2	14.1	2.6	1.9	6.6	5.8	19.7	9.0	2.4	2.4	4.0	2.1	7.6	19.6	6.3	15.4	1.3	7.0	5.7	8.0	35.6	10.1	10.6	25.1	2.0	5.3	11.4	18.8	14.1	2.3	23.5	12.1	6.5	10.6	1.8	1.6	8.6	1.2	0.7	4.4	0.4	41.3	5.9	13.6	10.7	13.7	8.2	10.2	8.3	21.1	10.3	15.9	6.4	10.6	9.5	2.3	11.6	7.9	9.1	8.8	21.8	13.3	9.8	5.9	7.0	11.6	7.0	1.8	9.3	6.4	1.5	44.6	11.2	44.5	3.8	11.0	7.4	5.3	14.3	22.1	12.8	7.5	4.7	3.5	18.0	10.1	6.6	22.0	2.5	8.9	6.5	10.4	9.0	11.4	23.2	8.8	3.7	9.1	9.0	6.8	7.9	12.4	21.1	15.7	6.4	5.9	9.4	12.7	15.5	36.7	0.1	1.2	8.6	0.8	0.9	0.5	0.7	0.6	1.1	1.6	1.8	1.1	0.8	1.6	0.7	0.4	0.7	4.4	0.4	16.6	17.9	10.1	13.6	15.2	14.1	19.7	9.0	19.6	18.8	14.9	3.5	5.2	16.6	55.6	46.3	2.1	0.0	6.7	14.8	7.0	125.7	42.8	10.0	2.2	39.6	3.8	8.0	0.0	1.6	37.2	12.8	3.8	2.3	0.5	7.7	41.3	8.7	1.8	5.2	16.4	17.3	4.6	25.3	6.4	12.1	7.1	3.2	7.0	4.9	0.3	43.8	0.0	5.3	15.2	25.1	35.5	74.6	7.7	11.8	13.3
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108929508-108963457	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	17.4	19.5	17.5	13.2	24.8	7.1	19.1	22.8	26.1	19.0	16.4	28.4	22.9	15.6	22.1	31.2	12.2	16.9	15.8	20.2	19.5	15.2	12.2	23.5	15.1	10.9	24.4	16.3	23.3	28.5	26.6	24.4	20.0	20.5	23.1	15.3	17.7	21.8	24.1	29.3	16.1	14.8	19.3	21.5	13.7	17.9	8.3	24.3	5.1	21.7	10.4	12.9	17.1	16.0	7.7	9.5	9.0	15.4	7.1	9.4	5.5	23.8	10.4	13.5	23.3	18.8	17.1	17.5	19.9	16.4	14.1	15.3	11.2	10.0	5.7	21.4	15.7	9.2	9.2	12.2	7.5	18.1	18.1	10.9	14.1	13.0	10.3	15.1	13.9	15.6	12.5	11.3	16.3	13.4	14.5	12.9	6.7	17.0	23.3	10.3	9.5	1.3	5.5	10.2	8.4	9.4	12.9	6.9	13.6	11.8	14.2	8.1	12.4	23.3	25.2	18.0	10.8	7.9	9.5	13.9	18.9	15.1	18.0	19.5	17.0	13.9	8.8	23.0	11.3	40.6	4.1	9.2	9.0	9.1	11.1	9.4	7.7	7.7	7.2	8.0	5.9	8.7	7.9	1.6	7.1	15.4	9.5	9.2	5.5	17.5	24.8	22.8	26.1	19.5	15.2	24.4	16.3	20.5	24.3	23.8	18.1	4.5	11.7	3.3	13.1	4.5	15.3	18.7	19.4	10.4	27.5	24.4	0.0	15.5	6.1	7.1	5.7	0.0	18.3	10.5	14.6	15.9	11.5	19.2	11.6	20.6	3.5	10.4	4.3	2.1	18.4	5.7	8.5	11.8	8.8	14.5	17.7	0.0	17.7	5.6	15.6	19.4	8.0	4.2	4.6	5.5	15.4	6.4	10.1	8.9
WDR47	KIAA0893	ENSG00000085433	"WD repeat domain 47"	O94967	1	108970214-109042113	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 83.1;Suprabasal keratinocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027287, HPA027289"	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Actin filaments"	Nucleoplasm	"HPA027287: AB_10599416, HPA027289: AB_10601862"	"unprognostic (8.55e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.05e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.39e-3)"	"unprognostic (7.90e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.09e-2)"	7.1	7.2	17.7	5.1	24.0	10.1	6.4	19.9	42.6	8.0	5.6	9.5	3.4	3.7	9.4	5.8	13.7	8.4	7.1	7.5	20.1	20.6	7.5	3.6	6.7	5.0	14.8	21.0	7.6	5.6	10.4	4.4	6.3	24.8	7.3	5.4	5.8	4.7	7.2	14.2	20.3	4.1	9.8	12.7	5.3	5.6	19.9	11.3	5.5	6.1	4.8	7.0	6.8	6.3	3.5	5.6	18.8	5.0	2.2	4.6	2.0	10.8	3.3	6.3	8.0	12.6	11.1	3.4	12.4	7.6	8.3	9.3	3.2	1.6	4.9	6.7	11.8	6.1	12.2	9.0	5.4	10.9	9.0	5.0	4.1	7.3	3.6	7.2	6.3	6.1	6.8	9.1	12.9	6.3	10.1	9.8	5.8	2.4	6.9	14.1	6.4	6.1	5.0	2.7	3.5	6.6	8.7	16.2	2.7	13.8	9.4	11.3	10.2	10.8	5.8	8.6	7.1	2.7	6.5	16.7	11.1	5.1	19.3	10.1	4.4	3.6	4.0	12.9	6.3	16.4	11.4	4.7	5.8	3.2	5.0	2.8	2.0	2.9	3.4	5.1	3.5	2.6	2.2	18.8	2.2	4.5	5.6	4.6	2.0	17.7	24.0	19.9	32.4	20.1	20.6	14.8	21.0	24.8	11.3	11.9	9.2	1.9	4.3	83.1	15.1	17.6	12.7	18.7	10.3	7.0	43.2	2.1	5.0	2.7	24.9	11.7	2.4	0.0	0.8	1.6	6.1	2.2	2.3	1.7	3.9	11.1	2.9	4.9	5.6	30.9	7.8	8.6	23.6	5.4	1.0	12.6	3.3	0.0	14.2	4.8	31.5	6.5	17.6	25.7	26.2	91.2	4.1	4.3	1.7	3.3
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.6	5.4	8.3	12.1	24.0	22.5	13.8	49.1	20.8	20.0	20.3	8.6	4.7	7.9	18.8	32.6	11.9	8.7	14.6	17.7	30.2	13.5	3.3	7.9	13.2	8.9	19.0	13.9	12.1	20.0	21.3	33.5	18.3	10.8	17.1	7.3	15.1	7.7	27.0	11.9	7.3	3.8	16.6	9.6	11.3	5.7	15.0	3.1	23.6	18.0	8.7	10.8	24.1	15.6	17.7	15.5	5.3	9.9	22.3	33.1	12.6	23.3	26.8	9.4	23.7	10.6	35.2	7.4	49.1	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7	17.9	21.1	8.2	9.3	62.4	4.5	57.2	10.2	16.0	26.1	7.0	0.0	15.5	11.6	14.4	29.0	19.7	31.6	23.3	18.1	26.6	20.6	18.8	13.9	35.8	16.4	6.4	30.6	24.5	29.7	2.9	8.6	18.4	13.5	12.6	26.1	10.8	24.9	20.1	12.0	26.2	7.5	6.5	26.2	9.8	15.7	72.0	45.9	7.7	10.5	25.9
TMEM167B	"AD-020, C1orf119, FLJ90710"	ENSG00000215717	"Transmembrane protein 167B"	Q9NRX6	1	109089803-109096934	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.89e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.96e-2)"	"prognostic favorable (8.86e-4)"	"unprognostic (3.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.25e-1)"	8.4	10.7	9.0	5.6	10.4	12.4	9.3	7.5	8.6	9.4	7.2			5.7	8.3	9.4	6.4	6.5	6.5	9.3	8.5	8.8	9.0	8.7	8.2	5.9	8.5		8.1	7.1	10.5	7.0	8.7		10.7	7.9		7.6	8.0	8.6	10.3	5.9	7.8	8.9	6.9	8.3	5.6			11.7		6.6	7.5	6.7	7.5	9.3	25.4	13.7	8.4	9.9	8.9	13.3	2.6	8.7	12.4	18.2	18.2	7.8	19.8	18.4	11.6	10.8	5.0	5.8	8.8	11.4	20.0	6.8	6.9	5.5	9.0	16.4	13.2	4.6	8.0	3.7	7.0	21.0	15.4	14.0	14.6	25.0	10.4	17.5	15.8	9.9	11.4	9.9	12.6	12.2	8.4	11.3	10.8	6.8	11.3	12.8	7.4	13.7	6.7	15.1	8.6	6.7	6.8	9.7	14.3	19.4	8.2	10.6	12.3	9.3	12.0	12.0	25.2	9.6	12.7	7.4	8.6	19.5	16.5	24.1	16.9	10.2	17.3	7.1	11.4	9.9	7.5	9.4	8.7	9.3	7.3	9.9	9.6	25.4	8.4	13.7	6.1	8.6	8.9											29.8	28.9	20.0	26.3	27.1	29.9	31.7	22.9	14.7	22.7	17.4	11.8	34.1	16.6	23.2	13.5	22.0	18.8	0.0	26.2	29.6	31.0	39.7	31.2	15.3	35.1	23.8	20.1	26.4	35.2	11.7	26.7	39.4	25.3	47.7	24.0	28.7	23.3	20.1	23.7	24.2	26.0	0.0	30.9	26.3	26.2	31.1	52.7	34.6	16.4	36.1
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.5;fallopian tube: 60.2;testis: 77.6"	"Group enriched"	"Detected in some"	10	"Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 36.5"	"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.3	0.4	1.5	0.3	6.8	0.3	0.4	0.3	2.6	1.8	0.3	12.3	0.0	0.4	1.0	11.1	0.4	60.2	0.3	0.3	3.0	1.6	0.3	0.3	7.5	0.4	0.5	1.8	10.3	0.7	0.4	2.7	0.3	36.5	0.4	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.7	0.3	0.5	77.6	2.3	0.0	0.5	0.0	0.3	0.5	0.2	0.2	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	6.3	0.3	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	6.8	0.3	2.6	3.0	1.6	0.5	1.8	36.5	2.3	0.0	2.6	0.0	0.2	0.0	0.6	2.0	0.0	776.3	56.9	0.0	0.0	0.0	0.0	0.0	1757.0	0.0	0.0	0.0	0.2	0.0	0.2	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	2679.4	19.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	6.5	0.0	176.3	13.0	0.1	0.0	0.0	0.0	0.0
KIAA1324	"EIG121, maba1"	ENSG00000116299	KIAA1324	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8;salivary gland: 169.4"	"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 98.1;Intestinal endocrine cells: 156.4;Mucus-secreting cells: 151.0;Undifferentiated cells: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;SCLC-21H: 9.3;SK-BR-3: 11.3;T-47d: 38.6;U-87 MG: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favorable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.7	0.9	3.7	3.6	7.9	0.0	16.4	0.7	5.6	23.9	11.8	0.4	0.0	14.6	5.5	5.7	1.3	7.8	19.1	0.6	3.3	2.3	0.6	0.6	2.2	0.7	1.0	2.7	1.2	79.8	6.1	46.6	0.0	1.1	15.8	10.0	0.0	169.4	0.0	0.6	2.5	16.5	0.2	0.9	0.9	27.3	9.4	1.1	0.0	3.9	5.2	11.5	0.9	0.6	0.2	0.0	33.8	0.0	0.2	4.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	14.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.0	9.3	0.2	0.0	11.3	0.0	0.0	38.6	0.0	0.2	0.0	1.4	0.0	0.1	0.8	2.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.9	0.2	3.9	1.7	0.0	0.0	1.8	0.7	33.8	0.2	0.0	0.0	4.6	1.0	3.7	7.9	0.7	5.6	3.3	2.3	1.0	2.7	1.1	1.1	14.9	43.1	0.0	6.2	0.5	5.1	1.5	0.0	34.8	62.6	0.0	3.9	0.5	0.0	0.9	32.7	0.5	13.1	0.0	33.1	0.6	1.6	98.1	22.1	0.0	0.9	1.6	156.4	1.3	1.6	12.3	4.0	2.3	3.3	0.0	151.0	1.4	16.5	24.6	2.1	0.0	2.6	0.0	1.4	13.7	1.7	1.4	0.5	4.4	73.4	8.3
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol		NA	NA		100000	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	33.3	13.1	25.2	37.9	37.9	34.4	43.4	35.1	36.4	30.5	38.1	25.3	10.3	36.0	18.2	49.4	17.0	18.3	39.2	49.6	35.5	25.4	23.9	13.9	16.2	18.3	76.2	17.5	15.7	42.3	86.8	35.9	78.3	26.0	36.3	45.5	31.8	45.1	29.6	31.9	19.4	8.9	10.5	20.0	31.0	16.1	32.2	16.1	23.2	17.7	35.0	18.6	16.8	27.1	95.1	20.0	15.3	20.9	28.6	18.2	22.9	25.8	24.5	34.4	13.9	29.5	57.4	19.3	61.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0	47.6	92.0	61.1	90.9	109.9	51.2	87.9	81.5	66.9	81.9	68.0	21.6	157.2	112.7	120.1	15.1	64.7	75.8	70.0	195.0	122.6	80.4	56.7	96.0	112.9	78.0	55.6	66.7	63.8	59.4	21.0	73.1	68.8	60.8	110.0	61.3	56.1	142.9	49.1	65.4	85.4	34.4	129.4	118.7	46.1	22.4	95.2	157.6	64.0	84.6	77.6
CELSR2	"ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3"	ENSG00000143126	"Cadherin EGF LAG seven-pass G-type receptor 2"	Q9HCU4	1	109250019-109275750	"G-protein coupled receptors, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.7;skin 1: 27.8"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 92.2;Muller glia cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.2;HaCaT: 24.9;MCF7: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013952	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA013952: AB_1846518"	"unprognostic (4.46e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.16e-2)"	1.5	2.3	12.6	1.1	16.0	0.9	5.4	9.2	31.7	6.9	1.8	13.7	3.4	1.4	3.1	4.3	10.9	18.8	1.8	5.3	17.1	8.1	5.6	1.2	1.8	1.3	10.0	15.4	1.2	4.8	7.8	2.3	1.6	8.3	3.5	1.4	5.4	6.4	10.4	9.3	27.8	1.5	2.4	14.1	1.0	2.0	11.0	8.6	0.5	10.9	2.7	3.2	2.3	6.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	7.0	6.6	25.2	4.6	0.0	0.0	6.8	0.8	0.6	1.5	0.4	1.0	0.2	1.2	5.7	0.5	1.2	24.9	6.5	4.0	0.8	0.1	2.7	0.5	6.0	1.4	0.5	0.3	3.2	0.1	9.8	0.6	0.4	5.7	0.3	4.0	4.1	0.3	0.0	28.7	0.7	0.3	8.1	0.8	1.2	6.4	2.3	0.3	5.5	2.4	10.2	4.8	3.8	8.5	5.4	6.2	8.0	1.6	0.0	0.0	4.6	0.4	6.2	1.6	0.4	0.3	1.4	0.5	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	16.0	9.2	31.7	17.1	8.1	10.0	15.4	8.3	8.6	8.9	5.3	0.0	4.8	14.0	7.2	9.4	5.1	2.7	4.5	17.4	3.9	1.9	1.7	2.2	4.9	0.8	0.5	0.0	0.4	1.0	1.0	2.1	1.1	5.9	0.9	92.2	1.7	0.0	0.0	5.3	3.1	0.5	10.1	0.0	0.3	32.3	1.7	0.0	18.0	2.7	5.2	6.5	2.0	0.9	3.4	19.9	0.5	0.0	1.2	5.7
PSRC1	DDA3	ENSG00000134222	"Proline and serine rich coiled-coil 1"	Q6PGN9	1	109279556-109283186	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 23.6;Extravillous trophoblasts: 28.6;Peritubular cells: 42.1;Rod photoreceptor cells: 70.6"	"Cancer enhanced"	"Detected in all"		"glioma: 50.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 12.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3"	"Low region specificity"	"Detected in all"			HPA056561			Approved	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"HPA056561: AB_2683175"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.36e-9)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	1.7	2.4	17.1	4.3	21.6	8.3	3.0	3.8	27.3	2.0	4.0	31.2	0.3	5.1	3.0	3.4	6.3	3.2	3.7	2.0	25.9	11.2	1.7	2.6	2.2	4.0	29.8	12.9	3.6	1.4	0.8	1.7	4.8	16.8	4.0	3.3	4.5	2.9	5.9	1.0	6.1	5.3	4.7	30.6	2.3	2.4	8.6	20.7	5.5	2.0	0.4	5.0	2.6	2.3	0.0	5.4	7.3	12.3	0.2	0.7	3.2	18.8	9.8	40.0	19.3	1.6	3.2	11.0	15.0	12.2	20.5	19.7	15.0	7.9	9.6	5.5	7.4	9.6	13.6	21.5	12.3	17.2	3.7	10.4	6.0	13.1	12.2	1.8	6.4	6.9	3.6	1.1	8.1	5.8	7.7	10.0	11.5	13.6	4.4	16.4	17.1	9.7	4.3	16.5	8.7	11.2	15.1	38.5	3.2	6.9	5.0	16.8	9.7	8.4	12.9	15.4	15.2	7.8	6.1	5.1	12.7	21.0	8.9	24.6	3.4	2.2	3.3	10.2	15.3	35.3	0.0	12.3	1.8	0.7	4.8	0.5	0.0	0.7	0.2	5.4	0.0	0.4	0.4	7.3	0.2	2.6	0.0	0.7	3.2	17.1	21.6	3.8	16.4	25.9	11.2	29.8	12.9	16.8	20.7	0.0	3.8	0.0	2.3	1.8	6.5	0.9	2.5	1.4	0.0	1.8	23.6	3.4	0.0	0.9	0.5	0.4	0.5	0.0	0.7	28.6	2.3	0.6	1.1	0.9	9.2	3.2	0.0	1.3	4.0	1.9	5.5	1.6	1.7	0.0	3.2	7.7	0.4	0.0	42.1	2.3	70.6	0.0	2.3	2.7	1.2	1.0	2.4	0.0	2.0	0.7
MYBPHL		ENSG00000221986	"Myosin binding protein H like"	A2RUH7	1	109292365-109307041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"heart muscle: 64.6"	"Cell type enriched"	"Detected in some"	14	"Cardiomyocytes: 139.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;Daudi: 1.5;Hep G2: 6.7;K-562: 1.7;RH-30: 3.9;THP-1: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA077633			Approved	Vesicles		NA	NA			Vesicles		"HPA077633: "	"unprognostic (6.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (5.89e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.10e-1)"	"unprognostic (7.05e-9)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.64e-1)"	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.3	1.3	0.0	64.6	0.4	0.1	0.0	0.0	0.7	0.0	1.4	0.1	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.8	0.5	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.6	0.4	0.1	1.4	0.1	0.4	0.9	0.0	3.2	0.0	0.1	0.0	1.1	139.3	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.7	0.0	9.8	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.5
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397951	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.1;epididymis: 75.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.0;non-classical monocyte: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000		"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	22.9	6.5	24.0	6.2	35.5	10.1	15.5	6.4	40.6	10.1	15.2	50.3	18.1	11.5	11.9	75.2	22.0	14.8	9.5	31.8	45.2	19.8	21.1	3.7	19.2	3.6	57.9	22.8	3.6	9.3	24.2	5.7	22.9	27.1	10.3	14.4	12.2	11.8	24.8	36.4	8.3	11.3	14.6	71.1	5.4	9.5	21.6	42.2	1.1	22.5	5.1	5.4	8.7	8.2	0.0	4.5	2.3	10.0	0.4	0.0	1.7	11.8	4.7	11.9	14.5	34.8	6.9	34.3	8.8	14.1	8.7	9.3	12.2	4.4	0.1	11.3	3.7	6.4	2.9	14.0	6.9	12.5	0.3	6.6	3.2	7.7	13.1	13.6	0.0	10.7	17.3	1.1	10.6	2.3	23.3	1.3	9.9	24.4	1.2	12.1	12.5	8.3	0.2	4.4	5.3	2.0	9.3	28.1	5.7	16.6	8.6	12.2	7.0	5.2	34.5	37.0	17.7	14.5	2.0	0.3	1.8	7.1	0.3	14.7	11.8	9.6	0.0	3.1	0.0	7.6	0.0	7.1	2.3	0.0	9.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.9	0.4	10.0	1.6	0.0	1.7	24.0	35.5	6.4	33.9	45.2	19.8	57.9	22.8	27.1	42.2	35.7	42.8	0.0	4.2	1.1	14.6	83.1	33.1	22.7	18.2	71.5	33.4	26.8	5.0	23.3	53.4	7.3	49.9	0.0	20.8	26.7	6.1	10.7	7.0	22.5	27.9	12.7	16.1	4.3	36.7	56.4	8.1	24.8	20.3	20.8	30.9	20.4	21.0	17.5	46.7	9.9	42.2	32.3	31.1	51.1	20.4	1.6	30.8	1.8	19.9	10.8
PSMA5	ZETA	ENSG00000143106	"Proteasome subunit alpha 5"	P28066	1	109399031-109426427	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 31.2"	"Low region specificity"	"Detected in all"							"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol		NA	NA		22000000	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	12.1	23.7	13.2	17.3	15.0	7.7	16.2	8.2	40.5	13.3	16.1	9.8	16.7	15.1	15.8	23.0	21.5	17.6	16.7	20.8	13.8	13.5	27.5	41.9	17.1	24.2	13.4	14.9	13.6	21.4	12.6	11.5	20.9	12.8	12.3	14.9	10.2	16.8	14.2	31.6	15.8	21.8	14.4	12.9	18.5	15.2	16.3	10.3	31.5	27.9	23.4	19.8	14.0	11.7	2.1	1.2	7.3	2.2	2.8	7.1	1.6	1.2	1.0	1.7	1.2	3.9	4.2	1.4	0.9	9.3	6.1	3.6	1.3	1.1	5.3	1.2	4.1	0.4	1.7	2.4	3.1	3.8	1.1	1.5	2.3	0.9	1.6	2.9	3.0	1.2	1.9	3.1	1.8	3.0	1.5	2.3	1.6	1.8	1.4	2.5	1.6	31.2	1.3	1.4	1.3	1.5	0.8	3.1	0.9	4.9	1.6	1.4	1.2	1.6	5.5	2.0	1.4	1.2	2.7	1.5	1.0	0.8	2.1	1.2	0.9	1.8	6.7	6.8	6.7	1.1	7.3	1.0	0.7	4.0	2.2	4.8	1.8	5.8	4.9	1.2	2.1	7.1	6.5	0.3	2.8	2.0	0.8	5.3	1.6	13.2	15.0	8.2	17.5	13.8	13.5	13.4	14.9	12.8	10.3	38.7	52.0	75.2	57.4	56.4	28.9	80.5	71.4	113.8	56.9	40.1	5.9	188.1	119.3	151.2	42.4	54.0	101.9	93.5	159.8	154.0	44.1	63.2	80.8	125.2	151.4	12.7	54.1	53.4	54.0	13.6	62.7	72.3	55.6	215.6	84.3	42.7	167.1	91.2	58.4	151.0	27.9	45.3	54.2	105.7	86.6	57.6	201.7	98.3	114.8	81.6
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466628-109482137	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 102.5;tongue: 25.6"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA076657			Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	0.9	3.9	0.8	0.3	0.7	0.1	1.4	0.5	1.2	1.6	1.9	0.3	0.8	0.3	2.5	4.3	1.6	0.4	1.1	7.4	0.8	0.2	6.0	4.7	0.6	0.3	0.3	0.0	1.1	3.2	3.7	0.4	1.2	0.8	1.2	0.5	1.7	1.6	2.2	102.5	0.2	0.6	3.5	0.1	0.4	1.1	6.0	0.2	0.0	5.1	25.6	1.2	2.5	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	20.2	8.5	0.0	8.6	27.3	2.7	1.0	0.0	0.0	0.0	0.0	14.1	0.3	0.0	7.3	0.0	0.5	0.0	3.1	0.0	0.2	0.1	0.4	0.0	0.7	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.9	2.1	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	1.2	0.8	0.2	0.3	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	1.5	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	4.9	0.0	0.0	2.3	0.4	1.5	0.0	0.1	0.0	0.0	0.0
ATXN7L2	"FLJ00381, MGC46534"	ENSG00000162650	"Ataxin 7 like 2"	Q5T6C5	1	109483479-109492804	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029827, HPA054952"	Uncertain		Approved	"Nucleoli rim,Vesicles,Cytosol"		NA	NA			"Nucleoli rim"	"Vesicles, Cytosol"	"HPA029827: AB_10602390, HPA054952: AB_2682647"	"unprognostic (4.53e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.77e-4)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.94e-3)"	4.2	5.2	7.5	4.0	9.2	10.2	2.6	15.2	10.9	2.8	2.8	5.1	1.2	2.7	4.4	1.8	2.8	3.3	3.8	2.0	6.5	3.3	3.4	3.0	3.4	3.8	5.7	7.0	7.3	2.4	1.6	9.9	2.5	4.7	2.2	1.4	5.7	1.8	3.2	13.3	3.5	3.1	2.0	3.1	5.4	2.9	8.8	4.8	2.7	4.2	1.0	2.6	3.2	2.4	2.4	1.3	2.4	2.4	2.7	5.6	2.2	2.2	1.7	1.2	4.6	1.6	2.9	3.2	1.6	2.1	3.4	2.3	3.6	1.5	5.8	2.6	2.0	0.9	2.5	2.4	2.2	0.4	5.3	3.4	3.2	3.6	1.6	1.0	4.8	7.6	3.1	1.2	3.5	0.0	1.4	0.8	6.3	5.4	3.3	0.6	7.0	8.4	6.3	7.0	2.3	2.5	6.0	2.9	4.1	1.2	2.3	10.7	4.3	1.7	5.7	2.6	0.3	1.0	5.0	0.3	2.4	7.1	2.2	6.4	2.2	1.4	5.5	2.8	4.0	6.0	0.0	1.9	2.4	5.4	2.4	5.0	2.3	4.3	5.6	1.3	2.4	4.0	3.8	1.9	2.7	1.6	1.0	3.8	2.2	7.5	9.2	15.2	10.9	6.5	3.3	5.7	7.0	4.7	4.8	0.0	0.3	0.8	1.4	0.6	3.2	1.6	2.5	0.0	2.3	1.8	2.0	1.2	0.0	1.2	1.8	0.9	0.6	0.0	1.6	1.2	1.5	0.4	4.6	1.0	0.5	3.2	1.7	1.8	1.2	0.0	1.1	0.8	0.0	0.0	1.0	1.6	1.4	0.9	1.4	0.6	1.6	0.0	1.0	3.8	3.8	0.6	2.6	2.5	0.9	0.6
CYB561D1	"FLJ39035, FLJ44753"	ENSG00000174151	"Cytochrome b561 family member D1"	Q8N8Q1	1	109494052-109502932	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027028	Uncertain					NA	NA					"HPA027028: AB_1847365"	"unprognostic (2.15e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (4.68e-4)"	"unprognostic (4.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.16e-6)"	"unprognostic (4.30e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.20e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.82e-2)"	6.1	10.5	8.7	10.7	12.0	9.1	7.0	21.7	13.4	4.2	8.4	7.9	13.4	7.1	6.9	14.8	9.3	7.0	6.7	4.6	9.6	5.6	8.2	4.2	7.4	12.8	9.7	10.2	9.4	19.4	11.1	11.2	7.0	8.8	6.8	7.7	4.6	10.8	8.4	7.8	22.5	12.2	6.8	7.8	12.1	9.0	3.9	11.1	10.6	10.3	6.6	12.8	7.0	12.2	4.5	3.0	10.8	4.5	8.7	8.3	3.5	8.3	5.0	3.6	4.2	12.6	9.3	9.3	7.3	5.7	8.4	6.0	4.9	3.8	7.6	7.9	9.4	5.5	9.7	4.8	6.0	5.5	6.2	4.4	5.1	6.8	3.8	5.9	10.3	16.0	9.9	15.0	8.3	4.4	5.3	6.0	7.5	3.2	3.5	5.4	10.6	3.7	5.5	1.7	6.4	7.7	6.1	14.8	3.0	7.7	14.3	5.4	4.7	8.3	8.2	7.7	5.3	5.6	5.6	7.8	8.4	9.9	11.3	5.9	4.0	2.9	3.8	8.5	8.6	9.2	3.8	3.8	5.6	6.3	4.2	5.5	3.5	6.6	5.6	2.7	4.5	8.3	5.8	10.8	8.7	4.5	3.0	4.7	3.5	8.7	12.0	21.7	13.4	9.6	5.6	9.7	10.2	8.8	11.1	0.0	6.6	4.9	1.5	2.1	7.6	3.4	5.1	2.7	3.4	3.5	2.0	2.2	0.0	2.8	0.0	2.1	7.4	0.0	6.9	1.0	2.1	1.5	1.1	1.8	1.1	3.2	4.1	1.3	3.8	0.0	2.3	2.3	1.7	1.0	2.7	2.4	4.5	0.0	3.9	2.3	5.5	0.0	2.8	1.1	1.5	2.6	0.9	6.9	3.4	2.3
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504175-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 27.9;Rod photoreceptor cells: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5"	"Group enriched"	"Detected in many"	21	"NK-cells: 1.9;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.6;SK-BR-3: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	5.3	14.8	11.8	3.7	19.1	1.0	4.7	23.4	33.9	4.8	6.6	4.8	4.0	3.2	5.7	16.4	4.1	4.9	4.3	11.0	12.2	14.3	7.6	3.5	6.4	5.2	9.9	15.0	12.8	9.2	21.1	8.1	3.0	15.6	9.2	3.7	10.3	9.6	11.1	22.4	3.3	4.1	6.5	6.0	4.6	5.0	4.1	5.3	1.7	9.1	1.9	4.6	4.5	3.8	0.1	0.0	0.0	0.1	1.9	5.4	0.9	2.6	1.2	2.7	9.5	3.6	1.5	3.4	4.4	2.2	5.1	2.4	0.5	0.1	0.2	1.2	2.8	1.2	1.4	7.3	0.3	4.3	1.0	0.6	0.0	1.7	0.8	2.9	2.1	5.4	0.7	3.2	1.7	0.0	0.5	1.2	1.5	2.1	0.0	0.1	4.4	0.4	4.4	1.7	2.2	3.0	0.7	0.0	0.4	5.9	1.3	9.6	3.2	1.0	12.6	3.5	1.2	3.6	3.1	1.1	0.2	5.9	3.4	1.8	0.2	0.0	0.0	1.9	0.0	2.7	0.0	0.0	0.0	1.5	0.1	1.6	0.1	2.2	2.5	0.0	0.0	5.4	3.9	0.0	1.9	0.0	0.0	1.5	0.9	11.8	19.1	23.4	33.9	12.2	14.3	9.9	15.0	15.6	5.3	3.0	1.3	0.0	0.4	0.6	27.9	6.7	2.5	0.0	0.0	3.5	3.9	1.0	0.0	1.0	0.0	0.8	1.0	0.0	0.8	0.1	0.6	1.1	0.0	0.8	0.2	4.8	4.6	0.6	0.0	0.0	2.0	0.0	0.0	1.0	0.7	7.1	0.7	0.9	5.3	0.5	8.8	0.0	1.0	0.7	0.9	0.4	0.2	0.0	1.5	0.3
GPR61	BALGR	ENSG00000156097	"G protein-coupled receptor 61"	Q9BZJ8	1	109539872-109548406	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 10.6;pituitary gland: 6.3;retina: 6.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 13.7;Cone photoreceptor cells: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.1;naive CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.6;Karpas-707: 1.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007326, HPA026088"	Supported					NA	NA					"HPA007326: AB_1849308, HPA026088: AB_10602323"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.46e-4)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.85e-2)"	0.5	4.0	4.9	0.7	8.2	0.7	0.5	6.4	10.6	0.5	0.6	0.2	0.0	0.8	0.8	0.6	0.7	0.5	0.7	0.9	5.4	3.9	0.6	0.6	0.5	0.8	1.7	8.3	0.6	0.5	0.5	6.3	0.6	4.9	0.6	0.5	6.3	0.7	0.5	2.3	0.8	1.0	0.5	1.2	0.6	0.6	1.7	1.2	0.0	3.6	0.0	0.5	0.7	0.3	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	1.0	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.3	0.3	0.0	0.0	0.1	0.5	0.1	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.3	0.5	0.0	2.3	0.4	0.2	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	4.9	8.2	6.4	10.6	5.4	3.9	1.7	8.3	4.9	1.2	0.0	0.0	0.0	0.0	0.0	13.7	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548611-109618321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 329.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		8400000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	25.2	13.0	12.3	15.5	11.3	26.4	15.8	12.8	10.7	19.0	14.7	10.3	14.3	12.1	19.7	15.7	34.8	12.5	13.2	9.3	12.3	9.4	18.1	25.8	13.2	23.8	13.1	8.3	18.4	13.7	10.7	11.0	22.4	11.5	17.2	13.8	8.0	16.2	14.4	8.6	27.9	17.0	15.9	12.9	21.6	12.1	14.0	12.0	22.2	12.9	25.2	20.6	20.0	20.4	6.1	9.6	16.8	13.1	5.8	7.2	9.3	14.1	5.0	9.6	5.6	9.2	11.1	7.9	10.7	8.6	10.9	10.9	7.6	4.9	7.6	7.1	11.4	6.7	7.5	9.0	10.9	15.3	8.5	5.5	6.6	8.6	6.5	7.9	10.3	6.1	8.2	9.3	12.6	8.7	7.6	13.1	5.8	8.6	7.5	10.8	9.6	7.9	8.4	9.6	6.8	5.8	5.7	22.6	4.9	12.1	10.8	6.2	10.8	7.5	8.5	11.7	7.8	6.5	9.1	11.8	9.2	12.7	13.8	12.1	8.0	9.0	8.8	15.3	10.2	14.3	8.5	9.1	16.6	6.8	13.1	7.2	6.1	6.7	6.5	9.6	5.0	5.6	6.4	16.8	5.8	12.3	4.3	6.9	9.3	12.3	11.3	12.8	10.7	12.3	9.4	13.1	8.3	11.5	12.0	41.7	29.8	72.9	89.8	134.3	27.1	11.7	28.1	46.8	34.2	55.8	329.9	74.3	54.7	94.8	7.0	65.3	47.7	23.3	88.0	115.2	72.4	62.2	45.1	49.5	96.4	23.8	80.9	47.9	103.4	6.0	45.1	89.9	70.9	77.5	58.1	44.4	82.3	52.6	44.6	40.9	23.4	51.8	82.4	64.2	49.4	164.6	89.4	82.8	47.9	147.8
GNAT2	ACHM4	ENSG00000134183	"G protein subunit alpha transducin 2"	P19087	1	109603267-109619929	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 27.6"	"Cell type enriched"	"Detected in some"	14	"Cone photoreceptor cells: 56.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.5;U-698: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA																							0.1	0.4	0.1	0.1	0.3	0.0	0.4	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.6	0.2	0.2	0.2	0.1	2.5	0.5	0.3	0.1	0.1	0.1	0.4	0.4	0.8	1.2	0.3	0.2	0.5	27.6	0.4	0.3	0.1	0.1	0.6	0.2	0.1	0.4	0.1	6.4	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	0.3	3.0	0.4	0.0	0.3	0.0	0.9	0.2	0.3	0.9	0.4	0.3	0.1	0.5	0.3	0.6	0.1	2.2	0.8	2.4	2.1	0.1	0.8	0.2	5.5	0.1	0.9	0.0	0.1	0.1	0.5	0.9	0.0	2.2	0.3	1.1	0.8	1.3	1.0	0.0	1.4	0.5	1.4	1.5	0.8	1.8	0.7	0.2	1.0	1.1	0.5	0.7	0.0	1.1	0.7	0.6	1.8	0.0	1.9	0.5	2.9	0.0	0.4	0.0	0.0	0.4	0.6	1.0	0.5	2.7	1.6	3.9	0.7	0.4	0.5	0.0	0.0	3.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	56.9	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.5	0.0	0.0	3.2	0.5	0.0	0.1	0.0	0.0	0.0
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.4"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 58.9;Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760, HPA050590"	Approved		Enhanced	Cytosol		NA	NA		380000	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443, HPA050590: AB_2681184"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	8.1	22.7	20.2	21.7	41.3	64.4	4.9	16.3	26.8	9.5	10.1	9.5	6.3	17.1	9.0	6.0	5.9	11.8	13.2	5.2	21.7	19.4	7.8	13.0	8.2	10.7	14.2	14.2	16.3	9.4	13.0	37.1	10.8	18.3	9.7	5.7	15.7	9.1	12.2	2.1	10.0	11.6	9.1	8.5	15.9	8.3	5.3	12.2	10.3	6.4	3.0	7.5	8.2	8.1	2.8	8.8	29.7	24.5	3.0	4.3	5.4	10.9	12.7	18.7	15.8	16.3	16.3	7.1	15.6	31.9	16.0	15.8	9.7	4.7	5.4	12.0	29.2	10.5	8.6	9.8	14.5	9.9	8.7	13.2	28.5	16.7	10.8	15.3	12.1	30.7	18.3	7.7	21.1	16.4	28.9	13.8	11.9	8.8	14.7	11.4	16.9	17.9	29.0	12.1	10.2	13.6	12.7	7.2	8.4	14.7	6.7	14.5	15.3	10.6	13.0	12.6	7.0	7.3	11.3	13.1	19.8	23.0	24.1	16.0	29.5	14.3	7.8	29.5	18.8	20.6	0.5	9.2	11.2	3.4	19.6	4.3	2.8	3.3	3.4	8.8	1.7	3.8	2.8	29.7	3.0	24.5	1.4	2.6	5.4	20.2	41.3	16.3	26.8	21.7	19.4	14.2	14.2	18.3	12.2	3.0	8.5	8.3	4.7	7.9	35.7	2.5	17.8	4.0	5.7	0.0	58.9	4.0	6.6	9.7	2.9	6.2	3.9	0.0	9.6	7.4	11.8	4.5	3.5	17.8	10.5	49.3	16.8	6.2	37.8	1.3	12.0	28.6	5.0	1.0	8.6	9.1	8.3	0.0	20.1	3.9	5.8	12.9	11.7	4.5	2.6	7.0	2.2	10.1	9.7	3.4
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656081-109674836	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 69.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		660000	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	12.5	17.6	14.0	12.3	20.2	3.6	10.9	12.9	24.7	12.6	33.2	18.0	9.4	85.3	12.1	15.3	15.9	11.0	14.5	14.7	13.7	12.3	27.2	22.0	7.4	10.1	14.8	16.9	31.4	12.2	23.1	9.9	5.1	15.8	14.7	23.2	20.5	15.4	26.3	47.4	10.6	77.2	19.0	16.1	16.2	14.7	11.8	14.0	4.0	14.9	14.5	12.8	22.2	14.2	3.6	7.8	69.8	3.0	2.5	3.1	2.3	5.3	2.4	4.3	32.5	9.7	15.0	5.5	1.7	14.0	4.1	5.4	17.1	0.6	5.0	6.7	7.7	8.0	5.5	11.1	5.8	2.6	7.4	0.0	10.9	10.1	15.3	15.8	3.7	13.2	9.5	5.8	5.2	0.0	11.5	3.3	12.9	5.0	7.5	2.8	5.0	3.1	16.4	3.3	22.5	13.0	6.7	2.4	7.3	16.0	3.8	3.1	7.2	0.0	28.2	21.8	3.4	7.6	8.0	1.4	4.7	18.7	5.2	2.5	11.2	19.6	0.4	15.6	5.5	13.3	2.0	2.9	69.8	2.7	3.0	1.6	3.6	2.0	3.1	7.8	2.8	2.0	2.3	0.4	2.5	0.7	2.7	2.8	2.3	14.0	20.2	12.9	24.7	13.7	12.3	14.8	16.9	15.8	14.0	8.9	2.4	13.5	21.7	16.1	5.5	25.8	25.5	10.7	7.9	29.6	0.0	18.5	86.2	40.9	2.6	9.0	85.7	0.0	50.8	15.9	20.4	8.2	20.7	21.9	30.0	4.8	6.9	16.0	14.6	4.7	27.9	17.0	38.8	15.4	33.9	22.1	36.3	28.8	23.3	64.5	4.7	32.3	32.0	5.7	6.9	13.4	7.3	17.8	57.6	10.4
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 56.8;Ciliated cells: 17.4;Club cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 41.4;HSkMC: 41.0"									"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		930000	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	23.8	27.3	30.7	14.7	48.3	5.7	31.7	13.7	25.0	36.4	20.9	19.9	54.3	14.5	24.0	37.1	15.4	31.4	15.7	35.2	32.5	21.7	15.9	6.0	11.1	7.5	17.0	21.1	90.1	17.8	20.4	40.2	5.8	22.4	30.7	10.7	36.0	26.6	87.5	88.5	39.2	13.6	22.0	24.9	10.7	16.4	9.2	28.9	6.7	20.4	25.6	8.7	20.2	31.0	5.2	16.5	16.0	3.5	8.9	20.9	5.8	0.0	1.2	13.0	13.3	15.5	41.4	2.5	8.2	14.5	7.6	9.7	2.3	0.0	0.3	8.8	20.6	6.2	0.0	1.0	0.0	9.9	0.5	0.3	4.7	0.1	3.1	10.5	0.4	8.7	41.0	0.3	11.3	0.0	20.5	5.4	3.9	1.3	0.2	16.5	0.1	6.3	8.1	2.4	0.2	11.1	7.9	0.0	0.0	2.3	0.2	2.8	6.4	0.0	0.3	4.2	8.1	13.2	2.3	0.1	8.4	0.4	12.1	0.6	4.1	6.0	0.5	12.7	0.1	0.1	1.0	2.2	16.0	1.9	3.5	1.8	5.2	5.3	2.0	12.7	3.7	20.9	8.9	1.3	8.9	2.1	16.5	4.5	5.8	30.7	48.3	13.7	25.0	32.5	21.7	17.0	21.1	22.4	28.9	0.0	3.7	1.5	1.9	4.2	1.5	56.8	2.5	17.4	20.5	3.5	0.0	0.3	0.0	0.1	1.2	2.4	0.3	0.0	0.0	0.2	3.3	0.6	2.3	0.6	1.2	3.2	0.0	1.3	1.5	6.8	14.4	1.0	5.0	0.0	0.8	11.0	0.1	0.0	9.9	0.8	0.2	6.5	3.1	0.4	0.4	2.5	0.5	4.3	0.4	0.7
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 8.9;Ciliated cells: 9.4;Club cells: 11.4;Ito cells: 8.0;Kupffer cells: 10.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 26.9;HeLa: 32.1;HHSteC: 25.7;hTEC/SVTERT24-B: 23.2;HUVEC TERT2: 19.7;MOLT-4: 34.6"									"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.9	0.0	0.4	0.0	0.1	0.2	0.0	0.1	26.9	32.1	0.5	25.7	0.0	0.2	0.0	0.0	23.2	0.1	15.4	19.7	15.8	0.0	18.0	0.8	0.0	34.6	0.2	17.3	0.0	0.0	0.1	0.1	3.4	2.8	0.0	1.7	0.2	0.0	0.1	0.1	0.8	0.3	14.2	0.0	11.5	0.6	0.2	0.0	14.4	19.0	1.1	9.9	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2	8.9	5.0	0.0	1.0	1.5	0.0	5.6	5.1	9.4	11.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.6	0.1	0.0	0.0	8.0	10.1	0.0	3.4	0.8	0.0	1.0	0.0	2.3	0.8	0.0	2.1	0.0	0.0	0.0	0.6	0.2	0.2	1.4	0.0	5.3	0.0	0.1
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in many"	6	"Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3"									"HPA048652, HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.6	1.6	0.3	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9	0.0	0.3	0.0	0.5	6.0	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.2	0.8	0.0	0.0	0.0	0.1	12.3	0.1	0.0	0.0	0.2	0.0	0.0	7.4	1.2	9.9	132.9	0.6	10.1	0.0	0.0	217.3	0.0	0.0	119.5	0.0	5.8	25.8	7.6	1.9	1.1	5.6	0.0	0.0	0.0	0.1
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 115.3;testis: 96.0"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 1724.2;Late spermatids: 2908.0;Spermatocytes: 818.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.1;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.7;T-47d: 96.9;WM-115: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Approved	Cytosol		NA	NA		560000	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992"	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	7.5	11.3	21.4	2.9	27.8	0.9	23.1	8.5	18.4	15.4	11.7	9.9	51.0	12.6	9.0	67.2	11.1	8.8	12.3	27.6	14.0	14.4	54.0	5.3	5.2	2.4	9.6	22.0	32.3	26.5	7.3	9.4	5.8	30.7	13.6	5.6	13.4	4.5	115.3	15.5	15.0	7.5	15.9	13.3	3.3	14.2	96.0	6.4	0.1	15.8	15.6	3.3	17.4	12.0	0.6	0.8	4.1	0.3	1.0	11.1	1.4	0.0	1.3	9.9	0.0	13.5	8.3	1.7	10.7	1.8	11.8	11.5	4.3	0.3	0.0	6.2	5.4	8.2	0.5	2.0	4.4	16.4	0.0	2.9	10.0	32.5	6.4	14.4	0.0	23.3	8.3	5.4	17.7	0.0	13.1	14.5	12.4	0.9	0.1	5.3	5.8	2.7	0.2	1.1	0.0	18.6	0.0	6.4	0.4	3.3	23.0	17.5	9.4	22.4	45.7	2.1	3.0	96.9	14.6	11.4	0.1	4.3	12.0	7.0	1.5	2.4	0.0	0.1	0.0	37.6	0.8	0.3	4.1	4.2	0.1	1.2	0.6	5.3	3.1	0.1	0.6	11.1	5.5	2.0	1.0	0.2	0.8	2.3	1.4	21.4	27.8	8.5	18.4	14.0	14.4	9.6	22.0	30.7	6.4	6.0	11.5	8.1	96.3	127.5	19.3	82.7	40.8	1.4	17.0	211.1	5.9	13.4	679.8	74.2	1724.2	31.5	27.6	0.0	131.2	7.7	152.1	47.5	9.2	2.5	8.6	14.3	48.5	54.0	6.6	2908.0	356.9	16.6	57.3	5.4	23.4	255.3	110.8	25.9	259.6	35.7	14.3	187.5	89.7	818.6	48.1	93.8	8.6	7.9	40.9	29.8
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 30.0;intestine: 115.1"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 255.7;Late spermatids: 82.4;Mucus-secreting cells: 88.8;Paneth cells: 126.3;Undifferentiated cells: 82.1"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	22	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"NK-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.6;CAPAN-2: 8.2;Hep G2: 19.4;OE19: 36.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favorable (1.82e-4)"	0.2	0.1	0.2	11.0	0.2	0.0	0.2	0.2	0.2	0.5	88.2	0.2	0.2	41.3	0.2	0.2	0.3	0.2	30.0	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.3	22.1	0.2	0.2	0.3	0.2	0.1	115.1	0.5	0.2	0.2	15.1	1.2	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	8.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	36.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	28.5	0.0	255.7	0.0	21.7	0.0	0.0	0.0	4.6	0.0	0.0	0.0	49.3	0.0	0.0	82.4	0.6	0.0	0.0	0.0	88.8	0.0	26.8	126.3	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	82.1	0.5
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 7.0;eosinophil: 16.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	NA	NA	270000	17000000	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	38.1	21.4	11.5	14.6	16.7	10.1	36.5	4.3	14.6	13.8	12.8	28.2	3.6	8.5	12.0	10.1	11.3	15.7	20.6	16.0	11.4	5.8	10.7	10.3	23.5	16.9	24.3	5.4	16.9	11.3	6.7	5.2	26.0	19.2	16.3	11.0	12.2	12.4	11.6	12.7	10.4	12.7	16.0	21.9	25.8	11.9	7.5	20.3	2.9	12.4	7.8	11.0	20.6	29.2	0.0	0.0	16.5	0.0	0.0	1.0	0.1	1.5	5.7	2.9	1.1	46.5	29.2	1.0	6.6	30.6	5.3	4.9	0.2	0.8	0.0	8.4	16.3	29.0	1.2	1.2	2.2	2.0	18.5	0.9	2.0	3.3	1.9	70.7	0.0	2.6	45.2	0.6	11.6	7.0	32.5	1.0	0.5	0.4	1.1	6.3	0.1	0.0	0.3	0.9	0.4	0.5	0.2	1.5	0.1	2.1	1.5	0.1	0.3	1.9	0.5	2.3	3.7	0.4	0.2	3.5	5.5	1.9	24.4	3.7	0.5	0.2	0.0	14.0	0.0	20.6	7.0	0.0	16.5	0.2	0.0	0.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	11.5	16.7	4.3	14.6	11.4	5.8	24.3	5.4	19.2	20.3	8.9	47.6	2.4	5.4	6.5	0.2	2.4	22.9	0.0	5.7	3.5	0.0	0.5	0.0	23.8	0.3	19.0	0.6	0.0	2.0	0.4	28.2	4.8	111.9	2.5	9.2	0.0	7.5	54.0	3.5	0.0	23.3	11.7	10.1	2.8	0.8	1.9	8.1	0.9	8.1	1.1	0.1	58.2	25.9	0.6	0.6	4.8	0.7	8.5	0.6	1.8
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984686-110023741	"Predicted intracellular proteins"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	24.0	25.7	61.7	11.7	71.2	4.8	19.7	33.2	61.4	26.7	26.3	47.7	17.7	46.5	21.0	36.0	18.3	28.0	24.7	13.9	51.6	57.2	38.6	25.4	16.5	10.5	72.3	49.9	17.6	27.1	53.0	16.3	20.6	55.7	17.3	19.7	9.7	17.9	25.8	27.1	14.2	22.9	21.8	48.8	12.1	19.6	10.2	47.5	6.8	28.6	8.6	13.4	16.7	15.3	8.0	6.2	8.7	9.3	3.9	8.2	3.7	22.7	19.4	18.3	18.9	44.3	26.1	30.2	18.1	20.5	17.2	17.0	15.0	13.2	9.7	15.5	26.7	13.1	14.7	16.2	20.7	22.8	81.2	14.0	16.0	25.2	15.8	46.0	13.7	11.3	26.6	13.1	21.4	31.4	42.0	21.6	16.5	11.5	19.7	17.7	18.1	11.4	6.8	21.6	32.2	15.0	12.4	38.1	10.7	37.6	23.1	17.9	11.6	28.1	33.7	37.7	29.2	18.0	13.8	18.6	16.6	16.3	19.5	16.0	16.3	6.7	8.3	34.1	15.1	33.8	5.0	8.8	7.7	4.3	9.3	4.4	6.8	4.4	5.7	6.2	8.0	4.6	4.4	8.7	3.9	6.3	5.7	8.2	3.7	61.7	71.2	33.2	51.5	51.6	57.2	72.3	49.9	55.7	47.5	32.8	64.0	27.3	82.1	79.2	59.7	41.9	107.0	33.5	34.2	111.7	210.1	72.2	106.1	110.2	22.2	52.0	80.5	23.3	97.7	41.1	77.1	89.9	31.1	135.4	38.2	60.4	82.1	64.4	67.4	22.3	86.6	50.2	59.1	34.3	66.6	96.8	88.6	38.6	76.7	118.7	100.2	45.3	90.1	25.8	13.5	94.7	83.9	28.0	71.2	97.0
STRIP1	"FAM40A, FAR11A, FLJ14743, KIAA1761"	ENSG00000143093	"Striatin interacting protein 1"	Q5VSL9	1	110031577-110074641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060302, HPA060498"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA060302: AB_2684247, HPA060498: AB_2684293"	"unprognostic (2.75e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.23e-2)"	14.7	15.8	25.6	11.8	20.2	21.7	14.1	30.3	30.7	16.6	14.6	19.7	10.1	14.0	21.0	17.8	15.6	17.7	13.0	13.5	22.3	19.0	12.3	10.0	13.7	15.1	17.7	18.1	24.7	15.7	24.8	16.7	21.2	24.5	13.5	15.0	15.3	14.6	16.2	13.6	18.0	19.8	20.1	11.1	23.8	13.8	21.9	16.4	18.6	14.5	10.9	17.3	16.2	15.2	13.0	13.5	15.9	15.7	17.3	18.4	13.1	12.3	8.2	22.5	15.2	19.7	13.0	16.3	19.4	17.1	20.4	17.8	8.6	7.2	10.1	10.7	17.2	13.0	11.8	11.9	13.8	14.4	21.4	14.4	16.8	14.6	11.1	10.9	15.1	16.8	13.9	16.6	17.2	19.0	15.1	16.2	14.0	14.9	13.0	19.6	14.6	17.3	16.0	18.1	9.3	11.2	16.9	28.9	8.9	14.2	18.2	29.1	16.7	16.6	21.2	12.5	13.6	10.5	13.8	16.6	15.4	14.8	17.8	12.9	13.3	7.3	10.3	17.6	16.4	22.2	12.2	11.5	15.9	17.7	12.7	15.5	12.8	15.1	18.4	13.5	13.0	17.5	15.5	10.7	17.3	15.7	6.2	13.3	13.1	25.6	20.2	30.3	30.7	22.3	19.0	17.7	18.1	24.5	16.4	3.0	8.5	13.7	9.0	12.2	12.0	6.5	2.5	0.0	6.8	8.7	17.7	13.0	1.7	8.7	38.2	9.8	13.6	0.0	6.2	8.4	10.0	8.6	6.9	8.3	11.3	6.4	14.5	16.0	10.8	33.5	9.2	9.3	3.3	14.4	11.2	5.8	9.5	9.5	9.6	3.1	19.6	6.5	13.3	9.5	9.2	11.2	21.6	13.8	9.8	14.2
ALX3	FND	ENSG00000156150	"ALX homeobox 3"	O95076	1	110059994-110070700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 19.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 2.4;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory region: 14.8"	"Low region specificity"	"Detected in single"			HPA074290			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA074290: "	"unprognostic (4.28e-1)"				"unprognostic (4.41e-2)"			"unprognostic (2.91e-1)"		"unprognostic (2.48e-2)"					"unprognostic (1.31e-1)"			0.5	1.8	1.2	1.0	2.7	0.8	2.6	0.9	4.1	0.7	0.4	1.2	0.3	1.6	2.7	0.9	2.6	2.6	1.7	0.7	1.3	1.5	0.8	0.4	1.0	2.3	0.5	1.9	3.1	1.0	0.2	5.3	0.7	0.5	0.8	0.0	19.3	2.0	0.3	2.8	8.0	2.7	0.3	0.4	2.4	0.8	1.8	0.6	0.3	2.1	1.8	0.3	1.4	2.4	0.4	0.0	1.4	0.1	0.0	2.0	0.2	3.3	1.7	4.3	6.3	0.0	0.0	8.1	8.5	11.2	0.0	0.0	3.4	1.5	1.8	3.5	0.1	1.3	5.1	0.0	0.0	0.0	4.5	6.2	1.1	3.9	2.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	4.4	0.0	3.5	2.9	0.5	0.0	3.9	1.4	1.6	4.5	2.4	4.8	3.1	5.4	1.5	0.0	4.5	5.3	7.4	3.9	6.0	5.7	4.8	2.7	3.2	3.3	5.1	4.4	6.4	2.1	3.3	1.2	2.0	5.4	4.8	3.5	0.8	0.1	1.4	0.1	0.0	0.3	0.2	1.1	0.4	0.0	0.4	0.1	2.0	0.0	0.0	0.1	0.0	0.1	0.2	1.2	2.7	0.9	4.1	1.3	1.5	0.5	1.9	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0
UBL4B	FLJ25690	ENSG00000186150	"Ubiquitin like 4B"	Q8N7F7	1	110112468-110113945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	79	"testis: 65.3"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 5150.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031364	Enhanced					NA	NA					"HPA031364: AB_10604000"	"unprognostic (2.92e-1)"	"unprognostic (3.48e-2)"		"unprognostic (3.53e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.65e-2)"		"unprognostic (5.24e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.87e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.20e-9)"	"unprognostic (3.29e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.90e-2)"	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1273.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5150.4	27.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.8	0.0	0.0	12.9	0.0	37.9	15.1	0.0	0.0	0.0	0.0	0.0
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150486-110202202	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 53.5"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	1.4	7.8	9.3	1.2	18.3	1.1	1.3	21.8	53.5	1.0	1.1	2.3	0.0	1.0	1.0	2.1	1.3	1.0	1.1	1.0	11.2	14.9	2.1	0.9	1.0	0.9	6.0	16.2	1.0	2.6	1.0	12.4	1.8	19.5	1.0	1.0	2.6	1.2	1.0	1.0	7.6	1.1	1.1	1.8	1.0	1.8	2.4	0.7	0.0	1.3	0.0	0.9	1.0	0.1	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.3	0.4	1.7	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.6	4.8	1.5	28.3	0.8	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	5.7	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.3	18.3	21.8	37.3	11.2	14.9	6.0	16.2	19.5	0.7	0.0	0.0	0.0	0.0	0.5	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	3.6	0.0	0.4	0.0	1.1	0.4	0.1	0.0	0.0	0.0
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110211343-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	2.3	4.7	12.1	1.6	3.2	0.7	3.3	9.2	12.7	1.9	1.4	1.9	1.1	0.8	4.5	3.1	2.1	3.7	4.8	4.5	9.1	14.2	5.1	1.1	3.0	1.9	6.8	2.0	3.4	4.3	11.2	3.8	2.8	14.3	2.4	1.3	4.7	7.1	3.7	4.5	4.0	2.0	2.6	3.6	3.3	2.8	2.2	1.1	7.2	2.3	7.8	2.3	1.2	1.5	0.8	0.7	0.9	0.4	0.3	1.5	0.1	1.9	1.5	0.4	2.9	1.1	0.3	3.5	8.5	1.5	0.6	0.8	4.8	0.9	3.3	3.4	3.1	2.6	3.2	1.4	0.7	0.4	16.5	1.6	0.1	3.3	0.7	0.5	2.7	0.8	0.3	0.3	1.9	0.2	0.5	4.4	1.8	0.6	1.4	0.0	0.4	1.8	0.6	1.7	0.7	3.9	2.7	0.1	0.5	4.1	0.1	0.6	0.8	0.4	8.3	0.8	2.7	1.1	1.4	1.6	1.1	4.0	0.7	0.3	2.1	1.9	0.6	14.7	2.3	9.5	0.8	0.4	0.2	0.5	0.2	1.5	0.6	0.9	0.4	0.0	0.8	1.3	0.5	0.9	0.3	0.3	0.7	0.4	0.1	12.1	3.2	9.2	12.7	9.1	14.2	6.8	2.0	14.3	1.1	0.0	1.4	0.0	12.5	2.9	1.4	6.7	7.6	4.0	2.3	3.5	39.3	0.3	0.0	5.0	0.3	9.8	2.2	0.0	14.8	0.3	2.4	7.4	1.1	0.5	1.2	3.2	12.7	63.3	3.1	0.4	1.4	0.5	1.7	1.8	5.7	3.7	8.7	6.6	3.9	0.5	44.8	25.8	5.1	0.0	5.7	2.6	0.9	1.3	8.3	10.3
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.37e-4)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	8.5	7.6	6.3	12.2	7.6	48.7	7.9	18.6	8.3	6.6	8.8	7.6	8.3	7.3	8.5	7.2	8.0	7.3	6.6	8.8	5.2	4.3	6.3	11.0	10.5	13.7	8.3	6.0	8.6	7.5	7.1	8.1	7.1	5.9	5.7	5.7	8.1	7.4	6.4	17.2	7.2	11.3	5.5	5.0	12.5	8.3	14.0	7.9	21.8	7.0	5.3	13.4	6.5	8.6	10.5	4.8	9.8	6.9	5.0	9.9	5.5	7.1	7.8	7.0	7.2	4.5	4.7	11.1	3.8	5.0	6.0	7.9	9.5	6.5	13.5	6.1	4.3	4.9	10.1	11.0	9.5	8.9	14.0	10.1	10.9	11.8	6.9	6.2	11.8	11.6	4.3	6.6	8.3	7.8	3.1	6.3	10.3	15.4	23.7	6.0	7.3	10.6	9.3	15.0	6.3	4.4	12.6	10.6	9.2	4.9	7.2	8.5	4.3	8.3	10.5	8.0	7.9	7.2	14.3	4.4	5.7	10.4	6.2	6.9	18.3	9.2	29.3	8.6	12.0	7.1	8.2	6.9	9.4	7.0	6.0	9.9	10.5	7.7	6.0	4.8	10.0	6.8	8.2	9.8	5.0	6.4	4.7	7.5	5.5	6.3	7.6	18.6	8.3	5.2	4.3	8.3	6.0	5.9	7.9	6.0	3.0	15.3	8.2	29.5	5.4	10.8	7.6	9.4	2.3	3.5	13.7	7.6	0.0	3.4	6.2	9.8	7.5	0.0	3.1	6.2	8.9	8.6	28.8	13.5	5.6	0.0	9.2	10.4	5.7	4.1	3.7	5.5	8.5	1.8	8.4	5.6	4.2	2.9	4.9	3.3	7.1	0.0	13.3	24.4	14.5	29.5	3.9	12.5	7.6	6.7
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 68.0;Proximal tubular cells: 176.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	5.5	1.2	1.8	4.0	7.8	11.6	3.0	11.7	1.0	2.9	1.7	17.3	0.3	3.3	9.4	0.1	0.3	0.0	1.1	1.1	0.3	1.4	0.3	1.1	1.7	11.6	0.3	0.3	5.7	0.1	1.7	0.1	25.2	2.4	0.4	0.2	0.6	1.9	0.5	0.2	0.3	0.3	0.0	0.2	0.1	0.8	0.1	2.0	0.2	0.7	0.4	0.3	5.6	17.8	5.6	0.3	0.0	0.2	0.7	0.4	0.2	0.8	0.3	0.0	0.9	0.6	0.2	3.2	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8	11.9	17.3	3.2	5.2	2.7	11.1	1.1	15.3	0.0	5.7	68.0	5.9	28.5	3.3	2.9	0.4	4.4	1.3	23.3	0.8	29.3	13.9	2.7	4.7	4.5	3.7	3.2	3.4	3.1	1.0	1.1	16.7	0.8	10.1	1.0	0.9	2.3	1.3	0.2	11.0	176.8	17.7	0.0	5.2	3.0	2.0	3.1	29.4	4.6	0.5	5.0
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 1943.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006812	Approved		Supported	Cytosol		NA	NA		270000	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (6.66e-2)"	29.0	32.1	38.9	21.0	35.2	60.9	30.1	25.2	35.8	23.6	29.8	24.4	28.9	23.7	21.6	47.3	30.4	26.7	31.0	63.8	33.2	34.8	118.7	54.3	26.7	28.1	41.5	28.5	29.7	34.8	28.9	35.2	46.3	35.8	28.0	31.6	31.0	32.9	29.6	64.0	21.5	34.2	22.9	36.4	30.7	28.6	24.0	29.5	22.6	37.8	56.7	32.3	27.8	24.7	62.0	59.0	86.1	42.6	25.4	32.4	42.1	47.1	39.5	35.9	21.4	60.2	45.9	35.8	40.2	31.7	34.0	32.4	34.4	23.3	37.6	42.9	38.8	41.8	19.2	36.3	33.5	42.0	40.3	40.8	27.5	47.6	69.5	46.0	39.4	34.3	40.0	52.0	35.1	22.4	43.3	40.7	28.1	32.4	35.5	49.3	76.8	35.7	47.7	25.4	26.6	65.8	24.8	64.8	28.5	78.4	53.1	26.5	34.6	35.6	52.1	86.8	32.4	20.1	56.0	38.6	25.8	33.5	64.8	37.6	37.4	41.7	47.9	84.5	39.5	59.2	47.1	42.6	86.1	25.2	41.2	22.1	62.0	29.5	27.0	34.7	54.6	25.9	27.3	65.6	25.4	39.0	59.0	32.4	42.1	38.9	35.2	25.2	35.8	33.2	34.8	41.5	28.5	35.8	29.5	148.9	152.7	204.3	232.1	273.4	108.4	553.2	219.1	164.6	125.1	422.2	23.6	369.9	943.3	353.9	46.9	202.1	225.2	116.8	288.3	319.7	236.7	264.3	143.1	274.5	366.0	84.2	213.4	124.6	149.1	80.3	245.1	172.6	332.3	321.0	240.5	175.3	354.9	273.5	224.9	1943.6	111.9	168.1	174.7	196.9	336.9	281.9	418.5	125.0	192.7	332.5
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451200-110457354	"Predicted secreted proteins"	Angiogenesis	"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"ovary: 107.6;testis: 52.8"	"Group enriched"	"Detected in some"	50	"Leydig cells: 160.2;Peritubular cells: 627.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.7"	"Region enriched"	"Detected in single"	9	"basal ganglia: 4.9"	"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.5;NK-cell: 1.0"	"Group enriched"	"Detected in many"	8	"NK-cells: 1.0;T-cells: 1.5"	"Cell line enriched"	"Detected in some"	11	"ASC diff: 23.8"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA						"unprognostic (2.66e-1)"	"unprognostic (2.71e-2)"		"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	0.8	2.8	0.1	0.1	4.9	0.0	1.2	0.1	0.3	3.4	0.2	0.2	0.5	0.0	0.3	1.5	0.3	1.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	107.6	0.1	0.0	0.1	18.0	0.5	3.6	0.0	0.1	0.1	4.0	0.2	0.4	0.1	0.1	0.4	0.3	0.0	52.8	0.1	0.1	0.2	0.2	0.1	1.5	6.8	0.1	0.0	0.0	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	627.9	0.0	0.0	0.0	0.0	3.1	1.1	0.0	0.8	0.0	0.0	0.1
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.4;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.2"	"HPA015061, CAB022564"			Uncertain	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"CAB022564: , HPA015061: AB_1855573"														"unprognostic (2.96e-2)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 28.0"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 24.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 10.9;SCLC-21H: 2.8;U-2 OS: 2.4;U-266/70: 3.6;U-266/84: 5.4;WM-115: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA					"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	3.2	1.4	7.1	2.2	13.1	0.8	1.2	17.2	28.0	1.2	1.6	3.1	0.0	1.4	1.0	1.3	1.7	1.1	1.6	1.6	7.2	6.1	0.9	0.9	1.0	1.9	7.2	14.5	1.1	1.9	0.8	1.4	0.7	21.1	1.8	2.0	1.4	1.8	2.4	2.1	1.6	1.6	1.6	2.8	1.3	1.3	2.5	3.8	0.3	5.3	0.0	3.5	1.4	0.5	0.5	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	2.8	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	2.4	0.0	0.0	3.6	5.4	0.2	0.1	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.3	0.5	1.8	1.3	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	4.1	0.1	7.1	13.1	17.2	26.3	7.2	6.1	7.2	14.5	21.1	3.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	4.9	0.0	2.9	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110675033	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 59.4"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 3.4;Melanocytes: 3.3;Sertoli cells: 6.5;T-cells: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 3.3;T-cells: 11.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;Karpas-707: 26.1;U-266/70: 18.9;U-266/84: 16.9"	"Low region specificity"	"Detected in all"							HPA016625	Approved					NA	NA					"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	1.9	1.3	4.0	7.8	5.7	5.6	1.3	5.0	5.6	1.7	3.1	0.5	0.0	3.2	1.1	0.4	1.1	1.3	2.3	1.4	3.5	4.3	1.5	1.3	7.8	14.5	1.5	3.1	1.3	0.9	0.4	1.8	0.9	3.1	1.1	2.6	0.5	3.7	0.3	0.5	0.8	5.9	0.7	1.9	7.7	5.3	1.4	1.5	59.4	2.1	0.3	10.9	5.8	1.3	3.3	1.0	0.0	0.7	0.9	11.5	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	26.1	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.0	18.9	16.9	6.5	0.0	1.5	0.0	0.0	0.7	0.0	7.2	0.0	8.2	2.3	10.8	11.5	1.0	3.3	8.5	6.4	0.0	0.9	0.1	0.5	9.5	2.9	4.0	5.7	5.0	5.6	3.5	4.3	1.5	3.1	3.1	1.5	0.0	3.4	2.2	0.0	0.3	1.3	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.6	0.0	0.0	1.6	3.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	6.5	0.0	0.9	0.2	0.5	0.0	8.7	0.0	0.0
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110873154-110899928	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 146.7;lymphoid tissue: 103.0"	"Group enriched"	"Detected in many"	7	"B-cells: 233.1;granulocytes: 158.2;Hofbauer cells: 322.4;Kupffer cells: 293.3;Macrophages: 340.3;T-cells: 289.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 87.2;HDLM-2: 37.5;HMC-1: 54.9;Karpas-707: 34.2;U-266/70: 47.3;U-698: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced					NA	NA					"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	29.7	8.1	6.1	50.6	10.3	20.4	6.6	1.6	5.8	4.5	9.6	7.6	1.2	6.7	4.3	6.0	5.5	9.9	11.0	6.4	6.4	5.9	9.6	8.8	28.9	93.8	13.3	2.7	4.7	3.8	0.8	3.1	10.6	8.5	5.2	10.5	4.5	10.1	2.3	2.3	2.2	35.2	10.0	14.9	103.0	7.5	4.8	10.0	37.2	4.6	4.1	82.1	15.2	4.0	97.5	74.6	138.0	97.0	59.2	91.8	146.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	4.6	0.0	0.0	0.0	10.4	54.9	0.0	0.0	0.0	0.0	0.0	0.0	25.0	1.9	34.2	0.0	0.0	17.7	12.4	0.0	0.0	0.0	17.2	0.1	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	15.7	3.1	0.0	0.0	0.0	0.1	47.3	21.4	27.0	0.2	12.1	0.6	138.0	87.0	54.1	91.8	93.3	82.8	97.5	67.5	80.8	74.6	83.3	49.2	70.8	136.2	59.2	97.0	61.4	85.0	146.7	6.1	10.3	1.6	5.8	6.4	5.9	13.3	2.7	8.5	10.0	14.9	35.6	233.1	0.4	6.3	0.0	0.8	5.1	8.1	15.9	1.8	0.0	1.7	0.0	0.0	0.2	7.2	0.0	23.3	0.2	4.2	5.0	0.3	158.2	1.7	322.4	0.0	0.0	15.4	293.3	0.9	2.0	340.3	37.1	39.7	0.0	0.0	0.2	0.0	0.4	1.1	0.6	6.5	0.7	0.1	0.7	4.8	3.4	289.1	0.0	0.3
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947185-110964079	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	9.0	11.2	13.7	15.4	15.5	5.9	20.7	15.6	14.7	7.9	7.5	6.6	7.8	7.0	8.1	23.9	8.1	9.6	6.7	16.1	12.7	13.3	9.6	16.7	11.9	17.6	10.5	7.5	18.4	6.9	5.8	17.5	25.1	10.3	9.9	7.6	7.3	8.6	9.2	20.5	10.6	8.4	6.0	12.4	14.0	8.1	27.7	10.1	16.8	12.6	10.2	19.0	10.0	28.5	21.0	11.4	21.4	8.2	18.0	19.4	8.4	12.0	5.3	10.2	6.9	4.7	7.7	11.5	7.4	8.6	13.1	10.6	13.4	15.3	9.2	10.7	5.6	14.0	7.9	4.8	4.4	15.9	16.7	5.7	10.2	5.4	13.8	14.0	19.2	12.5	4.8	12.4	9.0	15.9	5.5	7.0	9.9	31.8	42.6	8.7	4.0	1.9	15.3	15.3	7.4	12.3	12.8	16.7	11.2	3.4	6.3	8.5	9.4	0.0	12.9	21.6	6.5	10.6	31.3	4.9	11.6	0.4	13.6	6.0	19.8	6.8	17.4	6.6	22.0	20.0	13.0	5.7	12.3	15.3	6.3	19.4	21.0	12.1	15.8	11.4	15.5	13.5	18.5	21.4	18.0	8.2	10.3	11.1	8.4	13.7	15.5	15.6	14.7	12.7	13.3	10.5	7.5	10.3	10.1	11.9	6.7	21.2	56.0	12.8	19.8	20.2	10.2	21.4	10.3	8.7	17.7	16.2	13.3	13.9	9.9	18.0	11.4	0.0	17.5	26.9	16.6	45.6	8.1	25.1	12.1	14.3	10.9	13.5	8.5	8.9	14.7	18.8	30.4	19.0	10.4	26.9	17.0	13.9	13.1	7.9	30.3	12.9	23.0	32.1	49.1	15.4	31.6	28.7	9.8	43.3
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117333-111140216	"Predicted membrane proteins"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 18.0;THP-1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	21.8	10.1	5.9	14.4	6.6	7.9	18.4	13.5	6.9	8.4	12.0	7.5	5.7	10.6	8.6	11.1	10.0	12.7	9.1	11.7	5.3	6.0	13.0	9.2	11.5	19.9	9.3	4.2	12.3	8.2	5.7	9.9	14.1	8.4	10.1	8.7	8.8	10.7	7.1	10.6	7.0	15.2	10.1	15.1	24.9	9.5	6.1	8.3	15.0	10.6	6.7	14.7	16.8	7.7	16.1	11.2	3.0	10.9	6.2	10.4	11.4	2.1	0.1	3.4	2.1	8.7	7.4	6.2	8.3	3.2	2.0	4.7	2.5	1.1	7.5	5.5	4.1	2.9	2.4	4.9	1.3	4.0	9.0	3.5	4.2	2.6	1.2	6.6	0.7	1.9	5.2	6.2	3.4	1.3	3.4	1.0	4.8	2.3	3.3	2.4	1.4	4.0	5.4	6.6	3.7	4.2	3.8	3.9	3.2	7.5	2.2	6.6	2.5	0.9	2.8	18.0	2.4	4.8	19.8	3.6	0.6	0.8	4.2	5.5	4.3	1.2	12.7	1.5	8.3	1.3	2.7	10.3	3.0	6.5	10.9	10.4	13.6	9.0	8.1	11.2	16.1	9.5	7.9	2.1	6.2	7.6	11.2	5.4	11.4	5.9	6.6	13.5	5.4	5.3	6.0	9.3	4.2	8.4	8.3	11.9	11.8	165.2	43.6	41.8	11.3	21.7	28.1	46.8	10.3	41.8	2.0	75.5	36.5	45.2	6.8	30.1	51.2	23.3	40.9	73.1	42.1	53.3	24.1	20.8	163.1	19.1	12.7	38.6	143.2	5.9	31.1	92.1	77.6	53.3	43.0	19.9	40.7	48.4	23.3	58.6	7.4	38.8	31.9	4.2	7.4	46.3	61.3	39.9	38.8	55.3
CEPT1		ENSG00000134255	"Choline/ethanolamine phosphotransferase 1"	Q9Y6K0	1	111139627-111185102	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.20e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.27e-2)"	22.4	22.9	16.0	22.2	19.5	5.6	20.1	20.7	19.8	14.9	13.7	22.2	17.5	19.0	18.3	19.1	21.3	16.6	15.3	12.2	17.9	16.0	22.6	39.4	16.5	31.7	22.9	15.1	22.9	17.8	19.6	25.5	22.5	18.2	13.9	18.1	16.9	19.2	12.0	11.2	17.8	20.2	16.3	23.3	34.5	17.5	12.5	21.3	22.3	19.4	11.5	24.7	19.5	17.8	14.6	9.0	4.2	19.1	5.3	9.0	5.5	14.0	5.3	6.3	6.1	25.0	12.3	15.3	15.6	8.9	7.3	8.8	4.6	16.0	16.8	17.3	8.0	9.3	17.4	9.1	12.2	10.5	12.4	14.1	7.3	9.5	10.2	16.7	17.1	10.5	10.0	23.5	5.3	25.5	13.9	9.6	17.5	15.7	11.0	9.5	10.2	17.5	16.9	9.7	22.6	10.9	9.5	20.0	13.6	11.9	8.9	8.3	4.4	14.4	22.0	16.6	12.8	11.7	18.7	8.4	11.9	7.5	25.7	10.4	10.1	10.9	13.1	16.0	15.4	22.5	3.2	7.6	4.2	6.4	13.6	8.4	14.5	7.2	6.7	9.0	14.6	8.4	9.0	1.9	5.3	19.1	7.0	6.2	5.5	16.0	19.5	20.7	19.8	17.9	16.0	22.9	15.1	18.2	21.3	32.8	12.2	37.9	14.6	11.6	26.0	3.6	20.4	21.4	14.8	34.9	33.4	24.6	5.0	11.7	1.7	9.7	16.0	0.0	7.1	16.3	11.4	13.2	18.5	29.7	25.2	27.0	9.8	22.7	40.9	2.2	13.6	19.4	15.1	9.0	13.6	9.4	8.5	14.7	15.9	12.0	20.7	12.9	7.2	12.0	13.2	13.4	15.9	20.0	13.3	12.4
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111187174-111204535	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 51.0;lymphoid tissue: 67.6"	"Cell type enhanced"	"Detected in many"	8	"T-cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7"	"Group enriched"	"Detected in all"	6	"NK-cells: 45.1;T-cells: 51.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.0;MOLT-4: 52.9;SK-BR-3: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043630: AB_2678589, HPA048642: AB_2680474"	"unprognostic (1.72e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (8.66e-5)"	8.9	11.1	0.9	42.9	2.6	3.5	6.5	0.8	1.6	4.9	10.4	1.4	4.9	6.4	2.4	5.9	19.5	6.4	9.9	2.5	1.0	1.0	11.4	9.3	11.5	42.0	2.6	0.8	3.0	7.5	8.8	8.0	20.2	1.9	9.2	6.9	3.7	21.1	4.7	1.3	7.9	13.8	1.3	3.2	33.8	9.0	5.1	1.8	39.2	8.0	7.0	67.6	15.7	8.2	8.2	3.2	3.5	3.5	45.1	51.0	29.6	10.4	0.4	0.0	0.0	2.6	1.0	0.1	0.6	0.0	1.1	0.2	3.1	5.1	11.1	3.7	1.6	0.0	3.3	0.0	0.5	1.1	21.0	0.0	3.3	0.7	0.0	3.9	0.0	3.4	3.1	2.3	0.3	0.0	3.5	0.1	4.2	0.0	3.5	0.3	8.9	52.9	0.3	0.0	13.2	1.4	1.3	0.0	16.1	3.7	11.3	3.7	0.0	3.7	34.3	1.2	0.0	10.1	10.5	0.0	0.0	0.0	0.0	0.0	3.2	1.3	8.3	0.0	9.3	0.0	0.8	3.5	2.3	44.8	2.5	38.2	7.2	32.5	45.6	3.2	8.2	51.0	48.4	3.5	45.1	1.8	2.4	13.7	29.6	0.9	2.6	0.8	1.6	1.0	1.0	2.6	0.8	1.9	1.8	6.0	15.6	29.2	15.0	4.4	0.0	0.9	7.6	18.7	18.2	19.2	0.0	1.2	16.6	23.6	26.8	2.9	16.1	0.0	14.1	2.1	4.1	21.1	17.3	4.9	46.9	0.0	5.8	9.2	28.5	38.6	1.1	9.9	6.8	1.0	23.6	0.0	13.8	14.0	0.4	21.0	0.5	0.0	0.7	13.0	0.7	3.4	9.6	105.1	20.4	26.5
CHI3L2	"YKL-39, YKL39"	ENSG00000064886	"Chitinase 3 like 2"	Q15782	1	111200771-111243440	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.7;salivary gland: 47.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 113.5;B-cells: 47.6;Leydig cells: 69.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 104.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 36.0"	"Group enriched"	"Detected in many"	4	"B-cells: 16.8;T-cells: 36.0"	"Group enriched"	"Detected in some"	5	"JURKAT: 113.5;MOLT-4: 59.4"					"Low region specificity"	"Detected in all"			HPA005443	Approved				"Secreted to blood"	NA	NA		480000			"HPA005443: AB_1078510"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (9.10e-5)"	"prognostic favorable (2.19e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (8.59e-7)"	"unprognostic (7.15e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.20e-1)"	8.3	0.9	3.9	38.7	11.9	0.9	13.4	0.3	11.9	0.7	2.5	5.9	0.3	0.4	0.6	3.7	2.2	0.7	4.4	20.8	8.3	8.3	3.0	0.3	21.0	19.1	5.6	1.2	1.4	0.3	0.1	1.6	5.8	7.3	3.9	1.0	4.2	47.2	0.3	3.0	3.2	2.6	1.2	28.4	18.4	2.5	4.4	2.1	86.7	4.2	4.2	39.4	19.3	1.7	16.8	0.5	0.9	1.2	6.4	36.0	10.1	0.0	0.0	0.0	0.1	16.8	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.1	0.6	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.2	0.0	0.3	4.0	0.0	0.0	0.1	0.9	0.0	113.5	0.0	0.2	0.0	0.0	59.4	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.2	0.0	0.1	0.9	0.1	13.2	4.2	0.0	0.4	0.3	1.2	0.1	8.7	0.3	2.2	14.3	6.1	14.3	0.3	16.8	36.0	13.6	0.9	6.4	0.2	0.5	3.6	10.1	3.9	11.9	0.3	5.4	8.3	8.3	5.6	1.2	7.3	2.1	8.9	113.5	47.6	1.0	2.1	0.0	0.4	0.0	0.0	3.4	0.0	0.0	0.2	0.0	9.7	3.7	0.1	0.0	0.0	0.3	0.6	2.6	3.7	2.3	0.0	1.0	0.0	1.2	0.0	1.3	9.4	69.3	1.7	15.1	0.0	0.0	0.0	1.1	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.2	1.1	2.6	6.4	0.0	0.4
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase, acidic"	Q9BZP6	1	111290862-111320566	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"stomach 1: 66.6"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 2: 22.2"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.8;stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC diff: 6.0;HAP1: 3.1"					"Low region specificity"	"Detected in single"			HPA059193	Approved				"Intracellular and membrane"	NA	NA					"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.5	0.8	0.3	0.1	0.1	0.1	0.0	0.5	1.0	13.2	0.2	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	66.6	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	1.6	0.7	0.0	0.1	0.6	0.6	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.2	0.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.7	0.2	0.2	0.0	1.6	0.6	0.0	0.0	0.6	0.0	0.7	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIFO	"C1orf88, FLJ23853, pitchfork"	ENSG00000173947	"Primary cilia formation"	Q8TCI5	1	111346288-111353013	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.9;fallopian tube: 96.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 720.1;Early spermatids: 388.2;Late spermatids: 350.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 55.9"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	25	"B-cells: 1.6;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.5;hTERT-RPE1: 4.5;RPTEC TERT1: 6.2;RT4: 7.3;SuSa: 11.6;T-47d: 5.1;U-87 MG: 4.9"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (3.18e-3)"	"unprognostic (3.23e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.03e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.43e-4)"	"unprognostic (8.78e-7)"	"unprognostic (6.43e-3)"	"unprognostic (7.28e-2)"	"unprognostic (9.07e-3)"	"prognostic favorable (2.48e-4)"	"unprognostic (3.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.03e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.83e-2)"	1.1	2.0	6.6	1.2	10.1	0.8	3.8	0.7	3.9	4.4	3.0	15.9	3.5	1.1	4.9	15.5	2.8	96.8	2.7	6.4	8.6	8.6	5.4	0.8	10.8	0.9	5.0	6.5	9.2	4.2	5.1	13.8	4.3	55.9	7.5	1.4	4.2	2.2	4.3	0.9	1.6	1.1	3.4	4.2	1.0	2.6	26.5	5.4	0.4	8.8	0.1	1.1	5.4	0.6	1.6	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.1	0.7	0.8	0.8	0.9	1.4	0.0	1.7	0.4	0.0	1.3	1.4	0.0	0.3	0.0	1.5	0.0	1.2	0.2	0.0	1.8	0.2	0.0	0.2	1.1	0.7	0.0	0.0	0.9	4.5	0.0	0.0	4.5	0.0	0.4	0.2	0.1	2.6	0.1	0.7	0.0	2.6	0.1	0.0	0.0	0.0	0.0	6.2	7.3	3.1	0.3	0.0	0.2	0.2	11.6	5.1	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.4	0.5	4.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.3	1.6	0.9	1.0	0.0	0.9	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	6.6	10.1	0.7	3.9	8.6	8.6	5.0	6.5	55.9	5.4	3.0	14.4	0.0	7.4	3.8	0.8	12.3	0.0	720.1	70.5	5.2	3.9	7.2	18.3	11.6	388.2	0.9	0.0	0.0	1.9	3.6	3.9	10.1	0.0	0.0	1.1	0.0	2.9	0.0	0.0	350.3	5.5	2.0	8.5	0.0	0.0	10.4	1.5	0.0	3.2	19.3	5.4	6.5	2.0	97.0	7.2	2.5	5.8	0.0	0.0	2.6
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414314-111427777	"Plasma proteins, Predicted intracellular proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 240.9"	"Cell type enhanced"	"Detected in many"	11	"Syncytiotrophoblasts: 14.5"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.2;OE19: 9.2;SK-BR-3: 7.4"	"Region enhanced"	"Detected in some"		"cerebellum: 6.6"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Approved	Vesicles,Microtubules	"Intracellular and membrane"	NA	NA			"Vesicles, Microtubules"		"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	0.4	0.1	0.4	0.4	0.9	0.2	0.4	1.9	1.0	0.7	0.4	0.4	0.4	0.2	9.7	7.1	0.4	240.9	0.4	0.4	0.5	0.5	0.5	1.0	0.4	0.4	0.4	0.4	32.5	0.4	1.5	0.4	0.4	0.4	0.7	0.3	0.4	0.4	0.4	0.4	1.1	0.6	0.4	0.4	0.5	0.2	1.3	0.4	0.6	0.4	0.4	0.4	0.5	0.4	0.8	0.9	0.0	0.5	0.0	1.6	0.2	0.7	0.5	1.4	0.7	2.8	3.1	2.5	0.3	2.0	0.5	1.1	0.8	0.0	1.2	2.6	0.9	0.0	0.8	0.4	0.4	0.8	2.9	7.2	0.4	1.0	3.4	1.0	1.2	3.3	2.8	4.4	0.1	1.6	2.1	0.6	4.9	0.4	2.3	0.2	0.8	0.9	1.7	0.3	9.2	2.6	0.9	0.3	1.0	2.1	5.3	0.9	0.9	0.2	7.4	1.0	3.8	0.5	1.2	1.2	0.3	0.3	3.7	1.0	2.8	0.8	0.6	0.3	2.3	0.3	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.5	0.0	0.9	0.8	1.6	1.2	0.0	0.0	0.5	0.0	0.1	0.2	0.4	0.9	1.9	1.0	0.5	0.5	0.4	0.4	0.4	0.4	0.0	1.4	0.0	1.0	2.7	1.7	0.4	0.0	0.0	0.0	0.0	0.0	5.0	1.7	0.3	2.4	1.5	0.7	0.0	0.0	2.1	0.6	1.2	0.0	3.0	0.5	0.0	0.0	1.3	0.3	4.9	1.4	0.3	0.0	0.0	0.9	0.3	0.1	0.0	1.8	1.7	0.7	0.0	0.9	4.1	0.7	2.8	14.5	0.0	1.7	1.4
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 68.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	11.2	16.5	10.0	17.3	16.2	5.9	9.7	8.5	18.1	9.8	10.9	14.3	5.7	9.5	13.9	15.7	19.0	68.6	15.7	16.6	9.9	10.8	13.6	19.2	9.9	16.8	12.1	9.6	14.6	14.0	15.1	11.7	12.1	15.8	12.6	16.6	10.3	16.4	13.4	27.2	8.9	11.1	13.0	7.9	16.5	14.5	12.9	9.3	19.3	9.9	23.2	22.7	19.1	11.0	24.9	25.7	6.2	17.7	26.7	16.1	11.9	20.7	18.2	17.4	14.3	10.5	6.1	24.2	15.7	8.4	24.1	15.9	26.7	7.8	35.4	15.4	13.3	15.6	15.1	31.4	30.1	29.2	14.0	24.6	21.1	21.3	38.4	11.8	21.6	36.1	7.5	21.6	23.6	15.2	6.4	16.0	15.8	28.1	9.4	23.2	26.2	27.7	11.3	34.2	19.5	30.5	27.7	27.4	13.5	21.4	36.8	14.4	10.5	13.8	17.4	12.5	23.3	14.0	14.9	11.6	13.4	26.9	25.9	33.3	7.8	9.8	31.8	16.9	24.3	39.1	6.2	11.6	2.9	13.9	17.7	15.5	24.9	15.1	15.5	25.7	21.6	16.1	15.0	1.7	26.7	15.5	16.1	12.5	11.9	10.0	16.2	8.5	18.1	9.9	10.8	12.1	9.6	15.8	9.3	11.9	10.7	30.3	21.0	18.4	11.9	21.5	12.7	37.5	9.1	17.4	23.6	49.7	21.6	29.8	2.7	9.8	7.4	0.0	11.8	45.7	9.9	13.5	15.1	13.4	41.0	7.9	15.1	8.0	19.6	2.7	6.9	17.8	5.0	10.8	16.5	8.4	20.0	7.0	8.5	24.4	9.2	12.9	13.1	12.3	22.6	16.2	38.1	17.5	21.3	22.3
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		640000	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.26e-9)"	"prognostic favorable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	11.6	16.0	16.8	11.4	22.6	8.0	10.4	30.7	28.8	10.7	30.0	10.4	11.3	16.1	14.4	10.7	21.1	13.7	9.7	57.1	16.4	15.4	30.5	26.2	10.2	14.2	16.1	15.5	12.6	15.3	18.0	13.3	16.3	22.8	13.4	17.8	9.8	20.4	12.4	83.6	9.7	25.4	13.7	13.9	13.7	13.1	11.4	10.1	18.7	18.6	34.0	15.4	15.5	11.5	8.3	10.8	4.3	10.0	5.9	11.9	22.9	15.3	3.5	13.0	10.1	8.4	7.6	8.4	17.0	18.8	17.7	14.7	6.2	7.8	20.9	15.8	11.1	3.8	16.0	18.9	21.0	15.8	16.6	7.4	20.9	4.9	4.1	6.1	26.3	21.1	6.6	9.0	19.4	18.2	4.1	14.1	2.9	18.4	9.2	10.1	7.1	44.9	6.1	9.9	4.0	24.0	11.6	40.6	8.2	14.0	5.2	9.5	3.0	13.2	18.9	13.9	3.1	15.2	9.5	13.6	8.3	14.7	16.2	16.8	12.7	12.1	49.8	20.1	20.0	15.5	1.9	10.0	4.3	9.7	6.4	8.6	7.5	10.8	9.2	10.8	8.3	11.9	7.3	2.9	5.9	5.0	5.9	9.0	22.9	16.8	22.6	30.7	28.8	16.4	15.4	16.1	15.5	22.8	10.1	62.5	73.9	0.0	0.0	0.0	0.0	0.0	0.0	136.5	105.8	118.7	0.0	297.5	391.3	205.2	0.0	0.0	0.0	0.0	172.3	335.0	0.0	0.0	82.5	0.0	328.7	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	172.3	0.0	0.0	151.6	0.0	0.0	348.8	0.0	0.0	0.0	0.0	0.0	0.0	290.7	0.0	0.0	0.0
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.1;lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"	18	"granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7"									HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	39.8	9.3	9.2	25.1	17.9	37.5	20.1	4.6	9.3	5.2	6.3	4.9	0.8	2.7	5.4	7.4	4.9	10.2	11.7	14.8	13.4	4.7	17.3	14.8	40.1	86.6	17.5	1.9	5.8	4.5	1.3	9.7	5.6	15.3	5.0	6.9	5.0	5.9	2.5	7.2	3.6	8.3	13.5	31.0	78.1	5.8	6.1	13.9	10.6	6.2	1.1	20.0	7.2	6.7	24.7	83.3	98.7	119.1	40.1	27.8	74.8	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	45.4	0.1	0.1	0.1	0.0	0.2	22.1	3.7	0.0	0.9	0.3	0.3	0.3	0.6	0.2	0.2	0.1	0.1	0.1	0.1	12.3	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	17.5	0.0	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.1	36.7	0.5	68.4	82.5	98.7	14.2	119.1	4.1	17.5	17.7	8.2	83.3	24.7	27.8	16.8	11.4	40.1	86.3	24.9	5.0	74.8	9.2	17.9	4.6	9.3	13.4	4.7	17.5	1.9	15.3	13.9	20.8	66.7	71.8	0.5	7.0	3.7	3.1	12.7	1.4	7.9	7.0	2.0	1.1	0.0	0.2	33.3	3.7	0.6	0.0	0.2	1.2	5.8	0.7	175.8	6.4	198.4	0.0	1.7	17.8	675.1	60.1	2.6	367.2	11.8	1.0	0.0	0.3	0.2	0.0	0.7	0.6	3.9	32.3	4.2	1.8	1.7	5.6	1.4	95.6	0.6	0.3
TMIGD3	AD026	ENSG00000121933	"Transmembrane and immunoglobulin domain containing 3"	P0DMS9	1	111483348-111563962	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 28.2;brain: 16.4;testis: 50.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 216.3;Hofbauer cells: 179.2;Kupffer cells: 81.5;Late spermatids: 88.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	39	"eosinophil: 28.2"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 28.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.5;HMC-1: 3.1;Karpas-707: 2.2;NB-4: 6.3"															NA	NA						"prognostic unfavorable (3.58e-4)"	"unprognostic (7.64e-3)"	"unprognostic (7.47e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (9.48e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.46e-2)"	"unprognostic (9.50e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.44e-5)"	"unprognostic (9.22e-2)"	5.4	4.1	8.4	1.9	14.4	2.4	1.4	1.2	8.1	1.5	1.5	12.6	0.0	0.9	1.3	0.6	1.4	1.4	1.4	1.4	7.3	1.5	1.3	3.0	2.8	2.9	15.0	3.3	1.3	1.3	0.8	1.3	5.1	8.4	1.4	1.2	0.9	1.3	2.0	1.3	1.3	2.1	1.3	16.4	2.0	1.4	50.4	13.5	0.0	1.4	0.0	1.0	1.4	1.3	0.0	0.3	28.2	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.7	28.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.2	8.4	14.4	1.2	8.1	7.3	1.5	15.0	3.3	8.4	13.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	216.3	0.5	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.2	179.2	0.0	0.0	6.2	81.5	88.3	3.4	3.6	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.3	0.3	12.9	0.0	19.1	1.5	0.0	2.4	2.5	0.0	0.0
ADORA3	AD026	ENSG00000282608	"Adenosine A3 receptor"	P0DMS8	1	111499429-111503760	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 88.6;brain: 25.5"	"Cell type enhanced"	"Detected in some"	26	"Hofbauer cells: 17.7;Kupffer cells: 53.6;Late spermatids: 12.4"									"Cell type enriched"	"Detected in some"	40	"eosinophil: 88.6"	"Lineage enriched"	"Detected in many"	40	"granulocytes: 88.6"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 48.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA																							5.2	13.4	8.7	3.1	12.0	0.0	4.5	1.0	6.7	3.7	5.2	10.3	0.0	3.5	0.5	1.0	1.8	2.8	4.8	1.6	7.5		1.9	2.1	2.8	3.8	17.7	2.2	1.2	1.0	0.9	1.2	2.0	12.1	1.0	4.2	2.7	1.1	1.9	0.5	0.0	7.9	3.8	25.5	1.5	2.2	1.1	13.3	0.4	0.5	0.0	1.9	3.4	0.0	0.0	2.2	88.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	88.6	0.0	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.3											0.0	0.0	0.9	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.2	0.0	6.9	0.0	17.7	0.0	0.0	2.5	53.6	12.4	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0
RAP1A	"KREV-1, SMGP21"	ENSG00000116473	"RAP1A, member of RAS oncogene family"	P62834	1	111542218-111716691	"Predicted intracellular proteins, RAS pathway related proteins"	Neurogenesis	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 104.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		150000000				"unprognostic (7.37e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.98e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.08e-1)"	28.9	20.3	26.7	31.6	30.2	23.1	22.0	15.3	22.8	26.5	65.2	26.8	24.8	21.8	27.2	28.4	41.7	22.5	36.0	56.3	28.1	21.8	23.5	31.4	27.9	33.4	34.4	15.2	16.5	13.1	44.0	23.9	21.1	25.7	32.5	32.0	13.1	21.4	34.4	32.3	14.0	27.2	74.6	48.9	32.3	35.5	9.7	28.8	24.9	23.0	19.7	38.9	70.4	48.1	10.1	16.2	30.5	14.0	13.4	19.5	11.5	34.3	5.4	13.5	7.9	27.6	26.6	12.5	23.0	24.5	16.7	18.9	17.9	14.3	28.2	16.2	28.6	10.7	12.5	12.3	17.2	31.1	104.6	12.8	20.4	13.7	11.0	28.1	21.2	21.3	17.2	20.2	18.5	19.4	15.5	21.9	16.1	15.4	31.3	22.9	15.7	10.9	27.0	7.9	15.4	14.5	12.0	28.6	13.9	26.5	17.4	9.6	6.8	28.2	16.6	20.7	14.4	8.4	27.3	20.4	13.4	17.2	16.8	22.2	33.6	11.2	31.0	18.7	32.6	35.2	7.8	13.9	12.7	11.4	14.0	13.3	10.1	19.5	17.1	16.2	6.4	14.9	14.0	30.5	13.4	12.6	8.1	17.2	11.5	26.7	30.2	15.3	22.8	28.1	21.8	34.4	15.2	25.7	28.8	62.5	71.9	95.7	81.0	110.0	14.3	98.2	38.2	38.8	37.5	43.6	3.9	63.2	134.3	63.2	13.0	115.0	92.5	93.5	61.5	63.2	78.1	107.9	84.2	52.9	188.3	47.7	39.2	76.7	221.0	9.9	58.7	201.8	96.2	90.2	110.3	37.3	62.5	69.1	73.6	110.2	10.9	116.4	135.9	24.7	11.5	89.0	68.7	120.4	77.1	108.6
FAM212B	"C1orf183, FLJ31105, INKA2"	ENSG00000197852	"Family with sequence similarity 212 member B"	Q9NTI7	1	111680630-111739424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"Hofbauer cells: 3.6"	"Cancer enhanced"	"Detected in many"		"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	13	"neutrophil: 19.2"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.2;U-87 MG: 37.5;WM-115: 14.2"									"HPA027809, HPA027810, HPA027811"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872"	"unprognostic (1.92e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.81e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (9.96e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.50e-3)"	"unprognostic (9.92e-5)"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.07e-2)"	12.1	1.4	14.9	4.6	11.5	4.0	8.6	5.5	22.4	2.6	3.7	2.9	1.5	1.8	4.9	1.8	11.1	7.9	4.7	12.9	13.1	3.5	3.9	1.4	6.9	2.4	4.8	13.4	3.2	1.7	4.5	0.9	9.4	3.9	4.6	3.3	1.8	2.7	6.3	8.3	8.8	2.9	8.1	3.9	6.3	4.9	4.3	3.7	0.5	3.8	3.5	2.9	3.1	3.9	0.4	0.8	19.2	1.4	0.0	0.0	0.4	1.2	1.1	2.1	1.6	10.7	3.8	0.9	0.9	2.0	1.7	4.0	2.1	0.0	0.9	0.4	0.8	0.8	1.1	1.1	2.4	1.5	2.3	1.1	7.4	0.7	1.9	3.6	0.3	1.2	2.6	10.7	18.2	0.8	0.4	4.5	1.1	0.0	1.7	2.0	1.1	0.4	0.3	0.3	0.9	1.0	1.1	9.9	0.3	0.5	1.7	5.6	1.6	0.5	0.0	4.9	2.3	1.4	1.2	1.7	3.8	6.0	2.0	0.7	10.8	1.9	0.9	37.5	1.8	14.2	0.0	1.3	1.0	0.0	1.1	0.0	0.2	0.0	0.0	0.8	0.4	0.0	0.0	19.2	0.0	1.4	0.3	0.0	0.4	14.9	11.5	5.5	22.4	13.1	3.5	4.8	13.4	3.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
FAM212B	"C1orf183, FLJ31105, INKA2"	ENSG00000284755	"Family with sequence similarity 212 member B"		1	111722064-111755824	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 52.0;Late spermatids: 39.5;Sertoli cells: 32.3"									"Cell type enriched"	"Detected in single"	5	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;HHSteC: 3.7;HSkMC: 2.9;LHCN-M2: 3.5;SuSa: 3.5;THP-1: 2.5;U-87 MG: 2.5"									"HPA027810, HPA027811"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Nucleoplasm, Vesicles"	Nucleoli	"HPA027810: , HPA027811: AB_10600872"																		0.1	0.3	0.1	0.4	2.8	0.2	0.1	0.1	1.7	0.1	0.2	1.5	0.1	0.3	1.7	2.0	0.1	0.0	0.3	0.4	0.1		0.7	0.1	0.5	0.2	0.1	0.1	0.1	1.0	0.0	0.1	1.0	1.6	0.8	1.3	0.1	0.1	1.2	0.1	0.0	1.0	2.5	2.6	2.2	0.0	0.7	1.2	2.6	0.8	0.1	0.1	1.9	0.1	0.1	0.2	0.7	0.1	3.4	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	3.7	1.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	3.5	1.3	0.5	1.9	1.8	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.8	3.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	2.5	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.2	0.1	0.5	0.3	0.0	0.1	0.3	0.3	0.0	3.4	0.1	0.2	0.2	0.0											0.0	0.0	0.5	3.1	6.2	6.2	0.0	0.0	2.7	0.0	0.0	7.9	0.0	0.0	0.0	52.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	6.9	1.3	2.8	39.5	2.0	2.0	6.8	0.0	4.6	1.2	0.0	1.1	5.3	0.0	5.9	32.3	6.1	4.2	2.1	3.4	0.0	0.0	0.9	0.6
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111755245-111768016	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 81.7"	"Group enriched"	"Detected in many"	13	"Early spermatids: 570.4;Late spermatids: 538.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	3.1	2.8	2.9	2.7	4.3	5.9	9.8	5.8	5.1	2.7	2.6	1.8	2.6	2.0	4.0	2.9	2.6	3.7	1.7	2.0	4.3	1.6	2.7	2.4	4.1	3.8	2.4	1.9	3.9	2.9	4.0	3.9	2.7	3.4	2.9	2.6	1.2	2.6	2.7	5.1	2.5	3.5	2.9	5.6	4.5	2.8	81.7	3.3	5.1	3.2	1.7	4.1	2.9	5.0	11.9	7.4	12.7	7.4	10.5	14.1	7.8	11.4	4.7	12.2	11.0	8.8	7.0	11.4	11.2	8.7	16.1	15.7	7.0	4.0	26.8	8.8	7.6	5.7	9.2	14.4	11.3	18.0	12.2	13.0	13.0	9.2	7.2	8.8	12.8	9.6	7.0	9.9	13.7	13.9	4.5	11.1	10.5	12.4	9.8	12.2	10.8	15.7	13.0	15.3	6.9	9.6	15.4	20.1	6.7	10.5	9.0	12.7	11.5	10.8	13.5	18.0	10.6	8.4	13.6	9.8	9.8	14.5	17.5	13.0	4.9	6.9	20.5	10.2	13.2	22.1	12.7	7.0	6.9	10.0	7.3	13.3	11.9	11.7	11.8	7.4	10.1	14.1	12.3	5.0	10.5	7.4	5.2	11.7	7.8	2.9	4.3	5.8	5.1	4.3	1.6	2.4	1.9	3.4	3.3	11.9	6.5	3.7	7.8	9.6	12.2	5.9	2.5	13.4	12.5	5.2	2.0	8.6	3.3	8.9	570.4	7.1	2.4	0.0	6.0	6.8	4.8	3.0	7.0	4.9	8.0	6.4	4.1	3.7	9.1	538.8	15.3	8.7	1.7	3.6	5.7	6.3	6.3	2.9	12.4	6.9	8.9	6.5	10.3	41.2	25.6	6.4	4.2	7.0	5.8	5.5
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989155	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 38.5;Cardiomyocytes: 34.4;Early spermatids: 29.0;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"OE19: 6.6;SCLC-21H: 15.9;U-2 OS: 2.4;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved					NA	NA					"HPA029452: AB_10602239"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-3)"	"unprognostic (6.64e-3)"	3.3	0.8	6.8	3.1	6.9	0.0	2.1	25.9	11.9	1.3	2.5	1.3	1.3	0.3	4.1	9.6	3.2	3.4	4.2	5.5	5.6	5.6	1.3	11.6	1.3	1.3	8.9	5.7	1.3	2.2	4.1	1.5	1.3	1.6	9.2	1.6	1.9	1.3	10.0	2.8	5.1	1.3	7.7	1.3	2.0	1.7	1.3	1.3	1.3	1.3	2.3	1.3	3.7	1.3	0.5	0.4	1.2	0.3	0.9	0.3	0.7	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.4	0.0	0.0	0.0	0.8	0.1	0.0	1.6	0.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.3	6.6	0.0	0.0	0.1	0.0	0.0	0.3	15.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.5	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.4	0.5	0.3	0.2	1.2	0.9	0.3	0.3	0.1	0.7	6.8	6.9	25.9	9.3	5.6	5.6	8.9	5.7	1.6	1.3	0.0	9.4	0.0	10.7	6.6	38.5	34.4	0.0	0.0	1.2	0.0	3.9	0.1	0.0	0.7	29.0	1.8	0.0	0.0	21.1	0.1	1.4	14.3	0.0	23.7	0.2	28.6	0.0	1.8	0.6	20.3	16.7	0.0	3.3	0.0	0.2	6.1	4.4	0.3	1.8	0.2	4.2	0.0	3.1	1.1	0.7	5.8	0.0	0.0	0.0	12.3
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396181-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	18.8	5.3	10.0	9.8	13.0	0.5	15.0	10.6	12.4	12.9	15.3	14.4	5.0	7.5	18.3	7.6	20.0	8.8	17.0	8.9	10.1	7.9	10.3	5.5	16.5	5.7	10.8	7.8	10.1	4.7	9.6	9.3	20.1	10.2	9.5	15.2	9.7	10.8	10.0	4.4	20.0	12.3	13.9	18.7	10.1	8.5	5.8	11.0	2.6	8.9	7.2	9.5	13.6	15.6	0.5	10.6	0.1	3.3	0.0	2.3	0.5	9.6	3.6	11.9	5.6	8.0	10.6	4.0	15.2	14.3	9.9	9.8	2.7	4.9	1.5	6.1	11.4	4.9	7.9	7.7	10.5	11.6	3.1	3.7	2.0	6.2	2.1	9.3	0.7	3.6	12.5	6.4	12.2	10.7	11.4	24.0	2.6	1.8	1.4	13.6	2.8	1.3	0.2	7.6	2.7	5.6	2.3	11.1	0.0	15.0	7.2	5.8	6.1	11.8	2.4	6.1	11.9	1.9	0.8	30.9	9.9	11.7	10.1	7.1	0.1	1.3	0.0	10.3	0.9	26.0	0.0	3.3	0.0	0.0	2.6	0.0	0.1	0.0	0.0	10.6	0.5	0.0	0.0	0.1	0.0	0.5	4.6	2.3	0.5	10.0	13.0	10.6	12.4	10.1	7.9	10.8	7.8	10.2	11.0	53.6	19.0	8.2	19.2	34.5	10.1	7.5	5.1	14.7	44.3	21.0	5.9	13.6	3.3	29.9	2.4	60.8	30.5	23.3	18.9	10.6	17.4	23.0	18.5	1.0	12.3	4.8	7.9	35.0	23.6	2.1	9.8	40.9	15.1	45.1	23.1	11.4	36.6	31.6	10.6	16.6	8.8	19.4	14.6	14.2	15.0	53.1	21.3	1.0	17.2	51.7
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 66.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 74.2;Peritubular cells: 185.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.8;HSkMC: 13.0;SuSa: 5.3;TIME: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	3.4	1.9	1.7	3.4	4.6	0.2	2.1	2.6	2.9	9.2	12.0	0.8	3.7	3.9	7.5	5.4	7.6	4.4	8.0	3.6	1.6	1.7	1.8	0.5	5.2	0.9	2.0	2.4	28.7	2.0	1.2	1.9	6.0	1.5	7.3	6.8	66.7	1.7	18.3	1.3	13.4	9.1	12.9	3.0	1.2	4.4	16.2	0.8	0.5	1.4	5.6	1.9	10.3	8.5	2.3	1.2	1.7	0.7	0.8	1.2	0.1	0.7	0.4	3.4	0.8	3.4	6.8	0.6	1.4	1.5	0.4	0.6	0.3	0.7	1.8	0.3	1.6	0.4	2.1	1.1	0.5	0.3	0.1	0.7	0.2	1.1	0.5	2.9	0.2	0.8	13.0	1.2	0.6	0.2	1.9	1.7	0.5	0.2	0.3	0.4	0.5	0.1	0.2	0.6	0.1	0.5	0.1	0.5	0.0	2.4	0.4	0.5	0.5	1.3	0.2	1.1	5.3	0.1	0.4	5.2	0.5	2.0	1.3	0.4	0.2	0.1	0.0	1.4	0.2	1.3	0.9	0.7	1.0	0.9	0.3	0.8	1.4	1.2	1.0	0.3	2.3	0.4	0.7	1.7	0.8	0.5	1.2	0.4	0.1	1.7	4.6	2.6	2.9	1.6	1.7	2.0	2.4	1.5	0.8	11.9	3.5	0.5	1.6	9.0	13.0	3.9	2.5	4.0	2.3	1.8	25.5	1.6	0.0	0.7	3.5	8.4	2.3	0.0	1.2	0.7	7.8	1.5	2.3	0.0	1.0	4.8	8.1	4.9	1.6	2.8	74.2	5.7	3.3	1.8	1.7	8.2	1.6	4.2	185.6	0.6	30.4	0.0	2.8	4.2	4.2	12.2	1.6	1.9	1.5	2.0
ST7L	"FAM4B, FLJ20284, ST7R, STLR"	ENSG00000007341	"Suppression of tumorigenicity 7 like"	Q8TDW4	1	112523518-112620825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 151.6;Late spermatids: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042324, HPA075418"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA042324: AB_10794273, HPA075418: AB_2686749"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (8.34e-5)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-6)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.16e-4)"	"prognostic favorable (3.04e-5)"	"unprognostic (2.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.27e-2)"	7.7	9.3	5.7	5.5	9.0	8.6	8.2	12.1	7.9	8.1	6.9	10.0	7.2	5.5	10.0	7.8	6.1	7.9	6.0	8.6	5.6	5.9	6.3	7.6	5.7	5.3	6.1	5.1	9.4	11.6	5.2	12.8	6.4	6.3	7.3	8.0	9.4	7.0	9.0	10.2	8.9	6.2	7.9	6.4	5.2	5.8	49.0	7.0	4.6	11.8	4.6	5.6	6.8	7.7	4.2	3.5	0.3	2.1	6.9	5.2	1.9	4.8	1.5	8.7	6.1	11.9	11.8	2.1	6.3	4.8	2.7	4.0	2.8	4.8	2.1	2.6	2.5	8.1	3.4	10.2	8.1	4.1	3.1	6.0	5.9	7.6	1.8	6.8	5.0	6.4	2.2	2.0	3.1	6.4	6.4	8.7	7.4	3.4	6.9	11.0	1.9	2.6	2.0	3.9	2.3	5.3	4.2	4.6	0.8	5.5	6.0	6.4	3.9	3.4	4.7	4.4	1.6	3.6	3.0	8.3	6.2	6.1	8.0	6.0	1.8	1.3	2.1	5.6	8.0	13.5	0.1	1.8	0.2	2.4	2.1	3.9	4.2	3.6	1.8	1.7	1.8	5.2	2.8	0.3	6.9	1.6	3.5	2.4	1.9	5.7	9.0	12.1	7.9	5.6	5.9	6.1	5.1	6.3	7.0	20.8	8.1	4.5	14.2	15.0	16.4	6.1	20.4	12.0	13.6	8.7	5.9	11.0	8.3	7.6	151.6	11.9	5.1	0.0	7.4	5.7	9.2	11.9	8.1	6.8	7.5	23.8	5.2	4.9	7.8	193.4	16.7	7.5	20.3	4.6	9.5	19.1	6.4	3.5	15.2	5.7	22.0	19.4	7.6	33.6	11.3	15.9	5.1	8.7	9.7	9.3
CAPZA1		ENSG00000116489	"Capping actin protein of muscle Z-line alpha subunit 1"	P52907	1	112619173-112671619	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB045963	Approved					NA	NA		45000000			"CAB045963: AB_11126023"	"unprognostic (7.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (1.17e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.59e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.82e-1)"	16.0	13.3	12.1	22.1	20.1	26.7	11.7	16.3	19.2	10.7	17.0	14.5	17.4	13.6	18.8	21.7	32.9	9.9	11.9	9.4	20.6	12.9	15.3	15.7	17.8	28.7	16.3	17.3	10.6	12.3	6.4	15.7	17.3	15.2	14.8	20.3	17.2	13.9	20.1	8.2	18.7	16.9	13.0	17.7	28.3	13.8	35.9	15.2	6.2	25.0	9.8	37.7	15.1	17.1	31.7	32.6	82.9	62.7	22.1	38.9	47.9	43.3	12.9	22.8	18.7	29.2	33.6	28.5	35.1	37.4	36.8	33.0	17.1	18.8	49.0	25.5	42.7	16.7	21.0	31.1	38.3	46.3	33.8	16.0	42.6	22.2	21.7	34.7	75.7	56.5	36.6	29.6	36.1	34.7	22.0	41.8	21.3	43.1	29.1	52.6	25.6	36.1	33.8	22.3	27.1	28.1	27.2	46.2	23.9	32.7	30.7	16.0	17.1	42.3	38.9	28.5	19.0	20.0	67.6	47.2	29.9	29.2	48.2	42.9	19.8	18.0	53.1	51.2	58.4	67.3	49.8	40.5	48.0	29.3	59.4	32.3	31.7	32.5	35.1	32.6	23.8	18.4	29.6	82.9	22.1	62.7	25.7	38.9	47.9	12.1	20.1	16.3	19.2	20.6	12.9	16.3	17.3	15.2	15.2	26.8	43.5	158.7	59.0	160.6	30.5	17.9	53.5	41.5	43.3	96.0	23.6	121.2	77.9	89.9	361.4	69.7	94.6	46.7	97.7	174.0	101.1	82.8	91.1	66.8	207.4	41.3	58.7	85.3	269.4	164.6	52.9	192.3	116.4	196.6	82.9	29.6	126.3	122.4	51.9	57.9	29.7	64.7	68.9	141.5	47.5	207.9	153.9	169.4	80.5	127.7
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031627			Approved	Cytosol		NA	NA			Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	12.5	17.0	6.2	12.6	6.9	3.5	15.0	1.9	6.3	11.4	23.1	9.3	12.3	18.8	16.4	12.6	15.8	12.2	15.3	5.8	8.6	5.1	13.3	19.4	9.7	7.7	5.9	5.1	14.5	12.9	13.1	14.1	20.2	8.2	14.0	9.3	13.8	13.5	16.5	3.1	23.2	33.8	9.4	6.3	12.9	10.4	17.7	6.0	14.5	12.1	6.9	10.9	11.0	12.5	1.9	5.6	0.9	9.5	9.9	10.8	5.9	12.0	7.4	4.4	17.0	3.6	10.4	16.8	8.3	19.7	24.4	35.0	13.7	13.3	0.0	5.7	11.4	9.1	12.8	16.8	19.9	8.5	13.2	10.2	8.3	10.8	15.4	15.5	3.4	8.3	17.5	6.1	14.8	4.7	16.1	20.7	17.2	11.0	4.2	7.5	22.3	13.1	2.7	9.9	5.0	7.6	23.7	11.2	0.5	11.3	13.2	1.9	6.4	17.1	11.6	13.4	9.1	9.0	8.0	12.3	7.6	13.7	5.3	7.3	4.8	1.3	0.0	15.1	7.2	21.7	0.7	2.8	0.5	10.7	8.4	10.8	1.9	9.7	9.7	5.6	1.4	9.4	7.1	0.9	9.9	9.5	0.9	8.2	5.9	6.2	6.9	1.9	6.3	8.6	5.1	5.9	5.1	8.2	6.0	8.9	10.9	5.4	9.8	7.8	2.1	2.5	7.6	6.7	10.3	15.7	0.0	42.2	3.3	13.7	4.2	14.7	31.4	0.0	13.3	16.6	5.1	9.2	1.1	14.0	13.8	4.8	14.5	17.8	9.4	4.9	8.6	7.1	3.3	18.0	15.3	20.4	13.7	28.1	7.1	11.2	0.8	12.9	6.2	2.6	2.6	6.0	31.9	5.7	11.5	9.5
RHOC	"ARH9, ARHC, RhoC"	ENSG00000155366	"Ras homolog family member C"	P08134	1	112701106-112707434	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 917.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 129.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 207.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051461	Uncertain					NA	NA		54000000			"HPA051461: AB_2681493"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (2.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.79e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.51e-3)"	56.5	36.0	31.3	23.2	28.6	2.8	46.2	11.1	18.2	48.5	71.0	19.2	46.7	53.6	47.4	110.1	51.3	32.4	58.1	79.2	21.7	23.8	88.3	45.0	63.3	21.8	30.1	14.6	57.6	24.2	89.6	21.2	67.4	24.9	47.8	49.9	37.9	27.0	58.3	29.9	28.4	122.4	48.6	21.6	54.6	28.0	41.5	17.7	15.8	43.1	28.0	17.6	59.6	43.0	6.4	24.6	1.8	129.9	32.5	23.1	25.5	61.5	25.4	15.1	17.0	28.5	50.3	17.1	56.4	69.7	41.1	34.8	20.2	18.8	0.9	23.5	82.0	18.2	17.7	11.1	51.3	40.1	14.7	6.2	7.2	16.9	16.2	47.6	1.2	33.1	58.9	36.2	65.8	45.6	44.7	105.8	9.2	14.3	13.1	74.5	32.9	3.0	4.9	4.1	23.9	42.4	5.2	18.0	2.7	47.4	17.5	0.7	6.5	28.1	18.6	35.6	30.4	39.1	5.2	89.5	55.7	38.2	75.0	40.9	8.6	7.1	2.7	62.8	4.9	207.7	0.1	7.0	0.1	23.1	77.2	15.4	4.8	4.6	9.4	24.6	6.4	1.1	7.2	1.8	32.5	129.9	18.4	4.9	25.5	31.3	28.6	11.1	18.2	21.7	23.8	30.1	14.6	24.9	17.7	14.9	39.0	34.2	250.3	163.8	1.4	79.9	96.8	30.8	44.3	226.8	3.9	280.5	139.3	747.3	10.8	296.3	821.3	0.0	736.1	416.9	224.7	313.2	61.2	47.3	152.2	6.4	81.5	323.5	86.8	25.5	138.9	211.8	232.8	463.5	188.8	306.4	917.5	469.9	194.5	560.9	11.0	213.4	270.2	7.9	20.6	147.4	216.3	179.9	146.4	330.9
AL603832.3		ENSG00000271810			1	112702614-112711433	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"testis: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.4;myeloid DC: 1.3;non-classical monocyte: 2.1;plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.8;monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"WM-115: 8.3"															NA	NA						"unprognostic (1.42e-2)"	"unprognostic (4.26e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.03e-3)"		"unprognostic (1.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.93e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	0.4	2.3	0.4	0.4	0.5	0.0	1.8	0.7	0.7	0.2	0.4			0.8	0.4	2.5	0.3	0.3	0.0	0.5	0.4	0.5	0.5	0.3	1.4	0.0	0.5		0.7	0.3	3.0	0.3	0.8		0.3	0.6		0.4	3.1	2.1	0.6	0.5	0.0	0.3	1.9	0.6	8.8			0.3		0.0	0.3	0.4	0.3	4.8	0.0	2.1	0.1	0.2	0.5	4.3	0.0	1.1	2.4	0.7	3.5	0.2	2.3	2.2	0.4	1.3	0.6	0.8	0.0	0.7	2.8	1.5	1.1	1.1	2.2	0.2	0.0	0.3	0.5	0.0	0.4	2.7	0.0	0.0	5.5	4.4	2.9	2.4	2.8	5.8	0.4	0.9	0.0	2.1	3.0	0.0	0.0	0.5	1.2	2.4	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.9	3.1	2.0	6.0	1.4	0.0	2.7	2.2	1.8	0.0	0.2	0.0	0.1	0.6	4.2	0.2	8.3	0.0	0.3	0.0	0.0	1.4	0.2	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	2.1	4.8	0.0	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.9;skeletal muscle: 45.1;testis: 31.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 105.4;Late spermatids: 189.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 30.9"	"Lineage enriched"	"Detected in many"	17	"dendritic cells: 30.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 20.4"	"Region enriched"	"Detected in some"	8	"olfactory region: 33.6"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	0.8	2.3	6.4	0.9	4.8	0.8	1.9	7.8	6.8	0.9	0.7	2.1	1.6	0.7	1.4	14.8	3.0	2.4	1.3	5.4	4.3	4.8	1.2	0.7	0.7	2.4	3.7	4.4	1.3	3.8	2.4	1.1	0.8	3.9	1.4	0.7	1.5	2.3	2.3	45.1	13.3	0.6	1.3	1.6	1.3	0.7	31.9	0.7	1.4	1.6	5.3	1.9	1.6	1.5	0.4	30.9	0.0	1.7	0.0	0.0	0.3	2.7	0.1	1.6	1.7	0.8	1.6	1.2	0.3	0.8	0.3	1.0	1.2	0.8	0.4	0.5	0.8	0.9	5.1	1.1	4.8	0.4	0.0	2.8	0.8	0.2	0.2	1.0	0.0	0.2	1.8	3.2	0.9	4.9	1.1	2.2	0.2	1.0	0.0	1.2	2.9	0.0	0.0	1.7	1.5	2.4	0.1	0.2	0.0	2.9	0.1	0.8	0.2	0.6	4.6	1.4	2.4	20.4	0.0	1.2	0.3	3.0	0.0	0.2	0.1	0.0	0.0	2.5	0.6	2.7	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.0	1.7	30.9	0.0	0.3	6.4	4.8	7.8	6.8	4.3	4.8	3.7	4.4	3.9	0.7	0.0	0.3	0.0	3.5	1.9	3.1	4.8	0.0	0.0	1.2	1.8	9.8	0.9	8.3	2.0	105.4	2.2	0.5	0.0	3.7	1.1	1.3	3.3	0.0	0.0	0.6	0.0	0.0	0.6	0.8	189.5	2.8	1.8	0.0	1.0	0.7	19.0	1.6	3.2	2.5	0.6	8.4	6.5	2.7	2.3	11.5	2.5	0.5	0.0	0.6	2.3
FAM19A3	"TAFA-3, TAFA3"	ENSG00000184599	"Family with sequence similarity 19 member A3, C-C motif chemokine like"	Q7Z5A8	1	112720419-112727235	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"adrenal gland: 19.6;brain: 5.2;testis: 8.8"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 44.6;Cone photoreceptor cells: 64.8;Muller glia cells: 15.8;Rod photoreceptor cells: 17.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.7;BJ hTERT+: 9.5;HEL: 3.7;U-87 MG: 3.8"									HPA055927	Approved				"Secreted in other tissues"	NA	NA					"HPA055927: AB_2682972"	"unprognostic (9.96e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.63e-4)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.14e-6)"	"unprognostic (2.10e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	0.1	19.6	0.4	0.1	0.0	0.0	0.3	5.2	0.4	0.1	0.0			0.0	0.1	0.9	0.2	0.4	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.4	3.9		0.6	0.0	0.0	0.2	0.1		0.3	0.0		0.1	0.2	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.8			0.2		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.2	0.0	0.0	0.6	0.8	0.2	9.5	0.7	0.6	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.1	0.5	0.4	1.6	0.3	3.7	0.0	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.5	0.0	0.2	0.0	0.4	0.4	0.4	0.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.3	0.6	0.1	0.0	1.1	0.0	1.4	1.3	0.2	0.5	0.1	0.0	0.0	3.8	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	44.6	0.4	0.0	0.0	0.0	0.0	64.8	0.0	0.0	0.3	8.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.6	0.9	0.0	0.1	0.0	0.0	0.0
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	20.2	4.7	14.6	12.4	10.1	8.6	48.0	10.9	8.3	8.6	13.9	16.0	11.8	22.2	15.3	9.9	6.4	19.4	20.4	20.3	16.3	13.9	20.7	18.2	12.9	18.6	17.9	23.2	1.9	12.0	24.9	12.7	25.0	13.9	20.8	11.6	23.0	14.8	9.6	3.9	13.6	11.7	47.2	5.6	15.2	12.2	23.0	15.3	10.6	0.4	16.2	8.5	21.2	0.6	16.2	21.9	0.9	8.8	14.0	8.3	14.6	16.3	16.1	7.8	6.8	22.4	24.1	14.7	10.2	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5	0.0	1.6	15.2	6.7	79.3	17.1	109.7	5.1	0.0	1.2	0.0	149.2	57.9	0.0	2.0	102.1	20.4	27.6	0.0	2.9	62.5	30.5	13.5	9.2	34.7	13.7	19.1	3.4	8.0	9.1	75.6	10.9	4.8	37.1	1.8	14.9	221.8	5.1	5.7	7.1	10.2	246.9	0.0	20.6	35.1	10.2	34.5	38.4	6.9	13.6	0.9
LRIG2	KIAA0806	ENSG00000198799	"Leucine rich repeats and immunoglobulin like domains 2"	O94898	1	113073209-113132260	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015538	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		510000	"Golgi apparatus"	Nucleoplasm	"HPA015538: AB_2250170"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	8.3	7.7	10.1	11.4	10.6	4.7	10.7	15.6	10.0	11.6	9.2	16.1	6.0	10.8	15.1	14.9	7.8	9.2	8.2	7.3	9.3	9.1	9.2	6.3	8.0	9.7	13.0	6.7	15.0	8.5	13.4	11.6	10.1	9.2	9.3	8.6	14.6	9.0	11.2	13.1	16.6	9.5	8.9	11.6	10.1	8.1	9.4	13.4	10.4	12.6	5.0	10.7	8.6	10.7	4.4	2.6	4.9	2.5	4.8	3.9	1.7	4.3	2.4	6.7	5.0	6.4	6.6	3.8	2.8	4.2	3.4	5.8	3.5	2.8	4.5	5.0	3.5	1.9	5.0	4.6	3.0	5.7	3.1	2.7	4.8	4.5	1.7	6.5	5.7	2.3	6.5	5.5	5.4	7.1	5.3	4.4	6.3	5.7	4.3	4.2	3.2	5.7	6.1	6.2	1.8	4.0	5.3	8.4	2.2	3.3	2.9	4.8	3.8	5.0	3.3	6.4	5.7	2.5	6.4	6.6	6.4	3.4	8.7	4.5	4.7	2.2	4.6	6.8	3.6	5.9	4.9	2.5	1.5	3.1	2.0	3.5	3.1	3.4	3.2	1.9	4.4	3.9	3.6	1.7	4.8	2.1	2.6	2.6	1.7	10.1	10.6	15.6	10.0	9.3	9.1	13.0	6.7	9.2	13.4	0.0	13.3	5.9	2.5	7.4	19.1	8.1	12.7	12.0	6.8	14.0	35.3	5.8	0.0	3.2	0.9	6.3	9.9	0.0	2.3	3.7	5.7	4.7	5.7	4.3	4.1	17.5	5.2	6.2	8.5	0.0	17.0	5.9	6.8	1.8	7.1	27.0	2.7	7.0	15.2	4.1	21.3	0.0	4.2	8.6	14.9	5.8	4.5	7.0	8.3	3.4
MAGI3	MAGI-3	ENSG00000081026	"Membrane associated guanylate kinase, WW and PDZ domain containing 3"	Q5TCQ9	1	113390749-113685923	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 50.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 247.1;Bipolar cells: 91.7;Club cells: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008444			Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA008444: AB_2668069"	"unprognostic (4.07e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (4.29e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.60e-8)"	"unprognostic (1.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-2)"	4.4	4.3	9.5	9.0	6.2	0.4	11.6	11.3	11.9	4.9	15.3	1.3	1.7	7.4	6.2	8.7	10.0	4.8	6.3	4.2	6.6	9.5	9.6	8.0	50.7	2.6	8.0	7.9	8.0	13.3	7.1	8.2	9.2	5.2	5.5	10.5	5.9	7.8	3.6	2.4	3.1	25.1	5.9	5.4	3.6	14.6	4.9	3.9	3.9	16.5	9.1	9.0	4.5	9.8	0.1	0.7	1.1	0.2	0.8	1.8	0.2	8.1	9.4	9.0	4.0	4.2	6.1	2.7	5.8	2.7	4.4	5.0	8.3	2.4	0.3	4.3	5.1	3.7	3.6	8.1	4.3	5.5	8.8	8.7	3.5	8.2	3.8	1.0	2.8	5.3	3.2	2.2	4.6	10.3	5.3	6.0	3.7	4.4	7.8	5.9	5.3	4.6	0.7	3.3	13.8	5.9	6.6	14.4	1.0	5.2	3.6	8.3	8.6	6.7	11.3	2.0	11.9	5.8	1.5	10.6	7.3	9.2	6.6	7.9	3.1	2.5	0.0	3.8	1.4	5.8	0.4	0.2	0.0	0.5	0.0	0.5	0.0	1.3	0.2	0.7	0.1	1.8	0.1	1.1	0.8	0.2	0.2	0.0	0.2	9.5	6.2	11.3	11.9	6.6	9.5	8.0	7.9	5.2	3.9	247.1	72.0	0.0	7.8	9.6	91.7	7.5	15.3	21.4	97.8	12.2	47.1	12.8	6.6	8.8	20.1	12.0	41.6	0.0	9.3	1.7	11.3	11.7	5.8	12.2	3.3	38.1	13.2	9.8	1.8	21.6	9.5	2.8	11.8	0.0	19.0	36.6	11.9	26.6	10.6	4.3	46.3	12.9	6.9	15.9	10.1	6.6	4.6	1.8	25.9	8.9
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 138.9;Late spermatids: 106.5;Spermatocytes: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	6.5	10.4	11.5	7.9	8.6	19.5	11.8	31.6	15.1	7.1	5.4	4.0	7.6	4.5	6.6	9.6	3.4	13.1	8.8	8.2	10.1	12.4	8.9	10.1	10.8	11.9	8.2	12.9	4.0	8.2	15.3	20.9	8.5	10.4	5.8	6.5	8.2	5.2	6.9	5.5	2.4	4.9	8.4	6.4	10.5	8.0	33.8	6.6	3.4	6.1	2.4	7.7	8.1	6.3	3.0	4.5	6.0	2.6	4.3	5.7	1.7	12.8	6.7	19.1	10.1	9.5	8.6	5.0	11.8	15.7	10.6	17.4	7.3	10.4	3.7	16.8	8.2	7.8	7.1	7.2	4.7	12.2	15.2	7.2	8.9	14.1	8.4	7.9	10.9	12.6	7.2	1.3	14.2	3.1	15.4	19.5	0.0	5.3	17.1	12.8	19.0	0.1	11.0	15.1	4.8	10.9	11.5	28.7	7.4	17.0	5.6	13.5	12.4	13.2	6.5	7.0	10.4	2.6	8.9	20.6	8.4	11.6	15.4	11.4	23.9	24.2	6.9	20.6	9.5	22.7	3.0	2.6	4.9	3.0	1.3	2.3	3.0	3.7	3.7	4.5	1.6	0.1	2.6	6.0	4.3	1.7	3.0	5.7	1.7	11.5	8.6	31.6	15.1	10.1	12.4	8.2	12.9	10.4	6.6	6.0	10.9	21.0	6.3	2.2	28.1	7.4	15.3	49.5	10.3	5.2	51.1	17.2	8.3	9.9	138.9	17.6	2.7	23.3	18.2	7.7	11.1	7.1	20.8	7.6	10.9	27.0	18.4	9.2	13.2	106.5	7.5	9.8	5.0	10.8	2.7	5.3	15.5	0.0	8.5	5.4	45.4	0.0	11.4	106.3	31.1	1.5	22.1	18.7	2.9	6.5
RSBN1	"FLJ11220, ROSBIN"	ENSG00000081019	"Round spermatid basic protein 1"	Q5VWQ0	1	113761832-113812476	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042124, HPA049484"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA042124: AB_10794644, HPA049484: AB_2680787"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-3)"	10.4	8.4	8.6	9.4	14.6	35.8	10.3	23.9	12.0	17.0	14.4	6.9	8.1	7.7	13.4	8.6	9.7	10.9	8.4	8.1	8.9	9.1	10.4	7.9	11.5	11.8	8.1	7.3	18.3	13.3	17.6	15.1	8.2	8.4	11.5	10.9	9.6	10.1	10.7	17.1	10.7	10.9	11.5	7.2	12.8	8.8	12.4	10.0	22.6	11.8	5.7	12.7	16.6	10.7	20.7	16.4	25.7	9.2	14.3	20.8	7.3	11.9	3.4	11.8	7.0	7.0	8.1	5.7	4.2	9.2	8.7	9.1	4.0	3.6	10.5	6.8	5.2	4.0	5.3	8.3	5.2	14.2	10.1	6.0	7.9	3.7	4.6	5.3	14.8	8.5	6.1	5.7	7.4	7.1	7.4	6.8	11.8	11.9	6.6	6.3	12.2	11.8	8.8	9.9	3.8	5.9	21.6	11.5	5.4	5.2	5.2	11.9	9.5	8.1	8.0	7.2	6.2	3.9	10.0	8.1	7.8	8.5	11.6	6.9	8.8	6.6	13.3	8.1	9.1	13.0	25.7	9.2	14.6	18.6	6.9	18.8	18.3	20.1	17.1	7.6	20.7	20.8	16.9	17.9	14.3	7.5	16.4	17.4	7.3	8.6	14.6	23.9	12.0	8.9	9.1	8.1	7.3	8.4	10.0	32.8	16.1	30.8	35.7	66.3	83.2	16.9	15.3	29.4	29.6	24.4	62.8	21.1	16.6	17.4	15.1	40.5	36.7	23.3	22.6	20.3	33.4	36.6	34.7	17.0	17.1	92.2	47.3	27.0	20.5	4.0	46.6	26.3	38.8	34.3	43.1	59.4	19.0	44.2	46.7	12.8	100.8	38.8	50.9	94.3	33.0	57.0	26.3	58.9	38.5	36.5
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6"	"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	33.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.1	0.0	4.7	0.0	0.0	0.1	13.3	10.5	3.0	0.0	1.4	0.1	2.7	5.2	8.4	0.0	7.7	5.1	0.1	9.4	7.5	0.0	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.4	8.0	0.1	0.1	0.2	14.4	3.0	18.0	5.5	13.6	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4	0.0	9.2	29.6	0.2	2.3	0.4	0.5	0.0	4.0	0.0	1.8	2.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.5	0.2	0.9	0.2	26.6	0.6	7.1	0.0	0.0	0.6	19.2	0.6	0.0	20.5	3.3	1.8	1.0	0.0	0.6	0.0	0.0	0.0	0.4	12.9	0.9	0.3	0.2	2.4	0.1	65.4	1.7	0.2
BCL2L15	"Bfk, C1orf178, FLJ22588"	ENSG00000188761	"BCL2 like 15"	Q5TBC7	1	113878168-113887547	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 84.0"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 93.5;Exocrine glandular cells: 101.2;Pancreatic endocrine cells: 70.7;Undifferentiated cells: 44.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 19.5;EFO-21: 6.7;OE19: 21.8;RPTEC TERT1: 5.8"	"Region enriched"	"Detected in single"	32	"cerebellum: 36.9"	"Low region specificity"	"Detected in many"			"HPA029732, HPA029733"	Enhanced					NA	NA					"HPA029732: AB_10599615, HPA029733: AB_10600422"	"unprognostic (5.96e-2)"	"unprognostic (6.41e-3)"	"unprognostic (5.82e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.97e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-7)"	"unprognostic (5.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.04e-3)"	"unprognostic (4.27e-2)"	0.4	0.2	0.4	3.8	0.4	5.7	0.4	0.9	0.4	2.6	30.5	0.4	0.7	25.4	0.6	2.4	2.3	0.5	4.9	0.4	0.4	0.2	1.3	0.4	0.7	0.4	0.4	0.4	0.6	9.4	0.0	0.4	0.4	0.4	0.5	18.8	0.4	0.4	0.4	0.4	0.2	84.0	0.4	0.4	0.5	9.4	0.6	0.4	0.4	0.4	0.9	0.6	0.8	0.6	0.0	0.0	1.9	0.3	0.0	1.6	0.4	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	1.8	0.3	0.2	0.0	21.8	0.0	0.0	0.3	0.4	5.8	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	1.2	0.5	0.0	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.0	0.4	0.4	0.4	0.9	0.4	0.4	0.2	0.4	0.4	0.4	0.4	0.0	2.2	0.8	4.4	0.3	1.7	0.3	7.6	4.0	9.1	22.7	5.9	0.1	0.0	2.7	1.2	0.0	93.5	0.0	101.2	0.0	0.8	2.1	0.0	0.0	0.6	1.6	2.4	0.0	0.6	0.0	0.0	2.1	0.0	2.8	33.4	0.5	70.7	17.3	0.0	0.2	2.4	0.0	1.0	0.5	0.7	1.0	0.1	1.3	44.4	13.9
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 beta 1 subunit"	Q9Y6B7	1	113894748-113905201	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 40.3"					"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.5	8.8	11.5	18.3	19.1	23.3	11.4	23.1	16.7	12.4	13.3	14.1	4.1	16.4	12.5	18.5	12.2	10.5	12.6	11.0	12.2	11.4	9.2	8.2	9.5	16.4	15.3	13.2	16.1	14.1	8.1	19.7	7.6	13.4	9.4	16.8	14.0	10.7	8.3	13.0	13.9	13.6	11.9	14.2	20.0	10.6	10.5	14.7	13.7	11.6	7.7	17.2	9.9	12.5	11.8	12.8	14.0	10.9	11.7	16.6	9.3	6.5	5.9	6.7	6.8	10.2	8.5	3.8	6.0	5.6	7.8	9.6	4.0	4.5	12.8	9.7	7.6	4.4	5.9	7.5	7.8	9.7	10.2	6.2	10.4	9.3	5.3	5.8	11.5	10.6	9.9	3.9	15.4	9.7	4.9	13.5	13.0	7.5	11.5	10.1	40.3	9.1	12.0	5.9	4.5	11.9	8.9	13.5	7.4	7.7	3.3	6.7	5.0	7.0	11.2	4.3	6.1	3.7	9.3	12.3	9.6	8.5	10.5	11.5	9.2	8.9	14.2	14.5	15.1	14.7	14.0	10.0	8.2	15.5	10.9	16.6	9.7	12.3	13.2	12.8	11.8	13.9	12.0	1.1	11.7	8.3	9.3	10.3	9.3	11.5	19.1	23.1	16.7	12.2	11.4	15.3	13.2	13.4	14.7	3.0	7.9	3.4	3.5	3.2	7.4	7.0	2.5	2.7	12.5	3.5	29.5	3.3	1.7	6.7	3.1	7.1	6.2	70.0	23.4	3.3	4.4	2.9	2.3	3.0	4.8	7.9	2.9	6.2	9.7	1.5	2.6	6.1	6.8	3.6	4.3	3.9	10.4	6.0	4.6	3.0	20.3	12.9	5.6	11.6	8.9	3.1	1.4	15.0	6.9	2.7
DCLRE1B	"FLJ12810, FLJ13998, SNM1B"	ENSG00000118655	"DNA cross-link repair 1B"	Q9H816	1	113905141-113914086	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 15.4;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064934			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"HPA064934: AB_2685387"	"unprognostic (1.21e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.03e-7)"	"unprognostic (1.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.08e-2)"	8.7	4.9	6.7	8.3	6.8	13.1	7.3	15.4	7.8	6.7	6.8	8.3	0.4	4.3	6.9	4.3	8.4	7.0	5.8	5.4	7.0	5.6	5.3	4.2	8.0	15.1	6.7	4.5	7.7	3.8	3.4	3.1	8.7	6.5	4.4	7.8	6.1	4.6	5.0	3.4	7.0	5.5	8.7	8.5	12.8	4.7	7.2	6.4	20.9	5.1	8.2	9.6	5.9	5.9	2.3	4.2	2.4	7.0	8.7	4.4	3.5	8.3	3.1	5.9	6.6	4.4	3.1	3.7	6.6	4.8	9.1	10.0	3.7	2.7	7.9	4.5	5.1	4.7	4.3	8.1	7.2	11.9	6.8	5.7	6.5	4.9	3.2	1.1	7.4	6.6	3.9	2.5	13.1	7.2	2.5	4.8	9.9	9.8	6.7	9.8	34.0	11.4	5.6	4.6	4.2	7.3	9.2	17.8	3.8	3.1	3.0	5.2	4.6	6.4	5.4	4.3	5.3	3.5	7.5	2.8	11.1	11.8	18.0	9.3	3.2	3.3	8.9	9.3	7.7	18.3	2.4	7.0	1.9	3.4	6.4	4.3	1.4	4.4	3.1	4.2	2.3	2.6	3.6	0.3	8.7	3.7	1.5	2.4	3.5	6.7	6.8	15.4	7.8	7.0	5.6	6.7	4.5	6.5	6.4	3.0	1.3	2.7	1.0	3.2	2.8	0.8	2.5	4.0	0.0	0.0	2.0	3.5	1.7	4.0	0.8	2.3	0.2	0.0	2.4	8.0	1.5	1.2	1.1	1.0	8.9	1.6	2.9	3.1	5.9	0.0	1.7	11.7	0.0	15.4	1.8	0.8	2.7	0.0	2.1	1.4	1.3	25.8	3.8	3.4	12.0	2.4	1.1	2.9	3.4	1.1
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.2	6.7	9.3	7.1	10.9	5.7	6.3	5.7	6.9	8.1	7.8	7.7	3.2	11.1	7.8	9.0	3.0	5.6	12.0	6.6	11.8	8.0	6.0	16.1	8.4	8.1	9.1	12.8	20.0	6.2	9.7	10.4	10.6	7.7	12.0	19.7	11.0	12.0	11.6	62.4	16.8	7.3	9.5	6.2	6.0	10.2	27.3	3.9	7.3	7.1	4.1	5.5	10.4	11.2	7.3	10.8	6.5	18.5	11.6	8.0	10.8	13.0	8.6	7.5	5.8	9.6	9.0	10.4	18.2	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3	50.6	37.0	12.9	14.8	54.6	47.6	27.1	22.9	64.3	20.5	26.2	66.8	9.7	5.0	12.5	82.7	29.3	18.8	70.0	18.3	7.9	25.0	26.7	45.1	33.6	19.9	69.9	35.7	23.9	54.6	73.8	20.4	35.5	20.3	15.4	24.2	28.9	17.0	17.3	35.0	13.4	60.3	25.8	37.0	35.4	26.0	70.4	11.9	47.3	22.4	23.0
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	18	"Fibroblasts: 177.9;Ito cells: 73.6;Leydig cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 5.4"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.8;ASC TERT1: 46.4;BJ hTERT+: 52.9;HSkMC: 84.8;LHCN-M2: 84.6"	"Low region specificity"	"Detected in many"							HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		1500000	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	25.8	11.8	3.9	9.7	6.6	0.0	25.6	1.4	7.9	75.3	22.7	16.2	17.9	3.9	57.7	41.8	13.8	33.9	31.5	20.3	3.0	2.3	9.7	9.4	18.4	5.7	7.1	4.0	52.6	11.7	1.0	6.6	29.1	8.9	33.1	9.6	41.4	6.1	21.9	5.8	13.5	10.8	29.4	5.1	2.5	19.1	13.3	4.6	0.6	7.8	15.0	7.0	28.0	37.6	0.0	5.4	0.0	0.4	0.0	0.0	0.2	0.0	2.7	1.4	0.0	84.8	46.4	0.0	10.8	52.9	3.7	12.3	3.5	0.0	0.0	0.6	31.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.6	22.0	0.0	0.0	84.8	0.0	5.3	0.0	1.5	0.3	0.0	0.0	0.0	84.6	0.0	0.0	0.0	6.4	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.4	21.4	31.4	0.1	0.2	2.1	4.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	13.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	6.6	1.4	7.9	3.0	2.3	7.1	4.0	8.9	4.6	0.0	5.9	0.5	0.1	11.6	0.0	1.4	2.5	0.0	1.2	1.8	0.0	5.6	0.0	0.6	1.5	3.5	0.0	0.0	0.0	5.0	177.9	1.1	1.1	0.2	33.4	0.0	5.8	73.6	5.0	1.1	67.9	3.6	11.8	1.0	0.2	0.0	0.4	0.0	31.1	0.5	0.0	0.0	37.3	0.2	0.4	10.0	10.4	0.7	0.0	0.3
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153919	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.9;kidney: 3.7;pancreas: 11.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 5.6;Late spermatids: 9.2;Melanocytes: 3.3;Proximal tubular cells: 2.4"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 21.1;WM-115: 14.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 27.9;olfactory region: 87.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles		NA	NA			Vesicles		"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.3	2.2	2.6	0.8	6.5	0.3	2.1	0.2	10.4	0.4	0.3	5.1	0.0	0.9	0.4	0.2	0.2	0.3	0.5	0.3	2.3	14.9	3.7	0.3	0.4	0.3	2.8	1.3	2.3	11.1	0.7	0.3	1.4	3.9	1.5	0.6	0.9	1.1	0.2	0.4	0.4	0.5	0.3	4.2	0.3	0.3	0.9	3.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.6	6.5	0.2	9.3	2.3	14.9	2.8	1.3	3.9	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.2	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392777-114511160	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	15.2	12.8	16.9	18.4	19.9	27.1	17.1	38.3	21.8	16.9	14.3	11.0	21.9	10.9	19.8	38.3	16.4	15.0	15.6	10.8	18.1	12.5	17.3	15.0	14.3	15.2	12.1	18.0	19.8	15.7	21.8	22.4	27.2	15.2	16.5	13.0	10.7	16.4	19.1	14.3	19.5	14.8	20.2	12.9	14.9	14.1	29.0	16.3	20.5	17.9	9.8	16.6	17.9	28.7	3.4	4.0	12.2	2.8	4.7	4.4	1.0	13.1	7.1	13.4	10.0	5.7	6.0	22.9	6.7	7.2	9.4	10.0	8.0	5.6	14.1	7.0	7.8	6.1	7.6	12.2	7.8	13.0	10.6	7.2	13.6	9.4	9.3	6.3	17.1	11.3	5.7	5.8	11.1	11.4	7.2	7.8	12.0	16.9	10.0	8.9	49.4	17.2	7.3	18.1	5.0	7.2	14.9	20.5	4.6	6.7	20.7	9.3	9.8	12.7	15.4	12.1	9.0	7.0	9.4	8.8	6.5	10.6	15.1	9.4	7.0	6.5	14.7	9.2	10.0	18.5	12.2	1.6	7.4	3.5	1.8	3.1	3.4	3.7	3.7	2.0	2.2	2.9	4.4	4.8	4.7	2.8	4.0	2.0	1.0	16.9	19.9	38.3	21.8	18.1	12.5	12.1	18.0	15.2	16.3	17.9	29.5	19.1	25.9	46.9	71.6	22.0	25.5	10.7	25.0	52.4	92.3	49.7	1.7	18.3	155.1	31.1	23.6	23.3	20.5	27.8	32.1	38.2	36.9	40.5	26.3	25.4	50.1	37.4	44.7	78.9	45.5	39.2	18.6	17.2	31.4	33.5	25.3	32.6	34.6	12.6	58.2	32.3	23.7	54.0	29.6	48.4	73.3	35.5	28.9	48.8
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"		NA	NA			"Nuclear speckles, Centrosome"		"HPA067881: AB_2685915"	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (4.27e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	19.3	7.1	14.7	13.9	7.8	9.1	22.0	14.6	11.3	19.4	20.0	9.9	8.0	17.2	20.2	9.4	13.1	9.4	17.0	14.4	27.0	15.6	15.3	9.0	14.1	14.3	14.2	22.7	9.8	8.3	15.9	20.0	24.8	9.1	12.6	18.8	17.2	12.9	15.9	118.8	20.2	16.9	25.5	11.9	16.2	14.5	26.0	12.0	13.6	17.0	19.2	12.8	18.2	14.1	22.4	12.7	12.4	18.0	11.1	11.9	15.9	23.8	27.4	14.1	14.5	27.9	23.2	19.0	44.8	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6	26.8	38.4	63.6	94.6	69.1	63.3	63.3	28.1	42.8	36.4	47.1	35.3	67.4	81.2	56.2	17.0	43.9	22.2	23.3	58.4	73.6	49.8	51.7	99.1	27.7	58.7	36.5	47.9	27.0	31.0	13.7	36.8	54.3	64.1	50.5	30.7	70.3	45.0	31.1	41.1	72.5	55.6	38.8	78.0	57.0	37.7	55.5	84.7	66.0	31.3	106.5
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.7;skeletal muscle: 31.1"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 99.0;Basal keratinocytes: 97.0;Suprabasal keratinocytes: 150.2;Urothelial cells: 270.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 6.1;eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"U-2197: 10.3;U-266/70: 22.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA029935, HPA054955"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029935: AB_10601208, HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	1.9	0.7	1.5	0.7	1.5	0.8	1.7	1.4	1.1	8.6	1.1	0.5	0.8	0.6	4.2	1.7	28.7	1.0	1.1	1.5	1.3	0.5	0.8	2.1	1.7	1.7	0.6	0.3	1.1	4.0	2.4	3.6	0.3	1.9	2.5	0.6	1.6	3.0	1.4	31.1	10.6	0.6	2.4	0.6	0.5	0.8	4.5	0.2	0.0	1.3	16.0	10.4	6.2	6.6	0.6	0.1	6.1	0.2	0.3	0.5	0.3	1.7	0.0	0.1	1.2	1.5	1.7	0.3	0.5	0.9	0.6	0.9	0.2	0.0	0.0	0.8	3.5	1.2	6.5	1.2	4.0	0.6	0.0	1.6	1.0	0.4	0.1	0.5	0.0	1.6	1.7	3.9	2.4	2.0	0.1	0.2	0.4	0.1	0.3	2.1	5.1	0.2	0.1	0.8	0.0	0.9	0.0	5.5	0.1	0.1	4.9	0.0	0.0	3.9	0.1	0.4	1.1	0.8	0.3	0.2	0.9	1.3	10.3	0.1	22.5	4.0	0.0	0.9	0.0	0.7	6.1	0.2	2.1	0.5	0.0	0.5	0.6	0.1	0.4	0.0	0.4	0.3	0.2	0.5	0.3	0.1	0.1	0.2	0.3	1.5	1.5	1.4	1.1	1.3	0.5	0.6	0.3	1.9	0.2	26.8	2.1	0.0	99.0	97.0	21.6	6.9	12.7	20.1	4.5	7.0	19.6	0.1	0.0	5.6	23.7	8.7	0.0	0.0	6.4	0.0	5.3	46.7	2.3	11.0	0.2	0.0	0.0	13.5	3.4	9.1	4.6	1.6	6.8	1.0	0.8	2.0	20.3	0.0	2.1	0.6	8.7	0.0	8.5	23.4	49.0	150.2	0.0	0.7	0.5	270.3
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 212.4"	"Cell type enhanced"	"Detected in some"	19	"Late spermatids: 1.5;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"memory B-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"B-cells: 3.0"	"Cell line enriched"	"Detected in single"	32	"U-266/70: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	2.9	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.2	3.3	0.0	0.0	3.5	0.1	3.3	1.4	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.6	1.2	0.0	2.1	1.5	212.4	0.1	1.4	0.0	0.1	0.5	0.7	0.1	0.0	0.0	0.2	25.3	2.8	0.2	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRAS	N-ras	ENSG00000213281	"NRAS proto-oncogene, GTPase"	P01111	1	114704469-114716894	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010157, HPA049830, CAB079912"	Uncertain		Supported	"Plasma membrane"		NA	NA		4800000	"Plasma membrane"		"CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903"	"unprognostic (4.75e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.11e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (7.76e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.33e-2)"	18.0	9.7	13.1	16.5	14.4	33.5	12.4	9.7	16.6	10.0	18.4	15.8	3.8	14.4	9.8	6.2	19.7	8.7	11.8	7.1	11.7	13.8	24.0	23.9	13.4	18.7	15.3	9.6	10.3	14.2	8.3	7.6	27.4	19.0	9.2	18.5	8.4	12.4	5.2	7.9	16.1	23.4	9.6	20.9	19.5	14.4	9.8	9.7	45.0	11.1	14.0	19.6	13.2	10.5	11.0	9.9	23.7	15.0	12.1	11.1	10.1	24.7	6.7	18.1	6.8	7.5	16.1	12.9	11.8	13.2	22.2	25.0	13.5	9.3	18.8	15.7	15.9	15.5	7.1	24.1	19.2	31.9	25.6	9.4	12.7	10.2	16.0	14.9	31.6	19.8	14.5	15.6	25.4	18.6	7.0	28.2	14.9	20.2	21.7	19.5	66.1	21.8	12.3	30.7	8.1	4.9	16.7	32.2	11.7	19.6	13.4	11.0	16.5	12.1	10.0	28.4	22.0	8.8	25.7	21.5	12.1	23.2	22.6	24.2	38.4	26.4	22.1	24.2	17.3	43.6	23.7	10.0	9.6	9.8	15.0	8.9	11.0	8.0	9.7	9.9	8.8	8.7	11.1	2.7	12.1	12.7	7.7	10.4	10.1	13.1	14.4	9.7	16.6	11.7	13.8	15.3	9.6	19.0	9.7	14.9	13.9	22.5	24.9	27.2	4.4	4.0	25.5	18.7	12.5	21.0	7.9	18.9	11.6	31.0	2.9	23.3	32.2	0.0	27.3	39.9	16.8	25.2	31.1	24.5	43.1	4.8	23.6	40.5	41.2	4.4	7.5	27.8	21.9	41.5	29.5	7.1	39.8	29.4	6.0	27.8	2.2	6.5	10.8	6.5	14.1	31.7	26.1	20.3	24.7	34.0
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 266.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 226.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		13000	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	71.2	31.4	33.5	25.8	33.2	37.9	42.1	29.6	35.4	39.0	64.7	29.6	35.9	29.5	46.4	38.9	58.8	30.3	29.4	64.2	33.2	31.7	37.4	39.5	34.2	31.4	41.6	31.4	43.9	37.2	50.3	38.4	38.8	44.4	52.6	32.9	32.0	43.2	42.0	266.5	33.8	46.5	88.3	42.4	32.2	39.9	41.5	35.1	39.6	55.7	73.9	31.9	75.4	45.5	43.9	59.0	57.9	65.2	48.1	62.3	80.5	61.7	21.8	38.8	38.7	44.3	57.6	54.3	54.6	40.8	36.8	29.9	31.9	18.7	48.7	46.1	52.0	21.5	26.3	43.0	42.4	53.7	59.5	29.4	47.8	39.7	28.2	39.2	35.5	28.5	41.8	46.2	44.0	58.1	50.0	42.0	41.2	48.4	32.0	44.9	226.5	47.5	22.7	73.9	26.0	29.4	35.6	120.2	22.9	29.2	48.7	48.0	31.8	53.4	44.6	41.3	42.8	22.9	56.7	50.6	43.5	60.0	57.0	59.9	48.9	53.2	54.6	56.2	40.3	132.6	46.4	57.7	57.9	40.9	60.8	55.5	43.9	52.2	49.7	59.0	34.7	62.3	52.3	40.9	48.1	65.2	23.0	56.7	80.5	33.5	33.2	29.6	35.4	33.2	31.7	41.6	31.4	44.4	35.1	184.6	166.5	131.5	180.2	192.1	123.0	534.2	132.5	139.2	159.3	122.1	55.0	150.1	192.3	174.5	301.0	172.2	163.0	93.5	175.1	175.9	149.1	211.7	211.6	144.5	141.9	93.8	210.9	124.6	242.4	459.7	149.8	180.0	209.2	170.5	206.0	141.9	193.9	122.8	212.2	179.3	91.0	161.7	255.2	219.6	163.8	204.6	228.3	138.0	172.8	220.6
SIKE1	"FLJ21168, SIKE"	ENSG00000052723	"Suppressor of IKBKE 1"	Q9BRV8	1	114769479-114780685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024177, HPA025726"	Supported		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Vesicles	"HPA024177: AB_1848798, HPA025726: AB_1848800"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.52e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.05e-1)"	18.3	15.4	14.5	17.4	15.9	15.3	16.4	23.5	16.3	18.3	17.3	14.5	14.2	16.7	17.2	13.4	18.1	14.3	13.4	20.3	14.2	15.1	24.4	22.2	12.3	19.7	21.1	11.2	17.2	17.5	15.4	22.5	17.1	23.2	15.2	17.3	9.3	17.2	13.9	21.1	21.9	17.5	16.4	19.2	20.6	14.5	11.8	17.9	26.0	19.3	17.1	21.2	17.2	14.2	8.1	9.8	12.3	7.6	9.2	10.3	5.3	8.5	2.4	11.4	10.8	13.7	10.9	12.2	7.1	6.7	10.4	14.1	7.5	4.5	16.0	7.0	6.0	4.5	8.3	12.5	8.5	14.1	10.8	7.3	8.8	7.6	7.7	13.0	10.0	7.2	10.7	9.8	7.5	12.1	6.5	9.3	12.6	13.4	10.3	7.9	38.1	17.5	9.0	25.7	4.8	7.4	10.5	23.4	8.1	7.6	7.8	8.7	9.7	11.2	11.0	12.8	10.6	6.6	33.5	6.5	8.7	11.5	14.5	9.9	8.7	7.5	15.7	12.4	15.2	18.7	12.3	6.0	7.4	8.6	6.4	10.3	7.9	8.0	7.4	7.8	8.1	9.3	9.9	4.0	9.2	7.6	9.8	6.2	5.3	14.5	15.9	23.5	16.3	14.2	15.1	21.1	11.2	23.2	17.9	23.8	11.3	20.5	20.8	28.3	9.9	37.2	20.4	8.1	13.6	29.6	9.8	26.2	43.1	24.9	28.0	21.2	22.5	0.0	22.3	29.0	22.4	24.9	19.6	33.5	24.5	7.9	17.9	24.5	15.8	47.2	26.2	19.8	21.9	18.0	20.8	14.1	27.5	20.1	18.7	46.0	14.7	19.4	21.7	28.6	31.3	31.9	30.1	30.9	19.8	19.5
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854803-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 30.6"	"Cell type enriched"	"Detected in some"	14	"Spermatocytes: 1077.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	93	"THP-1: 19.5"	"Region enriched"	"Detected in single"	51	"cerebellum: 16.5"	"Not detected"	"Not detected"			HPA021083	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.0	1077.5	21.3	0.0	0.0	0.0	0.0	0.0
TSHB		ENSG00000134200	"Thyroid stimulating hormone beta"	P01222	1	115029824-115034309	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	77	"pituitary gland: 192.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;SH-SY5Y: 1.0;U-937: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022202, HPA042681"	Enhanced				"Secreted to blood"	NA	NA					"CAB022202: , HPA042681: AB_2732500"											"unprognostic (2.14e-4)"	"unprognostic (1.37e-1)"		"unprognostic (1.73e-1)"				0.1	0.0	0.1	0.9	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	1.4	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.3	0.1	1.4	0.1	0.1	0.1	0.1	1.6	0.0	192.4	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.1	0.1	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.1	2.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 44.6"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 11.9"	"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 35.0;NK-cells: 25.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	3.7	0.6	1.1	4.7	2.5	9.6	3.2	0.9	2.0	20.1	31.0	1.5	8.9	2.5	30.6	6.9	12.3	14.2	10.6	6.1	1.1	2.6	4.0	0.6	3.0	1.5	1.9	1.9	6.5	2.0	6.4	2.0	1.5	11.9	15.2	6.2	1.9	2.2	15.7	2.0	1.6	7.0	44.6	1.6	2.2	10.0	4.4	0.8	2.6	4.0	4.9	0.9	25.4	7.0	0.2	1.2	35.0	2.9	25.9	7.4	3.8	8.5	0.1	0.7	0.0	0.0	0.1	0.0	1.4	0.5	1.4	2.2	1.7	5.2	0.0	35.1	1.9	1.9	1.2	1.1	0.0	1.5	1.7	0.7	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	9.8	0.0	6.9	0.0	0.5	0.0	0.4	4.6	0.7	8.0	1.7	0.9	0.0	0.5	0.0	0.2	3.2	1.8	2.9	2.1	0.9	0.1	4.9	0.1	0.3	0.1	0.1	3.4	0.2	8.0	7.3	0.2	0.0	0.0	15.4	3.8	27.8	2.9	16.6	5.9	0.0	1.9	0.2	7.0	7.4	1.2	0.1	1.2	6.0	35.0	25.9	0.0	1.2	0.9	3.8	1.1	2.5	0.9	2.0	1.1	2.6	1.9	1.9	11.9	0.8	0.0	1.1	0.0	22.5	7.1	0.2	9.2	0.0	10.7	2.3	10.4	0.0	0.1	0.0	16.3	10.8	15.0	0.0	0.0	2.2	3.1	3.1	10.9	0.0	0.0	0.6	0.0	37.7	5.5	0.8	2.7	0.6	0.9	3.3	0.0	0.8	0.0	7.7	0.0	2.8	1.0	0.4	6.5	20.2	0.1	0.9	2.4	0.2	5.0	1.0	9.2
NGF	NGFB	ENSG00000134259	"Nerve growth factor"	P01138	1	115285918-115338236	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	29	"Leydig cells: 27.0;Sertoli cells: 116.4;Smooth muscle cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 36.2;BJ hTERT+ SV40 Large T+: 12.9;GAMG: 20.0;hTEC/SVTERT24-B: 12.6;hTERT-RPE1: 20.9;U-2197: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA	40000					"unprognostic (7.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.12e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.73e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.08e-7)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.62e-4)"	9.1	2.3	1.3	2.8	1.6	0.2	6.5	0.6	2.8	7.5	3.4	0.6	2.3	0.3	11.4	5.9	1.5	10.6	6.6	16.5	3.2	0.6	3.4	2.7	1.4	1.5	2.3	1.6	17.8	0.7	0.3	2.1	2.0	1.7	3.7	1.2	7.0	3.8	2.0	1.8	0.6	1.4	7.0	2.1	3.8	1.6	3.2	1.1	0.0	2.9	3.0	0.3	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	36.2	4.1	12.9	9.5	0.0	0.0	0.0	0.8	8.5	20.0	1.4	0.0	0.2	5.8	0.0	0.1	0.0	0.2	0.0	5.4	0.0	0.0	0.0	0.2	12.6	9.4	20.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.7	0.2	0.0	1.7	0.0	0.0	0.3	0.8	1.5	25.2	1.4	0.0	0.0	0.0	1.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.6	2.8	3.2	0.6	2.3	1.6	1.7	1.1	0.0	0.0	0.0	0.4	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.8	0.0	0.6	0.0	0.0	0.0	1.1	4.5	0.6	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	27.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	116.4	31.9	0.0	0.7	1.9	2.1	0.0	0.0	0.1
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641953-115698224	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 37.3;Ito cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	7.0	8.6	2.2	5.8	3.1	2.0	16.4	1.2	2.5	14.0	9.3	5.3	8.3	4.0	13.2	8.8	14.4	13.7	5.3	12.7	3.2	2.3	11.8	7.1	12.1	7.4	2.1	1.9	8.9	11.5	5.5	2.2	5.3	2.4	9.4	7.1	6.6	9.5	11.0	2.1	9.8	6.6	15.9	2.0	4.7	6.6	7.9	2.6	18.0	11.8	10.0	10.0	10.2	9.4	0.3	3.5	0.0	0.8	8.9	4.3	1.4	21.5	9.2	3.0	4.0	11.2	10.1	6.0	8.4	6.1	11.0	8.8	5.3	10.8	0.0	14.5	9.7	10.4	27.3	5.0	14.9	7.3	25.2	6.1	12.0	8.5	4.3	4.1	3.5	5.2	5.3	10.5	7.8	8.4	5.8	10.9	20.6	7.2	6.7	11.0	28.8	17.6	1.4	7.5	12.6	8.8	0.0	8.7	6.2	5.1	14.5	2.7	3.6	15.1	10.0	7.2	5.9	5.1	3.9	11.6	7.6	12.0	16.5	15.2	0.9	1.0	0.0	10.2	6.3	18.5	0.0	0.8	0.0	3.0	0.5	0.8	0.3	1.9	2.9	3.5	0.0	0.7	3.3	0.0	8.9	0.8	3.0	4.3	1.4	2.2	3.1	1.2	2.5	3.2	2.3	2.1	1.9	2.4	2.6	3.0	2.7	1.9	6.3	6.5	4.0	6.3	2.5	6.7	1.2	8.7	37.3	3.7	0.0	14.9	4.6	7.7	7.7	0.0	12.1	5.8	6.4	7.0	0.0	2.4	3.8	0.0	6.4	31.9	1.5	1.9	5.5	1.8	0.0	19.0	7.9	4.2	16.1	5.8	7.8	5.7	0.7	6.5	5.7	1.0	9.4	5.6	0.3	1.8	8.3	6.5
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700007-115768781	"Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 697.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.7"	"Cell line enriched"	"Detected in single"	19	"HSkMC: 17.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 48.4"	"Low region specificity"	"Detected in single"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.25e-5)"	4.9	0.6	0.4	1.8	0.7	0.1	1.6	0.7	0.5	4.3	11.1	0.6	1.1	0.6	6.2	6.3	13.6	3.0	1.9	172.4	0.4	0.5	0.7	0.2	1.1	0.2	0.6	0.5	5.0	0.3	0.5	0.2	0.3	1.0	12.1	3.1	4.6	1.8	3.6	46.5	1.0	3.2	45.9	0.5	0.2	3.5	1.9	0.0	0.0	1.4	17.2	1.8	36.4	1.8	0.0	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.7	0.5	0.4	0.5	0.6	0.5	1.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	697.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	90.5	23.9	0.1	0.2	0.3	0.0	0.0	0.0	0.0
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 16.6;skin 1: 10.5"	"Group enriched"	"Detected in some"	7	"Basal glandular cells: 2.1;Basal keratinocytes: 2.5;Cardiomyocytes: 2.6;Intestinal endocrine cells: 1.7;Spermatocytes: 4.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 36.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nuclear bodies"	Nucleoplasm	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.2	0.2	3.4	0.2	0.9	0.2	0.6	16.6	2.4	0.3	0.3	0.4	0.5	0.3	0.2	1.4	2.5	0.2	0.3	0.2	7.1	9.1	0.2	0.2	0.9	0.2	4.1	1.5	0.2	0.2	0.2	0.1	0.5	16.3	0.7	0.4	1.0	0.4	0.7	0.6	10.5	0.3	0.2	3.1	0.2	1.0	1.6	0.6	0.0	0.2	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	16.6	2.4	7.1	9.1	4.1	1.5	16.3	0.6	0.0	0.0	0.0	2.1	2.5	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	4.9	1.5	1.9	0.0	0.0	0.0	0.3
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976498-116070054	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.6;brain: 27.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 10.7;Cone photoreceptor cells: 9.8;Kupffer cells: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.1;hTERT-HME1: 27.9;NB-4: 15.2;THP-1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Uncertain					NA	NA					"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	2.9	4.5	7.0	3.2	14.1	34.6	2.3	8.6	11.1	2.6	2.1	27.8	0.7	1.7	1.9	2.2	5.5	2.4	2.9	6.1	9.9	8.0	4.9	1.3	6.3	1.7	20.0	8.1	2.0	4.2	7.5	4.5	2.9	15.1	2.8	2.7	2.5	4.6	2.7	0.8	11.8	1.7	1.7	14.1	3.5	4.8	1.8	17.6	0.0	4.0	0.8	1.9	2.5	4.6	0.5	0.3	3.9	2.9	0.2	0.0	0.3	1.6	0.1	1.2	0.0	2.2	2.7	0.8	2.7	3.9	1.6	2.9	0.0	0.3	1.8	2.9	1.3	1.4	2.5	2.0	5.5	1.6	0.0	1.3	1.8	1.9	0.2	7.3	2.7	2.5	2.7	21.1	0.0	27.9	0.1	0.0	0.0	0.1	0.0	2.7	1.5	0.0	15.2	1.7	1.5	1.3	0.0	0.0	0.0	2.3	0.9	1.3	1.1	4.6	0.9	7.8	1.9	0.2	16.5	0.0	2.9	1.6	0.5	0.6	2.8	2.6	0.2	3.1	4.5	4.6	1.0	2.5	0.9	0.0	0.7	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	3.9	0.2	2.9	0.0	0.0	0.3	7.0	14.1	8.6	11.1	9.9	8.0	20.0	8.1	15.1	17.6	0.0	10.7	0.8	2.9	2.5	2.1	7.5	0.0	4.0	2.3	5.2	9.8	0.5	1.7	1.1	0.6	0.0	0.0	0.0	0.3	0.3	1.3	0.8	1.1	0.0	2.9	7.9	8.1	1.3	8.6	0.0	0.9	5.9	1.7	1.0	0.2	0.8	1.7	0.2	0.4	0.1	2.0	0.0	1.0	0.2	0.2	2.6	0.0	0.5	0.4	0.9
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.9;skin 1: 8.7"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 41.7;Alveolar cells type 2: 51.9;Ciliated cells: 24.1;Club cells: 33.0;granulocytes: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 15.7;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039551			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039551: AB_2676565"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.3	0.0	0.3	2.7	0.3	0.8	0.5	0.3	0.3	2.8	2.1	0.3	0.3	0.2	0.3	0.3	9.9	0.0	0.3	0.3	0.3	0.2	2.0	3.1	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	2.2	0.3	1.1	1.8	0.3	1.3	0.7	0.6	8.7	3.4	0.3	0.3	0.3	0.4	0.7	0.3	0.3	0.3	2.5	1.7	2.1	4.2	2.6	1.3	5.5	1.2	4.4	0.7	0.0	3.4	0.1	0.8	0.6	0.1	0.0	5.3	0.6	0.2	0.0	0.0	0.3	1.3	2.1	15.7	0.1	0.3	2.9	0.1	0.1	0.1	0.7	0.1	0.9	0.4	2.8	0.0	0.9	0.5	0.0	0.4	0.1	0.3	0.1	0.0	0.5	0.9	2.4	0.0	0.3	0.5	0.5	2.2	0.7	1.0	0.8	0.8	0.4	0.6	15.1	0.5	0.8	2.4	2.0	0.6	2.5	2.5	0.4	0.5	1.0	2.5	0.7	0.6	2.3	4.0	1.0	0.5	0.3	1.0	2.6	1.2	0.3	0.6	0.6	0.5	0.8	0.4	0.5	0.3	2.6	0.7	0.7	5.5	4.4	0.7	1.3	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	41.7	51.9	0.0	2.3	0.6	0.0	0.4	0.0	24.1	33.0	3.5	0.0	3.8	1.7	0.0	0.1	0.0	0.7	0.0	0.2	0.5	0.0	0.7	16.3	0.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.5	11.4	0.0	1.0	0.6
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 195.4;parathyroid gland: 194.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 917.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 254.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		380000			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	17.4	25.6	22.4	16.2	40.3	10.5	26.9	74.2	67.4	17.8	121.9	14.2	56.1	92.3	13.1	38.3	34.9	17.7	65.8	41.1	26.1	18.7	162.7	34.6	35.1	9.6	19.2	27.6	17.4	78.6	194.4	25.0	19.2	34.1	22.1	65.7	24.1	84.4	53.7	19.0	40.5	195.4	17.7	20.7	13.7	25.0	17.0	13.9	9.1	101.2	13.7	16.2	14.2	23.1	10.3	22.0	6.4	29.7	10.4	30.2	17.2	33.7	12.4	12.9	6.5	26.0	25.3	66.6	20.2	40.3	24.9	35.4	49.8	24.2	26.7	28.6	23.9	25.3	44.1	25.5	42.6	36.3	9.8	28.3	15.5	23.5	42.0	19.9	38.9	21.9	28.1	71.5	29.0	38.3	35.2	30.5	16.3	25.6	25.8	22.0	67.0	15.7	14.1	30.4	53.6	25.0	15.2	30.3	23.6	90.1	34.8	12.7	11.2	31.4	59.6	254.2	33.2	15.7	22.6	26.9	14.2	19.9	36.7	40.9	12.5	9.7	20.5	43.6	22.5	83.4	6.4	13.3	6.1	23.2	20.9	24.8	10.3	26.4	24.9	22.0	5.3	30.2	22.0	1.6	10.4	29.7	11.1	20.3	17.2	22.4	40.3	74.2	67.4	26.1	18.7	19.2	27.6	34.1	13.9	256.1	246.7	58.7	265.3	245.9	76.0	62.7	540.1	113.8	203.6	731.0	375.0	70.1	316.7	432.8	25.0	117.9	917.6	93.5	278.3	130.8	110.9	297.5	43.8	66.4	114.8	96.9	169.4	90.9	77.6	11.5	109.0	130.5	197.4	47.7	304.0	513.0	192.4	264.8	94.7	289.6	141.6	32.3	179.2	17.9	27.5	235.0	56.5	95.6	365.5	236.0
CD58	LFA3	ENSG00000116815	"CD58 molecule"	P19256	1	116514535-116571039	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Macrophages: 115.4;monocytes: 225.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.3"															NA	NA		7100000				"unprognostic (4.48e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.32e-6)"	"unprognostic (9.84e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.17e-2)"	"unprognostic (9.66e-2)"	21.5	9.6	5.9	17.6	8.7	29.9	15.2	2.2	7.7	15.8	24.7	5.9	10.4	17.0	12.4	15.3	22.1	11.0	19.2	23.9	7.3	4.8	32.8	11.0	22.4	14.5	9.6	3.7	6.5	6.6	6.5	12.0	10.0	9.3	9.4	17.9	6.4	18.4	15.3	8.8	14.9	48.3	16.3	11.5	23.1	11.1	6.5	8.8	9.3	12.0	22.9	18.2	15.4	16.2	6.0	12.4	47.3	17.1	4.9	17.8	9.5	11.8	6.8	5.0	4.8	8.5	14.3	3.1	6.1	10.6	10.6	10.4	3.0	23.0	2.1	11.3	10.6	12.4	15.4	3.7	10.4	11.3	11.6	4.3	10.7	12.5	4.2	5.4	14.7	14.9	3.9	14.2	8.8	7.9	22.7	6.1	2.8	9.4	46.3	6.4	21.3	6.3	11.2	2.5	17.6	7.5	12.5	17.0	2.8	21.3	9.7	1.7	3.5	12.2	9.1	34.2	5.4	4.7	5.5	11.2	7.7	5.9	10.3	15.5	7.0	12.4	1.4	17.7	7.3	38.0	28.7	14.7	24.4	11.5	14.2	7.9	6.0	10.1	9.5	12.4	2.1	1.4	5.8	47.3	4.9	17.1	1.4	17.8	9.5	5.9	8.7	2.2	7.7	7.3	4.8	9.6	3.7	9.3	8.8	8.9	36.4	11.5	12.8	16.3	0.0	24.6	30.6	33.5	22.7	14.0	0.0	3.6	3.3	34.2	1.7	27.4	41.0	23.3	24.6	1.6	16.2	13.6	49.9	7.8	57.7	1.6	10.4	22.1	34.3	2.1	9.8	115.4	11.8	225.4	14.5	3.9	30.7	42.1	11.0	23.7	0.5	32.3	25.9	3.0	1.4	24.3	1.6	30.5	16.3	33.1
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.5;WM-115: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.4	1.5	1.9	1.2	5.1	0.1	7.7	2.5	8.3	5.8	5.7	1.5	3.0	6.7	2.5	6.5	22.0	1.7	3.5	7.9	1.8	2.8	10.7	0.8	7.4	0.3	1.8	2.8	0.7	4.5	1.4	2.7	42.9	4.1	5.1	5.1	7.8	9.3	5.5	1.1	16.1	12.9	2.4	1.7	0.5	7.3	3.6	0.9	6.2	8.1	9.0	9.3	8.2	9.8	0.0	0.2	0.3	0.6	0.0	0.7	0.2	5.4	9.3	7.2	1.8	1.6	3.5	19.3	0.0	0.2	0.7	0.2	5.3	3.1	0.0	2.9	0.0	4.0	15.2	3.2	7.5	0.3	62.5	2.3	2.9	3.6	0.1	0.0	0.2	5.7	0.4	5.9	0.0	1.3	1.3	0.0	1.0	0.9	0.0	0.1	19.1	0.2	0.1	4.5	3.3	0.2	2.2	8.8	0.0	5.5	6.8	4.2	12.8	2.2	21.5	13.7	14.4	7.2	0.3	0.0	1.2	4.3	0.0	5.6	0.0	0.3	0.0	0.5	0.1	60.3	0.0	0.6	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	1.9	5.1	2.5	8.3	1.8	2.8	1.8	2.8	4.1	0.9	14.9	25.2	0.0	7.0	17.4	1.9	14.4	12.7	8.1	5.7	14.0	0.0	10.1	3.3	13.2	1.8	2.1	14.7	0.0	1.7	24.6	6.6	7.2	1.1	0.0	1.9	6.4	2.9	1.8	1.6	2.1	1.1	0.9	8.5	5.4	5.5	12.8	11.2	8.6	0.0	11.3	0.5	0.0	2.1	0.5	4.3	24.2	11.1	0.0	7.1	9.6
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754385-116769228	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 101.7;lymphoid tissue: 164.4"	"Cell type enriched"	"Detected in many"	11	"T-cells: 299.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 44.4;MAIT T-cell: 42.5;memory CD4 T-cell: 65.3;memory CD8 T-cell: 74.2;naive CD4 T-cell: 34.2;naive CD8 T-cell: 52.4;NK-cell: 101.7;T-reg: 62.3"	"Group enriched"	"Detected in many"	9	"NK-cells: 101.7;T-cells: 74.2"	"Group enriched"	"Detected in some"	24	"HDLM-2: 58.9;JURKAT: 39.9;MOLT-4: 43.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in some"			"CAB002430, HPA003883"	Enhanced					NA	NA					"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	3.0	1.1	0.6	14.5	0.5	2.4	1.7	0.5	0.6	2.9	6.0	0.6	0.6	4.8	1.7	2.1	3.8	3.1	4.8	1.4	0.6	0.6	3.3	2.5	8.1	33.0	1.2	0.6	1.9	1.6	0.0	1.0	1.0	1.0	2.9	4.7	2.3	4.1	1.3	1.0	1.2	18.8	0.9	1.8	28.8	6.5	1.1	0.8	164.4	3.5	3.4	30.8	7.7	2.7	0.3	9.3	1.4	0.5	101.7	74.2	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.9	0.0	0.1	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.1	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.5	0.1	44.4	0.3	42.5	0.3	65.3	74.2	9.3	0.2	34.2	52.4	1.4	101.7	0.2	2.0	62.3	45.9	0.6	0.5	0.5	0.6	0.6	0.6	1.2	0.6	1.0	0.8	3.0	27.0	1.5	0.4	4.4	0.0	0.8	0.0	0.0	4.5	3.5	0.0	0.0	0.0	0.0	13.2	2.4	0.0	0.0	0.0	0.0	2.1	0.1	4.7	0.9	0.7	0.0	2.9	9.8	7.0	4.0	0.6	8.7	1.7	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	4.7	0.2	0.2	3.1	0.0	299.5	0.1	0.1
PTGFRN	"CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6"	ENSG00000134247	"Prostaglandin F2 receptor inhibitor"	Q9P2B2	1	116910057-116990358	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 58.7;Cardiomyocytes: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.3;U-87 MG: 46.2;WM-115: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017074	Approved					NA	NA		86000			"HPA017074: AB_1855888"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-2)"	6.9	14.9	3.7	8.4	4.7	0.0	6.3	1.2	6.6	17.1	26.2	2.5	10.1	6.5	23.9	10.7	23.5	17.8	20.5	29.5	3.0	2.6	3.4	5.3	4.4	1.7	2.8	6.1	15.6	17.1	4.0	3.5	24.6	3.2	13.3	13.2	8.1	13.3	15.0	2.4	12.4	15.3	27.8	3.0	2.5	8.7	6.3	2.2	2.8	5.9	13.5	9.7	15.2	15.3	0.0	3.0	0.0	1.1	0.3	0.9	0.3	11.8	3.1	5.7	13.2	1.0	2.6	0.8	0.8	1.3	4.8	1.8	2.1	2.6	0.0	11.2	3.2	3.9	21.2	12.7	22.7	3.0	0.1	7.7	0.8	7.7	3.3	0.3	0.0	1.2	11.9	20.6	0.6	11.4	6.8	9.2	1.3	4.8	0.0	7.2	15.1	0.0	1.6	6.6	1.0	0.0	0.0	31.3	0.0	16.0	9.8	2.8	6.5	24.4	17.3	6.8	10.5	15.0	3.7	23.6	7.0	10.6	11.5	7.5	0.0	0.0	0.0	46.2	0.0	34.2	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.7	0.3	3.7	4.7	1.2	6.6	3.0	2.6	2.8	6.1	3.2	2.2	3.0	5.1	0.0	9.1	58.7	4.4	78.3	12.7	5.3	4.5	3.5	0.0	0.4	1.7	26.5	4.7	10.6	12.9	0.0	27.4	4.1	12.5	11.3	0.0	10.4	3.7	0.0	13.4	2.5	6.7	4.0	17.8	3.4	8.5	4.6	21.7	1.3	25.1	3.5	28.3	0.7	0.1	19.4	12.1	0.5	5.7	39.5	0.7	0.5	23.3	12.6
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036476	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;lung: 17.5"	"Cell type enhanced"	"Detected in some"	9	"Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 33.7"	"Group enriched"	"Detected in many"	17	"dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 25.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria		NA	NA		42000	Mitochondria		"HPA049527: , HPA057763: AB_2683519"	"unprognostic (1.25e-1)"	"unprognostic (7.95e-3)"	"unprognostic (5.40e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-2)"	"unprognostic (7.15e-6)"	"unprognostic (7.00e-2)"	"unprognostic (8.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.28e-2)"	0.9	1.7	0.8	11.3	1.1	5.7	0.8	0.2	1.1	1.3	5.0	0.6	1.2	4.6	1.7	0.4	1.8	1.5	1.4	2.6	1.1	0.5	1.3	0.8	17.5	4.0	1.3	0.2	1.0	2.3	0.0	0.8	0.5	1.1	1.6	3.2	0.7	2.1	1.3	0.5	1.8	10.9	1.6	2.0	7.8	1.8	0.9	1.2	6.4	0.9	2.4	7.4	2.4	1.8	0.1	12.2	33.7	17.4	0.0	1.2	2.5	0.4	0.0	0.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.2	1.9	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.0	0.1	25.3	0.3	1.3	0.0	0.1	0.2	0.2	0.5	0.1	0.6	0.1	1.5	0.0	2.9	0.8	0.0	0.0	0.0	0.5	0.0	0.6	0.7	0.4	0.6	0.4	0.5	0.3	0.6	0.9	0.6	0.5	0.1	0.4	0.5	0.2	0.2	0.1	0.0	0.7	1.9	1.5	0.0	7.6	33.7	0.1	10.0	0.7	0.1	0.2	1.2	12.2	0.0	0.3	1.2	0.3	0.0	17.4	0.0	1.1	2.5	0.8	1.1	0.2	1.1	1.1	0.5	1.3	0.2	1.1	1.2	0.0	1.4	0.5	0.1	1.1	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.5	0.0	0.2	0.1	1.1	0.4	0.7	0.0	1.7	0.0	6.2	1.3	0.3	7.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.2	0.0	0.0	1.4	0.0	4.6	0.1	0.1
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060303-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005776, HPA070762"	Approved		Supported	Cytosol		NA	Yes			Cytosol		"HPA005776: AB_1080416, HPA070762: AB_2686307"	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	5.7	9.4	5.4	8.5	8.4	6.6	6.0	0.9	5.2	5.9	7.0	8.4	2.6	6.0	5.9	2.3	9.8	4.5	3.9	5.8	4.6	3.8	3.9	3.1	4.7	11.5	12.0	2.1	5.5	5.5	6.7	10.7	4.9	7.2	5.0	8.1	4.2	6.5	3.6	8.4	6.9	5.7	6.8	7.7	6.8	5.4	6.3	8.0	25.1	5.2	7.8	17.8	6.4	6.5	3.7	5.9	3.2	6.3	5.3	6.1	2.5	12.7	4.7	9.5	13.4	3.8	3.3	11.9	6.8	3.2	10.1	9.0	6.6	2.2	15.5	10.6	4.5	11.3	13.3	16.8	8.8	15.6	11.9	11.8	13.2	9.1	8.3	2.7	19.3	15.3	3.8	3.4	7.4	13.9	2.5	6.8	12.3	10.1	14.2	7.6	19.5	12.8	12.0	14.9	12.2	9.5	18.5	35.1	6.8	6.1	5.8	8.2	3.4	10.3	10.3	3.8	7.6	5.6	7.9	6.9	6.4	13.6	15.0	14.8	6.5	5.6	19.1	4.3	14.7	25.6	1.8	5.2	3.2	3.0	6.3	2.9	3.7	3.5	4.7	5.9	3.5	3.6	4.1	0.9	5.3	3.6	3.3	6.1	2.5	5.4	8.4	0.9	5.2	4.6	3.8	12.0	2.1	7.2	8.0	6.0	5.4	18.8	8.6	11.7	5.7	5.6	5.1	4.0	6.8	12.2	7.9	5.8	5.0	5.8	5.9	7.2	5.9	0.0	6.9	7.2	5.2	10.8	9.2	2.5	9.7	11.1	4.7	4.9	5.6	5.4	6.1	12.0	6.8	24.4	7.5	5.3	6.7	2.9	3.9	2.7	6.4	0.0	10.3	6.6	9.3	12.5	3.2	8.7	11.0	15.2
TRIM45	"FLJ13181, RNF99"	ENSG00000134253	"Tripartite motif containing 45"	Q9H8W5	1	117111060-117122587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 8.9;Cardiomyocytes: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030266, HPA054308"	Uncertain		Supported	"Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Cytokinetic bridge"	"HPA030266: AB_10795476, HPA054308: AB_2682445"	"prognostic favorable (1.58e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.27e-2)"	2.3	5.4	6.3	1.4	3.6	1.9	4.9	2.4	7.2	3.4	4.5	5.8	8.0	3.8	9.0	8.0	3.3	9.4	9.3	12.4	3.9	2.6	3.8	1.1	2.6	0.9	2.6	7.5	8.5	8.9	7.3	8.8	9.4	4.5	8.3	2.3	6.0	3.4	7.4	26.6	5.9	3.1	13.3	3.4	2.4	6.1	5.4	4.1	0.7	9.9	9.0	2.1	6.3	4.5	0.4	0.7	0.6	0.4	2.8	2.2	0.0	3.2	2.9	12.1	5.7	1.0	2.8	9.2	3.6	1.5	2.5	2.5	1.3	2.9	0.1	2.7	1.7	2.7	2.9	2.8	2.9	3.4	1.8	2.9	1.9	8.9	1.5	1.8	1.7	2.8	3.6	2.9	4.2	3.0	4.7	3.1	3.5	2.3	2.4	2.3	14.0	1.0	2.1	6.6	1.8	2.6	4.6	24.0	0.7	3.4	2.9	9.2	2.4	2.9	2.7	2.2	12.0	4.7	2.3	1.0	3.5	5.1	2.1	3.1	6.8	2.5	0.2	4.6	1.6	9.0	0.6	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.1	0.7	0.4	0.2	0.2	0.5	2.8	0.1	0.3	2.2	0.0	6.3	3.6	2.4	7.2	3.9	2.6	2.6	7.5	4.5	4.1	8.9	2.4	0.0	1.8	1.0	1.7	11.2	2.5	1.4	2.3	1.8	3.9	2.2	1.7	1.5	4.1	1.4	0.1	0.0	2.8	1.2	1.5	0.4	0.0	0.0	0.7	1.6	1.7	2.5	0.8	1.9	1.7	0.0	0.0	0.0	0.9	1.7	2.1	0.0	1.8	0.2	1.3	0.0	1.7	6.3	4.3	1.4	0.9	0.0	0.9	0.7
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 74.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA			"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	74.4	0.0	9.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.2	0.0	4.0	10.3	52.4	0.0	1.7	0.0	73.6	1.6	0.0	0.0	0.0	31.1	1.1	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.9
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.4	6.3	10.8	9.3	14.2	17.1	34.6	12.0	18.8	5.4	5.1	4.8	8.3	10.8	22.3	15.4	5.1	8.6	5.0	10.2	12.2	13.5	7.6	6.4	8.9	5.3	8.6	10.0	14.8	11.5	11.0	8.3	7.3	10.0	16.1	7.6	10.3	16.7	11.3	28.1	6.1	3.2	5.5	7.3	6.6	5.5	23.5	7.4	7.5	19.7	5.9	8.6	11.9	12.8	9.4	14.7	6.3	6.4	15.3	12.2	10.1	8.6	12.2	11.4	7.7	7.3	16.2	8.0	29.0	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4	35.7	30.2	42.7	29.6	27.5	59.3	85.6	35.7	42.8	40.9	41.8	21.6	40.9	14.9	26.4	27.9	33.3	25.6	23.3	52.0	201.3	31.7	37.6	15.1	78.0	25.6	41.3	20.8	34.4	30.7	15.9	49.8	22.8	38.8	12.6	32.4	40.2	36.9	21.0	61.5	21.5	39.0	38.8	29.1	63.9	52.5	30.2	318.2	30.5	26.4	37.2
FAM46C	FLJ20202	ENSG00000183508	"Family with sequence similarity 46 member C"	Q5VWP2	1	117605934-117628372	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 114.0"	"Group enriched"	"Detected in many"	9	"Early spermatids: 418.3;Late spermatids: 1175.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 16.3"	"Group enriched"	"Detected in many"	17	"B-cells: 9.7;granulocytes: 16.3;T-cells: 9.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 74.8;RPMI-8226: 44.6;U-266/70: 20.8;U-266/84: 17.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054049	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054049: AB_2682356"	"unprognostic (3.76e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.24e-3)"	"prognostic favorable (3.75e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (6.26e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.10e-2)"	3.2	1.8	1.2	24.5	1.1	28.9	4.4	1.1	1.1	8.1	16.1	1.8	8.4	5.6	4.8	16.6	6.9	3.3	9.7	6.4	1.2	1.1	5.0	5.5	11.2	16.3	1.2	0.1	8.3	114.0	7.2	5.3	10.6	3.9	6.4	9.5	4.4	37.8	11.9	10.0	1.8	10.6	4.7	1.4	19.1	12.2	34.0	0.2	1.5	10.3	10.9	37.0	9.5	8.6	9.7	0.2	16.3	0.0	0.6	9.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	6.7	0.1	0.0	0.4	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	4.2	0.4	9.2	0.0	0.0	0.0	5.4	11.9	0.0	0.0	0.1	0.0	0.0	0.0	2.5	1.2	74.8	0.0	0.9	0.0	5.5	0.9	1.1	0.6	0.0	0.0	44.6	0.0	0.9	0.5	0.0	0.4	0.6	0.4	0.1	0.4	0.0	0.1	0.0	0.5	0.0	0.1	20.8	17.2	0.4	0.4	1.9	0.6	16.3	0.0	10.5	2.5	0.0	2.2	9.7	2.5	3.1	0.0	8.0	0.3	1.4	1.1	0.6	0.0	0.2	9.2	2.1	1.2	1.1	1.1	1.1	1.2	1.1	1.2	0.1	3.9	0.2	6.0	42.9	52.6	7.5	7.6	0.0	0.0	5.1	21.4	36.4	0.0	0.0	1.9	0.0	0.0	418.3	2.8	12.0	93.5	0.0	2.0	7.3	6.6	7.0	4.3	1.1	0.0	19.0	0.0	1.5	1175.9	13.3	2.0	45.5	0.0	35.3	1.1	0.0	8.6	8.5	0.0	0.0	6.5	9.2	12.5	8.5	5.6	1.8	32.0	26.4	7.9
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929630	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	12.1	9.7	9.3	10.2	10.8	18.9	11.3	12.9	12.7	10.7	10.5	10.7	13.1	11.1	10.4	12.9	12.7	7.6	9.2	9.5	8.6	7.3	13.5	14.5	15.3	13.9	11.7	8.8	10.6	15.2	17.1	12.3	11.8	11.5	10.3	12.6	9.7	12.8	10.5	7.8	11.0	13.3	12.0	8.8	12.7	11.8	12.6	10.7	13.0	13.1	6.2	11.9	12.3	12.9	2.7	7.0	13.1	7.8	4.2	4.4	3.3	8.6	4.9	6.0	5.0	6.5	3.1	8.9	5.1	6.6	10.2	9.9	5.2	6.0	3.4	6.2	6.8	7.8	5.2	7.9	6.6	12.6	6.8	4.6	5.1	6.8	5.6	7.9	6.3	6.6	2.5	8.4	12.8	9.9	4.6	6.7	7.8	5.3	7.5	8.4	9.0	5.6	5.2	10.4	6.6	8.6	3.0	16.5	5.0	5.8	8.8	4.5	5.0	6.1	10.5	8.0	19.0	3.6	6.5	4.1	7.3	8.6	8.4	6.8	7.8	5.6	4.8	9.4	4.6	8.9	9.6	7.4	13.1	2.8	7.8	4.4	2.7	3.1	3.3	7.0	2.7	2.9	2.8	7.1	4.2	7.6	1.6	4.0	3.3	9.3	10.8	12.9	12.7	8.6	7.3	11.7	8.8	11.5	10.7	8.9	7.5	8.2	5.5	11.9	13.4	6.3	5.1	6.7	9.1	3.5	17.7	10.7	6.6	9.4	13.4	7.3	13.1	0.0	5.5	9.5	6.2	9.8	0.0	7.8	11.8	14.3	4.1	6.2	16.1	2.2	5.5	13.5	10.1	5.4	9.9	9.7	9.0	7.2	6.7	8.8	13.2	0.0	8.3	30.5	10.4	12.0	17.6	6.9	7.0	8.2
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.2	9.7	9.7	14.8	10.6	8.7	11.2	10.7	7.0	12.5	11.0	10.2	5.1	18.1	14.7	7.9	8.0	10.3	24.1	12.3	19.9	14.9	12.5	17.0	10.4	8.2	8.7	31.8	9.0	8.5	8.9	15.8	24.0	7.4	11.9	12.8	20.7	8.9	10.9	8.8	15.1	7.3	35.0	13.4	15.6	14.5	33.7	13.8	6.2	10.2	15.0	13.7	12.2	15.1	17.3	14.1	6.0	13.3	10.5	9.4	15.0	17.1	23.9	13.1	15.3	28.4	13.8	20.6	24.2	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9	8.9	11.0	9.2	10.8	18.5	9.6	14.0	5.1	25.4	33.0	7.0	5.9	9.2	8.3	8.4	28.6	11.7	2.7	0.0	11.8	7.5	9.5	8.9	15.1	25.5	7.2	14.3	3.5	11.6	6.3	34.2	11.5	7.4	10.1	2.8	5.1	6.5	10.6	3.5	11.0	6.0	6.4	12.9	14.6	25.9	60.1	19.6	4.2	5.7	9.4	7.7
SPAG17	"CT143, FLJ34497, PF6, RP4-776P7.2"	ENSG00000155761	"Sperm associated antigen 17"	Q6Q759	1	117953861-118185223	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;epididymis: 16.3;testis: 24.7"	"Cell type enhanced"	"Detected in many"	20	"Ciliated cells: 444.4;Early spermatids: 203.6;Late spermatids: 292.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 24.1"	"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;HMC-1: 1.5;RT4: 2.7;SCLC-21H: 3.1;SuSa: 2.8;U-2 OS: 1.1"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 12.2"	"HPA028597, HPA028666"	Enhanced					NA	NA					"HPA028597: AB_10600221, HPA028666: AB_10602281"	"unprognostic (3.67e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-5)"	"unprognostic (4.81e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.67e-2)"	0.8	0.1	1.4	0.2	5.6	0.2	1.3	0.0	0.2	2.0	0.2	7.4	2.2	0.2	0.9	16.3	8.6	11.8	0.7	0.2	2.6	3.0	3.0	0.1	6.1	0.1	0.1	0.3	7.8	0.7	0.3	9.2	0.3	24.1	0.2	0.2	0.6	0.3	0.4	0.5	0.3	0.2	0.2	0.4	0.2	0.9	24.7	1.5	0.0	1.4	0.1	0.8	2.1	2.7	0.0	1.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.7	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.7	3.1	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.6	0.0	0.2	2.6	3.0	0.1	0.3	24.1	1.5	6.0	3.8	0.0	0.1	0.3	0.4	0.6	0.0	444.4	78.5	10.4	31.4	1.7	1.7	0.4	203.6	0.1	0.0	0.0	0.6	0.5	0.6	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	292.1	1.4	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.1	0.6	0.0	0.0	0.1	43.2	5.6	0.3	0.6	0.0	0.0	0.7
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 6.3;Hepatocytes: 11.3;Melanocytes: 6.8;Smooth muscle cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.2;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.8;fHDF/TERT166: 14.4;HSkMC: 20.3;RH-30: 15.3;U-2197: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	28.2	12.0	0.0	2.4	3.3	6.4	10.8	0.0	0.0	0.0	1.4	14.4	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	20.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.1	1.2	0.0	0.1	0.0	15.3	0.2	1.6	0.7	0.3	0.0	0.8	0.0	0.3	0.3	0.0	0.3	0.0	3.5	2.1	14.3	0.1	0.2	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.1	1.8	0.0	0.0	0.0	0.0
WARS2	TrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140671	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028007, HPA069692"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028007: , HPA069692: AB_2686172"	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favorable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	17.3	16.7	6.8	11.7	8.3	2.8	14.6	7.5	8.7	12.9	11.2	7.7	7.6	12.3	13.5	10.4	13.4	14.9	8.8	12.1	6.2	6.1	15.3	14.9	9.2	12.4	6.4	6.1	14.7	17.8	15.1	12.3	14.9	8.3	14.1	12.7	11.3	10.5	10.4	12.2	10.0	13.1	9.0	5.4	9.9	11.2	6.9	6.1	11.6	12.8	13.2	14.2	14.3	10.4	7.2	9.0	0.5	6.9	5.3	7.4	4.9	10.3	4.5	6.1	6.4	7.8	17.6	6.6	5.8	8.3	6.1	7.3	11.3	4.7	15.2	9.5	9.3	3.7	7.0	10.9	9.9	9.4	8.2	14.2	7.2	12.1	10.8	15.9	11.6	4.1	13.4	7.7	8.9	16.3	8.1	9.1	6.7	11.2	11.1	11.3	12.0	6.9	6.7	8.2	7.8	9.3	5.1	20.2	7.7	16.7	14.5	9.0	5.5	9.1	12.7	13.1	11.2	5.6	9.1	6.9	6.7	8.0	12.5	11.0	5.4	3.6	6.7	8.2	9.8	12.3	0.0	6.9	0.5	5.1	4.9	7.4	6.6	5.4	6.7	9.0	7.2	6.5	6.2	0.3	5.3	3.0	4.5	6.0	4.9	6.8	8.3	7.5	8.7	6.2	6.1	6.4	6.1	8.3	6.1	8.9	10.5	8.8	16.5	8.5	6.3	9.2	7.6	16.0	10.3	10.4	5.9	14.1	14.9	9.0	52.2	6.8	5.2	0.0	10.3	13.0	10.8	11.7	8.1	7.3	8.4	6.4	6.4	1.8	7.3	24.7	9.2	6.3	10.1	15.4	9.5	4.9	9.1	3.5	7.8	12.6	7.7	6.5	9.5	3.5	5.9	9.4	16.7	6.4	14.6	11.3
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 65.1;liver: 90.2"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 210.7;Proximal tubular cells: 261.6"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BJ hTERT+: 1.2;HL-60: 2.0;SiHa: 1.5;U-698: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050355			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA050355: "	"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	65.1	90.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.7	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.3	0.5	0.0	0.6	0.8	2.0	0.4	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.8	0.2	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	2.5	0.0	0.0	10.4	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	210.7	0.1	0.0	0.0	3.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	1.9	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 36.4;SuSa: 16.3"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.0	0.4	0.5	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	115.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.8	0.0	0.0	0.0
ZNF697	MGC45731	ENSG00000143067	"Zinc finger protein 697"	Q5TEC3	1	119619422-119647773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 24.8;WM-115: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049933	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049933: AB_2680958"	"unprognostic (2.57e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.20e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.36e-1)"	6.1	4.1	4.5	1.7	5.2	1.0	5.0	1.6	6.9	2.0	2.8	0.7	3.5	2.1	3.1	3.4	1.2	2.0	2.0	6.3	1.8	1.2	11.1	5.3	6.5	0.6	2.1	6.6	3.3	7.3	4.2	6.4	9.7	3.8	6.2	1.9	1.0	10.8	1.3	2.9	2.3	1.9	4.4	1.5	2.3	2.5	5.0	1.2	0.5	4.6	2.2	0.7	2.4	1.5	0.0	0.6	0.3	1.5	0.0	0.1	0.3	1.1	0.6	3.0	1.0	4.0	4.5	4.1	5.3	7.4	3.1	2.9	1.8	0.2	0.0	1.8	2.9	2.4	1.3	2.3	5.2	7.4	0.0	2.3	1.9	1.1	3.5	7.7	1.2	1.3	7.5	1.5	7.0	15.0	3.4	6.1	1.7	1.7	0.2	1.4	0.9	0.0	0.9	15.9	1.0	1.7	0.0	7.3	0.1	1.4	2.7	0.6	4.1	1.2	1.3	24.8	9.9	0.6	1.8	14.0	5.2	6.6	3.6	9.1	0.7	1.1	0.0	7.4	1.4	25.4	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	4.5	5.2	1.6	6.9	1.8	1.2	2.1	6.6	3.8	1.2	0.0	0.3	0.0	1.5	1.9	0.9	8.6	0.0	0.0	2.3	1.8	0.0	6.5	3.3	1.7	1.3	3.5	1.0	0.0	0.7	1.7	4.8	4.5	0.0	3.0	2.3	0.0	2.4	4.9	6.5	2.2	4.4	2.2	5.0	0.0	2.2	1.9	1.9	2.0	6.0	5.3	0.8	6.5	2.1	0.2	0.4	1.6	16.6	0.0	1.4	0.9
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 99.3"	"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.6	5.6	14.6	35.0	8.4	11.0	27.2	12.3	22.3	17.7	29.3	28.8	2.4	0.0	5.4	33.0	1.9	18.4	27.0	25.7	12.5	0.1	24.6	4.3	19.6	19.9	17.3	27.5	0.1	15.8	43.0	16.9	20.0	9.9	12.7	48.8	7.9	32.6	7.8	53.5	18.4	8.4	36.4	10.6	42.5	16.2	25.3	2.3	1.2	16.2	15.7	14.4	9.0	6.1	99.3	13.9	12.3	47.0	0.1	2.9	15.3	17.9	13.8	26.9	6.7	27.5	35.8	38.5	22.7	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1	3.0	9.3	9.7	92.1	46.0	0.8	2.0	84.1	21.4	7.9	19.2	2.0	32.1	114.4	48.9	40.9	3.3	0.2	0.0	120.7	43.3	25.5	86.4	5.7	90.0	8.0	0.0	1.7	2.5	1.3	81.6	62.7	4.8	54.0	19.0	1.1	79.1	39.9	2.5	120.2	80.4	2.9	12.9	16.0	5.2	3.4	67.4	21.2	5.0	1.5	39.9
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell type enhanced"	"Detected in many"	24	"Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 35.4;RT4: 63.6"	"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria		NA	NA		820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.2	0.2	0.0	63.6	0.0	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3	3.0	6.7	7.5	3.6	0.1	0.0	4.5	68.8	0.0	0.0	29.6	0.0	0.2	0.0	0.0	1.5	0.0	76.1	0.0	0.0	0.1	0.0	10.3	4.6	901.4	0.2	0.0	70.2	16.0	17.8	2.7	1.4	0.0	5.0	0.0	249.3	0.0	0.1	126.7	0.0	0.3	0.0	6.5	0.0	0.5	0.4	0.3	7.9	0.0	248.3	15.4
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794018-119811660	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 55.1;intestine: 121.9"	"Group enriched"	"Detected in some"	14	"Intestinal endocrine cells: 425.3;Mucus-secreting cells: 633.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 18.1"	"Lineage enriched"	"Detected in single"	115	"T-cells: 18.1"	"Cell line enriched"	"Detected in some"	58	"OE19: 350.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	NA	NA		400000			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.2	0.1	0.2	4.2	0.2	0.0	0.2	0.2	0.2	0.2	55.5	0.3	0.2	36.3	0.2	0.2	1.2	0.1	55.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	23.8	0.0	0.2	0.2	0.2	0.6	43.1	0.2	0.6	0.2	0.2	0.1	121.9	0.8	0.2	0.2	2.2	0.7	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	18.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	350.7	6.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	18.1	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	38.0	0.0	0.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	425.3	0.0	0.0	18.8	0.6	0.0	0.0	0.0	633.6	0.0	2.0	28.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	21.8	0.1
ADAM30	svph4	ENSG00000134249	"ADAM metallopeptidase domain 30"	Q9UKF2	1	119893533-119896495	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	301	"testis: 30.0"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 53.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026080	Uncertain					NA	NA					"HPA026080: AB_1844581"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0
NOTCH2		ENSG00000134250	"Notch 2"	Q04721	1	119911553-120069626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	12.0	7.3	6.0	9.4	6.8	4.4	10.6	3.0	5.6	14.5	7.6	4.4	11.3	1.6	12.3	11.8	13.4	11.4	12.8	7.9	6.8	2.3	5.5	11.4	10.6	5.7	5.3	7.6	15.5	27.6	6.1	3.3	10.3	6.5	9.9	5.2	9.4	17.7	10.0	9.3	17.2	6.1	12.4	6.2	11.5	5.8	15.7	4.4	8.0	11.4	8.6	6.6	9.6	13.0	4.2	5.2	7.7	9.6	1.5	1.7	2.0	15.0	5.1	7.9	6.1	33.0	28.3	7.9	11.5	15.9	15.4	16.7	4.7	4.1	0.3	9.7	21.8	13.7	5.7	12.5	10.2	24.6	18.1	8.0	8.7	13.7	0.4	12.3	9.1	2.3	22.7	6.6	46.1	30.7	23.3	7.8	4.1	0.1	19.2	18.5	16.9	3.8	2.6	10.2	1.4	5.7	2.5	27.9	9.7	8.1	9.6	0.3	4.0	15.6	14.7	8.3	16.7	8.1	3.1	27.4	20.1	13.9	30.1	18.0	8.0	3.9	4.4	29.5	8.4	19.1	5.6	6.4	6.4	1.5	6.6	1.7	4.2	1.3	1.1	5.2	3.9	1.0	1.7	7.7	1.5	9.6	4.2	0.8	2.0	6.0	6.8	3.0	5.6	6.8	2.3	5.3	7.6	6.5	4.4	32.8	21.6	24.1	40.5	41.1	3.5	11.2	25.5	2.7	13.6	17.4	5.9	1.2	0.0	37.1	15.7	3.7	3.0	0.0	11.3	6.7	53.5	36.6	15.1	35.0	29.9	3.2	5.8	5.5	68.6	9.3	50.9	36.3	37.1	13.6	7.5	46.7	22.9	129.8	80.2	4.3	10.2	19.4	32.3	4.8	3.6	77.8	1.4	13.6	13.8	52.7
SEC22B	"ERS-24, sec22b, SEC22L1"	ENSG00000265808	"SEC22 homolog B, vesicle trafficking protein (gene/pseudogene)"	O75396	1	120150898-120176515	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB079017		Approved				NA	NA		980000			"CAB079017: "	"unprognostic (2.21e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (4.58e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (5.80e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.15e-1)"	11.9	12.0	7.4	8.9	8.3	6.2	10.3	7.6	10.2	12.3	8.5	8.2	15.5	10.0	11.1	18.3	7.3	7.0	10.1	7.7	6.3		10.7	23.6	8.8	9.2	7.6	9.1	10.1	19.6	11.1	25.6	24.8	8.8	11.8	11.2	9.8	19.4	13.4	8.2	6.7	12.4	9.2	7.2	8.9	10.2	7.1	8.3	10.9	11.4	6.3	9.4	11.1	7.8	12.4	16.1	25.1	16.6	14.5	17.8	10.7	9.9	3.3	6.4	9.9	37.0	26.2	8.4	23.5	19.5	16.6	30.8	5.4	4.3	6.3	11.6	14.8	10.1	4.1	6.0	6.3	22.9	8.0	5.6	7.1	18.7	9.3	21.2	9.6	8.7	25.4	8.2	21.4	11.6	29.1	10.2	8.3	4.6	13.6	22.4	19.3	8.9	5.2	9.2	7.0	8.8	8.4	14.9	7.0	12.7	7.6	6.6	7.1	8.4	12.2	12.4	9.7	6.4	11.2	13.9	22.9	10.9	39.7	15.3	9.4	6.4	9.8	35.3	8.6	25.2	17.4	16.6	14.1	13.3	14.9	17.8	12.4	15.0	13.6	10.0	11.0	15.3	17.0	25.1	14.5	13.1	16.1	11.7	10.7											26.8	35.7	29.7	22.2	0.0	30.0	15.7	43.3	18.7	27.3	40.1	31.4	56.3	94.5	35.1	4.1	27.0	42.5	46.7	34.0	57.8	20.6	54.1	50.7	64.8	44.2	11.1	40.8	36.8	48.0	4.2	46.6	36.7	0.0	32.5	67.3	56.4	32.0	24.6	45.3	46.1	137.0	51.8	24.3	20.0	13.5	0.0	91.4	42.0	36.3	29.4
NBPF26		ENSG00000273136	"NBPF member 26"		1	120723923-120841481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 17.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 50.6;Alveolar cells type 2: 23.7;granulocytes: 15.1;Paneth cells: 23.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in all"		"neutrophil: 17.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 17.7;monocytes: 10.0"	"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.31e-5)"	"unprognostic (9.78e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.65e-1)"	2.7	0.8	2.3	4.3	2.2	2.1	1.8	1.1	2.5	3.2	1.9	1.1	1.1	0.0	3.0	5.6	4.8	2.4	3.1	1.1	1.1		3.5	1.7	2.3	2.0	1.1	1.1	3.6	1.1	1.1	1.1	1.1	2.0	2.5	1.4	1.7	1.6	1.3	1.1	9.9	1.1	6.0	2.4	10.6	0.5	3.4	1.1	1.1	1.8	3.3	1.8	2.0	1.1	3.4	2.8	17.7	10.0	2.4	2.1	1.0	27.0	0.1	8.1	8.9	11.5	9.4	0.6	9.6	4.9	6.0	6.5	5.8	1.0	1.9	9.1	11.1	10.7	8.0	13.1	13.8	8.4	12.8	0.5	18.5	2.9	2.3	5.2	7.6	5.6	5.7	6.0	15.7	17.4	19.4	0.3	4.9	1.5	16.7	15.8	15.1	2.1	12.3	2.9	1.0	11.0	3.0	9.2	4.9	4.7	11.0	0.8	0.5	11.2	16.4	8.4	9.6	0.6	3.4	8.2	7.2	19.2	23.8	7.6	7.4	2.0	7.9	6.8	11.5	1.0	7.7	6.4	7.2	1.9	5.2	1.7	1.2	2.0	1.9	2.8	3.4	1.7	2.1	17.7	2.4	10.0	2.1	1.1	1.0											50.6	23.7	1.4	1.3	0.0	0.6	1.4	0.0	6.7	6.8	0.0	0.0	0.4	3.3	3.5	2.2	0.0	0.0	0.0	2.6	1.7	1.0	0.7	15.1	1.3	0.2	0.0	0.0	1.3	3.7	0.0	6.1	1.8	0.0	1.0	0.6	0.8	3.2	23.2	4.2	0.6	1.6	0.0	0.5	4.3	2.6	0.0	0.3	0.0	2.5	0.4
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.5;intestine: 1.6"	"Cell type enriched"	"Detected in single"	10	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 3.8;NB-4: 4.6;SK-BR-3: 4.7"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.3	0.8		1.0		1.4	0.2		1.2	0.0	0.0			1.6	0.0	0.0	0.0	0.0	0.0	0.1			0.2	1.2	0.0	0.5			0.1	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.2	1.0	0.0		0.4	0.4	0.0			0.0		0.0	0.0		3.0	3.2	0.6	1.6	2.2	2.4	3.5	0.9	0.0	0.1	1.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	1.0	0.7	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.2	3.8	0.3	0.6	1.7	4.6	2.5	0.0	0.0	0.8	1.5	1.9	0.0	0.0	1.0	0.3	0.3	4.7	0.4	0.1	3.1	2.5	0.7	3.0	1.2	2.9	1.7	1.4	0.9	2.5	2.6	1.6	3.2	0.2	1.6	0.6	1.4	1.2	1.4	3.0	2.3	2.4	3.1	2.2	1.5	2.4	0.0	2.2	1.2	3.2	2.4	3.5											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121096310	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;epididymis: 36.9"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 19.2;neutrophil: 21.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NB-4: 10.7;THP-1: 40.9"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	4.2	2.3	6.6	13.2	6.2	3.9	1.3	0.8	3.2	0.8	0.5	3.0	0.2	0.5	0.9	36.9	0.5	0.8	1.5	7.4	5.0	4.2	1.0	1.1	4.8	7.9	8.9	0.2	1.1	1.9	0.4	1.5	8.1	6.4	0.6	0.6	0.4	1.3	0.5	0.2	0.0	0.4	4.2	11.3	6.8	0.5	0.5	6.2	0.4	1.8	0.2	0.4	1.5	0.2	0.0	5.2	21.8	19.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	19.2	0.2	0.0	11.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	21.8	0.0	6.2	0.1	0.0	5.3	6.6	6.2	0.8	3.0	5.0	4.2	8.9	0.2	6.4	6.2	0.0	1.3	0.8	0.0	0.0	0.8	2.0	0.0	0.0	1.2	0.0	2.0	0.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	68.7	3.2	0.0	0.0	38.3	8.2	1.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.4	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.5;lymphoid tissue: 9.3"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 4.7;Spermatocytes: 14.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	1.0	0.8	1.3	4.1	1.0	6.5	0.6	5.1	1.0	0.5	1.0			1.3	0.4	0.2	3.0	0.5	1.0	0.2	1.6	0.9	0.3	0.4	0.8	9.3	1.4		0.4	0.1	1.5	0.1	1.4		0.2	1.3		0.5	0.0	0.0	2.1	1.3	0.7	1.4	3.2	0.9	3.6			0.2		7.9	0.9	0.9	0.8	3.3	0.1	2.4	0.8	1.4	1.1	12.0	4.4	7.4	3.6	0.7	1.1	5.8	6.4	2.7	7.5	6.3	0.1	6.3	26.6	8.9	1.2	7.4	7.5	10.1	3.6	11.6	17.6	7.5	11.5	4.9	5.3	0.4	20.0	10.3	0.6	0.4	5.9	12.0	1.9	4.5	22.2	15.0	16.4	5.4	5.0	10.0	16.5	13.9	6.5	9.1	15.0	15.9	12.2	2.9	1.4	8.0	4.6	4.8	3.8	3.7	7.9	5.0	15.6	1.5	6.2	10.5	12.0	11.3	14.6	18.2	26.3	5.5	21.7	14.3	0.0	2.4	0.0	0.0	0.9	0.0	0.8	0.4	0.5	3.3	0.3	0.0	0.1	0.1	0.8	1.1	0.4	1.4	1.1											0.0	0.0	3.7	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.7	1.0	1.7	0.0	0.2	1.9	0.5	0.0	0.0	0.0	0.9	0.0	0.0	3.1	0.6	1.2	0.6	0.7	0.0	3.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	14.9	3.4	0.9	0.1	1.0	0.4	0.0
SRGAP2C	SRGAP2P1	ENSG00000171943	"SLIT-ROBO Rho GTPase activating protein 2C"	P0DJJ0	1	121184810-121392822	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 16.5"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 50.6;Erythroid cells: 70.0;Ito cells: 64.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 39.8"									HPA078079			Approved	Cytosol		NA	NA			Cytosol		"HPA078079: "	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.48e-6)"	"unprognostic (2.40e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.18e-4)"	"unprognostic (6.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.71e-7)"	"unprognostic (4.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.66e-2)"	4.7	4.5	3.5	2.8	4.4	4.2	2.7	7.8	6.0	3.5	2.0	8.5	3.3	1.0	3.5	1.2	5.4	3.2	3.0	2.9	3.3		4.6	2.9	5.5	2.5	6.3	4.0	4.8	1.1	16.5	4.6	6.5	6.2	2.1	1.7	2.1	1.3	3.2	1.3	10.9	1.7	3.9	6.4	7.0	1.8	1.3	4.7	4.5	2.0	1.9	2.2	3.1	2.7	1.7	4.2	5.2	7.7	1.0	2.3	1.4	5.2	6.9	15.3	3.4	11.9	10.4	8.5	6.0	4.8	5.1	6.7	0.1	5.4	3.3	5.4	8.2	3.7	2.9	5.4	4.4	6.8	4.4	5.5	4.8	12.0	5.3	6.8	3.2	5.7	7.7	4.4	6.5	8.4	5.8	12.1	2.1	4.4	6.3	3.7	3.1	2.0	4.1	4.8	1.7	3.3	3.0	18.0	3.0	4.8	3.1	2.9	1.9	10.4	3.7	18.7	8.3	4.7	9.5	10.7	9.7	9.6	14.4	8.8	3.7	2.6	2.0	8.4	6.6	39.8	0.5	5.9	1.0	1.9	4.6	1.3	1.7	2.3	2.1	4.2	1.7	1.1	1.6	5.2	1.0	7.7	3.8	2.0	1.4											50.6	11.5	9.3	6.2	0.0	12.1	4.9	5.1	16.0	9.1	10.4	2.0	4.6	1.7	9.3	0.4	29.2	0.4	70.0	4.4	18.8	12.7	4.2	5.8	7.2	16.5	0.0	2.4	64.4	41.9	0.9	18.1	16.7	0.0	27.9	2.6	8.4	5.4	0.6	24.1	0.7	4.5	32.3	12.4	4.7	6.8	0.0	2.1	13.4	1.4	3.8
HIST2H3PS2	p06	ENSG00000203818	"Histone cluster 2 H3 pseudogene 2"		1	143905556-143905966	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adrenal gland: 9.1;lymphoid tissue: 7.0;ovary: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 8.6;NB-4: 9.8;SH-SY5Y: 10.4;THP-1: 10.0;U-2197: 7.4;U-87 MG: 5.5"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"																		0.6	9.1	0.5	0.6	0.5	0.0	0.2	1.4	0.3	0.2	0.1			0.1	0.7	0.0	1.4	1.1	1.1	0.3	0.5	0.7	0.0	0.0	0.5	1.3	0.7		8.9	0.7	0.3	0.3	0.0		2.3	0.0		0.5	0.4	0.0	0.3	0.2	1.4	1.5	7.0	4.7	0.9			1.0		0.4	2.4	0.2	1.5	1.0	0.1	3.5	2.4	0.3	0.8	0.0	0.0	0.0	0.0	3.5	0.9	0.0	8.6	1.9	1.7	1.6	0.0	1.2	0.0	1.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	2.1	0.0	3.4	0.0	0.2	2.0	0.0	0.3	0.0	0.0	0.0	0.0	9.8	0.0	1.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.4	0.0	3.1	0.0	0.0	0.0	10.0	0.0	1.0	0.0	7.4	0.4	0.2	0.0	0.0	5.5	0.0	0.2	0.0	1.2	0.0	0.0	1.7	0.0	0.7	0.1	0.3	1.0	1.5	0.0	0.1	0.1	2.4	3.5	0.6	0.0	0.8											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6;lymphoid tissue: 6.4"	"Cell type enhanced"	"Detected in some"	16	"Extravillous trophoblasts: 3.6;Sertoli cells: 6.5;Spermatocytes: 10.0;Spermatogonia: 3.2"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 29.2"									"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.1	0.0		1.6		3.6	0.0		0.0	0.0	0.2			0.5	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.0	6.1			0.0	0.0	0.0		0.3		0.0	0.6		0.0	0.0	0.0	1.5	0.0	0.1		0.5	0.1	1.9			0.0		6.4	0.4		1.1	0.4	0.0	1.0	1.7	2.2	0.6	8.6	5.0	6.1	2.7	0.3	0.8	5.9	4.3	1.4	5.8	4.5	0.8	10.4	20.6	5.7	0.5	5.5	8.3	8.1	2.6	6.3	7.1	4.8	8.9	4.4	1.5	0.3	18.1	8.1	0.2	0.0	4.5	11.9	1.3	2.5	16.6	15.5	9.7	0.3	0.6	10.7	14.0	4.9	9.7	3.3	13.6	4.4	14.6	1.0	1.1	3.1	5.6	4.2	2.4	2.3	6.6	6.0	15.6	1.7	4.6	7.6	6.0	9.4	20.3	29.2	12.2	2.5	11.3	2.9	0.0	1.0	0.0	0.1	0.3	0.0	1.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	1.7	0.6	0.1	2.2	0.6											0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	1.0	0.0	0.0	0.2	3.6	0.3	0.0	0.0	0.0	1.3	0.0	0.0	1.8	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	10.0	3.2	0.3	0.2	0.0	0.0	0.0
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.2;hTERT-RPE1: 1.9;NB-4: 1.4;SK-BR-3: 2.0;TIME: 1.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.4		0.0		2.7	0.0		0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0			0.0	0.7	0.0		0.0		0.0	0.0		0.0	0.0	1.8	1.1	0.4	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.7	0.6	1.9	2.0	3.4	2.9	0.6	0.6	0.5	0.4	0.1	0.0	0.0	0.4	0.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.3	1.0	0.0	0.0	1.9	0.1	0.5	0.3	0.0	0.6	0.4	0.2	0.0	0.2	0.0	0.0	2.0	1.0	2.9	0.5	1.9	1.3	1.6	1.3	0.5	1.7	0.5	0.5	1.9	3.4	1.5	0.6	0.8	0.6											0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF15	"MGC8902, NBPF16"	ENSG00000266338	"NBPF member 15"	Q8N660	1	144421386-144461674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 41.7;Club cells: 22.7;Paneth cells: 30.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5"	"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.84e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.26e-2)"	2.2	1.1	1.3	2.7	3.3	0.0	4.9	6.1	3.6	3.2	1.1	1.8	2.9	0.4	4.0	7.7	1.7	2.4	1.9	0.5	7.1		1.5	4.9	2.8	5.0	1.4	1.5	3.4	1.7	3.6	3.2	2.7	4.2	2.8	2.1	3.0	5.2	3.1	0.7	2.2	0.7	3.8	6.3	3.6	0.9	0.9	4.8	1.0	3.0	1.9	3.7	1.4	0.5	3.1	0.2	0.6	0.4	2.7	5.5	1.8	7.5	4.9	8.9	16.7	10.6	16.7	11.0	13.6	13.3	8.3	8.6	4.2	8.1	3.8	3.8	9.9	9.7	5.9	9.8	4.3	13.3	12.5	5.3	0.3	11.1	5.3	8.0	0.3	3.7	13.6	7.6	9.9	20.7	12.0	11.6	1.5	1.7	11.5	20.1	16.1	0.2	3.4	3.6	2.7	11.1	3.3	5.3	5.9	9.2	6.8	0.8	20.2	5.7	8.9	9.4	12.0	8.9	3.4	12.4	13.5	8.9	11.9	12.6	10.2	11.0	6.4	0.2	0.4	6.2	0.2	0.3	0.1	1.3	0.0	1.9	3.1	3.5	2.4	0.2	1.8	4.2	1.6	0.6	2.7	0.4	0.2	5.5	1.8											41.7	21.0	0.9	0.8	1.8	2.5	7.5	5.1	8.1	22.7	1.8	5.9	1.3	0.0	5.3	1.6	3.8	1.0	0.0	3.7	2.6	3.9	1.2	14.0	7.8	1.4	3.2	5.8	6.2	9.2	0.5	8.1	1.8	1.7	3.6	3.7	2.7	6.0	30.2	9.9	0.9	7.0	0.0	6.2	2.6	1.7	1.1	0.2	2.5	5.0	0.3
PPIAL4F		ENSG00000279782	"Peptidylprolyl isomerase A like 4F"	P0DN26	1	144592868-144593527	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (1.08e-1)"					"unprognostic (2.22e-2)"				"unprognostic (2.02e-1)"				0.0	0.0		0.0		0.0	0.6		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.9	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRGAP2B	SRGAP2P2	ENSG00000196369	"SLIT-ROBO Rho GTPase activating protein 2B"	P0DMP2	1	144887265-145095528	"Predicted intracellular proteins"	Neurogenesis			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 9.6"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 54.6;Kupffer cells: 49.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA078079			Approved	Cytosol		NA	NA			Cytosol		"HPA078079: "	"unprognostic (1.13e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.48e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-5)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-1)"	2.5	3.4		1.5		1.6	0.6		2.7	1.3	0.0			0.0	1.4	0.6	1.2	1.7	1.2	0.6			2.2	0.5	2.4	0.9			2.7	0.3	4.4		3.3		0.4	0.0		0.0	0.8	1.9	6.6	0.0	1.8		3.7	0.0	0.2			0.5		0.3	1.2		1.4	4.6	5.0	9.6	0.5	1.6	1.1	6.8	14.7	32.0	6.6	15.4	13.4	10.1	7.6	6.7	6.5	7.5	4.4	12.6	3.4	10.2	4.5	11.6	11.9	8.2	4.4	8.0	3.2	8.3	5.0	10.7	6.2	10.8	4.4	6.6	9.5	6.7	16.0	14.2	9.8	13.0	3.0	2.7	12.2	3.5	7.6	1.9	5.2	5.9	3.4	5.4	5.2	6.9	5.9	5.6	3.0	4.0	5.1	10.1	3.6	16.8	8.3	7.6	11.3	23.5	14.0	14.5	12.4	8.8	5.1	6.3	2.1	5.1	6.0	19.9	1.4	5.1	0.7	0.9	6.9	0.7	1.2	1.4	1.6	3.5	1.4	1.0	1.1	5.0	0.5	9.6	4.6	1.4	1.1											23.8	7.7	8.3	3.5	0.0	11.9	3.2	0.0	14.7	4.5	8.7	2.0	4.7	0.0	5.8	1.0	24.3	0.3	23.3	2.6	14.4	12.3	3.6	1.1	4.7	10.9	0.0	2.4	54.6	49.1	1.7	14.1	15.9	0.0	23.4	0.8	6.3	4.3	0.0	9.2	0.8	2.4	6.5	9.4	2.6	6.4	0.0	2.4	10.1	1.2	3.5
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145096000-145112696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7"	"Cell type enhanced"	"Detected in some"	22	"Extravillous trophoblasts: 4.6;Spermatocytes: 17.9;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	1.1	0.7	0.8	7.2	0.8	5.5	0.7	4.0	0.9	0.6	1.1	0.6	0.4	1.4	0.8	0.4	4.4	0.2	0.5	0.4	1.0	0.7	0.5	0.4	1.3	7.6	1.0	0.4	0.4	0.4	0.3	0.4	1.5	0.8	0.4	1.6	0.4	0.6	0.4	0.4	2.9	2.0	0.5	1.1	3.3	0.8	6.7	0.4	17.7	0.4	2.7	7.4	1.1	2.5	0.1	0.7	0.1	1.7	0.0	1.0	0.5	8.4	5.1	6.0	2.4	0.2	0.5	6.6	4.8	1.4	6.1	3.8	3.4	7.6	13.8	4.9	0.7	5.5	8.9	7.3	1.4	7.2	11.0	7.3	6.9	2.5	5.0	0.1	12.2	7.7	0.3	0.5	4.8	9.3	1.0	2.7	16.7	13.6	19.2	4.0	6.3	8.3	11.9	11.5	10.5	7.1	7.3	7.6	16.2	2.1	1.1	5.9	5.0	3.7	3.3	2.2	7.9	9.3	7.9	1.2	4.5	5.0	3.8	8.6	14.6	22.8	21.4	0.0	9.8	5.1	0.0	1.2	0.0	0.0	1.7	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.8	0.8	4.0	0.9	1.0	0.7	1.0	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.5	0.0	0.0	0.0	4.6	1.0	0.1	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.0	0.0	1.2	1.7	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	17.9	4.1	0.9	0.2	0.5	0.1	0.0
PPIAL4D		ENSG00000256374	"Peptidylprolyl isomerase A like 4D"	F5H284	1	145241630-145242124	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"blood: 5.4;brain: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;NB-4: 1.9;RPMI-8226: 1.0;SK-MEL-30: 1.8;THP-1: 1.5"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (9.32e-2)"					"unprognostic (1.33e-1)"				"unprognostic (3.05e-2)"				0.0	0.0	0.5	0.0	0.7	0.0	0.0	3.9	0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.2	0.7	0.0		0.0	0.0	0.0	0.0	0.7		0.0	0.5		0.0	0.0	0.0	0.5	0.1	0.0	0.2	1.0	0.0	0.0			0.2		0.0	0.0	0.0	4.5	3.8	0.7	3.7	1.8	4.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.9	0.4	0.0	0.0	0.0	1.8	0.0	0.6	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.7	1.4	0.3	1.2	3.7	1.4	4.5	2.7	1.7	3.6	3.1	2.8	3.5	0.0	1.8	1.8	3.8	4.1	5.4											0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0
NBPF20		ENSG00000162825	"NBPF member 20"		1	145289900-145405778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 13.3"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 27.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (6.25e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.54e-1)"	"unprognostic (4.26e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.45e-4)"	"unprognostic (9.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.70e-1)"	1.1	1.2	1.1	1.2	1.2	1.0	1.5	2.5	1.2	1.4	1.1			0.0	1.3	1.8	1.1	1.2	0.7	1.1	1.1	1.1	1.1	2.6	1.1	1.2	1.0		2.2	1.3	5.9	1.1	0.0		1.5	1.1		1.6	2.1	1.1	2.4	1.1	1.7	1.0	1.1	1.1	3.6			1.1		1.5	1.4	1.1	4.0	13.3	1.0	1.8	2.9	1.0	0.3	14.7	7.5	2.1	5.9	13.2	23.2	5.4	7.2	1.8	2.6	2.7	8.1	1.8	3.5	2.8	7.4	4.1	4.5	7.3	8.5	7.3	7.0	9.0	2.3	9.4	5.9	2.7	4.0	4.0	6.9	6.6	14.2	12.1	4.8	6.8	1.9	9.2	5.2	10.5	9.6	0.6	1.8	2.0	3.3	12.0	3.5	6.1	2.2	3.8	2.7	3.8	6.7	14.7	7.6	4.1	5.7	5.8	5.6	12.4	12.7	15.9	6.7	16.7	3.1	2.6	8.0	6.9	1.7	1.8	0.5	1.5	0.5	1.0	0.9	0.8	1.5	0.7	1.0	0.4	4.0	1.0	0.9	1.0	2.9	1.8	13.3	0.9	0.3											20.8	27.1	1.9	1.4	2.6	4.3	3.3	0.0	8.1	3.4	0.0	17.7	1.2	0.0	6.7	13.7	2.4	0.6	0.0	9.6	4.0	3.1	1.1	7.0	14.5	1.6	1.6	5.8	2.5	3.7	1.1	5.2	3.8	3.3	5.4	2.8	1.3	8.9	10.5	3.5	0.0	7.5	0.0	2.2	12.7	9.8	2.8	0.6	0.7	4.0	0.9
GPR89A	UNQ192	ENSG00000117262	"G protein-coupled receptor 89A"	B7ZAQ6	1	145607990-145670648	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 40.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.14e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.42e-1)"	"unprognostic (3.70e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.21e-1)"	4.0	9.3	4.3	3.8	5.4	2.2	9.2	4.6	6.9	6.2	4.7	7.0	7.5	5.4	9.0	4.5	4.1	4.7	5.9	5.9	5.2	5.1	17.5	15.3	4.8	9.6	4.9	4.0	4.2	13.6	5.9	4.2	3.5	3.9	5.5	7.5	4.9	9.0	9.9	7.6	3.3	7.0	6.1	4.7	2.9	8.7	6.7	4.0	3.3	6.6	6.5	7.0	5.2	8.8	6.2	5.5	6.3	5.1	7.6	8.3	2.8	10.4	6.9	8.4	3.7	19.6	17.7	8.2	9.8	10.8	13.9	17.7	14.5	9.0	3.1	5.4	13.4	5.7	9.1	9.0	9.9	12.8	7.6	6.2	3.9	7.8	7.9	11.1	12.1	3.1	18.7	13.8	11.7	13.1	7.0	8.5	7.4	11.2	14.9	22.2	13.4	5.0	6.3	11.0	12.4	11.1	5.5	10.0	18.4	9.4	6.0	2.6	7.8	9.1	20.6	7.4	13.7	15.4	9.4	5.0	13.2	3.4	7.9	10.5	6.0	12.8	8.7	9.5	7.5	9.9	6.3	4.2	4.0	7.1	4.7	8.3	6.2	5.2	7.2	5.5	3.0	5.2	6.1	0.3	7.6	5.1	5.4	6.1	2.8	4.3	5.4	4.6	6.9	5.2	5.1	4.9	4.0	3.9	4.0	20.8	5.1	11.8	7.8	6.8	6.5	11.1	12.7	5.3	6.8	14.0	11.8	17.5	0.0	12.8	5.5	4.7	9.2	0.0	17.6	17.8	8.8	7.2	5.7	9.0	8.2	3.2	13.1	7.4	4.0	6.8	8.9	4.5	10.1	8.2	9.4	6.9	13.3	6.6	6.7	10.2	6.2	12.9	7.6	40.7	17.9	7.4	13.5	14.1	8.9	4.7
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 49.2;kidney: 124.3"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 758.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in single"	17	"cerebellum: 10.0"	"Cell type enriched"	"Detected in many"	4	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 7.6"	"Group enriched"	"Detected in some"	4	"RPTEC TERT1: 43.1;T-47d: 112.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.1	0.6	0.2	0.2	0.3	0.0	5.8	10.0	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0.0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.0	1.1	0.5	0.2	7.6	1.8	0.5	1.3	0.2	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	18.9	0.1	0.1	0.2	1.1	0.0	0.6	0.0	0.1	0.1	1.8	0.3	0.1	0.4	7.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	1.1	0.1	0.2	0.2	0.2	0.5	0.0	1.3	0.2	43.1	0.0	0.1	1.2	0.3	0.3	0.0	1.2	112.0	0.1	0.1	0.2	0.2	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.1	1.5	0.2	0.6	1.0	0.4	1.8	0.2	1.0	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10.0	0.2	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.9	0.0	0.1	0.4	0.4	61.1	0.0	0.0	54.1	0.0	0.0	117.7	1.7	8.9	0.0	18.0	0.0	1.6	0.1	0.2	0.1	0.0	45.6	0.2	0.0	6.3	1.8	1.2	5.2	0.0	0.0	0.0	0.0	0.5	0.0	1.8	2.9	0.0	758.4	0.3	0.0	0.3	0.2	0.2	0.0	0.1	0.0	1.0	0.0
CD160	"BY55, NK1, NK28"	ENSG00000117281	"CD160 molecule"	O95971	1	145719471-145739288	"CD markers, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.9;brain: 15.2;intestine: 19.9;lymphoid tissue: 17.4"	"Cell type enriched"	"Detected in some"	5	"T-cells: 48.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 15.2"	"Group enriched"	"Detected in many"	9	"gdT-cell: 33.9;MAIT T-cell: 14.4;memory CD8 T-cell: 22.9;naive CD8 T-cell: 27.3;NK-cell: 23.2"	"Group enriched"	"Detected in many"	11	"NK-cells: 23.2;T-cells: 33.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 4.7"	"Not detected"	"Not detected"												"Intracellular and membrane"	NA	NA						"unprognostic (6.54e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.25e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.48e-5)"	"unprognostic (4.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-4)"	0.6	0.2	2.2	3.6	2.6	5.1	0.6	15.2	3.1	0.8	9.3	0.4	0.3	5.6	0.8	1.4	0.9	0.6	1.2	0.6	1.6	2.2	0.5	5.9	3.8	6.0	1.6	0.3	1.1	2.2	0.0	0.4	1.8	0.6	1.3	1.0	0.9	3.0	0.4	1.0	1.1	19.9	1.4	1.0	17.4	0.8	0.8	0.3	2.9	0.4	0.3	3.1	0.7	0.3	0.2	0.3	2.7	0.4	23.2	33.9	20.2	1.4	1.0	1.6	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.1	0.6	0.1	1.7	1.3	0.2	0.1	1.7	0.2	0.2	0.1	3.5	1.7	3.1	4.7	1.3	0.1	2.1	3.2	0.2	0.4	0.1	0.3	0.7	0.0	1.7	0.8	1.5	0.1	1.5	1.2	4.0	1.2	0.8	2.9	0.3	0.2	1.1	0.0	0.6	1.2	1.6	0.9	1.3	0.6	1.2	1.5	2.0	1.8	1.4	0.6	0.8	3.0	2.4	1.6	0.6	0.7	2.4	0.2	2.7	0.1	0.1	33.9	0.1	14.4	0.2	0.4	22.9	0.0	0.2	0.2	27.3	1.7	23.2	0.4	0.3	0.0	20.2	2.2	2.6	15.2	3.1	1.6	2.2	1.6	0.3	0.6	0.3	0.0	0.0	0.0	0.2	0.1	2.1	0.2	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.0	2.8	0.1	0.5	0.0	0.4	0.0	0.0	0.3	2.3	0.5	0.0	6.4	0.0	1.8	3.1	6.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	2.6	0.0	0.2	0.0	0.1	0.1	0.1	48.4	0.0	0.1
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.3	4.7	5.8	4.3	10.7	14.0	4.7	8.6	16.0	6.4	7.8	5.1	4.1	8.0	9.8	12.2	6.3	8.0	6.4	5.9	6.9	8.0	4.2	6.4	6.1	4.7	6.7	9.9	14.8	8.1	5.2	6.4	7.8	7.3	8.1	6.3	6.3	13.1	11.5	8.6	7.2	6.3	7.3	7.2	10.0	7.0	5.8	6.6	12.4	3.8	5.9	8.1	7.0	8.6	6.4	7.5	9.5	9.5	10.0	9.3	7.3	5.6	9.1	11.0	10.4	8.4	4.7	6.7	5.9	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4											14.9	29.8	29.4	28.9	18.3	96.0	134.9	25.5	24.1	26.1	17.4	108.0	23.1	28.2	34.8	52.4	66.1	14.0	23.3	69.3	24.5	48.2	51.0	31.1	28.7	32.3	77.9	26.0	66.3	32.6	18.4	36.5	29.9	37.1	88.4	19.7	66.7	49.7	20.9	76.0	37.2	104.3	58.2	49.2	78.7	54.1	15.7	16.6	66.0	23.8	32.8
POLR3C	"RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145842505	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 260.3;Late spermatids: 416.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	21.1	11.9	13.5	21.2	13.4	16.9	21.7	28.3	16.4	18.0	14.2	12.2	11.1	9.4	19.2	16.2	15.1	16.9	14.6	12.7	12.1	9.9	15.7	15.3	13.3	25.4	14.7	15.8	21.9	23.1	16.7	10.9	13.9	12.6	15.7	15.9	11.9	16.9	13.0	18.3	20.3	14.9	17.5	11.0	20.5	14.9	29.3	15.0	26.5	15.9	11.4	21.3	17.5	15.8	21.1	23.6	29.5	23.9	20.6	20.7	15.9	16.1	13.4	11.2	9.2	14.7	18.0	11.9	15.3	18.8	21.8	20.9	19.3	8.7	27.9	15.5	20.9	11.9	16.0	18.1	16.3	22.7	11.4	14.2	14.9	15.7	11.5	26.6	30.6	19.3	17.1	12.0	24.4	43.5	12.5	13.5	13.4	18.7	16.5	23.0	22.4	15.8	13.9	16.0	16.9	18.0	14.9	14.0	18.3	14.2	11.6	10.4	15.7	13.7	20.2	20.7	18.5	15.5	28.6	14.1	19.2	15.3	10.4	21.3	25.8	25.0	32.4	7.0	15.9	14.8	29.5	20.9	21.1	15.9	23.9	20.7	20.1	17.6	16.4	22.0	21.1	18.0	16.4	1.7	20.6	17.3	23.6	14.9	15.9	13.5	13.4	28.3	16.4	12.1	9.9	14.7	15.8	12.6	15.0	6.0	9.6	9.0	6.7	4.4	3.1	15.7	5.1	8.1	10.3	3.5	3.9	9.9	10.0	9.4	260.3	6.8	4.7	23.3	18.5	10.2	9.0	4.8	8.1	4.5	12.4	1.6	4.1	7.4	9.7	416.7	9.5	9.1	1.7	11.8	6.5	3.6	14.3	7.0	13.8	10.2	3.7	19.4	11.3	18.9	17.0	3.8	8.0	8.7	7.3	8.1
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845629-145848953	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 9.0;Spermatogonia: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 18.4;granulocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"T-47d: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	4.6	3.3	8.3	3.9	13.5	6.7	4.9	8.9	10.9	3.8	3.4	5.1	1.5	1.2	4.6	3.1	3.5	7.0	4.4	8.4	6.6	7.7	3.8	2.6	3.4	9.0	5.9	8.1	6.8	6.2	6.2	4.7	2.2	5.4	4.2	2.9	8.0	6.3	5.8	6.7	4.3	3.3	11.1	5.5	6.0	3.3	7.1	2.2	3.5	5.7	3.4	7.7	4.1	3.2	0.9	18.4	11.5	1.8	0.2	1.1	0.7	4.2	3.1	2.9	1.6	1.6	2.4	2.9	2.0	3.4	2.1	3.0	1.9	3.1	6.2	2.2	3.5	0.5	0.8	2.1	1.2	1.4	0.7	3.6	2.4	2.5	2.8	4.7	1.9	8.0	2.5	2.0	1.4	2.4	2.7	4.2	10.1	5.2	5.8	3.8	6.7	2.1	3.6	2.4	2.6	0.3	5.4	1.1	1.9	3.3	1.0	1.4	3.2	1.3	2.6	3.5	3.1	14.5	8.6	2.5	2.5	1.7	1.2	0.8	5.1	2.4	1.5	2.4	2.6	1.9	5.8	0.6	11.5	0.6	1.8	0.4	0.9	0.5	0.3	0.6	0.6	1.1	0.8	0.1	0.2	1.1	18.4	0.5	0.7	8.3	13.5	8.9	10.9	6.6	7.7	5.9	8.1	5.4	2.2	3.0	5.6	0.0	0.9	1.5	1.9	0.4	0.0	2.7	4.5	0.0	0.0	0.4	1.7	1.2	2.9	1.0	0.7	0.0	0.6	0.6	1.9	0.9	2.3	0.6	2.6	0.0	1.2	2.5	0.8	1.3	1.4	1.2	1.7	0.0	0.2	9.0	1.2	0.6	0.4	0.6	3.9	0.0	1.4	6.9	11.7	1.1	0.5	1.3	1.2	0.7
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006389: AB_2667576, HPA067383: AB_2685828"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	15.2	9.8	10.7	12.8	12.7	4.5	17.4	19.1	16.3	29.1	16.2	17.9	16.5	7.5	25.5	15.0	26.4	36.7	20.2	14.1	11.5	9.7	13.9	6.4	13.6	8.2	11.6	11.9	21.2	11.7	14.7	13.8	10.5	11.9	20.3	8.4	28.8	20.9	26.8	17.4	28.6	10.3	23.1	10.7	10.2	15.9	10.0	12.1	7.3	11.4	19.2	22.7	22.6	24.2	6.1	8.6	10.7	11.9	15.1	12.6	6.8	12.8	8.9	9.2	8.1	14.2	26.9	5.6	12.1	16.7	13.8	15.4	7.2	8.5	6.6	13.1	20.7	5.8	13.3	4.7	19.2	11.7	7.2	7.0	3.0	6.1	3.8	14.2	5.4	15.1	21.9	12.5	12.7	7.3	17.9	19.9	6.0	4.8	9.2	28.6	21.4	5.8	2.8	14.3	36.4	14.5	9.1	6.3	4.3	10.9	7.7	3.1	14.7	11.6	6.5	5.9	11.0	30.0	8.3	30.6	18.5	13.8	12.2	7.7	12.7	5.7	4.3	18.0	4.1	9.1	8.5	9.5	10.7	11.7	8.8	12.5	6.1	7.7	12.6	7.0	4.3	7.1	6.7	2.2	15.1	11.9	8.6	8.2	6.8	10.7	12.7	19.1	16.3	11.5	9.7	11.6	11.9	11.9	12.1	20.8	11.5	3.7	7.5	9.5	8.8	0.8	5.1	40.2	21.6	15.7	11.8	3.3	1.7	7.0	2.0	8.7	1.6	0.0	6.7	5.8	11.0	7.0	10.4	3.8	4.5	9.5	4.1	9.8	6.2	2.9	13.3	5.9	5.0	15.4	5.1	3.9	8.8	2.0	12.4	1.2	11.2	25.8	13.3	3.0	10.0	14.3	3.3	4.4	2.5	8.9
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 42.4"	"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	2.1	1.2	3.3	1.0	3.7	0.4	3.6	12.1	7.4	16.1	1.7	0.8	0.3	0.5	2.1	1.3	11.4	2.5	1.1	0.8	3.4	3.6	0.4	1.4	0.8	0.5	3.7	3.4	2.8	0.5	0.2	0.3	0.3	8.0	2.5	0.8	0.3	4.2	2.3	5.2	42.4	0.7	1.8	2.0	0.4	1.2	0.8	0.3	0.7	0.3	14.9	13.6	2.3	7.7	0.0	1.3	0.3	5.5	1.5	2.9	1.9	0.1	0.0	0.0	0.0	2.5	11.0	0.3	1.6	4.0	0.5	1.3	0.4	0.0	0.0	0.3	1.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	1.3	3.1	0.1	3.8	0.5	0.3	0.1	0.1	0.5	0.0	0.0	0.0	2.4	0.0	0.0	4.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	8.2	0.0	0.0	5.5	0.0	2.0	2.0	0.3	0.0	0.8	2.9	0.7	0.0	0.6	1.9	0.3	1.5	0.4	1.3	1.5	1.9	3.3	3.7	12.1	7.4	3.4	3.6	3.7	3.4	8.0	0.3	0.0	0.0	0.0	14.7	4.0	1.5	1.2	2.5	4.0	1.2	1.8	0.0	0.1	0.0	0.0	3.6	1.0	0.0	0.0	0.4	0.1	20.2	8.0	19.5	8.6	8.7	0.0	0.0	1.8	1.6	4.7	33.6	1.1	5.0	0.0	0.0	39.3	0.1	0.0	47.7	0.0	1.4	0.0	5.2	0.0	0.9	10.8	0.2	7.5	0.0	12.9
ITGA10		ENSG00000143127	"Integrin subunit alpha 10"	O75578	1	145891208-145910189	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 36.3;Endothelial cells: 21.6;Horizontal cells: 19.1;Ito cells: 30.7;Late spermatids: 33.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.8;HSkMC: 18.0;hTERT-HME1: 15.8;LHCN-M2: 27.3;TIME: 46.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (7.18e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.37e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.48e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.58e-6)"	"unprognostic (2.77e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.57e-2)"	3.7	2.9	2.7	1.8	6.0	0.7	9.7	5.1	7.1	12.6	4.4	3.3	0.0	3.2	6.7	5.0	2.5	3.0	3.4	7.2	2.2	1.5	2.5	1.3	13.1	2.1	9.7	4.1	4.9	1.4	2.8	4.8	4.3	10.2	3.7	1.8	12.2	4.2	2.4	16.0	3.3	4.0	4.5	15.5	1.7	3.4	3.4	3.7	0.0	4.4	4.2	2.1	6.8	2.5	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.5	0.1	0.1	0.5	19.8	0.0	0.2	5.3	0.0	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.2	0.2	0.0	0.1	0.0	0.2	3.6	0.0	0.2	18.0	1.0	0.7	15.8	7.4	8.8	0.5	0.0	0.0	27.3	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	46.2	8.5	0.1	0.1	0.1	0.1	0.2	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.0	5.1	7.1	2.2	1.5	9.7	4.1	10.2	3.7	0.0	3.0	0.0	5.9	2.1	10.6	2.4	0.0	0.0	4.5	7.0	7.9	0.8	0.0	0.0	36.3	21.6	0.1	0.0	0.2	0.7	1.0	2.8	0.0	0.8	0.5	19.1	0.0	30.7	0.0	33.3	0.9	0.8	0.0	0.0	0.1	0.7	0.0	0.0	0.7	0.0	7.3	0.0	3.8	6.0	2.0	2.4	0.7	0.5	0.3	1.1
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918837	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA017150, HPA050104"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017150: , HPA050104: AB_2681017"	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.67e-4)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	12.0	17.3	25.9	13.3	29.5	8.5	24.4	25.1	39.6	19.9	18.2	17.3	21.3	18.4	16.2	27.2	21.6	20.1	14.7	17.9	25.8	28.1	25.4	19.8	14.9	18.4	24.0	20.3	19.7	23.2	20.4	16.4	17.3	26.9	18.2	21.7	15.7	19.0	20.9	23.7	20.6	17.2	16.1	14.7	18.7	18.4	18.0	14.8	21.4	20.3	17.2	25.3	16.7	13.9	42.5	42.8	32.0	29.6	29.5	37.0	34.1	11.2	10.3	9.2	9.1	21.5	16.9	9.5	11.4	15.2	15.0	11.6	4.7	13.2	10.6	12.4	16.2	7.3	13.8	8.0	17.0	10.5	11.8	6.0	6.5	6.8	12.2	30.4	19.4	12.0	22.2	21.3	10.1	10.0	19.3	19.0	14.9	11.8	17.6	23.6	17.9	14.9	18.5	3.3	24.1	12.8	13.8	13.8	23.1	25.7	8.0	6.4	10.5	8.6	16.6	10.4	9.6	23.0	30.3	16.9	10.1	8.1	13.2	8.3	19.0	21.9	15.0	17.1	11.0	6.9	32.0	29.6	20.6	28.7	26.3	31.2	42.5	32.9	31.0	32.0	37.2	37.0	33.5	14.7	29.5	25.8	42.8	34.8	34.1	25.9	29.5	25.1	39.6	25.8	28.1	24.0	20.3	26.9	14.8	14.9	10.1	11.9	7.5	17.2	7.2	11.8	17.8	12.0	6.8	38.4	0.0	31.7	38.1	11.9	9.5	11.7	16.7	0.0	12.2	11.2	11.8	8.1	3.5	27.2	19.8	4.8	12.2	12.9	18.1	15.7	13.0	11.3	20.3	31.5	18.1	12.6	12.4	14.0	18.7	27.8	4.5	6.5	6.2	34.7	19.1	19.3	16.7	11.8	14.5	8.6
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 120.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		120000	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	6.2	6.5	9.1	9.5	9.8	18.7	6.1	6.3	9.8	8.3	6.2	9.6	9.8	6.2	7.4	5.0	15.1	5.7	5.0	6.4	7.3		6.4	6.5	5.5	11.2	7.0	7.1	7.6	5.1	6.9	5.5	7.9	13.5	5.7	5.0	5.7	6.2	6.3	24.6	7.2	6.0	6.8	13.2	6.5	5.8	8.5	9.5	6.8	6.3	4.8	11.7	7.1	3.5	101.9	120.1	118.0	85.5	85.3	89.3	115.9	51.9	42.6	38.9	31.0	14.0	13.8	47.9	31.8	21.6	45.9	33.8	56.2	39.6	47.8	50.4	21.9	24.2	35.8	41.4	34.8	37.7	42.3	39.4	36.8	32.3	41.5	19.8	61.4	32.3	15.1	26.3	41.0	44.0	20.1	34.0	41.6	55.3	45.3	35.2	143.7	61.7	48.7	66.9	45.3	74.3	54.7	34.0	47.5	29.3	50.2	40.0	49.0	47.5	24.4	43.2	35.2	45.7	74.8	35.0	37.0	47.2	36.3	87.0	51.2	80.8	70.1	33.2	37.0	31.9	89.7	77.6	118.0	86.5	85.5	82.1	101.9	82.5	87.8	76.5	90.1	77.7	86.3	89.3	85.3	79.9	120.1	89.3	115.9											65.5	127.4	197.4	354.6	295.8	63.8	60.9	81.5	131.2	154.7	83.7	51.1	325.5	159.2	190.8	135.1	157.7	103.0	116.8	192.9	427.5	170.0	170.0	239.0	101.1	184.0	33.4	152.5	103.2	99.7	35.5	94.6	186.8	197.4	240.7	91.6	97.7	203.4	129.8	80.2	155.5	75.0	97.0	213.9	194.7	163.6	277.9	615.1	199.5	104.0	335.7
AC243547.3		ENSG00000280778			1	145927258-145977811	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pituitary gland: 7.2;testis: 9.9"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 2: 1.4;Ciliated cells: 1.4;granulocytes: 1.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	5	"neutrophil: 5.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.2"	"Group enriched"	"Detected in some"	25	"U-698: 1.2;U-87 MG: 3.8"															NA	NA																							0.7	0.7	1.8	0.7	2.2	0.7	0.7	5.9	2.6	0.7	0.7	2.3	0.7	0.7	0.7	1.2	0.7	0.7	0.7	0.7	1.2		0.9	0.7	0.7	0.8	1.9	1.1	0.7	3.5	0.7	7.2	0.7	3.0	0.7	0.7	0.8	2.1	0.7	0.7	0.7	0.7	0.7	1.6	0.7	0.7	9.9	2.2	4.2	0.7	0.3	0.7	0.7	0.0	1.0	0.0	5.2	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.5											0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 53.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol		NA	NA			Cytosol		"HPA063598: AB_2685055"	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (5.27e-4)"	13.8	8.9	4.6	6.5	4.4	2.1	6.0	4.1	5.9	14.4	8.0	7.1	3.2	2.7	15.9	7.6	5.8	6.3	10.6	10.0	4.3		4.2	5.4	6.4	9.2	5.7	4.0	19.6	1.7	4.4	9.4	7.5	4.0	11.6	4.2	11.4	3.3	10.7	10.5	2.4	4.0	12.7	4.2	9.4	2.6	7.4	5.8	11.1	4.6	4.5	9.5	11.8	8.4	4.3	4.2	5.1	4.4	4.8	11.1	3.1	3.2	4.6	14.2	15.7	29.7	25.2	0.2	7.3	13.3	11.4	8.4	0.3	3.0	8.6	8.1	14.7	4.3	0.1	6.5	6.1	10.8	7.9	2.1	4.8	5.2	4.6	9.8	11.3	11.4	15.4	2.8	9.3	13.5	18.4	22.0	11.6	7.0	13.9	18.0	0.1	14.9	9.5	4.1	0.0	6.0	10.1	7.1	14.2	11.7	0.0	5.1	14.5	15.0	0.0	10.8	6.1	0.5	9.0	16.9	19.4	5.3	12.6	12.2	11.2	7.9	8.9	13.7	9.5	9.3	4.8	2.9	4.6	8.0	2.7	9.7	4.0	9.2	8.0	2.7	4.3	8.6	11.1	5.1	4.8	4.4	4.2	6.7	3.1											0.0	7.2	19.0	10.3	10.1	15.1	14.6	12.7	1.4	3.4	10.4	7.9	1.3	3.3	8.4	5.7	31.4	0.0	23.3	8.5	3.8	21.4	7.3	4.7	17.3	18.5	12.7	12.1	35.6	19.6	3.2	33.1	14.0	27.0	21.6	2.2	22.7	8.5	0.0	53.0	5.7	12.0	25.8	37.6	13.6	3.4	6.8	0.7	21.9	1.8	3.8
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959442-145964582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 18.1"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 8.1;Cardiomyocytes: 2.9;Muller glia cells: 1.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.5;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.8	1.3	6.4	2.0	10.5	0.3	0.6	7.8	18.1	0.9	0.7	1.2	0.0	1.6	1.5	1.2	0.9	0.7	1.1	1.7	4.2		0.5	0.2	0.7	1.4	0.4	6.7	1.6	0.5	2.0	1.2	0.5	5.7	1.7	0.4	1.3	0.8	2.2	2.3	0.8	1.6	1.6	0.0	1.4	1.1	0.5	1.0	0.0	0.6	0.0	1.5	0.9	0.0	1.5	0.4	0.6	0.3	0.3	3.5	1.0	1.4	0.8	0.7	2.5	3.6	2.8	0.3	2.7	5.2	0.6	1.7	0.2	0.8	2.8	0.3	3.5	1.4	0.6	1.1	0.8	0.4	5.9	1.7	0.2	2.1	0.0	0.5	0.3	2.3	2.5	0.3	2.3	2.6	3.7	0.9	2.3	1.3	6.4	4.0	2.5	1.1	0.8	0.3	0.2	3.1	0.3	0.7	12.6	1.1	0.1	3.5	2.5	0.5	0.1	1.6	0.3	3.6	0.4	0.8	6.3	4.3	5.3	1.4	4.5	8.6	0.4	6.2	2.2	0.5	0.0	0.1	0.6	3.5	0.3	2.6	1.5	1.7	1.9	0.4	1.4	2.3	3.4	0.3	0.3	0.0	0.1	1.7	1.0											0.0	0.0	0.0	0.4	0.2	8.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.5	0.3	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.1	0.0	1.4	0.3	1.4	0.0	0.7	0.4	0.4	0.1	0.1	0.0	0.0	0.1
POLR3GL	"flj32422, MGC3200"	ENSG00000121851	"RNA polymerase III subunit G like"	Q9BT43	1	145964702-145978848	"Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA027288	Uncertain					NA	NA					"HPA027288: AB_10602119"	"prognostic favorable (2.96e-4)"	"unprognostic (3.58e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (6.52e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	30.4	23.9	20.7	18.9	21.4	16.6	21.2	16.0	17.2	17.8	21.9	18.4	14.8	13.3	18.0	19.8	17.7	15.5	29.4	47.4	18.0	15.5	16.6	36.6	18.0	23.9	20.7	17.1	22.0	11.5	26.0	20.7	13.3	14.5	18.7	17.4	20.8	14.6	17.8	66.3	14.1	18.7	16.8	18.1	25.2	19.3	10.7	20.9	26.6	25.2	22.9	26.8	20.2	23.5	28.5	13.4	61.6	17.3	25.7	41.7	22.7	10.1	4.5	10.6	9.7	26.8	30.3	2.5	10.2	16.1	7.0	10.7	1.4	11.3	21.8	15.4	14.3	5.7	3.1	5.1	10.1	10.8	23.5	5.6	14.4	3.7	7.0	16.5	14.4	20.6	22.8	6.7	11.6	13.5	20.7	18.5	23.3	24.0	19.1	26.9	10.8	11.7	18.2	2.2	15.4	10.1	9.9	13.1	32.8	11.3	2.3	5.8	10.8	14.5	0.9	20.4	9.0	9.1	23.4	19.1	6.6	4.3	12.9	6.8	31.2	9.5	17.0	12.0	17.4	6.0	46.8	13.2	61.6	32.0	17.1	30.5	28.5	32.7	31.4	13.4	26.9	33.5	34.4	10.2	25.7	17.3	10.5	41.7	22.7	20.7	21.4	16.0	17.2	18.0	15.5	20.7	17.1	14.5	20.9	26.8	47.4	43.4	22.8	24.7	30.5	74.2	45.9	26.8	17.0	19.2	7.9	16.8	104.5	27.9	28.6	42.1	22.7	0.0	34.2	22.5	46.4	22.8	82.1	74.4	62.7	54.0	20.3	50.3	61.4	7.8	41.7	50.0	55.6	66.7	33.6	56.7	28.8	31.6	44.2	32.2	16.4	25.8	41.1	9.8	25.4	26.2	7.9	94.9	36.6	15.3
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996600	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Sertoli cells: 1177.1;T-cells: 976.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 109.0;HSkMC: 145.0;hTCEpi: 73.9;hTERT-RPE1: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	127.7	10.6	4.1	17.0	4.6	10.5	73.6	2.5	6.0	45.9	49.8	16.1	25.0	6.3	39.3	22.8	41.0	20.3	20.4	55.3	4.8		34.8	11.7	52.3	82.6	6.5	4.2	34.1	25.8	9.3	20.2	19.1	8.3	47.4	16.1	18.8	18.5	19.5	97.0	15.3	27.7	34.6	9.2	39.0	13.6	23.1	6.0	29.0	85.3	16.0	41.5	52.5	32.3	64.9	35.5	134.9	58.3	65.3	90.0	132.5	5.9	0.0	1.4	0.1	33.1	109.0	3.3	7.1	14.4	6.5	8.9	3.8	8.1	1.6	42.4	1.9	1.0	1.6	1.4	13.5	17.4	7.8	0.7	4.8	2.1	3.4	1.5	19.9	10.2	145.0	73.9	13.2	23.2	87.5	2.5	6.7	19.3	13.4	3.3	8.1	3.3	19.0	4.0	12.0	5.3	3.0	11.9	51.8	16.9	13.3	6.8	11.1	30.7	8.9	24.4	3.0	3.2	28.5	6.1	18.0	1.1	33.6	11.6	18.8	17.9	1.5	4.4	9.2	9.4	94.7	53.3	123.0	90.0	58.3	83.1	58.8	76.5	79.9	35.5	64.9	76.0	80.3	134.9	65.3	49.9	16.7	70.6	132.5											211.4	256.3	523.2	152.7	62.8	5.2	378.6	219.1	167.3	228.6	258.2	27.5	4.8	381.3	68.3	6.0	390.7	127.9	140.2	46.4	5.0	157.0	217.7	358.0	65.3	218.0	6.4	157.7	332.7	859.8	16.4	606.1	469.7	102.9	128.0	291.4	3.4	148.2	357.3	420.4	90.8	3.3	1177.1	168.0	6.4	34.1	63.1	9.2	976.9	145.3	211.3
HFE2	"haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC"	ENSG00000168509	"Hemochromatosis type 2 (juvenile)"	Q6ZVN8	1	146017468-146036746	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 49.4;skeletal muscle: 128.9;tongue: 28.2"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 163.4"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 87.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;HSkMC: 5.0;K-562: 4.8;RH-30: 1.7"	"Low region specificity"	"Detected in many"													NA	NA		42000				"unprognostic (2.30e-1)"			"unprognostic (6.98e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.55e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-8)"	"unprognostic (6.61e-2)"	"unprognostic (2.72e-1)"		"unprognostic (1.76e-2)"	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.5	0.0	0.0	14.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	128.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	28.2	2.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	163.4	0.0	0.0	0.0	2.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF10	AG1	ENSG00000271425	"NBPF member 10"		1	146064699-146144804	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 71.5;Basal keratinocytes: 50.6;Suprabasal keratinocytes: 92.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.05e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.64e-5)"	"unprognostic (1.60e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.68e-2)"	1.5	0.0		0.9		3.3	2.3		0.0	3.0	0.9			0.0	1.6	1.9	1.0	1.3	0.5	0.0			0.4	1.2	1.3	0.6			3.2	1.1	1.5		0.7		1.1	1.1		0.3	1.3	0.0	4.2	0.0	1.5		2.0	0.1	1.2			0.7		0.6	0.2		1.3	2.4	3.7	1.5	0.4	0.4	0.2	5.3	1.4	3.2	2.3	11.3	13.4	2.8	3.1	4.1	3.1	3.2	1.4	2.5	2.5	0.6	6.0	2.7	2.6	3.8	4.1	6.4	2.8	2.4	5.4	3.8	0.7	4.5	2.5	1.7	12.3	4.0	8.3	8.5	10.4	3.7	1.4	1.7	7.6	6.7	6.7	1.0	2.1	1.5	1.5	4.4	1.3	2.0	3.2	2.4	3.6	0.3	0.4	4.7	4.7	1.6	5.5	3.8	3.1	11.3	3.1	2.7	2.8	3.8	4.7	1.9	3.0	2.8	2.7	2.4	0.8	1.5	1.8	0.4	1.1	0.2	1.1	0.2	0.3	0.7	1.3	0.4	0.3	3.7	0.4	1.2	2.4	0.3	0.2											71.5	40.3	0.5	3.4	50.6	0.5	7.2	0.0	14.7	12.5	0.0	0.0	0.6	0.0	4.1	6.4	3.6	1.3	0.0	2.3	4.1	26.7	1.3	18.6	1.3	1.3	0.0	0.0	1.3	4.6	1.3	6.1	18.6	28.7	1.8	2.6	1.7	4.4	28.3	7.8	0.0	2.2	0.0	30.9	9.0	4.3	92.5	0.5	1.8	3.0	3.4
NOTCH2NL	N2N	ENSG00000264343	"Notch 2 N-terminal like"	Q7Z3S9	1	146146203-146229026	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 22.8"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 42.9;Melanocytes: 45.5;Suprabasal keratinocytes: 51.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 43.8"									CAB004669	Uncertain				"Secreted to blood"	NA	NA					"CAB004669: AB_426149"	"unprognostic (1.54e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-2)"	1.9	0.3		0.8		1.3	2.5		0.7	5.8	1.0			0.3	1.7	3.5	2.3	2.3	1.2	1.4			1.0	3.9	1.6	0.7			2.7	1.6	1.7		1.9		2.7	1.0		1.3	2.0	0.0	4.2	0.8	1.6		2.0	0.3	4.7			2.0		1.2	0.7		18.8	14.4	22.8	13.8	3.7	5.0	3.8	10.7	4.1	5.4	2.4	5.9	14.9	2.1	5.7	16.1	9.0	11.2	2.3	6.2	2.3	2.7	6.1	4.4	4.8	3.4	9.8	11.0	6.3	2.7	8.9	12.7	1.0	13.3	3.6	3.1	18.6	3.3	11.1	27.3	9.0	6.7	4.1	2.5	19.3	11.1	11.2	2.2	2.6	1.5	2.0	8.3	2.0	5.9	10.3	6.2	7.3	0.8	0.5	10.6	6.7	2.2	4.0	9.9	4.0	19.1	4.7	4.6	10.0	7.8	43.8	11.1	6.1	8.4	3.3	4.6	11.1	13.8	22.8	3.3	11.0	3.6	18.8	3.6	3.6	14.4	12.3	5.0	3.4	14.1	3.7	12.9	14.3	4.0	3.8											20.8	11.5	0.0	9.1	42.9	0.2	0.0	10.2	6.7	7.9	1.8	9.8	0.6	0.0	5.4	0.4	1.0	0.4	0.0	2.2	1.9	5.8	4.4	9.3	3.0	2.0	0.0	0.0	1.3	11.8	1.1	4.9	10.2	45.5	2.8	0.4	7.8	4.2	22.0	3.9	0.9	5.4	0.0	3.5	3.2	1.1	51.2	0.8	4.3	2.2	9.4
AC243756.1		ENSG00000270339			1	146344131-146344790	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.1;endometrium 1: 1.0;lymphoid tissue: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	15	"THP-1: 5.3"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (1.35e-1)"				"unprognostic (2.13e-3)"			"unprognostic (2.34e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.34e-1)"				"unprognostic (2.84e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.2	0.0			0.0	1.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.3		0.0	0.3	0.0	0.3	0.0	0.0		1.7	0.0	0.3			0.0		0.5	0.0		0.4	0.7	0.2	0.2	0.3	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.0	0.1	1.1	0.4	0.8	0.5	0.4	0.4	0.5	1.0	0.2	0.3	0.1	0.7	0.3	0.3											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"		1	146938744-146996202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"pancreas: 29.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.47e-5)"	2.7	1.7	2.2	4.0	3.9	5.1	3.2	4.4	4.7	2.6	1.9	5.8	2.2	2.4	6.0	3.6	1.5	2.4	3.1	0.9	2.3		1.7	6.1	2.8	3.4	4.2	4.2	4.3	29.8	4.2	5.0	1.8	3.8	2.5	1.8	4.2	3.5	4.0	0.9	2.5	1.9	3.0	3.2	3.1	5.3	7.0	1.1	3.3	2.9	0.9	2.9	1.2	3.9	3.8	2.6	6.1	2.3	0.9	3.5	0.8	6.7	5.4	11.4	9.8	5.4	5.0	7.4	7.0	5.3	5.0	5.1	4.9	6.4	15.1	4.4	6.0	5.3	5.0	8.1	4.0	4.8	5.6	5.7	6.6	11.7	4.2	4.5	4.9	9.8	5.3	7.2	4.9	11.4	6.5	4.5	10.9	10.4	2.6	4.0	10.3	10.6	6.2	6.6	8.2	7.1	10.3	4.2	3.6	3.8	14.9	5.7	12.0	9.2	8.2	4.6	17.8	6.9	14.9	5.3	4.4	7.3	10.0	9.7	9.2	6.8	6.3	4.8	3.5	5.0	6.1	2.3	1.8	3.5	1.1	2.0	3.4	2.3	1.9	1.0	3.8	2.6	2.0	0.7	0.9	1.4	2.6	2.2	0.8											29.8	20.0	11.1	2.6	3.4	16.0	7.2	0.0	9.4	11.4	5.2	43.2	3.3	0.0	9.6	5.2	4.5	6.5	0.0	7.5	3.0	5.0	1.4	23.2	11.3	3.3	9.5	10.3	8.6	14.3	2.5	5.2	7.1	1.7	9.0	9.9	9.5	10.0	14.0	9.9	0.8	17.2	6.5	5.0	12.2	5.7	3.8	1.6	10.9	11.5	0.9
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.1"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	7.7	7.6	5.6	4.6	7.1	4.7	7.6	13.3	10.9	9.3	24.6	8.9	8.9	19.1	13.0	8.1	10.0	7.4	6.5	15.2	5.6	5.2	6.2	32.6	6.3	3.8	5.9	9.3	8.1	21.0	18.4	6.2	7.5	7.8	10.9	6.9	6.3	5.7	12.6	52.1	9.4	19.1	20.5	8.4	5.7	11.1	6.9	5.5	2.6	5.8	19.9	4.7	19.0	10.3	1.2	1.7	2.9	1.6	5.1	2.5	0.8	3.9	2.2	5.9	4.5	14.0	12.1	21.3	7.5	4.1	5.0	5.5	8.8	7.9	7.2	3.8	5.9	2.9	10.6	6.8	8.4	4.9	2.8	4.7	3.2	7.0	14.2	9.6	3.7	1.4	9.5	16.9	5.2	24.7	7.5	4.9	5.6	4.4	2.9	4.3	4.0	2.7	2.1	12.3	6.8	9.8	4.3	7.9	3.5	3.6	3.2	3.8	7.1	5.6	6.4	26.7	22.0	6.0	4.6	5.6	5.7	12.6	5.2	12.1	4.7	5.1	3.7	5.9	3.3	7.4	2.9	1.2	1.9	1.5	1.2	2.5	1.2	1.6	0.9	1.7	1.1	1.7	1.1	0.3	5.1	1.6	0.8	0.7	0.8	5.6	7.1	13.3	10.9	5.6	5.2	5.9	9.3	7.8	5.5	3.0	1.3	5.0	9.8	14.7	13.2	57.1	25.5	4.0	2.3	17.4	13.7	15.9	1.7	5.0	0.4	6.7	25.7	0.0	6.0	30.8	10.6	4.3	1.1	35.0	5.1	11.1	10.9	6.7	7.3	1.1	8.9	4.1	15.1	9.0	10.7	6.6	7.4	10.1	15.2	4.7	18.6	19.4	21.1	12.4	9.4	12.3	17.2	7.5	8.8	3.9
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 117.2;Hepatocytes: 260.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.1	1.9	0.5	0.7	0.4	0.4	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.1	0.3	0.0	0.0	0.0	1.0	0.1	1.2	0.0	29.0	0.6	1.0	6.6	0.9	0.1	0.3	0.0	0.3	0.4	0.2	0.1	0.1	1.1	1.0	0.2	0.5	2.1	3.6	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	2.0	0.9	1.0	1.4	7.4	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0	8.9	48.6	8.5	3.5	1.4	2.0	1.4	117.2	21.4	13.6	14.0	0.0	1.2	6.6	4.3	5.9	2.7	52.0	0.0	5.1	0.9	1.3	4.1	5.7	260.8	3.2	3.2	6.4	3.1	10.1	4.1	2.6	2.6	27.0	0.0	25.3	0.3	5.7	28.1	1.4	41.5	1.3	0.0	0.8	1.8	0.7	1.4	1.1	4.3	16.4	6.2
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242641-147295766	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	11.2	12.2	16.1	14.1	16.5	26.9	18.2	23.0	20.0	9.8	16.1	29.5	6.4	18.4	16.0	12.2	10.4	13.4	12.5	9.2	17.3	13.6	11.8	26.1	13.7	16.1	27.3	12.6	9.5	18.5	12.6	17.9	11.8	18.2	13.2	20.0	11.6	9.5	11.9	12.0	15.9	20.9	18.4	24.7	21.3	12.9	27.8	22.2	18.5	8.9	9.4	16.9	8.5	11.9	15.3	19.0	7.6	8.3	8.2	9.1	9.0	19.0	16.5	18.9	12.0	13.3	13.0	15.7	17.1	14.5	16.0	15.1	15.9	13.3	24.8	8.0	17.1	9.8	18.1	16.0	18.6	14.2	24.6	22.4	23.8	13.2	40.5	14.1	30.6	15.3	12.1	9.2	15.8	18.2	13.8	17.5	26.2	27.1	11.6	19.4	21.1	23.2	16.5	24.9	33.1	21.8	26.0	17.5	19.5	15.1	13.6	11.4	19.3	15.4	19.4	14.9	26.1	10.6	44.6	15.9	10.8	16.5	9.7	26.6	10.0	13.8	20.5	22.0	13.5	16.3	7.6	8.1	3.7	9.0	6.8	9.1	12.5	7.9	7.8	19.0	15.3	8.0	8.9	0.8	8.2	8.3	15.8	5.5	9.0	16.1	16.5	23.0	20.0	17.3	13.6	27.3	12.6	18.2	22.2	11.9	17.0	17.4	7.7	10.2	6.5	5.9	15.3	14.7	19.4	5.2	5.9	18.4	18.3	9.2	15.1	12.7	11.7	23.3	7.1	15.4	11.0	9.8	20.8	27.6	18.8	1.6	8.6	3.7	19.8	18.3	6.6	19.1	15.1	13.6	14.8	13.5	9.0	14.0	10.6	11.2	8.8	6.5	10.2	31.2	27.2	9.2	9.8	10.7	18.0	5.8
BCL9		ENSG00000116128	"B cell CLL/lymphoma 9"	O00512	1	147541412-147626216	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020274	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA020274: AB_2670400"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	4.5	7.8	10.2	5.9	9.2	3.1	4.8	22.3	12.6	18.2	9.4	8.1	10.9	5.3	23.9	15.9	6.8	18.9	5.2	8.3	8.0	7.4	9.6	4.3	5.0	4.0	5.9	8.7	17.0	6.1	14.6	10.6	4.5	6.8	10.5	7.9	11.8	8.1	13.2	7.9	7.8	5.5	15.7	5.4	3.8	7.6	6.1	6.5	22.4	7.8	8.0	6.0	9.6	8.0	0.4	0.0	0.6	0.3	0.1	2.6	1.0	2.9	2.9	20.6	15.3	2.3	2.8	4.0	2.4	3.9	2.7	2.6	3.8	4.5	2.8	5.5	2.3	4.5	2.4	13.0	4.4	2.5	6.7	3.6	1.3	3.1	2.5	2.0	0.8	4.1	2.7	3.8	3.2	2.3	4.8	4.1	9.4	2.6	4.6	2.3	6.7	7.0	0.6	24.3	6.0	6.4	7.5	5.2	5.5	10.4	3.3	5.6	12.2	2.7	5.1	4.7	19.8	6.4	1.3	3.0	1.9	9.0	5.3	3.8	20.9	5.3	5.4	4.8	0.8	9.1	0.0	0.3	0.6	1.0	0.0	0.9	0.2	1.2	1.2	0.0	0.4	2.6	1.6	0.2	0.1	0.1	0.0	0.9	1.0	10.2	9.2	22.3	12.6	8.0	7.4	5.9	8.7	6.8	6.5	0.0	2.1	0.0	5.2	2.7	7.9	4.7	7.6	2.7	2.3	12.2	2.0	1.8	10.0	3.4	9.0	2.8	1.8	0.0	4.0	2.0	4.6	7.6	8.1	2.6	1.1	6.4	27.2	6.2	2.8	4.2	8.9	0.4	0.0	1.0	10.9	4.3	3.8	0.0	7.4	4.9	2.8	0.0	3.8	3.2	6.8	3.1	1.7	0.5	6.9	2.7
ACP6	"ACPL1, LPAP"	ENSG00000162836	"Acid phosphatase 6, lysophosphatidic"	Q9NPH0	1	147629652-147670496	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 38.9;RPTEC TERT1: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028560	Uncertain				"Intracellular and membrane"	NA	NA		64000			"HPA028560: AB_10602427"	"unprognostic (3.17e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.44e-4)"	6.0	14.5	8.8	6.6	10.7	4.7	19.3	10.5	9.1	12.6	10.5	7.6	13.1	7.7	10.0	17.6	8.1	13.9	13.6	8.5	13.0	6.0	17.0	13.3	7.6	3.8	10.2	8.0	11.6	18.5	18.1	22.5	4.4	11.6	13.6	10.2	12.7	12.3	19.2	7.6	9.2	8.9	9.7	11.2	6.6	12.8	8.2	12.7	10.8	20.7	5.8	9.7	16.8	6.9	2.9	4.8	11.5	2.2	0.3	12.4	2.6	7.4	3.1	2.6	4.6	1.7	1.6	7.5	1.7	5.4	5.5	6.5	3.6	11.6	2.1	6.5	3.7	4.2	13.0	3.5	11.6	5.7	2.9	5.8	7.8	4.4	6.8	5.0	1.4	0.3	2.4	8.6	2.8	5.8	6.6	5.5	11.0	3.6	1.2	6.2	5.5	5.7	3.6	6.2	38.9	23.0	4.1	2.2	25.2	44.4	14.9	2.2	2.6	6.3	4.6	12.8	6.2	7.4	2.1	3.8	1.7	3.3	0.3	5.4	4.9	7.3	0.9	3.2	0.1	9.4	0.0	2.2	11.5	4.3	0.7	7.5	2.5	7.2	5.8	4.8	2.9	8.0	6.9	3.3	0.3	0.3	3.0	12.4	2.6	8.8	10.7	10.5	9.1	13.0	6.0	10.2	8.0	11.6	12.7	17.9	11.5	0.0	4.7	1.0	1.9	5.6	15.3	14.7	4.5	15.7	0.0	17.2	14.9	6.8	4.7	2.2	3.8	0.0	13.3	5.8	2.0	5.7	1.1	9.6	4.0	0.0	8.7	5.5	3.7	0.9	5.5	3.9	3.3	3.6	8.1	11.8	14.6	5.8	3.9	12.4	1.0	12.9	3.1	3.9	4.4	1.1	6.8	5.7	8.4	5.1
GJA5	CX40	ENSG00000265107	"Gap junction protein alpha 5"	P36382	1	147756199-147773362	"Disease related genes, Predicted membrane proteins"			"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 60.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 113.4;Extravillous trophoblasts: 273.7"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 55.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013080, HPA071370"	Enhanced					NA	NA					"CAB013080: AB_2533263, HPA071370: "	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.93e-2)"	8.8	0.2	0.6	1.5	1.1	0.0	2.1	0.7	0.7	2.1	2.2	0.8	2.8	0.6	1.2	1.6	1.2	2.6	1.7	15.1	0.9		7.0	0.2	9.3	0.3	0.9	0.0	2.2	0.7	0.8	0.0	60.6	1.2	1.6	0.9	2.0	0.2	3.1	1.7	0.0	1.4	2.5	0.9	1.9	0.0	1.3	0.3	0.0	2.1	0.4	0.5	2.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	2.3	1.8	0.9	0.9	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.1	0.0	3.8	1.5	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	55.6	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7											3.0	6.2	0.5	0.0	0.0	0.0	9.4	0.0	1.4	0.0	3.5	0.0	113.4	0.0	0.0	6.1	2.1	0.0	0.0	0.0	273.7	2.1	0.0	0.0	0.0	13.6	0.0	0.0	30.1	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	4.7	1.4	0.4	0.3	26.0	0.0	0.0	0.0
GJA8	"CAE, CAE1, CX50, CZP1"	ENSG00000121634	"Gap junction protein alpha 8"	P48165	1	147907956-147909257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	76	"testis: 18.0"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 1.8;Early spermatids: 6.8;Late spermatids: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"RPTEC TERT1: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014715, HPA062940"	Enhanced					NA	NA					"HPA014715: AB_2732411, HPA062940: AB_2732693"										"unprognostic (3.73e-2)"					"unprognostic (2.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0
GPR89B	"GPR89, GPR89C, SH120"	ENSG00000188092	"G protein-coupled receptor 89B"	P0CG08	1	147928393-147993521	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.15e-4)"	4.0	5.1	4.0	4.0	4.0	2.0	5.4	5.1	5.4	6.0	4.1	4.0	4.0	6.0	4.9	4.0	4.0	3.6	4.0	4.0	4.0	4.8	20.3	9.4	4.0	4.0	4.0	4.0	4.7	5.1	4.4	4.0	4.0	4.0	4.8	3.9	4.0	4.7	4.3	5.2	5.4	7.9	4.0	5.3	4.0	4.8	7.6	4.0	4.0	4.0	4.0	4.0	4.0	4.0	8.2	9.5	9.3	8.1	10.8	12.6	7.1	7.1	1.0	7.1	7.4	8.3	9.0	10.7	8.8	7.9	10.5	11.2	10.2	11.2	13.8	8.4	7.3	8.2	10.2	10.2	7.2	8.5	12.7	11.0	8.4	7.4	4.6	14.6	10.0	5.4	8.5	10.4	6.7	13.9	3.4	9.5	9.8	6.6	11.8	6.6	16.3	11.5	5.9	13.6	17.8	10.8	10.6	11.8	21.1	13.7	6.8	4.7	5.8	19.2	6.1	8.7	13.3	11.8	10.8	3.0	7.6	3.5	11.5	10.7	19.2	16.0	8.5	9.8	7.6	5.4	6.7	7.7	9.3	11.3	6.1	12.6	7.6	12.4	12.0	9.5	8.2	11.3	10.7	4.3	10.8	8.1	7.9	9.7	7.1	4.0	4.0	5.1	4.1	4.0	4.8	4.0	4.0	4.0	4.0	6.0	4.0	6.9	5.2	0.1	3.2	5.7	0.0	6.7	6.8	5.2	2.0	12.1	0.0	6.1	3.4	3.8	7.7	0.0	6.2	11.1	5.1	3.6	6.9	6.6	3.7	0.0	4.6	3.1	1.0	3.6	5.2	2.9	0.0	3.6	6.8	2.9	5.5	7.8	3.2	20.0	3.6	0.0	5.1	23.7	9.1	0.0	13.2	11.8	5.1	3.1
NBPF11	NBPF24	ENSG00000263956	"NBPF member 11"	Q86T75	1	148102046-148152322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (8.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.78e-2)"	"unprognostic (6.67e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (3.20e-5)"	1.5	2.1	3.4	2.1	3.9	3.0	3.8	5.7	5.3	4.6	1.5	3.1	9.6	1.4	5.7	9.6	1.2	3.0	1.5	0.7	3.0		1.4	3.7	3.3	3.0	6.0	1.1	5.3	3.2	5.4	1.6	3.3	4.4	2.9	2.4	3.4	3.2	5.6	0.6	5.7	2.0	3.0	5.7	3.1	2.1	1.5	3.1	1.5	3.0	0.0	3.5	1.3	0.0	5.2	3.9	6.1	3.5	1.0	4.1	1.0	5.5	4.4	8.8	8.4	6.1	5.2	5.9	5.0	4.6	4.3	4.5	3.4	5.6	9.2	3.9	5.9	3.9	7.2	5.5	1.8	5.2	5.1	6.0	4.0	13.8	3.7	4.3	5.8	14.9	4.4	5.1	5.4	10.2	6.3	3.1	8.0	6.6	0.6	4.3	10.8	6.6	10.5	7.6	12.3	5.7	8.9	5.1	3.5	4.2	10.7	3.5	9.3	7.9	5.4	7.4	12.1	7.9	9.9	7.6	5.6	4.6	8.6	6.3	5.5	4.5	6.4	5.3	3.7	3.1	6.1	1.9	5.7	4.1	1.3	2.9	3.3	3.4	2.4	1.9	5.2	3.8	2.9	0.3	1.0	3.5	3.9	1.3	1.0											11.9	11.8	0.8	2.0	1.0	4.8	5.1	2.5	6.7	9.1	3.5	9.8	3.9	0.0	2.5	3.5	5.8	3.9	0.0	2.9	2.8	4.1	1.6	12.8	16.6	2.9	4.8	3.4	5.5	7.3	1.0	4.9	3.1	6.8	2.8	6.3	2.7	3.4	7.0	2.5	1.9	7.0	6.5	1.4	6.2	4.5	1.3	2.4	5.0	9.0	1.1
PPIAL4G		ENSG00000236334	"Peptidylprolyl isomerase A like 4G"	P0DN37	1	148479824-148483679	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;skeletal muscle: 6.8"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 6.1;Suprabasal keratinocytes: 10.9;T-cells: 6.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"		"unprognostic (2.17e-3)"			"unprognostic (3.63e-1)"	"unprognostic (4.83e-1)"		"unprognostic (2.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"		"unprognostic (3.95e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"				0.2	0.1	1.3	0.7	1.8	1.3	0.3	6.9	1.2	0.1	0.2			0.5	0.4	1.0	0.3	0.1	0.3	0.2	0.9	1.1	0.1	0.2	0.2	1.1	0.5		0.4	0.0	0.1	0.3	0.1		0.2	0.3		0.4	0.0	6.8	0.8	0.7	0.0	0.4	2.7	0.5	0.5			0.4		0.3	0.0	0.0	2.2	0.6	2.4	0.8	2.4	3.2	0.2	0.8	1.1	0.5	1.7	0.2	0.3	1.3	0.3	0.3	0.1	0.1	1.3	0.9	1.2	0.8	0.3	0.2	1.0	0.1	0.2	0.2	0.5	0.7	1.2	2.4	1.0	0.1	1.5	1.2	0.2	1.8	0.1	0.3	0.3	0.2	1.0	0.7	1.8	0.0	0.9	0.8	2.5	1.1	0.1	0.3	0.6	0.3	0.8	0.3	1.3	0.7	1.0	1.0	0.7	0.4	0.9	1.2	1.4	0.8	0.9	0.9	1.4	0.7	1.4	1.2	1.0	0.7	1.0	0.9	2.2	0.4	1.0	3.2	0.4	2.4	0.9	1.5	1.7	0.3	2.2	1.6	2.8	2.4	2.4	0.8	0.6	0.5	0.2											0.0	1.1	0.0	0.4	6.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.1	0.4	0.2	1.6	0.0	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	10.9	0.1	6.7	0.0	0.1
NBPF14	DJ328E19.C1.1	ENSG00000270629	"NBPF member 14"		1	148531385-148679751	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 25.2"	"Cell type enhanced"	"Detected in many"	9	"Paneth cells: 190.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in all"	5	"basophil: 9.8;classical monocyte: 17.2;eosinophil: 25.2;intermediate monocyte: 11.5;memory B-cell: 21.8;myeloid DC: 14.9;naive B-cell: 15.1;neutrophil: 22.9;non-classical monocyte: 13.1;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.28e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.92e-3)"	"unprognostic (7.13e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.69e-4)"	"unprognostic (7.23e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.15e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.52e-2)"	4.4	0.7	2.5	3.2	4.6	6.7	4.3	2.1	4.3	5.4	2.4	2.1	0.9	0.4	4.3	11.2	3.9	3.4	2.9	6.7	4.2		3.4	3.4	3.4	4.0	2.6	2.8	7.7	6.3	3.1	0.9	1.8	4.6	3.6	2.7	6.9	3.2	1.9	1.2	8.5	1.9	4.1	3.8	4.5	0.8	5.2	5.1	2.8	2.6	9.1	4.7	1.8	4.7	21.8	16.5	25.2	17.2	3.4	3.1	3.5	26.7	5.1	10.1	7.4	21.1	29.5	5.0	10.0	10.2	6.9	8.0	4.1	8.9	5.0	2.6	10.3	9.5	8.1	6.7	10.5	10.1	9.8	7.6	13.2	16.4	1.0	8.3	10.4	5.4	29.5	8.7	18.5	24.7	32.9	10.7	4.6	4.4	27.1	16.4	16.0	2.7	7.5	4.3	5.6	12.3	4.3	9.1	15.8	8.6	11.1	0.1	0.1	20.4	11.3	4.8	10.1	14.1	9.0	42.8	7.9	8.8	9.5	16.6	47.8	15.3	12.3	14.3	9.1	11.8	9.8	17.2	25.2	2.3	11.5	1.7	21.8	2.4	2.1	14.9	15.1	3.1	2.6	22.9	3.4	13.1	16.5	3.1	3.5											83.4	73.1	16.4	35.4	1.9	2.0	17.3	10.2	16.0	27.3	12.2	3.9	1.1	0.0	29.4	29.3	0.8	7.7	0.0	13.9	12.6	12.9	19.5	49.9	8.1	12.9	0.0	3.5	3.7	40.0	30.3	26.2	27.4	1.7	20.8	5.3	17.1	21.9	190.4	15.9	4.4	9.8	12.9	11.4	57.2	10.2	5.5	1.3	6.9	16.2	27.9
NUDT4B	NUDT4P1	ENSG00000177144	"Nudix hydrolase 4B"		1	148748894-148750099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.3;RT4: 21.1"									"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"					"unprognostic (1.24e-1)"									"unprognostic (4.01e-2)"				0.5	1.2		0.0		5.4	0.0		0.0	0.5	0.7			0.7	0.2	0.0	2.0	1.4	5.5	6.5			2.0	0.2	0.0	1.2			4.5	3.0	2.1		1.5		1.4	1.0		5.7	0.0	0.0	0.0	0.5	0.1		0.0	0.1	1.6			1.7		0.1	5.8		0.0	0.3	4.5	0.8	0.2	0.6	0.4	1.6	2.2	0.5	2.6	3.4	3.3	5.0	1.3	3.3	2.4	2.4	23.3	8.5	1.4	0.5	1.7	2.5	2.5	2.8	1.3	1.4	4.8	1.8	3.8	1.4	2.7	3.7	2.8	0.8	5.4	4.5	3.2	2.9	2.1	8.4	1.1	6.9	9.2	2.4	1.4	1.8	0.5	3.0	1.4	2.2	3.4	0.9	5.4	2.0	21.1	1.3	2.1	1.8	3.4	14.4	0.5	6.0	6.0	4.6	3.2	2.0	5.5	3.0	0.8	2.4	1.5	1.6	4.9	9.3	0.0	0.1	4.5	0.0	0.2	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.8	0.0	0.3	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE4DIP	"CMYA2, KIAA0454, KIAA0477, MMGL"	ENSG00000178104	"Phosphodiesterase 4D interacting protein"	Q5VU43	1	148808181-149048286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"heart muscle: 106.0;skeletal muscle: 276.2"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 631.5;Rod photoreceptor cells: 241.6;Syncytiotrophoblasts: 258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 63.3;ASC TERT1: 51.5;K-562: 51.7"	"Low region specificity"	"Detected in all"							HPA012678			Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA012678: AB_1855123"	"unprognostic (2.14e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.31e-2)"	"unprognostic (6.73e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	4.8	2.9	9.2	4.3	8.3	2.3	9.0	12.1	15.1	4.8	6.2	8.3	5.6	3.8	3.1	11.8	6.1	3.3	5.0	106.0	9.7	7.8	6.6	9.3	5.5	3.8	15.6	8.1	2.3	3.4	13.6	7.7	10.2	9.3	4.6	4.1	7.2	5.4	4.5	276.2	4.1	7.7	3.1	18.5	2.9	4.4	1.7	11.2	1.5	3.1	18.1	3.8	3.6	6.1	12.0	6.7	7.4	5.9	4.7	13.2	4.3	7.9	1.5	2.2	2.4	63.3	51.5	13.2	9.3	8.9	9.1	12.0	7.3	5.0	4.0	2.9	13.4	26.1	4.1	5.4	6.6	15.5	3.0	7.7	2.0	3.3	2.9	16.7	1.8	2.2	36.6	13.2	38.8	21.1	20.9	3.5	3.4	51.7	9.5	16.2	13.5	1.3	1.1	7.9	6.6	3.3	2.9	5.7	1.5	5.4	8.2	10.9	1.0	9.1	26.7	7.3	10.0	7.9	2.3	4.7	10.6	2.4	26.5	20.7	4.2	5.9	6.0	43.3	1.6	6.5	7.4	5.3	4.1	5.4	5.9	5.5	12.0	10.9	7.2	6.7	11.7	8.4	4.6	1.2	4.7	1.9	2.9	13.2	4.3	9.2	8.3	12.1	10.2	9.7	7.8	15.6	8.1	9.3	11.2	47.6	46.3	21.7	9.6	25.5	78.0	631.5	35.7	121.8	61.4	66.3	108.0	166.9	53.0	10.9	30.1	5.7	27.3	0.0	6.1	103.0	37.0	5.3	12.8	70.6	41.3	31.8	41.5	6.2	35.7	38.7	9.8	70.6	52.3	22.6	33.0	44.3	4.9	20.7	9.2	14.7	241.6	32.3	42.4	6.7	16.8	14.3	258.6	12.8	17.8	3.8
NBPF9	AE01	ENSG00000269713	"NBPF member 9"		1	149054027-149103561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 21.9"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 35.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.25e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.42e-6)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.63e-3)"	"unprognostic (8.80e-2)"	3.3	2.0	5.6	6.5	5.3	2.4	2.6	12.3	5.0	4.2	3.3	2.1	4.5	1.7	4.9	7.2	2.8	2.9	4.7	3.8	5.3		3.6	5.4	8.3	4.6	2.8	1.8	4.9	6.3	4.4	1.9	2.2	4.3	3.0	3.1	6.8	2.2	2.4	1.7	4.5	3.2	4.4	2.0	2.7	1.8	2.9	2.0	1.8	5.2	2.5	4.0	2.3	0.0	4.2	5.2	21.9	7.6	5.6	1.8	0.8	22.2	9.8	12.2	16.5	11.1	13.5	9.7	20.6	15.0	10.9	11.8	7.3	9.7	5.3	5.7	10.5	13.1	6.7	8.5	9.6	18.7	13.5	8.9	1.7	16.5	4.4	12.9	2.2	6.5	13.3	7.2	11.9	20.9	20.1	9.5	4.1	6.2	14.0	13.3	17.6	0.7	3.6	4.6	4.0	13.4	6.0	7.6	8.1	8.9	10.3	7.9	16.5	6.7	16.6	9.1	8.0	12.3	4.2	22.2	24.6	7.2	17.9	31.6	17.2	9.1	10.6	9.0	1.6	8.6	21.9	7.6	0.3	0.4	3.6	0.7	1.9	1.3	0.4	1.3	4.2	1.8	1.0	5.8	5.6	1.2	5.2	1.6	0.8											35.7	13.6	5.4	6.7	4.8	4.3	3.9	7.6	8.1	19.4	5.2	5.9	2.3	0.0	2.9	2.8	2.4	0.7	0.0	1.6	3.4	9.1	4.1	17.4	24.5	3.2	0.0	1.7	2.5	9.5	2.1	6.6	14.0	3.3	1.8	0.4	3.7	2.5	7.8	3.9	0.4	11.4	6.5	3.9	9.7	4.1	12.4	1.1	2.2	0.6	5.8
NBPF19		ENSG00000271383	"NBPF member 19"	A0A087WUL8	1	149390623-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 94.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (7.92e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.59e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (3.54e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.61e-2)"	6.8	0.9	3.2	10.4	2.7	9.5	8.4	1.7	4.5	6.6	3.7	4.0	10.1	1.1	8.8	8.0	5.3	6.0	7.3	4.8	3.4		2.3	3.1	12.1	6.0	3.2	4.7	10.6	6.2	4.0	0.9	7.0	5.5	5.0	3.9	7.5	7.7	8.6	6.2	13.0	1.7	6.0	2.6	6.7	1.7	9.5	2.9	2.5	6.3	5.2	5.2	3.9	7.4	6.2	11.7	18.0	16.7	6.9	7.0	1.5	23.8	6.4	13.9	7.1	27.1	23.5	6.5	11.8	9.1	8.3	8.2	5.6	8.7	7.0	2.9	18.2	10.7	11.0	19.0	11.0	12.9	12.6	10.6	20.0	17.8	1.9	5.6	19.9	7.3	16.3	4.9	23.8	31.1	11.0	5.3	10.4	4.8	11.4	17.4	17.5	10.9	11.9	12.0	6.7	9.9	9.9	15.1	11.5	5.2	12.1	1.2	2.9	27.9	9.8	5.3	20.1	18.1	27.3	31.6	16.6	12.3	10.3	18.2	9.5	5.4	22.1	19.0	13.9	4.9	9.8	16.7	5.3	7.0	6.4	4.7	2.3	3.8	2.5	3.2	6.2	5.2	6.5	18.0	6.9	5.2	11.7	1.4	1.5											47.6	49.9	6.4	15.8	0.0	7.8	21.2	2.5	21.4	18.2	3.5	25.5	1.3	1.7	14.5	16.9	1.9	1.1	23.3	5.3	5.4	5.3	6.2	18.6	7.4	6.5	3.2	1.2	0.6	29.4	4.2	30.0	33.9	0.0	15.4	3.4	25.4	8.8	94.8	28.3	0.3	51.8	19.4	4.2	26.5	6.0	0.0	1.1	7.5	7.7	8.6
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.9;intestine: 5.5"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 14.4;THP-1: 16.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.0	3.3		2.7		0.1	0.0		1.5	0.0	0.8			5.5	0.8	0.0	0.0	0.0	0.0	0.0			1.0	0.0	1.0	2.9			0.2	0.0	0.9		0.7		0.3	0.0		0.0	0.0	0.2	0.5	2.9	0.0		1.4	0.9	0.0			0.0		0.3	0.0		9.1	9.7	1.9	6.0	4.6	7.8	10.9	3.6	0.3	0.4	3.1	0.1	0.3	2.0	0.6	0.4	1.0	0.7	0.0	4.8	1.3	2.1	0.0	2.5	3.9	0.0	0.2	0.6	3.5	0.0	0.5	0.0	0.0	0.1	2.0	1.9	0.1	0.5	0.6	0.3	0.0	0.0	0.5	0.9	5.4	0.7	0.4	5.3	14.4	6.2	1.0	0.1	5.3	0.0	9.0	0.2	0.0	4.0	5.5	1.1	11.3	6.2	0.3	5.3	16.9	1.3	3.6	5.6	3.3	8.2	4.2	5.6	9.2	3.9	4.6	7.8	0.9	4.3	1.9	5.4	6.0	6.0	9.1	6.1	5.7	9.4	7.2	5.0	5.9	0.0	4.6	5.3	9.7	7.8	10.9											0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149792518	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.6;epididymis: 33.2"	"Cell type enhanced"	"Detected in many"	21	"Hofbauer cells: 235.7;Kupffer cells: 121.8;Late spermatids: 48.6;Macrophages: 101.0"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"					"Group enriched"	"Detected in some"	7	"classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5"	"Group enriched"	"Detected in many"	80	"dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6"	"Cell line enriched"	"Detected in some"	5	"THP-1: 61.0"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	3.9	2.4	6.7	14.1	4.4	5.0	0.7	0.3	3.5	1.1	0.3			0.0	0.1	33.2	0.3	0.7	2.4	0.7	5.3	4.9	1.0	1.1	8.9	3.4	10.1		0.3	1.0	0.5	1.2	10.8		0.4	0.3		0.7	0.2	0.0	0.0	0.1	5.5	14.3	7.0	0.3	0.9			0.3		0.0	3.3	0.0	0.2	9.5	25.5	35.6	0.0	0.2	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.5	35.6	0.4	0.0	14.0	0.2	0.2	0.0	0.1	9.5	0.0	0.0	0.0	25.5	0.0	2.8	0.2	0.1	11.2											0.0	1.9	3.5	0.0	0.1	1.5	1.2	2.5	1.4	2.3	0.0	2.0	2.1	0.0	0.0	28.2	0.1	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	235.7	0.0	0.0	1.3	121.8	48.6	0.3	101.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	6.5	0.0	0.7	0.4	0.0	3.4	0.0	0.0	0.0
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 32.1"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.6	0.6	4.6	3.1	0.3	7.9	4.1	6.0	5.3	0.3	2.2	0.4	0.6	4.5	5.2	1.3	0.1	0.5	4.7	1.2	0.9	0.4	1.5	0.0	6.7	0.2	1.8	5.5	0.0	7.8	1.9	1.7	3.4	0.3	1.2	2.4	0.8	0.9	3.1	3.8	0.4	4.1	1.0	0.3	1.1	0.7	2.9	0.4	2.7	7.3	4.2	3.5	0.3	0.7	1.3	9.8	1.4	1.5	0.0	11.5	2.0	32.1	1.0	1.3	5.3	0.3	3.4	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1	0.0	0.3	2.2	6.9	0.3	6.0	1.7	0.0	4.0	1.2	1.8	2.0	1.5	3.3	1.0	0.9	0.4	5.1	0.0	0.3	1.2	0.9	16.2	0.0	0.6	6.7	4.8	3.4	2.5	4.9	1.4	2.6	2.9	0.0	1.8	2.7	6.6	0.7	2.9	0.0	0.5	0.9	6.5	1.5	0.2	0.4	0.5	4.3	4.9	1.8	5.7
HIST2H3D		ENSG00000183598	"Histone cluster 2 H3 family member d"	Q71DI3	1	149813271-149813681	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;bone marrow: 9.3;lymphoid tissue: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 22.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (3.35e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.27e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-4)"	"unprognostic (6.95e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.48e-3)"	1.1	1.2	1.5	1.7	1.4	9.3	5.7	2.6	2.0	1.1	0.9	0.6	0.6	0.5	0.6	0.6	3.8	1.2	3.1	1.9	0.6	0.5	0.6	1.4	1.9	2.9	0.6	0.6	2.4	1.1	0.0	0.6	0.6	1.2	1.9	0.1	0.6	0.6	0.6	0.6	1.1	1.6	0.6	2.3	2.2	2.6	2.3	1.3	10.2	0.7	2.2	1.1	2.7	1.3	6.9	2.7	12.6	1.8	0.4	2.4	0.5	0.8	0.0	0.2	2.4	0.4	0.0	0.5	1.4	0.0	0.0	0.1	0.4	0.2	0.6	0.2	0.0	0.2	1.1	0.0	0.0	0.0	1.4	0.7	0.2	3.5	0.1	0.4	0.0	1.9	0.8	0.0	0.5	0.3	0.4	0.0	0.7	1.8	2.0	0.0	1.6	2.2	5.5	2.1	0.4	4.0	1.2	0.4	1.6	0.0	1.1	0.5	0.3	1.4	0.0	0.1	0.2	0.4	0.6	0.5	1.2	0.0	1.0	0.0	22.2	2.3	1.4	0.2	0.4	0.8	0.0	1.3	0.5	1.2	1.8	2.4	1.3	1.6	1.8	1.2	6.9	0.6	0.4	12.6	0.4	0.6	2.7	0.2	0.5	1.5	1.4	2.6	1.1	0.6	0.5	0.6	0.6	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
HIST2H4A	"H4/n, H4F2, H4FN, HIST2H4"	ENSG00000270882	"Histone cluster 2 H4 family member a"	P62805	1	149832659-149839767	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 56.4"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 14.3;Ciliated cells: 8.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 27.4;U-2 OS: 24.5;U-266/70: 22.9"									HPA042201	Approved					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (1.90e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.78e-4)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.99e-2)"	1.5	2.3	0.8	10.5	1.9	4.6	1.7	3.8	2.0	3.7	2.9	0.8	0.6	1.9	2.0	1.5	4.1	5.9	4.3	3.5	1.0		1.9	0.2	1.8	4.7	0.8	1.2	3.0	5.5	0.0	1.4	2.5	1.9	6.4	0.0	0.9	2.9	3.4	0.4	0.0	3.2	1.8	0.7	4.9	1.7	3.5	0.5	56.4	4.8	5.1	7.0	5.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.5	1.0	3.3	3.8	1.2	1.4	1.5	1.3	5.0	2.3	3.7	4.9	1.1	5.4	0.5	1.6	8.7	0.0	3.2	0.1	6.9	10.4	1.3	13.9	1.3	3.5	1.2	1.1	5.7	4.2	1.6	2.6	0.1	0.8	1.4	5.6	12.5	0.2	16.7	4.4	2.9	4.4	5.5	7.0	3.8	2.5	10.3	0.5	1.2	17.9	5.2	27.4	2.6	4.2	0.6	11.5	2.4	0.0	2.3	24.5	3.1	2.5	22.9	19.3	6.6	2.3	3.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.2	0.0	0.0	14.3	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2
HIST2H3C	"H3, H3.2, H3/m, H3F2, H3FM, MGC9629"	ENSG00000203811	"Histone cluster 2 H3 family member c"	Q71DI3	1	149839538-149841193	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;brain: 5.1;prostate: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;SiHa: 8.4;U-266/70: 7.4;U-266/84: 7.3"									"HPA042570, CAB069990"	Approved					NA	NA					"CAB069990: AB_10804539, HPA042570: AB_2678056"					"unprognostic (1.78e-1)"			"unprognostic (2.25e-1)"		"unprognostic (2.42e-1)"				"unprognostic (1.36e-2)"				0.4	0.5	0.7	0.4	1.4	3.8	0.0	5.1	2.9	0.1	0.3			0.8	0.2	0.0	0.4	1.0	0.0	1.4	0.7	0.2	0.1	0.6	0.3	0.5	0.3		0.0	1.9	0.0	0.1	0.3		3.6	0.0		0.9	0.0	0.2	0.5	0.6	0.0	0.4	0.4	1.1	1.4			0.1		0.0	0.4	0.6	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.3	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	0.4	2.6	0.0	0.1	0.2	0.8	5.6	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.3	0.1	0.6	2.5	3.1	0.1	2.3	1.5	2.1	1.8	4.0	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.4	2.3	0.4	1.0	1.5	1.8	0.0	0.6	4.8	0.3	0.4	7.4	7.3	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST2H2AA3	"H2A.2, H2A/q, H2AFO, HIST2H2AA"	ENSG00000203812	"Histone cluster 2 H2A family member a3"	Q6FI13	1	149842188-149842736	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 67.4"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 76.9;Ciliated cells: 64.3;granulocytes: 22.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.8;U-266/70: 96.9;U-266/84: 53.8"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.41e-2)"				"unprognostic (3.79e-1)"					"unprognostic (1.53e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.20e-1)"				6.1	2.7	3.7	6.8	3.7	67.4	7.8	3.7	5.4	10.1	4.0	3.7	3.7	4.2	3.7	3.7	6.5	5.4	5.0	4.5	3.7	1.6	5.6	9.9	14.6	4.4	3.7	3.7	5.1	3.7	0.4	3.7	8.9	3.7	35.8	1.7	3.7	22.4	3.7	4.5	11.7	3.7	3.7	8.0	12.8	9.6	11.2	3.7	18.9	3.7	3.7	5.4	3.7	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.6	0.0	5.3	2.5	3.6	3.0	0.0	1.0	1.5	3.8	2.3	0.0	0.9	0.3	1.1	0.4	2.5	0.0	0.7	7.0	0.9	2.4	0.0	0.7	11.8	2.0	0.9	1.0	0.0	0.9	0.0	7.8	19.8	1.2	0.0	0.0	5.9	0.0	2.9	4.2	0.8	0.0	7.4	1.4	1.8	0.0	0.0	6.7	0.0	0.2	0.0	5.2	2.0	2.0	0.7	8.9	0.0	0.5	96.9	53.8	2.1	5.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.7	3.7	5.4	3.7	1.6	3.7	3.7	3.7	3.7	17.9	76.9	0.0	7.4	10.5	0.0	2.8	0.0	64.3	13.6	1.8	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.1	2.8	4.2	22.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.2	13.7	1.8	1.9	0.0	4.1
HIST2H2AA4	H2A/r	ENSG00000272196	"Histone cluster 2 H2A family member a4"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 164.8;lymphoid tissue: 101.1"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 89.0;Ciliated cells: 155.2;Club cells: 42.1;granulocytes: 40.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Cell type enriched"	"Detected in all"	5	"neutrophil: 164.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 164.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 27.3;U-266/70: 68.1;U-266/84: 60.4"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				4.5	6.5	0.0	9.8	1.2	9.0	2.5	0.3	2.6	5.2	5.7	1.5	2.5	5.7	5.5	3.4	9.1	2.4	4.2	4.0	0.7		3.0	2.5	8.8	7.1	0.1	0.0	4.3	5.0	0.0	0.5	6.5	1.6	9.5	0.0	2.1	4.2	2.6	3.5	5.8	5.4	0.9	0.8	8.4	4.2	21.6	0.1	101.1	1.9	4.8	11.5	5.8	2.3	9.3	17.2	164.8	17.9	3.5	4.2	18.8	3.8	9.7	1.3	2.2	0.0	1.2	3.1	8.2	0.0	0.0	0.0	6.6	3.9	0.0	9.3	0.0	2.6	5.3	0.0	0.0	0.0	5.3	12.8	1.2	8.0	4.3	0.0	1.2	7.5	0.0	0.0	0.0	0.0	2.3	0.0	4.4	8.3	19.7	0.0	24.7	4.2	1.2	3.7	21.0	10.2	3.7	1.5	6.7	0.0	2.0	9.8	4.1	27.3	7.5	2.1	1.3	13.0	2.7	0.0	2.7	20.9	3.8	1.0	68.1	60.4	4.6	0.0	6.2	3.1	24.2	17.9	32.8	3.2	10.5	3.3	5.9	2.8	3.0	12.0	9.3	2.2	2.0	164.8	3.5	12.4	17.2	4.2	18.8											23.8	89.0	0.0	6.7	0.0	0.0	22.0	0.0	155.2	42.1	3.5	0.0	0.3	0.0	0.6	1.5	0.0	0.0	0.0	0.3	0.2	0.3	5.6	40.7	1.6	0.9	0.0	0.0	0.0	0.6	1.0	0.3	0.7	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	2.2	0.9	0.1	4.8
HIST2H3A	"H3/n, H3/o"	ENSG00000203852	"Histone cluster 2 H3 family member a"	Q71DI3	1	149852619-149854274	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 126.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;SiHa: 8.4;U-266/70: 7.4;U-266/84: 7.3"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"					"unprognostic (1.15e-1)"					"unprognostic (1.30e-1)"				"unprognostic (3.99e-2)"				1.3	0.9	1.3	22.4	2.0	4.6	2.1	5.0	3.6	0.5	4.4	0.0	0.0	1.2	0.5	1.5	6.6	0.9	1.3	1.9	1.3	0.6	0.4	1.0	1.6	5.9	0.7	0.0	0.3	2.4	0.2	0.7	4.5	0.0	2.4	0.3	0.0	1.3	0.3	0.6	0.9	2.9	0.2	1.1	6.1	1.5	2.1	0.0	126.9	0.4	8.5	12.6	0.7	0.7	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.3	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	0.4	2.6	0.0	0.1	0.2	0.8	5.6	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.3	0.1	0.6	2.5	3.1	0.1	2.3	1.5	2.1	1.8	4.0	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.4	2.3	0.4	1.0	1.5	1.8	0.0	0.6	4.8	0.3	0.4	7.4	7.3	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2	1.3	2.0	5.0	1.1	1.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST2H4B	H4/o	ENSG00000270276	"Histone cluster 2 H4 family member b"	P62805	1	149854045-149861210	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.4"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 3.0;Ciliated cells: 5.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.1;SiHa: 9.2;U-266/70: 10.9;U-266/84: 9.1"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"					"unprognostic (8.20e-2)"					"unprognostic (2.69e-1)"				"unprognostic (1.77e-1)"				1.5	3.2		0.0		1.2	0.5		2.3	0.0	0.1			1.3	1.9	2.4	0.0	2.8	0.0	1.9			0.8	0.7	0.2	0.4			1.4	1.1	0.0		0.2		1.4	0.4		0.5	0.5	1.8	0.0	0.3	2.0		1.2	0.8	0.0			0.0		0.0	0.0		8.3	4.1	9.4	3.4	2.1	4.4	4.4	0.0	0.0	1.0	0.2	1.0	1.1	0.2	1.7	3.3	0.2	0.0	0.0	0.7	1.0	1.7	0.9	0.2	0.0	0.6	0.0	0.2	1.8	0.6	0.0	3.8	0.0	0.0	0.1	0.0	2.7	0.0	0.3	0.0	1.4	1.3	2.4	0.0	5.6	0.1	3.6	0.3	0.5	0.1	1.0	0.0	1.3	0.4	0.1	0.4	0.7	6.1	3.7	9.2	1.0	0.3	0.0	2.0	0.2	2.2	0.4	2.2	0.6	0.2	10.9	9.1	1.5	0.9	0.3	1.4	2.6	2.1	2.4	2.5	3.4	4.4	3.2	2.9	2.1	3.1	8.3	2.3	3.7	9.4	2.1	1.7	4.1	4.2	4.4											3.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0
HIST2H2BE	"H2B, H2B.1, H2B/q, H2BFQ"	ENSG00000184678	"Histone cluster 2 H2B family member e"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.1"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 128.7;Syncytiotrophoblasts: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	14.3	16.2	9.8	22.2	10.0	19.4	16.9	17.2	14.0	31.3	9.0	11.2	10.5	6.4	18.5	24.9	25.5	13.3	9.6	51.1	13.1	10.1	12.5	10.2	27.5	24.5	12.4	8.7	28.0	13.4	5.8	15.4	17.2	8.5	72.8	7.6	19.4	24.1	15.3	43.1	33.5	8.6	18.8	18.2	22.0	17.5	9.3	11.6	198.1	12.1	12.4	25.3	27.2	33.8	2.3	4.5	29.9	5.5	0.7	1.2	5.1	1.1	1.1	1.9	0.4	10.3	2.8	0.9	4.1	2.7	1.7	0.5	0.4	1.8	0.2	1.1	3.6	2.4	4.5	1.5	0.7	0.9	1.4	1.2	0.3	4.6	0.8	3.2	0.3	5.4	9.4	3.4	0.7	2.8	2.1	0.5	1.7	4.9	24.3	2.1	6.9	1.2	2.1	1.2	9.4	2.5	1.5	0.7	5.5	1.6	0.9	13.1	2.1	14.1	1.9	1.0	4.8	10.0	0.9	0.7	1.3	14.7	0.9	0.3	40.5	21.7	1.1	1.7	1.5	0.8	8.4	2.1	3.8	0.7	3.2	1.2	0.8	0.9	1.1	1.6	2.3	1.2	1.1	29.9	0.7	5.5	4.5	1.0	5.1	9.8	10.0	17.2	8.5	13.1	10.1	12.4	8.7	8.5	11.6	8.9	11.7	10.4	57.7	5.4	47.2	56.8	2.5	12.0	5.7	34.9	21.6	22.3	23.2	13.5	1.1	4.5	15.3	23.3	5.9	10.4	14.1	128.7	10.5	5.9	22.3	20.6	53.7	8.6	11.0	0.0	4.6	16.7	18.6	4.6	18.8	12.9	8.3	21.0	0.4	8.8	32.5	0.0	9.8	0.5	6.1	11.8	134.0	22.4	9.0	59.1
HIST2H2AC	"H2A, H2A/q, H2AFQ"	ENSG00000184260	"Histone cluster 2 H2A family member c"	Q16777	1	149886975-149887364	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 47.7;bone marrow: 86.5;lymphoid tissue: 80.6"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"MCF7: 45.3"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.50e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (1.20e-10)"	"unprognostic (1.42e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.86e-5)"	10.5	8.5	4.2	6.5	4.2	86.5	8.6	3.1	4.1	13.8	7.5	2.8	5.4	4.6	8.1	6.0	10.9	6.4	8.1	13.2	3.9	3.1	8.2	6.1	10.5	12.5	2.9	3.7	15.3	15.8	3.6	7.6	8.4	2.3	10.6	4.3	13.8	6.0	10.1	7.2	10.1	6.4	9.7	7.6	10.7	5.8	4.9	2.4	80.6	6.0	8.1	10.5	16.2	8.9	15.8	11.6	47.7	15.9	7.9	11.0	10.8	2.6	3.2	3.7	11.2	0.0	0.6	5.5	0.7	0.9	1.8	2.7	1.9	0.7	5.5	0.1	0.2	0.3	1.2	0.2	1.2	0.0	0.3	4.4	1.3	0.4	9.4	0.0	3.2	2.9	0.7	0.2	0.1	0.4	0.1	1.3	1.4	1.1	6.7	0.4	45.3	3.8	3.2	4.8	3.1	7.8	1.2	1.5	1.0	0.7	1.9	1.1	5.2	1.5	0.8	2.5	0.3	0.4	3.2	1.1	0.8	7.4	1.4	1.9	3.1	1.9	2.8	2.0	4.4	1.6	17.0	15.9	8.1	11.0	10.6	10.0	6.2	9.7	8.7	8.1	15.8	6.8	6.7	47.7	7.9	10.6	11.6	7.3	10.8	4.2	4.2	3.1	4.1	3.9	3.1	2.9	3.7	2.3	2.4	6.0	6.4	11.2	15.2	3.3	9.8	1.6	7.6	2.7	5.7	1.8	9.8	4.0	8.3	12.0	3.7	6.8	8.0	46.7	11.6	15.4	4.3	7.6	8.1	6.4	8.1	7.9	9.1	6.2	7.6	2.1	7.5	12.4	3.3	19.0	6.1	13.7	11.0	4.3	6.0	3.9	14.1	0.0	6.2	0.4	1.6	5.5	7.3	11.7	6.3	11.2
HIST2H2AB		ENSG00000184270	"Histone cluster 2 H2A family member b"	Q8IUE6	1	149887524-149887916	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 126.3"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 2.4;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Muller glia cells: 4.3;Rod photoreceptor cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 8.0;U-266/70: 4.9;U-266/84: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	2.4	1.6	1.2	6.4	1.6	21.1	2.9	2.6	2.4	6.8	2.6	0.6	0.6	1.2	1.9	1.6	5.1	1.5	2.2	1.5	1.4	1.3	1.6	1.8	4.2	3.0	1.2	1.9	7.4	3.0	2.2	1.4	2.3	0.0	4.2	2.0	3.9	1.9	1.9	2.5	4.7	2.9	4.0	2.7	4.8	1.9	2.1	0.1	126.3	1.7	2.1	9.0	7.1	2.4	10.2	4.3	11.6	2.0	4.3	4.5	0.8	1.3	0.0	0.7	0.7	0.0	0.0	1.1	0.9	0.0	0.0	1.4	0.0	1.0	0.8	0.6	0.0	0.0	1.0	1.0	0.0	0.0	0.3	1.5	0.0	0.8	0.7	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.2	0.0	1.1	1.1	1.1	0.7	0.0	8.0	3.4	0.9	0.8	1.7	1.7	0.5	1.3	0.0	0.5	2.3	1.0	2.3	0.0	0.2	0.2	0.3	3.5	0.0	1.0	3.4	0.0	0.7	4.9	5.3	1.4	2.1	0.3	0.6	1.3	1.6	0.8	2.7	2.0	2.7	3.8	4.5	4.0	2.3	10.2	2.7	2.7	11.6	4.3	1.9	4.3	2.6	0.8	1.2	1.6	2.6	2.4	1.4	1.3	1.2	1.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	2.4	0.4	0.0	0.0	0.0	1.8	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.2	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7
BOLA1	CGI-143	ENSG00000178096	"BolA family member 1"	Q9Y3E2	1	149887890-149900798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 24.1;MCF7: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007005	Approved				"Intracellular and membrane"	NA	NA					"HPA007005: AB_1078294"	"unprognostic (5.73e-2)"	"unprognostic (9.86e-3)"	"unprognostic (8.84e-2)"	"unprognostic (8.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.41e-4)"	"unprognostic (3.14e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.93e-3)"	13.9	24.5	14.5	14.3	16.4	8.2	10.9	10.2	15.4	11.9	15.0	12.0	21.2	30.1	15.3	11.5	13.6	10.7	14.2	13.4	13.6	11.3	13.7	17.6	9.3	12.5	14.2	14.9	16.1	24.6	10.9	13.3	9.9	12.5	16.6	5.6	11.2	36.8	18.7	35.5	16.5	23.6	12.0	12.0	15.5	17.8	8.3	14.0	22.6	16.7	13.4	12.3	13.6	9.4	12.7	15.6	9.7	8.0	6.9	16.9	7.6	8.5	11.8	1.2	2.6	0.4	2.2	2.3	3.6	0.9	2.8	2.2	7.6	13.4	1.3	9.3	1.4	1.4	9.0	0.0	2.2	0.1	11.0	3.4	0.4	2.7	1.0	3.8	0.0	8.9	2.0	2.9	0.9	0.3	0.6	3.4	24.1	4.9	3.4	1.4	27.6	11.2	2.7	0.8	7.9	3.0	8.8	0.7	2.4	1.2	1.1	7.5	8.2	5.2	8.2	8.4	0.7	15.2	2.5	1.4	3.8	6.1	8.1	0.1	14.1	11.5	0.1	4.9	2.4	3.7	6.1	8.0	9.7	12.8	6.7	13.4	12.7	11.8	10.2	8.2	11.4	16.9	16.1	4.0	6.9	4.1	15.6	15.0	7.6	14.5	16.4	10.2	15.4	13.6	11.3	14.2	14.9	12.5	14.0	3.0	7.4	13.7	13.8	3.9	7.0	15.3	22.9	14.7	5.7	22.7	3.9	16.7	58.0	20.0	5.5	11.9	13.5	23.3	17.4	21.1	10.8	17.5	4.7	30.8	14.6	9.5	12.1	20.3	11.0	1.8	14.7	8.4	5.0	10.0	18.2	16.6	15.4	15.3	19.4	34.9	8.9	38.8	11.4	18.5	16.2	5.8	11.7	13.8	19.6	7.9
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917882	"FDA approved drug targets, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3;parathyroid gland: 34.0"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 95.8;Horizontal cells: 90.6;Muller glia cells: 25.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 27.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (8.05e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.24e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.81e-3)"	2.0	7.3	20.4	2.8	24.7	4.5	1.5	36.8	75.3	3.2	2.3	4.8	0.9	1.9	5.6	18.0	2.0	3.2	3.2	1.5	22.3	30.5	1.7	1.2	1.8	2.3	21.6	25.1	2.6	1.9	34.0	7.2	1.9	32.9	3.1	2.2	3.1	1.7	3.7	1.1	1.5	2.2	6.6	16.8	2.0	2.0	1.6	6.0	0.3	4.0	0.0	2.0	2.5	1.2	1.2	0.8	2.1	0.7	1.7	2.5	0.6	0.1	0.0	10.3	0.0	1.0	3.0	1.1	4.3	15.2	13.0	18.8	0.3	0.4	0.1	3.9	6.5	13.7	0.2	0.1	0.9	11.2	0.0	2.4	13.5	0.7	0.7	9.9	0.1	0.2	6.8	0.1	20.7	1.5	14.5	1.1	12.4	0.1	14.1	8.5	0.1	13.0	0.6	26.1	0.0	0.0	4.5	6.5	0.2	0.1	0.3	21.6	17.4	0.0	0.1	9.9	10.3	0.1	8.2	0.0	12.1	12.2	0.5	15.8	0.1	0.1	0.0	21.2	0.1	4.8	1.5	0.7	0.4	1.8	0.3	1.9	0.7	1.9	1.1	0.2	1.2	1.0	2.2	2.1	1.7	0.3	0.8	2.5	0.6	20.4	24.7	36.8	40.0	22.3	30.5	21.6	25.1	32.9	6.0	0.0	1.4	0.0	2.0	0.1	95.8	0.6	0.0	1.4	0.0	0.0	3.9	0.3	0.0	0.0	0.3	1.4	0.0	0.0	0.3	0.7	1.5	1.0	0.0	0.0	0.2	90.6	4.1	5.5	0.0	0.0	0.0	0.3	0.0	0.0	0.2	25.1	0.2	0.0	5.3	0.0	11.4	0.0	4.1	1.2	0.8	0.4	0.3	2.5	0.3	0.6
SF3B4	"Hsh49, SAP49, SF3b49"	ENSG00000143368	"Splicing factor 3b subunit 4"	Q15427	1	149923317-149928344	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028578, HPA064660"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028578: AB_10601601, HPA064660: AB_2685314"	"unprognostic (2.43e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.74e-7)"	"unprognostic (9.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	26.7	26.1	14.0	21.1	26.2	32.8	22.2	18.3	33.5	29.1	31.8	28.6	18.3	21.0	36.7	24.6	31.9	29.2	24.3	15.7	13.8	13.3	28.9	26.3	21.4	22.0	16.1	11.3	45.0	23.2	31.1	20.3	41.1	18.1	27.4	28.0	27.6	24.2	27.0	15.2	30.5	27.5	28.3	13.2	30.6	23.5	43.7	14.8	57.7	30.9	24.6	41.5	27.4	23.3	35.7	36.7	53.9	48.7	43.9	41.9	27.3	31.4	26.3	30.5	22.5	17.9	14.3	34.2	29.7	25.9	39.6	31.9	28.6	25.0	31.5	18.9	31.9	24.2	33.5	36.6	31.6	43.1	17.8	20.8	30.1	17.7	22.4	24.9	38.2	36.9	16.1	27.8	38.5	22.1	15.5	21.5	27.0	23.1	26.4	42.3	82.7	42.6	26.8	43.7	41.9	28.5	32.5	28.0	31.7	30.3	30.8	17.0	31.7	26.4	32.2	18.7	39.0	47.3	38.0	17.6	33.8	37.4	27.6	46.5	36.8	55.5	37.7	27.0	28.1	31.0	29.0	35.8	53.9	39.0	46.5	40.1	35.7	37.2	41.9	31.1	31.7	35.2	33.1	48.4	43.9	48.7	36.7	41.2	27.3	14.0	26.2	18.3	33.5	13.8	13.3	16.1	11.3	18.1	14.8	14.9	12.0	26.4	39.1	48.1	20.2	3.1	7.6	46.8	20.5	22.7	3.9	68.7	51.4	55.7	52.0	20.0	32.7	23.3	45.2	64.5	34.9	20.8	38.1	13.9	46.6	7.9	25.0	13.5	21.3	6.6	41.7	30.8	23.6	67.7	33.6	24.6	48.6	31.9	27.6	31.1	14.9	45.3	36.3	52.7	55.6	44.8	79.2	34.8	33.6	41.1
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 108.3;Mucus-secreting cells: 58.0;Paneth cells: 72.4;Undifferentiated cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	37	"dendritic cells: 4.2;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.7;OE19: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030351, HPA072906"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA030351: AB_10602185, HPA072906: "	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.2	12.0	4.9	15.0	8.4	0.0	5.4	1.5	3.9	9.5	36.8	2.7	5.8	15.9	10.0	6.2	4.4	7.2	17.0	3.1	2.6	2.8	9.7	1.8	3.4	1.5	2.0	2.8	14.5	2.2	5.8	6.3	9.6	5.2	5.5	20.8	4.5	2.1	6.5	1.1	7.4	49.9	11.4	5.0	1.8	4.0	4.9	2.5	0.0	1.6	4.0	1.5	5.8	6.8	0.0	4.2	0.0	3.2	0.0	0.0	0.5	2.3	5.7	2.5	2.1	7.4	8.4	4.7	2.4	8.2	3.2	4.0	0.1	10.3	0.0	5.6	8.4	4.0	3.3	0.3	4.1	1.8	0.1	0.0	0.0	1.7	0.7	1.9	0.0	0.0	5.2	1.3	3.2	5.3	13.7	3.8	0.0	0.1	0.1	6.3	7.7	0.0	0.0	0.5	16.5	2.0	0.0	0.9	0.1	4.8	0.7	0.1	0.2	1.4	2.3	0.8	1.2	2.5	0.0	2.6	3.5	4.3	2.9	1.9	0.2	0.9	0.0	3.3	0.0	0.3	0.0	1.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.5	4.9	8.4	1.5	3.9	2.6	2.8	2.0	2.8	5.2	2.5	0.0	1.1	0.0	2.5	3.7	0.0	1.6	10.2	1.4	3.4	14.0	0.0	11.9	1.7	12.5	0.5	2.1	108.3	0.0	15.3	9.0	8.1	2.6	0.0	1.1	4.9	0.0	15.1	4.9	13.3	0.0	5.2	6.4	1.7	3.6	58.0	0.0	28.8	72.4	11.3	15.3	0.0	6.5	6.2	0.3	0.2	5.6	23.8	1.3	48.1	3.7
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010676	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	8.8	6.2	5.8	2.6	12.3	0.3	6.2	8.5	8.9	8.6	6.3	20.6	4.0	4.6	8.5	4.1	6.1	7.6	4.3	5.3	6.0		4.5	8.6	5.6	0.9	12.7	5.1	9.2	4.5	12.5	4.3	5.3	11.6	5.3	5.6	7.4	5.4	6.3	13.2	4.3	5.1	8.9	8.5	2.3	5.2	9.6	12.5	0.0	8.3	2.3	2.1	6.3	7.1	0.6	0.6	4.7	0.3	1.4	2.3	0.2	11.5	9.3	6.5	10.9	8.6	8.1	6.2	8.2	12.0	9.8	6.8	6.8	9.4	0.1	5.3	14.8	4.4	9.2	9.2	9.0	10.4	11.1	4.7	4.4	12.9	4.6	9.2	5.0	4.9	8.9	7.0	16.6	14.6	7.7	8.0	1.4	12.1	12.6	7.0	11.8	0.9	1.4	8.3	8.7	9.1	1.2	9.0	2.9	3.8	15.9	4.2	8.0	14.4	10.6	12.9	8.9	8.8	2.7	9.5	10.2	9.5	6.8	9.5	13.5	13.0	1.3	9.1	1.5	16.7	4.7	0.3	1.3	2.3	0.2	1.7	0.6	1.0	1.4	0.1	0.6	0.9	1.0	1.2	1.4	0.3	0.6	0.6	0.2											32.8	9.4	2.2	22.0	14.2	25.3	16.2	12.7	12.0	15.9	10.4	100.1	16.8	6.6	11.5	56.6	14.7	19.3	23.3	9.6	7.6	13.6	16.9	0.0	29.3	2.8	22.3	16.7	12.3	0.6	57.7	13.6	2.5	35.4	7.2	12.2	25.5	16.8	21.0	21.5	10.3	66.3	0.0	11.3	10.7	6.4	14.4	17.7	6.7	9.2	21.0
VPS45	"h-vps45, H1, VPS45A, VPS45B"	ENSG00000136631	"Vacuolar protein sorting 45 homolog"	Q9NRW7	1	150067279-150145329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 156.0;Late spermatids: 101.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027425, HPA027441"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA027425: AB_10599415, HPA027441: AB_10602284"	"unprognostic (1.57e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.36e-3)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (4.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-2)"	15.5	22.1	26.4	9.8	29.6	4.9	15.9	40.7	25.9	19.1	15.4	12.2	13.8	10.5	16.0	21.0	14.9	13.5	12.1	32.4	19.6	16.7	18.9	10.6	13.3	10.4	17.4	21.8	13.0	8.7	20.0	26.5	14.9	17.6	17.3	15.5	13.5	11.7	18.7	14.3	12.4	13.8	22.3	19.8	12.6	13.8	9.0	20.1	12.3	17.7	9.3	12.8	15.5	12.4	11.1	18.6	12.7	20.1	9.3	12.3	12.4	15.9	12.5	21.9	14.2	20.4	16.3	10.1	23.2	12.5	24.4	20.3	9.2	14.0	9.8	14.1	19.4	10.7	13.7	22.4	14.2	26.8	19.2	16.4	12.5	17.7	8.5	13.5	8.9	16.3	14.2	13.3	23.3	12.4	16.1	19.7	20.1	17.4	14.9	21.3	27.0	17.4	8.9	15.1	14.8	20.3	12.2	22.3	13.9	16.9	15.4	15.2	32.2	18.1	16.1	23.9	26.1	26.1	23.9	17.1	11.2	13.3	10.0	16.2	11.2	24.1	9.5	16.7	12.7	15.9	12.7	19.0	3.2	12.3	20.1	11.5	11.1	10.7	11.6	18.6	8.6	10.2	10.8	1.9	9.3	13.3	10.2	11.8	12.4	26.4	29.6	40.7	25.9	19.6	16.7	17.4	21.8	17.6	20.1	11.9	12.3	6.6	7.5	6.5	19.3	42.4	10.2	8.1	4.5	15.7	17.7	18.9	6.6	10.2	156.0	7.5	7.3	0.0	6.4	7.5	10.8	6.9	5.8	6.2	16.6	28.6	7.5	12.3	14.0	101.3	19.8	10.7	10.1	12.6	6.8	19.3	8.4	12.2	13.8	7.3	21.7	32.3	12.3	16.4	15.6	6.8	12.4	7.1	9.2	6.8
PLEKHO1	"CKIP-1, OC120"	ENSG00000023902	"Pleckstrin homology domain containing O1"	Q53GL0	1	150149183-150164720	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 60.7"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 188.6;Late spermatids: 315.7;monocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061018			Supported	Mitochondria		NA	NA			Mitochondria		"HPA061018: AB_2684416"	"unprognostic (1.41e-2)"	"unprognostic (7.04e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.47e-11)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.52e-2)"	10.9	17.0	14.2	34.4	22.1	10.2	10.5	17.0	14.4	9.6	44.5	5.4	6.4	11.8	16.9	7.7	16.8	11.9	14.1	17.8	10.2	6.9	5.8	5.8	12.9	29.0	8.2	13.1	13.5	2.5	1.4	3.5	10.1	8.0	18.2	8.3	7.9	4.7	12.1	15.8	3.6	17.4	60.7	6.5	29.4	22.3	24.8	7.3	15.0	3.8	3.1	17.4	29.3	17.7	11.0	16.0	18.7	15.8	2.1	5.1	5.4	5.1	1.2	17.5	13.6	5.6	5.0	1.4	9.0	12.5	12.3	10.9	0.3	0.1	0.1	1.8	10.6	9.1	0.4	8.7	0.4	4.0	31.1	4.4	1.0	0.7	3.2	10.7	7.1	29.6	7.4	0.4	15.3	2.3	11.7	11.6	14.5	1.9	13.7	16.7	2.4	27.1	14.2	16.4	0.0	2.4	24.7	9.5	5.9	2.0	1.5	11.0	17.9	0.7	0.0	6.8	8.8	0.9	7.1	16.2	8.1	9.2	8.4	10.8	5.2	0.1	3.2	32.3	0.0	3.1	1.5	15.8	0.3	3.5	14.1	3.8	11.0	5.1	3.7	11.7	10.5	3.5	3.0	18.7	2.1	12.8	16.0	3.7	5.4	14.2	22.1	17.0	14.4	10.2	6.9	8.2	13.1	8.0	7.3	32.8	12.8	62.7	62.8	19.2	5.4	33.9	5.1	0.0	2.3	0.0	0.0	1.4	1.7	6.5	188.6	39.6	0.0	0.0	6.7	2.5	27.6	51.8	5.7	0.9	96.3	7.9	17.0	51.5	68.8	315.7	16.1	106.5	23.6	146.1	0.1	32.6	10.1	0.0	23.0	0.0	6.1	71.1	83.4	126.2	12.1	12.4	1.3	24.5	0.3	24.4
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		18000	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	11.5	18.3	31.2	21.0	30.9	38.4	10.6	50.3	20.6	14.3	11.3	18.3	13.5	12.9	16.5	21.0	12.8	12.8	11.9	19.8	22.9	25.9	18.6	16.8	13.3	38.4	26.5	19.5	19.1	6.9	20.1	14.7	12.3	21.2	14.2	10.9	20.1	9.2	20.9	25.5	12.5	14.5	25.2	32.7	20.3	9.9	6.0	17.8	52.2	18.1	13.6	34.7	20.6	12.1	24.5	8.2	20.7	10.5	14.6	27.0	15.7	34.3	22.2	46.4	23.0	3.6	5.4	17.7	18.5	10.5	17.9	17.2	16.4	24.4	62.6	16.5	10.6	10.6	12.0	26.1	11.5	25.7	71.6	15.8	43.3	27.6	23.6	3.4	87.0	22.0	4.4	1.8	16.7	15.4	8.8	13.2	30.5	41.4	37.1	16.3	35.6	35.5	22.7	46.8	11.2	10.2	37.8	25.8	32.9	12.7	13.8	15.2	26.2	38.6	6.2	10.8	21.5	16.8	44.5	13.6	9.2	25.9	9.4	36.9	47.9	48.1	61.3	10.4	62.8	16.7	20.7	10.5	16.3	18.0	7.3	27.0	24.5	24.2	19.7	8.2	17.0	17.4	21.6	7.2	14.6	8.8	5.7	25.7	15.7	31.2	30.9	50.3	20.6	22.9	25.9	26.5	19.5	21.2	17.8	11.9	78.4	61.4	38.4	86.4	117.9	90.4	22.9	60.2	30.7	69.8	31.4	37.5	72.9	27.5	1.1	45.4	12.3	140.2	23.2	113.7	65.8	16.5	60.2	48.9	46.0	60.4	13.8	39.9	41.9	1.4	28.1	57.2	64.1	62.3	11.5	131.8	20.8	17.5	31.5	44.8	110.8	25.8	85.5	9.3	21.8	86.1	34.0	89.3	28.0	19.3
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	16	"Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.7	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	22.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.1	57.1	4.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7	3.0	0.3	0.0	0.2	1.9	1.4	44.5	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	50.6	0.0	0.0	123.0	1.2	0.0	3.2	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.4
APH1A	"APH-1A, CGI-78"	ENSG00000117362	"Aph-1 homolog A, gamma-secretase subunit"	Q96BI3	1	150265399-150269580	"Predicted membrane proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037272	Approved					NA	NA					"CAB037272: AB_476776"	"unprognostic (1.00e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.87e-1)"	31.2	35.7	19.6	38.4	22.5	22.4	65.7	15.1	22.6	29.1	38.4	26.0	41.7	27.5	24.0	51.8	42.5	29.3	55.4	41.2	18.0	16.0	36.2	76.7	68.6	49.3	22.2	17.1	39.0	42.9	30.0	22.3	31.9	15.1	25.2	33.0	30.4	43.0	55.7	22.9	42.9	46.4	23.2	20.6	38.7	31.9	23.4	15.3	24.3	42.0	51.2	34.6	26.2	30.1	11.6	13.1	13.0	13.3	13.9	17.1	10.4	50.7	21.9	26.8	41.1	33.9	28.0	35.0	19.1	39.8	43.4	45.5	17.8	58.3	28.5	27.7	33.4	21.5	41.7	22.9	33.1	30.4	25.6	28.4	21.1	14.8	22.9	42.0	38.7	32.3	34.9	46.8	29.3	35.2	31.6	47.0	29.8	23.1	48.9	27.7	63.3	26.2	22.8	29.9	37.2	36.8	30.7	27.4	45.9	31.9	34.8	22.1	49.9	18.9	31.4	38.9	26.2	40.8	69.2	26.6	25.0	23.9	24.2	33.2	70.4	57.6	25.5	21.3	41.1	27.1	10.2	13.1	10.3	15.8	12.6	17.1	11.6	10.8	10.4	13.1	10.8	10.2	11.4	13.0	13.9	13.3	12.7	5.2	10.4	19.6	22.5	15.1	22.6	18.0	16.0	22.2	17.1	15.1	15.3	20.8	21.0	92.4	68.7	58.4	22.9	21.5	63.7	12.0	20.5	78.5	7.9	113.6	28.2	110.3	3.4	69.7	71.2	0.0	137.8	120.0	70.6	69.6	34.6	57.6	141.6	35.0	72.6	58.3	101.2	4.9	55.8	86.1	59.1	112.8	97.0	51.0	108.9	69.1	38.2	41.9	16.1	25.8	26.7	14.4	17.4	71.5	138.3	63.7	106.4	96.6
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"myeloid DC: 36.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.2"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2"	"Low region specificity"	"Detected in all"							"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	16.0	8.8	16.4	19.0	19.3	4.5	13.8	5.8	10.5	11.9	14.0	4.5	19.1	5.8	19.8	21.1	11.0	17.1	21.6	13.8	13.7	13.7	12.7	12.0	11.8	21.5	21.8	8.3	8.3	6.8	2.0	6.7	24.4	14.0	15.3	11.1	10.9	9.8	30.4	13.4	4.5	8.1	24.1	20.4	27.3	8.3	5.7	14.8	4.9	8.3	17.1	11.2	22.0	14.3	0.3	36.2	0.4	7.7	0.2	1.5	2.2	0.5	0.1	20.9	31.6	22.4	37.5	0.6	3.4	5.0	0.9	3.0	0.2	0.6	0.2	1.1	3.0	0.4	0.9	0.0	0.1	1.1	0.3	3.7	0.6	0.5	0.3	4.6	1.1	0.8	30.3	1.5	6.3	0.5	3.7	29.2	0.5	0.4	4.1	3.2	1.2	0.2	7.2	1.7	0.0	1.1	5.2	0.5	0.4	0.3	1.6	0.4	0.4	0.4	0.2	2.3	4.2	0.4	15.8	0.2	7.5	0.6	0.2	0.3	1.7	1.4	0.3	16.6	0.9	0.2	0.0	7.7	0.3	0.2	6.8	0.9	0.3	1.5	0.6	36.2	0.3	1.5	0.8	0.4	0.2	1.9	0.7	0.6	2.2	16.4	19.3	5.8	10.5	13.7	13.7	21.8	8.3	14.0	14.8	3.0	5.0	2.4	2.0	5.7	0.8	6.2	2.5	0.0	2.3	21.0	0.0	1.0	64.6	0.5	7.4	64.6	2.1	0.0	2.0	0.7	22.1	1.8	1.1	0.8	45.5	0.0	1.2	49.1	98.9	15.7	88.1	71.5	11.8	20.8	1.1	11.1	1.5	0.8	97.9	2.6	1.3	32.3	69.0	16.6	1.3	4.4	3.0	2.5	1.2	5.5
CIART	"BC017397, C1orf51"	ENSG00000159208	"Circadian associated repressor of transcription"	Q8N365	1	150282543-150287093	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Bipolar cells: 40.0;Cone photoreceptor cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.4;memory CD4 T-cell: 3.8;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	38	"T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;Karpas-707: 23.6;U-266/84: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027515, HPA054349"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027515: AB_10600757, HPA054349: AB_2682457"	"unprognostic (1.77e-1)"	"unprognostic (5.63e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.42e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.34e-2)"	4.8	10.0	6.9	2.9	18.4	0.6	6.7	14.2	26.5	9.1	11.8	6.3	11.1	3.0	7.4	8.2	7.3	6.2	4.0	23.5	5.4	7.1	8.3	11.5	3.0	2.1	4.9	5.8	11.5	4.4	7.5	10.6	2.6	8.4	7.2	2.8	20.5	14.2	21.1	40.2	19.7	4.9	12.9	3.1	2.4	7.3	6.3	4.2	0.8	16.1	19.6	6.5	10.3	5.2	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.1	0.6	4.8	2.2	1.8	0.8	4.1	2.9	7.1	3.8	5.0	1.1	16.2	0.0	5.0	6.2	8.6	2.8	0.1	2.8	5.7	0.0	0.4	0.1	0.2	0.0	6.5	0.9	2.4	2.5	4.3	9.6	2.0	8.9	0.6	0.1	0.1	23.6	2.1	12.5	0.0	0.5	5.3	2.8	11.9	0.6	0.0	0.1	3.8	0.6	2.5	0.9	4.8	0.4	8.6	1.2	4.1	0.4	1.2	10.8	0.1	0.4	6.3	5.0	16.8	0.1	9.7	0.0	6.4	0.0	0.0	0.0	0.5	0.0	3.4	0.0	3.8	0.0	0.0	0.0	2.4	1.2	0.0	0.0	0.0	0.0	0.3	0.3	6.9	18.4	14.2	26.5	5.4	7.1	4.9	5.8	8.4	4.2	0.0	1.0	0.0	5.3	0.0	40.0	5.6	5.1	1.4	2.3	0.0	96.2	0.2	8.3	2.5	0.2	1.1	1.3	0.0	1.3	0.1	0.0	3.5	0.0	3.0	1.0	6.4	2.4	0.6	0.0	1.1	4.9	0.3	0.0	1.8	0.3	18.4	3.1	0.3	8.9	2.6	18.0	0.0	2.9	4.3	7.9	0.0	0.0	0.0	0.6	1.0
MRPS21		ENSG00000266472	"Mitochondrial ribosomal protein S21"		1	150293720-150308979	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA078289			Supported	Mitochondria		NA	NA			Mitochondria		"HPA078289: AB_2686881"	"unprognostic (3.48e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.46e-1)"	10.5	17.7	10.8	8.6	16.5	8.6	14.2	8.7	18.8	9.7	8.5	8.1	9.7	10.1	10.4	15.1	9.5	12.1	9.3	15.0	8.9		13.3	12.2	8.1	10.3	8.4	16.7	16.4	11.5	10.9	13.6	8.3	15.9	9.3	7.5	10.0	9.9	12.2	16.9	9.0	8.6	10.3	7.9	9.6	9.9	10.3	9.3	6.2	13.8	11.7	11.7	8.7	9.4	37.8	43.7	15.7	25.8	21.2	36.9	30.3	25.9	21.8	28.2	14.3	27.0	26.8	23.3	19.2	16.4	19.1	18.5	4.5	24.8	26.6	13.3	21.0	5.6	24.9	24.1	20.5	17.1	17.9	31.0	15.4	32.3	31.7	21.4	23.0	13.5	29.6	21.9	23.0	26.2	11.4	24.1	23.4	25.4	35.2	25.4	59.7	19.5	21.1	48.0	50.2	38.2	17.8	14.6	45.2	22.0	19.2	21.8	45.9	16.2	32.9	31.2	32.2	17.9	33.7	17.0	7.4	14.1	19.8	21.1	30.5	32.1	26.5	9.6	12.8	14.1	11.8	25.8	15.7	24.8	24.5	29.7	37.8	32.2	28.3	28.6	33.1	36.9	31.3	6.0	21.2	21.9	43.7	30.1	30.3											104.2	104.0	163.5	169.4	106.9	66.9	259.0	229.3	202.1	128.5	249.5	31.4	245.7	446.0	195.9	694.8	155.8	149.1	70.0	269.9	209.7	167.2	161.3	128.3	304.8	248.0	46.1	133.1	141.8	166.8	412.5	213.2	158.3	172.1	281.3	121.3	85.2	275.1	103.0	219.2	414.9	47.8	97.0	163.5	202.6	93.1	128.6	196.7	126.4	148.9	171.7
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321476-150353195	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027226: AB_1855770, HPA067116: AB_2685783"	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	21.9	18.6	22.1	28.6	24.0	38.4	23.3	37.8	27.5	21.2	20.0	25.6	27.8	16.7	35.7	27.9	18.6	21.5	17.4	17.3	18.9	12.3	17.6	19.7	20.9	26.2	19.6	19.5	32.7	17.4	22.5	41.9	23.5	17.0	22.0	20.3	27.7	18.9	23.2	19.2	21.6	20.1	22.5	23.6	26.8	16.2	18.9	24.0	27.6	27.7	18.1	27.3	20.7	20.9	13.2	9.3	12.4	19.1	9.9	15.6	7.7	16.0	17.4	17.7	11.3	11.9	13.0	24.1	16.8	11.8	26.1	18.1	13.3	15.1	21.3	11.3	13.7	24.4	19.0	32.0	11.8	23.5	10.6	14.8	18.4	25.3	12.6	11.9	22.6	11.9	9.4	16.4	22.2	19.2	12.4	15.8	14.4	21.8	12.9	18.5	23.9	18.5	19.7	25.4	41.4	15.8	27.0	14.4	14.0	10.7	9.7	15.3	13.5	14.1	16.6	12.7	25.0	19.7	54.5	12.5	16.4	12.7	13.8	27.6	12.4	22.2	23.9	10.9	20.5	17.0	6.9	8.6	12.4	15.6	11.4	15.0	13.2	11.3	10.1	9.3	10.2	11.7	12.1	5.2	9.9	19.1	7.5	8.5	7.7	22.1	24.0	37.8	27.5	18.9	12.3	19.6	19.5	17.0	24.0	32.8	22.6	8.6	11.5	10.4	29.6	10.9	5.1	22.7	21.6	10.4	17.7	13.9	11.6	12.9	7.7	17.9	12.4	0.0	10.1	13.5	9.9	9.7	22.0	8.9	10.6	30.2	2.4	12.9	9.1	3.2	18.7	11.2	10.1	11.8	13.3	29.6	11.0	8.6	17.3	4.4	42.9	12.9	14.1	41.1	14.0	8.8	16.7	14.9	10.1	8.8
RPRD2	"FLJ32145, HSPC099, KIAA0460"	ENSG00000163125	"Regulation of nuclear pre-mRNA domain containing 2"	Q5VT52	1	150363091-150476566	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061693	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		91000	"Nucleoplasm, Vesicles"		"HPA061693: AB_2684587"	"unprognostic (1.68e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.38e-1)"	14.0	16.9	16.8	12.0	21.6	13.2	14.0	40.1	22.1	20.2	17.9	21.4	16.6	11.5	21.0	16.4	17.0	24.2	12.2	14.1	16.3	14.1	18.3	12.5	14.0	13.8	16.3	14.1	34.2	17.9	27.5	29.4	10.7	15.2	18.3	16.3	19.8	14.5	19.2	28.5	15.6	13.9	20.1	13.8	16.7	14.2	16.2	17.4	25.6	25.4	10.4	17.3	21.6	17.1	8.0	4.2	6.0	8.6	5.1	9.1	2.5	15.8	12.1	16.1	16.2	16.7	14.2	15.2	11.5	13.7	12.7	12.5	10.4	19.5	25.1	13.2	14.0	7.1	17.6	22.5	17.1	13.9	11.5	9.5	14.4	14.3	12.5	12.0	21.5	17.8	15.0	13.0	17.7	23.4	14.1	15.6	15.4	14.0	27.4	12.8	22.8	18.9	7.0	20.1	20.0	13.7	17.4	11.9	25.3	18.6	14.6	17.1	17.3	23.5	20.0	15.2	15.0	15.8	19.2	14.3	11.8	12.2	9.8	16.2	16.8	18.4	19.0	11.7	16.2	11.5	6.0	3.6	4.4	8.1	2.4	7.4	7.6	7.6	6.4	3.5	8.0	8.9	8.8	2.0	5.1	8.6	4.2	9.1	2.5	16.8	21.6	40.1	22.1	16.3	14.1	16.3	14.1	15.2	17.4	17.9	20.4	25.7	8.7	13.7	32.3	23.0	17.8	20.1	27.3	31.4	15.7	11.8	6.6	11.0	7.2	20.1	14.2	0.0	11.2	7.3	13.6	13.3	17.3	22.2	12.7	11.1	24.8	25.8	16.8	3.2	35.1	10.1	10.1	10.8	22.5	25.1	12.3	14.0	37.4	22.1	27.5	32.3	12.7	21.8	23.4	12.8	8.4	23.6	23.4	9.9
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	10.7	21.1	16.5	10.5	17.8	9.2	11.3	17.5	21.4	10.2	10.9	14.8	12.9	9.4	10.5	14.7	15.7	13.0	11.8	20.9	18.1	12.3	15.6	26.8	9.1	14.0	15.0	19.7	13.3	11.5	20.4	12.2	9.4	16.5	9.8	12.5	13.3	11.3	10.9	36.0	13.3	10.5	10.9	13.8	15.1	12.4	10.7	16.6	10.6	12.3	12.2	15.7	12.5	10.8	21.5	17.4	20.4	18.6	21.5	20.9	12.2	17.2	14.4	9.7	14.7	11.0	10.1	18.5	8.4	9.2	16.7	16.8	11.7	16.1	25.0	18.6	6.3	11.5	18.0	23.6	19.5	12.8	15.0	20.5	11.8	13.7	11.8	10.9	16.3	18.1	8.9	16.4	12.6	17.2	10.9	10.7	14.0	20.5	17.6	11.6	20.8	13.7	13.3	12.0	23.9	21.5	14.2	12.4	30.9	11.3	8.1	13.8	16.2	12.7	28.2	19.8	14.4	22.7	25.5	6.3	9.7	10.4	8.0	14.1	17.0	20.0	18.8	14.5	19.0	9.4	15.1	11.0	20.4	15.7	18.3	15.6	21.5	15.4	15.5	17.4	18.6	15.1	15.8	1.7	21.5	18.6	11.7	20.9	12.2	16.5	17.8	17.5	21.4	18.1	12.3	15.0	19.7	16.5	16.6	3.0	13.8	7.2	4.6	3.0	15.8	19.0	12.7	10.7	12.5	7.0	19.6	21.6	10.0	9.9	0.9	6.3	6.6	0.0	8.6	11.4	6.0	3.8	21.9	15.3	11.8	14.3	4.1	7.4	6.5	2.1	7.8	8.0	3.3	16.2	8.9	8.4	9.9	0.0	6.7	6.3	15.4	6.5	7.2	15.4	11.1	3.4	11.8	7.0	10.8	4.1
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.2	0.6	2.3	0.0	14.0	77.4	2.1	22.7	53.9	14.2	18.6	0.3	3.5	0.1	0.2	50.8	1.6	13.1	0.0	2.7	14.9	0.1	0.1	0.9	0.8	0.1	3.9	0.0	23.5	6.8	0.1	36.5	1.3	20.9	3.9	0.1	4.8	0.1	39.5	0.0	0.0	0.7	0.2	26.5	0.7	0.3	17.0	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.4	1.1	0.0	6.0	1.0	30.1	4.5	3.4	4.9	0.1	0.2	0.2	15.8	2.1	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0	0.0	0.6	1.4	1.8	13.1	0.7	1.1	12.7	0.0	2.3	3.5	0.0	1.3	0.0	4.8	0.2	4.4	0.2	0.0	3.7	26.0	80.6	1.0	10.3	0.6	16.0	1.6	0.0	56.4	2.1	0.0	9.2	4.8	70.9	0.0	0.3	0.8	42.0	0.0	20.8	0.0	1.1	12.9	16.1	0.5	0.4	16.7	9.2	0.0	0.2	5.8
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 157.1"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		47000000	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	14.4	2.4	0.8	8.9	1.4	2.2	13.2	0.7	1.1	11.0	8.2	1.5	3.9	2.2	9.7	8.1	19.7	11.1	6.6	10.7	1.0	0.2	3.4	14.9	13.3	2.3	1.4	0.4	14.5	1.8	0.2	1.3	157.1	3.4	9.4	2.4	19.1	5.7	2.3	21.1	5.4	6.0	17.4	2.2	3.9	8.9	3.3	1.1	0.8	3.8	15.5	4.8	19.1	15.9	0.0	0.5	2.3	3.5	0.0	0.1	0.6	6.7	0.1	0.1	1.2	6.2	30.2	63.6	6.5	5.7	3.9	2.2	0.5	2.6	0.0	1.3	4.4	0.0	3.4	0.2	0.9	1.6	0.5	0.1	1.9	0.7	2.7	5.0	0.0	0.9	14.2	0.2	0.9	2.2	3.3	0.0	0.0	20.3	0.2	0.6	0.1	0.0	0.3	1.1	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.2	2.0	5.0	0.0	3.3	1.4	3.5	1.2	0.2	1.8	2.7	0.1	0.6	0.1	1.4	0.2	1.2	0.1	0.0	1.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	3.5	0.0	0.0	0.6	0.8	1.4	0.7	1.1	1.0	0.2	1.4	0.4	3.4	1.1	0.0	1.0	0.8	2.1	2.2	1.0	2.0	7.6	1.4	0.0	0.0	0.0	113.3	0.0	1.1	0.4	3.5	0.0	0.0	0.5	39.4	15.5	1.3	2.3	9.2	28.7	0.0	0.0	1.3	22.6	0.0	27.9	16.5	3.3	25.2	0.0	2.4	7.4	0.0	3.2	0.0	2.4	0.0	1.4	0.0	0.9	2.5	83.2	0.0	0.1	1.7
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1, BCL2 family apoptosis regulator"	Q07820	1	150574551-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 335.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Approved		Enhanced	Mitochondria		Yes	No			Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	67.7	37.1	19.0	59.3	21.6	134.5	46.3	15.3	18.9	35.9	38.5	19.0	23.9	21.2	36.1	27.6	56.5	57.2	73.3	32.5	20.4	14.9	30.5	76.7	61.8	52.4	28.2	11.4	32.1	41.9	20.3	27.7	59.4	26.7	34.0	30.7	31.0	36.0	24.5	39.8	45.7	50.2	38.9	26.4	51.1	44.3	19.8	23.0	32.3	45.4	53.3	57.4	40.6	59.4	5.0	6.2	42.1	8.0	3.8	11.1	3.9	10.0	5.2	9.7	5.8	19.6	20.6	13.2	12.3	12.7	13.0	10.5	6.4	8.3	12.8	7.3	8.8	7.0	13.5	7.3	14.8	13.1	10.5	5.0	5.2	8.3	7.4	15.4	8.8	11.9	11.3	17.0	12.7	24.8	12.1	14.3	3.9	11.7	18.6	17.0	11.1	4.3	6.7	17.8	8.6	9.1	6.6	7.8	6.7	14.3	7.3	7.5	10.1	8.8	12.0	15.9	15.3	7.6	13.6	17.5	8.3	8.7	5.2	15.5	23.8	27.9	335.8	14.2	7.0	10.8	7.6	8.0	18.8	6.1	6.5	7.2	5.0	8.0	6.7	6.2	4.6	9.6	7.2	42.1	3.8	5.8	3.7	11.1	3.9	19.0	21.6	15.3	18.9	20.4	14.9	28.2	11.4	26.7	23.0	184.6	337.7	161.5	413.1	434.6	37.7	75.0	170.7	65.6	141.0	31.4	56.9	80.9	34.9	139.8	191.3	189.6	281.5	23.3	149.6	178.6	195.3	286.6	340.1	210.0	235.2	11.1	249.0	192.8	356.1	271.6	67.3	381.9	259.8	113.6	185.2	58.8	165.7	122.2	57.3	57.2	70.9	77.6	218.3	33.9	33.0	500.0	226.1	179.7	132.6	219.4
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 625.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"U-698: 429.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		22000	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	30.3	26.4	48.9	26.9	48.9	46.8	33.0	33.8	69.3	31.7	31.8	28.0	26.8	34.4	29.7	45.4	66.3	26.3	28.5	30.0	42.4	37.9	31.7	32.3	28.6	30.0	42.0	39.0	27.7	30.5	33.0	25.2	37.5	34.6	23.9	30.4	28.5	29.4	22.8	67.7	49.8	34.0	27.3	38.3	23.8	28.7	12.8	27.3	25.8	35.2	42.9	35.5	31.7	36.3	34.4	39.5	49.5	33.6	33.0	33.2	38.4	14.7	7.7	10.8	10.4	6.9	5.7	11.7	6.6	6.7	9.9	8.4	8.7	11.1	13.2	11.0	5.3	6.2	11.9	8.7	14.7	7.3	22.8	12.1	18.9	10.9	6.6	4.6	15.2	24.4	4.5	9.1	10.3	13.2	5.5	9.3	10.5	14.4	27.8	6.6	31.8	15.0	12.4	21.6	17.4	9.6	14.6	9.0	16.4	13.0	13.0	16.2	10.2	9.4	19.8	10.3	9.5	27.1	22.4	9.8	7.4	13.7	8.8	17.1	15.6	22.7	429.6	10.2	17.7	9.7	28.7	30.7	49.5	32.2	33.6	28.9	34.4	27.0	33.2	39.5	31.8	22.3	32.9	29.0	33.0	31.9	30.2	29.8	38.4	48.9	48.9	33.8	69.3	42.4	37.9	42.0	39.0	34.6	27.3	38.7	144.0	138.7	185.4	169.1	60.1	89.1	79.0	109.7	114.9	78.5	43.2	247.9	215.5	139.6	6.0	100.3	151.4	46.7	132.7	150.0	85.0	114.8	218.3	71.0	175.6	63.5	125.5	52.8	77.7	11.1	79.7	128.3	97.8	625.8	119.8	57.9	90.7	136.8	97.9	148.1	46.3	71.1	92.7	22.2	27.4	250.8	320.0	133.9	128.5	226.6
GOLPH3L	GPP34R	ENSG00000143457	"Golgi phosphoprotein 3 like"	Q9H4A5	1	150646225-150697144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 100.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072016			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA072016: "	"unprognostic (1.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.24e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-2)"	16.5	19.4	16.0	10.2	14.6	4.9	18.6	20.7	16.7	21.6	26.5	10.5	26.2	15.7	19.3	30.0	36.6	24.6	14.8	11.7	10.6	15.5	21.3	13.0	14.5	10.5	12.2	11.0	22.7	30.4	16.8	30.8	14.1	15.9	19.2	32.6	16.5	25.4	22.4	16.1	17.3	20.2	14.9	11.0	15.0	19.5	14.9	12.1	21.1	30.7	11.7	20.8	21.6	22.2	10.6	11.7	7.1	3.1	16.2	13.1	4.9	7.1	7.0	3.9	2.2	9.9	7.2	6.4	6.6	10.1	7.3	10.4	3.1	12.8	9.0	9.6	4.7	4.7	6.2	6.4	5.6	8.8	6.1	7.1	10.0	3.8	4.1	8.7	8.2	8.0	4.8	9.6	7.6	16.4	8.5	10.6	6.2	8.1	5.8	4.2	7.3	6.9	3.5	7.4	13.3	6.8	4.8	4.5	10.2	8.4	4.8	6.0	5.7	3.4	9.6	4.8	10.0	7.3	9.1	8.4	2.4	3.9	3.1	5.5	7.3	6.4	100.5	7.0	8.5	3.2	7.1	1.5	2.7	9.7	1.3	13.1	10.6	9.8	9.5	8.1	8.8	12.9	9.6	1.3	16.2	3.1	11.7	10.3	4.9	16.0	14.6	20.7	16.7	10.6	15.5	12.2	11.0	15.9	12.1	8.9	6.4	8.2	8.5	11.4	8.0	9.7	22.9	37.5	15.9	12.2	5.9	18.7	21.6	17.4	12.4	12.1	29.9	0.0	32.0	12.8	8.8	22.2	11.5	9.7	10.3	0.0	20.2	16.0	9.1	9.7	15.3	8.2	15.1	19.0	40.8	13.4	21.9	31.9	18.7	20.3	12.7	0.0	8.2	11.2	3.2	15.6	25.7	10.0	31.6	23.8
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720888	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 78.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 709.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.2;neutrophil: 4.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.4;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	3.2	0.1	0.1	0.1	0.4	0.0	78.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	4.4	1.2	0.0	0.2	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.1	6.8	0.0	11.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.2	0.3	0.2	0.4	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	4.4	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	54.2	0.1	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	22.1	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	32.3	0.1	709.1	118.4	8.2	1.8	0.0	0.0	0.0
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730196-150765957	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 171.4;lymphoid tissue: 111.4"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 672.3;Kupffer cells: 1992.4;Macrophages: 1161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.6;HMC-1: 51.4;U-698: 109.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		19000000	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	41.6	9.3	6.8	32.3	10.3	30.3	9.7	1.9	6.2	4.7	32.9	6.6	5.6	19.6	3.7	12.9	8.8	10.7	15.9	17.3	6.4	5.1	9.6	21.5	55.8	99.5	12.6	2.3	7.6	6.4	0.4	3.4	14.4	9.3	7.5	33.4	6.5	12.9	3.3	3.5	3.8	38.0	6.8	17.1	111.4	13.8	3.8	9.5	12.9	7.6	4.6	22.8	21.5	5.3	11.1	43.5	94.5	171.4	3.3	5.6	145.4	1.0	3.3	0.0	0.0	0.4	0.3	0.3	0.0	3.3	0.2	0.6	0.0	21.6	14.9	1.6	0.1	6.1	0.4	0.0	0.1	0.0	8.3	0.0	6.5	0.1	0.0	0.0	8.9	51.4	0.6	0.0	1.9	0.1	0.1	1.2	0.0	0.6	13.0	0.4	0.0	0.0	6.3	0.0	0.0	0.0	3.7	1.2	18.2	4.0	3.2	0.0	0.1	0.2	0.9	0.3	0.0	0.0	18.2	1.8	1.3	0.2	0.0	0.3	9.0	0.8	109.3	7.6	9.6	0.8	1.2	171.4	16.5	3.2	151.2	3.9	11.1	3.9	3.8	43.5	10.2	3.9	3.6	94.5	3.3	138.5	9.4	5.6	145.4	6.8	10.3	1.9	6.2	6.4	5.1	12.6	2.3	9.3	9.5	101.3	167.2	252.8	20.8	15.0	2.0	3.0	84.1	518.0	134.2	40.1	11.8	3.1	0.0	145.4	5.3	35.1	277.5	0.0	157.6	3.9	26.3	16.7	100.8	19.5	672.3	0.0	40.9	64.4	1992.4	1.7	4.9	1161.7	54.0	251.5	198.9	0.3	150.7	378.7	2.1	4.2	4.1	19.4	7.6	0.2	0.4	13.6	5.1	117.4	149.8	109.8
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 61.1;Leydig cells: 110.1;Melanocytes: 92.8;Peritubular cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Group enriched"	"Detected in some"	8	"ASC diff: 205.0;ASC TERT1: 75.1;BJ hTERT+: 165.6"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.4	0.3	205.0	75.1	0.2	5.8	165.6	0.4	0.9	0.0	0.1	0.1	0.2	11.4	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.1	0.1	0.4	14.9	0.5	4.6	0.1	13.1	0.6	0.1	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.7	0.3	0.0	3.1	0.9	0.2	0.2	0.4	0.2	0.1	0.2	0.3	0.7	0.5	1.1	17.4	0.0	1.0	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9	3.0	5.8	0.0	0.5	61.1	8.4	1.2	2.5	2.7	5.7	3.5	3.9	1.0	0.0	1.1	0.8	5.2	1.1	0.0	0.2	1.9	31.5	0.9	0.0	0.0	19.2	3.2	1.2	9.8	3.7	1.7	110.1	6.6	92.8	2.8	1.9	2.4	1.3	0.6	140.7	0.0	7.8	12.9	47.6	1.4	0.7	51.7	0.8	0.0	0.9	0.5
ARNT	"bHLHe2, HIF-1beta"	ENSG00000143437	"Aryl hydrocarbon receptor nuclear translocator"	P27540	1	150809705-150876768	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"U-698: 97.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001759, CAB004318"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB004318: AB_626698, HPA001759: AB_1078213"	"unprognostic (1.81e-1)"	"unprognostic (8.14e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.27e-3)"	"unprognostic (5.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.67e-1)"	"unprognostic (6.45e-2)"	"unprognostic (6.92e-2)"	23.5	20.8	12.1	14.5	12.6	11.3	25.1	25.4	14.4	28.0	17.2	18.7	12.8	10.9	26.1	14.4	16.6	20.4	17.9	20.0	10.2	8.2	14.4	32.2	21.6	12.0	11.6	9.5	31.8	22.4	16.5	22.9	31.7	12.3	18.2	16.4	28.3	15.2	16.3	25.5	21.9	15.2	22.6	14.0	19.2	16.5	14.9	12.3	18.8	16.1	13.9	18.0	23.0	24.4	6.6	12.7	23.9	15.6	8.0	8.8	9.7	4.0	4.2	6.4	4.8	13.7	13.2	8.6	4.6	9.2	6.4	5.8	3.6	4.2	4.3	4.2	8.3	3.1	4.7	5.8	5.2	5.6	6.9	3.5	5.2	7.2	4.2	7.9	6.1	6.1	10.3	4.9	7.7	6.8	7.7	7.8	5.9	6.6	8.7	6.5	8.0	4.9	3.4	5.2	7.4	3.3	6.2	7.7	6.1	5.0	4.2	4.2	6.3	9.0	6.2	3.6	9.0	7.8	13.4	5.5	5.3	4.8	4.2	4.0	9.9	7.2	97.0	6.5	0.2	3.6	23.9	15.6	13.9	8.8	14.7	7.9	6.2	7.2	8.4	12.7	6.6	7.0	7.1	8.1	8.0	14.7	5.2	7.2	9.7	12.1	12.6	25.4	14.4	10.2	8.2	11.6	9.5	12.3	12.3	11.9	9.3	9.7	7.8	12.6	20.9	10.6	22.9	6.7	11.4	10.4	51.1	20.7	3.3	8.1	4.2	11.7	8.6	0.0	8.5	31.6	20.3	7.2	3.5	36.0	17.1	6.4	19.5	31.9	35.9	2.1	30.0	15.7	10.1	14.4	15.1	7.7	8.6	7.0	30.8	9.3	37.6	12.9	15.0	18.6	15.7	13.4	24.7	10.1	8.0	8.6
CTXND2		ENSG00000283324	"Cortexin domain containing 2"		1	150887136-150913292	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in single"		"fallopian tube: 3.2"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 5.2"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	3.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.8		0.0	0.0		0.0	0.0	0.6	0.1	0.0	0.0		0.0	0.0	0.8			0.0		0.0	0.0		0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	16.9	15.4	9.5	21.2	15.9	16.9	17.7	21.6	18.2	18.6	15.4	25.2	18.6	13.0	22.8	18.9	15.6	16.8	14.0	10.9	9.6	8.5	13.3	12.7	15.6	20.7	15.3	13.2	23.9	17.6	21.0	15.4	18.4	13.7	14.9	16.8	20.6	16.1	18.5	20.0	18.0	17.1	17.9	13.7	21.9	15.0	33.5	14.2	24.5	18.6	12.0	20.7	18.6	16.3	11.2	12.8	6.9	14.9	7.6	9.1	5.3	5.9	6.9	10.0	6.6	4.8	6.4	16.7	4.9	5.7	7.1	6.1	4.6	8.2	11.6	6.8	5.4	2.8	7.4	9.3	5.3	5.6	5.6	11.5	6.6	7.1	5.3	6.8	11.6	6.3	8.4	5.9	5.8	9.5	7.2	8.3	7.5	11.0	9.5	5.0	11.4	8.0	6.8	13.7	8.3	5.5	9.3	6.5	8.6	5.4	6.8	7.3	13.3	7.5	8.8	5.9	12.6	9.5	15.7	5.6	4.1	4.3	4.5	6.8	9.9	10.6	90.6	4.3	4.1	4.0	6.8	10.7	6.9	8.3	14.9	8.7	8.7	7.4	9.1	12.8	11.2	8.3	8.3	6.5	7.6	10.6	8.6	4.7	5.3	9.5	15.9	21.6	18.2	9.6	8.5	15.3	13.2	13.7	14.2	6.0	12.3	5.3	7.2	4.8	10.9	4.1	5.1	9.4	6.8	7.0	17.7	11.4	3.3	6.6	23.5	6.9	6.2	0.0	5.0	7.2	4.9	6.2	7.0	6.2	8.8	6.4	3.5	10.4	14.2	21.8	9.5	10.4	1.7	7.2	10.3	6.3	7.3	10.7	9.2	5.4	10.1	6.5	5.9	22.4	14.5	4.4	8.4	7.0	9.3	6.4
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975004	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 142.3"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		24000	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	19.4	65.5	17.0	10.5	36.1	13.9	22.6	9.6	21.3	19.8	21.1	59.3	22.1	19.6	16.9	19.0	12.5	21.1	21.6	14.4	23.0	16.1	60.9	142.3	28.6	14.0	50.1	14.5	21.8	29.7	28.7	17.6	24.0	25.5	18.5	18.8	16.5	12.3	19.2	7.1	9.1	33.3	21.2	63.7	13.2	23.4	10.2	38.7	10.2	35.5	8.8	14.0	17.5	25.6	12.3	23.5	56.6	27.0	19.3	33.6	26.2	25.5	28.0	23.6	50.6	70.5	43.3	17.7	26.1	38.4	49.9	34.3	29.3	45.3	22.5	43.7	41.1	31.2	29.2	32.7	27.9	41.0	30.5	26.7	31.0	19.6	35.4	51.0	35.2	38.4	39.4	36.0	44.0	54.9	60.5	31.1	32.5	33.2	51.5	62.2	38.5	23.0	20.3	36.1	85.2	50.0	26.3	16.0	35.8	54.0	21.7	21.8	34.0	28.8	51.3	29.9	30.7	61.0	53.4	24.1	36.1	16.3	32.6	46.0	33.4	37.5	141.2	40.6	15.1	36.6	56.6	27.0	44.0	28.0	14.6	33.6	12.3	25.7	28.4	23.4	11.4	22.9	22.2	29.2	19.3	10.2	23.5	28.8	26.2	17.0	36.1	9.6	21.3	23.0	16.1	50.1	14.5	25.5	38.7	62.5	51.6	17.2	31.4	21.4	7.0	2.2	101.9	21.4	14.8	50.6	3.9	65.8	11.6	88.6	6.4	42.6	55.1	0.0	80.3	35.9	56.4	34.0	35.8	187.2	49.9	3.2	23.6	32.5	43.8	3.8	52.0	30.4	35.4	20.8	32.1	25.3	90.5	30.8	37.8	65.4	8.2	38.8	25.5	11.8	5.2	13.7	45.3	37.6	28.9	27.6
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982017-150995634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 62.0;seminal vesicle: 78.1"	"Cell type enhanced"	"Detected in many"	15	"Cholangiocytes: 45.9;Hepatocytes: 14.9;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.5;Hep G2: 14.6;MCF7: 19.5;OE19: 17.0;T-47d: 48.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	2.4	1.1	1.2	0.9	1.2	0.3	2.6	1.3	2.5	2.3	0.9	0.6	62.0	1.4	6.0	11.6	10.7	2.3	12.5	1.9	1.4	1.0	12.1	15.8	1.2	0.5	1.8	0.8	1.8	32.0	9.9	1.2	0.7	1.3	4.1	0.0	1.2	2.5	78.1	0.9	18.9	1.2	0.9	3.2	1.0	1.3	3.6	0.6	1.3	10.4	9.1	21.1	4.5	4.4	0.5	3.8	2.5	3.1	0.1	0.8	0.8	4.0	0.9	1.4	1.4	0.0	0.0	4.1	0.3	0.2	0.0	0.0	12.1	14.5	0.1	0.8	0.0	0.4	2.4	0.0	0.2	0.0	1.2	1.4	2.0	1.4	14.6	0.0	0.7	0.9	0.0	0.1	0.0	0.0	3.2	0.0	0.6	0.9	4.4	0.0	19.5	0.1	1.0	0.3	17.0	0.2	0.9	0.2	4.8	0.0	5.7	2.2	1.2	0.9	10.0	0.5	0.8	48.4	1.2	1.5	0.3	0.4	0.2	0.2	1.3	4.1	6.3	2.1	1.3	1.1	0.0	3.1	1.8	0.1	1.8	0.8	0.5	0.3	0.5	3.8	0.1	0.8	0.2	2.5	0.1	0.4	0.0	0.0	0.8	1.2	1.2	1.3	0.9	1.4	1.0	1.8	0.8	1.3	0.6	0.0	0.6	0.0	0.3	0.1	0.0	0.3	45.9	1.4	0.0	12.2	0.0	1.7	3.3	10.1	0.7	0.0	0.0	0.0	6.8	0.2	0.6	0.1	1.1	14.9	1.8	0.0	0.0	0.0	0.8	0.0	1.4	0.0	1.7	0.0	0.0	0.0	3.1	0.0	1.1	33.2	0.0	0.0	0.1	6.1	0.1	0.0	1.3	0.0	0.4	4.9
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 33.2;Ductal cells: 11.3;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.3;eosinophil: 19.1;neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		240000	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	9.2	9.7	14.0	6.7	31.1	5.6	13.0	18.4	21.2	13.1	13.5	53.8	14.8	14.0	14.7	6.5	24.1	14.4	11.8	24.5	17.6	10.1	26.6	12.2	10.9	5.2	37.5	13.5	19.3	37.3	26.2	12.3	5.9	25.0	11.7	14.8	16.9	25.3	21.0	11.9	17.1	12.1	13.7	34.1	10.7	15.9	14.7	35.7	0.9	39.9	7.9	10.3	12.3	13.0	0.6	4.0	30.4	3.2	1.5	2.2	3.4	6.1	4.0	4.3	6.1	7.8	6.5	3.6	2.0	5.1	2.8	4.5	8.6	14.7	0.4	4.8	2.6	0.9	3.1	3.4	3.7	1.3	4.6	5.1	6.0	7.4	7.3	1.7	1.8	2.4	5.3	3.4	5.1	1.4	9.6	7.2	2.1	3.7	15.5	2.9	9.5	0.3	4.0	2.0	1.9	1.4	4.5	0.8	18.9	13.4	12.2	7.5	5.5	3.8	7.0	4.2	2.1	27.9	6.1	6.7	2.4	3.2	1.2	1.7	5.7	5.2	20.6	5.8	4.0	11.4	26.3	3.2	19.1	0.1	1.5	0.1	0.3	1.3	0.3	4.0	0.6	2.2	0.7	30.4	1.5	0.9	0.6	1.6	3.4	14.0	31.1	18.4	21.2	17.6	10.1	37.5	13.5	25.0	35.7	8.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.8	3.5	0.0	3.4	33.2	11.3	0.0	0.0	0.0	0.0	6.1	0.6	0.0	0.0	3.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	7.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	7	"Alveolar cells type 2: 8.8;Collecting duct cells: 10.4;Proximal tubular cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		210000	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	9.3	9.7	9.3	8.8	11.6	3.7	16.0	15.7	16.4	15.0	12.5	10.9	16.2	11.7	17.9	15.7	11.5	15.6	12.8	31.3	10.5	10.3	18.0	12.8	10.1	11.8	11.9	9.2	17.1	16.2	16.5	16.2	7.2	8.8	12.2	14.0	12.7	13.3	18.2	24.4	10.5	11.8	14.7	7.9	11.0	10.5	16.3	8.6	15.0	41.6	8.5	12.9	13.8	13.6	12.1	9.5	14.7	8.9	14.3	19.0	18.3	3.9	4.2	7.5	7.2	9.4	2.6	4.2	1.9	4.1	7.0	6.1	5.1	4.7	8.1	8.2	2.5	2.0	5.7	7.3	4.9	5.6	8.7	8.3	9.5	4.4	7.4	5.1	6.2	4.8	3.2	9.3	3.7	3.6	5.8	3.3	10.7	7.4	6.8	3.3	9.4	9.5	5.1	7.0	14.3	5.5	8.7	4.8	7.7	5.0	5.4	10.9	8.9	6.3	8.8	5.8	11.1	12.1	9.4	2.3	2.5	3.0	2.7	2.9	16.6	14.0	62.0	2.4	4.7	6.2	12.5	6.4	13.4	14.0	6.0	16.9	12.1	15.5	15.7	9.5	11.6	19.0	15.0	14.7	14.3	8.9	5.1	14.5	18.3	9.3	11.6	15.7	16.4	10.5	10.3	11.9	9.2	8.8	8.6	6.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	10.4	0.0	3.6	0.0	4.9	0.0	0.0	0.0	0.0	4.9	3.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	2.8	0.0	0.0	5.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036570-151047600	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.5;skin 1: 68.6"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 14.9;Suprabasal keratinocytes: 49.9;Urothelial cells: 20.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"T-47d: 33.1"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.4;cerebellum: 2.7"	"Low region specificity"	"Detected in some"			HPA019946			Uncertain	Cytosol		NA	NA			Cytosol		"HPA019946: AB_2732424"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (6.81e-2)"	0.1	0.1	0.2	0.1	0.2	0.3	6.4	0.2	0.2	9.7	0.1	0.1	9.4	0.1	0.6	0.6	42.5	1.0	0.1	0.2	0.2	0.0	0.5	0.2	6.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	3.2	0.1	3.4	0.1	0.3	7.1	21.0	0.7	68.6	0.2	0.8	0.1	0.1	0.6	1.0	0.1	0.2	2.7	25.8	23.2	5.0	18.2	1.8	0.8	3.2	0.6	0.5	1.7	0.4	0.3	0.2	0.5	0.6	0.3	0.3	0.6	0.3	0.0	0.2	0.1	1.1	0.4	0.6	0.5	0.0	0.1	1.3	0.7	0.2	0.4	0.8	0.8	0.9	0.5	0.2	0.1	0.5	0.6	0.0	2.4	0.1	0.2	0.9	0.0	0.9	0.5	0.5	0.2	1.5	0.6	0.9	0.5	0.7	0.4	0.3	0.2	0.3	0.5	0.3	1.1	0.5	0.4	0.7	0.2	1.9	33.1	0.2	0.7	0.7	0.4	0.2	0.1	1.5	1.1	3.1	0.0	0.2	0.6	2.7	0.6	0.7	1.7	0.6	1.4	0.5	1.0	1.2	0.3	1.8	1.0	0.6	3.2	0.5	0.6	0.8	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.1	14.9	12.1	0.0	5.4	13.6	0.4	0.3	0.0	9.4	10.3	10.4	0.0	1.5	0.0	0.0	5.9	0.3	0.4	0.0	0.0	0.3	1.3	6.2	0.0	0.0	0.3	0.0	0.0	3.7	1.2	0.9	0.9	0.8	3.3	0.0	0.1	0.5	0.0	0.0	0.0	0.3	1.4	0.0	0.2	0.5	0.1	49.9	2.2	0.8	0.2	20.9
C1orf56	"FLJ20519, MENT"	ENSG00000143443	"Chromosome 1 open reading frame 56"	Q9BUN1	1	151047740-151051986	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 54.8;testis: 67.7"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 336.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037429, HPA037430"	Enhanced				"Secreted to blood"	NA	NA		90000000			"HPA037429: AB_10671755, HPA037430: AB_2675473"	"unprognostic (7.60e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.28e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.79e-2)"	3.3	6.4	2.9	2.0	3.6	0.9	3.1	3.8	3.5	3.7	2.7	5.2	5.1	2.9	3.4	5.6	3.1	4.3	4.6	5.6	3.1	2.1	4.0	6.4	2.6	2.8	3.3	2.0	4.8	7.0	3.9	6.3	3.0	3.4	4.7	1.2	4.3	6.5	6.4	4.0	3.3	2.0	3.8	2.3	2.7	3.1	67.7	3.8	0.7	7.1	1.2	1.7	3.3	3.0	16.3	7.8	54.8	15.4	15.5	28.4	1.0	4.0	8.1	2.8	1.3	4.8	4.7	2.6	2.3	3.4	1.5	1.2	3.5	5.8	0.9	3.7	2.5	3.2	5.5	1.6	0.3	0.8	5.2	1.8	1.0	6.4	4.3	3.3	1.1	0.8	3.4	1.8	2.3	0.8	2.9	2.2	1.8	2.1	2.1	1.3	15.8	1.5	2.8	4.7	3.2	4.6	1.3	2.8	2.9	1.2	2.3	3.8	7.4	7.4	3.8	5.3	5.6	7.5	3.0	2.3	2.0	3.6	5.3	2.0	5.0	3.9	12.7	3.8	0.6	2.5	54.8	7.3	13.7	27.8	15.4	20.8	14.2	24.2	24.2	5.5	16.3	20.6	28.4	20.2	15.5	12.7	7.8	13.7	1.0	2.9	3.6	3.8	3.5	3.1	2.1	3.3	2.0	3.4	3.8	6.0	8.5	68.1	31.4	57.5	18.6	7.0	48.4	6.7	10.3	40.1	19.6	38.8	33.2	18.8	336.7	30.8	8.0	46.7	12.8	26.9	47.4	29.5	39.1	34.7	28.3	17.5	14.3	63.3	73.4	44.3	26.4	65.6	84.4	83.0	12.5	13.8	26.2	17.5	24.1	24.8	24.2	25.8	37.6	148.7	13.6	72.8	74.8	126.9	12.0	45.1
CDC42SE1	"SCIP1, SPEC1"	ENSG00000197622	"CDC42 small effector 1"	Q9NRR8	1	151050971-151070325	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027634	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA027634: AB_10600861"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (9.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.86e-3)"	"unprognostic (4.12e-2)"	26.8	21.7	15.7	33.8	21.6	39.2	22.1	13.8	19.7	18.7	17.5	23.9	25.0	11.4	18.5	20.1	45.2	20.2	25.0	21.5	15.8	13.9	21.2	15.9	34.0	42.6	30.0	14.8	22.2	18.1	45.5	19.1	46.6	21.5	27.1	20.0	14.7	33.5	32.1	12.0	27.4	27.5	21.4	21.6	60.3	21.3	6.0	23.3	29.3	23.3	27.7	47.7	24.5	29.2	10.0	11.7	74.8	16.1	17.7	24.2	6.2	13.3	6.4	11.0	6.9	8.6	8.3	16.8	10.2	10.6	11.7	10.0	6.1	14.3	9.7	8.2	11.3	6.2	16.7	11.6	17.8	10.2	15.2	6.2	15.6	6.6	2.9	11.5	13.8	25.1	9.3	28.7	14.6	11.4	16.5	14.5	9.8	24.5	22.8	13.0	19.9	10.0	10.0	12.3	12.3	6.9	8.9	9.3	10.8	14.7	21.4	4.7	11.2	8.7	18.9	17.8	18.1	21.0	24.9	13.7	11.4	8.4	8.7	18.4	15.0	11.9	102.2	8.2	10.5	25.1	20.7	9.0	44.1	19.1	16.1	15.2	9.4	16.4	17.2	11.7	10.0	13.8	16.9	74.8	17.7	15.6	4.4	24.2	6.2	15.7	21.6	13.8	19.7	15.8	13.9	30.0	14.8	21.5	23.3	35.7	61.2	84.9	51.4	58.7	26.6	7.3	22.9	21.4	43.3	52.4	23.6	47.7	18.3	37.4	77.5	39.4	18.7	23.3	32.4	57.4	43.5	39.5	70.4	28.7	65.9	25.4	33.9	65.7	136.0	13.8	10.6	97.0	52.3	161.5	27.8	19.2	50.5	35.1	22.6	17.2	21.8	32.3	46.7	10.8	16.6	81.9	96.0	121.6	15.0	70.6
MLLT11	AF1Q	ENSG00000213190	"MLLT11, transcription factor 7 cofactor"	Q13015	1	151057758-151068497	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.1"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 72.1;Late spermatids: 161.6;monocytes: 56.9"	"Cancer enhanced"	"Detected in all"		"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 38.6;EFO-21: 29.3;SH-SY5Y: 42.4;U-698: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA000540: AB_2666024"	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	1.9	7.5	13.6	3.4	9.1	1.1	1.2	16.3	42.1	1.9	2.1	5.1	1.2	0.8	3.7	1.2	1.3	0.8	11.1	11.8	11.3	16.4	1.2	1.2	5.3	2.3	10.3	1.2	4.2	1.3	8.4	1.8	1.2	3.2	1.3	1.1	1.2	1.5	1.2	2.6	1.0	2.0	4.2	5.8	2.1	0.9	1.2	1.2	2.0	1.2	1.2	2.6	3.2	1.2	2.4	1.0	6.5	1.0	4.2	9.2	2.8	1.2	5.3	38.6	6.1	0.6	1.0	0.6	2.4	2.6	2.3	4.2	0.5	2.5	1.9	29.3	1.8	6.5	1.5	9.3	2.2	1.3	11.3	2.6	5.0	3.8	0.1	1.2	0.3	0.8	1.7	0.3	12.7	0.5	8.0	17.0	7.6	5.3	0.9	7.4	0.4	17.7	3.3	16.8	0.1	0.8	16.9	5.1	0.1	4.4	1.1	23.3	42.4	0.2	0.4	1.2	26.5	1.4	0.6	11.8	5.0	5.5	1.8	4.4	0.9	0.8	36.0	12.5	0.3	9.4	1.6	0.6	1.6	5.9	0.7	2.7	2.4	3.9	6.0	0.8	2.1	5.3	9.2	6.5	4.2	1.0	1.0	3.6	2.8	13.6	9.1	16.3	21.0	11.3	16.4	10.3	1.2	3.2	1.2	0.0	0.6	1.5	4.0	3.2	38.5	10.1	0.0	0.0	0.0	3.5	7.9	2.0	14.9	2.6	72.1	3.6	0.0	0.0	1.1	2.1	12.7	1.7	4.6	0.0	5.6	35.0	10.3	5.5	4.8	161.6	2.0	7.6	5.0	56.9	0.0	12.4	2.9	0.0	3.5	1.1	18.5	0.0	35.9	4.7	8.8	3.0	6.2	7.5	0.1	4.1
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor beta subunit 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 26.5"	"Low region specificity"	"Detected in all"							"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: AB_2683730"	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	9.9	8.3	9.5	9.3	13.3	12.2	10.9	12.3	12.2	10.0	8.5	14.8	10.7	7.0	10.1	8.0	8.7	10.2	10.7	11.0	11.6	5.8	7.9	6.4	7.7	9.9	14.4	9.7	17.6	7.8	15.1	12.8	6.5	11.4	9.4	9.8	11.0	7.6	12.6	10.0	13.9	8.1	12.0	10.2	10.1	9.8	20.2	15.2	15.7	10.0	11.6	9.8	9.9	16.6	4.7	5.0	4.7	5.1	2.6	4.8	2.6	6.9	2.4	1.7	2.1	6.1	9.0	2.2	6.4	4.0	3.7	2.6	0.7	5.2	7.2	2.4	6.1	2.0	6.1	3.7	3.3	5.5	2.7	1.4	2.0	3.8	0.1	4.1	7.8	4.1	4.9	3.8	5.1	7.7	2.9	1.4	7.7	4.8	5.1	4.4	9.8	10.8	1.4	0.8	4.0	2.7	3.2	2.8	3.4	3.1	1.9	3.0	1.2	8.2	2.9	2.4	1.7	7.2	8.6	4.1	1.0	3.2	6.6	5.1	2.8	1.3	26.5	3.0	5.9	4.4	3.6	2.8	1.6	4.4	3.3	2.7	3.1	4.8	3.9	2.5	4.7	4.3	4.7	4.7	2.6	5.1	5.0	1.7	2.6	9.5	13.3	12.3	12.2	11.6	5.8	14.4	9.7	11.4	15.2	8.9	12.6	13.8	9.2	10.2	26.2	21.4	25.5	24.1	18.2	12.2	23.6	4.9	8.3	5.6	28.3	9.0	9.8	0.0	5.1	4.2	10.8	6.2	6.9	5.9	7.3	31.8	9.2	16.0	14.8	13.9	20.8	8.0	8.5	9.0	15.4	15.4	4.6	10.5	20.1	3.3	39.9	6.5	16.0	54.6	51.3	8.8	3.8	14.4	14.9	6.7
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		290000	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.8	0.8	11.9	4.6	5.1	1.7	1.1	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.7	1.2	1.1	0.4	0.7	1.0	3.5	6.2	0.5	1.0	0.7	0.1	2.3	2.9	1.4	1.0	0.5	2.4	20.9	3.4	0.5	0.6	2.0	0.4	1.0	0.8	5.4	0.1	1.4	7.4	2.6	0.3	0.4	0.3	6.1	7.9	1.1	0.5	1.0	3.1	1.3	1.0	9.7	2.0	2.9	3.0	0.4	5.0	0.9	5.1	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6	0.0	3.2	1.7	0.8	1.4	4.2	15.3	2.5	0.0	1.2	0.0	19.6	0.2	0.0	0.3	0.5	3.1	0.3	0.0	0.4	0.4	2.1	0.5	0.0	2.4	0.3	6.4	0.0	4.9	1.6	2.1	5.2	0.0	1.7	0.0	0.0	1.7	0.4	0.0	2.5	2.7	6.9	0.0	2.0	2.8	1.1	0.9	0.1	0.0	0.2	0.5
TNFAIP8L2	FLJ23467	ENSG00000163154	"TNF alpha induced protein 8 like 2"	Q6P589	1	151156629-151159749	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 63.1;lymphoid tissue: 38.7"	"Cell type enhanced"	"Detected in some"	14	"Hofbauer cells: 59.6;Kupffer cells: 56.1;Macrophages: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 12.8;HL-60: 7.5;HMC-1: 19.9;NB-4: 10.8;THP-1: 41.5;U-937: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062742			Approved	Vesicles		NA	NA			Vesicles		"HPA062742: "	"unprognostic (3.19e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.15e-3)"	"prognostic favorable (3.64e-4)"	"unprognostic (9.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.23e-1)"	8.5	4.2	5.7	13.8	8.8	4.1	2.7	1.3	4.5	2.0	3.2	4.0	0.0	3.9	2.0	2.6	2.1	3.0	4.1	2.8	4.1	3.3	2.9	6.0	8.2	20.9	8.2	2.2	1.8	2.0	0.3	1.9	7.0	7.2	2.6	4.6	1.8	6.4	1.4	1.0	2.7	6.9	3.9	8.0	38.7	2.5	1.0	6.9	21.0	1.8	1.2	12.8	7.2	1.9	17.7	56.4	63.1	50.6	47.1	43.9	44.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.1	0.0	0.0	7.5	19.9	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	41.5	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.8	0.0	16.3	0.0	53.4	50.6	50.0	23.3	45.4	22.9	15.6	28.8	23.5	56.4	17.7	43.9	31.5	63.1	47.1	41.2	13.3	31.6	44.8	5.7	8.8	1.3	4.5	4.1	3.3	8.2	2.2	7.2	6.9	0.0	1.7	16.4	0.0	0.2	0.2	0.0	5.1	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.7	0.2	59.6	0.0	0.0	1.3	56.1	0.0	0.3	47.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.3	0.3	13.8	0.0	0.0
SCNM1	MGC3180	ENSG00000163156	"Sodium channel modifier 1"	Q9BWG6	1	151156664-151170297	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052439, HPA054324"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052439: AB_2681834, HPA054324: AB_2682451"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (2.17e-13)"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.71e-2)"	20.5	15.5	22.2	21.1	21.1	32.9	16.2	17.0	20.0	15.3	16.8	21.0	8.0	16.3	18.4	15.0	19.4	16.5	15.5	16.5	19.8	17.1	19.5	19.8	16.1	34.0	22.9	14.9	16.8	13.5	10.3	12.1	23.6	20.2	17.3	14.7	20.3	16.2	15.2	47.9	21.7	20.5	18.0	22.3	41.8	14.6	14.4	19.4	40.9	16.1	20.1	27.2	21.6	15.6	28.2	61.4	50.9	45.3	28.8	30.1	37.8	13.1	9.2	10.3	12.1	14.5	10.9	17.4	10.4	12.1	25.4	19.9	20.1	12.9	21.0	17.0	11.2	6.6	17.8	12.0	9.6	12.4	13.2	13.3	18.1	13.2	12.8	21.0	24.0	17.8	11.4	18.7	17.8	16.0	11.9	15.3	14.7	14.4	16.1	12.4	32.4	17.0	37.3	26.2	20.5	14.4	23.3	12.4	26.0	13.6	8.8	12.8	20.6	11.8	19.2	23.3	13.4	17.8	77.1	11.2	12.2	11.4	12.6	22.1	20.9	28.4	32.8	12.7	25.5	15.6	50.9	45.3	45.6	20.4	33.7	19.3	28.2	24.8	23.0	60.2	24.7	22.9	19.9	45.7	28.8	21.0	61.4	30.1	37.8	22.2	21.1	17.0	20.0	19.8	17.1	22.9	14.9	20.2	19.4	3.0	17.5	25.9	17.5	23.7	17.9	26.6	12.7	24.1	21.6	27.9	17.7	31.2	46.4	32.0	24.9	23.7	24.2	46.7	27.7	28.6	28.9	12.3	39.3	11.0	62.2	7.9	13.8	18.4	58.4	19.2	28.7	54.1	20.3	52.3	15.5	22.0	32.8	28.1	20.1	28.3	14.5	32.3	33.0	22.8	13.5	15.9	23.0	46.7	16.8	19.6
LYSMD1	"MGC35223, RP11-68I18.5, SB145"	ENSG00000163155	"LysM domain containing 1"	Q96S90	1	151159748-151165948	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028055, HPA064537"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028055: AB_10601912, HPA064537: AB_2685281"	"unprognostic (1.71e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.26e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.31e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.47e-3)"	"unprognostic (6.33e-2)"	8.2	11.2	9.0	4.7	11.2	2.1	10.0	20.8	13.4	11.0	9.3	13.0	10.7	10.6	12.1	7.9	8.6	11.4	8.7	13.2	8.8	9.1	9.4	9.3	5.9	5.2	8.5	9.9	19.8	10.9	13.8	14.8	13.2	11.0	10.6	9.8	11.1	9.0	15.4	20.6	9.2	8.7	12.4	9.3	6.3	8.2	7.3	10.6	8.2	11.1	6.4	5.7	10.0	8.8	3.6	3.3	7.2	2.1	3.1	3.5	0.7	4.1	4.5	9.7	7.6	5.7	6.4	7.6	6.1	5.3	7.2	6.5	2.8	5.0	5.5	7.4	3.9	3.7	7.3	7.6	4.2	5.3	10.5	8.4	3.1	7.4	3.0	9.0	3.2	5.1	8.9	9.4	6.7	9.7	9.8	3.0	12.6	6.2	5.3	5.0	6.6	8.3	4.1	6.2	4.2	5.8	6.0	7.1	3.2	5.3	1.9	11.8	14.4	4.5	13.9	7.8	12.9	8.5	11.2	3.0	5.6	3.1	3.5	7.8	16.9	12.9	2.6	4.8	1.3	5.2	3.8	2.1	3.0	2.1	1.3	2.4	1.7	2.5	1.4	1.6	3.6	3.3	3.5	7.2	3.1	1.7	3.3	3.3	0.7	9.0	11.2	20.8	13.2	8.8	9.1	8.5	9.9	11.0	10.6	0.0	0.3	0.0	0.8	0.8	4.1	7.5	0.0	4.0	4.5	5.2	5.9	3.4	3.3	1.8	0.3	0.9	3.4	0.0	0.5	2.3	2.7	1.0	0.0	3.2	0.5	1.6	4.1	2.5	0.0	0.0	4.0	0.0	1.7	0.0	1.9	3.4	1.9	0.0	5.6	4.3	7.9	0.0	3.0	1.6	2.5	1.0	2.4	0.0	2.7	0.9
TMOD4	Sk-Tmod	ENSG00000163157	"Tropomodulin 4"	Q9NZQ9	1	151169986-151176284	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 153.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 1.5;memory B-cell: 1.7;memory CD4 T-cell: 1.5;naive B-cell: 1.0;naive CD4 T-cell: 1.6;naive CD8 T-cell: 3.5;plasmacytoid DC: 1.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;dendritic cells: 1.0;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 6.5;NB-4: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028203	Enhanced					NA	NA					"HPA028203: AB_10600830"																		2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	4.0	1.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	1.6	0.1	153.5	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.3	35.0	1.6	0.4	0.1	1.7	1.0	0.4	0.3	0.0	3.5	0.6	0.5	0.4	0.9	0.1	0.7	0.2	1.6	0.1	0.6	0.4	0.1	0.0	0.6	1.4	0.7	1.7	0.5	0.5	1.4	0.3	0.5	2.7	6.5	2.6	2.2	0.0	1.1	1.5	3.2	0.0	0.4	1.3	3.0	1.6	0.8	3.4	1.6	2.3	0.2	2.3	0.7	8.1	1.4	0.1	2.7	2.5	0.3	0.1	0.5	1.6	1.8	1.1	0.7	0.0	0.1	0.7	0.8	5.0	1.0	0.2	1.1	2.3	0.7	3.0	5.6	1.2	0.8	4.5	0.6	0.0	0.3	0.4	1.5	0.0	0.4	1.7	1.5	0.2	0.1	1.0	1.6	3.5	0.2	0.0	0.3	1.0	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VPS72	"Swc2, TCFL1, YL-1, YL1"	ENSG00000163159	"Vacuolar protein sorting 72 homolog"	Q15906	1	151169987-151195321	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065709			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA065709: AB_2685540"	"unprognostic (2.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-1)"	23.7	19.7	28.2	20.9	26.3	11.8	19.2	30.2	30.2	21.0	19.2	20.6	20.5	17.8	26.1	21.6	24.6	26.5	19.2	22.0	25.7	26.2	20.1	14.9	18.2	19.6	26.5	25.1	27.3	18.5	19.8	16.4	23.7	21.8	23.8	17.7	19.2	23.8	24.6	66.6	22.5	16.3	32.8	27.0	19.3	19.6	17.3	21.9	21.4	22.2	20.2	26.4	29.0	21.3	35.4	28.8	41.4	25.8	38.2	33.8	27.9	20.1	13.8	32.4	23.3	14.3	12.6	27.8	22.0	11.7	17.7	12.9	14.8	17.0	20.4	27.1	16.5	12.3	19.0	23.9	14.2	13.4	24.1	25.2	17.4	10.9	10.1	20.0	25.6	15.7	10.1	19.7	20.1	16.8	18.5	23.1	25.3	33.1	15.2	13.9	33.8	22.0	17.4	37.7	36.2	23.0	24.3	18.6	31.9	16.4	10.3	22.9	40.9	15.1	23.5	26.4	31.9	26.4	38.1	21.7	9.3	15.6	14.7	27.8	28.6	40.2	32.8	15.3	17.8	17.0	25.9	25.8	41.4	32.1	24.5	31.0	35.4	28.9	27.2	28.8	27.4	28.9	26.2	18.9	38.2	19.6	18.3	33.8	27.9	28.2	26.3	30.2	27.3	25.7	26.2	26.5	25.1	21.8	21.9	6.0	7.8	16.6	24.1	25.2	13.8	11.3	25.5	10.7	12.5	22.7	3.9	48.9	54.7	44.6	9.5	27.5	20.1	23.3	40.3	44.6	28.0	21.9	31.1	16.2	28.2	14.3	19.4	22.7	20.8	9.5	23.3	19.8	40.5	40.5	28.1	22.4	46.9	27.9	23.3	25.9	11.5	51.8	32.2	34.2	33.8	27.7	52.7	20.8	25.4	31.0
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	18.1	19.5	15.7	15.4	21.0	9.6	20.2	22.6	27.6	19.8	18.0	20.3	14.7	16.4	24.8	22.6	20.7	19.4	20.7	18.9	17.3	13.4	17.8	18.3	21.7	17.1	12.7	17.5	20.4	16.6	21.8	25.3	44.6	14.6	17.3	15.6	29.5	17.8	15.2	26.1	20.4	20.4	27.2	16.1	20.1	16.8	42.1	14.0	19.3	20.1	13.9	22.3	16.2	17.7	9.1	8.7	11.7	6.2	4.7	5.9	6.3	17.7	13.8	21.4	24.7	14.1	15.0	21.1	23.5	33.0	43.9	39.4	25.1	17.2	16.2	25.0	25.0	19.8	15.1	27.7	16.1	38.5	24.3	19.8	12.8	18.3	12.0	26.7	22.9	16.2	19.9	15.0	27.3	34.6	19.4	17.8	25.8	12.5	13.8	22.0	24.9	22.8	11.4	31.7	13.6	21.5	22.1	18.7	12.0	22.5	10.3	14.4	19.0	31.7	24.4	20.6	37.4	25.6	21.7	17.1	17.5	24.4	16.1	28.2	19.3	32.1	36.5	17.0	6.7	20.8	0.1	5.5	7.3	5.3	6.2	4.1	9.1	5.0	5.9	8.4	4.6	5.4	4.2	11.7	4.7	4.8	8.7	3.9	6.3	15.7	21.0	22.6	27.6	17.3	13.4	12.7	17.5	14.6	14.0	29.8	13.5	19.0	21.3	58.7	33.2	17.3	12.7	12.0	11.4	29.6	92.3	21.0	8.3	11.8	2.8	13.2	15.9	0.0	7.5	24.0	19.1	15.9	11.5	11.6	11.1	25.4	5.8	17.8	10.1	3.6	12.4	11.5	11.8	10.0	8.4	13.8	13.3	8.4	10.3	7.9	43.5	12.9	19.6	46.5	22.4	43.7	53.1	8.7	9.5	32.5
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254703-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	27.5	28.0	44.3	24.4	46.4	25.5	29.9	25.7	50.4	21.9	28.6	28.3	16.5	22.7	25.1	41.5	26.7	31.4	21.8	38.7	37.5	36.8	25.3	44.7	20.2	28.2	47.5	44.8	26.7	27.7	27.4	19.3	30.0	43.2	23.0	28.1	24.3	25.6	31.2	86.7	28.0	20.5	39.3	29.6	26.3	25.8	35.9	29.1	23.1	23.7	25.7	36.2	28.0	19.8	62.7	65.1	111.6	76.0	54.2	74.2	88.2	42.3	51.0	37.7	30.8	41.1	30.5	41.1	28.7	35.3	45.9	36.7	66.7	48.5	34.4	70.6	40.5	31.8	44.4	48.4	43.4	39.3	56.1	42.2	33.6	43.5	68.7	45.4	39.4	39.2	33.0	36.1	52.4	48.5	34.5	40.0	38.7	52.2	43.8	38.4	124.8	36.2	48.0	71.6	65.6	51.6	30.8	36.7	62.1	45.0	36.3	29.6	50.5	31.9	46.9	38.0	58.2	49.0	78.0	35.1	22.9	36.0	28.1	49.0	52.5	65.1	73.4	38.0	37.2	41.7	59.6	71.5	111.6	43.0	76.0	48.4	62.7	50.5	47.3	65.1	61.1	46.4	46.0	95.8	54.2	75.5	39.2	74.2	88.2	44.3	46.4	25.7	50.4	37.5	36.8	47.5	44.8	43.2	29.1	53.6	55.8	113.9	90.7	78.8	48.8	216.6	79.0	80.3	42.1	57.6	25.5	289.4	142.6	149.2	182.3	103.4	106.2	93.5	163.0	189.2	97.9	84.2	80.9	96.2	163.2	31.8	80.8	69.3	92.1	179.3	97.5	96.7	99.5	354.3	71.9	58.4	143.7	95.1	92.6	161.4	44.8	116.4	130.8	169.8	77.8	75.7	346.7	94.7	97.0	85.8
ZNF687	KIAA1441	ENSG00000143373	"Zinc finger protein 687"	Q8N1G0	1	151281618-151292180	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 13.1;monocytes: 4.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021193, HPA023948"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021193: AB_1859415, HPA023948: AB_2671380"	"unprognostic (2.23e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.54e-2)"	"unprognostic (7.99e-2)"	9.8	13.6	9.9	10.7	11.4	36.1	10.6	16.1	21.0	13.6	17.3	17.1	10.9	11.7	13.5	12.9	12.9	13.2	12.8	10.0	9.2	9.7	13.0	14.4	10.2	14.8	9.4	10.7	16.6	21.4	23.0	16.4	13.5	10.6	13.3	8.1	17.6	16.2	13.3	12.5	14.1	15.2	11.4	9.6	17.9	12.5	22.5	9.8	19.6	14.0	8.3	15.4	13.9	9.9	1.3	0.9	13.1	4.1	0.5	0.9	1.0	9.4	14.3	13.2	8.0	7.4	6.3	18.3	5.3	8.4	8.9	8.9	11.2	12.4	8.1	13.1	7.7	9.6	14.7	11.5	9.8	4.0	12.0	12.6	7.7	11.5	12.7	8.2	8.7	11.3	9.9	10.0	7.4	7.9	7.9	5.9	9.1	12.0	14.4	4.9	28.1	12.2	10.5	17.9	12.2	10.8	10.9	10.8	14.7	7.4	13.9	12.3	19.6	13.2	15.6	12.7	12.9	20.6	19.0	5.7	7.1	8.3	9.2	7.6	18.0	15.1	19.8	9.1	5.9	9.0	0.4	1.8	13.1	0.6	2.2	0.7	1.1	0.6	0.6	0.9	1.3	0.8	0.9	9.6	0.5	4.1	0.8	0.4	1.0	9.9	11.4	16.1	21.0	9.2	9.7	9.4	10.7	10.6	9.8	3.0	5.8	1.9	3.0	4.1	6.4	1.2	7.6	1.4	1.2	1.8	9.8	5.7	3.3	5.1	1.6	2.5	5.9	0.0	5.1	4.2	4.1	3.5	0.0	4.0	4.5	7.9	2.4	4.3	3.8	2.1	5.8	4.3	0.0	5.4	6.5	6.1	6.4	2.9	6.7	3.3	10.6	12.9	2.2	8.6	8.6	3.0	7.9	3.3	7.5	4.1
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	25.5	22.2	29.8	21.6	32.3	41.6	27.3	42.6	47.2	30.8	27.1	44.8	26.6	21.8	38.6	35.8	25.6	33.0	25.1	23.8	26.3	22.5	25.6	19.3	27.2	26.2	38.7	28.8	38.6	22.6	41.8	35.5	24.2	29.6	32.2	28.1	28.8	27.1	29.9	36.2	36.9	25.3	39.8	22.7	34.7	23.7	33.1	34.0	26.2	41.2	24.6	28.7	27.1	30.1	17.1	19.7	27.9	20.4	14.7	20.3	17.1	19.7	16.5	14.4	22.5	40.0	29.6	12.2	21.0	36.7	27.5	22.9	21.0	18.0	18.7	24.2	32.1	17.4	18.6	23.8	21.6	21.3	25.3	21.1	13.3	19.6	10.8	28.0	15.3	25.8	30.9	26.3	30.4	21.8	23.9	26.5	19.2	22.8	28.4	23.3	36.7	16.2	12.4	11.5	28.2	25.1	14.6	12.1	21.9	19.0	25.1	17.4	15.0	14.6	29.8	18.8	23.8	25.1	29.2	20.6	19.8	15.6	15.7	22.3	30.2	19.6	36.4	22.5	16.1	34.2	25.2	17.5	27.9	15.6	20.4	17.4	17.1	16.1	20.3	19.7	15.1	13.6	12.5	17.2	14.7	19.6	11.4	15.9	17.1	29.8	32.3	42.6	47.2	26.3	22.5	38.7	28.8	29.6	34.0	14.9	25.3	16.7	17.9	19.8	30.2	6.7	20.4	9.4	14.8	12.2	19.6	22.5	16.6	17.6	8.9	15.8	24.9	0.0	21.6	16.5	23.4	16.5	18.5	10.9	24.5	33.4	17.7	9.8	15.9	11.5	21.6	17.4	13.5	31.5	17.8	18.9	18.2	17.5	23.3	12.4	26.6	12.9	23.7	24.7	23.0	27.1	40.7	21.0	18.0	26.9
RFX5		ENSG00000143390	"Regulatory factor X5"	P48382	1	151340640-151347357	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018519	Supported					NA	NA					"HPA018519: AB_1856209"	"unprognostic (1.17e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	10.1	21.7	12.5	25.4	11.1	10.4	10.1	14.6	18.8	11.2	15.9	13.0	11.9	16.7	16.2	11.5	11.7	11.1	15.0	10.6	12.0	12.5	13.8	7.5	14.9	32.8	12.0	13.0	8.4	9.2	19.7	14.8	6.6	19.8	12.6	16.1	11.6	11.5	15.4	11.8	7.6	20.4	17.6	10.7	28.2	12.9	8.8	7.4	30.5	14.2	10.9	38.0	17.4	8.6	25.4	22.6	5.3	14.0	14.9	12.9	9.6	11.3	10.9	16.9	9.5	9.7	7.7	3.8	5.5	9.6	13.9	18.3	3.7	15.9	42.6	19.5	6.0	13.4	18.4	6.9	10.8	10.4	50.4	13.0	15.6	27.3	6.9	5.5	14.4	18.2	8.7	6.3	9.2	3.9	11.2	12.3	27.2	7.8	27.1	10.1	10.5	21.8	10.3	12.2	9.5	6.9	27.0	9.4	24.4	13.5	14.7	6.3	18.6	10.9	17.9	16.2	21.7	16.6	32.9	11.5	7.8	7.7	3.6	10.5	33.5	32.6	48.0	12.7	8.2	9.6	2.4	11.2	5.3	9.1	13.6	8.1	24.7	7.3	8.9	22.6	25.4	5.8	6.5	1.4	14.9	14.0	12.1	12.9	9.6	12.5	11.1	14.6	18.8	12.0	12.5	12.0	13.0	19.8	7.4	8.9	6.9	24.9	10.4	6.0	6.6	3.6	12.7	1.4	10.3	7.0	0.0	6.5	8.3	12.6	6.5	6.8	5.2	0.0	8.1	2.8	4.7	10.3	23.1	4.4	11.3	1.6	4.1	11.1	14.5	13.6	4.6	12.7	5.0	52.3	4.0	5.6	8.5	0.0	9.2	8.7	2.8	6.5	7.2	16.4	7.7	5.4	2.9	14.9	6.7	12.9
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 401.2;Enterocytes: 467.1;Hepatocytes: 434.3;Paneth cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.5;HEL: 28.5;HSkMC: 19.8;OE19: 23.2;SK-BR-3: 68.7"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.3	8.0	0.4	38.5	15.4	2.0	1.6	0.8	0.8	1.6	4.3	1.3	0.0	7.4	2.6	0.0	0.0	0.0	0.1	0.6	0.0	3.7	28.5	14.4	6.9	8.1	0.0	0.0	19.8	0.2	1.3	0.0	0.1	4.8	0.0	2.8	0.0	2.0	3.2	0.0	0.0	6.4	23.2	8.1	0.0	0.4	0.1	1.8	0.0	0.1	0.1	0.0	68.7	0.0	6.8	11.8	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0	273.9	401.2	14.3	27.8	9.6	0.2	107.6	81.5	93.7	100.1	5.2	0.0	2.2	97.8	10.9	0.6	13.2	467.1	280.4	7.9	1.9	45.2	28.8	26.5	434.3	11.9	0.0	149.0	21.5	23.4	2.0	61.5	8.5	32.1	0.0	88.1	35.2	8.1	327.6	76.0	115.0	1.0	51.8	66.0	0.0	0.2	8.7	3.3	6.9	282.5	68.5
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome subunit beta 4"	P28070	1	151399534-151401944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		15000000	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	45.7	64.5	47.4	40.4	49.5	40.2	56.3	39.6	84.0	44.4	44.3	28.5	58.8	41.2	53.5	65.3	55.7	51.2	37.8	66.6	47.0	50.7	57.3	71.9	43.6	81.1	49.2	61.0	52.4	87.0	40.0	45.4	50.9	48.4	42.6	47.5	37.8	46.7	56.1	68.7	45.7	39.7	66.4	55.1	46.6	43.4	31.8	36.3	51.1	46.8	63.3	62.2	58.6	37.7	68.5	106.5	58.6	81.4	72.5	89.0	78.3	52.1	54.7	46.6	55.8	52.8	50.4	64.1	30.8	67.2	89.9	63.1	73.2	70.5	47.5	93.4	51.5	47.8	52.4	47.3	57.9	51.3	66.2	47.8	32.8	41.0	54.7	57.1	45.7	45.2	55.0	55.4	84.4	34.7	45.8	62.7	51.3	53.0	93.0	63.3	139.7	54.8	53.9	119.2	77.4	71.0	52.6	34.1	83.8	73.4	42.7	51.8	61.5	35.8	78.3	103.0	60.3	70.7	72.5	39.7	39.5	42.1	41.9	67.6	92.7	106.1	91.6	58.3	40.7	83.0	54.6	81.4	49.5	63.9	75.2	75.9	68.5	74.9	72.5	96.4	60.8	65.8	68.0	58.6	72.5	56.9	106.5	89.0	78.3	47.4	49.5	39.6	84.0	47.0	50.7	49.2	61.0	48.4	36.3	142.9	125.8	60.3	65.1	68.1	51.9	108.2	81.5	179.3	134.2	68.0	15.7	176.7	87.9	106.1	12.6	85.2	80.0	46.7	168.6	123.7	82.9	62.0	103.4	133.7	108.0	46.1	63.8	90.9	107.2	13.4	96.7	88.1	91.1	226.4	73.7	84.2	122.6	66.6	99.0	122.6	44.8	64.7	80.2	38.6	45.3	66.4	223.6	74.3	80.9	77.2
POGZ	"KIAA0461, ZNF280E, ZNF635m"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459465	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (4.40e-4)"	11.6	15.2	18.3	15.6	20.1	23.5	18.2	40.6	24.8	16.1	17.8	22.2	21.9	10.0	24.2	39.0	11.0	23.9	17.7	12.4	15.4	13.5	16.9	14.4	13.9	12.7	18.7	20.7	37.4	13.2	33.0	26.8	10.4	17.3	17.8	14.5	17.1	15.4	17.6	15.4	24.1	13.0	19.3	20.3	16.7	13.1	21.2	21.8	20.3	21.6	7.4	13.9	15.0	17.6	5.2	4.0	7.8	2.6	2.9	5.6	1.8	9.8	12.9	32.4	18.3	14.5	14.1	11.1	8.7	8.0	10.0	10.4	14.4	10.3	20.8	15.1	10.9	7.9	8.7	18.7	9.3	13.1	17.6	10.4	12.7	17.6	8.3	10.7	17.5	13.0	12.5	7.6	11.0	13.3	18.7	15.8	15.7	11.9	20.1	9.7	25.3	19.3	11.4	22.9	10.2	7.8	18.9	15.6	10.6	10.7	16.2	17.7	18.1	14.7	12.5	14.4	27.6	16.3	23.0	13.2	12.1	14.5	10.0	12.5	14.6	12.5	40.3	8.7	9.3	10.2	7.8	2.5	5.5	4.2	2.1	3.6	5.0	4.2	5.6	2.2	5.2	4.3	4.2	4.8	2.9	2.6	4.0	2.9	1.8	18.3	20.1	40.6	24.8	15.4	13.5	18.7	20.7	17.3	21.8	56.6	41.2	14.7	23.8	40.2	81.8	15.1	35.7	18.7	28.4	61.1	78.5	13.4	3.3	19.4	12.1	41.3	27.5	0.0	12.8	9.3	31.4	29.8	26.6	38.4	18.3	74.7	55.9	49.7	22.8	6.9	49.8	26.0	49.0	19.8	30.0	52.4	20.1	26.4	69.3	9.8	57.4	64.7	32.5	27.9	57.7	29.7	9.6	25.9	33.7	23.5
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 110.2;Ciliated cells: 50.9;Enterocytes: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;CAPAN-2: 24.3;OE19: 23.6;RT4: 17.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		24000000	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	3.9	0.3	2.1	8.5	5.1	0.0	4.1	11.9	3.5	2.2	18.0	3.7	15.5	23.9	1.0	3.5	5.9	6.1	11.9	0.5	1.4	1.4	10.7	15.0	12.4	0.2	5.0	1.0	1.4	25.3	22.1	4.7	1.9	4.8	4.6	11.6	1.8	19.8	14.4	0.2	11.6	44.1	1.8	1.9	0.2	13.6	6.4	4.3	0.9	3.6	2.3	4.3	6.9	3.8	1.2	0.9	2.6	1.0	1.6	2.4	0.1	11.5	1.3	1.1	1.9	0.0	0.0	14.8	0.0	0.0	0.3	0.4	36.9	24.3	0.5	4.0	0.0	2.0	11.1	3.6	2.0	0.2	6.9	2.4	1.0	0.5	0.7	0.0	0.2	1.6	0.0	0.4	0.5	0.3	0.0	0.1	3.3	0.5	3.5	0.0	10.7	2.0	0.2	9.5	23.6	1.0	2.2	1.2	1.7	7.8	17.9	3.7	1.9	0.7	11.3	0.4	4.5	13.9	0.1	0.2	0.1	3.6	0.2	0.5	3.3	3.2	2.0	0.1	1.3	0.9	1.1	1.0	0.4	2.4	0.4	0.7	0.7	0.7	0.5	0.1	1.2	0.8	1.4	2.6	1.6	0.5	0.9	0.7	0.1	2.1	5.1	11.9	3.5	1.4	1.4	5.0	1.0	4.8	4.3	110.2	25.7	0.0	3.7	0.2	2.7	0.4	15.3	50.9	26.1	3.5	0.0	2.1	0.0	19.2	0.0	0.0	85.9	0.0	22.2	0.2	0.3	9.6	0.0	25.2	0.2	0.0	9.9	0.0	0.0	0.5	0.6	0.7	3.3	3.6	26.7	16.6	34.9	40.1	0.7	2.6	1.4	0.0	0.3	0.7	7.1	1.6	0.3	0.0	21.4	13.9
TUFT1		ENSG00000143367	"Tuftelin 1"	Q9NNX1	1	151540305-151583583	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 54.9"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 61.5;Suprabasal keratinocytes: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 72.2"	"HPA028112, HPA054301"	Approved	Approved	Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA028112: AB_10603224, HPA054301: AB_2682442"	"unprognostic (6.16e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.29e-3)"	"unprognostic (9.06e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (4.53e-2)"	3.4	4.0	2.7	3.3	2.5	3.8	11.6	8.5	4.5	13.3	8.1	1.1	6.7	4.6	5.9	6.9	23.4	3.1	9.7	3.0	2.0	4.0	9.4	3.9	5.3	2.2	1.9	3.9	5.4	9.3	7.8	5.7	33.1	3.3	7.5	8.3	3.3	18.8	9.4	1.7	54.9	9.8	9.6	1.8	1.1	7.4	5.0	1.5	0.5	3.6	12.0	14.4	11.9	12.2	1.2	1.6	6.5	1.1	0.2	6.0	0.9	14.6	5.0	3.7	4.3	0.8	0.7	23.9	3.9	3.5	15.7	15.1	15.9	11.7	1.3	24.6	4.6	7.4	17.2	6.5	6.0	11.5	9.7	3.2	0.8	8.5	2.4	12.5	0.3	1.8	2.5	7.1	12.3	27.4	9.3	1.2	1.8	1.3	10.1	4.8	6.0	0.7	0.2	4.4	10.8	4.3	0.0	10.6	5.0	13.0	22.7	7.4	3.0	25.2	17.2	3.0	11.7	13.7	0.7	3.2	2.8	19.8	17.4	26.1	2.5	4.8	0.1	2.4	0.3	1.7	6.5	1.1	1.1	0.7	0.3	1.4	1.2	1.9	1.0	1.6	0.6	1.7	0.6	4.5	0.2	0.6	0.2	6.0	0.9	2.7	2.5	8.5	4.5	2.0	4.0	1.9	3.9	3.3	1.5	23.8	1.3	0.0	41.3	61.5	1.8	8.9	7.6	1.4	9.1	14.0	0.0	22.2	11.6	15.0	2.1	0.7	37.6	0.0	13.3	12.0	7.4	24.8	4.6	9.3	3.5	0.0	30.9	1.8	0.0	1.9	2.3	2.6	8.5	2.8	21.4	2.0	31.3	21.6	4.9	9.1	0.5	6.5	5.6	0.7	3.4	58.2	47.5	3.2	17.0	26.9
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin family member 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045816			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045816: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	10.9	12.5	21.5	12.5	28.6	13.4	12.6	25.0	27.7	14.8	15.9	23.4	13.5	9.1	12.1	16.2	12.1	13.9	11.5	12.1	23.0	21.3	24.2	12.8	13.6	10.4	23.7	19.2	17.2	10.0	26.0	14.8	17.5	20.3	14.8	13.0	13.1	9.7	20.6	25.6	16.0	10.1	21.3	23.1	17.0	11.2	12.8	18.7	8.8	12.8	7.7	10.8	17.4	21.7	2.5	8.4	20.3	18.6	1.7	3.6	7.3	5.9	8.9	9.5	11.9	15.0	11.1	21.1	3.2	6.7	5.7	6.2	7.2	8.0	5.7	7.1	5.2	6.2	7.5	12.1	6.5	7.2	8.1	4.5	9.1	5.2	8.1	10.0	10.8	6.3	8.8	4.9	6.5	7.5	5.8	6.4	9.1	5.5	35.1	7.5	10.7	6.4	7.5	16.7	11.8	5.8	6.7	9.2	7.3	8.9	9.0	9.5	8.1	8.7	16.2	6.2	10.7	10.4	9.2	8.5	8.1	5.5	8.4	6.7	7.4	7.4	11.5	9.7	7.0	9.0	9.5	18.6	2.6	2.6	16.1	3.6	1.8	3.2	2.3	8.4	2.5	3.1	2.5	20.3	1.7	16.9	2.1	2.5	7.3	21.5	28.6	25.0	24.6	23.0	21.3	23.7	19.2	20.3	18.7	11.9	21.9	11.2	13.8	18.8	42.4	25.5	20.4	8.1	15.9	27.9	25.5	40.5	21.6	21.5	23.7	16.1	12.3	23.3	18.3	18.4	17.5	15.0	3.5	17.9	37.8	38.1	18.0	22.7	76.7	6.6	28.1	28.6	28.7	32.5	15.2	22.7	21.5	10.5	37.4	51.8	27.3	32.3	19.4	41.7	29.4	21.7	87.6	12.9	15.8	13.2
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151702404-151716814	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 93.5;Cone photoreceptor cells: 37.3;Horizontal cells: 19.1;Intestinal endocrine cells: 50.7"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 28.6;SH-SY5Y: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	1.1	16.8	21.4	1.4	28.9	1.1	1.0	29.2	44.0	1.0	2.1	2.0	0.0	5.0	1.0	1.0	1.1	2.1	1.0	1.0	19.5	16.2	1.1	1.0	1.1	1.0	5.3	15.3	1.0	8.8	1.0	31.2	1.2	3.7	1.1	2.1	3.7	1.0	1.0	1.0	1.0	3.8	1.2	1.5	1.0	8.5	2.0	4.4	0.0	1.1	0.0	1.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	28.6	20.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	28.9	29.2	29.1	19.5	16.2	5.3	15.3	3.7	4.4	0.0	0.0	0.0	0.0	0.0	93.5	0.8	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	19.1	50.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.6	2.3	0.1	0.0	0.0	0.3	4.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 43.4;pituitary gland: 29.2"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 113.8;Early spermatids: 62.9;Intestinal endocrine cells: 44.4;Late spermatids: 46.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 6.6;SCLC-21H: 3.6;SH-SY5Y: 7.1;SK-BR-3: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.5	2.7	4.0	0.5	9.3	0.5	1.1	0.5	5.6	1.6	1.1	0.8	1.2	0.6	2.1	6.1	0.7	43.4	0.9	0.5	4.6	5.1	0.6	0.5	3.1	0.5	2.5	5.2	2.6	1.2	1.1	29.2	0.5	3.6	1.0	1.3	1.2	0.5	1.9	0.5	0.6	0.8	1.1	0.5	0.5	2.0	14.7	2.1	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	7.1	0.0	11.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.3	0.5	5.6	4.6	5.1	2.5	5.2	3.6	2.1	17.9	1.0	0.0	0.0	0.0	6.7	14.0	0.0	113.8	15.9	5.2	15.7	0.0	3.3	3.1	62.9	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.1	0.0	44.4	0.0	0.0	46.5	0.6	0.3	3.3	0.0	2.0	0.8	0.2	0.0	1.4	2.2	2.7	0.0	1.0	14.9	7.8	0.0	0.0	0.0	0.8	0.0
MRPL9		ENSG00000143436	"Mitochondrial ribosomal protein L9"	Q9BYD2	1	151759643-151763564	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008579	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA008579: AB_1079412"	"unprognostic (2.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.43e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.30e-2)"	28.5	22.3	23.3	26.3	25.3	23.0	26.4	27.3	30.9	22.1	26.7	22.2	19.8	21.7	26.8	25.4	28.4	22.5	24.3	24.5	21.7	24.6	29.9	35.1	19.5	28.7	24.0	19.4	33.2	31.9	35.1	18.4	29.0	27.6	29.0	22.3	19.7	40.6	25.3	50.7	25.7	23.1	23.7	21.2	28.5	23.0	24.0	18.3	41.2	38.2	34.2	29.3	25.3	23.5	30.6	31.5	15.0	16.5	24.4	37.6	21.6	29.4	24.2	15.9	18.7	11.5	12.9	26.1	16.4	15.7	25.6	20.6	36.9	27.6	19.3	33.3	16.5	16.6	26.1	27.8	20.6	20.4	26.3	26.8	15.2	20.5	23.4	18.7	42.2	14.4	14.1	19.1	22.8	28.7	17.0	24.7	29.6	31.6	25.4	19.7	68.7	26.1	30.2	34.5	33.6	35.0	23.1	19.1	37.3	15.5	23.3	26.3	26.9	19.5	28.1	22.9	22.7	42.5	51.1	18.3	20.3	20.6	17.4	36.3	28.5	40.4	61.4	25.4	27.9	22.6	15.0	13.6	8.8	27.8	16.5	31.8	30.6	32.1	32.3	31.5	27.8	30.9	28.8	1.6	24.4	14.2	26.5	37.6	21.6	23.3	25.3	27.3	30.9	21.7	24.6	24.0	19.4	27.6	18.3	26.8	17.9	43.1	41.8	27.8	17.4	3.8	28.1	38.8	33.0	31.4	5.9	85.5	54.7	60.9	60.3	38.8	18.1	0.0	55.8	100.4	33.3	38.4	39.4	26.1	56.9	17.5	27.5	39.9	21.1	21.0	36.2	30.2	33.7	78.5	26.7	30.6	59.8	24.6	44.2	67.2	17.1	71.1	34.0	37.2	31.7	27.7	62.4	44.9	45.9	35.0
OAZ3		ENSG00000143450	"Ornithine decarboxylase antizyme 3"	Q9UMX2	1	151762899-151771334	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 102.2"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 9340.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030136, HPA045808"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030136: AB_2673331, HPA045808: "	"unprognostic (2.12e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.05e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.36e-2)"	0.4	0.3	0.5	0.7	0.5	0.0	0.6	0.6	0.6	0.3	0.4	0.4	0.7	0.1	0.3	2.0	0.4	0.2	0.3	0.6	0.5	0.5	0.5	0.8	0.6	0.8	0.5	0.5	0.3	0.6	1.4	0.6	0.3	0.4	4.0	0.5	0.3	3.1	0.7	1.0	0.3	0.3	0.5	0.6	0.6	0.2	102.2	0.2	0.3	0.8	0.7	0.4	0.4	0.6	1.4	3.2	2.2	5.0	2.6	2.4	1.6	1.2	2.3	1.4	3.3	1.1	3.3	2.9	2.3	0.6	2.2	1.0	1.3	3.1	1.0	2.0	0.7	1.6	1.2	1.3	2.3	0.7	7.3	6.9	1.1	4.4	1.8	1.3	0.6	1.3	5.1	1.4	2.6	3.5	1.4	3.4	3.0	1.4	3.7	2.3	9.7	0.9	1.6	3.3	4.6	2.5	0.4	1.1	1.7	0.4	2.9	1.5	3.6	1.0	5.2	4.6	3.2	10.4	2.7	3.0	1.3	0.7	2.6	1.3	5.1	9.5	2.6	1.7	1.6	3.5	2.2	3.0	0.6	1.4	1.5	1.3	1.4	1.3	2.4	3.2	1.2	1.5	2.2	2.1	2.6	5.0	1.3	2.2	1.6	0.5	0.5	0.6	0.4	0.5	0.5	0.5	0.5	0.4	0.2	0.0	1.7	0.0	2.1	0.7	0.6	1.2	0.0	2.7	1.2	0.0	2.0	1.4	1.7	1.8	2210.4	2.7	3.0	0.0	2.7	2.3	1.1	27.3	1.1	2.6	4.0	0.0	3.5	1.8	4.0	9340.9	42.6	1.1	1.7	2.8	7.2	1.6	2.5	4.2	40.0	2.8	1.6	0.0	0.8	57.9	27.9	0.5	1.3	0.0	1.8	3.1
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	8.1	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	1.0	3.6	14.7	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.5	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	7.9	6.4	7.4	9.4	13.9	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9	3.0	8.8	0.9	1.9	0.2	3.4	2.6	0.0	1.4	2.3	7.0	3.9	2.2	1.7	2.5	17.5	1.0	0.1	0.0	2.2	2.5	0.4	1.7	4.6	0.6	4.4	6.4	0.0	1.3	1.3	48.0	0.3	1.3	1.7	3.6	0.9	1.5	1.8	0.0	2.1	1.3	3.0	12.9	1.2	46.8	21.1	0.1	2.1	1.3	1.0	0.9
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151806154	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 5.4;skeletal muscle: 17.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 1.2;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;JURKAT: 1.5;Karpas-707: 1.1;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA060781	Uncertain					NA	NA					"HPA060781: AB_2684361"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.5	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0			0.0	0.0	0.9	0.0	0.8	0.0	0.3	0.0	0.1	0.3	0.7	0.1	0.1	0.0		0.0	0.3	0.4	1.2	0.0		0.8	0.0		0.4	0.1	17.7	0.3	0.0	0.0	0.3	0.0	0.3	0.4			0.4		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	0.0	0.0	0.2	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831872	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.8;skeletal muscle: 63.8"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 29.9;Erythroid cells: 23.3;Hepatocytes: 48.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 28.3"	"Lineage enriched"	"Detected in single"	44	"T-cells: 28.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;Karpas-707: 11.2;MOLT-4: 5.7;RPMI-8226: 5.9;SK-BR-3: 5.1;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA065620			Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA065620: AB_2685521"	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	1.3	1.6	0.4	3.4	0.9	0.0	3.3	7.0	0.3	2.7	10.0	0.7	19.8	4.2	1.2	6.7	3.4	8.7	3.5	4.8	0.4	0.5	13.3	30.8	8.7	0.7	0.9	0.3	1.3	30.3	8.5	9.4	0.2	2.4	7.0	4.0	2.8	27.8	33.4	63.8	9.8	10.3	0.8	0.3	0.7	7.7	6.4	1.1	69.8	15.6	11.1	4.0	2.4	1.7	0.0	0.1	0.0	0.0	0.6	28.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	21.5	0.0	0.0	2.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	11.2	0.0	0.1	5.7	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.2	0.1	5.1	0.0	0.0	9.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	0.0	28.3	0.0	4.4	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	3.0	0.6	0.4	0.9	7.0	0.3	0.4	0.5	0.9	0.3	2.4	1.1	6.0	5.9	0.8	4.5	1.8	0.0	5.3	10.2	6.7	1.2	15.7	0.0	0.0	29.9	5.0	0.3	0.3	15.8	23.3	6.2	0.0	0.2	7.1	0.0	48.2	0.1	0.0	9.2	0.6	2.7	0.4	0.6	0.7	3.3	0.0	17.3	0.0	4.0	17.5	0.4	13.9	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	13.9	2.7
C2CD4D	FAM148D	ENSG00000225556	"C2 calcium dependent domain containing 4D"	B7Z1M9	1	151837819-151840557	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 4.1;skin 1: 4.9"	"Cell type enhanced"	"Detected in some"	10	"Distal tubular cells: 8.3;Intestinal endocrine cells: 5.2;Syncytiotrophoblasts: 8.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0;T-reg: 2.2"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Cell line enriched"	"Detected in some"	9	"HDLM-2: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.17e-3)"	"unprognostic (5.08e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (9.03e-4)"	"unprognostic (2.69e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.28e-2)"	0.4	0.8	0.9	0.7	0.6	0.0	0.4	1.9	2.3	0.1	1.0			0.5	0.0	0.0	0.6	0.5	0.7	0.4	1.6	0.8	0.9	0.2	0.8	0.8	1.4		0.0	2.6	0.0	1.2	0.0		1.0	0.1		4.1	0.6	0.4	4.9	0.6	0.0	3.3	0.5	1.9	0.5			0.3		0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.1	2.1	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	20.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.7	0.0	0.0	2.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.1	1.5	1.1	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	1.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1											0.0	0.0	0.0	0.8	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	8.3	0.2	0.0	0.1	0.3	0.0	0.4	0.1	0.0	1.5	0.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.6	0.0	3.3	0.0	2.1	0.9	0.5	2.6	0.4	0.6	0.3	0.0	0.0	0.2	0.2	0.9	8.9	1.3	2.3	0.7
THEM5	FLJ37964	ENSG00000196407	"Thioesterase superfamily member 5"	Q8N1Q8	1	151847263-151853697	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skin 1: 59.8;tongue: 24.7"	"Cell type enriched"	"Detected in some"	18	"Suprabasal keratinocytes: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.2"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 39.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"basal ganglia: 20.0"							NA	NA						"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.58e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.86e-3)"	"unprognostic (3.07e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.62e-2)"	0.1	0.6	0.3	0.5	0.2	0.0	1.8	0.2	1.6	3.6	0.1	0.2	0.1	0.3	0.8	0.1	4.4	0.1	1.0	1.1	0.3	0.2	0.3	0.2	0.3	1.9	0.2	0.8	0.1	0.3	0.0	0.2	5.8	0.1	0.1	0.0	0.1	1.5	0.1	0.2	59.8	0.1	0.1	0.3	0.1	0.5	0.3	0.1	0.4	0.1	24.7	1.7	0.6	1.1	0.0	0.5	0.5	0.2	0.0	4.2	5.6	4.4	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	39.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	1.2	0.1	0.0	4.7	0.7	0.3	0.0	0.2	0.5	0.0	0.0	0.3	0.1	6.0	1.4	0.8	1.0	1.0	1.4	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.8	0.2	4.2	0.0	1.6	1.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	1.9	5.6	0.3	0.2	0.2	1.3	0.3	0.2	0.2	0.8	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.9	0.0	0.0	0.0
THEM4	CTMP	ENSG00000159445	"Thioesterase superfamily member 4"	Q5T1C6	1	151873584-151909808	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 30.5"	"Low region specificity"	"Detected in all"							HPA028161	Approved					NA	NA					"HPA028161: AB_10603454"	"unprognostic (2.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.15e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-3)"	8.3	15.3	8.4	9.8	11.7	4.9	12.2	19.8	13.2	6.6	8.0	11.3	22.4	8.5	10.3	18.0	6.1	8.5	7.2	9.8	8.7	11.9	19.9	13.4	8.9	15.7	10.8	6.4	9.2	15.9	10.9	21.0	6.3	11.1	8.0	11.6	14.9	9.2	23.1	18.3	6.7	8.1	7.9	10.0	9.2	9.6	10.2	11.8	3.1	11.3	6.4	13.6	11.3	8.3	3.0	5.0	1.8	1.6	6.2	18.6	2.8	3.7	4.3	1.0	3.5	3.7	3.0	3.4	3.1	3.8	4.3	3.5	4.8	3.3	10.2	5.0	4.6	2.0	4.0	2.9	10.0	4.3	10.6	2.0	13.8	6.0	5.5	3.5	15.9	4.5	5.9	4.4	4.5	4.5	3.5	7.2	0.1	17.3	7.8	6.2	6.4	0.0	4.2	18.0	4.5	7.6	0.0	0.8	2.6	5.1	3.7	4.6	8.3	2.2	4.0	30.5	3.7	10.4	6.6	6.2	0.4	3.8	2.9	1.3	12.7	16.4	6.5	6.5	8.7	20.3	1.5	0.6	1.8	6.1	1.6	9.1	3.0	12.7	6.0	2.0	1.5	12.3	8.7	0.4	6.2	0.5	5.0	18.6	2.8	8.4	11.7	19.8	13.2	8.7	11.9	10.8	6.4	11.1	11.8	6.0	13.7	16.1	7.2	4.9	35.0	16.1	12.7	5.3	12.5	14.0	98.2	25.2	34.9	15.2	30.2	12.0	7.0	0.0	16.8	13.9	14.6	5.0	23.1	15.3	11.4	12.7	17.4	21.5	3.1	23.7	15.5	10.4	20.3	9.0	7.0	23.7	12.7	11.4	15.2	21.4	70.5	12.9	10.8	26.5	20.0	3.9	8.6	24.5	12.8	3.5
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151994390	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 148.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4"	"Cell line enhanced"	"Detected in many"		"OE19: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		230000	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	36.7	19.9	7.3	12.1	9.4	4.5	30.7	7.3	10.7	19.0	42.3	8.4	7.3	23.4	7.3	10.1	87.1	8.5	10.7	16.7	7.3	4.4	19.1	10.2	33.5	7.3	7.3	7.3	11.5	7.3	1.6	7.3	18.7	11.1	8.5	49.8	9.5	21.1	7.3	7.3	21.8	21.7	14.0	9.6	7.3	8.6	61.4	7.3	7.3	7.3	22.1	13.6	8.1	37.7	17.8	148.1	21.4	89.2	25.9	85.4	74.8	63.5	65.2	0.2	13.5	73.8	98.4	48.6	36.0	48.7	32.3	32.8	117.1	88.5	0.0	35.0	62.8	38.3	111.1	18.5	140.1	30.1	11.4	5.3	7.7	29.7	27.4	26.4	2.9	6.7	25.5	118.1	35.2	40.5	29.0	71.4	4.2	0.1	0.1	42.9	55.1	0.5	18.6	8.8	273.2	72.5	0.0	12.6	1.2	136.1	18.9	0.5	0.5	58.8	21.1	27.4	77.4	46.6	7.4	75.8	15.5	38.8	73.4	25.1	1.7	0.3	10.9	91.1	2.6	54.2	21.4	89.2	21.0	33.3	54.4	35.2	17.8	52.6	42.3	148.1	8.6	19.6	29.5	3.2	25.9	46.5	24.2	85.4	74.8	7.3	9.4	7.3	10.7	7.3	4.4	7.3	7.3	11.1	7.3	2373.2	509.0	165.5	824.9	1416.6	10.1	91.6	634.4	507.3	913.4	902.0	3.9	1028.8	1291.5	1817.5	320.0	1052.4	1898.6	46.7	1882.2	473.9	2108.7	1493.1	280.8	168.1	1060.4	15.9	1037.0	742.7	952.8	225.8	599.2	1623.9	1548.8	1432.9	1679.7	14.1	2865.9	3115.1	60.8	287.0	25.8	142.3	345.1	12.6	80.7	1085.7	314.3	441.6	1750.5	1802.8
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 485.8;esophagus: 373.9"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 5098.8;Pancreatic endocrine cells: 5004.9;Urothelial cells: 5957.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 485.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced					NA	NA		11000000			"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	98.4	18.7	9.2	32.7	17.3	24.9	48.0	2.7	9.2	96.3	22.2	14.7	41.3	12.1	42.2	48.0	373.9	42.1	45.6	30.2	7.4	6.5	107.9	17.2	74.6	73.4	16.5	3.4	35.1	23.4	77.0	20.1	197.6	14.3	60.8	22.9	29.6	108.3	49.0	23.9	65.3	31.0	31.2	19.4	89.9	38.7	16.9	11.3	46.7	44.3	181.3	272.3	71.0	130.7	9.2	81.7	485.8	124.5	18.4	39.3	110.7	92.1	73.5	3.6	27.5	101.4	127.2	59.8	90.3	130.8	72.8	74.7	34.1	104.0	0.1	81.0	115.9	58.8	130.5	3.6	161.3	41.3	44.7	7.4	8.0	43.5	19.6	78.5	7.2	56.6	96.4	163.5	79.9	101.0	42.5	55.3	0.0	16.3	17.9	106.0	147.7	0.9	33.8	26.2	199.2	74.6	0.1	38.8	69.9	216.4	156.9	0.1	5.9	68.7	91.5	60.9	92.7	70.0	79.9	79.3	39.1	27.7	60.8	47.9	0.1	0.8	0.3	88.6	23.8	46.1	173.6	124.5	187.4	20.4	119.9	26.9	9.2	39.3	24.1	81.7	5.3	11.7	13.2	485.8	18.4	120.9	28.3	32.6	110.7	9.2	17.3	2.7	9.2	7.4	6.5	16.5	3.4	14.3	11.3	128.1	149.6	114.3	3094.0	1963.3	0.8	19.8	593.6	871.3	419.7	2166.9	0.0	2722.8	863.7	4107.8	286.6	483.3	363.8	23.3	3796.2	5098.8	949.9	2329.5	431.4	7.2	3646.0	0.0	266.8	383.0	1219.9	479.5	297.1	2024.9	1179.3	2541.0	305.3	0.8	5004.9	526.1	242.9	548.1	2.2	207.0	593.3	5.1	23.4	2467.0	3138.8	205.4	310.2	5957.2
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.7"					"Not detected"	"Not detected"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane, Nucleoli"		"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skin 1: 28.8;tongue: 40.9"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 6.4;Kupffer cells: 15.0;Macrophages: 7.1;monocytes: 6.4;Spermatogonia: 10.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;SCLC-21H: 2.5;THP-1: 4.4"									HPA028375	Approved					NA	NA					"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.4	0.2	0.2	0.2	0.0	1.7	0.2	0.6	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.7	0.2	0.2	28.8	0.3	0.2	0.2	4.7	0.0	1.9	0.2	0.6	0.2	40.9	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.5	0.6	0.0	1.6	0.1	0.0	8.1	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.2	2.1	0.2	0.3	2.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.4	0.7	0.0	0.1	0.6	4.4	0.1	0.2	2.1	0.4	0.2	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	5.7	0.5	1.7	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.2	1.4	0.0	0.0	0.2	6.4	0.4	1.5	0.0	0.0	0.5	0.0	1.7	3.1	15.0	0.0	0.3	7.1	0.0	6.4	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	2.0	2.9	10.4	2.0	4.3	0.0	0.0	0.0
RPTN	FLJ39117	ENSG00000215853	Repetin	Q6XPR3	1	152153595-152159228	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 33.2;skin 1: 19.5;tongue: 71.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 3.7;hTCEpi: 1.9"									"HPA030483, HPA030485"	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA030483: AB_2673495, HPA030485: AB_10601159"		"unprognostic (1.37e-2)"				"unprognostic (5.06e-2)"		"unprognostic (2.35e-1)"	"unprognostic (4.54e-2)"		"unprognostic (4.00e-2)"						"unprognostic (5.23e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	71.0	33.2	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212082-152224193	"Plasma proteins, Predicted intracellular proteins"	Keratinization	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.0"	"Cell type enhanced"	"Detected in some"	24	"Horizontal cells: 1.6;Rod photoreceptor cells: 3.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"					"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.6;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.2;TIME: 1.2;U-2 OS: 1.6;U-2197: 1.5"									HPA031469	Uncertain		Approved	Mitochondria		No	No		210000000	Mitochondria		"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.3	0.4	0.0	0.1	0.2	0.1	0.3	0.0	1.3	0.7	0.1			0.1	0.5	0.0	1.8	0.8	0.6	0.5	0.1	0.1	1.0	0.0	0.1	0.4	0.0		1.6	1.5	0.0	0.4	0.1		0.6	0.0		0.2	0.0	0.1	4.0	0.2	0.0	0.1	0.1	0.1	1.3			1.6		0.0	0.4	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.6	1.2	0.1	1.6	1.5	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 21.9;skin 1: 109.7;tongue: 38.6"	"Cell type enriched"	"Detected in some"	13	"Suprabasal keratinocytes: 38.5"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.3;NTERA-2: 4.5;TIME: 3.0;U-2 OS: 3.5;U-2197: 3.7;WM-115: 2.8"									"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		NA	NA		500000	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.8	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.4	109.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	38.6	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	14.3	0.0	0.0	0.0	1.5	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	3.0	1.2	3.5	3.7	2.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0
FLG2	IFPS	ENSG00000143520	"Filaggrin family member 2"	Q5D862	1	152348735-152360006	"Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 107.4"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 21.1"	"Cancer enriched"	"Detected in some"	8	"melanoma: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.7"					"Not detected"	"Not detected"			HPA028699	Approved					NA	NA		19000000			"HPA028699: AB_10601905"		"unprognostic (2.58e-1)"				"unprognostic (2.33e-1)"		"unprognostic (3.08e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	7.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.3	107.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.9	0.1	19.6	0.4	0.1	0.2	0.3	0.3	1.2	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.9	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.8	0.4	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.2	21.1	0.0	0.0	0.0	0.3
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 459.6;lymphoid tissue: 187.9;tongue: 139.6"	"Cell type enriched"	"Detected in single"	6	"Late spermatids: 2.2"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.9;HaCaT: 1.1;HL-60: 1.2;hTCEpi: 1.0;K-562: 2.1;TIME: 1.2;U-266/84: 1.1;U-698: 1.5;U-937: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA024343, CAB026182"	Enhanced					NA	NA		36000			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	57.1	0.2	0.0	0.0	0.2	6.2	0.2	459.6	0.2	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	49.6	0.2	0.2	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.2	139.6	187.9	0.3	81.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	1.1	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE5A	"LEP18, SPRL5A"	ENSG00000186207	"Late cornified envelope 5A"	Q5TCM9	1	152510844-152512177	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 42.7"	"Group enriched"	"Detected in some"	6	"Melanocytes: 1.7;Suprabasal keratinocytes: 6.5"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"A549: 1.6;hTERT-HME1: 1.1"															NA	NA							"unprognostic (2.51e-1)"				"unprognostic (7.27e-3)"			"unprognostic (9.27e-2)"				"unprognostic (1.89e-1)"					0.1	0.0	0.1	0.1	0.1	0.0	7.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	42.7	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	4.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0
CRCT1	"C1orf42, NICE-1"	ENSG00000169509	"Cysteine rich C-terminal 1"	Q9UGL9	1	152514502-152516010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 212.8;lymphoid tissue: 82.6;tongue: 126.1;vagina: 69.4"	"Group enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 88.8;Suprabasal keratinocytes: 32.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 68.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 10.8"															NA	NA							"unprognostic (3.01e-2)"				"unprognostic (6.92e-2)"		"unprognostic (2.86e-2)"	"unprognostic (3.30e-1)"		"prognostic unfavorable (7.03e-4)"			"unprognostic (1.56e-2)"			"unprognostic (1.46e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	46.9	0.1	0.1	0.1	0.2	2.3	0.1	212.8	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	22.9	0.1	0.7	38.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	126.1	82.6	0.1	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	32.4	0.0	0.0	0.0	2.1
LCE3E	LEP17	ENSG00000185966	"Late cornified envelope 3E"	Q5T5B0	1	152565654-152566772	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 35.6;lymphoid tissue: 21.3;tongue: 38.9;vagina: 19.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"head and neck cancer: 40.7;melanoma: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"hTCEpi: 5.0"															NA	NA							"unprognostic (1.33e-1)"				"unprognostic (7.76e-2)"			"unprognostic (2.51e-1)"									0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.9	0.1	9.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	3.5	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	38.9	21.3	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE3D	"LEP16, SPRL6A, SPRL6B"	ENSG00000163202	"Late cornified envelope 3D"	Q9BYE3	1	152579381-152580504	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5"	"Cell type enriched"	"Detected in single"	36	"Pancreatic endocrine cells: 5.0"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 126.9;melanoma: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 8.7;hTERT-HME1: 8.1"															NA	NA							"unprognostic (1.34e-1)"				"unprognostic (1.09e-1)"			"unprognostic (2.87e-1)"									0.3	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	53.2	0.1	0.1	0.1	0.0	3.7	0.1	7.8	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	8.5	0.1	0.1	17.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.9	0.1	96.6	48.6	0.1	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE3C	"LEP15, SPRL3A"	ENSG00000244057	"Late cornified envelope 3C"	Q5T5A8	1	152600662-152601086	"Predicted intracellular proteins"	Keratinization	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"lymphoid tissue: 24.2;tongue: 17.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"head and neck cancer: 3.8;melanoma: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"hTCEpi: 1.3;hTERT-HME1: 4.8"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	17.3	24.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE3B	LEP14	ENSG00000187238	"Late cornified envelope 3B"	Q5TA77	1	152613811-152614098	"Predicted intracellular proteins"	Keratinization	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	23	"lymphoid tissue: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE3A	LEP13	ENSG00000185962	"Late cornified envelope 3A"	Q5TA76	1	152622834-152623103	"Predicted intracellular proteins"	Keratinization	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 50.6"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 3.0;Late spermatids: 1.0;Spermatogonia: 1.3"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 26.6;melanoma: 9.8"					"Cell type enriched"	"Detected in single"	33	"plasmacytoid DC: 3.3"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 3.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.1;LHCN-M2: 3.5;U-138 MG: 4.1;U-87 MG: 1.5"															NA	NA							"unprognostic (7.47e-2)"				"unprognostic (1.00e-1)"									"unprognostic (1.11e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2			0.0		50.6	0.0	10.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0
LCE2D	"LEP12, SPRL1A"	ENSG00000187223	"Late cornified envelope 2D"	Q5TA82	1	152663396-152664659	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skin 1: 52.0"	"Group enriched"	"Detected in some"	29	"Melanocytes: 1.7;Suprabasal keratinocytes: 4.1"	"Group enriched"	"Detected in some"	42	"head and neck cancer: 1.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;U-2197: 1.0"															NA	NA											"unprognostic (3.94e-2)"			"unprognostic (5.63e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	52.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0
LCE2C	LEP11	ENSG00000187180	"Late cornified envelope 2C"	Q5TA81	1	152675295-152676574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"skin 1: 75.3"	"Cell type enriched"	"Detected in single"	54	"Suprabasal keratinocytes: 12.4"	"Group enriched"	"Detected in some"	30	"head and neck cancer: 2.0;melanoma: 9.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.0;CACO-2: 2.0"															NA	NA											"unprognostic (1.47e-2)"			"unprognostic (7.00e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.9	75.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0
LCE2B	"LEP10, SPRL1B, XP5"	ENSG00000159455	"Late cornified envelope 2B"	O14633	1	152686123-152687401	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"skin 1: 101.7"	"Cell type enriched"	"Detected in some"	16	"Suprabasal keratinocytes: 27.6"	"Cancer enriched"	"Detected in some"	5	"melanoma: 11.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+: 2.1"															NA	NA											"unprognostic (3.04e-2)"			"unprognostic (1.36e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	1.0	101.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0
LCE2A	LEP9	ENSG00000187173	"Late cornified envelope 2A"	Q5TA79	1	152698364-152699442	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skin 1: 54.2;tongue: 14.1"	"Cell type enriched"	"Detected in single"	7	"Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	5	"melanoma: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.0;SK-MEL-30: 3.9;U-138 MG: 2.0;U-2197: 2.8;U-87 MG: 1.4"															NA	NA											"unprognostic (3.45e-2)"			"unprognostic (6.77e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	54.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.0	0.0	2.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
LCE4A	"LEP8, SPRL4A"	ENSG00000187170	"Late cornified envelope 4A"	Q5TA78	1	152708160-152709491	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BJ: 1.2;BJ hTERT+: 1.0;THP-1: 1.0"															NA	NA														"unprognostic (1.61e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf68	"LEP7, XP32"	ENSG00000198854	"Chromosome 1 open reading frame 68"	Q5T750	1	152719522-152720470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 123.1"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 68.4"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 2.4;melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057942			Approved	"Plasma membrane,Cytosol"		NA	NA		61000	"Plasma membrane"	Cytosol	"HPA057942: "		"unprognostic (1.73e-1)"				"unprognostic (7.46e-2)"			"unprognostic (9.34e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	123.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	68.4	0.0	0.0	0.0	0.0
KPRP	C1orf45	ENSG00000203786	"Keratinocyte proline rich protein"	Q5T749	1	152759561-152762052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 72.4"	"Cell type enriched"	"Detected in some"	10	"Suprabasal keratinocytes: 17.6"	"Group enriched"	"Detected in some"	22	"head and neck cancer: 6.9;melanoma: 13.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0;hTEC/SVTERT24-B: 5.8;LHCN-M2: 1.9;U-2197: 3.5;U-87 MG: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031988, HPA031990"	Enhanced					NA	NA		2700000			"HPA031988: AB_10671582, HPA031990: AB_2674102"		"unprognostic (1.03e-1)"				"unprognostic (2.67e-2)"			"unprognostic (1.22e-1)"								"unprognostic (1.03e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.2	0.0			0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.3	72.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.8	0.9	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0
LCE1F	LEP6	ENSG00000240386	"Late cornified envelope 1F"	Q5T754	1	152776372-152776728	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	21	"skin 1: 69.5"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 15.9"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 5.5;melanoma: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 11.7;hTERT-HME1: 5.4"															NA	NA											"unprognostic (2.21e-1)"			"unprognostic (8.43e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	69.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0
LCE1E	LEP5	ENSG00000186226	"Late cornified envelope 1E"	Q5T753	1	152786214-152788426	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skin 1: 39.5"	"Cell type enriched"	"Detected in some"	9	"Suprabasal keratinocytes: 15.9"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enriched"	"Detected in single"	15	"cerebellum: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HaCaT: 14.9"															NA	NA							"unprognostic (9.92e-2)"				"unprognostic (9.50e-2)"			"unprognostic (2.30e-2)"								"unprognostic (2.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.3	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	14.9	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0
LCE1D	LEP4	ENSG00000172155	"Late cornified envelope 1D"	Q5T752	1	152796751-152798181	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 46.0"	"Cell type enriched"	"Detected in single"	48	"Suprabasal keratinocytes: 11.0"	"Cancer enriched"	"Detected in single"	8	"melanoma: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HaCaT: 1.7;Karpas-707: 1.5"															NA	NA														"unprognostic (7.67e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0
LCE1C	LEP3	ENSG00000197084	"Late cornified envelope 1C"	Q5T751	1	152804835-152806628	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"skin 1: 100.1"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 72.5"	"Cancer enriched"	"Detected in some"	6	"melanoma: 17.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 2.5;HBEC3-KT: 5.3;hTEC/SVTERT24-B: 2.8;hTERT-HME1: 7.1"															NA	NA							"unprognostic (3.35e-2)"			"unprognostic (5.95e-2)"	"unprognostic (3.46e-2)"			"unprognostic (3.35e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	8.6	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.7	100.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.1	0.1	8.8	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	72.5	0.0	0.0	0.0	0.0
LCE1B	"LEP2, SPRL2A"	ENSG00000196734	"Late cornified envelope 1B"	Q5T7P3	1	152811971-152813109	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skin 1: 59.7"	"Cell type enriched"	"Detected in single"	18	"Suprabasal keratinocytes: 16.6"	"Cancer enriched"	"Detected in some"	10	"melanoma: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HBEC3-KT: 1.7;hTCEpi: 6.7"															NA	NA							"unprognostic (1.79e-1)"				"unprognostic (1.24e-2)"			"unprognostic (6.43e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	59.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0
LCE1A	LEP1	ENSG00000186844	"Late cornified envelope 1A"	Q5T7P2	1	152827473-152827894	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 97.7"	"Cell type enriched"	"Detected in some"	26	"Suprabasal keratinocytes: 35.3"	"Cancer enriched"	"Detected in some"	6	"melanoma: 14.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA											"unprognostic (3.82e-2)"			"unprognostic (1.70e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	97.7	0.0	0.0	0.1	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0
LCE6A	C1orf44	ENSG00000235942	"Late cornified envelope 6A"	A0A183	1	152842868-152843983	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"skin 1: 77.1"	"Cell type enriched"	"Detected in single"	11	"Suprabasal keratinocytes: 2.3"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	16	"RPMI-8226: 1.5"									HPA046376	Enhanced					NA	NA					"HPA046376: AB_10965998"						"unprognostic (4.25e-2)"			"unprognostic (8.73e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.2	0.0	0.1	0.1	0.1	0.2	77.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.8	0.1	6.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0
SMCP	MCSP	ENSG00000163206	"Sperm mitochondria associated cysteine rich protein"	P49901	1	152878317-152885047	"Predicted intracellular proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 121.7"	"Group enriched"	"Detected in some"	86	"Early spermatids: 3104.1;Late spermatids: 10668.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 4.3;hTERT-HME1: 4.1;U-2197: 2.1"									"HPA035105, HPA077113"	Enhanced					NA	NA					"HPA035105: AB_10601590, HPA077113: "						"unprognostic (5.51e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3104.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10668.6	78.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	25.8	0.0	79.8	45.2	0.0	0.0	0.0	0.0	0.0
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 62.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 78.9;RT4: 20.7;SK-BR-3: 23.8"									"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		8000000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	78.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	23.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	0.0	7.4
SPRR5		ENSG00000283227	"Small proline rich protein 5"	A0A1B0GTR4	1	152947154-152949258	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	8	"skin 1: 30.7;tongue: 32.7"	"Cell type enhanced"	"Detected in single"	38	"Exocrine glandular cells: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HaCaT: 4.1;hTCEpi: 10.7"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970666-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 51.9;tongue: 18.9"	"Group enriched"	"Detected in some"	27	"Early spermatids: 9.1;Late spermatids: 36.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.6;hTCEpi: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055963	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.1	0.0	0.1	0.7	0.1	0.0	4.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.4	0.1	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	51.9	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.8	0.1	18.9	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
SPRR1A		ENSG00000169474	"Small proline rich protein 1A"	P35321	1	152985231-152985500	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"esophagus: 495.3"	"Cell type enriched"	"Detected in some"	10	"Suprabasal keratinocytes: 126.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1736.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HaCaT: 13.0;hTCEpi: 38.1;RT4: 14.5"									CAB011237	Enhanced					NA	NA					"CAB011237: "		"unprognostic (1.39e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.64e-2)"		"unprognostic (1.19e-2)"		"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"prognostic unfavorable (1.03e-4)"			"unprognostic (1.96e-1)"			"unprognostic (1.04e-1)"	0.4	0.0	0.4	0.4	0.4	0.0	0.7	0.4	0.4	72.3	0.4	0.4	0.4	0.0	0.4	0.4	495.3	0.0	3.8	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	52.5	0.4	0.4	11.7	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	70.7	47.3	0.5	111.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.0	13.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	14.5	0.2	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	126.6	0.0	0.0	0.0	13.1
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 855.8;lymphoid tissue: 537.4;tongue: 389.6"	"Cell type enriched"	"Detected in some"	5	"Urothelial cells: 109.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 423.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.8;hTCEpi: 11.1;OE19: 4.2;RT4: 14.1;TIME: 4.0"									HPA044467	Enhanced					NA	NA		15000			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavorable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	157.6	0.2	0.0	0.0	0.2	11.5	0.2	855.8	0.2	1.8	0.5	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	1.2	0.0	0.2	0.2	0.0	93.4	0.2	0.4	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.2	389.6	537.4	0.6	163.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	6.8	3.5	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	1.3	0.0	0.0	14.1	0.0	0.0	0.4	3.3	0.0	0.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.9	0.0	0.0	0.0	0.0	3.4	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	109.5
SPRR1B	"GADD33, SPRR1"	ENSG00000169469	"Small proline rich protein 1B"	P22528	1	153031202-153032900	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 264.7;lymphoid tissue: 188.6;tongue: 618.5"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 333.0;Urothelial cells: 93.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 468.6;head and neck cancer: 1812.5;melanoma: 425.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"hTCEpi: 92.1"															NA	NA							"unprognostic (1.73e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.59e-2)"		"unprognostic (9.68e-2)"		"prognostic unfavorable (7.66e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (7.64e-5)"			"unprognostic (5.71e-2)"		"unprognostic (2.15e-1)"	"prognostic unfavorable (7.28e-4)"	0.1	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	94.9	0.1	0.1	0.1	0.1	9.5	0.2	264.7	0.2	2.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	48.7	0.1	0.2	33.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.9	0.1	618.5	188.6	0.2	113.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	333.0	0.2	0.0	0.0	93.4
SPRR2D		ENSG00000163216	"Small proline rich protein 2D"	P22532	1	153039725-153041931	"Predicted intracellular proteins"	Keratinization			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"esophagus: 246.4;tongue: 317.8"	"Cell type enriched"	"Detected in some"	6	"Suprabasal keratinocytes: 13.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 80.9;head and neck cancer: 353.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTCEpi: 26.2;hTERT-HME1: 23.0;SK-MEL-30: 11.3"															NA	NA							"unprognostic (7.50e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.17e-2)"		"unprognostic (5.14e-2)"		"unprognostic (1.49e-3)"	"unprognostic (3.58e-1)"		"unprognostic (1.37e-3)"			"unprognostic (6.85e-2)"	"unprognostic (1.90e-2)"		"prognostic unfavorable (1.62e-4)"	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.4	0.1	246.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	29.9	0.1	0.1	14.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	317.8	63.5	0.1	40.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	26.2	0.0	23.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.3	0.1	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.7	0.1	0.1	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.2	0.0	0.0	0.7
SPRR2A		ENSG00000241794	"Small proline rich protein 2A"	P35326	1	153056113-153057537	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 393.4;lymphoid tissue: 173.5;tongue: 572.8"	"Cell type enhanced"	"Detected in some"	26	"Ductal cells: 13.4;Exocrine glandular cells: 48.7;Pancreatic endocrine cells: 7.5;Suprabasal keratinocytes: 10.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 743.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.8;hTCEpi: 8.4;hTERT-HME1: 11.1;Karpas-707: 13.5;U-266/70: 2.8"															NA	NA							"unprognostic (3.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-3)"		"unprognostic (1.64e-2)"		"unprognostic (6.80e-3)"	"unprognostic (3.51e-1)"		"unprognostic (3.36e-3)"			"unprognostic (4.53e-2)"			"prognostic unfavorable (1.37e-5)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	82.8	0.2	0.0	0.0	0.2	3.0	0.2	393.4	0.2	0.7	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	58.3	0.2	0.2	1.3	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	572.8	173.5	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.0	11.1	0.0	0.0	0.0	0.8	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.8	0.3	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	1.5
SPRR2B		ENSG00000196805	"Small proline rich protein 2B"	P35325	1	153070224-153070840	"Predicted intracellular proteins"	Keratinization			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2"	"Cell type enriched"	"Detected in single"	58	"Leydig cells: 5.8"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 77.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SiHa: 1.3;U-2197: 1.2"															NA	NA							"unprognostic (1.52e-1)"				"unprognostic (1.44e-2)"			"unprognostic (3.62e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0			0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0		0.0	0.0		3.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	3.2			0.0		11.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR2E		ENSG00000203785	"Small proline rich protein 2E"	P22531	1	153093135-153106184	"Predicted intracellular proteins"	Keratinization			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 210.2;skin 1: 94.0;tongue: 291.9"	"Cell type enriched"	"Detected in some"	22	"Suprabasal keratinocytes: 38.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 612.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"hTCEpi: 19.7"															NA	NA							"unprognostic (2.27e-1)"				"unprognostic (3.86e-2)"		"unprognostic (5.04e-2)"	"unprognostic (3.40e-1)"								"prognostic unfavorable (9.47e-4)"	0.3	0.0	0.3	0.3	0.3	0.0	5.7	0.3	0.3	25.9	0.3	0.3	0.3	0.0	0.6	0.3	210.2	0.0	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	26.8	0.3	0.3	94.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.4	0.3	291.9	54.7	0.3	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	19.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0
SPRR2F		ENSG00000244094	"Small proline rich protein 2F"	Q96RM1	1	153112114-153113515	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"tongue: 310.0"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 2.7;Club cells: 5.7;Leydig cells: 9.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 53.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 7.6"															NA	NA							"unprognostic (7.40e-2)"		"unprognostic (1.14e-2)"		"unprognostic (1.48e-2)"		"unprognostic (2.41e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.57e-1)"				"unprognostic (2.54e-1)"	"unprognostic (2.96e-1)"		"unprognostic (1.78e-3)"	0.4	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	4.5	0.1	0.1	0.1	0.0	0.2	0.3	66.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	28.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.1	0.2	0.2	0.5	0.1	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	310.0	24.8	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	5.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SPRR2G		ENSG00000159516	"Small proline rich protein 2G"	Q9BYE4	1	153149582-153150869	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"skin 1: 128.3;tongue: 274.6"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 3.2;Extravillous trophoblasts: 11.6;Late spermatids: 6.4;Suprabasal keratinocytes: 4.8"	"Group enriched"	"Detected in many"	15	"head and neck cancer: 256.0;melanoma: 131.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Cell line enriched"	"Detected in single"	17	"hTCEpi: 9.0"															NA	NA							"unprognostic (3.93e-1)"				"unprognostic (1.90e-1)"		"unprognostic (3.25e-1)"	"unprognostic (2.44e-1)"								"unprognostic (1.69e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	5.4	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	4.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	128.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	274.6	9.3	0.1	5.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.7	0.0	0.0	0.0
LELP1		ENSG00000203784	"Late cornified envelope like proline rich 1"	Q5T871	1	153203443-153205120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	65	"testis: 147.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 16141.9"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"									HPA070231	Enhanced					NA	NA					"HPA070231: AB_2686237"															"unprognostic (1.77e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	147.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3232.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16141.9	82.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.8	0.0	0.0	45.3	0.0	103.7	46.9	0.0	0.0	0.0	0.0	0.0
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 33.1;tongue: 13.0"	"Group enriched"	"Detected in some"	16	"Early spermatids: 3.6;Late spermatids: 8.1;Syncytiotrophoblasts: 7.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 20.7"	"Not detected"	"Not detected"							HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.6	0.3	13.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	20.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0
LOR		ENSG00000203782	Loricrin	P23490	1	153259700-153262122	"Disease related genes, Predicted intracellular proteins"	Keratinization		"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 181.8"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 164.2"	"Cancer enriched"	"Detected in some"	11	"melanoma: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	89	"HDLM-2: 28.2"									"HPA076123, HPA077266"	Enhanced					NA	NA					"HPA076123: AB_2732302, HPA077266: AB_2732338"	"unprognostic (1.97e-2)"	"unprognostic (1.93e-2)"			"unprognostic (4.16e-2)"	"prognostic favorable (8.53e-4)"		"unprognostic (1.65e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.41e-1)"			"unprognostic (1.47e-1)"	"unprognostic (3.03e-1)"		"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.4	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.9	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	181.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	15.7	0.1	31.2	2.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	164.2	0.0	0.0	0.0	0.0
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 21.3;skin 1: 39.1;vagina: 10.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.5"					"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	15	"HaCaT: 8.8;HDLM-2: 3.5;hTCEpi: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"	NA	NA					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0			0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.9	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		3.8	0.0	10.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 1.8;Early spermatids: 1.6;Melanocytes: 1.7;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.2;HDLM-2: 5.3;hTCEpi: 1.7;Karpas-707: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025879			Approved	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	5.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.1
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell type enriched"	"Detected in many"	7	"Kupffer cells: 11072.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 233.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	36.6	0.0	0.0	2.2	0.0	15.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.7	0.0	0.8	0.0	0.0	0.0	0.7	0.3	0.0	2.9	0.0	0.3	0.0	0.2	0.0	0.0	0.5	7.7	0.0	9.5	0.1	0.0	0.3	233.1	0.1	0.1	3.6	29.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.7	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4	214.4	574.2	57.1	52.5	17.7	0.0	2.5	66.2	112.4	185.4	34.9	0.0	111.0	5.0	49.4	1.3	7.0	0.5	23.3	32.9	44.2	7.1	19.6	151.1	16.4	1627.6	0.0	0.0	71.2	11072.0	2.2	5.5	1162.8	0.0	4.6	2.1	0.0	10.3	0.8	0.0	16.3	0.2	0.0	2.5	0.3	1.3	29.1	1033.7	24.9	1.9	291.7
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373706-153375649	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 139.8;bone marrow: 329.6;lymphoid tissue: 94.7"	"Cell type enriched"	"Detected in some"	33	"Kupffer cells: 1264.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"classical monocyte: 91.9;neutrophil: 139.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 139.8;monocytes: 91.9"	"Group enriched"	"Detected in some"	7	"hTCEpi: 6.6;SK-BR-3: 2.2;THP-1: 4.2"					"Not detected"	"Not detected"			"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	NA	NA	28500000	6200000			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	6.7	0.5	0.9	8.9	1.7	329.6	0.8	0.3	1.0	3.5	1.1	0.2	0.0	0.6	0.5	0.4	9.2	3.3	1.1	41.2	0.7	0.8	1.6	4.0	34.4	27.4	3.3	0.0	1.5	5.0	0.4	0.7	3.9	2.8	0.8	0.4	0.7	1.9	0.4	1.3	0.8	0.5	4.4	0.8	94.7	1.4	3.4	0.5	3.9	4.5	15.3	4.9	1.7	36.0	0.2	9.6	139.8	91.9	0.0	0.1	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	2.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	91.9	0.3	0.1	3.3	0.0	0.2	0.0	0.1	9.6	0.0	0.0	0.0	139.8	0.0	0.7	0.6	0.1	59.2	0.9	1.7	0.3	1.0	0.7	0.8	3.3	0.0	2.8	0.5	17.9	38.5	0.0	0.2	0.1	0.0	0.4	7.6	13.4	10.3	1.8	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	12.8	3.0	9.0	0.0	0.0	11.1	1264.6	0.7	0.0	35.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Cell type enriched"	"Detected in many"	13	"Kupffer cells: 10543.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Group enriched"	"Detected in some"	28	"hTCEpi: 28.2;SK-BR-3: 103.3;THP-1: 54.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	530000000	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.7	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	28.2	0.0	0.9	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.4	103.3	0.0	0.0	0.7	54.9	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9	208.4	808.2	43.2	0.7	17.4	0.0	2.9	56.0	117.8	215.0	14.0	0.0	4.1	0.0	0.1	217.1	1.6	0.0	23.3	0.8	8.6	1.6	0.4	209.3	16.4	431.8	0.0	0.0	84.7	10543.8	69.5	3.7	783.2	0.0	0.0	0.0	0.0	0.9	0.0	1.4	14.7	0.0	0.0	1.0	2.2	0.5	99.0	5.6	20.3	0.0	19.6
S100A7A	"S100A15, S100A7f, S100A7L1"	ENSG00000184330	"S100 calcium binding protein A7A"	Q86SG5	1	153416524-153423225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"tongue: 178.1"	"Group enriched"	"Detected in some"	6	"Early spermatids: 1.1;Late spermatids: 1.6;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SK-BR-3: 3.4"									HPA006997	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"HPA006997: AB_1079860"	"unprognostic (2.18e-1)"	"unprognostic (1.26e-1)"				"unprognostic (3.73e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"				"unprognostic (1.17e-1)"			"unprognostic (4.40e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.9	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	178.1	12.5	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0
S100A7L2	s100a7b	ENSG00000197364	"S100 calcium binding protein A7 like 2"	Q5SY68	1	153437058-153439949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	12	"testis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057828	Uncertain					NA	NA					"HPA057828: AB_2683540"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 7.4;SK-BR-3: 17.3"									"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	NA	NA		17000000	Cytosol		"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.0	0.8	17.3	0.0	1.1	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	78.3	22.1	0.0	0.0	0.4
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Pancreatic endocrine cells: 22500.8;Urothelial cells: 12910.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 325.2;RPTEC TERT1: 363.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		5100000	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favorable (7.56e-4)"	126.4	32.6	14.8	104.9	29.9	73.8	223.6	13.3	14.6	95.4	176.8	10.1	51.2	70.2	65.0	135.5	126.5	42.2	264.5	112.3	13.0	22.5	103.4	6.0	151.9	61.5	45.6	7.9	38.1	13.5	0.5	17.7	100.1	27.3	85.1	85.5	28.5	58.7	55.2	59.1	45.1	98.1	88.9	35.5	27.5	69.9	29.6	17.8	4.9	76.9	183.0	36.2	150.9	145.0	30.7	130.1	303.7	180.7	9.1	69.2	201.7	75.2	84.2	0.0	6.9	141.8	184.0	0.2	92.3	230.5	46.8	61.5	5.8	157.5	0.1	29.3	137.0	43.4	32.7	1.5	132.6	22.1	31.0	0.0	15.8	56.4	5.1	53.7	0.7	10.8	85.8	110.2	50.1	86.8	64.3	103.8	0.0	0.0	0.1	116.7	11.3	0.2	6.4	0.1	325.2	138.6	0.0	10.4	27.2	363.5	69.9	21.7	3.8	125.5	127.9	94.9	0.0	17.6	24.4	151.6	45.2	11.8	92.4	149.8	0.2	0.2	0.2	175.8	16.8	96.6	139.8	180.7	74.1	62.0	96.8	67.3	30.7	58.5	60.3	130.1	17.2	37.3	49.5	303.7	9.1	86.9	68.3	69.2	201.7	14.8	29.9	13.3	14.6	13.0	22.5	45.6	7.9	27.3	17.8	4374.3	2209.1	330.5	4451.5	1322.1	4.2	292.3	1518.5	3121.1	4082.2	7746.6	0.0	1050.2	6310.0	5079.5	17.9	1309.7	5409.4	186.9	8886.8	1881.7	3759.3	5823.6	1721.8	17.4	2462.8	55.6	1958.6	890.1	3762.1	37.4	2790.2	5314.3	2911.9	5195.8	5391.4	88.0	22500.8	7016.5	1075.2	111.0	7.4	129.4	3153.8	7.1	13.9	872.0	1315.7	897.0	2304.5	12910.1
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.6;thyroid gland: 9.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7"	"Region enriched"	"Detected in single"	85	"olfactory region: 1210.8"	"Region enriched"	"Detected in single"	30	"olfactory region: 16.8"	HPA064184			Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.5	0.1	0.8	2.4	0.2	0.9	0.4	0.2	0.9	0.6	0.3	0.2	0.2	2.3	1.0	0.2	1.3	0.7	1.6	0.2	0.4	0.1	2.3	0.2	3.0	4.6	0.2	0.2	0.2	0.2	0.0	0.4	1.1	0.2	1.5	0.0	0.2	3.8	0.2	0.2	6.0	0.5	0.2	0.2	1.1	1.9	0.2	0.2	1.6	9.1	0.2	2.6	1.8	0.6	0.9	4.6	2.3	1.2	0.0	7.6	1.2	1.5	4.1	0.0	0.0	0.4	0.3	0.3	0.7	0.9	0.5	1.0	0.4	3.0	0.0	2.7	1.5	0.3	1.2	0.1	0.7	0.6	0.3	0.0	1.9	1.5	0.1	0.3	0.0	2.5	0.0	0.8	2.0	0.6	0.3	0.4	0.0	0.5	0.1	2.2	0.1	0.3	0.9	0.1	24.3	7.1	0.0	1.3	0.7	8.6	14.2	12.7	0.0	0.1	6.5	0.6	1.2	0.0	0.4	0.3	0.1	0.9	1.9	1.2	0.0	0.6	0.0	0.4	0.5	0.2	0.0	1.2	2.3	2.0	0.2	7.6	0.9	4.2	2.2	2.8	0.5	2.4	1.1	1.9	0.0	0.6	4.6	6.1	1.2	0.8	0.2	0.2	0.9	0.4	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	7.2	0.7	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.2	0.0	0.0	0.4
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 419.2"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 1794.8;Kupffer cells: 3413.1;Macrophages: 4385.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 115.2;ASC diff: 149.4;BJ hTERT+: 287.5;fHDF/TERT166: 205.6;RPMI-8226: 108.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		13000000	"Plasma membrane"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	125.9	10.1	2.6	29.2	8.3	75.2	171.6	2.2	4.6	52.1	33.9	2.7	25.8	7.3	26.8	52.2	58.6	27.9	34.7	59.9	3.0	1.7	27.8	6.1	80.7	53.2	10.8	3.1	12.7	6.7	0.0	3.0	46.9	6.6	49.5	28.0	19.3	29.8	13.4	25.4	44.5	25.5	38.5	8.9	55.9	17.2	18.2	6.2	8.5	23.7	57.5	26.4	34.9	58.2	18.6	213.1	281.6	293.3	17.3	162.7	419.2	0.5	115.2	0.5	3.3	149.4	103.1	0.1	73.0	287.5	1.4	6.5	0.8	8.1	0.0	13.3	205.6	0.1	2.9	0.4	1.0	1.1	16.4	0.0	49.2	25.6	2.5	0.2	4.3	83.3	16.0	1.1	2.8	0.6	0.2	0.1	0.0	0.4	0.1	104.7	0.4	0.1	51.0	0.3	8.4	44.2	2.6	0.1	108.6	4.5	3.1	4.4	0.5	1.3	55.6	0.4	18.7	3.3	61.7	0.1	0.3	0.6	98.1	0.4	3.6	24.5	0.5	0.2	54.8	5.6	49.5	293.3	30.8	141.2	201.4	147.2	18.6	127.2	112.3	213.1	6.2	22.4	66.5	281.6	17.3	253.9	37.4	162.7	419.2	2.6	8.3	2.2	4.6	3.0	1.7	10.8	3.1	6.6	6.2	455.6	554.5	203.3	20.0	686.7	0.6	8.4	30.6	108.4	174.0	847.9	0.0	45.2	94.5	21.8	4.3	34.1	4.4	116.8	21.4	168.0	716.5	10.9	1330.4	13.0	1794.8	42.9	4.6	120.3	3413.1	10.7	218.3	4385.9	1132.0	911.7	7.1	3.9	22.9	14.4	43.2	14.3	2.7	148.8	785.1	1.6	3.6	606.6	44.6	1190.0	8.0	60.2
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.7"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 19.6;Exocrine glandular cells: 21.7;Pancreatic endocrine cells: 15.4;Smooth muscle cells: 12.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 8.9;monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"A549: 33.9;HBEC3-KT: 18.1;HeLa: 22.1;U-2197: 19.8"					"Low region specificity"	"Detected in some"			"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		390000	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: AB_2683050"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	4.7	0.6	0.6	3.3	3.1	1.5	2.2	0.6	1.7	3.7	1.2	1.3	0.1	0.4	2.4	1.6	7.4	1.6	1.6	7.9	0.5	0.7	10.2	0.1	14.2	4.6	1.7	0.1	1.2	5.3	0.0	0.3	5.6	3.5	3.6	1.0	0.3	2.0	1.6	2.5	44.7	1.0	1.8	1.5	2.1	0.7	1.4	0.4	0.5	1.7	2.1	4.9	3.7	4.0	0.7	8.9	0.0	6.9	0.0	0.3	0.4	2.9	33.9	0.0	0.0	3.3	2.1	0.0	2.3	12.4	2.9	4.9	1.0	1.1	0.0	7.6	5.9	4.3	9.0	0.0	18.1	1.6	0.1	0.0	0.1	22.1	6.1	0.8	0.0	0.1	1.6	9.3	7.2	8.2	1.8	0.6	0.0	0.0	0.0	16.0	0.2	0.0	0.0	0.2	0.0	4.1	0.0	2.4	1.8	9.9	7.3	0.5	0.0	2.1	2.5	0.7	10.1	0.1	0.2	3.0	1.2	1.9	19.8	2.5	0.6	0.6	0.0	15.9	0.2	7.5	0.0	0.2	0.0	0.0	3.6	0.3	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.9	8.9	0.1	0.4	0.6	3.1	0.6	1.7	0.5	0.7	1.7	0.1	3.5	0.4	3.0	0.3	0.0	1.2	9.2	0.0	0.1	2.5	0.0	4.5	0.0	0.0	0.2	1.7	19.6	0.0	7.0	0.0	0.0	21.7	1.6	8.1	0.6	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.0	3.7	0.9	1.7	6.4	0.0	0.0	15.4	0.0	0.4	0.0	0.0	0.0	12.7	0.0	0.0	5.6	1.3	0.0	0.0	1.7
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Cell type enhanced"	"Detected in many"	20	"Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 671.5;RT4: 262.5"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	25.4	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.5	0.5	0.5	63.2	0.0	671.5	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	89.4	0.7	102.0	0.7	0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.6	4.9	0.0	16.0	0.0	15.9	262.5	0.5	0.0	1.1	0.1	0.2	0.2	0.1	0.1	0.1	0.4	22.2	2.9	8.6	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4	8.9	15.9	2.2	2667.8	10183.7	0.0	2.0	2.5	307.9	1714.1	207.6	0.0	0.1	1039.5	26.2	3.0	3.6	1.3	0.0	24.2	0.9	117.2	609.3	16.2	0.0	1.8	0.0	1.7	0.6	1.5	3.8	0.6	38.5	720.4	9.0	1.7	1.0	390.7	2.9	0.7	9.8	0.0	0.0	213.2	0.2	2.3	3170.0	0.2	1.3	1.5	4604.3
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-BR-3: 142.9"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		92000	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.4	27.2	1.4	3.2	9.4	35.7	3.7	32.3	29.7	26.6	23.6	25.5	31.6	0.0	51.9	48.3	6.0	41.5	0.0	72.5	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	34.8	117.9	0.0	0.6	0.0	58.5	75.0	0.0	0.1	6.0	100.1	73.6	0.0	16.4	0.1	100.2	20.3	0.0	0.1	23.8	142.9	4.7	12.9	44.4	0.3	63.2	16.0	25.6	15.4	73.0	0.0	0.2	0.1	47.6	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6	35.7	18.0	15.1	744.7	563.0	0.4	29.7	119.8	26.8	103.5	102.9	2.0	12.3	61.3	584.7	3.2	283.5	336.2	0.0	172.2	7.2	105.8	697.0	19.5	109.5	4.7	0.0	133.3	333.3	22.5	10.0	62.2	11.1	106.3	12.6	178.6	38.3	790.1	294.7	57.7	126.7	1.8	6.5	41.5	1.7	1.2	794.3	6.9	12.8	201.3	1359.9
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	11.1	0.0	0.1	0.0	0.0	84.7	0.0	120.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	179.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	129.5	0.1	0.0	0.0	0.2	0.6	4.0	0.0	0.0	0.1	126.4	0.1	3.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6	56.6	133.0	0.5	298.4	2079.3	0.0	4.4	214.0	18.7	91.0	33.2	0.0	0.6	41.4	164.9	0.0	0.2	1153.1	0.0	59.6	1.7	22.4	341.3	28.7	5.8	0.3	0.0	147.3	1.3	0.0	0.0	0.0	5.3	229.5	3.6	470.4	0.0	202.6	775.0	0.0	3.1	0.0	0.0	33.3	0.0	0.0	3157.3	0.2	0.7	410.3	819.7
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 714.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 94.7;SuSa: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	21.1	17.7	20.5	13.0	18.1	53.1	7.4	29.4	46.6	17.8	20.5	17.2	23.6	0.5	55.9	49.8	2.6	20.2	8.5	18.2	15.8	0.0	7.9	1.3	22.2	14.6	12.0	0.6	4.6	42.7	6.9	15.9	17.2	52.5	40.2	0.1	6.8	0.0	55.3	74.9	0.0	0.3	16.5	18.2	53.5	3.3	21.2	0.1	94.7	16.2	6.3	0.2	62.8	32.4	63.5	111.1	26.4	0.7	56.9	12.3	6.9	16.4	35.3	0.2	0.5	0.9	22.0	0.3	7.2	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5	26.8	88.4	17.1	154.8	98.1	2.0	108.1	175.8	60.2	93.3	441.4	0.0	118.0	210.5	277.9	6.5	300.3	126.3	46.7	281.2	170.7	294.9	188.4	23.1	34.1	128.8	0.0	119.8	371.4	32.4	21.5	714.6	43.9	226.0	20.8	107.7	97.5	336.0	115.8	295.2	330.9	5.7	0.0	84.3	7.5	18.3	66.1	62.5	8.6	64.8	157.7
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 465.5;skeletal muscle: 423.5"	"Cell type enhanced"	"Detected in many"	22	"Collecting duct cells: 146.5;Distal tubular cells: 137.6;Hofbauer cells: 149.3;Melanocytes: 323.9;Proximal tubular cells: 712.0"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Hep G2: 43.7;SK-MEL-30: 149.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		240000	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	27.7	3.2	70.0	2.8	67.3	2.2	14.3	4.1	42.5	2.0	2.4	47.3	0.0	3.5	2.6	8.5	14.1	8.8	2.6	465.5	44.9	42.9	20.0	2.6	2.4	2.5	85.0	30.7	2.2	4.5	2.0	4.3	4.5	31.4	6.3	2.1	4.3	99.3	3.7	423.5	4.0	2.9	2.1	87.7	2.4	3.3	2.8	31.8	0.0	29.0	57.6	4.7	2.9	0.1	0.6	0.6	2.1	1.0	0.3	0.5	0.5	0.7	0.3	0.5	4.6	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.9	0.4	0.5	19.6	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.4	1.0	0.6	43.7	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	3.5	0.5	0.0	1.2	0.1	0.5	0.2	0.5	0.4	3.1	0.4	1.1	0.8	1.7	0.7	0.2	0.3	1.4	149.9	1.4	4.5	2.3	0.4	0.4	0.3	0.3	0.4	0.7	0.7	0.7	0.3	0.8	0.2	2.1	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.5	0.0	0.6	0.3	0.0	0.0	0.3	1.0	0.6	0.0	0.5	70.0	67.3	4.1	42.5	44.9	42.9	85.0	30.7	31.4	31.8	0.0	0.0	0.0	1.1	8.7	0.6	57.3	5.1	0.0	0.0	146.5	2.0	0.9	137.6	0.7	0.5	2.1	0.9	0.0	3.4	0.8	2.3	1.2	0.0	3.2	149.3	0.0	1.7	13.5	0.6	1.5	6.1	1.3	323.9	0.0	2.2	60.1	1.1	0.0	8.5	712.0	2.2	0.0	2.1	0.9	0.7	1.9	2.9	0.0	1.5	0.6
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	22.1	26.5	34.6	33.0	41.1	42.5	32.8	40.6	51.0	25.1	22.7	29.1	29.7	23.4	29.9	30.0	28.5	30.0	22.1	35.3	32.3	24.9	26.0	29.9	32.3	33.6	42.6	32.8	34.6	37.9	31.9	29.2	31.0	32.3	27.0	26.5	20.8	25.0	30.5	83.6	31.5	25.4	29.1	47.1	37.7	25.9	35.0	39.8	34.5	32.8	30.6	33.3	21.6	33.1	29.2	34.8	43.0	28.2	20.5	31.9	27.4	26.4	23.4	39.8	24.1	17.3	12.7	31.6	18.7	17.4	26.8	23.2	26.0	26.9	30.0	28.5	17.5	17.6	24.5	38.2	27.4	17.8	35.0	35.2	23.6	35.7	21.5	21.6	36.1	29.7	14.8	31.8	25.8	36.9	22.4	21.4	33.0	28.9	23.2	20.0	33.6	38.7	36.6	46.2	38.7	29.3	24.1	24.3	33.1	26.0	36.7	24.2	28.1	20.0	29.1	31.3	27.6	31.1	50.1	18.3	18.1	26.8	22.7	30.2	32.5	27.1	34.8	19.0	29.6	21.0	43.0	28.0	25.2	31.7	28.2	31.5	29.2	31.2	30.7	34.8	27.4	31.9	28.4	19.8	20.5	25.5	26.8	31.8	27.4	34.6	41.1	40.6	51.0	32.3	24.9	42.6	32.8	32.3	39.8	29.8	31.2	60.7	103.3	55.9	38.3	63.7	43.3	24.1	34.2	50.6	31.4	78.2	43.1	53.9	18.8	54.0	43.4	46.7	56.5	101.7	51.2	66.2	45.1	36.6	60.9	41.3	57.8	47.3	40.7	12.7	41.4	41.9	33.7	72.1	44.9	42.0	50.7	48.0	39.6	37.8	49.7	19.4	59.0	110.0	97.7	54.0	107.6	44.9	46.5	107.5
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658654-153661830	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA		15000	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	21.8	32.5	20.2	14.5	25.9	8.4	30.2	12.1	26.3	17.5	19.2	18.5	17.2	9.1	19.7	25.0	20.7	20.4	21.4	38.1	17.4	17.7	21.8	22.1	15.7	26.1	21.6	17.8	17.9	22.9	18.0	10.8	14.5	20.5	17.9	14.7	15.6	14.1	22.6	56.9	16.1	13.2	24.9	22.1	19.4	16.0	16.5	20.8	18.1	19.9	29.8	21.7	19.6	13.9	42.4	50.8	44.6	49.9	35.4	42.8	42.8	20.1	24.8	21.1	12.7	27.0	18.1	13.6	17.1	19.0	24.3	18.5	17.6	16.2	14.5	34.6	17.4	11.9	27.0	17.3	22.3	17.0	19.3	23.9	16.0	19.1	8.4	27.9	15.7	10.2	21.7	16.7	18.1	20.7	24.5	22.7	17.0	13.6	11.2	24.3	32.6	17.9	9.2	11.4	31.7	26.7	17.1	18.4	38.3	26.8	19.4	16.1	28.2	19.7	22.9	22.4	20.7	34.8	16.8	20.0	11.3	17.3	22.4	16.0	27.3	29.8	22.1	21.6	9.9	14.7	27.6	49.9	44.6	30.9	49.1	35.0	42.4	31.4	31.0	50.8	36.9	34.8	31.8	10.4	35.4	39.0	38.1	42.8	42.8	20.2	25.9	12.1	26.3	17.4	17.7	21.6	17.8	20.5	20.8	17.9	17.6	24.3	31.9	18.3	13.6	35.0	22.9	36.1	22.7	27.9	7.9	54.7	63.0	60.4	5.7	30.1	18.8	0.0	57.1	40.8	26.9	29.4	30.0	25.5	77.8	20.6	13.3	31.9	48.5	18.5	28.4	40.8	25.3	91.0	20.8	57.6	41.2	25.7	46.7	60.8	17.2	45.3	38.2	29.6	39.2	20.6	61.7	26.6	25.6	33.4
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671048	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm		No	No		3800000	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavorable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	35.9	39.2	26.3	32.8	27.1	58.1	43.7	25.6	32.8	34.8	33.8	32.7	23.5	24.2	37.8	39.6	46.0	33.9	27.8	32.0	24.7	28.4	64.1	45.4	35.3	38.1	33.2	29.2	46.5	52.8	38.4	36.8	53.3	30.8	29.9	40.4	25.0	50.4	28.3	49.1	38.5	27.7	34.3	26.7	39.8	33.9	58.0	28.5	117.0	58.5	45.5	54.0	32.1	30.9	49.5	55.4	34.5	39.9	52.4	52.5	76.4	48.8	38.1	67.4	47.3	28.3	26.7	53.9	36.5	41.5	65.9	47.6	56.1	39.9	67.7	56.3	36.3	31.9	37.5	80.2	38.8	63.9	36.7	52.1	50.8	31.1	48.0	26.0	78.6	37.6	24.3	22.3	50.3	54.7	27.7	61.3	40.5	63.6	32.2	54.8	65.1	105.0	35.2	96.2	72.1	58.1	76.5	58.4	63.9	31.6	47.4	60.6	56.3	42.5	53.0	43.1	66.3	57.9	68.1	37.3	34.0	43.6	30.5	60.1	55.9	77.9	136.6	28.5	48.7	51.3	34.5	39.9	28.7	39.8	38.3	50.1	49.5	46.4	42.9	55.4	40.7	52.5	45.6	3.7	52.4	30.3	53.6	51.0	76.4	26.3	27.1	25.6	32.8	24.7	28.4	33.2	29.2	30.8	28.5	53.6	62.2	87.8	197.1	175.8	35.7	58.5	71.4	62.9	69.4	36.6	25.5	182.2	111.0	167.4	37.9	93.1	44.0	0.0	137.2	213.8	109.6	107.7	92.3	28.6	110.7	27.0	102.4	40.5	43.7	25.3	55.5	80.0	106.3	135.3	65.7	79.9	127.2	65.6	61.9	162.5	27.6	64.7	108.0	316.3	160.4	138.9	217.7	99.4	100.9	173.0
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell type enriched"	"Detected in many"	10	"Ito cells: 136.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 60.5"	"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in single"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	60.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.0	0.0	7.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2	0.0	5.8	0.0	0.4	1.3	0.0	4.8	5.1	0.0	0.0	14.0	0.0	0.1	0.0	0.6	8.0	14.2	0.0	0.0	0.0	0.9	3.9	0.4	0.0	1.5	0.2	0.0	0.0	136.2	6.0	7.9	9.5	0.0	0.0	9.0	0.0	0.0	0.7	0.0	3.9	2.8	0.0	0.0	0.9	0.2	0.1	0.9	0.6	0.0	0.0	0.0
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728067-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	16.2	21.9	18.8	14.4	20.0	12.0	16.3	20.7	23.1	20.4	19.9	19.5	25.1	10.0	24.4	23.7	14.3	26.7	20.5	15.3	16.0	10.6	17.9	11.1	16.6	12.6	15.9	16.4	30.8	17.5	23.6	23.6	16.5	15.6	15.9	11.4	16.1	14.0	31.0	16.2	16.9	14.7	21.2	13.4	15.4	17.6	16.5	16.0	16.2	18.6	9.2	14.1	19.9	18.8	1.8	3.8	2.7	6.2	2.7	2.5	1.5	13.2	13.9	10.1	14.5	11.5	13.0	10.3	10.1	7.3	12.1	9.8	9.7	12.6	11.5	20.3	13.3	7.2	13.5	19.3	13.0	9.9	12.1	11.3	7.2	21.2	4.6	7.8	10.7	13.0	11.7	6.5	10.4	9.5	11.0	11.6	8.6	10.1	9.4	9.3	10.8	10.0	5.7	12.4	15.3	12.9	13.6	5.7	7.4	6.2	17.4	8.0	11.7	9.6	23.2	6.4	14.7	13.4	14.5	8.5	12.0	5.2	11.8	9.1	8.4	7.7	12.7	13.1	6.6	8.3	1.3	1.8	2.0	2.1	1.4	2.5	1.3	1.3	2.0	3.8	1.8	1.4	1.5	2.7	2.7	6.2	0.8	1.3	1.5	18.8	20.0	20.7	23.1	16.0	10.6	15.9	16.4	15.6	16.0	20.8	21.4	8.8	8.7	9.3	22.5	4.0	10.2	13.4	10.3	29.6	19.6	11.5	0.0	10.1	12.1	12.6	8.1	0.0	7.1	11.7	11.9	9.9	5.7	13.6	10.7	20.6	11.6	27.0	11.8	5.9	8.9	14.3	6.8	13.6	16.1	19.3	9.6	10.8	11.3	12.4	23.9	25.8	9.0	9.3	13.0	8.9	8.6	7.7	12.2	11.2
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	4.0	0.2	1.7	0.8	35.6	6.9	3.1	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.2	1.7	0.3	12.5	1.7	1.4	0.4	0.3	2.3	0.8	2.2	1.0	4.3	1.4	2.9	4.6	4.7	0.2	0.9	0.6	4.8	0.2	0.4	0.7	0.2	18.8	0.1	4.1	4.1	8.6	1.9	7.1	0.3	0.4	1.0	0.5	3.5	3.9	0.8	8.3	1.5	2.4	2.2	4.1	1.1	0.8	1.7	4.4	0.0	1.3	1.2	0.1	2.0	4.8	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4	17.9	43.8	4.5	9.1	10.4	0.8	2.5	38.2	0.0	7.9	3.5	0.0	24.4	0.0	3.1	0.4	20.2	2.5	0.0	6.4	10.1	17.3	4.2	25.3	25.9	29.3	1.6	4.1	131.3	31.9	2.4	17.5	32.9	21.9	45.1	16.0	1.5	3.7	33.6	13.4	3.4	1.0	6.5	12.8	1.1	3.4	6.8	7.3	15.9	9.1	2.6
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	12.9	9.6	16.5	16.2	19.8	22.2	13.6	33.2	24.4	12.0	12.4	22.2	10.5	10.7	15.7	9.0	14.6	13.1	9.6	19.3	16.3	11.0	8.8	10.5	15.9	18.4	15.1	12.3	17.1	16.0	19.4	11.1	14.4	14.7	10.8	9.6	12.3	10.7	14.6	20.2	17.2	11.9	17.6	13.9	14.6	11.6	24.6	17.9	29.5	19.1	7.6	17.7	12.1	14.4	1.3	2.9	6.7	1.1	1.5	1.4	0.7	4.8	9.2	8.2	9.0	1.7	5.4	4.9	3.0	7.3	9.6	11.3	4.4	7.6	9.5	7.2	6.8	5.1	9.8	11.4	5.9	7.9	8.6	7.9	9.3	10.0	1.8	5.6	5.6	13.3	4.2	4.2	10.7	21.3	4.6	9.1	13.4	6.9	13.1	1.9	9.0	20.1	1.5	3.6	3.8	4.5	20.5	4.1	10.4	1.9	6.8	9.5	10.0	11.2	13.8	5.9	6.3	12.7	4.8	8.1	9.4	8.4	5.2	6.4	17.8	12.0	14.6	5.3	3.7	8.1	6.7	1.1	0.9	1.3	0.5	1.3	0.7	0.6	1.4	0.3	1.3	0.5	0.6	6.4	1.5	0.5	2.9	1.1	0.7	16.5	19.8	33.2	24.4	16.3	11.0	15.1	12.3	14.7	17.9	8.9	11.8	11.8	11.6	38.9	43.4	14.5	22.9	12.0	9.1	24.4	37.3	8.2	6.6	10.9	12.5	23.4	7.9	23.3	12.3	5.5	12.9	16.7	24.3	19.5	11.9	33.4	22.8	24.5	27.8	5.2	25.0	17.4	13.5	34.3	19.5	18.6	14.4	20.9	32.9	7.9	35.5	6.5	19.8	25.5	19.8	41.5	8.2	24.5	14.0	16.0
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946696	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	14.5	9.6	14.4	21.5	13.6	30.7	9.9	23.5	19.7	8.6	8.3	11.9	3.1	9.2	10.3	7.9	7.7	8.8	9.9	12.4	10.5	9.8	8.6	7.9	14.2	25.8	12.5	8.5	12.4	11.0	8.5	8.3	10.1	12.6	7.9	6.3	8.0	10.2	7.6	40.6	8.6	12.7	8.8	9.3	25.9	9.2	5.5	12.9	15.7	9.4	5.9	21.1	10.7	7.7	3.0	4.8	3.9	6.2	2.0	3.9	3.0	5.9	11.5	8.9	8.9	5.3	5.2	9.3	5.8	6.4	9.3	8.8	6.9	6.9	15.0	10.0	3.9	7.1	10.6	8.0	5.4	4.2	13.7	7.2	13.2	12.0	6.6	7.4	13.8	26.9	4.7	9.5	8.7	9.4	7.8	6.6	16.5	14.0	8.5	5.3	12.3	16.7	12.8	12.3	7.1	11.2	18.0	6.0	8.5	4.5	8.9	10.6	13.0	6.2	14.7	8.3	9.3	10.6	34.2	6.8	10.1	9.8	8.3	9.3	25.7	18.0	19.8	6.9	10.9	12.0	2.5	3.8	1.1	3.3	6.2	3.9	2.9	2.6	1.9	3.7	3.0	1.3	2.8	3.9	2.0	4.9	4.8	1.7	3.0	14.4	13.6	23.5	19.7	10.5	9.8	12.5	8.5	12.6	12.9	8.9	13.0	8.3	3.2	4.1	20.5	18.1	12.7	4.0	5.7	7.0	5.9	3.8	5.0	4.4	1.2	10.9	4.3	23.3	5.5	4.0	4.9	4.5	17.3	8.3	15.5	33.4	4.7	11.1	26.6	0.4	6.9	22.4	5.0	6.4	4.8	6.1	5.6	3.5	7.4	2.3	16.9	6.5	5.0	5.4	8.9	3.0	2.9	14.9	6.3	4.3
CRTC2	TORC2	ENSG00000160741	"CREB regulated transcription coactivator 2"	Q53ET0	1	153947669-153958625	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028454, HPA028465"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028454: AB_10599617, HPA028465: AB_10601991"	"unprognostic (4.91e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (4.32e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (7.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.12e-5)"	22.4	19.7	21.0	23.1	26.6	28.7	21.1	31.8	22.8	21.5	18.9	29.5	15.6	13.3	24.3	20.2	17.7	22.7	18.4	17.4	20.4	11.3	21.4	22.9	26.0	31.1	25.7	16.3	32.3	20.6	22.7	19.7	24.2	18.6	20.1	15.9	21.9	20.1	22.1	24.6	24.0	23.5	21.5	19.2	39.4	18.9	18.1	28.1	22.1	23.6	10.9	29.7	23.4	21.0	6.1	4.6	10.1	5.9	4.6	5.0	1.8	14.8	11.2	10.9	12.3	18.0	13.1	16.7	8.4	17.4	16.1	13.3	11.5	15.0	14.3	13.4	14.5	10.9	17.0	13.0	16.9	9.0	18.7	17.0	7.3	11.4	8.8	18.2	11.8	12.2	17.2	16.5	17.7	14.5	12.8	14.9	8.2	11.7	17.3	11.5	23.6	12.8	19.8	8.5	16.2	13.9	9.5	7.5	12.0	17.0	12.1	9.2	15.1	13.5	27.6	20.9	11.2	13.3	23.2	11.0	13.0	11.8	13.9	14.2	28.3	18.3	9.8	12.0	10.1	9.6	5.2	3.9	8.4	4.6	5.9	3.8	4.5	4.7	5.0	3.4	6.1	3.2	3.8	10.1	4.6	4.7	4.6	3.1	1.8	21.0	26.6	31.8	22.8	20.4	11.3	25.7	16.3	18.6	28.1	6.0	10.6	4.8	7.1	21.9	5.2	5.6	10.2	2.7	4.5	12.2	3.9	8.3	1.7	8.1	1.1	11.7	10.9	0.0	8.9	8.2	11.2	9.1	8.1	10.6	9.5	1.6	15.4	10.4	10.5	1.1	11.2	12.0	3.3	11.8	12.1	4.5	11.7	2.9	14.2	2.8	6.9	6.5	11.7	11.5	11.5	19.7	10.2	12.9	7.6	9.6
SLC39A1	"ZIP1, ZIRTL"	ENSG00000143570	"Solute carrier family 39 member 1"	Q9NY26	1	153959099-153968184	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 292.9;Extravillous trophoblasts: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.27e-2)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (5.26e-5)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (2.36e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-2)"	32.5	31.8	12.5	20.6	19.3	3.8	28.0	11.1	14.0	21.8	24.1	16.6	18.2	15.9	28.7	20.8	25.6	20.8	31.9	25.5	13.2	9.3	39.0	53.7	34.7	19.5	20.7	10.1	28.1	27.8	20.7	13.0	65.5	16.2	29.5	17.2	20.1	21.9	22.3	18.6	25.6	22.4	22.2	18.6	28.1	23.6	14.9	17.4	15.2	46.9	24.5	18.5	23.7	28.5	17.4	22.3	26.9	34.7	11.1	14.1	20.4	24.1	27.9	22.8	19.2	21.6	22.2	50.1	15.7	38.1	26.2	29.0	41.1	62.4	9.4	50.3	21.5	21.9	54.4	23.1	23.8	15.0	29.4	18.7	12.8	29.7	18.1	24.7	9.7	14.9	26.8	22.2	20.6	20.6	24.5	18.7	10.9	12.0	11.0	21.0	49.2	9.8	12.5	32.3	49.8	22.1	11.1	19.8	11.4	41.0	17.5	10.2	23.9	29.6	76.1	27.1	30.6	40.8	20.8	16.9	24.3	22.1	17.2	22.5	13.3	17.0	12.1	17.3	7.7	32.1	5.9	27.3	7.8	14.1	30.6	8.8	13.9	10.7	10.6	22.3	17.4	11.7	10.6	26.9	11.1	34.7	20.2	10.1	20.4	12.5	19.3	11.1	14.0	13.2	9.3	20.7	10.1	16.2	17.4	8.9	3.5	16.6	81.5	50.3	7.0	11.8	50.9	5.3	3.4	50.6	2.0	292.9	11.6	174.0	0.7	65.7	26.4	0.0	99.6	244.0	77.9	82.7	36.8	23.7	103.7	17.5	18.5	31.3	47.4	2.0	44.8	38.9	45.5	117.2	28.0	38.0	101.5	25.9	58.4	35.1	5.8	45.3	63.7	14.4	23.2	46.7	128.0	19.2	32.9	64.0
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974363	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 49.9"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 54.0;Mucus-secreting cells: 48.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	4.3	5.0	3.2	5.4	4.0	2.9	22.6	5.7	3.5	14.6	5.1	4.3	18.3	5.0	8.5	12.1	5.1	8.8	7.9	3.2	2.5	1.4	4.5	8.4	4.7	5.5	3.2	3.0	9.3	7.9	3.7	3.4	6.6	4.0	49.9	6.9	4.7	24.7	11.4	6.1	5.9	5.3	3.4	3.3	4.5	13.2	4.3	3.0	12.9	12.5	6.6	8.3	4.5	15.1	6.6	7.3	2.6	3.5	10.9	6.0	3.1	2.3	3.3	3.1	3.4	2.2	3.3	7.8	1.9	2.2	2.6	2.3	1.5	9.7	4.2	10.1	0.8	2.0	3.7	4.6	3.0	1.4	3.4	1.8	3.1	3.6	2.7	1.8	1.4	2.7	3.5	2.9	2.5	5.7	2.4	2.3	5.1	2.4	5.3	1.2	24.9	2.7	1.1	2.1	25.3	4.0	6.2	3.2	7.8	2.8	1.6	5.9	6.3	2.0	55.0	5.2	4.2	44.1	4.5	1.4	0.8	2.4	1.6	1.5	10.0	5.1	3.1	1.7	2.6	2.5	2.2	3.5	2.6	4.5	1.5	6.0	6.3	2.6	3.3	6.4	6.6	2.5	4.8	0.1	10.9	2.1	7.3	2.1	3.1	3.2	4.0	5.7	3.5	2.5	1.4	3.2	3.0	4.0	3.0	6.0	12.5	2.0	15.5	2.6	4.7	1.7	10.2	18.7	12.5	1.8	2.0	11.1	8.3	11.1	0.0	4.9	3.2	0.0	11.8	13.3	3.3	54.0	5.7	12.3	4.8	0.0	8.6	3.1	7.9	0.0	6.6	2.2	5.0	1.8	48.0	6.0	7.4	3.5	2.1	3.6	7.5	19.4	3.3	3.6	8.7	2.6	3.5	4.4	11.8	3.5
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977688	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006514	Approved		Approved	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	23.9	30.2	28.5	23.0	32.7	43.2	32.6	30.7	32.3	31.8	36.0	23.6	51.3	35.9	25.1	41.0	30.4	26.1	37.1	36.2	25.4	23.9	34.2	81.1	27.7	34.7	27.7	19.8	26.9	106.8	24.8	49.8	30.0	24.4	33.4	36.0	24.9	100.6	45.9	42.1	23.4	45.6	21.6	20.5	35.9	42.4	15.3	25.2	30.5	58.5	32.0	34.0	25.2	33.0	47.4	54.1	60.7	43.0	30.4	46.4	30.2	38.4	26.6	11.5	21.0	37.7	23.5	32.4	28.1	27.4	18.8	18.9	25.6	32.0	36.8	39.9	32.5	11.6	35.2	29.0	21.6	15.4	34.7	58.0	21.4	31.7	25.9	39.7	41.0	32.9	22.2	40.9	19.8	23.5	26.0	22.2	42.9	31.6	27.1	13.2	67.0	29.6	52.8	24.6	75.6	47.0	31.3	15.6	73.9	23.8	21.1	31.5	31.9	22.2	64.8	37.6	22.0	40.6	59.7	17.3	9.3	16.1	28.1	35.8	40.4	45.0	39.9	22.9	39.5	20.0	32.6	43.0	60.7	29.4	30.3	35.5	47.4	41.1	46.4	33.4	45.2	42.4	33.7	39.9	30.4	33.4	54.1	33.6	30.2	28.5	32.7	30.7	32.3	25.4	23.9	27.7	19.8	24.4	25.2	74.5	93.5	143.8	144.8	139.2	56.2	87.0	188.5	84.3	73.9	94.2	21.6	271.1	218.8	215.2	5.3	130.2	265.0	46.7	360.4	333.7	188.8	298.2	81.8	277.1	261.0	54.0	203.5	111.1	203.5	13.6	140.4	174.8	161.9	144.3	351.4	98.5	241.9	276.3	116.0	209.1	47.9	103.5	125.2	54.7	68.8	166.2	242.1	188.1	283.1	216.6
RAB13		ENSG00000143545	"RAB13, member RAS oncogene family"	P51153	1	153981617-153986358	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 7.7;myeloid DC: 10.7;plasmacytoid DC: 12.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 12.0;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 116.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003996	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		4600000	"Plasma membrane, Cytosol"		"HPA003996: AB_1079728"	"unprognostic (4.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.80e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (1.28e-2)"	49.0	40.4	18.1	28.7	30.2	29.7	52.1	13.6	23.5	33.1	33.6	13.7	46.6	17.8	28.5	47.1	43.2	25.0	46.7	36.9	21.9	17.0	61.3	51.5	40.8	36.7	22.9	11.1	39.2	65.6	28.4	11.1	29.0	29.1	41.5	24.5	21.6	47.4	44.4	26.8	25.0	28.7	35.3	31.3	44.8	34.5	24.0	24.7	5.9	54.8	35.0	24.9	41.0	78.4	1.0	12.0	0.9	7.7	0.0	0.7	2.4	17.2	21.3	19.3	20.3	65.0	116.2	6.3	21.1	50.0	19.1	19.5	21.5	14.7	0.0	31.8	25.1	9.7	11.9	11.4	19.2	26.6	11.1	8.8	14.4	13.4	12.0	27.3	0.0	10.2	84.5	16.6	32.9	14.6	53.9	33.2	0.0	3.0	0.0	32.4	35.9	0.0	7.3	31.0	23.7	20.4	4.2	25.2	0.0	43.0	18.3	1.2	16.0	27.6	23.9	42.5	30.0	39.3	11.5	61.5	34.8	20.6	21.5	22.8	0.1	0.0	0.2	54.2	2.5	52.7	0.0	7.7	0.1	0.0	1.4	0.1	0.8	0.1	0.1	10.7	1.0	0.1	0.7	0.9	0.0	0.2	12.0	0.0	2.4	18.1	30.2	13.6	23.5	21.9	17.0	22.9	11.1	29.1	24.7	38.7	70.7	13.4	148.7	81.7	1.1	69.4	104.4	56.2	63.7	102.9	2.0	102.3	114.4	187.9	86.7	180.9	76.1	0.0	130.8	137.5	109.8	182.0	40.3	126.2	237.1	0.0	85.5	141.2	101.8	184.7	98.4	112.5	94.5	413.0	147.2	16.7	149.6	95.1	116.7	162.0	3.2	148.8	189.5	61.2	17.1	85.7	77.7	12.5	130.8	173.5
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990755-153992155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 778.4;lymphoid tissue: 769.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"prognostic favorable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	120.7	72.5	74.9	188.7	118.6	186.7	268.2	51.3	91.4	172.5	114.2	35.9	136.4	58.1	169.0	135.6	107.5	129.0	144.1	176.5	59.6	50.1	98.6	102.5	167.8	769.0	92.1	76.0	317.8	227.2	44.6	91.5	67.5	71.2	117.6	113.6	63.5	248.2	116.1	243.8	160.1	115.9	254.3	65.6	159.3	111.5	119.0	81.9	118.2	113.0	224.0	270.9	162.9	286.0	720.2	296.5	132.9	139.9	324.1	750.5	778.4	103.7	121.7	160.9	87.6	378.8	373.5	99.8	125.8	301.7	169.5	153.2	243.8	114.7	236.3	105.7	181.5	56.5	104.6	141.7	208.3	143.3	114.7	182.7	93.1	161.4	158.1	251.1	206.9	122.8	362.6	409.8	134.8	248.4	252.8	138.9	197.5	113.6	128.5	160.9	260.8	222.5	131.0	194.8	347.8	177.5	142.6	117.8	183.8	156.6	210.3	85.5	190.7	72.1	254.0	218.7	229.1	141.6	415.8	82.0	58.6	97.1	93.4	125.7	258.2	263.2	286.4	101.7	116.2	80.3	132.9	139.9	68.1	393.0	138.9	473.7	720.2	594.4	502.0	179.5	637.3	750.5	579.6	32.4	324.1	127.0	296.5	397.8	778.4	74.9	118.6	51.3	91.4	59.6	50.1	92.1	76.0	71.2	81.9	2045.7	3610.2	12664.6	4456.3	11098.6	390.9	812.1	5699.4	2137.4	3923.0	2044.8	182.6	5213.2	3755.2	3414.7	2254.7	2990.8	2165.3	4461.9	9085.2	5382.4	5444.6	3827.3	4020.8	6408.4	3759.0	181.1	2910.0	5208.2	8634.5	6446.8	6571.4	6944.5	5609.6	8769.4	6097.0	734.9	5926.8	6112.7	3330.7	4371.1	465.9	2690.5	3231.1	1566.2	1451.5	12519.6	5337.4	8309.1	7958.0	4025.9
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 42.7"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 15.2;Late spermatids: 6.7;Sertoli cells: 6.5;Spermatocytes: 26.5;Spermatogonia: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	43	"MCF7: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.1	1.5	0.0	0.0	1.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.4	0.6	0.1	0.0	0.8	0.9	0.4	0.1	0.1	0.1	3.4	0.2	0.1	0.1	42.7	0.0	0.3	0.3	0.0	0.1	1.2	0.1	0.6	0.6	1.8	0.2	0.9	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.8	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.6	0.4	0.5	0.0	0.5	0.8	0.3	1.8	0.9	0.0	0.6	0.7	0.0	0.1	0.3	0.1	0.9	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	6.5	0.1	26.5	5.1	0.5	0.0	0.0	0.0	0.2
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		410000000	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	66.5	33.2	42.5	27.9	36.0	47.1	42.9	57.2	52.9	75.9	57.3	61.8	62.4	50.1	46.6	64.5	30.5	61.7	42.1	60.2	81.0	34.7	22.9	61.7	32.4	41.6	28.6	90.2	82.0	35.5	33.0	66.9	51.5	34.2	116.7	36.9	46.3	53.9	93.7	39.9	70.2	93.1	95.7	113.6	72.2	60.2	29.5	71.0	54.8	50.8	29.9	56.1	43.5	57.9	56.7	59.2	80.8	107.9	87.2	66.5	48.1	63.7	89.6	45.9	75.4	67.0	60.1	68.0	105.0	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4	577.7	334.3	245.8	179.3	132.8	84.5	62.7	104.4	335.9	395.8	92.5	29.5	101.3	89.5	278.9	51.0	357.1	327.9	0.0	302.5	278.2	125.9	137.0	499.8	99.0	485.9	287.6	135.3	175.6	320.5	131.0	43.1	444.6	145.1	764.7	164.6	45.8	384.6	230.6	28.0	130.8	59.1	19.4	73.4	34.9	54.6	125.3	85.2	233.3	208.9	254.0
C1orf189		ENSG00000163263	"Chromosome 1 open reading frame 189"	Q5VU69	1	154199372-154206333	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 11.9;fallopian tube: 41.8;testis: 21.0"	"Cell type enhanced"	"Detected in some"	31	"Ciliated cells: 28.1;Early spermatids: 63.9;Late spermatids: 12.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA045779	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"HPA045779: AB_2679448"	"unprognostic (8.23e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.01e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.05e-2)"	0.1	0.0	0.4	0.1	0.6	0.5	0.1	0.1	0.2	2.2	0.1	0.8	0.1	0.0	0.7	11.9	0.1	41.8	0.1	0.1	0.8	1.1	0.1	0.3	5.6	0.1	0.1	0.1	4.2	0.1	0.0	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	21.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.3	3.2	1.0	0.0	1.6	0.3	0.1	0.0	1.8	0.0	1.4	0.0	1.0	0.6	0.8	2.1	0.0	3.4	0.9	1.3	0.4	0.0	0.2	0.5	1.4	2.3	0.0	1.4	2.1	0.8	2.7	2.3	2.1	0.6	0.8	2.6	1.9	0.8	0.0	0.0	0.0	1.4	1.2	0.4	1.0	3.7	0.8	0.3	3.3	1.3	3.8	0.4	1.5	0.9	0.0	0.0	0.9	0.0	0.0	0.0	2.7	0.3	2.5	0.0	1.9	0.0	2.0	1.3	1.2	2.3	2.3	0.5	0.4	0.5	0.0	0.0	0.1	1.5	0.2	1.0	0.0	0.2	0.1	0.4	0.3	0.8	0.2	1.6	3.2	0.0	0.5	0.0	0.4	0.3	0.4	0.6	0.1	0.2	0.8	1.1	0.1	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0
C1orf43	"DKFZp586G1722, NICE-3"	ENSG00000143612	"Chromosome 1 open reading frame 43"	Q9BWL3	1	154206706-154220637	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010725	Approved					NA	NA					"HPA010725: AB_1078341"	"unprognostic (3.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.23e-1)"	36.4	36.5	45.5	20.4	47.7	20.7	43.4	36.0	43.5	29.0	33.7	36.2	28.0	34.9	23.1	36.7	30.9	30.9	31.8	53.5	39.9	35.2	55.5	80.2	30.5	27.6	48.4	29.4	23.4	68.9	28.8	24.2	25.1	31.1	29.8	37.2	25.2	31.0	29.0	124.2	27.0	36.6	27.4	46.1	27.0	30.1	19.5	33.8	22.0	38.4	49.0	28.4	32.7	29.0	29.2	59.0	39.0	56.1	21.2	41.6	56.4	29.2	31.3	26.3	31.0	39.4	39.7	16.3	29.5	51.2	34.4	32.1	21.4	41.7	38.8	45.0	26.5	29.9	30.0	36.1	26.7	24.8	30.5	39.9	29.8	34.8	27.7	61.4	37.4	35.6	32.2	63.6	36.5	76.3	47.0	39.7	43.4	31.3	36.9	44.6	46.8	28.1	34.3	50.7	66.9	48.0	25.8	24.2	70.0	42.9	31.0	42.9	56.5	26.6	71.0	99.6	31.7	70.1	83.1	27.0	26.9	22.6	32.2	37.1	68.1	66.2	37.0	45.0	37.7	71.5	39.0	56.1	35.7	25.4	50.4	30.5	29.2	29.6	27.7	59.0	25.6	31.3	26.1	32.2	21.2	45.3	43.6	41.6	56.4	45.5	47.7	36.0	43.5	39.9	35.2	48.4	29.4	31.1	33.8	107.2	81.5	107.4	106.1	83.7	119.7	121.4	99.3	81.7	92.1	68.0	27.5	74.2	213.9	137.1	214.9	101.4	115.5	23.3	177.2	103.3	70.6	146.8	60.1	134.8	162.0	55.6	117.1	78.0	135.6	130.5	60.1	121.7	118.1	155.1	116.8	73.7	139.3	133.6	70.4	192.0	62.3	71.1	86.3	64.5	69.8	88.0	105.5	73.4	115.3	130.8
UBAP2L	"KIAA0144, NICE-4"	ENSG00000143569	"Ubiquitin associated protein 2 like"	Q14157	1	154220179-154271510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 107.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035068	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA035068: AB_10696366"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (5.10e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (7.40e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-1)"	33.8	33.0	39.1	34.8	47.5	32.7	32.3	34.3	46.6	31.2	31.3	32.9	25.5	20.6	40.6	30.3	36.1	34.8	28.3	36.9	38.3	25.2	26.7	23.9	35.1	34.1	26.5	39.5	42.7	25.0	42.1	40.6	43.9	30.5	29.2	25.8	31.2	31.8	32.8	53.2	36.8	25.3	36.6	30.2	30.5	27.4	37.5	30.2	34.6	33.8	26.6	38.5	37.9	32.4	18.3	24.3	17.6	26.5	24.6	20.6	18.3	42.5	41.1	40.3	31.7	28.7	32.9	34.6	49.1	35.5	44.7	31.1	44.1	33.2	53.3	51.1	41.1	21.2	37.1	52.8	36.2	39.4	46.9	45.2	57.6	42.6	36.8	27.1	60.0	34.2	31.3	15.8	40.3	25.8	28.0	35.2	20.9	52.4	25.9	35.0	46.4	46.8	22.5	75.0	31.3	39.1	33.7	31.8	47.1	27.9	49.9	41.2	49.8	56.5	53.1	21.4	46.3	53.4	41.6	56.5	27.7	29.4	34.0	46.6	56.8	61.1	72.6	29.7	33.0	41.4	8.8	19.2	13.2	17.5	25.1	19.1	15.6	16.4	15.7	24.3	18.3	19.1	20.6	17.6	24.6	26.5	11.4	14.7	18.3	39.1	47.5	34.3	46.6	38.3	25.2	26.5	39.5	30.5	30.2	23.8	33.4	27.4	15.2	16.4	18.0	33.7	10.2	26.8	37.5	17.4	7.9	42.0	14.9	26.8	78.5	19.4	11.8	0.0	23.4	31.4	24.6	14.5	24.3	17.8	30.9	14.3	22.4	28.3	22.4	107.3	19.8	23.2	18.6	20.8	19.9	17.4	24.0	11.5	21.2	11.9	20.2	12.9	20.8	25.7	41.7	17.9	65.1	14.6	19.9	18.0
HAX1	"HCLSBP1, HS1BP1"	ENSG00000143575	"HCLS1 associated protein X-1"	O00165	1	154272511-154275875	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055141, HPA075289"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA055141: AB_2682714, HPA075289: AB_2686742"	"unprognostic (1.32e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.96e-1)"	24.0	25.4	28.6	16.0	33.9	12.2	29.2	15.1	36.6	24.9	24.8	21.9	22.9	18.6	20.2	42.7	27.7	24.5	20.2	59.5	24.7	26.3	32.1	61.7	17.3	20.3	25.8	20.3	29.3	47.8	21.0	35.2	18.4	23.5	26.1	25.0	26.6	52.0	26.3	90.4	17.8	27.8	25.1	22.6	23.2	23.9	31.3	17.0	23.8	32.4	45.8	27.7	27.0	18.6	39.1	34.9	59.1	39.6	30.9	51.8	42.8	20.5	17.6	14.9	32.7	18.5	20.7	24.2	19.6	32.2	41.6	38.7	23.3	23.2	30.0	28.5	33.2	19.5	17.8	34.2	27.1	32.2	30.7	25.6	14.6	14.5	20.1	41.3	30.3	31.7	19.2	50.2	31.2	37.5	14.6	23.1	44.0	28.4	44.8	26.7	49.6	30.4	25.1	16.5	49.0	38.6	21.6	11.0	57.6	21.9	11.5	23.0	22.9	17.5	42.5	59.3	25.7	35.1	83.9	11.5	17.3	23.3	18.1	27.0	52.3	54.5	56.2	26.4	28.0	28.5	58.3	28.4	59.1	34.2	33.5	39.1	39.1	43.1	38.7	34.0	38.2	51.8	41.2	17.2	30.9	39.6	34.9	50.8	42.8	28.6	33.9	15.1	36.6	24.7	26.3	25.8	20.3	23.5	17.0	26.8	32.8	105.0	105.1	66.2	57.5	96.8	56.0	32.1	31.8	43.6	45.2	70.2	154.2	76.6	107.7	63.1	62.2	46.7	92.7	108.3	57.2	80.6	98.1	74.9	86.5	38.1	55.3	44.8	55.3	88.4	56.7	70.8	82.7	180.3	58.5	75.4	79.5	58.8	58.4	123.1	86.4	58.2	76.2	186.3	97.5	66.9	74.3	99.1	65.0	89.4
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 2.5;granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4"					"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0
ATP8B2	"ATPID, KIAA1137"	ENSG00000143515	"ATPase phospholipid transporting 8B2"	P98198	1	154325553-154351307	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 12.3;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046680	Approved					NA	NA					"HPA046680: AB_2679749"	"unprognostic (1.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.40e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.52e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.77e-3)"	"unprognostic (6.58e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (5.29e-5)"	13.6	7.0	5.5	15.0	7.1	3.4	11.9	26.8	8.9	29.1	11.2	7.4	11.5	8.6	28.9	15.2	14.4	21.5	18.4	11.7	7.0	6.8	6.6	2.6	12.2	16.1	6.2	5.8	27.5	5.3	5.1	13.9	10.9	6.1	15.3	6.8	12.5	5.4	16.4	4.3	6.1	11.8	29.4	5.1	14.7	11.4	12.7	5.1	18.9	11.2	8.1	13.6	20.5	24.9	0.6	0.7	3.1	0.0	0.9	6.5	1.0	0.7	5.1	6.5	6.7	41.8	28.3	0.1	15.7	26.2	9.1	10.9	0.1	0.2	0.6	8.3	37.9	6.0	3.2	7.8	1.8	6.4	17.2	6.3	6.5	6.3	5.9	12.7	0.0	5.1	18.2	0.4	13.8	13.2	12.0	14.0	8.3	12.9	15.8	7.7	6.7	12.2	0.8	15.5	0.1	6.5	13.6	4.5	23.4	1.7	0.1	5.8	8.0	4.1	0.9	9.8	9.7	4.8	4.9	12.2	13.8	7.0	17.3	4.7	21.9	26.8	3.9	4.8	0.7	8.4	3.1	0.0	3.0	2.2	0.0	1.5	0.6	3.5	3.7	0.0	0.4	2.9	2.5	0.1	0.9	0.0	0.7	6.5	1.0	5.5	7.1	26.8	8.9	7.0	6.8	6.2	5.8	6.1	5.1	3.0	5.0	2.2	1.5	2.3	0.7	5.1	0.0	6.7	3.4	0.0	2.0	0.1	0.0	1.2	0.4	8.4	0.0	0.0	0.2	0.4	8.1	4.3	7.0	0.9	0.4	7.9	0.0	12.3	1.0	0.4	10.6	0.0	6.8	0.0	0.0	2.6	1.4	0.0	13.8	0.1	0.4	0.0	6.2	2.6	3.6	1.4	0.2	8.2	0.0	0.4
IL6R	CD126	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 107.2;Hepatocytes: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 55.9;U-266/84: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA	24800000	22000000				"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (7.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	8.4	4.0	4.7	14.8	5.1	9.0	6.5	1.4	6.3	6.1	16.9	4.8	1.2	9.6	6.3	4.7	5.2	7.9	6.9	5.0	5.2	2.9	8.9	38.1	20.8	15.4	7.2	2.2	5.7	5.3	0.0	7.7	3.7	7.8	4.5	6.0	3.6	5.4	1.7	59.6	4.7	12.6	5.3	5.0	11.3	6.6	3.7	5.0	4.2	2.5	6.1	13.3	6.3	4.8	0.6	14.3	35.0	11.7	0.5	8.0	5.5	0.8	1.5	0.1	0.1	0.9	1.3	0.1	0.8	0.6	0.5	0.2	0.1	1.0	0.0	1.9	1.0	3.1	0.4	0.3	4.5	0.4	15.1	0.5	0.2	0.6	3.4	0.1	2.4	1.3	0.8	2.7	0.4	6.8	0.1	0.6	0.0	0.1	6.2	0.1	0.3	0.0	3.9	0.4	0.2	3.4	0.0	0.0	13.0	2.8	1.1	0.1	0.0	0.2	9.2	15.1	1.2	0.8	55.9	0.6	0.9	0.9	0.8	0.5	10.7	65.8	0.1	1.1	15.2	1.4	2.8	11.7	10.4	0.2	7.1	0.6	0.6	6.4	0.7	14.3	0.2	6.4	2.2	35.0	0.5	3.0	5.1	8.0	5.5	4.7	5.1	1.4	6.3	5.2	2.9	7.2	2.2	7.8	5.0	107.2	76.2	9.0	41.2	33.7	0.0	8.5	25.5	37.5	59.1	1.8	0.0	0.4	0.0	3.5	35.4	7.1	43.2	0.0	1.0	0.9	20.1	71.1	57.9	81.0	36.1	0.0	7.5	3.1	36.2	9.6	0.3	29.9	23.6	39.7	5.7	5.6	4.9	5.3	0.4	12.6	0.2	0.0	27.0	0.2	0.9	26.0	0.8	4.4	11.5	12.5
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502113	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 54.7;Ito cells: 72.4;Spermatocytes: 36.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 33.8;TIME: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037417	Approved				"Secreted - unknown location"	NA	NA					"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	22.0	6.5	4.7	4.3	4.9	1.0	28.4	2.3	4.2	7.7	7.1	3.2	5.2	3.3	12.3	8.4	6.9	7.6	6.8	14.1	3.7	2.4	6.1	5.5	19.0	11.6	4.8	2.0	8.8	2.2	6.6	2.5	16.3	4.3	9.6	4.3	5.0	3.5	4.6	7.6	4.1	5.4	8.3	3.1	17.3	3.5	15.8	2.5	2.0	26.8	6.2	3.3	7.6	17.7	1.9	7.7	4.6	2.8	3.3	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.7	9.2	0.0	0.2	0.9	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.8	0.6	0.4	3.1	2.8	2.3	1.9	1.4	1.3	0.2	1.9	1.8	2.0	4.6	3.3	2.0	7.7	0.0	0.9	4.7	4.9	2.3	4.2	3.7	2.4	4.8	2.0	4.3	2.5	0.0	18.9	0.0	0.5	3.0	0.0	2.9	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	10.0	54.7	0.0	0.0	0.0	0.0	2.2	0.5	3.5	1.1	1.1	0.0	0.0	72.4	20.1	13.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	36.3	16.4	1.4	0.1	0.0	0.0	0.1
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 48.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 47.9;Late spermatids: 66.1;Spermatocytes: 133.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 2.2;HUVEC TERT2: 7.7;RPMI-8226: 2.1;TIME: 4.1"					"Low region specificity"	"Detected in all"			HPA054327			Approved	Vesicles		NA	NA			Vesicles		"HPA054327: AB_2682452"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.04e-5)"	"unprognostic (1.62e-1)"	4.1	1.4	0.7	1.1	0.9	0.0	2.6	0.7	1.4	1.3	0.8	0.9	1.4	0.5	2.1	2.0	1.0	2.1	1.2	2.3	0.7	0.0	1.0	1.5	3.3	1.6	0.9	1.2	4.6	0.7	0.8	0.8	1.4	1.2	1.1	1.1	0.7	0.7	1.0	1.1	0.7	1.0	1.4	1.2	3.5	0.5	48.4	0.8	0.7	4.9	1.5	1.0	1.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.1	4.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.7	1.4	0.7	0.0	0.9	1.2	1.2	0.8	3.0	7.9	0.0	0.0	0.6	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	47.9	4.7	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.0	0.3	0.0	0.0	6.2	3.5	66.1	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	133.2	17.2	0.3	0.0	0.0	0.0	0.0
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome		No	No			Nucleoplasm	Centrosome	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	17.2	14.9	21.1	16.1	21.7	22.4	18.3	17.1	26.0	22.0	17.8	16.7	18.4	21.2	24.6	23.8	18.4	15.0	24.8	19.8	19.0	21.3	15.7	16.8	13.3	16.1	27.4	27.3	27.1	21.5	26.3	17.8	20.7	24.0	28.2	19.7	14.1	26.3	28.1	26.7	16.6	20.1	28.8	41.3	25.4	19.2	14.7	22.3	24.2	18.3	21.5	30.1	17.3	32.6	27.9	37.7	19.9	41.7	19.6	14.3	15.9	16.9	18.2	32.2	23.8	28.1	16.0	19.4	21.5	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0	29.8	21.6	22.7	16.5	14.3	38.7	26.9	25.5	34.8	20.5	15.7	3.9	15.3	10.0	13.0	2.7	27.8	23.7	0.0	18.0	14.1	15.8	22.6	10.4	34.2	23.2	57.2	32.3	32.5	41.4	4.3	16.4	19.3	13.5	15.4	30.4	45.6	21.9	11.5	18.0	15.1	19.3	12.9	13.2	30.7	24.4	16.7	16.4	20.8	20.4	22.9
CHRNB2		ENSG00000160716	"Cholinergic receptor nicotinic beta 2 subunit"	P17787	1	154567781-154580026	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 28.4"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 12.2;Cone photoreceptor cells: 13.7;Horizontal cells: 39.7;Late spermatids: 8.0;Rod photoreceptor cells: 7.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 20.7;SH-SY5Y: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.13e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.84e-1)"	0.9	3.2	7.8	1.2	16.4	1.0	1.8	8.1	28.4	0.9	1.1	1.6	0.0	1.4	1.0	0.9	1.1	1.0	0.9	0.9	9.4	8.9	0.9	0.9	0.9	0.9	7.9	9.8	1.0	2.1	0.9	3.3	0.9	15.4	0.9	1.2	3.1	1.0	0.9	0.9	1.3	1.2	1.1	1.4	0.9	1.6	2.0	1.7	0.0	0.9	0.0	0.9	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.7	20.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	7.8	16.4	8.1	22.1	9.4	8.9	7.9	9.8	15.4	1.7	0.0	0.0	0.0	0.0	0.1	12.2	1.6	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	39.7	3.5	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.6	30.9	26.5	32.6	26.8	27.8	31.5	18.4	36.9	61.6	53.5	26.6	26.2	48.0	29.7	29.3	34.2	25.9	33.8	34.9	31.4	46.6	16.9	25.0	21.9	15.0	29.2	35.3	27.8	27.0	25.5	31.5	32.3	25.2	31.5	34.7	23.6	37.0	21.5	32.5	42.6	18.2	43.7	35.7	23.3	40.8	21.8	38.6	21.1	29.7	26.4	31.5	31.7	51.3	37.6	41.3	34.5	43.5	28.7	22.1	21.8	18.2	21.2	43.8	48.0	51.6	21.5	23.3	24.9	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9	77.4	46.4	72.2	33.2	29.7	90.3	15.5	33.1	41.5	43.3	45.4	90.3	33.7	8.3	43.8	3.6	83.1	68.1	23.3	58.0	42.0	39.5	47.9	61.1	78.8	46.9	158.9	60.6	78.0	80.2	9.5	68.1	57.4	18.6	68.5	54.5	46.8	58.0	53.7	55.5	36.0	81.7	51.8	36.9	11.7	23.2	35.3	26.3	58.3	48.2	41.3
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870280	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8;memory B-cell: 4.8"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	1.7	2.5	20.6	6.5	21.7	1.0	1.8	5.7	26.7	9.3	9.1	12.4	1.1	5.4	12.6	1.7	3.5	10.3	3.1	4.0	21.6	8.0	3.5	1.0	3.1	5.8	12.0	10.9	2.1	1.0	1.5	2.6	0.7	13.3	3.4	4.6	0.1	2.7	2.7	8.5	1.1	3.9	10.6	8.1	5.0	4.4	1.3	15.5	0.2	3.7	3.5	9.2	8.3	4.9	4.8	0.4	5.8	2.7	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	31.0	0.3	0.0	0.1	0.0	0.4	0.0	1.2	0.0	7.7	8.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	29.9	3.9	10.0	0.3	0.0	2.9	5.8	0.0	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	20.6	21.7	5.7	10.3	21.6	8.0	12.0	10.9	13.3	15.5	11.9	2.4	0.0	0.5	1.1	0.2	2.2	0.0	32.1	3.4	0.0	2.0	0.0	3.3	0.2	2.6	16.9	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.0	0.4	0.0	4.1	5.5	0.0	6.2	0.3	0.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.5	0.1	1.5	0.0	0.0	0.0	0.1
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924734-154936991	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved					NA	NA					"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	21.0	28.3	31.3	15.9	34.0	7.2	19.4	13.9	31.7	17.0	18.9	25.3	10.2	26.4	12.1	14.7	30.1	20.2	15.7	24.7	23.9	23.9	26.9	39.3	16.2	18.7	29.6	29.3	18.8	22.2	26.8	26.1	13.8	22.4	17.0	12.0	22.2	18.8	15.9	39.8	26.1	25.2	16.7	23.9	20.5	21.8	15.9	22.8	9.9	17.8	25.3	18.9	12.2	22.8	29.1	22.9	20.4	47.3	13.4	30.4	17.7	11.7	16.6	10.7	16.8	9.9	7.1	11.4	9.5	6.4	8.7	8.3	6.7	23.3	16.7	18.2	10.7	9.5	11.5	14.5	14.1	4.0	23.4	6.6	7.6	22.4	6.2	9.2	11.6	7.0	8.4	13.1	15.8	11.2	4.4	8.7	15.1	8.1	51.9	9.0	23.5	9.1	11.2	9.7	27.1	21.3	13.9	7.0	38.5	14.6	8.6	9.0	21.5	10.2	17.8	11.6	8.4	34.0	20.6	7.4	8.5	7.0	20.1	14.1	42.2	33.7	29.5	14.1	18.7	10.9	4.6	19.8	20.4	17.5	46.9	27.9	29.1	24.0	17.8	22.1	23.9	15.7	15.7	1.7	13.4	47.3	22.9	30.4	17.7	31.3	34.0	13.9	31.7	23.9	23.9	29.6	29.3	22.4	22.8	53.6	29.1	50.4	97.4	62.0	37.2	44.8	76.5	12.0	20.5	50.6	7.9	202.5	225.5	58.9	6.4	26.7	90.5	0.0	62.5	77.8	60.1	55.3	21.9	125.4	120.4	35.0	63.8	33.7	65.6	10.4	39.4	42.6	62.4	49.5	62.3	77.7	52.4	54.7	44.9	190.8	21.7	32.3	55.9	42.4	43.2	79.2	190.4	59.5	69.9	62.7
PBXIP1	HPIP	ENSG00000163346	"PBX homeobox interacting protein 1"	Q96AQ6	1	154944076-154956123	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 200.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"Karpas-707: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006949	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA006949: AB_1079572"	"unprognostic (6.17e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (8.94e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (7.19e-4)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.64e-4)"	"unprognostic (1.20e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (3.89e-1)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.26e-3)"	25.3	48.1	35.4	24.9	54.9	13.7	19.9	18.3	31.4	26.8	36.2	26.1	28.1	25.5	28.3	29.8	23.6	22.8	31.1	21.9	46.6	28.6	18.1	13.3	22.6	28.6	41.8	34.4	50.1	17.6	42.4	56.7	21.2	47.8	26.4	14.3	38.6	20.7	48.3	57.2	13.2	28.6	52.6	29.0	27.5	28.1	15.9	33.8	27.9	33.1	22.4	26.8	37.5	25.7	9.2	4.0	42.9	6.6	13.0	46.8	14.4	1.0	2.7	4.3	2.9	15.1	4.7	3.2	3.6	8.0	1.7	3.4	0.7	3.5	4.3	11.6	4.3	2.5	3.8	1.0	2.3	1.2	2.3	1.6	1.0	3.6	2.7	7.0	1.2	12.2	7.1	3.8	2.2	0.4	20.3	6.5	3.4	0.5	159.6	4.3	1.5	2.4	3.8	1.6	2.7	2.0	2.8	6.2	9.5	4.8	2.0	0.7	5.5	4.6	1.4	3.6	8.6	4.5	5.1	6.1	1.7	1.3	1.1	1.1	21.9	18.3	1.0	6.2	1.7	1.3	26.7	2.5	42.9	11.0	3.6	30.4	9.2	29.5	17.2	2.2	5.7	19.7	12.1	23.7	13.0	6.6	4.0	46.8	14.4	35.4	54.9	18.3	31.4	46.6	28.6	41.8	34.4	47.8	33.8	62.5	78.3	31.8	22.2	9.0	23.1	34.4	22.9	26.8	37.5	40.1	15.7	14.6	0.0	37.4	112.5	21.6	20.0	23.3	16.1	20.0	28.9	16.8	49.8	14.3	13.0	1.6	80.4	24.5	16.1	134.8	59.5	13.3	25.3	31.5	22.2	200.0	21.7	25.9	121.3	9.1	6.5	51.8	57.0	2.4	12.9	10.0	22.7	93.7	14.3	12.9
PYGO2		ENSG00000163348	"Pygopus family PHD finger 2"	Q9BRQ0	1	154957026-154963853	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023689, HPA074813"	Supported		Supported	"Nucleoplasm,Plasma membrane"		No	No			Nucleoplasm	"Plasma membrane"	"HPA023689: AB_1855974, HPA074813: "	"unprognostic (1.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.76e-4)"	14.0	28.4	22.2	22.8	23.7	6.6	26.1	28.5	26.8	20.8	20.5	23.4	22.1	21.3	18.7	27.9	21.4	24.1	21.6	15.0	18.7	22.9	19.1	17.4	17.2	26.7	22.2	19.4	32.5	17.5	37.7	31.0	18.4	21.3	24.5	17.9	21.3	25.3	32.6	16.4	25.0	22.5	18.3	22.1	26.4	19.1	15.7	22.1	30.9	35.5	12.9	30.1	20.3	21.8	8.9	4.3	10.5	8.2	6.3	12.8	5.7	12.9	9.2	19.6	17.3	19.8	9.7	18.0	8.1	11.0	12.9	11.1	12.3	16.3	16.3	12.9	9.4	14.0	17.7	17.0	11.3	8.5	16.1	12.1	13.0	15.0	10.9	9.2	11.9	11.6	8.0	16.4	11.6	9.8	14.7	7.9	25.0	17.0	27.8	12.1	19.8	16.4	13.9	20.9	26.1	16.6	18.6	12.5	25.7	13.1	12.3	23.6	35.1	12.8	23.4	16.1	19.9	28.7	21.5	6.6	11.5	17.4	12.4	11.7	27.6	24.4	17.4	9.6	15.2	15.2	2.4	3.9	10.5	9.0	6.8	11.6	7.5	11.5	11.9	4.3	8.9	12.8	9.6	4.0	6.3	8.2	4.2	6.0	5.7	22.2	23.7	28.5	26.8	18.7	22.9	22.2	19.4	21.3	22.1	8.9	8.2	8.4	3.2	4.8	10.2	4.2	5.1	1.4	6.8	12.2	2.0	12.8	16.6	5.0	2.7	6.8	7.0	0.0	5.1	10.1	5.3	4.2	0.0	7.8	5.5	20.6	5.2	6.7	6.9	1.8	8.3	3.9	5.0	4.6	9.7	9.8	8.0	8.6	8.5	7.6	6.1	6.5	6.6	4.1	10.9	4.5	9.7	11.7	9.5	2.8
SHC1	"p66, SHC, ShcA"	ENSG00000160691	"SHC adaptor protein 1"	P29353	1	154962298-154974395	"Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001844, CAB005374, CAB016305"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826"	"unprognostic (4.12e-2)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (7.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-1)"	45.1	36.4	14.6	27.8	15.9	20.4	43.6	11.8	12.6	33.9	30.5	11.1	32.9	23.1	34.8	28.1	31.4	32.5	30.5	23.4	11.7	8.5	30.1	54.7	37.5	36.5	13.9	8.7	36.1	21.5	23.0	44.7	47.3	18.9	31.9	23.7	31.5	22.4	24.9	22.1	20.3	39.5	35.4	16.0	38.6	25.8	16.2	11.1	19.9	37.7	21.1	29.8	40.4	31.2	13.9	21.8	31.9	27.0	12.7	23.7	19.8	13.8	28.7	22.1	35.5	24.2	48.6	11.6	50.5	46.0	29.4	22.4	10.2	33.4	7.4	41.4	60.7	8.4	11.9	5.8	50.0	26.5	9.1	3.2	19.1	23.6	18.0	63.4	6.1	21.7	72.2	59.4	36.6	45.6	80.2	64.3	3.2	8.4	60.2	61.4	11.3	7.0	3.7	19.3	11.3	12.2	6.4	7.3	15.4	14.1	10.5	2.8	76.9	30.2	16.9	16.5	40.4	24.7	13.0	76.3	46.4	29.0	9.8	26.4	27.2	17.4	12.6	45.3	8.3	60.0	17.0	20.8	31.9	23.7	27.0	23.5	13.9	19.0	20.9	21.8	13.3	15.6	14.1	17.0	12.7	25.7	10.0	14.1	19.8	14.6	15.9	11.8	12.6	11.7	8.5	13.9	8.7	18.9	11.1	26.8	24.2	12.3	42.7	31.7	4.8	2.0	20.4	6.7	15.9	5.2	5.9	21.8	6.6	27.1	0.6	78.8	30.8	0.0	24.3	49.6	36.6	37.1	17.3	38.1	20.4	23.8	12.1	79.2	21.7	1.5	21.3	17.3	16.9	10.8	23.3	10.0	25.1	25.1	32.5	7.7	6.8	19.4	41.2	2.8	5.0	31.9	50.9	14.1	20.4	37.3
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979249	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 303.7;Extravillous trophoblasts: 535.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	25.3	14.5	13.5	13.4	19.0	36.4	24.8	4.2	14.6	15.6	17.4	12.4	19.8	14.7	14.7	13.8	28.2	15.2	14.1	16.5	15.3	8.0	16.6	29.5	12.9	23.8	29.5	8.8	14.2	12.8	8.3	9.4	35.6	15.9	11.7	18.8	7.5	12.8	13.1	5.9	22.6	22.9	12.5	19.8	18.0	14.7	22.8	21.5	30.2	15.5	19.3	25.5	11.1	23.3	23.9	30.4	2.2	32.8	9.0	12.2	8.7	59.7	82.4	61.8	33.5	8.9	9.2	49.4	27.8	21.6	60.4	48.4	79.6	88.4	56.9	47.6	18.4	33.9	55.5	61.2	39.9	56.8	51.1	39.7	38.5	36.7	55.9	2.7	46.3	35.4	5.3	17.3	51.6	71.6	12.4	30.3	39.5	62.5	77.4	45.4	59.4	43.4	35.8	78.4	57.4	74.4	43.7	50.9	72.9	21.5	21.9	25.2	63.7	42.0	39.9	46.0	74.9	53.4	64.8	16.8	39.2	40.6	32.4	66.2	47.8	92.7	80.3	24.9	39.5	54.1	0.7	4.4	2.2	7.0	26.0	8.4	23.9	9.9	9.5	7.2	22.6	12.2	11.5	0.6	9.0	32.8	30.4	10.6	8.7	13.5	19.0	4.2	14.6	15.3	8.0	29.5	8.8	15.9	21.5	11.9	26.6	58.1	85.2	193.2	2.1	8.9	68.8	40.2	40.9	27.9	0.0	103.2	68.0	71.4	12.5	39.5	35.7	303.7	98.8	535.3	106.1	48.1	20.7	75.7	110.7	1.6	19.7	30.1	33.8	18.8	70.5	54.9	108.0	55.9	35.3	15.6	87.5	41.8	43.2	64.8	2.4	19.4	106.1	117.9	120.7	178.0	110.3	47.9	49.4	87.8
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	16.5	16.5	20.3	15.5	18.9	12.1	17.4	15.9	20.8	14.1	16.4	19.3	14.7	19.6	15.9	21.2	19.8	16.7	11.8	16.1	18.2	10.4	19.0	36.5	13.5	20.0	20.8	15.6	14.5	19.0	13.6	12.0	18.5	15.9	18.7	19.0	16.1	16.2	16.3	26.3	23.3	23.9	17.6	12.4	22.9	16.1	19.1	18.9	15.7	20.8	18.4	22.0	15.5	15.4	25.1	24.5	15.2	24.1	14.9	26.4	22.7	13.0	20.9	13.3	22.7	11.6	8.6	25.4	9.9	8.2	14.4	12.4	18.6	16.1	15.2	20.0	9.1	7.5	17.1	25.6	20.5	9.4	15.8	19.2	12.3	16.6	13.1	15.9	17.8	16.1	12.3	26.9	16.4	17.6	7.0	16.7	16.3	19.8	12.4	12.2	28.1	12.2	12.5	29.1	28.4	21.7	20.7	6.6	34.9	13.7	18.2	22.5	30.9	15.5	35.1	19.5	27.0	30.0	27.1	10.5	9.1	12.5	11.6	15.5	19.4	24.0	26.2	10.9	14.5	14.5	15.2	23.0	14.8	24.0	20.9	26.4	25.1	22.1	22.7	24.1	20.5	20.5	20.2	5.2	14.9	24.1	24.5	23.3	22.7	20.3	18.9	15.9	20.8	18.2	10.4	20.8	15.6	15.9	18.9	8.9	8.8	15.9	13.2	23.6	15.2	34.3	20.4	16.0	11.4	24.4	5.9	36.7	26.6	22.3	20.5	11.2	23.6	23.3	24.5	35.2	12.7	16.8	8.1	24.5	24.6	14.3	11.5	9.8	14.6	61.7	9.5	14.0	13.5	41.5	18.3	19.0	20.5	17.5	9.2	27.4	14.7	6.5	13.3	20.0	17.9	24.1	30.1	16.0	19.9	17.0
LENEP	LEP503	ENSG00000163352	"Lens epithelial protein"	Q9Y5L5	1	154993586-154994315	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.0"	"Cell type enhanced"	"Detected in single"	35	"Muller glia cells: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 1.7;hippocampal formation: 3.0;pons and medulla: 2.5"	"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;BEWO: 1.1;Daudi: 1.1;HaCaT: 1.6;HAP1: 1.6;Karpas-707: 1.2;MCF7: 1.1;PC-3: 1.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.03e-1)"	"unprognostic (3.60e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.32e-5)"	"unprognostic (5.26e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	0.1	0.4	1.7	0.1	0.2	0.0	0.2	0.4	0.2	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	3.0	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.7	0.3	0.0	0.3	0.2	2.5	0.6	0.3	0.1	1.9	0.1	0.5	1.4	1.3	0.1	1.8	0.1	0.3	0.3	0.1	0.1	1.6	0.1	0.1	0.1	0.2	0.2	0.8	0.0	0.1	0.0	1.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.4	1.2	0.0	1.1	0.0	0.0	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.2	0.4	0.2	3.0	0.2	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.0"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 141.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	9.4	11.1	3.0	8.8	4.7	11.6	11.1	4.0	4.9	9.5	33.7	11.3	22.3	27.3	5.4	4.5	29.1	5.9	13.2	6.4	4.3	2.1	9.3	19.1	10.5	6.3	8.0	4.3	6.2	18.2	5.1	6.4	11.3	5.9	9.9	8.1	9.6	19.1	18.6	11.8	33.3	54.0	5.4	5.6	10.3	11.2	3.8	7.3	1.8	14.3	11.2	16.0	8.6	12.4	2.0	2.3	5.7	3.4	1.5	2.5	4.3	7.5	13.5	1.2	4.1	6.2	3.5	16.6	5.2	6.2	5.5	6.4	9.0	11.0	3.3	9.4	5.8	4.3	11.5	3.8	7.3	1.1	18.0	4.3	5.5	22.5	6.0	9.1	4.2	15.2	4.6	26.2	7.5	9.3	7.4	4.3	0.5	7.8	15.3	3.1	14.3	0.1	9.4	4.1	12.1	11.2	3.1	0.9	20.7	8.2	7.9	7.7	7.9	10.0	26.8	4.2	5.3	16.7	14.1	3.6	3.6	6.3	7.0	4.3	18.2	11.1	3.5	8.3	14.0	4.0	0.9	3.2	2.9	1.5	3.4	0.5	1.6	2.0	0.9	2.3	2.0	1.7	0.5	5.7	1.5	2.9	0.2	2.5	4.3	3.0	4.7	4.0	4.9	4.3	2.1	8.0	4.3	5.9	7.3	8.9	0.0	4.7	8.4	31.3	14.0	1.4	20.4	0.0	1.2	5.2	2.0	9.2	10.0	11.9	2.2	4.1	141.0	0.0	13.0	12.8	5.6	21.8	5.7	23.7	12.7	15.9	6.4	4.9	30.8	5.6	8.3	16.2	15.1	6.4	27.3	5.1	14.5	48.0	6.7	8.9	9.8	0.0	6.3	0.4	1.2	46.9	23.0	7.4	33.0	16.9
DCST2	FLJ32934	ENSG00000163354	"DC-STAMP domain containing 2"	Q5T1A1	1	155018520-155033781	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 8.6;testis: 20.8"	"Cell type enhanced"	"Detected in some"	18	"Cone photoreceptor cells: 15.7;Early spermatids: 43.0;Late spermatids: 21.0;Rod photoreceptor cells: 17.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.0;Karpas-707: 3.7;U-266/70: 4.9"	"Low region specificity"	"Detected in some"													NA	NA						"unprognostic (8.08e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.04e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.78e-10)"	"unprognostic (6.95e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-3)"	0.8	0.2	0.5	0.5	0.5	0.1	2.2	0.7	0.5	1.8	0.6	0.5	0.5	2.5	0.7	0.5	1.2	1.5	0.5	0.5	0.5	0.1	0.5	0.8	0.5	0.5	0.5	0.5	0.8	0.5	0.0	0.5	0.5	0.5	1.9	0.7	5.3	3.0	1.2	0.5	8.6	1.5	0.5	0.5	0.5	0.6	20.8	0.5	0.5	0.7	0.5	0.5	0.5	2.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.3	0.4	1.2	1.6	0.9	0.8	0.9	0.1	0.5	0.3	0.0	0.0	1.2	0.2	1.0	0.2	0.3	3.0	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	0.2	0.1	0.9	2.2	0.1	0.4	0.5	0.0	0.1	0.1	3.7	0.0	1.1	0.0	0.1	0.2	1.3	0.2	0.3	0.1	1.3	0.4	0.1	0.6	0.3	1.1	0.6	0.8	0.8	0.7	0.0	0.0	0.0	1.0	0.0	0.0	4.9	1.9	0.0	0.0	0.4	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.7	0.5	0.5	0.1	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.8	0.8	1.1	0.4	0.0	0.0	0.0	0.0	15.7	0.3	0.0	0.0	43.0	0.1	1.1	0.0	0.2	9.8	0.2	0.2	0.0	0.0	0.4	1.6	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.0	0.7	0.5	17.6	0.0	0.8	2.6	1.6	1.1	0.7	0.0	0.6	0.4
DCST1	FLJ32785	ENSG00000163357	"DC-STAMP domain containing 1"	Q5T197	1	155033824-155050930	"Enzymes, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"retina: 18.2;skin 1: 6.8;testis: 10.7"	"Cell type enhanced"	"Detected in some"	19	"Cone photoreceptor cells: 11.8;Early spermatids: 23.4;Late spermatids: 15.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.9;HeLa: 4.1;RPMI-8226: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060314	Uncertain					NA	NA					"HPA060314: AB_2684250"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.58e-2)"	"unprognostic (8.75e-4)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.33e-15)"	"unprognostic (7.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.7	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	18.2	0.7	0.1	0.1	6.8	1.6	0.1	0.1	0.2	0.4	10.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.8	0.8	0.9	1.2	0.0	1.0	0.1	1.5	0.7	2.7	1.5	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.7	3.3	1.6	0.5	0.0	0.7	4.9	0.0	0.0	0.0	1.2	0.4	0.4	4.1	0.3	0.0	1.2	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.1	2.3	0.0	1.0	0.0	0.3	0.2	0.2	2.2	0.0	1.1	5.6	0.0	0.8	0.9	1.8	0.6	1.8	0.2	1.1	3.5	0.1	0.0	0.4	0.2	0.8	0.4	1.0	0.8	0.3	0.7	1.6	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.8	0.4	0.2	0.3	0.0	1.0	0.2	0.2	0.0	1.2	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.6	0.0	1.4	2.3	0.0	11.8	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
ADAM15	MDC15	ENSG00000143537	"ADAM metallopeptidase domain 15"	Q13444	1	155050566-155062775	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 139.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 12.0;myeloid DC: 28.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 28.7;monocytes: 17.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 64.1;RPMI-8226: 67.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011633, HPA072878"	Uncertain		Uncertain	Vesicles		NA	NA		13000	Vesicles		"HPA011633: AB_1844574, HPA072878: "	"unprognostic (6.35e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (5.83e-5)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.64e-9)"	"unprognostic (3.35e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.40e-2)"	32.7	8.3	7.3	13.3	8.9	19.3	47.9	7.8	13.9	19.9	21.2	22.2	11.9	10.7	20.4	16.2	36.0	19.3	30.3	42.3	8.0	7.7	12.4	12.8	29.2	23.3	10.8	8.3	15.7	17.5	18.9	6.9	25.5	13.9	17.8	15.9	15.4	20.4	12.1	13.6	45.8	20.3	25.6	13.6	16.0	19.6	8.3	7.4	2.7	14.6	41.5	19.7	13.4	26.5	1.1	28.7	0.7	17.2	0.7	4.5	8.1	20.8	6.7	1.3	29.8	11.0	9.2	12.9	9.2	11.8	11.8	8.0	4.8	12.0	5.8	41.7	12.1	5.2	26.2	6.7	28.4	3.1	2.6	8.7	1.4	13.2	4.7	19.2	11.8	1.5	9.8	30.1	11.9	17.2	16.3	53.4	1.8	2.2	24.4	8.7	11.3	0.1	8.7	4.2	36.4	64.1	1.8	4.0	67.6	8.6	5.5	4.1	8.8	20.2	25.5	7.9	2.2	37.7	7.3	39.3	11.6	4.9	11.5	10.2	2.7	2.1	2.5	8.4	9.0	12.6	0.0	17.2	0.3	4.5	12.0	3.1	1.0	2.3	2.6	28.7	1.1	1.0	1.2	0.7	0.7	2.8	2.3	3.8	8.1	7.3	8.9	7.8	13.9	8.0	7.7	10.8	8.3	13.9	7.4	3.0	7.0	6.0	22.9	43.5	8.9	9.2	33.1	4.0	5.7	8.7	27.5	9.0	0.0	34.2	1.5	86.7	58.2	0.0	22.4	139.2	17.1	43.0	1.1	17.4	29.2	6.4	12.2	51.0	57.4	1.0	16.1	18.9	13.5	3.6	62.3	8.0	30.5	51.8	17.0	2.2	15.6	12.9	16.1	0.9	6.1	49.9	14.9	5.0	53.8	32.0
EFNA4	"EPLG4, LERK4"	ENSG00000243364	"Ephrin A4"	P52798	1	155063731-155069553	"Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 72.2;Paneth cells: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB021350	Uncertain				"Secreted to blood"	NA	NA					"CAB021350: "	"unprognostic (4.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.97e-3)"	"prognostic unfavorable (3.14e-4)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.29e-2)"	5.5	10.8	3.5	6.1	1.9	0.9	16.8	2.0	2.1	12.0	18.9	1.9	13.2	9.7	9.4	12.3	20.0	4.9	9.6	6.5	3.0	1.3	8.4	12.8	5.3	10.8	2.4	2.5	16.1	6.3	4.2	2.7	9.7	2.6	11.5	11.5	7.5	20.1	9.5	2.2	25.3	27.0	4.0	1.9	7.0	5.0	5.1	2.2	6.4	12.0	13.5	16.3	6.6	11.5	17.1	18.2	7.8	9.2	2.6	9.5	4.7	6.1	4.6	11.5	16.9	6.8	4.4	9.5	2.7	5.3	5.5	5.1	6.8	10.3	7.9	15.9	2.8	4.3	14.6	6.8	4.2	2.2	3.6	2.0	0.7	4.2	9.5	2.4	1.7	12.5	2.6	13.0	2.7	3.3	4.8	10.9	6.6	3.2	5.3	3.0	13.6	4.0	4.4	21.0	23.5	9.7	14.0	4.5	7.7	8.5	5.3	2.8	12.6	5.5	20.9	2.4	8.7	13.6	5.5	5.6	3.2	9.7	6.5	4.1	5.4	5.6	7.7	3.1	4.2	3.3	0.0	7.4	5.0	5.9	6.6	6.1	17.1	6.5	6.7	6.0	14.1	9.5	6.3	7.8	2.6	9.2	18.2	6.2	4.7	3.5	1.9	2.0	2.1	3.0	1.3	2.4	2.5	2.6	2.2	0.0	4.6	5.4	6.7	22.2	0.2	1.2	7.6	5.3	4.5	15.7	0.0	7.9	1.7	23.3	0.0	5.8	20.0	0.0	12.2	72.2	10.5	12.9	1.1	1.8	10.8	0.0	2.9	4.9	5.1	0.0	7.2	5.4	16.9	7.2	17.5	5.2	17.8	37.9	5.3	3.8	0.0	0.0	5.1	0.4	2.7	28.5	8.2	7.4	25.2	8.4
AL691442.1		ENSG00000251246			1	155063748-155086807	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 6.8;U-266/70: 5.9"															NA	NA															"unprognostic (9.62e-2)"								1.9	2.4	1.3	2.2	1.4	0.4	7.7	1.5	5.6	5.2	8.8	0.0	5.8	1.1	3.9	5.4	9.4	1.6	4.0	2.4	1.3	1.4	3.4	5.7	1.8	4.6	1.4	0.3	7.4	3.4	1.2	1.5	4.1	0.4	5.0	1.5	2.9	9.4	4.0	2.8	1.9	13.0	1.5	1.3	2.7	1.6	2.8	0.2	2.3	5.2	6.0	7.4	2.4	2.7	2.2	2.3	2.1	1.0	1.0	2.4	0.2	0.6	0.8	0.6	1.7	1.2	0.3	0.3	0.0	1.0	0.1	0.1	0.4	1.1	1.5	2.3	0.5	0.2	2.4	0.0	0.4	0.0	0.9	0.4	0.1	0.0	0.8	0.2	0.8	2.3	0.2	0.3	1.3	0.0	2.0	1.2	1.1	0.4	1.2	0.2	0.9	1.8	0.9	0.4	2.2	1.5	2.0	0.5	6.8	0.0	0.1	2.6	2.8	0.0	1.7	0.1	0.9	2.2	0.6	0.5	0.3	0.0	0.0	0.1	5.9	4.0	0.6	0.5	0.2	0.0	0.0	1.0	2.1	1.6	1.0	1.5	1.7	0.8	0.7	2.2	2.2	2.0	0.4	0.0	1.0	0.8	2.3	2.4	0.2	1.3	1.4	1.5	1.6	1.3	1.4	1.4	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EFNA3	"Ehk1-L, EPLG3, LERK3"	ENSG00000143590	"Ephrin A3"	P52797	1	155078872-155087538	"Predicted membrane proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.3;skin 1: 41.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 56.1;Suprabasal keratinocytes: 95.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 27.8;SCLC-21H: 16.8;T-47d: 15.7"	"Low region specificity"	"Detected in all"							CAB010494	Uncertain					NA	NA					"CAB010494: AB_2097783"	"unprognostic (3.75e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.66e-10)"	"unprognostic (2.83e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-3)"	1.0	1.3	5.9	1.1	15.5	0.7	5.8	1.7	17.3	4.7	3.9	0.8	0.0	1.5	1.3	4.4	13.3	1.3	1.1	0.8	6.4	5.6	0.7	1.1	1.0	1.0	2.2	8.6	1.5	1.3	1.6	5.6	1.2	12.2	1.8	4.1	0.4	4.0	1.0	1.1	41.3	1.5	1.2	1.3	1.1	1.3	2.2	1.7	0.0	0.9	8.9	3.8	1.1	9.0	3.1	3.4	2.0	1.8	6.5	3.5	1.1	3.6	0.9	1.6	10.3	1.8	0.9	1.2	0.2	0.3	0.4	0.6	0.6	1.6	2.8	1.7	0.4	0.9	6.2	11.3	2.3	0.4	1.6	2.5	0.3	0.4	0.8	0.2	0.4	2.1	0.5	2.8	0.2	0.6	4.9	0.9	1.8	1.7	1.8	0.4	4.8	0.5	1.5	1.1	27.8	3.0	3.6	0.9	9.3	1.2	0.1	16.8	5.1	0.6	11.0	0.3	1.5	15.7	0.6	0.3	1.1	3.3	0.5	0.3	3.5	1.5	0.7	2.0	1.4	0.1	0.0	1.4	2.0	2.1	1.8	2.1	2.6	1.7	1.1	3.4	3.1	2.5	1.2	0.1	6.5	0.8	2.6	3.5	1.1	5.9	15.5	1.7	17.3	6.4	5.6	2.2	8.6	12.2	1.7	0.0	1.1	0.5	4.0	56.1	1.3	0.1	0.0	0.0	1.2	0.0	0.0	0.7	1.7	3.3	0.5	2.4	1.1	0.0	2.6	18.7	1.9	6.6	0.0	0.8	1.9	3.2	1.2	0.0	1.5	0.2	1.1	1.6	8.5	1.0	6.0	8.6	2.8	7.0	0.4	0.8	1.1	0.0	1.7	4.7	6.8	95.1	2.4	1.0	5.3	3.7
EFNA1	"ECKLG, EPLG1, LERK1, TNFAIP4"	ENSG00000169242	"Ephrin A1"	P20827	1	155127460-155134857	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 123.2"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 660.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 12.1;naive CD8 T-cell: 6.0"	"Lineage enriched"	"Detected in single"	26	"T-cells: 12.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 58.2;HaCaT: 20.4;SiHa: 33.5;SK-BR-3: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069549	Approved				"Secreted to blood"	NA	NA		2100000			"HPA069549: "	"unprognostic (5.14e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	16.2	6.1	6.8	2.9	14.5	0.4	29.5	4.4	10.9	7.1	27.6	11.8	10.7	21.7	7.2	11.7	12.6	8.0	8.7	13.3	6.4	4.6	16.1	123.2	27.0	2.7	15.7	4.3	5.7	14.0	4.9	5.3	38.2	13.8	18.6	20.2	5.0	17.7	17.2	10.4	27.5	27.5	5.1	9.6	2.3	13.1	3.3	14.8	3.7	30.2	7.8	4.1	10.7	12.7	0.3	0.0	0.4	0.0	0.3	12.1	2.0	3.1	1.3	0.1	2.5	0.4	0.0	58.2	0.0	0.0	0.0	0.0	3.2	7.1	0.0	5.9	0.0	1.9	20.4	1.3	7.1	0.0	2.0	0.4	0.0	4.5	17.6	0.1	0.0	0.3	0.9	17.3	0.0	6.0	1.5	10.9	0.2	0.5	0.1	0.0	11.6	0.0	0.2	0.4	10.9	4.2	1.2	0.3	2.0	13.7	5.0	2.0	3.1	33.5	51.5	1.2	11.3	10.8	0.0	1.3	0.0	2.0	0.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.7	0.0	0.3	12.1	6.0	0.4	0.3	0.0	0.0	0.0	2.0	6.8	14.5	4.4	10.9	6.4	4.6	15.7	4.3	13.8	14.8	184.6	95.0	4.2	57.3	113.4	3.4	35.5	84.1	53.5	91.0	17.4	0.0	130.6	11.6	117.4	0.2	123.9	167.8	0.0	55.8	660.1	20.2	202.8	5.8	108.3	24.7	4.8	17.9	76.1	6.4	0.0	4.4	7.0	59.1	1.0	105.2	4.9	63.4	143.2	0.4	26.7	0.9	0.0	30.9	0.2	0.1	190.3	212.6	5.0	70.3	74.6
SLC50A1	"HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1"	ENSG00000169241	"Solute carrier family 50 member 1"	Q9BRV3	1	155135344-155138857	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 115.3;Mucus-secreting cells: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018095	Approved					NA	NA					"HPA018095: AB_1856048"	"unprognostic (4.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (4.36e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.39e-2)"	11.6	23.4	4.9	16.3	5.7	7.2	13.6	4.2	6.7	13.6	19.8	5.6	28.7	17.2	11.5	49.0	20.3	10.0	21.3	7.5	5.1	7.0	23.8	34.5	22.8	24.3	5.3	4.3	13.6	55.3	12.7	10.3	19.5	6.2	14.4	25.0	11.3	37.5	17.2	4.5	15.9	28.6	9.8	6.1	27.0	19.9	9.3	6.7	12.8	23.4	15.9	25.0	12.4	10.2	32.2	15.3	12.0	18.2	24.0	14.7	15.3	15.8	4.9	5.2	9.4	13.7	13.1	10.7	6.2	16.1	10.5	14.1	8.6	54.8	11.2	17.1	9.1	11.1	22.6	7.1	18.8	8.2	19.6	2.4	9.2	4.6	5.4	21.2	6.1	12.5	14.3	42.7	12.4	30.7	13.7	9.3	5.4	10.1	17.3	10.1	15.6	4.5	8.7	7.0	30.1	16.3	8.6	3.0	33.6	21.3	4.6	9.2	6.9	10.4	21.3	16.9	8.0	44.3	8.8	5.3	7.0	6.1	9.1	3.1	19.6	11.6	9.8	11.3	13.9	6.9	11.3	12.9	12.0	10.4	18.2	12.6	27.1	13.6	12.2	15.3	32.2	14.7	12.9	5.8	24.0	16.8	14.9	13.7	15.3	4.9	5.7	4.2	6.7	5.1	7.0	5.3	4.3	6.2	6.7	20.8	28.1	41.2	17.9	14.3	6.6	4.1	10.2	22.7	26.1	22.7	11.8	31.6	11.6	37.2	0.4	30.6	61.6	23.3	42.8	115.3	23.2	36.2	23.1	16.3	41.3	6.4	22.4	22.1	24.0	1.1	12.4	30.6	27.0	43.3	113.0	6.2	34.6	38.6	5.3	20.4	6.7	6.5	21.7	9.3	5.2	16.2	52.5	27.4	43.3	33.3
DPM3	"MGC125904, MGC125905, MGC34275"	ENSG00000179085	"Dolichyl-phosphate mannosyltransferase subunit 3"	Q9P2X0	1	155139891-155140595	"Disease related genes, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014667	Approved					NA	NA		160000			"HPA014667: AB_1847848"	"unprognostic (6.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.83e-3)"	"unprognostic (4.71e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (1.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.64e-4)"	21.6	32.2	18.8	14.6	21.3	21.8	28.4	13.0	20.7	25.9	36.1	14.6	43.4	31.0	23.4	42.9	19.6	25.1	31.7	26.1	17.4	18.0	23.9	42.5	19.2	17.9	18.1	15.3	19.9	62.6	9.2	32.7	12.4	14.3	22.3	9.9	23.7	42.1	44.8	29.6	13.4	23.4	23.3	15.1	20.0	24.2	21.5	12.2	13.1	47.0	22.2	11.9	17.3	18.1	43.3	49.6	40.4	45.2	36.4	42.1	37.6	22.6	25.3	7.9	18.6	14.6	13.6	8.5	7.5	9.5	10.1	10.6	8.0	26.8	7.3	23.0	6.1	3.4	16.3	3.0	8.7	1.2	10.4	52.3	8.1	37.6	27.1	13.8	7.2	10.8	13.4	16.1	7.3	3.1	4.9	11.7	18.5	9.0	39.4	7.5	54.9	15.9	16.6	19.6	26.6	19.7	13.8	9.0	43.7	12.1	15.7	13.9	28.7	17.0	20.3	27.0	3.0	14.0	35.2	9.3	6.3	15.2	8.9	10.8	33.5	16.9	21.9	16.5	15.7	4.7	20.3	45.2	40.4	38.8	27.8	42.1	43.3	41.4	37.9	43.7	41.8	39.7	37.9	25.0	36.4	27.6	49.6	32.6	37.6	18.8	21.3	13.0	20.7	17.4	18.0	18.1	15.3	14.3	12.2	47.6	64.3	56.3	56.1	24.4	27.7	97.4	104.4	92.3	59.1	167.5	9.8	59.1	56.3	50.1	36.1	63.7	136.5	0.0	141.2	58.3	64.6	65.2	69.3	221.9	77.0	12.7	95.4	77.3	64.8	9.5	85.7	58.5	92.8	28.9	187.9	74.4	61.4	155.6	91.9	122.9	22.5	38.8	60.8	23.6	10.6	29.5	34.1	44.9	139.7	53.3
KRTCAP2	KCP2	ENSG00000163463	"Keratinocyte associated protein 2"	Q8N6L1	1	155169408-155173475	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.57e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (7.81e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.70e-11)"	"unprognostic (3.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.94e-3)"	43.7	39.6	25.5	30.1	28.8	27.7	71.1	14.4	27.4	49.9	39.6	26.9	64.5	30.1	47.3	69.0	39.2	35.4	53.1	54.5	25.3	26.9	52.5	71.9	40.2	72.8	28.4	23.0	46.3	144.2	27.2	42.0	49.1	29.8	40.5	35.8	35.8	87.6	91.5	38.2	27.4	44.8	40.3	34.5	38.4	42.1	46.4	21.5	42.6	74.8	36.0	41.8	37.5	37.3	69.6	121.1	74.4	51.5	43.7	77.3	62.3	22.9	42.1	20.1	22.5	60.8	42.9	21.0	27.5	32.5	32.5	26.5	52.2	45.8	17.8	44.3	50.7	19.2	31.2	22.1	31.4	20.5	24.7	47.1	19.5	47.1	25.9	56.5	38.5	21.1	40.5	71.8	37.5	49.1	25.2	29.0	35.2	28.2	83.0	33.0	77.7	17.9	36.3	20.1	80.9	56.6	22.7	13.0	95.5	48.1	34.6	31.8	20.3	27.8	48.4	29.7	30.8	36.1	25.5	19.1	20.5	19.5	17.8	26.2	46.5	35.9	28.6	35.0	27.9	22.9	74.4	51.5	50.7	68.1	40.9	76.8	69.6	77.3	71.9	53.6	60.2	58.9	63.3	22.4	43.7	33.6	121.1	70.3	62.3	25.5	28.8	14.4	27.4	25.3	26.9	28.4	23.0	29.8	21.5	65.5	91.4	132.0	46.6	56.1	13.2	1.0	170.7	168.6	108.1	197.1	3.9	69.0	38.1	180.8	194.5	164.1	160.7	70.0	259.6	175.7	160.0	45.7	83.1	218.4	144.7	7.9	126.6	183.0	173.2	53.9	211.5	152.7	239.6	85.6	209.2	30.2	227.0	198.6	154.5	134.1	9.9	116.4	109.9	280.1	70.9	79.2	78.7	132.0	157.9	49.3
TRIM46	"FLJ23229, TRIFIC"	ENSG00000163462	"Tripartite motif containing 46"	Q7Z4K8	1	155173787-155184971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4;epididymis: 11.0"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 5.3;Early spermatids: 4.7;Late spermatids: 4.2;monocytes: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055583	Enhanced					NA	NA					"HPA055583: AB_2732599"	"unprognostic (1.06e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (2.61e-7)"	"unprognostic (1.75e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.65e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-12)"	"unprognostic (8.58e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-2)"	1.3	1.7	6.0	2.4	12.6	1.7	1.7	21.4	15.5	1.7	1.2	6.5	0.0	1.6	3.4	11.0	1.1	2.9	2.0	1.0	7.8	7.4	1.1	0.9	1.7	2.3	5.1	7.3	1.0	2.1	0.8	4.5	1.1	7.4	1.7	1.4	0.5	0.9	3.6	1.0	1.2	1.8	3.9	5.8	1.8	1.6	2.5	3.5	6.7	0.9	0.0	1.7	1.3	0.8	0.4	0.5	1.5	0.4	0.8	3.0	0.6	2.0	2.8	2.1	0.2	0.4	1.7	0.1	2.1	2.2	2.5	3.0	0.0	1.2	0.9	1.5	2.4	0.5	2.4	0.0	1.0	0.7	5.0	0.9	1.7	3.0	0.1	1.1	0.5	6.2	1.9	0.5	2.6	0.9	6.2	3.8	5.5	0.0	4.4	1.3	1.4	3.3	0.3	7.6	0.3	3.1	5.1	0.2	1.0	0.6	0.0	5.7	13.0	0.9	0.7	1.5	0.8	4.1	4.1	4.5	4.9	1.9	0.3	1.0	4.1	1.6	0.8	5.2	0.8	1.4	1.5	0.1	0.1	1.2	0.4	1.1	0.3	2.1	2.0	0.2	0.4	0.8	1.0	0.8	0.8	0.3	0.5	3.0	0.6	6.0	12.6	21.4	14.2	7.8	7.4	5.1	7.3	7.4	3.5	0.0	0.0	0.0	0.8	0.3	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.7	0.5	0.0	0.0	0.2	0.0	0.5	0.5	0.0	0.0	0.8	0.0	1.7	0.6	0.0	4.2	0.3	0.0	0.0	4.6	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.4	0.4	0.0	0.0	1.0	0.0	0.5
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA		4900000	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.4	0.7	1.9	0.0	139.4	0.0	10.1	1.1	0.3	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	1.5	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	65.3	0.2	0.2	0.0	3.4	107.0	0.1	0.6	0.2	3.3	5.9	0.1	0.5	47.0	0.6	0.2	0.4	0.8	1.3	0.1	2.1	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5	402.0	1308.2	0.9	16.1	0.6	1.0	0.4	384.7	92.3	252.5	465.9	3.9	0.1	29.9	144.7	27.3	3.5	49.2	0.0	994.6	1.2	3.1	11.6	45.2	0.5	0.2	1.6	29.4	1.3	3.4	68.9	2.3	2.6	5.0	42.3	249.7	1.1	807.2	66.2	1.4	0.9	0.2	0.0	1.9	6.2	0.8	1.0	0.2	0.0	132.5	164.3
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"Early spermatids: 241.6;Late spermatids: 766.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		4100000	Vesicles		"HPA006293: AB_10602898, HPA073242: AB_2732223"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	10.5	5.5	6.2	12.2	19.5	5.4	15.4	4.7	10.0	20.7	12.6	8.5	8.2	3.4	34.4	24.7	15.1	13.8	19.2	14.4	5.8	3.3	10.1	8.1	8.5	3.2	9.5	6.1	17.5	11.4	12.8	9.5	8.6	7.0	11.4	7.5	8.1	7.5	11.4	5.7	12.9	8.0	24.5	6.1	6.4	8.1	8.3	4.2	1.1	14.3	23.5	7.4	14.4	11.4	1.7	3.5	2.2	4.1	0.9	4.3	2.0	1.4	3.6	13.3	13.5	7.3	8.5	0.8	6.1	9.1	2.8	5.2	0.4	11.0	1.0	6.9	13.4	0.8	3.6	0.3	2.3	2.1	2.4	0.8	0.8	3.9	0.5	7.8	0.7	1.8	14.6	8.1	4.2	5.8	36.1	5.1	2.2	0.7	2.1	2.5	5.3	0.5	1.3	3.0	3.1	1.8	11.8	0.5	2.3	5.9	3.7	19.7	11.2	1.5	3.0	3.1	20.1	8.9	1.8	3.9	9.5	2.2	1.7	2.1	5.2	0.6	0.2	8.6	0.7	0.8	0.0	4.1	1.6	1.8	2.2	1.1	1.7	2.7	2.2	3.5	0.9	3.0	1.0	2.2	0.9	0.7	0.5	4.3	2.0	6.2	19.5	4.7	10.0	5.8	3.3	9.5	6.1	7.0	4.2	0.0	14.7	0.0	2.1	7.0	2.7	1.2	2.5	2.7	1.2	0.0	0.0	1.1	1.7	3.7	241.6	6.3	2.6	0.0	2.3	1.5	11.7	2.2	0.0	3.9	10.0	7.9	4.6	1.8	4.8	766.9	21.6	4.9	10.1	1.0	4.8	1.7	4.0	2.9	9.6	2.8	2.7	0.0	8.1	21.2	2.5	4.5	1.1	0.7	3.1	1.3
MTX1	"MTX, MTXN"	ENSG00000173171	"Metaxin 1"	Q13505	1	155208699-155213824	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 517.8;Late spermatids: 1060.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011543	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA011543: AB_1853824"	"unprognostic (2.57e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-2)"	15.4	19.8	11.6	9.9	12.6	22.9	15.8	5.7	18.1	15.8	15.9	12.2	14.8	12.4	14.9	13.9	18.0	21.4	13.5	11.8	10.8	10.0	24.4	36.4	12.8	18.7	11.8	12.9	14.0	26.3	23.4	12.0	28.4	11.7	12.3	12.7	14.6	20.7	19.2	10.4	13.8	13.7	12.7	10.2	17.1	14.7	60.0	9.0	14.5	19.3	14.3	18.0	11.6	11.5	14.4	23.1	43.8	26.8	12.2	14.0	14.4	17.4	28.7	9.2	13.1	17.2	15.5	29.1	9.0	18.3	26.9	18.8	35.7	29.2	14.4	29.9	20.7	8.5	17.5	13.5	25.5	9.8	10.5	31.7	9.1	23.0	34.4	27.2	16.8	12.9	19.8	23.9	27.7	18.7	10.3	23.7	21.3	18.4	7.2	15.9	42.3	18.8	21.2	18.3	24.8	33.4	15.5	5.8	34.1	24.2	15.1	15.0	18.7	11.2	35.6	10.3	14.7	28.8	27.3	9.8	12.9	14.5	8.5	15.1	13.9	11.5	14.6	17.0	8.6	13.7	10.2	26.8	6.3	9.8	13.7	9.2	14.4	12.1	10.3	23.1	12.4	12.1	10.9	43.8	12.2	7.9	12.4	14.0	14.4	11.6	12.6	5.7	18.1	10.8	10.0	11.8	12.9	11.7	9.0	8.9	17.1	31.2	37.1	18.0	0.0	1.1	30.6	36.1	9.1	33.2	0.0	91.6	82.9	61.0	517.8	26.4	34.8	0.0	73.6	112.1	34.7	39.6	26.5	48.6	89.5	0.0	19.0	20.9	42.2	1060.3	40.0	30.1	47.2	74.9	33.2	0.0	60.6	41.8	37.1	103.2	0.0	45.3	25.4	80.9	35.8	18.3	74.1	22.4	48.1	34.2
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 101.2"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		200000			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	19.2	29.7	14.8	13.9	24.5	21.9	15.3	8.7	33.4	16.5	20.1	25.2	18.1	13.8	16.9	30.4	18.9	12.7	16.5	13.6	15.8	18.9	31.8	24.6	17.9	15.4	18.5	16.5	13.1	19.2	101.2	32.1	46.2	28.1	14.4	23.5	25.3	22.3	24.3	6.0	21.6	16.6	17.7	19.3	24.5	14.6	9.7	13.1	13.7	22.2	8.7	17.5	16.3	15.2	7.3	13.9	17.9	22.3	6.6	14.0	12.4	8.5	16.6	5.9	8.0	62.2	13.7	6.8	15.2	54.1	22.7	28.7	9.7	31.5	5.9	16.9	35.6	36.4	17.5	8.3	10.8	12.1	12.5	5.8	4.9	11.0	5.2	17.8	5.8	20.8	17.9	9.1	47.7	7.2	24.0	20.1	5.2	5.2	10.1	26.6	18.6	7.2	2.7	3.8	14.1	11.8	6.1	9.7	24.4	15.2	6.6	5.7	7.8	13.3	31.9	33.7	11.4	23.9	14.2	15.3	17.1	7.6	21.4	12.1	20.2	17.0	4.6	29.9	5.3	13.1	12.2	21.6	9.1	13.4	22.3	8.7	7.3	10.3	9.0	13.9	5.5	7.4	7.8	17.9	6.6	21.2	7.8	14.0	12.4	14.8	24.5	8.7	33.4	15.8	18.9	18.5	16.5	28.1	13.1	3.0	3.2	4.5	5.7	5.4	3.4	7.9	17.8	6.7	2.3	12.2	2.0	27.5	3.3	26.2	1.1	11.3	17.3	0.0	28.1	23.9	12.9	8.2	6.9	20.7	57.7	4.8	14.0	20.9	39.9	2.2	9.2	13.9	25.3	28.9	13.1	13.2	25.6	19.8	8.5	17.0	5.4	0.0	6.7	4.8	5.7	3.9	49.7	9.6	11.6	4.3
FAM189B	"C1orf2, cote1"	ENSG00000160767	"Family with sequence similarity 189 member B"	P81408	1	155247205-155255483	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006659, HPA050674"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006659: AB_1078339, HPA050674: AB_2681213"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.86e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.43e-7)"	"unprognostic (4.16e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.25e-2)"	18.7	13.5	18.8	12.0	17.3	6.4	20.1	18.3	18.4	11.2	16.9	5.6	16.6	14.4	14.8	6.9	14.7	10.9	13.9	10.3	15.2	11.0	11.0	10.1	10.1	7.8	10.1	16.3	11.6	11.8	15.9	13.2	11.0	19.7	12.3	8.1	7.2	13.9	18.7	41.1	12.9	12.5	17.1	13.0	9.7	13.6	10.3	11.2	3.8	8.9	10.8	7.2	18.6	19.3	0.2	0.2	0.1	0.3	1.2	0.8	0.3	12.6	9.5	8.6	16.2	8.2	11.3	2.5	10.8	8.1	8.1	7.0	10.7	6.8	10.9	16.8	8.2	4.7	12.8	10.2	10.3	3.8	15.5	23.0	7.8	8.0	6.2	11.0	2.5	9.1	10.4	6.5	8.2	7.7	9.4	10.7	6.6	6.5	4.6	6.3	6.8	11.2	3.9	10.8	10.6	23.0	11.6	6.4	12.3	5.5	3.4	12.3	16.5	5.0	18.0	12.6	5.5	14.8	9.8	9.1	7.5	10.4	8.6	11.6	9.9	9.8	5.8	9.1	4.6	6.2	0.0	0.3	0.0	0.1	0.3	0.8	0.1	0.4	0.2	0.2	0.2	0.0	0.2	0.1	1.2	0.0	0.2	0.0	0.3	18.8	17.3	18.3	18.4	15.2	11.0	10.1	16.3	19.7	11.2	3.0	2.1	7.5	10.8	5.4	15.2	10.7	5.1	5.3	2.3	12.2	17.7	10.6	1.7	12.3	3.2	12.6	7.1	0.0	9.0	13.3	7.3	10.3	5.7	5.9	6.9	38.1	6.4	14.1	9.7	4.2	8.9	4.0	6.8	4.6	8.6	7.2	9.9	3.5	8.5	4.8	16.5	0.0	9.8	17.7	6.6	7.2	12.0	3.8	9.2	10.4
SCAMP3	C1orf3	ENSG00000116521	"Secretory carrier membrane protein 3"	O14828	1	155255979-155262430	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071167			Supported	Vesicles		NA	NA			Vesicles		"HPA071167: AB_2686352"	"unprognostic (4.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.18e-2)"	23.6	41.8	21.0	20.8	25.6	16.8	28.8	22.5	35.5	21.9	19.0	36.1	26.8	24.1	20.7	17.8	27.1	21.9	21.5	37.8	19.8	20.2	33.3	40.8	23.4	25.5	27.1	26.3	22.6	41.5	41.5	20.0	37.0	26.2	23.0	17.3	26.0	33.0	28.1	45.3	30.0	20.9	18.9	30.4	27.0	24.4	14.5	26.4	21.6	27.3	23.6	27.3	23.9	20.8	32.2	32.5	25.6	35.0	29.9	28.7	30.0	13.9	30.0	9.1	18.1	22.2	17.4	9.3	16.8	19.9	19.0	17.9	16.4	19.9	12.9	25.1	19.5	18.6	21.8	13.1	12.7	7.0	17.7	24.0	9.1	19.6	13.3	22.2	17.1	15.5	15.3	16.3	23.8	10.9	12.6	15.8	13.3	16.2	31.4	20.5	27.9	15.8	15.9	17.5	24.0	32.9	13.6	7.4	39.8	11.3	12.5	11.8	23.8	11.7	27.4	19.4	9.0	29.6	26.8	12.9	21.4	12.1	22.0	24.8	41.8	38.8	16.1	21.0	18.4	24.6	25.6	29.0	23.2	28.7	31.1	25.6	32.2	26.6	26.8	31.6	30.5	24.6	26.3	2.6	29.9	35.0	32.5	26.6	30.0	21.0	25.6	22.5	35.5	19.8	20.2	27.1	26.3	26.2	26.4	14.9	36.2	29.6	20.5	34.0	17.4	31.9	28.1	20.1	28.4	31.4	3.9	72.8	8.3	46.2	1.4	29.2	26.9	0.0	60.3	45.7	27.2	20.1	24.3	33.4	50.8	17.5	28.9	28.8	21.0	4.3	15.8	24.5	23.6	54.1	21.9	20.0	40.9	24.3	17.7	21.2	10.5	12.9	21.7	10.7	3.4	35.0	59.6	32.4	24.2	19.7
CLK2	clk2	ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	15.3	16.6	14.6	15.0	19.0	12.9	17.1	33.1	20.2	22.3	18.0	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17.0	13.5	27.0	13.7	13.7	20.3	18.1	22.9	8.0	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	5.9	5.1	18.7	5.7	9.4	5.1	16.0	5.3	6.5	4.1	4.2	5.4	4.3	13.0	7.4	3.6	2.2	8.6	9.3	6.9	3.9	9.4	7.3	10.3	5.4	6.9	8.1	12.8	10.4	4.1	6.4	6.0	12.2	11.9	7.2	11.1	14.5	9.0	6.2	10.3	8.7	7.6	12.2	15.0	7.3	9.7	11.3	13.9	10.5	13.4	8.9	12.7	2.0	6.4	4.9	14.7	9.8	15.7	4.7	2.5	6.8	4.6	4.4	17.2	14.7	11.8	5.1	9.2	2.9	4.8	1.7	3.4	2.0	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19.0	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3	14.9	22.4	4.8	4.8	4.0	5.8	13.3	12.7	4.0	18.2	7.0	3.9	6.8	0.0	5.2	6.3	8.3	4.3	0.0	3.8	7.3	7.2	3.9	9.3	5.8	6.0	4.8	6.4	8.0	10.5	5.4	7.2	5.8	3.3	7.2	7.9	5.4	4.4	3.5	2.8	2.8	5.7	6.5	3.3	8.3	3.8	4.0	10.4	4.4	6.3	4.3
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277583-155289848	"Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved					NA	NA					"HPA026584: AB_1850534"	"unprognostic (1.04e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (6.93e-4)"	1.6	3.5	4.5	2.0	7.5	1.5	2.1	20.3	9.5	3.6	4.4	3.3	3.6	7.7	4.5	2.1	3.9	2.2	3.0	1.6	4.0	8.2	4.4	10.2	1.9	2.3	4.1	8.5	4.7	4.7	6.4	12.6	2.4	9.5	2.7	5.0	4.0	4.4	3.6	1.1	9.2	6.6	2.8	3.0	1.9	3.2	1.7	2.1	1.6	2.6	1.3	3.0	2.3	3.6	0.3	0.0	0.0	0.1	0.0	0.6	0.0	1.6	1.8	7.9	3.2	1.3	1.5	1.9	1.3	1.2	1.6	1.9	2.8	5.5	1.5	1.1	1.0	3.4	6.9	2.2	1.0	0.9	2.1	2.8	0.6	5.1	1.8	0.5	0.6	1.6	0.9	1.0	1.1	0.2	1.8	0.3	2.5	3.7	4.4	1.9	2.2	1.1	0.6	2.7	4.2	2.1	3.9	1.9	2.9	2.2	1.7	6.5	4.6	1.2	1.6	0.5	1.5	2.8	1.3	0.1	1.9	1.7	4.0	1.2	1.4	0.6	1.3	1.5	1.1	1.7	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.5	20.3	9.5	4.0	8.2	4.1	8.5	9.5	2.1	0.0	1.1	0.0	0.6	1.1	2.4	0.8	2.5	0.0	1.2	1.8	3.9	0.3	0.0	0.9	0.1	0.0	4.6	0.0	0.3	0.3	1.3	0.8	1.1	1.5	0.7	0.0	4.1	3.1	0.0	0.4	0.9	1.3	0.0	1.0	2.3	1.4	0.9	2.9	1.1	0.8	1.8	0.0	0.3	1.5	2.1	2.4	0.0	0.5	3.8	0.9
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"K-562: 48.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA		2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	36.0	19.6	72.1	26.0	16.9	62.0	25.7	17.2	34.1	27.5	44.8	31.7	85.9	27.5	41.9	15.0	65.7	40.3	42.9	149.6	25.8	15.0	30.7	15.9	35.0	38.3	27.8	25.8	18.3	44.1	23.7	43.7	22.0	12.5	47.9	40.8	28.5	74.2	28.6	38.7	33.0	25.1	43.3	26.8	28.7	28.5	31.3	76.3	72.5	24.1	28.1	24.0	17.7	32.3	29.7	42.9	23.3	70.2	34.8	15.4	18.9	9.5	31.4	31.5	24.2	49.1	15.0	27.6	24.2	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5	68.5	144.0	64.8	78.5	32.6	65.5	1.4	107.0	85.6	83.0	50.6	58.9	177.4	116.0	154.2	171.3	113.0	197.2	93.5	286.2	162.6	57.3	89.5	62.2	111.9	95.6	52.4	68.5	133.8	57.6	52.3	56.4	56.4	91.1	217.4	74.5	75.0	194.9	143.8	66.1	113.5	78.0	71.1	63.8	41.9	15.5	52.2	120.0	77.8	106.3	110.3
RUSC1	NESCA	ENSG00000160753	"RUN and SH3 domain containing 1"	Q9BVN2	1	155320896-155331114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028510, HPA029922, HPA029923"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288"	"unprognostic (1.98e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.78e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (9.24e-6)"	"unprognostic (7.59e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.40e-1)"	10.9	15.9	24.8	8.7	24.1	8.9	12.2	46.1	45.4	16.6	20.2	5.6	9.2	17.5	13.0	7.4	21.8	12.4	13.6	12.2	18.5	22.3	12.9	4.9	11.0	7.4	14.4	26.4	13.3	12.5	11.5	21.5	14.7	26.1	16.3	19.0	8.7	18.1	18.1	8.7	22.7	19.5	15.3	8.9	7.6	14.2	3.1	6.2	12.6	8.4	11.4	8.8	12.1	16.1	3.4	7.5	5.1	18.9	2.6	6.4	4.2	22.7	14.4	8.3	12.2	10.3	11.3	16.1	10.9	7.0	14.4	16.2	16.5	15.1	4.5	8.3	11.0	8.2	31.8	12.8	15.8	6.2	6.1	16.4	6.4	14.3	8.6	8.5	6.4	11.2	11.5	10.0	14.4	5.0	7.0	14.8	9.9	9.7	3.1	12.4	43.4	8.0	8.2	16.3	42.0	23.0	10.9	5.8	7.9	13.5	17.4	8.6	14.0	9.2	25.9	5.5	14.1	38.6	11.0	6.7	18.6	15.4	17.4	21.5	2.5	5.6	2.7	13.0	8.6	5.0	5.1	6.8	3.2	5.8	8.1	6.4	3.4	4.7	5.8	7.5	1.5	2.6	5.5	0.9	2.6	18.9	7.1	4.7	4.2	24.8	24.1	46.1	45.4	18.5	22.3	14.4	26.4	26.1	6.2	8.9	10.1	10.9	16.6	24.8	14.6	9.0	10.2	6.7	18.2	17.4	5.9	25.0	19.9	19.9	0.3	23.5	60.7	0.0	15.6	61.6	23.7	24.2	8.1	6.4	18.6	35.0	15.0	12.9	10.4	0.0	17.0	11.5	18.6	10.0	42.2	12.8	20.4	37.4	17.0	22.0	6.6	19.4	21.7	1.8	7.2	30.6	31.8	13.8	33.3	22.1
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155562807	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	20.1	10.1	12.1	17.7	14.5	12.3	14.5	23.6	15.5	15.4	17.7	15.5	20.4	8.2	18.7	12.5	12.5	12.2	10.0	11.0	11.8	10.6	13.0	8.9	10.6	9.4	16.6	11.5	23.5	10.0	24.4	22.6	12.9	13.2	18.9	10.7	10.7	11.8	22.2	21.8	12.8	12.8	17.4	14.5	8.6	10.4	7.8	14.3	15.6	16.8	7.1	10.6	17.8	19.9	11.0	5.7	16.5	5.3	8.6	10.7	1.7	13.6	11.7	7.7	6.6	17.4	18.7	8.7	11.1	11.6	7.6	6.4	8.7	9.1	6.1	11.2	14.5	5.8	14.2	12.1	9.7	12.0	6.0	7.8	7.5	11.6	4.7	8.4	8.3	5.9	11.5	10.8	12.7	12.5	11.5	9.0	6.0	10.7	9.2	12.6	10.7	5.6	4.5	7.3	17.0	11.4	5.2	15.9	7.0	8.4	15.1	7.9	11.7	17.5	15.8	8.6	8.4	12.7	18.2	13.8	11.7	12.6	11.1	13.6	8.6	4.9	9.7	9.1	6.3	10.1	16.5	5.3	11.0	8.3	3.2	7.9	10.0	7.8	6.3	2.5	11.0	10.7	5.5	12.8	8.6	3.5	5.7	8.6	1.7	12.1	14.5	23.6	15.2	11.8	10.6	16.6	11.5	13.2	14.3	56.6	88.1	42.2	92.1	92.3	138.8	87.3	43.3	45.5	96.7	48.8	190.5	40.3	14.9	37.0	14.5	82.3	61.6	23.3	34.5	22.1	98.4	94.0	78.6	28.8	21.6	108.1	64.8	59.5	40.8	12.1	94.6	55.1	50.6	62.3	49.5	77.4	31.8	59.1	111.7	23.9	119.9	97.0	97.6	85.7	46.2	97.9	63.7	68.9	46.6	109.1
MSTO1	"FLJ10504, LST005, misato, MST"	ENSG00000125459	"Misato 1, mitochondrial distribution and morphology regulator"	Q9BUK6	1	155610205-155614967	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	30	"Early spermatids: 324.7;Late spermatids: 974.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005899, HPA005914"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA005899: AB_2667460, HPA005914: AB_2667466"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.28e-1)"	9.5	5.8	3.5	5.0	3.8	3.0	6.9	5.3	4.2	5.1	3.9			4.6	6.8	10.6	4.8	6.3	3.5	4.6	4.4	4.3	5.7	11.5	4.6	5.6	4.3		6.9	8.3	9.6	8.9	4.3		7.4	4.8		4.8	9.3	1.6	4.5	4.9	6.6	2.9	7.5	4.6	7.1			7.9		5.2	3.8	4.0	7.6	8.3	3.1	8.0	8.8	10.9	6.3	12.2	15.8	15.0	22.8	12.9	10.1	17.6	15.0	13.4	19.3	15.2	16.7	7.9	20.3	14.9	13.6	11.9	13.6	21.5	20.7	13.7	8.3	18.2	18.4	15.2	9.7	20.2	19.6	15.3	10.8	11.0	21.5	31.9	9.0	16.1	15.4	14.6	9.7	16.0	20.0	12.4	13.7	19.1	20.6	21.9	11.5	13.7	19.2	16.2	12.4	12.5	15.0	11.3	33.1	14.0	17.7	18.8	25.7	10.7	12.9	13.7	13.2	23.5	20.8	17.0	15.5	14.2	18.6	16.2	3.1	5.7	0.2	10.4	8.0	10.9	7.6	9.7	9.7	8.0	5.5	10.6	6.3	0.5	8.8	5.0	8.3	6.8	6.3											6.0	5.9	7.5	4.2	2.4	9.1	8.7	5.1	13.4	5.7	7.0	21.6	6.7	3.3	7.9	324.7	6.4	2.1	0.0	11.6	19.0	5.5	4.0	13.9	6.2	7.6	11.1	5.2	1.8	2.7	974.9	8.3	6.0	3.3	10.0	3.4	3.7	6.8	0.0	10.6	6.9	9.8	0.0	4.7	18.6	13.2	1.3	5.5	5.0	3.7	2.5
YY1AP1	"HCCA2, YAP, YY1AP"	ENSG00000163374	"YY1 associated protein 1"	Q9H869	1	155659443-155689000	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006986, HPA064249"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA006986: AB_1080620, HPA064249: AB_2685226"	"unprognostic (1.96e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (6.81e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.84e-2)"	18.6	15.1	21.1	20.3	22.2	35.9	19.5	29.1	27.3	20.5	24.4	20.5	12.4	12.3	21.9	22.0	21.8	19.2	19.9	29.0	16.8	13.6	14.5	18.7	21.6	18.7	18.9	17.2	23.9	20.1	23.6	20.1	18.0	18.1	18.1	19.7	19.2	18.6	21.6	52.4	22.8	16.3	23.5	14.8	17.3	18.1	50.1	20.7	24.4	18.3	18.8	25.8	22.0	20.0	17.8	22.3	31.9	18.0	26.9	25.5	20.5	24.1	12.6	16.2	18.4	18.4	16.7	34.9	15.7	23.0	28.4	24.3	19.3	26.1	19.3	15.5	23.0	14.6	24.0	24.3	21.9	26.8	17.9	12.2	16.2	14.9	12.1	19.5	25.3	22.0	17.7	22.6	21.5	26.7	19.8	17.5	18.9	21.0	27.6	20.7	21.7	25.9	12.5	25.5	33.2	18.6	20.7	14.0	30.7	17.3	17.9	16.3	19.4	20.7	30.1	20.0	30.7	32.4	41.9	14.2	16.0	14.2	16.7	20.7	35.7	23.4	48.2	15.8	16.7	18.3	22.2	17.8	31.9	24.2	18.0	25.3	17.8	20.9	25.3	22.3	13.9	18.3	18.2	19.6	26.9	16.6	10.4	25.5	20.5	21.1	22.2	29.1	27.3	16.8	13.6	18.9	17.2	18.1	20.7	17.9	26.1	14.1	26.3	30.8	22.8	20.7	20.4	16.0	21.6	12.2	41.2	20.0	11.6	15.0	56.6	23.2	21.3	0.0	16.6	23.6	21.6	23.5	24.3	18.8	18.8	15.9	33.6	16.0	21.9	62.5	25.9	23.2	18.6	20.8	22.5	20.4	14.2	14.4	24.1	9.6	24.3	6.5	24.7	66.3	20.6	31.1	37.6	20.8	21.9	27.8
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.4	21.1	17.2	27.3	25.5	32.3	42.5	27.4	29.0	28.2	24.7	38.9	40.0	46.3	55.9	22.3	18.1	33.2	25.6	23.9	30.8	29.0	18.7	28.2	18.8	35.2	34.9	38.6	25.2	27.0	34.3	35.9	47.6	22.1	27.7	43.0	60.9	33.0	29.3	43.2	33.9	45.2	30.5	51.1	34.5	28.0	21.6	49.2	33.5	31.2	20.1	35.6	26.3	77.6	47.2	33.4	48.2	63.5	23.6	24.0	25.3	29.6	45.9	36.1	53.9	53.4	23.9	34.6	30.8	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1	41.7	35.8	49.1	58.4	48.8	26.0	99.7	45.9	68.3	58.0	15.7	19.6	67.1	56.3	62.2	13.1	35.0	35.4	93.5	68.2	87.5	44.8	51.6	61.1	48.1	67.9	12.7	24.6	34.4	47.0	10.6	30.0	61.0	33.7	88.4	35.3	13.3	67.0	31.6	23.7	57.4	46.0	12.9	47.2	38.7	26.6	55.2	118.4	64.7	54.9	62.6
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749662-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696"	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	17.4	12.5	13.5	16.1	18.9	13.6	18.3	30.1	21.6	17.6	15.7	14.4	18.7	11.8	25.8	18.3	13.7	15.9	12.0	14.0	14.8	10.2	14.9	12.7	16.7	18.3	14.8	13.0	17.2	16.3	26.0	22.3	15.9	15.3	16.1	15.4	16.3	15.2	15.8	18.8	17.8	17.5	18.3	16.5	21.1	15.1	14.1	16.0	25.1	18.8	11.4	24.8	16.9	16.0	7.0	5.2	10.2	4.7	8.4	6.6	2.5	11.4	9.5	18.4	11.3	11.6	14.6	11.6	10.4	12.9	13.5	13.2	11.3	10.5	13.2	11.4	13.6	6.8	13.3	13.6	12.1	15.7	12.3	9.6	13.2	11.7	6.3	11.0	15.5	12.3	12.9	10.7	14.9	14.2	13.9	15.9	14.7	16.8	5.1	11.3	11.7	13.4	9.4	20.3	14.4	10.9	12.4	11.7	14.7	9.9	13.8	10.3	17.3	12.7	12.9	10.0	19.4	14.1	18.6	17.8	11.0	9.1	11.2	12.9	20.7	13.8	22.2	9.6	9.3	12.1	5.0	4.7	4.0	6.6	3.7	4.4	3.7	4.3	4.6	4.7	7.0	4.5	4.1	10.2	8.4	3.1	5.2	4.2	2.5	13.5	18.9	30.1	21.6	14.8	10.2	14.8	13.0	15.3	16.0	14.9	32.6	21.4	18.8	10.8	69.8	18.6	15.3	16.0	34.2	19.2	123.7	20.5	8.3	19.9	17.3	35.0	19.8	0.0	15.7	19.3	20.6	22.5	38.0	11.0	17.2	73.1	31.2	23.4	16.3	8.5	32.5	21.6	15.1	34.3	17.7	44.4	18.7	20.1	25.8	10.1	164.4	38.8	17.6	49.5	37.5	15.3	37.6	34.6	19.6	19.5
SYT11	"DKFZp781D015, KIAA0080, MGC10881, MGC17226"	ENSG00000132718	"Synaptotagmin 11"	Q9BT88	1	155859509-155885199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 148.3"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 79.9;Horizontal cells: 84.2;Muller glia cells: 149.4"	"Cancer enriched"	"Detected in all"	12	"glioma: 117.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 57.3;SCLC-21H: 22.9;SH-SY5Y: 24.9;U-87 MG: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064091	Enhanced					NA	NA					"HPA064091: AB_2685189"	"unprognostic (1.83e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (2.14e-1)"	"unprognostic (8.02e-3)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-3)"	6.0	13.3	34.4	6.2	52.0	3.3	2.7	35.4	148.3	9.3	5.1	44.5	0.0	3.4	11.5	8.6	4.7	5.2	7.9	8.9	32.9	32.3	4.5	2.4	6.0	7.2	35.9	32.2	9.6	3.2	2.4	11.8	7.0	48.3	8.7	5.4	4.4	2.6	11.3	2.8	2.3	4.3	12.7	42.0	6.9	3.8	4.7	29.0	0.0	2.8	0.0	6.5	7.3	3.3	1.6	5.6	4.1	6.1	5.8	14.4	5.7	0.0	0.2	14.7	0.3	10.8	5.7	0.0	2.7	7.4	2.9	5.3	0.0	0.4	2.8	1.2	9.8	4.5	0.2	1.2	0.0	4.4	13.7	0.2	2.7	0.4	0.0	3.1	1.5	8.5	3.6	0.0	10.5	0.2	16.6	9.3	0.1	0.0	57.3	3.9	0.0	0.1	0.7	9.6	0.0	0.0	0.5	1.5	0.0	0.4	0.0	22.9	24.9	0.4	0.0	3.3	0.3	0.0	0.3	6.9	5.5	3.5	3.7	3.4	15.3	7.4	5.8	27.6	0.0	4.2	4.1	3.8	0.1	14.4	4.8	4.0	1.6	7.6	9.9	5.6	1.4	0.8	7.8	2.1	5.8	6.1	0.3	13.3	5.7	34.4	52.0	35.4	59.4	32.9	32.3	35.9	32.2	48.3	29.0	0.0	0.0	1.7	0.1	0.5	79.9	9.7	0.0	1.4	0.0	1.8	21.6	0.0	0.0	0.8	0.0	13.5	0.0	0.0	0.9	0.1	3.1	0.2	11.5	0.0	4.7	84.2	4.6	2.5	7.9	0.4	2.6	7.9	3.3	12.6	0.0	149.4	2.3	0.0	14.9	0.8	12.7	19.4	8.2	1.1	1.1	0.9	0.0	7.1	0.0	0.2
RIT1	"MGC125864, MGC125865, RIBB, RIT, ROC1"	ENSG00000143622	"Ras like without CAAX 1"	Q92963	1	155897808-155911404	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"monocytes: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053249	Approved					NA	NA					"HPA053249: AB_2682089"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.64e-6)"	"unprognostic (3.80e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.33e-3)"	16.4	12.3	11.0	15.0	13.8	47.7	17.0	5.7	8.7	15.5	12.1	9.8	10.1	9.1	12.9	11.7	31.1	8.9	12.0	14.4	10.8	9.5	21.0	10.0	20.9	26.7	13.8	9.0	10.1	8.9	9.4	14.4	15.7	11.5	12.3	9.7	13.8	12.8	14.5	10.1	9.4	11.7	14.8	10.8	19.5	14.2	11.6	11.0	17.3	11.2	11.5	17.7	17.6	17.6	6.9	11.4	40.1	15.4	9.9	8.4	9.7	9.2	9.3	19.4	9.7	9.7	12.0	5.5	17.1	16.2	15.4	16.0	10.1	18.6	4.2	22.4	18.8	11.2	11.6	14.0	8.3	13.6	5.5	6.8	9.2	10.6	6.6	25.5	9.2	18.0	15.4	10.3	18.3	12.4	21.3	20.9	8.3	8.4	12.6	24.8	12.2	12.3	6.9	10.7	16.0	5.9	10.4	14.7	8.7	13.7	18.4	8.8	13.4	11.9	23.8	15.2	37.0	16.8	13.1	28.3	14.2	10.3	12.7	13.4	14.5	13.0	16.4	14.9	10.2	19.2	8.1	15.4	16.3	7.7	9.5	6.4	6.3	6.9	7.3	11.4	6.9	8.1	7.5	40.1	9.9	9.9	4.9	8.4	9.7	11.0	13.8	5.7	8.7	10.8	9.5	13.8	9.0	11.5	11.0	44.7	22.9	12.3	30.9	25.6	8.7	13.2	10.2	1.4	13.6	17.4	9.8	13.9	18.3	38.7	6.7	39.3	12.4	23.3	20.6	12.7	21.3	33.2	13.9	6.6	44.8	6.4	12.1	22.1	45.1	7.8	6.6	38.2	32.1	101.8	11.0	24.3	26.1	14.0	14.9	55.4	11.3	25.8	27.2	10.8	24.0	26.8	28.0	29.9	7.8	75.7
KHDC4	"BLOM7, KIAA0907, SNORA80EHG"	ENSG00000132680	"KH domain containing 4, pre-mRNA splicing factor"	Q7Z7F0	1	155913043-155934400	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 54.1;monocytes: 23.4;Syncytiotrophoblasts: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008796	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008796: AB_1079369"	"unprognostic (6.31e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.22e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.79e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (2.78e-10)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (4.36e-5)"	15.6	17.9	22.5	18.4	24.6	9.3	20.0	42.2	26.7	23.0	19.0	19.5	25.2	20.4	24.4	42.5	16.3	17.2	17.4	15.8	22.7	11.0	20.1	16.2	19.1	23.5	25.0	13.3	29.8	18.8	19.5	39.4	20.5	20.2	23.1	25.0	18.9	22.3	19.9	21.9	25.7	20.4	23.8	21.7	22.3	24.3	15.8	24.8	21.8	20.4	7.1	25.6	21.5	20.8	6.5	3.6	7.6	6.1	5.1	7.2	2.4	12.3	9.5	20.2	12.2	10.9	15.3	12.6	10.7	8.5	16.3	16.9	9.8	27.5	15.4	12.0	6.0	11.7	23.0	18.5	7.5	16.2	12.2	38.7	13.8	28.9	11.7	7.6	16.2	12.0	9.9	20.0	11.4	8.9	19.3	11.7	17.6	16.6	17.8	14.8	5.9	15.5	16.0	22.3	11.7	13.7	18.5	11.0	13.6	14.4	6.8	14.1	14.1	7.9	8.4	11.4	17.4	17.6	27.4	9.8	15.9	11.0	5.1	14.3	29.0	12.5	13.7	11.4	15.2	11.9	7.6	3.5	6.5	5.3	4.6	6.8	6.1	5.6	6.8	3.4	6.5	7.2	6.5	4.5	5.1	6.1	3.6	4.6	2.4	22.5	24.6	42.2	26.7	22.7	11.0	25.0	13.3	20.2	24.8	11.9	16.3	0.0	0.0	0.0	0.0	0.0	0.0	22.7	22.7	54.1	0.0	20.8	3.3	9.5	0.0	0.0	0.0	0.0	6.2	17.7	0.0	0.0	5.8	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	23.4	0.0	0.0	13.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0
RXFP4	"GPCR142, GPR100, RLN3R2, RXFPR4"	ENSG00000173080	"Relaxin/insulin like family peptide receptor 4"	Q8TDU9	1	155941710-155942949	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"blood: 1.8;bone marrow: 1.3;intestine: 5.4"	"Cell type enriched"	"Detected in some"	16	"Intestinal endocrine cells: 56.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;NB-4: 2.0;OE19: 2.7;SK-MEL-30: 1.9;T-47d: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.86e-2)"	0.2	0.0	0.0	0.5	0.1	1.3	0.1	0.7	0.0	0.0	5.2			3.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.4		0.1	0.1	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.2			0.0		0.0	0.6	0.0	0.6	0.4	1.8	1.4	0.7	0.8	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	1.1	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.3	0.5	0.2	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.2	0.1	2.0	0.2	2.7	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.9	1.9	0.0	2.1	0.0	0.6	0.1	0.0	0.0	0.0	0.1	1.2	0.6	1.1	0.2	0.1	0.0	0.9	1.8	0.0	1.1	0.0	0.0	0.5	0.8	0.4	0.6	0.0	0.1	1.1	0.7	1.4	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0
ARHGEF2	"GEF-H1, KIAA0651, LFP40, P40"	ENSG00000116584	"Rho/Rac guanine nucleotide exchange factor 2"	Q92974	1	155946851-156007070	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Mitosis, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043437	Approved					NA	NA					"HPA043437: AB_2678481"	"unprognostic (2.27e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.20e-6)"	"unprognostic (5.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.85e-3)"	"unprognostic (7.98e-2)"	19.8	6.2	20.6	24.5	33.2	36.2	19.1	36.2	42.8	14.3	19.6	44.8	8.3	12.5	17.6	10.8	12.8	19.1	20.6	19.2	26.4	13.9	10.9	5.9	41.4	28.9	30.2	23.7	14.2	6.4	12.8	7.4	21.1	19.8	11.2	19.4	10.4	12.2	10.9	8.6	7.2	17.1	20.1	46.2	30.0	23.4	11.4	26.0	32.5	19.0	7.1	21.6	18.4	14.8	11.7	13.9	24.7	15.7	8.4	12.8	16.4	7.5	6.2	10.9	7.4	10.4	13.2	11.2	16.9	21.9	16.7	17.9	5.5	5.7	18.9	10.4	12.9	8.8	11.1	6.5	5.4	12.7	7.6	5.6	24.9	9.6	3.3	41.3	32.6	21.8	15.4	22.4	24.8	30.6	12.6	13.6	14.7	13.8	23.2	23.5	4.2	16.3	44.3	12.0	12.8	4.1	17.9	15.2	32.0	7.0	4.5	17.9	8.2	7.3	10.7	58.2	11.3	11.1	45.0	17.8	14.4	8.3	12.5	21.5	38.6	39.2	13.3	20.6	16.5	35.3	10.0	14.7	12.2	12.8	13.9	8.9	11.7	8.1	9.1	13.9	11.1	8.1	9.0	24.7	8.4	15.7	6.7	7.5	16.4	20.6	33.2	36.2	42.8	26.4	13.9	30.2	23.7	19.8	26.0	35.7	76.2	51.1	20.4	13.5	54.3	4.4	7.6	5.3	12.5	15.7	2.0	2.9	6.6	13.9	41.4	29.0	13.1	0.0	4.6	18.0	27.5	13.4	27.6	0.2	27.1	1.6	29.3	14.7	35.7	11.4	10.6	36.3	23.6	97.4	17.2	13.7	11.4	22.0	9.6	1.7	2.4	58.2	41.8	2.8	3.3	12.0	2.9	25.8	12.7	34.0
SSR2	"TLAP, TRAPB"	ENSG00000163479	"Signal sequence receptor subunit 2"	P43308	1	156009048-156020959	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.93e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.55e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.28e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.30e-1)"	37.4	62.1	17.8	30.6	23.9	36.7	49.6	14.5	27.1	54.6	44.0	23.6	42.5	24.5	57.9	85.9	40.3	35.8	46.8	28.2	16.2	14.4	49.2	77.1	41.3	65.2	16.9	15.6	81.3	168.9	18.7	30.5	50.1	17.4	52.2	44.8	34.8	89.2	39.9	29.4	34.0	42.0	37.4	17.5	45.4	42.6	33.3	14.9	76.1	53.3	32.1	59.9	49.6	37.2	60.1	63.1	82.8	61.7	60.4	78.0	136.9	30.8	25.0	43.0	74.2	70.8	79.6	31.1	49.0	85.3	67.2	69.3	29.2	53.6	27.5	45.6	92.7	25.6	35.0	29.6	38.5	65.2	25.6	30.1	18.7	28.4	36.8	54.6	48.6	35.9	63.1	48.2	48.1	67.5	61.5	86.0	31.5	17.8	79.0	67.5	45.9	24.5	37.6	59.6	74.1	38.3	21.1	26.6	92.8	44.4	24.0	33.4	83.6	35.1	81.4	52.7	51.0	50.4	92.1	41.3	28.9	28.7	27.2	47.2	98.2	47.0	33.1	40.0	39.8	47.9	82.8	61.7	48.8	68.0	45.7	78.0	60.1	73.6	69.6	53.9	50.1	75.4	66.0	53.0	60.4	41.2	63.1	59.1	136.9	17.8	23.9	14.5	27.1	16.2	14.4	16.9	15.6	17.4	14.9	157.8	126.0	294.8	183.3	214.9	39.7	35.3	224.2	44.2	116.0	113.4	31.4	367.9	119.3	418.1	40.6	152.0	181.4	0.0	498.3	593.2	367.3	202.3	184.5	121.8	318.4	17.5	220.2	184.1	230.2	62.7	263.2	289.4	283.5	296.6	251.7	76.4	380.4	228.0	199.4	221.7	35.5	161.7	208.3	203.6	67.9	208.0	476.9	318.1	250.0	213.5
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035301-156053794	"Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	7.1	6.7	13.8	7.4	19.9	3.9	12.4	23.1	25.2	9.9	7.8	6.5	4.2	7.2	11.9	8.9	11.6	10.2	6.2	9.3	17.7	9.7	7.9	10.2	8.5	7.3	15.0	18.7	15.1	14.1	10.6	3.6	8.4	12.4	8.9	8.8	6.4	12.4	11.8	24.3	11.6	7.4	13.1	8.7	6.8	9.4	6.9	13.7	7.9	6.8	6.6	8.9	8.2	8.4	1.9	2.0	9.7	1.2	1.7	3.2	1.1	16.2	19.6	18.8	18.4	12.9	8.0	18.6	13.7	7.6	13.8	10.4	17.6	14.8	27.7	12.6	12.5	7.5	18.3	19.0	14.8	13.2	23.3	20.1	15.2	11.2	16.9	8.3	16.3	28.8	6.0	19.1	19.0	15.5	12.2	16.4	8.9	28.4	15.5	12.4	20.0	17.9	16.5	25.8	41.9	18.3	23.0	13.9	27.4	11.2	16.5	13.9	40.2	13.8	34.3	14.1	19.1	33.1	18.0	15.8	12.8	17.0	13.0	14.7	34.5	27.4	30.2	7.8	16.5	17.9	9.7	1.1	0.6	2.5	1.2	3.2	1.9	2.0	2.7	0.9	1.5	1.5	2.1	0.0	1.7	0.2	2.0	1.6	1.1	13.8	19.9	23.1	25.2	17.7	9.7	15.0	18.7	12.4	13.7	6.0	4.0	4.5	7.5	11.8	5.9	4.3	15.3	2.7	4.5	22.7	5.9	7.1	3.3	10.9	0.7	6.8	6.6	0.0	9.3	8.1	7.9	16.4	1.1	19.4	8.6	6.4	10.3	9.8	7.2	2.3	6.1	7.4	16.9	17.2	9.7	6.1	11.1	5.8	8.5	9.2	5.2	0.0	8.0	3.6	5.1	12.8	6.9	5.7	13.3	10.5
LAMTOR2	"ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3"	ENSG00000116586	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2"	Q9Y2Q5	1	156054752-156058510	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004126	Approved		Approved	Nucleoplasm,Vesicles		No	No		17000	"Nucleoplasm, Vesicles"		"HPA004126: AB_1849916"	"unprognostic (2.09e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.35e-1)"	24.3	33.5	30.3	18.8	27.2	23.4	35.3	14.2	30.6	22.5	27.5	13.8	34.3	24.5	17.0	38.1	27.6	25.4	25.7	37.2	25.8	24.9	31.7	63.5	27.7	37.9	26.4	22.8	11.4	75.2	16.6	18.0	21.1	23.4	18.8	27.5	16.4	35.9	34.3	35.5	20.4	26.2	26.2	19.3	26.0	27.3	12.1	20.3	20.2	20.9	30.2	23.6	21.9	17.0	47.2	89.8	60.4	80.6	32.6	47.6	56.7	15.1	34.5	16.4	22.4	33.3	27.1	18.0	13.6	23.1	17.0	19.5	15.8	26.0	22.5	23.7	26.2	15.0	22.4	16.6	36.7	9.6	18.7	25.2	13.1	23.4	20.8	26.4	18.5	21.4	31.9	23.0	18.1	23.3	23.8	34.6	33.8	11.8	16.9	24.4	30.6	19.1	26.4	17.2	60.3	51.9	16.2	12.2	32.9	37.3	22.3	6.3	36.5	17.3	48.2	27.5	27.2	33.9	54.5	23.4	14.4	13.3	20.9	12.7	25.6	37.5	13.1	25.7	20.6	15.4	41.8	80.6	60.4	30.9	71.6	30.2	47.2	34.2	33.5	89.8	38.3	26.2	28.2	39.6	32.6	56.5	47.5	47.6	56.7	30.3	27.2	14.2	30.6	25.8	24.9	26.4	22.8	23.4	20.3	53.6	42.8	84.0	54.8	42.9	27.7	101.0	124.9	48.2	29.6	102.9	5.9	124.2	328.3	164.5	35.9	83.1	242.4	23.3	156.0	159.6	83.8	73.9	107.1	259.1	359.6	6.4	121.0	78.0	197.4	46.6	43.7	177.6	150.1	338.2	124.1	62.7	171.6	238.4	47.7	425.0	20.8	32.3	55.6	21.8	36.0	69.9	64.5	60.9	143.9	71.1
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070514	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.3"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 238.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 24.3;CAPAN-2: 23.6;MCF7: 32.8;OE19: 75.9;RT4: 29.8;SK-BR-3: 48.5;T-47d: 45.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.4	0.3	0.3	10.9	0.3	0.0	10.8	0.5	0.4	23.6	28.4	0.3	28.1	14.8	4.0	15.9	98.3	9.7	33.3	0.3	0.3	0.3	18.2	1.0	19.1	0.6	0.3	0.2	2.3	27.4	8.6	9.5	19.1	0.3	13.3	16.2	0.4	44.1	26.8	0.4	48.0	43.0	2.1	0.4	0.3	16.2	1.1	0.2	3.7	36.1	74.6	60.9	13.0	31.8	0.1	0.0	0.0	0.0	0.0	3.4	0.8	17.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	17.5	23.6	0.0	0.0	0.0	0.0	21.5	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.9	75.9	0.0	0.0	0.0	0.0	0.0	29.8	2.6	0.0	0.0	48.5	0.0	4.4	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	2.8	0.8	0.0	0.0	3.4	2.9	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.3	0.5	0.4	0.3	0.3	0.3	0.2	0.3	0.2	26.8	27.6	0.0	90.6	48.9	0.0	0.1	79.0	53.5	27.3	82.0	0.0	84.0	140.9	146.8	0.0	0.1	182.7	0.0	132.5	23.0	3.7	95.3	5.7	0.0	6.1	0.0	82.1	0.0	0.0	0.0	0.3	2.5	20.3	6.4	160.3	0.0	154.4	238.4	0.0	16.8	0.0	0.0	2.1	0.2	0.7	135.3	67.2	1.5	195.0	192.0
MEX3A	"RKHD4, RNF162"	ENSG00000254726	"Mex-3 RNA binding family member A"	A1L020	1	156072013-156081998	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.2;ovary: 10.1"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 9.8;Ductal cells: 9.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 25.4;NTERA-2: 23.1;SCLC-21H: 24.1;SH-SY5Y: 43.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062703			Supported	Cytosol		NA	NA			Cytosol		"HPA062703: AB_2684840"	"unprognostic (8.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.23e-8)"	"unprognostic (4.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.96e-2)"	0.4	0.2	1.8	1.0	1.8	0.8	2.5	3.3	5.1	2.5	1.3	1.4	0.2	0.7	7.2	0.7	1.4	1.7	1.1	0.2	3.5	1.0	1.1	1.8	0.6	3.4	1.9	2.1	10.1	0.6	0.4	0.4	0.8	2.2	1.7	1.0	1.0	2.0	0.6	0.2	0.7	0.6	1.7	1.0	1.4	0.5	3.1	2.0	3.6	1.5	0.2	1.1	1.9	1.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	25.4	6.3	0.3	0.4	3.0	0.6	0.1	1.0	0.9	1.4	0.3	0.8	3.0	0.3	0.6	0.5	11.0	0.4	1.2	1.2	3.0	0.6	1.1	2.5	0.5	0.3	0.5	0.7	0.8	0.5	0.4	2.6	4.8	5.8	5.7	0.0	1.4	1.6	2.9	0.4	23.1	1.0	3.3	9.3	2.0	0.1	0.8	1.1	24.1	43.9	0.7	2.8	1.5	11.1	4.9	1.9	1.6	1.6	3.9	0.4	1.4	0.6	0.4	1.3	0.1	0.7	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	3.3	2.0	3.5	1.0	1.9	2.1	2.2	2.0	0.0	0.3	0.0	2.6	3.5	1.6	0.8	0.0	2.7	0.0	0.0	9.8	0.6	1.7	9.9	0.1	6.0	0.0	0.0	1.3	1.8	2.8	2.1	0.0	5.6	1.7	3.2	5.8	7.4	1.5	0.0	4.6	0.0	5.0	0.0	0.5	1.4	4.2	0.0	1.1	7.5	2.7	0.0	2.7	0.0	2.7	3.0	0.2	0.0	2.2	1.1
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140089	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"granulocytes: 1139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4"	"Cell line enhanced"	"Detected in many"		"WM-115: 137.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006523, HPA006660, HPA012078"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA		3200000	"Nucleoplasm, Nuclear speckles"		"CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231, HPA012078: "	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	64.0	37.3	7.4	51.4	11.8	21.3	88.6	9.0	10.8	62.8	32.6	21.9	27.2	28.6	69.1	52.3	62.2	40.1	77.7	62.5	8.8	7.5	25.9	26.6	51.8	39.6	15.7	11.2	60.3	30.9	15.2	17.4	73.3	18.1	34.0	15.2	32.7	37.5	26.4	36.3	68.7	29.9	63.0	10.3	22.4	36.7	30.2	12.9	9.4	31.5	140.0	35.6	46.4	51.2	1.1	34.8	10.4	3.5	1.7	35.4	6.4	59.1	58.7	6.5	17.4	32.9	57.1	20.0	64.0	81.5	48.3	33.4	14.8	58.6	0.5	38.0	98.4	24.9	69.3	9.5	49.6	12.6	20.1	5.6	18.7	47.2	34.3	29.7	3.2	55.2	34.1	21.6	39.2	27.0	25.0	43.1	0.0	10.0	4.5	52.9	46.7	0.1	10.3	4.8	68.6	74.8	0.2	22.7	17.3	47.8	28.4	6.6	13.3	43.2	46.9	59.4	10.0	39.6	15.4	76.8	46.1	29.3	56.9	51.6	4.4	1.2	1.2	75.3	3.1	137.4	10.4	3.5	0.1	1.2	0.8	1.0	1.1	8.9	3.4	34.8	0.0	0.1	0.3	0.8	1.7	0.1	0.3	35.4	6.4	7.4	11.8	9.0	10.8	8.8	7.5	15.7	11.2	18.1	12.9	244.2	393.4	23.4	924.2	542.3	8.1	85.2	119.8	93.7	315.1	153.5	45.2	422.7	92.9	335.7	28.0	269.0	358.5	46.7	313.5	336.4	599.3	268.8	1139.0	91.5	324.9	12.7	414.0	194.0	35.3	30.8	267.2	305.5	814.9	19.0	337.1	35.8	392.9	289.2	270.1	93.5	18.0	200.5	784.5	74.2	30.2	526.5	569.5	18.5	345.1	767.5
SEMA4A	"CORD10, FLJ12287, SEMAB, SemB"	ENSG00000196189	"Semaphorin 4A"	Q9H3S1	1	156147366-156177752	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis"	"Developmental protein"	"Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 46.8"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 61.4;Collecting duct cells: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 26.4;eosinophil: 25.2;intermediate monocyte: 29.5;myeloid DC: 40.3;neutrophil: 46.8;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 40.3;granulocytes: 46.8;monocytes: 29.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 55.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA069136	Supported					NA	NA		2400000			"HPA069136: AB_2686093"	"unprognostic (1.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.24e-1)"	"unprognostic (5.20e-2)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (8.77e-2)"	"unprognostic (4.63e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.28e-2)"	4.5	1.0	19.2	21.4	17.6	23.1	6.5	2.9	19.2	5.6	4.7	2.5	10.3	2.6	2.1	37.0	19.8	5.7	8.3	2.9	8.4	12.7	11.6	1.7	11.7	28.7	6.3	12.2	3.6	2.9	1.4	2.5	7.4	4.8	10.2	4.4	24.6	19.5	13.7	1.9	21.6	3.0	2.7	2.7	17.5	7.1	2.5	3.5	11.0	24.0	9.3	30.8	7.3	10.1	3.1	40.3	46.8	29.5	0.9	1.9	11.4	4.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.1	0.2	0.0	4.3	0.3	3.6	0.1	1.2	0.0	0.1	0.0	0.1	0.1	6.5	0.4	0.2	3.4	0.0	0.1	0.8	0.3	1.0	0.4	55.9	0.2	5.4	0.0	2.3	1.3	4.4	0.0	0.2	0.1	1.8	6.6	8.8	0.0	0.1	0.0	7.1	0.3	0.6	8.1	8.4	0.3	0.0	0.0	0.0	0.0	10.8	1.0	24.3	0.2	6.3	0.1	3.0	26.4	25.2	0.9	29.5	1.9	3.1	0.3	1.8	40.3	2.8	0.0	0.3	46.8	0.9	15.6	5.8	0.3	11.4	19.2	17.6	2.9	19.2	8.4	12.7	6.3	12.2	4.8	3.5	17.9	61.4	10.7	21.4	20.8	1.0	4.5	10.2	12.0	10.3	38.4	0.0	0.7	1.7	4.9	4.1	3.8	1.0	0.0	0.6	0.4	12.7	13.0	17.3	0.0	15.8	0.0	3.5	7.4	18.6	3.7	1.7	34.4	15.1	16.2	20.4	5.8	1.0	3.5	1.1	0.7	0.3	0.0	5.3	1.9	0.5	24.1	1.5	1.9	18.3	12.4
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 115.9;Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	14.3	9.0	15.9	9.3	23.1	10.2	8.9	18.6	31.9	9.1	10.4	19.7	6.6	16.8	8.1	11.1	9.0	7.8	10.7	10.6	16.1	16.7	25.9	31.2	10.6	8.7	14.4	18.1	7.1	8.3	17.7	10.9	7.8	22.5	8.7	11.1	9.3	7.0	9.5	12.8	9.1	13.9	10.8	13.5	13.3	8.4	8.9	12.1	10.6	9.7	6.0	11.2	9.7	7.9	3.7	6.3	33.8	9.1	4.2	4.9	5.6	10.3	17.7	8.7	11.5	19.0	10.3	6.8	11.1	16.4	20.3	16.6	17.3	9.4	8.2	9.8	16.6	11.0	15.5	31.7	13.1	18.0	9.4	10.6	7.5	11.3	10.4	14.5	9.7	13.8	14.4	11.5	20.5	12.4	9.8	16.4	10.2	7.8	13.6	13.9	18.6	10.1	6.9	20.5	19.8	18.4	6.5	8.8	14.0	26.5	12.3	13.6	18.3	13.0	23.6	14.8	16.0	17.8	15.9	13.2	11.7	9.9	13.1	13.2	14.0	10.6	12.5	12.9	10.2	11.5	6.5	8.4	8.7	4.7	9.1	4.9	3.7	3.8	4.4	6.3	2.4	3.1	3.7	33.8	4.2	7.1	2.8	3.3	5.6	15.9	23.1	18.6	31.9	16.1	16.7	14.4	18.1	22.5	12.1	11.9	24.8	12.3	4.8	24.6	12.6	30.7	7.6	4.0	14.8	8.7	19.6	4.3	5.0	5.4	115.9	11.7	9.2	0.0	4.9	3.3	17.9	6.1	4.7	29.8	6.5	19.1	5.8	10.4	8.6	71.2	6.6	12.2	11.8	1.8	8.5	7.2	4.9	5.8	5.3	13.9	8.8	19.4	12.2	9.1	7.7	29.7	6.9	7.5	7.5	6.3
PMF1-BGLAP		ENSG00000260238	"PMF1-BGLAP readthrough"		1	156212982-156243332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 2.7;Distal tubular cells: 3.3;Proximal tubular cells: 2.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (8.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.65e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.85e-4)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.36e-1)"	9.8	15.7	16.2	10.3	16.2	12.1	7.8	18.1	14.6	14.6	13.0	13.9	13.4	8.6	13.1	16.3	11.7	15.0	12.9	24.6	14.1	14.2	20.6	17.4	11.0	16.4	12.6	9.0	15.6	15.0	10.4	16.2	19.2	8.8	15.7	7.0	14.8	21.5	13.2	31.8	10.7	10.5	10.9	11.2	14.0	9.5	7.4	11.8	12.5	16.4	26.4	15.8	9.8	11.1	9.8	7.1	10.2	8.9	5.1	10.7	8.1	7.0	7.3	9.7	6.6	2.6	6.8	4.2	6.4	4.2	6.3	5.2	5.4	6.5	6.2	10.8	5.7	2.6	4.9	9.0	8.2	3.2	10.6	15.2	4.3	7.1	10.0	12.4	4.2	7.7	8.3	7.7	5.7	5.0	7.9	5.9	5.7	4.2	10.0	4.4	8.6	3.7	9.0	19.9	4.8	13.4	7.1	3.8	9.1	4.9	3.4	6.7	8.6	4.2	1.7	11.0	8.8	9.9	17.0	6.5	3.1	3.1	3.9	5.7	6.1	7.3	9.4	4.5	5.6	6.2	3.6	8.9	4.4	4.9	5.8	4.8	4.8	7.7	7.1	6.6	9.8	10.7	6.0	10.2	5.1	6.1	7.1	8.4	8.1	16.2	16.2	18.1	12.8	14.1	14.2	12.6	9.0	8.8	11.8	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.4	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.6	0.3	0.0	0.0	0.6	1.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	2.2	0.0	6.5	0.0	0.2	0.5	0.0	0.8	0.0	0.5	0.3
PMF1		ENSG00000160783	"Polyamine modulated factor 1"	Q6P1K2	1	156212993-156240042	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (1.17e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"	20.6	21.7	18.2	19.8	20.4	40.8	23.3	24.3	23.7	27.4	20.3	26.1	25.2	20.1	25.2	27.5	26.4	20.4	24.4	37.9	16.4	15.5	38.0	32.4	21.3	30.5	23.9	17.4	25.1	28.0	23.6	22.8	35.5	17.1	25.5	18.0	27.6	26.8	20.5	65.7	28.9	20.1	20.9	21.3	29.9	22.8	13.4	22.4	23.6	30.5	48.3	29.5	21.6	22.7	22.8	41.1	26.2	36.5	19.9	31.1	29.0	21.2	26.3	28.4	21.4	5.4	11.2	22.1	11.1	15.7	30.1	25.0	32.2	30.7	19.6	24.2	14.1	10.4	14.3	28.5	18.5	15.5	14.0	33.8	14.5	20.1	28.7	11.2	20.4	20.2	10.1	18.7	13.5	14.3	11.6	22.6	14.4	21.6	22.8	14.5	43.4	21.3	26.4	49.3	31.5	23.4	23.5	15.1	38.8	31.4	16.1	26.0	32.7	18.4	21.2	14.4	21.7	34.5	25.1	13.0	13.0	16.7	14.4	21.7	17.1	17.6	38.5	10.4	19.8	18.0	7.9	36.5	16.4	20.2	25.2	18.1	22.8	19.9	18.8	30.0	21.6	19.4	19.5	26.2	19.9	22.1	41.1	31.1	29.0	18.2	20.4	24.3	23.7	16.4	15.5	23.9	17.4	17.1	22.4	17.9	21.4	70.7	66.4	44.3	11.4	9.7	48.4	6.7	22.7	71.5	11.8	119.8	149.2	81.5	4.4	45.6	19.1	23.3	85.9	94.2	46.0	45.9	43.9	44.8	68.8	7.9	47.1	37.4	37.6	4.2	36.2	38.4	81.0	60.5	42.8	53.7	66.2	42.9	26.5	90.8	23.8	25.8	42.9	14.7	35.1	44.5	131.6	52.3	46.9	60.9
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156241962-156243321	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0"	"Cell type enhanced"	"Detected in some"	13	"Melanocytes: 3.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"NK-cell: 2.2;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 4.2;NK-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.5;U-87 MG: 6.4"														"Secreted to blood"	NA	NA	15500000	430000				"unprognostic (2.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.82e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.44e-5)"	"unprognostic (2.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.70e-2)"	"unprognostic (9.67e-6)"	"unprognostic (3.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.64e-3)"	1.6	0.7	6.0	6.7	6.9	2.2	1.4	5.2	11.0	1.1	9.3	6.2	0.0	3.2	4.8	1.4	0.8	2.3	1.7	0.7	4.3	2.9	1.2	1.6	1.4	2.3	6.2	6.8	3.4	0.8	1.5	1.3	3.1	9.7	2.1	3.4	0.0	3.6	2.8	2.2	6.8	6.4	3.9	8.4	2.1	2.3	0.3	4.1	0.6	1.6	0.0	1.2	0.7	1.2	0.0	4.2	0.2	0.0	2.2	0.1	0.1	0.3	0.7	1.6	0.5	0.0	0.5	1.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.4	0.0	0.7	0.6	0.0	0.4	0.0	1.8	0.9	0.0	2.0	1.1	0.5	0.0	0.4	0.0	0.6	0.6	0.6	7.5	0.6	1.5	0.5	2.2	0.0	1.9	0.0	1.4	0.8	0.1	0.3	0.9	0.1	1.4	0.6	0.0	0.2	1.8	0.6	0.3	0.7	0.3	1.1	0.0	0.0	0.0	0.4	0.4	0.4	2.7	2.5	1.4	6.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	4.2	0.0	0.1	6.0	6.9	5.2	11.0	4.3	2.9	6.2	6.8	9.7	4.1	0.0	0.0	0.0	0.9	1.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.2	1.1	0.6	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	1.4	0.0	3.3	0.0	0.1	0.3	0.0	0.0	0.4	1.1	0.5	6.5	0.0	0.5	0.9	1.1	0.3	0.0	0.6	0.7
PAQR6	"FLJ22672, PRdelta"	ENSG00000160781	"Progestin and adipoQ receptor family member 6"	Q6TCH4	1	156243321-156248117	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	12	"brain: 138.1"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 71.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 34.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 10.5"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 10.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 20.9"															NA	No						"unprognostic (1.64e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (7.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.50e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.99e-4)"	"prognostic unfavorable (1.58e-8)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.86e-4)"	2.1	3.6	42.5	2.2	38.0	7.6	2.2	8.7	71.6	2.0	2.7	102.9	0.0	2.8	2.3	2.9	2.5	2.2	2.9	2.0	48.1	37.6	2.0	2.1	2.1	2.1	82.7	16.1	1.6	1.6	2.4	1.2	2.2	72.5	3.5	2.3	0.0	3.2	3.0	2.1	11.5	3.0	2.0	138.1	2.3	3.1	2.5	46.0	0.0	2.0	0.0	2.0	2.5	0.3	0.8	1.6	0.0	0.0	10.5	1.2	0.1	1.8	2.0	3.3	3.4	0.6	0.5	8.2	0.2	0.5	0.0	0.2	1.0	6.4	3.3	1.5	0.5	0.2	5.8	0.0	0.7	0.4	1.9	2.7	2.0	1.7	0.9	0.3	0.6	5.3	1.6	2.6	2.4	2.4	3.3	0.3	6.7	1.5	9.5	0.6	6.7	0.2	1.0	3.8	1.1	0.9	1.4	0.7	1.5	2.3	10.7	2.9	5.8	0.7	0.7	3.8	6.9	10.8	1.1	0.5	1.0	5.3	1.7	0.5	20.9	4.6	2.0	0.2	7.5	0.9	0.0	0.0	0.0	0.4	0.0	1.2	0.8	0.6	0.2	0.0	0.1	0.0	0.0	0.0	10.5	0.0	1.6	0.1	0.1	42.5	38.0	8.7	34.4	48.1	37.6	82.7	16.1	72.5	46.0	0.0	0.3	0.0	0.2	1.1	3.2	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.7	0.7	0.0	3.0	0.1	0.6	0.7	1.1	0.9	0.5	6.4	4.1	0.6	0.6	0.6	0.3	0.7	0.0	0.0	0.4	71.8	1.3	0.0	2.1	0.0	10.3	0.0	0.2	0.7	0.4	1.3	0.2	4.6	0.9	0.4
SMG5	"EST1B, KIAA1089, LPTS-RP1, LPTSRP1, RP11-54H19.7, SMG-5"	ENSG00000198952	"SMG5, nonsense mediated mRNA decay factor"	Q9UPR3	1	156249224-156282825	"Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA072651			Uncertain	"Cytoplasmic bodies"		No	No			"Cytoplasmic bodies"		"HPA072651: AB_2686544"	"unprognostic (2.09e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (3.20e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.70e-9)"	"unprognostic (1.28e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.26e-2)"	18.0	28.8	30.3	17.9	38.3	34.8	19.7	30.0	40.3	14.2	20.4	38.4	23.6	23.4	19.1	22.6	23.4	21.9	16.6	43.3	28.7	24.4	27.2	30.5	20.7	20.2	45.1	24.1	19.3	21.1	43.1	26.3	22.8	32.5	22.9	19.6	21.3	20.1	22.3	39.4	31.1	23.7	24.5	30.6	22.0	20.8	25.6	44.1	14.5	20.1	13.2	20.8	20.5	24.3	6.2	4.9	9.4	8.5	5.7	8.1	5.3	19.3	17.0	20.8	15.4	20.3	11.6	30.2	20.1	18.1	30.6	26.1	42.8	25.3	17.6	23.7	24.0	24.4	23.5	36.6	25.5	19.9	19.8	30.4	20.4	15.9	23.4	26.4	21.2	20.8	14.6	25.4	29.3	31.4	15.8	19.6	26.4	27.6	17.8	21.4	19.8	17.3	17.3	42.0	35.6	35.7	28.1	15.9	18.7	20.0	23.5	28.1	23.4	25.6	38.1	22.8	28.8	32.8	45.7	16.4	21.3	23.9	22.4	29.2	27.4	6.3	33.0	18.8	21.3	26.9	3.1	6.3	9.4	8.1	8.5	6.8	6.2	6.2	6.0	4.7	6.2	5.4	5.6	8.5	5.7	8.2	4.9	4.0	5.3	30.3	38.3	30.0	40.3	28.7	24.4	45.1	24.1	32.5	44.1	14.9	11.2	17.4	7.2	13.1	11.0	34.0	25.5	8.1	7.9	19.2	31.4	15.0	6.6	11.0	2.1	9.0	29.2	0.0	12.5	8.5	7.3	11.4	12.7	16.3	11.0	17.5	21.8	11.6	12.9	3.2	7.8	7.1	5.0	12.6	19.1	8.5	15.2	16.4	6.7	13.3	11.4	6.5	9.0	7.4	7.4	10.7	14.3	7.1	16.2	10.7
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 47.5;skin 1: 35.7;tongue: 37.2"	"Cell type enhanced"	"Detected in many"	9	"Suprabasal keratinocytes: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 22.0;SK-BR-3: 18.1;T-47d: 19.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	1.2	1.3	2.4	1.2	5.1	2.0	3.4	3.4	3.7	12.5	1.2	3.6	1.9	1.8	1.3	1.9	47.5	1.5	1.9	1.0	2.0	1.1	1.1	1.4	1.0	1.8	5.6	1.4	1.5	1.0	3.8	2.5	4.5	3.1	19.0	1.1	1.2	9.4	2.1	1.9	35.7	1.3	1.1	3.2	1.6	1.6	0.9	5.2	3.7	1.5	37.2	24.2	3.3	20.5	5.2	4.1	7.8	4.1	3.0	5.2	3.1	8.2	4.9	1.7	3.2	1.2	1.3	4.1	2.4	1.0	4.4	1.7	5.7	2.3	1.6	5.3	0.6	1.6	7.4	1.9	3.7	1.9	5.5	2.8	1.5	2.0	1.6	2.3	1.7	2.3	1.3	22.0	3.3	3.3	3.2	0.9	5.6	6.9	10.3	2.0	9.8	4.8	2.7	2.5	6.2	3.9	5.7	1.6	3.3	0.9	2.6	3.0	3.3	2.9	18.1	4.7	2.1	19.4	5.0	2.3	8.1	2.7	2.9	6.4	8.0	8.3	3.5	5.6	4.1	6.1	0.0	4.1	5.6	3.9	1.4	3.9	3.7	3.4	4.0	3.2	5.2	4.4	5.2	7.8	3.0	2.6	4.1	4.0	3.1	2.4	5.1	3.4	3.7	2.0	1.1	5.6	1.4	3.1	5.2	3.0	1.0	2.0	1.1	11.7	3.2	0.8	5.1	2.7	2.3	1.8	2.0	5.9	1.7	1.9	0.1	1.5	2.6	0.0	2.9	1.6	1.9	11.3	0.0	2.0	3.0	7.9	2.9	1.3	2.4	0.0	1.4	1.4	5.0	6.4	2.1	1.5	3.0	2.5	0.7	1.1	2.2	0.0	0.8	1.2	1.9	29.0	6.2	3.5	2.6	4.9
GLMP	"C1orf85, MGC31963, NCU-G1"	ENSG00000198715	"Glycosylated lysosomal membrane protein"	Q8WWB7	1	156290089-156295689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029121	Uncertain					NA	NA					"HPA029121: AB_10600794"	"unprognostic (2.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.35e-5)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.68e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	22.6	44.5	9.0	9.4	10.3	10.0	16.7	5.1	14.1	21.5	21.3	13.5	15.7	18.4	15.6	26.3	17.3	13.4	26.7	19.2	6.7	7.6	43.9	34.8	24.1	27.7	8.6	7.9	13.9	18.3	12.3	12.3	46.5	11.2	36.3	12.7	37.5	22.6	13.4	6.0	17.3	26.7	14.7	8.9	20.9	16.7	10.8	8.0	8.9	17.1	12.5	16.5	22.6	15.7	6.1	13.7	11.4	31.7	6.9	18.3	14.2	5.7	10.5	1.0	7.4	61.5	33.5	7.3	10.5	44.9	15.5	21.5	12.9	17.8	0.0	22.3	15.3	0.5	3.9	0.1	7.6	5.0	1.2	10.7	2.0	6.3	15.0	27.7	4.8	15.4	34.1	9.7	14.6	4.8	23.8	23.2	4.7	8.1	0.9	9.0	7.1	2.5	0.0	12.0	14.3	5.3	4.4	0.0	18.5	14.2	6.4	3.4	11.2	7.4	19.8	31.4	12.5	10.5	13.7	12.4	7.8	1.4	12.5	7.0	7.0	11.4	2.9	12.8	4.0	10.0	11.4	29.7	5.0	10.7	31.7	10.0	6.1	10.8	9.4	13.7	3.7	11.0	10.1	8.9	6.9	22.1	9.0	18.3	14.2	9.0	10.3	5.1	14.1	6.7	7.6	8.6	7.9	11.2	8.0	3.0	18.4	9.3	10.4	0.0	2.1	5.8	22.9	10.7	9.1	29.6	0.0	61.3	23.2	40.6	0.6	10.8	16.4	0.0	33.6	52.4	11.3	35.0	8.1	62.3	163.3	1.6	10.5	43.0	45.3	0.0	15.3	23.2	0.0	19.0	25.2	18.4	30.4	26.4	13.1	50.1	1.5	12.9	13.4	0.2	2.1	0.0	58.2	10.2	14.5	14.6
VHLL	"VHLP, VLP"	ENSG00000189030	"VHL like"	Q6RSH7	1	156298624-156299299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;pancreas: 1.6;skeletal muscle: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.0;Daudi: 2.5;hTCEpi: 3.0"															NA	NA										"unprognostic (1.61e-1)"									"unprognostic (2.45e-1)"				0.1	0.1	0.1	0.0	0.3	0.0	0.0	2.6	0.2	0.0	0.1			0.0	0.3	0.0	1.2	0.1	0.8	0.1	0.2	0.2	0.0	0.4	0.1	0.1	0.0		0.2	1.6	0.0	0.1	0.1		0.2	0.1		0.0	0.0	1.5	0.3	0.0	0.2	0.1	0.2	0.1	0.6			0.1		0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		4000000	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	38.8	68.8	37.6	41.8	43.2	26.9	51.2	54.5	51.4	35.1	42.1	46.2	33.8	37.9	50.4	34.8	56.1	52.2	29.2	41.5	36.7	41.6	60.8	61.9	30.9	48.1	43.5	32.8	53.0	59.0	56.7	55.9	39.2	43.0	38.1	50.0	35.3	34.4	41.4	66.4	38.2	39.5	59.7	41.2	41.6	41.9	49.8	47.6	62.1	60.0	49.9	60.7	44.8	82.4	34.8	39.3	14.2	30.5	30.8	45.1	43.9	50.4	57.6	39.3	37.7	43.7	32.5	51.3	47.2	37.5	74.7	46.0	57.0	46.8	83.4	55.0	39.5	47.6	47.6	124.4	61.4	63.9	44.7	78.3	52.9	46.8	45.0	32.2	65.4	44.5	41.2	36.8	67.1	62.5	36.7	63.2	50.4	90.7	30.2	44.3	46.9	86.0	40.1	79.6	99.6	83.5	69.2	39.8	90.3	54.8	32.0	53.3	55.0	43.5	76.7	42.1	66.0	67.8	80.1	43.6	30.4	45.4	31.8	84.1	56.1	99.6	124.1	35.4	41.7	49.3	14.2	25.3	11.2	31.2	30.5	41.6	34.1	34.7	34.2	39.3	34.8	45.1	37.8	3.6	30.8	30.2	25.5	35.5	43.9	37.6	43.2	54.5	51.4	36.7	41.6	43.5	32.8	43.0	47.6	50.6	46.8	129.4	183.9	128.7	109.7	102.4	58.6	127.2	85.3	85.5	100.1	202.7	96.2	186.6	88.8	105.6	80.4	23.3	158.9	172.8	109.3	142.8	72.6	72.7	143.2	69.9	120.2	69.3	70.6	169.9	77.3	80.0	106.3	208.2	75.5	134.0	167.6	87.7	82.7	157.7	195.7	116.4	117.4	367.9	233.1	139.6	154.4	96.5	112.5	146.5
TSACC	"C1orf182, SIP, SSTK-IP"	ENSG00000163467	"TSSK6 activating cochaperone"	Q96A04	1	156337314-156346995	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 262.0"	"Group enriched"	"Detected in many"	10	"Early spermatids: 5429.3;Late spermatids: 13574.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"basophil: 12.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029897			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA029897: AB_2756315"	"unprognostic (3.95e-1)"	"unprognostic (5.82e-3)"	"unprognostic (8.24e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.63e-6)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.28e-2)"	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.1	0.0	1.6	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	262.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.0	2.1	12.0	0.6	2.3	2.1	0.4	3.3	4.5	2.0	2.2	1.5	2.7	3.7	1.6	0.9	2.2	2.4	4.1	2.4	4.8	2.6	0.9	2.4	3.8	3.8	0.5	2.1	2.8	8.3	3.3	6.6	4.4	1.0	3.0	2.9	1.0	6.4	2.2	2.9	1.2	0.7	4.8	9.0	3.1	0.4	5.7	2.9	1.8	6.2	8.1	5.5	3.4	0.8	4.7	5.7	2.0	3.1	1.7	2.3	6.3	2.5	9.1	3.4	3.2	1.6	1.4	2.3	1.2	2.2	5.7	9.1	7.3	0.9	1.7	1.2	12.0	0.5	0.1	1.5	0.3	0.7	1.7	1.1	1.3	0.3	2.0	2.1	1.8	0.2	2.3	0.6	2.1	1.2	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.2	0.2	0.2	0.6	0.0	4.0	2.3	3.5	0.0	4.6	1.7	1.0	5429.3	0.0	0.0	0.0	0.6	1.1	0.3	0.4	0.0	3.0	0.9	0.0	0.0	0.0	0.3	13574.2	103.3	0.0	0.0	0.0	0.4	0.3	1.3	0.0	80.6	3.7	0.9	51.8	0.1	941.5	81.3	0.4	2.3	0.0	0.4	0.6
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein (gene/pseudogene)"	Q9H310	1	156369212-156385219	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 23.2;kidney: 16.9;ovary: 5.9"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in some"	15	"cerebellum: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0"					"Low region specificity"	"Detected in all"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	23.2	0.1	0.3	0.3	0.0	1.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.1	16.9	3.3	0.1	0.0	0.1	0.1	5.9	0.2	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.3	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	1.1	1.2	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.2	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	21.0	0.0	0.0	16.6	0.3	10.7	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	4.3	0.1	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	1.0	0.0	1.1	0.1	0.0	0.4	0.9	0.0	0.0	0.0	2.2	0.4	0.4	0.0	0.0	0.0	0.0
C1orf61	CROC4	ENSG00000125462	"Chromosome 1 open reading frame 61"	Q13536	1	156404250-156430701	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	29	"brain: 184.8"	"Group enriched"	"Detected in some"	7	"Late spermatids: 222.1;Muller glia cells: 843.1"	"Cancer enriched"	"Detected in some"	116	"glioma: 77.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 6.3;MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	34	"T-cells: 6.3"	"Cell line enriched"	"Detected in some"	6	"BEWO: 17.3"															NA	NA						"unprognostic (6.20e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.35e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.16e-7)"	"unprognostic (5.87e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.88e-2)"	2.0	1.9	71.9	1.9	69.5	2.1	2.0	20.2	184.8	1.9	2.0	19.3	0.0	2.0	2.0	2.0	2.0	2.0	1.9	1.9	48.9	45.2	1.9	2.0	1.9	2.1	65.3	23.6	1.9	1.9	2.0	0.0	1.9	27.4	1.9	2.0	1.4	2.0	1.9	1.9	1.9	2.0	2.0	22.7	2.1	1.9	3.1	14.8	0.0	1.9	0.0	2.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.5	0.0	0.8	0.0	0.3	0.0	0.0	17.3	0.0	0.0	0.0	0.1	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.4	0.8	0.0	0.5	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.9	0.3	0.4	0.0	0.0	0.0	6.3	0.0	5.2	0.0	1.5	3.3	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.6	0.5	71.9	69.5	20.2	43.5	48.9	45.2	65.3	23.6	27.4	14.8	0.0	1.1	0.0	0.2	0.6	8.1	2.4	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	76.9	0.3	0.0	0.0	0.5	2.2	0.3	0.2	0.0	0.0	0.8	0.0	1.2	0.6	0.0	222.1	0.9	0.0	0.0	0.0	0.0	843.1	0.0	0.0	1.1	0.0	21.1	0.0	0.3	37.7	5.3	0.0	4.0	1.3	0.0	0.1
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500828	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.8"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 163.0;Sertoli cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 55.0;U-266/70: 48.3;U-266/84: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	18.1	19.6	14.9	15.7	27.5	47.6	15.5	27.0	40.3	23.8	21.1	12.1	10.5	11.0	28.6	12.9	13.8	19.5	16.6	26.3	11.8	9.6	10.4	10.6	20.0	13.9	8.6	21.1	26.7	22.4	21.4	15.0	16.2	11.6	17.2	10.6	22.3	11.3	18.8	97.8	17.5	14.8	22.0	8.4	17.2	16.1	9.9	9.9	17.2	14.7	19.4	15.6	21.9	19.3	1.7	8.5	8.1	2.0	1.5	2.3	0.8	4.6	8.6	1.8	2.8	4.4	6.1	2.8	6.1	8.0	3.2	3.5	2.7	6.3	10.8	7.1	8.2	3.2	4.6	2.1	3.5	1.9	14.7	2.8	2.6	10.7	1.5	5.4	6.3	8.6	6.8	5.9	5.6	7.7	6.8	6.1	3.4	1.9	19.1	5.1	4.4	4.2	14.6	2.6	2.6	4.4	20.8	3.9	12.4	2.8	2.3	3.0	4.7	5.9	12.9	10.2	3.7	3.5	55.0	10.2	7.7	7.2	5.6	4.5	48.3	49.9	20.7	6.5	5.0	4.1	1.3	2.0	2.3	1.9	1.1	2.3	1.7	1.4	1.7	1.4	1.7	0.7	1.3	8.1	1.5	1.9	8.5	1.6	0.8	14.9	27.5	27.0	40.3	11.8	9.6	8.6	21.1	11.6	9.9	6.0	18.1	14.4	10.3	33.1	78.1	35.2	20.4	2.7	15.9	1.8	163.0	3.9	0.0	7.0	1.3	21.1	33.9	0.0	9.7	4.3	21.3	16.3	3.5	11.3	15.8	66.7	20.6	18.4	22.5	4.6	29.1	18.3	13.5	10.0	29.7	16.8	18.5	28.1	30.4	2.6	80.6	97.0	38.1	5.1	9.8	33.2	12.8	12.9	11.0	14.9
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.8;intestine: 13.0"	"Cell type enhanced"	"Detected in some"	14	"Cholangiocytes: 5.1;Late spermatids: 16.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	Yes			"Nucleoli rim"	Nucleoplasm	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	3.2	1.2	0.3	5.4	0.3	14.8	0.6	0.3	0.8	1.4	10.1	0.4	1.3	7.0	1.1	3.7	9.8	0.3	1.8	1.8	0.4	0.2	1.5	1.1	2.6	1.4	0.3	0.3	0.5	0.4	0.0	0.3	6.5	0.8	0.8	5.5	0.4	1.8	0.3	0.5	3.8	13.0	2.9	1.5	1.5	5.1	6.8	0.3	12.2	0.4	3.1	7.3	0.9	3.1	0.2	0.9	0.5	0.3	0.6	2.6	0.0	23.5	11.4	10.7	7.5	0.6	1.7	5.2	17.5	11.7	17.2	15.5	13.0	21.8	2.1	6.5	10.3	9.1	22.5	7.3	9.0	15.5	0.0	6.5	3.1	22.4	6.4	0.1	3.8	0.0	0.5	1.0	14.4	21.3	4.2	10.0	5.1	6.3	3.4	12.6	12.4	2.2	5.5	7.8	23.3	11.5	7.6	12.0	2.4	4.4	8.1	6.8	10.5	15.9	18.7	6.4	13.1	14.9	10.3	6.5	15.6	18.7	12.7	20.6	1.6	0.8	1.0	5.2	6.1	17.6	0.5	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.6	0.1	0.1	0.1	0.2	0.6	0.3	0.9	2.6	0.0	0.3	0.3	0.3	0.8	0.4	0.2	0.3	0.3	0.8	0.3	0.0	0.0	0.5	0.0	1.1	0.0	0.8	5.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.7	0.0	1.1	0.0	0.0	3.1	0.5	0.2	0.0	0.0	3.4	0.0	1.2	4.3	0.3	16.8	0.3	2.2	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	3.8	2.4	0.9	0.7	0.0	2.9	0.4
TTC24		ENSG00000187862	"Tetratricopeptide repeat domain 24"	A2A3L6	1	156579727-156586770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 13.3;lymphoid tissue: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"JURKAT: 12.4;MOLT-4: 3.7;REH: 13.9;U-698: 2.7"									HPA029799			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029799: AB_10601684"	"unprognostic (2.43e-3)"	"unprognostic (5.61e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-6)"	"unprognostic (6.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.87e-9)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.76e-4)"	0.2	0.0	0.2	2.7	0.3	2.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	8.4	0.2	0.2	0.2	0.2	0.0	3.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.6	0.0	2.6	0.2	0.2	5.1	0.4	0.2	0.2	1.4	0.2	0.2	7.5	0.2	0.2	2.2	13.3	0.3	0.0	3.8	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	1.1	0.1	2.2	0.2	1.9	0.3	3.8	0.0	13.3	0.0	0.6	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 120.4;Distal tubular cells: 170.8;Proximal tubular cells: 189.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.6	42.0	13.4	24.0	17.9	12.3	16.0	10.9	16.7	18.7	19.8	34.9	21.3	21.5	33.2	13.9	16.2	30.9	13.4	26.1	13.3	22.7	29.3	17.8	24.0	23.1	20.5	22.3	18.3	12.3	33.8	23.8	22.2	15.0	25.4	29.0	18.1	19.6	19.1	56.3	24.5	27.2	16.6	43.8	32.8	24.7	12.6	56.8	25.3	26.3	32.5	31.0	26.2	50.1	38.5	19.8	48.6	32.9	14.8	13.5	21.1	19.1	23.8	50.8	30.7	20.5	18.6	13.3	20.8	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2	38.7	23.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	43.3	64.6	0.0	120.4	170.8	89.3	0.0	0.0	0.0	0.0	87.1	28.1	0.0	0.0	4.7	0.0	80.7	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	71.3	0.0	0.0	83.0	0.0	0.0	189.4	0.0	0.0	0.0	0.0	0.0	0.0	68.0	0.0	0.0	0.0
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594487-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	18.2	13.3	14.7	16.9	27.7	9.4	15.1	6.9	22.5	10.0	12.1	8.3	3.9	9.7	13.8	10.0	14.0	11.6	7.2	11.9	12.6	12.1	18.0	23.1	10.0	15.7	15.3	12.4	15.3	12.9	19.6	16.2	10.0	24.2	12.6	14.6	5.7	11.5	11.9	47.1	10.9	10.0	15.1	10.2	16.6	12.5	8.8	13.2	8.0	10.3	19.0	19.1	12.5	10.1	16.6	10.1	0.3	11.2	10.7	15.9	7.6	17.1	23.7	10.0	14.4	9.2	7.1	13.0	21.3	8.5	16.7	9.8	24.2	13.0	41.4	17.7	14.9	10.8	12.0	22.7	18.8	18.5	12.3	22.5	24.7	23.2	18.5	8.3	55.1	16.0	8.0	15.9	31.6	28.0	4.7	11.7	13.5	40.4	10.4	13.5	32.0	22.6	13.3	43.8	29.9	25.0	22.6	17.1	28.7	11.5	20.4	15.8	23.8	20.4	44.9	13.1	11.4	14.7	26.8	17.8	15.9	21.7	16.5	38.1	19.1	21.0	53.4	14.4	28.6	24.0	0.0	5.4	0.1	13.3	10.5	13.4	16.6	13.5	14.7	10.1	16.6	15.4	15.9	0.3	10.7	11.2	6.4	8.5	7.6	14.7	27.7	6.9	22.5	12.6	12.1	15.3	12.4	24.2	13.2	29.8	34.7	41.0	38.8	65.5	7.1	24.8	28.1	16.0	40.9	15.7	7.9	31.9	21.6	38.5	7.6	30.2	8.5	23.3	48.9	40.5	22.6	43.6	56.6	37.8	33.7	7.9	35.5	14.7	10.7	7.4	24.7	22.6	21.9	19.8	19.7	4.3	44.1	14.0	25.1	25.9	5.9	32.3	59.0	37.1	39.9	54.7	12.9	29.7	28.3	36.6
HAPLN2	BRAL1	ENSG00000132702	"Hyaluronan and proteoglycan link protein 2"	Q9GZV7	1	156619294-156625725	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	39	"brain: 108.1"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 32.3"	"Cancer enriched"	"Detected in some"	10	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.1;U-266/70: 4.6;U-87 MG: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045765	Enhanced				"Secreted in brain"	NA	NA					"HPA045765: AB_10964781"	"unprognostic (3.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.5	11.0	1.3	21.1	1.3	1.3	4.4	45.3	1.3	1.3	43.6	0.0	2.7	1.6	1.3	1.3	1.4	1.3	1.3	21.2	13.9	1.4	1.3	1.4	1.3	49.3	9.3	1.3	1.3	1.6	0.0	1.3	43.1	1.9	1.3	0.0	1.4	1.5	1.9	1.6	1.7	1.3	108.1	1.3	1.3	1.7	31.5	0.0	1.3	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	4.6	0.1	0.2	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.1	4.4	15.1	21.2	13.9	49.3	9.3	43.1	31.5	0.0	0.0	0.0	0.0	0.1	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	32.3	7.6	0.7	1.9	0.0	0.0	0.0	0.0	0.1
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 144.2"	"Group enriched"	"Detected in some"	22	"Horizontal cells: 103.3;Melanocytes: 177.2"	"Group enriched"	"Detected in many"	77	"glioma: 348.5;melanoma: 75.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.7;K-562: 34.8;U-266/70: 20.9;U-266/84: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"	NA	NA		98000			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	1.4	5.8	51.8	1.6	35.9	1.3	1.4	10.4	144.2	2.3	2.4	30.5	1.3	4.6	2.7	9.5	1.6	2.4	3.1	1.5	40.8	22.9	1.4	1.3	1.5	1.5	26.6	21.5	1.4	1.3	1.3	0.7	1.7	15.1	1.4	1.3	4.3	2.0	2.4	1.6	9.0	5.0	2.4	13.0	1.6	2.4	2.0	26.7	0.0	1.4	0.0	1.3	2.3	0.3	0.6	0.0	8.2	0.4	0.0	0.0	0.0	14.0	9.7	0.0	2.6	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.3	6.9	0.0	15.0	0.0	0.3	9.9	0.1	0.0	0.0	24.7	0.9	2.4	6.4	8.0	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.3	0.0	1.3	34.8	6.9	0.0	4.0	0.0	0.0	0.7	7.5	1.4	0.0	16.1	0.0	0.0	1.7	0.0	0.2	0.0	0.0	14.6	0.8	0.0	0.9	3.0	0.0	8.0	2.9	3.8	20.9	40.2	0.0	2.9	6.5	1.1	8.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	35.9	10.4	33.3	40.8	22.9	26.6	21.5	15.1	26.7	0.0	0.0	0.0	0.0	6.2	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.4	103.3	1.7	0.0	0.0	4.3	0.3	0.0	177.2	0.0	0.0	1.9	0.4	0.0	0.0	0.0	2.3	0.0	1.9	5.4	6.4	1.5	0.0	0.0	0.0	0.0
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677397	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.9"	"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 191.0;Endothelial cells: 67.1;Sertoli cells: 103.5;Smooth muscle cells: 44.2"	"Group enriched"	"Detected in all"	6	"glioma: 147.0;melanoma: 101.4;testis cancer: 34.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 92.5;HUVEC TERT2: 46.8;LHCN-M2: 74.7;RH-30: 76.5;SuSa: 52.8;WM-115: 36.1"					"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	22.1	4.2	6.2	7.1	7.6	0.4	13.8	6.0	13.3	16.9	5.9	13.0	7.5	3.1	23.4	12.3	10.0	12.5	8.9	77.9	6.5	5.1	15.7	4.5	16.0	4.2	8.2	5.1	13.2	2.2	7.5	5.6	8.9	12.8	14.6	4.0	12.2	3.8	20.0	25.3	3.2	4.9	16.1	12.0	26.8	4.2	5.3	6.2	0.4	8.0	16.8	3.5	12.7	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.5	19.7	0.2	5.1	0.0	22.3	17.6	0.3	0.5	14.6	0.2	0.0	5.3	2.1	0.0	0.4	9.3	0.0	0.2	0.0	0.1	0.1	1.3	6.6	0.8	0.0	5.5	4.3	0.0	0.8	0.0	0.7	46.8	0.0	0.6	0.0	74.7	0.6	0.0	0.0	15.0	0.8	12.8	0.1	76.5	0.0	0.0	0.0	0.2	14.9	0.5	0.6	17.2	52.8	0.2	0.1	33.8	0.1	5.2	0.6	1.2	0.0	3.3	0.0	2.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.6	6.0	6.3	6.5	5.1	8.2	5.1	12.8	6.2	0.0	7.9	0.0	0.4	2.2	0.3	191.0	0.0	0.0	1.2	17.4	0.0	0.2	0.0	1.4	0.4	67.1	0.0	0.0	0.0	1.9	14.4	0.4	0.0	0.0	1.5	0.0	0.0	23.4	0.6	0.0	7.5	1.1	1.7	1.8	0.0	13.2	0.4	0.0	3.9	0.0	1.1	103.5	44.2	0.5	3.1	2.0	0.1	0.0	0.0	0.3
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 154.2;tongue: 80.5"	"Cell type enhanced"	"Detected in many"	14	"Fibroblasts: 286.6;Glandular cells: 140.0;Suprabasal keratinocytes: 166.6;Urothelial cells: 412.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 163.8;MCF7: 62.5;T-47d: 126.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	4.9	1.1	1.0	1.7	3.2	0.7	16.8	1.3	2.1	66.8	1.3	1.2	38.5	0.0	13.9	2.8	154.2	13.1	2.8	1.2	0.9	2.1	1.4	0.2	0.7	0.4	0.8	2.9	5.9	0.8	2.7	5.0	7.0	3.7	6.7	0.7	7.9	10.6	28.0	0.5	25.7	0.9	8.8	1.1	0.8	0.5	1.1	0.9	2.1	2.2	80.5	33.5	10.0	66.6	0.1	0.0	0.4	0.0	0.0	1.3	0.5	10.4	0.5	12.0	0.1	15.6	23.4	0.0	22.2	163.8	1.8	2.2	18.6	38.6	0.1	11.0	23.6	0.2	13.6	2.9	0.0	0.5	0.2	0.8	0.0	1.4	0.1	3.1	0.0	0.2	7.4	1.1	2.6	0.0	1.4	0.0	0.2	0.1	0.2	0.2	62.5	0.1	0.1	14.4	1.2	5.9	0.1	0.0	0.3	0.2	0.4	29.8	2.1	0.3	38.7	0.1	23.5	126.9	0.0	0.0	0.4	6.8	3.7	1.3	1.0	2.2	0.1	3.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	0.0	0.1	1.3	1.2	0.4	0.0	0.0	0.0	0.0	0.5	1.0	3.2	1.3	2.1	0.9	2.1	0.8	2.9	3.7	0.9	0.0	1.6	0.0	100.3	57.8	1.7	0.6	0.0	4.0	10.3	15.7	2.0	42.7	0.0	12.0	2.0	4.3	0.4	0.0	4.5	5.4	286.6	140.0	0.0	0.0	8.9	0.0	0.0	10.4	0.0	0.7	18.4	1.0	59.1	0.0	0.5	0.8	11.9	0.0	35.3	0.0	0.5	0.0	22.7	1.4	6.6	166.6	15.1	2.9	0.6	412.9
ISG20L2	FLJ12671	ENSG00000143319	"Interferon stimulated exonuclease gene 20 like 2"	Q9H9L3	1	156721891-156728799	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.1"	"Group enriched"	"Detected in many"	29	"Early spermatids: 725.4;Late spermatids: 2397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028005, HPA054285"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028005: AB_2126319, HPA054285: "	"unprognostic (1.67e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (5.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.32e-1)"	8.0	7.9	8.5	9.5	10.5	12.1	9.7	15.4	11.2	8.6	8.9	10.2	8.9	7.7	10.6	8.5	13.8	9.3	7.9	8.2	7.9	6.1	8.6	10.1	7.9	11.1	8.5	7.6	11.1	9.3	8.4	10.6	10.5	8.3	8.8	11.3	7.5	8.8	9.0	7.2	10.6	10.5	11.6	7.9	10.6	9.2	98.1	9.4	14.1	8.4	7.6	14.3	9.8	9.2	9.5	8.0	20.4	10.6	11.9	9.9	5.5	13.5	10.2	9.5	10.1	9.9	7.7	14.6	9.7	9.2	13.4	9.3	14.0	10.8	25.6	12.3	7.9	6.0	18.8	22.0	16.3	10.3	13.3	13.8	13.8	7.9	7.9	9.8	33.1	15.1	7.7	16.1	12.4	13.6	8.2	12.1	11.8	22.1	12.0	8.6	18.5	15.0	8.6	30.1	29.2	17.6	18.5	10.8	16.9	9.2	10.6	18.6	23.5	11.7	32.0	9.3	14.7	20.6	21.3	7.2	7.6	11.0	8.7	18.8	15.9	24.6	33.3	6.8	16.8	9.8	20.4	8.3	15.5	8.5	10.1	9.9	7.7	7.0	8.7	8.0	9.5	6.8	8.3	16.0	11.9	10.6	5.1	6.2	5.5	8.5	10.5	15.4	11.2	7.9	6.1	8.5	7.6	8.3	9.4	26.8	40.8	21.7	36.3	47.1	22.4	9.3	25.5	21.4	35.2	7.0	23.6	30.5	14.9	20.2	725.4	23.9	29.3	0.0	15.0	33.1	22.9	32.1	26.6	16.8	18.7	22.3	30.6	18.4	19.8	2397.2	27.0	25.7	21.9	10.8	28.3	18.4	18.3	21.0	24.4	10.9	18.9	25.8	24.7	35.8	26.8	53.1	31.4	27.7	23.0	34.6
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047426: AB_2680041"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	14.1	19.4	12.4	22.6	19.0	8.7	19.1	15.3	18.8	17.6	25.7	20.8	31.2	22.5	20.3	22.9	18.4	24.4	20.2	12.5	13.3	10.9	15.9	25.8	14.5	14.4	19.9	14.5	24.5	29.2	24.3	18.8	20.5	16.1	21.8	14.8	20.2	22.5	24.5	21.9	23.9	26.6	12.9	14.7	18.5	19.3	25.9	17.7	11.9	30.3	13.5	15.9	21.7	27.9	4.9	5.9	7.0	4.0	6.5	8.6	2.9	5.9	11.8	8.8	8.6	23.7	10.9	13.4	4.5	13.9	7.8	5.9	6.4	27.6	10.2	13.6	7.1	11.0	25.6	12.2	10.6	3.2	20.2	10.3	6.1	11.2	4.7	14.9	9.1	16.8	16.8	20.4	7.8	14.9	9.3	6.5	9.2	14.6	23.1	4.1	14.4	4.6	10.7	10.1	26.0	3.7	7.6	5.8	23.6	9.3	6.5	11.4	16.5	8.0	16.5	9.8	14.0	21.8	19.6	6.3	4.9	6.0	7.5	6.0	26.9	26.3	12.6	5.4	10.3	5.8	6.7	3.3	4.7	6.8	2.5	6.9	3.4	6.6	4.8	5.9	4.9	5.3	6.0	7.0	6.5	4.0	2.2	8.6	2.9	12.4	19.0	15.3	18.8	13.3	10.9	19.9	14.5	16.1	17.7	6.0	10.8	9.7	21.1	9.0	9.9	6.1	20.4	6.7	10.3	3.5	11.8	21.2	8.3	10.3	44.1	11.3	18.0	0.0	11.6	14.3	9.4	17.5	4.7	18.5	9.6	7.9	9.2	9.2	10.2	10.3	10.3	6.6	8.5	9.0	16.6	20.3	9.4	17.5	8.9	11.6	11.6	12.9	6.2	15.8	22.8	10.0	27.1	8.3	16.5	15.9
MRPL24	MRP-L18	ENSG00000143314	"Mitochondrial ribosomal protein L24"	Q96A35	1	156737303-156741590	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030295, HPA054323"	Approved				"Intracellular and membrane"	NA	NA					"HPA030295: AB_10600932, HPA054323: AB_2732583"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.47e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	27.3	33.3	25.4	14.4	28.9	7.0	25.6	11.1	27.6	19.3	22.8	24.3	27.3	14.4	21.0	36.0	22.5	27.0	21.0	35.1	22.3	18.5	27.9	63.8	12.5	17.9	29.5	20.0	24.9	62.7	26.6	14.7	14.7	22.9	25.4	25.1	15.9	25.2	25.5	47.7	17.8	14.8	28.0	24.5	17.7	20.6	15.4	21.0	14.5	26.4	23.6	19.5	21.2	16.9	30.6	28.0	9.5	25.3	29.8	34.4	30.2	27.5	46.2	9.9	12.1	31.8	34.3	19.6	22.4	14.1	30.5	17.3	18.5	29.2	21.4	37.8	29.5	14.9	27.5	23.8	46.4	30.7	25.8	29.8	19.9	31.9	17.8	35.9	21.8	14.1	31.7	40.5	46.1	48.8	18.6	26.6	26.6	19.7	25.4	30.3	49.3	24.3	21.8	18.3	94.7	56.8	15.9	26.7	43.4	37.5	20.3	12.7	25.8	13.6	77.1	35.4	19.8	46.0	24.9	20.1	28.4	21.8	27.9	38.1	28.7	24.1	21.9	26.8	25.9	28.1	9.5	21.9	3.6	22.9	25.3	34.4	30.6	30.4	28.2	28.0	29.5	30.8	32.2	1.1	29.8	23.7	23.3	23.6	30.2	25.4	28.9	11.1	27.6	22.3	18.5	29.5	20.0	22.9	21.0	29.8	24.0	38.5	58.2	27.1	13.1	145.2	79.0	41.5	38.7	40.1	3.9	85.3	131.0	46.4	20.4	39.4	30.9	46.7	66.8	70.9	46.3	47.7	59.9	104.1	71.9	14.3	34.5	32.5	27.2	9.6	51.8	39.2	70.9	64.1	40.0	19.5	45.3	21.0	49.8	170.4	12.7	32.3	71.2	40.9	47.8	32.0	34.1	26.6	66.7	60.9
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742107-156766925	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm		NA	NA		300000	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	27.6	24.0	24.4	26.4	24.6	78.7	51.5	26.7	22.1	29.7	57.9	22.4	23.9	40.6	22.1	22.9	53.0	34.9	38.1	41.7	23.5	18.3	64.5	92.6	38.0	32.6	23.7	12.9	29.0	35.3	25.6	19.0	49.1	20.4	21.3	37.5	15.9	26.5	30.6	57.2	39.2	83.1	21.7	25.5	30.0	25.6	11.8	22.4	79.0	38.3	64.8	44.0	30.9	29.6	7.5	14.5	10.4	12.3	6.1	9.7	7.8	72.9	36.2	41.6	19.8	24.1	33.2	46.0	24.2	61.9	56.8	37.2	40.9	78.0	49.4	47.9	48.2	25.3	51.7	61.9	54.4	56.6	40.0	43.9	42.2	52.6	35.7	32.1	61.8	35.7	23.8	52.2	44.4	86.8	45.3	41.8	39.1	55.2	41.4	46.2	53.7	50.9	68.5	73.5	117.0	51.4	57.5	24.9	65.9	62.4	24.7	62.2	67.6	57.8	76.5	29.1	53.8	61.1	96.1	36.9	28.8	44.7	36.4	61.4	55.9	69.4	86.0	38.3	49.2	36.6	6.0	12.3	10.4	8.5	10.4	6.3	6.7	7.3	7.5	14.1	7.5	6.6	6.2	7.1	6.1	11.4	14.5	9.7	7.8	24.4	24.6	26.7	22.1	23.5	18.3	23.7	12.9	20.4	22.4	65.5	86.4	36.5	146.2	130.9	60.7	81.8	79.0	123.1	80.8	68.0	25.5	38.8	68.0	89.5	37.7	46.6	109.5	70.0	112.1	90.8	73.3	173.1	30.0	144.0	46.2	50.9	119.7	27.6	33.2	33.1	37.7	55.8	37.1	37.9	83.0	56.2	134.0	51.8	43.2	94.2	31.4	19.4	48.5	28.7	24.6	139.4	45.9	41.5	82.1	206.9
PRCC	RCCP1	ENSG00000143294	"Papillary renal cell carcinoma (translocation-associated)"	Q92733	1	156750610-156800817	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.3	24.9	28.5	25.8	29.7	33.7	23.7	33.2	43.5	29.8	30.0	35.9	21.8	24.6	35.1	22.8	30.3	25.6	28.7	23.8	28.0	24.5	26.1	33.1	22.0	30.1	22.1	25.2	30.1	23.7	31.0	22.7	38.8	22.6	25.6	21.5	25.6	37.2	24.0	47.4	33.6	30.1	25.7	20.4	29.7	24.1	26.2	19.2	51.9	27.5	29.8	30.7	25.4	23.8	21.4	27.1	36.9	23.1	19.3	22.1	16.9	20.1	17.4	13.8	15.8	11.6	9.2	24.0	14.1	13.8	15.7	13.6	27.3	17.0	20.7	24.4	11.1	9.1	21.0	19.6	14.8	12.3	25.8	25.6	15.1	12.9	17.6	14.3	20.8	17.9	13.0	17.2	13.7	12.5	12.3	14.4	13.7	24.9	19.3	11.0	35.9	23.7	24.4	33.3	28.1	21.7	20.8	12.2	27.8	16.5	19.4	24.5	43.8	14.9	37.6	23.3	23.7	27.0	33.5	13.2	16.0	16.8	17.6	23.1	49.7	74.3	32.0	15.8	13.5	14.8	26.9	20.0	36.9	20.5	20.6	19.6	18.0	18.5	22.1	22.4	21.4	18.4	18.9	19.3	19.3	23.1	27.1	18.5	16.9	28.5	29.7	33.2	43.5	28.0	24.5	22.1	25.2	22.6	19.2	8.9	16.0	27.9	32.9	46.5	17.3	10.6	20.4	12.0	15.9	19.2	21.6	54.4	18.3	35.7	5.8	27.0	25.1	0.0	28.1	52.6	29.2	25.0	16.2	15.3	37.9	27.0	33.0	23.4	18.7	7.1	28.1	25.4	20.3	51.3	23.1	16.5	29.8	27.4	26.9	23.7	16.8	32.3	32.5	33.6	48.1	44.8	84.6	34.1	27.7	31.8
SH2D2A	"F2771, TSAd"	ENSG00000027869	"SH2 domain containing 2A"	Q9NP31	1	156806243-156816862	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.5;lymphoid tissue: 41.2"	"Cell type enriched"	"Detected in many"	8	"T-cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 26.5"	"Group enriched"	"Detected in many"	30	"NK-cells: 10.1;T-cells: 26.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.4;HMC-1: 16.1;Karpas-707: 38.9;RPMI-8226: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074482	Enhanced					NA	NA					"HPA074482: "	"prognostic favorable (4.96e-4)"	"unprognostic (2.76e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.26e-12)"	"unprognostic (1.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.31e-4)"	4.1	1.4	0.6	14.3	2.3	4.3	2.0	0.8	1.8	2.6	2.6	1.1	0.5	3.0	2.1	3.8	1.8	2.0	6.2	3.4	0.7	0.8	2.6	2.9	10.3	14.1	1.3	0.4	1.7	1.5	0.0	2.6	1.0	1.4	3.5	2.6	3.1	3.1	2.4	1.3	0.6	9.1	2.0	1.6	20.5	3.4	0.6	1.0	41.2	2.2	2.5	16.0	5.2	1.8	0.3	0.0	0.6	0.0	10.1	26.5	5.9	1.2	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	3.3	0.0	0.0	0.0	0.2	0.6	0.0	21.4	0.0	3.1	0.3	0.4	0.1	0.2	16.1	0.2	0.0	0.1	1.6	0.0	0.1	5.6	0.8	38.9	0.0	0.1	2.6	0.3	2.3	1.9	4.0	0.4	0.0	11.3	0.0	0.1	3.6	0.0	0.7	0.4	0.3	0.2	0.1	0.6	1.0	0.0	0.0	0.1	0.2	5.6	7.4	3.9	0.0	3.2	0.1	0.3	0.0	0.0	26.5	0.0	24.8	0.3	11.2	16.2	0.0	0.1	4.3	11.1	0.6	10.1	0.0	0.0	12.8	5.9	0.6	2.3	0.8	1.8	0.7	0.8	1.3	0.4	1.4	1.0	3.0	2.9	0.8	0.1	1.9	2.7	0.6	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.6	1.0	1.4	0.2	8.1	0.6	1.0	0.0	1.2	1.3	0.6	0.0	0.0	1.0	0.0	0.0	0.9	0.4	3.6	0.3	0.0	0.0	1.2	0.0	1.4	0.0	3.4	1.1	0.1	62.3	1.3	0.4
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Group enriched"	"Detected in some"	8	"granulocytes: 56.4;Horizontal cells: 54.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 42.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	6.8	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5	0.0	2.2	0.0	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	56.4	0.0	0.1	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	2.5	0.1	0.0	0.0	0.0	0.0
INSRR	IRR	ENSG00000027644	"Insulin receptor related receptor"	P14616	1	156840063-156859018	"Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.5;brain: 5.9;kidney: 8.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 1.3;Cardiomyocytes: 1.7;Early spermatids: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 5.5;SH-SY5Y: 19.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA025285	Uncertain					NA	NA					"HPA025285: AB_1851814"	"unprognostic (1.19e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.66e-2)"	0.9	5.5	0.0	0.3	5.9	0.1	0.8	1.9	1.4	1.9	0.1	0.0	0.0	0.1	2.7	0.1	0.1	0.6	0.3	1.9	0.5	1.3	8.3	0.1	0.1	0.4	0.8	0.6	0.3	0.9	0.1	1.7	0.4	5.6	2.7	0.1	2.1	0.6	0.5	0.4	0.1	0.2	0.3	0.0	0.2	3.0	4.2	0.4	0.3	0.3	0.0	0.8	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	19.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.9	1.4	0.5	1.3	0.8	0.6	5.6	0.4	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		35000000	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	18.5	7.1	1.8	3.0	5.1	2.8	29.2	1.2	2.9	16.5	5.8	2.7	6.3	2.3	15.9	10.5	6.6	8.9	10.3	11.1	2.7	1.8	6.8	3.8	12.0	10.1	3.2	2.1	10.6	3.2	1.7	3.9	15.5	3.7	9.6	1.4	15.5	4.1	5.5	11.4	4.4	4.1	9.6	3.1	12.2	4.1	8.1	1.5	0.6	10.5	5.8	2.1	6.7	11.5	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.2	1.3	0.4	0.0	0.0	1.8	0.0	5.4	9.1	2.2	1.3	0.1	0.2	0.0	0.2	4.0	0.2	0.1	0.0	13.8	0.6	0.0	0.0	6.7	0.2	0.3	10.4	0.0	0.0	5.4	0.0	3.1	0.7	0.5	24.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	39.2	0.0	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	1.8	5.1	1.2	2.9	2.7	1.8	3.2	2.1	3.7	1.5	0.0	5.6	0.0	0.0	0.8	1.3	5.6	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.1	26.3	0.0	23.3	0.3	0.1	5.1	0.1	1.1	0.0	0.4	0.0	1.7	34.4	1.3	1.9	41.1	0.4	5.0	0.0	1.0	0.3	0.9	0.0	33.6	0.0	0.2	25.8	14.6	0.7	1.1	1.0	0.2	0.0	0.0	0.1
LRRC71	"C1orf92, FLJ32884"	ENSG00000160838	"Leucine rich repeat containing 71"	Q8N4P6	1	156920650-156933094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;fallopian tube: 16.9;testis: 26.4"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 96.4;Early spermatids: 207.3;Late spermatids: 442.9"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.4;PC-3: 3.8;TIME: 3.4;U-2 OS: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.18e-1)"	"unprognostic (1.68e-7)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	0.3	0.8	1.1	0.1	4.0	0.1	0.1	0.0	0.3	1.1	0.1	5.6	0.0	0.1	0.5	5.6	0.1	16.9	0.1	0.1	1.7	1.8	0.1	0.1	3.0	0.1	0.2	0.4	3.6	0.1	0.1	0.0	0.3	9.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	26.4	1.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	4.0	0.0	0.3	1.7	1.8	0.2	0.4	9.5	1.2	0.0	2.6	0.0	0.0	0.0	0.2	0.4	0.0	96.4	18.2	0.0	0.0	0.0	0.0	0.0	207.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	442.9	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	10.9	2.3	0.0	0.0	0.0	0.0	0.0
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045370	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 47.5;Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	11.9	13.0	17.5	11.6	13.4	4.3	12.3	28.8	22.4	12.3	13.2	9.2	22.0	14.4	14.7	11.9	13.1	12.2	14.3	13.2	13.6	16.0	10.9	7.6	12.7	8.0	13.9	13.7	15.6	11.0	31.7	15.4	12.3	13.1	11.4	12.9	14.5	9.3	25.1	14.7	11.2	23.3	15.2	9.1	9.8	11.9	20.9	9.9	1.0	14.9	5.3	6.3	13.2	12.6	0.4	0.9	3.3	2.8	0.0	1.0	0.7	7.0	14.0	12.0	9.1	16.0	8.3	13.7	7.0	10.5	11.0	8.1	9.4	7.5	0.9	12.3	12.3	8.4	7.7	8.1	7.3	6.1	10.1	5.0	3.5	8.3	6.1	9.3	7.1	12.5	12.7	8.0	10.1	7.9	8.3	7.9	3.1	5.7	0.6	7.3	9.2	1.8	3.9	14.9	11.2	8.6	0.2	5.9	3.9	5.4	11.6	2.3	13.7	15.1	12.2	12.8	10.9	10.9	16.2	11.8	11.3	7.2	9.9	7.2	10.1	6.2	0.7	7.2	0.9	37.4	0.0	1.4	0.0	0.0	2.8	0.0	0.4	0.6	0.0	0.9	0.0	0.6	1.0	3.3	0.0	1.5	0.0	0.3	0.7	17.5	13.4	28.8	22.4	13.6	16.0	13.9	13.7	13.1	9.9	3.0	3.4	0.8	2.3	1.0	47.5	11.8	0.0	1.4	2.3	1.8	88.4	1.5	1.7	1.0	5.3	3.5	14.6	0.0	1.4	0.5	3.0	3.2	9.2	4.9	3.6	20.6	5.2	2.5	7.5	6.7	4.4	4.0	1.7	0.0	4.0	12.3	1.1	5.1	4.2	0.8	54.7	0.0	4.1	3.0	4.8	1.8	1.3	0.0	3.9	2.2
ETV3L	FLJ16478	ENSG00000253831	"ETS variant 3 like"	Q6ZN32	1	157092044-157099808	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.8;breast: 4.4;lymphoid tissue: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.8;pons and medulla: 7.8"	"Group enriched"	"Detected in some"	13	"classical monocyte: 1.5;intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 27.7"					"Not detected"	"Not detected"									NA	NA						"unprognostic (7.39e-4)"	"unprognostic (1.53e-1)"			"unprognostic (3.22e-2)"	"unprognostic (1.79e-5)"		"unprognostic (2.25e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.57e-2)"			"unprognostic (3.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.37e-1)"		0.1	0.0	0.9	2.0	3.8	0.1	4.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.3	0.3	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.0	1.8	0.1	7.8	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.1	0.0	5.0	0.1	0.1	0.1	0.0	5.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.8	0.0	0.7	0.5	0.3	1.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ETV3	PE-1	ENSG00000117036	"ETS variant 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 155.1;Suprabasal keratinocytes: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	15.2	7.0	8.9	9.2	10.1	17.8	10.9	9.0	9.3	14.2	12.7	10.2	13.1	13.0	13.1	10.6	20.8	10.8	11.3	9.4	8.6	7.7	6.4	7.4	13.0	8.1	8.9	5.7	11.8	7.2	25.9	7.5	19.5	9.9	12.7	8.6	9.7	11.0	8.1	9.9	37.2	15.1	13.2	7.1	10.7	10.4	8.9	11.0	14.4	8.4	13.6	17.0	14.0	14.3	4.4	7.4	8.9	8.1	6.6	10.8	3.8	6.9	6.9	7.2	6.1	10.8	7.2	6.1	6.5	6.9	6.6	6.2	7.3	6.9	8.4	8.4	8.0	3.5	10.8	7.9	10.1	8.5	18.3	5.0	7.0	7.1	3.9	6.5	11.0	11.1	8.0	11.9	9.8	8.2	5.2	6.6	5.5	8.1	6.2	7.3	9.2	3.3	6.2	23.4	10.1	5.3	5.1	8.5	9.6	4.9	26.2	6.0	11.7	7.1	17.0	17.3	13.2	8.6	12.2	11.2	8.3	7.4	8.0	8.2	15.2	7.8	10.2	9.6	6.4	27.3	8.3	8.1	5.4	7.9	6.7	10.8	3.8	6.9	7.8	7.4	4.4	7.2	6.3	8.9	6.6	6.2	2.2	5.2	3.8	8.9	10.1	9.0	9.3	8.6	7.7	8.9	5.7	9.9	11.0	32.8	15.2	9.0	15.3	62.5	2.5	7.3	10.2	24.1	20.5	12.2	9.8	6.4	0.0	5.2	7.3	14.6	16.6	0.0	5.5	6.6	20.6	12.8	21.9	6.8	8.3	1.6	10.3	16.5	13.7	4.7	3.7	27.5	15.1	155.1	11.3	3.8	8.0	11.8	4.2	2.2	5.4	12.9	11.2	6.4	9.0	68.8	12.5	22.4	11.3	42.4
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552520	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4"	"Group enriched"	"Detected in some"	7	"B-cells: 61.9;Early spermatids: 51.2;Melanocytes: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 11.4;naive B-cell: 13.3"	"Lineage enriched"	"Detected in single"	19	"B-cells: 13.3"	"Group enriched"	"Detected in some"	5	"U-266/70: 5.8;U-698: 12.3"														"Secreted to blood"	NA	NA	169000000	36000000				"unprognostic (1.30e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.32e-5)"	"unprognostic (2.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.51e-10)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.78e-1)"	0.7	0.4	0.3	33.9	0.3	1.1	1.3	0.3	0.3	1.6	7.4	0.1	0.0	3.6	0.5	0.1	4.6	0.8	0.8	0.4	0.3	0.3	1.6	0.8	1.6	17.4	0.3	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.5	2.7	1.0	12.4	0.8	0.3	0.3	6.4	0.1	0.3	29.5	2.5	0.9	0.0	3.1	1.1	0.7	39.1	5.3	0.6	13.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	4.5	61.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.6	0.3	4.4	0.3	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	1.1	0.0	0.0	0.6	0.5	0.0	0.0
FCRL4	"CD307d, FCRH4, IGFP2, IRTA1"	ENSG00000163518	"Fc receptor like 4"	Q96PJ5	1	157573749-157598080	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 5.4;lymphoid tissue: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Cell line enriched"	"Detected in single"	104	"U-266/70: 10.4"					"Not detected"	"Not detected"			HPA054030	Approved					NA	NA					"HPA054030: "	"unprognostic (6.06e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.57e-1)"	"unprognostic (5.08e-2)"		"unprognostic (4.69e-4)"		"unprognostic (2.06e-2)"			"unprognostic (6.38e-2)"			"unprognostic (1.99e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-1)"	"unprognostic (6.77e-2)"	0.1	0.1	0.1	15.6	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	2.5	0.0	0.1	0.1	5.4	0.0	0.1	2.2	0.3	0.1	0.0	1.1	0.1	1.9	14.9	0.4	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700857	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;lymphoid tissue: 32.2"	"Cell type enhanced"	"Detected in some"	28	"B-cells: 38.7;Early spermatids: 7.0;Late spermatids: 7.6;T-cells: 14.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 20.3"	"Group enriched"	"Detected in many"	56	"B-cells: 20.3;NK-cells: 10.7;T-cells: 10.8"	"Cell line enriched"	"Detected in some"	7	"Daudi: 14.6"					"Low region specificity"	"Detected in single"			HPA048022	Enhanced					NA	NA					"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"	0.4	0.2	0.2	29.4	0.2	0.4	0.3	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.5	0.2	1.5	0.3	0.6	0.3	0.2	0.2	0.5	0.6	0.9	26.4	0.4	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.5	0.6	0.2	5.6	0.0	0.4	0.2	8.7	0.1	0.2	22.4	0.6	0.2	0.0	5.2	0.6	0.6	32.2	1.2	0.3	20.3	0.0	0.2	0.0	10.7	10.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	1.0	16.1	1.4	7.2	0.0	20.3	0.1	4.7	0.2	10.7	0.0	0.0	5.6	3.5	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.6	0.0	0.0
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 20.2;intestine: 14.9;lymphoid tissue: 27.0"	"Cell type enriched"	"Detected in some"	17	"B-cells: 57.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	50	"memory B-cell: 20.2;naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	65	"B-cells: 20.2"	"Group enriched"	"Detected in some"	4	"Daudi: 15.0;U-698: 12.2"															NA	NA						"unprognostic (3.94e-3)"	"unprognostic (1.47e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.69e-3)"		"unprognostic (5.11e-5)"	"unprognostic (1.67e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.19e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.60e-7)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.48e-1)"	0.4	0.2	0.2	22.6	0.2	1.5	0.2	0.1	0.2	0.2	1.3	0.1	0.1	1.2	0.3	0.1	1.4	0.2	0.4	0.2	0.2	0.2	0.5	0.9	0.7	15.6	0.3	0.1	0.5	0.2	0.0	0.2	0.1	0.2	0.4	1.7	0.6	2.8	0.7	0.1	0.2	14.9	0.1	0.2	27.0	0.8	0.2	0.1	0.3	0.5	0.1	23.3	1.4	0.2	20.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.2	0.0	12.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.0	1.4	57.3	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.1	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.3
FCRL1	"CD307a, FCRH1, IFGP1, IRTA5"	ENSG00000163534	"Fc receptor like 1"	Q96LA6	1	157794403-157820105	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 31.6;lymphoid tissue: 55.1"	"Cell type enriched"	"Detected in some"	60	"B-cells: 69.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	51	"memory B-cell: 16.8;naive B-cell: 31.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 31.6"	"Group enriched"	"Detected in some"	33	"Daudi: 5.7;U-698: 19.4"					"Low region specificity"	"Detected in all"			HPA013323	Enhanced					NA	NA		120000			"HPA013323: AB_1848480"	"unprognostic (6.52e-4)"	"unprognostic (3.49e-3)"	"unprognostic (8.68e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-5)"	"unprognostic (1.47e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.74e-2)"	0.5	0.2	0.2	55.1	0.2	6.2	0.3	0.2	0.2	0.2	0.7	0.0	0.0	0.0	0.2	0.1	2.4	0.3	0.2	0.3	0.2	0.2	0.7	0.5	1.9	19.2	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.5	0.3	0.3	5.4	0.7	0.2	0.2	10.1	0.0	0.2	25.3	0.4	0.2	0.0	1.1	0.7	0.4	49.0	4.5	0.8	31.6	0.0	0.4	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.8	0.0	0.0	0.0	31.6	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830914-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 178.3"	"Group enriched"	"Detected in some"	28	"Hofbauer cells: 208.7;Kupffer cells: 384.3"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;Karpas-707: 2.0;REH: 2.0;RH-30: 1.2;U-266/70: 3.6"	"Not detected"	"Not detected"							"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	NA	NA	4030000000	6800000000			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		0.2	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	21.3	0.2	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	178.3	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	2.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	208.7	0.0	0.0	10.4	384.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
KIRREL1	"KIRREL, NEPH1"	ENSG00000183853	"Kirre like nephrin family adhesion molecule 1"	Q96J84	1	157993273-158100262	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 17.9;Ductal cells: 4.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 75.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030458	Approved					NA	NA		590000			"HPA030458: AB_10601438"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.76e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.12e-8)"	"unprognostic (2.11e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.85e-4)"	27.8	11.6	1.9	9.4	2.5	0.0	27.0	1.4	2.2	21.8	12.1	2.1	9.5	2.8	28.8	10.4	12.2	14.3	18.0	9.5	1.5	2.5	12.4	4.1	13.2	9.2	2.2	2.2	32.6	3.7	2.7	4.5	20.4	4.6	14.0	5.5	23.5	6.8	12.8	7.2	6.0	6.6	20.9	2.2	11.9	6.8	10.9	1.3	5.1	11.4	8.5	6.1	17.3	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	9.7	17.3	15.6	24.8	21.7	0.0	17.4	23.0	14.2	11.5	17.3	13.8	0.0	29.7	19.3	10.1	12.8	9.7	15.8	11.2	0.0	2.1	0.0	9.9	0.0	18.4	0.0	0.2	27.9	6.4	24.0	18.7	18.1	8.9	4.3	0.1	0.0	13.0	0.0	2.4	0.0	13.6	0.0	7.6	2.7	8.1	0.1	40.1	0.2	2.7	0.1	15.0	0.0	32.2	18.7	1.3	0.3	16.4	19.0	12.1	18.6	23.2	0.0	0.0	0.0	16.3	0.0	75.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.4	2.2	1.5	2.5	2.2	2.2	4.6	1.3	17.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	4.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158179947-158184896	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.5;lymphoid tissue: 17.8"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 27.5;Kupffer cells: 52.9;Macrophages: 34.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 49.5;monocytes: 49.5"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 45.7"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: AB_2686545"	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	1.5	1.2	0.0	8.6	0.0	2.6	1.2	0.0	0.0	0.8	2.5			9.5	1.5	0.0	0.4	1.4	2.0	1.4	0.0	0.1	1.6	10.5	2.3	5.5	0.2		0.3	0.7	0.0	0.6	0.0		1.4	3.7		0.7	0.3	0.6	0.0	12.2	2.2	0.4	17.8	1.4	1.4			1.8		3.4	1.6	0.5	6.3	49.5	2.5	49.5	0.1	0.1	23.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	2.9	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	3.2	0.4	0.0	0.6	0.0	0.0	45.7	0.0	0.0	0.0	0.0	11.2	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.3	0.0	3.1	0.4	0.0	49.5	0.1	0.0	22.4	0.1	6.3	0.0	0.0	49.5	4.7	0.0	0.0	2.5	0.1	3.6	0.5	0.0	23.5											0.0	5.1	27.5	0.4	0.2	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.2	2.2	0.0	0.0	0.1	0.2	0.0	1.1	5.3	11.3	1.6	2.4	4.3	52.9	0.9	0.0	34.3	0.0	10.0	2.0	0.3	0.0	3.7	0.0	0.0	0.1	0.0	0.5	0.5	0.9	0.1	0.1	0.0	3.9	0.0
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254137-158258269	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 105.1"	"Cell type enhanced"	"Detected in some"	17	"Basal keratinocytes: 6.5;Kupffer cells: 1.6;Macrophages: 2.9;Melanocytes: 1.7;Suprabasal keratinocytes: 6.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4"	"Group enriched"	"Detected in many"	35	"B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9"	"Group enriched"	"Detected in some"	86	"JURKAT: 21.2;MOLT-4: 33.8"									"CAB000009, HPA010734"	Enhanced					NA	NA					"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (7.21e-5)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.37e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.49e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.1	0.9	0.1	0.0	1.0	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.2	0.1	8.0	0.0	0.6	0.1	0.1	0.0	0.2	0.1	1.8	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.9	0.1	0.1	20.9	0.3	0.1	0.1	1.4	0.3	0.2	0.1	105.1	0.1	1.0	2.7	0.4	1.1	6.8	10.2	0.0	5.9	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.7	0.2	6.8	0.0	0.0	10.2	5.4	0.1	0.0	0.0	0.0	0.2	0.2	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.0	0.0	0.0	0.0	0.0
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289786-158293630	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 70.8;lymphoid tissue: 111.4"	"Cell type enhanced"	"Detected in some"	21	"B-cells: 37.2;Macrophages: 73.3;Melanocytes: 18.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 18.6;myeloid DC: 70.8"	"Group enriched"	"Detected in many"	8	"B-cells: 18.6;dendritic cells: 70.8"	"Group enriched"	"Detected in some"	9	"JURKAT: 11.0;MOLT-4: 34.8"															NA	NA		240000				"unprognostic (2.55e-3)"	"prognostic favorable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"	1.8	0.4	0.5	8.2	0.6	0.0	2.2	0.5	0.5	1.1	1.2	0.5	1.3	0.4	1.4	1.2	1.8	1.6	5.1	0.6	0.5	0.3	1.6	1.5	2.8	13.2	0.6	0.5	0.7	0.7	0.0	0.6	0.7	0.6	1.0	4.8	0.9	3.0	1.0	0.6	5.5	11.7	1.3	0.5	24.6	1.2	0.8	0.5	111.4	1.0	2.4	20.5	1.4	1.3	18.6	70.8	0.2	5.9	0.9	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	34.8	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.1	5.9	0.0	0.0	5.1	0.0	18.6	0.0	0.0	70.8	9.3	0.0	0.0	0.2	0.9	0.6	0.3	0.1	3.3	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.5	0.6	0.5	0.0	6.9	37.2	0.0	11.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.1	2.3	0.0	3.5	0.0	4.0	0.0	0.0	0.0	5.9	3.3	0.0	73.3	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	6.5	0.0	0.0	0.0	0.0
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 188.8"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"myeloid DC: 16.3"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 16.3"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 112.0"									HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.8	0.1	0.2	1.9	0.2	0.0	0.6	0.2	0.2	0.8	0.6	0.3	0.2	0.0	0.3	0.2	0.9	0.7	1.3	0.2	0.2	0.0	0.6	0.3	1.7	4.0	0.2	0.2	0.3	0.3	0.0	0.2	0.2	0.2	0.2	5.6	0.2	0.6	0.2	0.2	6.2	0.8	0.3	0.2	1.9	0.9	0.2	0.2	188.8	0.4	0.4	2.4	0.5	0.8	0.0	16.3	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	112.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	17.4	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 308.0"	"Cell type enriched"	"Detected in some"	9	"Macrophages: 75.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"myeloid DC: 29.7"	"Lineage enriched"	"Detected in many"	13	"dendritic cells: 29.7"	"Cell line enriched"	"Detected in some"	42	"MOLT-4: 171.9"					"Not detected"	"Not detected"			HPA057769	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057769: AB_2683522"	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	1.0	0.2	0.7	2.8	0.7	0.0	1.1	0.7	0.7	1.5	1.0	0.7	0.7	1.2	0.9	0.7	7.0	1.9	3.9	0.7	0.7	0.2	2.0	0.7	2.4	4.7	0.7	0.7	0.7	0.8	0.0	0.7	0.7	0.7	1.8	4.8	0.8	1.9	0.8	0.8	11.5	2.1	0.8	0.7	3.8	3.1	0.9	0.7	308.0	1.0	1.3	8.1	2.4	2.7	0.0	29.7	0.0	2.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	171.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.1	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.7	0.7	0.7	0.7	0.2	0.7	0.7	0.7	0.7	3.0	0.3	0.0	0.0	7.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.6	0.0	0.0	0.0	6.4	0.0	0.0	75.9	8.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	6.1	0.1	0.0	0.0	0.0
OR10T2		ENSG00000186306	"Olfactory receptor family 10 subfamily T member 2"	Q8NGX3	1	158398522-158399466	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"JURKAT: 1.6;MCF7: 1.2;MOLT-4: 4.0;SCLC-21H: 3.7"					"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10K2		ENSG00000180708	"Olfactory receptor family 10 subfamily K member 2"	Q6IF99	1	158418210-158426237	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"blood: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059125	Uncertain					NA	NA					"HPA059125: AB_2683913"																		0.1	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.1	0.1			0.4	0.1	0.7	0.1	0.4	0.2	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.0		0.6	0.7	0.0	0.1	0.1		0.1	0.2		0.1	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.1	0.2			0.2		0.0	0.0	0.1	0.7	0.2	1.2	0.2	0.4	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.5	0.5	2.2	0.2	0.2	0.2	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.2	0.1	0.4	0.8	0.1	0.3	0.0	0.0	0.9	0.1	0.1	0.2	0.1	0.2	0.6	0.1	0.2	0.0	0.7	0.3	0.4	1.2	0.4	0.2	0.2	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10K1		ENSG00000173285	"Olfactory receptor family 10 subfamily K member 1"	Q8NGX5	1	158461574-158470857	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;esophagus: 2.9"	"Group enriched"	"Detected in some"	149	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 13.9;Ciliated cells: 22.7;Club cells: 9.1;granulocytes: 8.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA059125	Uncertain					NA	NA					"HPA059125: AB_2683913"																		0.2	0.4	0.2	0.8	0.3	2.0	0.2	0.2	0.4	0.7	0.3			0.2	0.3	0.8	2.9	0.2	0.2	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2		0.3	0.3	0.1	0.3	0.0		0.2	0.0		0.2	0.0	1.6	0.4	0.3	0.0	0.3	0.5	0.3	0.9			0.2		1.0	0.8	0.3	1.4	0.5	2.4	0.6	0.9	1.2	0.1	1.2	1.0	1.0	1.0	0.7	0.6	1.3	0.7	0.5	0.1	0.4	0.6	0.9	1.2	1.8	0.3	2.8	1.0	0.4	0.4	1.5	1.6	0.4	1.3	1.1	0.8	0.3	0.9	1.6	0.1	0.1	0.9	0.4	0.7	0.1	0.6	0.9	3.8	0.1	0.4	1.2	1.6	2.1	0.2	0.2	1.0	0.5	0.8	0.0	0.9	0.8	1.2	0.8	0.4	2.0	0.9	0.9	1.1	0.4	1.2	2.2	2.1	0.9	2.1	1.6	1.0	0.7	1.0	1.9	1.6	0.6	0.2	1.2	0.5	1.2	0.7	0.9	1.0	0.3	1.4	0.9	1.0	2.4	0.9	0.4	0.5	0.8	0.1											20.8	13.9	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10R2	OR10R2Q	ENSG00000198965	"Olfactory receptor family 10 subfamily R member 2"	Q8NGX6	1	158472220-158480936	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"MOLT-4: 26.4"									"HPA059775, HPA060399"	Uncertain					NA	NA					"HPA059775: AB_2684124, HPA060399: AB_2684276"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			1.2		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6Y1	OR6Y2	ENSG00000197532	"Olfactory receptor family 6 subfamily Y member 1"	Q8NGX8	1	158544550-158554405	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.4	0.4	0.3	0.2	0.4	2.5	0.4	0.4	0.4	0.9	0.4			0.6	0.3	1.2	0.4	0.3	0.5	0.4	0.3	0.3	0.3	0.6	0.3	0.5	0.4		0.5	0.4	2.6	0.3	0.0		0.3	0.2		0.8	0.0	0.6	2.6	0.4	0.0	0.4	0.4	0.8	0.9			0.4		0.2	0.7	0.4	1.1	0.5	2.5	0.8	0.6	0.6	0.0	1.4	0.7	1.1	1.6	0.6	0.6	1.2	0.9	0.1	0.0	0.1	0.8	1.1	0.9	1.1	0.5	1.8	1.4	0.6	0.8	0.7	1.4	0.4	1.5	2.9	1.0	0.5	1.1	1.7	0.4	0.7	2.0	0.8	0.8	0.1	1.2	1.2	2.9	0.5	1.4	1.4	1.6	1.9	0.8	0.8	0.9	5.3	0.8	1.0	1.5	1.0	1.1	0.7	0.7	1.2	1.4	1.1	0.9	1.4	1.2	2.1	1.6	0.6	1.8	1.2	1.0	1.1	1.3	0.9	2.5	0.4	0.6	0.6	0.3	0.4	0.6	0.5	0.5	0.3	1.1	0.6	0.4	1.3	0.6	0.8	0.5	0.4	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6P1		ENSG00000186440	"Olfactory receptor family 6 subfamily P member 1"	Q8NGX9	1	158560606-158570580	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	10	"testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047466	Uncertain					NA	NA					"HPA047466: AB_10963091"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10X1	OR10X1P	ENSG00000279111	"Olfactory receptor family 10 subfamily X member 1 (gene/pseudogene)"	Q8NGY0	1	158578919-158579899	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		1.4	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10Z1		ENSG00000198967	"Olfactory receptor family 10 subfamily Z member 1"	Q8NGY1	1	158605268-158612514	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"bone marrow: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"K-562: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.1	0.7	0.1			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.9	0.1	0.2	0.0	0.1	1.0	0.3	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.1	0.1	0.2	0.3	4.8	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.8	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPTA1	EL2	ENSG00000163554	"Spectrin alpha, erythrocytic 1"	P02549	1	158610706-158686715	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin capping, Actin-binding"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 41.0"	"Cell type enriched"	"Detected in some"	42	"Erythroid cells: 70.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"K-562: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016193, HPA028048, HPA028253, CAB037246"	Enhanced					NA	NA		45000000			"CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.50e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.73e-8)"	"unprognostic (6.08e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.85e-3)"	0.6	0.0	0.0	1.1	0.0	41.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	8.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.6	4.6	0.0	2.2	0.0	0.3	0.9	0.0	0.0	0.0	2.8	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.1	0.0	70.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6K2		ENSG00000196171	"Olfactory receptor family 6 subfamily K member 2"	Q8NGY2	1	158699678-158700652	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6K3		ENSG00000203757	"Olfactory receptor family 6 subfamily K member 3"	Q8NGY3	1	158716327-158720720	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 10.4;bone marrow: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in many"	6	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055949	Uncertain					NA	NA					"HPA055949: AB_2682982"																		0.1	0.1	0.0	0.0	0.1	4.8	0.1	0.1	0.1	0.2	0.1			0.3	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	2.2	0.3	0.1		0.2	0.1	0.1	0.1	0.1		0.1	0.0		0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.1	0.4			0.1		0.0	0.2	0.1	1.3	1.0	10.4	0.9	0.9	1.5	0.3	0.2	0.3	0.1	0.9	0.6	0.2	0.5	0.2	0.4	0.4	0.2	0.6	0.7	1.1	0.3	0.2	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.5	0.2	0.8	0.4	0.9	0.6	0.3	1.8	0.4	0.3	0.7	0.5	2.8	0.2	0.7	0.3	1.0	0.2	0.5	0.0	0.4	0.2	0.4	0.2	0.6	0.4	0.0	0.0	0.3	0.1	0.7	0.2	0.0	1.6	0.6	0.5	0.4	0.1	0.6	0.6	0.6	0.0	0.6	0.7	10.4	0.9	0.9	1.3	0.8	1.4	1.1	1.3	1.0	0.4	1.3	1.4	1.5	1.7	0.9	0.7	1.0	0.9	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6N1		ENSG00000197403	"Olfactory receptor family 6 subfamily N member 1"	Q8NGY5	1	158747814-158772195	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 7.5;bone marrow: 4.4"	"Cell type enriched"	"Detected in single"	33	"Distal tubular cells: 3.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6K6		ENSG00000180433	"Olfactory receptor family 6 subfamily K member 6"	Q8NGW6	1	158754720-158755891	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"blood: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	57	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	57	"granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6N2		ENSG00000188340	"Olfactory receptor family 6 subfamily N member 2"	Q8NGY6	1	158774222-158781204	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"blood: 2.9;bone marrow: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	21	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056637	Uncertain					NA	NA					"HPA056637: AB_2683198"																		0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.4	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"	"Group enriched"	"Detected in some"	15	"NB-4: 36.7;THP-1: 69.4;U-937: 45.4"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		110000	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3	32.8	82.3	20.5	0.0	2.2	0.6	0.7	10.2	14.7	17.0	0.0	0.0	0.8	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.9	2.3	0.0	40.7	1.3	203.8	0.0	0.0	6.2	493.3	0.9	1.1	520.9	1.7	25.2	0.0	130.5	0.0	0.0	0.0	1.1	4.7	12.9	9.2	0.3	0.2	1.9	0.8	1.0	0.0	0.0
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977054	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.4;lymphoid tissue: 23.3"	"Cell type enriched"	"Detected in some"	11	"T-cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.4;T-cells: 33.4"	"Cell line enriched"	"Detected in some"	6	"U-698: 33.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	4.0	0.6	0.5	20.1	0.5	3.9	2.1	0.4	0.4	2.0	2.7	0.2	0.3	1.2	2.2	1.4	1.7	1.6	3.2	1.2	0.6	0.5	1.8	2.6	11.7	18.8	0.7	0.0	1.6	0.8	0.0	0.8	1.7	0.4	2.6	1.8	1.2	3.4	1.2	0.7	0.9	7.8	0.4	1.3	20.7	2.0	1.0	0.0	6.6	2.5	1.9	23.3	5.7	1.6	4.9	0.1	1.2	0.1	11.4	33.4	6.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	33.1	0.0	5.1	0.0	0.4	0.1	0.1	33.4	0.1	19.1	4.9	14.2	25.2	0.1	2.4	4.8	16.0	1.2	11.4	0.1	0.1	21.0	6.0	0.5	0.5	0.4	0.4	0.6	0.5	0.7	0.0	0.4	0.0	11.9	3.2	9.5	0.7	0.3	0.2	0.3	0.0	9.4	3.4	3.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.4	2.3	1.3	2.1	0.0	0.0	3.1	4.3	0.0	0.0	1.4	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.1	0.5	0.1	126.8	0.0	0.3
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	7.0	0.5	2.4	0.1	17.0	56.4	0.0	15.0	40.3	42.3	56.3	0.0	9.1	41.5	12.9	9.2	13.6	20.5	0.3	15.2	16.9	12.8	0.1	10.6	3.1	0.0	31.9	3.6	0.7	53.1	27.3	21.6	30.8	20.3	44.4	36.7	0.2	30.4	23.4	0.0	48.7	3.4	6.5	0.0	5.5	23.0	15.6	47.9	5.9	2.7	1.1	0.0	19.6	0.1	42.6	10.2	0.0	4.3	25.0	10.9	5.1	30.6	6.3	28.4	13.2	39.0	31.3	12.0	26.2	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0	35.7	66.1	149.1	95.2	84.3	0.2	6.9	22.9	58.9	119.4	40.1	0.0	3.0	1.7	32.6	4.0	196.0	5.6	0.0	40.2	1.9	91.8	23.0	129.9	2.9	175.9	0.0	11.6	126.4	165.6	4.9	108.7	168.3	79.2	49.5	16.2	31.8	42.0	24.6	49.8	4.4	0.9	84.1	124.0	2.6	1.9	59.6	2.7	201.5	21.7	108.0
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 44.7;lymphoid tissue: 43.8"	"Group enriched"	"Detected in some"	6	"B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"memory B-cell: 44.7;naive B-cell: 14.3"	"Lineage enriched"	"Detected in many"	9	"B-cells: 44.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7"	"Low region specificity"	"Detected in all"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	0.7	0.3	1.3	28.2	0.9	0.4	0.6	0.5	0.6	0.4	1.9	0.1	0.0	0.7	0.2	0.2	4.1	0.5	1.1	0.5	1.2	0.6	0.9	0.8	2.0	24.1	0.5	0.2	0.6	0.3	0.0	8.8	0.4	0.5	0.7	1.0	0.5	1.9	0.0	0.2	0.3	12.8	0.2	2.6	43.8	1.3	1.4	1.4	1.4	0.7	0.6	25.9	4.0	0.5	44.7	1.2	4.7	2.4	0.0	3.3	1.4	5.3	0.0	0.3	0.0	0.0	4.4	0.0	0.0	0.5	0.4	0.3	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	44.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	2.9	0.0	2.8	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.1	14.8	11.1	0.3	13.7	1.2	2.3	4.2	2.4	0.0	0.6	2.1	1.7	44.7	1.6	1.1	1.2	14.3	0.1	0.4	4.7	0.0	2.2	0.0	3.3	1.4	1.3	0.9	0.5	0.6	1.2	0.6	0.5	0.2	0.5	1.4	0.0	0.0	18.9	0.1	0.0	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	19.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.9	24.1	0.3	1.0	3.3	1.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	2.1	0.0	0.4
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.5;placenta: 43.1"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 103.2;Fibroblasts: 46.4;Horizontal cells: 33.4;Melanocytes: 23.6;Muller glia cells: 35.4"	"Cancer enhanced"	"Detected in many"		"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 19.8;HSkMC: 66.3;hTERT-HME1: 35.5;U-2 OS: 9.9;WM-115: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced	Supported	Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000	Cytosol		"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (5.75e-4)"	8.9	5.4	23.3	8.5	41.0	0.9	6.1	88.4	96.5	18.0	8.8	6.9	0.7	3.2	2.2	1.6	7.2	3.2	4.1	4.3	23.2	27.4	1.1	1.1	2.9	7.8	18.5	22.4	1.2	2.0	1.0	7.4	43.1	30.4	1.7	8.9	4.5	2.6	3.6	2.0	7.7	6.4	4.1	9.6	7.6	2.8	2.4	4.6	0.0	4.8	0.7	5.9	10.2	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	19.8	0.0	0.0	66.3	0.0	0.0	35.5	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.1	0.0	0.0	1.5	0.0	0.0	2.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	41.0	88.4	55.6	23.2	27.4	18.5	22.4	30.4	4.6	0.0	0.3	0.0	0.0	6.0	103.2	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.1	4.0	0.0	0.0	0.0	0.4	46.4	0.1	0.0	0.0	1.0	33.4	0.0	4.3	0.0	4.7	0.6	0.0	23.6	0.0	0.0	35.4	0.0	0.0	0.0	0.0	7.5	0.0	3.9	0.9	1.7	3.8	0.6	0.0	0.0	0.0
ACKR1	"CCBP1, CD234, DARC, Dfy, FY, GPD"	ENSG00000213088	"Atypical chemokine receptor 1 (Duffy blood group)"	Q16570	1	159203307-159206500	"Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"Blood group antigen, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.8"	"Cell type enhanced"	"Detected in many"	26	"Bipolar cells: 50.1;Endothelial cells: 278.7;Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 22.5;HSkMC: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016421, HPA017672"	Enhanced					NA	NA					"HPA016421: AB_1849219, HPA017672: AB_1849221"	"unprognostic (8.74e-3)"	"prognostic favorable (2.52e-5)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.84e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.82e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.30e-2)"	109.8	4.0	6.7	16.2	4.2	5.7	54.5	23.3	5.4	40.1	13.1	2.4	10.2	6.5	28.8	23.0	32.6	27.1	26.9	47.1	9.1	3.4	5.7	1.3	27.8	36.8	19.2	0.6	22.3	8.1	3.9	2.0	5.8	14.0	29.1	7.1	5.3	12.8	9.8	38.3	19.8	11.5	36.6	9.4	25.0	13.0	21.6	6.4	3.0	16.5	29.9	15.5	42.3	24.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	22.5	0.0	0.0	4.2	0.0	0.0	24.5	0.0	0.0	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.7	4.2	23.3	5.3	9.1	3.4	19.2	0.6	14.0	6.4	6.0	19.1	0.0	1.6	0.0	50.1	8.1	0.0	1.4	3.4	0.0	2.0	0.2	0.0	0.0	1.6	278.7	0.0	116.8	9.1	0.2	6.3	1.9	4.7	0.0	0.8	6.4	0.0	6.7	0.8	2.0	1.1	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.4	0.0	3.6	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.9
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"blood: 494.6"	"Group enriched"	"Detected in some"	4	"granulocytes: 258.2;Macrophages: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 494.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 494.6"	"Cell line enriched"	"Detected in some"	94	"HEL: 100.1"					"Low region specificity"	"Detected in all"			"CAB022102, HPA036051, CAB055526"	Approved					NA	NA					"CAB022102: , CAB055526: , HPA036051: AB_2674919"	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	5.8	1.4	1.6	3.6	0.8	6.0	9.2	0.9	1.3	8.0	3.4	1.1	3.4	3.2	10.6	5.6	12.1	2.0	25.4	4.1	4.3	1.3	3.6	2.4	27.8	0.6	1.0	5.3	1.5	2.6	0.5	1.9	0.5	2.7	9.4	5.4	6.5	5.9	4.7	1.2	17.9	4.1	6.0	2.8	3.5	2.3	1.5	6.8	2.4	2.5	19.7	16.2	3.8	4.9	0.0	75.4	494.6	0.3	0.4	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	494.6	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	75.4	0.0	0.0	0.1	0.4	0.4	0.2	10.4	0.0	3.0	1.6	0.8	0.9	1.3	4.3	1.3	1.0	5.3	2.7	6.8	6.0	53.5	20.1	0.0	33.5	0.0	0.2	0.0	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	7.2	0.0	258.2	0.0	6.6	0.0	0.0	0.0	2.5	0.6	0.0	206.7	43.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.6	0.0	0.2	29.7	0.0	0.0	0.0	0.0
OR10J3	OR10J3P	ENSG00000196266	"Olfactory receptor family 10 subfamily J member 3"	Q5JRS4	1	159313670-159314659	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"placenta: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"LHCN-M2: 5.6"									HPA042963	Uncertain					NA	NA					"HPA042963: AB_10961176"																		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	3.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10J1	"HGMP07J, HSHGMP07J"	ENSG00000196184	"Olfactory receptor family 10 subfamily J member 1"	P30954	1	159437845-159443078	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 10.9"	"Group enriched"	"Detected in some"	47	"Early spermatids: 31.7;Late spermatids: 34.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;RT4: 1.1"					"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.9			0.0		0.0	0.0	0.0	0.8	0.4	2.4	0.5	0.5	0.5	0.2	0.2	0.5	0.3	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.6	0.7	0.3	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.8	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.2	1.1	0.0	0.5	0.3	0.2	0.2	0.0	0.0	0.2	0.2	1.0	0.1	1.1	0.1	0.0	0.1	0.3	0.0	0.1	0.4	0.3	0.0	0.6	0.6	0.2	0.4	0.3	0.2	0.3	0.4	0.2	0.3	2.4	0.5	0.4	0.3	0.2	0.2	0.3	0.3	0.3	0.1	0.8	0.3	0.5	2.1	0.5	0.5	0.4	0.1	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
OR10J5		ENSG00000184155	"Olfactory receptor family 10 subfamily J member 5"	Q8NHC4	1	159535078-159536007	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	8	"liver: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587825-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 316.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 3479.3"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;RH-30: 4.3;SiHa: 2.2;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	76000000000			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	316.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.7	4.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.7	0.2	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	451.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.0	0.0	0.0	70.0	5.1	0.0	0.0	0.0	0.0	3479.3	0.0	0.0	0.0	63.8	73.6	0.0	0.0	0.0	0.0	5.4	0.0	0.0	16.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"liver: 1139.7"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 2991.5"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5400000000	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	17.2	0.1	0.1	0.0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.3	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.9	0.0	13.1	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	55.9	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	0.0	0.0	220.4	1.2	0.0	0.0	23.3	52.3	0.0	0.0	0.0	0.0	2991.5	0.1	0.0	0.0	82.9	72.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	97.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.0"	"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	25.0	28.0	7.6	9.3	10.5	11.2	27.3	4.4	9.0	15.5	15.9	5.9	6.6	17.2	12.2	15.0	21.2	10.9	12.6	14.9	7.8	5.2	88.0	80.8	12.1	15.4	8.5	4.6	12.3	21.5	12.5	4.3	7.4	9.6	18.0	9.1	9.5	37.8	10.9	32.8	15.8	16.1	7.7	9.6	8.7	11.0	9.7	7.3	5.7	27.0	17.4	11.4	10.5	19.1	13.6	59.7	49.9	43.2	21.3	24.0	24.0	12.2	13.2	0.1	0.0	12.9	11.1	0.1	5.0	4.1	5.9	4.6	5.4	14.1	0.0	30.0	5.5	1.3	0.5	3.4	4.5	3.2	3.0	1.5	16.9	4.8	0.0	19.3	10.2	13.0	46.8	12.3	3.8	13.9	4.3	22.6	0.0	7.7	6.2	8.3	22.2	1.0	0.4	22.9	22.1	18.9	0.0	0.0	5.8	7.2	2.1	5.8	12.8	9.1	20.0	23.4	2.4	12.9	16.0	16.5	4.9	0.2	0.6	0.0	4.4	10.3	0.1	8.3	8.2	3.7	20.0	43.2	49.9	24.0	33.4	13.3	13.6	18.1	22.5	59.7	9.8	11.0	16.4	43.2	21.3	22.1	13.6	15.7	24.0	7.6	10.5	4.4	9.0	7.8	5.2	8.5	4.6	9.6	7.3	38.7	65.7	25.0	97.5	66.2	8.4	26.4	94.3	38.8	83.0	48.8	5.9	13.5	222.2	148.8	39.6	154.1	106.2	0.0	394.0	20.1	31.9	94.9	53.1	219.9	155.2	1.6	34.0	66.3	86.6	5.5	24.5	94.8	40.5	32.5	101.6	59.7	258.6	101.7	14.9	620.9	7.1	12.9	32.0	3.2	13.0	65.1	4.8	43.7	91.6	102.1
FCRL6	"FcRH6, FLJ16056, IFGP6"	ENSG00000181036	"Fc receptor like 6"	Q6DN72	1	159800511-159816251	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.4;lymphoid tissue: 15.5"	"Cell type enriched"	"Detected in some"	37	"T-cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdT-cell: 39.4;memory CD8 T-cell: 36.0;naive CD8 T-cell: 29.2;NK-cell: 13.2"	"Group enriched"	"Detected in many"	27	"NK-cells: 13.2;T-cells: 39.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 2.4;hTCEpi: 2.6;Karpas-707: 1.8;U-937: 1.7"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.64e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.18e-2)"	2.2	1.5	0.6	7.0	0.6	6.8	1.6	1.1	0.8	1.3	0.7	0.7	0.0	0.8	4.6	2.4	0.8	1.2	7.2	3.6	0.6	0.6	1.5	4.0	7.5	9.0	0.7	2.4	1.4	0.9	0.0	0.9	1.3	1.0	3.2	0.3	2.7	2.8	0.1	1.1	0.9	2.5	0.7	1.8	15.5	1.1	1.2	0.0	3.2	1.3	1.2	3.4	2.0	1.0	0.0	0.9	0.3	0.3	13.2	39.4	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.4	0.0	0.0	2.4	2.6	0.0	0.5	0.0	0.1	0.3	0.0	1.8	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	0.2	1.7	0.9	0.0	0.0	0.0	39.4	0.0	0.8	0.0	7.3	36.0	0.9	0.0	3.3	29.2	0.3	13.2	0.3	0.0	0.0	11.1	0.6	0.6	1.1	0.8	0.6	0.6	0.7	2.4	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	0.0
SLAMF8	"BLAME, CD353, SBBI42"	ENSG00000158714	"SLAM family member 8"	Q9P0V8	1	159826750-159837249	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.1"	"Group enriched"	"Detected in some"	10	"Hofbauer cells: 37.6;Kupffer cells: 13.7;Macrophages: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;HL-60: 3.6;U-138 MG: 5.0;U-87 MG: 2.8;U-937: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA067601	Enhanced					NA	NA					"HPA067601: AB_2685870"	"unprognostic (1.04e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	16.9	4.6	1.5	20.1	3.4	0.4	5.4	8.2	1.6	3.1	6.0	1.4	0.6	4.6	1.8	4.2	3.1	3.6	6.1	7.1	5.2	1.7	7.8	2.2	19.6	44.1	4.1	0.7	3.8	2.0	0.1	4.2	5.4	5.0	2.7	7.1	3.0	4.2	1.0	2.2	3.1	7.0	5.4	4.1	22.7	3.1	2.4	2.7	9.7	4.8	3.0	12.7	8.6	2.8	0.0	12.1	0.5	6.6	8.1	3.8	2.8	0.0	0.1	0.0	0.0	0.5	4.2	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.8	0.0	0.0	0.0	3.6	0.7	1.4	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.8	0.2	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.7	0.0	5.0	0.2	0.0	0.9	0.0	0.0	0.0	2.8	2.6	0.0	0.0	5.1	0.0	3.2	6.6	0.2	0.0	1.1	3.8	12.1	0.0	0.2	2.6	0.5	8.1	0.4	0.1	0.0	2.8	1.5	3.4	8.2	1.6	5.2	1.7	4.1	0.7	5.0	2.7	0.0	2.9	0.0	0.0	1.5	0.2	0.2	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	37.6	0.0	0.0	0.0	13.7	0.0	0.3	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.5	0.8	0.0	0.0
VSIG8		ENSG00000243284	"V-set and immunoglobulin domain containing 8"	P0DPA2	1	159854316-159862657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 83.5"	"Cell type enhanced"	"Detected in some"	14	"Basal keratinocytes: 10.0;Collecting duct cells: 5.2;Intestinal endocrine cells: 3.5;Suprabasal keratinocytes: 4.0"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0"	"Region enriched"	"Detected in single"	13	"cerebellum: 4.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.4;U-87 MG: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA023219	Uncertain					NA	NA					"HPA023219: AB_1845635"	"unprognostic (8.66e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.94e-7)"	"unprognostic (1.72e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.99e-1)"	0.4	0.1	0.2	0.2	0.3	0.0	0.2	4.2	0.2	2.2	0.2	0.2	0.2	0.2	0.2	0.2	2.5	1.0	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.2	0.2	0.2	1.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	0.2	4.3	0.2	0.2	18.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.4	83.5	9.2	0.2	2.0	0.6	0.0	0.1	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	0.2	0.2	0.4	1.0	1.1	0.2	0.0	1.4	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.5	0.6	0.3	0.5	0.0	0.0	0.7	0.5	0.1	0.7	0.0	0.0	0.3	0.0	0.2	0.3	4.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.5	10.0	2.6	0.0	0.0	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.3	0.1	1.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.2	0.0	3.5	0.6	0.0	0.0	0.6	0.0	0.0	0.0	1.7	1.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	4.0	0.1	0.5	1.1	0.6
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900163	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 35.5;testis: 29.7"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 306.5;Early spermatids: 187.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.2;HEL: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.3	0.3	2.0	0.4	7.5	0.6	0.5	0.0	0.2	2.5	0.2	11.9	0.0	0.4	1.3	10.5	0.4	35.5	0.2	0.5	3.1	2.8	0.3	0.2	6.1	0.3	0.1	0.1	7.3	0.1	0.1	0.2	3.3	12.5	0.2	0.2	0.0	0.2	0.5	0.2	0.3	0.2	0.4	0.5	0.5	0.6	29.7	3.4	0.0	0.7	0.0	0.3	0.4	0.1	0.7	0.3	6.0	0.3	0.2	0.5	0.2	2.5	0.6	0.0	0.0	0.1	0.3	11.2	1.3	1.6	2.4	1.0	1.9	3.3	1.1	0.5	0.6	1.3	1.6	0.3	0.3	1.4	0.6	0.3	14.5	0.6	0.1	0.7	1.2	0.5	1.0	0.8	2.6	0.9	3.4	1.7	0.4	1.5	0.5	0.4	3.5	0.2	1.1	0.6	2.1	1.2	0.0	1.2	0.5	0.4	0.6	1.0	0.2	1.3	3.9	0.4	3.4	3.8	0.2	2.2	1.0	3.0	2.0	2.4	1.2	0.0	0.4	5.4	0.5	0.8	0.0	0.3	6.0	0.0	0.3	0.0	0.5	0.3	0.5	0.3	0.7	0.0	0.5	4.9	0.2	0.0	0.3	0.0	0.2	2.0	7.5	0.0	0.1	3.1	2.8	0.1	0.1	12.5	3.4	0.0	3.7	0.0	0.7	0.0	0.0	0.8	0.0	306.5	54.6	5.2	0.0	1.5	0.0	1.4	187.0	2.3	0.0	0.0	2.0	6.4	0.4	0.9	3.5	0.0	0.4	0.0	0.0	1.3	1.6	33.1	2.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	1.4	0.4	0.0	0.0	0.4	19.0	2.3	0.0	0.7	0.0	0.0	1.1
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925732	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 2167.7;monocytes: 1311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		540000000	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	80.6	26.4	19.7	57.5	25.6	47.9	62.8	7.9	18.3	49.1	45.9	16.6	54.5	43.3	39.2	49.4	96.3	36.3	63.6	57.3	15.9	18.5	68.0	178.2	107.7	65.0	24.3	9.8	45.7	51.2	8.8	18.1	122.2	24.8	43.8	43.0	24.7	67.2	62.9	35.3	62.6	74.6	36.2	20.0	95.8	96.8	46.4	20.2	60.5	37.7	150.7	76.5	57.2	62.0	53.0	114.4	220.7	42.4	44.0	41.7	106.7	110.3	59.7	1.8	0.7	21.3	53.1	68.9	62.2	71.5	135.4	65.9	61.9	86.7	68.6	53.0	73.9	38.0	86.7	30.5	77.5	83.6	78.2	24.7	91.4	57.9	3.6	25.2	64.2	102.9	52.7	60.2	79.7	41.3	90.7	81.5	18.3	39.1	48.3	46.1	42.0	29.0	40.5	51.5	69.2	101.9	0.2	31.8	102.5	28.1	43.3	28.6	27.1	73.0	119.5	32.1	100.7	63.0	63.3	93.5	81.1	94.3	73.5	167.4	19.4	8.6	40.2	104.9	41.2	49.8	66.9	42.4	177.0	34.7	25.2	30.6	53.0	38.6	33.4	68.5	39.7	20.4	22.4	220.7	44.0	18.9	114.4	41.7	106.7	19.7	25.6	7.9	18.3	15.9	18.5	24.3	9.8	24.8	20.2	166.7	130.7	257.0	252.6	487.7	6.1	8.0	109.5	111.1	142.1	174.5	17.7	477.1	63.0	1095.0	40.8	397.3	292.6	0.0	1053.3	2167.7	440.6	225.0	408.8	47.4	432.7	3.2	305.0	192.1	247.2	61.8	109.9	313.3	317.2	1311.1	280.8	63.0	865.9	140.6	60.1	122.4	18.8	181.1	346.3	4.8	17.6	500.5	192.7	223.4	182.9	345.3
IGSF9	"IGSF9A, KIAA1355, Nrt1"	ENSG00000085552	"Immunoglobulin superfamily member 9"	Q9P2J2	1	159927039-159945604	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 65.3"	"Cell type enhanced"	"Detected in many"	17	"Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 150.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.2;HaCaT: 22.2;hTCEpi: 9.8;NTERA-2: 11.3;SCLC-21H: 19.9;SH-SY5Y: 10.2;T-47d: 11.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA037753	Uncertain				"Intracellular and membrane"	NA	NA					"HPA037753: AB_10672915"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (3.30e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	2.7	0.0	0.3	4.5	0.5	0.0	2.2	0.4	0.3	2.3	6.7	0.4	3.4	6.6	1.3	5.9	6.8	4.2	1.4	0.7	0.4	0.1	0.4	65.3	0.7	0.3	0.3	0.3	2.4	1.0	0.9	0.3	1.5	0.6	4.0	3.8	21.2	4.0	6.2	0.3	20.2	13.7	0.9	0.5	0.3	11.8	3.0	0.4	1.1	1.1	7.0	2.7	2.1	3.9	0.9	1.4	1.6	0.1	0.0	0.2	0.0	5.0	0.0	2.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	7.1	2.6	0.0	0.2	0.0	0.0	22.2	1.1	3.1	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.3	0.0	0.0	0.8	0.2	0.0	0.0	9.4	0.2	0.0	11.3	8.5	2.3	0.0	0.0	0.9	0.0	6.8	19.9	10.2	0.6	8.7	0.0	2.0	11.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.2	1.4	0.9	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.3	0.5	0.4	0.3	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.0	0.0	3.4	11.8	11.2	1.2	15.3	2.7	2.3	0.0	88.4	1.0	0.0	3.9	16.7	0.3	29.4	0.0	30.5	2.6	1.5	1.7	0.0	11.4	0.2	1.6	7.9	0.6	0.3	2.4	0.3	0.0	0.0	0.0	7.6	3.7	19.4	12.2	0.0	0.0	150.3	0.0	0.4	0.5	1.0	10.9	0.6	0.0	3.2	1.3
SLAMF9	"CD2F-10, CD84-H1, SF2001"	ENSG00000162723	"SLAM family member 9"	Q96A28	1	159951492-159954254	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"adipose tissue: 20.3;blood: 5.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.9;Hofbauer cells: 7.2;Late spermatids: 22.7;Macrophages: 7.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.5"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 5.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 6.7;HEL: 9.1;PC-3: 3.7;SK-MEL-30: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035153	Uncertain					NA	NA					"HPA035153: AB_10670586"	"unprognostic (1.05e-1)"	"unprognostic (1.54e-5)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.54e-4)"	"unprognostic (5.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (6.17e-5)"	"unprognostic (8.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	20.3	0.0	0.1	2.3	0.1	1.1	0.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.7	1.0	0.1	0.4	0.1	0.0	0.1	2.6	1.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.7	0.2	2.9	0.1	0.5	0.1	0.7	0.5	2.9	0.5	0.1	5.5	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	6.7	0.0	0.0	0.0	9.1	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	3.7	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	4.0	1.0	0.7	1.5	0.0	1.3	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	2.4	7.2	0.0	0.0	0.0	1.8	22.7	0.3	7.3	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.6
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium voltage-gated channel subfamily J member 10"	P78508	1	159998651-160070483	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.1;kidney: 28.1"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 83.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.7;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA					"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	1.4	1.5	23.6	3.0	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0.0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2.0	1.8	25.5	0.0	1.5	0.0	2.9	1.5	0.1	0.0	0.0	0.0	0.3	1.7	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.2	1.7	0.2	0.0	1.1	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	2.2	0.1	0.0	0.0	0.2	0.4	0.0	0.3	3.7	1.0	0.1	0.5	0.1	0.1	0.3	0.9	0.0	3.8	1.7	0.0	0.2	0.2	1.8	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	1.7	0.3	0.0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	3.5	3.9	0.0	10.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	1.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
PIGM	GPI-MT-I	ENSG00000143315	"Phosphatidylinositol glycan anchor biosynthesis class M"	Q9H3S5	1	160024953-160031991	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047418	Uncertain					NA	NA					"HPA047418: AB_2680039"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.85e-2)"	"prognostic favorable (3.27e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.50e-1)"	6.5	9.1	7.4	6.7	9.9	2.9	9.7	7.7	8.7	7.9	6.7	17.1	8.8	7.8	7.3	11.7	8.0	7.3	7.7	6.2	7.6	6.7	7.7	14.9	6.6	7.1	17.3	5.2	8.8	18.3	14.9	10.4	6.2	12.6	11.3	7.9	10.2	10.5	9.1	3.0	9.8	8.4	5.8	21.8	8.0	9.1	9.6	12.5	14.9	11.0	3.1	7.5	7.8	6.1	6.2	10.4	8.3	14.6	9.5	10.6	7.7	5.0	4.6	5.7	8.2	7.5	6.3	1.9	7.7	4.9	5.1	4.8	2.5	9.5	3.6	6.3	5.0	4.4	10.4	6.2	6.2	6.6	7.6	6.6	8.3	6.0	3.7	4.6	10.6	6.5	5.6	4.1	6.1	4.8	4.5	4.3	8.0	4.4	6.8	5.9	8.5	6.8	5.7	5.9	9.5	6.6	2.2	5.8	15.7	5.6	7.0	8.0	12.4	8.4	9.9	6.0	5.7	18.7	12.7	6.0	6.8	6.0	10.1	4.7	12.4	13.6	0.2	6.2	5.5	7.5	8.3	14.6	5.6	8.1	11.4	8.4	5.8	8.3	6.4	8.8	6.2	10.6	8.3	2.6	9.5	14.2	10.4	8.5	7.7	7.4	9.9	7.7	8.7	7.6	6.7	17.3	5.2	12.6	12.5	11.9	16.6	6.1	4.5	3.8	14.8	3.7	20.4	13.4	17.0	15.7	9.8	6.5	1.7	11.1	4.3	8.4	7.5	0.0	15.9	3.1	6.7	5.8	4.7	19.2	6.4	15.9	12.1	12.9	12.7	2.3	7.8	5.8	8.5	3.6	13.9	38.7	10.4	3.5	8.5	5.5	11.7	19.4	4.4	24.7	8.3	4.0	1.5	4.8	11.1	3.0
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium voltage-gated channel subfamily J member 9"	Q92806	1	160081570-160090563	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"brain: 52.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 12.8;Horizontal cells: 7.9"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced					NA	NA					"HPA070478: AB_2686270"	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	1.4	1.9	15.6	1.4	15.3	1.4	1.4	32.1	52.0	1.4	1.4	11.9	0.0	1.4	1.4	1.4	1.4	1.4	1.4	1.4	18.4	11.1	1.5	1.4	1.4	1.4	18.3	20.6	1.4	1.4	1.4	0.7	1.4	7.4	1.4	1.4	0.0	1.4	1.4	1.4	1.4	1.5	1.4	11.4	1.4	1.5	1.7	11.6	0.0	1.4	0.0	1.4	1.4	0.0	0.8	0.0	0.0	0.3	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.2	2.3	2.7	0.0	0.1	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	2.9	0.2	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.1	0.4	0.2	1.1	0.0	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	15.6	15.3	32.1	27.2	18.4	11.1	18.3	20.6	7.4	11.6	0.0	0.0	0.0	0.0	0.0	12.8	0.6	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
IGSF8	"CD316, CD81P3, EWI2, PGRL"	ENSG00000162729	"Immunoglobulin superfamily member 8"	Q969P0	1	160091340-160098943	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.2"	"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011917, HPA075970"	Approved		Supported	Vesicles		NA	NA		190000	Vesicles		"HPA011917: AB_1851536, HPA075970: "	"unprognostic (4.08e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.75e-3)"	9.9	10.4	25.2	9.0	30.3	2.4	11.1	40.9	54.2	9.6	11.8	53.5	6.4	18.2	8.6	16.6	7.0	13.9	8.5	11.6	32.4	24.1	10.4	19.3	10.1	10.3	32.2	29.9	15.1	19.1	9.0	8.7	7.8	25.9	13.8	7.4	11.2	21.0	14.0	6.0	34.0	14.4	5.1	42.6	10.6	9.8	11.5	25.3	6.2	10.0	5.9	6.2	6.0	6.9	14.3	5.6	1.2	4.0	4.7	15.6	6.4	8.9	5.4	7.0	17.9	4.1	2.6	14.8	4.4	5.8	9.5	8.9	6.1	6.2	13.2	16.6	6.4	8.2	17.3	2.8	6.5	1.3	15.7	5.1	1.7	6.0	10.4	6.9	4.5	14.7	3.2	13.2	6.1	2.0	6.7	1.9	14.6	2.3	7.6	2.2	8.5	11.2	10.5	14.8	18.8	8.6	6.4	3.6	9.5	8.6	9.3	2.9	12.8	5.0	16.5	58.9	6.4	11.7	5.8	1.9	4.2	9.1	7.5	3.5	21.0	23.2	5.9	14.8	1.8	10.9	0.0	2.9	1.2	13.3	4.0	11.7	12.2	11.0	15.4	3.3	14.3	14.8	15.6	0.8	4.7	2.4	5.6	14.9	6.4	25.2	30.3	40.9	54.2	32.4	24.1	32.2	29.9	25.9	25.3	8.9	3.5	22.5	26.4	38.8	54.6	3.2	12.7	0.0	1.2	36.6	9.8	28.1	5.0	30.1	3.1	7.9	34.9	0.0	10.8	187.6	24.7	18.9	10.3	26.8	13.7	62.0	19.1	9.8	3.2	0.5	15.5	8.0	40.5	85.6	23.2	90.2	17.8	37.4	14.9	13.3	11.7	6.5	16.3	1.7	5.8	54.5	58.0	14.4	27.4	24.0
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 109.8;skeletal muscle: 305.8"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 142.4;Muller glia cells: 63.9;Peritubular cells: 37.1;Sertoli cells: 84.1;Smooth muscle cells: 32.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;HHSteC: 9.6;RH-30: 10.7;U-87 MG: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022230	Enhanced					NA	NA					"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	12.6	3.9	61.4	2.8	80.1	2.3	6.5	30.4	109.8	4.7	6.6	27.4	2.4	3.7	4.2	7.4	15.3	6.0	5.3	35.4	42.2	27.0	3.3	2.5	3.8	2.4	45.6	37.9	9.9	2.6	2.4	4.6	3.6	58.0	13.8	5.6	12.5	3.1	14.2	305.8	2.8	4.4	5.4	51.5	2.7	2.8	3.9	28.3	0.0	2.6	17.7	2.5	5.5	1.3	0.6	1.4	1.7	0.4	0.6	0.5	0.3	0.0	0.0	32.9	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	2.9	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.7	0.6	0.3	0.5	1.7	0.6	0.2	1.4	0.2	0.3	61.4	80.1	30.4	52.0	42.2	27.0	45.6	37.9	58.0	28.3	0.0	0.0	0.0	0.8	0.5	0.7	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	26.7	0.0	0.0	0.0	0.0	63.9	0.0	0.0	37.1	0.0	1.9	84.1	32.5	0.3	0.2	0.5	0.1	0.0	0.0	0.5
ATP1A4	ATP1AL2	ENSG00000132681	"ATPase Na+/K+ transporting subunit alpha 4"	Q13733	1	160151570-160186977	"Enzymes, Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 13.1;seminal vesicle: 19.0;testis: 35.8"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 20.6;Early spermatids: 67.0;Syncytiotrophoblasts: 31.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BEWO: 10.8;HDLM-2: 26.8;RT4: 32.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.33e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (2.20e-4)"	0.4	0.3	0.4	0.8	0.3	0.0	2.2	0.4	0.3	0.3	0.3	0.0	11.2	0.0	0.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.2	0.2	0.3	3.8	0.3	0.0	0.2	0.2	0.0	0.3	13.1	0.0	0.6	0.0	0.4	1.2	19.0	3.2	0.3	0.5	1.6	0.3	1.1	0.3	35.8	0.0	0.9	0.2	0.2	1.6	8.9	5.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.0	5.5	0.2	0.0	0.8	0.0	0.0	0.0	1.8	0.0	20.6	0.0	0.0	67.0	0.0	0.0	0.0	0.0	11.9	0.4	0.7	1.1	0.0	2.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.2	0.2	0.0	31.9	0.0	0.0	11.2
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.2	0.2	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.0	36.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	16.7	0.0	1.4	0.0	0.0	2.0	1.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	13.0	0.0	0.8	1.4	1.0	0.0	3.8	0.0	0.0	0.3
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205337-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 199.4"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 420.2;Muller glia cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 30.6"	"Group enriched"	"Detected in all"	6	"B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		240000	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	45.3	20.4	105.3	28.7	83.6	3.8	25.3	30.5	173.1	25.1	15.5	68.1	5.0	8.0	21.5	21.8	22.6	19.2	22.1	53.9	70.5	81.3	14.8	10.4	23.8	16.6	106.5	67.0	19.7	9.7	14.9	10.2	25.1	74.1	24.4	15.3	18.2	12.3	31.1	10.2	16.9	8.8	47.4	199.4	23.8	10.0	17.5	53.7	1.6	12.6	6.0	22.9	22.4	17.5	7.6	22.1	1.8	30.6	3.1	3.5	5.4	16.9	5.9	24.6	10.6	45.6	25.6	8.2	73.6	64.4	61.3	43.1	13.0	9.2	7.9	26.7	91.9	29.5	18.6	9.1	23.0	48.0	4.2	5.1	6.5	4.1	3.3	56.4	2.1	8.0	21.4	13.0	33.7	43.1	33.9	46.0	5.8	6.7	14.4	81.9	8.4	2.5	5.1	16.3	20.1	17.0	4.2	25.9	5.4	22.2	8.9	4.9	13.0	39.0	26.7	22.4	55.7	16.4	15.3	61.3	40.8	32.0	30.3	31.6	11.4	7.0	15.0	37.6	4.1	57.7	0.3	15.3	1.8	3.5	30.6	2.7	7.6	2.6	2.8	22.1	5.0	1.6	1.8	0.7	3.1	13.9	9.7	2.9	5.4	105.3	83.6	30.5	78.2	70.5	81.3	106.5	67.0	74.1	53.7	14.9	34.6	27.0	105.8	71.2	125.0	203.8	12.7	14.7	27.3	5.2	68.7	17.0	24.9	58.7	49.2	107.8	6.4	0.0	40.4	47.2	66.7	105.1	31.1	4.9	63.6	87.4	11.5	95.2	34.2	51.6	61.9	76.5	70.9	420.2	11.3	271.7	77.0	3.5	103.3	8.1	109.8	45.3	97.6	12.7	2.7	64.1	37.9	14.9	9.7	151.1
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262531	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	26.6	28.7	26.3	21.6	29.5	21.2	26.4	37.6	38.3	22.2	28.0	39.6	31.6	25.0	28.7	38.2	24.6	27.6	29.0	35.8	25.9	20.0	25.6	42.2	23.0	25.5	30.1	29.2	29.8	34.6	45.3	33.1	21.5	31.7	23.8	19.0	29.3	29.0	44.9	86.4	28.8	26.1	26.8	23.8	28.6	28.6	20.8	32.5	25.7	36.9	27.2	22.7	28.0	21.6	26.6	17.8	22.4	21.6	24.9	26.6	14.4	17.1	21.5	24.4	22.0	30.7	23.3	21.3	20.4	28.9	17.1	15.3	22.6	29.8	19.0	38.3	23.1	12.6	21.3	11.8	19.2	10.8	43.5	23.2	21.1	30.1	17.7	25.0	17.6	27.0	27.6	20.3	15.2	22.1	19.0	26.4	24.6	19.0	35.0	15.8	16.3	22.7	17.6	17.5	22.6	21.4	22.3	14.4	37.1	19.6	30.6	16.6	16.0	34.2	38.3	22.9	24.7	35.9	26.7	31.7	21.1	10.9	12.9	18.8	57.5	39.2	30.9	23.5	16.6	17.2	22.4	17.5	18.1	26.6	16.9	26.1	23.7	23.6	25.0	14.8	26.6	26.2	23.8	19.9	24.9	21.6	17.8	24.3	14.4	26.3	29.5	37.6	38.3	25.9	20.0	30.1	29.2	31.7	32.5	53.6	45.7	13.9	17.0	16.4	43.6	50.1	22.9	48.2	38.7	24.4	60.9	25.4	53.0	18.8	1.7	23.6	23.7	0.0	18.8	17.5	22.0	14.7	31.4	60.2	20.7	38.1	24.1	17.2	29.6	1.9	25.9	19.5	13.5	30.7	19.1	36.1	17.3	10.5	30.8	27.6	56.3	12.9	25.5	27.5	17.9	21.1	37.1	28.0	19.0	8.2
AL139011.2		ENSG00000258465			1	160217464-160285130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0"									"HPA027218, HPA027381, HPA044837"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496"	"unprognostic (4.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.04e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-3)"	8.6	4.0	3.7	3.0	10.2	2.0	4.4	15.4	11.4	4.8	4.7	8.6	2.5	3.5	6.3	4.2	5.3	6.4	4.6	16.7	3.8	3.9	6.2	10.8	4.1	3.2	3.6	5.9	7.6	4.0	6.7	4.1	5.0	9.1	5.5	3.5	6.1	5.5	3.0	14.6	4.0	4.2	7.8	4.1	3.7	4.3	4.8	4.1	2.5	7.9	3.8	3.4	5.8	4.7	5.8	8.9	6.7	6.5	8.0	5.0	8.0	0.1	2.1	0.3	0.5	6.7	1.9	0.6	0.9	5.9	3.3	0.8	0.0	0.8	0.2	6.6	1.0	5.2	0.8	1.1	0.2	0.0	6.0	0.0	0.3	0.7	0.2	3.4	0.0	0.3	3.2	0.2	3.0	3.4	3.5	0.5	0.8	1.0	4.7	0.5	0.3	1.1	0.0	0.3	0.6	0.6	0.5	0.0	0.3	0.3	0.8	0.6	0.8	0.2	1.4	0.0	1.0	2.8	5.6	0.0	0.8	0.8	0.0	0.2	0.8	3.4	0.5	0.4	0.3	0.3	6.4	6.3	6.2	3.6	6.5	5.0	5.8	4.4	4.7	8.9	3.9	2.5	3.2	6.7	8.0	6.3	2.5	4.9	8.0	3.7	10.2	15.4	11.4	3.8	3.9	3.6	5.9	9.1	4.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276812-160286348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA044837: AB_10962496, HPA051966: AB_2681677"	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	41.9	20.4	21.5	8.0	27.8	6.2	24.4	10.0	30.6	12.5	12.9	23.8	8.9	11.0	13.0	15.0	14.6	13.6	11.3	21.7	18.5	21.0	19.5	61.6	12.2	8.7	20.3	17.2	14.5	12.6	17.5	14.3	15.0	25.0	16.8	13.8	17.8	16.2	16.3	32.9	14.1	12.7	10.0	17.4	11.8	12.7	11.4	12.9	9.1	22.2	12.1	11.3	13.4	8.7	9.7	13.0	11.8	15.6	6.9	10.2	7.5	12.4	7.6	29.5	9.1	25.2	24.9	22.2	10.2	21.1	19.0	15.1	14.0	15.3	15.4	17.5	15.5	11.1	12.2	14.1	18.4	15.0	13.3	7.0	10.7	10.8	14.3	20.6	19.4	13.6	37.3	21.3	25.7	16.5	15.3	13.3	21.3	16.1	11.9	21.3	6.9	14.5	6.3	21.0	15.9	20.1	18.4	14.5	18.3	19.2	25.3	9.6	16.0	40.8	20.7	15.4	31.6	20.2	19.1	10.1	11.0	13.2	12.5	12.1	17.7	22.7	28.0	18.2	8.4	16.2	9.2	12.2	11.8	10.2	15.6	8.3	9.7	5.9	7.2	13.0	5.6	7.5	6.8	4.8	6.9	10.2	6.3	8.7	7.5	21.5	27.8	10.0	30.6	18.5	21.0	20.3	17.2	25.0	12.9	8.9	19.4	9.8	17.0	8.9	18.7	41.6	20.4	10.7	5.7	15.7	9.8	24.5	41.4	18.8	4.2	13.2	23.3	0.0	12.9	43.8	15.3	16.7	16.1	52.9	26.1	23.8	10.9	20.3	12.7	2.2	20.1	13.5	20.3	31.5	14.5	30.7	16.8	19.0	27.6	34.2	9.6	32.3	17.8	13.9	25.9	8.7	32.4	14.4	15.5	19.0
COPA	HEP-COP	ENSG00000122218	"Coatomer protein complex subunit alpha"	P53621	1	160289273-160343400	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		260000	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	38.3	32.7	29.2	28.9	41.0	22.9	32.4	43.1	48.4	46.3	34.3	53.2	24.5	38.4	37.0	33.1	28.4	31.5	28.6	38.4	33.3	35.2	36.3	64.3	33.8	26.6	42.7	29.3	36.8	47.8	49.1	57.4	45.1	56.2	35.3	39.9	28.8	42.1	33.9	40.5	28.7	50.3	40.4	42.8	36.6	32.8	21.2	35.8	36.0	42.8	21.0	34.1	30.3	27.5	15.4	31.4	25.1	29.1	18.1	21.2	25.3	28.2	22.2	23.6	22.9	60.8	50.1	27.7	38.9	46.3	33.2	39.2	28.9	19.3	20.8	25.3	59.1	19.1	28.5	27.2	28.0	38.3	23.6	18.4	23.9	30.6	30.4	45.7	29.1	25.1	46.8	17.1	44.3	41.3	41.1	38.9	19.9	22.1	23.3	39.6	20.7	18.7	12.6	25.8	37.2	26.0	16.8	27.1	32.0	27.2	26.8	19.6	24.8	44.0	38.7	41.1	41.4	43.1	39.3	45.8	25.0	19.5	33.5	25.5	38.4	26.6	32.1	32.6	15.2	37.2	25.1	29.1	20.1	17.1	27.3	21.2	15.4	14.3	18.3	31.4	12.1	13.2	15.2	10.8	18.1	27.9	13.3	17.5	25.3	29.2	41.0	43.1	48.4	33.3	35.2	42.7	29.3	56.2	35.8	71.5	41.2	52.3	29.9	25.0	49.9	41.1	48.4	53.5	42.1	38.4	76.6	33.9	11.6	44.6	11.0	42.1	70.4	0.0	43.3	55.4	50.4	56.4	43.9	64.8	46.0	42.9	53.2	53.4	85.0	4.5	65.9	62.1	25.3	31.5	79.0	38.2	46.4	45.6	53.4	38.5	48.0	38.8	52.3	37.9	23.8	27.9	57.9	41.5	60.4	44.0
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343272-160358952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol		NA	NA		120000	Cytosol		"CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	25.6	23.8	12.7	15.3	20.9	12.8	23.3	15.8	24.3	21.8	24.1	39.0	16.5	31.7	24.1	23.3	23.3	19.9	19.5	23.7	13.8	13.9	25.3	37.8	24.7	19.8	28.2	14.2	29.5	41.3	38.9	21.8	63.3	21.5	18.5	24.6	25.1	49.2	19.6	24.2	20.2	38.5	20.7	25.4	25.8	21.4	22.4	22.8	20.3	25.9	13.6	20.6	26.1	20.1	12.5	28.8	27.0	30.5	13.1	11.1	16.8	10.4	12.9	22.2	18.1	68.0	34.4	24.5	21.5	39.4	20.9	24.6	10.0	30.8	7.7	44.8	44.0	14.5	17.8	10.0	20.5	17.7	12.3	8.8	7.3	16.0	15.0	27.0	15.8	33.7	35.0	20.4	19.9	20.8	45.9	30.6	11.9	13.6	22.2	29.8	7.3	5.6	8.3	18.1	27.3	7.2	7.7	13.7	21.7	29.2	14.6	7.4	16.7	23.2	26.5	15.7	37.0	23.7	39.5	24.6	15.7	10.3	10.9	16.3	28.8	40.7	7.7	24.5	10.0	28.6	17.8	29.9	25.0	11.1	30.5	10.4	12.5	9.5	9.5	28.8	11.2	9.9	9.4	27.0	13.1	27.9	16.9	10.0	16.8	12.7	20.9	15.8	24.3	13.8	13.9	28.2	14.2	21.5	22.8	6.0	9.4	20.1	21.7	9.3	17.2	15.2	35.7	12.0	12.5	50.6	49.1	93.6	6.6	34.8	2.1	17.5	49.8	0.0	23.7	84.3	24.4	16.5	12.7	26.8	52.0	17.5	19.4	28.3	43.7	3.1	25.0	26.3	16.9	14.4	31.1	35.8	29.7	28.1	19.8	21.9	19.7	25.8	15.0	43.2	41.7	9.9	123.2	16.0	27.7	17.4
NHLH1	"bHLHa35, HEN1, NSCL, NSCL1"	ENSG00000171786	"Nescient helix-loop-helix 1"	Q02575	1	160367067-160372848	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 10.8;skin 1: 4.2"	"Cell type enhanced"	"Detected in some"	11	"Cone photoreceptor cells: 2.0;Horizontal cells: 3.2;Intestinal endocrine cells: 1.7;Kupffer cells: 1.5;Rod photoreceptor cells: 1.3"	"Group enriched"	"Detected in some"	6	"glioma: 2.4;testis cancer: 0.8;urothelial cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 24.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"Region enriched"	"Detected in some"	12	"cerebellum: 37.9"	HPA017943			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA017943: AB_2732421"	"unprognostic (6.95e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-8)"	"unprognostic (4.09e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.36e-1)"	1.0	0.5	0.9	1.1	4.1	0.4	0.3	10.8	2.0	0.3	0.8	0.3	0.3	0.4	0.3	0.5	0.3	0.2	0.4	0.3	3.2	2.2	0.3	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.2	0.4	0.3	2.3	0.3	0.3	0.6	1.3	0.3	0.6	4.2	0.6	0.5	2.5	1.0	0.4	0.8	0.3	0.3	0.3	0.3	0.4	0.4	0.3	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.1	2.5	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.2	1.1	0.5	0.2	0.5	0.0	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.4	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.0	24.8	0.2	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.7	0.6	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	4.1	10.8	1.6	3.2	2.2	0.8	0.3	2.3	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	3.2	1.7	0.6	1.5	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	1.3	0.0	0.2	0.7	0.5	0.0	0.2	0.0	0.0	0.0
VANGL2	"KIAA1215, LPP1, LTAP, MGC119403, MGC119404, STB1, STBM, STBM1"	ENSG00000162738	"VANGL planar cell polarity protein 2"	Q9ULK5	1	160400586-160428678	"Disease related genes, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 39.5"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 31.4;Intestinal endocrine cells: 16.1;Mucus-secreting cells: 15.6;Suprabasal keratinocytes: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 45.8;AN3-CA: 11.3;NTERA-2: 18.5;SH-SY5Y: 12.5;SuSa: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027043	Uncertain					NA	NA					"HPA027043: AB_10601709"	"unprognostic (4.32e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.84e-3)"	"unprognostic (9.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-2)"	1.4	2.1	7.5	2.9	6.9	0.6	6.6	18.4	12.6	10.6	6.0	13.5	9.9	5.9	8.1	7.5	11.2	7.1	3.8	4.5	11.7	8.8	3.7	0.7	4.9	5.0	9.5	4.3	10.9	5.6	6.8	4.3	6.8	10.9	10.0	6.4	13.0	11.3	9.8	2.2	39.5	6.8	4.6	11.9	2.5	4.6	2.8	11.8	5.3	9.6	5.4	7.6	7.8	11.6	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.5	0.6	45.8	11.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.2	0.0	5.8	0.0	0.0	2.6	7.5	0.4	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.1	0.0	1.7	3.4	0.0	0.3	0.0	2.9	0.1	18.5	0.2	0.0	6.0	2.4	0.0	0.0	0.0	4.2	12.5	0.0	0.0	4.0	16.6	0.0	0.6	0.0	0.0	7.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.5	6.9	18.4	7.5	11.7	8.8	9.5	4.3	10.9	11.8	0.0	0.3	0.0	2.2	14.1	3.1	2.4	2.5	2.7	1.2	0.0	31.4	0.0	0.0	4.2	1.0	2.0	1.1	0.0	1.4	0.0	2.3	6.4	0.0	0.0	0.1	9.5	16.1	0.6	0.0	0.7	3.4	0.0	6.8	0.0	15.6	4.5	3.3	0.0	6.7	0.4	0.0	0.0	3.8	0.5	3.4	14.9	0.0	0.0	6.4	4.5
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 51.9"	"Cell type enhanced"	"Detected in some"	15	"B-cells: 8.3;Early spermatids: 9.3;Late spermatids: 16.5;T-cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 33.3;U-698: 49.0"									"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	3.9	0.8	0.4	21.0	0.4	1.2	1.0	0.4	0.4	1.1	3.8	0.3	0.4	1.1	1.0	0.6	2.3	1.6	2.8	1.2	0.4	0.4	2.1	1.6	4.7	51.9	0.6	0.4	0.6	0.8	0.0	0.6	1.7	0.7	1.4	1.5	1.5	5.6	1.0	0.5	0.7	11.9	0.4	0.8	29.6	2.3	0.9	0.2	12.9	1.8	0.6	30.4	4.1	1.3	15.2	0.3	8.4	1.0	15.9	28.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	0.0	8.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	49.0	0.0	0.2	0.0	2.5	0.1	8.4	22.9	0.3	15.8	14.7	14.6	28.6	0.1	15.2	8.2	16.4	1.0	15.9	1.0	0.3	16.8	7.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6	0.4	0.7	0.2	0.0	2.2	8.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.8	0.9	0.0	0.0	3.7	3.8	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	20.8	0.0	0.0
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.0"	"Cell type enhanced"	"Detected in many"	14	"granulocytes: 177.3;Hofbauer cells: 84.2;Kupffer cells: 123.8;Macrophages: 52.0;monocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.6;HEL: 24.3;HL-60: 6.8;HMC-1: 27.7;MOLT-4: 6.7;U-698: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		36000000	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	15.9	4.8	3.8	18.5	4.5	6.7	3.7	1.3	3.4	3.3	3.2	7.9	7.7	2.5	2.5	4.3	2.7	3.1	6.4	5.0	3.8	3.0	3.1	5.1	9.2	26.0	6.0	2.2	1.8	4.3	0.9	1.9	7.1	5.3	3.7	4.7	2.4	4.3	9.8	1.6	2.7	9.6	4.1	11.1	25.6	3.5	2.8	5.9	13.8	2.9	2.3	16.3	5.8	2.7	5.1	5.4	21.0	7.3	1.0	8.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	6.8	27.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.0	0.0	6.7	5.1	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	1.5	0.0	21.0	7.3	11.0	6.9	6.3	5.2	5.1	5.9	8.2	5.4	4.7	3.5	6.3	1.0	1.0	2.4	3.2	7.9	6.1	3.8	4.5	1.3	3.4	3.8	3.0	6.0	2.2	5.3	5.9	0.0	8.3	23.1	0.7	2.2	0.2	1.2	5.1	1.4	2.3	0.0	0.0	0.4	0.0	0.0	0.6	2.6	0.0	0.0	0.2	0.3	0.8	0.6	177.3	0.9	84.2	0.0	0.0	5.5	123.8	0.5	0.6	52.0	5.0	78.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	2.0	0.8	42.4	0.0	0.7
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608100-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 97.8"	"Cell type enhanced"	"Detected in some"	18	"Melanocytes: 13.5;monocytes: 38.7;T-cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.1"	"Group enriched"	"Detected in many"	10	"B-cells: 8.8;T-cells: 24.1"	"Cell line enriched"	"Detected in single"	111	"HDLM-2: 58.4"									"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	NA	NA		590000			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"	2.5	0.3	0.3	14.2	0.3	4.4	1.4	0.2	0.3	1.2	2.3	0.4	0.5	2.2	0.5	1.2	2.2	0.8	2.3	1.3	0.2	0.2	2.0	1.0	4.0	14.8	0.2	0.1	0.6	0.9	0.0	0.5	2.3	0.3	1.1	2.1	0.6	4.1	0.6	0.8	1.1	7.6	1.0	0.5	10.6	2.4	0.4	0.2	97.8	1.5	1.9	26.3	3.5	1.1	8.8	1.6	0.2	0.1	0.0	24.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.1	0.0	4.2	0.0	24.1	6.2	17.2	12.1	0.1	8.8	6.6	1.6	0.2	0.0	0.0	1.6	21.5	3.5	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.0	6.9	8.1	0.1	1.8	0.0	0.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.3	0.0	0.0	0.0	1.2	6.2	0.0	5.0	13.5	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.1	20.2	0.0	0.0
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5"									"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.6	43.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	14.2	0.0	0.0	13.5	6.7	0.0	0.0	0.0	0.8	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	61.5	15.8	0.0	11.7	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2	0.0	14.8	233.4	0.5	4.8	0.0	0.8	5.1	4.0	2.3	3.5	0.0	0.7	1.7	0.1	0.0	0.7	0.0	23.3	0.2	0.7	3.1	0.2	88.9	1.8	87.6	0.0	1.2	8.6	195.5	0.4	1.7	131.8	37.1	8.2	0.0	0.0	0.1	0.0	0.4	1.5	0.0	0.0	0.7	0.4	0.1	2.6	0.3	297.5	0.0	0.3
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.9;lymphoid tissue: 45.0"	"Cell type enriched"	"Detected in many"	5	"monocytes: 204.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"U-266/70: 80.7"					"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles		NA	NA		620000	Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.46e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.57e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-2)"	5.5	1.0	0.7	28.6	0.7	2.3	3.4	0.6	0.7	4.1	11.9	0.2	0.4	11.1	1.9	1.3	6.7	1.6	6.2	1.0	0.7	0.7	2.4	3.1	10.2	24.6	0.8	0.4	2.5	2.2	0.0	0.9	1.3	0.6	1.8	10.2	2.9	15.1	4.8	0.9	2.0	15.8	0.8	1.2	45.0	11.0	1.5	0.4	5.9	2.1	4.2	38.7	11.5	2.6	3.7	27.4	1.1	14.9	17.3	32.9	8.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	2.2	0.0	0.7	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	80.7	6.8	0.0	2.2	0.0	0.0	0.0	1.6	0.3	32.9	11.0	25.4	3.7	3.5	22.4	7.2	0.6	1.1	13.6	1.1	17.3	14.9	27.4	0.0	8.7	0.7	0.7	0.6	0.7	0.7	0.7	0.8	0.4	0.6	0.4	8.9	8.9	20.2	1.4	0.7	0.0	0.8	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	23.3	2.3	0.1	1.1	1.8	8.1	0.0	8.9	0.0	0.0	0.6	6.0	0.0	0.0	12.8	18.6	204.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	39.5	0.0	3.0
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.8;intestine: 11.3;lymphoid tissue: 43.7;urinary bladder: 28.6"	"Group enriched"	"Detected in some"	19	"B-cells: 55.0;Erythroid cells: 23.3;Melanocytes: 67.4;T-cells: 45.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 30.6;MAIT T-cell: 30.7;memory B-cell: 15.2;memory CD4 T-cell: 26.8;memory CD8 T-cell: 29.6;naive B-cell: 13.9;naive CD4 T-cell: 30.5;naive CD8 T-cell: 30.8;plasmacytoid DC: 18.6;T-reg: 19.7"	"Group enriched"	"Detected in many"	4	"B-cells: 15.2;dendritic cells: 18.6;T-cells: 30.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;JURKAT: 7.4;Karpas-707: 14.9;U-266/70: 37.8;U-266/84: 14.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050917	Approved					NA	NA		23000			"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.8	0.5	0.4	20.9	0.4	6.9	2.7	0.4	0.4	1.4	3.7	0.2	0.4	2.4	0.9	0.8	3.5	1.0	2.0	0.9	0.4	0.4	1.7	1.3	6.1	35.3	0.4	0.0	1.1	0.5	0.0	0.5	0.2	0.1	1.0	2.3	1.0	6.5	0.4	0.4	0.8	11.3	0.1	0.7	25.3	3.4	1.1	0.0	35.7	1.6	1.8	43.7	28.6	1.2	15.2	18.6	0.6	0.2	5.2	30.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	14.9	0.0	0.0	1.1	0.2	0.0	0.4	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	37.8	14.6	0.1	0.0	2.1	0.0	0.2	0.2	0.1	30.6	0.2	30.7	15.2	26.8	29.6	1.3	13.9	30.5	30.8	0.6	5.2	0.2	18.6	19.7	12.9	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.1	0.0	0.0	2.6	55.0	0.5	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	23.3	0.2	0.0	0.5	0.2	0.0	0.4	2.0	0.0	1.2	2.5	2.4	0.0	0.0	2.2	67.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.9	0.1	45.3	0.0	0.4
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862855	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 75.8;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 9.6;Kupffer cells: 15.1;T-cells: 19.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 75.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 75.8"	"Cell line enhanced"	"Detected in some"		"HEL: 10.9;HMC-1: 38.3;NB-4: 7.5;U-937: 15.3"					"Not detected"	"Not detected"									NA	NA						"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.9	0.4	0.5	3.3	0.5	8.6	0.6	0.3	0.7	0.9	3.1	0.4	1.6	2.8	1.4	0.7	1.0	0.7	1.7	2.0	0.5	0.5	0.7	4.1	5.3	7.4	1.7	0.0	1.6	0.5	0.0	0.5	1.8	1.1	1.6	1.2	1.0	1.6	0.9	1.1	0.5	6.0	2.6	1.5	22.1	0.8	2.8	0.6	0.7	0.6	0.0	4.0	1.5	0.8	0.0	7.9	75.8	13.2	14.0	14.8	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.2	3.5	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	15.3	0.0	75.8	8.2	20.1	14.8	11.2	7.3	0.0	0.8	8.1	7.9	0.0	1.1	7.8	0.6	14.0	13.2	0.4	0.0	11.3	0.5	0.5	0.3	0.7	0.5	0.5	1.7	0.0	1.1	0.6	3.0	9.6	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	1.6	0.0	0.2	0.0	3.5	0.0	0.6	0.0	0.0	0.0	15.1	1.9	1.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.0
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell type enriched"	"Detected in many"	16	"Mucus-secreting cells: 1345.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Group enriched"	"Detected in some"	4	"HEL: 3.8;HL-60: 2.8;OE19: 10.5;U-937: 10.6"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	NA	NA	294000000	160000000			"CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764"	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.5	0.0	0.0	0.0	1.5	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	10.6	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2	0.0	6.7	0.9	0.1	0.0	0.0	6.1	2.5	1.4	3.4	3.5	0.0	0.0	0.0	0.0	0.5	0.0	20.4	0.0	3.3	0.7	0.0	0.3	1.1	0.0	0.8	0.0	17.2	81.0	86.0	0.4	13.6	0.0	0.0	0.0	1345.2	0.0	4.3	11.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	43.2	0.1
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 88.4"	"Cell type enriched"	"Detected in some"	9	"Alveolar cells type 1: 71.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 15.4;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9;SuSa: 5.4"									"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	2.6	0.0	4.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.0	4.9	5.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	71.5	7.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	8.0	0.0	0.0	1.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021348	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 235.2;Urothelial cells: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 44.5;neutrophil: 32.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 44.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 45.8;OE19: 44.1;SuSa: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"		NA	NA		41000000	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589"	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	20.7	13.3	3.0	9.6	3.6	6.4	11.8	2.0	3.5	14.5	36.3	3.9	21.4	20.5	8.6	11.2	41.5	12.3	30.5	10.0	3.4	3.2	35.9	69.8	55.0	10.4	3.6	1.8	10.9	37.9	18.5	16.3	61.8	5.3	17.8	19.5	5.7	59.3	23.7	9.0	22.0	59.8	4.9	4.0	27.0	18.8	11.0	3.3	8.1	52.2	25.8	29.9	16.8	19.7	1.3	7.0	44.5	8.9	2.2	3.8	6.6	26.4	3.4	1.0	0.3	0.7	0.0	21.5	0.1	0.0	0.9	0.9	24.5	35.0	1.9	18.0	0.0	5.2	45.8	5.4	22.7	1.4	1.5	4.0	5.5	1.4	11.1	1.1	5.1	16.5	0.3	28.7	0.1	7.6	5.5	21.5	4.2	7.5	0.5	0.1	11.4	1.6	2.9	18.2	44.1	4.9	2.4	0.0	8.5	15.4	20.1	7.6	2.0	6.4	27.5	5.7	54.5	29.9	9.2	12.9	0.0	0.6	0.1	0.2	6.4	12.6	0.6	4.1	5.1	1.7	7.6	8.9	44.5	3.8	4.5	2.0	1.3	3.5	2.3	7.0	0.9	3.4	2.7	32.2	2.2	3.4	5.3	1.5	6.6	3.0	3.6	2.0	3.5	3.4	3.2	3.6	1.8	5.3	3.3	235.2	115.8	3.7	97.8	31.3	0.8	3.0	61.1	163.3	161.5	73.3	2.0	64.9	6.6	66.4	6.8	40.7	78.8	0.0	61.9	148.6	11.0	102.0	17.4	55.2	27.9	0.0	59.7	24.5	14.6	1.5	2.0	22.4	8.5	63.1	64.1	1.4	68.6	75.0	0.7	11.9	2.5	0.0	3.1	12.9	1.2	44.3	52.7	8.7	42.7	227.3
TSTD1	KAT	ENSG00000215845	"Thiosulfate sulfurtransferase like domain containing 1"	Q8NFU3	1	161037631-161038990	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.5;OE19: 39.8;SK-BR-3: 52.8;T-47d: 51.1;U-266/70: 59.7;U-266/84: 41.9"	"Region enriched"	"Detected in some"	4	"olfactory region: 8.2"	"Low region specificity"	"Detected in many"			"HPA006518, HPA006655"	Approved		Approved	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytosol, Cytoplasmic bodies"		"HPA006518: AB_2667608, HPA006655: AB_10600919"	"unprognostic (6.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.88e-3)"	9.1	19.9	14.8	15.4	29.8	13.1	24.2	3.6	13.9	10.1	18.1	4.4	45.4	12.2	4.2	34.7	23.3	21.8	16.0	14.4	12.2	8.1	28.4	26.0	19.2	14.6	4.1	13.2	15.0	62.2	27.7	32.9	10.1	6.3	26.0	12.8	11.9	79.8	46.0	9.2	18.7	16.5	5.6	1.9	10.4	14.1	15.0	5.5	20.4	61.3	19.5	27.1	12.3	11.0	77.0	30.9	55.0	14.8	42.1	58.7	31.9	21.4	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	21.2	4.6	13.0	0.0	0.0	19.9	0.0	8.5	0.0	17.8	16.0	2.4	8.1	0.0	2.3	8.0	0.1	0.1	5.3	0.0	0.9	0.0	2.9	19.1	0.0	25.2	2.5	37.5	21.7	0.1	0.1	39.8	0.1	7.1	0.0	33.0	18.5	6.0	13.1	7.0	0.0	52.8	0.1	11.1	51.1	0.1	0.1	0.0	8.0	0.1	0.9	59.7	41.9	4.6	0.0	0.0	0.0	55.0	3.6	51.2	36.3	10.5	34.8	75.8	47.8	40.2	10.9	77.0	54.7	45.9	51.6	42.1	14.8	30.9	58.7	31.9	14.8	29.8	3.6	13.9	12.2	8.1	4.1	13.2	6.3	5.5	235.2	172.5	87.8	263.5	76.6	11.5	49.7	221.7	445.7	177.5	349.0	25.5	237.9	580.3	133.0	14.1	14.6	335.6	0.0	132.4	100.5	27.4	450.5	120.3	124.5	63.7	3.2	210.0	12.3	18.3	14.6	7.8	47.2	143.4	288.6	340.6	29.3	129.9	191.5	9.2	413.9	23.8	19.4	22.1	31.3	40.7	118.7	126.3	120.4	248.2	338.2
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178"	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favorable (1.95e-5)"	15.4	17.0	21.6	16.9	24.4	14.3	13.8	31.0	27.6	15.2	17.6	15.6	15.6	17.7	15.1	15.5	12.6	17.1	16.2	17.4	21.6	22.1	15.2	19.1	16.7	23.8	19.7	19.4	17.2	9.8	19.0	12.3	17.3	17.1	14.4	18.0	14.7	13.8	19.0	27.4	14.6	17.8	18.0	18.3	26.7	13.7	8.5	18.7	21.9	16.1	13.5	30.3	18.5	13.8	3.9	5.7	8.6	4.7	2.0	4.0	2.0	8.2	12.6	15.1	17.5	20.4	11.7	20.3	7.0	15.1	21.8	17.0	8.8	10.5	10.7	14.8	11.5	9.5	10.4	17.8	11.0	12.3	9.9	10.5	9.2	10.5	9.2	11.9	12.8	12.9	9.5	11.1	15.7	12.8	13.9	20.3	18.4	15.1	11.6	13.6	9.7	19.7	14.0	31.1	18.1	16.5	17.2	11.8	13.0	10.8	13.3	8.5	16.4	12.7	16.5	8.8	22.8	13.7	41.8	11.9	10.9	6.9	6.6	11.2	9.8	12.4	17.0	9.4	12.5	8.3	4.7	4.7	2.7	4.0	4.5	2.4	3.4	2.5	2.9	5.4	3.9	2.7	2.6	8.6	2.0	4.2	5.7	2.7	2.0	21.6	24.4	31.0	27.6	21.6	22.1	19.7	19.4	17.1	18.7	6.0	8.6	3.2	0.6	2.1	3.6	0.7	0.0	8.1	2.3	3.5	2.0	1.9	1.7	1.6	0.3	1.9	6.3	0.0	1.2	3.3	1.8	1.0	10.5	0.4	2.8	4.8	2.9	0.0	1.9	0.0	0.3	3.2	5.0	2.8	2.7	2.0	2.1	7.0	0.0	2.5	3.4	6.5	1.4	0.5	0.4	1.6	2.9	4.6	3.2	1.3
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;lymphoid tissue: 45.9"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 64.9;Hofbauer cells: 51.2;Kupffer cells: 65.0;Macrophages: 65.9;monocytes: 85.6;T-cells: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.5;HL-60: 24.3;HMC-1: 34.3;Karpas-707: 25.5;MOLT-4: 19.7;THP-1: 24.2;U-266/70: 38.3;U-266/84: 25.3;U-698: 26.9;U-937: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	6.1	3.0	2.6	23.3	3.9	20.4	3.1	0.6	2.4	2.2	3.9	3.5	1.4	3.5	2.0	3.7	8.0	3.3	5.9	4.1	1.9	1.7	3.0	3.3	11.3	27.9	4.3	0.7	1.8	1.8	0.3	1.5	2.5	3.4	2.3	3.2	2.6	6.1	1.8	0.9	11.2	13.7	2.9	4.3	45.9	4.1	1.4	4.5	38.1	2.0	2.4	33.2	5.6	3.8	8.3	12.3	27.1	24.0	10.2	19.7	14.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	31.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	14.6	0.0	10.5	0.0	0.0	0.0	24.3	34.3	0.0	0.3	0.0	0.0	0.0	0.0	15.3	0.1	25.5	0.0	0.2	19.7	5.6	0.0	0.2	0.0	12.4	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	24.2	0.2	0.0	0.1	0.0	0.1	38.3	25.3	26.9	0.1	19.5	0.0	3.3	15.5	17.6	19.7	18.3	15.1	7.1	13.2	16.1	12.3	8.3	11.0	14.7	27.1	10.2	24.0	8.4	13.2	14.7	2.6	3.9	0.6	2.4	1.9	1.7	4.3	0.7	3.4	4.5	3.0	25.1	39.8	2.9	4.9	0.2	1.2	5.1	9.4	11.4	0.0	3.9	0.5	0.0	2.2	2.1	2.1	0.0	0.0	5.3	1.2	0.9	3.8	64.9	1.5	51.2	0.0	0.0	7.4	65.0	0.4	0.3	65.9	5.0	85.6	0.3	0.2	7.6	0.0	0.0	0.5	3.0	0.0	1.4	0.0	0.1	21.5	3.8	106.6	0.3	13.6
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 321.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		11000	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.2	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	0.0	18.2	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.3	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.1	23.7	0.0	3.3	15.3	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	6.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	18.7	14.8	15.7	0.0	24.1	0.0	34.7	0.0	0.0	0.0	0.0	26.2	43.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	321.3	0.0	0.0	0.0
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032058, HPA043197"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA032058: AB_10601439, HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	1.0	3.7	4.0	1.0	8.4	0.9	1.4	3.1	9.5	1.8	2.4	2.3	5.6	1.6	2.4	3.9	1.1	5.7	2.4	1.7	3.3	4.9	5.9	2.6	1.7	1.0	3.6	7.4	2.5	3.6	4.1	4.8	1.0	5.6	3.2	1.6	3.5	2.9	2.4	2.5	0.8	1.6	1.1	1.6	1.1	2.4	24.3	2.2	0.0	5.0	0.0	1.1	1.5	0.6	0.9	0.1	0.0	0.2	0.0	1.1	0.1	0.4	2.7	1.0	2.9	0.0	0.3	0.3	0.0	0.7	0.1	0.0	0.0	0.2	0.0	5.0	0.0	0.0	1.6	0.0	0.0	0.0	3.5	3.7	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.5	0.0	1.5	0.5	2.4	2.6	0.0	1.9	0.6	0.0	2.5	1.1	0.0	1.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	4.0	8.4	3.1	9.5	3.3	4.9	3.6	7.4	5.6	2.2	0.0	4.1	0.0	11.1	0.8	13.0	8.5	7.6	53.5	9.1	27.9	2.0	2.3	48.0	6.8	336.6	3.3	3.2	0.0	4.9	2.8	3.5	10.5	1.1	7.3	0.5	3.2	5.2	1.8	0.3	352.6	7.5	0.3	6.8	1.0	12.5	27.9	4.2	7.0	7.8	29.8	16.9	12.9	1.9	259.8	11.1	0.6	0.7	0.0	7.6	5.6
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118111	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 570.2;Suprabasal keratinocytes: 561.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol		NA	NA		60000	Cytosol		"HPA028700: AB_10603983, HPA058304: AB_2683673"	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	36.5	30.4	47.2	22.7	41.7	40.9	20.9	25.1	38.8	19.6	19.9	27.8	15.1	19.1	20.8	29.1	19.7	18.5	16.0	38.2	41.4	48.6	25.9	41.1	18.5	23.5	52.2	32.9	18.5	20.8	13.6	29.3	25.1	42.7	20.1	17.9	12.9	21.2	20.8	62.2	15.0	18.4	19.4	48.6	21.2	17.8	22.1	31.8	14.7	18.3	20.9	24.3	22.7	26.2	34.4	61.7	33.4	37.3	18.2	28.5	21.0	43.4	29.2	22.7	29.4	20.7	19.8	24.8	32.4	29.4	28.0	22.2	38.4	33.1	29.5	38.1	21.0	27.7	32.3	34.4	39.7	33.8	32.1	35.5	32.6	41.5	54.2	61.0	44.7	32.7	22.2	52.3	45.0	128.2	21.3	31.4	30.8	47.8	20.8	25.1	44.1	33.4	53.1	44.5	51.2	73.2	28.7	23.0	35.2	30.3	26.1	30.0	50.0	24.9	32.9	51.6	30.9	27.1	56.4	27.6	29.0	42.6	36.4	67.6	32.0	30.4	56.6	35.3	30.6	39.8	24.7	32.7	33.4	19.2	31.4	21.8	34.1	23.5	23.1	39.1	34.4	24.8	24.1	16.2	18.2	37.3	61.7	28.5	21.0	47.2	41.7	25.1	38.8	41.4	48.6	52.2	32.9	42.7	31.8	29.8	37.8	97.5	214.7	570.2	76.9	106.9	73.9	81.7	40.9	109.9	15.7	156.1	290.1	151.8	21.8	101.2	75.9	0.0	130.4	209.7	150.8	165.7	97.0	123.5	154.2	20.6	97.3	81.6	57.7	15.7	117.1	160.7	175.5	129.8	71.4	55.8	186.7	64.2	103.6	225.6	50.4	77.6	263.3	153.5	288.9	561.7	150.2	74.8	76.8	356.8
NIT1		ENSG00000158793	"Nitrilase 1"	Q86X76	1	161118086-161125445	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006657	Approved					NA	NA		82000			"HPA006657: AB_1079485"	"unprognostic (3.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.94e-2)"	16.0	43.0	13.9	13.5	15.5	7.5	15.8	10.3	21.6	15.4	21.3	14.8	24.7	25.8	16.9	19.1	14.8	15.9	17.9	16.4	12.6	15.7	24.4	44.1	15.3	14.2	14.2	19.0	15.0	29.7	26.7	19.3	18.7	17.1	16.5	19.5	12.9	22.9	20.2	15.9	14.3	35.0	15.1	12.4	17.8	14.8	17.6	10.6	20.9	23.3	10.1	14.1	14.8	13.1	10.3	15.3	26.8	18.8	6.8	10.1	9.5	10.6	15.9	15.6	4.7	20.8	12.6	9.3	8.5	12.7	10.5	10.3	10.6	21.6	11.7	14.2	11.7	14.7	11.6	9.0	19.8	8.8	10.2	7.3	8.0	10.3	11.9	16.1	4.8	6.9	15.2	19.9	19.8	21.1	17.3	14.9	17.7	8.6	7.8	16.6	9.6	10.0	6.0	7.1	20.0	12.7	10.6	8.3	15.0	22.7	7.4	6.6	8.5	11.7	21.4	11.5	31.6	21.6	11.9	8.7	4.9	10.8	7.7	6.5	23.0	14.0	10.2	10.1	4.3	7.5	26.8	17.1	14.9	9.1	15.3	9.0	10.3	9.6	7.5	14.2	10.0	9.5	8.0	12.5	6.8	18.8	15.3	10.1	9.5	13.9	15.5	10.3	21.6	12.6	15.7	14.2	19.0	17.1	10.6	17.9	14.1	23.0	20.3	7.7	12.5	5.8	53.5	17.4	6.8	22.7	17.7	37.9	54.7	24.9	5.7	14.9	47.9	23.3	27.0	24.1	12.5	14.1	11.5	46.5	34.5	17.5	11.1	13.5	11.8	3.6	15.0	16.8	15.1	23.4	21.4	20.9	25.8	24.6	21.2	89.1	16.0	38.8	15.5	32.1	21.7	11.2	46.8	13.8	27.7	18.8
DEDD	"CASP8IP1, DEDD1, DEFT, FLDED1, KE05"	ENSG00000158796	"Death effector domain containing"	O75618	1	161120974-161132688	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030681, HPA073628"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030681: AB_2797220, HPA073628: AB_2732230"	"unprognostic (2.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.20e-3)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.43e-2)"	24.4	15.7	15.8	17.3	16.4	24.2	20.8	19.3	24.0	16.6	20.4	19.3	16.4	19.4	19.6	14.8	24.0	18.4	20.1	18.5	14.3	12.8	16.5	26.3	20.3	17.8	12.9	11.8	22.1	18.7	14.5	14.0	36.7	18.2	17.2	13.1	17.5	18.1	16.0	39.0	21.5	17.9	20.0	13.8	21.2	16.6	35.8	14.7	19.2	18.7	24.2	19.5	20.1	18.5	16.3	21.3	33.6	23.8	16.5	24.0	18.7	13.2	13.1	15.6	13.5	12.0	12.2	10.7	11.4	16.3	13.3	14.8	9.1	23.0	14.2	11.5	17.1	9.8	12.1	11.8	17.8	8.6	14.1	12.8	13.2	15.7	12.2	21.3	9.2	20.1	15.3	19.1	14.2	22.7	17.7	21.3	19.7	11.2	21.3	15.4	20.8	22.3	10.1	25.9	26.6	13.6	18.4	10.7	18.9	13.2	16.2	16.5	25.0	11.6	30.8	19.8	17.8	18.4	18.9	14.9	14.5	15.5	16.8	16.5	29.5	18.6	25.1	17.3	10.0	10.3	33.6	23.8	32.1	19.0	21.9	16.2	16.3	19.0	18.9	21.3	15.4	21.5	17.5	26.6	16.5	22.5	18.8	24.0	18.7	15.8	16.4	19.3	24.0	14.3	12.8	12.9	11.8	18.2	14.7	23.8	9.4	6.8	11.7	22.3	6.0	8.7	12.7	5.3	7.9	8.7	5.9	16.8	19.9	11.5	30.8	18.0	10.6	0.0	16.8	16.5	15.0	8.8	16.1	9.2	13.3	12.7	10.9	14.1	18.6	37.1	10.9	15.9	13.5	17.2	8.7	5.0	11.9	11.5	9.2	11.3	9.2	6.5	18.6	15.7	14.7	21.8	22.5	8.3	9.9	13.7
UFC1	HSPC155	ENSG00000143222	"Ubiquitin-fold modifier conjugating enzyme 1"	Q9Y3C8	1	161152776-161158856	"Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027481, HPA028722"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		180000	"Nuclear speckles"	Cytosol	"HPA027481: AB_10599850, HPA028722: AB_10601674"	"unprognostic (2.16e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.62e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.22e-2)"	34.2	38.6	52.6	25.4	54.7	35.1	45.6	21.1	41.8	35.4	37.3	27.8	47.7	36.9	31.5	57.2	40.6	69.9	40.8	36.0	42.5	45.9	56.1	55.2	32.0	29.8	46.3	35.6	48.7	85.5	39.3	40.6	54.2	34.4	44.0	46.8	29.2	63.6	40.3	34.3	36.1	48.6	35.8	34.4	39.1	39.1	22.2	33.9	38.9	50.2	38.9	38.9	37.9	33.4	41.1	43.6	22.4	33.0	40.9	54.1	48.0	22.4	20.8	18.4	23.1	24.7	39.7	38.8	22.9	27.0	21.9	19.4	27.2	46.1	31.2	38.5	31.8	15.1	11.7	15.4	22.0	16.3	26.5	42.2	19.0	31.0	32.6	24.5	41.9	48.6	33.8	35.7	27.3	18.9	37.3	38.1	31.8	31.5	22.9	27.9	27.1	19.4	38.3	33.8	67.0	22.9	23.8	13.4	43.4	42.4	27.4	21.2	33.7	20.0	66.3	26.3	31.0	25.3	78.0	28.5	16.3	15.9	15.6	33.4	39.9	51.0	28.2	25.8	26.7	20.6	22.4	32.8	20.4	39.0	33.0	47.2	41.1	41.8	41.5	40.4	31.0	36.7	39.5	6.0	40.9	24.0	43.6	54.1	48.0	52.6	54.7	21.1	41.8	42.5	45.9	46.3	35.6	34.4	33.9	65.5	68.2	142.4	148.8	88.7	59.5	99.6	142.7	566.1	94.4	99.5	39.3	208.4	373.0	191.0	103.8	125.8	138.7	140.2	332.6	317.7	97.7	152.4	116.6	83.9	213.1	44.5	196.3	79.8	133.0	302.8	97.2	153.3	124.9	257.9	166.3	88.5	242.7	175.4	85.6	257.5	52.6	64.7	102.4	96.2	34.8	105.8	361.2	152.3	163.7	181.2
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	11.8	16.4	22.1	12.8	21.2	15.3	19.1	23.6	24.8	18.1	16.1	25.5	14.0	15.5	19.7	14.6	18.3	33.3	14.1	13.7	20.9	12.1	15.4	10.6	14.0	16.7	26.4	14.1	28.3	19.0	24.4	17.2	15.2	20.5	18.1	13.1	17.1	19.0	25.3	19.4	23.5	15.4	15.1	17.0	18.7	16.0	17.0	22.9	16.0	24.5	9.6	15.6	17.9	19.2	14.1	12.0	18.3	11.1	13.4	17.2	10.7	7.4	12.9	16.9	16.3	13.5	11.3	10.4	5.5	9.0	15.2	11.9	11.8	14.7	9.8	9.5	6.8	9.5	12.9	10.9	10.7	8.4	18.6	18.4	11.6	18.6	9.2	9.8	10.3	8.7	9.5	14.4	10.4	15.1	17.2	10.7	21.7	17.2	13.6	9.7	13.7	18.2	16.2	15.8	14.6	16.4	17.3	5.6	16.4	8.9	8.9	15.4	19.9	10.3	10.9	8.3	13.2	23.9	16.7	6.3	10.9	9.8	7.6	9.4	27.6	21.3	14.5	10.0	8.9	9.8	13.0	11.1	18.3	14.9	7.1	17.2	12.8	13.8	15.4	12.0	14.1	16.0	14.6	9.6	13.4	7.7	12.0	13.3	10.7	22.1	21.2	23.6	24.8	20.9	12.1	26.4	14.1	20.5	22.9	0.0	3.0	1.7	1.5	1.3	3.9	2.2	10.2	10.7	3.4	1.8	5.9	3.6	1.7	1.4	0.6	2.8	2.0	0.0	2.0	2.1	2.4	2.0	2.3	1.7	1.9	0.0	5.2	6.2	7.6	0.4	4.6	1.7	1.7	0.0	4.1	3.0	1.7	2.9	3.9	1.8	4.4	6.5	1.9	3.6	2.7	1.3	2.6	2.5	3.7	1.4
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166410-161178013	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	7.3	14.8	11.6	9.1	12.1	31.7	10.2	23.5	16.5	11.0	9.9	13.2	8.5	6.0	11.7	13.5	7.5	33.2	9.5	9.5	11.5	12.5	12.0	9.1	10.2	11.2	14.2	16.1	13.0	13.1	10.5	12.3	10.1	12.1	11.0	6.7	14.4	11.3	14.6	8.5	15.9	7.1	10.0	10.6	12.0	8.2	6.9	13.7	9.2	11.0	6.1	8.7	8.7	8.2	9.8	11.5	6.9	7.7	12.3	16.7	8.9	7.1	6.6	9.9	6.4	7.5	8.0	3.3	4.9	5.7	6.1	8.1	7.7	6.9	5.6	11.9	3.4	3.1	4.9	7.6	7.9	5.5	3.9	15.0	6.7	14.8	17.6	8.0	2.2	3.7	6.4	8.0	5.9	8.4	9.2	11.5	5.2	19.9	8.7	4.4	6.7	8.9	7.1	7.1	9.0	14.1	10.9	6.8	13.2	11.6	3.1	7.8	12.7	6.0	8.7	9.9	12.5	15.8	10.5	4.0	5.6	6.2	4.9	6.3	15.5	11.3	8.6	5.7	4.9	4.3	6.9	7.7	5.5	12.7	7.7	8.4	9.8	9.8	8.8	11.5	8.6	8.6	8.8	1.6	12.3	5.3	7.2	16.7	8.9	11.6	12.1	23.5	16.5	11.5	12.5	14.2	16.1	12.1	13.7	3.0	13.6	4.5	7.2	10.6	16.2	7.7	7.6	62.9	13.6	7.0	21.6	17.7	18.3	8.8	8.4	9.1	4.9	0.0	4.9	8.3	10.3	3.6	5.8	5.8	8.0	14.3	5.8	8.0	4.3	10.0	9.5	7.9	1.7	10.0	6.5	9.6	6.4	3.6	6.3	14.8	17.3	6.5	6.7	9.6	6.1	13.0	8.7	13.1	7.6	4.7
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 74.9"	"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.9	6.6	9.8	12.9	14.6	7.5	15.7	5.7	10.2	11.8	10.9	13.0	20.4	9.2	16.3	6.4	11.3	10.2	10.3	6.3	7.0	9.6	12.6	5.3	4.4	10.4	10.5	10.3	14.8	10.4	9.4	10.9	11.9	14.2	13.4	12.1	17.0	20.8	9.6	10.3	6.7	9.9	12.3	20.1	14.1	8.2	5.5	22.7	10.1	6.2	14.0	16.6	5.7	15.1	11.9	13.9	15.1	18.9	5.6	5.9	10.7	6.7	16.6	74.9	40.4	12.3	8.8	8.9	9.4	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4	17.9	18.3	36.5	26.3	34.2	12.6	9.5	7.6	10.7	6.8	24.4	2.0	38.4	5.0	25.4	7.0	20.2	14.7	0.0	19.9	75.2	19.5	33.5	9.2	11.6	25.2	25.4	27.6	26.4	16.8	4.0	8.9	13.8	21.9	6.4	22.4	7.4	28.1	14.4	6.7	17.3	6.3	25.8	34.6	9.8	42.9	36.6	95.5	34.6	21.7	45.5
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell type enriched"	"Detected in many"	7	"Smooth muscle cells: 356.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.1	3.9	0.6	4.9	0.2	0.4	2.8	0.2	0.1	0.2	4.1	1.5	0.0	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.3	0.0	10.9	0.1	0.0	13.2	0.1	0.1	0.3	0.3	0.1	0.0	0.2	4.9	0.0	0.0	0.1	4.8	0.1	0.0	0.1	0.1	7.4	0.0	0.1	0.1	0.3	0.2	0.5	11.1	6.9	0.1	0.3	9.8	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7	0.0	5.5	0.0	2.3	27.7	2.2	2.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	43.0	0.0	0.0	0.0	0.2	33.3	8.7	0.0	0.8	0.8	3.2	0.0	48.5	1.5	0.0	0.3	6.0	33.7	1.8	0.0	0.3	0.0	0.0	1.1	0.0	1.0	51.8	356.4	2.3	0.6	16.7	0.3	1.5	0.0	4.4
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214395	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		16000	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	14.6	30.7	16.6	8.0	25.4	10.2	15.5	23.4	25.4	13.0	25.6	17.9	11.7	23.6	12.3	11.2	16.7	14.5	10.6	75.4	17.6	14.8	37.4	52.6	12.8	9.2	28.0	25.0	14.1	14.3	25.6	10.7	11.5	24.1	12.7	27.2	11.4	14.6	14.5	104.9	14.0	22.1	15.7	16.1	13.0	19.4	8.8	25.3	10.4	12.3	37.1	15.1	13.2	10.5	18.9	47.3	26.6	42.2	20.3	29.2	32.4	17.2	27.8	17.6	20.4	25.9	23.0	15.2	15.7	23.1	31.1	24.5	30.5	18.0	22.0	29.6	24.2	17.1	23.2	28.1	28.1	27.5	14.6	23.6	21.4	20.9	26.6	26.9	23.2	19.9	33.1	24.8	25.1	28.7	20.6	35.5	23.0	27.4	12.0	29.2	19.9	14.7	12.4	32.1	60.6	25.7	12.7	18.2	30.9	36.9	20.7	18.7	27.8	19.0	46.9	26.8	26.3	42.1	60.8	22.7	15.1	12.9	10.6	21.2	16.9	26.7	18.4	23.1	19.6	19.4	26.6	35.9	18.9	20.5	42.2	19.9	18.9	20.9	20.7	47.3	15.7	21.6	21.8	20.2	20.3	37.0	31.8	29.2	32.4	16.6	25.4	23.4	25.4	17.6	14.8	28.0	25.0	24.1	25.3	32.8	43.7	52.8	39.4	34.6	72.7	193.6	76.5	68.3	35.2	73.3	29.5	125.8	281.8	158.0	7.1	61.2	199.4	23.3	126.2	94.3	73.7	24.9	68.1	177.0	131.6	87.4	69.2	58.9	83.7	4.7	40.3	64.2	79.2	127.2	94.1	51.2	124.2	89.2	31.5	226.7	49.8	45.3	68.0	36.7	32.1	37.9	132.5	50.1	138.8	41.7
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 262.7;lymphoid tissue: 176.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 677.9;Hofbauer cells: 2071.1;Kupffer cells: 1979.2;Macrophages: 2000.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 262.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 17.5;HMC-1: 71.6;THP-1: 63.0;U-266/84: 19.4;U-937: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					NA	NA		9800000			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	62.6	20.5	12.1	49.5	22.4	71.5	17.6	2.4	10.8	10.6	14.6	14.1	1.3	8.0	7.2	15.9	6.9	20.5	18.8	21.2	15.3	11.2	18.9	35.9	71.2	124.8	23.4	4.5	11.4	7.4	2.9	7.9	38.1	17.0	9.7	21.3	9.7	12.8	7.4	11.9	5.7	13.6	28.5	33.3	176.3	10.9	11.6	16.0	6.5	11.5	6.7	14.7	22.4	10.5	0.9	135.4	73.5	262.7	66.6	2.0	132.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	17.5	0.1	3.3	0.0	3.6	71.6	1.4	0.7	0.5	0.0	0.1	0.1	0.4	0.0	1.7	0.5	0.1	0.3	8.5	0.3	0.0	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.6	0.3	0.0	63.0	0.1	0.4	0.1	0.2	0.2	0.7	19.4	0.2	0.4	19.7	0.1	64.3	129.8	12.1	0.5	210.3	0.6	0.9	0.4	0.4	97.1	0.3	0.7	2.0	73.5	66.6	262.7	135.4	0.8	132.1	12.1	22.4	2.4	10.8	15.3	11.2	23.4	4.5	17.0	16.0	80.4	219.7	81.8	1.4	35.1	0.0	4.0	20.4	28.1	50.0	17.4	0.0	11.9	0.0	0.5	1.4	15.7	0.6	46.7	0.8	13.5	26.5	1.8	677.9	7.6	2071.1	0.0	1.7	49.7	1979.2	4.7	4.9	2000.4	75.9	55.9	0.0	0.2	0.7	0.9	1.1	3.9	2.6	71.1	23.6	0.9	2.6	31.5	19.8	270.2	0.2	1.6
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	321	"liver: 932.2"	"Cell type enriched"	"Detected in some"	61	"Hepatocytes: 43650.4"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 610.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	210000000000			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	932.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.0	2.9	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	67.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	610.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.8	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	153.8	0.0	0.0	0.0	0.0	647.1	0.0	0.0	0.0	0.0	0.5	1.7	0.0	1.2	0.0	0.0	186.9	0.5	1.1	0.0	0.0	0.0	43650.4	4.6	0.0	0.0	550.0	711.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.5	0.0	4.7	0.0	0.0	0.0
TOMM40L	"FLJ12770, TOMM40B"	ENSG00000158882	"Translocase of outer mitochondrial membrane 40 like"	Q969M1	1	161225939-161230744	"Predicted intracellular proteins"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051304	Approved					NA	NA					"HPA051304: AB_2681432"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.46e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-2)"	"prognostic favorable (7.80e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.14e-1)"	8.7	6.6	11.1	7.2	15.4	13.4	6.5	10.4	20.5	5.9	10.6	9.3	9.9	14.7	7.0	3.5	8.7	4.9	4.4	24.2	10.9	8.6	9.7	14.0	6.7	6.3	9.4	15.1	4.9	3.4	13.9	5.2	6.4	11.2	5.8	11.5	6.4	5.3	10.0	23.5	7.5	12.1	9.0	6.1	7.1	6.9	2.2	8.0	5.9	5.2	8.2	7.7	9.4	5.5	2.0	7.6	3.6	3.9	3.7	3.8	2.9	4.7	4.3	7.4	7.9	12.2	6.5	5.6	6.8	8.3	13.4	11.7	24.9	5.8	13.4	8.7	8.9	5.0	6.0	13.8	13.5	7.8	11.6	9.4	12.5	6.4	12.4	5.4	23.9	21.2	6.9	8.7	14.8	8.1	6.8	15.1	14.2	17.5	11.6	9.3	7.3	9.7	3.6	8.0	10.2	12.5	11.2	5.6	12.7	10.3	9.8	17.6	7.8	6.4	18.4	6.1	8.3	14.1	18.5	11.5	7.0	4.9	6.1	10.1	10.3	8.7	10.1	7.2	14.8	7.2	3.6	3.5	2.9	2.7	3.9	3.1	2.0	1.8	2.9	6.8	1.4	1.7	3.8	1.8	3.7	3.1	7.6	3.8	2.9	11.1	15.4	10.4	20.5	10.9	8.6	9.4	15.1	11.2	8.0	0.0	3.5	4.2	1.2	0.5	5.9	3.5	2.5	1.4	1.2	1.8	5.9	2.2	6.6	3.8	3.2	2.8	8.1	0.0	6.8	2.5	1.9	0.9	3.5	4.3	8.4	4.8	7.5	2.5	6.2	1.7	2.0	7.6	0.0	5.4	2.7	2.0	4.6	3.5	0.7	4.3	8.9	0.0	3.1	0.7	1.9	1.5	0.7	3.9	6.3	1.3
NR1I3	"CAR, CAR1, MB67"	ENSG00000143257	"Nuclear receptor subfamily 1 group I member 3"	Q14994	1	161229666-161238302	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"liver: 63.1"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 124.3"	"Cancer enriched"	"Detected in single"	67	"liver cancer: 17.6"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA051365			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051365: AB_2616454"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.92e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.62e-2)"	0.1	0.0	0.2	0.1	1.9	0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	3.5	63.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.3	2.3	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.7	0.3	0.0	0.6	0.3	0.3	0.9	1.1	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	9.4	0.3	1.0	0.6	0.0	0.3	0.6	0.0	0.0	0.0	1.0	0.9	0.0	0.2	2.2	0.0	1.7	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.9	1.2	0.4	0.0	0.8	0.3	0.6	1.7	1.8	1.3	0.9	0.8	0.6	0.0	1.8	2.3	1.4	0.3	2.9	0.4	1.4	2.1	1.2	2.2	0.7	0.7	1.5	0.2	1.5	2.2	1.3	0.5	2.9	0.5	0.7	0.2	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.9	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	20.8	16.0	2.2	1.1	0.6	0.7	0.3	2.5	8.1	9.1	3.5	0.0	0.1	3.3	0.1	1.7	0.3	0.0	0.0	0.0	0.1	0.4	0.4	12.7	124.3	0.3	0.0	0.0	3.1	5.3	1.2	0.3	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.4	28.7	1.7	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.8
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258727-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;urinary bladder: 33.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8"	"Group enriched"	"Detected in all"	5	"basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8"	"Cell type enhanced"	"Detected in single"		"T-reg: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Group enriched"	"Detected in some"	6	"RT4: 16.1;T-47d: 10.5"	"Low region specificity"	"Detected in all"							HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	3.2	1.0	5.7	1.3	67.7	0.6	2.2	4.4	28.9	4.3	4.3	1.4	1.5	2.2	2.2	3.3	16.5	2.1	3.9	1.3	3.9	6.3	1.0	4.3	5.0	0.7	7.8	4.6	2.6	0.5	0.6	21.9	0.9	30.8	5.5	3.2	5.9	1.2	17.8	1.0	2.8	3.3	6.8	7.5	0.8	1.2	2.3	5.3	0.0	1.0	0.0	3.0	33.2	4.1	0.0	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	16.1	2.2	0.0	0.0	0.3	0.0	0.2	10.5	0.4	0.2	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.7	67.7	4.4	17.9	3.9	6.3	7.8	4.6	30.8	5.3	3.0	5.4	0.0	23.9	0.0	34.5	0.2	0.0	0.0	7.9	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.2	1.8	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	1.8	0.0	4.1	19.4	9.5	0.2	0.2	0.3	1.5	0.0	0.0	42.7
MPZ	"CMT1, CMT1B, CMT2I, CMT2J, HMSNIB"	ENSG00000158887	"Myelin protein zero"	P25189	1	161304735-161309972	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.7;retina: 60.6"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 5.4;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in many"	11	"melanoma: 83.9"	"Region enriched"	"Detected in many"	4	"midbrain: 118.7"	"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.9"	"Cell line enriched"	"Detected in some"	5	"WM-115: 68.2"	"Group enriched"	"Detected in some"	5	"olfactory region: 3.6;pons and medulla: 1.4"	"Region enriched"	"Detected in single"	58	"midbrain: 262.7"	HPA068925	Enhanced					NA	NA					"HPA068925: AB_2732123"	"unprognostic (6.77e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.62e-8)"	"unprognostic (6.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.32e-2)"	14.3	12.6	2.2	3.4	2.9	1.3	4.7	6.0	2.2	4.5	6.1	2.6	9.9	2.6	1.7	7.5	8.7	1.5	4.3	7.2	2.4	4.3	3.2	7.9	3.1	1.3	118.7	0.7	1.9	2.2	0.5	7.4	0.8	28.4	7.3	5.0	60.6	6.4	15.6	4.2	2.3	6.3	5.6	40.9	6.8	2.1	2.7	0.8	0.2	2.8	26.3	3.0	9.3	3.3	0.1	0.0	1.9	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.9	0.4	0.1	0.1	0.1	0.0	0.5	0.0	0.0	0.7	0.5	0.1	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.3	0.1	12.6	0.4	1.5	1.2	1.4	0.0	2.1	0.1	0.0	0.9	0.6	3.2	0.0	1.4	0.0	0.2	2.5	0.5	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	0.0	0.0	6.5	0.3	0.0	3.1	0.9	0.1	0.1	0.9	0.0	0.3	0.3	0.4	1.6	5.7	68.2	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.1	2.2	2.9	6.0	2.2	2.4	4.3	118.7	0.7	28.4	0.8	3.0	1.1	0.0	2.3	0.5	2.8	0.2	0.0	0.0	0.0	3.5	2.0	0.4	0.0	0.1	4.2	0.8	0.0	0.0	1.0	0.5	0.2	1.3	0.0	0.8	1.6	1.6	1.7	3.1	2.7	1.1	1.4	1.2	3.3	5.4	0.4	0.7	0.1	0.0	0.4	0.3	1.1	6.5	0.8	0.5	0.7	0.4	0.2	0.5	0.4	1.4
SDHC	"CYB560, cybL, PGL3"	ENSG00000143252	"Succinate dehydrogenase complex subunit C"	Q99643	1	161314257-161375340	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 658.2;Proximal tubular cells: 706.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.48e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-3)"	"unprognostic (3.77e-1)"	36.8	49.7	25.6	17.1	27.3	14.1	24.1	14.4	36.2	20.6	29.1	31.2	17.0	34.3	22.1	19.7	35.2	21.4	19.3	35.5	21.5	21.8	65.9	75.3	17.8	20.9	28.6	20.1	20.1	17.2	28.8	17.0	19.2	28.0	20.8	28.4	23.9	28.5	21.9	98.0	21.6	33.4	23.2	24.9	21.2	24.3	17.0	16.2	25.7	35.9	45.4	22.4	20.6	19.2	31.3	60.4	28.3	48.2	29.0	38.6	47.9	29.6	21.7	30.6	26.4	40.4	32.3	33.8	32.9	26.2	25.5	19.8	32.1	36.9	8.8	42.8	33.2	22.9	34.7	40.8	34.6	29.7	31.5	40.0	20.4	20.8	32.9	23.0	37.7	21.9	34.1	28.5	29.7	20.0	31.6	26.6	31.4	28.7	8.3	41.1	28.6	26.8	21.8	30.1	66.8	23.0	28.1	29.9	37.4	53.8	29.5	21.4	36.4	39.6	74.6	47.0	38.0	60.9	47.3	23.4	17.8	27.2	25.1	28.4	43.4	53.0	52.2	26.0	24.7	34.4	27.7	48.2	28.3	36.0	44.9	38.6	31.3	32.3	35.5	60.4	30.6	36.3	35.7	23.9	29.0	38.8	44.8	35.2	47.9	25.6	27.3	14.4	36.2	21.5	21.8	28.6	20.1	28.0	16.2	41.7	50.7	84.8	120.9	55.0	71.4	87.7	163.1	97.7	59.1	143.1	60.9	207.5	658.2	185.1	14.4	65.2	106.6	23.3	127.6	211.0	62.7	94.7	56.6	206.9	208.7	68.3	64.2	75.5	101.7	25.9	95.3	83.6	123.2	205.6	95.6	90.0	123.2	105.2	102.6	706.4	61.9	51.8	92.0	89.9	105.2	66.9	257.2	81.0	139.7	129.5
CFAP126	"C1orf192, Flattop, Fltp"	ENSG00000188931	"Cilia and flagella associated protein 126"	Q5VTH2	1	161364731-161367874	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 53.4;fallopian tube: 85.7"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 370.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	7	"pons and medulla: 53.4"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;RPTEC TERT1: 2.5;SCLC-21H: 2.5;T-47d: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045904	Enhanced					NA	NA					"HPA045904: AB_10960411"																		0.7	0.7	5.8	0.7	7.5	0.7	1.1	1.2	2.7	3.0	0.7	23.3	0.0	0.7	2.7	14.8	0.7	85.7	0.8	0.7	7.0	8.0	1.8	0.8	8.1	0.7	4.1	3.9	11.2	0.8	0.7	3.3	0.7	53.4	0.8	0.7	0.0	0.7	1.2	2.8	0.7	0.7	0.7	3.3	0.7	0.7	15.3	4.3	0.0	2.7	0.1	0.8	0.7	0.0	0.0	0.1	0.6	0.5	0.0	1.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.8	7.5	1.2	2.7	7.0	8.0	4.1	3.9	53.4	4.3	6.0	2.6	0.0	0.5	0.0	0.4	0.0	0.0	370.7	35.2	0.0	0.0	0.0	0.0	0.3	53.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	1.1	1.0	0.1	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 145.9;Kupffer cells: 155.0;Macrophages: 311.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.3;HMC-1: 28.9;K-562: 8.4;NB-4: 8.1;THP-1: 30.7;U-937: 13.2"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.3	4.1	28.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	8.4	0.2	0.0	0.0	0.2	8.1	0.0	0.0	0.6	0.1	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	30.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	13.2	3.6	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2	20.8	63.3	13.7	0.4	7.7	0.0	1.2	5.1	6.7	21.6	0.0	0.0	0.8	8.3	0.2	37.5	2.6	0.0	0.0	0.5	1.1	5.8	0.3	29.0	0.8	145.9	0.0	0.0	4.3	155.0	35.2	1.4	311.2	16.9	1.8	0.0	0.3	0.7	0.0	0.0	7.9	0.1	6.5	5.8	0.3	0.4	6.8	1.4	4.1	0.0	0.3
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526910	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;vagina: 99.8"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 208.5;Cone photoreceptor cells: 119.8;Glandular cells: 327.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 67.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 67.6"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 34.0"									"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	6.8	11.9	9.4	10.3	12.4	3.5	43.0	3.5	6.0	1.4	1.9	2.2	1.7	1.9	2.2	1.3	3.2	1.1	9.6	4.5	4.5	9.3	3.1	14.6	13.5	2.1	13.7	1.3	9.3	5.4	0.9	5.4	20.8	5.7	3.3	1.9	1.7	2.9	5.8	1.4	4.4	1.7	4.2	13.2	11.2	3.6	1.4	5.0	1.3	5.8	1.8	2.8	3.1	99.8	0.0	2.5	67.6	9.0	1.6	1.4	2.1	0.5	1.0	0.0	0.2	0.0	0.8	0.7	0.4	0.3	0.1	0.3	0.3	0.5	0.1	1.5	0.1	0.5	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.9	0.0	0.0	0.1	2.2	0.1	0.7	0.3	0.0	0.0	0.0	0.1	0.4	34.0	0.0	0.0	0.1	0.8	0.0	0.2	3.6	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.6	1.9	0.1	0.3	0.4	0.1	0.1	0.3	0.3	2.3	4.7	0.2	0.0	0.9	0.8	1.5	0.8	7.5	2.7	1.4	9.0	0.2	0.0	0.1	0.7	2.5	0.0	0.0	0.3	67.6	1.6	7.3	0.0	0.0	2.1	9.4	12.4	3.5	6.0	4.5	9.3	13.7	1.3	5.7	5.0	8.9	12.4	14.4	208.5	26.1	28.3	9.9	0.0	2.7	2.3	5.2	119.8	0.9	0.0	0.1	1.3	20.4	0.0	0.0	0.0	6.9	58.3	327.0	2.3	0.0	62.4	9.5	68.0	1.3	51.5	0.4	5.2	96.6	97.8	0.0	0.0	27.5	0.4	0.0	0.0	1.0	32.8	0.0	68.0	1.9	0.2	19.1	15.3	34.5	0.0	46.1
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 223.6;lymphoid tissue: 60.8"	"Cell type enhanced"	"Detected in many"	22	"Hofbauer cells: 191.4;Kupffer cells: 556.1;Macrophages: 266.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 109.4;non-classical monocyte: 223.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 73.0;monocytes: 223.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.8"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	NA	NA		2500000000			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	11.9	9.7	7.5	20.5	12.4	4.4	4.1	1.6	7.0	1.9	2.1	5.5	0.8	0.8	1.1	2.4	1.0	2.4	5.1	6.4	6.3	7.3	2.6	22.5	43.2	8.0	12.7	1.9	1.4	2.9	1.8	3.9	14.6	6.8	2.6	2.3	2.2	2.7	1.3	1.3	0.3	1.2	14.3	25.7	60.8	1.3	1.2	8.0	1.4	1.8	1.3	1.3	6.3	2.3	0.1	11.7	73.0	223.6	7.9	33.9	35.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.0	0.8	0.5	0.4	0.0	0.0	0.5	1.3	0.4	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.5	33.9	109.4	0.3	0.1	0.3	13.2	11.7	0.0	0.2	12.2	73.0	7.9	223.6	0.2	0.1	35.8	7.5	12.4	1.6	7.0	6.3	7.3	12.7	1.9	6.8	8.0	20.8	30.6	13.0	0.0	0.5	0.1	0.4	7.6	10.7	19.4	3.5	2.0	1.1	0.0	0.0	0.9	0.8	0.0	0.0	0.0	1.1	0.3	0.0	17.4	3.4	191.4	0.0	0.0	9.2	556.1	1.5	0.3	266.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	19.4	0.0	0.0	0.5	0.0	1.7	99.7	0.0	0.1
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"blood: 334.5"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.1;Ciliated cells: 4.0;Club cells: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	95	"neutrophil: 334.5"	"Lineage enriched"	"Detected in many"	95	"granulocytes: 334.5"	"Cell line enhanced"	"Detected in single"		"K-562: 1.5"														"Secreted to blood"	NA	NA						"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	9.9	0.8	1.8	30.8	1.5	13.8	1.5	0.9	1.8	0.9	0.8	0.5	0.2	0.0	0.4	0.5	1.7	2.8	6.8	4.6	1.2	0.9	0.9	2.9	15.2	16.9	5.0	0.5	1.2	1.2	0.0	0.6	4.5	1.9	1.5	0.0	1.3	0.9	0.9	0.8	1.4	0.8	2.0	4.0	44.3	1.3	1.5	0.9	0.6	0.8	0.2	0.9	11.1	4.7	0.0	0.1	334.5	3.5	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	334.5	0.1	3.5	0.0	0.0	0.5	1.8	1.5	0.9	1.8	1.2	0.9	5.0	0.5	1.9	0.9	3.0	11.1	0.0	0.0	0.0	0.0	0.3	0.0	4.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0
FCGR2B	"CD32, CD32B, FCG2, FCGR2"	ENSG00000072694	"Fc fragment of IgG receptor IIb"	P31994	1	161663147-161678654	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Host-virus interaction"	"IgG-binding protein, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 53.3;placenta: 83.2"	"Group enriched"	"Detected in many"	5	"Ito cells: 479.4;Macrophages: 138.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 53.3;memory B-cell: 42.2"	"Group enriched"	"Detected in many"	18	"B-cells: 42.2;dendritic cells: 14.5;granulocytes: 53.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.7;HMC-1: 23.5;NB-4: 5.2;RPMI-8226: 8.4"									"CAB007796, HPA014730"	Enhanced					NA	NA					"CAB007796: AB_562288, HPA014730: AB_2669074"	"unprognostic (1.58e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.12e-2)"	"unprognostic (6.79e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.37e-1)"	11.3	2.4	0.0	2.0	0.2	0.0	4.1	0.0	0.0	1.9	3.4			0.2	0.9	0.2	2.1	2.1	2.3	3.7	0.0	0.2	2.0	9.5	5.6	2.5	0.5		0.8	0.6	0.0	0.3	83.2		0.3	2.0		3.3	0.2	0.5	2.0	4.6	3.1	4.7	6.7	1.5	0.1			1.7		5.6	3.3	1.2	42.2	14.5	53.3	1.9	0.1	0.3	2.4	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	53.3	1.8	5.4	0.3	1.9	0.1	42.2	0.1	0.2	14.5	34.3	0.0	0.3	11.2	0.1	1.7	0.0	0.0	2.4											0.0	4.6	57.3	0.0	4.7	0.0	1.9	5.1	0.0	2.3	0.0	0.0	0.2	0.0	0.0	4.2	1.4	0.0	23.3	0.0	0.2	2.7	0.0	2.3	2.5	7.6	0.0	0.0	479.4	63.3	2.3	0.6	138.2	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.2	2.8	0.3	4.9	0.0	0.0
FCRLA	"FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595"	ENSG00000132185	"Fc receptor like A"	Q7L513	1	161706972-161714352	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 66.3;lymphoid tissue: 51.8"	"Group enriched"	"Detected in some"	57	"B-cells: 105.0;Melanocytes: 64.1"	"Cancer enriched"	"Detected in many"	21	"melanoma: 38.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 66.3;naive B-cell: 61.9"	"Lineage enriched"	"Detected in many"	9	"B-cells: 66.3"	"Group enriched"	"Detected in some"	6	"Daudi: 94.0;SK-MEL-30: 38.7;U-698: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016545	Enhanced				"Intracellular and membrane"	NA	NA					"CAB016545: AB_2247037"	"unprognostic (5.46e-4)"	"unprognostic (7.19e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.48e-4)"	"unprognostic (1.45e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.66e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.84e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-2)"	0.4	0.2	0.6	31.7	0.7	1.3	0.3	0.2	0.3	0.2	0.9	0.2	0.0	0.2	0.2	0.0	2.4	0.2	0.2	0.6	0.5	0.3	0.6	0.4	0.4	26.3	0.4	0.0	0.2	0.2	0.0	0.2	0.1	0.2	0.5	0.9	0.6	4.8	0.0	0.4	0.6	13.9	0.0	0.7	42.4	1.3	0.2	0.1	2.0	0.5	0.3	51.8	1.9	0.4	66.3	6.9	0.0	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.1	0.0	0.0	94.0	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	10.8	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	52.0	0.6	0.0	9.3	0.0	0.0	0.0	0.1	0.0	0.0	66.3	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	6.9	0.0	2.7	0.6	0.7	0.2	0.3	0.5	0.3	0.4	0.0	0.2	0.1	0.0	1.1	105.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0
FCRLB	"FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2"	ENSG00000162746	"Fc receptor like B"	Q6BAA4	1	161721563-161728143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.9;lymphoid tissue: 5.0"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 6.7;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 7.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"basophil: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.1;Daudi: 7.4;fHDF/TERT166: 10.9;HMC-1: 9.4;PC-3: 5.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB026139	Uncertain		Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"CAB026139: "	"unprognostic (1.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (5.77e-3)"	"unprognostic (7.49e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.14e-2)"	0.5	0.2	0.2	3.4	0.3	0.0	0.3	1.0	0.8	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	1.4	0.6	0.3	2.4	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	1.2	0.0	0.2	0.7	2.7	0.2	0.3	0.8	0.2	0.4	1.5	0.2	0.2	0.2	0.2	0.3	0.2	5.0	0.8	0.2	4.9	0.6	8.9	0.2	5.3	2.7	0.6	0.7	0.1	0.0	0.3	0.5	0.8	0.0	4.6	6.1	1.5	1.5	0.1	0.2	7.4	0.2	10.9	0.3	0.1	0.2	0.4	4.0	0.1	0.3	0.2	0.1	0.2	0.2	0.0	9.4	1.4	0.0	2.7	0.2	0.5	1.3	0.0	0.4	0.3	0.2	0.4	0.0	2.6	0.2	0.0	5.5	0.0	0.5	0.3	0.2	0.2	0.0	0.0	0.0	0.2	2.3	0.3	0.0	0.0	0.8	1.6	0.7	1.7	0.8	0.0	0.0	2.9	3.3	0.4	0.8	8.9	0.1	2.4	2.7	0.1	1.0	4.6	1.6	1.5	0.6	4.9	0.8	1.2	1.5	5.3	0.2	0.0	0.0	0.6	0.2	0.3	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	2.2	1.0	1.0	0.0	1.6	0.0	0.0	0.0	3.5	0.0	1.8	5.0	1.1	0.1	1.1	0.0	0.0	1.0	4.6	0.7	0.4	0.0	0.8	1.3	0.0	1.2	6.7	2.4	0.0	0.0	2.3	1.7	0.0	0.0	3.1	0.9	0.0	0.4	10.5	0.4	0.0	1.4	2.7	1.2	0.4	0.7	2.2	0.0	0.7
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	15.6	12.1	15.0	16.0	17.2	37.8	21.2	27.2	20.3	14.0	14.2	13.9	16.6	11.7	19.5	14.0	12.7	15.6	12.1	11.9	12.6	12.7	14.0	11.4	14.1	18.5	18.6	13.1	18.4	16.7	10.7	18.7	16.4	14.7	13.6	16.0	15.2	13.8	15.1	8.6	12.6	14.4	16.5	12.0	17.4	13.8	8.2	19.4	11.1	15.9	9.4	18.4	14.4	14.1	16.0	17.8	18.7	15.4	23.1	19.4	10.6	18.2	17.3	18.9	12.7	10.1	11.0	17.9	14.6	19.1	22.6	17.5	24.5	16.1	11.1	15.3	17.7	14.2	13.2	14.7	17.9	22.0	14.5	13.0	9.9	15.7	15.9	21.4	21.1	9.9	14.8	19.7	19.6	35.3	12.8	15.7	15.6	17.6	12.2	16.2	17.0	12.3	24.0	30.2	19.4	25.1	18.1	18.5	18.2	12.7	22.5	12.1	25.7	12.4	20.8	24.2	21.7	18.1	24.4	10.9	19.5	18.2	15.2	31.1	20.6	17.0	26.5	12.1	21.4	19.2	18.7	13.9	10.2	16.1	15.4	19.4	15.5	18.1	15.3	17.8	16.0	17.5	19.1	5.5	23.1	9.2	8.2	15.3	10.6	15.0	17.2	27.2	20.3	12.6	12.7	18.6	13.1	14.7	19.4	17.9	10.9	26.6	12.4	12.0	14.1	4.4	7.6	4.0	12.5	7.0	7.9	18.4	18.3	17.8	3.2	19.6	5.3	0.0	21.0	18.7	16.5	15.2	17.4	6.6	17.6	9.5	10.9	16.5	25.1	0.5	8.1	14.3	10.1	19.0	9.7	11.1	16.9	5.8	16.6	14.6	15.6	0.0	20.0	10.6	12.0	11.4	14.8	20.1	11.8	10.7
ATF6	ATF6A	ENSG00000118217	"Activating transcription factor 6"	P18850	1	161766294-161964070	"Disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005935	Approved					NA	NA		26000000			"HPA005935: AB_2667472"	"unprognostic (1.31e-1)"	"unprognostic (5.15e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.57e-3)"	21.6	14.9	10.6	13.8	12.7	8.6	16.0	14.6	14.5	14.2	14.5	14.7	18.9	9.9	16.0	22.9	14.0	12.5	11.9	13.5	10.5	11.0	20.1	43.1	18.5	19.6	16.3	9.1	17.5	37.4	30.7	18.3	28.9	12.4	14.4	15.2	18.1	17.5	15.7	14.4	18.1	13.2	15.9	16.0	20.5	15.0	13.4	14.2	18.5	18.5	12.1	17.2	17.0	13.1	4.9	7.1	19.6	10.2	4.2	5.6	5.2	10.6	6.6	7.8	8.5	11.9	10.9	10.5	12.6	17.9	12.0	12.0	4.8	13.7	7.3	16.5	19.0	7.6	12.6	7.3	10.6	13.0	9.5	5.4	9.0	9.1	4.8	23.3	15.5	15.0	11.2	17.1	12.1	30.2	13.9	26.3	12.3	15.1	9.3	10.8	5.6	6.3	5.3	6.4	12.5	8.1	5.6	10.7	15.5	11.7	6.6	4.4	7.7	13.0	9.3	18.4	16.7	9.2	15.8	26.9	10.8	7.7	4.4	14.0	13.2	12.7	10.5	15.7	2.6	11.7	5.3	9.5	6.2	5.3	10.1	5.1	4.4	5.1	4.3	7.1	4.9	5.6	5.4	19.6	4.2	10.2	2.6	4.5	5.2	10.6	12.7	14.6	13.2	10.5	11.0	16.3	9.1	12.4	14.2	95.3	73.2	17.0	39.2	30.9	35.5	19.4	28.1	81.7	87.6	48.8	47.1	39.9	6.6	40.5	8.2	44.3	22.0	0.0	33.0	36.5	28.2	43.6	51.0	45.5	43.0	25.4	35.6	31.9	47.6	6.6	21.3	48.5	25.3	47.7	24.2	37.8	31.1	11.5	23.0	14.7	29.6	6.5	28.8	37.2	25.1	41.8	86.2	30.5	19.5	41.4
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023854	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 8.8;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	10	"monocytes: 8.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 45.1"	"Low region specificity"	"Detected in many"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	19.6	6.6	1.7	12.8	3.0	0.3	12.3	0.6	4.1	13.0	14.5	2.9	6.5	1.5	14.2	21.8	3.2	9.8	33.7	25.4	2.9	1.6	3.9	1.2	12.8	24.1	2.9	1.2	7.0	2.3	3.2	2.6	27.6	2.2	6.6	2.2	14.5	9.0	6.1	6.1	8.9	5.0	15.1	3.6	22.4	3.4	12.5	2.1	1.9	18.3	13.7	8.5	12.4	7.3	0.0	0.8	0.3	8.8	0.0	0.1	0.2	0.0	0.1	2.6	0.8	8.4	16.0	0.0	0.8	4.1	1.7	4.6	0.0	0.0	0.0	0.1	9.7	1.7	0.0	0.2	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	45.3	0.0	2.0	0.0	0.8	0.2	0.0	0.0	0.4	7.4	0.0	0.0	0.1	0.8	0.0	0.4	0.0	34.6	3.3	0.6	0.0	0.3	0.1	3.4	0.0	0.2	8.0	0.0	0.0	0.0	1.0	0.2	1.5	1.3	0.0	0.0	0.0	9.9	1.0	0.5	0.0	0.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	6.5	0.0	0.0	0.2	1.7	3.0	0.6	4.1	2.9	1.6	2.9	1.2	2.2	2.1	0.0	1.1	0.0	0.0	3.0	0.0	2.5	0.0	0.0	1.2	1.8	0.0	0.2	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.3	9.3	0.1	1.1	0.0	31.7	0.0	0.0	1.8	20.4	4.5	19.2	9.9	1.7	1.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	6.5	12.6	1.5	0.9	1.9	0.2	0.0	0.0	0.0
NOS1AP	"CAPON, KIAA0464"	ENSG00000198929	"Nitric oxide synthase 1 adaptor protein"	O75052	1	162069774-162370475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.1"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 192.4;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 6.9;HaCaT: 5.2;HEL: 8.3"	"Low region specificity"	"Detected in all"							"CAB018582, HPA030066, HPA055561"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851"	"unprognostic (7.04e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.08e-3)"	2.1	7.9	10.2	1.6	7.0	4.8	6.2	23.1	34.1	2.4	3.7	3.1	7.1	2.7	2.4	1.7	2.2	2.6	7.4	2.3	19.0	10.1	2.9	7.6	2.3	1.4	6.5	13.0	1.6	3.5	2.0	2.7	2.2	5.5	2.5	3.9	2.7	4.6	9.7	1.7	2.4	3.1	2.1	4.4	1.3	3.8	4.0	3.1	0.0	1.6	0.2	1.8	1.8	2.2	0.0	0.1	1.1	0.5	0.0	0.3	0.1	6.9	0.0	3.2	1.9	0.1	0.0	0.5	0.6	0.8	0.9	0.8	1.5	1.7	0.0	4.4	0.2	1.1	5.2	1.1	0.2	0.3	0.1	3.2	8.3	1.2	1.7	0.0	0.0	0.1	0.3	0.2	0.0	0.3	0.9	1.7	1.0	0.6	0.1	0.1	3.6	0.6	0.0	2.4	1.1	3.1	0.1	1.3	0.2	1.5	2.3	2.6	1.8	1.6	0.3	1.2	0.9	1.9	0.4	0.8	0.1	0.8	0.0	1.2	4.7	0.0	0.0	1.1	0.1	0.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	10.2	7.0	23.1	21.1	19.0	10.1	6.5	13.0	5.5	3.1	0.0	0.3	0.0	5.3	2.6	8.5	1.9	2.5	1.4	1.2	21.0	192.4	0.0	8.3	0.9	24.7	1.6	3.8	0.0	1.0	0.2	1.2	9.9	0.0	19.5	0.1	63.5	6.4	2.5	0.6	8.0	4.0	0.0	0.0	0.0	7.3	20.7	0.6	5.5	6.7	0.2	2.2	6.5	0.3	1.9	1.3	1.8	0.5	0.0	4.4	6.4
AL512785.2		ENSG00000254706			1	162365407-162383531	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 10.3;U-266/70: 5.7"									HPA074060			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074060: "	"unprognostic (1.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.50e-1)"		"unprognostic (9.12e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.57e-1)"		"unprognostic (3.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.07e-2)"		"unprognostic (1.19e-2)"	"unprognostic (6.10e-2)"	0.9	1.0	0.0	0.2	0.0	1.3	2.7	0.6	0.0	2.6	2.8			2.3	1.5	0.0	1.1	1.4	2.7	0.7	0.1	0.1	2.0	4.6	0.6	0.1	0.3		0.2	4.3	0.0	0.4	0.6		1.3	0.2		5.5	6.3	0.2	1.5	1.2	0.6	0.9	0.0	3.5	2.0			0.0		0.0	1.7	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.6	4.7	0.0	4.0	3.3	0.3	0.0	0.0	0.2	0.6	0.2	0.0	2.5	2.4	0.0	5.0	0.0	1.4	0.5	0.0	0.8	0.0	0.0	3.7	10.3	0.1	4.1	0.2	0.4	0.0	0.9	0.3	0.0	0.3	1.0	0.4	1.1	1.2	0.2	0.2	3.4	0.1	0.0	1.1	2.7	3.6	0.4	0.0	0.0	2.2	3.5	2.1	2.1	1.7	0.6	2.4	0.8	5.1	0.0	3.0	0.1	0.9	0.0	1.8	5.7	0.0	0.0	0.5	0.2	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf226	FLJ13137	ENSG00000239887	"Chromosome 1 open reading frame 226"	A1L170	1	162366908-162386818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.6"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 27.5;Early spermatids: 20.6;Hepatocytes: 22.6;Late spermatids: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.2;HEL: 16.9"	"Low region specificity"	"Detected in all"							"HPA052251, HPA074060"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"prognostic favorable (2.60e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.71e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-3)"	"prognostic favorable (4.44e-5)"	"unprognostic (9.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.13e-4)"	1.5	8.2	1.5	3.4	1.5	1.2	7.1	4.8	2.0	3.7	18.0	1.5	1.5	4.9	1.9	1.6	4.4	2.5	3.2	1.5	1.6	2.4	5.2	15.2	3.0	1.5	1.8	1.5	2.0	3.5	1.4	6.9	18.9	1.5	3.2	8.3	2.0	8.2	7.6	1.5	3.3	28.6	2.4	2.3	2.2	5.8	2.7	1.5	1.5	1.5	7.4	5.1	2.2	1.5	0.0	0.0	0.8	0.7	0.0	0.0	0.2	13.2	0.7	10.9	8.3	0.3	0.0	0.2	1.2	1.1	0.8	0.4	1.5	6.1	0.0	9.1	0.2	4.0	9.7	3.2	0.7	0.5	0.2	4.4	16.9	0.5	7.4	0.2	0.0	0.1	1.2	0.8	0.0	0.6	3.0	3.3	1.8	1.4	0.1	0.2	4.3	0.6	0.0	6.8	11.9	6.1	0.2	1.7	0.0	9.3	5.4	4.7	3.2	4.5	1.2	2.6	4.2	4.9	0.7	2.3	0.0	1.4	0.2	3.3	6.3	0.0	0.0	1.6	0.2	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	1.5	1.5	4.8	2.0	1.6	2.4	1.8	1.5	1.5	1.5	3.0	1.6	0.0	1.4	0.7	0.7	3.3	2.5	1.4	1.2	14.0	27.5	0.0	0.0	0.8	20.6	1.1	8.0	0.0	2.0	0.1	0.6	3.7	0.0	22.6	0.1	6.4	2.4	3.7	1.0	30.4	2.0	0.0	0.0	0.0	10.3	6.5	1.7	3.5	1.8	0.0	0.3	0.0	0.2	0.7	0.7	1.3	0.1	0.0	5.6	2.0
SPATA46	C1orf111	ENSG00000171722	"Spermatogenesis associated 46"	Q5T0L3	1	162373203-162376870	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"testis: 60.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.8;AF22: 2.2;HaCaT: 1.8;SCLC-21H: 4.0;SH-SY5Y: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.71e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.80e-2)"		"unprognostic (1.32e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.59e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-2)"	0.1	4.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	60.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	2.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.4	0.0	0.5	0.0	0.0	0.8	4.0	2.4	0.4	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SH2D1B	EAT2	ENSG00000198574	"SH2 domain containing 1B"	O14796	1	162395266-162412138	"Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 67.4"	"Cell type enriched"	"Detected in some"	7	"T-cells: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"NK-cell: 67.4;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	34	"monocytes: 27.0;NK-cells: 67.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.9;EFO-21: 5.6;Karpas-707: 9.2;PC-3: 1.7;TIME: 2.7"					"Low region specificity"	"Detected in all"			HPA054791	Uncertain					NA	NA					"HPA054791: AB_2682600"	"unprognostic (7.82e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.89e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.15e-3)"	1.2	0.2	0.4	2.2	0.3	5.3	0.5	0.2	1.1	2.7	3.7	0.1	0.0	1.2	3.0	0.7	3.2	0.3	0.7	1.0	0.5	0.3	0.6	3.9	9.1	6.8	0.4	0.0	0.6	0.2	0.0	0.4	3.7	0.1	1.4	0.6	2.6	1.6	0.9	15.0	0.3	2.6	0.1	1.0	14.8	0.3	0.6	0.0	1.3	0.3	0.4	2.6	0.4	1.7	0.0	1.3	0.6	27.0	67.4	1.3	10.7	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.9	0.0	5.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	9.2	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.3	5.9	0.0	0.0	0.0	0.3	1.3	0.0	0.1	0.2	0.6	67.4	27.0	0.1	0.0	10.7	0.4	0.3	0.2	1.1	0.5	0.3	0.4	0.0	0.1	0.0	3.0	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	1.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	21.9	0.0	0.0
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529629	"Enzymes, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071190			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	No			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA071190: AB_2686358"	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	21.6	22.0	23.5	18.9	26.2	30.1	23.5	10.8	30.5	14.3	16.3	17.2	30.8	16.3	11.5	12.9	16.0	12.9	12.1	11.4	27.0	31.8	27.9	32.4	16.9	24.3	30.6	20.3	12.1	11.8	25.0	12.5	16.5	33.4	14.7	17.4	14.1	15.9	22.9	30.6	11.5	21.8	9.6	20.5	21.3	16.8	10.4	14.1	23.0	17.1	11.7	24.1	16.1	12.8	5.7	4.3	4.5	9.2	5.9	8.5	4.0	21.1	9.9	5.2	12.7	14.9	11.8	11.7	28.0	15.3	23.0	16.6	6.4	13.3	17.3	24.5	20.9	11.2	12.3	9.9	15.5	37.1	23.7	7.2	17.1	12.3	5.8	11.5	24.9	20.0	12.1	16.4	22.6	21.7	16.1	13.2	12.0	14.9	24.1	39.4	8.9	13.2	6.6	6.9	15.9	13.4	8.5	23.3	14.4	15.3	21.9	9.5	8.8	24.7	23.0	18.0	7.5	19.9	28.0	20.5	26.3	14.9	18.1	39.0	25.0	34.7	20.5	21.9	12.2	23.8	4.5	3.3	3.7	8.2	8.6	8.5	5.4	6.2	6.8	3.6	5.7	6.3	7.1	2.0	5.9	9.2	4.3	4.9	4.0	23.5	26.2	10.8	30.5	27.0	31.8	30.6	20.3	33.4	14.1	17.9	32.1	50.1	25.7	26.2	21.7	29.4	56.0	41.5	50.0	50.6	11.8	22.6	48.0	23.2	35.7	30.8	40.7	0.0	20.2	32.6	19.3	44.8	45.0	71.0	27.6	22.3	32.1	35.0	64.6	34.6	19.8	51.7	27.0	44.1	35.0	13.6	28.8	34.8	18.4	49.4	21.6	0.0	27.3	23.4	22.0	21.5	18.8	52.2	31.1	52.1
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.8;U-251 MG: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	30.5	2.2	6.1	4.9	29.8	23.9	4.2	44.9	16.6	34.7	28.3	5.8	14.4	1.2	10.1	34.4	12.5	5.3	6.9	13.1	57.2	4.8	10.3	5.4	7.0	11.4	14.0	9.2	3.7	11.0	6.2	38.0	107.8	15.9	21.2	9.6	30.5	12.6	46.4	5.6	5.3	5.9	4.5	31.4	10.0	4.8	11.9	14.9	5.4	3.6	6.6	6.8	19.6	12.2	10.4	7.5	6.0	10.5	36.0	17.5	16.1	44.0	70.2	21.2	7.4	10.1	10.0	4.3	11.0	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7	6.0	30.4	17.9	120.0	119.7	10.0	26.6	17.8	53.5	38.7	15.7	7.9	22.4	61.3	24.8	36.3	23.3	84.7	0.0	56.9	52.1	141.3	91.8	33.4	88.9	14.0	6.4	52.6	21.5	7.0	11.8	46.9	15.2	81.0	27.9	124.5	14.0	55.8	69.1	38.9	20.2	12.3	19.4	160.3	182.9	121.8	71.5	81.7	20.1	59.9	111.6
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787400	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Supported	"Plasma membrane,Actin filaments"		Yes	No		850000	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	42.1	43.5	4.7	10.9	6.9	0.2	15.6	7.9	7.1	30.3	30.4	9.0	18.6	3.3	24.2	17.7	25.0	13.4	16.6	15.4	7.9	4.7	4.0	3.3	8.9	5.1	12.9	3.4	26.4	2.2	2.1	4.0	6.6	12.7	21.8	9.1	30.7	6.4	19.3	5.2	6.1	10.1	34.3	19.7	3.4	14.1	8.3	7.5	0.0	8.6	12.8	4.1	29.0	18.3	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	16.3	61.7	61.0	0.2	24.0	45.1	10.5	15.1	0.0	0.0	0.0	0.0	32.3	2.1	0.0	0.0	0.1	14.4	12.9	0.1	0.0	0.1	0.0	26.8	0.0	0.0	43.3	0.1	18.5	0.5	17.0	12.1	0.1	0.1	5.1	9.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	6.9	0.1	0.0	0.0	0.0	9.9	0.0	0.0	0.8	0.9	0.0	0.0	0.6	16.8	3.7	8.5	3.3	0.7	1.3	0.0	15.2	0.0	17.0	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.7	6.9	7.9	7.1	7.9	4.7	12.9	3.4	12.7	7.5	3.0	2.9	0.0	2.4	11.2	3.1	23.3	2.5	4.0	1.2	0.0	0.0	0.5	0.0	0.5	6.9	21.3	2.0	0.0	1.5	0.4	84.7	4.1	1.1	3.0	1.1	0.0	1.2	24.5	2.1	4.0	58.4	1.5	21.9	0.0	0.7	19.0	1.5	1.7	83.1	0.9	2.9	38.8	68.4	0.9	0.9	7.5	0.8	1.3	0.6	3.3
HSD17B7	"PRAP, SDR37C1"	ENSG00000132196	"Hydroxysteroid 17-beta dehydrogenase 7"	P56937	1	162790702-162812817	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.3;liver: 16.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047496	Approved					NA	NA					"HPA047496: AB_2680068"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.47e-5)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.17e-2)"	1.9	9.2	1.4	2.0	1.0	0.7	4.3	1.4	1.9	2.8	2.9			3.1	2.1	4.4	4.7	2.2	1.6	1.6	1.9	2.6	2.2	16.8	4.3	3.7	1.5		3.6	2.6	2.5	4.1	1.8		2.8	4.0		3.1	1.3	2.0	3.6	3.1	1.8	3.2	2.9	2.9	0.6			2.8		3.9	2.2	2.8	12.5	9.6	15.8	7.4	7.0	16.3	10.5	6.3	6.5	17.3	7.7	10.0	10.8	11.3	2.6	8.3	5.1	10.2	9.0	20.6	15.3	5.9	2.2	31.0	10.3	15.7	22.2	5.3	6.7	8.4	3.9	4.9	14.1	8.3	6.9	6.9	6.5	12.4	19.6	6.4	4.0	8.4	10.7	7.3	10.6	4.3	4.5	8.9	7.4	11.0	12.3	8.1	5.0	10.4	9.8	18.0	10.2	14.8	7.7	4.1	4.0	3.9	15.6	6.5	8.8	4.9	2.3	5.6	3.5	5.0	6.5	6.4	15.2	3.7	0.6	5.7	15.8	6.0	11.2	13.9	6.1	14.6	12.5	10.5	13.4	6.5	10.9	13.0	13.1	5.0	7.0	7.4	9.6	16.3	10.5											0.0	23.8	19.9	22.2	9.7	23.0	2.0	15.3	18.7	15.9	10.4	58.9	14.2	3.3	11.4	1.7	11.7	10.9	0.0	23.7	12.6	13.1	20.2	4.7	22.5	11.6	11.1	5.8	7.4	2.8	1.0	6.4	13.0	16.9	10.0	7.9	14.1	12.6	14.0	6.7	9.3	42.9	0.0	11.3	2.1	5.4	11.0	16.0	20.2	8.5	11.5
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;lung: 7.2;tongue: 7.5"	"Cell type enriched"	"Detected in some"	27	"Ciliated cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.2	0.1	1.1	0.2	1.7	0.0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0.0	0.2	0.8	8.3	1.1	1.3	1.0	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.1	2.6	5.1	5.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.4	0.0	9.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	48.2	0.0	1.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3
RGS4	SCZD9	ENSG00000117152	"Regulator of G protein signaling 4"	P49798	1	163068775-163076802	"Disease related genes, Predicted intracellular proteins"		"Signal transduction inhibitor"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 88.0"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 10.1;Intestinal endocrine cells: 49.4;Muller glia cells: 14.1;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 91.6;LHCN-M2: 36.1;SH-SY5Y: 71.9;TIME: 146.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030802			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA030802: AB_10602295"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.02e-2)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.97e-4)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.30e-2)"	2.9	20.9	9.1	2.1	45.3	0.5	1.4	1.1	88.0	4.0	1.7	1.0	0.0	2.9	4.8	1.4	6.3	4.9	11.2	4.7	13.9	10.1	1.5	2.6	2.1	2.3	12.1	36.2	1.1	2.7	1.2	6.2	1.3	16.0	3.3	1.8	1.0	0.9	3.9	0.7	0.6	1.6	3.0	1.9	1.5	3.7	2.1	2.1	0.0	1.5	0.2	0.7	2.8	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	3.5	18.5	0.0	12.5	13.6	1.8	4.8	0.0	0.0	0.0	5.5	8.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	19.7	2.4	91.6	19.1	0.0	0.0	0.0	36.1	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	71.9	0.0	0.0	0.0	0.7	0.0	0.0	146.6	14.9	0.7	2.9	20.7	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.1	45.3	1.1	78.8	13.9	10.1	12.1	36.2	16.0	2.1	0.0	0.0	0.0	0.8	0.2	0.2	0.5	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	10.1	0.5	0.0	0.0	0.2	0.0	1.7	0.5	0.0	0.0	0.4	0.0	49.4	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	14.1	4.1	0.0	0.0	0.0	1.6	0.0	10.3	0.0	0.2	0.3	0.1	0.0	0.0	0.1
RGS5		ENSG00000143248	"Regulator of G protein signaling 5"	O15539	1	163111121-163321791	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"Sertoli cells: 5031.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 226.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 92.7;SH-SY5Y: 307.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001821		Supported				NA	NA					"HPA001821: AB_1079806"	"unprognostic (3.75e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-1)"	38.3	96.6	23.8	16.1	42.1	0.5	18.4	11.9	28.6	62.6	28.5	11.6	20.8	19.5	23.3	19.8	28.1	22.7	43.5	67.8	28.3	22.0	32.4	10.3	24.9	9.2	37.9	20.8	15.5	9.3	19.5	18.3	6.3	41.7	34.4	13.8	59.3	8.8	59.9	37.1	6.8	48.6	83.1	19.7	5.7	27.3	13.4	20.8	4.1	53.6	35.0	11.7	77.5	20.7	2.2	0.4	0.5	0.5	0.6	2.3	0.5	0.0	0.0	4.5	0.5	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	1.0	92.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	2.7	48.3	0.1	0.0	0.0	0.2	0.0	0.0	0.3	307.8	0.0	0.0	0.1	14.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.4	0.4	2.3	2.2	2.1	1.0	0.4	1.2	2.1	2.0	0.5	0.6	0.5	0.2	1.1	0.5	23.8	42.1	11.9	28.6	28.3	22.0	37.9	20.8	41.7	20.8	3.0	9.3	0.0	5.0	15.1	0.7	0.0	0.0	8.1	12.5	1.8	3.9	1.1	1.7	0.8	16.0	24.8	0.0	0.0	1.0	0.7	13.7	10.9	1.1	0.0	1.0	0.0	0.0	0.0	0.0	12.4	6.4	10.2	21.9	1.0	0.2	2.4	2.4	0.0	2.5	1.9	4.6	5031.8	595.0	4.1	1.8	11.0	1.0	0.5	0.2	5.7
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2, NDC80 kinetochore complex component"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.6;testis: 29.0"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 232.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	1.3	0.9	0.8	9.8	0.9	14.1	0.6	0.5	0.9	1.4	2.5	0.6	0.9	2.3	0.6	2.1	6.1	0.5	0.7	1.5	0.8	0.6	0.7	0.6	1.9	9.9	0.8	0.6	0.7	0.4	0.3	0.4	3.6	0.7	0.6	2.9	0.8	1.3	0.0	0.5	2.2	3.2	1.0	1.4	4.4	1.6	29.0	0.3	38.6	0.5	5.1	9.2	1.5	1.8	1.4	0.6	2.6	0.2	3.0	7.7	1.0	26.3	9.2	24.5	10.2	0.7	2.5	13.3	16.7	11.8	27.2	23.9	7.0	23.3	22.7	14.0	6.7	11.3	15.5	14.9	6.3	34.5	23.7	10.7	8.9	10.6	10.0	0.0	15.3	18.4	0.3	0.6	13.7	9.7	5.1	12.3	22.3	16.7	31.5	25.7	5.1	27.9	20.6	13.3	19.4	14.2	19.0	21.4	20.1	7.7	3.6	18.3	21.1	8.9	9.7	9.2	15.9	14.9	32.1	8.7	20.3	22.8	15.2	33.6	22.6	31.8	43.3	6.7	12.6	22.4	2.6	0.2	2.5	2.4	0.1	1.0	1.2	3.6	2.4	0.5	1.4	2.5	2.1	0.9	3.0	0.2	0.6	7.7	1.0	0.8	0.9	0.5	0.9	0.8	0.6	0.8	0.6	0.7	0.3	0.0	0.3	3.7	1.8	5.3	1.0	0.8	0.0	0.0	4.5	0.0	0.0	2.7	0.0	0.7	15.8	0.1	0.8	46.7	0.2	23.9	1.8	0.4	4.6	0.2	11.3	0.0	0.0	1.8	3.7	10.7	2.3	2.5	0.0	1.0	0.9	2.5	0.2	0.0	2.1	0.0	2.0	6.5	0.5	232.2	40.5	2.0	3.3	3.8	2.2	1.4
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"HEL: 30.9;NTERA-2: 30.3;SK-BR-3: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	13.2	17.3	14.9	8.3	15.0	1.4	16.4	14.1	17.4	73.4	26.3	11.2	15.9	13.6	67.2	15.3	20.8	35.1	25.8	12.6	10.9	9.7	15.4	4.2	10.4	2.3	11.6	14.6	35.2	29.4	21.3	12.4	9.6	8.1	27.6	9.3	10.2	19.6	25.1	16.8	6.0	14.6	56.8	8.0	5.1	13.9	9.7	8.7	2.7	17.4	8.5	6.6	32.2	24.7	0.0	0.1	2.9	0.0	0.3	0.2	2.5	1.1	22.6	22.3	6.0	15.1	7.3	1.3	9.5	6.1	2.6	1.8	4.3	4.0	0.0	2.0	12.9	1.4	7.9	8.8	2.5	1.0	1.1	9.4	30.9	18.2	0.0	10.0	0.0	7.9	7.2	0.0	1.6	0.7	5.6	0.1	0.0	0.0	0.0	0.7	14.9	0.0	0.1	30.3	1.3	1.1	0.0	7.4	9.0	1.8	13.5	0.8	13.2	10.9	62.4	0.0	21.3	23.7	0.0	0.1	1.3	3.1	8.8	2.7	2.8	21.3	0.0	0.1	0.0	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.1	0.0	2.5	14.9	15.0	14.1	17.4	10.9	9.7	11.6	14.6	8.1	8.7	20.8	15.2	0.9	91.3	20.3	27.6	44.2	91.7	25.4	21.6	31.4	104.1	89.0	28.2	41.5	72.1	39.2	28.0	0.0	58.9	4.5	75.2	44.0	71.4	17.3	8.6	4.8	87.2	60.8	1.6	78.2	59.0	6.8	15.1	1.8	35.4	34.9	31.8	59.6	97.6	49.4	28.8	38.8	62.7	0.9	11.5	24.6	87.5	3.2	39.4	82.1
LMX1A	"LMX1, LMX1.1"	ENSG00000162761	"LIM homeobox transcription factor 1 alpha"	Q8TE12	1	165201867-165356715	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 7.3;pituitary gland: 8.0"	"Group enriched"	"Detected in some"	33	"Early spermatids: 29.1;Intestinal endocrine cells: 40.3;Late spermatids: 14.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA028051, HPA030088"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA028051: AB_10599731, HPA030088: AB_10601106"	"unprognostic (1.73e-1)"		"unprognostic (9.57e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.82e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.22e-2)"			"unprognostic (2.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.82e-3)"		2.2	0.0	0.0	2.0	0.0	0.0	1.2	2.6	0.5	0.5	1.7	3.4	3.1	4.0	0.1	1.3	1.1	0.5	0.2	0.2	0.9	1.5	0.0	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	8.0	0.0	7.3	0.2	2.1	0.5	1.5	0.3	1.4	0.3	2.2	0.9	0.1	0.0	0.2	4.3	0.3	0.0	0.3	3.5	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.9	1.5	2.2	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 23.6;Melanocytes: 27.0;Muller glia cells: 9.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 29.0"	"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	29.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4	0.0	0.0	0.0	0.0	0.6	0.3	2.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.9	4.6	0.0	27.0	0.0	0.0	9.1	0.1	0.0	2.1	0.0	4.0	12.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LRRC52	FLJ25811	ENSG00000162763	"Leucine rich repeat containing 52"	Q8N7C0	1	165544007-165563961	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"testis: 31.9"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 118.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"U-937: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (9.09e-2)"			"unprognostic (1.76e-2)"	"unprognostic (6.48e-2)"			"unprognostic (3.79e-2)"	"unprognostic (8.45e-2)"	"unprognostic (6.70e-4)"						"unprognostic (6.05e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165630861-165661796	"Enzymes, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		40000	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	42.8	30.8	52.5	9.7	30.5	19.0	51.2	17.9	56.0	18.4	39.7	18.4	19.1	65.2	19.5	101.8	19.7	20.6	26.5	133.6	38.1	33.9	45.2	29.5	20.8	11.0	44.2	37.6	22.7	17.7	11.1	18.3	30.9	39.6	21.2	40.4	20.3	29.8	20.6	87.2	15.6	53.4	24.7	38.7	12.4	29.8	19.4	23.3	2.7	25.7	41.8	8.2	19.9	17.3	21.3	35.1	20.7	47.0	15.7	38.0	40.7	22.2	16.3	17.7	13.9	62.1	37.3	88.9	18.6	30.0	14.5	25.3	17.0	29.0	1.4	14.7	22.7	14.3	27.2	4.3	18.2	14.7	94.3	11.1	3.4	12.8	7.7	17.5	5.3	7.5	31.8	14.7	20.0	7.7	28.6	23.6	6.1	8.3	8.5	27.1	4.9	5.9	12.3	38.7	97.4	21.0	5.6	7.6	2.8	76.5	20.9	13.7	16.8	18.7	24.3	37.0	37.1	18.5	26.2	21.4	18.0	10.7	12.4	13.4	6.3	4.3	0.7	33.4	14.1	11.6	10.4	45.7	20.7	30.1	37.0	30.3	21.3	38.0	33.5	35.1	19.9	24.4	26.7	9.8	15.7	47.0	15.1	32.3	40.7	52.5	30.5	17.9	56.0	38.1	33.9	44.2	37.6	39.6	23.3	95.3	125.6	83.1	202.5	202.9	129.1	591.8	331.2	242.2	134.2	528.7	251.3	1846.4	848.8	339.3	13.2	253.1	716.8	630.8	371.6	1154.8	298.4	174.8	89.0	248.3	760.5	123.9	146.8	184.8	114.8	21.3	359.3	238.2	492.6	405.8	197.9	162.7	335.4	599.7	375.8	841.2	122.6	498.0	374.9	15.6	33.3	203.4	1983.2	87.4	339.8	197.4
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	28.8	48.5	28.1	18.7	29.8	17.2	34.1	21.5	28.7	30.2	47.4	26.9	37.6	43.0	28.4	43.3	34.3	24.9	30.6	25.9	23.8	26.8	62.6	89.8	24.9	23.6	27.2	21.0	30.6	37.3	32.6	50.1	47.0	31.1	30.7	48.8	29.9	43.5	38.5	20.2	20.9	70.9	23.7	31.4	29.4	29.9	34.4	22.4	36.3	53.7	24.1	31.1	29.4	25.2	46.0	76.6	52.5	57.6	45.1	61.7	78.0	28.0	31.7	24.3	14.6	44.8	21.2	23.7	48.2	34.2	28.4	29.6	45.2	42.5	17.9	50.1	34.9	12.5	40.0	31.5	25.3	31.0	45.4	29.2	22.6	36.9	27.9	36.2	38.4	29.8	28.9	29.5	33.0	26.6	26.2	20.6	22.1	58.6	35.1	39.8	21.7	30.4	29.2	31.0	92.2	36.0	22.4	27.2	45.2	34.4	37.0	25.0	43.8	36.9	39.3	29.3	37.4	51.5	48.9	22.6	26.2	21.8	22.9	44.6	67.2	90.9	63.0	21.0	25.1	34.7	52.5	55.6	51.2	53.0	50.8	55.6	46.0	56.5	56.5	41.8	39.8	46.0	53.2	43.1	45.1	57.6	76.6	61.7	78.0	28.1	29.8	21.5	28.7	23.8	26.8	27.2	21.0	31.1	22.4	89.3	64.3	79.5	78.2	75.3	77.8	52.9	242.0	129.8	92.1	202.4	64.8	116.6	36.5	176.6	62.6	87.0	250.8	46.7	166.4	124.7	115.1	88.8	73.0	298.8	125.0	71.5	85.0	87.8	100.9	101.4	114.5	87.4	94.5	55.9	105.0	214.5	177.4	168.4	121.6	108.8	60.1	122.9	83.4	191.2	73.2	81.2	93.1	105.4	127.3	85.0
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827531-165911618	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.8"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057128: AB_2683346"	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavorable (9.22e-8)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.5	7.1	6.5	11.1	8.6	11.6	17.5	16.9	9.6	9.3	18.4	8.9	11.0	15.3	10.1	15.3	20.5	8.8	9.0	9.6	6.4	6.6	6.6	14.6	11.1	10.3	10.5	6.6	7.5	17.6	7.9	9.4	65.8	11.2	8.1	19.9	5.0	16.1	9.9	20.9	15.0	24.8	10.0	8.2	7.7	13.2	7.2	7.9	13.1	6.4	12.4	12.3	9.0	11.1	3.4	14.7	0.8	5.6	3.4	3.9	2.0	25.2	26.3	14.2	12.7	7.3	12.2	23.1	27.9	20.6	29.8	34.0	24.9	27.8	12.5	19.9	17.3	12.1	20.8	26.6	32.8	26.7	22.9	22.4	14.5	22.6	25.6	18.2	28.3	11.1	11.5	16.9	56.2	35.0	7.2	19.6	24.1	38.3	18.0	26.7	18.3	25.1	18.2	38.9	35.2	25.5	11.5	15.6	42.5	13.8	16.5	21.4	25.3	19.9	39.4	19.3	28.3	24.3	27.0	20.4	16.7	23.3	18.9	29.5	24.2	36.0	46.3	14.4	18.8	12.7	0.8	5.6	0.1	1.8	3.7	3.9	3.4	1.7	2.4	14.7	3.4	0.0	1.4	0.2	3.4	3.2	14.0	2.2	2.0	6.5	8.6	16.9	9.6	6.4	6.6	10.5	6.6	11.2	7.9	0.0	1.4	3.0	24.7	20.4	4.3	4.1	12.7	1.4	4.5	8.7	0.0	1.2	6.6	15.0	94.9	15.3	22.2	0.0	19.1	46.9	11.0	10.1	0.0	4.9	11.9	0.0	6.4	4.9	3.5	31.3	6.1	7.1	10.1	17.2	13.7	4.0	38.8	14.4	3.2	5.8	4.2	0.0	9.0	5.2	11.5	26.0	22.1	4.8	18.3	20.9
FAM78B		ENSG00000188859	"Family with sequence similarity 78 member B"	Q5VT40	1	166057426-166166969	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 82.5;Horizontal cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.4;SK-MEL-30: 11.2;U-2 OS: 3.0;WM-115: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052789, HPA073246"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA052789: AB_2681949, HPA073246: AB_2686588"	"unprognostic (7.38e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.87e-11)"	"unprognostic (7.41e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.69e-2)"	3.3	1.5	5.1	2.7	6.4	1.4	3.1	8.6	10.5	3.6	2.8	1.0	0.3	3.5	3.6	1.1	1.6	1.1	2.3	3.2	2.4	1.1	2.7	2.8	1.6	1.8	1.1	3.1	2.1	5.2	1.1	3.5	1.4	2.1	1.8	1.1	5.7	2.2	1.3	3.1	2.0	1.6	1.1	1.2	2.2	3.6	3.7	1.5	0.0	1.7	1.7	1.3	2.7	2.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.3	0.1	0.6	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.8	0.5	0.0	0.2	11.2	0.0	0.3	0.4	0.2	0.7	3.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.4	8.6	10.5	2.4	1.1	1.1	3.1	2.1	1.5	0.0	1.7	0.0	0.4	0.5	11.9	9.8	2.5	0.0	0.0	0.0	82.5	0.0	1.7	0.6	1.4	0.7	0.0	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.0	77.9	0.0	0.6	0.3	1.8	1.1	0.0	1.7	1.0	0.4	2.0	0.3	0.0	0.7	1.2	13.4	0.0	0.3	0.5	2.1	0.1	0.0	0.0	0.9	0.1
POGK	"BASS2, KIAA15131, KRBOX2, LST003"	ENSG00000143157	"Pogo transposable element derived with KRAB domain"	Q9P215	1	166839447-166856344	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007838, HPA031630, HPA075919"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: "	"unprognostic (3.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (4.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	12.1	10.3	24.3	15.1	27.3	10.4	24.2	18.4	23.6	17.6	13.1	27.6	8.4	10.2	17.6	12.6	16.1	13.5	12.4	11.1	24.4	18.4	15.7	12.0	20.9	13.5	27.7	17.7	19.9	14.8	30.0	10.0	15.1	21.1	12.0	15.4	12.2	12.9	15.2	6.6	20.2	12.1	16.8	30.5	14.5	14.9	6.8	25.6	9.2	13.0	5.2	17.7	16.9	24.2	9.4	10.0	6.3	10.8	9.9	7.3	5.6	15.8	13.5	14.8	18.2	15.7	13.1	8.4	11.0	11.3	14.2	10.8	10.2	13.6	17.9	16.6	11.4	12.1	15.9	18.4	14.7	13.0	21.7	12.6	7.0	12.3	7.2	13.4	25.1	19.8	9.9	23.2	15.9	22.9	12.6	12.6	16.8	24.1	12.1	13.5	7.6	15.5	6.3	24.2	18.6	15.6	17.8	8.1	15.8	14.8	38.9	19.4	23.4	15.7	21.8	20.3	23.0	20.7	23.4	11.6	15.1	15.0	11.8	19.9	17.2	22.1	23.4	8.4	12.6	14.2	2.8	7.7	6.3	6.7	9.9	7.3	9.4	6.5	7.1	10.0	5.8	6.1	6.3	1.1	9.9	10.8	5.0	5.6	5.6	24.3	27.3	18.4	23.6	24.4	18.4	27.7	17.7	21.1	25.6	50.6	15.0	10.2	22.1	19.5	30.6	7.9	15.3	12.0	23.9	12.2	9.8	9.2	1.7	15.3	2.2	16.8	7.4	0.0	13.9	10.1	12.1	19.9	23.1	12.1	14.0	46.1	8.6	12.3	18.1	0.7	10.0	16.1	8.5	10.0	12.1	14.5	12.4	14.0	17.0	7.4	27.0	12.9	13.4	0.9	2.1	21.0	7.6	7.5	15.2	25.1
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876327	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	6.5	10.6	13.8	7.1	18.5	17.8	10.2	18.2	20.0	11.3	9.1	17.0	3.4	8.3	10.5	8.6	10.1	9.8	6.6	9.2	13.2	14.6	12.9	28.9	6.7	10.1	11.1	14.3	12.7	7.5	11.3	13.7	12.5	15.0	9.2	10.2	13.4	8.7	8.4	10.7	8.5	9.0	8.5	10.8	7.3	8.0	12.0	10.3	16.7	11.5	7.1	10.9	8.6	7.8	13.4	13.0	8.1	8.2	16.2	19.5	15.1	8.2	7.9	14.9	8.8	4.5	5.8	8.9	4.3	5.3	7.3	6.3	7.2	6.7	15.7	8.5	5.1	5.9	6.3	12.0	7.7	5.9	9.9	11.5	5.2	6.8	11.8	6.7	14.6	9.6	4.4	8.9	4.3	11.0	5.2	5.9	11.9	18.5	9.6	5.6	5.7	18.0	11.6	22.7	13.3	8.9	15.2	6.6	19.9	9.7	11.1	9.6	16.8	7.8	10.1	9.1	14.3	13.8	15.4	4.4	6.0	6.9	6.5	9.1	13.6	18.5	29.4	4.1	6.7	5.6	1.8	8.1	8.1	14.0	8.2	15.5	13.1	15.2	15.8	13.0	13.4	19.5	15.3	1.3	16.2	6.2	8.5	14.3	15.1	13.8	18.5	18.2	20.0	13.2	14.6	11.1	14.3	15.0	10.3	8.9	2.4	2.9	4.3	5.5	7.4	9.4	0.0	4.0	4.5	3.5	7.9	5.3	5.0	3.2	3.4	3.7	3.8	0.0	3.5	6.3	4.0	4.4	4.7	17.1	3.7	1.6	6.9	3.7	5.1	1.3	4.0	2.5	1.7	5.4	5.3	6.6	3.0	0.0	2.8	5.0	5.7	0.0	3.8	4.7	12.9	4.4	6.1	5.3	5.1	3.2
ILDR2	C1orf32	ENSG00000143195	"Immunoglobulin like domain containing receptor 2"	Q71H61	1	166895711-166975482	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;testis: 18.0"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 116.0"	"Cancer enhanced"	"Detected in some"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012545, HPA012815"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012545: AB_2126894, HPA012815: "	"unprognostic (9.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.89e-5)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	0.8	1.1	9.8	0.9	6.4	1.4	0.5	2.1	14.6	0.7	2.9	3.6	0.1	0.7	0.9	1.4	0.9	0.8	1.3	3.1	7.2	7.7	6.3	1.3	1.4	1.0	2.7	8.0	0.8	0.7	0.5	3.3	0.8	3.1	2.3	1.2	2.8	0.8	2.8	0.8	0.7	0.8	2.0	2.3	0.7	0.7	18.0	3.1	1.9	0.9	0.0	1.1	0.9	0.3	0.0	0.4	0.3	0.0	0.0	0.3	0.5	0.0	0.0	9.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.8	0.3	0.0	0.4	0.0	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.2	0.0	3.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.1	0.2	0.0	5.1	0.0	3.3	0.1	0.0	0.0	0.3	0.7	0.7	0.2	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.0	12.5	0.0	6.6	2.3	0.0	0.5	1.4	1.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.5	9.8	6.4	2.1	11.4	7.2	7.7	2.7	8.0	3.1	3.1	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.1	1.6	1.2	0.0	0.0	13.8	0.6	0.0	0.0	1.0	0.0	116.0	0.1	0.0	0.0	4.6	6.5	0.0	0.1	3.3	1.3	0.0	0.2	0.0	0.2	0.0
MAEL	"CT128, FLJ14904, SPATA35"	ENSG00000143194	"Maelstrom spermatogenic transposon silencer"	Q96JY0	1	166975582-167022214	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 90.7"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 1028.7;Late spermatids: 292.6;Spermatocytes: 368.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.9"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enriched"	"Detected in some"	8	"NTERA-2: 8.8"	"Region enriched"	"Detected in single"	5	"thalamus: 1.2"	"Not detected"	"Not detected"			HPA078602	Approved					NA	NA					"HPA078602: AB_2732386"	"unprognostic (1.36e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	0.1	0.0	0.8	0.1	0.2	0.0	0.1	0.6	1.3	0.1	0.3	0.1	0.1	0.0	0.1	0.7	0.2	0.0	0.2	2.1	0.7	0.5	0.6	0.3	0.1	0.1	0.4	0.1	0.1	0.6	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.1	0.0	90.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	8.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.8	0.2	0.6	1.3	0.7	0.5	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.1	1.3	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1028.7	0.1	0.0	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	292.6	10.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	9.6	4.3	1.3	0.0	0.3	368.4	143.2	0.0	0.2	0.0	0.0	0.1
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 101.1"	"Group enriched"	"Detected in some"	10	"Enterocytes: 384.9;Mucus-secreting cells: 185.3;Paneth cells: 288.3;Undifferentiated cells: 97.5"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 17.8;T-reg: 13.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 17.8"	"Cell line enriched"	"Detected in some"	12	"OE19: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced					NA	NA					"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.2	0.2	0.2	12.1	0.2	0.0	0.2	0.2	0.2	0.2	46.9	0.2	0.1	31.6	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	1.6	0.2	0.1	0.2	0.2	0.0	0.2	0.3	0.2	0.2	43.5	0.2	0.3	0.1	0.2	0.2	101.1	1.4	0.2	0.6	0.2	0.2	0.1	0.6	0.2	0.1	0.6	0.2	0.2	1.7	1.7	0.1	2.5	0.1	17.8	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	1.4	17.2	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	2.5	1.1	0.1	7.6	3.9	1.7	1.7	17.8	2.4	0.1	0.1	1.6	0.0	13.0	4.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	384.9	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.5	0.0	25.1	0.0	2.6	1.3	0.3	0.9	0.0	0.0	185.3	0.7	0.1	288.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	97.5	0.1
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 131.1"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 18.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	131.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220829-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	6.9	5.7	15.5	7.3	11.9	12.6	7.2	36.4	13.8	7.7	6.6	9.5	5.2	4.1	7.5	8.4	5.3	6.5	4.3	5.1	14.5	6.7	7.0	5.8	6.6	8.2	7.7	10.8	8.1	6.1	15.5	8.3	9.6	7.1	6.7	6.8	12.0	5.5	6.5	10.5	8.8	6.6	5.5	6.3	9.3	6.1	10.1	10.9	7.4	6.9	4.9	9.7	7.6	6.2	7.5	5.9	8.6	5.9	1.4	4.4	2.2	6.4	5.2	13.5	4.1	1.6	1.6	5.5	0.8	1.4	1.6	1.6	7.5	3.7	7.3	3.5	1.3	1.5	5.0	8.2	2.5	2.4	2.9	3.1	5.1	3.6	6.1	1.0	5.6	3.4	1.1	1.4	1.8	3.3	2.0	2.1	5.1	5.4	4.2	2.1	3.4	5.1	3.6	15.7	3.5	2.1	7.5	4.9	3.2	2.8	3.6	8.2	6.2	5.0	3.7	3.3	7.1	4.1	6.9	3.4	3.1	4.9	1.9	3.1	4.0	1.8	16.9	1.4	3.4	3.9	8.6	2.3	2.8	4.4	2.7	3.3	7.5	2.3	2.0	2.5	6.8	3.2	2.4	3.3	1.4	5.9	5.9	2.1	2.2	15.5	11.9	36.4	13.8	14.5	6.7	7.7	10.8	7.1	10.9	11.9	12.1	21.9	10.4	11.8	54.9	13.2	12.7	6.7	10.3	19.2	96.2	15.4	5.0	8.8	23.3	16.6	8.5	0.0	10.1	15.3	13.4	14.9	19.6	11.6	11.2	44.5	23.2	11.1	35.6	28.6	23.9	14.6	6.8	23.4	14.3	47.2	12.6	7.0	19.4	6.9	106.3	25.8	11.9	18.5	40.0	9.7	43.3	13.8	13.0	9.7
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 62.8;lymphoid tissue: 129.5"	"Cell type enriched"	"Detected in many"	10	"T-cells: 248.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	26	"gdT-cell: 62.8;MAIT T-cell: 35.4;memory CD4 T-cell: 32.4;memory CD8 T-cell: 36.7;naive CD4 T-cell: 41.3;naive CD8 T-cell: 33.5;NK-cell: 33.4;T-reg: 39.0"	"Group enriched"	"Detected in many"	31	"NK-cells: 33.4;T-cells: 62.8"	"Group enriched"	"Detected in some"	25	"HDLM-2: 46.4;JURKAT: 34.6;MOLT-4: 48.9"	"Region enhanced"	"Detected in single"		"thalamus: 0.7"	"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced					NA	NA					"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favorable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"	2.3	0.5	0.9	13.5	2.1	17.8	1.3	1.2	1.1	1.4	4.4	0.7	0.7	2.9	1.5	1.6	1.4	1.2	2.9	1.0	0.8	1.4	1.9	3.2	7.3	24.3	1.0	0.5	1.0	0.5	0.0	0.6	1.3	0.7	2.0	1.8	1.7	3.3	0.4	1.4	0.6	9.8	0.8	0.9	28.6	2.7	0.9	0.5	129.5	1.8	0.9	18.1	3.5	1.4	1.5	0.4	1.4	0.2	33.4	62.8	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.1	0.0	62.8	0.2	35.4	1.5	32.4	36.7	0.2	0.5	41.3	33.5	1.4	33.4	0.1	0.4	39.0	31.4	0.9	2.1	1.2	1.1	0.8	1.4	1.0	0.5	0.7	0.5	3.0	26.0	2.2	0.1	1.3	0.2	0.4	2.5	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.1	0.7	0.1	5.8	0.6	0.3	3.2	0.0	5.5	5.9	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.1	1.5	0.5	0.1	248.3	0.0	0.0
CREG1	CREG	ENSG00000143162	"Cellular repressor of E1A stimulated genes 1"	O75629	1	167529677-167553767	"Predicted secreted proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Hofbauer cells: 442.0;Kupffer cells: 417.0;monocytes: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 15.1;classical monocyte: 36.8;eosinophil: 21.7;intermediate monocyte: 21.5;myeloid DC: 26.9;neutrophil: 13.0;non-classical monocyte: 19.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 26.9;granulocytes: 21.7;monocytes: 36.8"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 158.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056390			Approved	Vesicles,Microtubules	"Secreted to blood"	NA	NA		550000	Microtubules	Vesicles	"HPA056390: AB_2683113"	"unprognostic (3.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.54e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.99e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.16e-1)"	50.9	52.6	15.7	21.0	17.9	29.6	56.7	11.8	15.0	23.0	32.8	21.7	21.3	16.5	22.0	46.8	41.9	25.0	40.8	48.9	15.5	13.6	39.8	81.3	68.5	83.8	16.4	9.6	43.3	41.6	19.1	36.2	46.8	14.7	41.4	23.7	28.7	39.0	22.6	33.0	37.1	30.4	40.9	21.0	98.2	22.7	27.6	15.1	12.6	53.1	32.7	23.7	50.8	40.9	1.3	26.9	21.7	36.8	3.3	5.3	13.9	12.0	5.4	2.8	5.8	44.8	12.5	7.2	5.2	2.3	4.1	5.4	8.8	13.9	13.3	15.2	5.7	7.7	19.1	3.2	11.2	2.8	18.0	11.0	5.4	4.5	4.9	15.4	12.0	40.1	13.0	33.8	4.8	5.3	5.8	1.3	4.7	27.9	54.6	5.7	5.0	2.4	12.4	3.0	27.8	8.5	4.2	7.9	158.5	7.4	8.5	1.9	3.5	13.0	17.8	14.4	9.9	23.6	32.9	2.5	1.1	5.4	17.0	3.3	10.7	21.3	8.7	18.0	12.5	2.1	15.1	36.8	21.7	1.6	21.5	2.5	1.3	2.4	2.0	26.9	0.6	5.3	2.6	13.0	3.3	19.9	1.8	1.1	13.9	15.7	17.9	11.8	15.0	15.5	13.6	16.4	9.6	14.7	15.1	32.8	78.6	17.9	43.5	39.2	16.0	45.9	63.7	22.7	31.8	52.4	84.4	79.1	19.9	26.7	18.6	34.9	20.0	116.8	34.5	36.0	45.2	30.0	29.9	79.5	442.0	14.3	28.2	43.0	417.0	20.2	40.3	100.2	23.6	450.0	40.4	25.3	26.6	24.6	26.9	45.2	30.1	12.9	41.5	32.9	43.2	44.7	106.0	14.6	47.5	37.3
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167706249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 128.0;Kupffer cells: 116.2;monocytes: 64.1;Sertoli cells: 77.6;T-cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 48.3;REH: 48.5;RPMI-8226: 33.1;THP-1: 25.5;U-266/70: 32.4;U-698: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		NA	NA		150000	"Plasma membrane"		"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	8.5	2.9	3.5	33.3	4.8	19.2	7.3	1.2	3.1	3.0	8.4	3.6	1.3	3.6	2.7	5.4	4.1	3.1	8.8	18.4	3.9	3.6	4.2	3.7	9.0	45.6	5.1	2.2	2.5	1.5	0.8	2.0	7.0	3.1	3.7	5.0	3.1	6.5	2.5	52.3	2.3	20.1	7.4	6.9	40.6	4.9	3.7	3.4	70.8	4.8	12.7	29.2	7.4	4.5	51.0	22.1	56.4	38.2	26.6	27.8	26.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.3	0.0	0.0	0.0	8.3	0.9	0.1	0.0	0.1	0.0	0.0	0.0	19.7	15.5	14.2	6.5	0.0	15.3	11.9	0.4	0.0	0.0	48.5	0.2	33.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	25.5	0.1	0.0	0.1	0.0	0.0	32.4	9.6	31.8	0.0	15.8	0.0	48.4	38.2	56.4	15.2	25.1	18.3	45.6	19.8	18.9	22.1	51.0	17.2	15.9	38.5	26.6	24.1	12.8	27.8	26.3	3.5	4.8	1.2	3.1	3.9	3.6	5.1	2.2	3.1	3.4	3.0	10.7	128.0	1.2	1.0	0.6	40.7	0.0	0.0	5.7	1.8	0.0	0.4	0.0	0.1	0.4	17.9	0.0	0.0	0.0	0.2	3.1	0.7	12.8	1.7	37.5	0.0	0.0	27.0	116.2	1.5	0.9	47.2	5.0	64.1	0.0	0.0	0.1	0.0	0.4	0.3	0.7	77.6	21.5	0.0	0.1	1.5	1.0	84.1	0.0	0.3
MPZL1	"FLJ21047, PZR"	ENSG00000197965	"Myelin protein zero like 1"	O95297	1	167721192-167791919	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026966, HPA063538"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA026966: AB_10600931, HPA063538: AB_2685034"	"unprognostic (6.54e-2)"	"unprognostic (9.26e-3)"	"unprognostic (4.59e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.27e-6)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (3.55e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (4.21e-2)"	34.4	19.1	13.6	21.4	13.9	3.2	42.0	14.3	13.7	32.2	27.3	15.4	15.9	18.5	34.8	25.2	32.1	30.1	34.3	29.2	12.0	14.0	22.2	20.9	22.2	20.7	14.4	10.0	38.3	25.4	13.7	24.3	34.0	14.3	28.3	28.2	28.0	51.7	19.4	11.0	17.7	26.6	30.5	13.0	19.6	21.3	27.7	10.9	9.7	29.0	25.8	28.0	33.6	35.0	4.2	12.5	51.4	8.9	2.9	2.4	3.0	18.1	26.5	20.8	16.1	67.3	30.5	65.9	28.4	36.8	18.6	23.2	48.9	25.4	6.4	33.3	35.9	16.4	30.7	20.7	31.4	15.8	14.5	11.2	5.3	14.2	11.7	41.9	6.2	3.4	28.0	39.7	29.7	33.4	26.3	24.7	19.7	19.7	13.5	22.0	6.0	20.9	7.4	13.2	36.6	11.4	12.8	17.9	28.3	28.5	17.6	12.1	19.9	25.3	26.4	14.6	50.2	14.2	3.3	28.0	21.4	9.6	27.4	15.3	20.3	31.3	29.8	30.6	7.3	3.3	1.9	8.1	5.4	0.8	6.8	0.4	4.2	0.8	1.2	10.9	2.5	2.4	0.8	51.4	2.9	8.9	12.5	0.1	3.0	13.6	13.9	14.3	13.7	12.0	14.0	14.4	10.0	14.3	10.9	26.8	25.9	20.1	58.0	67.9	7.6	5.3	20.4	21.4	37.5	19.2	5.9	107.3	5.0	59.9	1.4	40.7	44.8	0.0	66.1	111.2	70.6	98.3	3.5	16.9	33.1	9.5	45.9	22.7	24.2	2.4	64.7	22.2	15.1	124.4	41.1	10.6	61.2	28.8	78.8	10.2	13.2	19.4	47.4	9.7	24.9	48.6	64.3	5.2	51.7	53.8
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809388-167914215	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"liver: 14.9;testis: 38.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 64.6;Late spermatids: 64.3"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;T-47d: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015243, HPA017749"	Approved					NA	NA					"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.1	0.2	0.1	0.3	0.0	1.3	1.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.3	14.9	0.1	0.1	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	38.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.4	0.6	0.0	0.3	0.4	0.3	0.1	0.2	0.2	0.6	0.5	2.7	0.1	1.0	0.3	1.1	1.6	0.1	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.2	0.4	1.6	0.5	0.3	0.7	0.1	0.0	0.0	0.1	1.9	0.8	0.6	0.3	0.0	0.7	1.2	0.1	0.1	0.0	0.5	0.8	1.0	0.8	0.0	0.1	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.5	1.6	5.0	0.8	0.1	0.2	0.0	0.3	0.1	1.2	0.6	0.8	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.4	0.2	0.3	1.6	0.3	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	64.6	0.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	5.9	0.1	0.0	0.0	1.3	0.0	64.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	4.1	0.7	0.4	1.5	0.0	0.0	0.1
MPC2	"BRP44, DKFZP564B167, SLC54A2"	ENSG00000143158	"Mitochondrial pyruvate carrier 2"	O95563	1	167916729-167937040	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 111.7"	"Cell type enhanced"	"Detected in all"	13	"Early spermatids: 1811.9;Late spermatids: 3927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 94.3"	"Low region specificity"	"Detected in all"							HPA056091	Uncertain					NA	NA					"HPA056091: AB_2683035"	"unprognostic (3.25e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.79e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.67e-1)"	13.5	22.5	22.6	11.5	21.6	33.5	23.0	15.0	25.3	11.7	26.8	12.1	10.2	27.1	7.8	12.5	12.2	9.9	25.2	46.2	19.0	17.7	46.4	92.9	9.9	11.4	18.8	16.7	9.6	14.7	9.6	18.4	9.9	13.5	34.4	24.8	11.9	20.6	10.8	45.0	9.3	26.3	13.1	16.5	7.4	29.6	111.7	11.4	12.7	11.9	23.5	10.9	11.2	8.1	23.4	28.7	45.3	18.5	27.4	40.2	37.2	18.3	17.6	7.8	17.7	19.5	18.1	1.7	30.1	16.9	14.2	16.6	40.8	10.3	31.9	21.9	17.2	11.6	14.9	10.5	16.3	14.7	40.8	15.7	13.9	18.0	32.4	13.1	15.0	10.3	11.6	14.9	25.5	14.7	12.4	12.4	23.7	17.1	18.7	25.3	8.5	22.2	15.5	12.9	42.3	22.1	11.7	14.2	25.3	94.3	16.1	12.4	12.6	17.3	20.6	16.6	18.9	37.0	19.3	11.4	15.3	11.3	22.2	13.9	24.9	28.3	35.1	39.4	13.6	8.0	41.0	16.6	45.3	23.7	14.6	25.3	23.4	29.3	25.0	28.7	20.6	27.7	26.5	31.8	27.4	18.5	20.7	40.2	37.2	22.6	21.6	15.0	25.3	19.0	17.7	18.8	16.7	13.5	11.4	32.8	46.1	92.5	122.7	112.0	55.3	407.2	440.8	125.8	42.1	123.9	21.6	444.8	868.7	156.5	1811.9	78.2	261.8	93.5	128.1	44.4	116.0	241.3	87.6	688.4	140.6	42.9	318.3	49.7	62.2	3927.7	98.4	101.0	114.7	412.0	246.3	79.1	95.6	240.2	106.1	749.3	55.3	64.7	116.9	623.0	121.0	100.0	287.0	99.6	339.8	130.5
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.9"	"Group enriched"	"Detected in all"	4	"Cardiomyocytes: 200.2;Early spermatids: 375.8;Late spermatids: 573.8;monocytes: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Nucleoplasm, Focal adhesion sites"		"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	10.6	17.0	10.9	7.8	12.2	6.2	8.8	10.5	17.8	10.2	11.5	3.9	8.4	6.2	9.5	11.4	9.3	7.7	8.2	43.8	7.6	5.5	9.5	26.2	7.3	4.8	5.2	11.5	8.3	6.1	10.8	11.3	7.8	6.5	10.5	8.7	5.7	10.3	11.9	155.9	6.4	7.8	10.2	4.8	5.9	9.8	21.5	4.8	7.8	8.2	27.3	7.3	9.1	7.3	6.2	7.7	12.5	13.9	4.4	7.2	5.0	23.0	11.0	6.1	9.9	20.3	28.9	21.6	23.6	35.4	16.8	25.1	18.3	19.5	19.1	13.8	30.5	8.0	17.4	9.6	17.7	23.8	10.8	10.2	20.3	16.8	13.1	16.4	9.1	9.7	20.5	17.9	15.9	13.3	25.6	18.3	6.1	22.9	15.8	24.7	5.3	10.1	8.3	3.9	12.9	12.3	7.8	12.7	14.8	41.9	11.3	9.0	7.2	18.9	17.4	12.9	13.4	29.7	11.2	25.8	16.8	10.5	16.2	9.7	17.0	13.8	14.9	22.4	7.8	6.8	6.0	7.0	12.5	6.7	9.6	7.2	6.2	5.4	5.8	7.7	4.5	5.0	6.4	7.2	4.4	13.9	4.6	6.1	5.0	10.9	12.2	10.5	17.8	7.6	5.5	5.2	11.5	6.5	4.8	53.6	33.4	19.8	24.8	51.4	13.4	200.2	45.9	60.2	53.4	24.4	21.6	61.0	14.9	25.7	375.8	29.8	24.8	46.7	16.9	26.6	39.2	32.0	18.5	81.0	17.8	4.8	20.3	25.8	28.6	573.8	53.2	22.6	35.4	176.7	27.3	14.6	18.0	28.1	45.6	26.9	16.7	32.3	37.1	78.4	58.9	34.8	68.0	20.8	28.8	23.7
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.5	9.9	3.7	6.6	0.0	5.9	6.5	5.1	5.4	24.0	1.0	0.0	3.3	8.9	9.6	18.4	3.7	5.8	3.0	2.3	4.8	2.2	3.0	0.1	1.6	0.6	1.5	2.3	3.8	4.4	7.1	11.9	10.2	1.9	2.0	0.1	7.7	0.5	0.7	0.1	6.3	10.3	6.0	1.8	6.7	0.0	2.7	1.7	3.1	13.7	6.5	0.2	17.8	6.1	3.4	0.7	13.7	10.5	5.5	14.1	6.7	0.0	0.0	0.0	2.8	0.0	2.7	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8	3.0	0.6	0.0	5.0	1.9	1.7	2.0	0.0	1.4	1.2	0.0	0.0	0.4	0.0	3.6	0.4	6.3	0.0	0.0	7.2	0.2	6.3	4.6	0.0	0.0	0.7	149.4	0.0	4.3	1.8	0.6	6.9	1.3	1.7	1.8	1.7	2.7	2.9	0.0	15.9	0.0	1.5	19.4	12.2	0.0	0.7	1.3	0.3	0.0	2.3	2.3
TIPRL	"dJ69E11.3, MGC3794, TIP41, TIPRL1"	ENSG00000143155	"TOR signaling pathway regulator"	O75663	1	168178933-168202114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027995, HPA054282"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA027995: AB_10602900, HPA054282: AB_2682435"	"unprognostic (3.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.45e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.61e-2)"	19.6	22.3	17.0	18.6	29.6	29.7	21.4	18.4	29.1	19.4	21.9	11.2	12.9	18.9	25.9	17.7	28.5	17.5	17.1	23.1	17.4	20.5	22.9	38.3	16.2	20.2	18.0	19.3	21.6	22.2	23.8	31.9	19.8	23.1	19.9	22.7	11.4	17.9	18.6	32.0	16.2	23.2	23.5	16.0	19.0	16.1	22.8	12.4	35.2	17.8	21.1	21.2	23.3	18.5	17.7	21.5	36.2	21.4	19.3	23.9	17.7	26.2	11.5	18.1	16.4	14.8	21.5	10.8	19.7	20.8	21.6	19.4	17.8	19.6	18.4	27.2	18.8	16.1	31.8	13.4	19.1	20.9	17.7	13.7	17.8	11.9	8.5	26.0	35.4	24.7	17.3	24.7	18.8	25.2	14.4	22.7	29.4	25.6	26.2	18.6	9.1	31.6	18.4	14.5	36.8	20.6	15.5	18.5	25.2	19.4	13.0	11.7	26.2	15.2	21.6	38.6	21.5	23.6	36.5	20.6	18.3	21.0	17.1	26.5	28.7	29.7	41.1	11.9	23.5	20.9	36.2	18.7	24.2	16.2	21.4	16.2	17.7	19.0	17.2	21.5	17.7	17.1	16.9	24.2	19.3	21.4	16.1	23.9	17.7	17.0	29.6	18.4	29.1	17.4	20.5	18.0	19.3	23.1	12.4	23.8	14.8	32.8	35.9	42.7	25.6	43.2	22.9	29.4	23.9	21.0	15.7	37.2	24.9	58.5	31.5	34.6	29.9	0.0	77.6	52.7	32.1	27.7	39.3	31.6	57.2	49.3	23.1	33.7	19.7	8.9	34.8	40.9	28.7	62.3	33.7	41.8	57.8	20.1	35.7	54.3	18.4	25.8	36.3	133.2	39.6	36.5	24.3	35.2	36.5	31.3
SFT2D2	"dJ747L4.C1.2, UNQ512"	ENSG00000213064	"SFT2 domain containing 2"	O95562	1	168225938-168253025	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042207	Approved					NA	NA					"HPA042207: AB_10794789"	"unprognostic (4.34e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.62e-3)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.15e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.71e-1)"	16.5	9.2	11.4	12.2	13.5	37.9	14.2	1.9	8.2	16.8	11.3	18.8	9.2	7.0	36.0	13.0	18.3	11.7	10.1	7.5	9.1	7.4	17.6	15.1	12.1	13.2	14.3	6.5	21.3	8.9	13.1	35.3	8.3	12.6	11.6	11.6	9.4	19.9	7.2	5.6	20.5	15.5	14.1	13.7	17.1	9.6	20.6	14.5	19.4	12.9	13.6	23.4	9.7	11.7	4.1	28.6	7.5	13.7	3.5	5.1	3.7	9.9	13.3	5.1	9.4	15.1	8.5	10.7	7.4	5.2	5.6	6.4	13.3	10.2	8.9	11.2	10.3	5.0	33.8	8.8	7.8	7.5	12.4	3.2	7.1	16.2	9.6	8.1	11.0	10.6	9.9	5.9	7.3	6.6	4.3	7.6	12.6	6.4	11.8	6.2	4.1	9.4	8.2	6.2	14.9	2.9	10.5	7.3	7.0	8.2	12.6	3.3	6.3	8.8	11.2	9.1	8.8	8.9	11.0	8.4	7.5	5.6	7.7	9.2	4.6	8.4	13.6	5.8	7.8	7.7	7.5	6.6	2.3	5.1	11.3	3.1	4.1	3.1	3.2	9.1	4.1	2.9	3.2	3.2	3.5	13.7	28.6	3.3	3.7	11.4	13.5	1.9	8.2	9.1	7.4	14.3	6.5	12.6	14.5	41.7	30.7	36.3	13.8	24.8	0.6	3.9	22.9	32.1	31.8	36.6	3.9	8.8	1.7	19.9	50.9	23.3	33.2	23.3	17.9	22.2	30.2	27.0	48.5	50.5	39.8	3.2	30.6	25.8	86.0	103.6	22.5	47.6	40.5	26.2	23.5	12.1	27.4	14.4	31.8	32.2	6.5	25.8	17.8	13.1	7.0	42.2	8.2	24.1	25.7	19.7
TBX19	"dj747L4.1, TPIT"	ENSG00000143178	"T-box 19"	O60806	1	168281040-168314426	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"pituitary gland: 50.4"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 9.4;HDLM-2: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005800, HPA072686"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005800: AB_1080219, HPA072686: AB_2732209"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.14e-7)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (8.57e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	1.0	0.4	1.0	1.0	1.0	0.5	2.5	1.0	1.0	1.5	1.3	1.0	1.0	0.8	5.3	1.0	1.1	2.0	1.4	1.0	1.0	0.8	1.0	1.0	2.2	2.1	1.0	1.0	2.9	1.0	0.2	50.4	1.0	1.0	1.2	1.1	1.0	2.2	1.4	1.0	1.9	1.0	3.6	1.0	2.1	0.6	1.0	1.0	1.0	1.0	1.0	1.3	1.3	1.2	1.6	6.3	2.7	2.4	2.6	3.1	1.3	1.6	0.1	1.4	5.3	2.5	1.2	1.7	2.9	1.5	1.0	1.6	2.4	1.7	1.5	2.9	1.1	1.5	9.4	0.8	0.7	1.4	8.1	1.4	0.3	1.7	0.7	2.9	2.6	3.6	2.2	2.6	0.3	1.5	2.6	1.2	0.6	1.8	2.4	1.3	0.3	1.4	2.4	0.4	5.6	1.0	2.2	0.7	0.5	2.3	0.7	1.9	2.8	1.6	1.2	1.6	2.4	0.4	2.2	2.1	1.0	2.4	2.0	2.9	1.6	1.3	1.2	0.2	0.8	2.8	0.5	1.8	0.8	3.1	1.3	1.4	1.2	2.2	2.0	1.8	1.6	1.5	1.3	2.7	2.6	2.4	6.3	2.0	1.3	1.0	1.0	1.0	1.0	1.0	0.8	1.0	1.0	1.0	1.0	0.0	0.3	0.0	1.1	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	2.7	0.9	0.0	0.3	0.2	2.3	3.4	4.6	0.5	1.1	0.0	1.2	0.0	2.1	0.4	3.1	2.8	0.0	2.8	0.7	0.8	1.4	0.0	2.5	0.3	0.0	0.0	0.8	0.5	0.7	2.9	0.1	1.8	0.8	2.0
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540765-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 73.4"	"Group enriched"	"Detected in some"	23	"Melanocytes: 32.1;T-cells: 124.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 73.4"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 73.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 7.2;HSkMC: 1.3;RT4: 3.0;SuSa: 1.6"									HPA057725	Approved				"Secreted to blood"	NA	NA					"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.9	0.6	0.5	10.0	0.5	11.8	3.0	0.4	0.4	1.2	1.4	0.2	0.9	2.6	5.4	2.8	0.9	1.4	4.7	2.0	0.5	0.5	1.2	4.6	6.7	4.4	0.6	0.4	0.6	1.9	0.0	0.7	7.0	0.3	2.2	1.1	2.4	4.8	0.9	0.4	0.6	3.9	1.0	1.1	19.3	2.3	0.4	0.0	10.6	1.3	1.4	3.9	2.3	1.2	0.0	0.0	0.3	0.0	73.4	9.5	2.9	0.4	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	1.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.0	0.7	9.4	0.0	0.0	0.4	7.6	0.3	73.4	0.0	0.0	0.0	2.9	0.5	0.5	0.4	0.4	0.5	0.5	0.6	0.4	0.3	0.0	0.0	1.4	0.8	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.6	0.3	0.0	0.0	1.3	3.4	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	124.6	0.0	0.0
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576473-168582077	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 33.8;lymphoid tissue: 29.6"	"Group enriched"	"Detected in some"	9	"Melanocytes: 37.1;T-cells: 113.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 33.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 33.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.4;Hep G2: 5.5;SCLC-21H: 5.3;SuSa: 9.7;U-266/70: 7.5;U-266/84: 2.7"									HPA057725	Approved				"Secreted to blood"	NA	NA					"HPA057725: AB_2683511"	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"	1.7	0.4	0.6	8.8	0.6	5.0	1.3	0.7	0.5	1.5	1.1	0.2	0.0	1.4	4.8	2.8	1.4	1.8	1.6	2.6	0.6	0.9	1.8	3.9	4.1	10.7	0.8	0.0	1.0	2.4	0.0	0.7	3.7	0.3	1.6	1.5	1.6	3.7	0.6	0.4	0.6	2.6	1.0	1.1	10.6	1.7	0.5	0.1	29.6	1.3	2.2	5.9	2.9	1.3	0.0	0.0	0.8	0.0	33.8	3.3	0.7	1.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.3	0.0	0.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	7.5	2.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.2	0.0	0.1	0.0	0.5	3.3	0.0	0.0	0.1	2.5	0.1	33.8	0.0	0.0	0.0	0.7	0.6	0.6	0.7	0.5	0.6	0.9	0.8	0.0	0.3	0.1	3.0	8.5	0.0	0.0	3.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.4	0.2	0.0	0.2	0.8	4.3	0.1	2.3	0.4	0.3	0.0	0.0	1.3	1.2	0.0	0.0	0.8	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	3.8	0.7	113.6	0.3	0.0
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695459-168729264	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.1"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 155.7;Leydig cells: 214.6;Peritubular cells: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 55.3;fHDF/TERT166: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		25000	Vesicles		"HPA065548: AB_2685511"	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	128.1	6.1	0.8	22.6	0.8	0.0	99.3	0.8	2.4	51.0	81.7	0.9	19.8	2.4	20.4	38.8	33.1	23.0	52.3	48.8	0.8	0.3	2.4	6.0	9.6	7.7	0.8	0.8	12.8	13.4	0.0	0.9	7.8	0.9	24.0	9.4	1.8	14.4	10.2	13.0	8.6	23.1	76.1	0.8	1.0	23.6	8.7	0.8	2.3	16.3	55.7	22.8	48.7	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.2	0.0	0.0	2.4	2.7	2.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	2.4	0.8	0.3	0.8	0.8	0.9	0.8	3.0	1.7	0.0	0.1	28.3	0.0	5.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.6	0.4	0.0	0.0	0.2	0.3	155.7	0.2	0.0	0.0	0.6	0.0	0.0	12.9	0.0	0.7	214.6	0.0	37.1	0.0	0.0	0.0	0.3	0.0	116.3	0.0	0.0	0.0	15.0	0.3	0.3	28.0	0.3	0.0	0.0	0.5
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 239.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 1634.8;Proximal tubular cells: 927.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 127.3;RPTEC TERT1: 68.9;SH-SY5Y: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					NA	NA		4100000			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	3.9	26.3	48.7	8.6	45.1	1.3	14.9	39.4	92.1	8.7	43.8	34.5	11.3	61.3	19.8	11.2	28.7	9.4	50.1	36.0	86.3	68.2	239.7	30.6	16.9	1.9	82.3	52.6	11.5	33.0	130.6	16.7	8.3	111.5	9.8	34.8	15.5	55.7	15.4	55.1	11.2	51.2	17.8	64.0	9.6	69.5	8.4	25.9	0.9	60.1	23.7	13.9	12.3	9.0	1.4	8.4	10.5	3.0	5.6	9.1	1.4	12.3	30.2	9.8	7.5	2.3	0.4	3.4	6.1	5.0	6.4	6.7	36.8	25.0	0.0	23.1	4.8	7.2	14.6	5.4	11.6	6.6	0.1	2.4	0.7	22.8	17.1	3.7	0.5	1.1	1.3	2.9	4.7	6.1	11.2	5.8	0.9	0.1	0.1	7.3	4.7	1.0	1.9	3.9	127.3	6.5	0.1	11.9	2.1	68.9	15.4	7.8	57.2	36.1	36.4	1.6	12.5	7.5	1.2	12.3	4.9	13.2	8.3	21.8	0.7	0.9	0.2	5.9	1.8	6.6	10.5	1.0	0.1	2.9	3.0	1.5	1.4	3.4	1.1	8.4	0.2	1.0	1.1	0.3	5.6	0.9	0.4	9.1	1.4	48.7	45.1	39.4	92.1	86.3	68.2	82.3	52.6	111.5	25.9	223.4	199.8	17.7	144.1	46.6	22.3	136.8	749.1	187.4	257.0	1634.8	13.7	3.9	782.5	509.0	2.8	15.2	580.2	0.0	519.8	7.5	62.9	68.0	22.0	232.9	298.5	548.2	154.6	46.6	63.5	4.1	83.1	111.4	234.5	43.3	240.2	24.3	309.0	614.7	140.0	927.9	48.2	6.5	23.6	8.6	62.0	27.7	8.2	25.4	319.0	251.2
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	17.5	13.5	15.7	12.2	18.6	19.7	17.3	21.0	24.1	19.6	14.3	7.8	12.7	10.5	14.4	13.2	29.3	11.8	14.5	14.7	13.8	11.6	19.6	13.1	11.3	9.4	14.0	18.0	17.4	12.0	15.5	30.3	16.9	20.5	19.9	14.1	7.5	16.0	15.2	13.5	15.7	17.3	18.8	16.7	10.9	12.4	35.6	15.8	19.1	19.1	17.5	13.6	22.1	20.8	5.2	5.1	31.4	7.5	8.9	10.9	5.1	24.9	8.0	8.0	6.9	12.2	18.9	13.0	22.3	15.7	23.7	26.2	9.3	16.4	3.7	12.6	14.8	15.0	18.3	7.8	13.9	18.7	7.7	7.7	6.7	9.9	6.5	12.8	12.8	9.5	13.8	17.9	17.7	16.1	13.3	12.4	7.4	11.6	10.1	21.7	5.3	5.5	5.9	9.7	18.0	12.0	3.3	12.6	7.8	22.8	8.5	5.0	15.1	14.6	19.8	16.6	14.2	22.0	9.2	14.8	14.1	11.0	13.1	18.0	10.2	12.1	9.4	10.9	5.9	21.7	31.4	5.9	23.2	6.2	7.5	7.9	5.2	7.7	7.0	5.1	4.8	6.9	7.4	12.0	8.9	7.0	3.9	10.9	5.1	15.7	18.6	21.0	24.1	13.8	11.6	14.0	18.0	20.5	15.8	20.8	16.0	8.1	38.5	16.4	14.4	27.9	12.7	36.1	22.7	10.4	13.7	15.4	19.9	21.3	111.7	10.3	14.0	0.0	11.6	14.4	16.6	14.2	25.4	4.3	12.2	31.8	12.1	8.6	10.2	53.5	13.6	11.1	13.5	6.4	10.5	15.1	24.8	11.5	16.6	16.7	25.7	0.0	20.2	33.9	22.8	13.7	16.8	15.0	8.5	70.2
CCDC181	"C1orf114, FLJ25846"	ENSG00000117477	"Coiled-coil domain containing 181"	Q5TID7	1	169394870-169460669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 22.3;testis: 29.2"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 168.6;Early spermatids: 201.9;Rod photoreceptor cells: 81.8;Spermatocytes: 143.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 7.2;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.5;SH-SY5Y: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027189, HPA027275, HPA027281, HPA027312"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349"	"unprognostic (2.45e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.89e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.41e-2)"	0.8	3.3	6.3	1.0	8.3	0.9	0.9	5.9	8.4	2.6	0.7	1.6	0.4	0.7	4.6	2.7	0.9	14.5	4.6	2.3	6.6	9.9	7.5	0.6	2.4	0.6	5.2	5.0	8.0	3.0	17.3	22.3	0.5	8.7	2.9	0.7	5.3	0.8	2.9	0.7	1.1	0.9	2.7	4.9	0.5	1.2	29.2	4.1	0.0	1.1	0.0	0.5	1.4	0.8	0.1	0.0	3.2	0.1	0.0	0.2	0.0	0.2	0.3	7.2	0.1	0.2	0.2	0.2	0.1	0.0	1.8	3.8	0.1	0.1	0.1	0.1	0.0	7.4	0.1	0.3	0.0	0.3	0.2	1.6	1.7	0.1	0.0	0.0	1.9	0.1	0.7	0.0	0.4	0.0	0.2	0.1	5.7	0.1	0.1	1.3	0.1	4.3	0.0	13.8	0.1	0.0	0.0	5.9	0.1	1.1	0.0	8.5	10.0	0.0	0.3	0.5	4.0	0.0	0.0	0.5	1.4	4.5	0.2	6.1	2.1	1.8	0.0	2.8	0.1	5.5	3.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.3	8.3	5.9	8.4	6.6	9.9	5.2	5.0	8.7	4.1	3.0	6.6	0.0	0.1	0.0	68.6	5.8	0.0	168.6	38.7	8.7	62.8	0.0	13.3	0.9	201.9	0.4	0.0	0.0	1.4	0.0	0.0	0.3	1.1	0.0	0.1	23.8	18.5	0.6	0.0	50.5	2.8	0.0	0.0	0.0	0.0	18.7	0.7	0.0	9.9	14.1	81.8	6.5	1.7	143.9	41.9	0.0	0.1	0.0	0.0	0.6
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169486003	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.7"	"Cell type enhanced"	"Detected in many"	12	"Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	23.1	11.1	1.9	5.3	4.4	4.8	14.2	7.4	6.1	5.9	5.4	2.8	2.7	2.1	5.0	9.0	7.5	10.0	17.5	14.8	2.7	2.1	8.6	23.4	9.2	3.1	2.8	1.7	10.3	14.4	6.8	16.3	22.1	4.7	9.4	2.8	16.4	10.4	4.6	75.7	7.5	6.6	11.3	3.7	1.8	9.4	7.3	1.8	3.6	7.9	21.6	3.9	10.4	9.8	1.4	1.9	3.0	4.6	2.6	3.3	0.7	4.5	3.2	7.3	5.7	22.8	8.4	16.2	3.6	2.7	3.0	4.2	13.1	4.8	4.0	4.2	2.4	5.5	4.9	8.8	5.4	3.3	11.5	8.2	3.8	10.4	11.9	12.4	9.6	3.8	9.9	7.9	4.8	12.3	4.2	4.4	7.1	15.4	2.6	5.0	3.0	4.9	4.3	16.6	8.8	4.9	0.0	15.8	4.6	7.9	9.7	6.4	8.6	5.0	8.7	17.8	8.7	5.5	6.3	3.7	3.6	5.0	4.4	7.1	3.6	3.3	1.3	5.3	3.7	4.7	0.0	1.7	3.0	0.9	0.7	3.3	1.4	1.1	2.1	1.9	1.2	3.1	3.0	1.1	2.6	4.6	0.7	1.0	0.7	1.9	4.4	7.4	6.1	2.7	2.1	2.8	1.7	4.7	1.8	8.9	17.1	0.9	13.6	26.3	4.7	24.0	7.6	13.4	11.4	5.2	2.0	19.6	0.0	7.1	4.4	2.3	6.3	0.0	4.6	3.0	20.6	10.4	10.3	23.1	6.2	6.4	8.6	0.6	3.7	0.4	6.4	5.7	20.3	0.0	4.4	2.6	8.2	5.7	4.6	1.8	4.7	0.0	9.4	3.4	3.4	44.2	130.8	1.5	4.7	21.3
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell type enhanced"	"Detected in many"	22	"Cholangiocytes: 79.0;Cytotrophoblasts: 65.0;Hepatocytes: 221.3;Syncytiotrophoblasts: 49.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in some"	23	"Hep G2: 13.8;OE19: 52.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1	3.0	1.1	0.0	4.4	0.1	0.1	8.6	79.0	5.3	3.4	0.0	2.0	65.0	0.0	1.6	0.7	1.0	0.0	0.0	0.2	1.6	7.7	0.3	0.0	221.3	4.7	0.0	24.2	3.1	18.7	0.0	0.0	0.2	3.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	49.8	1.3	0.0	9.0
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Endothelial cells: 42.8;Ito cells: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"basophil: 6.0;neutrophil: 2.4;T-reg: 8.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 6.0;T-cells: 8.9"	"Group enriched"	"Detected in some"	37	"EFO-21: 25.2;HEL: 22.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced					NA	NA		830000000			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (3.37e-2)"	"unprognostic (2.98e-4)"	"unprognostic (4.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.26e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (5.30e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.66e-1)"	14.2	2.1	0.4	8.4	0.4	1.0	10.9	0.4	0.4	14.8	3.7	0.6	7.5	3.3	10.6	6.2	5.6	7.7	7.0	9.6	0.4	0.4	7.5	4.6	11.3	12.9	0.4	0.4	5.0	1.5	3.8	2.8	7.4	1.3	14.8	2.9	24.7	3.4	4.3	3.7	2.3	5.2	10.5	1.0	1.9	3.5	3.1	0.3	1.4	4.9	7.7	13.0	11.5	27.2	0.9	0.1	6.0	0.5	0.4	8.9	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.5	0.7	0.0	0.2	0.0	0.9	0.6	0.3	0.0	0.2	0.2	0.1	2.4	0.4	0.0	0.1	8.9	8.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	0.3	0.0	5.1	0.0	0.0	3.3	0.0	2.0	2.5	0.0	0.0	1.8	0.0	2.4	0.0	0.0	0.9	42.8	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.5	0.2	0.0	0.0	14.1	0.0	0.0	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.0	3.4	0.0	0.0	0.0
C1orf112	FLJ10706	ENSG00000000460	"Chromosome 1 open reading frame 112"	Q9NSG2	1	169662007-169854080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 27.7;Spermatogonia: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023778, HPA024451"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023778: AB_1848665, HPA024451: AB_1848667"	"unprognostic (4.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.65e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	3.4	3.1	3.3	7.4	4.9	10.1	5.0	8.4	3.6	5.2	3.2	5.0	2.2	1.5	4.8	3.5	4.0	2.2	1.8	2.3	2.7	2.4	2.6	5.2	2.6	7.4	5.0	1.5	3.3	2.6	20.1	3.7	4.2	4.5	3.2	5.3	4.9	3.3	4.9	1.9	3.1	3.3	3.6	3.6	4.2	3.0	19.7	5.9	24.6	3.2	2.9	9.5	4.0	3.3	2.9	2.7	4.3	4.9	4.9	1.6	1.6	16.5	8.9	11.7	6.0	1.9	2.6	17.3	11.0	5.7	16.2	16.5	9.9	14.6	14.8	5.0	3.6	5.7	13.6	14.6	7.7	18.6	8.7	8.6	14.0	12.0	7.2	0.6	18.2	6.2	0.8	1.1	12.0	2.9	1.9	6.8	9.1	22.5	25.3	13.1	4.0	15.8	5.1	15.4	11.8	6.4	12.0	13.1	10.0	2.2	8.4	8.6	9.0	6.9	11.6	3.6	11.6	11.0	9.5	4.9	13.1	10.4	9.5	14.9	6.9	10.3	15.7	4.9	13.6	12.6	4.3	1.8	2.2	1.3	4.5	1.0	2.9	1.6	1.4	2.7	2.8	0.6	1.4	0.3	4.9	4.9	0.7	1.6	1.6	3.3	4.9	8.4	3.6	2.7	2.4	5.0	1.5	4.5	5.9	0.0	3.5	2.2	2.6	1.5	3.8	0.4	0.0	2.7	1.2	0.0	5.9	6.0	0.0	2.3	5.9	2.1	0.9	0.0	3.0	7.4	2.3	0.8	4.6	3.0	5.0	1.6	0.0	4.3	3.1	3.1	2.0	3.0	3.3	1.0	1.0	2.6	2.5	0.0	3.5	0.4	6.5	6.5	1.2	27.7	17.7	0.9	3.2	1.9	1.6	1.4
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690667-169711698	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 227.5;lymphoid tissue: 77.8"	"Group enriched"	"Detected in many"	6	"B-cells: 178.5;Kupffer cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		NA	NA		8100000000	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favorable (3.76e-4)"	"prognostic favorable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	6.9	0.9	2.0	25.1	4.6	30.3	1.5	1.1	2.5	0.9	1.4	1.1	0.0	0.4	1.0	1.1	4.2	3.2	5.4	4.1	2.5	2.2	2.3	2.5	11.4	77.8	5.2	0.2	0.8	1.0	10.7	7.9	3.4	2.7	1.2	1.3	3.8	12.1	0.1	0.9	0.8	8.8	2.9	5.2	67.7	1.7	1.0	2.3	43.8	1.9	1.3	64.0	8.1	6.1	40.4	40.7	227.5	49.7	130.8	69.5	90.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	7.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.8	0.8	0.3	0.0	0.0	0.0	0.0	1.2	18.6	0.0	0.9	0.0	0.8	12.8	0.1	0.0	0.2	0.2	4.9	0.1	0.3	3.9	0.2	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	24.1	0.0	11.2	1.3	7.0	0.1	170.8	49.7	88.6	16.5	11.2	4.5	33.8	30.7	17.0	40.7	40.4	69.5	39.6	227.5	130.8	4.5	32.8	52.7	90.1	2.0	4.6	1.1	2.5	2.5	2.2	5.2	0.2	2.7	2.3	8.9	20.2	178.5	0.3	0.3	0.0	0.3	2.5	2.7	3.4	10.4	0.0	9.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.6	0.8	0.0	9.3	0.4	5.6	0.0	0.0	1.8	97.5	0.0	0.6	7.5	1.7	0.0	0.0	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	23.8	20.3	0.0	0.5
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722641-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 50.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 41.0;Endothelial cells: 101.9;Melanocytes: 43.9;Suprabasal keratinocytes: 41.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HUVEC TERT2: 5.3"	"Not detected"	"Not detected"							CAB002143	Enhanced					NA	NA	8140000	640000000			"CAB002143: AB_563608"	"unprognostic (2.39e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	14.9	2.7	0.9	30.4	1.2	0.2	8.3	0.3	1.0	13.7	2.7	1.9	4.4	0.4	18.1	3.2	6.7	20.1	7.4	4.4	0.9	0.9	2.5	4.9	10.6	2.0	1.2	0.0	9.8	1.4	21.0	3.1	0.9	5.4	21.2	1.9	4.3	2.0	4.6	2.2	3.7	2.4	13.1	4.8	0.2	3.4	5.6	0.5	0.9	9.0	50.0	15.5	16.4	4.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.9	1.2	0.3	1.0	0.9	0.9	1.2	0.0	5.4	0.5	0.0	6.7	0.0	1.0	41.0	0.0	5.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	101.9	0.0	0.0	0.0	0.0	12.4	3.2	1.1	5.9	0.0	0.0	0.0	1.8	0.0	1.6	0.0	0.2	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.0	41.8	0.0	0.0	0.0	0.6
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794966	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.28e-4)"	8.7	7.3	12.1	9.9	9.0	3.8	11.5	13.5	11.8	6.5	6.8	3.5	8.4	5.6	7.7	9.8	7.8	8.2	5.2	10.2	8.5	6.8	8.6	8.5	5.9	16.5	11.1	10.1	10.4	9.4	31.9	9.4	6.3	9.2	11.2	6.8	3.4	8.4	7.5	5.0	6.5	9.2	6.3	12.7	14.3	8.2	6.7	11.2	9.8	10.0	8.0	11.8	7.8	8.9	13.4	5.4	12.2	5.8	12.4	19.3	9.8	9.0	5.2	8.5	5.8	5.0	9.3	5.9	4.2	4.9	5.4	4.7	6.6	14.7	15.4	11.8	5.6	7.9	10.4	8.5	9.6	7.3	9.2	6.8	11.0	4.7	5.4	10.3	11.6	5.1	4.2	10.1	5.5	6.0	5.5	10.3	11.9	11.6	7.3	7.2	4.4	12.2	7.9	10.7	19.5	13.1	9.1	8.4	11.6	8.7	9.1	6.3	9.7	9.0	10.2	12.4	13.2	13.5	12.8	4.6	6.8	6.5	6.8	9.8	14.3	18.6	20.8	5.0	9.3	6.8	9.3	5.2	12.2	14.6	5.8	18.5	12.1	16.3	17.0	5.4	13.4	19.3	18.3	3.0	12.4	3.4	4.2	18.4	9.8	12.1	9.0	13.5	11.8	8.5	6.8	11.1	10.1	9.2	11.2	3.0	5.8	1.5	5.6	1.3	7.5	5.3	5.1	13.4	5.7	5.2	0.0	11.5	21.6	9.3	13.7	7.8	3.9	0.0	6.9	4.9	5.6	3.4	6.9	2.6	6.5	6.4	2.9	2.5	4.7	3.6	5.8	2.8	5.0	1.0	4.9	8.5	5.3	5.8	4.9	7.0	6.1	0.0	2.8	14.4	9.4	0.6	9.6	10.0	4.9	2.1
SCYL3	"PACE-1, PACE1"	ENSG00000000457	"SCY1 like pseudokinase 3"	Q8IZE3	1	169849631-169894267	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005624	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			Microtubules	"Nuclear bodies"	"HPA005624: AB_1854916"	"unprognostic (2.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.54e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (8.85e-4)"	10.8	11.4	8.5	15.4	10.6	5.0	15.8	10.5	11.9	12.1	14.6	11.0	14.6	10.7	12.6	14.0	14.4	10.6	11.0	7.8	7.3	6.5	12.1	18.0	11.8	13.7	9.3	7.8	13.0	12.8	22.7	14.4	15.8	9.5	13.2	13.9	12.3	15.5	13.8	14.6	14.1	14.9	13.0	7.3	12.6	11.3	9.1	8.9	17.2	13.3	9.5	16.0	16.0	12.7	8.3	13.6	12.3	4.3	11.8	10.5	5.9	3.4	4.5	7.0	4.8	9.0	6.5	8.0	5.4	7.1	6.3	6.0	4.1	6.7	7.1	4.0	5.6	3.5	8.1	4.1	4.8	5.7	13.1	3.8	4.9	5.0	2.6	6.4	7.1	6.4	6.3	4.8	4.4	6.1	6.0	6.0	8.0	7.8	9.5	6.0	2.7	5.7	5.5	5.6	23.5	2.2	5.3	3.8	8.5	6.7	6.3	5.2	7.6	4.3	14.3	8.5	10.3	8.0	6.6	4.4	4.6	3.0	5.4	4.3	12.8	11.3	8.5	3.4	5.4	5.0	12.3	3.7	9.7	8.0	3.9	10.5	8.3	10.4	8.7	6.0	7.3	9.2	7.5	8.2	11.8	4.3	13.6	9.5	5.9	8.5	10.6	10.5	11.9	7.3	6.5	9.3	7.8	9.5	8.9	6.0	11.8	5.2	1.7	2.2	9.6	3.4	22.9	2.7	9.1	1.8	9.8	14.5	8.3	5.3	2.9	5.8	10.8	0.0	8.0	4.3	4.3	3.7	5.7	8.6	5.5	9.5	8.7	7.4	10.8	1.5	4.0	5.3	1.7	7.2	12.7	8.9	5.8	10.5	5.3	4.9	17.6	6.5	4.1	7.2	6.4	1.6	9.7	10.2	9.9	2.3
KIFAP3	"FLA3, KAP-1, KAP3, SMAP"	ENSG00000075945	"Kinesin associated protein 3"	Q92845	1	169921326-170085208	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 130.0;Late spermatids: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023738, HPA023742"	Supported					NA	NA					"HPA023738: AB_1857285, HPA023742: AB_1857286"	"unprognostic (5.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.17e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.22e-2)"	11.4	25.0	21.7	7.8	28.8	4.1	11.6	24.2	49.1	14.1	13.5	12.3	6.7	8.0	12.3	16.9	9.0	13.8	10.8	34.1	25.6	27.2	16.5	11.3	10.6	9.2	19.3	26.8	14.1	9.3	20.1	16.4	10.0	40.6	10.5	11.2	8.3	9.1	12.0	15.3	8.9	9.7	11.0	18.0	7.1	6.9	22.8	10.6	9.3	11.8	6.8	9.3	8.8	11.4	6.1	6.8	12.4	13.7	17.1	13.9	6.5	6.1	5.7	8.6	9.3	20.6	21.9	4.9	7.8	9.7	9.8	12.0	2.8	9.9	11.0	11.5	15.9	4.5	13.4	18.3	10.9	9.2	23.2	9.6	26.7	7.0	2.5	10.3	7.8	4.6	15.4	15.0	17.1	15.0	11.6	10.9	14.3	22.2	8.4	12.1	1.6	14.5	4.6	1.9	16.0	5.2	5.8	7.6	6.9	18.4	2.3	10.3	15.9	10.7	8.8	11.6	20.9	8.1	4.9	11.6	21.0	4.8	13.1	9.2	16.3	11.0	10.2	9.7	2.8	13.3	12.4	3.0	10.9	10.9	8.1	12.3	6.1	11.0	12.3	6.8	5.9	12.7	13.0	1.1	17.1	13.7	6.0	13.9	6.5	21.7	28.8	24.2	49.1	25.6	27.2	19.3	26.8	40.6	10.6	29.8	26.7	8.0	10.1	8.0	54.0	28.3	35.7	85.6	38.7	27.9	41.2	11.6	8.3	19.7	130.0	15.7	15.4	0.0	7.1	13.6	12.9	5.3	30.1	11.9	8.4	46.1	30.9	11.1	8.3	146.6	35.6	7.6	10.1	10.0	11.2	40.1	10.2	8.6	20.5	25.1	59.6	0.0	21.7	68.7	58.5	9.4	7.3	20.0	13.3	9.6
METTL11B	"C1orf184, HOMT1B"	ENSG00000203740	"Methyltransferase like 11B"	Q5VVY1	1	170146001-170167790	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"heart muscle: 7.0;skeletal muscle: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NTERA-2: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028049	Uncertain					NA	NA					"HPA028049: AB_10610139"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.62e-2)"		"unprognostic (7.59e-2)"	"unprognostic (7.25e-2)"		"unprognostic (1.19e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.76e-3)"			"unprognostic (5.43e-2)"	"unprognostic (4.56e-1)"		"unprognostic (5.79e-4)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	7.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.9	9.6	6.3	7.8	12.1	6.9	7.2	3.2	8.8	7.5	9.0	7.9	4.5	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.7	6.6	5.1	8.3	4.5	7.4	6.9	8.6	5.4	4.3	6.8	3.7	7.3	1.2	9.5	6.0	8.5	11.6	6.3	5.7	6.4	10.0	6.2	3.8	2.5	5.3	6.5	7.9	18.2	6.4	5.0	11.7	6.9	11.0	5.8	4.3	10.8	6.7	7.3	6.6	9.2	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3	0.0	10.7	6.0	2.9	2.5	3.9	6.7	7.6	1.4	6.8	5.2	2.0	5.2	3.3	9.4	1.6	7.4	5.1	0.0	5.3	5.6	10.4	4.1	12.8	5.8	6.3	4.8	0.0	3.7	6.3	2.6	13.0	3.9	3.3	10.0	6.4	3.4	5.8	7.0	6.0	4.4	7.2	6.5	8.5	13.1	7.7	1.4	4.7	5.7	6.0	2.7
PRRX1	"PHOX1, PMX1"	ENSG00000116132	"Paired related homeobox 1"	P54821	1	170662728-170739419	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 327.5;Late spermatids: 303.2;Leydig cells: 237.3;Peritubular cells: 98.3;Smooth muscle cells: 139.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 73.9;ASC TERT1: 59.0;BJ: 20.9;BJ hTERT+: 41.3;HSkMC: 30.1;U-138 MG: 29.0;U-2197: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051084, HPA063566"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051084: AB_2681338, HPA063566: AB_2732702"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (6.60e-10)"	"unprognostic (4.23e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.69e-3)"	44.8	4.4	5.2	7.2	6.3	0.0	21.0	4.0	9.2	58.5	4.1	6.7	10.6	0.4	31.4	19.4	10.8	17.9	14.5	19.5	6.8	4.5	1.8	0.7	10.4	13.0	6.1	5.3	27.6	1.9	3.4	3.1	2.7	7.7	17.3	2.5	17.4	18.4	34.1	58.6	11.9	2.2	23.0	6.6	1.0	2.3	17.6	6.8	5.0	21.7	28.7	14.9	19.4	31.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	73.9	59.0	0.0	20.9	41.3	2.9	2.9	0.0	0.0	0.0	0.0	17.2	0.0	0.0	3.6	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	30.1	0.0	14.4	0.0	5.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	29.0	0.5	27.6	3.2	0.0	0.0	0.0	15.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.2	6.3	4.0	3.9	6.8	4.5	6.1	5.3	7.7	6.8	0.0	0.3	0.0	0.4	14.4	0.0	29.7	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.9	327.5	6.4	0.0	0.0	0.2	0.2	42.1	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	303.2	237.3	3.9	13.5	0.0	0.0	0.3	0.9	0.0	98.3	0.0	0.1	51.8	139.5	6.0	1.4	10.3	0.1	0.0	0.0	1.3
MROH9	"ARMC11, C1orf129, FLJ23550"	ENSG00000117501	"Maestro heat like repeat family member 9"	Q5TGP6	1	170935471-171064765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.1;testis: 4.7"	"Cell type enhanced"	"Detected in some"	27	"Ciliated cells: 17.4;Club cells: 4.5;Early spermatids: 2.7;granulocytes: 3.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"pons and medulla: 1.9"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in some"		"BJ: 1.3;BJ hTERT+: 1.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;Daudi: 2.2;SK-MEL-30: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (1.04e-1)"		"unprognostic (7.94e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.73e-2)"		"unprognostic (7.62e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.07e-5)"		"unprognostic (3.66e-8)"	"unprognostic (5.96e-2)"				0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	7.1	0.1	0.1	0.1	0.0	0.1	0.1	2.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	1.0	0.7	1.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.4	4.5	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
FMO3		ENSG00000007933	"Flavin containing monooxygenase 3"	P31513	1	171090877-171117819	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 170.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 378.8"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 25.4;ASC TERT1: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA					"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	9.5	2.0	0.0	0.8	0.2	0.0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0.0	0.1	6.4	170.2	3.7	1.5	0.2	0.0	0.9	0.7	0.3	2.7	0.0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0.0	0.8	1.2	2.6	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	5.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.1	11.9	0.3	0.9	0.3	0.3	0.0	0.3	5.1	32.1	27.3	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	378.8	0.0	0.0	0.0	4.9	6.9	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	6.5	3.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0
FMO2		ENSG00000094963	"Flavin containing monooxygenase 2"	Q99518	1	171185208-171211230	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;esophagus: 35.3;lung: 53.0"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 428.8;Club cells: 348.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	57	"ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028261	Approved					NA	NA					"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	40.0	11.8	1.2	1.7	4.4	0.0	22.5	1.5	0.6	7.6	5.0	0.6	2.9	0.3	1.9	3.5	35.3	6.7	2.0	17.4	1.8	1.2	9.4	1.8	53.0	5.7	3.9	1.2	6.1	2.1	1.8	7.0	0.0	2.4	6.0	0.7	8.3	14.0	1.3	7.6	1.7	1.5	2.5	1.9	0.4	2.4	3.3	1.3	0.4	5.8	6.8	5.5	5.0	10.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	29.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	4.4	1.5	0.6	1.8	1.2	3.9	1.2	2.4	1.3	428.8	20.8	0.0	5.3	0.3	0.2	6.9	0.0	62.9	348.1	1.8	0.0	0.0	0.0	0.0	2.7	5.3	0.0	0.0	0.0	0.0	0.6	3.0	3.5	0.0	0.0	0.0	0.0	4.3	0.0	2.3	0.9	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.4	0.2	0.0	3.4	0.3	0.0	0.0	0.0	0.0	0.0	1.1
FMO1		ENSG00000010932	"Flavin containing monooxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 70.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 142.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	36	"naive B-cell: 3.5"	"Lineage enriched"	"Detected in single"	36	"B-cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA078132	Approved					NA	NA					"HPA078132: "	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	3.4	3.6	0.1	0.1	0.3	0.0	5.6	0.1	0.4	5.6	0.8	0.3	0.8	0.0	2.5	3.0	5.0	3.3	1.8	0.9	0.1	0.0	70.4	1.0	0.8	0.1	0.1	0.1	5.9	2.4	0.1	1.1	0.8	0.2	1.1	0.0	4.0	4.2	1.5	0.1	4.0	14.4	1.5	0.1	0.1	0.5	1.6	0.1	1.8	1.7	5.3	10.3	1.4	1.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.4	2.9	0.0	8.7	5.1	0.0	0.0	3.5	0.0	0.2	11.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	10.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	2.5	142.2	0.0	6.5	1.4	0.0	0.0	1.9	0.7	0.0	0.0	0.0
FMO4	FMO2	ENSG00000076258	"Flavin containing monooxygenase 4"	P31512	1	171314208-171342084	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 33.8;liver: 42.2"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.9;HSkMC: 9.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	5.3	3.6	1.4	5.1	4.8	0.9	4.5	0.6	2.7	4.5	6.0	4.8	3.1	4.2	3.0	10.0	4.6	3.8	4.6	6.3	2.3	1.5	33.8	42.2	3.4	2.8	7.5	2.8	4.1	3.2	5.5	5.0	2.3	3.7	3.9	3.7	6.7	2.7	2.0	1.6	2.9	16.1	2.0	7.0	3.8	3.9	2.0	6.2	2.7	4.5	3.3	3.4	2.9	3.7	5.3	2.9	0.9	4.0	3.9	4.9	2.0	0.1	0.0	0.4	0.6	5.5	5.0	0.2	1.1	5.0	1.6	1.7	0.8	7.2	4.4	7.9	0.0	2.6	0.3	0.8	1.3	2.2	2.1	1.1	0.0	0.0	0.1	0.8	0.9	1.0	9.3	3.2	0.6	1.3	0.6	0.3	2.2	0.2	3.3	0.7	1.0	2.1	1.9	0.5	1.3	1.6	0.4	0.5	2.5	3.5	0.0	0.2	0.0	1.5	1.5	3.0	5.7	3.1	1.3	0.1	1.3	0.4	1.4	1.0	4.0	1.3	2.7	2.4	1.5	1.1	0.6	2.6	0.9	2.5	4.0	1.8	3.1	2.4	3.3	2.2	5.3	3.3	2.5	0.5	3.9	2.7	2.9	4.9	2.0	1.4	4.8	0.6	2.7	2.3	1.5	7.5	2.8	3.7	6.2	0.0	1.6	0.5	3.8	2.5	0.0	3.5	2.5	6.7	0.0	8.7	0.0	2.1	24.9	1.6	4.0	0.9	8.6	0.0	1.2	1.2	3.1	1.1	1.1	19.8	3.2	0.0	1.2	1.8	5.7	0.4	1.4	2.3	5.0	1.8	1.9	1.5	0.9	0.0	0.4	33.2	0.0	0.0	1.2	0.2	0.2	1.4	1.6	0.5	1.4	1.7
PRRC2C	"BAT2D1, BAT2L2, KIAA1096, XTP2"	ENSG00000117523	"Proline rich coiled-coil 2C"	Q9Y520	1	171485551-171593511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025766, HPA028659"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA025766: AB_1845277, HPA028659: AB_10600786"	"unprognostic (4.16e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.71e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (7.03e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.34e-2)"	33.1	21.2	32.9	40.1	35.7	61.2	32.6	44.3	37.0	35.1	26.0	19.8	41.4	21.2	32.9	38.8	37.3	28.5	26.3	23.5	27.4	25.4	25.5	30.2	35.2	39.8	33.8	30.2	37.3	29.6	47.2	43.7	35.9	30.6	28.7	32.4	18.2	31.4	53.9	24.5	38.5	33.2	32.9	36.7	37.3	27.6	27.3	36.9	45.3	29.5	30.3	41.1	35.3	33.8	4.8	4.4	7.5	2.9	5.8	3.0	1.0	26.6	20.7	29.0	19.1	20.6	24.0	21.5	15.4	22.0	18.1	16.6	31.6	19.1	39.3	24.3	22.5	14.7	23.9	31.4	24.5	28.0	22.1	16.7	29.9	16.0	22.0	21.4	48.3	24.4	23.1	18.9	30.6	45.8	16.4	26.3	21.6	39.3	21.8	20.5	12.7	28.8	20.5	38.3	21.4	36.0	21.8	21.6	19.2	25.6	29.9	18.8	19.3	23.4	28.0	17.8	40.1	19.0	34.0	32.7	20.6	19.0	19.9	31.9	18.3	19.5	57.8	13.1	23.9	18.4	3.4	2.9	1.5	2.9	2.7	3.0	3.7	2.8	2.8	1.2	4.8	2.6	3.0	7.5	5.8	2.8	4.4	2.1	1.0	32.9	35.7	44.3	37.0	27.4	25.4	33.8	30.2	30.6	36.9	276.9	218.4	153.4	214.3	148.4	154.9	94.9	127.4	184.7	273.0	82.0	131.6	168.2	21.6	138.0	25.6	177.6	134.0	46.7	131.7	178.0	148.4	210.4	252.2	99.5	112.3	130.3	158.3	113.5	118.5	20.7	128.9	166.9	91.1	219.2	79.1	116.7	164.6	91.2	90.5	36.1	164.3	77.6	114.7	173.0	161.2	127.5	398.8	179.9	89.0	320.3
MYOCOS		ENSG00000283683	"Myocilin opposite strand"	A0A1B0GUC4	1	171600621-171638799	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;epididymis: 4.8;fallopian tube: 3.9"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 1: 3.0;Club cells: 1.2;Proximal tubular cells: 2.2"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HEL: 24.6"															NA	NA																							0.0	0.0		0.0		0.1	0.0		0.0	8.1	0.0			0.0	1.3	4.8	0.0	3.9	0.0	0.0			1.1	0.0	0.0	0.0			0.0	0.4	0.0		0.1		0.0	0.0		0.0	0.8	0.1	0.0	0.0	0.0		0.0	0.1	1.1			0.8		0.0	0.3		0.9	0.6	1.6	0.3	0.1	1.3	0.0	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	24.6	0.4	0.4	0.1	0.1	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.3	0.4	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.1	0.9	1.8	0.2	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.6	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.2	0.3	0.2	1.0	0.9	0.4	1.1	0.1	0.9	0.5	0.4	1.6	0.1	0.0	0.6	1.3	0.0											3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652683	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 100.8"	"Cell type enriched"	"Detected in some"	4	"Peritubular cells: 35.3"	"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027364	Uncertain				"Secreted to extracellular matrix"	NA	NA		12000000			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	26.9	0.8	0.0	0.5	0.0	0.0	8.4	0.0	0.0	5.4	6.0	0.0	5.3	2.4	8.1	7.6	40.7	7.4	8.3	12.6	0.1	0.0	0.2	0.1	3.7	0.0	0.0	0.0	3.9	2.1	0.2	0.1	0.1	0.2	9.0	2.5	100.8	10.5	4.8	21.7	2.4	2.6	39.4	0.3	0.1	29.9	2.8	0.0	0.6	14.9	28.2	5.0	26.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0
VAMP4		ENSG00000117533	"Vesicle associated membrane protein 4"	O75379	1	171700160-171742247	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050418	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050418: AB_2681121"	"unprognostic (9.38e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (5.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.15e-1)"	16.0	20.1	14.3	13.0	25.3	7.3	14.1	24.3	22.9	13.2	12.3	12.7	15.6	12.3	13.9	14.4	13.8	10.9	13.2	12.1	16.1	16.1	13.1	13.0	16.3	16.0	16.0	21.6	11.7	15.7	19.8	30.3	16.0	26.8	12.2	11.6	17.2	15.5	20.6	9.0	15.4	12.1	12.9	20.6	14.9	13.3	18.3	15.3	13.2	18.5	7.5	13.0	14.2	13.7	9.5	7.3	12.8	10.4	10.4	14.6	10.8	6.7	2.2	6.1	4.9	9.2	10.9	3.9	12.4	9.9	3.1	3.9	1.9	9.1	4.3	11.2	10.0	4.7	4.6	2.4	4.1	4.5	7.6	3.6	3.6	3.0	1.6	5.6	3.1	2.8	4.9	7.3	3.8	7.3	8.9	5.7	5.9	8.8	5.3	6.6	2.3	7.4	4.3	2.9	13.2	8.7	6.3	4.7	11.1	6.5	2.2	3.7	7.1	6.2	6.6	5.2	7.0	9.0	5.9	6.6	9.8	3.3	13.8	11.8	19.4	16.1	5.8	15.0	2.8	7.7	10.0	10.4	12.8	10.5	8.4	14.6	9.5	14.2	12.0	4.9	7.6	10.2	10.9	3.8	10.4	8.3	7.3	12.4	10.8	14.3	25.3	24.3	22.6	16.1	16.1	16.0	21.6	26.8	15.3	20.8	9.4	6.5	12.4	13.7	11.3	10.7	7.6	9.4	9.1	3.5	21.6	9.7	13.3	7.2	21.1	18.0	10.3	0.0	6.7	12.0	18.5	15.5	24.3	12.9	13.6	9.5	9.8	14.7	13.3	31.4	8.6	10.6	11.8	9.0	12.2	13.4	8.5	14.4	12.4	11.1	8.5	19.4	12.9	28.6	17.6	15.2	11.2	20.3	6.9	12.8
METTL13	"CGI-01, KIAA0859"	ENSG00000010165	"Methyltransferase like 13"	Q8N6R0	1	171781664-171814023	"Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044498, HPA053705"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044498: AB_10960884, HPA053705: AB_2682235"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.12e-1)"	"unprognostic (6.86e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.13e-1)"	13.0	20.7	18.3	13.3	17.8	9.0	14.7	19.0	21.8	14.6	13.6	14.7	13.6	15.1	16.5	24.8	14.9	16.2	11.2	11.7	14.1	10.9	13.2	16.9	15.1	15.9	16.3	17.9	15.3	16.0	14.0	11.0	11.4	14.7	12.6	15.1	11.7	19.2	14.5	18.4	14.2	14.0	15.4	11.4	16.8	14.7	18.9	16.2	16.3	13.1	9.4	17.7	13.7	12.6	10.2	10.0	3.2	8.7	11.5	12.0	7.8	11.8	28.2	7.4	7.8	10.8	9.9	20.5	15.0	11.8	18.2	14.2	21.2	12.3	21.9	18.0	10.4	11.9	12.2	23.1	12.0	14.3	14.0	13.2	15.1	14.6	9.3	8.0	19.8	15.4	8.6	11.2	18.9	8.3	8.3	10.8	11.9	30.2	7.5	13.8	9.0	15.8	13.6	29.0	23.9	38.2	14.6	10.0	20.0	10.5	12.2	12.5	17.1	11.1	25.8	13.7	19.5	18.8	17.6	8.9	12.3	11.3	12.4	17.6	19.5	21.8	25.2	9.3	13.8	10.9	1.8	8.7	3.2	9.9	8.5	11.5	10.2	9.9	8.4	8.6	8.0	9.1	12.0	2.6	11.5	7.4	10.0	7.4	7.8	18.3	17.8	19.0	21.8	14.1	10.9	16.3	17.9	14.7	16.2	8.9	3.2	7.7	6.4	7.6	7.2	7.5	20.4	6.7	5.7	3.5	5.9	14.0	10.0	17.2	33.4	10.5	9.8	0.0	13.4	20.0	7.6	8.6	9.2	11.6	15.1	4.8	10.4	11.6	14.9	8.4	9.2	8.5	3.3	12.6	11.5	8.1	16.0	7.0	7.4	10.9	6.9	12.9	7.2	4.7	14.5	7.9	8.0	7.2	11.1	7.5
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 19.5;Cone photoreceptor cells: 27.5;Endothelial cells: 14.6;Rod photoreceptor cells: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.2;HMC-1: 8.5;RPTEC TERT1: 15.7;U-251 MG: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	5.0	19.3	14.1	2.3	28.3	2.6	3.4	41.4	39.7	6.8	2.7	26.8	0.0	1.9	5.9	3.1	3.0	6.0	5.1	3.0	14.3	16.3	5.8	1.4	7.5	2.5	19.6	17.7	4.6	2.6	3.5	10.3	1.6	47.3	3.6	2.7	2.9	3.7	3.6	2.5	4.0	2.4	5.7	16.4	3.6	5.3	5.4	22.1	0.0	3.4	0.0	2.2	4.3	3.6	0.7	0.7	1.1	0.4	1.0	4.0	3.8	0.6	2.0	1.6	0.3	1.2	0.8	0.0	0.4	1.0	0.8	1.0	0.0	3.0	0.0	6.3	0.9	1.0	0.2	1.2	2.3	0.7	0.8	2.4	18.2	3.0	0.0	0.1	0.3	8.5	0.6	0.4	1.0	0.5	0.9	0.4	1.6	0.0	0.3	0.3	0.0	1.1	0.1	4.7	7.5	1.4	1.2	8.2	0.0	15.7	0.1	3.2	0.6	2.2	0.6	0.2	0.6	0.0	0.7	0.2	2.3	3.2	1.9	11.3	3.1	0.5	0.1	2.2	0.9	0.8	0.0	0.4	0.0	0.7	0.0	0.9	0.7	1.0	0.5	0.7	0.0	1.2	1.5	1.1	1.0	0.3	0.0	4.0	3.8	14.1	28.3	41.4	31.6	14.3	16.3	19.6	17.7	47.3	22.1	0.0	5.0	0.0	1.2	2.2	19.5	2.1	0.0	1.4	0.0	0.0	27.5	0.0	3.3	0.3	6.5	14.6	0.0	0.0	0.3	0.1	3.3	0.4	1.1	0.0	0.7	7.9	0.0	4.3	0.0	2.3	1.7	1.3	0.0	0.0	0.4	3.1	1.6	0.0	2.5	0.5	28.5	0.0	1.4	5.0	0.3	1.5	0.2	0.0	0.5	0.9
PIGC		ENSG00000135845	"Phosphatidylinositol glycan anchor biosynthesis class C"	Q92535	1	172370189-172444086	"Enzymes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036663	Uncertain					NA	NA					"HPA036663: AB_10669912"	"unprognostic (3.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (7.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-1)"	13.8	13.1	10.0	9.0	11.2	14.4	13.9	11.3	12.3	14.4	12.3	9.0	20.9	9.3	14.5	26.1	11.6	15.1	12.1	14.1	8.4	10.2	11.5	12.5	9.0	13.1	12.0	6.6	14.9	16.4	9.2	11.6	14.4	9.6	17.1	12.3	13.2	12.7	15.7	14.8	21.3	15.8	13.5	9.9	12.4	10.5	13.5	9.8	14.2	15.8	10.8	12.3	11.0	10.8	18.9	12.5	27.4	14.5	25.1	33.8	19.2	17.7	15.3	20.9	14.2	15.8	14.4	15.6	11.6	13.0	20.1	17.6	13.7	26.1	9.6	17.1	13.8	15.9	19.2	13.6	16.8	16.2	21.1	15.7	11.7	14.6	17.1	17.6	23.9	15.4	21.5	20.2	14.4	15.9	15.7	12.7	18.5	17.6	18.4	16.1	9.1	18.1	21.4	21.5	36.5	21.5	15.0	17.0	17.0	30.9	13.2	10.9	20.9	16.8	19.9	26.1	30.9	17.6	17.1	11.6	12.8	21.5	15.6	12.3	12.3	17.4	15.0	9.2	15.7	24.2	27.4	14.5	27.3	19.4	13.5	16.4	18.9	22.7	20.4	12.5	16.7	33.8	24.2	9.5	25.1	14.1	12.4	19.8	19.2	10.0	11.2	11.3	12.3	8.4	10.2	12.0	6.6	9.6	9.8	8.9	10.1	18.2	17.0	11.9	14.3	17.9	15.3	20.1	7.9	27.9	7.9	53.2	28.2	27.8	72.4	18.6	18.4	23.3	35.8	42.5	35.1	14.9	7.0	12.5	31.2	19.1	7.5	19.6	25.3	53.5	43.7	17.2	25.3	25.2	19.3	18.1	26.8	22.6	38.2	18.2	14.2	32.3	18.5	28.9	16.0	16.7	19.8	26.6	20.4	14.1
C1orf105		ENSG00000180999	"Chromosome 1 open reading frame 105"	O95561	1	172420688-172468831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 28.8;testis: 23.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 112.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enriched"	"Detected in some"	8	"BEWO: 25.0"	"Not detected"	"Not detected"													NA	NA						"unprognostic (2.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.27e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.47e-2)"		"unprognostic (8.22e-2)"	"unprognostic (1.92e-1)"		"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (3.85e-1)"		"unprognostic (1.94e-1)"	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	7.0	0.3	0.0	0.0	28.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.1	1.1	0.0	0.1	1.2	0.0	1.7	0.6	0.4	0.0	0.1	0.0	0.0	23.0	0.0	0.2	0.1	3.6	0.3	0.0	0.0	0.1	0.0	2.6	0.2	0.0	0.5	0.2	0.0	0.2	0.3	0.1	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.6	0.2	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.5	0.4	0.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	112.5	0.0	0.0	0.0	0.5	8.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	0.0	0.0	0.0	24.1	2.0	0.0	1.5	0.0	0.0	0.0
SUCO	"C1orf9, CH1, OPT, SLP1"	ENSG00000094975	"SUN domain containing ossification factor"	Q9UBS9	1	172532349-172611833	"Predicted membrane proteins"	Osteogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047251	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		14000	"Nucleoli fibrillar center, Cytosol"		"HPA047251: AB_2679999"	"unprognostic (1.28e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	"unprognostic (7.05e-2)"	8.8	9.2	8.0	6.2	9.8	43.4	9.0	7.9	8.4	8.9	7.6	6.5	48.6	6.1	8.1	39.5	8.3	9.9	7.3	8.0	7.6	8.3	11.2	8.0	6.4	5.5	7.5	5.1	13.4	24.7	16.9	24.7	18.2	8.7	9.0	5.9	9.4	13.0	52.5	2.8	8.7	22.9	6.1	8.8	7.1	8.0	14.3	8.0	11.1	11.0	6.0	7.1	10.7	9.1	9.5	7.7	11.3	6.7	10.4	8.9	4.6	13.9	6.3	18.3	16.3	9.4	9.1	20.7	17.0	10.0	10.8	13.3	11.2	15.0	7.0	10.3	9.7	11.1	22.1	7.8	6.7	18.7	4.0	5.6	5.5	3.9	6.8	11.0	8.7	7.9	8.1	6.8	13.3	11.0	33.7	9.3	8.1	3.5	10.0	16.2	3.3	5.8	6.0	16.6	16.1	14.7	5.9	10.6	4.5	16.8	19.6	9.9	12.7	7.8	13.6	14.9	32.9	13.4	9.6	12.2	9.8	10.4	9.4	17.3	15.2	12.2	12.7	9.5	4.6	15.4	9.4	6.6	11.3	8.6	6.0	8.3	8.3	7.8	7.2	5.4	9.5	8.7	8.9	6.1	10.4	6.7	7.7	5.6	4.6	8.0	9.8	7.9	8.4	7.6	8.3	7.5	5.1	8.7	8.0	44.7	22.8	15.2	31.2	23.4	41.5	21.5	7.6	32.1	46.6	26.2	47.1	30.1	3.3	13.2	28.0	22.2	15.8	23.3	27.4	21.5	20.9	37.1	12.8	13.9	11.7	44.5	25.3	11.6	10.8	39.6	42.3	14.1	25.3	16.2	24.1	65.0	22.9	7.0	26.5	11.8	49.4	25.8	15.3	44.7	24.5	23.6	41.3	20.3	9.9	30.9
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659018-172666874	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.6;lymphoid tissue: 13.4"	"Cell type enriched"	"Detected in some"	7	"T-cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 25.6"	"Group enriched"	"Detected in many"	12	"NK-cells: 16.0;T-cells: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;LHCN-M2: 2.5;NB-4: 1.2;RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600				"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.9	1.1	0.5	1.9	0.7	3.6	1.8	0.5	0.8	0.7	2.6	0.6	0.0	3.0	3.9	1.2	1.0	0.8	1.6	1.2	0.5	0.5	1.2	2.2	6.8	7.7	1.4	0.0	1.5	0.6	0.0	0.7	2.4	0.6	4.7	1.2	2.8	1.9	0.3	0.4	0.5	3.8	1.9	1.7	13.4	2.1	0.4	0.0	1.2	1.1	0.0	10.1	1.4	0.9	0.0	0.0	1.6	0.0	16.0	25.6	5.5	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.0	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.7	0.1	0.0	0.1	0.3	0.6	2.5	0.0	0.0	1.2	0.4	0.2	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.8	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	25.6	0.0	15.8	0.0	5.4	13.7	0.0	0.0	1.1	11.7	0.8	16.0	0.0	0.0	0.1	5.5	0.5	0.7	0.5	0.8	0.5	0.5	1.4	0.0	0.6	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	30.5	0.0	0.0
TNFSF18	"AITRL, hGITRL, TL6"	ENSG00000120337	"TNF superfamily member 18"	Q9UNG2	1	173039960-173050963	"Predicted membrane proteins"	"Adaptive immunity, Immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;tongue: 9.9"	"Cell type enriched"	"Detected in single"	8	"Hofbauer cells: 4.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hippocampal formation: 7.3"	"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"	"Group enriched"	"Detected in some"	11	"EFO-21: 21.0;HUVEC TERT2: 31.6;TIME: 43.8"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.78e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.71e-4)"	"unprognostic (8.42e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.74e-2)"	0.9	0.4	0.4	0.3	0.8	0.0	0.4	1.1	4.6	0.4	0.4	3.2	0.0	1.1	0.3	0.0	3.6	0.3	5.0	1.5	7.3	0.4	0.7	1.9	1.0	0.2	0.4	1.0	0.3	0.3	2.2	0.7	1.3	1.4	0.4	1.0	0.2	0.3	0.0	0.3	0.4	3.5	0.1	0.6	0.6	0.4	0.3	0.0	0.0	0.7	9.9	1.4	0.6	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.0	0.2	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	31.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.4	0.8	1.1	2.4	7.3	0.4	0.4	1.0	1.4	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
TNFSF4	"CD252, gp34, OX-40L, TXGP1"	ENSG00000117586	"TNF superfamily member 4"	P23510	1	173183734-173207313	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"		Cytokine	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.5;testis: 14.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;monocytes: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 18.7;HHSteC: 8.1;HUVEC TERT2: 36.8;LHCN-M2: 30.6"									HPA059579	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059579: AB_2684071"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-7)"	"unprognostic (3.73e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.98e-2)"	2.1	4.0	1.7	8.2	2.3	0.9	3.7	4.5	3.4	1.7	1.8	1.0	0.8	0.3	1.5	1.5	1.6	1.4	2.1	2.1	3.0	2.0	1.5	1.6	2.5	11.5	1.9	0.8	2.7	2.1	1.0	3.3	1.2	1.2	2.8	2.5	1.0	0.8	1.0	0.8	0.3	2.5	1.6	1.9	9.7	1.4	14.4	1.2	9.3	0.8	0.8	3.7	1.6	1.6	1.3	2.6	1.7	0.2	3.4	1.2	6.5	0.0	0.0	0.2	0.5	1.3	6.7	0.0	1.8	0.4	0.1	0.1	0.0	0.0	0.0	0.3	18.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	8.1	0.1	0.0	2.9	0.1	0.9	0.1	0.6	36.8	0.7	0.0	0.2	30.6	0.0	0.3	0.1	0.1	0.0	0.3	0.9	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.1	0.3	0.6	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.4	0.6	0.1	0.1	3.4	2.0	0.0	0.2	0.3	1.1	0.1	0.8	1.1	0.7	0.9	0.8	1.3	1.2	1.1	1.7	3.4	0.1	2.6	0.9	6.5	1.7	2.3	4.5	3.4	3.0	2.0	1.9	0.8	1.2	1.2	0.0	0.3	0.0	0.4	0.7	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.1	1.2	0.5	0.0	0.9	0.4	0.0	0.0	0.0	0.8	0.9	0.3	0.2	1.7	12.6	0.0	1.0	0.2	0.0	1.8	0.0	0.3	0.0	1.9	0.2	0.2	0.5	0.0	1.5	0.0	0.1
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	52.1	16.0	26.6	29.5	103.2	50.5	22.5	106.5	36.3	44.5	31.6	30.2	35.1	33.9	34.1	87.2	16.4	30.5	34.8	34.3	36.2	29.8	32.1	22.5	27.4	34.1	58.2	23.5	7.4	41.8	34.8	24.4	34.2	28.0	43.6	14.2	50.0	7.0	50.5	10.7	15.9	31.0	58.5	28.7	99.6	19.1	30.8	34.6	66.6	11.9	12.4	23.0	36.7	43.2	24.4	40.0	36.5	33.2	29.3	17.3	19.9	26.2	28.9	10.6	15.7	27.9	20.8	20.5	15.8	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1	163.8	131.5	140.0	350.9	209.2	31.5	477.5	249.7	195.4	161.5	263.5	27.5	589.1	729.5	163.2	193.0	183.6	264.7	256.9	175.5	640.5	290.3	337.6	341.6	875.0	302.1	42.9	136.4	174.3	152.8	441.3	315.2	140.2	173.7	230.0	253.4	390.8	159.2	306.9	391.7	634.8	41.0	181.1	254.2	113.1	58.3	231.0	805.7	161.9	278.6	280.8
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500464-173603094	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 24.9"	"Cell type enhanced"	"Detected in some"	13	"Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Group enriched"	"Detected in some"	4	"BEWO: 1.8;THP-1: 3.7"					"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.4	0.1	0.3	0.0	1.3	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.5	0.0	0.1	0.4	0.0	1.7	0.0	0.1	0.5	0.3	0.2	0.0	0.4	0.1	0.0	0.4	0.8	0.3	0.1	0.4	0.5	0.5	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.3	1.0	0.3	24.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	1.3	0.0	1.6	0.5	0.3	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.3	0.0	5.9	0.1	0.0	0.0	4.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.1	0.0	0.0	0.0
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 33.5;Cone photoreceptor cells: 35.3;Early spermatids: 19.6;Late spermatids: 9.9;Spermatocytes: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.5;GAMG: 4.1;HBF TERT88: 4.3;SH-SY5Y: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	12.0	0.0	0.0	1.0	2.1	0.1	4.2	3.8	6.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.8	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2	0.0	1.7	0.0	0.2	0.2	0.5	0.7	0.0	33.5	1.2	5.2	35.3	0.2	1.7	0.6	19.6	1.5	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	9.9	1.7	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.4	0.5	1.8	0.0	0.3	28.6	4.9	0.0	0.1	0.0	0.0	0.1
TEX50		ENSG00000232113	"Testis expressed 50"	A0A1B0GTY4	1	173635333-173637134	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	176	"testis: 17.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"GAMG: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL20	"KHLHX, KLEIP"	ENSG00000076321	"Kelch like family member 20"	Q9Y2M5	1	173714941-173786702	"Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025034, HPA053704"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA025034: AB_1852578, HPA053704: AB_2682234"	"unprognostic (2.97e-3)"	"unprognostic (3.11e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.62e-2)"	18.2	14.5	10.4	12.5	15.1	6.9	15.4	18.8	18.0	17.9	16.1	14.3	17.3	9.1	21.9	13.0	14.4	14.2	13.9	15.2	11.6	10.3	15.1	21.7	13.6	12.0	13.3	10.5	18.0	9.7	12.3	20.6	15.4	16.2	18.8	12.7	11.5	11.3	15.4	17.1	12.9	16.0	18.8	14.8	16.4	11.0	20.7	15.2	20.7	13.3	14.7	13.6	14.3	14.8	6.2	7.1	9.7	5.0	4.7	9.5	3.3	8.3	5.3	8.5	8.8	20.0	18.6	7.0	13.2	12.9	10.2	10.8	3.8	5.8	5.9	11.3	14.1	5.4	8.4	7.5	9.5	12.0	7.2	4.1	5.4	7.3	4.5	12.9	10.0	6.3	15.7	11.0	9.4	12.7	11.9	14.9	6.0	11.9	6.8	18.6	3.0	5.8	5.2	9.0	7.4	24.4	6.3	10.5	6.3	7.8	5.3	3.6	10.1	12.0	8.2	7.8	12.1	7.3	11.8	14.8	9.9	5.9	12.0	10.3	9.1	4.7	9.0	6.4	7.3	10.9	9.7	4.5	6.3	7.3	5.0	6.5	5.9	7.2	8.7	4.3	6.2	9.5	9.1	2.5	4.7	3.5	7.1	8.1	3.3	10.4	15.1	18.8	18.0	11.6	10.3	13.3	10.5	16.2	15.2	14.9	20.4	12.6	7.8	9.8	11.7	8.5	17.8	4.0	9.1	12.2	35.3	11.0	1.7	8.7	93.8	14.9	10.2	0.0	10.5	8.4	16.1	6.1	7.0	13.4	9.6	11.1	9.2	43.6	19.3	24.0	20.8	8.9	3.3	3.6	9.4	15.0	8.8	10.5	26.9	11.3	19.2	0.0	15.5	53.5	31.7	9.3	8.2	13.4	8.1	6.7
CENPL	"C1orf155, dJ383J4.3, FLJ31044"	ENSG00000120334	"Centromere protein L"	Q8N0S6	1	173799550-173824720	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 29.5"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 70.0;Spermatocytes: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044520	Uncertain					NA	Yes					"HPA044520: AB_10794500"	"unprognostic (8.72e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.34e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.88e-3)"	"unprognostic (6.43e-6)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.60e-4)"	"unprognostic (1.78e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.46e-10)"	"unprognostic (2.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.09e-1)"	4.0	2.7	3.1	3.8	3.7	10.9	3.1	5.0	3.8	3.6	3.0	2.8	1.7	3.0	2.5	1.5	4.2	1.8	2.0	2.2	3.0	2.5	2.1	1.4	2.6	7.8	3.9	1.7	2.6	1.4	1.5	2.3	3.8	4.0	2.3	3.9	1.8	2.9	1.8	2.8	3.2	2.9	3.0	2.9	6.6	2.6	13.7	4.5	29.5	2.3	1.9	7.2	3.2	3.7	6.0	5.3	4.2	1.4	10.6	8.4	3.2	16.3	4.4	8.4	11.1	2.5	4.3	6.2	14.7	8.6	15.0	10.6	5.7	8.7	11.7	7.0	7.5	6.1	10.8	8.7	6.9	16.8	10.7	4.3	9.0	4.9	3.3	1.3	13.4	9.1	2.1	2.3	10.6	8.6	2.9	8.7	9.3	15.1	17.7	13.8	3.8	10.8	5.9	8.7	11.3	24.7	11.5	10.5	10.1	5.3	4.6	8.4	7.1	11.4	14.2	9.5	7.1	10.1	10.8	5.4	18.5	12.5	9.3	16.7	9.8	16.9	19.3	6.0	9.8	16.4	4.2	1.3	2.7	6.1	1.4	6.9	4.3	5.6	6.8	1.2	6.0	7.1	7.6	1.0	10.6	0.9	5.3	8.4	3.2	3.1	3.7	5.0	3.8	3.0	2.5	3.9	1.7	4.0	4.5	8.9	3.0	10.5	4.2	4.1	4.9	3.6	2.5	1.4	2.3	1.8	13.7	6.0	0.0	2.2	1.7	3.8	2.8	70.0	3.2	13.3	5.0	5.5	4.6	0.0	5.5	1.6	1.7	1.3	2.7	2.2	4.4	4.3	5.0	4.6	4.1	2.8	2.5	2.9	1.8	0.8	3.8	0.0	6.2	34.3	11.5	5.3	4.9	10.8	3.0	3.1
DARS2	FLJ10514	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824503-173858546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	17.0	22.2	6.3	10.1	8.1	5.4	9.0	7.5	8.6	7.8	15.1	6.7	8.3	11.7	10.4	6.1	13.4	6.4	5.9	11.2	5.5	6.0	21.9	14.8	8.2	11.0	6.4	4.2	9.5	14.9	18.1	15.3	10.9	10.0	8.5	16.6	10.2	10.2	6.2	10.6	6.0	16.1	6.2	9.0	11.4	11.3	8.4	6.9	26.1	12.2	6.3	12.5	9.7	8.1	9.3	9.0	4.8	10.7	5.0	9.3	5.2	29.0	19.4	12.1	7.5	9.2	13.1	15.5	12.8	10.6	18.5	14.2	18.2	26.1	15.7	17.5	10.2	12.2	29.8	33.4	21.6	25.3	17.9	16.4	13.6	9.7	12.6	9.0	11.5	12.4	9.5	9.9	18.7	19.1	5.9	18.4	11.9	27.5	12.4	15.4	8.0	14.6	6.5	23.4	32.5	17.4	17.2	15.4	28.9	16.8	9.7	15.9	14.5	14.0	31.3	20.2	19.0	32.8	15.2	8.1	9.5	15.0	13.1	20.4	9.7	24.5	18.2	5.5	12.7	20.5	4.4	7.0	4.8	6.6	10.7	9.3	9.3	7.2	5.8	9.0	7.3	7.7	4.8	0.7	5.0	7.4	3.7	5.1	5.2	6.3	8.1	7.5	8.6	5.5	6.0	6.4	4.2	10.0	6.9	3.0	1.9	4.3	3.6	1.5	2.2	10.5	7.6	1.4	3.4	5.2	0.0	7.3	6.6	3.9	1.9	3.2	4.5	23.3	2.3	13.0	3.4	2.3	5.7	4.3	8.9	3.2	4.1	1.3	3.5	1.0	2.8	5.0	1.7	6.4	5.0	2.4	3.6	0.0	1.4	6.4	2.7	0.0	2.3	5.7	6.4	1.4	3.5	2.9	6.0	2.5
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 49.0;Rod photoreceptor cells: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	6.4	4.0	6.9	6.5	9.8	11.1	5.8	6.4	7.9	5.3	4.0	11.2	3.7	4.0	9.1	5.5	3.4	4.6	4.7	5.6	7.2	3.7	5.3	4.8	6.0	7.7	9.9	5.2	7.6	4.5	6.8	9.2	4.7	7.8	5.3	3.9	10.6	4.6	4.9	4.0	7.0	5.2	6.8	9.5	7.9	5.1	18.4	8.8	7.7	6.1	2.8	6.3	4.8	5.5	1.8	2.4	6.0	1.0	2.3	2.8	0.8	2.4	3.7	5.6	2.4	3.5	2.8	6.2	2.2	1.6	4.0	2.9	4.6	3.1	6.6	4.7	3.4	2.1	3.1	4.8	2.4	3.4	3.7	3.0	9.1	3.9	2.2	2.1	5.3	5.8	2.5	1.7	6.0	4.0	2.5	2.0	4.7	8.0	4.4	4.2	1.8	3.6	1.4	5.4	1.8	0.9	2.4	5.0	2.2	2.2	6.1	4.2	5.3	3.1	4.3	4.4	6.2	6.2	5.6	3.6	5.3	5.7	2.6	3.5	8.0	5.9	10.6	3.5	3.0	3.2	0.4	1.0	3.4	2.8	1.0	1.2	0.7	1.3	2.0	0.6	1.8	0.7	1.8	6.0	2.3	1.0	2.4	1.0	0.8	6.9	9.8	6.4	7.9	7.2	3.7	9.9	5.2	7.8	8.8	6.0	4.6	11.9	3.1	2.6	26.9	8.4	12.7	9.4	2.3	10.4	31.4	6.8	6.6	2.8	40.4	5.2	3.9	0.0	3.3	3.4	4.3	4.2	2.3	4.3	4.2	17.5	3.4	13.5	15.1	49.0	8.1	7.6	10.1	2.8	3.6	11.9	2.5	3.5	12.4	4.4	67.3	6.5	6.2	17.6	13.3	5.1	7.7	12.9	3.3	2.7
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903804-173917378	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	203	"liver: 450.5"	"Cell type enriched"	"Detected in some"	54	"Hepatocytes: 2236.3"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	35	"Hep G2: 42.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		210000000000			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	450.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	42.6	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	14.0	0.0	0.0	0.0	0.1	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2236.3	0.2	0.0	0.0	37.4	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1
RC3H1	"KIAA2025, RNF198, roquin, RP5-1198E17.5"	ENSG00000135870	"Ring finger and CCCH-type domains 1"	Q5TC82	1	173931214-174022297	"Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027428, HPA027434, HPA027448"	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683"	"unprognostic (6.91e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.43e-3)"	"unprognostic (6.83e-3)"	10.4	7.8	11.8	8.0	10.3	32.6	10.6	26.7	14.0	9.9	10.3	12.3	8.3	6.9	10.9	8.4	11.8	9.4	8.1	9.0	11.9	7.4	8.1	11.2	11.3	8.8	10.4	7.1	10.8	9.8	10.2	14.6	9.1	12.4	8.7	8.6	13.3	9.0	7.6	19.1	14.0	10.6	8.4	9.3	13.6	9.1	9.7	9.0	15.2	9.9	7.7	13.6	8.4	9.8	2.8	1.6	10.4	3.9	2.3	2.7	1.1	7.3	10.2	5.7	8.8	10.8	8.4	7.8	5.0	7.2	5.8	5.1	9.4	8.2	10.4	9.0	8.1	4.5	7.1	8.5	7.1	8.2	7.2	2.1	9.0	7.6	7.8	6.6	11.7	10.5	8.0	5.5	8.4	5.7	5.4	8.9	5.1	10.2	6.4	7.0	5.5	7.0	10.6	9.8	6.8	1.1	7.7	10.2	7.6	10.3	14.2	6.8	6.1	9.5	12.3	4.8	10.0	8.2	11.9	12.9	7.6	7.6	6.5	6.4	8.0	8.1	13.4	5.1	5.3	7.6	4.5	3.2	4.0	2.0	3.2	2.1	2.1	1.9	2.3	1.6	2.8	2.7	2.3	10.4	2.3	3.9	1.3	1.5	1.1	11.8	10.3	26.7	14.0	11.9	7.4	10.4	7.1	12.4	9.0	38.7	30.9	19.0	14.5	30.6	34.5	22.4	22.9	25.4	19.4	22.7	76.6	8.9	8.3	21.9	9.1	26.3	25.0	0.0	16.3	6.7	36.9	24.8	15.1	29.4	10.0	36.5	32.8	33.7	35.2	6.7	14.7	18.5	28.7	19.8	27.4	25.7	19.9	17.5	9.9	8.1	44.8	19.4	26.8	35.6	11.7	35.8	9.7	30.5	23.4	26.1
RABGAP1L	"FLJ38519, HHL, KIAA0471, TBC1D18"	ENSG00000152061	"RAB GTPase activating protein 1 like"	"B7ZAP0, Q5R372"	1	174159410-174995308	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 89.4"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 201.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 46.9;Karpas-707: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054695	Uncertain					NA	NA					"HPA054695: AB_2682577"	"unprognostic (2.57e-2)"	"unprognostic (7.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (6.96e-3)"	"unprognostic (8.55e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.66e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.14e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-1)"	9.9	5.4	27.2	19.9	22.7	16.2	9.5	31.4	34.1	9.6	11.8	9.5	8.9	12.8	9.0	10.4	11.2	11.5	13.1	89.4	21.2	14.5	10.2	9.6	15.3	22.2	13.7	26.1	18.0	13.4	10.8	25.1	22.2	19.0	7.5	12.8	15.0	13.3	6.8	6.0	10.0	16.3	8.2	28.0	15.8	13.3	16.9	10.7	9.6	7.4	5.4	27.9	15.1	8.8	10.7	16.0	31.0	48.9	22.6	12.1	9.3	5.3	2.8	2.2	2.4	6.0	8.8	4.8	6.4	5.6	2.8	3.8	2.6	19.6	46.9	4.5	4.9	3.3	6.9	1.8	4.3	4.0	13.0	3.0	11.7	4.0	4.2	3.7	5.2	4.8	6.9	2.9	2.1	3.0	4.8	6.2	4.5	6.9	31.1	4.5	1.9	4.0	5.0	13.2	7.2	1.7	14.1	4.3	15.6	5.5	24.6	6.3	3.8	6.0	10.2	4.1	7.0	5.0	6.2	8.6	3.8	3.4	4.0	3.7	27.1	8.8	29.4	4.0	3.5	2.7	4.4	15.0	31.0	8.1	24.3	7.1	10.7	10.0	9.8	11.8	7.9	5.0	7.5	26.5	22.6	48.9	16.0	12.1	9.3	27.2	22.7	31.4	34.1	21.2	14.5	13.7	26.1	19.0	10.7	68.5	88.4	30.5	10.8	11.0	34.9	201.7	40.8	68.3	33.0	31.4	29.5	32.3	11.6	21.9	81.5	11.7	30.6	0.0	31.8	8.0	14.7	11.5	23.2	13.0	33.4	20.6	47.2	21.5	41.5	91.0	14.4	28.4	15.1	93.8	38.8	15.8	24.3	36.0	17.7	11.7	21.3	6.5	14.7	37.9	17.7	11.4	23.6	48.4	25.8	19.6
GPR52		ENSG00000203737	"G protein-coupled receptor 52"	Q9Y2T5	1	174448111-174449198	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"brain: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"basal ganglia: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.0;Daudi: 1.5;Karpas-707: 2.5"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"				"unprognostic (8.60e-2)"		"unprognostic (2.61e-2)"			"unprognostic (3.65e-1)"			"unprognostic (2.27e-1)"			"unprognostic (4.49e-1)"	0.3	0.3	0.8	0.2	28.0	2.2	0.1	0.2	7.4	0.1	0.2	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.1	0.9	0.4	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.6	0.2	0.6	0.0	0.2	0.3	0.4	5.0	0.0	0.1	0.0	0.8	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	28.0	0.2	3.2	0.2	0.7	0.2	0.1	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.3	21.0	30.9	13.2	10.3	11.6	19.9	23.3	13.8	30.2	22.1	21.6	19.0	32.0	24.3	16.5	21.7	16.6	38.5	17.0	31.3	16.9	23.5	24.0	20.7	23.1	7.8	32.2	15.1	7.8	10.5	24.8	15.0	15.6	21.2	28.8	48.0	18.0	21.7	11.3	49.5	29.5	29.4	45.8	9.8	22.4	22.0	36.9	21.5	24.3	21.3	20.5	15.8	27.7	24.0	43.6	21.5	28.2	10.9	17.2	18.4	24.0	37.3	17.4	50.0	71.0	14.4	28.3	19.9	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5	80.4	34.1	105.0	107.7	103.9	56.2	89.6	38.2	80.3	52.4	33.2	58.9	184.6	129.3	83.6	75.6	64.3	63.7	23.3	82.6	245.4	120.8	92.6	91.1	35.8	172.4	28.6	114.6	40.5	47.3	21.9	79.7	120.6	102.9	341.8	42.9	55.2	88.9	53.2	69.3	119.5	79.1	32.3	106.6	100.9	149.2	74.9	120.0	115.4	82.3	81.3
MRPS14	HSMRPS14	ENSG00000120333	"Mitochondrial ribosomal protein S14"	O60783	1	175010789-175023425	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051087	Uncertain		Supported	"Nuclear membrane,Mitochondria"	"Intracellular and membrane"	NA	NA			Mitochondria	"Nuclear membrane"	"HPA051087: AB_2681339"	"unprognostic (9.24e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-2)"	17.7	23.6	31.8	11.8	27.6	4.5	23.7	19.6	26.3	19.5	14.9	22.9	18.3	13.8	20.1	25.6	15.4	18.0	15.8	16.6	26.9	26.5	23.4	29.7	14.7	16.0	32.7	14.5	21.8	19.1	28.3	26.1	17.1	22.5	23.6	18.1	15.4	18.4	20.4	13.7	12.7	14.7	17.2	33.5	17.4	15.3	15.8	24.5	22.6	26.5	14.5	16.2	14.3	11.7	14.5	13.6	6.5	12.9	14.3	19.2	11.6	11.0	8.9	21.2	7.5	24.0	17.3	6.8	9.7	11.9	16.6	17.3	11.6	9.8	14.1	11.9	13.0	7.3	9.9	13.1	11.3	17.7	15.5	18.0	11.6	17.5	13.2	10.2	12.8	10.4	18.8	14.0	9.7	6.8	14.7	13.7	12.3	14.0	12.5	11.5	6.1	14.0	9.3	11.6	20.8	4.7	12.2	11.2	16.7	11.4	9.0	17.9	12.6	14.1	13.1	9.3	17.4	15.5	13.7	11.2	5.6	6.3	11.8	8.7	13.8	11.7	17.6	8.1	12.2	11.8	6.5	12.9	6.2	13.4	12.7	18.8	14.5	14.2	14.1	13.6	13.5	19.2	16.2	4.5	14.3	9.7	11.8	15.1	11.6	31.8	27.6	19.6	22.6	26.9	26.5	32.7	14.5	22.5	24.5	26.8	23.2	38.7	45.3	19.6	13.8	73.8	40.8	34.8	34.2	52.4	13.7	85.5	116.0	57.8	11.2	35.8	23.6	46.7	38.9	90.2	43.7	47.0	17.4	59.4	70.3	1.6	30.5	34.4	33.2	8.5	43.1	29.4	47.2	88.4	32.3	32.0	49.2	49.1	40.3	89.3	18.4	38.8	36.4	71.7	37.5	25.6	46.9	31.0	46.9	40.3
TNN		ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067858-175148066	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.2;gallbladder: 14.2"	"Cell type enhanced"	"Detected in some"	14	"Ito cells: 2.5;Smooth muscle cells: 2.7;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;NB-4: 4.7;THP-1: 14.4;U-266/70: 3.7;U-937: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	NA	NA		11000000			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	15.2	0.2	0.1	1.5	0.2	0.0	7.9	0.4	0.8	0.3	0.8	0.1	0.1	1.0	0.1	0.5	0.3	0.0	14.2	0.6	0.1	0.0	0.4	1.8	1.8	0.1	0.1	0.9	0.1	0.3	1.8	3.7	0.1	0.6	0.1	0.1	4.8	6.4	0.1	0.1	5.3	1.0	0.8	0.7	0.6	0.5	0.1	0.3	0.3	2.6	7.5	0.3	0.1	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.0	0.1	0.9	0.6	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.7	1.6	0.1	0.0	0.0	0.0
KIAA0040		ENSG00000235750	KIAA0040	Q15053	1	175156987-175192999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 315.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.8;RPMI-8226: 23.3;U-698: 42.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA016895, HPA068812"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016895: AB_2669476, HPA068812: AB_2686041"	"unprognostic (5.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-1)"	25.7	4.0	2.7	18.4	7.4	5.1	16.0	2.0	3.9	8.0	7.7	1.8	3.5	5.2	8.6	7.9	7.0	9.2	11.0	16.3	3.2	2.9	17.8	12.1	25.3	16.1	6.9	1.0	5.0	17.9	4.6	13.6	45.6	7.6	7.9	5.6	12.2	15.2	4.1	11.1	5.1	10.2	6.0	5.4	27.6	9.8	3.4	3.5	14.8	9.6	7.2	18.6	6.6	10.7	16.5	5.4	26.4	6.1	3.3	9.6	5.4	3.1	0.1	0.1	0.0	0.0	0.0	0.0	1.4	3.8	0.0	0.0	1.6	4.6	32.8	7.8	0.0	0.1	13.2	2.3	15.4	0.0	11.1	1.9	3.5	7.2	0.2	0.4	0.2	0.4	0.0	4.2	0.0	5.9	0.0	5.1	4.8	2.8	5.5	0.0	0.7	4.1	0.0	1.0	2.7	2.8	3.5	1.7	23.3	5.0	7.9	0.2	1.2	2.4	12.9	0.3	8.4	8.2	0.7	2.0	0.0	1.5	0.0	0.3	13.6	16.5	42.2	0.6	0.0	3.5	12.8	6.1	1.0	5.9	3.3	5.3	16.2	6.5	4.9	5.4	16.5	6.9	5.9	26.4	3.3	1.2	1.2	9.6	5.4	2.7	7.4	2.0	3.9	3.2	2.9	6.9	1.0	7.6	3.5	35.7	5.6	53.8	61.7	23.7	0.0	3.1	12.7	20.1	15.9	12.2	0.0	57.4	11.6	11.3	0.5	20.2	11.2	0.0	20.8	5.6	39.4	46.5	10.5	6.0	10.4	0.0	4.1	13.5	10.6	1.2	15.5	16.9	6.8	10.0	5.5	4.3	17.8	14.2	9.9	4.7	0.0	25.8	65.9	0.3	3.3	9.7	315.3	25.4	10.3	30.7
TNR		ENSG00000116147	"Tenascin R"	Q92752	1	175315194-175743770	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"brain: 56.4"	"Cell type enriched"	"Detected in some"	168	"Horizontal cells: 548.2"	"Cancer enriched"	"Detected in single"	46	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 5.8;THP-1: 2.3;U-937: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022343, HPA027134, HPA027150, HPA029859"	Enhanced				"Secreted in brain"	NA	NA		230000			"CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916"	"unprognostic (1.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.03e-3)"	"unprognostic (7.26e-4)"	"unprognostic (4.48e-4)"	"unprognostic (3.26e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	1.2	3.0	21.8	1.4	14.2	1.3	1.2	9.1	56.4	1.2	1.2	17.2	0.0	1.2	1.3	1.4	1.3	1.2	1.3	1.2	18.1	14.4	1.2	1.7	1.7	1.4	16.5	13.3	1.2	1.7	1.2	2.0	1.2	16.1	1.2	1.3	0.1	1.2	1.2	1.2	1.2	1.3	1.3	8.2	1.4	1.6	1.6	14.3	0.0	1.3	0.0	1.6	1.3	0.1	0.4	0.1	0.6	0.0	1.9	0.1	0.0	0.0	0.3	1.2	0.2	0.1	0.1	0.7	0.3	0.2	0.3	0.1	0.8	0.2	0.4	0.7	1.1	0.1	0.7	0.0	0.6	0.2	0.3	0.0	0.1	0.6	0.4	0.0	0.4	0.1	0.5	0.8	0.1	0.4	0.1	0.2	0.2	0.3	0.4	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.3	5.8	0.6	0.3	0.2	0.4	0.4	2.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.5	4.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.1	0.4	1.9	0.0	0.1	0.0	0.0	21.8	14.2	9.1	23.7	18.1	14.4	16.5	13.3	16.1	14.3	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	548.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
COP1	"FLJ10416, RFWD2, RNF200"	ENSG00000143207	"COP1, E3 ubiquitin ligase"	Q8NHY2	1	175944831-176207493	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 24.8;Extravillous trophoblasts: 29.0;Syncytiotrophoblasts: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.99e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	22.4	15.8	14.8	20.1	16.7	19.1	19.3	24.6	19.7	21.4	23.9	15.3	17.7	16.1	23.5	16.5	22.3	14.9	15.5	14.5	12.8	11.6	17.2	22.9	17.8	24.1	13.1	11.3	14.4	20.8	15.6	24.5	17.2	15.7	15.4	26.1	18.1	20.2	21.4	19.2	25.4	22.1	19.7	10.9	27.1	17.5	23.4	15.0	39.3	18.3	15.8	25.0	22.6	17.6	1.5	2.0	13.7	3.4	0.5	2.7	1.0	14.2	7.7	12.5	6.7	12.5	12.9	23.5	11.0	13.5	11.8	11.2	12.9	15.0	29.1	10.9	12.5	8.7	13.4	11.5	16.8	10.6	9.0	7.0	12.3	9.4	12.8	13.2	22.2	14.3	11.3	14.0	11.6	14.8	11.3	16.7	12.4	18.0	11.5	14.0	17.7	13.1	11.7	21.3	25.9	0.8	11.3	10.8	16.9	16.3	43.9	10.0	17.6	12.9	20.6	14.0	21.8	14.6	29.7	16.1	10.0	7.0	13.4	9.4	14.7	25.2	26.4	8.4	13.2	11.5	6.1	2.7	10.1	1.8	3.4	1.4	1.4	2.1	1.4	2.0	1.5	2.7	2.0	13.7	0.5	3.1	1.1	1.5	1.0	14.8	16.7	24.6	19.7	12.8	11.6	13.1	11.3	15.7	15.0	20.8	16.4	0.0	0.0	0.0	0.0	0.0	0.0	8.1	5.7	8.7	0.0	24.8	18.3	12.3	0.0	0.0	0.0	0.0	19.7	29.0	0.0	0.0	7.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	18.0	0.0	0.0	17.6	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Group enriched"	"Detected in many"	7	"Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	4.6	2.2	3.8	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	21.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	5.2	0.0	0.8	10.0	0.0	1.9	0.0	0.0	0.0	0.2	11.6	0.6	0.0	0.0	0.2	1.2	0.0	135.4	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.2	47.6	1.2	0.0	10.3	0.3	1.1	6.5	0.5	1.2	1.9	0.0	61.9	0.0	0.0	0.0
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 19.9;brain: 52.5"	"Cell type enhanced"	"Detected in some"	20	"Horizontal cells: 22.3;Late spermatids: 9.9;Rod photoreceptor cells: 8.8"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.0;NTERA-2: 4.6;SCLC-21H: 2.8;U-2 OS: 3.7;U-266/84: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	1.4	19.9	21.5	1.6	23.8	1.1	1.7	15.0	52.5	1.3	1.5	7.4	1.9	1.5	2.3	5.4	1.2	3.2	1.9	1.7	17.4	13.7	1.3	1.4	1.4	1.2	8.5	18.8	8.9	1.7	1.2	8.2	1.6	9.8	2.4	1.6	2.2	2.0	3.3	1.3	1.1	1.5	2.2	5.8	3.6	1.2	1.9	7.2	0.0	1.2	0.0	1.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	23.8	15.0	27.2	17.4	13.7	8.5	18.8	9.8	7.2	0.0	0.0	0.0	0.0	0.1	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	22.3	0.0	1.8	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	8.8	0.0	0.1	4.2	0.2	0.0	0.1	0.0	0.0	0.0
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177171497-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 11.5;brain: 27.9"	"Cell type enriched"	"Detected in some"	9	"Horizontal cells: 14.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"	NA	NA					"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.4	11.5	12.2	0.3	8.2	0.3	1.9	0.4	27.9	0.3	0.4	0.6	0.0	0.3	0.5	0.9	0.3	0.6	0.4	0.4	7.0	6.0	0.3	0.4	0.3	0.3	4.5	3.6	0.3	0.3	0.3	2.0	1.0	0.8	0.4	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.4	1.5	0.5	0.3	1.8	0.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	2.6	3.0	0.0	0.0	0.0	0.0	9.7	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.2	0.4	15.9	7.0	6.0	4.5	3.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 43.4;liver: 47.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 57.2;Late spermatids: 36.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.5;CAPAN-2: 9.0;EFO-21: 6.9;HDLM-2: 6.9;Karpas-707: 6.1;RPMI-8226: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"		NA	NA			"Endoplasmic reticulum, Plasma membrane"	"Actin filaments"	"HPA054292: AB_2682439, HPA072913: AB_2732213"	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	1.4	1.8	1.1	3.2	0.9	0.0	1.5	0.9	2.3	1.7	19.6	0.9	0.9	14.3	1.3	0.9	0.9	1.6	2.5	2.2	0.9	0.4	2.5	47.4	0.9	0.9	0.9	0.9	1.8	4.8	0.1	1.4	0.9	1.0	0.9	1.6	0.9	1.4	0.9	3.9	0.9	43.4	0.9	0.9	2.7	4.0	0.9	0.9	0.9	1.4	0.9	1.0	0.9	1.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	2.3	1.9	0.1	1.9	2.5	8.5	0.1	1.9	0.6	0.1	0.9	1.3	9.0	0.8	6.9	1.5	0.1	0.0	0.5	0.2	0.1	6.9	0.1	0.0	0.0	4.2	0.2	0.1	0.0	5.0	0.6	0.3	0.1	0.2	2.7	0.0	0.0	6.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	7.8	0.1	0.2	0.8	1.6	0.1	0.2	1.0	0.0	0.1	1.6	0.9	1.3	0.2	0.8	0.0	2.0	0.8	0.1	3.4	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.1	0.9	0.9	2.3	0.9	0.4	0.9	0.9	1.0	0.9	0.0	1.3	0.5	0.2	0.2	1.0	0.4	10.2	2.7	2.3	1.8	2.0	0.3	0.0	0.4	9.0	1.4	1.0	0.0	1.0	0.0	0.8	0.1	1.1	57.2	0.6	11.1	3.5	4.3	2.7	36.6	2.3	0.6	1.7	0.0	4.4	0.8	1.2	3.7	1.1	1.7	4.3	0.0	1.4	0.3	0.9	0.9	0.0	0.0	4.3	0.1
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094141-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 179.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.05e-4)"	13.5	3.8	4.2	2.8	5.1	0.4	7.1	2.7	8.5	9.5	4.2	3.7	4.2	2.4	10.9	5.5	24.4	5.8	9.0	15.5	3.8	5.9	7.1	2.7	9.2	1.5	4.0	6.5	6.3	5.0	6.1	6.7	21.2	5.6	5.0	4.3	10.7	9.6	4.5	8.3	7.5	3.3	7.1	3.8	2.9	3.7	9.0	2.7	0.0	5.0	13.1	4.8	5.6	13.2	2.1	0.5	1.4	0.6	0.3	0.1	0.0	16.3	5.4	7.1	2.3	4.8	6.5	9.9	8.2	8.0	7.0	5.3	8.6	8.7	0.0	13.7	8.0	11.5	13.8	5.7	13.1	6.5	0.0	3.1	0.0	5.7	3.4	5.7	2.3	0.3	20.4	2.6	8.3	30.0	7.3	6.3	0.0	0.5	0.0	9.7	1.7	0.0	1.9	5.3	3.1	1.0	0.1	2.9	0.0	3.8	2.2	5.5	2.7	6.4	5.0	5.0	6.3	5.8	2.6	11.9	9.3	9.5	9.7	10.9	3.6	0.0	0.0	7.3	1.2	6.6	1.4	0.4	0.1	0.1	0.3	0.0	0.6	0.0	0.0	0.2	2.1	0.1	0.1	0.8	0.3	0.6	0.5	0.0	0.0	4.2	5.1	2.7	7.1	3.8	5.9	4.0	6.5	5.6	2.7	71.5	11.7	1.4	7.8	14.2	47.0	33.2	17.8	37.5	14.8	15.7	143.3	11.6	5.0	19.0	12.3	41.2	5.2	0.0	10.9	12.1	14.7	18.7	7.0	5.4	15.0	79.4	32.7	43.0	2.5	5.1	18.1	13.1	3.3	12.6	14.6	22.8	23.0	2.9	21.5	5.7	179.6	64.7	27.8	28.6	32.2	21.1	35.0	0.7	12.8	29.3
CLEC20A	"FLJ44005, LINC00083, NCRNA00083, RP4-593C16.2"	ENSG00000188585	"C-type lectin domain containing 20A"		1	178479247-178499634	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 12.9;testis: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory B-cell: 3.5;naive B-cell: 12.9"	"Lineage enriched"	"Detected in many"	8	"B-cells: 12.9"	"Cell line enriched"	"Detected in single"	5	"REH: 4.8"															NA	NA																							0.0	0.0		0.4		2.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	2.9			0.0	0.0	0.0		0.0		0.3	0.0		0.0	0.1	0.0	0.0	0.0	0.0		1.0	0.5	5.3			0.0		1.9	0.0		12.9	0.5	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.3	12.9	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX35	"C1orf49, DKFZP564J047, TSC24"	ENSG00000240021	"Testis expressed 35"	Q5T0J7	1	178513077-178548602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 66.9"	"Group enriched"	"Detected in some"	127	"Early spermatids: 1093.6;Late spermatids: 1941.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039190	Approved					NA	NA					"HPA039190: AB_10794425"	"unprognostic (2.20e-1)"	"unprognostic (1.77e-2)"				"unprognostic (1.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-1)"	"unprognostic (5.41e-2)"	0.2	0.1	0.2	0.2	0.3	1.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	1.0	0.2	0.1	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.6	66.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.0	3.4	0.9	0.4	1.1	0.0	1.4	0.8	2.9	3.9	2.4	3.6	8.5	1.5	2.3	1.4	0.8	2.0	1.0	2.5	1.5	1.1	2.0	1.2	2.7	0.8	1.2	2.1	1.0	2.6	3.3	3.7	0.5	3.3	1.4	3.0	1.3	1.7	3.5	2.0	0.6	2.5	2.2	2.3	1.1	1.0	1.9	2.2	5.2	1.7	1.5	1.7	1.3	2.0	2.2	2.1	2.2	1.7	2.9	3.5	0.8	2.6	1.5	2.2	2.3	3.4	2.4	2.1	2.1	2.7	3.2	2.0	2.6	2.5	0.8	0.9	0.8	1.2	1.0	0.3	0.3	0.9	0.9	0.7	0.5	1.7	1.1	0.7	3.4	0.4	0.9	1.0	0.5	0.0	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1093.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1941.7	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	6.5	0.0	11.8	4.3	0.0	0.0	0.0	0.0	0.0
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.7"	"Cell type enhanced"	"Detected in all"	10	"Cone photoreceptor cells: 194.4;Rod photoreceptor cells: 376.7;Spermatocytes: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 17.8;naive B-cell: 14.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 17.8"	"Cell line enhanced"	"Detected in many"		"U-266/84: 62.7;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"	5.5	6.4	5.0	27.9	10.5	6.2	5.4	8.9	5.1	8.0	9.9	1.2	7.2	5.8	8.2	7.3	14.0	8.7	4.7	4.7	6.0	3.2	6.1	16.4	3.7	25.3	2.2	4.1	11.5	5.0	6.2	8.4	4.6	3.8	5.3	6.4	9.9	9.2	7.4	2.1	10.0	19.7	6.1	3.2	26.1	6.8	37.7	2.1	16.0	4.3	4.7	29.4	7.5	8.4	17.8	0.5	1.4	0.1	0.3	0.5	0.8	10.3	3.4	10.5	0.1	11.8	17.3	4.1	9.1	20.1	7.4	6.7	4.1	10.2	22.0	3.0	26.7	3.7	8.6	4.6	2.3	9.7	0.0	2.7	0.0	2.2	3.8	2.0	2.8	0.1	7.6	2.0	9.5	6.7	5.1	6.4	4.1	5.3	0.8	4.8	1.6	4.3	0.9	7.2	4.0	3.6	6.1	10.8	0.2	2.5	6.6	1.6	4.7	5.9	6.6	12.8	7.5	7.9	1.4	4.7	3.4	3.3	12.3	4.3	25.1	62.7	51.4	1.9	1.5	3.8	0.5	0.1	1.4	0.2	0.0	0.2	17.8	0.1	0.1	0.2	14.6	0.5	0.1	0.8	0.3	0.0	0.5	0.0	0.8	5.0	10.5	8.9	5.1	6.0	3.2	2.2	4.1	3.8	2.1	11.9	8.6	135.8	14.0	13.2	83.6	11.7	5.1	26.8	7.9	14.0	194.4	6.4	18.3	12.8	103.8	2.7	23.8	23.3	10.3	8.6	12.0	23.1	8.1	51.8	5.0	12.7	34.4	3.1	7.5	137.4	46.3	3.6	8.5	1.8	18.2	23.8	20.4	24.6	43.9	6.6	376.7	19.4	8.1	162.4	24.7	29.7	2.7	4.8	13.0	54.0
ANGPTL1	"ANG3, ANGPT3, AngY, ARP1"	ENSG00000116194	"Angiopoietin like 1"	O95841	1	178849705-178871052	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Leydig cells: 394.4;Peritubular cells: 199.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.3;naive B-cell: 2.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.9"	"Group enriched"	"Detected in some"	18	"ASC diff: 48.7;ASC TERT1: 19.6;HHSteC: 21.1;HSkMC: 48.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009976	Approved				"Secreted to blood"	NA	NA		100000			"HPA009976: AB_1844822"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (3.81e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.31e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.61e-3)"	17.7	16.3	1.2	8.5	1.1	0.0	14.4	0.7	1.4	26.3	36.2	0.9	9.6	2.6	34.6	46.5	33.6	29.7	16.6	12.9	1.0	0.6	15.9	7.1	12.4	15.8	0.6	2.5	35.7	6.4	0.0	2.2	42.0	1.6	16.7	8.7	0.9	14.2	4.2	20.0	4.5	28.2	22.7	1.8	7.0	13.1	24.7	0.4	0.9	19.3	57.5	2.8	25.5	13.7	2.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	48.7	19.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	21.1	0.0	0.0	48.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.7	1.4	1.0	0.6	0.6	2.5	1.6	0.4	0.0	0.0	0.5	0.0	3.3	2.2	3.1	30.6	1.4	0.0	1.8	5.9	0.5	1.7	0.7	0.8	2.9	0.0	0.0	0.4	0.6	51.8	0.1	0.0	0.9	1.3	0.0	0.0	11.6	0.0	1.9	394.4	0.0	3.3	0.0	0.0	36.6	0.0	0.0	199.4	0.0	12.4	38.8	35.0	0.7	0.7	3.1	1.1	0.0	0.0	0.1
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B, glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076562	"Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		280000	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	18.2	21.3	17.7	12.8	20.9	8.8	26.0	16.1	26.4	15.8	20.8	10.8	13.3	8.7	18.5	14.7	17.5	14.7	17.3	32.9	17.1	17.2	16.2	14.8	14.6	9.1	16.1	19.9	19.0	10.1	22.5	16.9	15.2	15.2	15.6	13.4	14.5	9.9	18.8	19.0	11.4	10.6	25.9	13.6	10.5	14.4	6.8	9.4	7.3	16.5	7.7	9.4	17.6	28.7	4.9	3.6	2.3	2.3	4.4	4.1	1.5	17.9	16.5	12.8	13.5	22.9	24.2	14.2	15.0	17.2	10.6	9.5	8.2	18.0	9.3	19.8	26.4	8.7	13.2	13.0	11.0	15.6	11.8	8.8	29.7	15.6	10.4	11.4	19.6	18.8	14.0	12.1	14.4	11.2	16.2	13.0	13.1	33.0	13.7	16.9	10.0	8.5	7.1	16.8	20.3	3.5	10.5	13.5	12.4	8.9	20.4	17.1	42.1	15.8	18.0	15.3	19.0	15.5	14.4	13.7	16.9	14.9	23.2	20.2	11.2	20.4	8.2	16.8	9.6	16.7	2.3	2.0	0.6	3.8	1.7	4.1	4.2	2.4	3.5	2.2	4.9	3.5	3.2	1.9	4.4	2.3	3.6	2.7	1.5	17.7	20.9	16.1	26.4	17.1	17.2	16.1	19.9	15.2	9.4	6.0	10.7	11.2	8.9	13.9	12.3	31.9	17.8	8.1	7.9	17.4	23.6	8.0	3.3	8.2	4.2	11.2	4.1	0.0	11.0	5.7	12.4	14.8	16.2	12.2	6.9	36.5	13.8	10.4	8.9	2.5	16.4	6.9	15.1	10.0	7.6	7.8	11.0	0.0	20.1	5.4	20.2	12.9	20.3	12.9	15.8	11.3	6.3	6.9	6.6	23.8
TOR3A	"ADIR, ADIR2, FLJ22345"	ENSG00000186283	"Torsin family 3 member A"	Q9H497	1	179081377-179098023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 59.3;U-266/84: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028766	Approved				"Intracellular and membrane"	NA	Yes					"HPA028766: AB_10602251"	"unprognostic (5.55e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.82e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (4.78e-8)"	"unprognostic (4.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	12.3	13.5	8.0	22.9	11.4	20.6	14.9	4.5	15.5	11.0	15.9	12.5	9.5	13.8	14.3	13.2	12.9	13.3	21.3	9.9	7.4	8.4	12.4	17.3	13.5	28.1	8.2	11.8	13.4	26.8	14.2	14.9	10.7	8.7	13.3	15.5	11.0	22.2	14.6	20.4	12.0	18.0	13.3	8.3	31.3	16.0	6.5	6.2	18.1	17.7	13.6	25.0	14.8	11.1	31.3	29.3	6.4	23.0	9.7	13.6	16.5	11.0	13.6	3.9	10.8	7.9	6.2	12.1	8.3	9.9	9.7	7.0	5.8	17.5	17.8	14.9	8.0	5.9	14.4	10.7	6.9	5.1	13.7	10.0	19.4	8.1	8.8	12.8	21.1	16.9	6.9	6.3	7.6	6.5	4.0	7.0	7.0	23.4	34.1	6.6	23.6	13.0	11.8	7.9	13.2	7.6	10.0	6.8	17.3	6.1	15.5	7.8	10.4	12.3	19.5	5.1	6.9	14.6	15.5	4.4	7.7	5.4	12.6	10.8	59.3	64.0	15.1	5.4	15.0	5.5	1.7	23.0	6.4	10.9	17.9	13.6	31.3	10.1	12.2	26.4	21.8	7.9	9.3	4.7	9.7	17.2	29.3	13.5	16.5	8.0	11.4	4.5	15.5	7.4	8.4	8.2	11.8	8.7	6.2	3.0	9.4	42.4	12.5	15.0	3.2	9.3	15.3	10.7	3.4	10.4	9.8	27.3	3.3	27.9	0.8	16.4	11.8	0.0	39.1	50.7	19.2	15.1	10.4	8.6	51.9	0.0	13.8	11.1	22.5	0.0	15.8	26.1	15.1	72.1	16.3	15.7	18.6	14.0	17.7	7.7	9.0	6.5	14.4	0.9	5.1	13.8	9.2	23.6	24.3	10.7
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099327-179229684	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 32.3;TIME: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	14.3	5.2	8.6	7.4	13.7	3.7	8.3	14.9	10.6	9.2	6.6	5.8	4.5	4.0	5.4	4.7	3.9	4.3	18.8	6.8	9.7	3.9	4.9	4.3	11.5	3.7	6.5	6.1	5.6	8.4	9.2	8.4	6.1	8.1	5.1	5.2	5.8	4.5	4.4	5.2	6.6	3.7	6.9	6.2	3.9	4.7	9.2	8.6	3.6	5.8	3.1	3.6	6.7	11.2	2.8	2.0	3.8	1.2	1.8	2.2	0.6	10.1	5.6	3.7	2.5	3.2	7.4	2.3	11.3	9.3	13.9	10.1	4.1	3.1	5.9	8.4	8.0	9.6	5.1	5.4	3.8	19.8	3.7	4.9	2.8	5.1	2.0	5.9	3.1	0.9	6.8	5.0	19.8	32.3	6.0	15.4	3.0	6.7	1.7	18.1	2.7	2.5	1.7	3.6	2.0	1.8	3.7	6.3	2.9	4.7	1.6	2.3	5.2	9.4	3.0	23.2	5.9	2.7	2.6	30.1	14.5	10.8	6.9	18.1	3.1	3.9	6.1	6.8	1.8	13.9	3.8	1.2	0.4	2.2	0.4	1.0	1.8	1.4	1.4	0.9	2.8	1.9	2.0	2.6	1.8	0.5	2.0	0.8	0.6	8.6	13.7	14.9	10.6	9.7	3.9	6.5	6.1	8.1	8.6	20.8	26.6	12.4	33.8	41.7	36.0	7.0	17.8	6.7	10.3	10.4	157.1	7.7	10.0	12.7	14.0	46.7	9.7	0.0	11.9	6.7	36.0	32.7	16.2	14.5	21.0	23.8	25.9	33.7	32.7	21.4	14.1	36.5	65.8	12.6	9.6	9.8	30.1	14.4	12.7	8.4	34.1	6.5	29.3	18.2	26.3	33.5	8.7	10.1	13.9	20.7
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 87.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	23.9	87.4	4.1	8.3	5.7	7.0	9.6	2.9	4.0	6.8	7.2	5.6	7.8	5.5	8.2	6.0	3.4	8.3	9.8	5.7	5.5	4.1	12.1	8.8	18.6	13.0	6.2	2.3	10.8	15.5	8.1	14.6	11.6	4.9	13.1	6.9	9.6	51.1	8.9	4.1	5.8	7.0	7.5	10.5	13.6	8.1	6.8	4.9	4.0	6.2	2.9	7.2	9.4	8.7	6.6	24.3	19.8	26.8	18.5	16.0	14.8	20.4	9.6	7.9	11.7	30.9	16.9	42.5	9.9	17.5	22.0	25.7	9.8	23.4	11.6	15.7	18.0	26.8	7.5	25.1	5.9	23.8	13.2	5.2	5.4	8.1	10.2	12.7	9.2	2.1	13.3	3.8	25.7	22.1	9.3	9.4	14.3	11.6	6.0	34.2	4.3	9.8	3.0	3.8	3.3	3.2	12.2	10.3	6.8	19.4	12.8	2.4	6.2	15.3	6.5	5.7	9.8	6.8	6.3	8.9	26.2	12.6	28.6	21.8	8.5	31.0	9.9	10.4	5.0	48.5	19.6	26.8	0.7	14.0	17.0	13.5	6.6	13.1	13.1	24.3	5.5	12.7	12.6	19.8	18.5	11.1	4.4	16.0	14.8	4.1	5.7	2.9	4.0	5.5	4.1	6.2	2.3	4.9	4.9	20.8	33.1	10.4	8.5	8.9	7.2	5.6	22.9	48.2	14.8	19.2	13.7	14.8	1.7	33.4	19.5	13.0	7.9	0.0	21.9	46.9	18.6	33.8	13.9	21.9	69.5	6.4	57.5	21.5	66.9	10.8	30.2	63.1	21.9	44.1	27.7	6.8	20.1	10.5	24.4	12.8	13.0	25.8	13.0	5.6	8.2	4.5	7.3	27.9	16.8	6.5
AXDND1	"C1orf125, FLJ32940"	ENSG00000162779	"Axonemal dynein light chain domain containing 1"	Q5T1B0	1	179365720-179554735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 18.0"	"Group enriched"	"Detected in some"	7	"Early spermatids: 179.9;Late spermatids: 188.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;HBF TERT88: 1.9;SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071114	Enhanced					NA	NA					"HPA071114: AB_2686345"	"unprognostic (1.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.78e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.48e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.25e-1)"	0.0	0.5	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.1	0.1	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.1	1.7	1.2	0.3	18.0	0.0	0.0	0.6	0.0	0.3	0.3	0.0	0.2	0.0	2.1	0.4	0.0	0.6	0.0	0.4	0.0	0.0	0.9	0.0	0.0	2.8	0.9	0.3	0.9	0.2	0.0	0.9	0.3	0.1	0.0	0.5	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.0	0.0	0.9	0.0	0.3	0.0	1.1	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.0	0.1	1.2	0.6	0.0	0.0	0.3	1.7	0.0	0.0	0.2	0.8	0.7	0.0	0.2	0.7	0.5	0.0	0.1	1.0	1.4	0.0	0.8	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.1	0.1	0.0	0.6	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.8	0.0	4.0	1.2	0.0	2.0	0.1	0.0	0.0	179.9	0.0	5.5	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	188.8	1.4	0.2	0.0	0.0	0.6	0.4	0.3	1.4	1.8	0.0	0.4	0.0	0.0	27.1	3.2	0.0	0.1	0.0	3.3	0.1
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	143	"kidney: 66.5"	"Group enriched"	"Detected in some"	12	"Collecting duct cells: 19.2;Early spermatids: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"NTERA-2: 5.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB037267, HPA049486"	Enhanced					NA	NA					"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0
TDRD5	"FLJ34823, TUDOR3"	ENSG00000162782	"Tudor domain containing 5"	Q8NAT2	1	179591613-179691272	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 37.7"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 32.5;Late spermatids: 6.7;Spermatocytes: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 3.6;SK-BR-3: 6.0;T-47d: 10.5;U-266/70: 14.7;U-266/84: 12.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA029418	Enhanced					NA	NA					"HPA029418: AB_10603035"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-4)"	"unprognostic (3.96e-1)"	"unprognostic (4.39e-3)"	"unprognostic (4.41e-4)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.31e-1)"	0.1	0.2	0.9	0.3	3.0	0.4	4.1	0.0	1.4	0.1	0.7	0.1	2.0	0.6	0.0	7.6	0.6	1.0	0.8	0.0	0.7	1.1	1.2	0.0	0.1	0.0	0.8	1.4	0.2	0.2	0.3	3.4	0.2	3.1	0.8	0.8	0.5	1.1	1.6	0.0	0.3	0.5	0.0	0.2	0.0	0.4	37.7	0.5	0.1	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.8	10.5	0.2	0.0	0.0	1.6	0.0	0.0	14.7	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.0	0.0	1.4	0.7	1.1	0.8	1.4	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	20.4	3.1	0.3	0.0	0.0	0.2	0.0
FAM163A	"C1orf76, MGC16664, NDSP"	ENSG00000143340	"Family with sequence similarity 163 member A"	Q96GL9	1	179743163-179816198	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2"	"Group enriched"	"Detected in some"	12	"Early spermatids: 27.4;Late spermatids: 35.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	9	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 51.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.74e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.67e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	0.2	10.9	0.7	2.1	1.5	0.0	0.0	0.4	2.1	0.0	1.3	0.7	0.0	1.9	0.1	1.7	0.0	0.6	5.5	0.3	0.4	0.8	0.1	0.4	0.0	1.0	1.2	1.0	0.4	0.6	0.0	24.2	0.4	19.2	0.4	0.9	0.2	0.0	0.1	0.1	0.1	1.3	0.6	0.2	0.4	1.7	9.0	0.0	25.5	1.5	0.0	1.2	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	51.2	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.7	1.5	0.4	2.1	0.4	0.8	1.2	1.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278"	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	13.3	16.4	11.2	7.3	13.1	30.4	17.5	12.1	11.6	9.1	19.8	10.0	26.9	15.2	11.4	18.7	15.9	8.5	10.1	11.2	11.1	10.0	11.7	37.9	13.2	9.5	9.7	10.4	13.5	16.4	17.4	19.3	41.3	11.0	9.3	8.3	10.0	9.9	16.9	23.0	12.0	30.7	11.6	12.0	9.0	12.2	8.8	11.2	6.7	17.4	10.5	9.5	10.4	13.4	6.9	9.2	17.7	8.7	4.9	7.4	2.5	12.8	12.9	10.3	21.1	25.4	14.2	40.5	17.0	20.9	13.9	14.2	19.1	22.4	10.4	21.7	18.5	7.7	19.4	17.7	17.7	18.8	11.7	9.6	12.7	21.1	15.8	18.6	13.4	14.7	22.3	13.8	18.7	20.4	12.3	19.5	10.0	24.4	11.2	16.7	7.5	9.6	9.3	24.4	14.4	3.2	10.7	14.4	14.8	10.7	22.3	8.6	21.8	19.3	21.6	16.6	20.8	21.5	9.8	25.1	20.2	18.6	11.2	13.4	17.8	25.3	20.9	11.1	9.8	19.0	17.7	6.6	7.7	7.1	8.7	6.8	6.9	6.8	6.1	4.4	6.9	7.4	7.2	13.4	4.9	7.9	9.2	5.7	2.5	11.2	13.1	12.1	11.2	11.1	10.0	9.7	10.4	11.0	11.2	142.9	48.3	19.0	58.0	222.7	27.1	30.5	122.3	32.1	64.8	73.3	35.3	86.6	21.6	52.0	23.9	50.1	79.9	46.7	55.0	166.0	51.6	49.3	18.5	210.0	37.5	30.2	21.1	42.4	43.5	15.3	54.1	35.3	45.5	47.7	44.5	44.6	76.2	32.8	80.2	38.5	31.3	51.8	41.2	27.2	29.1	218.2	150.8	44.9	38.5	99.9
TOR1AIP1	"FLJ13142, LAP1B"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179925000	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 252.7;Late spermatids: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		17000	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	29.3	26.4	27.1	25.1	28.1	52.2	25.4	28.6	30.5	33.2	40.0	24.6	38.2	11.6	33.6	33.0	30.1	27.6	27.2	29.3	28.3	20.8	27.2	27.1	25.5	28.2	31.7	23.6	42.5	24.6	31.1	30.5	20.3	27.3	33.6	17.0	27.0	21.9	42.9	44.7	17.8	21.6	46.9	26.1	27.8	30.9	23.5	32.2	24.9	34.5	28.8	21.8	40.7	30.5	19.0	27.9	61.0	35.9	21.4	29.4	29.9	13.2	13.3	9.2	11.8	41.8	28.1	17.8	18.0	21.4	16.9	17.4	10.4	25.1	3.4	20.0	18.3	11.9	23.3	8.6	14.4	19.8	22.5	8.7	9.5	12.6	10.1	19.2	32.0	29.4	22.6	11.3	20.6	19.4	18.9	15.0	14.5	13.7	17.6	17.6	11.8	13.1	10.0	13.2	17.2	5.2	8.1	14.5	9.1	16.3	25.9	7.9	10.9	22.2	21.4	29.9	14.3	16.7	33.1	15.4	23.8	10.0	15.6	21.0	20.0	26.1	7.0	8.9	17.8	35.8	45.8	26.4	61.0	24.9	29.1	29.4	17.7	23.0	24.9	27.9	19.0	23.8	24.4	41.0	21.4	35.9	20.2	24.2	29.9	27.1	28.1	28.6	30.5	28.3	20.8	31.7	23.6	27.3	32.2	29.8	29.7	21.3	56.6	38.5	11.5	22.2	17.8	25.4	25.0	19.2	15.7	14.9	11.6	16.7	252.7	29.5	10.5	0.0	21.9	20.2	28.2	41.1	34.7	27.6	24.0	6.4	19.4	31.9	46.0	162.0	44.0	27.6	13.5	20.8	9.9	36.5	21.9	11.5	55.2	15.6	12.9	25.8	37.5	11.2	19.5	32.9	15.2	37.1	8.1	46.4
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954738-180114880	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 741.2;Late spermatids: 585.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome		NA	NA			Centrosome		"CAB079754: AB_2665828, HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: AB_2673633"	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	17.2	11.3	13.8	18.9	18.0	26.5	14.0	23.1	14.8	15.3	16.9	13.1	10.5	11.1	13.9	11.9	13.4	11.9	10.8	12.8	13.1	9.4	11.4	12.6	12.4	16.9	17.7	12.3	18.0	13.7	27.2	25.5	14.4	16.2	11.6	13.9	9.0	13.5	12.1	44.2	15.1	22.1	11.5	14.6	17.8	13.4	28.8	18.5	29.8	13.9	11.6	16.5	17.0	20.1	7.2	5.9	8.1	3.7	3.2	6.1	1.3	12.9	9.4	12.2	4.3	10.3	9.6	11.4	8.8	11.9	7.6	8.4	10.4	7.8	14.4	9.6	8.0	6.6	16.1	9.1	5.1	10.0	13.9	6.3	10.2	11.9	6.5	11.3	20.1	9.6	9.6	8.0	9.9	13.1	5.6	9.3	13.7	19.8	10.9	8.2	9.5	11.8	5.6	11.3	12.7	2.4	10.3	13.4	11.1	5.4	27.1	8.6	9.1	14.7	9.9	16.8	9.0	10.7	18.2	9.5	10.9	7.6	9.6	9.3	19.1	24.1	28.1	5.1	8.7	16.1	2.3	3.7	8.1	5.4	3.4	6.1	4.1	3.9	3.4	3.0	7.2	4.2	3.5	7.3	3.2	3.0	5.9	5.7	1.3	13.8	18.0	23.1	14.8	13.1	9.4	17.7	12.3	16.2	18.5	110.2	57.9	32.6	27.9	33.8	54.3	69.8	28.1	71.0	53.4	12.2	80.5	16.2	5.0	20.5	741.2	46.8	32.1	23.3	33.4	20.9	31.5	29.9	27.8	25.1	25.1	58.8	44.4	71.2	59.9	585.2	49.8	51.5	18.6	83.8	25.2	34.6	32.4	21.0	39.6	8.4	50.5	25.8	38.7	171.0	27.4	40.8	22.0	43.7	25.5	37.7
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 1528.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 197.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		3200000000	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	42.1	6.0	1.4	18.0	18.4	38.1	71.7	44.9	45.4	38.4	27.1	0.7	13.6	0.6	27.9	35.9	5.3	9.2	1.7	12.1	18.8	2.5	2.7	1.3	3.5	1.8	197.7	4.6	13.0	20.3	5.5	40.9	49.1	50.6	56.5	3.1	1.9	6.6	25.2	7.3	0.9	8.6	4.9	29.2	17.3	1.8	3.3	1.1	6.3	12.0	5.2	5.3	13.1	17.9	8.7	3.4	3.2	21.9	66.5	48.1	18.9	32.2	37.9	4.8	7.9	1.1	18.3	14.8	14.4	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1	53.6	87.2	7.8	26.2	12.2	9.8	43.7	68.8	14.7	43.3	68.0	23.6	13.2	0.0	189.3	48.3	38.6	47.7	0.0	114.6	1528.4	54.2	30.1	25.3	1.5	63.8	6.4	44.4	101.9	45.4	16.5	164.5	43.6	42.2	44.1	163.8	43.9	172.2	143.8	66.8	9.5	6.5	32.3	17.5	20.9	25.4	8.7	129.1	15.0	96.4	58.0
LHX4	Gsh4	ENSG00000121454	"LIM homeobox 4"	Q969G2	1	180230286-180278982	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"retina: 21.0"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 48.5;Cone photoreceptor cells: 49.1;Early spermatids: 42.7;Late spermatids: 55.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 6.1;BEWO: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055705			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055705: AB_2682892"	"unprognostic (2.83e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.86e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.76e-5)"	"unprognostic (9.39e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-3)"	"unprognostic (4.07e-8)"	"unprognostic (3.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.44e-3)"	"unprognostic (7.83e-3)"	0.8	1.4	0.8	2.3	0.8	1.5	0.9	4.3	1.4	0.9	1.2	0.8	0.8	2.5	1.3	0.8	1.2	1.3	1.2	0.8	0.8	0.4	4.6	0.8	1.0	2.2	0.8	0.8	2.2	2.5	0.0	2.4	2.8	2.1	1.2	1.1	21.0	1.4	0.8	1.3	3.4	2.4	0.8	1.4	2.2	1.4	3.6	0.8	0.8	1.9	0.8	0.8	1.3	1.5	0.6	0.1	0.6	0.7	0.2	0.7	0.0	1.4	6.1	1.6	3.3	0.0	0.0	14.7	1.6	0.4	0.4	0.1	1.2	2.7	1.5	0.4	0.0	0.6	2.6	2.9	0.0	0.7	0.8	2.4	1.0	5.8	0.6	0.0	1.7	1.8	0.0	0.0	0.0	0.0	0.6	0.0	1.6	1.7	0.6	0.0	3.1	0.9	3.0	1.3	0.5	0.3	1.0	3.9	0.6	0.0	1.2	1.5	1.3	1.7	1.3	0.5	1.4	3.4	0.3	1.9	1.4	2.6	1.5	1.0	1.1	0.4	1.4	0.5	1.3	1.5	0.0	0.7	0.0	0.6	0.2	0.4	0.6	0.3	0.4	0.0	0.5	0.6	0.3	0.6	0.2	0.5	0.1	0.7	0.0	0.8	0.8	4.3	0.8	0.8	0.4	0.8	0.8	2.1	0.8	0.0	0.0	0.0	0.0	0.1	48.5	0.3	0.0	0.0	0.0	0.0	49.1	0.1	0.0	0.0	42.7	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	55.3	0.6	0.0	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.8	5.3	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.2	0.0
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 143.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	6.5	7.5	7.3	9.7	7.7	9.1	7.1	17.4	8.1	8.0	5.2	6.5	9.6	5.8	8.6	7.6	5.4	6.0	7.1	8.9	6.6		6.8	5.5	6.8	11.2	6.1	7.9	10.5	9.7	6.8	10.5	11.3	5.8	6.8	5.0	6.5	7.2	7.6	9.5	6.3	5.2	7.8	4.0	6.8	6.1	18.2	7.3	8.1	8.1	7.7	7.1	7.6	6.9	11.5	14.5	2.7	13.3	16.4	10.9	7.7	21.2	15.8	13.6	10.0	9.5	16.6	28.5	9.8	19.7	17.1	15.5	22.3	15.6	18.8	20.3	9.6	8.4	15.3	10.0	18.1	10.9	14.2	19.5	14.8	14.3	12.7	24.5	25.3	13.4	15.0	25.9	10.6	16.7	15.0	19.0	15.3	23.2	15.3	13.7	19.3	21.6	23.9	15.0	14.5	7.5	21.8	11.3	35.9	14.5	11.1	21.4	27.4	13.1	22.0	13.1	14.2	23.1	18.9	15.3	12.8	15.4	15.6	21.1	32.4	16.7	42.7	14.0	15.6	15.1	1.9	8.4	2.7	9.3	13.3	10.7	11.5	8.0	7.9	14.5	8.8	10.0	10.9	0.6	16.4	10.0	11.8	7.4	7.7											29.8	24.1	29.2	23.8	18.9	50.3	40.9	17.8	34.8	39.8	15.7	37.3	143.2	34.9	32.0	69.5	28.1	4.2	0.0	36.3	31.1	30.4	19.4	18.6	11.6	38.5	49.3	18.7	20.9	11.1	43.0	47.5	25.5	35.4	34.3	18.7	36.3	29.4	14.0	47.7	38.9	5.8	58.2	26.4	104.2	59.8	19.6	70.6	22.5	24.7	15.2
XPR1	"SLC53A1, SYG1, X3"	ENSG00000143324	"Xenotropic and polytropic retrovirus receptor 1"	Q9UBH6	1	180632004-180890251	"Disease related genes, Predicted membrane proteins"		"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016557	Supported					NA	NA					"HPA016557: AB_2669382"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.44e-2)"	10.1	13.6	10.6	7.4	13.1	5.7	9.5	13.5	14.7	21.7	16.0	8.4	14.3	11.3	11.9	8.2	9.8	16.3	9.0	30.3	9.2	15.7	21.4	6.7	12.1	5.8	11.0	9.1	9.9	13.6	20.3	27.3	14.5	11.4	8.3	10.7	10.2	10.7	11.5	8.8	6.4	20.3	10.3	8.1	7.8	5.3	16.7	9.5	9.6	14.4	5.3	8.7	12.0	7.3	2.4	4.3	4.9	13.5	3.0	3.8	3.5	6.0	8.6	21.3	7.4	7.2	9.8	20.3	7.0	9.3	4.7	5.1	12.4	9.0	5.7	16.7	8.0	7.6	16.5	8.5	12.4	7.1	8.0	5.5	7.4	6.1	8.8	8.4	6.2	8.1	8.1	12.3	6.7	14.1	7.8	10.3	7.8	22.7	9.6	11.2	5.5	5.9	2.8	20.1	7.7	1.9	6.2	7.7	7.6	12.1	12.5	13.6	57.6	9.6	8.6	6.1	15.3	7.6	7.1	8.5	6.3	6.1	8.9	8.7	10.7	10.1	11.5	4.5	6.2	10.2	0.9	5.2	2.3	3.8	9.4	3.2	2.0	3.5	3.4	4.3	2.4	3.3	3.3	4.9	3.0	13.5	1.2	3.5	3.5	10.6	13.1	13.5	14.7	9.2	15.7	11.0	9.1	11.4	9.5	8.9	15.6	5.1	16.1	22.8	16.7	42.0	15.3	12.0	14.8	5.2	25.5	11.6	3.3	15.9	15.8	18.8	17.8	0.0	38.1	5.6	10.0	10.6	7.0	9.4	8.4	12.7	11.5	16.5	19.8	8.2	4.4	14.6	10.1	5.4	7.0	10.2	25.2	7.4	13.4	20.0	10.7	6.5	6.8	13.5	17.4	14.9	6.4	7.4	8.1	12.4
KIAA1614		ENSG00000135835	KIAA1614	Q5VZ46	1	180913154-180951614	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 58.8;retina: 23.8"	"Group enriched"	"Detected in many"	17	"Bipolar cells: 91.9;Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 171.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.8"	"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 12.3;SH-SY5Y: 31.1"					"Low region specificity"	"Detected in all"			"HPA028227, HPA061684"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA028227: AB_10601765, HPA061684: AB_2684585"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.61e-5)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.35e-2)"	4.6	1.5	2.4	1.4	2.6	0.1	2.2	58.8	11.3	4.5	4.6	1.8	0.8	3.0	5.2	1.6	4.6	3.5	3.1	7.5	2.7	1.4	3.0	0.4	3.2	1.1	1.5	3.8	6.3	2.1	0.0	1.3	3.6	3.3	3.5	0.5	23.8	4.6	2.8	2.1	3.0	2.5	4.1	1.4	2.6	2.2	1.2	2.5	0.4	7.6	0.9	0.4	4.3	5.1	0.5	0.5	4.4	0.5	0.5	0.6	0.3	1.1	0.5	0.9	2.1	3.0	7.5	3.3	2.2	2.6	1.1	0.6	1.0	1.2	0.5	2.1	2.7	0.5	2.2	0.2	0.0	0.3	0.6	0.9	1.6	0.4	1.4	4.1	1.0	1.2	3.5	0.1	0.1	0.0	1.8	1.5	1.7	1.3	0.8	1.0	0.9	1.3	0.4	2.3	0.3	0.3	0.7	12.3	1.6	1.8	1.0	8.5	31.1	0.7	0.8	4.9	1.0	0.9	1.4	3.5	2.4	1.8	2.8	0.9	1.6	2.0	1.0	0.3	0.8	1.6	4.4	0.5	1.2	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.4	0.6	0.4	0.7	0.5	0.1	0.5	0.2	0.3	2.4	2.6	58.8	11.3	2.7	1.4	1.5	3.8	3.3	2.5	0.0	2.6	0.0	0.8	0.3	91.9	2.8	0.0	0.0	2.3	1.8	123.7	0.2	1.7	0.2	3.4	1.7	0.0	0.0	0.2	0.4	2.8	0.3	1.1	0.0	1.4	3.2	0.0	2.5	0.0	1.3	7.2	0.0	3.3	1.8	0.0	7.6	1.0	0.0	5.3	1.3	171.7	6.5	1.4	0.7	0.2	0.3	0.2	0.0	0.0	0.0
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	12.2	10.4	17.6	14.1	18.9	2.9	12.4	21.7	25.5	13.4	10.4	15.5	7.2	9.8	11.3	10.7	22.2	10.3	9.6	8.1	18.6	13.2	11.6	6.5	15.3	12.7	18.5	13.1	11.5	5.5	9.2	6.8	15.0	16.1	10.1	11.1	6.4	10.7	9.6	5.7	16.5	9.9	11.8	15.0	11.6	10.5	7.3	20.0	14.1	15.3	7.3	17.8	16.3	15.6	1.7	5.1	5.9	3.6	0.4	3.2	1.4	9.8	11.1	11.0	14.6	11.6	13.7	18.6	12.7	16.4	10.0	8.6	10.3	9.9	10.0	17.6	13.9	6.3	17.7	9.9	22.4	11.8	7.2	7.3	6.7	8.4	10.0	11.5	9.5	8.7	12.4	20.6	16.9	17.5	18.1	20.2	9.4	12.2	7.1	13.3	14.2	9.1	9.0	17.1	12.4	5.6	8.0	13.4	14.4	11.9	24.8	15.6	16.6	13.3	25.7	13.9	19.7	15.6	8.7	16.6	13.9	7.3	12.9	10.1	12.1	6.7	7.3	6.8	9.4	8.1	5.9	3.6	4.5	1.8	2.9	1.9	1.7	2.6	2.7	5.1	1.7	3.2	2.4	3.4	0.4	2.5	1.7	3.2	1.4	17.6	18.9	21.7	19.1	18.6	13.2	18.5	13.1	16.1	20.0	14.9	15.2	3.7	16.3	43.5	11.7	5.6	0.0	13.4	11.4	17.4	5.9	22.0	10.0	9.1	6.4	22.4	7.8	0.0	8.5	21.8	11.5	17.4	11.5	4.3	24.6	7.9	22.4	11.1	21.9	8.0	7.8	30.2	6.8	19.0	12.7	6.0	11.1	14.0	12.4	6.7	10.1	6.5	13.3	4.7	14.5	33.0	17.2	13.3	9.8	18.7
MR1	HLALS	ENSG00000153029	"Major histocompatibility complex, class I-related"	Q95460	1	181033425-181061938	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048304			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA048304: AB_2680347"	"unprognostic (6.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-2)"	10.5	13.8	5.3	10.2	7.1	7.7	8.3	1.7	5.5	8.6	8.2	5.3	6.8	5.3	10.4	10.9	12.6	8.6	13.2	8.9	5.2	3.1	10.5	10.7	16.6	16.2	5.9	5.0	13.9	5.1	12.4	17.6	11.5	5.1	13.2	6.3	12.3	8.1	8.6	3.8	10.1	7.8	9.6	6.1	14.9	6.7	5.5	6.2	23.2	13.6	7.1	18.4	16.4	9.6	12.9	15.6	24.0	22.2	14.9	14.3	11.1	3.7	2.6	0.1	2.2	16.0	19.5	6.8	7.4	20.4	6.2	10.6	1.0	15.2	4.5	15.5	13.3	4.9	9.9	0.3	8.7	5.4	13.7	2.4	6.6	3.0	4.5	5.4	5.3	19.9	12.7	24.3	9.2	10.0	11.6	0.6	8.5	12.2	12.4	12.0	4.1	5.6	3.8	0.0	0.0	0.4	6.4	0.1	12.6	6.7	11.0	0.1	0.2	3.9	7.2	5.2	3.1	7.6	11.5	3.8	6.1	0.8	10.6	3.6	20.6	6.9	8.5	5.7	7.2	0.6	24.0	17.9	18.1	14.3	22.2	12.7	12.1	13.0	12.7	15.6	12.9	9.7	14.3	13.4	14.9	18.7	8.4	13.6	11.1	5.3	7.1	1.7	5.5	5.2	3.1	5.9	5.0	5.1	6.2	17.9	25.9	17.9	7.5	4.4	0.8	3.9	10.2	10.7	11.4	14.0	0.0	13.9	5.0	7.7	0.2	4.4	1.4	23.3	5.6	7.4	9.3	6.2	16.2	9.0	24.5	0.0	2.4	1.8	22.5	0.0	10.0	17.1	6.8	25.2	3.2	4.5	6.1	5.5	11.3	2.1	0.4	0.0	6.6	0.3	1.1	4.6	20.5	15.2	4.0	12.7
IER5		ENSG00000162783	"Immediate early response 5"	Q5VY09	1	181088712-181092899	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029894	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA029894: AB_10601433"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.81e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	9.4	7.2	4.7	16.2	5.4	45.7	13.8	6.2	12.6	7.8	7.8	5.1	5.9	6.6	12.8	5.3	20.9	14.3	10.3	22.9	6.0	4.9	3.7	6.7	22.6	9.6	10.1	5.7	4.4	4.3	1.8	4.6	34.5	6.9	6.7	6.9	3.7	5.7	4.9	42.3	16.6	10.8	9.6	7.2	27.3	6.8	5.1	5.0	11.2	4.3	22.9	19.8	8.4	16.3	5.4	1.6	5.4	7.8	1.5	2.1	0.9	12.1	10.7	5.9	5.1	8.2	11.4	15.8	21.6	23.0	12.3	10.9	2.9	6.9	4.0	9.6	8.3	8.6	22.5	1.9	14.7	8.0	23.0	9.3	3.6	5.5	2.0	12.9	4.1	11.7	8.1	15.0	14.2	9.5	9.3	8.3	3.4	14.8	18.3	21.6	5.5	4.1	6.6	6.1	4.6	5.4	4.7	10.3	15.1	4.4	6.7	8.6	9.3	10.9	10.7	23.9	7.5	8.5	3.6	12.5	8.8	15.5	10.0	13.0	12.1	4.2	3.1	6.9	4.4	2.4	5.4	2.1	3.8	1.6	7.8	1.9	5.4	1.4	2.1	1.6	3.6	0.3	0.9	1.8	1.5	7.3	0.2	1.8	0.9	4.7	5.4	6.2	12.6	6.0	4.9	10.1	5.7	6.9	5.0	20.8	75.0	63.8	120.3	62.0	22.9	92.8	17.8	14.7	19.4	8.7	35.3	8.9	0.0	9.0	3.6	66.0	73.5	0.0	6.0	36.7	51.2	79.2	34.7	4.9	43.9	7.9	54.2	36.2	111.7	8.2	11.2	133.8	43.9	41.5	70.2	18.9	15.6	54.7	8.9	1.1	19.9	0.0	68.4	3.6	5.0	52.1	28.6	25.4	34.5	130.7
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 30.8"	"Cell type enhanced"	"Detected in single"	15	"Cardiomyocytes: 1.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.6	3.0	17.9	2.1	19.7	3.1	0.5	3.9	22.5	0.6	0.8	1.3	0.0	0.6	0.6	4.4	1.1	2.3	0.6	0.6	30.8	5.8	3.8	0.6	0.6	1.4	2.4	10.6	0.5	0.6	0.5	0.2	0.8	4.2	0.5	0.8	0.5	0.5	0.5	0.6	0.5	1.1	1.0	5.2	0.9	0.8	2.8	2.4	0.0	0.6	0.0	1.0	0.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.9	0.1	0.0	0.0	0.0	1.1	1.4	0.0	2.3	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.1	0.0	0.0	7.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	17.9	19.7	3.9	22.5	30.8	5.8	2.4	10.6	4.2	2.4	0.0	0.0	0.0	0.0	0.1	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
ZNF648	FLJ46813	ENSG00000179930	"Zinc finger protein 648"	Q5T619	1	182054570-182061712	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;liver: 1.7;ovary: 3.0;testis: 2.2"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.8;Melanocytes: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	80	"HMC-1: 29.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA053897	Uncertain					NA	NA					"HPA053897: AB_2682297"	"unprognostic (3.52e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.30e-1)"		"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.16e-6)"	"unprognostic (4.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.83e-1)"	0.0	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.3	0.2	0.0			0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0		3.0	0.4	0.0	1.0	0.0		0.0	0.0		0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Late spermatids: 6809.8;Muller glia cells: 5699.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		28000	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	3.0	1.2	14.0	0.0	141.5	100.1	10.3	5.1	16.6	3.1	2.8	7.4	3.1	2.6	5.6	9.9	2.8	7.0	6.1	36.4	2.6	7.0	17.0	34.3	5.8	14.3	7.5	15.1	27.4	86.5	43.7	3.9	46.4	4.7	6.2	8.4	28.8	1.5	11.0	1.7	23.5	14.5	10.4	4.2	6.5	8.5	3.7	4.4	5.4	13.3	9.6	6.3	1.4	18.7	2.0	11.7	18.2	19.1	4.6	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.7	8.6	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2	116.1	193.4	39.3	480.1	119.7	83.9	198.1	163.1	242.2	133.1	78.5	49.1	126.6	63.0	92.2	1437.2	175.0	45.7	210.2	99.7	54.7	230.2	354.1	758.5	179.4	734.4	41.3	312.5	129.5	692.2	6809.8	451.3	662.6	129.9	48.7	226.1	5699.1	116.5	83.4	352.5	40.4	128.3	90.5	209.3	38.8	52.4	112.0	196.8	96.9	130.8	1061.5
TEDDM1	"EDDM9, Epdd1, HE9, TMEM45C"	ENSG00000203730	"Transmembrane epididymal protein 1"	Q5T9Z0	1	182398117-182400616	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	33	"epididymis: 128.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 1.3"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;NB-4: 4.3"					"Not detected"	"Not detected"									NA	NA						"unprognostic (4.21e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"		"unprognostic (6.71e-4)"		"unprognostic (4.43e-3)"		"unprognostic (2.86e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.99e-3)"	0.1	0.0	0.1	0.1	0.2	0.0	0.4	1.3	0.1	0.5	0.1	0.1	1.8	0.0	0.4	128.3	0.1	0.7	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.0	0.3	0.0	0.3	0.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	2.3	0.1	0.1	0.3	0.1	0.1	0.1	0.6	0.9	0.4	3.8	0.5	0.4	0.6	0.1	0.0	0.2	0.1	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.4	0.1	4.3	0.2	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.4	0.3	0.4	0.2	0.1	0.2	0.4	0.4	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	1.3	0.5	1.0	0.6	0.1	0.4	0.1	0.2	0.1	0.1	0.9	0.5	0.3	3.8	0.4	0.5	0.4	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGSL1	RGSL2	ENSG00000121446	"Regulator of G protein signaling like 1"	A5PLK6	1	182409192-182560599	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"testis: 22.6"	"Group enriched"	"Detected in some"	34	"Early spermatids: 91.5;Late spermatids: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;T-47d: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA							"unprognostic (1.33e-1)"				"unprognostic (5.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.47e-2)"		"unprognostic (4.45e-1)"		"unprognostic (1.64e-1)"	"unprognostic (2.69e-5)"	"unprognostic (2.93e-1)"	"unprognostic (9.18e-2)"		"unprognostic (1.42e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	91.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	8.1	10.8	7.4	9.5	10.9	3.7	8.3	5.7	7.7	12.5	9.3	6.7	8.5	8.0	12.4	11.9	10.0	8.8	8.0	5.8	7.0	5.3	9.9	3.9	8.4	10.1	7.7	3.3	14.0	5.3	13.5	18.0	8.5	10.1	10.5	10.8	13.3	10.5	10.3	4.1	6.3	12.2	9.6	7.4	10.5	8.8	3.5	6.7	13.3	13.3	2.8	11.0	13.9	11.0	5.0	7.2	26.9	13.5	5.0	9.2	4.9	2.3	3.3	1.4	0.5	7.7	13.4	2.6	4.5	5.7	4.7	4.3	1.9	5.2	5.1	8.0	5.1	2.1	4.3	3.4	4.7	1.8	4.1	2.8	6.0	1.2	0.2	3.9	11.1	11.9	9.5	10.8	2.5	0.7	3.0	2.0	7.6	2.1	4.0	4.0	3.4	3.2	4.6	1.1	7.6	0.9	4.8	1.1	2.6	4.9	3.1	0.7	0.2	4.1	5.0	3.9	3.8	5.1	12.4	2.6	2.4	1.9	2.6	2.5	3.5	1.2	0.6	3.8	6.8	3.5	16.8	7.2	24.6	4.9	7.6	6.4	5.0	5.8	5.2	6.0	3.8	9.2	6.7	26.9	5.0	13.5	7.2	4.6	4.9	7.4	10.9	5.7	7.7	7.0	5.3	7.7	3.3	10.1	6.7	6.0	3.4	2.4	2.7	0.9	1.9	1.2	2.5	8.1	5.7	3.5	3.9	3.4	6.6	5.6	0.0	3.6	6.3	0.0	1.6	2.6	3.7	2.7	5.7	1.5	5.5	1.6	2.4	3.1	10.0	0.0	2.6	4.6	0.0	1.0	7.1	9.1	2.6	3.5	6.0	6.1	6.3	19.4	2.1	0.1	0.9	0.9	2.2	6.9	3.0	4.2
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604408	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"thyroid gland: 67.5"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 519.8;Smooth muscle cells: 484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.0;NB-4: 17.6;SCLC-21H: 33.4;U-266/70: 37.8;U-698: 47.2"	"Region enriched"	"Detected in many"	5	"thalamus: 87.4"	"Group enriched"	"Detected in many"	6	"midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053250: AB_2682090, HPA055824: AB_2682934"	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	17.8	7.5	4.5	18.6	9.8	3.0	5.2	3.3	9.9	2.4	6.4	20.7	7.2	2.3	2.6	3.7	4.5	8.0	10.8	3.6	7.4	12.3	6.7	6.8	13.3	10.8	12.0	1.3	2.9	4.3	6.0	28.1	7.9	16.5	3.7	4.1	9.1	3.3	40.8	5.2	3.0	3.5	8.0	25.0	6.1	5.1	1.2	10.7	0.3	67.5	16.2	4.9	6.1	4.2	5.8	11.5	2.2	0.9	3.4	5.4	1.4	0.2	0.0	1.9	0.0	0.3	0.0	14.8	0.0	0.5	0.0	0.0	0.0	0.1	32.0	0.1	0.0	0.0	0.1	3.5	0.3	0.0	3.6	2.6	3.3	0.3	0.0	0.5	5.3	2.9	0.7	5.4	0.0	0.2	0.0	0.0	1.1	0.1	5.6	0.0	3.5	0.1	17.6	10.3	0.2	1.0	0.0	10.6	7.6	0.0	1.5	33.4	3.5	0.0	2.7	0.0	2.0	1.1	4.2	0.0	0.1	0.7	0.9	1.6	37.8	1.7	47.2	0.1	3.4	1.7	2.2	0.4	0.7	0.4	0.5	0.8	5.8	5.4	0.6	0.6	2.3	2.5	0.8	1.4	3.4	0.9	11.5	3.2	1.4	4.5	9.8	3.3	9.9	7.4	12.3	12.0	1.3	16.5	10.7	125.0	148.7	13.4	6.7	73.2	519.8	16.5	0.0	4.0	31.8	8.7	17.7	6.1	0.0	1.6	0.4	67.1	1.3	23.3	2.0	125.4	54.3	12.1	72.5	1.0	15.6	30.2	48.3	25.8	3.7	0.0	0.3	13.9	77.6	20.8	3.8	129.8	2.8	0.9	0.4	0.3	30.5	64.7	484.2	0.0	1.5	55.2	28.8	5.7	1.9	9.0
RGS8	"MGC119067, MGC119068, MGC119069"	ENSG00000135824	"Regulator of G protein signaling 8"	P57771	1	182641816-182684576	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 29.8;thyroid gland: 15.0"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 66.1"	"Group enriched"	"Detected in some"	13	"glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;Daudi: 2.4;SCLC-21H: 18.6;U-698: 3.8"	"Region enhanced"	"Detected in all"		"cerebellum: 477.3"	"Low region specificity"	"Detected in all"			HPA076764	Enhanced					NA	NA					"HPA076764: AB_2732321"	"unprognostic (6.75e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-5)"	"unprognostic (2.60e-1)"	"unprognostic (2.37e-1)"		"unprognostic (9.29e-3)"		"unprognostic (1.16e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.02e-1)"	0.3	2.6	2.0	0.4	23.3	0.3	0.3	3.7	7.5	0.3	0.3	2.7	0.0	0.5	0.3	0.4	0.5	0.3	0.5	0.3	1.4	3.3	0.4	0.4	0.4	0.6	3.9	2.0	1.2	0.3	0.3	0.5	0.3	29.8	0.3	0.4	1.3	0.6	0.3	0.3	0.3	0.3	0.6	2.6	0.3	0.4	5.7	7.1	0.0	15.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	23.3	3.7	3.5	1.4	3.3	3.9	2.0	29.8	7.1	0.0	0.0	0.0	0.0	0.0	66.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.0"	"Cell type enhanced"	"Detected in many"	18	"Cytotrophoblasts: 103.5;Hofbauer cells: 387.9;Ito cells: 109.2;Kupffer cells: 121.2;Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.0"	"Group enriched"	"Detected in many"	36	"granulocytes: 76.0;monocytes: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	14.9	6.8	10.9	14.2	12.3	12.4	5.3	3.5	10.2	3.9	5.3	15.0	11.4	2.4	2.5	23.7	8.0	4.1	10.1	4.7	9.2	8.7	37.4	15.4	14.3	20.4	16.0	8.6	2.8	3.2	2.5	2.5	32.9	15.4	4.4	7.4	3.9	5.7	5.8	2.4	6.5	4.8	5.8	15.3	32.1	4.0	4.0	14.4	3.1	3.4	1.3	10.9	11.8	5.5	0.7	1.3	76.0	23.6	0.0	1.3	10.3	2.7	0.5	0.8	0.0	2.4	2.4	0.7	0.9	1.8	1.0	0.5	0.0	1.2	7.3	1.3	0.0	0.0	1.1	1.6	2.0	0.2	0.0	1.2	11.6	0.3	0.1	1.3	4.4	7.0	1.9	7.8	0.2	0.0	0.1	0.1	8.5	8.7	11.7	1.8	0.9	0.2	2.9	9.3	5.7	0.9	1.1	0.6	8.9	0.2	6.1	2.6	3.9	4.2	0.2	3.7	0.9	2.4	7.1	0.2	1.0	2.0	0.6	0.1	8.4	10.1	7.4	2.1	7.8	3.0	3.6	23.6	18.0	1.0	20.8	0.9	0.3	0.8	0.9	1.3	0.7	0.7	0.9	76.0	0.0	16.0	0.2	1.3	10.3	10.9	12.3	3.5	10.2	9.2	8.7	16.0	8.6	15.4	14.4	0.0	5.6	9.1	4.0	5.5	5.1	2.5	2.5	0.0	1.2	7.0	2.0	103.5	16.6	1.0	14.0	2.1	1.3	23.3	2.1	6.6	3.3	1.2	5.7	2.4	387.9	6.4	1.7	109.2	121.2	20.9	0.9	25.3	10.1	21.6	1.1	2.4	1.4	0.0	0.4	55.2	2.4	0.0	2.9	8.6	8.3	6.1	89.7	3.5	0.8	3.9
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839369-182887751	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		97000	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	30.2	25.9	25.7	28.5	28.6	68.9	32.9	42.5	33.1	31.9	24.5	23.3	25.2	19.8	38.2	24.2	27.7	30.6	19.7	22.9	24.4	22.6	36.2	31.4	27.8	32.0	34.2	23.1	37.5	24.9	51.8	35.8	28.5	28.0	25.7	30.1	21.1	28.2	29.4	27.6	26.6	27.0	31.6	25.3	32.8	26.5	29.4	37.4	68.3	30.1	31.6	41.2	32.4	31.9	16.8	22.9	12.0	17.4	14.7	21.9	15.0	35.7	35.0	50.3	27.6	26.3	20.4	49.7	31.7	29.1	46.1	31.3	39.1	27.6	57.4	31.0	28.4	27.6	31.0	76.3	34.3	51.7	23.3	37.9	38.2	28.7	26.4	14.8	55.3	26.2	18.1	17.3	45.2	12.3	20.9	36.0	29.5	60.0	20.6	36.9	31.4	55.9	13.6	63.7	38.5	21.6	51.0	46.9	32.8	29.8	41.6	36.3	41.6	44.9	28.4	18.5	44.2	33.3	31.3	28.1	28.6	32.0	29.0	42.9	21.7	35.4	68.1	18.0	30.4	38.8	5.6	16.0	12.0	19.2	17.4	21.9	16.8	16.8	17.6	22.9	14.6	18.4	19.9	6.5	14.7	14.3	11.1	15.4	15.0	25.7	28.6	42.5	33.1	24.4	22.6	34.2	23.1	28.0	37.4	38.7	64.9	41.5	53.0	47.7	55.9	37.2	35.7	72.3	69.4	48.8	49.1	40.4	16.6	39.6	17.1	44.9	31.7	0.0	43.7	37.7	35.9	40.6	42.8	24.3	35.2	27.0	51.6	38.1	37.7	32.0	55.8	34.4	28.7	27.1	33.8	42.7	42.4	25.9	44.2	33.5	72.8	38.8	45.7	63.0	65.2	41.3	41.4	32.4	45.7	48.7
SHCBP1L	C1orf14	ENSG00000157060	"SHC binding and spindle associated 1 like"	Q9BZQ2	1	182899865-182953525	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	198	"testis: 87.2"	"Group enriched"	"Detected in some"	13	"Early spermatids: 410.2;Spermatocytes: 552.4"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"BEWO: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA036124, HPA036125, HPA064821"	Enhanced					NA	NA					"HPA036124: AB_2674953, HPA036125: AB_10671834, HPA064821: AB_2685360"		"unprognostic (1.29e-3)"								"unprognostic (1.03e-1)"				"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.44e-2)"		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	410.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	12.9	0.0	552.4	4.3	0.0	0.1	0.0	0.0	0.0
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023460-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	15	"B-cells: 3.2;dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 170.5;ASC TERT1: 93.8;HSkMC: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		90000000	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.85e-5)"	49.0	6.8	2.9	11.3	4.0	0.2	51.5	5.9	3.4	30.4	27.7	2.8	12.8	4.9	30.5	28.7	31.5	21.5	25.9	39.5	3.4	2.0	10.0	6.8	22.5	10.6	3.9	2.7	22.7	9.8	7.4	4.1	73.1	3.5	23.9	11.4	11.7	11.6	17.3	32.2	15.6	17.6	41.3	3.0	4.7	22.3	16.1	2.7	3.5	21.7	16.4	7.3	40.2	37.6	3.2	1.3	0.0	0.1	0.0	0.0	0.2	5.2	8.5	28.2	8.0	170.5	93.8	42.7	38.6	38.8	15.6	9.2	25.3	6.0	1.9	17.8	18.5	9.2	13.1	5.3	10.2	11.9	0.0	5.4	0.0	7.7	9.2	26.8	1.6	0.9	105.6	5.5	18.6	14.7	27.9	27.1	0.0	0.0	5.7	18.9	2.3	0.0	1.7	11.4	9.7	1.6	1.3	23.8	0.9	25.2	14.0	1.8	5.3	10.1	0.0	9.9	50.7	2.2	4.4	50.0	19.1	7.5	17.6	9.6	2.2	0.0	1.2	15.8	1.2	18.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	2.9	4.0	5.9	3.4	3.4	2.0	3.9	2.7	3.5	2.7	32.8	16.3	4.5	38.6	27.8	1.9	48.8	25.5	10.7	17.0	34.9	3.9	80.1	1.7	50.0	5.4	59.4	0.7	0.0	19.8	53.9	99.3	48.3	2.3	17.8	16.1	1.6	1.2	26.4	10.8	3.8	111.9	5.3	32.1	10.0	1.7	2.0	39.3	3.5	58.7	10.2	0.6	71.1	83.0	7.0	39.9	14.8	60.3	0.5	2.6	21.6
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183244900	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Pancreatic endocrine cells: 902.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, CAB078165"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	No	No			Cytosol		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689"	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	2.6	0.0	1.0	20.6	4.1	0.0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19.0	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0.0	7.0	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10.0	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	49.4	2.2	0.0	0.0	0.4	1.1	3.6	0.3	0.4	0.1	0.0	3.6	44.7	0.0	19.0	0.1	1.4	22.3	0.0	221.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	17.2	0.5	137.0	0.2	2.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	18.1	3.1	0.0	0.1	0.0	53.2	12.9	2.7	0.0	1.3	0.0	0.0	1.4	0.1	0.2	0.3	0.2	2.7	1.3	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1.0	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9	202.5	19.1	0.0	163.7	76.6	0.0	1.1	15.3	66.9	51.2	22.7	0.0	26.6	0.0	197.8	16.4	0.5	28.1	0.0	81.6	9.8	7.8	209.4	0.0	0.0	2.2	0.0	8.6	0.0	0.0	8.3	3.1	2.9	8.5	4.6	13.0	0.0	902.6	26.0	0.4	0.0	0.0	0.0	2.3	3.7	1.0	26.0	69.7	0.7	7.1	119.2
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418602	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 30.1;Early spermatids: 50.3;Horizontal cells: 19.1;Late spermatids: 19.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 12.9;SCLC-21H: 37.5;SuSa: 12.3;U-2197: 21.9;U-87 MG: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	9.6	7.7	26.2	1.9	34.5	1.0	2.9	53.9	53.5	3.6	2.2	2.0	0.0	1.5	2.5	2.7	1.9	3.8	4.1	19.6	20.6	15.1	1.5	1.1	1.8	1.7	8.6	28.3	1.5	2.9	1.3	17.4	2.0	15.6	1.3	2.1	0.5	1.5	4.1	1.3	1.7	2.0	2.7	4.1	1.2	2.1	8.7	6.3	0.0	7.2	0.0	1.7	1.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.2	2.5	0.0	1.5	6.2	2.2	1.6	4.1	0.8	0.2	1.2	2.4	0.0	6.8	0.4	0.7	1.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	12.9	0.5	1.0	0.2	5.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.2	4.4	0.0	2.4	0.0	0.1	0.0	2.8	2.0	37.5	2.9	0.3	0.1	0.0	12.3	0.3	0.6	1.4	1.2	0.4	21.9	1.5	0.3	0.0	0.0	17.1	0.1	0.1	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.2	34.5	53.9	34.7	20.6	15.1	8.6	28.3	15.6	6.3	0.0	1.0	0.0	0.2	0.7	10.7	30.1	0.0	2.7	3.4	0.0	0.0	0.6	0.0	0.1	50.3	2.9	0.0	0.0	0.0	9.6	0.4	0.1	0.0	0.0	0.5	19.1	0.0	0.0	0.6	19.5	0.0	0.5	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.6	19.4	5.0	0.5	0.2	0.3	1.1	0.0	0.0	0.0
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7, nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	14.6	14.3	20.7	17.1	25.3	30.9	17.6	35.8	29.3	17.6	18.1	19.9	6.6	16.8	16.6	13.6	19.1	22.1	12.9	20.0	17.8	14.8	18.2	18.7	15.6	19.7	16.0	23.1	22.7	18.7	25.9	20.2	18.7	15.9	15.1	20.4	15.9	17.2	14.5	19.2	20.5	17.8	15.2	14.4	18.9	18.3	52.1	15.1	31.6	19.9	12.7	23.9	14.5	22.3	9.3	11.7	11.2	9.6	9.5	10.3	8.0	21.5	13.1	19.0	14.8	13.0	12.3	31.7	13.3	24.5	14.8	11.3	19.4	16.9	30.4	15.3	16.4	13.5	23.4	25.5	19.7	17.6	13.5	11.2	24.6	14.2	15.7	13.2	32.1	15.7	11.2	18.1	20.3	47.1	12.1	16.2	16.9	30.4	21.5	15.3	21.8	22.5	14.2	32.9	25.8	7.5	14.3	21.3	23.7	11.4	20.2	25.6	20.0	20.5	29.1	15.8	33.9	29.0	13.1	15.4	16.8	17.5	16.6	18.8	23.6	27.6	25.2	13.7	18.2	17.9	3.1	9.3	9.5	9.7	9.6	8.9	9.3	8.8	9.5	10.7	8.5	9.9	10.3	11.2	9.5	5.0	11.7	7.8	8.0	20.7	25.3	35.8	29.3	17.8	14.8	16.0	23.1	15.9	15.1	20.8	19.4	14.9	8.8	24.0	22.5	27.4	20.4	21.4	19.4	26.2	29.5	9.9	8.3	11.4	52.6	24.5	30.7	0.0	13.5	13.1	10.8	13.7	20.9	41.4	11.4	28.6	33.1	24.5	36.2	38.5	14.1	24.4	10.1	4.6	20.4	9.3	13.7	20.3	11.7	10.6	18.0	38.8	16.5	37.0	19.6	23.5	9.0	15.3	16.3	17.0
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Group enriched"	"Detected in many"	6	"Ductal cells: 59.6;Hofbauer cells: 199.3;Kupffer cells: 138.6;Macrophages: 192.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 13.4;HMC-1: 11.7;hTERT-HME1: 28.0;U-2 OS: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.4	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	0.3	7.6	0.0	9.9	1.6	8.4	0.0	0.0	3.4	3.1	0.0	1.0	11.7	0.0	2.2	1.8	28.0	1.1	0.0	0.0	0.0	3.0	3.1	0.1	0.1	0.5	0.2	0.8	0.8	3.6	1.2	10.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.0	1.5	4.7	0.6	0.0	27.2	0.0	2.5	0.5	0.7	0.3	0.2	5.4	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2	8.9	17.8	4.8	0.1	4.8	0.4	1.1	10.2	26.8	13.6	0.0	0.0	0.8	3.3	59.6	1.0	0.7	0.0	0.0	3.3	0.8	2.1	0.3	7.0	0.4	199.3	0.0	0.0	4.3	138.6	2.1	0.6	192.4	6.8	20.8	0.0	0.0	18.4	1.1	0.0	0.1	0.6	12.9	3.4	0.0	0.2	3.8	1.6	1.3	0.0	0.8
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	51.8	28.8	24.8	17.0	20.5	29.3	59.3	71.3	55.0	31.1	25.4	26.0	36.8	47.7	81.2	41.0	20.1	36.1	17.4	24.3	16.5	68.7	15.6	28.8	39.2	22.4	33.4	41.8	56.3	35.4	25.9	37.6	29.9	35.7	36.4	33.8	21.9	39.6	40.2	21.3	39.0	11.3	23.6	40.3	11.1	36.3	22.0	46.0	17.4	26.9	10.8	28.9	74.3	32.1	27.6	27.1	32.2	37.4	81.1	45.4	23.6	50.8	68.6	47.2	52.1	32.7	35.8	30.2	34.9	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5	348.4	174.9	170.6	139.1	221.2	29.2	25.0	142.7	81.7	120.6	78.5	13.7	419.1	140.9	316.3	26.2	168.2	202.4	0.0	245.8	625.6	206.8	137.2	247.7	72.7	547.8	36.5	193.8	182.3	533.2	18.6	116.5	649.2	241.3	607.8	124.2	50.0	287.4	192.9	172.5	110.5	24.5	239.3	277.9	83.0	95.6	214.0	166.8	309.6	117.5	206.4
RGL1	RGL	ENSG00000143344	"Ral guanine nucleotide dissociation stimulator like 1"	Q9NZL6	1	183636085-183928531	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 46.1;Kupffer cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.6;HSkMC: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019788	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA019788: AB_1856215"	"unprognostic (3.08e-1)"	"unprognostic (5.25e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.49e-5)"	"prognostic favorable (4.32e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.88e-2)"	22.1	15.7	22.1	16.9	24.8	1.5	19.7	14.2	23.2	18.1	9.9	25.5	8.8	7.9	17.4	11.5	9.9	14.4	20.3	15.0	21.5	15.0	25.7	14.3	18.4	17.4	18.2	16.3	18.7	6.3	10.5	9.7	14.2	19.1	12.5	11.9	21.0	7.8	11.1	3.0	8.4	9.4	19.8	19.6	37.5	7.6	13.0	20.4	1.7	9.1	2.9	8.9	18.1	12.6	0.0	2.4	0.2	5.2	0.0	1.1	1.2	0.1	0.7	13.7	2.1	18.6	8.6	13.9	6.3	10.6	2.9	3.6	6.1	0.4	0.1	5.9	4.4	2.2	0.3	0.9	1.6	2.8	0.2	1.0	0.1	1.4	6.2	5.0	0.2	0.7	29.2	0.3	7.3	1.7	13.7	10.6	1.4	0.0	10.1	6.0	0.0	1.4	0.1	4.9	0.4	0.4	11.8	0.9	12.0	0.8	3.8	1.7	4.1	1.9	2.1	1.0	4.6	0.1	0.1	7.7	4.1	1.6	12.8	3.4	1.0	0.2	0.0	4.3	0.1	11.3	0.0	2.1	0.0	0.2	5.2	0.4	0.0	0.8	0.0	2.4	0.0	1.1	0.6	0.2	0.0	1.8	0.0	0.6	1.2	22.1	24.8	14.2	21.9	21.5	15.0	18.2	16.3	19.1	20.4	8.9	10.5	2.2	2.1	7.2	2.4	7.5	5.1	16.0	11.4	5.2	0.0	3.9	5.0	2.6	10.2	13.6	2.1	0.0	0.8	1.7	10.8	3.3	3.5	2.1	33.6	7.9	0.0	46.1	85.8	11.8	12.0	15.6	5.0	1.0	0.8	26.6	0.8	0.0	19.4	23.7	1.9	25.8	4.7	1.6	2.7	4.1	4.3	0.5	0.4	1.4
APOBEC4	"C1orf169, FLJ25691, MGC26594, RP1-127C7.4"	ENSG00000173627	"Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4"	Q8WW27	1	183646404-183653316	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 15.9;testis: 23.6"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 93.7;Early spermatids: 101.4;Late spermatids: 71.2"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA								"unprognostic (2.27e-1)"	"prognostic favorable (2.65e-4)"				"unprognostic (2.61e-1)"		"unprognostic (3.84e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.73e-1)"		"unprognostic (7.10e-2)"	"unprognostic (4.00e-2)"			0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.1	0.2	5.4	0.0	15.9	0.0	0.0	0.1	0.1	0.0	0.0	4.1	0.0	0.0	0.0	5.6	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	23.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	93.7	19.4	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	71.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 38.2;Late spermatids: 52.3;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 12.7;OE19: 10.2;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	2.1	9.4	10.8	1.7	16.6	1.9	2.8	10.6	39.0	2.0	3.0	31.3	0.0	1.4	3.0	5.2	1.7	3.5	3.7	11.7	15.3	7.9	1.8	1.0	4.5	1.1	20.2	12.9	2.3	3.5	1.0	1.9	0.8	17.4	8.1	2.0	3.5	4.4	3.7	11.0	1.1	1.4	3.0	21.8	1.3	3.4	5.0	22.5	0.0	5.1	1.8	1.5	2.4	1.4	0.0	0.0	8.1	0.0	0.7	0.6	0.1	0.1	0.0	4.4	0.2	2.3	3.4	0.1	1.2	0.5	0.6	0.7	2.1	0.2	0.0	0.3	3.3	0.8	0.0	4.2	0.0	1.1	4.6	2.3	0.3	0.0	12.7	0.1	4.1	0.0	2.0	0.0	0.6	0.1	6.4	0.0	0.1	4.1	5.4	4.6	0.1	0.2	0.2	3.0	10.2	0.0	0.4	0.0	0.0	0.0	0.9	1.7	2.7	0.2	0.0	13.7	2.9	0.0	0.2	0.0	0.5	0.4	0.0	13.1	8.0	0.0	0.0	0.4	2.0	16.9	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	10.8	16.6	10.6	17.2	15.3	7.9	20.2	12.9	17.4	22.5	0.0	0.0	0.0	0.4	0.3	0.8	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	38.2	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	52.3	2.0	1.5	1.7	0.0	0.0	4.8	1.0	0.0	3.9	0.2	0.2	12.9	0.5	0.3	0.4	0.4	0.0	3.5	0.0	0.3
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	14.2	17.5	20.6	13.2	22.1	16.2	17.3	14.0	34.0	16.4	16.8	25.4	7.8	11.2	16.7	24.5	12.7	13.9	12.3	17.2	22.1	19.0	12.8	14.2	15.9	16.3	27.6	16.6	15.0	19.2	13.0	13.4	16.0	20.7	16.3	11.8	13.2	13.9	14.5	31.8	13.7	10.3	15.0	34.5	13.4	13.9	12.4	24.2	20.8	19.4	15.4	15.2	13.7	12.5	14.0	20.2	15.9	14.2	28.2	21.9	17.6	22.7	7.6	9.9	12.2	8.3	7.9	28.2	10.9	19.6	16.5	16.3	7.1	9.9	14.8	12.0	12.2	10.1	10.5	10.7	9.2	16.9	21.7	6.8	6.7	5.7	9.4	15.3	26.4	9.4	5.4	17.9	7.2	15.1	6.7	9.2	25.6	14.9	41.5	14.6	11.0	26.3	13.4	21.2	27.1	8.6	16.7	16.5	31.3	10.5	7.6	10.3	15.2	14.3	11.4	27.6	10.9	14.4	16.6	4.7	11.0	24.8	7.5	17.4	56.5	38.6	22.6	10.5	14.8	23.9	15.9	9.8	13.5	20.4	14.2	17.6	14.0	19.3	20.9	20.2	10.4	15.0	20.4	1.8	28.2	13.0	18.1	21.9	17.6	20.6	22.1	14.0	34.0	22.1	19.0	27.6	16.6	20.7	24.2	44.7	7.2	17.1	10.6	9.8	8.6	28.6	10.2	6.7	14.8	12.2	3.9	38.5	46.4	27.7	1.2	12.0	3.3	0.0	36.4	40.6	19.8	10.9	31.2	33.9	27.3	3.2	6.4	17.8	13.1	1.7	20.1	20.1	32.1	24.4	7.9	13.0	30.5	3.5	18.4	51.8	12.1	12.9	20.6	40.8	50.7	11.5	18.9	35.9	10.2	9.5
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387058-184629020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5"	"Group enriched"	"Detected in many"	12	"NK-cells: 7.5;T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;Karpas-707: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	12.0	15.9	16.8	7.5	9.5	2.1	25.2	17.5	18.8	20.2	18.5	4.4	16.7	8.7	17.3	14.2	14.1	10.1	9.2	20.0	12.5	8.8	4.1	7.5	12.2	3.5	8.3	13.3	13.9	4.7	12.6	7.6	5.7	11.8	17.8	13.1	10.7	5.1	18.9	51.7	30.1	15.8	25.2	7.6	8.2	10.7	4.1	5.4	1.5	4.4	13.6	3.9	22.0	23.5	0.0	0.7	0.2	0.1	7.5	11.4	2.1	0.6	0.1	3.6	0.3	11.4	9.4	6.1	3.2	3.1	2.0	1.8	0.0	0.3	0.0	0.0	3.6	0.7	2.0	2.3	2.6	1.9	23.3	3.7	0.1	1.0	0.0	4.5	2.0	1.0	11.3	7.7	2.3	2.0	8.2	2.4	3.5	0.0	17.7	3.1	2.4	2.3	0.6	5.4	4.8	0.6	3.0	3.8	3.5	0.0	1.2	2.1	5.4	1.6	1.4	6.6	3.4	0.2	0.2	2.3	4.1	2.1	6.2	3.9	11.0	5.1	0.0	4.1	3.3	4.7	0.0	0.1	0.0	11.4	0.0	1.1	0.0	1.9	5.9	0.7	0.0	0.6	5.9	0.2	7.5	0.0	0.2	0.0	2.1	16.8	9.5	17.5	15.9	12.5	8.8	8.3	13.3	11.8	5.4	35.7	88.4	1.5	208.9	135.5	27.4	78.1	28.1	17.4	53.4	1.8	0.0	92.1	6.6	5.0	34.6	101.3	150.2	0.0	16.6	76.1	45.1	118.1	9.3	55.0	34.1	25.4	18.4	81.6	6.3	26.6	70.8	10.1	60.8	32.5	59.7	30.7	19.0	164.9	18.0	5.7	8.7	19.4	53.8	2.3	16.6	127.2	238.0	44.5	61.0	172.9
EDEM3	C1orf22	ENSG00000116406	"ER degradation enhancing alpha-mannosidase like protein 3"	Q9BZQ6	1	184690231-184754913	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025754, HPA025755, HPA027297"	Approved		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.63e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.01e-1)"	12.5	12.6	10.8	11.3	13.8	6.4	11.1	15.2	11.8	13.2	17.6	7.5	10.8	16.0	11.7	7.7	10.9	10.2	10.4	10.4	9.1	8.2	9.6	27.8	13.3	8.9	13.5	8.4	8.8	27.3	18.4	26.4	17.9	10.6	12.3	21.3	7.6	18.3	14.3	20.8	7.1	14.4	10.6	13.3	9.5	31.3	6.2	11.5	15.8	11.5	6.3	10.6	11.6	16.1	2.7	5.9	7.4	6.8	4.0	6.3	3.4	6.6	5.0	7.0	6.1	25.4	26.2	11.3	13.5	9.4	5.2	5.4	2.6	19.3	4.6	14.8	10.2	5.2	9.1	6.6	7.0	7.6	4.5	5.4	6.1	5.3	3.7	9.8	15.9	9.0	14.9	8.7	12.5	11.2	9.7	13.8	12.5	16.0	21.7	9.8	5.5	12.7	8.3	9.7	15.1	4.7	5.6	5.3	15.8	7.5	4.7	7.8	11.1	6.6	11.5	9.3	12.1	10.8	25.0	16.2	7.4	3.4	15.7	11.3	33.3	12.8	6.2	9.9	18.2	16.2	7.4	6.8	4.1	2.9	6.7	5.1	2.7	4.5	3.5	5.9	2.0	6.3	3.3	6.9	4.0	6.3	3.0	3.0	3.4	10.8	13.8	15.2	11.8	9.1	8.2	13.5	8.4	10.6	11.5	17.9	13.4	12.2	6.8	14.8	27.8	13.7	10.2	22.7	23.9	14.0	23.6	10.6	0.0	11.1	14.7	22.4	27.1	0.0	30.7	9.0	21.5	26.1	20.7	38.0	11.5	20.6	29.4	20.9	41.6	5.6	19.0	19.1	18.6	4.6	60.6	8.0	21.3	21.0	17.0	8.1	14.2	19.4	14.1	14.3	8.1	17.9	16.2	13.1	29.1	15.2
FAM129A	"C1orf24, GIG39, NIBAN"	ENSG00000135842	"Family with sequence similarity 129 member A"	Q9BZQ8	1	184790724-184974550	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 129.1;urinary bladder: 90.3"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 641.6;monocytes: 234.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 32.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		40000	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.52e-4)"	10.1	3.5	1.1	16.9	1.8	2.3	7.8	0.8	1.3	13.0	39.3	1.0	14.9	2.5	14.6	11.0	32.3	10.7	30.4	52.2	1.1	1.1	1.8	1.2	6.1	10.7	3.0	0.5	8.0	27.3	0.8	1.9	2.9	1.7	34.6	5.1	13.8	59.3	14.7	21.4	4.1	8.3	129.1	2.1	6.5	30.0	4.1	1.3	4.9	4.7	14.7	8.7	90.3	20.3	0.5	2.3	32.7	1.5	2.6	5.3	0.8	13.8	0.1	0.0	0.0	9.9	15.1	0.5	7.1	14.7	6.2	7.8	0.0	5.9	0.0	4.7	18.3	1.6	15.7	0.8	0.5	10.0	27.6	1.1	5.8	2.9	0.0	23.2	18.8	6.6	13.8	22.7	18.0	21.9	4.4	0.0	2.1	1.3	29.4	0.2	0.0	0.6	3.3	3.8	0.0	1.5	4.4	3.4	0.2	8.5	0.2	0.8	0.7	0.1	0.0	10.2	2.5	3.1	6.0	1.1	12.3	0.0	2.2	14.6	24.7	9.7	2.9	24.1	7.9	12.0	7.1	1.5	4.7	2.5	0.9	2.1	0.5	2.2	2.3	2.3	0.1	0.2	0.9	32.7	2.6	0.3	0.2	5.3	0.8	1.1	1.8	0.8	1.3	1.1	1.1	3.0	0.5	1.7	1.3	8.9	24.2	6.6	12.3	11.2	0.1	641.6	7.6	9.4	48.9	1.8	0.0	0.2	0.0	2.5	0.0	17.7	0.0	0.0	61.8	0.9	15.1	45.2	2.3	0.0	13.2	4.8	1.7	11.6	31.3	0.2	10.0	78.8	13.5	234.4	0.1	0.0	33.4	0.0	6.7	0.3	0.0	84.1	72.3	0.0	0.1	7.3	0.3	29.8	0.6	15.6
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045364-185102608	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	17.8	15.0	14.3	13.9	12.4	15.3	29.7	15.6	23.6	16.6	12.0	7.8	20.7	10.4	16.2	12.6	15.2	11.5	13.1	12.0	16.0	13.1	13.7	11.1	16.7	20.7	9.4	10.4	19.9	15.0	12.3	26.5	28.4	11.4	13.2	13.5	10.1	17.3	20.6	13.1	12.5	9.8	14.8	11.2	16.2	12.2	27.8	9.4	17.2	15.1	11.5	16.1	17.6	16.9	14.7	19.9	20.6	22.1	17.4	19.4	12.0	13.8	7.6	28.2	11.2	8.0	13.7	26.8	9.8	12.4	15.5	12.5	12.1	23.1	4.1	12.3	12.0	10.5	4.9	19.3	14.2	18.9	12.1	10.1	22.3	4.7	10.6	11.8	22.8	12.6	12.9	8.7	12.7	16.3	12.6	15.6	14.4	17.6	9.9	11.2	8.6	19.7	6.7	37.8	11.7	4.2	22.6	17.5	3.9	11.7	9.8	8.3	14.3	6.8	4.1	19.9	32.0	8.7	12.2	11.0	11.2	14.5	10.6	12.4	16.4	10.6	15.4	7.0	10.8	12.5	19.3	17.0	20.6	13.5	21.1	19.4	14.6	12.5	12.6	19.9	14.7	12.8	12.6	7.9	17.4	22.1	10.0	13.2	12.0	14.3	12.4	15.6	23.6	16.0	13.1	9.4	10.4	11.4	9.4	3.0	5.4	10.8	18.7	20.6	9.2	5.9	7.6	5.3	3.4	8.7	3.9	22.5	19.9	10.5	4.8	17.9	4.0	0.0	11.1	42.7	21.1	12.7	12.7	7.3	17.9	6.4	28.4	21.5	20.3	5.2	8.9	21.4	20.3	28.9	10.4	8.5	10.4	11.5	11.0	10.6	5.9	0.0	12.1	29.9	78.0	17.8	23.8	15.0	11.5	33.6
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118098-185157072	"Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	7.6	12.9	9.4	10.1	12.8	5.9	8.9	14.2	11.3	10.5	10.0	9.6	9.6	9.6	9.3	11.3	10.5	12.6	8.2	13.2	10.3	10.6	15.3	16.0	10.3	11.1	11.2	9.1	13.7	8.3	18.0	26.9	9.7	11.9	11.7	8.5	5.2	7.6	10.0	27.4	5.5	8.7	8.5	12.4	12.8	8.4	29.4	12.8	16.5	12.4	7.6	13.0	11.8	12.2	16.2	12.1	19.0	15.8	11.0	12.7	8.1	7.8	14.5	10.0	7.5	14.8	13.6	14.2	7.6	6.9	10.4	11.0	13.1	15.2	8.6	19.1	5.2	16.0	10.2	16.8	10.0	10.3	10.2	7.3	8.2	11.0	13.3	10.3	12.1	13.7	6.5	13.6	10.6	10.8	11.1	11.4	11.7	21.6	11.9	12.4	6.6	9.2	7.1	16.5	16.2	3.0	10.9	14.4	13.7	10.0	8.8	8.9	7.9	14.8	14.5	10.3	23.9	14.8	6.8	11.0	9.6	7.7	6.6	10.2	19.1	25.6	13.7	6.3	10.8	9.2	16.8	9.8	19.0	7.4	13.4	7.9	11.7	9.7	8.9	12.1	16.2	12.2	9.5	11.1	11.0	15.8	5.1	12.7	8.1	9.4	12.8	14.2	11.3	10.3	10.6	11.2	9.1	11.9	12.8	11.9	10.4	9.8	7.8	2.4	8.7	25.8	10.2	45.5	15.9	15.7	7.9	13.5	23.2	9.3	32.0	7.0	7.9	0.0	5.3	9.1	7.4	5.4	8.1	20.2	11.2	3.2	5.8	8.6	13.7	15.5	11.5	12.8	1.7	18.0	7.9	9.5	6.6	10.5	11.3	18.8	8.2	0.0	5.2	83.9	26.0	2.0	9.5	7.5	7.1	4.7
SWT1	"C1orf26, FLJ20121, HsSwt1"	ENSG00000116668	"SWT1, RNA endoribonuclease homolog"	Q5T5J6	1	185157080-185291765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.1"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 99.9;Late spermatids: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024214, HPA027334"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA024214: AB_1845642, HPA027334: AB_1845643"	"unprognostic (2.67e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.41e-3)"	"unprognostic (5.71e-3)"	"unprognostic (9.26e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.35e-2)"	5.0	4.8	4.1	3.4	6.0	8.7	8.4	6.5	5.9	5.0	5.8	5.7	7.1	5.6	6.6	5.4	3.8	4.1	4.5	4.4	4.2	4.7	5.7	4.7	5.4	7.6	5.2	4.6	7.7	12.4	5.8	9.9	18.1	6.8	5.7	4.1	3.2	6.7	7.9	5.0	3.9	5.4	4.0	9.1	4.8	6.1	39.1	6.5	7.6	6.1	3.2	3.6	5.2	9.1	4.5	1.5	12.0	4.8	1.0	7.2	1.5	1.9	1.7	4.7	2.6	7.9	6.1	4.0	1.9	3.3	2.4	3.8	1.4	1.6	1.9	3.9	1.5	2.5	1.6	2.8	2.6	3.1	5.1	1.9	2.0	1.2	1.8	3.9	0.6	1.7	4.4	2.7	2.7	2.4	4.2	5.9	3.9	4.3	9.6	2.5	0.6	2.2	1.8	5.1	5.1	1.0	1.7	4.2	4.6	2.3	1.1	1.0	7.4	1.6	2.4	6.7	11.6	2.8	1.3	2.8	3.2	2.1	3.1	1.2	17.5	13.3	0.7	3.6	1.2	1.2	12.0	2.5	3.4	2.0	2.2	3.7	3.1	4.0	3.0	1.5	4.5	3.9	2.9	7.2	1.0	4.8	1.4	7.2	1.5	4.1	6.0	6.5	5.9	4.2	4.7	5.2	4.6	6.8	6.5	3.0	0.6	2.2	1.7	0.9	3.9	7.0	2.5	1.4	4.5	5.2	3.9	2.8	0.0	2.2	99.9	3.4	3.5	0.0	2.3	5.4	4.1	2.4	2.3	3.2	3.0	7.9	0.0	8.6	5.7	37.0	4.4	2.8	1.7	3.6	2.9	2.4	1.6	8.6	5.3	5.0	4.4	0.0	1.9	22.7	11.5	0.5	5.6	2.1	2.4	1.6
IVNS1ABP	"HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP"	ENSG00000116679	"Influenza virus NS1A binding protein"	Q9Y6Y0	1	185296388-185317329	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 171.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003405	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA003405: AB_1079141"	"unprognostic (4.11e-3)"	"unprognostic (9.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.18e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.28e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	23.7	8.7	9.9	19.8	35.8	171.2	29.0	9.9	13.8	12.5	17.0	19.2	28.5	16.2	10.2	12.9	17.1	9.0	15.9	19.3	10.9	8.6	38.7	10.2	26.5	29.9	23.0	7.8	12.7	17.1	11.6	11.9	15.8	16.8	12.6	21.5	9.2	36.2	38.8	13.5	19.5	14.3	7.9	19.3	12.8	18.3	9.0	20.8	13.1	17.3	16.0	16.3	11.5	22.5	4.6	9.1	24.5	8.1	7.4	7.9	8.1	6.8	7.6	22.2	8.9	7.9	2.6	21.0	13.5	4.2	8.5	7.8	8.0	11.0	11.0	11.2	6.6	3.8	9.6	8.1	8.9	9.2	8.1	7.8	10.4	11.4	6.4	3.1	7.2	4.1	1.9	10.1	6.5	21.0	19.1	11.0	10.8	6.8	6.2	15.4	5.2	11.9	5.0	14.0	16.6	1.7	7.0	5.9	5.9	72.8	9.2	15.6	13.3	12.0	10.0	8.1	30.6	4.5	3.5	7.5	12.0	7.3	3.0	9.6	8.9	7.1	6.5	8.8	7.4	5.3	5.1	8.1	7.7	7.9	5.9	7.0	4.6	6.0	5.7	9.1	3.3	6.7	6.3	24.5	7.4	7.2	2.5	6.1	8.1	9.9	35.8	9.9	13.8	10.9	8.6	23.0	7.8	16.8	20.8	41.7	67.3	23.9	76.0	167.8	12.2	45.1	25.5	46.8	72.8	122.1	49.1	11.2	139.3	33.5	33.7	62.5	117.0	23.3	36.8	54.3	54.5	48.7	39.4	20.2	32.0	20.6	58.0	23.4	104.1	26.3	5.5	105.9	96.2	13.6	93.0	11.3	26.3	37.4	2.5	68.4	31.5	6.5	42.2	28.1	16.2	158.7	15.3	55.8	81.7	88.9
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734551-186190949	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 8.2;Fibroblasts: 12.4;Horizontal cells: 25.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;hTERT-RPE1: 9.8;MCF7: 35.5;SK-MEL-30: 23.4;WM-115: 21.0"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"olfactory region: 22.1"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		2000000	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	14.9	1.3	1.0	4.8	2.5	0.0	10.9	0.4	1.7	9.8	8.4	0.8	0.5	0.8	5.9	3.0	12.0	1.9	6.8	13.4	0.9	0.9	2.2	7.9	23.9	2.6	1.3	0.2	4.4	1.1	0.1	6.2	7.7	2.0	8.4	2.9	8.1	7.8	1.3	4.4	4.0	3.7	4.5	1.8	13.1	1.9	2.4	0.4	0.5	3.3	15.8	6.1	3.0	4.3	0.0	0.0	0.3	0.0	0.0	3.0	0.0	0.1	0.0	0.7	0.0	2.3	2.3	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.9	0.1	10.5	0.8	2.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.0	2.7	0.2	9.8	1.3	0.0	0.0	0.0	0.0	35.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	23.4	2.2	0.0	0.0	0.0	6.7	0.6	0.0	2.4	0.1	0.0	0.1	1.3	0.0	21.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.0	2.5	0.4	1.7	0.9	0.9	1.3	0.2	2.0	0.4	3.0	6.5	0.0	0.2	2.9	0.7	2.3	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.6	12.4	0.1	0.0	1.5	0.1	25.4	0.0	5.5	0.8	1.5	3.4	0.0	5.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314562	"Disease related genes, Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.9;liver: 76.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 298.2"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 81.7"	"Low region specificity"	"Detected in many"							HPA028523	Uncertain				"Secreted to extracellular matrix"	NA	NA		4300000000			"HPA028523: AB_10669642"	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	20.9	0.7	0.1	1.0	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11.0	0.1	0.3	0.2	76.0	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1.0	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	81.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.5	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	4.0	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1	20.8	14.4	8.2	0.0	0.6	0.0	0.8	7.6	20.1	38.7	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.2	0.1	15.1	298.2	0.1	0.0	0.0	7.4	8.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.1
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 640.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	21.6	18.7	28.1	16.3	22.6	20.2	29.6	24.9	16.7	17.6	16.4	28.2	18.5	25.4	19.3	16.9	12.1	28.4	21.1	17.0	21.8	19.0	23.1	33.8	30.3	19.7	12.1	36.0	22.2	15.4	10.3	26.5	20.6	16.3	20.7	14.6	40.7	22.9	18.7	18.7	17.9	9.6	30.9	19.8	6.5	21.2	22.0	22.0	14.4	26.1	15.3	24.3	29.0	19.3	15.6	40.1	21.4	23.0	29.1	17.6	16.8	19.4	30.1	25.1	29.3	23.2	11.3	18.4	15.7	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8	202.5	98.3	78.9	89.1	89.9	87.4	160.6	35.7	133.8	120.6	55.8	74.6	117.3	19.9	88.2	106.7	100.9	41.3	23.3	65.3	89.1	87.0	62.9	77.5	34.3	63.0	93.8	65.1	57.1	60.2	23.6	116.2	74.5	52.3	147.9	49.2	93.4	74.7	52.6	110.3	23.7	104.0	129.4	82.9	640.0	239.5	86.7	126.1	97.0	64.6	75.6
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	15.9	18.2	7.0	22.9	12.2	13.7	27.7	18.7	13.9	10.3	11.4	16.2	12.5	9.6	16.6	9.5	9.1	10.3	11.8	14.3	11.3	16.1	20.0	10.4	6.1	21.9	14.0	12.1	26.5	44.8	26.5	13.4	16.0	16.1	12.8	9.7	18.3	15.3	10.3	9.5	14.8	9.0	21.3	10.1	12.8	8.1	19.1	9.0	19.0	10.1	6.9	10.4	9.7	4.1	8.6	4.4	11.8	10.6	6.2	4.6	7.5	8.5	9.5	7.5	11.6	11.1	18.0	12.4	7.9	8.1	8.0	16.7	17.5	5.4	14.8	6.1	7.3	19.5	6.9	6.6	7.8	4.7	7.1	5.0	10.9	9.5	10.7	8.3	6.3	8.4	13.5	9.4	15.2	8.5	8.6	5.6	18.9	11.0	9.8	8.0	5.9	8.2	13.1	29.4	2.9	6.7	6.4	14.8	16.0	7.7	6.8	10.6	9.4	20.3	14.4	17.5	17.7	7.2	7.9	11.3	7.1	7.8	11.5	13.4	8.1	8.4	6.3	4.5	10.2	1.5	10.5	2.7	3.8	10.0	5.5	4.1	4.8	5.0	8.6	3.1	6.0	4.6	4.4	10.6	11.8	5.4	6.2	4.6	18.2	22.9	27.7	18.7	14.3	11.3	21.9	14.0	16.0	19.1	26.8	28.6	0.0	0.0	0.0	0.0	0.0	0.0	28.1	54.6	24.4	0.0	20.7	8.3	18.4	0.0	0.0	0.0	0.0	22.2	19.9	0.0	0.0	11.6	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	11.8	0.0	0.0	21.7	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0
OCLM		ENSG00000262180	Oculomedin	Q9Y5M6	1	186400572-186401455	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 8.5"															NA	NA						"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-5)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.81e-2)"	1.8	0.9	0.1	1.1	0.2	6.2	1.8	1.5	0.9	1.3	0.9			0.5	1.7	4.2	1.2	1.4	0.7	1.9	0.2	0.2	0.7	1.2	2.1	1.8	0.1		2.8	4.9	2.2	1.5	1.7		1.3	1.6		2.2	0.1	1.1	3.5	1.4	1.0	0.5	1.2	1.6	1.4			2.0		1.2	1.4	2.0	1.1	1.3	0.6	1.0	0.9	1.8	0.0	0.6	2.1	1.6	3.8	1.2	1.0	3.7	0.9	0.3	0.4	0.8	1.9	2.6	2.4	1.0	1.4	0.1	2.7	1.5	0.6	0.4	0.3	0.8	0.5	5.6	1.0	0.2	1.7	1.6	1.2	2.4	1.1	4.0	1.8	0.8	1.0	2.0	4.2	1.1	1.8	0.8	0.9	3.1	0.4	0.0	1.6	1.1	1.3	0.1	2.5	1.6	2.3	1.6	2.4	0.0	2.9	1.5	0.9	2.6	3.5	1.8	3.1	1.3	8.5	1.7	1.0	1.0	1.1	1.2	0.0	1.0	0.4	0.8	0.2	0.5	0.3	1.0	0.6	0.6	1.1	1.2	1.8	0.6	0.9	0.6	1.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PDC	MEKA	ENSG00000116703	Phosducin	P20941	1	186443566-186461122	"Predicted intracellular proteins"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 56.6"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 341.6;Rod photoreceptor cells: 807.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;BJ: 1.9;BJ hTERT+: 3.6;hTERT-HME1: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062235	Enhanced					NA	NA					"HPA062235: AB_2684720"	"unprognostic (2.06e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.53e-2)"		"unprognostic (2.43e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.07e-7)"	"unprognostic (3.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.67e-2)"	0.5	0.0	0.3	0.2	0.5	0.2	0.2	2.0	1.5	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.4	0.1	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.6	0.4	0.2	0.5	0.5	0.0	0.2	0.2	0.2	0.7	0.0	56.6	0.6	1.2	2.3	0.7	0.2	0.2	0.4	0.2	0.2	1.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.0	1.9	0.0	1.9	3.6	0.0	0.0	0.0	0.3	0.4	0.3	0.3	0.0	0.2	0.0	0.3	0.7	0.1	0.0	0.0	0.7	0.3	0.0	0.7	0.1	0.0	0.0	0.2	1.9	0.4	0.0	0.6	0.1	0.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.1	0.1	0.7	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.4	0.0	1.2	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	2.0	0.5	0.5	0.3	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.0	0.0	341.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	0.0	0.0	0.0	0.0	807.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 318.6;Glandular cells: 122.9;granulocytes: 329.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 95.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in all"			"CAB000113, HPA001335"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.6	0.5	0.0	21.8	95.4	0.1	0.8	3.4	4.0	0.0	0.0	0.1	0.6	2.9	0.0	1.7	0.3	0.0	0.0	0.2	0.5	0.0	3.2	0.0	0.1	0.2	0.6	2.7	6.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	4.6	0.1	3.2	0.1	0.0	0.0	0.0	6.7	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9	318.6	102.3	0.5	47.5	105.6	0.0	1.9	0.0	8.1	53.4	0.0	0.0	0.1	0.0	0.8	0.2	14.3	0.0	0.0	0.2	0.2	36.1	122.9	329.1	0.0	11.5	0.0	1.2	6.7	16.5	0.0	0.0	112.3	33.7	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.2	0.0	21.7	0.1	0.4	24.8	0.5	0.0	1.3	107.5
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 19.1;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.0;OE19: 33.2;RPMI-8226: 28.5;U-2197: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		78000	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	15.8	0.0	0.0	9.9	4.0	0.0	0.6	6.1	0.7	1.3	0.1	6.2	0.0	0.0	0.0	2.8	1.1	9.9	2.9	0.3	4.8	0.2	2.9	23.0	0.0	6.1	4.3	1.5	2.2	2.0	7.9	1.6	1.0	6.6	1.3	6.4	2.3	0.0	0.0	0.0	0.0	0.8	33.2	2.1	0.0	0.0	28.5	0.0	2.1	0.0	0.0	2.3	0.8	2.8	0.3	0.3	5.8	1.3	5.9	0.8	27.0	1.2	0.9	0.0	0.0	2.1	12.8	8.3	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3	0.0	0.6	0.0	2.8	19.1	0.0	0.8	0.0	1.4	1.2	0.0	0.0	0.1	1.7	1.6	0.7	6.0	1.3	0.0	0.0	0.0	4.3	1.7	10.4	0.0	5.5	0.0	1.2	1.3	8.8	0.6	9.8	6.0	5.0	1.0	1.7	0.0	1.1	2.8	13.8	0.1	0.2	0.0	3.4	0.5	0.1	7.9	0.0	0.0	2.9	10.5
BRINP3	"DBCCR1L, DBCCR1L1, FAM5C"	ENSG00000162670	"BMP/retinoic acid inducible neural specific 3"	Q76B58	1	190097662-190478404	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;intestine: 18.6"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 35.8"	"Group enriched"	"Detected in some"	14	"breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054693	Uncertain				"Secreted in other tissues"	NA	NA					"HPA054693: AB_2682575"	"unprognostic (3.18e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.40e-1)"			"unprognostic (1.72e-1)"			"unprognostic (8.25e-2)"	"unprognostic (3.65e-1)"		"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.58e-3)"	0.7	2.4	11.3	1.0	11.9	0.3	2.0	18.4	30.4	0.5	7.2	2.1	0.0	5.3	0.6	3.7	2.2	0.9	2.0	5.6	8.9	12.2	2.8	0.4	1.6	0.3	6.0	12.7	0.4	0.3	0.4	0.4	0.3	7.4	7.8	7.6	0.0	1.6	6.3	0.4	0.4	18.6	1.0	6.8	0.3	0.7	3.7	2.7	0.0	2.4	0.0	0.5	1.1	0.3	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	11.3	11.9	18.4	19.1	8.9	12.2	6.0	12.7	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.0	35.8	0.0	4.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	1.9	0.0
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158457-192185815	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 66.0;lymphoid tissue: 37.3"	"Cell type enhanced"	"Detected in some"	26	"granulocytes: 24.3;Kupffer cells: 118.0;Macrophages: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 66.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 66.0"	"Group enriched"	"Detected in some"	5	"HEL: 29.3;HL-60: 22.4;NB-4: 21.1;U-937: 19.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		NA	NA		380000	"Golgi apparatus"		"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	3.9	1.9	4.8	11.4	4.6	9.9	1.8	0.9	3.1	2.0	2.2	1.0	0.0	2.3	1.1	2.3	2.0	2.2	4.5	7.5	3.6	2.5	2.7	4.2	16.1	23.0	4.9	0.8	1.6	1.2	0.0	1.2	3.8	4.2	1.8	2.3	0.6	1.6	0.8	0.9	0.9	4.8	2.3	9.2	37.3	1.4	1.3	4.4	3.0	1.3	0.4	3.5	4.6	1.3	0.0	9.8	66.0	14.9	0.1	1.3	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	27.4	9.8	66.0	0.1	12.9	1.3	0.0	0.1	0.2	9.8	0.0	0.0	0.0	32.4	0.1	14.9	2.3	0.0	16.4	4.8	4.6	0.9	3.1	3.6	2.5	4.9	0.8	4.2	4.4	6.0	0.0	2.2	0.0	0.2	0.0	0.4	0.0	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	24.3	0.4	7.6	0.0	0.0	0.6	118.0	0.2	0.3	42.4	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	12.9	0.0	0.1	0.2	0.1	0.1	7.1	0.0	0.0
RGS21		ENSG00000253148	"Regulator of G protein signaling 21"	Q2M5E4	1	192316992-192367285	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Early spermatids: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052843	Uncertain					NA	NA					"HPA052843: AB_2681971"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS1	"1R20, BL34, IER1, IR20"	ENSG00000090104	"Regulator of G protein signaling 1"	Q08116	1	192575727-192580031	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 124.8"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 1329.7;Hofbauer cells: 403.4;Macrophages: 726.1;monocytes: 582.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 16.7;T-reg: 14.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.7;T-cells: 14.5"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 145.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074572	Approved					NA	NA					"HPA074572: "	"unprognostic (3.68e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.87e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.91e-5)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.56e-2)"	46.1	25.9	8.9	46.3	12.0	37.9	19.3	1.9	11.0	15.8	17.5	12.2	2.6	6.8	5.5	5.0	19.0	6.2	32.5	8.4	16.2	19.4	5.9	16.4	39.8	36.5	32.9	4.9	5.1	5.1	2.7	11.4	5.9	43.7	12.8	33.3	5.9	15.6	4.1	4.5	4.6	22.5	23.7	124.8	20.1	9.8	7.9	20.0	24.8	6.3	12.6	24.0	40.3	10.5	0.0	3.3	16.7	0.1	0.5	14.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	16.7	0.6	0.1	1.3	0.0	3.7	3.2	0.4	0.0	0.3	2.9	0.1	0.5	0.0	3.3	14.5	0.4	8.9	12.0	1.9	11.0	16.2	19.4	32.9	4.9	43.7	20.0	11.9	168.0	115.1	5.1	43.7	0.7	1.2	7.6	18.7	23.9	0.0	0.0	2.0	0.0	0.0	1.4	2.7	1.4	70.0	2.4	1.7	15.5	2.9	1329.7	0.8	403.4	0.0	4.6	3.1	135.8	6.5	2.8	726.1	237.8	582.5	0.4	1.0	0.2	3.5	0.7	1.0	1.5	19.4	9.8	0.4	1.1	35.1	5.0	265.3	0.4	6.4
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660306	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.9"	"Cell type enriched"	"Detected in some"	9	"granulocytes: 489.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	35	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 9.2"	"Cell line enriched"	"Detected in some"	17	"Daudi: 34.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA076656	Enhanced					NA	NA					"HPA076656: "	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	2.2	0.1	0.1	46.9	0.6	0.2	1.3	0.1	0.1	2.4	4.2	0.0	1.1	2.2	1.5	1.3	1.3	0.4	3.5	0.4	0.1	0.4	0.5	0.2	3.6	31.7	0.2	0.0	0.2	0.7	0.0	0.8	0.0	0.1	3.9	1.0	0.5	1.4	1.6	0.3	1.9	11.9	2.9	0.2	1.2	1.9	0.7	0.0	0.6	0.6	1.7	22.9	1.4	1.8	0.2	0.1	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	3.0	53.5	3.7	2.5	1.6	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	489.4	0.0	0.3	0.0	6.8	0.0	0.8	0.0	0.0	4.6	6.8	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.3	0.3	0.0
AL136454.1		ENSG00000231767			1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 13.4;Club cells: 30.7;Distal tubular cells: 36.5;granulocytes: 33.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.5;SK-MEL-30: 6.6;THP-1: 7.8"									"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	1.7	0.9	0.3	2.3	0.6	1.9	2.6	0.9	0.9	1.3	0.7	0.0	3.9	2.8	1.8	2.5	0.8	0.7	1.8	0.8	0.5		1.2	0.4	1.3	3.3	1.7	0.2	2.6	7.3	0.0	0.0	0.6	0.8	1.5	0.0	0.4	5.9	4.2	3.4	0.1	1.6	0.6	0.7	3.0	1.2	0.4	1.0	0.2	0.6	2.5	0.8	3.0	2.3	6.1	2.6	1.3	1.9	4.5	7.4	6.4	1.7	0.7	0.5	1.1	0.5	0.0	4.4	0.2	1.0	0.0	0.6	0.0	1.3	0.4	4.4	0.0	0.3	1.8	0.3	0.5	0.0	1.4	0.9	0.8	0.9	3.3	0.4	1.2	2.3	0.5	0.8	0.3	0.0	0.1	0.3	0.4	0.2	1.3	0.0	0.9	1.5	7.5	1.9	0.2	0.4	1.7	0.5	1.0	0.6	2.2	1.4	2.7	0.3	2.7	6.6	0.2	1.7	7.8	0.9	1.1	2.1	1.4	4.0	2.6	1.8	1.5	1.4	1.2	0.2	1.3	1.4	0.7	3.2	1.9	4.6	6.1	5.7	3.5	2.6	5.8	7.4	7.0	0.4	4.5	1.4	2.4	3.6	6.4											8.9	8.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	30.7	1.8	0.0	0.0	36.5	1.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812283	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Translation regulation"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.2"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 1743.9;Macrophages: 609.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 135.8;neutrophil: 234.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 234.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 39.9;hTERT-HME1: 27.6;Karpas-707: 26.2;PC-3: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol		NA	NA			Cytosol		"HPA013385: AB_2668827"	"prognostic favorable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavorable (2.90e-5)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	22.7	62.0	8.1	39.2	20.1	84.9	23.3	6.0	10.0	20.7	57.5	4.5	50.6	23.2	43.3	34.2	45.5	27.4	35.0	14.2	8.2	13.2	9.4	10.8	24.3	32.6	8.9	6.6	25.1	84.3	1.9	52.6	16.7	16.9	99.8	19.1	44.0	5.0	54.5	4.4	6.4	33.9	135.0	19.0	50.6	22.5	13.0	7.9	3.9	4.2	5.7	6.2	72.1	28.5	0.3	6.2	234.2	26.6	0.1	1.8	12.2	0.0	5.5	7.1	0.6	14.1	2.2	0.4	2.7	3.4	0.9	0.9	4.8	3.2	0.4	0.7	2.5	0.7	2.6	4.6	4.8	0.8	0.7	3.4	1.3	3.6	0.1	6.2	3.2	0.8	2.3	39.9	1.8	27.6	5.1	6.6	2.4	1.1	26.2	2.7	0.0	1.7	4.5	9.5	0.5	63.1	1.7	1.6	1.4	4.6	4.4	2.6	13.4	1.9	0.1	3.0	7.6	0.2	1.6	1.8	1.3	1.2	1.4	1.4	15.6	0.4	1.4	19.2	0.6	4.8	135.8	26.6	38.0	0.8	10.5	1.8	0.3	0.5	0.5	6.2	0.1	0.3	0.3	234.2	0.1	17.7	0.8	0.3	12.2	8.1	20.1	6.0	10.0	8.2	13.2	8.9	6.6	16.9	7.9	47.6	315.5	133.6	46.1	37.5	21.4	56.8	2.5	30.8	62.6	129.1	17.7	168.7	0.0	22.6	22.0	24.3	61.9	23.3	26.0	21.8	64.8	43.7	1743.9	2.1	326.0	20.6	335.5	23.9	383.7	13.9	15.3	609.2	84.4	77.5	43.4	36.4	13.0	20.1	59.1	2.2	35.7	0.0	69.0	5.0	9.4	27.1	103.9	144.7	17.8	7.5
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	15.7	18.3	20.1	16.1	26.2	16.0	18.2	30.1	34.8	10.9	17.7	11.5	12.6	19.0	12.5	14.7	26.1	10.7	11.9	22.0	21.6	20.6	21.6	28.3	12.4	19.9	21.3	29.4	13.4	24.8	15.6	16.2	17.8	33.3	17.8	18.8	10.3	19.3	12.9	29.1	16.7	18.0	13.9	20.1	17.3	14.0	9.9	17.5	20.0	15.1	19.1	23.0	14.8	14.8	22.5	20.8	23.8	21.1	35.6	30.9	20.9	33.6	18.7	16.2	16.6	9.5	9.6	19.3	19.8	10.1	19.0	16.5	17.7	22.9	26.4	19.2	11.0	11.5	20.9	21.6	25.6	25.2	27.2	15.5	31.3	24.2	23.4	15.2	49.1	17.6	8.9	11.4	27.3	24.2	8.7	18.7	26.6	68.6	21.6	16.1	27.2	36.1	18.2	15.0	23.1	11.8	21.0	18.2	51.4	17.7	19.8	16.5	20.3	17.8	25.8	27.6	17.9	21.0	24.8	12.2	17.8	5.4	18.0	31.5	16.8	26.0	29.8	10.7	30.6	30.3	23.8	16.5	19.0	28.3	19.5	30.9	22.5	25.9	26.9	19.4	18.0	28.2	30.5	10.0	35.6	21.1	20.8	24.8	20.9	20.1	26.2	30.1	34.8	21.6	20.6	21.3	29.4	33.3	17.5	8.9	24.6	13.7	12.3	21.6	18.3	68.2	15.3	26.8	29.6	26.2	41.2	31.3	38.1	21.6	1.8	20.4	19.5	0.0	24.6	27.1	16.4	17.3	53.3	22.2	24.8	23.8	10.4	18.4	20.3	3.4	13.8	24.5	16.9	19.8	18.3	25.7	20.3	7.0	16.3	30.8	41.8	19.4	17.0	14.0	16.8	26.2	21.1	27.7	20.6	10.5
TROVE2	"Ro60, SSA2"	ENSG00000116747	"TROVE domain family member 2"	P10155	1	193059422-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002835, HPA005142"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		28000	Cytosol	Nucleoplasm	"HPA002835: AB_1857490, HPA005142: AB_2667307"	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (5.62e-2)"	21.2	13.7	13.3	11.4	16.2	29.7	18.5	13.7	16.5	16.9	12.3	13.2	11.7	8.4	15.3	10.9	16.8	11.3	10.9	18.0	13.9	7.7	14.3	13.6	15.0	13.0	19.6	11.8	19.8	12.1	16.8	13.0	13.6	15.1	17.3	9.4	11.4	14.8	14.7	23.4	16.5	11.6	22.7	20.4	14.7	10.9	24.3	17.0	15.1	14.9	8.7	12.9	19.9	19.8	19.1	13.9	38.3	14.6	19.6	24.3	14.5	8.8	15.8	18.3	17.1	15.9	14.7	11.1	13.5	12.6	9.4	12.7	8.1	12.1	18.3	12.5	15.1	8.9	13.6	14.4	10.2	16.6	22.6	11.0	22.1	15.1	10.8	14.6	25.7	16.2	13.7	12.2	17.2	19.2	9.5	15.2	8.0	24.0	24.6	16.1	14.4	15.4	6.8	13.8	7.5	5.2	12.8	15.8	20.8	9.1	18.4	6.5	12.9	16.5	20.2	17.3	13.2	16.6	8.8	20.4	18.0	6.6	16.9	17.2	14.4	14.7	17.4	9.6	12.9	27.6	38.3	13.9	17.4	24.3	13.1	23.4	19.1	17.9	20.3	13.9	17.2	19.0	21.2	22.7	19.6	14.6	12.2	17.9	14.5	13.3	16.2	13.7	16.0	13.9	7.7	19.6	11.8	15.1	17.0	71.5	25.9	47.7	45.1	63.0	52.6	45.3	35.7	34.8	28.4	45.4	117.8	40.8	34.9	43.8	316.3	70.0	20.6	46.7	33.6	38.5	64.8	51.1	57.8	29.4	29.3	44.5	32.6	40.5	33.7	126.5	78.9	44.3	45.5	49.5	21.2	163.1	32.0	20.1	97.9	43.8	149.2	129.4	76.9	43.9	41.4	67.5	40.2	59.1	19.9	30.7
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 789.5;Late spermatids: 1440.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: AB_2683373"	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	14.1	17.9	13.8	9.7	12.2	10.7	16.3	7.4	22.0	7.8	14.9	6.6	7.4	14.7	6.7	14.5	13.1	5.1	8.8	23.5	13.0	13.3	14.3	28.2	7.8	6.1	16.5	13.1	5.4	10.4	4.6	9.9	9.5	22.3	21.8	11.7	7.4	8.6	11.6	28.5	8.9	12.7	10.9	12.3	7.6	10.3	27.9	8.7	2.3	7.7	11.6	9.0	9.6	10.2	10.8	17.4	19.6	21.4	11.6	14.1	10.9	13.9	17.2	4.4	9.8	16.3	10.6	7.8	20.5	8.9	17.0	14.1	10.6	13.4	6.2	11.5	8.5	20.7	13.6	5.2	11.7	17.4	13.7	9.7	12.0	11.6	12.3	17.4	9.8	12.1	7.1	10.2	23.3	11.8	6.6	10.7	4.1	17.7	6.6	20.5	19.3	7.8	18.0	5.1	22.3	12.6	7.1	7.1	14.2	16.3	9.2	4.2	3.8	8.3	24.6	69.6	6.8	10.7	11.1	6.5	13.3	3.4	28.9	21.1	13.3	13.7	11.9	12.7	11.3	18.4	7.8	15.2	19.6	10.8	17.9	11.9	10.8	11.3	9.7	17.4	8.2	10.2	11.4	7.6	11.6	21.4	7.3	14.1	10.9	13.8	12.2	7.4	22.0	13.0	13.3	16.5	13.1	22.3	8.7	8.9	8.5	18.7	19.2	16.3	7.1	57.9	15.3	8.1	7.9	15.7	5.9	33.7	24.9	36.1	789.5	17.5	28.0	0.0	35.9	32.5	22.1	28.9	45.1	29.9	40.5	1.6	13.3	10.4	12.1	1440.5	16.1	26.5	25.3	24.4	19.0	6.6	33.9	28.1	17.0	53.0	11.2	6.5	24.5	10.8	26.4	17.3	20.7	13.8	20.9	15.9
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121997-193253901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	23.4	20.0	18.1	16.8	22.9	21.0	20.1	25.6	22.6	20.4	20.1	14.5	16.3	12.0	26.8	15.2	20.6	14.9	16.4	21.4	18.4	15.0	18.8	17.1	17.2	16.6	19.7	15.9	23.3	14.5	27.1	24.8	17.3	19.4	26.9	16.2	13.6	17.3	19.0	44.5	15.0	14.5	25.6	23.9	16.0	15.7	16.3	22.1	20.6	27.1	14.1	15.8	26.8	35.0	6.6	6.7	10.2	7.0	9.0	12.5	5.2	13.4	12.1	16.0	10.3	15.0	14.6	12.3	14.5	14.1	17.6	15.4	8.3	16.0	17.5	10.3	17.8	9.7	13.2	14.5	13.7	21.5	11.1	6.9	12.7	10.9	8.0	14.1	17.2	12.7	11.9	13.3	16.5	15.8	15.6	14.9	10.0	19.2	14.2	23.5	12.4	14.1	8.5	15.4	19.8	4.5	12.6	9.7	16.7	20.6	9.4	4.8	13.2	18.1	22.4	20.7	18.6	19.2	12.5	16.6	17.1	4.0	14.5	14.8	13.3	9.9	14.4	10.3	10.6	29.9	6.6	7.0	10.2	9.3	6.8	12.5	6.6	9.2	9.2	6.7	5.4	8.4	8.7	7.4	9.0	5.7	4.9	9.3	5.2	18.1	22.9	25.6	22.6	18.4	15.0	19.7	15.9	19.4	22.1	32.8	20.1	34.3	31.1	33.1	31.2	36.4	20.4	20.1	19.4	31.4	33.4	21.8	28.2	29.4	11.9	30.1	16.2	23.3	28.5	34.0	29.2	33.5	39.4	14.3	28.0	20.6	10.9	22.1	25.9	6.1	31.1	38.8	27.0	47.7	15.3	33.5	28.2	13.1	33.9	26.4	36.3	25.8	57.1	56.5	32.0	30.6	31.8	29.8	16.1	23.2
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193179045-193186654	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;gallbladder: 19.0;heart muscle: 25.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 11.9"	"Lineage enriched"	"Detected in single"	57	"T-cells: 11.9"	"Group enriched"	"Detected in some"	4	"AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.7	2.0	11.3	1.3	8.9	0.7	0.9	1.4	32.9	0.8	1.7	1.2	0.9	1.6	0.6	1.8	1.2	0.7	19.0	25.1	10.1	7.9	1.7	0.8	2.6	0.7	5.7	19.1	13.8	0.8	0.4	0.9	0.9	5.0	6.5	2.0	0.3	0.5	7.1	0.6	0.7	4.1	0.8	6.5	1.4	2.1	1.4	4.7	0.0	1.8	0.0	1.6	2.0	0.7	0.0	0.2	0.1	0.0	0.0	11.9	0.3	0.0	0.0	16.4	0.0	0.4	7.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.4	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.3	11.3	8.9	1.4	32.9	10.1	7.9	5.7	19.1	5.0	4.7	0.0	0.3	0.0	0.0	0.2	47.7	27.8	15.3	4.0	0.0	1.8	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	2.3	0.0	0.2	7.9	2.9	1.3	0.3	0.0	29.4	0.1	0.0	0.0	0.3	1.7	0.4	0.0	19.8	0.0	5.8	0.0	0.4	0.0	0.0	0.3	0.0	5.1	0.4	0.0
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.7;Early spermatids: 12.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 4.3;hTERT-RPE1: 12.4;SCLC-21H: 9.3;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	3.9	2.8	4.8	1.3	5.5	0.6	2.2	1.4	8.3	1.8	2.3	0.6	0.0	2.1	2.2	1.7	4.0	2.7	5.9	6.8	9.4	3.1	1.8	10.5	5.5	1.3	1.8	5.2	14.9	1.1	0.9	14.1	1.8	3.7	4.2	2.5	2.9	2.6	2.5	1.2	1.9	2.1	2.6	5.2	1.4	2.6	3.3	1.0	0.0	4.5	3.4	1.2	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.3	0.0	0.0	1.3	0.3	2.7	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.6	0.0	4.3	0.0	0.0	1.0	0.0	0.4	0.1	12.4	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.3	0.0	0.2	0.0	0.3	0.0	0.0	0.7	9.3	8.4	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.5	1.4	8.3	9.4	3.1	1.8	5.2	3.7	1.0	38.7	0.6	0.0	0.3	0.3	0.0	1.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.0	0.0	2.5	0.0	2.3	6.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651878-196747504	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 295.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1052.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 16.5"	"Lineage enriched"	"Detected in single"	27	"T-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	396000000000	110000000000	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113"	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1.0	3.9	3.7	2.5	8.7	15.2	3.4	17.0	47.3	2.0	1.2	7.0	295.2	11.0	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19.0	3.3	10.0	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22.0	22.8	5.8	17.2	16.8	0.0	0.1	0.6	0.1	0.0	16.5	1.0	0.0	13.6	0.0	0.0	21.4	12.1	0.0	5.5	13.5	0.7	2.9	0.0	2.5	0.0	2.0	0.0	0.0	0.4	0.0	5.0	0.5	0.2	0.0	4.1	16.2	0.0	26.9	0.1	0.0	26.3	0.0	4.0	1.7	81.0	16.8	0.0	15.3	0.5	19.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.6	4.3	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	16.2	0.2	0.1	0.1	0.1	0.0	0.0	2.9	0.0	1.2	0.0	0.1	0.0	1.8	0.0	16.5	0.0	6.0	3.5	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	1.0	1.6	3.8	2.6	2.7	2.0	1.2	5.3	1.7	5.3	2.9	8.9	14.5	21.0	47.7	39.3	0.4	6.2	30.6	119.1	131.9	5.2	0.0	0.0	0.0	1.9	1.5	55.0	0.0	0.0	0.7	0.0	200.9	8.6	3.5	1052.9	0.9	0.0	0.0	57.1	34.9	3.6	262.9	6.0	42.2	0.0	0.0	0.3	6.4	0.0	130.4	0.0	1.4	6.5	36.8	0.7	0.6	33.4	0.1	10.2	0.0	49.2
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774795-196795406	"Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"liver: 121.9"	"Cell type enhanced"	"Detected in some"	18	"B-cells: 5.3;Erythroid cells: 23.3;Hepatocytes: 11.3;Ito cells: 9.2;Kupffer cells: 8.5"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;SuSa: 3.1;T-47d: 6.9;U-266/70: 12.6"														"Secreted to blood"	NA	NA	582000000	3800000000				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	121.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.4	0.0	0.6	0.2	0.1	1.4	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.0	0.1	0.0	0.0	3.4	0.1	0.0	0.0	0.4	0.5	0.0	1.4	0.0	0.0	0.0	0.7	0.0	3.1	6.9	0.0	0.0	0.1	0.3	0.3	0.0	12.6	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.3	0.4	0.6	0.1	0.5	0.3	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.5	0.0	0.0	11.3	0.0	0.0	1.7	9.2	8.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
BX248415.1		ENSG00000276911			1	196819745-196959210	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	938	"liver: 93.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 2.6"									"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA					"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	93.7	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819757-196832189	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	174	"liver: 218.9"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 7.6;Erythroid cells: 23.3;Hepatocytes: 8.9;Ito cells: 17.2;Kupffer cells: 14.9"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;HeLa: 3.2;HL-60: 4.8;U-266/70: 6.3"									"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		15000000000	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	218.9	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.3	0.2	2.7	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.7	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.2	0.2	4.8	0.8	0.2	0.0	0.0	0.0	1.0	0.1	1.0	0.3	2.4	0.8	0.0	1.5	0.0	0.9	0.0	0.0	0.8	2.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.5	0.4	0.0	1.4	0.9	0.4	0.2	0.2	6.3	0.0	1.1	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1											3.0	0.0	0.0	0.1	0.3	0.0	1.4	7.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.0	0.0	1.0	0.0	0.0	8.9	4.2	0.0	0.0	17.2	14.9	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.6	0.0	0.2	0.0	0.0	0.1
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196850241-196918972	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	188	"liver: 61.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 31.7"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.0;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 5.0;U-266/84: 2.1"														"Secreted to blood"	NA	NA		180000000									"unprognostic (5.97e-1)"	"prognostic favorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.6	2.5	0.0	5.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	3.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943772-196959226	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1462	"liver: 146.2"	"Group enriched"	"Detected in some"	19	"Erythroid cells: 23.3;Hepatocytes: 31.8"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.9;TIME: 1.2"									"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA		5700000000			"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"							"unprognostic (1.25e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009674	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	241	"liver: 85.5"	"Cell type enriched"	"Detected in some"	24	"Hepatocytes: 88.3"	"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 1.0"									"HPA038915, HPA040726"	Supported				"Secreted to blood"	NA	NA		1700000000			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.3	0.0	0.0	0.0	3.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197039191-197067267	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"liver: 76.3"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 49.0"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;Hep G2: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		3400000000			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Cell type enhanced"	"Detected in many"	16	"Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	20.1	11.3	18.3	11.2	1.1	2.5	6.9	16.1	11.3	16.0	12.7	7.8	15.7	20.5	5.7	12.6	7.0	20.3	15.7	6.4	20.0	18.5	11.9	14.4	26.5	7.5	0.2	21.5	10.3	0.2	0.6	12.8	9.0	4.1	16.8	16.6	18.0	24.4	16.4	7.9	17.2	10.0	8.3	16.2	3.1	13.2	25.2	15.1	5.8	5.5	9.6	13.7	22.9	11.8	5.1	11.8	13.2	8.9	12.8	9.9	9.7	17.0	29.2	7.0	9.5	11.9	7.8	5.9	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2	0.0	0.6	3.7	0.6	5.5	0.0	1.0	0.0	0.0	1.2	1.8	0.0	6.4	0.0	0.3	2.9	0.3	0.3	70.0	0.0	13.2	1.3	0.7	1.1	1.0	9.3	0.0	0.0	1.8	4.0	3.3	0.6	3.1	0.0	1.0	1.5	0.5	0.4	0.0	1.4	0.0	0.3	0.0	0.0	32.6	30.2	3.0	3.1	4.9	4.9	1.7
ZBTB41	"DKFZp686C06120, FLJ36199, FRBZ1, ZNF924"	ENSG00000177888	"Zinc finger and BTB domain containing 41"	Q5SVQ8	1	197153680-197200542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034841, HPA034842"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA034841: AB_2674355, HPA034842: AB_10669995"	"unprognostic (2.36e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.01e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.58e-1)"	2.6	3.8	4.1	1.8	4.0	0.2	5.9	10.8	5.0	4.5	2.2			2.1	3.2	3.8	2.4	2.8	3.2	2.3	4.0	4.7	4.3	3.3	2.3	2.4	4.2		5.9	2.9	5.6	3.8	2.2		3.3	2.5		2.9	2.6	3.3	2.4	1.8	2.2	4.8	3.0	3.2	2.6			6.4		2.2	3.1	2.1	1.5	1.4	1.7	0.7	1.8	2.2	0.7	7.3	4.1	5.5	4.4	8.8	13.3	4.4	4.4	7.3	4.7	4.5	2.6	6.2	2.7	6.5	10.1	2.8	6.1	3.8	3.9	7.5	2.4	2.3	2.2	5.6	2.4	7.8	4.3	2.2	5.4	10.2	4.7	8.2	9.6	3.2	3.1	5.1	3.3	12.0	3.6	3.2	2.4	2.1	5.1	1.5	2.2	7.7	4.8	5.8	4.2	7.9	7.0	8.0	14.1	8.4	4.2	10.7	3.3	5.2	9.3	5.4	7.3	5.8	3.8	1.9	2.9	4.4	1.6	12.9	1.7	0.7	0.4	1.2	0.4	2.2	1.5	1.6	1.6	1.4	1.4	2.2	2.0	0.0	1.8	0.6	0.7	1.0	0.7											17.9	6.2	7.2	4.6	6.6	13.6	12.8	7.6	10.7	10.3	15.7	2.0	3.3	1.7	6.1	2.9	5.5	3.8	0.0	4.9	3.2	6.1	8.3	1.1	8.3	3.7	23.8	12.6	8.0	7.9	2.7	14.4	4.6	11.8	6.4	6.5	30.0	6.0	0.0	11.3	9.1	8.1	6.5	6.1	6.5	4.5	8.8	2.9	4.5	7.6	5.2
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs 1, cell polarity complex component"	P82279	1	197268204-197478455	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 155.1;Muller glia cells: 100.9;Rod photoreceptor cells: 136.0"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 9.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 9.4"	"Cell line enriched"	"Detected in some"	8	"HeLa: 17.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA061250: AB_2684458, HPA063127: AB_2684944"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	1.1	1.1	11.9	0.9	11.0	1.8	1.2	31.4	20.4	0.9	0.9	10.4	0.0	0.9	0.8	1.2	1.1	2.0	1.0	1.2	11.4	6.2	1.1	0.9	1.0	1.0	4.0	8.9	2.6	1.7	0.7	1.9	0.9	14.1	1.0	0.9	9.0	0.8	0.9	2.4	0.9	0.9	0.8	8.7	0.9	1.5	7.3	9.6	0.0	1.3	0.0	0.8	0.9	0.1	0.1	0.0	9.4	0.0	0.1	0.4	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	17.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.0	11.9	11.0	31.4	10.5	11.4	6.2	4.0	8.9	14.1	9.6	0.0	0.0	0.0	0.2	0.2	12.7	1.2	0.0	0.0	0.0	0.0	155.1	0.0	0.0	0.0	1.4	0.0	0.0	23.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.0	100.9	0.0	0.0	0.4	0.0	136.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0
DENND1B	"C1orf218, FAM31B, FLJ20054, MGC27044"	ENSG00000213047	"DENN domain containing 1B"	Q6P3S1	1	197504748-197775696	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042586	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA042586: AB_2678064"	"unprognostic (8.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-2)"	5.9	3.9	6.2	12.7	8.3	6.4	8.7	3.9	5.6	5.7	13.0	1.4	8.8	7.5	3.6	6.4	9.0	3.1	5.4	7.3	4.9	4.9	7.9	6.6	7.3	7.8	4.0	2.7	5.6	8.7	9.9	15.9	3.6	3.7	7.5	7.8	6.4	9.9	15.8	6.5	3.8	21.6	4.1	3.5	7.7	6.1	4.4	2.6	17.9	8.2	6.5	11.7	6.9	6.8	2.3	2.0	5.0	0.6	5.8	3.6	0.7	6.0	1.5	1.7	2.9	0.8	4.5	2.7	4.6	3.2	2.9	1.7	1.6	3.9	11.0	2.4	7.1	1.7	3.1	2.7	3.4	2.5	8.3	3.0	4.0	3.0	0.8	2.4	12.9	4.9	1.5	4.6	1.1	3.2	8.8	1.2	6.4	3.0	17.1	2.8	1.1	6.9	6.6	0.6	1.5	1.5	4.3	1.5	8.6	7.1	5.7	3.0	4.7	7.1	4.8	1.2	2.9	2.0	11.3	3.4	0.3	2.8	0.1	2.7	8.7	0.0	5.6	3.0	5.3	5.3	5.0	0.3	2.3	2.1	0.6	1.1	2.3	1.4	3.3	1.5	0.7	0.8	1.5	1.0	5.8	0.6	2.0	3.6	0.7	6.2	8.3	3.9	5.6	4.9	4.9	4.0	2.7	3.7	2.6	38.7	11.5	19.6	20.9	7.4	19.3	24.6	12.7	4.0	12.5	14.0	23.6	8.1	14.9	8.1	25.6	4.8	51.6	0.0	19.9	7.7	8.9	21.4	63.5	14.3	17.9	4.8	13.8	8.0	21.7	19.7	22.2	29.4	15.1	13.6	24.1	7.1	17.6	42.1	12.4	13.2	13.8	0.0	2.9	8.0	13.3	10.7	6.2	33.8	22.4	47.8
C1orf53		ENSG00000203724	"Chromosome 1 open reading frame 53"	Q5VUE5	1	197902647-197907367	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 10.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065352			Approved	Vesicles,Aggresome		NA	NA			Vesicles	Aggresome	"HPA065352: AB_2685477"	"prognostic favorable (1.63e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.37e-1)"	3.3	10.8	6.5	1.5	3.2	1.7	2.1	1.0	6.6	3.1	5.6	2.8	4.0	4.2	1.6	6.2	3.2	1.7	4.7	7.5	4.8	4.0	8.6	20.9	5.0	2.4	2.7	2.9	2.9	8.2	0.5	6.0	2.9	3.7	2.7	3.0	4.5	4.8	1.5	6.6	1.2	4.3	2.2	1.6	2.2	3.5	4.7	3.5	0.1	4.6	2.1	1.4	1.6	1.5	0.1	2.6	0.0	10.5	0.0	0.8	1.1	4.3	5.2	0.4	2.0	2.7	8.1	3.0	6.7	4.4	5.3	2.8	4.7	3.1	7.2	10.6	7.1	1.3	1.7	1.7	1.2	0.6	2.3	13.6	4.3	3.9	7.9	1.2	9.6	6.3	4.7	3.9	1.9	0.7	3.3	2.0	1.3	1.2	1.6	3.2	6.5	0.5	8.5	4.4	4.4	7.7	1.0	2.8	2.8	8.3	6.3	16.0	12.0	8.3	1.5	2.4	2.1	3.7	3.6	4.5	6.4	7.3	8.9	3.9	3.3	2.4	1.7	4.2	2.9	6.5	0.0	3.6	0.0	0.4	10.5	0.0	0.0	0.2	0.8	2.6	0.1	0.4	0.4	0.0	0.0	5.1	0.7	0.1	1.1	6.5	3.2	1.0	6.6	4.8	4.0	2.7	2.9	3.7	3.5	8.9	8.8	1.4	3.8	2.3	1.9	10.2	28.1	10.7	9.1	21.0	0.0	16.4	16.6	8.2	12.9	1.1	7.3	0.0	12.1	8.3	6.7	6.1	1.1	53.9	8.1	3.2	7.5	2.5	4.0	1.0	13.0	3.7	8.5	1.8	11.1	4.7	9.5	11.5	9.9	19.5	3.8	0.0	1.9	6.1	2.3	2.5	9.8	0.7	15.3	4.3
LHX9		ENSG00000143355	"LIM homeobox 9"	Q9NQ69	1	197911902-197935478	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ovary: 22.1;retina: 24.3;testis: 17.5"	"Group enriched"	"Detected in some"	10	"Leydig cells: 145.9;Peritubular cells: 47.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"fHDF/TERT166: 78.9"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3"	"Group enriched"	"Detected in many"	5	"midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4"	HPA009695	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009695: AB_1079251"	"unprognostic (8.05e-2)"	"unprognostic (1.18e-1)"		"unprognostic (1.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.42e-1)"		"unprognostic (1.88e-1)"	0.3	0.2	1.7	0.1	1.0	0.1	0.1	0.1	0.5	1.1	0.3	0.7	0.4	0.2	0.8	4.1	0.1	0.4	0.2	1.5	0.7	2.6	0.1	1.2	2.7	0.1	0.8	0.0	22.1	0.1	0.1	1.4	0.1	3.1	0.1	0.2	24.3	0.1	0.2	0.9	0.1	0.2	0.1	0.5	0.1	0.1	17.5	0.5	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	2.2	0.1	0.0	0.0	0.0	0.0	78.9	0.0	0.0	1.9	0.0	0.6	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.4	2.3	0.9	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.1	0.5	0.7	2.6	0.8	0.0	3.1	0.5	3.0	9.6	0.0	0.0	0.0	0.0	1.4	0.0	1.4	1.2	0.0	0.0	0.0	1.7	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.8	145.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	47.4	0.0	0.3	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	0.0
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156963-198322420	"Enzymes, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 85.5;fHDF/TERT166: 115.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	31.7	31.4	24.9	15.2	23.0	5.6	23.7	7.8	15.6	19.3	20.6	25.5	13.7	11.3	24.5	11.4	18.7	12.8	15.1	74.7	23.9	20.4	16.1	16.0	22.3	14.9	26.8	13.4	17.2	11.1	14.6	17.6	40.5	18.0	20.0	13.2	11.8	13.5	21.3	29.9	10.6	15.8	30.9	34.9	16.4	11.7	9.5	22.6	18.0	14.9	12.8	12.5	27.4	20.7	1.6	2.1	6.1	2.2	3.8	14.7	1.4	7.1	1.9	2.3	0.9	6.0	6.9	2.7	85.5	35.8	34.8	16.5	3.5	7.1	2.6	6.2	115.4	2.0	4.4	3.5	4.6	35.2	8.1	5.0	3.5	8.2	1.4	7.2	5.9	7.3	4.3	4.0	22.9	6.9	13.0	6.6	21.6	2.7	6.4	15.9	2.2	5.1	3.5	1.2	5.7	1.4	2.7	5.7	4.5	5.9	3.7	1.4	2.7	14.2	8.2	9.5	3.4	6.0	5.4	14.5	9.8	8.3	28.0	8.9	4.5	4.1	1.7	4.2	5.4	7.5	1.9	2.2	3.0	3.2	1.9	14.7	1.3	3.6	4.6	2.1	1.6	2.9	3.6	6.1	3.8	1.7	1.4	6.0	1.4	24.9	23.0	7.8	15.6	23.9	20.4	26.8	13.4	18.0	22.6	26.8	24.2	12.3	15.3	45.6	9.4	150.0	10.2	25.4	21.6	17.4	13.7	11.6	10.0	8.8	2.1	26.3	19.8	46.7	16.9	13.3	24.9	20.4	8.1	19.2	15.2	3.2	19.0	35.0	42.5	1.7	27.0	23.7	28.7	16.2	19.6	10.0	34.6	17.3	36.0	11.6	25.0	19.4	44.2	7.5	5.7	43.0	53.8	20.1	14.9	22.4
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"ductus deferens: 16.9;kidney: 33.4"	"Cell type enriched"	"Detected in some"	43	"Distal tubular cells: 376.4"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028701	Enhanced					NA	NA					"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	1.8	1.3	0.4	0.0	0.0	0.0	0.6	6.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	376.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase, receptor type C"		1	198638457-198757476	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"blood: 116.9;lymphoid tissue: 172.5"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	9.8	2.9	3.4	48.0	6.2	36.1	4.3	1.3	3.5	3.1	5.6	2.8	0.5	4.9	2.9	3.9	4.8	5.6	8.8	4.9	3.9	4.5	4.4	5.2	27.5	93.2	7.9	1.3	2.9	2.1	0.3	2.5	4.5	5.3	4.2	5.8	3.3	10.7	1.0	1.7	2.5	22.2	4.5	13.2	89.3	6.5	2.3	5.3	172.5	4.6	3.9	53.2	13.1	3.7	28.5	42.8	94.7	103.8	53.7	76.1	116.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	26.6	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	61.5	0.5	0.7	0.0	0.0	35.5	14.5	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	0.0	0.0	19.7	0.3	0.0	0.2	0.1	0.1	22.0	20.0	28.2	0.0	21.5	0.1	20.8	52.0	56.3	76.1	99.7	64.5	28.5	52.9	72.7	42.8	26.8	60.2	60.3	94.7	53.7	103.8	6.4	54.6	116.9	3.4	6.2	1.3	3.5	3.9	4.5	7.9	1.3	5.3	5.3	41.7	86.9	266.4	0.7	14.1	0.0	4.1	7.6	21.4	26.1	1.8	0.0	0.4	0.0	0.0	2.0	11.9	0.1	23.3	0.0	0.5	8.9	0.9	232.9	3.0	90.3	0.0	1.2	14.1	338.8	1.5	1.1	290.3	20.3	120.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	6.5	4.3	0.2	0.2	13.2	0.7	539.1	0.5	0.9
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027602-200177424	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 38.7;liver: 36.1;pancreas: 100.4"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 35.9;Exocrine glandular cells: 46.6;Hepatocytes: 34.2;Ito cells: 46.1;Pancreatic endocrine cells: 31.2;Undifferentiated cells: 29.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A549: 19.7;HAP1: 12.0;HMC-1: 5.2;HUVEC TERT2: 16.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.5"					"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	2.9	0.2	0.2	4.5	0.3	0.0	2.6	0.2	0.2	2.3	23.8	0.2	0.6	8.1	3.5	1.3	0.7	1.3	5.7	0.5	0.2	0.4	0.4	36.1	1.6	0.7	0.3	0.3	1.0	100.4	0.0	0.3	0.3	0.3	1.1	6.3	0.3	0.5	1.3	1.0	0.7	38.7	1.8	0.4	0.3	0.6	0.6	0.2	0.2	0.8	0.3	0.4	0.8	1.1	1.3	1.4	5.5	1.2	1.5	1.1	0.3	0.0	19.7	0.0	0.1	0.0	0.2	0.5	0.0	0.3	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.6	0.5	12.0	0.0	0.0	2.5	0.8	0.0	0.2	2.0	0.4	0.0	5.2	0.1	0.0	0.0	0.1	0.0	16.5	0.1	0.0	0.3	0.0	0.5	0.0	0.3	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.6	3.8	0.3	0.1	0.8	0.2	0.1	0.1	2.8	1.8	2.0	0.3	0.1	0.1	5.5	1.2	1.1	0.6	0.7	0.7	0.7	1.0	0.8	0.4	1.3	1.1	1.0	4.2	1.5	0.5	1.4	0.9	0.3	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3	0.3	0.2	0.0	1.7	0.0	0.1	1.6	0.1	6.2	22.9	1.4	0.0	0.0	0.0	0.0	0.0	25.4	0.2	16.3	35.9	0.0	46.6	0.0	0.6	0.2	12.7	34.2	0.1	0.0	4.7	46.1	6.5	0.0	0.6	0.0	0.0	5.4	9.8	0.0	31.2	24.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.3	0.0	0.0	29.8	0.2
ZNF281	ZBP-99	ENSG00000162702	"Zinc finger protein 281"	Q9Y2X9	1	200404940-200410056	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051228	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051228: AB_2681396"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.71e-3)"	"unprognostic (8.30e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.26e-2)"	"unprognostic (4.86e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.83e-1)"	8.4	5.7	8.8	11.4	18.3	31.2	8.8	22.4	13.1	8.5	7.9	9.1	4.0	6.2	8.8	4.6	4.6	6.8	11.3	5.2	10.5	9.2	8.1	22.9	9.1	11.4	17.3	8.1	6.7	7.6	7.0	8.7	10.3	12.0	6.1	5.0	4.1	6.4	5.1	7.8	3.1	7.3	9.8	11.2	11.4	7.5	10.0	19.9	19.9	5.9	4.8	12.3	8.8	10.2	7.1	5.3	24.5	5.4	4.7	9.3	2.2	11.0	10.8	15.1	7.0	6.0	8.3	13.2	11.6	18.3	11.7	11.1	10.6	8.7	15.9	6.9	13.2	13.7	7.5	16.2	10.8	14.0	17.1	9.9	12.7	8.2	10.9	6.6	11.6	7.3	8.0	12.1	12.6	13.8	14.9	10.5	8.7	18.3	2.6	11.8	5.2	11.9	7.3	35.1	3.4	9.8	11.3	10.5	9.5	12.0	5.6	5.3	14.1	11.5	7.7	10.1	24.8	15.4	8.5	14.2	21.9	16.4	5.0	12.3	9.9	9.6	20.4	11.6	9.2	11.6	8.4	5.1	18.4	6.6	5.4	6.7	7.1	5.7	6.9	5.1	6.5	9.3	8.1	24.5	4.7	4.9	5.3	6.7	2.2	8.8	18.3	22.4	13.1	10.5	9.2	17.3	8.1	12.0	19.9	59.6	29.3	27.2	21.7	42.7	47.6	12.9	30.6	17.4	23.9	26.2	27.5	11.5	11.6	18.9	2.1	26.6	10.7	23.3	9.2	25.2	20.8	19.3	5.8	62.2	18.0	17.5	25.7	28.3	42.5	0.9	9.2	21.8	21.9	16.2	10.4	17.4	14.8	13.1	7.4	15.8	32.4	12.9	20.8	46.8	38.7	19.8	10.3	27.4	10.6	13.6
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620734	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.0;lymphoid tissue: 34.4"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 20.6;Spermatogonia: 18.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		NA	Yes			Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.4	0.6	0.2	2.7	0.4	9.0	2.6	0.3	0.3	0.7	2.0	0.4	0.2	1.8	0.4	0.5	3.8	0.2	0.2	0.5	0.3	0.3	0.4	0.8	1.2	4.7	0.2	0.2	0.3	0.3	0.0	0.2	2.8	0.6	0.6	1.8	0.4	0.9	0.2	0.2	1.4	2.4	0.8	0.6	2.0	1.1	4.5	0.2	34.4	0.3	0.6	4.9	0.8	1.3	0.5	0.1	2.4	0.2	0.7	1.9	0.2	15.6	9.3	14.7	8.2	0.4	1.7	8.2	10.8	6.4	10.3	9.4	5.6	8.2	9.5	3.9	5.1	6.4	12.5	11.7	7.2	14.9	11.6	6.2	15.2	13.2	5.4	0.0	23.8	8.7	0.3	0.3	11.5	9.9	2.2	7.3	14.3	22.8	12.4	12.8	6.4	13.9	7.4	12.4	4.6	8.2	12.8	19.5	12.1	3.5	4.5	7.0	7.8	15.3	5.2	6.2	11.5	7.0	6.1	6.0	8.2	9.7	8.9	18.7	4.5	4.5	13.9	4.8	12.8	16.6	2.4	0.1	0.1	0.1	0.2	0.1	0.5	0.5	0.4	0.0	0.4	0.2	0.1	0.5	0.7	0.1	0.1	1.9	0.2	0.2	0.4	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2	0.0	0.0	1.5	0.9	2.2	2.0	0.8	0.0	1.4	1.2	0.0	2.0	1.0	0.0	0.2	2.5	0.5	0.0	0.0	0.0	6.3	1.7	0.8	2.3	0.9	4.3	0.0	0.0	1.8	2.6	1.5	0.6	1.0	0.0	0.0	0.8	0.6	0.2	0.0	0.7	0.0	0.7	6.5	0.4	20.6	18.9	0.6	1.1	0.7	1.2	1.4
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669969	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	14.0	14.4	12.1	16.4	14.8	23.7	22.7	16.7	11.2	14.5	11.6	10.8	12.6	8.1	15.8	17.6	12.0	13.8	11.4	18.0	12.0	9.9	13.6	15.1	11.8	15.1	15.1	6.7	17.1	21.6	13.9	10.7	46.5	12.8	14.1	12.5	15.0	19.4	12.9	28.6	21.5	12.4	14.0	17.2	20.9	10.4	9.9	14.5	18.5	15.1	10.1	13.2	12.8	12.7	12.2	9.5	23.1	16.2	12.4	15.6	7.9	9.4	10.9	12.7	10.6	5.7	10.0	28.3	10.6	9.5	11.4	9.3	3.4	11.1	9.6	5.4	8.4	9.3	9.0	7.1	10.8	8.1	30.3	7.3	7.3	14.0	10.1	11.5	10.5	13.6	10.7	16.4	8.6	23.5	9.5	8.7	13.8	9.2	14.3	11.0	10.9	6.3	15.8	13.4	5.7	8.9	5.3	8.8	18.5	12.2	11.0	7.7	20.0	16.8	17.5	18.6	17.2	15.1	14.8	7.8	9.6	5.4	9.5	10.9	10.9	14.2	12.7	9.2	6.6	16.4	23.1	10.3	19.0	13.0	8.9	10.6	12.2	10.9	11.7	8.5	11.5	11.3	10.3	18.2	12.4	16.2	9.5	15.6	7.9	12.1	14.8	16.7	11.2	12.0	9.9	15.1	6.7	12.8	14.5	17.9	19.0	14.5	11.1	14.3	3.3	15.9	5.1	10.7	7.9	7.0	2.0	18.5	13.3	7.5	2.0	15.9	7.4	0.0	7.3	22.7	10.8	10.1	19.7	6.4	11.5	6.4	1.2	10.4	8.6	0.2	7.5	11.7	5.0	17.2	10.7	8.5	7.9	8.0	12.7	8.4	6.0	0.0	12.3	12.1	19.0	13.7	36.6	13.1	8.8	8.6
CAMSAP2	"CAMSAP1L1, KIAA1078"	ENSG00000118200	"Calmodulin regulated spectrin associated protein family member 2"	Q08AD1	1	200739558-200860704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026304, HPA026511, HPA027302"	Enhanced		Supported	"Microtubule ends,Cytosol"		NA	NA			"Microtubule ends"	Cytosol	"HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380"	"unprognostic (1.19e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (8.23e-3)"	"unprognostic (9.56e-2)"	11.6	11.9	12.8	4.5	15.2	0.1	7.4	16.8	29.7	11.3	5.8	16.6	5.9	2.7	14.4	7.7	8.1	6.6	8.9	7.7	13.0	11.9	8.9	5.0	10.5	2.3	10.3	11.1	14.5	3.9	20.7	6.1	13.0	17.4	8.2	4.7	8.6	5.0	10.0	5.4	9.0	2.7	11.6	10.2	5.6	5.0	10.1	7.0	1.8	13.8	5.3	4.1	13.1	7.4	0.1	0.5	0.7	0.6	0.0	1.4	0.1	11.4	7.7	10.7	9.6	8.6	11.5	12.3	11.6	10.0	9.4	7.8	5.6	6.9	0.0	6.6	12.8	8.6	10.3	11.0	17.1	11.3	6.8	5.6	0.6	11.7	2.5	9.7	0.7	2.9	8.3	26.4	15.0	58.9	10.1	14.2	1.0	1.4	3.6	15.1	6.0	0.1	0.2	10.0	3.5	11.0	4.6	11.8	5.2	8.0	8.5	5.6	10.0	17.0	10.6	9.6	13.6	10.1	0.6	16.9	15.4	9.1	9.5	14.3	7.3	12.1	6.1	11.1	1.8	11.6	0.7	0.6	0.0	0.3	0.1	0.4	0.1	1.4	0.0	0.5	0.0	1.4	0.4	0.0	0.0	0.1	0.2	0.8	0.1	12.8	15.2	16.8	16.3	13.0	11.9	10.3	11.1	17.4	7.0	56.6	33.7	0.0	26.4	71.0	45.8	78.1	5.1	5.3	47.8	14.0	13.7	14.9	1.7	13.5	26.4	49.5	1.6	0.0	7.0	14.2	39.9	20.8	4.7	5.0	8.6	47.7	11.3	33.2	11.8	27.7	26.4	18.8	18.6	2.8	2.4	58.6	14.1	2.5	42.8	4.5	15.4	25.8	43.3	21.7	16.2	43.0	33.4	1.9	3.3	28.4
GPR25		ENSG00000170128	"G protein-coupled receptor 25"	O00155	1	200872955-200874178	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 22.9;lymphoid tissue: 11.6;stomach 1: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 15.1;T-reg: 22.9"	"Group enriched"	"Detected in many"	63	"B-cells: 8.1;T-cells: 22.9"	"Cell line enriched"	"Detected in single"	6	"U-266/70: 5.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.80e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-4)"	"unprognostic (2.21e-3)"	"unprognostic (4.49e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-6)"	"unprognostic (1.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.22e-6)"	0.2	0.2	0.1	3.4	0.9	0.2	0.1	0.1	0.7	0.2	0.6	0.4	0.0	0.5	0.7	0.1	2.6	0.8	0.2	1.6	0.1	0.4	0.2	0.1	1.7	1.7	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	5.2	0.1	0.3	0.1	1.9	0.1	0.1	2.9	7.3	1.5	0.0	1.0	0.3	1.5	11.6	0.9	0.5	8.1	0.0	0.1	0.0	0.2	22.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	6.1	8.1	15.1	4.8	0.0	0.7	0.4	1.3	0.1	0.2	0.0	0.0	22.9	3.1	0.1	0.9	0.1	0.7	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INAVA	"C1orf106, FLJ10901"	ENSG00000163362	"Innate immunity activator"	Q3KP66	1	200891048-200915735	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.3"	"Cell type enhanced"	"Detected in some"	16	"Ductal cells: 31.1;Exocrine glandular cells: 40.0;Pancreatic endocrine cells: 75.5;Proximal tubular cells: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 24.0;CAPAN-2: 20.7;HaCaT: 28.4;OE19: 21.7;RPMI-8226: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027499, HPA027511"	Uncertain					NA	NA					"HPA027499: AB_10599708, HPA027511: AB_10600334"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.84e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.73e-2)"	0.2	0.0	1.2	7.2	1.3	1.5	0.6	0.5	1.3	5.7	41.6	1.2	0.4	24.3	0.6	2.8	26.0	1.9	29.5	0.2	1.0	0.8	12.0	0.6	3.0	0.2	0.7	0.6	1.0	11.2	0.0	0.6	3.1	0.8	6.6	14.1	0.7	6.9	2.4	0.2	23.4	62.3	1.3	0.3	0.2	14.2	0.7	1.0	0.9	0.2	12.3	21.8	11.0	9.3	0.8	0.3	1.2	0.2	0.4	1.2	0.1	11.5	16.4	8.7	0.0	0.0	0.0	24.0	0.0	0.0	0.2	0.2	19.3	20.7	0.0	5.8	0.0	0.4	28.4	0.0	7.3	0.2	0.0	1.9	1.4	0.7	6.5	0.0	2.9	0.3	0.0	10.6	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	17.1	21.7	3.5	0.0	3.7	19.5	9.3	14.6	0.0	1.1	0.9	16.7	0.0	10.6	6.8	2.8	0.0	0.0	4.1	0.0	1.0	18.0	7.4	0.0	0.0	3.1	0.7	0.5	0.2	1.2	0.4	0.1	0.3	0.6	0.4	0.2	0.1	0.8	0.3	0.4	1.0	0.4	0.2	0.3	1.2	0.1	1.2	1.3	0.5	1.3	1.0	0.8	0.7	0.6	0.8	1.0	11.9	6.5	0.0	0.0	0.0	0.0	0.0	0.0	8.1	9.1	14.0	0.0	5.8	5.0	31.1	0.0	0.0	0.0	0.0	40.0	11.7	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	75.5	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023700	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;brain: 20.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	2.2	1.6	19.8	10.0	12.9	34.3	1.5	3.7	20.4	1.5	2.8	6.0	1.0	2.7	1.4	1.0	1.5	1.4	2.9	1.5	15.1	12.5	1.4	1.7	4.3	15.7	8.3	12.7	1.4	1.5	11.3	0.9	1.6	7.1	1.2	2.6	8.6	2.1	1.7	0.9	1.3	6.1	1.5	4.3	11.5	3.2	11.1	4.9	10.8	1.2	0.0	9.1	3.7	1.1	0.9	0.2	8.0	0.5	2.4	1.7	0.6	0.5	0.5	4.7	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.1	15.7	0.2	0.0	1.4	0.1	0.4	0.1	0.1	0.7	0.1	3.7	0.1	0.0	0.4	11.4	16.8	0.3	1.6	0.1	0.3	0.0	0.6	31.6	1.7	19.8	0.0	0.0	9.1	4.1	2.0	1.5	0.0	3.2	0.0	16.8	0.1	0.0	3.2	0.4	0.2	0.2	0.2	0.8	0.0	3.4	1.1	0.0	1.4	0.0	0.1	36.2	16.7	7.8	1.6	4.9	0.1	8.0	0.1	1.0	1.6	0.4	1.7	0.9	1.2	1.7	0.1	0.7	1.0	1.1	2.0	2.4	0.5	0.2	1.0	0.6	19.8	12.9	3.7	20.0	15.1	12.5	8.3	12.7	7.1	4.9	0.0	6.7	6.1	0.2	0.9	21.3	1.2	0.0	0.0	0.0	1.8	55.0	0.0	0.0	0.6	20.0	1.8	0.0	0.0	1.4	0.1	0.9	0.3	5.8	0.0	1.4	1.6	0.0	0.6	3.8	57.7	0.9	2.5	0.0	2.8	1.1	22.6	1.7	0.0	0.0	0.0	23.6	6.5	1.2	1.4	2.5	0.9	0.0	11.7	0.7	1.8
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112566	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 83.1"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 1.4;Cone photoreceptor cells: 5.9;Early spermatids: 1.4;Late spermatids: 3.3;Rod photoreceptor cells: 1.2"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"BEWO: 5.5;HSkMC: 7.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	13	"olfactory region: 5.3"	"CAB009507, HPA048892, HPA056815"	Enhanced					NA	NA					"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
ASCL5	bHLHa47	ENSG00000232237	"Achaete-scute family bHLH transcription factor 5"	Q7RTU5	1	201113953-201127184	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 5.2;pancreas: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;MCF7: 1.7;OE19: 3.0;PC-3: 2.7;SCLC-21H: 3.1;U-2 OS: 1.7"	"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 2.1;hippocampal formation: 1.8"											NA	NA						"unprognostic (9.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.84e-2)"	"unprognostic (9.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.25e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-2)"	0.2	0.4	2.5	0.3	5.2	0.1	0.2	0.4	1.8	0.2	0.2	1.3	0.2	0.3	1.6	0.2	0.2	0.3	0.2	0.2	1.2	1.8	0.2	0.2	0.6	0.5	0.6	0.2	0.9	7.3	0.1	0.5	0.2	1.9	0.5	0.1	0.2	0.2	0.2	1.4	0.1	0.5	0.2	0.2	0.5	0.5	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.9	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.1	0.3	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.0	1.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.7	0.0	0.1	0.2	3.0	2.7	0.0	0.0	0.0	0.0	0.2	3.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	5.2	0.4	1.8	1.2	1.8	0.6	0.2	1.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	12.4	33.4	32.3	8.4	33.3	10.1	20.4	19.9	43.5	31.3	13.1	23.0	20.1	10.9	24.4	30.4	12.0	34.5	17.2	18.4	31.2	35.9	25.7	21.8	18.2	13.4	24.2	29.4	32.8	36.0	20.2	19.0	12.3	23.0	25.9	11.3	28.3	26.3	22.0	15.9	11.0	9.5	16.6	17.0	9.4	15.2	22.2	12.2	7.8	30.7	7.0	10.8	17.6	14.9	28.0	29.3	21.2	32.7	15.1	36.8	37.2	15.0	28.5	18.1	41.8	9.8	14.0	32.1	11.9	12.7	19.0	17.2	27.9	24.5	8.0	17.4	17.8	17.6	30.2	18.9	19.5	9.4	5.1	32.5	13.9	46.0	18.2	18.9	6.6	13.0	16.6	21.7	17.7	10.8	23.0	11.7	11.3	24.8	8.8	16.3	19.3	8.0	10.9	27.6	13.8	70.5	14.5	27.0	10.4	21.8	11.7	16.9	34.5	21.2	36.4	21.9	28.2	44.7	11.7	8.7	21.4	17.8	17.0	14.3	36.2	31.1	6.1	16.2	7.2	10.3	19.1	32.7	16.9	25.5	20.9	28.7	28.0	24.8	20.9	26.9	27.0	36.8	24.2	21.2	15.1	18.9	29.3	21.5	37.2	32.3	33.3	19.9	43.5	31.2	35.9	24.2	29.4	23.0	12.2	47.6	38.0	4.5	30.3	11.4	64.1	33.1	48.4	54.9	40.9	34.9	29.5	35.6	14.9	74.6	47.8	25.3	7.4	0.0	65.8	41.2	50.3	37.0	12.7	32.1	24.1	7.9	30.6	29.4	15.0	47.1	65.6	14.5	21.9	11.8	25.4	102.0	41.4	18.2	49.8	48.1	26.0	12.9	32.0	44.2	81.2	12.2	10.9	12.8	28.5	22.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin-like and fibronectin type III domain containing 1"	Q86VF2	1	201190825-201228952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skeletal muscle: 118.8"	"Group enriched"	"Detected in some"	8	"Leydig cells: 20.4;Peritubular cells: 8.5"	"Group enriched"	"Detected in some"	11	"renal cancer: 1.8;thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HeLa: 37.7"									HPA050415	Enhanced		Approved	"Midbody ring"		Yes	NA			"Midbody ring"		"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.5	0.0	0.6	0.1	0.4	0.0	0.1	0.4	1.4	0.3	0.2	0.3	0.1	0.0	4.3	6.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.3	0.2	0.3	4.6	0.0	0.7	0.1	1.7	0.2	0.0	1.6	0.1	0.1	118.8	0.0	0.1	0.3	0.1	0.1	0.0	1.1	0.2	0.1	11.3	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.4	0.3	0.3	0.2	0.3	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	20.4	0.0	1.7	0.0	0.0	0.0	0.4	0.0	8.5	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2700000	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	45.1	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.2	1.1	26.1	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	46.2	124.1	6.7	1.3	0.0	0.0	4.5	0.0	2.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	1.0	0.0	7.1	21.9	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	1.2	3.2	9.4	0.0	0.0	0.0	37.2	0.0	3.9	0.0	0.0	357.5	0.1	0.0	0.0	44.2
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377762	"Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	241	"heart muscle: 679.2"	"Cell type enriched"	"Detected in many"	289	"Cardiomyocytes: 11884.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"RH-30: 189.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB015371, HPA015774, HPA017888"	Enhanced		Uncertain	"Nucleoplasm,Nucleoli,Focal adhesion sites"		No	No		50000	"Nucleoplasm, Nucleoli"	"Focal adhesion sites"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	0.1	0.3	0.1	0.1	0.7	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	679.2	0.9	0.0	1.9	0.0	0.7	0.3	0.1	1.1	0.1	0.3	0.0	0.2	0.7	0.1	0.7	0.0	0.0	0.2	0.1	2.0	1.3	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.4	0.5	0.0	0.0	189.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	2.1	0.9	0.0	0.1	1.1	0.1	0.0	3.0	4.0	0.0	1.1	3.1	1.0	11884.8	0.0	0.0	1.2	1.8	0.0	2.3	0.0	0.5	9.4	0.0	1.6	0.0	0.3	0.9	41.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	13.6	0.6	0.0	0.0	4.6	0.5	0.0	0.7	0.8	1.1	0.8	0.5	0.0	0.4	0.0	0.2	6.4	3.5	0.0	2.8	1.4
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201373244-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;tongue: 66.9"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 171.5;monocytes: 433.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 36.7;CAPAN-2: 32.6;HaCaT: 47.4;HBEC3-KT: 36.0;hTCEpi: 35.0;MCF7: 40.2;OE19: 50.5;RT4: 34.6;SK-BR-3: 56.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.3	0.2	0.3	10.7	0.3	0.0	3.0	0.3	0.3	15.9	17.5	0.3	22.1	17.4	2.9	4.4	83.9	2.8	56.9	2.0	0.3	0.2	17.2	5.4	3.6	1.5	0.3	0.3	1.5	29.5	0.0	0.4	16.0	0.4	6.9	12.1	0.5	17.1	25.0	1.3	49.7	39.1	1.5	0.3	0.4	13.8	0.6	0.3	3.0	1.6	66.9	42.5	8.9	29.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	36.7	0.3	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.0	23.8	32.6	0.0	2.1	0.0	0.0	47.4	0.0	36.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	35.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	40.2	0.0	0.1	0.9	50.5	0.4	0.0	1.6	0.4	24.4	34.6	1.9	0.0	0.0	56.7	0.6	1.5	8.5	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3	3.0	27.8	1.5	72.1	78.6	0.0	1.8	89.2	4.0	28.4	29.6	0.0	2.9	38.1	140.9	1.0	0.2	171.5	0.0	107.2	4.6	4.1	25.8	0.0	8.5	0.4	0.0	17.4	0.0	0.3	2.4	0.0	2.5	10.1	433.8	49.1	0.0	149.1	89.0	0.4	54.9	0.0	0.0	5.2	0.0	0.0	133.5	8.7	0.0	93.8	117.6
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 559.6"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 50.9"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"RH-30: 106.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA		25000	Nucleoplasm	Nucleoli	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.9	9.5	0.0	0.1	6.6	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.8	0.0	559.6	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.7	83.8	10.7	0.0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	106.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	50.9	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	2.7	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0
PHLDA3	TIH1	ENSG00000174307	"Pleckstrin homology like domain family A member 3"	Q9Y5J5	1	201464383-201469237	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Basal glandular cells: 220.5;Urothelial cells: 526.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 71.6;WM-115: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027601	Approved					NA	NA					"HPA027601: AB_10601389"	"unprognostic (1.51e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (8.55e-3)"	"unprognostic (4.34e-3)"	"unprognostic (5.55e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (9.32e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.45e-2)"	48.6	11.8	12.2	8.0	28.9	1.0	33.3	4.1	17.3	13.7	32.4	26.3	12.8	4.5	13.6	12.6	22.5	15.6	14.7	13.8	15.0	14.4	5.1	3.6	20.0	2.7	37.2	15.4	11.9	7.8	9.0	7.5	14.8	27.6	21.1	6.4	7.1	17.5	27.9	26.2	25.8	6.9	18.5	24.0	4.1	13.6	4.5	27.0	4.2	8.2	10.4	6.3	22.7	16.8	0.5	0.6	3.3	0.5	1.1	2.5	0.2	12.5	14.9	2.8	8.3	12.9	12.3	71.6	18.6	14.3	4.5	5.3	0.9	9.8	0.0	0.8	9.1	3.9	22.0	0.2	15.0	0.9	0.0	5.5	0.0	6.3	11.4	14.7	0.0	0.2	17.1	22.7	7.4	6.5	13.6	6.6	1.1	0.0	0.0	9.5	9.0	1.9	0.2	4.8	0.0	0.9	0.6	13.0	0.0	4.3	28.2	0.1	2.9	6.5	0.2	14.7	11.7	6.2	0.8	9.6	10.7	17.6	9.0	3.9	0.3	0.0	0.0	26.0	0.0	40.7	1.5	0.5	0.3	0.5	0.4	0.1	0.2	0.6	0.2	0.6	0.5	0.2	0.3	3.3	1.1	0.4	0.6	2.5	0.2	12.2	28.9	4.1	17.3	15.0	14.4	37.2	15.4	27.6	27.0	8.9	7.8	0.5	220.5	69.4	4.2	5.3	2.5	5.3	6.8	47.1	0.0	72.2	10.0	33.4	31.8	13.2	0.9	0.0	16.3	17.2	34.7	72.8	0.0	1.0	17.7	0.0	5.1	6.2	0.6	103.1	24.7	10.0	30.4	31.5	1.5	70.5	47.6	0.0	39.3	5.4	4.1	0.0	48.1	0.6	1.4	89.2	31.4	3.2	3.1	526.5
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 338.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 327.5;Smooth muscle cells: 369.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		25000000			"HPA045617: AB_2679391"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	33.9	17.1	39.0	27.3	53.5	5.1	39.6	12.0	56.6	75.6	200.1	92.2	63.2	23.2	159.3	48.5	116.7	81.5	49.4	15.5	41.9	29.6	15.5	14.4	31.1	7.8	55.6	29.8	46.1	14.0	30.9	10.1	26.8	42.2	123.0	56.5	13.9	30.9	338.6	6.7	17.0	41.2	247.1	41.7	15.0	73.6	17.1	62.2	1.6	20.7	8.9	8.5	214.4	40.4	11.0	27.0	26.2	20.9	12.6	21.8	16.4	10.0	26.9	6.8	15.2	11.2	14.4	35.7	76.0	66.7	59.9	47.8	28.4	7.5	9.7	4.7	41.4	12.8	18.4	4.3	15.6	44.8	21.2	3.9	11.1	32.3	3.9	52.0	8.8	1.5	13.2	13.7	48.5	22.1	33.4	65.9	4.5	0.5	9.7	39.2	29.1	5.9	1.4	0.1	12.5	9.3	2.3	39.5	33.5	27.7	17.5	3.6	3.1	30.5	66.1	20.7	3.5	11.3	9.4	76.4	40.4	25.6	27.3	31.4	5.3	10.1	3.9	40.5	17.4	26.4	25.5	19.8	26.2	16.2	19.8	16.2	11.0	15.9	15.2	27.0	7.3	9.2	11.3	2.2	12.6	20.9	2.1	21.8	16.4	39.0	53.5	12.0	56.6	41.9	29.6	55.6	29.8	42.2	62.2	35.7	48.7	12.3	252.2	43.7	3.6	21.5	15.3	34.8	54.6	45.4	0.0	68.5	41.4	149.4	19.4	56.7	80.6	0.0	151.8	327.5	64.0	87.3	27.6	22.4	61.2	0.0	55.6	90.2	24.3	32.7	38.0	44.7	119.8	111.8	58.6	112.9	109.7	63.1	274.8	18.6	3.3	142.3	369.1	0.7	3.0	30.6	134.6	27.7	55.0	93.5
NAV1	"DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1"	ENSG00000134369	"Neuron navigator 1"	Q8NEY1	1	201622885-201826969	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 47.0;Intestinal endocrine cells: 50.7;monocytes: 100.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.2;myeloid DC: 4.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.4;granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"TIME: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012302, HPA018127, HPA027887"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040"	"unprognostic (2.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (3.45e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	17.0	4.3	28.4	10.9	20.6	2.3	12.0	6.9	27.4	8.8	9.4	26.7	1.6	5.3	8.5	6.5	9.5	6.0	10.5	20.1	22.4	11.8	4.5	3.0	9.1	5.4	14.9	20.5	4.2	5.5	9.0	5.6	16.1	16.8	7.4	7.9	6.0	10.3	10.1	6.1	8.8	5.2	14.4	17.8	4.9	7.6	9.6	21.8	0.5	8.6	4.9	5.2	11.1	12.3	0.7	4.4	6.2	1.0	0.3	0.6	0.5	0.4	0.8	8.6	1.1	25.8	21.4	15.5	13.0	12.7	10.6	9.3	0.0	4.6	0.1	0.2	17.8	5.8	6.3	6.5	4.3	8.6	0.7	0.9	0.4	1.6	0.0	6.9	0.0	5.7	9.3	1.6	18.7	10.9	28.6	23.8	0.5	0.2	0.7	8.8	0.1	0.0	0.0	12.6	0.2	0.5	1.1	19.4	2.6	1.4	1.2	6.6	1.3	3.2	14.1	4.5	6.0	0.1	0.3	54.9	16.5	3.4	16.3	11.3	2.4	0.6	0.0	17.9	1.7	14.0	6.2	1.0	0.3	0.4	0.8	0.3	0.6	0.5	0.1	4.4	0.7	0.6	0.3	0.1	0.3	0.7	1.2	0.0	0.5	28.4	20.6	6.9	22.8	22.4	11.8	14.9	20.5	16.8	21.8	3.0	1.0	1.5	2.0	9.7	32.4	31.9	2.5	4.0	2.3	12.2	0.0	12.0	0.0	11.5	1.7	21.8	1.4	0.0	7.3	47.0	16.2	1.6	16.3	0.9	12.7	23.8	50.7	28.3	11.3	2.2	10.0	8.8	21.9	100.0	3.0	12.9	16.4	3.5	0.7	0.6	3.7	6.5	11.3	0.4	2.1	6.0	13.2	0.7	3.4	2.3
IPO9	"FLJ10402, Imp9"	ENSG00000198700	"Importin 9"	Q96P70	1	201829141-201884294	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059540			Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		30000	Cytosol	Vesicles	"HPA059540: "	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (8.92e-3)"	"unprognostic (2.23e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.78e-4)"	16.8	18.0	27.1	14.2	26.5	11.0	15.2	29.1	27.8	14.2	14.3	18.7	11.0	11.5	19.7	24.2	15.2	17.4	12.2	12.0	22.3	17.9	14.9	23.1	16.5	15.7	17.7	22.8	20.9	16.5	24.9	26.0	18.1	21.2	16.3	18.1	24.7	11.2	14.7	15.4	21.9	13.3	21.5	15.0	18.3	13.4	12.8	17.2	21.1	18.4	8.4	20.3	14.4	13.7	10.9	14.6	10.7	15.3	11.0	13.3	8.3	17.8	19.0	26.0	21.1	15.1	10.2	19.5	13.8	14.0	23.1	22.5	30.3	15.6	10.6	7.9	13.2	20.3	16.6	17.5	19.1	20.0	9.7	15.5	7.9	30.8	22.6	11.5	10.3	13.1	11.3	8.8	24.8	20.3	15.5	23.1	14.6	15.7	10.1	16.5	17.9	11.9	13.5	26.1	16.1	6.2	12.7	27.1	10.5	12.5	28.5	22.1	25.2	15.2	24.1	12.2	41.9	17.6	13.1	12.5	21.8	19.5	12.2	25.2	7.5	4.5	12.3	10.8	12.2	16.2	10.7	11.7	9.7	12.2	15.3	10.6	10.9	11.9	13.3	14.6	10.3	9.7	10.4	2.9	11.0	14.9	7.7	10.7	8.3	27.1	26.5	29.1	27.8	22.3	17.9	17.7	22.8	21.2	17.2	20.8	42.9	23.1	13.3	14.1	57.4	22.8	7.6	8.1	26.1	7.0	56.9	22.0	1.7	15.1	6.0	18.8	6.3	23.3	16.1	16.8	22.1	10.7	10.5	17.1	16.6	71.5	10.9	21.5	17.0	6.3	18.7	16.7	13.5	10.0	12.7	40.4	15.2	10.5	26.5	7.9	54.1	38.8	21.7	24.9	32.2	12.4	18.9	13.8	15.0	10.8
SHISA4	"C1orf40, hShisa4, TMEM58"	ENSG00000198892	"Shisa family member 4"	Q96DD7	1	201888680-201892306	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 175.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 18.3;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061273, HPA067885"	Uncertain					NA	NA					"HPA061273: AB_2684460, HPA067885: "	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.48e-3)"	"unprognostic (2.12e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.06e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"	5.2	15.8	22.2	3.8	18.8	2.5	3.3	9.6	34.8	4.7	3.3	29.1	2.1	2.7	4.4	4.5	4.0	3.9	4.7	14.7	17.5	14.6	4.1	3.8	4.0	2.7	19.2	14.8	6.8	4.1	4.1	3.8	3.8	21.3	6.2	2.9	7.2	12.1	5.1	175.2	4.2	3.2	4.7	14.0	3.4	3.2	4.2	8.2	0.0	6.3	18.8	2.7	3.9	2.6	0.0	0.7	18.3	7.8	0.0	1.5	0.5	1.1	8.8	1.0	6.3	9.5	5.7	0.9	7.7	12.6	3.2	4.5	1.5	2.3	0.0	10.5	9.5	12.6	2.2	0.1	1.3	2.1	0.9	0.5	0.1	2.6	1.0	6.7	0.0	5.6	5.8	2.8	4.1	2.0	16.6	5.8	0.1	0.0	0.3	5.6	1.0	0.0	0.0	0.6	0.6	10.7	0.1	0.0	1.7	3.1	3.4	0.4	5.7	2.7	1.3	7.8	5.3	3.6	0.7	5.9	4.6	4.5	2.5	3.9	1.5	1.2	0.0	7.4	0.0	7.9	0.0	1.4	18.3	1.5	6.4	0.6	0.0	0.3	0.3	0.7	0.0	0.0	0.3	8.2	0.0	7.8	0.0	0.0	0.5	22.2	18.8	9.6	34.8	17.5	14.6	19.2	14.8	21.3	8.2	0.0	1.7	0.0	3.6	12.6	9.2	18.3	7.6	0.0	2.3	10.4	3.9	1.5	28.2	22.4	0.5	7.4	0.0	0.0	13.5	19.0	16.6	9.5	1.1	3.4	2.9	4.8	1.7	11.6	2.9	1.5	14.7	4.2	21.9	6.4	0.0	19.3	10.6	0.0	27.6	5.0	3.4	19.4	13.3	1.4	0.7	5.9	2.3	2.2	0.0	1.8
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 127.6;Leydig cells: 116.2;Peritubular cells: 258.9;Rod photoreceptor cells: 66.8;Sertoli cells: 194.1;Smooth muscle cells: 158.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.2;BJ: 11.9;BJ hTERT+: 19.3;fHDF/TERT166: 9.6;HSkMC: 8.5;hTERT-RPE1: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No			Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	9.2	1.1	0.7	11.9	19.3	0.7	0.9	0.0	0.1	0.0	0.4	9.6	0.1	0.2	0.3	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	8.5	0.0	0.5	0.0	31.2	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.2	5.6	0.4	0.0	0.0	0.1	0.4	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7	0.0	1.4	0.0	0.7	1.1	4.9	22.4	0.0	1.4	0.0	0.0	127.6	1.1	0.0	0.0	1.9	2.1	0.0	0.0	0.5	0.2	13.9	0.6	0.0	0.0	0.8	3.2	0.0	13.5	0.0	3.6	116.2	0.0	3.3	0.0	0.0	4.5	0.0	0.0	258.9	0.0	66.8	194.1	158.8	1.4	0.2	1.9	1.0	0.0	0.0	0.3
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955491-201970661	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	16.6	27.6	22.7	18.7	23.2	16.9	16.8	16.3	29.3	16.5	19.3	9.9	19.2	17.2	15.0	24.1	17.9	11.8	10.7	39.0	32.3	19.6	25.1	53.7	13.5	15.3	20.6	27.0	11.2	18.7	21.5	14.8	17.4	25.0	14.5	21.8	11.7	24.8	17.1	42.1	11.5	13.0	19.6	13.4	14.4	16.3	13.7	14.2	11.3	21.6	30.4	18.9	15.9	12.7	17.6	28.9	16.0	24.9	15.9	20.6	17.8	26.4	27.0	24.5	29.3	20.7	21.7	41.4	42.3	30.3	34.8	31.3	31.6	27.6	36.7	15.6	36.2	25.5	21.2	44.9	25.3	37.5	26.9	28.1	20.2	35.9	29.9	21.4	43.1	21.8	25.0	28.2	35.5	29.8	25.1	36.3	23.2	51.0	20.6	40.8	16.9	23.1	23.4	31.1	26.7	14.6	22.9	28.5	46.0	42.7	25.2	37.0	26.2	25.9	66.4	39.1	32.5	36.7	29.3	29.0	23.3	24.7	27.0	43.9	31.3	33.7	30.8	24.8	32.9	25.9	8.9	19.0	16.0	13.6	24.9	17.5	17.6	14.9	17.2	28.9	12.7	14.2	16.7	4.4	15.9	24.7	19.3	20.6	17.8	22.7	23.2	16.3	29.3	32.3	19.6	20.6	27.0	25.0	14.2	35.7	37.0	55.2	74.7	81.9	22.9	117.0	40.8	46.8	42.1	36.6	33.4	102.6	116.0	97.2	44.4	41.4	33.9	0.0	74.9	170.0	67.6	57.0	54.3	165.4	105.8	33.4	32.6	35.6	45.4	26.9	31.1	72.6	50.6	99.2	41.2	32.7	83.8	23.0	36.0	93.3	25.4	25.8	62.2	38.1	50.8	86.4	222.1	56.4	49.3	91.8
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		6600000	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.1	20.9	12.5	18.7	20.4	19.2	31.4	14.8	28.8	18.6	21.0	15.0	24.6	4.2	19.1	26.1	11.5	34.9	15.9	29.0	13.0	11.4	20.5	10.5	10.0	14.0	17.4	26.7	37.1	17.5	30.0	16.6	19.1	23.1	33.4	10.4	23.8	6.2	18.8	17.5	3.6	11.4	17.6	30.6	10.4	14.0	17.6	29.6	38.6	17.5	14.4	12.2	36.7	45.8	14.8	25.3	34.8	15.2	23.8	8.7	11.8	8.5	18.0	13.9	11.2	3.8	8.7	22.7	17.4	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0	8.9	19.2	23.6	35.3	25.5	11.5	9.0	43.3	13.4	15.9	24.4	9.8	99.1	16.6	59.5	4.4	20.4	152.6	0.0	44.9	74.5	19.0	29.0	15.0	46.6	92.1	11.1	43.1	27.0	67.5	3.8	23.6	48.7	23.6	85.6	66.6	10.8	41.4	81.6	21.5	50.1	7.7	25.8	18.6	15.7	8.2	18.9	73.2	17.5	73.0	31.8
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017188	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 1511.9;Glandular cells: 1015.6;Paneth cells: 1043.9;Urothelial cells: 1629.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 40.5;CAPAN-2: 57.8;OE19: 37.3;RT4: 41.5;SK-BR-3: 80.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	0.3	0.1	0.1	16.0	0.2	0.0	34.0	0.2	0.2	13.2	80.7	0.2	12.5	34.4	3.8	8.9	59.3	8.6	67.7	1.1	0.1	0.1	38.1	33.3	24.6	0.1	0.1	0.1	5.8	38.4	1.1	1.7	16.7	0.3	39.9	31.3	0.7	37.9	11.3	0.7	3.5	100.8	9.5	0.3	0.2	29.9	1.9	0.1	0.6	5.7	25.5	43.5	44.7	22.7	0.3	0.8	2.0	0.3	0.2	0.3	0.0	10.6	40.5	0.0	0.0	0.0	0.0	12.6	0.0	1.5	0.0	0.0	9.0	57.8	0.0	4.8	0.0	0.3	10.5	0.0	0.0	0.0	1.2	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	0.6	37.3	3.4	0.0	0.0	0.5	15.4	41.5	0.0	0.0	0.4	80.2	0.0	1.9	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.8	0.3	0.2	0.1	2.0	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.1	273.9	377.1	5.4	575.3	4.5	1.7	1.2	448.4	586.2	343.5	312.3	17.7	60.7	34.9	553.5	0.0	1.1	1511.9	0.0	565.5	107.5	4.2	1015.6	40.3	30.4	7.8	0.0	434.4	0.6	1.3	0.0	0.0	12.0	8.5	25.2	963.0	2.0	453.3	1043.9	0.0	114.1	63.9	0.0	0.4	0.0	0.2	7.3	215.1	2.2	773.6	1629.9
GPR37L1	ETBR-LP-2	ENSG00000170075	"G protein-coupled receptor 37 like 1"	O60883	1	202122858-202133592	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 44.0"	"Cell type enriched"	"Detected in some"	11	"Muller glia cells: 51.7"	"Cancer enriched"	"Detected in some"	57	"glioma: 36.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HaCaT: 2.9;MCF7: 3.3;T-47d: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064454	Enhanced					NA	NA					"HPA064454: AB_2685268"	"unprognostic (2.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.52e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.26e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.49e-1)"	1.6	2.0	20.5	1.6	25.2	1.9	1.6	13.2	44.0	2.0	2.4	33.4	0.0	1.9	1.8	1.8	1.7	1.8	1.7	1.6	22.3	12.6	1.5	1.6	1.6	1.5	17.7	22.1	1.7	1.5	1.5	0.4	1.6	23.8	1.7	1.9	0.9	1.9	2.3	1.7	1.8	2.1	1.7	11.1	1.6	1.6	1.9	15.7	0.0	1.8	0.0	1.5	1.6	0.2	0.9	0.9	1.8	0.9	0.6	1.4	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.1	2.9	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.1	1.2	0.0	0.1	9.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.0	0.8	0.7	0.5	0.9	0.7	0.6	0.3	0.2	0.6	0.9	0.7	0.5	1.8	0.6	0.4	0.9	1.4	0.2	20.5	25.2	13.2	39.3	22.3	12.6	17.7	22.1	23.8	15.7	0.0	0.0	0.0	0.5	0.3	1.1	0.8	0.0	0.0	2.3	0.0	3.9	0.0	0.0	2.5	3.5	0.0	1.0	0.0	1.1	0.8	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.5	51.7	1.5	2.9	1.8	0.0	4.7	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.4	0.8
ARL8A	"ARL10B, FLJ45195, Gie2"	ENSG00000143862	"ADP ribosylation factor like GTPase 8A"	Q96BM9	1	202133404-202144743	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038759, HPA040515, HPA045924"	Approved					NA	NA					"HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500"	"unprognostic (1.20e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (5.15e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.66e-2)"	24.1	26.5	30.5	18.0	34.5	44.7	17.8	24.4	54.4	15.6	13.0	52.8	8.2	16.3	16.9	13.6	15.5	15.6	16.4	24.0	39.0	34.6	16.7	20.8	20.7	14.2	42.6	23.0	18.9	21.4	12.9	13.6	23.2	41.2	17.2	8.7	15.0	18.2	16.3	28.6	14.6	15.5	16.6	61.6	19.9	15.9	11.9	30.8	9.7	14.6	10.1	11.4	15.1	13.4	2.3	3.9	9.7	3.1	0.9	2.4	1.1	10.5	11.4	11.9	14.4	10.8	9.4	5.1	12.5	16.5	14.4	11.1	4.1	8.4	10.2	8.3	13.0	13.4	15.2	7.9	8.7	4.6	19.9	11.1	6.2	6.0	4.2	21.5	12.4	29.3	10.2	23.0	12.5	10.9	15.2	14.5	10.5	5.8	15.7	10.0	11.5	8.6	17.2	17.0	3.6	4.0	8.4	10.5	8.9	13.4	9.1	11.1	28.9	10.2	33.6	19.7	15.7	15.5	14.0	17.2	11.6	10.5	19.8	10.6	24.8	23.3	8.5	9.4	6.6	9.6	4.7	3.1	9.7	2.4	3.0	1.7	1.7	1.9	1.9	2.2	2.3	1.1	1.5	7.6	0.9	2.8	3.9	2.1	1.1	30.5	34.5	24.4	49.3	39.0	34.6	42.6	23.0	41.2	30.8	17.9	12.2	9.5	20.4	36.7	33.0	1.8	17.8	5.3	7.9	10.4	13.7	28.6	5.0	33.0	0.4	26.5	12.3	0.0	25.4	12.3	27.3	25.2	18.5	34.2	49.7	50.9	19.8	20.9	48.0	1.5	31.1	36.6	30.4	31.5	16.2	44.2	40.1	19.2	25.8	23.9	17.8	25.8	19.8	0.9	5.1	45.2	63.6	18.1	9.2	31.9
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Group enriched"	"Detected in many"	5	"B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	16.7	0.0	0.0	0.0	36.3	48.9	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.7	1.5	0.0	0.0	4.9	15.8	0.0	0.0	0.0	0.7	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	7.4	1.8	10.5	0.0	26.2	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9	3.0	9.0	40.6	1.0	2.1	2.4	0.7	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.4	2.9	0.0	0.0	0.0	0.1	1.7	0.5	137.4	0.5	15.6	0.0	0.0	4.9	6.2	1.3	4.9	23.4	8.5	9.0	0.0	5.6	0.1	0.0	2.1	0.6	4.4	0.0	0.9	0.9	0.4	2.0	0.7	156.8	0.0	0.5
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193901-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	41	"T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0"	"Region enriched"	"Detected in some"	9	"olfactory region: 30.0"					HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.1	0.9	0.8	3.2	1.8	7.9	6.0	2.4	2.6	2.2	1.5	0.5	0.2	1.6	7.3	4.4	13.8	49.6	12.3	0.7	3.3	0.9	1.4	6.9	1.1	6.8	0.2	2.2	0.5	0.1	15.9	0.9	9.3	6.7	1.1	0.8	8.5	2.5	0.3	3.2	1.6	2.6	1.6	5.3	0.7	4.9	3.9	0.2	4.1	2.6	3.4	3.2	2.9	0.0	0.0	0.0	0.0	0.3	14.3	2.5	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	1.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.9	0.0	1.7	8.3	0.0	0.0	0.7	4.7	0.0	0.3	0.0	0.0	0.4	2.5	0.9	3.2	6.0	2.4	0.7	3.3	6.8	0.2	9.3	3.9	0.0	0.0	0.0	2.8	1.1	0.0	8.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	3.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.0	3.3	0.1	0.7	0.5	1.7	0.3
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.4	29.1	43.3	20.4	4.0	7.4	24.8	33.3	18.6	38.1	26.9	20.7	37.4	35.5	13.2	12.1	28.4	24.9	40.0	19.5	34.4	32.2	22.9	21.7	15.8	23.6	1.8	25.9	26.4	2.6	4.7	29.9	12.5	9.1	22.1	40.1	27.3	29.3	29.8	28.3	46.4	33.1	16.8	31.7	14.8	36.0	46.1	30.8	14.6	14.6	34.1	34.8	23.3	28.7	11.1	13.5	30.2	16.4	10.8	17.2	27.5	30.0	39.5	14.9	29.1	45.2	17.0	27.0	35.6	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8	0.0	2.1	10.4	11.0	12.7	5.2	12.2	0.0	6.7	7.9	5.2	0.0	33.9	5.0	11.2	13.0	1.9	2.7	186.9	6.6	82.9	4.8	2.2	8.1	1.7	23.5	9.5	1.2	4.3	1.8	6.6	2.8	5.2	3.3	3.6	9.0	1.3	7.8	0.0	3.9	7.9	0.9	6.5	1.9	115.5	96.9	9.5	18.8	9.5	19.6	4.1
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 105.2"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 719.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 15.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	10.6	2.8	6.9	8.1	9.0	1.8	7.7	13.9	10.5	55.3	62.0	15.0	31.0	5.8	105.2	9.4	37.4	21.9	17.4	83.1	5.8	4.5	5.0	2.9	8.1	4.2	10.1	9.2	18.7	2.3	2.0	4.5	8.4	9.5	36.4	16.3	13.7	5.7	50.3	17.6	5.3	14.1	59.5	7.3	6.9	20.8	3.4	11.1	1.3	5.0	11.2	3.5	35.1	11.4	2.3	1.7	15.9	1.8	0.7	1.7	0.5	2.6	5.3	4.1	3.9	5.8	4.2	6.7	2.1	2.1	2.2	2.1	2.2	4.7	3.0	1.0	3.9	5.3	8.4	6.0	3.2	2.4	3.8	3.7	3.0	7.7	1.4	1.4	6.3	3.4	3.3	3.7	3.1	3.3	11.3	1.8	3.4	4.4	3.5	3.8	2.0	4.7	4.0	2.8	2.9	1.1	3.1	10.5	4.3	1.8	9.6	5.0	3.8	4.0	4.8	2.4	5.6	4.2	2.9	2.3	3.1	1.9	2.3	1.8	5.2	4.8	3.2	2.9	5.2	12.3	1.8	1.8	1.3	1.7	0.9	1.4	1.7	1.1	1.0	1.4	2.3	1.4	1.0	15.9	0.7	1.4	1.7	1.6	0.5	6.9	9.0	13.9	10.5	5.8	4.5	10.1	9.2	9.5	11.1	11.9	17.5	3.7	31.2	15.3	56.6	719.4	12.7	16.0	18.2	12.2	70.7	12.7	10.0	7.2	30.9	9.2	21.3	0.0	11.3	7.2	19.0	16.4	17.4	6.8	7.8	25.4	23.1	20.9	18.5	10.9	11.2	6.0	8.5	1.8	14.0	11.8	6.3	11.5	48.1	4.5	32.3	32.3	105.4	11.9	13.7	9.5	21.3	11.5	30.2	28.9
SYT2		ENSG00000143858	"Synaptotagmin 2"	Q8N9I0	1	202590596-202710417	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	Differentiation		"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 40.1"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 3.4;Cardiomyocytes: 2.4;Horizontal cells: 3.2;Leydig cells: 3.1;Rod photoreceptor cells: 4.1"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.8"	"Group enriched"	"Detected in many"	5	"cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;NTERA-2: 8.8;U-2 OS: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA063655	Enhanced	Supported				NA	NA					"HPA063655: AB_2685077"	"unprognostic (1.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.35e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.17e-3)"	1.1	6.1	0.4	1.1	5.9	0.5	0.3	36.2	14.7	0.6	0.7	0.3	0.0	1.1	1.7	4.1	0.4	0.8	1.1	1.5	0.6	1.5	0.5	0.4	0.6	0.7	5.5	0.4	3.1	0.4	0.2	0.3	0.5	40.1	0.9	0.7	1.6	1.1	0.5	1.1	0.7	1.3	0.5	7.1	1.2	0.7	2.4	1.1	0.0	0.6	0.0	0.5	1.0	0.3	0.1	0.0	2.4	0.1	0.1	0.2	0.0	0.0	0.2	12.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.4	5.9	36.2	14.7	0.6	1.5	5.5	0.4	40.1	1.1	0.0	0.0	0.0	1.3	0.5	3.4	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.2	1.3	0.5	0.1	0.0	0.2	2.0
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724491-202809470	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.0"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 181.0;Spermatocytes: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	7.7	7.1	5.9	8.2	7.8	14.8	12.3	12.7	9.0	12.9	9.6	5.1	9.7	5.0	13.6	9.4	17.6	8.6	8.4	5.7	6.1	4.5	6.0	4.6	9.0	5.4	3.7	7.3	13.3	9.0	9.8	8.6	23.1	5.0	11.3	9.0	16.0	11.1	8.8	4.3	19.5	7.3	10.1	4.9	6.9	8.2	74.0	5.2	25.8	9.1	6.2	10.4	12.2	12.6	4.1	3.0	16.0	5.2	7.3	4.4	2.6	10.6	4.3	28.9	13.9	13.7	12.4	24.4	7.3	11.3	7.7	8.2	3.6	11.3	0.0	5.0	11.4	5.7	16.4	13.6	12.0	9.9	0.1	5.2	5.8	4.1	5.8	11.7	18.0	7.7	12.9	20.0	11.0	14.5	20.8	17.1	7.2	18.0	0.0	7.7	10.8	5.0	21.5	19.6	7.4	7.6	21.2	0.0	0.0	11.1	18.4	8.8	19.5	15.5	9.5	12.9	39.6	19.5	12.9	12.6	6.8	5.1	0.8	4.2	1.1	0.7	4.5	6.0	6.7	2.8	16.0	2.9	6.4	3.7	3.4	3.1	2.8	3.3	2.7	3.0	4.1	4.2	1.8	9.5	7.3	5.2	2.1	4.4	2.6	5.9	7.8	12.7	9.0	6.1	4.5	3.7	7.3	5.0	5.2	83.4	33.4	5.4	32.8	57.2	30.9	7.3	10.2	54.9	40.9	15.7	58.9	35.8	5.0	41.9	155.3	25.3	16.1	0.0	19.5	25.5	34.2	40.2	25.5	9.6	7.0	14.3	41.9	19.0	17.8	181.0	33.6	10.8	25.3	10.0	31.3	68.3	38.0	17.3	30.8	5.9	133.9	32.3	21.7	261.1	71.6	101.6	68.9	12.5	27.0	45.7
RABIF	"mss4, RASGRF3"	ENSG00000183155	"RAB interacting factor"	P47224	1	202878957-202889135	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027715, HPA054936"	Approved		Approved	"Microtubules,Cytokinetic bridge"		NA	NA			"Microtubules, Cytokinetic bridge"		"HPA027715: AB_10602151, HPA054936: AB_2732590"	"unprognostic (4.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.62e-3)"	"prognostic favorable (5.64e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.23e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.47e-1)"	7.1	7.0	13.4	10.3	13.8	14.0	7.9	11.5	17.9	8.9	10.4	10.9	3.1	9.9	6.3	8.2	13.8	6.2	8.4	6.7	12.7	15.4	11.2	10.9	8.9	11.7	13.4	10.4	4.0	5.7	6.0	9.2	11.2	14.5	8.6	11.7	6.6	7.9	6.8	7.4	10.6	12.0	9.3	18.2	10.2	7.0	30.2	10.6	8.9	6.3	8.8	15.8	9.4	7.5	15.7	17.7	31.1	21.0	14.9	18.7	15.6	12.4	13.5	9.6	11.0	15.2	11.7	10.6	13.9	7.7	14.4	13.5	9.3	10.9	10.3	6.9	11.0	9.9	11.8	7.6	8.8	10.9	12.2	14.1	8.5	11.1	9.7	12.3	11.6	14.8	9.7	12.7	18.1	4.7	7.2	18.9	13.4	13.4	11.4	14.0	20.8	12.9	12.6	7.8	9.8	16.7	9.3	13.0	14.1	14.7	13.0	13.7	12.0	12.0	21.2	10.7	12.5	13.7	8.5	14.5	10.1	9.3	4.6	12.2	6.0	13.2	11.0	9.9	10.8	9.3	24.1	20.0	27.6	18.3	21.0	13.3	15.7	17.4	17.2	17.7	15.5	15.9	16.7	31.1	14.9	18.8	16.9	18.7	15.6	13.4	13.8	11.5	17.9	12.7	15.4	13.4	10.4	14.5	10.6	0.0	15.7	22.8	29.0	48.2	4.6	9.3	7.6	9.4	7.9	12.2	2.0	43.7	13.3	34.0	555.0	24.8	30.4	0.0	46.5	41.5	19.7	25.2	12.7	28.9	36.9	1.6	22.4	16.0	37.6	2502.1	26.2	34.4	50.6	48.7	12.4	10.8	58.5	31.6	28.3	47.7	5.7	12.9	27.6	68.8	55.8	45.4	66.0	26.1	13.4	37.3
KLHL12	C3IP1	ENSG00000117153	"Kelch like family member 12"	Q53G59	1	202891100-202928636	"Predicted intracellular proteins"	"ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 101.2;Late spermatids: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071324			Supported	"Vesicles,Centriolar satellite"		NA	NA		9600000	"Vesicles, Centriolar satellite"		"HPA071324: AB_2686389"	"unprognostic (1.69e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.11e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.22e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.87e-2)"	14.1	18.3	19.3	17.1	20.2	16.1	20.1	18.6	35.5	14.1	18.4	14.2	13.5	13.9	14.7	23.2	17.2	18.5	12.6	25.2	19.2	25.6	21.5	17.1	20.4	29.6	19.6	20.1	18.1	25.6	17.9	19.0	15.0	24.7	19.6	23.2	12.7	13.8	16.6	14.6	13.5	14.3	19.7	25.2	19.4	15.4	41.3	14.6	15.9	19.6	10.1	20.6	16.1	16.2	9.5	12.7	18.4	14.9	10.2	13.3	9.9	10.1	12.1	15.5	17.4	24.0	18.2	18.1	12.2	14.2	15.4	14.1	11.4	16.6	28.2	9.5	13.8	15.6	12.9	20.7	17.1	16.9	14.7	8.7	9.9	9.5	11.4	17.4	20.6	16.5	17.3	21.8	13.3	29.3	12.1	13.7	28.8	24.6	18.7	20.9	13.6	17.1	10.0	22.0	12.7	9.2	18.2	27.1	18.0	13.3	12.5	11.5	13.1	15.2	13.9	16.4	29.4	25.3	14.5	11.1	15.1	10.6	3.6	10.8	13.5	10.8	23.8	14.7	14.8	14.3	9.2	12.0	18.4	9.1	14.9	13.2	9.5	9.1	10.8	12.7	9.3	9.6	10.3	12.4	10.2	14.7	7.6	13.3	9.9	19.3	20.2	18.6	35.5	19.2	25.6	19.6	20.1	24.7	14.6	6.0	8.6	6.9	9.0	4.7	9.9	14.6	7.6	2.7	4.5	15.7	11.8	9.8	19.9	10.1	101.2	6.4	11.1	0.0	7.9	10.1	6.7	8.5	3.5	5.9	14.9	4.8	10.4	11.1	12.3	66.5	7.8	9.8	5.0	15.4	14.3	10.8	10.2	10.5	7.8	12.3	9.0	6.5	6.2	16.9	45.6	5.8	9.3	11.4	12.1	6.4
ADIPOR1	"ACDCR1, PAQR1"	ENSG00000159346	"Adiponectin receptor 1"	Q96A54	1	202940823-202958572	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.63e-2)"	26.8	24.8	20.4	16.4	25.9	65.7	29.6	18.1	29.0	22.2	19.3	33.2	17.1	16.2	18.0	33.7	49.1	24.8	18.5	39.6	19.8	19.5	30.5	56.8	41.5	33.6	20.7	14.3	22.6	66.2	30.4	21.6	63.1	20.2	23.1	21.6	38.3	39.7	17.9	43.5	46.1	24.4	18.2	30.2	36.9	24.8	24.9	18.3	21.9	26.6	28.6	32.1	25.0	29.3	21.6	28.8	112.6	49.9	16.0	23.4	63.8	24.9	23.8	14.6	16.0	30.5	23.5	74.4	28.0	32.7	29.1	27.0	23.7	30.3	16.7	20.8	31.7	23.3	31.0	21.7	38.4	26.4	31.5	24.7	12.8	30.2	18.8	30.1	26.5	19.5	27.8	62.6	31.6	32.3	29.1	28.6	29.5	33.0	35.5	29.3	27.2	21.9	19.5	32.0	22.5	27.3	17.5	35.4	32.3	28.2	30.0	24.0	24.8	29.6	44.2	34.4	40.8	32.1	25.7	25.5	21.5	17.0	10.5	30.8	37.5	50.8	18.9	30.8	15.3	25.1	39.6	49.9	59.9	19.7	33.5	20.4	21.6	21.0	19.3	28.8	21.4	21.0	18.4	112.6	16.0	32.3	19.9	23.4	63.8	20.4	25.9	18.1	29.0	19.8	19.5	20.7	14.3	20.2	18.3	32.8	48.6	40.6	78.1	208.7	24.6	48.9	30.6	50.9	36.4	50.6	27.5	96.5	58.0	65.0	51.8	53.4	41.2	210.2	76.0	142.7	52.5	96.6	35.9	53.5	89.9	11.1	47.2	52.8	115.1	42.9	26.4	67.3	81.0	74.9	43.5	23.3	91.5	45.6	23.0	46.9	35.3	38.8	45.3	11.6	29.6	200.0	169.6	42.7	43.1	136.7
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		860000	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.5	5.3	4.7	9.6	43.9	10.1	46.1	17.1	16.2	11.2	10.0	4.4	10.1	5.3	14.6	17.1	6.2	47.3	3.8	14.7	7.4	7.6	9.7	3.0	6.5	5.0	15.8	2.6	7.6	16.2	48.7	12.3	6.7	9.5	7.3	6.6	8.9	9.6	40.2	10.0	3.2	2.3	3.1	7.7	10.3	5.4	22.7	11.3	10.6	10.2	4.0	5.0	9.6	32.0	13.9	10.7	14.8	5.8	7.1	12.8	5.4	4.8	9.5	9.0	10.6	2.5	14.1	4.0	9.5	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7	20.8	24.3	13.0	30.5	166.3	19.6	98.7	33.1	58.9	20.5	27.9	27.5	100.3	6.6	35.7	4.3	29.5	11.9	23.3	41.7	159.6	29.6	19.2	27.7	36.0	54.2	9.5	18.4	23.4	39.9	5.4	27.6	33.5	60.8	9.0	10.9	56.4	53.6	10.5	29.4	32.1	25.9	12.9	34.0	24.6	2.7	137.6	245.4	17.5	14.2	47.8
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007386-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: AB_2686539"	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	12.2	12.6	22.4	13.5	20.8	50.1	17.2	31.9	30.4	14.4	21.1	12.4	6.7	20.0	13.6	15.2	19.3	12.0	15.0	11.5	19.8	21.0	16.0	21.1	13.4	20.2	19.3	14.8	15.0	29.9	12.0	8.2	10.9	20.8	15.0	23.6	11.1	22.2	13.6	8.8	16.1	18.8	17.6	12.4	14.5	15.8	27.7	12.3	23.3	20.5	14.8	17.7	15.3	20.7	17.4	27.2	35.6	24.4	26.4	23.7	24.3	12.7	12.4	15.9	26.1	21.1	15.9	26.3	12.8	12.7	14.9	13.1	15.0	13.5	31.9	9.3	16.5	6.0	16.2	21.3	18.0	12.4	10.3	25.9	15.7	14.5	16.5	15.3	28.1	13.9	15.6	20.1	12.2	24.8	15.1	18.7	25.8	32.2	11.6	13.8	28.4	22.9	28.9	43.8	17.3	19.8	17.7	27.2	25.6	23.0	12.5	20.5	25.7	19.2	32.1	18.4	26.5	22.9	22.2	13.8	10.1	14.1	17.2	14.0	11.8	18.9	24.7	11.1	21.9	10.6	21.1	24.4	35.6	18.1	20.4	17.9	16.6	20.5	20.5	27.2	17.4	23.7	19.3	21.3	26.4	18.5	19.5	21.2	24.3	22.4	20.8	31.9	30.4	19.8	21.0	19.3	14.8	20.8	12.3	14.9	15.6	44.9	49.0	65.3	20.7	10.9	48.4	28.1	28.4	33.2	9.8	46.3	59.7	71.4	117.2	35.8	68.3	23.3	66.2	74.0	37.9	74.7	17.3	45.7	54.3	17.5	50.6	32.5	53.2	96.3	25.0	47.0	37.1	59.5	68.9	18.9	55.2	56.1	27.6	74.5	26.2	19.4	47.6	72.3	76.8	71.8	43.1	44.7	83.1	77.4
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 32.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 72.6;cerebral cortex: 21.1"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 7.4;hTERT-RPE1: 12.8;RH-30: 13.2;U-266/70: 8.3;U-87 MG: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced					NA	NA					"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.6	1.3	9.2	1.0	10.9	1.6	0.9	72.6	21.1	1.8	1.0	1.4	0.0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5.0	1.9	0.6	1.2	0.8	3.0	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2.0	2.0	2.2	0.8	3.3	2.3	0.0	0.9	0.4	0.8	0.9	0.9	0.0	1.4	1.3	0.9	0.0	0.6	0.0	7.4	0.0	0.1	1.9	0.0	0.3	0.3	0.4	0.9	0.7	3.1	0.3	0.3	0.3	1.6	1.7	0.2	0.8	0.6	1.4	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.4	0.1	0.4	0.0	12.8	0.0	1.5	0.1	0.3	6.2	1.0	0.5	0.9	0.9	0.0	0.3	1.3	13.2	2.1	0.0	0.0	2.5	3.2	0.8	0.1	1.0	1.2	0.2	0.6	0.0	4.7	2.8	0.1	0.0	8.3	0.2	0.1	12.1	0.6	0.5	0.0	0.9	1.3	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.6	0.0	9.2	10.9	72.6	21.1	6.6	5.0	3.0	10.8	11.4	2.3	0.0	0.0	0.0	0.1	0.0	2.4	32.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	6.4	0.0	1.3	0.0	1.9	0.3	0.0	0.0	0.0	0.0	2.6	0.5	0.0	1.8	0.0	0.8	0.0	0.9	0.5	1.2	0.0	0.2	0.0	0.0	0.0
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083132-203086036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 60.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	200	"HSkMC: 18.0;RH-30: 34.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028336			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	2.4	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.7	13.3	1.7	0.0	0.0	0.8	0.8	2.3	1.3	1.8	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.8	0.4	0.7	1.0	0.8	0.5	0.6	0.3	0.6	0.9	1.0	1.4	1.8	1.3	0.8	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 38.7"	"Group enriched"	"Detected in some"	4	"granulocytes: 23.0;Muller glia cells: 40.0"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;MCF7: 11.9;RH-30: 32.7;RPTEC TERT1: 15.9;SK-BR-3: 17.7;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044383			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044383: AB_2678921"	"unprognostic (3.93e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.76e-4)"	4.5	1.0	19.7	2.6	21.7	0.8	6.1	9.7	38.7	1.1	1.6	27.4	0.0	2.0	2.0	1.6	1.6	2.0	1.8	13.8	19.8	12.1	4.2	1.0	2.8	1.4	22.8	13.4	0.8	15.5	15.5	0.9	8.9	25.0	1.2	1.6	1.8	8.9	1.3	2.0	1.9	1.8	1.3	20.7	7.4	1.6	16.3	15.9	0.0	3.2	0.0	1.4	3.4	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.3	0.1	0.1	0.8	0.1	1.0	1.5	0.4	0.2	19.7	0.3	0.0	4.5	3.6	2.4	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	3.2	0.0	3.2	0.0	0.0	3.1	11.9	0.0	0.0	5.1	0.0	0.0	0.0	32.7	1.0	15.9	0.0	0.3	0.4	2.1	17.7	0.2	1.9	1.0	0.4	0.0	10.6	5.4	0.0	5.7	0.0	0.1	0.0	5.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	19.7	21.7	9.7	25.7	19.8	12.1	22.8	13.4	25.0	15.9	0.0	0.0	0.0	0.0	0.0	0.5	2.5	5.1	0.0	0.0	3.5	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	3.0	1.0	0.7	0.0	23.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.4	1.7	0.0	0.0	40.0	0.5	0.0	0.7	1.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175813	"Predicted intracellular proteins"	"Cell adhesion"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in single"	33	"Alveolar cells type 2: 2.2"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA061383: AB_2684497"	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.8	0.1	1.1	0.8	0.8	0.3	0.4	0.4	0.6	0.1	0.1	0.0	0.0	0.1	0.4	4.4	3.9	0.2	0.1	0.2	0.4	0.3	1.1	1.5	0.2	0.3	1.3	0.0	0.1	0.2	0.1	0.6	0.3	1.0	4.2	0.1	0.0	8.8	0.1	53.8	0.2	0.1	0.1	0.4	0.4	0.1	0.2	2.1	0.9	3.9	12.7	2.0	0.3	0.8	0.0	6.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	1.1	0.8	0.4	0.6	0.4	0.3	1.3	0.0	1.0	2.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CHI3L1	"GP39, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186749	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 336.4"	"Cell type enriched"	"Detected in many"	7	"Hofbauer cells: 335.7"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	490	"neutrophil: 81.3"	"Lineage enriched"	"Detected in single"	490	"granulocytes: 81.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	14	"olfactory region: 10.7"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	230000000	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	19.0	0.8	20.3	53.4	58.0	81.6	23.9	1.2	69.4	4.3	2.1	5.0	0.0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10.0	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10.0	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2.0	1.7	14.6	61.5	4.0	0.0	0.0	81.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.7	90.8	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	80.6	0.0	0.2	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.4	0.0	38.1	0.2	0.0	0.0	0.2	4.8	0.0	37.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.1	0.0	0.0	0.1	20.3	58.0	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5	6.0	39.7	0.0	19.4	3.8	0.0	0.8	2.5	4.0	15.9	26.2	0.0	1.2	0.0	49.4	0.0	0.4	0.0	0.0	0.0	0.9	2.2	2.2	0.0	28.7	335.7	0.0	0.0	0.0	0.3	0.0	0.9	3.9	13.5	1.8	0.0	40.4	3.1	0.0	0.0	0.1	1.8	0.0	1.7	0.0	0.0	1.0	0.7	0.0	0.0	1.6
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell type enriched"	"Detected in single"	44	"Hofbauer cells: 42.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	42.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
BTG2	"APRO1, MGC126063, MGC126064, PC3, TIS21"	ENSG00000159388	"BTG anti-proliferation factor 2"	P78543	1	203305491-203309602	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 927.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.5;HMC-1: 39.2;RT4: 30.5;U-266/70: 60.7;U-266/84: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002355	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA002355: AB_1078304"	"prognostic favorable (8.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.86e-3)"	61.6	45.9	10.1	61.4	20.6	46.9	27.8	13.0	10.4	23.0	53.3	27.8	27.0	15.2	27.1	24.6	55.7	103.7	76.1	65.3	10.4	10.0	22.3	4.3	40.7	20.0	12.2	5.5	102.0	117.6	7.0	52.2	42.7	28.3	61.0	38.5	30.4	18.1	104.1	98.9	30.5	36.6	50.8	22.7	32.7	67.1	11.5	9.9	82.9	36.7	45.2	49.0	64.7	21.5	14.1	17.3	34.5	14.2	5.7	8.5	7.1	0.9	1.4	2.6	1.0	3.3	2.4	22.1	2.6	5.1	0.7	2.5	1.9	0.4	37.5	1.8	0.8	0.4	16.5	9.5	10.0	1.3	2.4	4.6	19.6	2.7	4.3	7.3	0.1	39.2	2.5	18.6	2.5	4.6	2.3	13.7	1.9	9.1	26.0	6.8	0.8	4.1	1.2	1.1	0.4	0.2	2.6	8.9	18.8	1.3	30.5	0.4	2.7	2.0	0.8	0.3	20.6	2.2	2.3	3.4	0.0	4.4	0.6	0.1	60.7	30.6	24.0	0.5	0.9	1.5	3.2	8.1	9.9	4.7	12.1	7.1	14.1	5.3	4.8	5.1	13.1	8.5	5.9	34.5	5.7	14.2	17.3	4.9	7.1	10.1	20.6	13.0	10.4	10.4	10.0	12.2	5.5	28.3	9.9	145.9	242.1	142.2	203.8	204.5	25.9	219.9	10.2	57.6	52.4	177.9	27.5	38.6	13.3	59.7	0.8	123.6	335.6	23.3	145.5	16.4	143.3	218.8	358.2	1.6	99.0	3.2	927.5	46.6	65.9	1.7	67.3	167.7	114.7	31.5	370.7	221.0	58.8	329.8	51.9	10.8	21.5	122.9	223.5	0.9	0.6	391.6	115.4	202.7	212.8	200.1
FMOD	SLRR2E	ENSG00000122176	Fibromodulin	Q06828	1	203340628-203351489	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 50.6;Leydig cells: 25.9;Mucus-secreting cells: 57.0;Peritubular cells: 26.9;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;CACO-2: 21.3;HHSteC: 6.9;HSkMC: 12.8;OE19: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		2400000				"unprognostic (1.48e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (9.40e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (2.67e-4)"	35.9	6.0	1.0	12.6	2.0	0.0	32.2	1.2	2.0	62.5	14.2	2.0	12.0	12.1	69.6	43.6	16.9	31.2	87.1	58.3	1.1	1.2	10.8	6.1	22.8	27.4	3.0	2.5	86.7	39.4	5.0	12.1	21.0	5.0	37.5	16.0	44.3	25.0	16.2	20.1	10.5	8.4	27.4	7.5	18.3	36.5	14.2	0.6	2.7	57.6	20.4	37.6	32.0	42.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.4	0.1	4.0	4.5	0.0	0.6	21.3	0.0	0.0	0.5	4.3	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.0	6.9	0.0	0.0	12.8	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.5	0.1	1.1	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	1.2	2.0	1.1	1.2	3.0	2.5	5.0	0.6	0.0	7.5	0.0	5.1	6.2	0.0	0.8	0.0	1.4	3.4	7.0	0.0	0.7	0.0	1.2	0.0	5.4	0.8	0.0	0.6	0.6	50.6	13.8	0.0	0.0	1.1	0.0	5.8	13.5	0.0	0.0	25.9	0.6	11.8	1.0	57.0	7.8	2.1	0.0	26.9	0.0	0.8	6.5	33.2	0.0	0.0	3.8	2.6	0.0	6.8	1.0
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475828-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 183.7"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 65.7;Leydig cells: 93.2;Melanocytes: 182.2;Muller glia cells: 156.5;Peritubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 18.7;BJ: 7.6;fHDF/TERT166: 11.5;SuSa: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		280000				"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.02e-4)"	46.7	16.0	6.3	7.7	5.8	1.1	52.3	3.6	5.0	57.4	35.7	3.7	16.8	5.0	45.3	17.8	46.2	29.5	27.4	58.6	7.0	1.8	8.1	7.3	49.9	5.2	6.4	9.5	62.3	6.6	1.8	7.3	8.3	8.6	48.3	6.6	64.6	10.4	52.5	24.5	16.4	17.0	61.8	7.7	22.6	13.5	23.4	3.3	0.0	25.1	16.1	11.5	98.7	183.7	1.0	1.0	4.0	1.2	1.1	0.8	0.6	0.2	0.2	0.5	0.2	18.7	0.5	0.5	7.6	1.0	0.2	0.2	0.0	0.2	1.2	0.7	11.5	0.2	0.7	0.2	0.3	0.3	0.1	0.2	0.4	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	2.1	0.1	0.4	0.3	0.5	1.4	0.1	0.2	0.5	0.5	0.3	0.1	0.4	0.2	0.5	0.0	0.3	1.1	0.3	0.2	0.2	0.8	5.6	0.3	0.2	0.6	0.5	0.3	0.3	0.1	0.3	0.4	1.2	0.1	0.2	0.5	4.0	1.2	1.7	0.7	1.0	0.8	0.6	0.7	0.5	0.4	1.0	0.7	0.6	2.7	1.1	1.1	1.0	0.6	0.6	6.3	5.8	3.6	5.0	7.0	1.8	6.4	9.5	8.6	3.3	0.0	8.0	0.5	0.9	16.3	2.9	4.3	0.0	2.7	1.2	0.0	2.0	0.0	0.0	0.0	0.6	10.9	0.0	0.0	0.0	0.1	65.7	0.5	4.7	0.0	0.3	1.6	0.0	30.7	0.0	2.3	93.2	1.9	182.2	0.0	0.0	156.5	0.0	0.0	187.7	0.0	4.7	25.8	26.8	2.7	0.8	8.7	0.2	0.0	0.0	0.7
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494143-203508864	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"retina: 245.8"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 1.4"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.0;HeLa: 1.4;hTERT-RPE1: 1.3;NTERA-2: 2.4;RT4: 1.5;SCLC-21H: 1.2;SuSa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA034951, HPA034952"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA034951: AB_10669852, HPA034952: AB_2674379"				"unprognostic (3.29e-1)"	"unprognostic (1.56e-1)"					"unprognostic (7.69e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.70e-3)"		"unprognostic (8.24e-2)"	"unprognostic (3.65e-2)"			0.3	0.0	0.2	0.1	0.2	0.0	0.2	0.4	1.0	0.4	1.3	0.1	0.1	0.4	1.3	2.2	0.8	0.8	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	1.1	0.3	0.0	0.1	0.4	0.1	0.7	0.3	245.8	0.1	0.6	0.1	1.1	0.2	1.1	0.1	0.1	0.1	2.6	0.1	0.1	0.2	0.1	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.7	0.0	0.1	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626561-203744081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 153.7;Suprabasal keratinocytes: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.5;fHDF/TERT166: 45.1;SuSa: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	23.0	14.0	24.8	10.8	14.2	5.9	11.6	9.4	23.6	32.6	44.2	7.5	12.9	5.3	69.6	13.1	20.4	27.0	13.9	24.0	13.1	8.7	5.0	14.2	16.1	5.3	6.4	19.2	21.9	6.4	8.0	4.8	16.2	9.3	17.0	13.4	11.6	7.5	31.5	5.4	22.0	13.2	74.2	5.7	4.8	16.4	13.1	7.5	9.0	8.3	8.4	7.7	32.8	14.2	1.0	4.2	4.5	2.2	4.2	10.4	2.6	9.2	1.7	3.4	3.2	26.0	38.8	18.0	41.8	59.5	7.1	6.1	0.8	4.7	2.1	6.1	45.1	9.5	9.0	4.9	5.8	7.5	26.5	1.7	6.2	8.3	0.5	9.3	8.8	11.0	28.1	5.7	22.8	3.5	17.3	13.5	12.3	2.7	4.2	5.2	0.5	8.9	2.9	2.0	1.7	5.2	4.7	2.5	3.3	2.4	0.8	1.0	1.4	14.7	2.2	6.6	49.6	1.9	4.3	11.8	17.3	2.5	29.0	10.0	2.8	4.2	1.1	17.3	6.4	5.1	3.0	2.2	0.0	10.4	1.5	7.9	1.0	6.6	8.3	2.4	0.3	1.6	4.2	4.5	4.2	2.2	4.2	6.3	2.6	24.8	14.2	9.4	23.6	13.1	8.7	6.4	19.2	9.3	7.5	83.4	62.7	10.4	15.6	86.3	2.8	64.1	7.6	34.8	40.9	17.4	2.0	22.3	0.0	31.1	4.3	39.1	3.9	23.3	13.2	13.3	48.3	9.5	9.3	15.7	31.0	111.2	23.0	54.6	14.6	1.3	40.6	13.2	25.3	7.2	1.9	153.7	25.2	11.9	35.7	5.0	6.9	19.4	82.4	22.3	2.1	132.0	21.7	45.7	2.6	43.3
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765176-203776233	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.7"	"Group enriched"	"Detected in some"	5	"granulocytes: 78.7;T-cells: 27.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0"	"Group enriched"	"Detected in many"	19	"B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 11.7;U-266/70: 14.4;U-266/84: 32.4;U-698: 12.3"					"Low region specificity"	"Detected in all"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	1.6	0.6	0.4	19.9	0.4	1.3	1.3	0.4	0.4	1.8	3.4	0.0	0.2	2.1	1.2	1.1	4.5	1.1	3.8	0.6	0.4	0.4	1.0	0.8	6.3	17.4	0.4	0.0	0.7	0.6	0.0	0.5	0.1	0.0	2.2	2.6	1.1	5.7	1.5	0.5	1.0	5.5	1.1	0.5	11.7	3.4	1.0	0.0	22.7	1.1	0.7	26.7	6.3	2.8	6.5	0.0	0.3	0.0	4.6	9.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	11.7	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	32.4	12.3	0.0	0.9	0.0	0.0	0.0	0.3	9.9	0.0	7.4	6.5	5.7	7.3	0.0	1.5	4.5	5.9	0.0	4.6	0.0	0.0	6.0	2.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	3.4	11.5	0.3	1.0	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	78.7	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.9	10.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	27.9	0.0	0.4
ZC3H11A	"KIAA0663, ZC3HDC11A"	ENSG00000058673	"Zinc finger CCCH-type containing 11A"	O75152	1	203795654-203854999	"Predicted intracellular proteins"	"mRNA transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (8.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.41e-1)"	21.7	18.1	19.0	17.7	15.9	23.2	49.0	27.7	17.9	16.8	20.4	16.9	15.7	18.4	21.9	12.5	18.8	15.2	13.7	15.5	20.7	12.8	16.2	23.9	20.8	22.4	22.9	11.0	19.0	17.2	23.0	42.7	30.8	18.8	16.9	16.8	11.0	19.5	15.6	23.0	23.4	25.4	15.5	20.5	23.9	18.5	42.1	18.7	23.1	21.0	14.1	22.8	21.5	44.7	6.7	5.1	15.1	6.3	5.9	9.5	4.9	13.8	11.2	22.0	14.4	13.6	10.5	24.1	16.1	11.1	13.2	14.8	15.6	17.6	17.8	9.9	16.3	10.6	19.9	17.3	9.4	18.0	25.9	12.5	17.1	18.4	7.7	7.5	23.7	30.8	9.0	11.6	13.9	13.7	16.4	11.7	19.4	33.8	24.4	10.7	11.4	26.1	9.6	21.2	9.9	9.3	19.2	25.8	11.7	9.5	24.3	16.4	15.4	16.0	13.1	14.6	26.2	14.2	17.8	18.6	19.3	17.2	16.5	15.0	18.1	17.0	28.4	12.3	13.8	14.6	15.1	4.4	6.5	6.9	4.3	9.5	6.7	6.3	6.2	5.1	5.0	8.0	5.8	9.2	5.9	6.3	2.8	5.8	4.9	19.0	15.9	27.7	17.9	20.7	12.8	22.9	11.0	18.8	18.7	11.9	25.6	37.1	51.4	90.1	41.6	53.6	56.0	20.1	22.7	0.0	43.2	26.1	0.0	0.2	31.1	62.7	40.4	46.7	0.2	22.8	64.8	79.2	24.3	53.9	28.2	79.4	44.9	55.3	49.7	7.6	55.8	34.3	45.5	0.0	60.1	40.3	0.4	38.4	63.3	0.0	47.2	77.6	59.5	48.9	36.6	97.5	42.7	34.6	45.7	81.4
ZBED6		ENSG00000257315	"Zinc finger BED-type containing 6"	P86452	1	203795714-203854999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526, HPA068807"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533, HPA068807: AB_2686040"	"unprognostic (1.79e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.28e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.47e-2)"	9.1	10.1	7.8	4.9	6.3	4.3	21.8	13.3	7.3	12.1	8.4	6.8	6.2	8.4	12.2	4.7	8.7	7.4	8.1	6.8	8.6	2.4	8.3	9.9	8.9	6.7	9.6	4.1	12.0	10.0	10.1	18.9	13.3	7.7	7.6	5.4	4.0	11.0	7.4	11.7	10.6	10.8	6.3	8.5	8.8	7.6	18.6	7.6	9.7	11.9	5.5	6.9	9.0	19.8	0.7	1.5	0.4	0.5	1.8	0.8	0.1	3.8	5.3	8.6	4.0	10.7	19.2	3.9	4.6	13.9	4.4	5.6	1.2	4.1	2.8	1.1	10.4	2.2	5.4	2.8	5.1	7.8	6.0	2.1	5.6	5.2	1.4	4.9	3.4	3.5	9.8	3.4	5.1	5.5	9.9	13.6	3.3	5.9	10.0	9.8	2.4	2.8	3.3	2.2	2.1	2.3	1.8	7.2	2.5	3.9	5.3	1.8	9.9	6.1	9.1	2.4	9.6	10.5	5.1	15.9	7.7	6.2	3.0	3.3	4.0	1.4	1.0	7.2	2.3	6.3	0.0	0.5	0.2	0.8	0.2	0.1	0.7	0.3	0.6	0.4	0.2	0.1	0.6	0.4	1.8	0.2	1.5	0.3	0.1	7.8	6.3	13.3	7.3	8.6	2.4	9.6	4.1	7.7	7.6	8.9	4.6	4.8	31.2	14.2	18.0	1.7	7.6	13.4	17.0	0.0	29.5	12.1	0.0	0.1	0.8	11.5	20.6	0.0	0.0	11.2	15.3	35.0	33.4	3.8	5.4	11.1	17.7	7.4	5.0	0.8	18.4	9.8	13.5	0.0	5.4	18.8	0.1	14.4	14.2	0.0	18.7	25.8	18.6	5.6	5.4	14.9	29.2	15.2	10.6	38.3
SNRPE	Sm-E	ENSG00000182004	"Small nuclear ribonucleoprotein polypeptide E"	P62304	1	203861603-203870550	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"									NA	NA		75000				"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.87e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (3.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-3)"	21.0	30.2	19.3	27.6	19.3	41.0	39.4	17.2	18.5	25.5	28.0	14.5	23.6	20.2	33.5	33.0	25.5	22.9	18.8	18.9	16.6	17.6	24.3	27.1	16.6	39.1	18.8	21.4	41.0	39.9	11.8	20.9	23.5	21.7	23.6	23.6	15.8	39.9	23.2	22.7	18.5	19.6	24.1	16.2	23.7	22.1	26.7	16.6	52.2	22.8	38.1	30.2	27.0	21.6	19.1	29.7	9.2	15.9	24.6	21.8	15.8	50.5	30.7	60.9	31.0	14.0	26.5	40.6	35.5	22.6	34.2	32.6	36.9	39.4	53.2	32.5	21.8	33.2	35.0	50.5	40.6	42.9	29.9	44.3	33.8	44.0	41.8	21.9	67.7	33.0	23.1	12.5	36.8	35.2	29.7	31.2	53.9	64.8	31.4	29.5	52.0	69.0	71.6	79.2	33.5	32.1	46.1	55.6	58.7	41.5	31.0	32.7	46.4	25.2	54.7	61.3	58.1	40.4	54.3	19.8	25.2	42.3	25.7	66.1	25.3	37.9	99.7	24.8	38.5	29.5	7.3	14.9	9.2	15.1	15.9	21.8	19.1	19.2	17.5	22.8	16.9	21.1	20.9	5.6	24.6	15.7	29.7	17.8	15.8	19.3	19.3	17.2	18.5	16.6	17.6	18.8	21.4	21.7	16.6	119.1	108.0	190.6	209.9	216.8	43.6	66.7	211.5	124.5	146.7	122.1	13.7	416.8	359.8	339.4	15.6	193.0	78.8	46.7	408.0	479.9	195.3	185.2	108.7	227.4	265.7	54.0	156.8	120.9	164.1	28.0	219.5	164.8	163.6	256.1	231.7	98.2	365.8	98.2	154.2	312.4	37.9	97.0	165.8	194.0	231.8	223.7	188.2	136.4	293.3	242.6
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box 13"	Q9UN79	1	204073115-204127743	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 4.1;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.0;SK-BR-3: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051790: AB_2681610, HPA054843: AB_2682622"	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	22.2	10.7	11.0	6.9	8.6	0.8	18.4	9.2	9.9	37.0	17.2	14.4	16.1	13.5	30.3	12.4	10.9	22.3	16.4	9.7	11.0	6.9	19.0	12.3	20.5	4.3	13.7	7.0	13.5	12.8	34.2	5.6	27.3	14.3	23.5	8.3	13.7	13.1	18.7	14.2	9.9	16.8	18.2	12.1	8.4	8.2	8.7	13.3	0.1	10.4	7.5	7.0	19.5	19.2	0.0	0.0	0.5	0.0	4.1	2.6	0.3	8.5	5.5	11.9	0.8	11.4	3.4	24.0	3.3	2.0	5.3	3.3	4.6	6.4	0.0	11.0	2.1	1.4	13.9	4.5	4.3	2.5	3.9	2.2	0.0	3.7	5.1	2.6	0.0	5.0	3.5	2.2	3.3	2.9	2.6	7.6	0.1	0.0	0.0	1.1	10.5	0.0	0.0	15.7	13.9	6.7	0.1	4.0	5.2	4.0	19.8	1.8	0.9	3.4	50.1	15.0	11.1	22.3	1.0	4.4	1.2	3.2	5.1	2.3	0.0	0.0	0.0	1.9	0.1	3.1	0.2	0.0	0.5	2.5	0.0	2.6	0.0	1.2	1.4	0.0	0.0	0.0	1.0	0.3	4.1	0.0	0.0	0.0	0.3	11.0	8.6	9.2	9.9	11.0	6.9	13.7	7.0	14.3	13.3	6.0	11.4	0.8	7.9	1.9	0.5	24.3	10.2	1.4	4.5	8.7	0.0	4.3	1.7	2.7	8.5	12.7	12.6	0.0	1.3	5.0	5.0	6.6	16.2	5.9	1.2	0.0	7.5	8.0	0.0	20.2	19.2	0.7	1.7	0.0	5.5	6.3	2.9	7.6	18.4	3.5	0.9	38.8	15.5	0.2	0.7	1.4	1.6	1.9	5.4	5.7
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152003	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 65.9;liver: 80.5;testis: 45.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 370.3;Late spermatids: 1080.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5"	"Group enriched"	"Detected in many"	11	"NK-cells: 1.5;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.4;MCF7: 25.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"basal ganglia: 24.7"	HPA057167	Enhanced					NA	NA					"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	3.3	2.3	4.0	0.8	4.7	0.9	6.3	0.9	4.0	5.1	1.6	1.9	6.5	0.8	3.1	11.0	8.3	4.9	1.9	2.6	2.6	2.5	65.9	80.5	1.2	2.0	2.7	1.9	13.1	4.3	6.2	8.8	2.3	2.7	3.8	0.9	4.8	7.6	7.8	0.6	5.1	0.8	2.4	1.5	2.4	1.1	45.0	1.9	1.1	4.0	3.9	12.9	3.8	6.2	0.2	0.0	0.2	0.2	1.5	4.8	1.0	5.2	1.8	5.3	10.1	2.0	0.6	5.3	5.4	12.0	7.5	3.3	9.0	2.6	0.2	9.1	1.3	8.8	4.7	9.4	7.6	5.2	0.2	8.4	0.1	1.0	13.8	8.0	0.2	0.3	2.7	26.4	1.6	0.3	3.9	5.4	5.7	0.7	0.2	0.9	25.5	1.5	0.1	11.1	0.2	4.0	0.4	6.3	0.2	6.5	2.0	1.4	7.6	3.4	16.1	2.5	17.6	15.6	0.3	0.3	2.1	11.7	0.4	3.9	0.2	0.1	0.2	0.1	0.2	3.0	0.1	0.2	0.0	4.8	0.0	4.6	0.0	1.3	2.9	0.0	0.2	2.9	3.6	0.2	1.5	0.1	0.0	0.7	1.0	4.0	4.7	0.9	4.0	2.6	2.5	2.7	1.9	2.7	1.9	0.0	0.0	0.5	9.8	3.7	1.8	0.9	5.1	2.7	0.0	3.5	3.9	4.8	33.2	8.0	370.3	1.0	0.0	0.0	5.6	7.9	5.7	10.1	9.2	156.9	0.7	0.0	1.2	1.8	5.1	1080.2	27.0	0.6	10.1	0.0	0.0	2.6	4.6	0.0	39.6	120.8	0.8	0.0	3.8	9.3	5.9	2.0	7.9	0.9	0.0	8.3
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 63.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 6.1;Late spermatids: 19.3"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Region enriched"	"Detected in single"	12	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;BJ: 4.9;HMC-1: 6.5;RT4: 1.8;SK-BR-3: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000				"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	0.4	0.3	0.0	0.0	1.2	0.0	0.5	0.0	0.0	3.1	0.2	0.0	0.8	0.1	4.4	13.5	0.1	0.3	0.0	0.6	0.0	0.0	63.6	0.4	0.3	0.0	0.0	0.0	11.6	0.0	0.0	0.4	14.4	0.0	0.3	0.1	0.4	0.3	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.0	0.2	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	4.9	1.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	4.6	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	1.2	6.1	0.0	0.0	0.0	1.0	0.2	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	2.7
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196486	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"placenta: 267.2"	"Cell type enriched"	"Detected in many"	41	"Syncytiotrophoblasts: 1117.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Group enriched"	"Detected in some"	8	"basal ganglia: 11.3;hypothalamus: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"BJ: 55.9;U-2 OS: 22.8"					"Low region specificity"	"Detected in all"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"CAB017775: , HPA035542: AB_2674677"	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.29e-6)"	0.2	0.0	0.2	0.2	11.3	0.0	0.2	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	55.9	0.7	1.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	22.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.3	1.0	0.2	0.2	4.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	3.3	27.0	0.3	5.1	0.0	4.0	4.1	0.4	1.8	0.0	2.9	14.5	0.0	0.0	1.3	0.0	3.1	0.3	0.0	0.0	0.0	0.6	0.0	2.9	0.8	0.0	1.2	0.0	0.0	0.1	0.1	0.4	0.0	1117.8	0.0	1.9	2.2
GOLT1A	"CGI-141, FLJ42654, GOT1, MGC62027, YMR292W"	ENSG00000174567	"Golgi transport 1A"	Q6ZVE7	1	204198160-204214092	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 35.9;liver: 74.9"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 38.2;Hepatocytes: 109.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 80.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 8.8;cerebellum: 3.8;hypothalamus: 3.8"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 10.8;Hep G2: 13.3;MCF7: 22.5;OE19: 8.5;RT4: 14.7;SK-BR-3: 14.8"					"Not detected"	"Not detected"									NA	NA						"unprognostic (3.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (6.20e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-3)"	"prognostic favorable (1.51e-4)"	0.3	0.0	1.2	0.8	8.8	0.0	1.7	3.8	0.8	3.5	13.7	0.4	1.7	15.5	0.3	3.6	0.3	1.0	3.4	0.3	1.0	3.8	5.9	74.9	3.1	0.3	0.8	0.4	0.4	12.5	7.1	8.7	1.0	0.9	2.9	1.6	0.5	1.0	3.7	0.6	0.0	35.9	1.6	0.6	0.3	1.9	0.5	0.3	0.4	0.6	0.3	0.4	10.9	2.5	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.2	4.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	9.3	10.8	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.1	8.5	0.1	0.0	0.0	0.2	4.6	14.7	0.7	1.0	0.4	14.8	0.0	0.4	4.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.4	1.4	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.6	1.2	8.8	3.8	0.8	1.0	3.8	0.8	0.4	0.9	0.3	0.0	17.9	0.0	11.9	0.0	2.5	0.3	38.2	0.0	5.7	15.7	0.0	11.4	11.6	24.4	0.6	0.0	13.1	0.0	16.1	0.2	0.4	10.6	1.1	109.9	1.1	1.6	9.9	3.1	2.8	0.0	0.0	0.0	1.7	0.0	3.2	0.0	18.5	1.7	0.0	10.4	0.1	0.0	0.1	2.3	0.9	0.1	22.1	0.0	7.4	12.9
PLEKHA6	"KIAA0969, PEPP3"	ENSG00000143850	"Pleckstrin homology domain containing A6"	Q9Y2H5	1	204218851-204377665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.1"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 37.9;Cholangiocytes: 35.7;Enterocytes: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.3;BEWO: 33.0;CAPAN-2: 27.6;OE19: 27.6;RT4: 22.9;SK-BR-3: 20.4;T-47d: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028152, HPA028157"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	Vesicles	"HPA028152: AB_10601048, HPA028157: "	"unprognostic (9.81e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.57e-4)"	2.4	4.6	18.2	4.1	27.8	0.4	10.6	60.1	34.5	3.4	23.2	13.4	1.4	18.2	2.6	10.0	13.0	7.4	9.8	11.8	14.2	11.4	20.9	13.9	2.4	0.6	11.5	23.3	2.8	7.6	3.7	17.6	6.3	18.9	9.4	21.9	21.7	5.2	11.2	2.6	2.0	20.8	4.8	19.0	1.9	29.1	2.7	14.2	0.0	2.2	1.3	1.9	7.3	6.1	0.9	1.4	0.1	0.2	0.0	0.4	0.0	20.3	12.8	8.1	0.0	0.1	0.1	33.0	0.7	2.3	0.0	0.1	6.1	27.6	0.1	6.2	0.4	0.1	2.3	0.1	2.2	0.1	0.0	1.3	0.0	5.0	8.7	1.2	0.0	0.0	0.3	6.9	0.0	1.8	2.5	3.6	0.3	0.0	0.0	8.3	9.1	0.0	0.0	2.5	27.6	15.7	0.0	0.0	0.0	8.2	22.9	1.7	16.9	9.2	20.4	0.1	1.8	19.5	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	18.2	27.8	60.1	34.5	14.2	11.4	11.5	23.3	18.9	14.2	0.0	10.4	0.0	4.3	0.1	37.9	13.9	35.7	2.7	1.2	8.7	19.6	5.7	3.3	6.8	6.8	1.1	45.2	0.0	4.5	1.4	2.6	7.3	0.0	18.7	0.7	17.5	16.1	0.6	0.0	2.9	4.9	0.2	0.0	0.0	27.5	0.9	9.4	28.8	3.5	9.1	6.7	0.0	0.2	0.1	0.1	0.5	18.1	0.9	24.0	6.9
PPP1R15B	FLJ14744	ENSG00000158615	"Protein phosphatase 1 regulatory subunit 15B"	Q5SWA1	1	204403387-204411791	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"		"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061088			Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA061088: AB_2684426"	"unprognostic (2.91e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (9.52e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.50e-2)"	31.3	15.9	10.1	21.6	14.7	66.4	34.0	17.3	12.9	13.4	16.8	14.2	14.8	13.5	15.7	9.3	19.2	23.0	19.1	13.1	11.8	8.9	14.5	29.1	22.5	18.4	18.7	10.6	18.3	24.3	12.4	12.7	47.7	12.3	14.5	15.1	10.1	39.5	20.7	12.9	16.2	18.6	18.2	15.6	18.7	21.1	9.5	15.3	25.3	17.8	15.9	16.2	18.5	24.2	2.7	5.7	13.9	6.6	3.5	6.2	3.2	12.0	9.6	11.6	9.7	15.0	10.3	46.9	9.9	12.0	13.8	12.5	11.5	17.0	19.9	6.9	12.1	9.6	15.4	17.0	10.1	12.9	15.3	12.2	11.8	23.7	7.4	18.3	20.0	21.2	12.9	13.1	13.5	15.0	9.9	14.9	17.1	18.0	39.7	9.3	11.9	19.0	12.6	19.8	11.1	14.0	13.7	21.0	20.4	13.8	14.8	11.1	17.0	17.9	25.6	20.4	16.3	16.8	20.8	8.3	9.6	13.7	12.3	16.7	27.0	11.9	19.8	8.7	13.8	9.9	10.6	6.2	6.4	4.1	5.8	4.3	2.6	4.0	3.7	5.7	2.7	6.2	4.2	13.9	3.5	6.6	2.4	5.1	3.2	10.1	14.7	17.3	12.9	11.8	8.9	18.7	10.6	12.3	15.3	44.7	35.2	29.4	38.3	65.5	18.3	13.8	25.5	16.0	22.7	17.4	19.6	16.4	3.3	14.5	2.6	31.5	55.1	46.7	20.6	35.7	53.1	38.1	47.4	39.4	29.2	7.9	42.8	25.8	33.5	3.4	12.0	54.4	47.2	37.9	27.4	17.3	27.0	31.6	12.0	12.3	16.9	6.5	54.5	14.4	13.2	56.1	41.2	24.9	19.0	78.0
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 32.3;Ito cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;RT4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.6	5.9	5.4	3.5	0.3	32.3	0.4	1.3	1.3	0.9	3.9	8.7	5.6	1.2	0.7	1.1	8.2	3.5	2.3	0.5	3.4	0.9	0.1	13.1	1.4	0.2	1.9	4.3	0.4	2.5	0.3	0.2	0.5	8.6	5.7	2.0	3.8	0.1	7.3	6.7	5.6	5.4	12.9	4.2	7.3	1.5	1.0	1.6	33.8	6.5	3.6	11.7	16.4	3.8	2.2	7.3	1.0	0.3	0.2	2.1	0.6	0.1	4.1	1.1	7.3	0.2	3.0	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0	0.0	12.6	11.1	1.9	3.4	16.6	6.4	0.0	2.7	4.5	3.5	0.0	3.8	0.0	1.1	0.6	20.0	14.8	0.0	3.0	3.4	4.1	2.2	32.3	3.9	3.3	14.3	9.2	27.0	2.2	0.0	1.1	2.3	3.3	2.8	23.7	2.5	3.3	10.5	7.1	1.9	1.0	0.0	3.1	0.0	1.5	6.9	1.8	2.5	13.2	6.3
MDM4	"HDMX, MDMX"	ENSG00000198625	"MDM4, p53 regulator"	O15151	1	204516379-204558120	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018919, HPA048821"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018919: AB_1853694, HPA048821: AB_2680531"	"unprognostic (4.63e-2)"	"unprognostic (3.73e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.87e-4)"	"prognostic unfavorable (7.06e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.49e-4)"	12.7	8.8	14.4	21.1	18.0	59.1	14.6	19.7	16.4	12.2	10.6	20.4	15.8	7.6	12.5	23.6	10.4	12.3	10.3	11.3	13.7	8.0	11.1	12.3	15.4	21.0	20.5	9.5	19.0	16.7	11.1	19.0	12.4	13.4	13.1	12.4	14.2	11.3	15.4	12.0	23.7	15.2	18.5	13.5	19.9	11.9	19.6	19.4	55.8	15.1	9.5	21.0	13.9	12.7	15.1	9.0	8.1	4.8	4.9	7.8	2.4	3.6	7.1	7.2	9.9	5.0	5.6	34.0	2.7	2.8	3.5	5.2	3.7	4.9	12.4	2.6	3.8	2.9	3.9	4.8	4.0	4.7	3.7	3.4	9.8	15.8	4.3	3.8	7.7	9.8	5.7	2.6	5.7	10.2	3.7	3.4	8.0	5.6	18.1	3.0	12.0	4.7	6.8	9.9	1.3	3.0	5.6	5.9	4.1	3.4	17.5	3.2	7.2	2.7	5.4	5.1	7.5	10.2	4.5	3.4	4.0	7.1	2.6	4.4	9.1	3.2	10.3	2.8	3.3	5.7	8.1	4.7	6.2	7.2	4.8	6.0	9.0	5.4	5.0	4.1	15.1	7.8	6.5	7.8	4.9	4.3	9.0	3.0	2.4	14.4	18.0	19.7	16.4	13.7	8.0	20.5	9.5	13.4	19.4	26.8	49.9	72.9	46.9	54.7	91.7	33.5	40.8	20.1	61.4	66.3	159.0	39.1	11.6	25.4	65.9	50.6	37.1	93.5	23.0	23.0	48.1	52.9	63.6	48.4	30.6	39.7	62.4	94.5	85.6	124.4	74.2	75.3	40.5	23.4	44.0	44.1	23.4	40.8	50.9	12.8	196.4	51.8	36.2	60.6	71.3	59.7	50.9	73.9	39.6	40.0
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 49.3"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	4.9	6.6	11.8	3.7	16.5	2.4	3.3	9.7	20.3	1.9	7.9	5.3	1.0	1.9	3.9	0.8	2.4	10.2	6.1	6.0	11.7	12.8	7.3	0.7	2.5	2.9	6.3	13.8	3.3	1.4	19.1	9.7	1.3	8.1	1.6	7.5	12.2	2.8	3.7	2.2	0.7	3.3	9.9	3.1	6.3	1.4	3.8	6.1	3.2	2.8	0.0	1.3	2.1	1.5	0.4	0.1	1.7	0.3	0.7	0.8	0.2	0.0	3.3	2.7	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	7.1	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	1.1	0.0	14.3	0.0	0.1	0.2	0.0	22.2	0.0	0.1	1.9	0.3	4.4	0.1	0.0	8.2	7.9	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.7	0.7	0.0	0.1	0.8	0.2	11.8	16.5	9.7	15.7	11.7	12.8	6.3	13.8	8.1	6.1	0.0	0.0	0.0	0.5	0.3	4.6	1.0	0.0	0.0	0.0	1.8	2.0	0.1	0.0	2.7	0.0	0.7	1.7	0.0	0.8	0.1	1.1	0.3	0.0	0.0	5.3	49.3	10.9	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.9	3.3	0.3	0.0	2.7	0.9	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.7	0.3
NFASC	"FLJ46866, KIAA0756, NF, NRCAML"	ENSG00000163531	Neurofascin	O94856	1	204828651-205022822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 165.2;Horizontal cells: 208.2;Rod photoreceptor cells: 212.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"BJ: 13.3;fHDF/TERT166: 24.1;hTERT-RPE1: 11.8;SCLC-21H: 11.2;U-138 MG: 31.3;U-87 MG: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008832	Enhanced					NA	NA		2100000			"HPA008832: AB_1854411"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (1.56e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.26e-3)"	4.9	8.7	21.1	3.9	25.9	0.6	3.8	22.3	37.3	4.6	7.8	49.6	1.1	5.1	9.1	10.4	11.3	12.0	6.6	17.4	19.5	10.8	10.7	2.4	5.7	2.6	27.9	25.2	11.9	6.4	1.6	11.7	11.2	28.7	8.7	6.8	8.1	2.6	18.4	3.3	4.2	5.6	15.3	17.5	6.8	5.3	2.0	34.0	0.0	3.0	0.2	3.4	8.9	7.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.2	0.4	0.0	13.3	0.0	9.7	2.9	0.0	0.0	0.0	0.0	24.1	9.1	6.3	0.2	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	6.1	0.3	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.1	0.0	1.1	0.0	0.0	0.0	11.2	0.6	0.0	0.7	0.0	1.0	0.1	0.0	0.0	31.3	6.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	7.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	25.9	22.3	35.0	19.5	10.8	27.9	25.2	28.7	34.0	0.0	1.1	0.0	1.5	1.9	165.2	19.5	0.0	0.0	1.2	0.0	11.8	0.3	0.0	0.2	5.3	4.9	0.0	0.0	0.0	0.2	10.1	1.0	0.0	2.0	0.4	208.2	36.4	2.5	0.6	9.7	6.1	0.0	1.7	0.0	4.8	12.0	0.8	0.0	5.3	1.4	212.3	51.8	51.4	1.9	3.2	4.1	0.6	0.0	0.9	0.7
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078284	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 78.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 10.8;Late spermatids: 18.2"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 5.7;SCLC-21H: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		13000			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	2.0	2.4	15.6	2.1	52.5	1.6	1.6	11.0	68.8	1.8	2.3	78.5	0.0	1.7	1.6	1.7	1.9	1.7	1.8	1.7	27.4	15.9	1.6	1.6	1.6	1.7	59.8	22.0	1.6	1.6	1.6	2.7	1.6	41.9	1.8	2.3	0.0	2.2	2.4	1.6	2.3	2.2	1.8	55.4	1.7	1.7	9.1	48.3	0.0	1.6	0.0	2.0	1.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	15.6	52.5	11.0	28.4	27.4	15.9	59.8	22.0	41.9	48.3	0.0	1.1	0.0	0.0	0.0	0.2	3.4	0.0	2.7	1.2	1.8	0.0	0.0	0.0	0.4	10.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	18.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1
TMEM81	"HC3107, KVLA2788, MGC75217, UNQ2788"	ENSG00000174529	"Transmembrane protein 81"	Q6P7N7	1	205083129-205084460	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.2"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 3.5;Early spermatids: 7.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052515			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA052515: AB_2681858"	"unprognostic (9.19e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (8.91e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.67e-4)"	1.5	2.7	2.8	1.6	3.8	2.0	2.1	11.2	5.3	2.1	1.3			1.2	1.5	3.5	1.4	1.2	1.1	2.2	3.3	2.7	4.2	3.3	1.5	2.3	2.8		2.3	1.0	3.4	2.2	2.0		1.8	1.7		1.4	2.1	4.6	4.1	1.2	1.7	2.4	3.0	1.0	6.1			1.4		2.7	0.9	1.6	1.5	1.5	4.3	1.4	0.2	4.6	0.9	2.4	3.7	6.2	8.1	9.1	3.6	3.1	4.5	2.7	2.3	1.4	6.5	1.7	4.5	3.2	2.5	3.4	2.1	9.9	3.8	4.0	3.9	3.9	3.7	5.2	3.2	6.3	1.9	2.1	3.6	6.8	3.6	1.8	6.1	4.5	5.4	8.3	1.9	2.9	4.7	4.3	8.1	4.7	3.0	5.4	3.0	7.1	4.6	5.3	2.3	3.9	6.1	2.8	3.4	7.1	10.0	2.5	8.0	2.1	4.3	2.3	5.5	4.8	4.3	5.3	3.6	6.2	2.9	7.3	4.3	1.2	0.2	4.6	1.4	0.2	1.5	2.3	1.1	1.5	1.4	2.5	4.0	2.5	0.2	1.4	1.5	2.7	0.9											0.0	0.0	0.5	0.5	2.1	0.6	1.2	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.5	7.9	1.0	0.3	0.0	0.5	0.3	0.8	0.6	0.0	1.0	0.5	1.6	0.0	0.6	0.0	1.3	0.0	0.0	1.7	0.0	0.2	1.1	0.7	0.0	0.4	1.4	1.0	0.0	0.6	0.2	1.1	2.3	0.1	0.0	0.8	0.4
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	12.9	17.0	13.7	10.9	23.1	13.5	13.0	20.9	23.3	13.7	11.2	16.4	6.7	11.3	16.4	12.8	11.9	12.6	9.9	10.4	13.2	12.9	20.6	17.3	10.5	16.5	13.5	12.5	16.2	16.8	15.9	21.5	10.3	15.0	11.8	13.2	12.7	14.6	12.0	18.8	14.9	12.7	11.6	10.5	14.0	10.7	9.5	13.7	22.5	17.4	8.9	19.8	11.7	16.7	8.6	6.1	19.1	7.7	7.7	9.6	3.3	10.7	11.4	11.0	13.0	15.4	8.9	12.0	10.2	8.8	13.1	13.1	12.0	13.0	16.8	7.9	7.5	10.7	12.4	18.3	6.8	15.6	14.2	9.8	14.0	11.6	9.7	10.0	17.5	11.5	7.1	8.9	12.2	10.4	8.8	10.5	12.1	27.0	17.2	10.9	9.9	16.8	7.5	17.9	9.4	19.0	15.1	23.5	20.9	9.1	7.9	17.3	14.0	14.4	15.3	13.0	13.8	16.5	9.9	7.9	10.9	11.7	15.9	13.4	8.5	11.7	20.6	9.7	11.0	16.7	19.1	5.2	7.5	8.6	6.3	9.2	8.6	8.1	8.8	5.4	7.1	8.0	9.6	11.9	7.7	7.7	6.1	8.1	3.3	13.7	23.1	20.9	23.3	13.2	12.9	13.5	12.5	15.0	13.7	17.9	13.5	16.3	9.4	23.9	13.8	6.5	7.6	14.7	17.0	21.0	27.5	8.0	8.3	10.8	6.4	13.8	14.0	0.0	10.0	8.2	9.8	10.8	12.8	20.2	9.7	15.9	11.6	17.8	14.1	1.7	11.8	15.2	18.6	10.0	12.4	15.8	11.6	10.5	15.2	23.1	18.8	19.4	9.8	8.8	18.1	29.5	9.0	21.7	13.3	12.2
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5"	ENSG00000133059	"Dual serine/threonine and tyrosine protein kinase"	Q6XUX3	1	205142505-205211566	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 84.2;Melanocytes: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044140	Approved		Uncertain	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA044140: AB_10965031"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (8.73e-5)"	6.4	9.2	13.8	4.4	13.3	19.6	8.2	20.4	16.4	8.4	6.5	6.8	4.2	3.3	10.5	7.4	6.7	9.2	5.4	5.7	10.7	9.0	9.3	2.5	7.3	5.4	8.1	11.8	14.0	5.9	22.0	11.0	7.1	12.2	7.2	4.6	9.2	6.2	8.8	14.6	14.0	4.8	8.8	11.0	7.0	5.3	11.5	9.2	7.1	8.4	3.6	5.3	7.6	6.4	3.5	3.1	9.8	3.5	4.8	5.1	1.6	6.9	4.5	4.9	5.9	7.1	12.0	3.4	8.7	8.7	9.1	6.2	2.0	3.8	5.1	2.6	14.6	5.0	4.9	5.3	5.6	9.3	2.4	5.7	9.3	6.0	2.2	6.4	2.6	5.0	7.0	8.5	9.3	8.9	10.9	6.6	3.7	12.0	3.5	7.2	4.7	2.0	2.3	5.2	1.3	5.4	1.8	8.8	4.5	6.1	4.4	2.7	5.3	7.4	7.7	24.3	5.9	5.6	3.4	6.6	5.7	5.7	8.6	5.7	3.6	2.5	3.0	6.6	3.6	20.3	9.8	3.5	6.0	4.6	2.5	4.3	2.7	3.4	3.8	3.1	3.5	5.1	3.7	5.1	4.8	1.8	2.3	2.0	1.6	13.8	13.3	20.4	16.4	10.7	9.0	8.1	11.8	12.2	9.2	26.8	13.3	11.1	5.8	13.3	46.4	9.5	12.7	29.4	17.0	15.7	31.4	5.9	5.0	10.9	8.6	14.9	3.2	23.3	7.8	4.9	18.1	8.2	23.1	7.4	7.8	84.2	12.2	24.5	20.2	17.3	15.3	13.1	86.0	10.0	5.8	50.7	8.5	3.5	17.0	6.2	34.9	25.8	12.0	20.0	12.7	12.2	2.2	14.9	7.6	5.6
TMCC2	"FLJ38497, HUCEP11"	ENSG00000133069	"Transmembrane and coiled-coil domain family 2"	O75069	1	205228176-205273343	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 83.6;brain: 25.9"	"Cell type enhanced"	"Detected in many"	23	"Erythroid cells: 140.2;Horizontal cells: 38.1;Rod photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 27.3;WM-115: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014254	Approved					NA	NA					"HPA014254: AB_1851326"	"unprognostic (2.59e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.18e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-5)"	"unprognostic (3.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.99e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.43e-3)"	2.6	4.5	22.2	2.3	17.4	83.6	1.8	22.7	24.0	2.4	2.0	16.5	0.0	2.2	2.8	1.9	2.1	2.5	2.2	2.5	25.9	16.8	2.5	1.8	2.5	2.2	25.4	13.3	4.2	2.0	3.7	3.3	7.9	22.4	2.2	1.9	9.3	2.3	2.3	6.4	2.9	2.5	2.4	24.1	5.6	2.2	3.4	14.2	0.0	2.1	0.0	2.0	2.1	2.2	0.0	0.0	1.1	0.0	0.0	0.3	4.4	1.6	0.8	1.6	3.5	0.6	0.2	0.8	2.1	1.0	2.2	1.6	0.2	0.2	1.6	0.3	0.6	5.8	2.9	1.0	0.5	0.6	4.3	3.3	5.7	0.4	0.1	0.3	0.3	3.0	0.3	0.1	1.1	0.0	1.8	0.3	1.6	3.4	2.3	0.8	0.1	0.0	0.8	3.8	0.0	4.7	2.2	3.7	7.8	0.4	0.1	27.3	3.9	0.2	0.0	7.0	1.4	0.6	0.4	0.6	1.5	2.2	3.7	2.3	3.9	1.6	1.0	1.2	0.5	9.1	0.0	0.0	1.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	4.4	22.2	17.4	22.7	24.0	25.9	16.8	25.4	13.3	22.4	14.2	0.0	0.0	0.0	0.2	0.9	21.3	3.3	0.0	0.0	0.0	1.8	9.8	0.1	0.0	1.2	1.4	2.2	0.0	140.2	0.0	0.1	0.9	0.1	0.0	0.0	0.7	38.1	3.4	2.5	1.2	0.0	1.1	0.0	3.3	13.6	0.0	13.2	0.3	0.0	0.4	0.2	35.3	0.0	0.8	1.2	5.5	0.6	0.0	0.0	0.0	0.0
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.4"	"Group enriched"	"Detected in all"	4	"B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1.0	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2.0	1.5	7.5	9.8	9.7	2.0	0.7	12.9	15.4	0.9	2.7	10.4	2.0	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.1	11.6	7.1	0.3	0.1	0.3	22.8	2.8	2.9	7.6	3.1	12.2	0.4	3.4	1.7	0.7	12.5	4.2	1.6	4.2	3.3	0.0	0.2	0.0	0.7	2.1	4.9	0.0	0.0	1.3	3.1	4.4	2.6	1.7	0.3	0.0	0.4	0.9	1.4	0.5	0.0	0.0	4.5	1.5	0.3	0.0	0.5	17.6	20.9	0.0	1.1	0.1	0.8	3.3	0.3	24.7	3.3	0.0	0.8	2.7	1.3	0.3	4.3	6.2	0.9	2.1	0.4	0.0	1.0	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1.0	5.5	1.5	2.0	2.4	6.0	5.0	9.1	0.8	1.0	0.8	1.4	20.4	2.7	0.0	31.4	0.0	6.5	5.0	40.9	1.7	2.2	20.3	0.0	1.5	27.7	4.0	1.8	0.0	2.9	4.6	0.0	10.4	1.3	11.7	1.2	0.0	6.5	6.8	48.7	40.0	1.7	7.2	2.9	0.0	15.0	0.5	6.5	2.5	0.5	0.9	4.6	3.4	4.5	18.7	0.2
KLHDC8A	FLJ10748	ENSG00000162873	"Kelch domain containing 8A"	Q8IYD2	1	205336065-205357090	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	12	"ovary: 93.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 46.6;Erythroid cells: 46.7;Muller glia cells: 17.4;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in many"		"glioma: 45.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;HAP1: 11.5;NTERA-2: 2.8;SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.92e-1)"	"unprognostic (8.37e-3)"	"unprognostic (7.39e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.84e-7)"	"unprognostic (4.53e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.20e-2)"	0.3	8.0	2.2	0.4	6.0	2.3	0.5	7.8	2.4	0.7	0.5	2.3	0.1	0.6	1.2	1.7	1.4	5.7	0.5	0.4	3.6	5.0	0.3	0.3	0.4	0.3	2.2	1.8	93.4	1.1	0.3	6.5	0.3	8.0	0.4	0.5	3.0	2.2	0.3	0.3	0.5	0.5	1.2	1.3	0.4	1.4	1.8	0.8	0.0	1.5	1.7	1.4	0.3	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	11.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	11.7	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	6.0	7.8	2.4	3.6	5.0	2.2	1.8	8.0	0.8	0.0	0.0	0.0	0.0	0.0	46.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	46.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.8	0.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	17.4	0.5	0.0	19.8	0.0	4.6	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Group enriched"	"Detected in some"	129	"Early spermatids: 869.0;Late spermatids: 3077.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0	0.0	1.6	0.0	1.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.4	869.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3077.5	11.8	0.0	0.0	0.0	0.0	0.9	4.0	0.0	13.1	1.5	0.7	6.5	0.0	15.3	7.2	0.0	0.3	0.0	0.0	2.2
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504595-205532793	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.7;heart muscle: 58.9"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 69.8;Paneth cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 20.1;HeLa: 17.7;hTERT-RPE1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	2.6	4.3	13.6	2.7	31.8	1.0	2.4	4.2	25.0	7.6	6.9	38.1	20.2	17.3	3.4	4.0	2.7	5.7	6.4	58.9	22.1	16.2	13.7	4.7	6.5	1.9	47.8	16.7	7.5	10.7	3.7	4.0	9.6	22.1	3.1	6.1	5.3	16.5	23.5	3.9	1.6	15.1	4.8	98.7	3.5	9.1	0.9	36.4	0.4	4.8	1.4	2.5	3.7	4.7	0.1	1.4	0.0	2.1	0.6	0.9	0.6	11.7	0.8	0.1	0.6	0.0	0.0	12.7	0.2	2.4	0.5	3.1	5.3	8.8	7.0	1.8	0.1	1.0	10.6	2.6	20.1	0.5	1.9	2.3	1.6	17.7	5.4	2.3	0.0	0.0	1.3	1.0	0.0	0.4	17.2	0.0	10.0	0.1	8.5	0.1	9.5	0.6	0.3	10.0	3.4	0.4	0.9	0.0	8.8	1.9	7.5	4.1	1.6	3.6	1.7	7.8	14.7	7.9	3.4	0.0	0.0	4.8	0.0	0.0	2.4	1.1	1.4	0.1	5.0	2.0	0.0	0.8	0.0	0.1	2.1	0.9	0.0	0.2	0.0	1.4	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.6	13.6	31.8	4.2	19.7	22.1	16.2	47.8	16.7	22.1	36.4	0.0	0.3	0.0	6.7	3.1	4.7	25.0	7.6	0.0	1.2	69.8	0.0	4.9	6.6	15.9	1.6	1.9	20.6	0.0	5.8	1.9	4.8	1.9	0.0	3.9	5.1	0.0	5.8	1.3	1.6	2.8	0.9	3.6	3.3	7.2	12.9	19.1	6.3	98.2	1.4	15.4	1.2	6.5	12.5	1.4	10.0	1.1	1.6	0.5	11.5	5.9
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;kidney: 37.6;stomach 1: 60.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.0;Ciliated cells: 5.3;Club cells: 11.4;Collecting duct cells: 8.7;Distal tubular cells: 11.6;Exocrine glandular cells: 5.6;Proximal tubular cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.1;HAP1: 2.7;HMC-1: 4.6;SCLC-21H: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0"							NA	NA						"unprognostic (7.15e-4)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	1.7	0.6	17.3	0.8	10.6	0.3	2.1	18.8	24.9	4.9	7.3	1.3	0.0	1.2	0.8	5.2	1.0	1.6	11.1	0.8	11.9	4.3	37.6	0.5	3.8	0.5	3.6	13.3	0.6	1.0	0.4	3.2	3.5	8.4	1.1	9.5	2.4	8.6	0.6	0.6	3.3	1.1	0.7	2.8	0.6	60.0	0.5	0.2	0.0	0.7	0.8	2.8	0.9	0.8	1.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.8	0.1	0.8	0.0	0.1	2.1	2.7	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	4.6	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.2	0.5	5.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.3	0.1	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	17.3	10.6	18.8	24.9	11.9	4.3	3.6	13.3	8.4	0.2	6.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.4	8.7	0.0	0.5	11.6	1.2	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ELK4	SAP1	ENSG00000158711	"ELK4, ETS transcription factor"	P28324	1	205597556-205631962	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028863	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028863: AB_10602492"	"unprognostic (2.08e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (2.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-3)"	14.1	7.1	10.0	14.7	12.7	12.0	13.8	16.2	10.4	10.1	8.9	10.4	8.6	7.3	11.3	9.2	11.7	9.5	11.4	10.8	10.6	5.0	15.2	15.6	13.8	19.1	10.0	6.9	13.1	12.4	13.6	16.8	9.5	9.5	32.6	8.7	12.2	12.4	8.2	14.7	17.6	13.5	10.5	8.2	18.3	9.4	8.4	11.0	24.4	10.8	8.3	19.6	15.1	13.2	2.2	1.5	8.7	1.1	1.2	3.1	0.6	8.2	7.5	2.9	7.7	7.1	9.1	7.5	5.6	5.8	4.4	5.2	3.2	8.4	17.6	5.3	6.9	3.3	10.4	6.2	6.8	7.7	20.0	4.4	7.6	12.2	6.8	9.7	14.2	30.3	8.0	8.5	7.0	14.4	8.6	18.6	8.4	6.9	14.8	6.2	11.2	11.7	5.3	4.9	1.9	4.5	8.7	18.3	14.3	5.9	18.2	3.5	4.1	14.4	7.9	9.5	5.4	7.3	4.8	13.4	9.0	10.6	8.0	10.5	11.1	10.1	11.9	7.8	5.8	10.5	8.7	0.8	1.2	1.6	1.1	2.1	1.4	1.8	2.1	1.1	2.2	2.2	3.1	0.4	1.2	0.6	1.5	1.8	0.6	10.0	12.7	16.2	10.4	10.6	5.0	10.0	6.9	9.5	11.0	8.9	11.5	21.4	29.2	34.9	95.4	18.7	28.1	17.4	15.9	29.6	11.8	11.3	3.3	12.9	11.6	35.7	9.8	0.0	15.6	5.2	25.6	62.3	27.7	28.9	8.9	23.8	12.6	25.8	20.0	14.0	23.6	18.5	28.7	5.4	15.8	10.6	12.9	3.5	14.5	13.9	26.7	25.8	23.4	20.0	9.8	42.4	15.3	37.4	17.3	61.0
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680459	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 115.0"	"Group enriched"	"Detected in many"	11	"Glandular cells: 50.8;granulocytes: 117.6"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	226	"basophil: 22.6"	"Lineage enriched"	"Detected in single"	226	"granulocytes: 22.6"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 141.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	0.8	1.5	2.5	1.5	6.2	0.7	0.8	0.4	5.8	1.9	2.1	19.0	0.0	2.1	0.9	0.6	0.9	1.1	1.8	0.7	4.2	2.0	1.1	4.0	1.7	1.6	13.2	1.6	1.0	0.7	0.5	1.9	0.6	7.2	115.0	1.6	0.2	0.9	0.7	2.2	0.9	2.1	0.8	12.4	5.0	6.4	1.4	11.1	0.0	0.5	0.7	0.7	1.5	0.4	0.0	0.0	22.6	0.0	0.0	0.0	0.2	1.5	0.5	0.4	0.4	0.0	0.0	0.3	0.2	0.0	0.5	0.4	1.1	2.9	0.4	0.7	0.0	0.5	0.5	0.2	0.5	0.0	0.6	0.4	4.7	0.1	0.3	0.3	0.8	141.5	0.0	0.1	0.3	0.0	0.3	1.6	0.7	0.7	0.2	0.2	0.3	0.1	1.3	2.0	2.7	1.7	0.1	0.7	0.2	0.6	2.2	0.2	0.5	0.2	3.5	0.6	0.4	0.8	0.2	1.5	0.2	1.6	0.5	1.1	0.0	0.1	0.0	0.3	0.2	1.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	6.2	0.4	5.8	4.2	2.0	13.2	1.6	7.2	11.1	0.0	5.6	1.3	1.1	0.0	0.2	1.7	5.1	2.7	1.2	1.8	0.0	0.4	0.0	1.8	0.1	0.6	3.4	0.0	0.5	0.1	0.6	50.8	117.6	4.9	2.0	0.0	0.0	0.0	0.6	0.0	1.7	0.9	0.0	1.0	7.4	0.2	2.4	7.0	1.4	1.8	0.0	6.5	1.0	0.0	1.5	0.1	0.0	0.0	4.4	0.8
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712819-205750276	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	25.6	25.3	46.9	17.3	55.5	12.1	31.3	45.0	49.2	33.0	24.2	38.3	18.8	12.5	36.5	27.8	25.3	32.1	22.5	40.6	43.8	35.6	30.9	43.9	20.6	29.4	43.6	47.6	49.1	17.4	50.3	21.0	20.8	32.8	31.9	21.1	21.9	19.0	32.7	43.1	21.7	14.6	42.9	49.1	22.6	17.9	14.2	38.9	35.3	42.5	20.6	24.8	32.0	22.6	7.8	7.4	4.5	4.9	10.7	11.8	4.0	40.6	25.0	67.5	26.6	18.7	25.9	31.8	29.4	30.3	41.3	33.3	13.7	47.0	45.2	17.1	28.6	13.1	30.1	51.2	24.6	47.4	21.6	25.6	29.4	22.1	14.9	13.8	46.1	10.5	20.5	22.3	24.5	42.8	22.2	32.2	29.3	47.1	14.5	32.2	47.0	41.8	23.3	68.9	16.3	18.7	43.7	83.2	25.9	23.1	25.1	28.1	52.0	43.3	34.7	23.5	54.6	53.1	34.8	32.1	31.7	28.2	36.1	51.9	13.4	15.7	36.5	21.8	26.0	42.6	4.5	3.4	3.7	9.9	4.9	9.6	5.8	9.2	8.6	4.7	7.8	11.5	11.8	0.6	10.7	4.0	7.4	5.5	4.0	46.9	55.5	45.0	36.6	43.8	35.6	43.6	47.6	32.8	38.9	199.5	245.2	149.9	252.8	229.2	349.8	365.7	310.8	239.6	291.2	287.9	68.7	230.3	326.6	177.1	41.7	224.6	54.9	233.6	148.6	321.5	312.0	255.4	201.9	550.1	225.1	298.8	172.0	219.1	173.7	32.2	474.1	194.8	165.4	192.0	193.2	516.1	113.3	94.7	456.1	297.2	177.2	310.4	243.6	46.5	115.0	213.3	148.2	154.5	216.0	173.7
RAB29	"RAB7L, RAB7L1"	ENSG00000117280	"RAB29, member RAS oncogene family"	O14966	1	205767986-205775460	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 97.4;Proximal tubular cells: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020822, HPA026303"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB020822: , HPA026303: AB_1856016"	"unprognostic (5.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (9.50e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.42e-1)"	10.7	14.4	13.8	12.0	16.5	4.0	12.3	5.9	16.2	6.1	10.3	10.4	3.0	6.8	6.9	16.2	11.0	5.1	11.0	9.5	12.6	8.6	46.6	19.9	9.3	20.1	19.0	9.2	5.8	7.9	11.1	8.3	4.6	13.3	9.4	6.7	8.9	15.4	9.6	5.2	4.4	10.4	13.0	20.2	16.8	8.7	3.2	15.9	6.5	21.8	3.1	17.3	13.7	10.8	17.9	11.6	23.5	17.8	32.1	34.8	15.9	8.2	7.7	1.2	5.6	23.0	13.1	4.1	5.9	18.2	12.4	14.9	2.3	12.0	8.9	5.8	10.0	14.7	4.7	13.8	15.5	11.4	36.1	6.4	6.7	3.2	3.9	11.2	6.6	10.0	12.7	10.6	9.9	14.1	10.4	15.6	8.3	6.5	10.3	17.4	3.2	7.1	3.4	5.5	10.4	5.9	1.5	18.3	7.3	14.5	11.5	1.9	5.4	4.1	19.2	15.3	4.6	9.3	5.4	16.2	12.8	6.6	18.5	8.4	16.9	34.5	4.7	13.0	10.9	9.5	23.5	7.7	20.8	34.8	14.8	32.6	17.9	19.5	29.3	11.6	16.6	14.2	24.4	3.1	32.1	17.8	3.5	18.0	15.9	13.8	16.5	5.9	16.2	12.6	8.6	19.0	9.2	13.3	15.9	17.9	15.3	43.0	5.5	0.0	0.4	17.3	28.1	5.3	11.4	29.6	0.0	9.9	24.9	13.4	5.2	11.8	2.6	0.0	8.9	5.2	2.9	11.3	12.7	27.1	27.5	0.0	4.7	12.3	22.5	2.7	13.3	29.4	0.0	97.4	3.0	22.5	8.7	3.5	19.4	145.9	1.4	6.5	2.0	0.9	10.2	0.0	2.4	40.3	5.0	7.1
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.8	9.6	6.1	9.7	7.6	7.5	8.3	11.2	11.0	11.4	10.1	4.8	6.2	15.7	7.1	10.2	9.5	11.3	5.9	8.2	3.9	28.8	9.0	3.8	9.5	0.7	7.3	0.0	11.0	9.5	6.9	13.0	9.3	9.5	7.0	12.8	7.0	6.6	9.1	6.7	7.0	1.1	7.2	2.9	4.4	8.3	18.3	3.8	2.6	13.5	5.1	6.5	8.6	7.7	7.0	5.3	5.5	4.0	8.7	13.6	8.8	12.4	11.6	22.0	14.6	5.2	10.6	5.0	8.4	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3	3.0	16.5	12.6	19.3	18.4	12.9	157.4	10.2	9.4	12.5	0.0	47.1	1.7	1.7	8.2	1.5	20.4	0.0	0.0	9.4	12.7	8.0	15.4	6.9	1.8	2.7	17.5	5.8	4.3	2.2	1.7	9.2	3.2	8.5	0.0	0.8	18.0	8.8	0.6	8.9	13.7	21.3	0.0	19.4	6.8	15.0	15.8	2.6	8.5	1.0	20.0
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828022-205850132	"Enzymes, Predicted secreted proteins"		"Hydrolase, Lyase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"pancreas: 103.5"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 18.7;Proximal tubular cells: 5.8"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.5"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 6.6"	"Low region specificity"	"Detected in all"												"Secreted to digestive system"	NA	NA		3000000				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.5	0.0	0.0	0.5	0.2	0.0	0.6	0.1	0.4	0.0	0.2	0.6	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.3	0.3	0.0	3.2	0.1	0.2	0.5	0.2	0.0	0.3	103.5	0.0	0.0	0.1	0.4	0.8	0.0	0.3	0.2	0.4	0.0	14.3	0.1	0.1	0.1	0.4	1.2	0.2	0.1	0.1	0.1	0.1	0.4	1.5	0.3	0.3	0.0	0.8	0.2	0.0	4.5	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.3	0.3	0.9	2.4	0.0	0.2	0.3	0.9	0.0	0.0	0.2	0.0	4.5	1.0	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 108.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	6.4	0.1	0.1	0.0	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.1	0.1	0.0	0.1	108.4	0.1	0.1	1.9	0.1	0.1	0.1	0.1	17.8	0.1	0.1	0.2	0.4	1.1	2.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	51.6	0.0	0.0	0.0	0.0	25.8	0.0	4.0	4.5	1.8	0.0	0.0	1.7	2.9	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
RAB7B	"MGC16212, MGC9726"	ENSG00000276600	"RAB7B, member RAS oncogene family"	Q96AH8	1	205976740-206003461	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 21.3;skin 1: 23.7"	"Cell type enhanced"	"Detected in many"	12	"Club cells: 11.4;Cytotrophoblasts: 23.0;Hofbauer cells: 33.5"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"myeloid DC: 8.4"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 11.7;HBEC3-KT: 15.3;HL-60: 9.6;HMC-1: 41.5;hTCEpi: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.18e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.82e-3)"	21.3	0.0	0.5	1.9	1.3	0.0	4.5	0.0	2.0	6.6	0.6	4.0	3.6	0.6	3.3	4.7	7.7	0.9	6.5	1.7	0.5		0.0	0.5	6.1	2.6	0.5	0.0	1.7	0.0	0.0	0.0	5.8	3.0	2.5	0.9	1.5	1.9	3.2	0.6	23.7	0.5	4.2	1.3	1.0	2.5	1.6	0.8	3.4	3.0	13.3	4.4	3.3	0.3	0.0	8.4	0.0	1.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.9	6.9	1.6	3.0	3.7	1.3	1.2	0.4	1.1	0.0	1.1	11.7	1.4	3.0	0.0	15.3	0.4	0.1	0.0	0.0	0.0	0.4	0.0	9.6	41.5	2.3	17.8	2.5	0.0	0.8	0.0	0.0	0.2	0.0	0.8	0.1	0.0	5.9	0.1	0.5	0.0	0.0	0.8	0.3	0.4	0.1	0.0	0.0	0.4	0.0	1.9	3.3	1.0	3.4	0.0	0.8	2.1	0.8	0.2	0.0	0.0	0.0	5.6	4.1	1.4	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4											3.0	4.6	0.0	7.4	0.0	0.0	0.6	5.1	0.0	11.4	0.0	0.0	23.0	0.0	3.1	0.0	0.1	0.0	0.0	0.2	0.9	4.8	0.6	2.3	0.0	33.5	0.0	0.0	0.0	4.5	0.4	1.7	8.5	0.0	6.4	0.0	2.8	0.5	0.0	3.2	0.0	0.2	0.0	1.1	0.0	0.0	0.0	5.3	0.0	0.0	1.4
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206009264-206023909	"Enzymes, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 57.9;intestine: 47.3;stomach 1: 153.0"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 98.3;Club cells: 77.3;Exocrine glandular cells: 240.3;Pancreatic endocrine cells: 151.8;Paneth cells: 175.6"	"Group enriched"	"Detected in many"	8	"lung cancer: 68.8;pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"OE19: 201.7"	"Not detected"	"Not detected"							"HPA012940, CAB032687"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB032687: AB_637901, HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favorable (5.26e-5)"	0.2	0.1	0.1	3.7	0.1	3.0	0.1	0.1	0.1	0.1	47.3	0.3	0.8	29.3	0.1	0.7	0.6	0.5	57.9	0.3	0.1	0.1	0.2	0.2	24.9	0.0	0.1	0.0	0.1	2.2	0.0	0.5	0.0	0.1	1.3	3.2	0.0	0.1	0.0	0.1	0.1	29.7	0.0	0.1	0.2	153.0	0.1	0.0	0.3	4.2	0.0	1.1	1.8	0.4	0.2	0.7	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	201.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	98.3	20.9	0.0	0.1	0.0	0.0	0.4	17.8	13.4	77.3	0.0	0.0	0.0	0.0	44.2	0.0	0.0	5.1	23.3	240.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	2.8	8.1	0.0	151.8	175.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206052723-206102459	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 117.7"	"Cell type enriched"	"Detected in some"	14	"granulocytes: 308.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 42.8;ovarian cancer: 41.1"					"Cell type enriched"	"Detected in some"	51	"basophil: 117.7"	"Lineage enriched"	"Detected in many"	51	"granulocytes: 117.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 189.5"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.3	0.0	0.0	3.9	0.0	0.0	1.8	0.0	0.0	13.1	3.1	0.0	12.1	0.9	6.2	8.2	3.4	1.6	16.2	0.4	0.0		6.8	1.8	5.2	4.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	9.4	3.3	2.9	0.0	16.9	1.5	0.2	4.0	7.0	0.0	0.4	2.4	1.1	0.0	0.6	0.0	1.7	2.5	4.3	10.0	0.3	2.2	117.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.1	0.0	8.6	189.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	38.1	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	117.7	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2											0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	19.2	0.0	1.5	1.7	2.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	308.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AVPR1B	AVPR3	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206109692-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"pituitary gland: 52.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;NTERA-2: 1.0;PC-3: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075404	Enhanced					NA	NA					"HPA075404: AB_2732291"		"unprognostic (4.87e-2)"		"unprognostic (1.44e-1)"	"unprognostic (4.82e-1)"			"unprognostic (2.82e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.66e-3)"	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.5	0.1	1.3	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	52.8	0.1	0.1	0.2	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	1.0	0.0	3.6	0.0	0.0	0.2	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM72A	"LMPIP, MGC57827, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 14.9;Kupffer cells: 15.6;Late spermatids: 22.6;monocytes: 10.8;Spermatocytes: 13.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	3.4	2.5	1.9	4.7	1.6	6.3	3.2	8.0	1.3	0.8	1.5			2.4	0.6	0.0	2.5	1.8	2.2	0.9	2.4	1.8	1.0	1.3	2.4	8.9	2.6		0.8	0.7	2.3	0.4	2.8		0.5	1.7		0.7	0.2	0.2	5.0	2.2	1.3	3.1	6.3	0.8	6.3			0.5		6.2	1.1	1.2	2.1	5.6	1.2	9.2	0.6	3.6	2.4	9.7	8.0	8.4	3.6	1.2	1.5	10.1	7.0	3.0	8.1	6.1	4.7	14.6	25.1	6.0	1.8	9.1	11.7	9.7	3.8	9.7	13.8	8.0	11.3	7.3	6.3	0.8	19.5	12.8	2.1	0.7	7.2	12.8	2.4	5.0	21.9	22.5	17.3	5.0	5.7	12.1	17.5	15.3	6.9	10.7	13.5	14.6	18.9	4.6	1.5	8.4	4.9	5.0	4.6	4.1	10.0	9.7	10.6	2.6	6.5	7.5	8.4	11.5	14.0	20.5	22.5	5.3	16.1	8.9	0.0	7.5	0.0	0.9	9.2	0.2	2.1	1.8	1.8	5.6	0.8	0.2	0.4	1.2	0.6	5.4	2.3	3.6	2.4											0.0	1.0	0.9	0.1	1.5	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.4	0.0	0.8	14.9	5.2	0.9	0.0	0.7	2.8	2.4	0.4	0.0	0.0	7.8	0.0	0.0	6.7	15.6	22.6	0.0	6.0	3.3	10.8	0.4	0.5	0.3	0.0	0.0	0.1	0.1	0.0	1.7	13.5	4.5	0.9	0.6	0.9	0.4	0.5
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.1"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 53.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	3.5	2.4		2.2		3.3	0.7		4.3	1.3	0.0			0.0	1.4	2.0	1.2	1.7	1.5	0.5			0.7	0.5	2.4	1.9			3.1	0.5	7.4		3.4		0.1	0.1		0.0	0.9	0.0	8.5	0.0	2.3		4.2	0.6	1.0			0.0		1.8	1.1		4.8	12.7	14.1	9.9	1.4	3.0	2.2	19.1	12.9	43.9	11.1	20.9	18.9	17.2	16.6	12.4	14.5	15.9	8.8	14.7	7.5	9.6	18.3	19.4	15.6	13.0	10.9	14.6	9.3	10.6	15.4	23.1	13.2	8.7	10.6	17.3	17.1	9.5	18.6	13.0	15.8	25.1	9.8	12.6	24.4	9.2	13.3	8.4	9.4	14.1	3.4	14.9	19.1	18.0	17.7	6.2	3.5	14.6	6.7	14.1	10.6	20.6	17.2	13.1	18.9	24.9	14.3	17.3	17.5	15.2	16.2	14.5	7.1	17.2	14.8	34.7	0.6	9.3	0.5	2.6	9.4	1.0	2.2	2.1	2.6	6.3	4.8	0.8	1.8	14.1	1.4	9.9	12.7	3.0	2.2											8.9	15.5	13.7	5.2	21.2	41.0	3.3	12.7	4.0	7.9	10.4	3.9	2.9	0.0	5.7	53.8	24.8	0.3	0.0	1.8	17.0	12.3	3.6	8.1	1.5	15.6	1.6	1.2	35.6	37.7	28.5	7.2	27.3	15.1	17.2	1.5	8.2	3.3	0.2	2.5	0.5	5.3	0.0	11.5	7.9	9.4	31.9	3.5	7.5	1.2	4.9
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 20.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.1	0.9	1.0	17.3	3.4	4.3	1.4	1.1	1.7	2.2	4.8	1.5	1.7	3.9	2.0	3.9	6.1	1.2	3.6	1.1	2.9		1.5	0.6	3.7	13.6	2.1	0.7	1.0	1.5	0.0	0.8	2.5	1.9	1.8	4.3	1.5	8.3	2.9	0.1	8.9	4.2	1.0	2.9	12.8	4.0	0.0	2.4	18.8	2.6	4.4	19.5	4.4	0.4	12.9	4.6	4.2	15.9	10.8	24.8	12.3	9.0	7.1	2.0	0.2	3.6	5.2	2.1	3.6	11.5	5.0	5.6	5.6	14.7	17.9	9.9	7.3	6.0	12.2	0.0	9.3	1.0	2.9	1.7	2.5	4.2	3.9	4.7	15.2	8.1	6.6	1.6	4.1	0.8	5.8	7.2	4.9	1.2	5.5	5.2	1.8	9.7	25.6	2.9	2.1	5.5	5.2	2.1	14.2	5.9	15.4	0.0	0.0	1.6	12.3	2.2	2.6	7.3	10.8	14.0	5.0	3.1	3.6	4.1	1.9	0.9	11.6	9.4	12.8	2.0	4.2	15.9	0.3	10.5	11.2	7.5	12.9	16.7	15.2	4.6	7.4	13.3	13.6	1.1	10.8	6.4	1.5	24.8	12.3											0.0	5.0	8.9	3.6	1.6	0.0	0.8	0.0	2.7	0.0	0.0	0.0	3.5	0.0	10.6	2.7	0.6	10.5	0.0	10.9	3.6	2.4	2.6	4.7	0.8	12.5	0.0	3.5	1.3	11.9	5.2	0.9	5.3	6.8	1.8	6.8	0.0	12.0	20.1	0.7	2.0	0.0	0.0	0.5	0.2	0.5	4.3	1.3	14.4	8.0	9.6
RASSF5	"Maxp1, NORE1, RAPL"	ENSG00000266094	"Ras association domain family member 5"	Q8WWW0	1	206507530-206589448	"Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.0;lymphoid tissue: 34.1"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 57.0;granulocytes: 136.3;T-cells: 81.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 24.9;JURKAT: 20.4;Karpas-707: 52.1;MOLT-4: 21.5;RPMI-8226: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA070480	Approved					NA	NA					"HPA070480: AB_2686271"	"unprognostic (1.92e-3)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.37e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.17e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.28e-3)"	1.7	3.5	1.5	14.1	1.7	29.2	1.6	0.0	6.2	1.9	2.1	2.0	7.8	2.2	1.0	1.7	13.7	2.8	8.5	1.6	1.6		0.5	4.9	8.8	17.8	0.2	1.8	1.7	7.2	2.6	3.1	1.0	2.8	2.7	2.4	1.8	12.3	12.6	1.6	5.2	2.7	2.0	1.3	23.9	4.9	0.5	0.6	34.1	1.1	8.7	24.6	7.4	4.4	7.0	10.3	61.0	18.2	29.2	29.1	30.1	2.6	1.1	0.0	0.4	0.9	0.5	0.0	0.1	1.3	0.5	0.6	0.1	5.4	8.5	0.7	0.5	0.1	4.1	0.9	0.6	0.4	5.8	3.4	9.2	0.2	0.0	0.3	15.3	24.9	0.6	2.6	0.6	0.7	0.9	0.1	20.4	3.7	52.1	0.2	0.2	21.5	9.8	0.5	0.0	1.0	10.2	1.2	56.7	0.0	4.0	1.2	0.0	4.6	0.4	0.1	0.0	1.0	9.8	0.0	0.1	1.8	2.4	0.5	18.5	13.3	7.9	0.8	9.0	0.2	41.0	9.1	61.0	27.7	12.5	25.1	7.0	20.9	29.1	10.3	6.4	29.0	26.8	37.1	29.2	18.2	8.1	17.9	30.1											35.7	37.1	57.0	15.5	29.1	1.3	5.3	5.1	8.1	12.5	0.0	0.0	0.1	3.3	5.9	0.1	3.4	0.0	0.0	7.9	0.0	6.7	8.7	136.3	5.1	11.5	7.9	2.4	5.5	41.0	0.0	6.9	49.4	13.5	20.8	0.4	0.0	6.6	0.0	8.5	0.6	0.1	0.0	15.3	0.0	0.2	23.8	0.1	81.6	1.7	39.8
EIF2D	LGTN	ENSG00000143486	"Eukaryotic translation initiation factor 2D"	P41214	1	206571292-206612463	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028220	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA028220: AB_10602022"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.09e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.13e-2)"	19.4	22.3	12.3	14.6	17.0	15.7	25.0	16.7	14.5	23.6	22.2	19.4	23.7	12.1	24.5	21.1	22.3	25.2	19.0	15.2	13.5	9.0	19.6	20.0	15.4	19.9	19.7	10.0	36.2	38.1	19.7	17.3	15.2	14.9	22.8	18.9	18.1	26.9	18.3	27.7	19.2	15.2	22.6	14.5	16.0	21.9	13.1	18.5	29.3	29.3	20.0	21.7	21.0	21.1	19.2	16.6	5.6	13.1	16.4	21.3	10.5	20.3	12.6	10.3	8.9	30.5	40.2	12.5	11.5	23.9	20.9	20.6	10.2	17.8	34.6	8.9	23.5	6.7	14.5	16.7	26.1	18.6	11.3	21.5	12.1	15.1	19.3	33.6	21.9	12.5	36.5	34.8	16.6	33.1	26.7	26.5	25.4	28.1	16.3	18.2	16.0	19.6	10.2	8.4	15.3	19.3	15.9	22.1	38.1	21.2	7.6	9.7	8.9	10.1	27.2	24.5	16.1	20.8	17.3	18.5	11.6	11.6	5.3	15.3	14.9	8.3	24.2	15.6	14.9	8.6	5.6	10.3	1.6	11.8	9.2	15.9	19.2	16.4	14.5	16.6	15.5	21.3	15.3	0.2	16.4	13.1	8.8	14.5	10.5	12.3	17.0	16.7	14.5	13.5	9.0	19.7	10.0	14.9	18.5	14.9	13.7	22.9	30.1	12.8	10.6	8.4	2.5	18.7	18.2	10.4	3.9	33.5	21.6	16.0	30.3	18.0	8.1	0.0	17.2	21.7	17.7	20.5	17.3	7.9	19.3	3.2	4.7	20.3	12.6	10.3	26.7	12.8	16.9	25.2	12.2	9.4	16.1	11.5	25.8	24.5	13.6	19.4	17.6	23.3	9.3	20.3	21.4	20.8	31.5	23.6
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.5	0.8	4.9	8.7	7.8	0.1	8.2	18.1	7.5	9.7	0.2	1.3	3.7	1.2	9.6	13.2	0.7	4.2	6.6	8.0	0.0	2.8	5.4	4.4	0.8	13.8	3.7	3.5	5.5	4.3	12.9	35.7	7.7	5.8	5.7	10.4	0.7	11.5	0.9	8.2	2.1	6.9	0.2	6.5	20.4	2.6	0.0	2.4	0.1	5.0	3.7	7.3	0.3	10.0	1.0	0.9	0.9	4.3	15.7	5.9	7.6	6.8	2.9	1.1	4.4	9.3	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1	3.0	5.1	0.5	10.3	5.8	0.1	10.3	2.5	13.4	5.7	1.8	9.8	0.0	0.0	3.0	160.9	4.2	0.0	0.0	1.9	0.1	7.3	3.2	0.0	1.1	0.9	0.0	2.4	2.5	1.5	27.7	3.7	1.9	8.5	1.8	0.3	3.0	1.4	0.0	1.8	1.0	7.4	6.5	10.3	17.6	3.4	3.1	0.3	0.0	0.2	3.5
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	21.2	8.4	11.7	13.2	34.6	20.3	14.6	14.8	33.7	22.7	21.4	16.1	10.4	10.2	10.4	29.9	14.2	16.1	8.7	15.8	16.3	11.9	6.6	17.2	10.5	10.3	26.7	25.4	57.6	28.0	20.2	21.8	24.1	18.9	18.5	13.9	19.8	46.7	18.3	26.4	10.2	18.4	13.5	7.5	11.8	26.2	24.6	3.3	17.1	13.1	9.4	12.1	17.5	29.6	20.5	22.8	14.4	24.7	17.6	20.5	17.3	23.7	20.2	60.9	54.0	8.3	23.2	15.5	6.7	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6	50.6	53.7	28.9	47.2	75.9	11.3	97.2	40.8	6.7	29.6	29.6	19.6	5.0	13.3	28.0	71.3	26.3	27.4	23.3	50.4	7.0	28.6	55.9	34.6	34.4	22.4	0.0	59.3	21.5	27.7	20.1	21.0	27.9	32.1	12.6	32.0	17.7	50.5	21.2	16.3	21.0	14.8	25.8	48.7	11.8	4.1	63.0	13.8	37.4	24.1	68.1
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206772494	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.3"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 25.9;Kupffer cells: 36.4;Macrophages: 43.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;intermediate monocyte: 4.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.4"	"Group enriched"	"Detected in some"	8	"HMC-1: 18.6;U-266/70: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	NA	NA	5670				"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	10.9	3.1	1.1	10.7	1.2	4.1	2.1	0.3	1.3	1.6	1.8	2.1	0.5	0.8	1.0	1.9	1.7	4.0	5.2	3.9	0.8	0.9	1.3	3.1	4.3	9.2	1.8	0.9	1.5	1.2	0.4	2.3	3.6	2.3	1.7	1.8	2.1	1.6	0.8	0.9	0.7	2.1	4.6	2.2	28.3	2.0	1.6	1.4	2.2	2.4	0.9	3.5	4.1	1.0	0.2	0.5	0.5	5.4	0.1	1.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	9.6	0.3	0.3	0.0	0.1	0.0	0.5	5.4	0.1	0.2	4.0	0.0	0.1	0.2	1.0	0.5	0.2	0.1	0.1	0.3	0.1	1.4	0.1	0.9	1.0	1.1	1.2	0.3	1.3	0.8	0.9	1.8	0.9	2.3	1.4	0.0	3.4	1.4	0.3	0.9	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	6.9	0.3	0.0	0.0	0.0	0.1	0.6	0.3	1.1	0.0	25.9	0.0	0.0	0.6	36.4	2.2	0.0	43.8	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	1.0	0.1	1.3	0.0	0.4
IL19	"IL-10C, IL-19, MDA1, NG.1, ZMDA1"	ENSG00000142224	"Interleukin 19"	Q9UHD0	1	206798870-206842981	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7"	"Cell type enriched"	"Detected in single"	4	"Exocrine glandular cells: 1.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"					"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	172000					"unprognostic (6.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.17e-2)"		"unprognostic (2.48e-5)"		"unprognostic (1.07e-1)"	"unprognostic (8.72e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.04e-3)"			"unprognostic (9.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0			0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		6.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2			0.3		0.3	0.9	0.8	0.7	0.6	1.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	11.8	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.7	0.1	0.6	0.1	0.3	0.4	0.2	0.1	0.0	0.2	0.6	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865354-206869223	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"seminal vesicle: 19.5"	"Cell type enriched"	"Detected in some"	7	"Basal keratinocytes: 61.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.9;GAMG: 1.6;hTCEpi: 1.0;SiHa: 5.9;SK-MEL-30: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"	NA	NA	109000				"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	4.6	2.2	0.2	0.2	0.2	0.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.8	0.2	0.4	0.7	1.3	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.3	0.0	0.2	0.6	19.5	0.2	3.8	0.2	3.2	0.2	0.2	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.9	0.0	2.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	5.3	61.8	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	8.7	0.0	0.0	0.0	5.8
IL24	"C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16"	ENSG00000162892	"Interleukin 24"	Q13007	1	206897443-206904139	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.7;lymphoid tissue: 22.5"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 2.2;Basal keratinocytes: 6.1;Smooth muscle cells: 1.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 18.7;T-cells: 12.0"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 63.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.9"	CAB025972	Uncertain				"Secreted to blood"	NA	NA	140000				"CAB025972: "	"prognostic favorable (5.09e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.43e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.33e-2)"	5.3	0.0	0.2	9.2	0.2	1.6	0.2	0.2	0.4	0.2	1.3	0.2	0.2	0.3	0.9	0.7	0.9	1.4	1.7	0.8	0.2	0.0	0.6	2.4	2.5	22.5	0.2	0.2	0.9	0.2	0.0	0.2	1.1	1.3	1.3	0.0	0.2	0.2	0.2	3.9	0.2	1.3	0.2	0.2	19.6	0.9	0.5	0.2	0.4	0.2	0.9	2.7	3.3	0.3	18.7	0.4	0.7	0.0	3.4	12.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.8	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.9	7.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.6	0.1	5.1	0.2	0.0	0.0	0.0	0.9	0.4	2.8	0.1	3.3	0.2	0.5	0.5	0.0	0.1	0.4	0.0	0.0	4.3	0.0	6.2	18.7	6.8	6.4	0.0	18.6	11.8	6.5	0.7	3.4	0.0	0.4	12.0	3.6	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	1.3	0.2	0.0	2.2	0.8	1.3	6.1	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.5
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206904386-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9"	"Group enriched"	"Detected in many"	11	"B-cells: 125.3;T-cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 99.6;T-cells: 60.0"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 53.0;U-266/70: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA		2400000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	15.5	0.6	0.5	42.9	0.5	2.9	1.5	0.4	0.4	0.8	2.5	0.4	0.3	1.2	1.2	0.8	3.4	1.3	2.6	1.0	0.5	0.5	2.4	1.5	3.9	77.2	0.5	0.0	1.3	0.7	0.0	0.9	0.8	0.2	1.4	2.3	1.3	10.1	0.3	1.9	0.6	30.1	0.4	0.6	78.8	2.8	0.5	0.0	51.8	1.8	1.2	84.9	8.5	1.2	99.6	1.4	5.3	0.4	18.4	60.0	28.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.1	0.0	0.0	3.4	0.0	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	2.7	0.0	7.4	0.0	0.1	1.0	0.1	0.0	0.0	0.0	1.7	0.2	53.0	0.0	0.1	0.0	0.0	1.0	0.2	5.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	26.7	1.9	7.4	0.3	0.0	0.2	0.5	0.2	0.2	20.3	0.4	26.4	80.3	28.1	26.2	0.2	99.6	49.5	33.3	5.3	18.4	0.3	1.4	60.0	28.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.2	0.0	0.0	4.6	125.3	3.9	0.0	0.0	3.0	7.6	1.4	2.3	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	2.6	0.1	0.6	2.6	0.0	1.1	3.8	0.0	0.0	5.5	5.1	0.0	0.3	1.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.1	1.0	0.0	0.0	41.7	1.2	7.1
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928518-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 2375.7;Mucus-secreting cells: 2056.5;Paneth cells: 2331.9;Undifferentiated cells: 3429.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Intracellular and membrane"	NA	NA		1900000000			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favorable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	0.3	0.3	0.3	74.2	0.3	0.0	6.9	0.3	0.3	35.1	232.8	0.6	0.4	158.9	2.6	0.5	2.6	0.7	139.0	0.3	0.3	0.3	52.5	5.0	25.1	0.3	0.3	0.3	0.6	4.2	0.0	0.9	0.4	0.3	3.0	75.6	0.4	398.1	0.6	0.4	0.4	320.1	2.0	0.3	0.4	25.3	0.6	0.3	0.4	0.4	23.9	22.5	4.9	0.6	3.4	1.1	1.4	0.5	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	1.4	0.2	0.0	0.0	0.2	0.0	5.0	0.1	1.3	0.6	2.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.2	0.3	1.0	0.0	0.1	0.0	1.4	0.5	0.3	0.4	0.2	0.5	3.4	0.3	0.3	1.1	3.4	0.5	0.5	1.4	0.5	0.3	0.9	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	86.4	488.0	21.0	2.7	0.2	0.0	0.8	662.5	127.2	379.9	102.9	0.0	0.0	14.9	60.9	0.0	0.5	2375.7	0.0	58.6	0.0	0.0	57.7	51.8	26.7	0.3	0.0	410.4	1.8	1.5	0.0	0.0	3.2	1.7	1.0	2056.5	0.0	144.1	2331.9	0.0	262.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3429.8	34.0
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 26.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HMC-1: 1.0"									HPA056505	Enhanced					NA	NA		3600000			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.1	0.1	0.1	23.0	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	23.9	7.6	0.1	8.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.4	0.1	0.1	0.1	1.0	0.1	0.5	0.6	0.1	0.2	0.1	0.2	0.2	0.1	9.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.9	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.1	0.3	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018521-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 163.8;Alveolar cells type 2: 71.9;Club cells: 78.5;Urothelial cells: 120.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 18.2;CAPAN-2: 32.4;HaCaT: 40.0;HBEC3-KT: 38.4;hTCEpi: 20.4;RPTEC TERT1: 18.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		7900	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.3	0.2	1.6	0.2	0.0	4.1	0.2	0.4	7.1	8.3	0.3	0.2	8.4	1.0	1.1	49.4	0.6	14.0	0.2	0.3	0.1	4.3	1.1	42.8	0.2	0.2	0.2	0.5	7.0	0.0	0.9	1.4	0.4	18.8	2.7	0.3	12.5	1.9	0.3	14.4	16.5	0.6	0.2	0.4	20.3	0.4	0.2	0.4	6.8	16.0	37.1	6.1	12.3	0.0	0.0	0.7	0.0	0.1	0.0	1.8	18.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	32.4	0.0	2.1	0.0	0.0	40.0	0.0	38.4	0.0	0.0	0.0	3.3	0.3	0.5	0.0	0.0	0.2	0.0	20.4	0.0	11.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	1.0	0.0	0.0	0.0	18.7	4.8	0.0	0.1	0.3	3.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.4	0.2	163.8	71.9	0.0	39.9	18.4	0.0	42.3	28.1	41.5	78.5	10.4	0.0	0.0	13.3	21.7	4.8	0.0	31.1	0.0	21.6	0.0	0.5	57.3	5.8	0.0	0.2	0.0	10.3	0.0	0.0	3.3	0.3	0.6	0.0	0.0	16.3	0.0	41.6	7.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	20.5	0.0	0.0	7.4	120.4
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 70.2;Late spermatids: 128.8;Rod photoreceptor cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 13.9;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 16.7;granulocytes: 13.9"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	3.3	6.1	9.8	5.8	16.6	15.7	5.1	2.1	14.6	7.3	16.0	19.5	5.3	23.2	4.0	9.1	7.7	4.5	9.1	22.8	14.1	7.7	22.0	3.6	10.9	5.3	13.4	15.1	4.3	11.9	6.2	27.5	3.0	25.3	3.9	18.1	22.4	6.3	3.5	34.9	6.4	18.7	4.0	17.4	12.5	10.7	6.1	15.1	6.5	38.4	8.8	5.0	3.4	3.6	1.6	16.7	13.9	1.9	1.1	0.4	0.4	9.7	4.3	2.8	4.9	5.9	2.9	4.7	1.4	1.7	2.4	1.3	10.5	14.1	1.7	2.2	2.2	7.4	13.9	2.1	5.2	1.4	0.3	2.1	13.8	10.8	3.9	4.9	0.0	9.7	4.1	8.0	2.3	13.2	2.9	0.5	5.8	9.4	0.1	1.3	2.9	2.3	0.4	3.9	4.7	6.5	0.0	0.0	0.2	3.3	10.1	4.5	2.7	9.1	15.4	11.4	3.2	10.6	1.1	0.2	0.0	5.3	7.5	1.3	4.5	4.4	0.9	6.1	0.0	2.6	1.0	0.9	13.9	0.2	1.9	0.3	1.3	0.1	0.3	0.8	1.6	0.3	0.4	2.6	1.1	1.3	16.7	0.0	0.4	9.8	16.6	2.1	14.6	14.1	7.7	13.4	15.1	25.3	15.1	6.0	42.0	4.5	3.4	13.5	7.3	70.2	5.1	14.7	5.7	15.7	0.0	0.5	21.6	4.0	47.4	2.7	43.0	0.0	6.7	0.4	2.5	6.5	9.2	4.9	4.9	3.2	5.8	1.3	11.3	128.8	2.6	6.0	20.3	1.8	18.9	8.1	10.5	27.7	2.8	30.6	111.9	0.0	3.2	3.1	3.3	10.2	1.3	1.0	27.6	11.2
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 69.8;Urothelial cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 40.3;K-562: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		40000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	4.5	4.6	4.0	4.0	5.3	44.7	6.6	4.8	7.5	6.1	3.9	7.6	2.6	4.1	4.0	3.1	24.5	3.7	3.5	5.0	4.0	2.2	4.5	5.2	9.4	4.2	7.1	4.4	3.5	3.6	2.5	5.1	6.3	5.1	3.4	4.0	3.4	9.7	3.0	6.5	14.9	4.8	2.7	8.5	5.2	8.4	5.6	6.9	14.3	5.8	10.0	8.2	5.8	12.3	0.5	1.3	3.9	1.5	1.2	1.8	0.9	5.4	2.9	4.6	2.7	1.6	2.1	9.0	3.6	2.8	2.7	2.8	5.5	5.6	2.8	1.5	2.2	1.3	6.0	0.0	4.4	3.1	2.3	4.9	40.3	11.9	2.6	1.5	5.2	14.2	1.5	3.4	2.2	8.6	3.2	2.4	5.9	28.0	0.0	2.3	0.0	4.6	2.9	4.4	2.2	6.5	2.3	0.2	2.1	2.7	6.1	2.4	5.3	5.9	6.9	7.7	4.2	2.4	3.7	1.1	2.4	6.2	1.9	4.7	4.6	0.2	4.2	2.8	0.0	1.6	3.9	1.2	2.0	1.1	1.5	1.5	0.4	1.7	0.9	1.3	0.5	1.4	1.8	2.9	1.2	1.0	0.7	0.8	0.9	4.0	5.3	4.8	7.5	4.0	2.2	7.1	4.4	5.1	6.9	38.7	9.8	0.8	21.4	28.0	7.8	5.3	5.1	13.4	5.7	1.8	3.9	2.3	1.7	3.8	28.6	3.5	9.8	46.7	9.3	2.7	5.7	29.8	8.1	5.4	2.4	11.1	8.5	3.7	8.5	69.8	1.4	6.4	13.5	1.8	3.5	4.2	15.5	4.9	2.1	5.4	16.2	6.5	3.1	8.8	4.1	35.1	1.5	7.5	5.4	62.9
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088842-207099993	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 156.5"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 556.0"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.6;T-cells: 2.5"	"Group enriched"	"Detected in some"	16	"CACO-2: 38.6;HeLa: 16.0;Hep G2: 50.1;OE19: 18.8"					"Low region specificity"	"Detected in all"			HPA051620	Approved				"Secreted to blood"	NA	NA	265000000000	1300000000			"HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	0.5	0.0	0.1	0.5	0.1	0.0	0.3	0.1	0.1	0.5	2.0	0.1	0.1	0.6	0.1	0.9	0.2	0.1	1.0	0.6	0.1	0.0	0.2	156.5	0.6	0.1	0.1	0.1	9.9	2.2	0.0	0.1	1.3	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.9	0.2	0.1	0.1	1.5	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	3.6	0.0	0.0	0.0	2.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.6	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	50.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.5	0.8	0.0	0.0	0.0	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.9	1.3	1.5	0.0	0.0	0.0	0.4	45.9	2.7	4.5	0.0	0.0	0.7	1.7	11.0	3.9	0.0	3.1	0.0	76.8	0.1	0.2	0.2	0.0	556.0	1.6	0.0	1.7	9.8	9.4	1.8	0.0	0.4	0.0	1.0	3.4	0.0	52.0	11.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	2.3	0.0
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104262-207144972	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 377.2"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 458.5;Alveolar cells type 2: 461.5;Hepatocytes: 752.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	153	"neutrophil: 21.6"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 21.6"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 28.7"									"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	NA	NA	30800000000	34000000000			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	377.2	26.0	0.1	0.1	0.1	0.3	1.8	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	458.5	461.5	0.0	0.0	0.0	0.0	0.1	30.6	6.7	40.9	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	23.3	16.0	0.0	0.0	0.4	3.5	752.2	0.2	0.0	0.0	23.4	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.1
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321376-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 2069.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 101.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 79.2;HMC-1: 105.8;PC-3: 63.1;U-2197: 64.2"									"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	NA	No	32300000	310000000			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	21.8	63.2	5.8	27.2	20.2	31.9	17.9	4.6	10.5	34.0	14.8	13.8	7.8	12.8	16.3	11.9	36.1	10.4	18.0	32.0	7.5	10.1	9.6	16.7	114.6	41.1	16.7	4.7	31.3	9.1	8.1	12.8	107.0	11.9	9.7	12.4	8.2	82.3	12.8	108.8	37.5	26.0	23.5	11.4	30.4	17.7	10.2	18.8	4.2	13.2	31.4	19.1	39.3	19.1	18.6	18.3	101.4	31.6	19.0	16.9	20.3	4.8	6.6	0.0	2.2	8.5	9.1	34.6	9.2	16.2	5.3	5.7	20.8	6.9	9.4	7.7	5.4	19.8	2.8	10.6	2.0	4.9	4.3	3.9	12.2	79.2	3.4	27.6	7.4	105.8	4.3	25.0	6.5	28.7	21.0	27.3	1.5	13.1	4.5	3.0	5.2	0.7	5.1	6.7	11.4	63.1	1.1	6.6	7.4	8.8	4.7	2.6	0.0	49.8	10.1	8.0	15.5	8.6	6.3	11.9	2.7	5.1	64.2	3.5	3.7	4.4	6.3	7.2	2.9	12.1	39.3	26.9	35.9	5.5	26.3	8.2	16.9	7.4	5.8	18.3	18.6	16.9	16.4	101.4	19.0	31.6	9.8	5.0	20.3	5.8	20.2	4.6	10.5	7.5	10.1	16.7	4.7	11.9	18.8	2069.5	358.8	93.2	172.8	626.3	1.3	63.2	2.5	389.5	704.1	22.7	0.0	192.2	3.3	54.9	311.7	62.4	158.4	0.0	162.7	371.1	199.2	136.1	142.1	6.6	62.3	1.6	16.6	41.1	161.1	60.3	30.2	161.4	151.8	53.3	67.0	5.8	238.8	150.8	8.5	3.3	2.5	6.5	60.8	7.7	4.1	669.5	708.9	76.1	69.0	491.7
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 97.2"	"Cell type enriched"	"Detected in some"	15	"B-cells: 25.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 13.3;naive B-cell: 16.2"	"Lineage enriched"	"Detected in many"	9	"B-cells: 16.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.5;JURKAT: 3.7;MOLT-4: 11.8;RPMI-8226: 4.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002659, HPA052942, HPA060715"	Enhanced					NA	NA		150000000			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favorable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	0.5	0.3	0.4	97.2	0.3	0.0	0.4	0.3	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	2.8	0.3	0.3	0.3	0.4	0.4	1.4	0.4	2.0	72.8	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.0	6.0	0.0	0.4	0.3	11.5	0.0	0.4	63.4	1.4	0.5	0.0	6.5	0.7	0.3	56.3	0.6	0.3	16.2	0.0	0.2	0.0	0.0	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.1	11.8	0.0	1.9	0.0	0.2	0.0	0.2	4.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	13.3	0.7	0.5	0.0	16.2	1.8	1.6	0.2	0.0	0.0	0.0	0.0	1.1	0.4	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 42.3"	"Group enriched"	"Detected in some"	4	"B-cells: 23.8;Erythroid cells: 46.7;Kupffer cells: 50.8;Macrophages: 12.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.2"	"Group enriched"	"Detected in some"	9	"HL-60: 9.0;HMC-1: 21.1;NB-4: 8.4"									"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		27000000			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	9.0	1.1	0.6	17.0	0.6	5.8	1.5	0.4	0.5	0.6	1.7	0.2	0.0	0.5	0.7	5.6	1.4	2.2	1.1	8.0	0.6	0.5	2.3	3.8	4.0	42.3	0.6	0.0	1.7	1.2	0.0	0.6	5.5	1.0	1.7	0.7	0.5	1.9	0.0	0.8	0.5	5.1	3.6	0.7	42.0	1.1	0.9	0.1	1.3	0.7	0.0	11.1	3.2	1.3	2.8	0.2	23.2	2.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	9.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.2	2.3	9.4	0.0	1.4	0.4	2.8	0.6	0.3	0.2	1.4	0.1	0.1	9.1	0.0	1.2	0.0	0.0	0.6	0.6	0.6	0.4	0.5	0.6	0.5	0.6	0.0	1.0	0.1	0.0	6.2	23.8	0.0	0.0	0.0	0.8	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	46.7	0.0	0.1	0.2	0.0	1.1	0.0	8.0	0.0	0.0	0.0	50.8	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 4.3"	"Cell type enriched"	"Detected in some"	19	"Erythroid cells: 93.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 3.1;HMC-1: 7.8;K-562: 3.8"									HPA049348	Approved				"Intracellular and membrane"	NA	NA					"HPA049348: AB_2680723"	"unprognostic (2.35e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.68e-2)"	0.4	0.3	0.2	1.3	2.5	6.1	0.2	0.2	4.0	0.7	0.3	0.9	0.9	0.1	0.2	0.1	0.2	1.3	0.1	0.2	0.8	0.2	3.2	0.8	2.8	1.3	1.0	1.7	0.9	0.2	0.1	0.2	2.6	1.1	0.3	0.2	0.0	0.9	1.0	0.2	0.2	0.6	0.1	4.3	1.0	0.2	0.2	3.3	0.0	0.3	0.0	0.8	0.2	0.2	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.2	4.0	0.8	0.2	1.0	1.7	1.1	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	5.0	0.4	0.0	0.1	0.0	93.5	0.0	0.2	0.0	0.3	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752057-207795513	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 69.8"	"Low cell line specificity"	"Detected in all"											"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"		NA	NA		1000000	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (1.42e-2)"	"prognostic unfavorable (8.54e-5)"	"unprognostic (3.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.78e-3)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.76e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.49e-2)"	38.0	78.0	13.0	22.9	20.5	18.5	57.0	12.9	17.8	27.5	35.4	25.3	64.3	32.9	39.7	32.6	43.2	30.4	25.2	20.6	16.1	15.5	50.8	57.8	43.6	25.0	21.4	13.2	27.6	47.9	86.6	32.7	119.6	29.1	47.0	28.5	26.7	68.4	60.5	18.8	18.4	39.8	25.0	21.8	26.9	33.9	16.5	20.7	20.3	25.3	21.8	30.3	37.2	27.0	7.7	8.1	69.8	14.1	7.5	13.5	14.9	26.7	15.1	14.2	6.5	44.8	44.4	21.6	20.1	29.2	13.3	18.0	14.8	71.2	4.1	20.5	20.0	18.3	36.3	10.6	27.6	20.3	20.5	15.1	8.9	16.6	26.6	28.5	19.3	31.0	38.1	41.1	20.0	15.8	31.4	37.1	16.3	18.6	17.9	20.4	12.6	9.2	17.0	16.2	16.0	15.1	6.2	22.6	25.2	54.3	53.0	14.4	9.8	25.4	57.2	33.0	29.6	45.0	16.6	31.8	14.3	12.7	30.0	22.8	24.1	29.0	12.4	20.9	12.8	13.4	41.7	13.5	63.7	9.2	14.0	12.5	7.7	11.7	10.1	8.1	6.0	13.5	11.2	69.8	7.5	14.1	4.2	10.1	14.9	13.0	20.5	12.9	17.8	16.1	15.5	21.4	13.2	29.1	20.7	187.6	224.8	34.3	81.1	47.1	61.8	56.5	86.6	227.5	213.9	137.9	62.8	190.0	13.3	67.0	176.4	91.0	82.1	0.0	68.5	62.2	54.2	160.9	108.9	100.2	53.0	38.1	69.8	78.5	81.8	23.7	43.7	72.9	59.1	50.5	91.2	28.9	65.3	92.2	41.4	61.7	79.1	51.8	66.9	13.8	23.3	40.1	287.4	51.1	85.2	127.3
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 32.6;MOLT-4: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		69000000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	61.9	8.8	4.6	12.8	7.6	1.9	37.5	3.1	6.7	38.3	15.9	5.2	20.5	5.0	41.4	40.3	33.8	22.3	20.6	51.2	5.4	4.9	18.8	2.2	25.0	11.9	8.1	6.7	20.7	8.6	7.8	3.6	78.9	6.3	21.0	7.4	12.8	12.4	20.5	39.7	21.2	12.1	42.3	4.7	9.2	11.3	23.1	4.7	3.5	25.8	35.9	11.0	33.6	33.1	0.6	1.7	1.6	0.3	0.6	0.5	1.5	0.0	0.0	0.1	0.0	1.6	0.1	0.1	0.2	1.2	0.3	0.9	0.0	0.0	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	32.6	0.5	0.0	0.0	0.8	0.0	32.1	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	1.1	0.0	4.9	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.6	0.2	0.3	0.5	0.2	0.5	0.3	0.3	0.2	0.2	0.6	0.3	0.3	1.1	0.6	0.3	1.7	0.2	1.5	4.6	7.6	3.1	6.7	5.4	4.9	8.1	6.7	6.3	4.7	3.0	8.5	0.0	0.1	14.8	0.4	12.3	2.5	0.0	0.0	3.5	2.0	0.2	0.0	0.2	10.9	214.1	0.0	0.0	0.2	0.3	22.6	0.2	1.1	0.5	0.3	0.0	0.0	81.0	0.3	4.2	135.4	2.2	16.9	0.0	0.0	0.3	0.2	0.0	115.6	0.0	0.0	6.5	4.1	0.7	0.5	11.3	0.1	0.0	0.0	0.3
PLXNA2	"FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2"	ENSG00000076356	"Plexin A2"	O75051	1	208022242-208244320	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 39.9"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 235.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.8;HaCaT: 19.3;HUVEC TERT2: 24.6;TIME: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009763	Approved					NA	NA		580000			"CAB009763: AB_2166388"	"unprognostic (8.25e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.88e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.40e-1)"	7.2	2.4	8.3	2.9	11.8	1.0	3.9	27.5	14.7	4.7	10.5	2.5	2.0	8.2	5.4	3.0	13.2	4.6	7.0	6.0	9.7	4.0	4.3	2.7	12.0	1.6	3.7	10.9	16.9	39.9	2.0	2.8	10.2	6.7	4.2	8.8	5.7	3.7	4.5	7.6	10.8	9.0	12.0	2.9	1.7	11.0	1.2	3.9	0.4	7.2	4.7	4.4	8.3	9.1	0.2	0.7	1.1	0.7	0.0	0.4	0.2	2.1	1.3	2.4	0.3	2.7	5.4	18.8	1.7	1.1	1.0	0.1	0.0	0.0	0.0	3.5	1.3	0.4	19.3	0.0	10.9	0.3	0.6	0.3	0.0	2.3	1.2	1.1	0.0	0.0	1.4	3.5	0.8	5.1	0.7	24.6	0.0	0.0	0.0	10.7	0.2	0.0	0.0	0.3	3.8	3.3	0.0	2.5	1.6	2.0	1.3	0.7	4.4	2.0	1.6	2.0	4.9	0.1	0.0	56.5	0.4	0.6	2.0	3.5	0.1	0.0	0.0	2.3	0.0	0.9	0.0	0.7	1.1	0.2	0.2	0.3	0.0	0.0	0.2	0.7	0.2	0.0	0.4	1.0	0.0	0.3	0.0	0.0	0.2	8.3	11.8	27.5	14.7	9.7	4.0	3.7	10.9	6.7	3.9	26.8	25.8	2.0	10.2	4.2	1.0	3.9	10.2	12.0	39.8	0.0	2.0	5.0	1.7	3.6	0.6	31.8	40.9	0.0	13.3	2.1	9.8	4.5	5.8	4.9	2.5	235.2	8.7	29.4	3.5	0.0	9.2	2.2	5.0	1.0	27.3	0.3	17.0	37.7	6.3	1.1	2.5	6.5	5.9	0.6	0.6	9.3	1.6	1.0	24.2	22.6
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	"Calcium/calmodulin dependent protein kinase IG"	Q96NX5	1	209583717-209613938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.4;ovary: 29.2"	"Group enriched"	"Detected in some"	6	"Peritubular cells: 6.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.6;hTERT-RPE1: 6.9;SK-MEL-30: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-3)"	"unprognostic (8.55e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.43e-2)"	0.7	3.5	7.5	0.9	34.4	1.0	0.7	1.3	27.8	1.1	0.8	0.7	1.2	0.8	1.8	6.1	0.6	0.9	1.5	0.6	10.9	9.2	6.9	0.9	1.2	0.8	3.6	17.7	29.2	1.3	0.6	2.0	2.8	3.9	4.6	0.8	0.6	0.6	7.4	0.6	0.6	0.8	2.3	0.9	6.1	0.7	1.4	2.7	0.0	0.7	0.0	0.8	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.9	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	11.6	0.0	6.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	1.6	0.0	0.0	0.2	2.0	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	34.4	1.3	27.8	10.9	9.2	3.6	17.7	3.9	2.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.3	0.3	0.0	6.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652466	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 205.4;Basal glandular cells: 278.5;Pancreatic endocrine cells: 523.1;Urothelial cells: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.9;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.5;HaCaT: 66.0;HBEC3-KT: 161.1;hTCEpi: 51.6;hTERT-HME1: 32.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		15000	Vesicles		"CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228"	"prognostic favorable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	24.5	8.4	1.2	5.5	1.7	3.3	11.7	0.8	4.1	10.2	9.9	0.9	3.2	12.1	7.0	3.1	22.1	6.3	8.4	8.9	1.1	0.8	4.7	4.7	11.0	1.6	1.2	2.2	1.4	2.1	0.0	1.1	16.1	1.1	11.9	6.3	0.8	19.1	10.3	1.9	17.9	22.8	2.7	1.4	2.1	28.7	1.7	0.8	4.9	1.1	35.8	30.2	16.2	13.3	0.1	1.9	3.4	0.5	0.4	0.4	0.1	21.1	3.1	0.0	0.0	2.3	1.5	0.1	0.6	1.9	0.7	1.1	8.3	43.5	0.0	1.8	0.4	1.1	66.0	0.0	161.1	1.1	1.5	0.1	0.1	11.2	0.1	0.3	0.1	0.1	0.3	51.6	2.4	32.1	1.4	0.7	0.0	0.3	0.8	0.2	0.0	0.0	0.1	0.0	9.7	9.1	0.0	2.1	19.3	8.9	13.2	0.0	0.0	9.0	1.0	1.8	0.1	0.2	1.1	16.8	3.6	7.8	0.1	12.6	0.2	0.4	0.0	5.3	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.9	0.1	0.4	0.0	3.4	0.4	0.0	0.0	0.0	0.1	1.2	1.7	0.8	4.1	1.1	0.8	1.2	2.2	1.1	0.8	205.4	75.6	2.2	278.5	97.4	0.2	6.9	2.5	44.2	151.2	45.4	0.0	0.1	0.0	174.0	4.1	1.1	142.2	0.0	132.9	1.1	4.3	108.8	18.4	3.9	2.1	3.2	7.5	0.0	0.0	7.4	1.7	10.1	8.5	3.6	43.8	0.8	523.1	80.7	0.7	1.9	0.3	0.0	4.2	0.3	0.7	22.7	0.5	0.0	20.5	285.9
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675420-209676388	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 203.9;liver: 154.7"	"Cell type enhanced"	"Detected in many"	6	"Pancreatic endocrine cells: 558.7;Urothelial cells: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	62	"neutrophil: 89.5"	"Lineage enriched"	"Detected in single"	197	"granulocytes: 89.5"	"Group enriched"	"Detected in some"	6	"ASC diff: 77.1;HBEC3-KT: 116.4;PC-3: 29.2;RPMI-8226: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"	130.1	23.3	1.1	18.5	1.1	203.9	85.2	2.0	0.9	2.0	11.3	1.4	29.9	1.6	6.1	9.3	2.0	4.0	13.5	43.7	1.1	0.8	22.2	154.7	51.6	6.4	1.8	0.0	18.4	5.3	0.5	1.2	2.6	1.3	8.7	1.1	3.1	49.2	73.5	97.9	3.0	3.5	3.8	1.5	6.3	7.1	5.3	1.1	0.0	3.1	14.3	6.1	12.6	13.1	0.0	0.0	89.5	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.0	77.1	2.7	0.0	0.1	0.2	0.3	0.3	3.0	2.4	0.0	0.6	0.5	0.4	0.0	0.0	116.4	0.7	0.1	0.2	0.0	0.2	0.1	6.3	0.0	0.0	8.0	0.2	5.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	29.2	0.0	0.0	37.1	0.2	0.0	0.1	0.2	2.6	0.0	0.6	0.0	0.0	8.9	11.7	0.0	0.8	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	1.1	1.1	2.0	0.9	1.1	0.8	1.8	0.0	1.3	1.1	8.9	93.3	5.6	295.9	206.4	0.2	325.1	12.7	41.5	55.7	10.4	0.0	1.1	253.7	40.5	12.3	26.3	16.9	0.0	123.5	3.9	183.7	312.4	36.0	83.1	183.0	0.0	28.2	14.1	41.0	7.4	106.2	375.5	310.4	50.5	30.7	19.9	558.7	40.3	67.1	223.2	0.0	32.3	88.6	21.4	1.1	141.0	3.5	4.8	37.5	443.6
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734950	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 183.4"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 560.1"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	20	"T-cells: 9.2"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 151.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		77000			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	4.6	1.6	1.1	3.0	3.1	0.3	2.4	9.9	3.9	0.6	1.0	1.6	2.7	0.5	0.8	8.7	1.5	0.9	1.9	3.0	1.8	0.9	2.6	183.4	7.2	1.3	8.2	2.0	12.6	0.9	0.3	1.5	26.5	3.3	7.1	0.9	1.5	0.6	3.0	1.5	6.3	0.9	2.7	1.3	3.5	1.4	2.3	2.5	0.0	1.0	0.6	0.6	3.9	1.4	0.2	0.0	0.2	0.1	0.4	9.2	0.8	0.0	0.0	0.0	0.0	151.9	15.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	1.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.2	9.2	2.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	2.4	0.8	1.1	3.1	9.9	3.9	1.8	0.9	8.2	2.0	3.3	2.5	3.0	0.0	2.4	0.5	0.1	0.0	0.8	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	10.8	0.5	0.0	560.1	8.7	0.0	0.0	8.6	8.9	2.2	27.0	2.2	0.0	1.0	0.0	15.4	0.2	0.0	7.4	0.0	0.3	0.0	2.1	0.0	0.2	0.1	0.2	0.5	0.0	1.6
TRAF3IP3	T3JAM	ENSG00000009790	"TRAF3 interacting protein 3"	Q9Y228	1	209756032-209782320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 86.5;lymphoid tissue: 69.5"	"Cell type enhanced"	"Detected in many"	20	"B-cells: 61.1;granulocytes: 55.6;T-cells: 188.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.7;JURKAT: 22.7;Karpas-707: 16.5;MOLT-4: 20.5;NB-4: 23.6;THP-1: 22.3;U-266/70: 24.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040796	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA040796: AB_10794861"	"prognostic favorable (4.11e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.36e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-5)"	"unprognostic (3.83e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.08e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.21e-2)"	2.2	0.8	1.7	30.6	2.1	9.8	1.3	0.6	1.5	1.5	3.8	2.2	0.3	2.3	1.5	1.4	2.5	1.7	4.6	1.2	1.7	1.4	3.4	2.4	5.8	32.6	3.8	0.6	1.2	1.3	0.0	1.0	1.0	2.7	2.2	3.6	1.7	8.4	1.3	0.7	1.1	19.8	1.0	3.8	38.3	4.1	1.4	2.6	69.5	2.4	1.5	33.6	5.7	1.9	43.9	25.3	54.9	29.5	50.1	86.5	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	39.7	0.0	3.7	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	16.5	0.0	0.0	20.5	23.6	0.0	0.0	0.0	2.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	24.5	8.5	1.5	0.0	11.1	0.0	54.9	24.1	24.8	48.9	25.7	51.8	43.9	67.8	55.9	25.3	41.4	76.9	60.8	6.5	50.1	29.5	18.6	86.5	56.3	1.7	2.1	0.6	1.5	1.7	1.4	3.8	0.6	2.7	2.6	3.0	14.8	61.1	3.6	2.1	1.5	0.6	2.5	1.4	0.0	0.0	0.0	0.3	10.0	0.1	8.9	0.7	0.2	0.0	0.2	0.3	1.1	0.4	55.6	3.2	22.1	0.0	0.0	4.3	27.4	5.7	0.3	22.8	10.1	5.4	0.2	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.3	0.5	0.2	1.9	0.3	188.4	0.4	2.0
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavorable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	2.5	3.9	5.7	5.5	8.5	2.3	5.8	10.4	8.9	2.7	3.8	5.8	4.0	3.3	2.3	5.2	10.4	2.8	2.3	4.1	3.7	2.9	4.9	4.1	2.2	9.8	5.1	4.6	2.5	4.5	4.5	6.5	3.4	4.8	4.6	5.2	3.9	5.1	2.7	2.3	15.0	4.1	2.4	4.9	4.9	3.9	3.9	5.0	4.9	3.2	0.0	5.7	3.9	4.7	6.3	5.5	5.9	1.9	2.8	2.9	1.9	5.6	3.0	1.9	1.1	2.6	3.0	4.4	3.2	4.2	4.0	4.1	6.0	4.4	6.0	1.9	2.1	2.4	11.5	1.2	9.4	4.7	5.9	3.9	4.0	2.2	0.5	3.6	5.5	1.8	1.8	8.3	4.9	8.1	3.3	2.3	8.2	7.8	4.4	3.4	2.9	4.6	5.7	8.0	4.0	5.1	4.9	9.1	8.4	3.4	4.9	7.7	8.2	4.4	3.4	4.9	4.6	5.3	2.9	2.2	3.4	3.9	3.5	5.2	4.0	4.1	6.6	3.0	4.6	4.7	5.9	1.6	1.4	2.9	1.9	2.1	3.8	1.4	2.3	3.2	6.3	2.4	2.8	1.1	2.8	1.0	5.5	1.2	1.9	5.7	8.5	10.4	8.9	3.7	2.9	5.1	4.6	4.8	5.0	3.0	2.1	1.4	6.1	1.9	1.4	2.0	0.0	1.4	1.2	0.0	0.0	3.1	6.6	1.7	0.0	0.6	2.0	0.0	1.8	5.7	0.6	4.8	1.1	2.0	2.3	1.6	3.5	1.3	0.3	0.2	2.3	0.8	0.0	1.8	4.4	2.3	2.7	2.6	0.0	4.8	1.2	0.0	0.4	3.7	3.6	4.3	3.3	0.0	2.9	11.4
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785623-209806175	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 344.0;Suprabasal keratinocytes: 482.8;Urothelial cells: 297.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 8.6;pons and medulla: 4.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 16.4;HaCaT: 59.6;HBEC3-KT: 21.8;hTCEpi: 48.0;hTERT-HME1: 24.0;RT4: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.0	6.3	1.1	4.1	1.0	0.3	13.3	8.6	0.9	11.7	12.9	1.0	38.6	9.2	3.9	31.4	63.7	7.6	17.5	10.3	1.1	0.8	12.9	18.4	8.8	0.3	0.9	0.7	3.9	13.9	10.3	6.8	26.7	4.4	21.8	11.3	1.5	24.8	34.6	0.6	45.6	20.3	3.1	1.1	1.2	9.5	4.3	0.3	13.0	22.1	32.3	33.8	15.0	19.1	0.9	0.5	2.0	1.0	0.6	2.8	0.7	16.4	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.1	0.0	0.0	3.4	5.8	0.0	0.0	0.0	0.0	59.6	0.0	21.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	24.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	2.1	21.3	5.3	1.7	0.4	9.5	0.5	1.1	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.2	0.1	2.0	2.8	1.0	1.9	0.6	0.6	0.9	0.5	0.9	2.1	1.1	0.1	0.6	0.1	0.2	0.0	0.7	1.1	1.0	8.6	0.9	1.1	0.8	0.9	0.7	4.4	0.3	14.9	7.2	0.8	177.1	344.0	0.0	23.2	40.8	46.8	50.0	33.2	0.0	79.7	23.2	31.5	0.9	4.3	54.6	0.0	16.8	20.9	7.3	126.3	2.3	30.2	7.1	0.0	57.5	1.3	1.2	0.0	0.6	2.3	33.7	1.8	54.2	5.2	36.6	51.8	0.0	10.3	0.4	0.0	10.3	9.0	3.6	482.8	135.1	0.0	36.4	297.3
DIEXF	"C1orf107, DEF, MGC29875, UTP25"	ENSG00000117597	"Digestive organ expansion factor homolog (zebrafish)"	Q68CQ4	1	209828007-209857565	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026640	Approved					NA	NA					"HPA026640: AB_2067139"	"unprognostic (3.11e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (7.01e-2)"	12.4	10.0	10.1	9.5	19.2	6.5	16.2	6.9	16.8	10.2	8.4	13.2	5.5	7.0	11.8	9.2	10.3	11.6	6.9	6.8	7.7	8.4	9.2	20.0	6.4	11.1	9.1	9.6	18.5	12.7	10.9	7.3	8.2	11.5	9.2	9.9	5.4	9.7	8.8	8.1	12.7	9.2	10.6	9.6	10.2	8.4	5.2	11.1	8.8	10.7	5.5	11.3	12.0	9.8	7.8	4.5	4.0	5.6	6.6	8.1	3.7	8.7	9.1	3.4	6.0	7.3	7.0	10.0	11.3	13.8	8.2	7.6	5.7	9.8	10.8	6.8	12.0	10.0	9.8	10.1	6.9	11.4	7.7	9.9	5.7	6.2	3.9	5.2	8.3	5.9	6.8	9.9	13.4	12.6	7.1	6.7	5.8	14.3	7.1	8.4	4.4	7.4	4.7	14.8	8.1	6.7	5.9	10.9	13.7	5.9	8.3	8.0	9.8	5.8	15.0	11.3	9.5	6.2	6.6	7.9	17.4	8.1	11.2	12.3	7.8	8.5	10.4	7.6	6.3	6.9	4.0	3.4	1.1	5.9	4.3	7.8	7.8	6.3	5.5	4.5	7.7	8.1	7.2	0.4	6.6	5.6	3.1	4.5	3.7	10.1	19.2	6.9	16.8	7.7	8.4	9.1	9.6	11.5	11.1	11.9	6.1	8.8	9.3	13.1	5.9	0.0	0.0	9.4	9.1	0.0	3.9	5.5	0.0	0.0	0.7	6.8	3.2	0.0	0.0	6.9	5.4	4.8	5.7	10.5	5.5	3.2	5.2	4.3	6.7	1.6	6.6	3.7	1.7	0.0	8.9	3.3	0.0	2.9	5.6	0.0	5.7	0.0	5.3	7.4	15.4	16.2	3.3	4.3	7.8	5.9
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209938174-210171389	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 28.8;Cone photoreceptor cells: 25.5;Horizontal cells: 49.3;Rod photoreceptor cells: 28.8;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.0;GAMG: 8.8;SCLC-21H: 6.8;TIME: 10.8;U-138 MG: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles		NA	NA			Vesicles		"HPA036963: AB_10670378"	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.7	3.2	5.9	0.8	7.4	0.8	0.6	17.4	10.2	0.6	0.7	3.8	0.0	0.7	1.4	0.8	0.6	0.6	0.6	0.6	4.5	2.6	0.9	0.6	0.7	0.7	3.3	5.9	0.8	1.2	0.6	31.1	0.6	5.0	0.8	0.8	1.1	0.6	0.6	0.7	0.7	0.7	0.7	2.4	0.7	0.9	9.5	3.0	0.0	15.9	0.0	0.6	0.6	0.4	2.0	0.8	2.1	0.5	1.1	0.8	0.1	3.3	0.1	0.0	0.0	0.3	0.0	0.0	2.7	13.0	2.7	1.4	0.0	0.2	0.0	0.1	0.3	8.8	4.1	0.0	0.0	3.3	0.5	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	1.9	5.7	1.7	0.5	0.0	0.0	0.0	4.9	0.0	0.0	0.0	4.5	0.0	1.8	0.0	0.1	0.1	0.2	3.0	6.8	3.1	0.0	0.0	5.6	1.0	0.0	0.1	10.8	8.2	3.9	0.7	1.4	0.1	0.1	0.0	0.7	0.0	1.9	2.1	0.4	0.6	0.8	0.2	0.4	0.6	0.5	0.4	0.3	2.0	0.4	0.6	1.8	1.1	0.5	0.8	0.4	0.1	5.9	7.4	17.4	10.2	4.5	2.6	3.3	5.9	5.0	3.0	0.0	0.0	0.0	0.1	0.0	28.8	1.6	0.0	0.0	0.0	0.0	25.5	0.0	3.3	0.1	12.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	49.3	0.0	0.0	0.0	3.2	0.6	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.3	28.8	0.0	0.0	4.9	19.3	0.0	0.0	0.0	0.0	0.1
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232799-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 36.3"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 14.8;Ciliated cells: 14.7;Extravillous trophoblasts: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.4;BEWO: 7.7;SCLC-21H: 7.7;SK-BR-3: 8.8;T-47d: 10.8;U-2 OS: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.5	1.0	2.3	0.7	7.7	0.1	12.3	2.6	4.3	6.2	6.2	1.5	4.6	1.1	6.2	3.2	15.7	3.2	2.9	4.2	1.8	2.1	2.5	0.2	3.4	0.4	2.8	0.4	2.5	0.2	1.5	1.4	11.7	3.0	3.6	3.3	1.0	36.3	11.1	0.5	5.3	1.1	6.0	2.7	0.3	2.3	0.7	2.1	1.9	3.2	14.6	7.7	1.7	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.2	1.6	0.0	0.8	0.8	7.7	1.9	1.9	1.4	2.6	0.3	0.9	0.0	0.2	0.4	1.2	3.6	0.3	0.6	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.8	0.3	0.0	0.0	0.0	0.3	1.8	0.0	0.0	5.4	6.0	0.3	0.0	2.5	0.0	1.3	1.3	7.7	6.7	1.2	8.8	0.1	3.2	10.8	0.0	2.4	2.1	9.2	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.7	2.6	4.3	1.8	2.1	2.8	0.4	3.0	2.1	6.0	3.8	0.0	10.1	14.8	0.5	0.6	2.5	14.7	11.4	8.7	0.0	13.2	6.6	1.6	0.6	1.4	0.0	0.0	3.5	37.9	4.4	2.2	0.0	0.0	1.3	0.0	1.2	1.3	0.0	0.6	0.6	0.6	10.1	0.0	4.3	0.3	5.2	0.0	1.4	0.0	0.2	0.0	0.9	0.0	0.6	4.1	3.7	0.0	3.7	1.8
HHAT	"FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn"	ENSG00000054392	"Hedgehog acyltransferase"	Q5VTY9	1	210328252-210676296	"Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 17.4;Muller glia cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 7.1;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.4;LHCN-M2: 11.2;RH-30: 12.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA016462	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA016462: AB_2669360"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.89e-3)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-3)"	"prognostic favorable (8.47e-7)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.67e-2)"	3.8	11.7	5.1	5.4	5.3	1.3	7.5	0.9	5.0	10.4	4.9	3.9	9.7	3.3	12.8	10.6	4.7	8.1	8.5	4.1	3.1	2.6	6.3	4.3	4.1	2.3	2.7	3.8	4.9	5.2	4.2	15.1	3.8	3.3	11.6	4.0	11.5	10.4	6.6	2.8	5.3	4.2	5.1	2.3	3.8	3.9	6.2	2.5	7.1	12.8	3.1	5.7	6.7	4.9	3.0	7.1	0.0	0.7	0.2	2.6	0.7	0.7	0.9	2.3	1.4	1.0	1.3	4.7	1.1	1.0	1.8	3.1	0.2	0.9	0.0	1.2	0.9	3.0	0.6	0.5	0.5	2.2	1.6	1.1	0.0	0.1	1.0	0.2	0.3	13.4	1.2	2.7	1.6	1.2	3.1	0.3	1.1	0.0	0.0	11.2	1.1	0.6	0.0	0.6	0.6	0.1	1.2	12.2	0.0	7.3	2.5	1.9	7.7	2.0	0.0	5.6	6.1	3.9	0.7	1.7	2.8	8.5	1.6	4.3	3.8	0.1	0.0	1.2	0.8	2.3	0.0	0.6	0.0	1.5	0.7	2.6	3.0	1.8	1.7	0.7	2.7	0.1	0.6	0.0	0.2	0.2	7.1	0.4	0.7	5.1	5.3	0.9	5.0	3.1	2.6	2.7	3.8	3.3	2.5	0.0	3.7	1.4	4.9	1.9	0.4	2.2	2.5	17.4	0.0	8.7	0.0	4.0	3.3	2.6	0.7	2.1	1.3	0.0	0.6	2.6	1.1	5.2	0.0	2.1	1.8	0.0	0.0	2.5	2.4	0.0	1.1	0.9	0.0	0.0	3.1	21.1	1.2	2.5	0.4	0.8	0.5	0.0	1.0	0.3	0.9	2.3	1.8	0.8	1.9	4.6
KCNH1	"eag, eag1, h-eag, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134180	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 20.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 9.0;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.3;RH-30: 7.2;RPTEC TERT1: 4.2;SH-SY5Y: 9.2;SK-MEL-30: 8.6;T-47d: 6.5"	"Low region specificity"	"Detected in all"							"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.9	2.3	6.3	1.3	13.3	0.7	0.6	19.1	20.2	1.0	1.3	3.3	0.2	1.2	1.5	1.0	0.9	1.2	1.0	0.7	3.8	1.7	1.0	0.7	0.7	0.7	1.1	7.5	0.8	0.9	0.9	0.8	1.1	1.7	1.3	1.3	0.0	0.8	0.9	0.7	0.9	1.0	1.0	2.1	0.6	1.5	2.4	1.5	0.0	0.8	0.0	0.7	0.9	0.7	0.1	0.7	0.7	0.1	0.1	0.3	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.7	0.1	1.5	1.7	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	4.2	0.0	0.3	9.2	1.6	0.1	8.6	1.2	6.5	0.0	0.0	1.1	0.1	1.4	0.8	0.0	0.0	0.0	0.2	0.0	0.6	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.7	0.1	0.0	6.3	13.3	19.1	20.2	3.8	1.7	1.1	7.5	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
AL590132.1		ENSG00000284299			1	210858125-211134146	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"brain: 17.5"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 2.1;SH-SY5Y: 4.8;SK-MEL-30: 3.1;T-47d: 2.1"															NA	NA																							0.8	1.3	5.3	1.3	11.4	0.6	0.6	16.5	17.5	0.6	0.7	2.6	0.0	0.7	0.7	0.6	0.6	0.6	0.6	0.6	3.1		0.7	0.6	0.6	0.7	0.0	6.3	0.6	0.6	0.8	0.2	0.6	1.2	0.7	0.7	0.0	0.8	0.6	1.5	0.6	0.6	0.6	0.0	0.7	0.7	0.7	1.1	0.0	0.6	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.3	2.1	0.1	0.1	0.0	0.2	4.8	0.0	0.2	3.1	0.0	2.1	0.0	0.0	0.7	0.2	1.2	0.7	0.0	0.0	0.0	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC092017.3		ENSG00000283952			1	211082872-211188533	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"intestine: 1.2;testis: 2.8"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;HSkMC: 1.5;hTEC/SVTERT24-B: 1.7"															NA	NA																							0.3	0.0		0.0		0.1	0.0		0.0	0.8	0.2			1.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	15.1	15.0	17.2	14.9	19.6	25.8	18.9	33.7	21.7	17.3	16.2	17.3	26.8	11.8	19.1	21.9	13.5	16.0	17.1	20.8	16.3	14.4	15.7	13.5	15.8	15.3	18.8	20.8	27.5	18.2	21.4	23.8	14.1	18.6	23.7	13.4	17.3	18.0	35.5	55.3	17.7	16.5	23.6	18.1	17.5	14.4	31.4	21.3	20.6	30.0	16.4	13.4	17.9	16.3	10.0	9.5	27.3	8.5	11.8	10.7	5.4	9.9	7.8	15.9	8.9	13.8	12.9	17.7	11.3	11.3	12.8	13.3	7.6	13.0	14.6	7.9	14.5	9.0	15.0	12.7	11.2	10.0	14.9	7.5	13.3	14.0	10.1	15.5	20.1	12.9	14.3	10.6	13.9	17.2	14.1	7.9	14.5	13.8	18.3	18.5	6.6	10.3	11.6	17.4	6.8	9.6	11.3	30.8	16.7	10.6	17.2	10.2	22.2	29.0	15.1	21.1	15.7	18.9	14.4	10.8	11.4	13.0	14.7	12.7	16.2	10.6	18.3	9.5	12.0	10.0	15.3	8.1	27.3	6.0	7.5	7.9	10.0	6.5	6.2	8.5	8.0	10.7	7.6	13.7	11.8	8.5	9.5	7.6	5.4	17.2	19.6	33.7	21.7	16.3	14.4	18.8	20.8	18.6	21.3	35.7	41.5	10.2	9.5	12.9	43.2	61.3	28.1	25.4	29.6	14.0	33.4	21.6	18.3	8.4	51.5	15.5	17.7	0.0	13.4	12.4	17.2	13.2	18.5	18.7	17.5	22.3	32.8	20.9	20.2	93.2	20.8	21.1	21.9	17.2	17.5	25.7	9.1	16.7	25.5	19.9	49.5	0.0	20.2	56.9	31.5	14.8	21.3	17.5	16.9	7.6
TRAF5	RNF84	ENSG00000082512	"TNF receptor associated factor 5"	O00463	1	211326615-211374946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 48.9;Early spermatids: 42.9;Late spermatids: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008052, CAB010277"	Enhanced		Supported	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"CAB010277: AB_2287961, HPA008052: AB_1858230"	"unprognostic (6.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.94e-10)"	"unprognostic (3.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (7.29e-5)"	7.5	3.1	3.9	33.6	6.5	3.1	6.1	1.2	4.6	11.1	11.6	3.3	9.9	4.2	24.3	17.4	6.1	17.1	10.4	4.5	3.4	2.3	5.3	1.9	5.4	22.7	1.9	3.1	8.6	19.4	1.7	3.1	4.4	5.3	8.7	8.1	9.6	13.3	17.8	1.6	2.9	15.5	21.4	1.9	16.5	8.6	5.6	1.7	15.9	3.1	4.1	27.4	12.0	6.5	14.7	0.9	5.3	0.3	13.1	11.9	4.8	3.8	2.9	5.2	4.6	4.6	3.3	1.8	5.5	6.6	8.0	7.2	1.4	7.7	11.8	3.2	8.7	4.1	0.7	9.7	0.9	4.0	22.7	3.5	0.6	4.2	0.0	6.6	1.8	8.7	3.9	1.7	4.3	1.3	12.1	5.6	10.4	4.7	5.6	2.2	3.0	5.1	2.1	6.2	6.1	2.4	7.8	7.2	10.9	6.1	2.7	9.2	9.6	4.1	0.2	11.8	20.0	2.9	0.2	3.4	5.2	4.1	1.7	6.1	1.6	2.3	12.6	1.4	0.0	1.9	5.3	0.2	0.3	6.3	0.2	11.9	14.7	7.9	8.4	0.9	13.0	7.2	7.0	0.4	13.1	0.3	0.7	10.8	4.8	3.9	6.5	1.2	4.6	3.4	2.3	1.9	3.1	5.3	1.7	11.9	11.1	48.9	3.5	3.3	1.0	2.0	0.0	13.4	10.3	10.4	0.0	7.1	0.0	0.7	42.9	7.4	1.6	0.0	8.4	1.7	8.6	2.6	14.0	0.0	8.4	0.0	14.3	6.2	3.7	38.6	13.3	7.5	8.5	23.4	10.9	0.8	7.3	8.6	25.8	0.5	0.4	12.9	10.3	3.0	1.1	3.4	1.1	26.3	10.2	1.6
RD3	"C1orf36, LCA12"	ENSG00000198570	"Retinal degeneration 3"	Q7Z3Z2	1	211476522-211492917	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"Bipolar cells: 87.9;Cone photoreceptor cells: 94.2;Rod photoreceptor cells: 61.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"HEL: 3.6;HMC-1: 9.5;SH-SY5Y: 13.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029941, HPA029943"	Approved					NA	NA					"HPA029941: AB_2732449, HPA029943: AB_2732450"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-2)"		"unprognostic (1.14e-2)"		"unprognostic (6.07e-2)"		"unprognostic (2.96e-2)"		"unprognostic (2.18e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.58e-2)"		"unprognostic (2.86e-2)"	2.0	2.0	0.1	0.2	0.4	1.2	0.1	0.1	1.0	1.1	0.3	0.1	0.1	0.4	1.2	2.3	1.4	0.6	0.6	2.8	0.1	0.8	1.2	0.1	1.2	0.1	0.1	0.1	0.1	0.2	0.0	1.3	0.1	0.1	0.6	0.0	1.0	0.3	0.2	0.1	1.0	0.8	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.4	0.0	0.1	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.1	0.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	87.9	0.4	0.0	0.0	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211578742	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 53.3"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	11.4	16.6	9.3	7.5	11.4	15.5	17.3	5.2	13.6	13.0	15.3	6.9	4.9	17.2	7.1	7.6	9.0	9.2	12.9	6.1	9.7	7.9	13.4	53.3	12.0	3.5	9.5	8.0	9.5	8.9	8.8	4.8	9.3	8.7	7.3	8.9	7.7	5.9	9.2	3.6	13.9	28.1	7.5	8.3	10.7	6.4	12.5	5.5	3.1	11.0	5.2	4.4	7.7	8.4	0.5	2.5	3.9	4.2	1.3	1.7	1.0	4.7	6.9	3.8	4.9	16.6	7.7	33.7	13.0	9.6	6.9	6.9	3.0	22.6	2.6	11.4	11.9	9.6	8.1	5.7	7.5	8.3	6.7	4.3	2.1	14.1	6.9	9.3	7.4	4.8	11.5	19.0	8.8	14.4	10.4	4.2	1.6	8.4	12.5	8.5	4.3	1.4	4.6	11.7	5.1	5.5	4.5	1.8	9.6	21.5	12.7	3.8	6.7	12.7	6.7	29.0	7.5	3.4	9.7	6.8	5.2	12.1	17.3	10.3	5.5	8.4	2.2	4.8	7.5	4.5	3.9	3.9	1.3	1.2	4.2	1.7	0.5	0.9	0.8	2.5	0.3	0.9	1.2	0.4	1.3	3.2	1.7	0.8	1.0	9.3	11.4	5.2	13.6	9.7	7.9	9.5	8.0	8.7	5.5	8.9	9.8	5.1	7.2	25.3	10.9	17.9	17.8	6.7	2.3	34.9	5.9	9.8	1.7	5.4	21.7	18.0	37.9	46.7	10.7	27.0	15.0	12.6	4.7	83.9	29.4	6.4	9.1	15.4	33.3	2.8	9.2	15.1	20.3	5.4	23.6	26.5	7.9	31.7	7.1	29.5	8.5	6.5	11.6	33.0	9.4	40.4	20.5	10.2	20.5	11.4
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Not detected"	"Not detected"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.7	22.2	17.0	12.2	1.0	1.7	18.8	11.9	11.2	21.0	18.1	11.8	30.3	16.4	5.7	9.2	13.3	16.5	14.8	8.9	26.5	25.0	12.3	7.8	19.4	15.9	0.1	15.4	10.7	0.5	1.1	16.1	17.4	5.1	13.5	16.7	21.4	28.8	21.0	8.6	16.8	10.4	16.1	19.9	11.4	16.6	26.1	24.9	7.3	8.8	15.4	17.1	17.2	19.2	14.9	15.2	29.6	9.2	7.0	10.5	20.8	20.6	31.9	11.9	22.0	21.7	9.1	11.9	17.4	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.8	0.5	2.6	0.7	0.4	0.0	2.7	3.4	0.0	0.0	0.9	0.0	0.1	44.4	0.1	1.1	93.5	0.2	11.4	0.2	0.3	0.0	0.0	4.7	3.2	0.0	2.5	2.8	28.5	2.3	1.1	0.0	0.0	1.2	0.8	0.0	0.8	0.7	0.0	1.9	6.5	0.0	191.1	25.4	1.5	1.1	0.7	2.3	0.9
LPGAT1	"FAM34A, FAM34A1, KIAA0205, NET8"	ENSG00000123684	"Lysophosphatidylglycerol acyltransferase 1"	Q92604	1	211743457-211830772	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 288.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.70e-2)"	15.9	17.4	11.8	10.7	20.3	14.9	16.5	12.3	22.7	10.5	13.3	25.9	9.9	19.5	7.9	9.4	6.7	7.5	10.4	9.7	15.1	13.6	8.6	75.6	9.6	13.8	19.0	11.9	6.1	13.1	15.1	9.0	7.7	15.5	9.5	9.0	21.8	9.0	15.6	8.3	5.2	39.8	10.3	16.0	13.3	6.4	17.5	18.9	5.1	22.1	3.9	8.0	9.2	6.9	1.6	2.7	13.4	2.3	4.5	1.2	0.7	14.7	16.3	5.4	12.8	9.7	13.7	7.7	10.6	16.9	9.9	9.2	4.8	12.4	6.0	6.2	16.4	11.1	8.1	18.0	9.5	12.6	11.8	6.1	6.3	13.7	11.0	11.7	15.6	10.9	8.0	11.7	9.1	12.0	18.3	11.9	8.8	7.2	0.1	13.1	4.6	5.9	5.8	5.9	6.4	2.7	14.3	21.3	1.8	11.0	12.3	31.2	16.2	17.4	18.5	18.1	8.7	9.4	10.2	11.4	18.1	8.0	16.6	17.2	8.9	10.9	16.3	9.0	13.3	12.4	9.5	2.3	13.4	1.2	1.9	1.0	1.6	0.8	0.9	2.7	1.0	0.2	0.7	10.4	4.5	1.3	2.1	0.2	0.7	11.8	20.3	12.3	22.7	15.1	13.6	19.0	11.9	15.5	18.9	26.8	18.9	11.0	47.5	10.9	140.9	25.4	73.9	37.5	18.2	12.2	58.9	1.6	1.7	53.5	288.3	27.4	28.8	0.0	50.8	3.5	14.7	35.8	12.7	49.1	18.6	33.4	13.2	21.5	35.6	39.3	43.7	26.7	28.7	19.8	12.2	31.9	50.2	16.9	52.3	18.6	121.2	19.4	20.6	61.8	32.6	6.6	0.9	16.6	19.1	57.7
INTS7	"C1orf73, DKFZP434B168, INT7"	ENSG00000143493	"Integrator complex subunit 7"	Q9NVH2	1	211940399-212035542	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 24.2;Late spermatids: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072611			Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA072611: AB_2732204"	"unprognostic (1.25e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.44e-2)"	6.7	8.6	10.2	7.3	14.2	8.6	8.4	15.6	11.6	6.9	7.7	9.4	3.5	7.1	6.1	8.6	12.5	5.8	5.7	6.5	8.0	6.9	5.6	13.4	6.6	10.3	10.5	5.7	6.1	8.2	3.9	21.5	7.1	10.0	7.2	9.8	7.9	7.1	4.1	8.7	9.3	6.4	8.7	9.1	7.9	6.5	24.7	14.5	19.4	8.6	7.9	12.0	7.9	8.3	8.7	9.8	8.2	8.2	19.3	12.9	6.7	16.3	14.6	11.8	9.3	8.6	9.5	14.2	13.4	8.6	16.2	20.6	13.7	14.3	19.1	7.3	9.7	12.6	15.1	17.5	10.8	13.5	18.3	15.0	16.6	16.2	10.0	9.4	29.5	15.6	8.4	13.3	25.8	19.7	7.6	9.6	10.6	24.3	17.1	13.2	9.5	23.6	8.6	21.5	11.3	14.6	14.7	21.9	28.1	9.3	12.4	20.0	15.7	17.5	19.0	11.2	14.3	15.8	14.2	6.7	13.2	14.3	12.1	20.0	7.5	12.4	23.0	11.7	12.1	14.8	8.2	6.7	5.3	8.4	6.8	7.0	8.7	8.5	9.8	9.8	8.1	5.3	6.4	0.7	19.3	8.2	6.9	12.9	6.7	10.2	14.2	15.6	11.6	8.0	6.9	10.5	5.7	10.0	14.5	0.0	11.8	3.7	6.1	8.9	7.7	4.2	5.1	5.3	2.3	3.5	3.9	9.0	1.7	4.2	24.2	2.9	5.1	0.0	6.0	6.8	5.1	4.0	4.6	8.7	4.9	4.8	1.2	3.1	3.3	27.8	4.6	4.4	1.7	3.6	5.0	3.8	4.6	0.0	6.3	3.3	5.6	0.0	5.2	15.7	17.2	10.5	5.7	4.9	6.5	3.9
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.6	10.8	18.5	9.2	1.1	2.3	9.1	15.9	9.9	15.1	22.5	6.7	11.2	9.6	6.0	6.1	9.7	9.9	24.4	13.4	21.8	11.6	11.7	15.3	14.3	8.1	0.0	20.1	9.6	1.0	0.4	24.4	13.0	2.7	6.9	17.0	18.2	19.6	17.4	5.1	26.8	9.2	21.4	9.6	12.5	21.3	32.7	18.5	4.3	8.8	11.6	18.2	15.1	14.5	6.5	19.7	12.4	9.2	3.7	15.1	11.3	15.6	17.9	7.2	11.2	22.2	7.6	13.3	14.6	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1	0.0	0.0	7.8	0.4	2.1	0.0	6.1	2.5	0.0	1.2	0.0	0.0	7.5	0.0	0.2	17.8	1.8	0.5	23.3	0.0	13.2	1.2	0.2	0.0	0.0	3.9	0.0	0.0	1.3	0.3	7.9	1.1	1.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	35.9	19.1	1.5	1.3	1.9	2.9	0.0
PPP2R5A	"B56A, B56alpha, PR61A"	ENSG00000066027	"Protein phosphatase 2 regulatory subunit B'alpha"	Q15172	1	212285537-212361863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 187.3;Late spermatids: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059288, HPA078841"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA059288: AB_2683966, HPA078841: "	"unprognostic (3.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	40.9	8.4	21.9	23.2	24.1	46.6	26.5	13.7	17.6	19.5	23.9	19.6	18.9	15.9	21.2	13.4	36.7	12.9	25.7	31.9	17.5	16.6	22.4	34.0	37.9	17.1	25.6	14.2	11.8	27.5	17.0	14.4	21.5	16.4	30.6	23.2	16.5	22.2	20.0	24.3	20.0	27.6	28.5	21.1	28.6	26.4	10.0	24.4	35.2	27.6	29.2	18.3	28.8	38.8	2.1	1.6	14.5	3.0	3.1	4.9	1.4	17.6	7.3	3.7	7.6	41.5	25.4	30.7	7.8	14.9	8.7	8.3	21.9	17.8	12.4	5.9	12.1	9.1	12.6	7.1	10.8	9.1	10.7	9.4	8.0	8.1	8.0	13.4	16.3	12.4	10.6	14.8	7.9	11.6	11.0	20.9	10.9	11.4	13.1	4.8	7.6	6.4	11.2	6.4	15.5	16.0	8.4	6.0	15.4	15.6	8.0	5.5	3.7	10.6	33.3	25.2	16.6	20.7	14.8	4.4	6.1	6.3	9.6	8.3	20.8	15.9	16.1	7.4	12.7	4.5	14.5	2.0	9.4	4.6	2.2	3.1	1.4	3.6	4.1	1.3	2.1	2.1	4.2	9.9	3.1	3.0	1.6	4.9	1.4	21.9	24.1	13.7	16.1	17.5	16.6	25.6	14.2	16.4	24.4	92.3	86.7	14.7	20.8	60.9	18.6	59.8	30.6	18.7	19.4	14.0	2.0	9.1	82.9	20.6	187.3	37.9	31.9	0.0	30.1	21.8	19.8	31.9	39.3	45.7	19.2	49.3	15.5	47.3	26.0	383.1	17.8	23.5	16.9	18.0	33.3	34.4	24.1	31.6	13.4	14.6	10.7	32.3	35.6	13.5	9.5	71.0	6.9	39.8	26.7	33.1
TMEM206	"C1orf75, FLJ10874"	ENSG00000065600	"Transmembrane protein 206"	Q9H813	1	212363931-212414901	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.8"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008540	Uncertain					NA	NA					"HPA008540: AB_10794083"	"unprognostic (2.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.10e-2)"	"unprognostic (6.98e-2)"	3.7	3.7	10.7	5.5	11.7	7.1	3.5	3.8	22.5	2.3	2.6	35.3	2.2	2.9	4.2	3.0	3.8	2.1	4.2	3.3	15.4	11.8	14.3	2.1	4.3	9.9	21.8	7.1	2.0	3.9	3.4	3.1	5.9	19.7	4.4	3.3	1.4	2.8	2.5	2.0	2.9	3.1	4.2	50.8	6.1	2.2	7.7	17.8	7.8	2.7	1.3	7.2	6.5	3.0	7.7	17.7	11.6	10.1	6.2	6.4	5.2	7.5	5.8	8.9	14.6	5.2	2.9	8.8	4.4	3.5	7.4	6.6	4.9	5.6	9.0	3.6	2.1	7.2	6.8	8.4	4.0	7.4	6.7	9.1	8.5	4.2	6.0	7.5	13.5	13.3	2.5	4.3	6.8	4.9	7.4	8.3	13.2	7.6	5.3	5.1	2.9	14.9	13.9	11.7	3.5	7.8	12.3	9.9	8.6	3.7	3.8	13.8	21.4	5.1	7.6	19.4	9.1	11.4	16.7	7.2	4.9	5.5	11.5	11.4	6.9	11.1	12.5	6.5	12.5	13.4	11.6	7.7	4.3	4.9	10.1	6.4	7.7	3.8	5.7	12.5	7.3	5.6	6.0	0.6	6.2	8.7	17.7	5.3	5.2	10.7	11.7	3.8	12.8	15.4	11.8	21.8	7.1	19.7	17.8	3.0	0.0	12.3	2.6	11.2	3.1	3.2	0.0	1.4	1.2	5.2	0.0	11.4	1.7	6.1	1.5	5.2	0.7	0.0	3.6	5.8	5.0	4.2	12.7	0.8	25.2	0.0	4.6	2.5	12.4	0.4	2.3	13.9	6.8	31.5	0.5	26.1	5.7	2.9	1.8	18.7	4.9	6.5	3.3	11.6	25.1	11.2	6.9	5.1	1.9	3.9
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432887-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain				"Secreted - unknown location"	NA	NA		2400000			"HPA026763: AB_1854379, HPA028488: AB_2672638"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	21.9	19.9	33.5	10.1	47.7	12.8	44.4	16.2	30.6	41.9	23.9	45.2	24.0	12.7	24.1	42.2	19.4	27.6	19.6	50.6	31.3	31.4	32.0	25.8	18.0	20.4	38.3	21.3	38.3	43.4	21.0	47.1	17.9	23.6	26.7	23.9	19.8	22.1	36.1	53.6	16.5	12.2	29.7	49.5	13.2	16.8	9.6	24.5	6.5	23.6	26.0	16.2	19.3	19.9	7.2	13.3	1.9	6.7	0.8	9.2	2.5	23.0	12.2	6.6	29.9	48.8	36.9	11.8	11.7	28.7	20.9	20.6	14.2	14.8	8.9	9.0	27.8	20.8	15.0	16.4	17.0	17.1	13.5	32.8	5.7	7.9	4.1	18.5	5.7	20.7	26.4	25.1	14.5	12.1	23.6	13.5	16.3	17.6	12.0	18.2	9.5	13.2	26.9	11.5	21.7	38.3	11.7	11.9	14.9	21.3	4.1	13.3	23.2	12.1	27.6	20.9	13.1	21.0	22.3	2.6	16.4	15.2	22.7	21.5	11.3	18.1	6.9	17.9	8.1	12.5	1.0	4.8	1.9	4.1	6.7	7.3	7.2	4.9	9.2	7.7	5.1	6.5	6.5	0.5	0.8	4.5	13.3	5.7	2.5	33.5	47.7	16.2	30.6	31.3	31.4	38.3	21.3	23.6	24.5	11.9	22.9	67.7	184.9	147.7	34.2	125.7	140.1	4.0	13.6	235.5	11.8	249.5	139.3	36.9	4.9	69.1	63.2	93.5	42.5	152.2	182.5	294.0	48.3	169.3	166.2	36.5	130.4	101.9	99.0	12.5	275.5	153.8	177.2	70.3	141.5	167.3	33.6	57.5	210.4	431.6	22.2	116.4	173.1	10.1	130.6	149.2	154.2	56.5	129.6	224.5
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.4"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 644.1;Intestinal endocrine cells: 855.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 39.9;SuSa: 49.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	41.5	21.5	9.5	41.0	7.1	9.4	30.2	3.0	8.0	30.0	16.2	15.3	36.4	5.0	34.9	28.6	31.4	38.1	33.4	31.8	6.5	6.9	19.4	36.1	42.8	4.6	13.5	6.5	23.1	16.0	15.1	12.4	65.1	9.4	30.4	15.0	8.1	12.1	138.4	13.2	39.5	11.4	76.1	13.0	5.4	31.6	10.7	12.4	1.5	45.5	37.3	7.4	38.3	33.8	0.3	2.2	6.1	8.1	0.0	0.4	0.8	6.1	0.3	12.3	2.6	1.2	3.2	39.9	4.4	3.5	3.8	9.1	8.1	4.6	0.1	2.0	0.2	20.8	3.4	7.3	1.1	6.3	29.1	7.1	0.4	3.6	2.9	22.6	2.6	6.9	5.5	19.8	10.6	24.7	0.7	0.7	7.1	2.8	23.2	0.5	0.8	7.9	1.6	8.8	3.3	2.6	2.3	8.2	5.2	0.5	0.9	5.5	5.6	5.7	10.3	17.3	49.4	6.0	1.9	0.7	1.1	5.9	3.7	2.0	18.3	7.7	2.1	3.6	1.4	3.2	6.1	0.9	0.0	0.4	5.5	0.4	0.1	0.1	0.0	2.2	0.3	0.0	0.0	0.3	0.0	8.1	1.1	0.0	0.8	9.5	7.1	3.0	8.0	6.5	6.9	13.5	6.5	9.4	12.4	393.1	144.2	7.7	234.8	180.1	3.7	604.8	73.9	128.5	135.4	52.4	0.0	136.7	1.7	158.3	2.8	136.2	500.9	0.0	108.1	256.8	236.1	644.1	77.3	21.2	99.6	1.6	855.0	28.8	13.4	2.5	16.1	211.8	165.4	55.1	427.3	12.1	155.6	312.1	1.1	1.2	2.5	97.0	421.2	0.3	2.1	177.2	351.7	6.9	216.0	169.1
FAM71A	FLJ32796	ENSG00000162771	"Family with sequence similarity 71 member A"	Q8IYT1	1	212624474-212626778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	149	"testis: 57.1"	"Group enriched"	"Detected in many"	135	"Early spermatids: 1249.7;Late spermatids: 344.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;SK-BR-3: 1.6;U-266/70: 1.0"					"Not detected"	"Not detected"			"HPA028462, HPA060344"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028462: AB_10601904, HPA060344: "																		0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.8	0.5	0.0	0.0	2.5	0.0	3.4	0.0	0.0	2.0	0.0	0.4	1249.7	0.1	0.5	0.0	1.1	1.5	0.4	2.9	1.1	0.0	1.2	0.0	1.2	3.1	0.0	344.8	4.9	1.0	0.0	0.0	2.6	0.3	1.0	0.9	2.5	0.0	0.0	0.0	0.9	3.6	1.8	0.1	2.4	0.0	1.7	0.6
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686418-212699985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.8"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8"	"Group enriched"	"Detected in many"	36	"dendritic cells: 16.5;monocytes: 26.8"	"Cell line enriched"	"Detected in some"	12	"HDLM-2: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	10.4	1.3	6.7	6.3	9.4	5.4	3.5	0.4	5.2	2.0	2.4	3.3	0.2	1.4	1.8	0.4	1.8	2.6	3.8	4.1	5.5	2.1	2.6	2.3	7.2	8.7	9.5	2.8	3.1	3.2	1.2	1.3	4.6	4.3	2.3	1.6	0.5	2.2	1.2	1.5	1.1	4.3	3.7	4.7	9.5	3.2	1.1	7.1	5.0	2.1	2.6	4.9	3.0	6.0	0.2	16.5	0.6	26.8	0.3	0.4	2.4	0.3	0.9	0.1	0.0	0.0	0.6	0.7	0.5	1.1	1.1	1.2	0.0	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.2	0.8	93.1	2.2	0.0	0.3	0.0	0.2	4.2	0.6	0.1	0.0	2.2	0.3	0.1	0.0	7.7	0.1	1.1	0.2	0.0	3.2	1.7	0.4	0.0	1.5	0.6	0.4	0.0	1.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	3.0	0.0	0.5	2.1	0.1	2.4	0.1	0.2	0.5	1.5	3.8	1.1	0.0	4.1	0.0	0.0	18.0	0.0	0.2	0.0	0.0	16.5	0.0	0.0	0.0	0.6	0.3	26.8	0.0	0.4	2.4	6.7	9.4	0.4	5.2	5.5	2.1	9.5	2.8	4.3	7.1	3.0	1.1	0.5	2.2	5.0	0.1	0.3	0.0	4.0	2.3	0.0	0.0	0.8	0.0	0.7	0.3	5.8	0.0	0.0	0.3	36.2	8.5	6.6	4.7	0.2	4.6	0.0	0.0	6.2	10.5	0.8	0.9	24.9	1.7	98.2	0.0	0.2	1.3	0.0	0.0	0.5	0.4	0.0	25.8	1.1	4.3	2.5	3.8	1.0	0.0	0.9
NSL1	"C1orf48, DC8, DKFZP566O1646, MIS14"	ENSG00000117697	"NSL1, MIS12 kinetochore complex component"	Q96IY1	1	212726153-212791782	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA045761, HPA053721"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA045761: AB_2679444, HPA053721: AB_2682240"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.66e-2)"	15.1	14.6	23.1	16.5	26.3	16.1	19.7	22.9	20.6	14.5	12.9	27.2	9.9	15.4	14.9	12.3	14.2	13.8	13.2	21.5	23.9	21.5	17.4	20.6	12.5	22.0	25.6	15.0	17.1	10.9	12.0	19.2	17.2	20.7	13.9	11.8	12.8	12.4	11.3	19.4	8.3	17.1	13.3	36.0	18.9	11.5	12.4	25.0	24.4	14.9	8.8	16.2	16.3	11.4	33.1	32.4	35.3	35.6	24.4	29.9	31.2	14.7	17.5	18.8	17.2	9.6	9.3	23.4	12.5	10.1	16.8	14.9	14.8	16.6	21.7	11.6	7.9	8.7	11.2	17.8	13.1	14.6	39.7	13.5	14.3	14.7	23.6	9.2	23.6	14.0	8.8	7.7	16.8	9.2	8.2	12.7	25.6	31.5	18.8	12.7	8.9	30.3	11.9	33.7	8.2	13.1	26.4	27.7	24.4	16.4	7.6	16.3	23.0	18.0	8.8	21.2	18.0	25.4	17.5	12.7	16.0	13.6	14.4	20.6	10.5	28.2	27.7	13.9	16.6	19.6	12.7	29.1	35.3	22.7	35.6	26.6	33.1	24.6	24.3	32.4	26.9	29.9	26.6	29.4	24.4	35.1	31.4	28.5	31.2	23.1	26.3	22.9	18.9	23.9	21.5	25.6	15.0	20.7	25.0	14.9	16.5	22.6	20.5	13.2	33.6	19.4	17.8	26.8	20.5	17.4	13.7	53.8	36.5	27.2	18.5	24.0	12.3	0.0	18.5	55.3	28.6	9.1	14.0	23.8	53.2	31.8	20.8	26.4	61.2	12.5	32.2	35.8	18.6	55.1	11.7	30.6	22.2	13.5	30.8	44.4	31.0	58.2	28.2	49.2	58.4	14.2	17.5	29.9	18.2	8.2
TATDN3		ENSG00000203705	"TatD DNase domain containing 3"	Q17R31	1	212791828-212816626	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032092	Approved		Approved	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			Nucleoplasm	"Golgi apparatus, Focal adhesion sites"	"HPA032092: AB_10671086"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.34e-3)"	"unprognostic (5.02e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.96e-3)"	13.0	14.8	14.4	10.9	24.7	11.9	11.0	12.5	22.9	7.6	8.8	16.6	6.8	7.0	8.5	15.2	8.3	8.7	8.3	20.7	13.7	15.2	18.3	11.1	8.5	16.2	14.5	18.9	10.1	11.3	12.8	11.9	8.0	22.1	8.0	8.6	11.4	9.4	8.2	29.4	7.4	8.1	11.6	15.5	11.5	11.9	10.5	12.0	11.3	13.1	8.3	10.8	10.6	6.5	15.6	30.1	23.8	24.1	5.3	6.9	8.7	6.6	6.6	5.8	8.6	9.4	14.1	13.4	7.4	8.0	5.9	7.4	1.7	9.4	14.7	7.0	6.3	3.4	4.3	7.1	10.0	6.4	9.0	9.2	7.4	5.5	3.2	10.9	17.7	9.3	11.3	7.2	8.0	19.9	6.4	8.5	21.0	14.4	12.3	6.5	3.1	15.1	5.9	7.8	8.2	4.3	8.7	11.0	26.3	6.1	3.3	12.4	10.6	8.1	13.8	16.2	11.0	14.7	11.0	5.8	4.5	6.0	9.3	7.2	11.0	16.9	24.4	11.6	14.1	6.7	8.5	15.6	23.8	5.5	23.7	4.9	15.6	6.9	6.6	18.4	12.7	5.5	6.6	17.5	5.3	24.1	30.1	6.4	8.7	14.4	24.7	12.5	22.9	13.7	15.2	14.5	18.9	22.1	12.0	6.0	15.2	14.3	8.7	3.9	14.8	33.0	10.2	10.7	3.4	3.5	17.7	10.9	34.9	14.4	7.5	6.3	3.9	0.0	14.5	14.4	6.0	4.5	6.9	5.5	16.4	14.3	9.8	4.3	25.0	2.9	4.9	17.6	13.5	30.7	4.0	14.9	11.0	7.0	4.6	20.7	27.3	6.5	6.9	21.3	16.9	3.9	7.8	10.2	5.8	5.5
SPATA45	"C1orf227, LOC149643"	ENSG00000185523	"Spermatogenesis associated 45"	Q537H7	1	212830141-212847649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 4.4;pancreas: 4.4;testis: 14.2"	"Group enriched"	"Detected in some"	23	"Early spermatids: 131.3;Late spermatids: 94.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049921	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA049921: AB_2680953"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-3)"	0.1	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.2			0.0	0.3	0.9	0.0	0.9	0.4	0.1	0.3	0.3	0.2	0.4	0.4	0.8	0.4		0.1	4.4	0.0	0.4	0.2		0.2	0.0		0.1	0.0	0.0	0.0	0.2	0.6	0.5	0.5	0.1	14.2			0.3		0.4	0.0	0.1	2.8	0.7	4.4	0.9	0.5	1.2	0.5	0.4	4.0	0.9	2.6	0.8	2.1	2.6	0.4	0.0	0.8	1.2	0.8	0.6	0.9	0.1	0.0	1.7	0.3	1.7	0.0	1.0	3.7	0.0	0.0	0.0	2.1	1.2	0.0	1.7	1.5	0.0	0.4	0.0	0.0	0.0	1.7	0.0	1.8	2.3	2.5	0.2	0.9	0.6	0.8	1.4	2.1	0.2	0.0	2.1	0.4	0.9	2.7	1.6	0.0	0.0	0.9	0.6	1.3	0.0	0.9	0.1	1.9	1.1	1.1	1.7	4.4	0.3	1.6	1.1	0.0	0.4	4.4	0.7	0.9	0.9	0.3	0.1	0.0	0.7	2.8	0.6	1.2	2.4	0.5	0.7	0.1	0.3	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.0	0.0	0.0	5.0	0.0	131.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	94.9	1.4	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	0.0
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA"	ENSG00000162769	"Feline leukemia virus subgroup C cellular receptor 1"	Q9Y5Y0	1	212858255-212899363	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	3.2	3.8	4.6	4.5	7.2	7.8	4.8	11.3	5.9	4.4	12.9	4.7	3.3	13.5	4.0	7.5	3.2	3.6	3.6	2.5	5.0	7.5	3.5	3.1	3.7	4.1	5.3	5.9	4.0	5.1	7.0	16.8	3.5	7.2	5.3	4.4	4.0	2.9	4.3	1.6	4.3	40.6	3.8	4.8	4.2	7.1	4.0	5.5	5.4	3.6	2.1	3.3	4.0	5.0	1.2	1.6	4.7	0.8	0.7	1.4	0.2	4.8	6.4	10.0	3.0	1.7	2.1	18.9	1.4	1.1	2.9	1.8	9.4	9.0	5.3	2.7	1.0	6.2	7.4	10.8	3.2	2.9	3.1	4.7	3.1	6.3	8.5	2.0	8.3	5.1	1.6	2.1	3.1	4.0	1.5	2.2	3.7	8.3	4.4	1.9	1.8	2.3	4.1	33.1	6.4	4.6	5.2	9.2	6.1	3.6	4.7	10.9	7.7	6.6	6.6	6.0	8.7	10.8	3.9	1.3	1.4	3.4	4.6	6.5	2.7	5.5	6.3	2.1	4.8	1.7	1.6	0.8	4.7	0.8	0.6	0.9	0.9	1.2	1.0	0.5	1.2	1.2	1.1	2.6	0.7	0.8	1.6	1.4	0.2	4.6	7.2	11.3	5.9	5.0	7.5	5.3	5.9	7.2	5.5	11.9	13.6	12.6	8.8	12.7	22.7	3.3	7.6	9.4	15.9	19.2	33.4	3.0	1.7	3.8	3.2	7.7	17.9	0.0	11.7	5.3	7.8	10.1	6.9	4.9	5.5	15.9	31.2	10.4	10.3	5.3	5.8	9.0	5.0	8.2	8.6	6.3	7.3	10.5	2.5	4.1	31.2	6.5	7.2	10.1	5.9	8.2	2.1	8.9	6.5	3.7
VASH2	FLJ12505	ENSG00000143494	"Vasohibin 2"	Q86V25	1	212950520-212992037	"Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.2"	"Group enriched"	"Detected in some"	12	"Early spermatids: 75.2;Late spermatids: 59.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"AF22: 9.6;AN3-CA: 11.7;NTERA-2: 18.4;RH-30: 54.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045820			Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA045820: "	"unprognostic (2.22e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-5)"	"unprognostic (1.95e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.81e-4)"	3.1	0.7	2.6	5.8	6.0	1.4	3.7	1.1	4.8	3.3	1.4	0.1	1.0	1.3	4.2	3.8	7.8	1.5	4.9	2.8	1.5	1.8	1.1	0.8	2.2	3.8	1.2	1.7	1.8	0.8	1.8	7.7	1.4	3.6	7.7	1.2	5.7	1.6	1.6	1.6	1.2	2.0	3.5	1.1	2.1	1.3	23.2	1.1	9.7	1.2	3.1	3.7	2.9	6.3	0.2	3.2	0.0	0.0	0.0	0.4	0.0	0.1	0.6	9.6	11.7	0.1	0.0	1.5	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.1	0.0	0.2	0.0	3.9	0.0	0.4	7.7	1.4	0.7	0.5	0.5	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.2	0.1	4.4	0.0	2.3	0.8	0.1	4.9	0.6	18.4	0.0	1.4	2.9	54.2	0.5	0.0	0.7	2.2	3.4	1.2	0.1	0.1	5.2	1.8	0.3	0.0	0.4	1.1	0.2	0.5	1.3	2.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.4	0.0	2.6	6.0	1.1	4.8	1.5	1.8	1.2	1.7	3.6	1.1	0.0	0.6	0.0	0.7	1.3	1.9	0.8	0.0	1.4	0.0	0.0	2.0	0.1	0.0	0.5	75.2	0.3	0.0	0.0	0.2	0.2	5.8	1.4	0.0	0.0	0.2	1.6	1.2	0.0	0.3	59.3	0.3	1.3	0.0	1.0	0.0	0.8	0.1	0.0	0.7	0.3	2.1	0.0	1.7	1.0	1.0	1.4	0.0	0.0	0.0	0.4
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015826	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	11.4	11.7	18.0	10.8	32.6	9.5	17.8	21.6	22.7	14.5	9.3	16.9	8.6	8.6	14.8	14.2	10.2	12.2	10.4	9.2	17.4	13.8	13.3	13.0	11.0	15.8	17.0	13.9	19.1	10.5	15.5	14.8	10.8	13.8	14.5	11.0	12.3	9.8	11.2	11.0	15.1	10.7	12.2	14.9	15.5	10.5	9.0	15.9	19.5	14.0	7.9	14.9	10.8	9.7	7.8	7.2	7.6	5.9	14.1	11.3	6.7	8.7	7.0	11.4	9.7	8.7	12.9	10.2	7.2	12.0	11.5	11.5	4.7	6.5	8.5	6.6	7.1	6.4	6.9	13.1	6.9	11.7	15.9	7.9	8.5	5.6	4.6	9.6	8.4	10.2	7.9	8.9	9.0	9.3	9.8	9.7	7.7	9.8	8.8	13.2	2.9	9.6	5.7	26.9	4.8	5.1	4.9	20.5	8.9	9.0	5.9	5.6	16.3	8.6	11.7	13.3	12.7	9.0	6.2	7.2	9.5	5.1	11.7	10.9	6.5	6.2	5.7	10.7	6.3	8.7	7.4	5.9	7.6	7.4	5.5	9.1	7.8	9.2	7.6	7.2	5.3	9.8	8.1	4.0	14.1	4.4	4.4	11.3	6.7	18.0	32.6	21.6	22.7	17.4	13.8	17.0	13.9	13.8	15.9	44.7	9.8	14.6	7.5	6.2	21.3	12.6	17.8	28.1	15.9	12.2	9.8	12.8	10.0	8.7	1.2	11.3	6.7	0.0	9.2	12.6	10.6	8.8	16.2	11.5	10.5	27.0	6.4	11.6	19.2	1.5	14.4	11.3	3.3	10.8	9.2	13.4	8.4	7.0	13.1	13.5	17.6	19.4	9.0	7.4	16.2	6.0	9.2	18.1	8.8	6.2
RPS6KC1	humS6PKh1	ENSG00000136643	"Ribosomal protein S6 kinase C1"	Q96S38	1	213051233-213274773	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026531, HPA031565"	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: AB_2673935"	"unprognostic (3.90e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (8.10e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.44e-2)"	12.0	14.1	15.6	10.0	19.4	6.4	17.1	13.5	19.4	14.1	13.1	12.6	8.8	9.2	15.9	8.4	10.3	11.8	11.6	9.4	17.3	15.6	9.8	10.8	13.6	7.5	17.8	16.8	14.4	13.5	19.9	16.7	12.3	15.3	17.6	10.1	7.3	8.9	17.7	14.1	6.7	8.7	18.5	22.3	11.0	12.5	26.5	13.2	6.8	10.4	6.1	7.8	14.6	16.0	2.5	8.7	13.7	6.8	4.0	3.3	2.2	7.3	6.4	10.5	11.3	10.5	15.6	9.2	9.7	14.3	15.1	17.4	5.2	8.2	4.7	6.6	14.6	9.9	6.1	12.7	7.9	11.5	9.8	4.7	12.6	7.5	7.1	9.7	7.9	15.0	10.2	6.9	13.2	7.2	12.7	12.5	4.6	16.2	7.3	15.4	4.0	3.3	2.6	15.2	6.6	7.2	3.9	9.9	4.5	6.9	7.4	6.1	15.9	10.5	8.3	13.9	18.7	11.9	3.3	11.6	10.3	9.5	11.8	6.3	4.3	8.2	3.6	4.4	3.1	10.5	13.7	4.6	3.3	2.8	6.8	2.3	2.5	2.3	2.4	8.7	1.9	1.5	3.3	0.5	4.0	6.3	1.0	1.6	2.2	15.6	19.4	13.5	19.0	17.3	15.6	17.8	16.8	15.3	13.2	8.9	4.3	1.4	2.2	2.6	17.1	8.9	7.6	4.0	4.5	0.0	13.7	2.6	0.0	4.4	25.9	6.5	4.0	0.0	6.8	3.3	6.9	4.5	7.0	8.1	6.1	19.1	3.5	10.4	8.6	33.0	10.3	9.8	6.8	6.4	3.2	6.6	5.4	2.8	7.1	4.6	18.9	12.9	5.1	13.4	17.2	3.9	3.2	5.1	3.7	2.6
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041502	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 72.4"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 195.1;Hepatocytes: 270.2;Horizontal cells: 494.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 16.0;RH-30: 8.5;SH-SY5Y: 41.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	2.3	9.6	3.7	2.1	8.1	1.0	2.9	14.0	5.8	1.8	3.0	13.1	0.3	2.7	1.9	2.0	1.5	3.0	2.6	13.1	6.2	4.1	5.4	72.4	2.0	13.5	8.4	4.3	7.3	13.9	1.0	11.4	1.3	5.5	1.4	3.2	2.4	1.1	1.3	4.1	1.5	3.1	1.7	9.6	14.9	2.8	5.9	9.2	0.0	7.5	0.6	1.5	1.6	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.5	0.3	0.0	16.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	1.2	2.8	0.0	0.2	0.0	0.2	0.0	0.8	1.0	0.7	0.0	8.5	1.2	0.1	0.2	1.2	41.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	8.1	14.0	5.8	6.2	4.1	8.4	4.3	5.5	9.2	0.0	2.9	0.0	1.0	5.3	195.1	97.2	84.1	1.4	2.3	8.7	2.0	0.0	13.3	17.3	37.5	17.8	2.6	0.0	2.4	0.1	6.7	2.3	0.0	270.2	0.7	494.2	64.2	4.9	4.5	5.9	1.1	1.1	10.1	0.0	15.2	38.7	5.2	79.3	1.1	0.3	8.6	0.0	2.7	0.2	0.1	4.0	0.0	0.0	8.0	0.6
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"		NA	NA			Cytosol	"Intermediate filaments, Mitochondria"	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.5	7.1	9.7	6.8	10.0	17.5	41.3	13.9	11.5	17.6	20.0	28.0	21.0	12.7	14.3	15.7	9.6	11.6	9.2	25.8	17.1	10.6	10.7	4.1	12.0	22.3	9.0	17.8	2.9	18.7	14.6	12.2	9.7	12.2	12.7	12.2	12.9	3.2	15.7	12.8	12.4	11.2	8.7	14.4	9.7	7.7	23.5	10.8	17.4	18.0	9.6	22.4	10.8	38.9	28.6	23.3	30.3	11.9	14.6	13.7	20.2	7.5	21.5	13.1	4.9	14.6	17.8	14.2	15.6	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2	17.9	11.9	11.2	14.0	18.3	3.8	109.6	22.9	48.2	12.5	3.5	0.0	142.7	26.6	32.4	113.6	10.8	12.7	0.0	17.4	93.2	12.2	8.9	3.5	15.5	33.9	14.3	4.1	22.1	17.4	93.5	10.9	9.9	15.1	10.8	15.2	15.2	22.5	10.5	3.5	27.8	4.6	12.9	15.7	15.2	43.7	15.7	71.9	12.8	20.8	7.6
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase, non-receptor type 14"	Q15678	1	214348696-214552449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	13.6	10.0	3.0	6.5	2.4	0.2	15.0	0.8	3.7	13.6	8.5	2.6	11.0	1.0	15.4	8.0	8.6	9.2	9.7	7.0	3.5	1.9	11.2	2.0	12.2	6.6	2.4	1.3	11.8	5.0	6.3	4.0	13.2	4.9	10.6	2.9	7.2	9.2	23.4	21.6	18.8	3.5	9.4	4.3	5.3	5.7	8.3	2.4	1.4	8.1	6.9	3.7	12.4	17.7	1.0	0.5	1.9	0.4	1.0	0.6	0.1	8.8	3.9	3.2	4.7	5.6	9.6	9.5	10.1	9.4	7.7	6.5	7.9	4.6	0.0	11.2	23.4	4.4	7.9	4.4	11.2	13.2	0.1	3.3	0.8	11.3	1.5	10.2	0.1	0.4	7.1	11.8	13.4	21.6	12.7	14.9	0.3	0.0	0.1	18.6	0.9	0.1	0.1	7.0	1.6	4.3	0.1	16.2	0.0	13.9	4.5	0.0	0.7	12.5	8.2	5.1	11.9	8.1	0.3	26.5	18.1	7.1	6.4	14.2	0.5	0.0	0.0	9.7	0.1	15.0	1.3	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.4	0.1	1.0	0.5	0.6	1.9	1.0	0.4	0.5	0.6	0.1	3.0	2.4	0.8	3.7	3.5	1.9	2.4	1.3	4.9	2.4	68.5	15.9	0.5	27.7	50.3	0.4	17.5	2.5	21.4	44.3	27.9	0.0	30.2	6.6	12.0	8.1	42.7	0.4	0.0	9.4	11.6	27.8	19.5	1.1	0.8	4.0	0.0	3.4	36.8	1.2	4.0	24.2	2.5	10.1	0.0	5.0	3.3	20.7	0.0	27.6	12.5	1.3	19.4	20.6	0.7	7.2	31.6	20.3	1.8	2.9	24.0
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664588	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.5;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	1.6	1.5	1.0	10.7	1.3	19.5	1.1	0.4	0.9	2.1	5.6	0.3	0.0	4.6	1.2	1.7	9.4	0.8	0.4	1.7	0.6	0.6	1.0	0.8	3.2	6.2	0.6	0.5	1.4	0.6	0.0	0.4	6.4	0.8	0.7	4.5	0.4	1.9	0.0	0.5	4.7	6.4	1.6	1.5	3.8	2.3	9.4	0.6	67.5	0.6	7.6	7.6	1.4	2.9	0.3	0.3	0.0	0.0	0.7	1.9	0.2	32.6	18.5	39.9	20.8	1.5	2.0	15.6	20.2	8.3	12.2	12.0	14.7	20.2	31.1	12.0	11.2	11.0	20.3	24.6	13.2	20.7	27.1	15.4	25.5	28.4	20.9	0.2	36.1	14.0	0.7	1.0	17.5	20.2	3.5	12.7	14.3	23.0	18.6	21.7	12.4	21.3	14.4	35.3	9.8	8.2	22.7	56.4	10.2	11.9	8.1	18.7	25.5	27.3	18.2	10.5	22.2	21.7	13.8	16.7	22.1	26.0	18.3	41.7	14.3	15.4	29.9	9.6	26.1	19.5	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1.4	0.4	0.3	0.3	1.9	0.8	0.0	0.7	0.0	0.3	1.7	0.2	1.0	1.3	0.4	0.9	0.6	0.6	0.6	0.5	0.8	0.6	0.0	1.9	40.2	1.2	8.2	3.2	1.9	2.5	26.8	14.8	0.0	0.0	9.1	0.0	1.8	32.4	2.8	1.3	303.7	0.4	74.0	7.7	1.0	1.1	1.9	26.4	1.6	0.0	9.8	11.2	9.4	1.1	9.9	1.7	0.0	5.3	1.1	0.5	0.0	2.8	0.0	2.8	0.0	0.3	20.9	88.3	4.8	4.2	10.9	15.5	0.9
KCNK2	"K2p2.1, TREK-1"	ENSG00000082482	"Potassium two pore domain channel subfamily K member 2"	O95069	1	215005775-215237093	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"adrenal gland: 49.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 1.1;Fibroblasts: 1.4;Melanocytes: 3.3;Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 31.4;fHDF/TERT166: 27.6;hTERT-RPE1: 18.9;T-47d: 42.0;U-2197: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.81e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-6)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.46e-3)"	2.9	49.1	4.8	1.1	7.4	0.5	6.1	1.1	6.2	2.3	1.1	2.5	0.0	0.6	0.8	2.6	1.2	1.0	1.6	0.5	5.1	4.3	1.2	0.5	0.7	0.5	2.3	7.3	3.5	2.0	0.5	0.5	0.5	3.3	1.2	1.6	0.0	0.8	3.7	1.2	3.4	2.3	1.5	4.5	0.4	3.7	1.5	3.3	0.0	8.9	2.7	0.4	2.6	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	7.9	31.4	0.0	11.0	7.3	3.5	8.3	0.0	0.4	0.0	0.0	27.6	0.0	0.0	4.9	0.0	6.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	8.1	0.0	8.4	0.8	18.9	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.9	1.5	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.8	0.2	0.1	0.0	42.0	0.0	0.0	6.1	0.2	15.0	0.6	0.6	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	7.4	1.1	6.2	5.1	4.3	2.3	7.3	3.3	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.2	1.3	0.0	0.0	0.0	0.0
KCTD3	NY-REN-45	ENSG00000136636	"Potassium channel tetramerization domain containing 3"	Q9Y597	1	215567392-215621807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 70.8"	"Low region specificity"	"Detected in all"							HPA015142	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA015142: AB_1852174"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (2.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.27e-1)"	"unprognostic (3.31e-3)"	18.4	47.6	17.3	7.3	16.6	7.7	37.5	23.6	16.9	19.8	35.1	24.1	20.3	25.1	22.6	18.4	25.8	12.1	15.7	10.3	17.4	14.4	16.3	39.6	10.9	4.4	18.7	13.1	13.8	18.2	24.5	12.4	18.1	19.5	22.7	16.4	13.9	24.5	17.9	10.0	10.6	35.1	17.1	26.6	7.5	16.6	13.3	15.0	5.3	15.8	11.0	9.2	18.1	21.9	2.6	2.6	3.3	2.1	2.5	1.3	0.6	15.7	11.4	12.9	7.5	11.0	18.6	17.9	13.0	12.2	11.6	12.2	10.0	26.4	4.4	7.3	13.5	3.5	15.5	13.5	13.3	13.4	2.4	14.1	7.9	22.0	14.0	9.1	8.0	1.5	17.1	9.3	14.8	11.3	14.7	10.5	5.9	15.3	4.3	12.7	13.7	3.4	4.2	21.7	22.9	14.6	5.3	18.3	17.1	13.6	10.7	15.3	17.1	20.2	29.6	11.0	17.0	70.8	10.4	9.4	11.7	11.6	14.3	14.8	3.9	5.3	1.5	9.1	4.2	8.8	1.8	2.1	1.0	1.0	1.1	0.8	1.6	1.1	1.0	2.0	2.6	1.2	1.3	3.3	2.5	1.0	2.6	0.6	0.6	17.3	16.6	23.6	16.2	17.4	14.4	18.7	13.1	19.5	15.0	8.9	12.3	5.1	20.2	16.0	27.6	12.2	20.4	16.0	21.6	10.4	17.7	22.5	19.9	19.6	1.1	12.1	16.9	0.0	18.1	13.1	21.6	24.9	4.7	56.2	6.9	17.5	38.1	19.0	10.5	2.0	25.6	5.8	15.1	4.6	38.5	19.2	13.9	22.0	21.2	23.7	22.3	25.8	16.5	6.7	16.1	15.4	14.6	1.7	24.8	37.9
USH2A	"RP39, USH2"	ENSG00000042781	Usherin	O75445	1	215622894-216423396	"Disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"liver: 13.7;retina: 36.6"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 190.5;Rod photoreceptor cells: 174.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 1.6;SCLC-21H: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA						"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.38e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.62e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.28e-11)"	"unprognostic (2.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.09e-4)"	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	0.1	0.2	0.3	13.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.1	0.1	0.5	0.0	0.0	36.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	3.6	2.5	0.0	0.0	0.0	190.5	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.7	0.0	3.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.4	0.0	174.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0
ESRRG	NR3B3	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5;parathyroid gland: 37.2;placenta: 40.8"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 55.0;Syncytiotrophoblasts: 179.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"pons and medulla: 49.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 15.4;SH-SY5Y: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.5	5.1	2.8	0.4	3.3	0.2	2.9	6.9	10.3	1.4	0.7	0.7	2.2	4.0	0.5	1.5	1.4	2.1	0.8	8.3	3.2	2.6	22.0	0.8	0.7	0.4	6.8	1.7	0.8	4.4	37.2	9.9	40.8	49.5	2.6	0.4	10.7	11.0	2.4	6.3	1.5	3.7	0.9	2.6	1.0	22.2	1.0	1.5	0.0	4.6	7.2	0.4	1.0	0.7	0.4	0.2	1.5	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	15.4	2.4	1.7	5.5	29.5	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.0	2.8	3.3	6.9	10.3	3.2	2.6	6.8	1.7	49.5	1.5	0.0	2.6	0.0	3.3	0.2	26.3	45.0	7.6	18.7	1.2	22.7	55.0	29.1	46.4	3.1	4.5	0.3	0.0	0.0	2.1	3.1	1.5	8.3	0.0	0.8	3.8	46.1	7.9	0.6	0.8	4.6	0.3	0.0	8.5	0.0	0.7	12.3	0.6	0.2	0.7	23.0	34.7	0.0	1.0	1.4	0.1	0.3	179.8	0.0	0.2	1.4
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631082	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cone photoreceptor cells: 161.0;Rod photoreceptor cells: 125.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	11.0	10.4	14.6	13.7	19.0	6.7	17.1	12.2	19.9	15.1	12.4	10.6	19.4	11.4	15.9	19.2	13.4	12.2	14.8	11.6	12.9	13.7	12.7	11.4	10.4	11.0	11.0	13.4	13.6	12.5	18.2	27.7	14.6	12.8	17.0	11.2	8.5	12.2	19.5	13.0	12.0	13.8	12.3	11.5	11.7	11.2	16.6	12.2	20.6	16.5	11.7	12.7	12.2	13.3	5.2	9.0	6.6	6.0	4.8	6.0	2.7	6.9	8.0	8.6	6.7	7.6	7.8	7.1	6.5	8.1	9.2	8.7	7.0	9.1	7.5	6.7	5.6	5.7	8.3	9.6	7.7	10.8	5.5	5.5	4.9	6.6	4.4	9.5	7.4	5.9	6.8	11.4	10.7	17.6	8.0	6.3	8.4	12.0	0.1	6.6	6.6	9.9	5.3	15.6	5.6	8.8	4.9	19.8	8.9	6.5	15.2	10.2	14.4	11.7	10.8	8.6	14.2	10.1	7.3	6.4	8.6	6.0	12.1	6.1	7.9	5.6	7.2	6.6	5.0	6.1	6.6	6.0	1.9	5.1	3.4	3.5	4.6	6.0	3.5	6.1	5.2	5.3	4.8	0.9	4.8	4.9	9.0	5.1	2.7	14.6	19.0	12.2	19.9	12.9	13.7	11.0	13.4	12.8	12.2	11.9	12.8	16.6	15.6	13.9	49.4	13.0	28.1	17.4	17.0	17.4	161.0	17.3	11.6	17.9	30.7	18.0	16.5	23.3	15.6	17.4	18.3	19.4	9.2	11.5	13.4	47.7	20.0	16.0	6.1	20.2	18.4	13.8	5.0	12.6	12.7	34.2	12.7	14.0	21.5	12.7	125.4	19.4	13.3	55.3	22.5	16.9	18.1	12.5	18.3	15.9
SPATA17	IQCH	ENSG00000162814	"Spermatogenesis associated 17"	Q96L03	1	217631324-217871696	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 48.0"	"Cell type enhanced"	"Detected in many"	21	"Ciliated cells: 161.9;Early spermatids: 584.1;Late spermatids: 424.1;Spermatocytes: 138.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030099	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA030099: AB_2270988"	"unprognostic (4.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.24e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.82e-1)"	0.5	0.6	1.4	0.3	5.2	2.4	0.9	0.5	1.2	1.0	0.5	2.7	2.9	0.6	0.7	9.7	0.5	6.8	0.8	1.1	2.3	2.2	2.8	0.4	3.0	0.3	0.8	1.6	3.3	0.6	3.0	10.8	0.4	11.1	0.7	0.3	1.2	0.6	1.2	2.9	1.0	0.7	0.2	0.7	0.4	0.6	48.0	1.4	0.0	3.1	0.3	0.2	0.5	0.5	1.3	0.6	2.3	0.6	0.6	1.0	0.1	0.6	1.2	1.2	1.2	0.3	2.0	0.9	0.5	0.7	0.6	0.3	0.8	3.2	0.6	1.0	0.4	0.4	2.2	0.8	1.1	0.7	0.6	1.2	0.5	1.5	0.8	0.6	0.3	0.5	0.7	2.3	1.2	1.2	1.4	0.1	0.7	0.7	1.3	0.6	2.5	0.4	1.0	2.3	1.6	1.2	0.4	0.4	0.4	2.3	0.9	4.8	1.9	0.7	0.8	0.6	2.0	1.5	0.6	0.6	0.8	0.6	0.9	0.5	1.3	0.8	0.3	1.9	0.5	1.1	2.3	0.5	0.5	0.9	0.5	0.8	0.7	0.7	0.7	0.3	1.3	0.9	1.0	1.5	0.6	0.6	0.6	0.3	0.1	1.4	5.2	0.5	1.2	2.3	2.2	0.8	1.6	11.1	1.4	3.0	0.0	0.0	0.8	0.6	0.4	1.4	0.0	161.9	25.0	3.5	19.6	0.7	5.0	1.7	584.1	0.5	0.0	0.0	0.6	0.5	0.7	1.6	0.0	0.0	0.2	0.0	1.7	0.0	0.0	424.1	8.1	0.7	1.7	0.0	1.0	5.1	0.2	0.0	6.3	8.4	18.5	0.0	0.1	138.2	8.1	0.9	0.2	0.0	0.6	0.4
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285287-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	10.3	7.2	8.9	8.0	9.9	8.5	11.6	11.6	10.4	8.4	8.0	5.5	5.4	5.3	10.1	7.1	8.7	8.9	5.0	11.4	8.6	6.3	9.3	10.7	7.5	8.3	8.0	5.0	9.8	8.4	12.1	10.0	8.7	8.6	7.8	7.2	5.8	7.9	6.4	33.5	8.5	6.8	11.8	9.4	10.3	7.6	6.3	9.0	6.5	8.9	10.5	8.3	8.5	9.4	5.1	3.3	0.6	2.4	3.1	5.7	1.6	8.1	6.1	6.8	4.9	5.0	7.0	5.9	8.3	6.3	8.8	6.4	11.9	7.5	11.8	11.5	6.4	5.9	7.4	11.6	11.0	14.7	4.7	8.7	9.1	5.8	6.6	10.3	14.1	5.0	4.8	6.8	11.4	15.3	3.9	5.6	5.5	18.6	3.9	9.8	7.5	9.3	6.9	13.6	6.5	12.8	6.6	4.2	11.6	7.0	7.6	8.0	11.5	7.1	13.3	12.2	8.5	9.5	10.2	7.9	7.1	6.6	12.5	15.4	4.7	7.2	12.2	8.1	6.9	11.2	0.6	1.6	0.2	3.5	2.4	4.8	4.7	4.2	2.9	2.4	5.1	5.7	5.5	0.5	3.1	2.1	3.3	2.5	1.6	8.9	9.9	11.6	10.4	8.6	6.3	8.0	5.0	8.6	9.0	29.8	25.5	31.5	28.8	58.0	29.7	58.0	17.8	13.4	30.7	34.9	9.8	32.1	23.2	30.7	5.9	26.0	2.9	0.0	44.6	48.1	26.3	14.3	30.1	37.6	29.3	25.4	11.6	19.0	13.3	2.7	34.8	25.8	20.3	17.2	18.6	20.3	31.8	2.9	23.3	23.5	21.8	25.8	28.8	46.4	75.7	41.7	15.1	22.4	25.7	22.8
TGFB2		ENSG00000092969	"Transforming growth factor beta 2"	P61812	1	218346235-218444619	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 71.5;Muller glia cells: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 21.0;hTERT-RPE1: 56.1;U-2 OS: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	4890000					"unprognostic (7.24e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.86e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.04e-2)"	2.9	2.6	13.4	3.2	11.4	0.8	7.0	5.2	13.7	12.3	5.2	10.0	7.0	1.6	10.8	7.5	3.6	6.9	3.9	9.5	13.3	6.7	2.9	1.6	12.4	1.6	5.9	9.9	8.1	3.5	4.3	6.3	20.1	10.2	27.8	2.1	11.6	16.9	18.7	6.9	3.8	1.8	8.5	19.0	4.4	2.8	2.1	8.2	0.0	4.8	2.8	1.9	5.2	7.4	2.6	0.5	0.0	0.0	0.0	0.1	0.0	1.3	7.0	0.6	5.5	1.6	0.8	0.0	1.0	0.1	11.2	8.0	1.8	16.9	0.0	21.0	0.0	9.3	3.6	0.4	0.9	11.6	0.0	0.1	0.0	0.6	0.0	17.4	0.0	0.0	0.7	1.9	1.5	5.9	56.1	3.0	0.0	0.0	0.0	10.6	0.1	0.0	0.0	0.5	0.0	0.6	0.0	3.1	0.0	3.6	0.0	0.1	0.0	11.6	1.4	0.2	15.1	1.0	0.4	13.0	7.9	20.8	6.5	10.6	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	11.4	5.2	13.7	13.3	6.7	5.9	9.9	10.2	8.2	71.5	4.6	0.0	5.8	7.7	6.2	3.0	12.7	12.0	14.8	5.2	0.0	0.3	0.0	30.1	16.2	3.5	0.0	0.0	15.1	10.2	15.5	11.6	1.1	0.0	1.2	1.6	0.0	3.1	0.6	22.2	7.5	1.7	11.8	1.8	0.0	97.9	15.5	0.0	13.1	0.3	2.0	0.0	22.4	0.2	0.4	2.5	0.5	0.0	0.0	2.0
LYPLAL1	Q96AV0	ENSG00000143353	"Lysophospholipase like 1"	Q5VWZ2	1	219173844-219212865	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 177.4;Proximal tubular cells: 276.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045806	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA045806: AB_10966647"	"unprognostic (1.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	10.7	22.3	19.0	9.4	17.4	2.1	12.4	15.2	13.2	10.6	7.2	14.4	4.4	10.7	19.4	5.9	10.0	7.1	10.5	39.7	17.9	15.4	46.6	29.9	8.9	9.5	19.5	12.3	12.5	12.9	14.6	25.0	9.9	14.9	16.3	7.7	16.1	9.9	8.6	12.0	11.5	9.2	15.6	28.2	6.5	7.7	10.6	17.0	7.3	19.3	9.9	10.3	9.0	12.9	12.8	6.8	8.9	9.6	4.0	7.3	5.3	6.7	6.8	3.0	0.0	6.1	12.2	7.8	3.8	4.4	3.6	4.0	3.1	9.1	7.3	11.4	3.4	3.7	3.6	6.1	8.7	5.2	10.2	7.1	4.1	3.6	6.9	24.7	8.8	3.1	14.2	7.9	3.7	8.9	8.4	10.4	7.2	12.3	7.2	8.0	4.4	4.1	7.5	5.9	6.3	11.0	2.4	7.8	12.2	14.1	5.0	7.3	4.8	4.5	12.0	13.5	10.2	11.3	11.3	6.3	2.9	2.0	5.9	4.7	6.6	3.8	5.3	9.6	7.2	6.4	2.4	8.6	4.7	3.6	6.3	5.7	12.8	4.9	4.2	6.8	7.6	7.3	5.7	8.9	4.0	9.6	6.0	4.8	5.3	19.0	17.4	15.2	12.9	17.9	15.4	19.5	12.3	14.9	17.0	23.8	28.6	20.5	17.9	19.7	28.4	100.7	30.6	32.1	15.9	48.8	7.9	74.1	177.4	41.0	24.6	15.0	13.8	0.0	46.1	29.2	23.4	15.9	16.2	42.9	57.6	17.5	17.9	30.7	27.1	5.9	25.0	31.3	40.5	14.4	18.4	92.9	39.4	14.4	29.0	276.5	27.0	12.9	20.6	24.2	22.3	25.6	52.3	9.2	11.4	10.6
ZC3H11B	ZC3HDC11B	ENSG00000215817	"Zinc finger CCCH-type containing 11B"		1	219608347-219613145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	4	"testis: 8.9"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.4;Collecting duct cells: 1.8;monocytes: 1.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA026439, HPA028490, HPA028526"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (1.75e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.87e-2)"	0.1	0.1		0.5		0.1	0.0		0.1	0.0	0.0			0.2	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.4	0.8	0.1	0.0		0.1	0.0	8.9			0.0		0.0	0.0		0.5	0.7	2.1	0.9	0.6	0.9	0.6	1.0	0.8	2.2	1.3	0.4	0.3	1.9	1.9	0.3	0.3	0.4	0.9	0.9	0.7	0.5	0.3	1.0	1.5	0.2	0.2	0.3	3.1	0.8	0.5	1.1	0.8	0.1	0.8	1.8	0.2	0.1	0.4	0.5	0.8	0.0	1.9	2.2	2.3	0.2	0.4	1.6	1.1	1.2	0.2	0.6	0.7	1.5	0.7	0.2	0.9	0.9	1.4	1.1	1.7	1.3	1.0	1.4	3.2	1.1	1.0	1.3	1.0	2.0	1.4	1.2	1.1	2.3	1.4	2.0	1.0	0.9	0.7	0.7	0.4	0.8	0.5	0.6	0.7	0.7	0.5	0.7	0.6	2.1	0.6	0.3	0.3	0.9	0.6											0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 33.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 23.4;Enterocytes: 12.9;Hepatocytes: 19.8;Late spermatids: 27.7"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.4;HEL: 2.2;Hep G2: 4.3;K-562: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced					NA	NA					"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.3	0.3	2.9	0.7	3.5	0.4	0.3	1.8	3.9	0.3	7.1	1.9	0.0	5.9	0.3	0.3	0.3	0.3	0.5	0.3	3.5	1.6	0.3	33.4	0.3	0.3	1.7	1.7	0.6	0.3	0.3	0.4	0.4	2.5	0.3	1.7	0.6	0.3	0.3	0.3	0.3	6.8	0.3	0.8	0.3	0.3	1.9	1.9	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.4	2.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.5	1.8	3.9	3.5	1.6	1.7	1.7	2.5	1.9	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.4	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.0	19.8	0.1	0.0	0.0	0.6	0.6	27.7	1.1	0.0	1.7	0.0	0.1	3.4	0.0	3.2	1.4	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.2	0.0	0.6	0.0
EPRS	"EARS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase"	P07814	1	219968601-220046658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		29000	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	25.0	20.4	16.8	18.6	22.2	13.2	20.6	24.2	26.3	19.3	20.4	15.4	13.6	15.8	17.8	15.3	25.2	15.9	11.9	20.1	15.9	18.0	23.3	31.6	17.4	20.8	21.7	16.1	21.3	32.7	47.1	38.6	15.7	34.9	14.3	23.2	9.4	64.0	16.3	42.9	19.6	23.3	18.9	24.7	22.3	20.1	13.2	20.8	28.0	25.1	25.7	23.4	18.3	16.3	14.7	15.4	6.4	16.6	14.2	19.8	10.7	30.1	19.2	13.9	38.0	29.6	32.9	34.9	39.5	27.7	25.7	28.9	22.7	24.4	57.9	22.0	41.6	10.4	32.3	34.9	31.8	34.6	28.3	22.2	31.5	25.9	19.4	32.4	52.2	27.0	23.7	40.9	32.8	41.1	21.5	28.1	28.0	54.1	45.7	25.1	14.9	22.4	12.7	26.9	35.7	39.8	23.8	24.6	56.6	23.5	13.3	33.1	26.0	23.1	38.3	40.3	20.8	35.4	57.1	24.9	12.3	22.7	37.6	36.7	31.0	35.2	49.0	28.3	37.6	38.8	4.2	11.9	6.4	14.0	16.6	19.8	14.7	14.1	15.6	15.4	11.5	15.9	16.3	0.4	14.2	13.7	5.0	13.5	10.7	16.8	22.2	24.2	26.3	15.9	18.0	21.7	16.1	34.9	20.8	65.5	52.5	37.9	33.6	17.6	45.2	67.4	15.3	69.6	69.4	29.6	62.8	36.3	18.3	58.3	19.1	33.8	24.4	23.3	87.1	48.7	27.0	24.9	47.4	18.8	38.0	39.7	29.4	22.1	23.8	7.4	43.7	27.7	20.3	53.3	32.2	45.5	61.8	14.4	44.6	21.4	47.0	38.8	27.8	57.6	34.9	17.8	30.6	29.8	41.8	29.3
BPNT1		ENSG00000162813	"3'(2'), 5'-bisphosphate nucleotidase 1"	O95861	1	220057482-220090462	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048461	Approved		Approved	"Nuclear speckles"		NA	NA		170000	"Nuclear speckles"		"HPA048461: AB_2680404"	"unprognostic (6.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.19e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	11.1	24.1	12.7	22.2	17.2	2.9	13.4	13.7	16.5	12.9	27.9	15.9	14.4	30.5	10.6	8.0	14.9	11.5	16.1	11.6	11.3	10.8	31.0	17.0	11.5	21.5	14.0	10.6	13.5	8.6	14.1	20.2	12.7	11.9	9.6	22.5	11.8	22.2	12.2	7.6	10.6	49.0	12.3	17.6	12.0	12.9	10.4	13.3	15.6	13.8	12.6	28.8	13.5	10.4	18.9	10.9	11.6	8.5	12.1	13.8	7.6	11.8	9.8	7.4	5.9	13.2	10.6	11.0	16.0	7.8	13.8	12.8	12.9	24.1	60.2	21.1	10.4	6.4	8.6	14.9	13.4	11.2	21.6	17.3	10.8	12.7	15.9	7.7	28.8	10.2	9.9	6.4	20.4	7.6	8.6	10.8	17.4	18.8	6.0	13.1	6.7	16.5	7.9	6.3	9.6	12.1	11.9	21.3	17.0	17.1	16.3	13.7	11.3	20.2	24.3	13.2	7.5	19.1	10.0	18.0	8.6	6.7	11.9	19.8	10.6	25.5	28.5	7.7	10.8	19.4	11.6	7.8	5.0	11.0	8.5	8.7	18.9	11.3	11.0	9.0	14.1	13.8	10.2	1.1	12.1	7.8	10.9	11.5	7.6	12.7	17.2	13.7	16.5	11.3	10.8	14.0	10.6	11.9	13.3	26.8	19.2	20.8	9.9	3.0	12.5	11.1	15.3	10.7	17.0	14.0	9.8	11.9	11.6	15.3	1.9	4.2	50.6	0.0	13.9	11.4	7.2	5.8	3.5	11.3	8.6	6.4	18.5	4.9	5.7	2.4	8.9	8.3	10.1	7.2	12.6	10.1	15.8	24.6	12.7	21.7	11.2	12.9	6.6	12.5	12.6	4.4	21.1	7.0	15.5	10.7
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	38.3	36.0	20.7	20.3	31.3	31.6	49.9	23.4	25.2	25.9	21.0	34.6	40.1	35.5	31.7	28.9	20.1	37.3	28.7	29.2	30.0	24.5	34.6	17.6	29.4	38.8	19.5	27.9	19.1	22.8	29.8	28.0	29.0	25.1	25.2	23.1	43.4	20.6	33.9	21.3	22.0	20.2	26.9	30.0	23.9	19.5	41.3	56.8	37.3	25.8	11.2	31.5	35.4	55.0	36.4	24.8	63.6	31.7	25.7	25.6	21.4	34.3	39.1	17.7	27.1	25.8	27.1	22.0	28.3	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7	32.8	33.1	24.4	24.3	17.9	26.7	126.1	15.3	58.9	45.5	27.9	23.6	68.4	10.0	37.8	12.3	43.0	33.8	0.0	56.4	44.9	24.9	20.4	18.5	88.4	40.3	19.1	34.8	38.6	46.6	2.0	34.5	26.7	18.6	25.2	50.3	28.6	54.2	28.8	40.0	28.3	31.0	45.3	22.6	32.5	40.2	23.2	60.0	22.7	61.0	20.5
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272454	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	16.7	16.2	14.9	19.6	18.7	14.3	17.8	24.2	22.4	15.6	13.5	14.3	13.9	12.2	16.8	14.9	15.6	12.8	12.8	15.3	16.5	18.8	18.9	15.6	14.3	18.2	17.1	15.6	16.2	14.5	35.6	28.3	19.8	21.9	14.2	13.5	11.6	15.6	15.8	19.9	13.1	15.0	14.9	15.2	14.9	14.5	10.1	15.5	26.1	20.5	11.9	21.7	16.0	15.8	7.1	5.2	12.3	5.1	3.6	8.9	4.6	13.9	10.6	12.9	9.7	14.8	17.7	14.6	14.4	13.7	13.0	15.4	9.7	11.6	17.3	10.2	13.8	9.8	13.3	13.3	11.0	15.1	14.5	8.7	13.5	14.1	9.1	19.6	19.3	13.9	14.0	12.6	12.6	19.7	14.6	11.8	7.6	23.3	11.3	14.6	3.9	14.8	6.8	27.7	7.5	6.3	8.1	17.8	15.4	11.1	11.5	12.9	15.6	14.9	14.5	23.3	14.5	15.2	18.4	17.1	14.3	6.7	9.8	15.3	10.0	12.1	15.3	12.2	16.3	16.7	12.3	3.9	7.5	7.1	4.9	8.6	7.1	7.0	8.9	5.2	5.5	6.3	7.4	2.5	3.6	5.1	3.3	8.0	4.6	14.9	18.7	24.2	22.4	16.5	18.8	17.1	15.6	21.9	15.5	38.7	21.6	17.1	12.0	10.3	54.4	31.3	22.9	12.0	23.9	24.4	64.8	15.7	5.0	16.3	2.6	17.6	16.9	0.0	14.3	11.2	17.7	17.2	18.5	20.3	21.2	39.7	34.0	25.8	29.8	1.6	16.7	20.6	13.5	16.2	20.3	46.1	17.6	14.0	24.4	14.5	51.3	6.5	14.4	15.6	11.8	8.5	19.3	19.3	18.8	11.3
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528183-220664461	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 23.6;Cardiomyocytes: 19.9;Cone photoreceptor cells: 29.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 35.7;SuSa: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain					NA	NA					"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favorable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	14.3	5.6	11.4	4.6	13.5	0.9	9.0	15.2	22.7	9.8	6.7	4.7	6.4	2.1	7.8	26.6	9.4	5.9	5.0	19.1	10.0	12.5	4.7	1.5	4.8	2.3	10.3	12.4	3.7	3.0	5.8	12.1	3.9	13.2	7.2	4.1	6.2	5.0	11.3	4.2	3.5	3.4	10.1	7.1	3.2	4.3	16.0	4.6	0.4	8.4	5.3	5.7	8.8	14.9	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	4.5	1.2	0.0	0.0	1.9	1.5	2.2	1.6	2.4	0.0	0.0	0.0	0.0	0.0	3.3	2.3	9.5	6.2	1.1	0.0	7.0	0.0	2.4	0.0	0.0	0.7	0.9	0.7	5.3	0.0	2.9	0.8	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.8	4.5	2.2	0.0	7.1	0.0	0.0	35.7	6.6	5.8	0.3	0.3	0.4	11.1	0.7	0.0	0.0	0.0	3.5	4.8	6.2	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	13.5	15.2	17.5	10.0	12.5	10.3	12.4	13.2	4.6	0.0	0.3	0.5	2.4	3.1	23.6	19.9	0.0	1.4	2.3	3.5	29.5	1.7	0.0	1.6	5.5	3.0	1.1	0.0	0.0	1.8	3.1	1.7	0.0	0.0	0.2	9.5	8.6	4.3	0.3	3.0	2.0	0.0	0.0	0.0	0.2	15.1	0.1	0.0	6.0	0.0	10.6	0.0	15.1	17.9	5.2	2.9	0.8	0.0	0.4	3.9
C1orf115	FLJ14146	ENSG00000162817	"Chromosome 1 open reading frame 115"	Q9H7X2	1	220689845-220699157	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;intestine: 32.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 168.2;Hepatocytes: 103.9;Syncytiotrophoblasts: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.6;HUVEC TERT2: 19.4;TIME: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.69e-3)"	"unprognostic (8.65e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.24e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.07e-1)"	12.4	1.6	16.2	3.2	27.0	0.0	8.9	3.1	32.9	3.9	8.1	2.1	2.4	30.6	3.1	5.8	2.9	3.8	4.6	4.7	9.6	2.9	14.4	27.6	6.2	1.7	2.5	17.8	4.9	3.9	8.5	6.2	19.0	5.7	8.6	6.2	3.3	20.2	2.8	3.3	2.6	32.1	3.2	1.1	12.7	5.5	2.8	3.7	1.0	5.5	1.1	2.2	2.1	2.3	3.6	0.2	0.0	0.6	0.0	0.9	0.3	0.6	2.8	0.1	4.0	0.0	0.0	11.5	0.8	3.1	1.6	7.3	2.8	2.9	0.0	1.2	0.2	3.4	0.1	6.6	1.3	1.5	0.0	6.6	0.1	0.6	23.6	3.8	0.0	0.1	0.5	2.2	0.1	0.8	0.0	19.4	0.0	1.7	0.0	0.1	2.5	0.0	0.1	4.8	7.8	2.0	0.0	0.0	0.2	3.5	3.7	2.1	2.9	0.0	4.8	11.6	7.3	7.9	0.1	36.2	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.8	0.0	0.3	1.9	0.9	0.2	0.2	3.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.2	27.0	3.1	32.9	9.6	2.9	2.5	17.8	5.7	3.7	3.0	7.0	9.9	3.4	3.1	11.4	12.2	10.2	1.4	5.7	29.6	5.9	57.1	33.2	10.0	1.1	33.7	168.2	0.0	14.6	51.0	2.4	13.3	0.0	103.9	5.6	0.0	8.1	11.1	4.7	1.9	2.8	1.1	8.5	7.2	22.1	5.6	13.2	46.0	18.0	52.2	3.9	0.0	3.1	0.3	3.9	1.5	153.8	0.5	13.3	2.1
MARC2	"FLJ20605, MOSC2"	ENSG00000117791	"Mitochondrial amidoxime reducing component 2"	Q969Z3	1	220748225-220784815	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.3;parathyroid gland: 63.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 81.6;Proximal tubular cells: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 14.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.4;T-47d: 21.9;TIME: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015085, HPA017572"	Enhanced					NA	NA					"HPA015085: AB_1848780, HPA017572: AB_1848778"	"unprognostic (8.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.40e-10)"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.23e-2)"	8.1	8.2	5.5	4.6	5.9	0.1	9.5	2.7	5.6	4.4	19.4	3.7	5.0	16.7	4.8	6.6	6.7	3.8	10.3	10.2	5.0	3.7	38.2	73.3	12.5	2.2	4.0	5.7	9.2	12.7	63.3	4.3	3.5	8.0	6.4	5.9	6.9	24.3	3.9	8.8	2.0	36.4	8.1	1.9	4.5	9.1	7.4	2.7	0.4	19.6	6.2	2.9	5.5	9.0	2.2	0.0	14.1	0.1	0.0	0.0	0.1	5.6	4.7	2.5	3.3	6.3	2.9	1.9	4.1	7.1	4.9	5.0	3.1	7.2	0.0	2.8	3.8	2.7	0.7	0.0	5.6	4.6	0.0	9.7	0.0	9.2	6.5	5.9	2.6	0.0	5.0	8.7	1.9	0.0	7.5	13.5	0.0	3.6	0.0	3.1	1.4	0.0	9.2	4.0	1.9	4.7	0.0	8.0	0.1	17.4	6.1	1.4	3.7	6.4	0.0	8.7	2.9	21.9	3.4	20.3	0.0	3.0	6.5	7.1	1.2	0.0	0.0	1.1	0.0	0.1	14.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	5.9	2.7	5.6	5.0	3.7	4.0	5.7	8.0	2.7	35.7	26.1	3.9	0.0	0.8	0.6	22.0	20.4	5.3	6.8	17.4	0.0	0.7	10.0	0.0	0.4	8.2	18.8	0.0	0.0	0.4	5.2	0.0	5.7	81.6	0.7	0.0	0.0	9.2	3.2	1.3	19.2	1.0	13.5	0.0	13.0	10.2	0.0	11.6	23.0	51.6	0.5	12.9	8.2	0.5	0.5	1.1	4.7	0.0	14.4	0.0
MARC1	"FLJ22390, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786759-220819657	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 71.3;breast: 81.3"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 94.8;Extravillous trophoblasts: 36.6;Syncytiotrophoblasts: 62.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5"	"Group enriched"	"Detected in many"	32	"granulocytes: 28.5;monocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.6;HeLa: 22.0;Hep G2: 25.3;NTERA-2: 21.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA028702	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	71.3	3.0	4.6	7.5	6.1	7.3	81.3	3.1	4.0	3.4	7.8	2.1	18.7	3.3	1.4	5.5	3.4	2.8	6.4	6.7	3.7	4.6	3.4	33.6	4.3	4.3	4.0	3.3	2.5	4.0	4.0	3.3	9.7	4.3	14.9	6.8	4.4	27.8	10.5	4.2	1.4	3.8	2.6	2.6	4.3	3.2	0.6	1.4	0.1	22.0	2.7	1.4	3.9	7.5	0.2	0.7	28.5	20.6	0.0	0.1	4.9	5.7	3.1	2.0	0.0	0.4	0.1	51.6	0.5	0.4	0.3	0.5	17.0	0.3	0.0	2.1	0.5	0.0	0.0	10.7	1.0	0.7	0.0	10.9	0.0	22.0	25.3	1.3	0.1	0.1	2.0	0.6	0.0	0.0	0.0	0.3	0.0	1.6	0.1	0.3	5.6	0.0	10.9	21.8	16.8	9.5	0.0	0.0	0.1	2.4	6.4	6.1	14.2	3.1	3.8	0.0	6.0	14.4	13.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.0	20.6	8.1	0.1	1.5	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	28.5	0.0	0.4	0.2	0.0	4.9	4.6	6.1	3.1	4.0	3.7	4.6	4.0	3.3	4.3	1.4	0.0	12.8	0.9	0.0	0.8	5.7	5.1	0.0	2.7	0.0	8.7	0.0	94.8	1.7	0.0	4.4	2.9	6.3	0.0	0.0	36.6	1.0	0.0	2.3	22.1	10.4	0.0	4.1	3.1	22.0	2.6	0.6	0.2	0.0	0.0	22.2	12.4	0.0	9.5	5.6	2.5	1.4	0.0	3.1	0.0	0.7	0.5	62.8	0.0	9.5	0.0
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879400-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 23.3;Hofbauer cells: 27.0;Ito cells: 38.6;monocytes: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 25.8;neutrophil: 28.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.5;THP-1: 47.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	27.7	3.0	2.7	8.8	3.0	54.0	18.4	0.9	2.3	5.7	24.3	2.0	3.8	4.5	7.4	3.6	8.7	5.0	7.5	15.2	3.3	0.9	4.0	11.5	14.3	10.5	6.2	0.3	4.9	4.9	1.8	2.0	14.0	2.5	6.9	2.4	4.2	2.3	3.8	10.4	5.7	11.1	4.2	6.4	10.9	3.1	3.9	3.1	1.4	6.3	3.0	3.2	10.4	12.9	2.2	5.5	28.5	6.3	0.2	0.1	1.8	0.0	1.9	0.0	1.4	4.3	6.9	3.6	5.2	8.6	6.0	5.0	0.4	0.1	0.0	0.1	3.2	1.1	0.0	1.1	0.0	2.5	1.3	3.8	0.0	2.2	0.2	7.6	1.7	0.4	8.0	0.2	6.7	0.4	0.5	2.6	0.0	2.2	0.0	0.8	0.0	0.0	6.2	0.2	0.0	3.6	0.1	4.1	0.0	0.6	0.0	0.0	2.0	0.7	0.1	13.5	0.3	0.0	47.4	0.8	4.0	0.0	0.6	4.1	0.0	0.0	0.0	6.5	5.4	1.6	25.8	6.3	10.7	0.0	1.8	0.0	2.2	0.0	0.0	5.5	1.1	0.0	0.0	28.5	0.2	0.3	3.5	0.1	1.8	2.7	3.0	0.9	2.3	3.3	0.9	6.2	0.3	2.5	3.1	8.9	7.7	1.5	0.1	2.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	11.7	0.0	23.3	0.3	0.6	4.6	0.1	3.5	6.7	27.0	0.0	0.0	38.6	17.7	0.0	2.3	17.3	0.0	67.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	6.5	9.5	0.1	1.0	2.8	0.3	0.0	0.0	0.1
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;HaCaT: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.1	2.6	0.2	0.2	19.2	9.9	0.2	4.1	10.8	6.9	5.3	0.1	1.7	4.8	1.4	10.7	5.0	42.3	0.9	4.0	6.0	12.3	0.5	8.2	1.2	0.7	4.5	3.6	5.6	13.8	2.9	7.4	7.5	3.2	0.2	1.2	0.8	1.7	6.5	0.1	0.7	2.8	0.6	1.3	0.3	0.4	11.7	0.3	2.3	3.7	15.8	1.2	0.5	0.5	17.5	2.5	0.9	2.1	1.5	3.5	0.9	5.3	5.1	2.9	2.0	2.6	5.4	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1	0.0	1.7	1.9	12.6	45.2	4.5	3.3	10.2	8.1	6.8	3.5	19.6	2.2	0.0	27.3	29.1	6.3	1.0	0.0	7.8	2.7	8.3	10.9	135.7	50.4	22.0	1.6	42.1	1.8	11.0	2.7	23.0	23.9	21.9	13.6	9.9	13.5	21.9	0.0	12.0	0.7	32.3	0.0	5.1	3.8	2.0	36.1	2.9	29.9	2.2	14.4
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"	No	NA			Mitochondria	Cytosol	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	16.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.3	0.0	18.4	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.0	9.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.5	0.0	0.0	0.0	0.0	0.0
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054334: AB_2682453"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"	7.3	6.9	5.5	8.6	8.2	4.8	6.4	7.6	8.1	7.3	4.7	8.2	5.0	4.8	8.0	6.1	5.9	6.4	5.5	5.6	4.3	6.7	4.2	6.3	5.5	11.5	7.3	3.8	13.7	5.3	5.3	16.9	8.4	8.0	6.6	5.2	6.4	5.5	5.6	2.8	4.1	6.1	6.5	8.9	8.3	6.5	11.7	8.0	6.4	10.0	3.3	10.2	7.4	7.0	10.5	7.1	2.7	3.3	4.0	6.7	2.4	8.4	4.6	12.4	4.3	4.3	3.8	11.0	5.7	4.4	6.9	8.5	4.8	9.3	7.7	11.2	2.0	5.5	8.5	8.2	3.5	9.8	5.0	6.2	4.6	3.7	4.6	4.9	11.1	2.1	2.0	3.8	7.7	9.8	3.3	2.8	5.4	14.0	3.5	9.4	3.1	12.9	7.8	25.0	9.7	13.2	8.0	24.8	7.4	2.9	4.5	7.0	14.8	8.7	5.1	6.0	6.6	2.9	5.6	3.7	7.0	7.0	12.3	14.1	4.3	3.9	10.0	6.2	7.1	9.2	1.5	2.1	2.7	4.6	3.3	6.7	7.3	4.1	4.2	2.0	10.5	4.9	6.0	0.4	4.0	3.2	7.1	3.4	2.4	5.5	8.2	7.6	8.1	4.3	6.7	7.3	3.8	8.0	8.0	0.0	0.6	2.2	5.2	7.6	9.1	1.4	2.5	1.4	1.2	3.5	5.9	6.6	1.7	2.7	1.2	1.5	1.2	0.0	0.6	5.7	6.8	3.7	1.1	2.1	3.9	6.4	1.2	1.8	4.5	0.4	5.2	2.8	0.0	1.8	1.8	3.1	1.1	1.9	2.1	1.3	7.3	6.5	3.1	7.7	10.2	2.5	4.9	3.2	2.8	7.8
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA family member 3, ER export factor"	Q5JRA6	1	222618086-222668012	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA055922, HPA056816"	Supported		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		750000	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	20.5	24.1	21.4	17.4	23.7	25.8	25.0	32.8	25.0	23.3	19.3	10.0	26.2	18.7	23.5	24.4	15.7	18.1	18.5	19.5	18.4	17.4	19.5	63.7	18.4	19.0	17.0	18.8	23.4	34.1	30.2	34.7	22.7	25.6	30.1	23.1	9.9	32.8	31.7	25.5	16.5	23.2	21.3	22.9	23.0	36.6	29.3	19.6	19.5	25.6	19.5	19.3	26.8	19.8	18.6	14.9	29.4	20.1	22.0	18.3	11.1	11.7	8.9	13.9	21.1	44.1	22.2	23.3	16.9	25.3	18.7	22.3	9.2	12.2	9.7	16.1	19.1	11.3	20.1	14.8	15.6	19.2	16.6	9.2	13.3	9.2	14.4	40.5	22.8	16.1	20.3	15.0	17.9	31.7	21.9	19.6	14.6	17.0	23.7	14.1	7.1	17.8	14.7	15.3	36.8	12.8	12.1	37.7	23.3	9.6	11.7	15.0	15.8	17.4	15.8	14.0	20.4	16.9	15.0	14.2	12.7	9.8	21.4	17.9	27.1	17.2	12.1	15.9	11.0	16.6	23.6	14.6	29.4	17.4	19.5	18.3	18.3	15.0	17.0	10.4	18.6	17.8	17.4	24.8	22.0	20.1	14.9	16.0	11.1	21.4	23.7	32.8	25.0	18.4	17.4	17.0	18.8	25.6	19.6	65.5	44.7	27.0	22.7	16.7	55.5	55.8	28.1	60.2	58.0	5.2	29.5	23.4	0.0	21.4	25.4	21.9	30.2	23.3	30.0	14.2	25.4	40.1	16.3	52.3	18.5	42.9	58.0	17.8	17.4	18.1	34.2	23.7	18.6	13.6	83.2	42.1	26.6	22.0	46.0	21.6	37.6	19.4	25.6	49.2	40.6	14.1	30.0	34.1	22.9	26.0
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	37.7	20.7	22.6	20.2	28.1	9.8	33.7	19.8	20.4	28.7	32.6	13.3	20.1	13.7	22.3	32.7	31.5	17.9	22.7	43.2	21.6	23.8	27.9	27.6	30.5	25.0	25.2	17.0	25.4	21.0	16.4	22.5	26.0	25.7	29.6	20.5	13.7	16.1	24.9	20.2	14.9	19.5	33.3	27.5	24.9	19.7	23.1	22.5	21.1	30.5	13.5	27.9	42.0	39.7	14.2	6.7	4.4	4.4	3.3	9.1	3.8	18.2	14.1	16.8	18.0	47.8	45.2	18.4	34.3	36.8	24.6	22.7	16.0	15.7	9.8	17.4	40.5	19.0	11.3	20.7	22.7	30.1	14.6	7.6	12.4	17.0	15.3	25.2	15.2	7.3	27.4	20.4	29.2	28.4	26.6	29.9	12.6	18.7	13.9	46.1	6.8	9.9	9.4	41.9	20.8	30.3	10.8	47.4	14.2	28.4	12.4	11.1	18.6	22.9	13.6	20.8	27.1	11.1	9.5	23.7	33.2	16.4	32.1	40.3	10.4	19.5	8.8	30.8	9.6	32.5	4.4	2.6	2.6	5.7	4.0	4.9	13.7	7.3	6.2	2.4	14.2	7.6	5.8	1.5	3.3	4.4	6.7	9.1	3.8	22.6	28.1	19.8	20.4	21.6	23.8	25.2	17.0	25.7	22.5	20.8	37.5	39.7	31.9	28.8	17.4	7.5	15.3	38.8	20.5	31.4	31.4	17.3	24.9	34.0	14.2	47.6	16.2	23.3	32.8	46.9	47.4	44.9	3.5	31.0	28.3	22.3	34.7	44.8	32.3	16.7	55.8	29.7	35.4	74.9	21.2	22.9	42.9	21.0	47.7	42.5	13.4	32.3	50.5	35.9	15.1	26.5	7.6	24.0	19.0	25.1
BROX	"C1orf58, FLJ32421"	ENSG00000162819	"BRO1 domain and CAAX motif containing"	Q5VW32	1	222712553-222735196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		190000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA031445: AB_10602697"	"unprognostic (1.27e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.50e-2)"	24.0	21.1	22.7	15.7	25.3	33.0	22.2	21.6	24.9	17.8	23.6	22.0	13.8	19.8	18.2	15.6	30.1	17.7	18.3	14.9	22.5	20.2	22.6	21.0	18.5	22.7	30.2	22.7	21.4	16.2	28.3	21.8	28.1	29.6	17.0	23.7	11.8	21.3	17.9	23.7	23.5	33.0	16.8	27.5	22.9	23.2	12.6	30.1	24.4	25.0	22.5	19.7	21.1	19.8	8.8	13.4	30.9	21.7	14.2	15.3	8.5	25.6	15.4	9.5	8.3	13.9	14.8	18.5	17.6	22.1	14.5	16.7	8.6	33.6	8.5	21.2	21.8	7.9	22.6	10.6	16.9	22.2	10.6	9.5	12.7	17.2	8.5	15.7	14.5	12.1	13.0	16.7	18.1	21.6	16.6	13.1	5.6	19.2	11.7	17.8	7.7	6.1	7.5	12.0	21.1	18.4	6.4	28.9	19.1	17.2	25.6	10.7	16.9	19.3	22.2	13.1	9.5	26.9	14.9	18.9	20.0	11.6	20.6	19.9	8.8	14.7	7.7	16.2	12.3	18.2	30.9	15.8	18.3	12.0	21.7	13.3	8.8	15.3	12.0	13.4	8.3	10.3	13.0	27.3	14.2	21.0	7.5	13.8	8.5	22.7	25.3	21.6	24.9	22.5	20.2	30.2	22.7	29.6	30.1	68.5	33.2	19.3	26.5	43.0	16.4	34.1	30.6	77.6	30.7	48.8	7.9	23.9	48.0	33.6	16.0	24.8	34.2	46.7	28.3	27.0	25.7	39.8	15.1	22.1	32.3	33.4	30.6	33.7	50.9	16.7	22.5	40.8	47.2	35.1	45.9	31.0	43.0	40.3	30.1	41.6	19.5	51.8	26.8	21.8	22.2	40.8	43.1	43.7	38.4	39.3
FAM177B	"FLJ43505, RP11-452F19.2"	ENSG00000197520	"Family with sequence similarity 177 member B"	A6PVY3	1	222737207-222750805	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 26.5;stomach 1: 34.2"	"Group enriched"	"Detected in some"	8	"B-cells: 12.3;Cardiomyocytes: 15.7;Cholangiocytes: 15.3;Early spermatids: 7.0;Late spermatids: 7.7;Mucus-secreting cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	21	"memory B-cell: 17.9;naive B-cell: 26.5"	"Lineage enriched"	"Detected in many"	25	"B-cells: 26.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;fHDF/TERT166: 1.2;HUVEC TERT2: 2.4;RPMI-8226: 2.4"					"Low region specificity"	"Detected in some"			HPA063059	Uncertain					NA	NA					"HPA063059: AB_2684933"	"unprognostic (8.19e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.57e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-6)"	"unprognostic (5.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.29e-2)"	0.6	1.1	1.1	6.4	5.5	0.0	0.5	0.4	2.3	0.4	4.6	0.2	2.0	3.3	0.5	0.1	0.8	0.4	12.6	0.4	1.8	0.7	0.6	0.5	1.6	10.3	1.8	0.0	0.4	0.6	0.2	1.3	2.0	2.0	0.8	6.5	0.6	8.3	0.3	0.4	0.4	14.2	0.6	4.9	5.6	34.2	1.2	1.5	0.3	0.5	1.4	14.6	1.0	0.6	26.5	1.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	1.6	0.2	1.2	0.0	0.7	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	1.0	1.1	0.0	0.0	2.4	0.5	1.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	26.5	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.6	1.1	5.5	0.4	2.3	1.8	0.7	1.8	0.0	2.0	1.5	0.0	0.0	12.3	0.6	0.3	0.0	15.7	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	1.3	0.0	0.3	0.0	0.5	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.3	7.7	0.0	0.0	0.0	0.0	27.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.4	0.4
DISP1	"DISPA, DKFZP434I0428, MGC13130, MGC16796"	ENSG00000154309	"Dispatched RND transporter family member 1"	Q96F81	1	222872271-223005995	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 12.7;Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051411	Uncertain		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA051411: AB_2681475"	"unprognostic (2.10e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-1)"	"prognostic favorable (5.00e-4)"	"unprognostic (4.13e-1)"	"prognostic favorable (3.86e-5)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (4.16e-4)"	"unprognostic (9.69e-3)"	8.3	7.7	2.7	3.8	8.5	0.1	3.9	2.5	2.9	3.8	10.3	4.2	6.7	3.3	5.9	11.5	6.9	3.1	24.0	4.9	3.3	3.1	7.9	8.1	33.3	1.5	2.6	2.1	6.5	3.2	6.9	3.9	6.9	6.6	14.2	2.9	9.2	2.5	4.0	4.7	4.2	4.8	18.8	2.1	4.9	6.9	28.1	2.7	0.7	7.5	5.1	2.5	12.3	3.3	3.1	1.4	0.1	1.2	2.5	4.4	1.1	0.6	2.2	5.8	3.8	11.5	7.9	2.6	3.9	2.7	1.6	2.3	2.6	1.8	0.3	4.3	1.7	2.7	0.5	1.7	1.0	1.8	7.2	2.8	1.0	8.4	1.2	5.2	0.8	0.9	5.3	3.4	2.7	1.4	7.0	2.4	1.4	0.1	0.1	3.8	1.3	1.1	1.1	3.5	7.3	1.3	1.8	15.9	0.2	8.7	1.0	1.5	2.6	1.7	0.9	2.1	3.0	3.4	1.9	2.2	2.3	1.6	4.1	4.2	1.1	0.6	0.4	3.7	0.7	5.3	0.0	0.7	0.1	2.6	1.2	4.4	3.1	1.5	2.9	1.4	2.4	2.0	1.3	0.0	2.5	0.9	0.7	0.7	1.1	2.7	8.5	2.5	2.9	3.3	3.1	2.6	2.1	6.6	2.7	6.0	1.7	0.9	0.5	0.5	2.8	3.3	12.7	4.0	4.5	10.4	0.0	1.2	0.0	1.6	1.7	1.4	1.7	0.0	2.3	1.5	4.9	0.5	0.0	3.4	4.8	0.0	0.0	8.0	1.0	3.1	1.4	3.5	0.0	1.0	1.7	1.2	1.3	1.7	3.2	4.6	2.0	0.0	1.4	1.9	1.5	1.0	0.7	1.3	1.1	0.1
TLR5	"FLJ10052, MGC126430, MGC126431, SLEB1, TIL3"	ENSG00000187554	"Toll like receptor 5"	O60602	1	223109406-223143282	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 17.8;Collecting duct cells: 21.0;Kupffer cells: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0"	"Cell line enhanced"	"Detected in some"		"A-431: 4.4;HaCaT: 6.7;OE19: 3.9;SK-BR-3: 4.3;T-47d: 4.8"	"Low region specificity"	"Detected in many"							CAB009013			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB009013: AB_2240732"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	3.8	2.4	5.3	4.8	7.3	0.4	9.7	0.8	5.3	7.1	2.7	3.4	1.7	1.7	2.4	6.2	9.0	5.6	4.8	5.8	5.0	2.6	4.6	2.2	6.5	12.5	7.0	0.8	22.5	5.3	6.6	6.3	3.5	6.8	6.2	2.3	3.2	12.6	2.9	1.4	3.7	2.3	3.7	12.8	6.7	4.5	2.3	8.1	1.2	4.3	3.5	5.7	5.9	7.8	0.1	12.8	13.4	17.0	0.2	1.4	5.7	4.4	0.4	0.7	0.4	0.3	0.0	0.6	0.2	0.0	0.1	0.1	0.0	1.3	0.0	0.9	0.4	0.1	6.7	0.1	0.5	0.4	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.1	1.9	0.5	0.2	1.7	0.9	0.0	0.0	0.6	1.0	0.3	2.5	3.9	0.0	0.1	0.0	0.2	2.1	0.8	1.8	0.4	1.3	4.3	0.1	1.0	4.8	0.0	0.0	0.1	0.1	0.0	1.2	0.2	0.0	0.2	0.0	0.7	0.5	0.0	17.0	0.2	0.1	15.7	0.2	0.1	0.9	0.2	12.8	0.0	1.4	0.4	13.4	0.2	6.3	0.2	0.6	5.7	5.3	7.3	0.8	5.3	5.0	2.6	7.0	0.8	6.8	8.1	3.0	10.5	0.0	5.9	0.5	0.0	1.7	17.8	8.1	15.9	21.0	2.0	1.2	3.3	3.0	3.3	1.0	0.0	0.0	3.4	0.3	5.0	3.3	2.3	0.6	15.6	0.0	1.2	0.6	23.7	4.0	8.6	11.1	3.3	0.0	0.3	1.1	2.0	0.0	8.1	0.0	0.1	0.0	1.4	4.3	4.5	1.4	0.7	0.0	1.2	6.5
SUSD4	FLJ10052	ENSG00000143502	"Sushi domain containing 4"	Q5VX71	1	223220819-223364202	"Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0;esophagus: 33.8"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 26.6;Horizontal cells: 20.6;Leydig cells: 19.0;Urothelial cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7"	"Lineage enriched"	"Detected in single"	66	"T-cells: 11.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.1;RPTEC TERT1: 8.4;SCLC-21H: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058296	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA058296: AB_2683672"	"unprognostic (2.90e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.82e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.51e-6)"	"unprognostic (3.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.11e-2)"	0.8	5.2	15.9	1.5	33.0	0.9	8.1	9.9	21.3	3.4	0.9	4.0	4.7	1.5	0.9	24.3	33.8	3.6	1.3	9.6	30.6	14.6	13.7	4.0	3.2	1.9	6.8	12.8	27.8	7.6	8.3	16.5	1.0	6.6	4.4	0.8	1.2	13.2	5.7	1.2	3.5	0.9	0.9	2.4	0.8	7.6	5.1	3.8	0.3	1.5	8.1	13.8	2.7	9.1	0.0	0.0	0.0	0.1	0.1	11.7	1.8	4.3	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.7	0.5	4.5	1.3	0.0	1.4	0.1	0.0	7.1	0.2	1.1	0.7	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	5.0	0.4	0.0	0.3	3.2	3.1	0.0	0.1	2.1	0.9	0.0	0.1	0.0	8.4	2.0	29.0	0.3	0.0	2.4	0.0	0.6	1.8	0.2	0.0	1.3	5.2	0.0	2.6	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.1	6.0	0.0	7.4	1.9	0.0	0.0	11.7	2.1	0.0	0.1	0.0	0.0	1.0	1.8	15.9	33.0	9.9	17.9	30.6	14.6	6.8	12.8	6.6	3.8	0.0	4.5	0.0	5.3	0.6	15.9	9.1	0.0	8.1	12.5	15.7	9.8	0.0	26.6	0.6	2.5	0.4	0.0	0.0	6.3	0.0	0.7	6.8	0.0	1.5	2.1	20.6	1.2	0.0	0.0	2.8	19.0	0.1	5.0	0.0	0.0	1.1	2.7	0.0	11.7	0.2	6.1	0.0	1.0	0.5	5.9	1.5	0.0	1.3	0.0	26.8
CCDC185	"C1orf65, FLJ35728"	ENSG00000178395	"Coiled-coil domain containing 185"	Q8N715	1	223393417-223395470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	150	"testis: 31.6"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 545.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.71e-1)"	"unprognostic (1.55e-2)"		"unprognostic (2.41e-6)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.12e-2)"		"unprognostic (1.53e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"		"unprognostic (1.37e-3)"		"unprognostic (3.13e-1)"	"unprognostic (2.61e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	545.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.0
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665734	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.0;stomach 1: 85.8"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"OE19: 51.0;RT4: 30.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA			"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.2	0.0	0.5	10.3	0.3	0.0	7.5	0.2	0.3	1.0	7.9	0.6	0.2	2.2	0.3	3.3	0.6	0.4	32.0	0.2	0.2	0.1	2.5	0.2	13.0	0.2	0.2	0.2	0.2	8.0	0.0	0.2	0.8	0.2	4.6	9.9	0.2	4.6	0.3	0.3	1.5	4.0	3.2	0.2	0.2	85.8	0.4	0.2	0.3	0.2	1.5	1.2	15.1	3.9	0.4	0.0	1.1	0.0	0.0	1.4	1.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.1	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	51.0	1.6	0.0	0.0	0.0	0.6	30.2	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.9	0.7	0.0	0.0	0.1	1.4	1.1	0.0	0.0	0.0	0.0	1.5	0.5	0.3	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	26.8	123.4	0.0	6.0	0.1	0.0	2.2	15.3	24.1	94.4	24.4	0.0	0.1	0.0	0.4	1.4	0.0	30.0	0.0	19.7	0.0	0.0	3.3	10.4	0.0	0.5	0.0	2.9	0.0	0.0	3.5	1.7	0.4	0.0	0.0	49.6	0.0	21.9	16.9	3.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	13.2	15.4
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 366.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		1500000	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	56.2	41.0	23.8	20.7	22.2	11.1	61.1	26.1	20.9	40.3	44.8	18.3	23.3	14.5	29.1	44.5	56.3	40.1	58.9	33.0	26.5	13.1	41.6	13.3	58.6	18.2	27.4	18.2	32.4	26.8	53.7	12.7	26.4	23.8	27.2	44.4	16.5	62.5	31.9	48.1	16.5	22.7	35.7	32.3	15.9	48.2	17.2	24.7	5.0	29.9	39.7	35.9	28.3	38.8	9.0	41.6	1.7	29.1	6.0	28.7	28.2	46.1	29.6	9.5	6.3	31.7	44.0	9.1	43.7	63.5	31.8	18.1	23.4	37.2	0.0	14.4	48.5	25.0	28.9	10.2	69.1	29.6	11.8	10.6	0.8	15.1	2.9	28.5	2.4	1.5	23.5	22.4	49.5	26.5	57.1	63.0	0.0	13.3	12.4	93.6	0.9	0.1	2.1	5.2	5.7	38.7	3.9	31.0	0.7	54.8	2.7	2.0	11.0	22.5	61.5	13.6	24.0	9.3	11.1	96.9	29.8	24.7	25.6	56.0	3.7	6.9	0.1	74.6	5.2	32.7	1.7	29.1	1.7	28.7	19.5	24.5	9.0	20.0	27.7	41.6	3.6	6.4	17.4	1.5	6.0	17.5	1.9	19.9	28.2	23.8	22.2	26.1	20.9	26.5	13.1	27.4	18.2	23.8	24.7	366.3	110.0	19.7	85.8	42.0	12.0	35.9	96.8	180.7	191.1	50.6	31.4	18.1	154.2	234.2	86.1	110.2	114.4	0.0	171.9	77.1	101.6	155.1	26.6	6.0	36.6	12.7	23.6	33.2	58.4	173.5	71.7	66.7	106.3	13.6	104.2	15.8	261.3	139.7	64.7	17.0	17.0	38.8	112.7	3.0	3.2	24.1	6.9	57.7	90.7	256.2
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779899-223845972	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: AB_2681124"	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	10.0	8.3	26.5	17.2	28.7	38.8	20.8	9.3	17.9	10.9	12.0	12.6	8.1	7.9	11.9	9.8	15.9	9.4	17.4	10.9	17.3	14.7	10.1	13.9	21.4	18.6	18.7	8.6	15.5	13.0	16.4	8.3	8.2	12.9	9.6	9.5	17.7	10.2	8.1	12.0	9.9	9.5	12.2	13.0	10.6	9.7	10.2	14.9	17.3	22.1	7.4	11.7	11.8	14.8	2.2	2.9	6.7	2.7	7.2	4.0	2.0	15.6	7.9	21.4	13.5	7.6	7.5	13.7	10.1	14.4	14.8	12.7	16.3	9.5	0.0	8.9	8.4	10.7	10.7	16.7	6.0	19.9	30.2	16.4	20.8	7.6	5.5	15.5	17.1	14.6	8.9	6.7	13.6	14.0	11.1	8.7	11.6	26.3	15.8	12.2	4.5	12.9	10.6	18.5	9.5	7.7	17.2	22.3	1.7	13.3	9.9	18.6	24.0	11.1	13.9	14.6	14.7	7.8	23.5	10.1	15.2	10.8	16.3	18.9	7.8	8.1	13.0	9.2	11.5	17.3	6.7	2.7	1.6	2.3	2.6	2.8	2.2	2.6	4.0	2.9	1.9	2.7	1.9	3.2	7.2	2.0	1.7	1.6	2.0	26.5	28.7	9.3	17.9	17.3	14.7	18.7	8.6	12.9	14.9	44.7	24.3	6.5	41.6	15.2	4.4	15.4	12.7	17.4	42.1	7.0	49.1	9.1	1.7	18.3	0.9	10.9	9.1	23.3	9.3	5.0	17.9	31.4	47.4	9.7	8.6	0.0	14.3	10.4	14.8	1.4	9.8	15.0	8.5	6.4	7.9	6.9	17.8	5.8	8.1	4.4	45.8	0.0	20.8	11.4	22.2	10.2	4.0	10.9	9.8	38.8
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114087-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003289			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	17.4	13.1	16.4	14.9	19.7	12.1	19.6	22.5	21.6	18.7	15.9	15.0	13.1	13.3	16.2	13.3	22.2	14.1	15.1	15.0	15.3	15.6	21.4	26.6	14.0	14.9	15.9	13.6	18.7	13.4	25.7	16.2	15.8	20.2	16.5	17.1	11.9	16.6	14.9	24.6	32.3	14.4	15.7	15.6	16.1	13.7	11.9	15.5	19.4	15.7	13.1	16.1	17.5	20.0	10.3	10.0	14.7	8.9	10.9	11.0	5.7	14.1	6.3	9.8	10.4	10.3	11.8	16.1	14.3	11.7	9.7	9.3	8.6	11.1	6.8	14.8	13.0	6.2	12.5	14.4	13.9	16.8	9.6	16.1	8.6	7.9	6.2	12.8	16.3	11.4	11.5	16.8	14.0	25.6	11.4	16.1	8.9	14.1	9.8	17.4	4.6	8.4	8.3	23.3	18.8	13.5	9.0	14.0	12.8	18.3	9.4	15.9	17.0	14.9	22.9	15.9	10.7	12.1	16.4	18.4	12.1	9.2	15.1	26.9	10.7	12.6	10.7	15.0	8.0	23.4	8.9	8.7	14.7	7.8	8.1	10.1	10.3	8.2	9.6	10.0	10.2	8.3	9.1	5.3	10.9	8.9	4.7	11.0	5.7	16.4	19.7	22.5	21.6	15.3	15.6	15.9	13.6	20.2	15.5	6.0	8.8	12.3	21.3	30.5	18.7	10.6	7.6	6.7	11.4	10.4	21.6	12.1	8.3	10.9	19.1	14.2	10.6	23.3	9.8	11.5	11.0	18.7	13.9	22.2	12.3	17.5	17.7	9.8	16.3	11.5	12.0	13.9	27.0	10.8	14.0	10.1	13.4	10.5	12.4	17.9	18.4	12.9	11.3	26.0	26.5	34.3	19.2	17.5	11.9	27.2
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 164.4"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	19.2	10.7	14.7	14.1	15.7	20.0	28.6	11.9	17.8	17.8	17.0	19.9	15.8	15.0	17.2	13.4	16.1	13.1	13.5	16.6	15.1	16.4	12.8	17.3	16.1	24.5	22.0	17.4	14.4	9.3	11.8	15.1	40.1	17.9	27.6	9.4	15.9	14.8	20.1	7.6	164.4	12.1	23.3	22.1	13.0	14.6	9.2	19.3	7.7	19.7	12.3	15.7	15.5	24.9	31.7	39.5	43.6	25.7	16.1	24.4	16.8	14.9	10.6	14.0	10.4	61.0	39.4	10.9	42.0	47.3	29.5	35.5	9.8	11.5	11.9	54.6	38.0	17.9	15.9	16.3	14.3	32.8	17.4	29.1	8.6	11.7	5.9	37.1	17.2	18.7	39.2	32.0	27.1	15.3	30.9	29.1	6.6	12.6	13.2	37.8	5.5	8.7	9.3	17.4	8.2	15.7	8.0	19.8	7.7	37.5	4.1	9.1	14.7	22.3	35.2	22.2	26.8	11.9	25.1	26.5	28.4	9.0	32.6	40.9	9.4	11.1	11.0	30.6	8.6	31.8	32.3	22.3	43.6	12.7	25.7	24.4	23.9	21.5	17.5	39.5	31.7	17.1	15.0	26.1	16.1	17.4	13.2	22.0	16.8	14.7	15.7	11.9	17.8	15.1	16.4	22.0	17.4	17.9	19.3	77.4	27.7	37.9	37.6	218.5	30.5	15.7	12.7	22.7	20.5	10.4	13.7	229.8	11.6	30.3	15.3	49.6	4.2	23.3	38.8	36.5	83.9	44.4	103.9	18.1	85.9	17.5	14.3	60.2	49.3	8.5	58.4	80.4	65.8	75.7	5.0	21.7	25.8	5.8	74.6	25.8	15.9	103.5	85.6	67.0	42.8	280.0	166.4	61.0	5.6	12.9
NVL	NVL2	ENSG00000143748	"Nuclear VCP-like"	O15381	1	224227334-224330387	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	11.3	12.6	13.3	14.3	12.6	12.5	16.2	24.4	15.7	14.2	13.8	16.9	11.4	9.0	17.1	12.2	11.6	13.5	8.5	9.8	10.4	9.9	13.6	9.4	11.8	16.9	10.5	10.8	16.9	19.3	16.8	20.7	25.8	13.4	14.2	16.0	16.5	11.6	12.6	9.8	22.7	12.5	17.5	13.3	16.4	11.1	9.4	12.0	23.8	15.5	8.5	19.1	14.4	13.7	14.0	9.9	12.5	15.2	12.3	13.5	7.9	14.6	8.3	17.4	13.9	6.5	9.4	17.5	12.5	8.7	16.5	15.2	12.7	12.6	20.4	13.5	7.9	6.6	13.9	18.9	11.7	18.0	15.9	26.1	9.8	14.2	6.5	11.2	19.3	15.6	7.6	9.3	14.7	16.6	7.9	10.8	12.4	25.6	12.6	10.8	11.4	14.9	9.6	26.8	11.0	14.9	18.8	21.7	13.1	10.0	10.3	15.4	13.5	18.9	28.9	17.1	15.5	13.8	17.6	10.4	13.2	8.6	15.3	23.1	8.3	18.1	21.7	8.4	15.7	13.7	12.5	8.2	8.2	13.1	13.0	13.0	14.0	13.5	9.6	9.9	10.1	11.3	11.5	0.8	12.3	15.2	9.6	9.5	7.9	13.3	12.6	24.4	15.7	10.4	9.9	10.5	10.8	13.4	12.0	20.8	23.9	8.8	3.8	4.6	13.9	8.8	5.1	21.4	13.6	1.8	9.8	16.6	11.6	8.1	5.6	6.0	8.6	0.0	7.2	11.3	8.7	4.4	15.1	2.9	9.1	9.5	4.1	5.5	5.7	2.2	8.9	6.6	5.0	5.4	11.5	9.4	6.7	17.5	10.3	5.6	21.0	0.0	8.3	14.6	12.6	4.0	15.3	7.5	14.5	3.8
CNIH4	HSPC163	ENSG00000143771	"Cornichon family AMPA receptor auxiliary protein 4"	Q9P003	1	224356850-224379459	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044268	Approved					NA	NA					"HPA044268: AB_10965330"	"unprognostic (2.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (4.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.96e-3)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.27e-6)"	"unprognostic (3.15e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.63e-2)"	19.8	21.1	13.6	12.9	16.3	26.7	42.3	13.9	21.1	15.6	21.2	13.6	12.7	18.5	19.8	14.6	23.9	16.0	13.7	35.4	12.8	13.5	22.4	20.2	29.3	36.3	17.1	11.3	17.2	19.1	12.9	16.2	20.6	19.3	14.5	17.9	18.6	15.2	18.7	22.9	19.2	22.4	27.6	15.3	16.8	17.2	15.7	13.0	8.6	17.7	18.5	12.7	18.0	20.1	8.1	17.3	23.1	47.0	9.7	17.4	18.5	24.9	34.7	17.2	15.3	31.2	20.2	14.0	17.3	16.5	18.3	17.0	35.5	30.8	7.7	28.7	17.6	19.9	31.0	30.8	19.5	19.6	9.1	32.7	6.5	23.1	18.1	26.8	12.6	13.0	20.4	26.4	22.7	30.3	18.6	24.3	13.7	15.1	10.2	21.6	19.3	5.5	11.8	22.7	33.8	20.5	6.0	31.4	8.4	30.5	29.1	4.3	14.7	26.5	29.8	20.9	22.6	22.5	30.0	23.3	17.2	14.9	21.3	35.0	4.5	5.7	7.8	21.1	17.7	18.0	15.2	21.1	23.1	13.2	34.2	12.5	8.1	17.4	14.9	17.3	7.5	14.0	15.4	16.2	9.7	47.0	5.8	11.5	18.5	13.6	16.3	13.9	21.1	12.8	13.5	17.1	11.3	19.3	13.0	116.1	62.1	29.8	106.2	59.1	18.3	111.8	56.0	61.6	76.2	50.6	27.5	126.7	24.9	126.4	12.2	66.8	112.0	93.5	108.9	152.0	90.0	85.1	31.2	66.4	98.6	19.1	15.0	63.3	131.7	9.4	60.9	75.2	55.6	36.9	30.0	44.6	118.2	84.2	61.2	82.7	24.4	84.1	70.7	140.1	52.1	75.9	134.8	42.6	64.1	124.0
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385143-224437033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	8.2	7.2	6.7	6.7	6.7	18.5	7.2	8.2	7.3	7.8	7.0	6.7	6.7	4.0	6.8	9.3	13.0	5.9	7.0	7.5	6.7	5.0	6.7	9.3	9.0	7.2	6.7	6.7	7.0	6.9	9.2	6.7	8.7	6.7	7.0	6.7	6.7	7.2	6.7	15.2	9.9	6.7	7.1	6.7	10.2	6.3	63.9	6.7	6.7	7.0	6.7	7.4	6.7	8.3	1.5	2.1	8.3	3.9	2.7	2.7	1.3	11.9	6.2	19.3	8.9	25.8	29.4	13.9	17.6	28.8	16.1	15.2	9.8	13.6	14.2	17.7	28.3	6.2	10.9	11.3	15.1	26.5	11.1	12.9	9.8	8.1	9.2	28.1	10.2	17.2	27.3	21.9	17.0	16.1	26.7	26.8	8.7	12.9	14.7	21.1	6.6	10.5	9.9	18.6	12.4	7.2	9.7	20.2	11.2	19.6	12.1	7.0	17.9	20.0	27.1	21.5	21.1	31.1	16.8	28.1	13.8	6.3	12.9	21.1	15.7	7.5	9.7	15.7	7.3	17.0	4.1	1.9	3.3	2.7	2.4	1.5	1.5	1.9	2.1	1.8	1.4	1.4	2.1	8.3	2.7	3.9	2.1	1.6	1.3	6.7	6.7	8.2	6.7	6.7	5.0	6.7	6.7	6.7	6.7	98.3	43.8	19.4	25.3	99.0	23.8	42.4	45.9	41.5	50.0	33.2	29.5	23.4	5.0	19.2	178.7	37.6	21.6	0.0	20.3	11.8	51.5	39.3	46.2	31.0	44.5	36.5	34.0	44.2	119.9	79.7	34.2	49.8	43.9	12.6	40.3	16.9	26.6	25.9	26.5	17.0	22.9	19.4	41.9	36.4	24.6	107.0	57.1	31.6	23.8	59.3
CNIH3	"CNIH-3, FLJ38993"	ENSG00000143786	"Cornichon family AMPA receptor auxiliary protein 3"	Q8TBE1	1	224434660-224740549	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 16.1;pancreas: 21.7"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 26.6;Early spermatids: 14.0;Late spermatids: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.8;hTEC/SVTERT24-B: 24.9;hTERT-RPE1: 14.1;NTERA-2: 9.2;U-266/70: 13.3;U-87 MG: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.03e-1)"	"unprognostic (3.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.63e-1)"	2.0	0.8	7.0	0.5	5.1	0.2	1.3	1.0	16.1	1.7	0.6	0.6	0.0	0.8	1.5	0.9	0.6	1.9	1.2	0.6	9.8	5.0	1.5	0.6	0.9	0.9	5.4	8.0	3.6	21.7	0.3	0.7	0.4	3.5	0.9	0.7	0.2	0.6	1.1	0.7	0.4	0.6	1.0	1.4	0.6	0.6	3.9	0.1	0.2	1.0	0.0	0.9	0.7	0.9	0.9	0.3	0.0	0.0	1.8	0.9	0.1	0.2	0.2	0.3	0.3	0.3	0.5	0.1	1.8	9.8	0.2	0.5	0.0	2.2	0.0	0.9	4.2	0.7	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.7	0.3	0.0	24.9	0.3	14.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	3.0	9.2	0.1	1.1	0.0	0.5	0.0	1.5	0.9	0.3	0.2	0.0	0.0	6.1	1.0	0.0	0.2	0.0	0.0	2.3	0.0	0.2	13.3	0.5	0.0	29.6	0.1	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.3	0.3	0.0	0.6	0.0	1.8	0.0	0.0	0.9	0.1	7.0	5.1	1.0	11.1	9.8	5.0	5.4	8.0	3.5	0.1	0.0	1.3	0.5	2.4	2.5	3.3	1.2	2.5	13.4	0.0	1.8	0.0	1.5	26.6	0.6	14.0	2.7	0.4	0.0	2.6	0.4	3.2	2.0	2.3	1.7	5.2	0.0	1.2	1.8	0.0	26.2	2.6	1.9	0.0	1.0	2.3	9.2	0.7	0.0	1.1	9.0	0.5	0.0	0.9	2.3	9.6	1.9	4.2	1.8	1.7	1.3
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 32.4;testis: 29.9"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 102.3;Spermatocytes: 58.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"K-562: 25.5"									"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome		NA	NA			Centrosome		"HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851"	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.6	5.2	6.3	2.7	2.5	2.5	5.2	0.9	3.4	3.1	2.9	0.2	3.8	1.7	3.3	6.5	2.0	2.6	5.3	3.7	7.0	5.5	4.2	6.8	5.4	0.6	2.9	4.6	5.5	11.2	3.4	32.4	2.6	7.2	4.3	3.7	3.6	3.4	7.8	0.6	1.0	1.1	4.6	8.5	1.0	3.8	29.9	0.8	3.2	7.1	0.9	0.4	2.5	1.9	0.6	0.2	0.4	0.2	3.5	0.9	0.0	10.4	5.4	4.9	5.4	2.0	4.1	11.8	2.2	2.0	4.0	3.5	8.4	11.5	0.0	5.4	2.2	0.0	0.1	7.6	2.1	6.8	0.0	12.6	5.0	3.6	1.8	2.4	10.3	1.7	3.9	4.6	5.5	3.9	4.3	1.3	7.3	25.5	0.0	6.8	2.8	1.8	10.8	13.9	11.8	6.6	0.0	18.8	9.5	3.7	4.8	8.3	9.4	8.4	6.3	16.9	8.6	11.6	9.0	0.2	0.0	8.0	0.2	0.1	11.6	7.2	0.1	0.0	0.0	7.5	0.0	0.1	0.3	0.1	0.2	0.0	0.6	0.3	0.7	0.2	0.3	0.4	0.5	0.4	3.5	0.1	0.0	0.9	0.0	6.3	2.5	0.9	3.4	7.0	5.5	2.9	4.6	7.2	0.8	11.9	11.5	0.0	10.9	1.8	29.3	4.4	10.2	5.3	4.5	19.2	31.4	8.6	6.6	11.0	102.3	2.9	1.1	0.0	8.7	10.5	3.0	8.7	13.9	7.6	3.0	27.0	7.9	2.5	0.0	31.3	2.6	1.6	3.3	1.0	4.3	11.2	8.0	0.0	3.2	6.4	3.4	6.5	0.9	58.5	19.2	0.6	9.6	0.0	4.1	6.8
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.7"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049840, HPA062236"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes			"Nuclear membrane"		"HPA049840: AB_2680908, HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	16.7	4.2	5.6	22.9	7.8	37.0	14.6	5.5	7.2	23.4	37.7	14.5	10.8	16.8	31.4	19.5	17.2	21.8	11.1	7.2	6.5	6.1	15.4	18.9	12.3	31.0	9.9	4.2	14.3	11.8	2.4	5.0	11.2	9.4	19.6	19.7	6.2	8.2	16.6	6.8	7.3	20.4	32.8	9.9	25.4	21.5	8.0	8.9	88.7	8.7	6.9	28.1	28.8	16.2	14.1	13.1	70.9	15.0	12.2	19.9	20.2	25.1	9.9	33.5	14.9	14.1	8.8	16.9	6.6	8.4	13.9	14.9	19.8	43.4	51.9	14.8	6.9	8.3	19.2	23.9	7.0	21.0	30.2	24.8	12.9	9.6	16.9	8.7	56.1	22.9	7.6	4.5	12.6	11.2	7.2	17.6	25.7	39.1	35.3	9.3	3.5	51.4	31.7	30.2	24.7	3.4	34.7	30.5	48.3	15.9	11.8	9.0	11.9	11.3	8.4	5.5	15.2	11.5	37.0	11.5	3.8	20.0	10.7	23.8	12.7	17.3	58.0	5.2	25.4	13.0	22.2	15.0	21.1	15.3	10.1	17.1	13.8	14.6	16.2	13.1	14.1	14.7	17.4	70.9	12.2	7.8	6.6	19.9	20.2	5.6	7.8	5.5	7.2	6.5	6.1	9.9	4.2	9.4	8.9	26.8	31.3	74.4	22.1	24.0	4.2	5.1	50.9	28.1	45.5	29.6	5.9	27.8	5.0	20.9	0.7	42.7	17.2	163.5	17.2	18.7	25.9	27.1	9.3	64.4	38.4	11.1	25.9	44.2	84.0	2.3	31.4	51.1	25.3	15.4	30.9	12.0	18.1	21.0	30.4	22.5	9.8	38.8	33.0	14.0	27.7	31.0	9.3	46.3	62.8	28.9
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH, actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 61.0"	"Low region specificity"	"Detected in all"							"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		18000	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	19.2	17.4	15.8	11.9	17.0	0.6	11.1	7.6	17.6	17.8	24.4	15.3	39.9	9.3	21.9	19.9	16.7	11.8	29.0	18.2	16.7	15.3	5.8	5.9	13.8	3.5	13.7	11.3	24.3	16.7	22.5	10.3	13.5	12.7	26.4	8.0	3.3	14.5	44.9	20.2	8.2	8.0	61.4	13.4	17.3	21.0	18.5	17.2	5.3	6.8	11.4	3.5	35.3	21.9	2.1	0.4	1.0	0.3	0.5	0.4	0.0	20.5	16.5	20.5	18.5	8.0	10.6	26.4	22.9	11.0	13.8	10.5	10.6	7.6	8.7	61.0	35.3	12.4	18.2	23.9	8.6	13.2	0.1	14.8	9.1	14.7	14.2	24.0	1.0	0.3	16.3	10.4	17.9	22.9	11.3	10.9	2.5	0.6	0.4	13.6	4.0	4.1	1.0	34.5	5.4	15.0	6.2	28.9	0.2	6.3	15.9	20.2	16.3	44.9	17.2	15.1	16.3	20.4	1.3	21.2	35.9	26.4	29.8	45.3	1.0	2.5	5.9	19.7	1.1	18.3	1.0	0.3	0.2	0.4	0.1	0.3	0.6	0.4	0.3	0.0	2.1	0.4	0.4	1.0	0.5	0.2	0.4	0.2	0.0	15.8	17.0	7.6	13.7	16.7	15.3	13.7	11.3	12.7	17.2	11.9	31.2	2.2	136.9	114.6	7.8	109.0	56.0	123.1	56.9	21.0	58.9	50.3	3.3	71.8	67.2	59.1	5.1	0.0	86.5	13.1	84.6	122.2	4.7	9.6	9.4	15.9	39.7	22.1	1.8	19.9	53.8	7.0	79.2	5.4	28.6	30.0	72.6	14.4	158.7	10.5	19.1	90.5	115.4	8.0	40.0	117.2	50.6	0.0	23.0	87.2
SRP9		ENSG00000143742	"Signal recognition particle 9"	P49458	1	225777813-225790466	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	39.3	60.1	77.2	30.7	61.8	34.8	54.8	48.8	63.2	39.6	47.8	49.4	28.7	37.3	39.2	52.4	41.8	38.8	38.1	43.2	62.4	72.0	61.6	78.2	31.8	40.7	75.4	48.3	45.2	32.4	39.8	60.4	32.7	59.9	45.6	48.4	39.7	43.5	34.7	56.7	30.1	42.4	39.1	69.8	36.0	34.5	25.4	38.2	48.3	56.3	40.1	43.0	37.7	27.5	69.1	74.1	76.4	71.4	73.5	93.2	109.8	68.3	40.7	106.5	54.6	43.0	53.7	44.3	47.0	50.5	50.4	59.0	46.4	50.6	64.4	63.4	55.3	49.0	43.9	66.7	55.0	73.4	55.0	93.5	51.3	55.6	57.1	37.6	92.7	45.6	40.0	51.3	45.9	60.5	55.5	78.1	68.4	95.5	46.3	83.3	28.4	86.6	67.5	33.6	123.6	63.9	71.0	99.8	74.5	80.1	62.9	94.0	80.9	54.6	62.0	64.6	58.0	75.6	89.4	52.5	46.5	41.6	61.3	88.3	28.5	74.0	62.6	53.8	64.0	91.5	57.2	67.7	76.4	61.2	71.4	77.0	69.1	76.5	69.7	74.1	59.7	92.6	78.4	38.3	73.5	59.8	54.3	93.2	109.8	77.2	61.8	48.8	63.2	62.4	72.0	75.4	48.3	59.9	38.2	98.3	74.2	161.8	151.2	233.5	67.7	141.3	201.2	155.2	86.4	165.7	29.5	187.5	507.3	221.8	17.5	168.0	120.0	70.0	163.8	213.5	196.0	238.7	82.0	175.1	183.7	60.4	230.3	104.3	130.8	20.0	173.4	138.5	300.3	186.7	182.8	336.7	161.4	174.6	199.8	387.4	81.5	129.4	220.5	242.9	139.9	253.7	166.5	176.9	194.1	220.1
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810092-225845563	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4;liver: 265.0"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 721.1;Leydig cells: 288.2"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 157.2;SiHa: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					NA	NA		83000			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	39.5	156.4	16.8	5.7	20.1	3.4	31.3	8.3	25.1	31.3	12.6	28.7	15.3	16.6	21.8	15.7	24.9	26.2	17.8	11.5	16.3	11.2	36.8	265.0	24.1	6.9	17.1	14.5	45.6	85.0	39.5	14.0	5.4	23.6	25.9	8.4	27.3	26.3	21.3	16.4	8.8	9.6	18.6	10.7	8.3	12.1	22.7	12.6	3.6	24.9	15.6	14.9	20.9	32.3	0.5	2.2	0.5	6.6	1.4	1.3	2.3	4.5	43.3	1.7	15.9	157.2	16.4	3.4	5.2	6.6	3.8	5.3	8.9	46.0	0.1	19.7	19.6	4.3	5.0	4.7	2.5	1.5	1.0	8.2	3.2	18.3	49.9	17.1	2.0	1.9	15.3	5.7	10.7	1.0	14.9	2.8	1.9	2.2	4.0	6.7	5.3	1.9	3.7	9.3	21.7	12.2	4.2	2.0	13.1	11.4	28.5	14.9	1.9	74.7	26.8	6.9	4.3	19.9	5.8	8.2	6.5	5.2	8.7	8.3	1.3	6.8	0.6	9.7	2.1	8.5	0.0	6.6	0.2	0.5	1.9	0.9	0.3	0.9	0.5	1.5	0.5	1.3	1.0	0.5	1.4	0.8	2.2	0.7	2.3	16.8	20.1	8.3	25.1	16.3	11.2	17.1	14.5	23.6	12.6	0.0	12.3	2.9	88.1	17.4	7.0	1.4	96.8	16.0	12.5	48.8	27.5	40.2	14.9	84.0	9.3	77.9	28.9	23.3	63.2	4.5	52.6	51.6	5.7	721.1	118.3	1.6	10.4	74.9	24.4	15.1	288.2	14.5	40.5	8.2	13.8	96.3	71.3	21.0	149.6	79.4	10.3	219.9	78.5	3.1	3.6	15.4	19.1	10.2	31.9	79.3
TMEM63A	KIAA0792	ENSG00000196187	"Transmembrane protein 63A"	O94886	1	225845536-225882369	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.4"	"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.5;SK-BR-3: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066504, HPA066936, HPA068918"			Enhanced	"Vesicles,Centriolar satellite"		NA	NA		96000	"Vesicles, Centriolar satellite"		"HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057"	"unprognostic (5.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.92e-2)"	10.5	7.4	14.7	11.6	38.8	18.6	12.2	4.1	23.2	14.3	14.0	91.4	17.3	12.2	12.2	11.2	6.6	13.9	12.9	8.5	30.2	15.1	14.3	15.1	12.6	15.4	59.3	16.4	13.1	22.4	11.6	5.3	11.3	34.9	22.3	17.8	5.7	55.8	19.1	6.9	9.9	13.3	8.8	71.0	14.0	22.9	3.0	49.6	11.2	8.0	4.5	12.4	13.3	9.6	5.4	10.0	5.5	4.1	8.7	16.6	5.7	9.2	2.8	2.4	7.0	19.4	6.7	16.8	7.1	7.7	7.9	8.0	10.1	6.9	2.6	13.1	8.6	4.7	14.3	2.6	4.3	3.7	8.6	4.6	11.3	6.5	6.0	4.5	4.2	29.7	7.0	2.7	4.7	2.8	11.0	5.1	5.9	9.3	2.2	6.2	5.8	3.7	4.2	13.2	29.7	4.6	3.7	7.5	37.5	12.1	24.6	0.2	1.3	5.2	41.7	5.1	5.9	9.6	4.0	6.1	4.6	3.2	4.2	6.4	0.9	3.4	0.6	4.2	2.3	8.4	5.5	3.2	3.0	9.4	2.7	10.6	5.2	12.1	8.9	2.5	5.4	10.9	6.3	5.1	8.7	4.1	10.0	16.6	5.7	14.7	38.8	4.1	23.0	30.2	15.1	59.3	16.4	34.9	49.6	6.0	8.6	16.0	22.4	3.0	0.8	3.6	28.1	14.7	11.4	19.2	2.0	32.4	1.7	29.4	9.1	4.6	17.3	0.0	22.5	4.5	7.8	60.8	17.3	16.0	15.3	0.0	18.5	11.1	9.1	8.0	17.0	10.3	3.3	5.4	32.5	18.8	18.4	20.1	12.4	11.1	1.3	25.8	8.2	0.6	4.9	3.6	18.8	17.0	46.1	29.3
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5"	"Cell type enriched"	"Detected in many"	4	"Undifferentiated cells: 330.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	35	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 34.0"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.2	0.0	0.6	4.5	1.1	0.0	0.2	1.2	0.9	0.6	26.6	0.2	1.5	0.0	0.7	19.0	0.4	0.1	0.2	0.2	0.6	0.7	3.6	0.2	0.3	0.2	0.2	0.2	2.0	46.5	0.0	0.3	0.3	0.2	0.6	15.1	0.3	0.5	1.6	0.2	0.0	0.8	0.4	0.2	0.2	0.4	2.1	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.0	0.0	12.1	0.0	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.0	3.6	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.6	1.1	1.2	0.9	0.6	0.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	14.5	1.5	0.0	6.7	0.0	27.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	2.1	1.4	0.0	0.0	0.0	45.3	0.8	0.5	73.7	1.8	4.8	1.3	0.0	0.3	1.6	1.5	0.0	0.0	0.0	330.1	1.3
AL117348.2		ENSG00000255835			1	225886696-225924278	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;HaCaT: 1.4;SCLC-21H: 1.2;U-266/70: 1.9"															NA	NA										"unprognostic (8.52e-4)"					"unprognostic (3.37e-1)"								6.4	4.4	4.2	4.7	5.6	3.4	3.5	6.0	7.8	4.1	3.6	8.3	4.8	3.4	4.8	3.4	3.4	4.1	4.7	4.0	4.6	5.5	4.2	7.0	4.2	5.8	5.2	6.0	6.9	5.6	3.4	4.4	3.9	5.7	3.6	3.4	3.7	5.6	3.4	6.3	3.4	3.4	3.9	5.2	4.1	4.1	3.4	4.5	7.0	3.8	3.4	3.6	5.0	3.0	0.0	0.0	0.0	0.1	0.0	0.4	4.5	0.4	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.6	0.0	0.2	0.0	1.0	0.0	0.0	1.4	0.3	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	1.9	0.8	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.5	4.2	5.6	6.0	7.8	4.6	5.5	5.2	6.0	5.7	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	21.4	37.2	25.7	24.0	28.2	29.5	17.2	14.3	38.2	21.8	17.4	40.0	25.8	16.1	25.3	20.0	17.7	33.2	24.6	38.0	27.9	28.3	23.4	35.0	22.0	30.3	34.0	30.8	34.5	29.0	26.6	29.8	22.2	29.5	22.4	13.7	21.5	26.3	32.1	36.0	15.3	16.7	22.3	38.4	25.9	20.1	17.6	24.7	35.0	19.2	20.0	23.5	24.6	16.2	19.3	25.9	16.4	12.7	28.3	36.1	18.1	16.9	14.0	8.6	14.4	9.7	10.1	18.1	17.9	11.2	12.2	10.9	18.3	14.1	29.8	38.5	13.1	9.6	19.6	12.3	14.1	7.0	35.8	25.6	28.5	14.6	18.3	15.1	25.0	46.8	9.7	17.8	13.8	15.9	10.9	11.6	25.0	41.1	20.0	12.3	13.9	31.4	28.4	47.9	26.7	19.5	28.2	19.2	61.8	15.8	13.5	10.8	14.0	14.9	11.9	37.4	7.2	15.3	47.9	9.7	9.6	11.5	20.3	24.6	32.0	35.1	29.5	15.1	19.1	26.5	15.1	8.7	16.4	21.1	12.7	22.2	15.9	20.6	19.5	13.6	19.3	36.1	29.2	6.0	28.3	10.8	25.9	18.6	18.1	25.7	28.2	14.3	38.2	27.9	28.3	34.0	30.8	29.5	24.7	17.9	21.4	27.4	51.9	13.2	13.0	38.6	15.3	60.2	17.0	33.2	13.7	79.6	41.4	44.2	5.9	22.9	13.5	46.7	30.3	34.9	22.5	33.6	38.1	16.3	35.3	12.7	25.4	19.0	20.8	5.6	35.4	21.2	32.1	65.9	14.1	38.4	25.0	13.9	35.3	24.0	36.1	25.8	18.9	33.6	40.3	11.2	34.9	45.7	13.6	34.4
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941489	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"endometrium 1: 61.1;ovary: 80.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 16.3;Late spermatids: 27.4;Leydig cells: 16.7;Peritubular cells: 11.3"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NTERA-2: 24.3;RPMI-8226: 26.2;SuSa: 15.6"									"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	0.5	0.4	0.1	0.3	0.2	0.0	0.5	0.1	0.2	15.2	0.5	0.7	0.1	0.0	61.1	4.5	0.2	1.1	0.1	0.8	0.4	0.0	0.4	0.1	0.7	0.1	0.2	0.1	80.0	0.1	0.0	8.5	16.3	0.6	0.9	0.0	0.9	0.1	4.4	0.2	0.0	0.2	14.7	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.3	0.5	0.5	0.0	0.9	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.3	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.3	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.7	0.8	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.3	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	27.4	16.7	0.0	1.7	0.0	0.1	0.3	0.0	0.0	11.3	0.0	0.1	0.0	1.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999331	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	25.6	11.2	10.7	13.3	12.8	33.6	21.6	10.8	11.5	12.3	10.6	17.9	9.0	11.0	15.1	11.5	14.3	12.8	13.4	12.2	10.8	11.0	11.9	17.9	16.2	13.9	14.1	9.8	16.2	14.2	15.6	13.9	14.5	12.5	12.9	11.6	11.1	12.0	11.2	20.9	18.0	12.9	12.7	13.5	14.4	11.5	14.1	14.4	33.9	15.8	11.0	14.1	15.6	16.9	8.2	7.8	17.9	7.2	12.5	11.2	6.3	8.5	6.2	10.1	10.7	7.1	7.9	12.6	9.1	8.7	12.5	9.6	9.0	9.8	12.5	14.3	7.7	4.9	11.0	12.6	7.9	15.3	9.5	10.3	13.8	5.3	8.2	13.0	13.5	16.8	8.7	11.5	13.3	16.9	7.1	8.6	15.1	25.1	15.2	9.2	2.5	18.8	10.8	14.0	13.2	6.6	15.9	13.0	16.2	7.5	6.0	9.1	15.1	10.4	11.4	17.1	8.5	11.2	16.7	8.4	10.7	7.6	13.8	19.9	9.1	6.5	15.5	11.0	8.4	21.1	16.3	6.0	5.5	8.2	6.2	11.2	8.2	8.3	7.9	6.7	7.1	8.6	8.0	17.9	12.5	7.2	7.8	6.4	6.3	10.7	12.8	10.8	11.5	10.8	11.0	14.1	9.8	12.5	14.4	26.8	23.5	17.7	14.0	38.7	5.2	7.3	2.5	13.4	25.0	8.7	0.0	7.6	13.3	5.8	47.5	16.2	11.3	23.3	6.1	8.4	15.4	11.4	34.6	17.9	9.7	14.3	16.7	12.9	16.1	12.7	9.2	13.9	18.6	5.4	10.7	11.4	8.2	10.7	6.0	9.0	7.7	6.5	17.3	15.1	13.9	51.7	11.9	15.0	9.8	16.6
H3F3A	"H3.3A, H3F3"	ENSG00000163041	"H3 histone family member 3A"	P84243	1	226061851-226072001	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 258.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 258.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011481, CAB037178, HPA042570"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (3.66e-2)"	"unprognostic (8.03e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.03e-2)"	39.0	43.4	37.2	83.4	33.4	126.8	67.9	45.0	42.8	44.6	54.0	31.6	62.9	47.9	43.4	60.6	66.3	42.4	49.6	59.4	36.1	31.2	45.9	59.2	73.2	217.9	37.8	23.2	44.4	79.7	30.8	34.8	59.1	29.2	38.4	59.4	42.7	49.0	49.7	37.0	47.1	50.0	42.0	48.6	71.9	41.4	87.6	31.7	148.9	38.5	71.0	84.1	43.5	47.6	39.2	44.6	258.7	56.9	23.6	34.9	60.5	53.9	30.8	120.2	67.8	33.4	38.9	90.3	25.6	31.1	41.6	32.9	32.1	90.0	51.9	56.9	31.4	20.7	51.8	59.4	46.6	40.9	32.1	102.6	64.2	45.6	42.9	33.1	65.9	78.0	35.6	54.0	29.1	38.3	56.4	61.5	67.9	90.4	88.9	47.3	31.2	136.8	122.6	163.0	137.1	61.1	92.6	87.8	133.8	86.0	57.7	117.4	174.5	73.0	92.4	63.2	71.8	104.7	154.7	34.6	30.3	42.3	40.9	74.1	39.6	50.7	90.7	28.9	63.0	64.7	40.0	56.9	80.8	23.1	44.9	23.6	39.2	25.0	24.9	44.6	36.0	23.7	25.7	258.7	23.6	50.8	36.6	34.9	60.5	37.2	33.4	45.0	42.8	36.1	31.2	37.8	23.2	29.2	31.7	485.3	628.9	1112.7	1421.3	1190.0	539.7	34.4	1036.9	1187.2	831.4	919.5	155.1	1193.7	1374.4	1195.9	1414.0	1038.4	1355.7	2359.5	1184.4	1689.1	947.0	1270.6	649.3	699.9	1338.0	554.6	1437.2	842.8	2198.6	1327.8	1016.5	1622.8	1010.6	1191.2	1707.9	908.2	1197.9	2104.2	985.0	1310.8	429.3	976.6	889.6	588.0	858.5	1210.5	1352.2	961.6	1983.9	1893.1
ACBD3	"GCP60, GOCAP1, GOLPH1, PAP7"	ENSG00000182827	"Acyl-CoA binding domain containing 3"	Q9H3P7	1	226144679-226186730	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015594	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA015594: AB_1844491"	"unprognostic (1.82e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.54e-3)"	38.0	19.7	17.6	21.4	21.3	22.3	27.9	23.0	20.5	30.1	22.7	19.1	25.4	17.2	25.8	28.5	39.8	23.0	23.9	23.8	19.2	18.8	26.3	30.6	25.3	19.1	20.6	18.4	31.6	27.5	31.1	35.4	45.0	25.9	25.9	25.9	14.2	31.2	30.8	29.0	28.9	21.0	23.4	20.0	22.4	30.8	19.2	23.4	21.8	29.3	26.2	28.5	34.7	31.8	8.4	2.5	3.2	3.0	1.7	2.9	1.1	18.7	12.8	10.9	6.7	33.9	30.4	21.2	23.7	24.8	14.2	18.3	16.5	23.5	20.1	21.8	30.5	12.9	14.8	15.4	15.5	20.0	8.3	18.0	9.7	13.4	15.0	21.8	15.6	12.1	22.4	20.8	17.6	23.3	20.3	16.2	9.8	18.0	14.3	22.8	9.5	11.5	12.2	16.2	31.5	16.9	10.7	24.0	20.2	13.3	17.1	12.5	18.0	21.1	23.6	22.4	16.1	24.2	18.0	20.3	14.3	10.1	34.4	22.3	27.3	28.3	25.2	17.0	10.5	23.4	3.2	2.4	2.3	1.8	3.0	2.9	8.4	2.4	1.7	1.8	7.9	2.8	2.5	2.6	1.7	2.6	2.5	2.9	1.1	17.6	21.3	23.0	20.5	19.2	18.8	20.6	18.4	25.9	23.4	62.5	37.4	38.7	53.4	46.1	34.6	31.5	28.1	24.1	42.1	33.2	53.0	37.1	13.3	22.4	13.7	43.8	30.3	0.0	30.2	54.9	48.0	53.5	23.2	44.0	33.3	25.4	41.8	25.2	23.7	2.9	37.7	29.9	47.2	4.6	46.9	46.0	32.3	28.8	30.8	24.7	35.1	32.3	41.2	50.4	45.1	68.0	52.2	20.3	28.1	83.3
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227054	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 23.9;lymphoid tissue: 8.9"	"Cell type enhanced"	"Detected in single"	17	"Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Group enriched"	"Detected in some"	5	"cerebellum: 5.1;cerebral cortex: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;Hep G2: 13.3;SuSa: 3.1;U-698: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA005662			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.6	0.2	0.6	8.9	0.4	0.3	0.3	5.1	1.8	0.7	1.4	0.4	0.0	2.7	0.4	0.1	0.6	0.3	0.2	0.4	0.6	0.6	0.3	0.6	0.5	8.2	0.6	0.0	1.2	0.2	2.3	0.3	0.3	0.6	1.0	1.1	0.2	4.9	0.4	0.2	0.3	1.3	0.0	0.5	7.8	1.4	2.2	0.0	1.0	0.4	0.7	7.0	2.6	0.3	7.5	7.7	23.9	12.2	14.6	9.5	4.0	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.1	2.7	0.0	0.2	0.0	0.1	0.2	0.2	13.3	0.7	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.2	1.9	0.0	0.1	0.1	0.0	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	3.1	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	23.9	4.7	8.4	4.8	7.1	9.5	7.5	5.6	5.4	4.8	7.2	7.4	7.3	12.9	14.6	12.2	7.7	7.1	4.0	0.6	0.4	5.1	1.8	0.6	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0
LIN9	TGS	ENSG00000183814	"Lin-9 DREAM MuvB core complex component"	Q5TKA1	1	226231149-226309869	"Predicted intracellular proteins"	"Cell cycle, DNA synthesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 34.4;Spermatogonia: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA030241	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030241: AB_10601542"	"unprognostic (9.90e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.51e-5)"	"unprognostic (2.80e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.26e-2)"	3.7	3.0	3.9	5.9	3.9	6.9	4.3	17.5	5.6	5.0	7.9	2.6	3.3	5.1	4.1	2.1	6.0	3.2	2.9	15.9	4.2	2.8	4.3	2.4	5.1	5.8	2.4	1.9	6.6	3.1	2.3	3.1	5.0	4.5	4.6	5.0	2.3	3.8	3.0	4.6	4.7	7.8	3.6	3.7	5.0	4.0	11.6	4.6	22.0	4.8	5.8	5.8	4.3	4.3	4.3	1.3	6.2	5.1	2.9	6.8	2.0	9.0	5.7	9.6	6.9	0.9	2.5	18.9	6.7	4.3	11.7	10.6	6.3	12.0	8.6	8.7	2.9	5.2	8.5	9.2	3.4	10.6	8.1	16.6	5.4	7.4	4.5	0.8	10.3	5.8	0.9	2.5	6.0	6.2	2.8	5.8	8.0	18.4	10.4	7.1	3.2	11.0	7.1	15.6	11.5	10.5	10.8	16.6	11.3	3.8	4.6	8.6	12.2	11.9	14.2	8.7	6.2	7.9	13.8	2.7	6.8	10.1	9.3	17.1	4.9	11.3	18.2	4.0	9.7	15.9	6.2	2.0	1.8	2.5	2.6	3.7	4.3	4.3	5.5	0.8	3.7	6.8	5.0	0.3	2.9	5.1	1.3	5.5	2.0	3.9	3.9	17.5	5.6	4.2	2.8	2.4	1.9	4.5	4.6	8.9	3.2	0.0	1.1	3.0	0.8	12.7	0.0	5.3	2.3	0.0	0.0	11.3	1.7	1.7	9.0	3.0	1.6	0.0	2.7	5.9	2.1	1.0	1.1	0.8	2.3	3.2	2.4	1.8	3.4	2.2	4.0	0.6	0.0	0.0	2.2	1.7	2.6	3.5	4.2	1.0	0.9	0.0	2.8	34.4	15.6	1.6	12.9	1.3	3.9	1.3
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
STUM	"C1orf95, DKFZp761P211"	ENSG00000203685	"Stum, mechanosensory transduction mediator homolog"	Q69YW2	1	226548800-226609214	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HEL: 25.6"	"Group enriched"	"Detected in many"	5	"amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4"	"Low region specificity"	"Detected in many"			HPA074381			Approved	Cytosol		NA	NA			Cytosol		"HPA074381: AB_2732253"	"unprognostic (3.23e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.14e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-3)"	2.8	2.2	30.4	2.1	16.2	0.6	3.5	2.4	32.2	3.7	8.1	6.3	0.0	2.8	3.7	3.0	8.9	3.1	1.6	2.5	21.8	7.0	5.8	0.7	1.2	0.9	6.8	15.9	2.7	1.0	1.9	4.2	1.2	18.2	6.2	3.7	1.4	2.0	2.4	5.0	3.7	3.5	8.7	3.0	1.8	1.8	2.0	7.4	0.0	0.8	0.4	1.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	4.2	0.3	25.6	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	0.2	0.0	3.9	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	16.2	2.4	30.0	21.8	7.0	6.8	15.9	18.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.1"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 35.8;Ito cells: 27.0;Smooth muscle cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	23.8	4.2	34.7	13.0	35.1	14.8	15.2	11.1	33.6	14.3	19.7	32.4	8.5	6.0	27.1	15.6	12.6	15.3	8.9	7.8	27.9	24.8	9.7	3.2	13.4	22.7	50.4	16.3	8.8	4.8	10.1	4.2	13.5	40.0	13.1	6.3	20.8	24.9	21.3	9.8	10.5	12.5	32.6	63.1	19.0	12.4	3.2	34.0	20.0	5.9	4.3	17.1	19.6	8.5	3.1	0.9	7.7	3.5	3.0	7.9	2.6	2.8	3.0	4.9	5.7	3.9	2.5	1.3	0.8	3.4	1.6	3.7	0.5	3.6	13.1	4.7	0.7	0.3	4.2	6.3	2.5	0.8	1.8	4.3	5.8	3.4	0.0	1.5	5.4	10.3	2.8	3.7	1.7	1.6	4.4	10.7	6.7	0.0	1.8	0.2	2.7	9.9	7.3	10.9	2.1	4.9	3.8	8.9	2.9	11.5	4.6	2.9	3.8	2.3	1.7	28.6	5.1	7.3	6.1	7.4	2.1	1.6	1.8	4.6	0.1	4.6	16.0	0.5	4.9	7.5	1.2	1.4	7.7	4.4	2.1	3.9	1.9	5.3	4.5	0.9	3.1	7.9	5.7	5.4	3.0	3.5	0.8	3.0	2.6	34.7	35.1	11.1	27.9	27.9	24.8	50.4	16.3	40.0	34.0	0.0	6.1	11.1	3.8	10.9	0.3	5.6	0.0	2.7	5.7	7.0	0.0	0.5	3.3	2.0	2.0	35.8	1.3	0.0	2.0	1.1	8.5	6.5	9.3	0.9	16.4	0.0	4.1	27.0	17.7	16.5	6.6	8.6	18.6	2.8	2.6	1.4	2.3	3.2	8.9	0.5	0.0	0.0	32.0	0.9	2.3	8.8	0.3	22.3	2.9	2.1
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226896105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013634, HPA038005"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013634: , HPA038005: "	"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	8.9	13.2	9.5	5.9	7.9	1.2	8.1	16.6	10.7	9.2	9.2	5.9	7.3	9.4	16.4	9.0	9.4	8.7	12.0	9.7	6.5	10.8	7.8	7.7	9.0	11.6	8.1	9.3	13.1	31.6	14.0	15.2	7.6	14.8	12.8	6.9	15.9	9.6	13.4	22.1	6.8	12.2	17.0	4.9	10.6	7.1	21.8	5.3	1.4	6.0	7.2	7.0	9.0	7.2	5.1	7.7	19.4	18.7	12.3	3.4	3.1	9.0	13.6	4.0	12.6	5.5	1.8	6.7	7.7	15.1	9.6	7.4	10.6	11.7	0.1	10.4	9.8	6.6	4.6	7.1	7.3	3.9	9.7	13.1	6.1	9.6	6.9	9.3	4.8	10.1	5.4	8.2	11.5	6.3	6.8	4.4	0.0	10.5	4.1	5.6	7.6	0.1	5.5	12.4	11.3	11.2	0.1	14.8	14.5	8.5	7.7	7.1	11.8	6.2	17.1	30.5	11.8	14.7	6.1	4.8	6.8	5.8	6.2	9.6	16.6	24.4	0.4	12.2	1.5	9.0	19.4	5.7	12.1	3.2	6.5	3.4	5.1	1.1	2.9	7.7	2.6	0.6	1.7	1.2	12.3	18.7	0.6	1.4	3.1	9.5	7.9	16.6	10.7	6.5	10.8	8.1	9.3	14.8	5.3	14.9	13.3	3.0	4.2	1.4	6.0	7.5	12.7	2.7	3.4	5.2	0.0	12.2	1.7	11.0	1.9	7.7	6.7	0.0	15.7	4.3	7.6	4.8	13.9	6.8	16.3	15.9	5.8	23.4	5.3	0.9	6.6	8.3	32.1	30.7	4.3	20.0	11.9	5.8	12.4	6.0	5.4	6.5	4.7	0.7	4.5	1.6	38.3	2.5	4.1	3.9
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 216.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 18.7;Collecting duct cells: 31.4;Exocrine glandular cells: 28.2;monocytes: 19.8;Proximal tubular cells: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 32.8;RPMI-8226: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria		NA	NA			Mitochondria		"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5.0	6.1	41.0	2.7	1.8	3.8	17.7	2.7	4.1	5.0	2.4	7.2	20.3	1.6	1.6	2.0	3.8	6.5	2.0	1.9	7.2	5.0	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3.0	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.1	5.8	1.5	4.4	4.7	3.0	23.4	1.5	1.3	2.1	2.8	9.1	5.1	9.4	7.2	1.0	1.2	3.7	2.9	3.3	0.5	9.9	32.8	6.6	4.8	15.0	1.0	9.9	4.0	5.9	5.0	1.7	2.3	2.1	1.0	9.7	11.3	7.8	0.3	4.3	5.7	14.6	6.4	24.3	11.9	5.7	7.0	29.9	0.7	2.4	24.1	9.9	2.9	11.7	8.5	1.7	6.2	13.5	1.2	2.5	2.3	3.4	5.4	17.5	15.3	4.9	2.3	11.3	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9.0	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5.0	2.4	3.8	4.7	3.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	7.9	31.4	0.0	10.4	13.3	14.2	0.0	0.0	0.0	0.0	28.2	7.8	0.0	0.0	12.8	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	19.8	0.0	0.0	14.5	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Horizontal cells: 211.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	17.2	15.2	19.1	8.6	21.1	3.9	14.0	29.2	20.4	21.1	19.3	16.4	13.1	16.9	15.8	9.9	12.3	12.9	16.6	14.1	21.7	17.7	20.8	17.0	11.7	3.5	20.0	16.3	17.4	15.1	29.3	29.6	14.8	19.3	21.1	12.4	11.0	8.4	18.5	11.9	7.6	17.2	27.6	16.6	8.8	25.2	26.7	19.9	0.7	9.8	7.3	2.5	23.4	23.1	0.1	0.7	2.0	0.1	0.0	0.1	0.0	9.5	9.0	9.7	4.5	9.7	12.0	3.4	11.0	15.6	7.6	8.0	7.3	21.8	0.0	11.8	18.2	5.7	4.4	7.1	6.1	9.3	0.0	5.7	7.4	10.8	2.8	11.0	5.9	3.3	8.4	7.9	12.3	12.4	9.5	25.3	5.9	18.7	0.0	12.3	2.6	0.1	1.0	7.9	12.4	8.7	0.0	16.3	0.0	12.2	18.5	7.0	10.2	18.6	7.8	10.9	6.2	10.1	0.3	25.5	13.9	7.3	15.9	14.5	0.0	0.0	0.0	18.5	0.0	18.6	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	19.1	21.1	29.2	20.4	21.7	17.7	20.0	16.3	19.3	19.9	38.7	29.4	1.4	19.9	10.4	96.7	50.6	25.5	21.4	35.2	41.8	111.9	5.2	11.6	22.3	90.9	47.3	45.2	23.3	35.4	6.1	27.8	25.0	6.9	24.5	3.2	211.4	25.3	42.4	7.1	98.3	40.9	6.8	15.1	9.0	24.1	34.1	46.5	54.5	80.2	32.9	64.0	77.6	45.3	40.8	51.3	6.9	1.1	1.3	26.4	26.8
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"	Nucleoli	"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	9.0	7.6	8.2	6.6	16.2	7.1	8.8	19.4	10.8	9.3	7.2	6.7	7.1	5.4	9.2	6.2	6.1	7.7	7.4	7.4	8.9	6.3	6.4	5.3	7.8	9.8	12.7	8.2	9.9	12.6	7.2	19.4	9.7	8.9	10.6	10.8	4.6	7.6	6.3	6.2	5.2	6.6	7.5	14.2	9.5	7.6	8.7	15.5	12.0	12.7	5.1	9.1	8.2	9.4	6.6	3.2	7.1	1.1	2.2	3.2	1.5	2.0	3.2	11.9	13.5	1.5	3.4	7.2	2.7	2.7	4.1	4.4	2.6	2.6	8.3	7.2	1.2	2.2	4.0	7.0	1.8	6.8	3.5	13.4	3.9	2.5	1.6	2.7	6.6	10.6	3.0	3.4	2.5	5.3	3.1	3.9	9.3	9.9	13.1	4.5	1.7	9.1	2.3	10.4	3.0	5.4	7.1	7.7	3.2	3.0	6.5	5.1	9.9	4.1	4.9	2.0	6.1	6.8	8.4	2.5	5.1	4.9	4.6	5.6	4.2	9.6	9.1	2.1	1.2	5.3	7.1	1.1	1.3	2.5	0.3	3.0	6.6	2.5	1.4	2.1	4.5	2.2	3.2	0.2	2.2	0.7	3.2	2.7	1.5	8.2	16.2	19.4	10.8	8.9	6.3	12.7	8.2	8.9	15.5	3.0	5.3	4.7	3.6	2.1	11.6	3.6	5.1	5.3	4.5	3.5	3.9	1.8	1.7	3.3	0.6	4.7	1.5	0.0	4.4	2.1	3.4	5.6	3.5	1.6	1.4	1.6	9.2	3.7	3.7	0.2	6.9	2.2	0.0	1.8	3.9	4.2	2.9	4.5	2.5	1.1	6.7	0.0	2.1	7.2	10.0	0.5	1.1	7.5	2.6	3.4
SNAP47	"C1orf142, SNAP-47, SVAP1"	ENSG00000143740	"Synaptosome associated protein 47"	Q5SQN1	1	227728539-227781231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028167	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA028167: AB_10603032"	"unprognostic (3.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-1)"	7.4	23.8	21.2	10.8	27.8	6.7	16.2	21.2	29.0	12.4	10.0	10.7	6.9	8.3	21.3	13.4	10.8	15.7	9.8	30.7	21.0	15.1	11.9	14.7	10.0	13.5	12.9	17.4	29.5	17.1	20.7	15.8	16.2	11.6	11.3	8.5	12.6	14.8	10.4	20.4	11.2	8.0	16.6	8.4	9.0	9.2	25.5	11.4	11.6	15.6	9.2	11.9	11.5	9.9	15.4	14.7	20.2	15.1	18.2	29.8	14.7	17.3	24.1	15.2	14.5	18.7	14.7	19.5	11.3	18.1	18.5	15.5	15.9	16.1	12.5	20.7	18.2	14.9	19.1	19.3	21.4	15.9	24.5	34.2	10.7	17.0	10.8	11.5	15.5	9.8	16.8	17.8	24.0	12.9	16.3	15.5	15.1	19.4	12.9	19.1	11.4	15.6	14.8	24.2	22.9	35.0	17.6	17.1	19.3	13.4	15.9	30.2	17.8	17.4	24.6	17.0	16.6	29.8	15.0	11.6	17.6	21.2	16.9	27.5	16.3	11.8	15.2	16.0	12.1	22.4	10.1	13.0	20.2	19.2	12.4	18.4	15.4	21.8	22.0	14.3	13.9	18.6	17.0	4.7	18.2	15.1	14.7	29.8	14.7	21.2	27.8	21.2	29.0	21.0	15.1	12.9	17.4	11.6	11.4	6.0	12.5	22.7	14.5	11.8	28.6	10.1	12.7	9.4	11.4	14.0	25.5	21.8	29.9	17.7	39.1	9.0	8.9	0.0	15.7	23.8	13.7	11.9	5.7	11.6	14.4	39.7	15.5	9.2	6.7	71.2	23.9	6.4	11.8	23.4	7.5	28.1	14.4	0.0	19.4	14.6	31.0	12.9	10.3	24.5	23.0	13.4	23.0	22.0	9.5	8.4
JMJD4	FLJ12517	ENSG00000081692	"Jumonji domain containing 4"	Q9H9V9	1	227730425-227735411	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 59.1;Late spermatids: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027260, HPA052861"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA027260: AB_10602608, HPA052861: AB_2681975"	"unprognostic (1.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.68e-3)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.68e-1)"	10.1	17.5	9.6	8.3	8.3	5.9	13.1	10.1	17.1	10.1	12.0	9.7	13.1	7.9	11.7	12.8	10.0	13.5	11.7	11.7	10.0	9.6	8.7	19.8	7.9	25.0	9.7	10.0	14.9	17.5	9.5	14.4	12.0	6.3	12.2	4.6	11.8	18.2	11.6	14.9	9.8	8.7	8.3	7.2	13.7	8.6	20.1	3.2	21.5	9.7	11.1	14.4	8.5	6.8	8.5	11.6	2.9	6.4	13.2	12.7	7.0	10.7	16.0	5.2	5.7	5.7	3.2	19.2	6.8	7.2	10.6	6.6	13.6	9.3	14.5	10.4	6.5	5.7	11.0	3.6	10.9	1.2	7.7	17.2	8.9	7.9	10.5	10.1	9.3	4.4	5.7	6.9	10.1	7.5	4.2	5.4	10.7	11.5	4.9	5.1	9.2	11.4	4.9	9.0	8.3	25.2	10.6	6.4	13.0	6.2	10.2	10.3	6.9	6.5	23.2	8.7	2.8	18.7	10.1	4.7	5.4	5.5	6.5	12.5	9.0	2.8	5.6	5.4	4.5	14.8	2.9	6.4	2.3	10.2	6.4	11.7	8.3	7.9	7.2	5.8	8.5	12.7	11.0	0.6	13.2	3.4	11.6	8.8	7.0	9.6	8.3	10.1	17.1	10.0	9.6	9.7	10.0	6.3	3.2	6.0	7.4	8.1	5.9	3.7	12.2	3.1	5.1	6.7	4.5	7.0	0.0	10.9	5.0	17.7	59.1	4.2	9.7	46.7	25.0	11.7	6.9	8.8	6.9	13.4	14.4	11.1	8.6	5.5	7.9	160.3	10.6	4.3	11.8	14.4	5.8	11.7	19.1	5.5	3.9	9.2	13.7	6.5	4.2	20.2	7.4	4.1	8.0	8.7	6.4	6.7
PRSS38	MPN2	ENSG00000185888	"Serine protease 38"	A1L453	1	227815693-227846470	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"blood: 2.2;testis: 8.4"	"Group enriched"	"Detected in some"	10	"Spermatocytes: 9.6;Spermatogonia: 8.5"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	18	"gdT-cell: 1.4;NK-cell: 2.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 2.2;T-cells: 1.4"	"Cell line enriched"	"Detected in single"	20	"U-266/84: 5.2"	"Not detected"	"Not detected"							"HPA028003, HPA055809"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA028003: AB_1853572, HPA055809: AB_2682931"										"unprognostic (9.54e-3)"					"unprognostic (3.61e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	8.5	0.0	0.0	0.0	0.0	0.0
WNT9A	WNT14	ENSG00000143816	"Wnt family member 9A"	O14904	1	227918656-227947898	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 9.4;Club cells: 5.7;Leydig cells: 4.0;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.1;PC-3: 8.8;RH-30: 13.5;SCLC-21H: 12.3;SiHa: 11.9;U-2197: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.27e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.93e-2)"	2.4	1.4	1.0	13.1	0.5	0.2	2.6	1.4	1.0	4.0	14.1	2.6	2.2	1.9	6.3	4.7	9.5	5.4	15.3	14.6	0.7	0.9	0.8	0.4	9.2	2.1	0.8	0.1	8.9	7.5	0.8	4.3	4.3	3.1	4.7	1.6	4.9	4.9	4.2	20.2	1.0	6.8	8.3	0.6	1.2	5.7	1.8	1.0	0.6	1.8	10.6	4.0	7.1	3.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.7	2.6	0.3	0.1	0.3	0.6	6.7	0.9	0.8	0.1	0.0	0.0	7.1	0.0	3.9	1.2	2.7	13.1	0.3	0.6	0.0	1.3	0.5	0.0	4.4	0.2	0.3	0.0	0.4	0.1	3.3	0.1	0.1	0.2	0.8	0.0	0.0	0.1	1.5	1.7	0.0	0.0	0.8	0.0	8.8	0.2	13.5	1.3	3.7	0.8	12.3	0.0	11.9	5.4	0.0	4.5	6.8	1.4	0.5	1.8	1.1	8.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.5	1.4	0.7	0.7	0.9	0.8	0.1	3.1	1.0	3.0	1.1	0.0	1.1	0.8	0.0	1.1	0.0	9.4	5.7	1.8	0.0	0.1	0.0	0.4	0.1	0.4	0.0	0.0	1.2	0.1	1.8	1.3	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	1.6	0.0	4.2	0.0	0.0	0.0	0.4	0.0	2.3	0.3	0.0	0.0	0.0	3.3
WNT3A		ENSG00000154342	"Wnt family member 3A"	P56704	1	228007051-228061260	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"lung: 7.4;placenta: 19.9"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 11.9;Basal glandular cells: 2.4;Basal keratinocytes: 3.1;Syncytiotrophoblasts: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HEK 293: 2.8;U-2 OS: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA066281: AB_2685647"	"unprognostic (9.84e-3)"	"prognostic favorable (6.11e-5)"	"unprognostic (2.40e-1)"	"unprognostic (3.37e-1)"		"unprognostic (7.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.54e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	7.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	19.9	0.1	2.4	0.0	0.1	1.7	0.1	0.1	3.0	0.1	0.1	0.6	0.1	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	11.9	0.0	0.0	2.4	3.1	0.0	1.4	0.0	0.0	1.2	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	2.4	0.0	0.0	0.5
ARF1		ENSG00000143761	"ADP ribosylation factor 1"	P84077	1	228082660-228099212	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB007742	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB007742: AB_562043"	"unprognostic (9.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.73e-1)"	"unprognostic (8.95e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.94e-1)"	72.0	70.1	64.8	51.0	82.5	111.1	59.3	50.0	116.9	76.0	76.7	53.5	63.6	73.6	71.1	63.3	81.1	66.8	58.5	101.1	70.3	65.9	81.7	135.9	77.4	55.6	52.7	56.5	73.5	109.2	64.9	79.7	129.6	61.4	70.1	55.7	67.8	106.7	68.6	96.5	57.5	91.6	54.7	45.9	81.5	66.0	73.0	33.8	75.6	102.9	60.5	76.5	72.6	57.6	37.4	73.3	111.7	70.0	41.5	64.7	110.7	64.1	44.4	36.5	36.2	42.2	53.4	60.7	56.9	61.0	63.3	55.6	52.5	61.8	32.7	61.2	60.6	29.5	41.6	44.7	55.7	31.8	48.1	71.3	31.8	31.3	52.2	81.7	45.9	47.5	51.0	68.0	58.3	61.5	54.0	62.4	37.4	60.9	75.1	60.9	46.2	46.6	68.0	46.8	90.7	90.9	37.8	32.3	101.9	44.7	33.3	51.6	45.6	36.7	111.5	63.4	13.2	76.6	93.4	55.8	46.6	37.0	67.7	85.3	71.0	39.6	44.9	64.1	39.2	93.9	104.5	70.0	77.2	53.1	66.5	64.7	37.4	45.7	49.1	54.5	34.9	36.2	39.4	111.7	41.5	63.0	73.3	51.8	110.7	64.8	82.5	50.0	116.9	70.3	65.9	52.7	56.5	61.4	33.8	160.8	159.4	184.0	242.8	233.2	114.0	114.2	104.4	214.2	168.4	109.9	43.2	328.6	195.6	344.6	194.6	176.5	349.6	46.7	355.5	480.3	217.0	287.7	192.9	110.7	362.5	149.4	220.8	138.7	177.0	322.5	212.3	230.8	285.1	408.4	315.0	144.2	328.8	293.4	213.6	122.7	61.1	226.4	208.9	174.2	166.0	249.9	565.9	208.8	250.8	292.8
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	10.1	12.7	14.3	15.6	17.0	12.7	12.0	23.9	15.7	12.5	11.2	11.6	16.1	12.5	13.7	10.6	17.3	14.9	8.1	8.0	13.8	10.0	10.6	10.2	11.0	12.5	17.7	13.6	19.0	21.0	12.5	10.0	12.4	15.0	13.2	6.4	10.4	19.1	16.1	14.0	24.1	11.3	13.3	9.2	12.6	13.2	8.8	13.2	14.6	12.4	6.9	12.0	12.8	13.9	20.2	26.7	21.9	18.4	17.6	21.5	10.3	9.6	10.7	6.9	4.1	3.7	3.8	16.1	7.4	3.4	6.6	4.9	9.7	9.2	9.4	16.2	2.6	4.6	10.8	6.5	7.2	2.5	10.7	34.4	5.8	7.5	9.5	6.3	13.0	7.4	3.4	8.6	6.3	6.1	3.9	7.3	10.9	14.8	5.2	4.9	11.3	17.3	16.7	13.5	12.2	25.0	12.3	10.9	15.6	5.8	7.2	12.1	11.4	7.0	11.2	9.6	2.1	13.3	12.3	6.3	5.3	7.7	13.8	15.7	9.7	5.0	8.7	6.4	7.7	8.2	6.3	16.3	21.9	16.2	18.4	20.9	20.2	18.1	17.7	20.4	16.7	21.5	18.1	2.2	17.6	17.5	26.7	18.0	10.3	14.3	17.0	23.9	15.7	13.8	10.0	17.7	13.6	15.0	13.2	20.8	19.0	30.7	27.5	59.3	48.2	15.4	12.7	17.4	11.4	36.6	17.7	65.7	38.1	35.0	3.0	27.0	34.4	23.3	34.3	47.2	35.1	28.5	24.3	19.5	36.1	44.5	25.2	28.3	24.7	2.6	47.5	35.5	30.4	27.1	35.6	37.2	33.3	33.4	43.9	30.1	49.8	64.7	30.0	35.6	47.1	70.4	23.7	36.7	41.6	21.3
MRPL55		ENSG00000162910	"Mitochondrial ribosomal protein L55"	Q7Z7F7	1	228106679-228109312	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027641	Supported				"Intracellular and membrane"	NA	NA					"HPA027641: AB_10600825"	"unprognostic (4.84e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.03e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.15e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (5.54e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	20.1	27.1	31.9	13.5	30.9	39.7	18.7	20.7	37.4	16.1	19.9	16.8	24.2	22.7	17.6	27.4	15.8	17.1	21.3	32.8	27.3	26.5	20.1	31.4	14.4	18.1	27.8	23.0	15.1	27.9	13.8	20.6	13.6	20.5	19.4	8.0	17.7	40.8	25.0	42.2	18.5	23.7	17.3	20.6	16.7	18.2	21.3	14.8	13.6	21.2	18.2	16.0	17.6	12.3	52.6	57.0	30.5	42.7	33.2	47.2	38.1	15.4	23.7	5.1	9.1	5.9	6.6	20.6	10.6	5.8	11.9	10.0	23.9	15.0	12.1	22.6	7.3	6.1	13.3	4.9	11.6	2.8	10.3	54.2	5.4	18.1	26.3	10.0	14.5	6.4	7.3	9.6	10.6	5.9	4.9	9.5	18.8	13.9	13.1	5.5	18.0	17.0	22.0	17.0	15.3	67.2	15.2	10.0	32.4	7.1	8.3	13.4	13.4	8.6	27.1	19.5	1.8	22.8	13.2	8.1	10.0	11.2	18.9	20.3	11.7	14.5	14.6	16.6	12.5	19.7	22.7	42.7	30.5	36.1	41.9	42.6	46.4	41.3	39.1	41.3	52.6	42.9	45.3	26.6	33.2	34.3	57.0	47.2	38.1	31.9	30.9	20.7	37.4	27.3	26.5	27.8	23.0	20.5	14.8	41.7	60.2	77.3	63.7	67.9	32.6	75.4	96.8	46.8	36.4	89.0	7.9	121.4	200.6	58.3	98.7	63.7	105.7	46.7	81.6	108.7	77.9	59.1	46.2	224.7	108.5	22.3	75.2	62.6	57.2	160.4	71.9	70.8	69.2	99.2	65.7	50.2	69.0	62.0	65.7	189.7	36.7	77.6	100.9	66.9	81.3	84.8	92.5	52.4	77.6	56.7
GUK1		ENSG00000143774	"Guanylate kinase 1"	Q16774	1	228139962-228148984	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028118, HPA048587, HPA068324"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		240000	Nucleoplasm	Cytosol	"HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: "	"unprognostic (9.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.91e-1)"	"unprognostic (5.41e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-2)"	44.6	38.2	106.4	32.5	76.0	76.7	43.0	25.2	74.4	31.5	33.3	30.1	27.3	41.5	26.3	34.1	77.0	28.0	42.5	61.6	93.1	43.9	31.9	43.5	34.6	39.0	60.0	52.9	24.7	62.2	12.8	26.0	29.2	40.1	25.5	12.1	37.4	66.5	29.4	35.8	59.6	42.1	34.8	49.6	36.1	44.3	22.2	34.9	27.5	31.6	29.3	24.1	45.9	44.5	43.9	97.7	110.1	62.9	55.8	83.7	84.5	57.5	20.3	9.0	27.7	27.1	32.6	45.0	38.4	19.7	22.4	17.6	11.6	40.1	21.7	45.6	25.0	18.8	38.3	7.7	42.1	2.4	33.0	59.7	12.9	50.1	25.2	49.3	14.6	22.7	45.2	25.7	15.6	12.6	16.1	30.2	47.0	34.7	34.7	18.3	48.0	65.8	31.5	28.1	28.2	88.0	25.2	16.9	57.6	21.1	27.1	29.6	53.1	24.7	42.4	49.6	2.4	31.3	31.5	52.7	40.9	27.0	59.9	63.1	32.0	34.6	24.0	51.5	23.8	41.2	55.5	57.1	110.1	77.3	59.8	75.2	43.9	64.8	83.7	48.9	36.6	48.7	61.1	74.9	55.8	62.9	97.7	64.6	84.5	106.4	76.0	25.2	74.4	93.1	43.9	60.0	52.9	40.1	34.9	56.6	78.2	181.8	216.6	586.3	182.4	113.0	193.6	93.7	91.0	225.1	675.4	207.7	588.6	495.6	100.8	397.7	599.7	607.3	597.7	329.8	327.6	443.3	180.0	320.2	368.6	103.3	258.9	305.7	236.3	483.4	216.3	309.1	492.6	406.6	288.0	169.2	724.2	491.0	229.1	543.7	445.9	245.8	394.4	82.0	73.0	629.1	219.5	279.1	243.7	436.5
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149852-228159826	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 34.3"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 11.8;Peritubular cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.9;SCLC-21H: 5.2;TIME: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.4	1.9	4.6	1.2	10.0	0.5	2.0	2.2	14.8	2.8	2.6	34.3	0.0	0.6	4.5	2.0	1.7	4.8	1.4	1.6	9.3	5.3	0.6	0.5	3.1	1.2	27.2	5.6	3.4	0.9	2.9	0.6	1.2	18.3	2.1	0.8	0.0	1.5	4.0	1.5	2.4	1.2	3.8	32.6	1.9	1.2	1.0	15.7	0.0	0.9	0.0	0.7	1.3	1.8	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.5	1.4	0.7	1.9	1.4	0.4	0.6	0.8	0.9	1.2	0.2	9.9	2.6	0.8	1.0	0.3	0.3	0.3	0.4	1.6	0.3	2.5	2.2	2.5	0.0	0.0	0.4	0.2	0.8	0.5	1.2	0.2	1.7	1.1	0.3	0.4	0.6	1.9	0.6	0.6	0.0	2.0	0.4	0.3	0.1	0.8	0.0	5.2	3.0	0.4	0.1	0.3	0.1	0.1	0.3	4.6	1.4	3.8	4.5	1.6	0.3	0.6	0.2	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	4.6	10.0	2.2	10.4	9.3	5.3	27.2	5.6	18.3	15.7	0.0	1.1	0.0	1.2	3.1	1.5	1.4	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.4	0.0	1.2	0.3	0.0	0.0	0.1	3.2	0.0	0.0	0.6	0.0	2.3	0.0	1.7	0.0	0.0	0.3	0.7	0.0	3.9	0.0	0.6	0.0	1.7	0.0	0.0	1.5	0.0	0.0	0.1	0.9
IBA57	"C1orf69, FLJ12734"	ENSG00000181873	"IBA57, iron-sulfur cluster assembly"	Q5T440	1	228165815-228182257	"Disease related genes, Predicted intracellular proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030555, HPA030556, HPA030557"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433"	"unprognostic (3.00e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.01e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.71e-9)"	"unprognostic (4.94e-2)"	"unprognostic (5.02e-1)"	"unprognostic (5.04e-3)"	"unprognostic (7.14e-2)"	5.2	7.5	4.7	5.3	5.5	8.2	6.1	7.8	5.1	4.7	4.5	4.1	3.8	4.5	5.3	4.2	4.7	3.8	6.8	7.9	4.9	3.2	5.8	9.5	6.3	12.7	3.5	4.5	5.9	18.3	7.4	2.9	6.4	5.2	4.5	3.9	4.9	5.3	3.1	22.9	8.0	5.7	4.9	3.5	4.9	5.3	3.1	3.2	5.0	5.2	6.4	4.7	3.6	3.7	2.8	3.4	4.7	1.7	2.8	3.5	0.9	3.3	3.5	3.8	1.7	2.0	2.3	4.6	2.0	1.0	1.6	0.9	7.3	2.9	7.2	4.5	2.2	0.9	6.2	2.9	4.4	1.4	1.5	6.3	4.3	4.3	3.5	1.7	4.8	4.8	3.1	2.7	1.8	2.2	1.5	2.2	4.6	7.1	3.4	1.5	2.6	4.8	2.9	2.8	4.6	4.0	6.0	4.3	1.2	2.3	6.9	5.8	4.0	3.4	10.5	2.6	0.7	8.3	6.6	5.1	4.3	4.0	2.9	5.1	2.5	1.2	3.7	1.9	2.0	3.2	4.7	1.7	0.8	2.3	1.4	3.5	1.5	1.9	1.8	1.2	2.8	2.8	2.6	2.7	2.8	1.5	3.4	1.7	0.9	4.7	5.5	7.8	4.6	4.9	3.2	3.5	4.5	5.2	3.2	8.9	14.1	9.1	7.6	7.2	5.4	13.5	5.1	4.0	13.6	0.0	11.8	9.6	6.6	4.4	17.2	6.7	9.9	23.3	5.8	7.0	4.2	5.1	15.0	7.3	4.8	3.2	6.9	5.5	4.3	24.4	3.4	4.4	6.8	2.8	5.6	5.4	7.1	5.3	6.7	5.4	19.9	6.5	4.1	11.9	11.2	5.3	13.6	5.4	9.5	7.4
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell type enriched"	"Detected in many"	14	"Cardiomyocytes: 136.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	0.6	1.0	0.4	1.1	0.2	2.2	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	5.4	0.4	9.4	5.3	1.3	0.3	5.0	2.1	1.6	8.8	0.8	1.8	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	2.4	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6	0.0	5.6	0.0	5.9	1.9	3.2	136.5	2.5	1.4	4.5	5.2	9.8	0.1	10.0	2.9	3.8	1.6	0.4	0.0	0.4	0.4	1.5	1.9	6.9	0.5	0.1	0.0	0.0	1.3	0.0	4.0	2.8	0.3	1.7	0.0	1.7	9.7	1.0	0.0	4.2	4.2	2.8	0.0	1.2	0.1	2.5	1.5	1.0	1.8	1.1	3.4
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.9	13.2	7.1	9.7	5.4	4.4	33.6	9.1	6.1	10.6	8.5	16.1	12.2	10.5	10.2	6.1	7.0	22.7	8.6	8.8	4.5	11.6	20.6	8.7	12.2	8.6	14.6	10.9	13.2	6.0	14.0	11.0	5.5	5.4	5.2	17.2	19.7	13.5	5.4	9.0	13.2	17.2	18.1	11.8	11.7	13.0	6.4	12.6	6.9	17.1	11.9	21.8	7.6	21.6	12.0	3.0	15.3	18.3	5.8	6.8	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.8	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8	3.0	7.2	3.9	12.3	14.1	12.6	2.8	7.6	4.0	7.9	1.8	2.0	13.8	14.9	13.0	105.9	8.3	22.7	0.0	9.7	12.0	7.0	15.1	5.7	4.9	10.0	4.8	13.8	6.7	10.0	12.4	8.9	9.7	5.0	25.2	16.1	8.1	14.3	17.3	7.1	6.3	1.7	6.5	9.7	5.5	11.8	16.9	47.9	24.9	13.4	22.9
TRIM17	"RBCC, RNF16, terf"	ENSG00000162931	"Tripartite motif containing 17"	Q9Y577	1	228407940-228416861	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;testis: 18.3"	"Group enriched"	"Detected in some"	56	"Early spermatids: 233.3;Late spermatids: 64.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;HEL: 3.5;NTERA-2: 3.3;SH-SY5Y: 4.1;T-47d: 9.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054908	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA054908: AB_2682638"	"prognostic favorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.96e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-1)"	1.3	0.8	14.4	1.5	19.1	1.1	1.9	25.8	11.8	1.5	0.9	0.6	1.7	1.4	3.6	1.7	1.3	3.9	1.7	1.5	8.9	3.4	1.2	0.6	1.7	2.0	0.7	9.2	2.2	1.1	0.8	1.0	1.3	2.7	2.0	0.8	1.9	5.9	3.8	0.8	3.5	1.6	1.1	0.9	5.3	1.4	18.3	4.7	0.0	2.9	0.1	1.2	2.5	1.3	1.7	0.6	0.7	0.3	0.0	1.0	0.1	0.3	0.7	0.5	0.4	0.0	0.0	7.8	0.5	0.0	0.0	0.1	1.7	0.9	0.1	1.9	0.0	0.2	1.7	0.0	0.0	0.1	0.3	0.8	3.5	1.0	0.2	1.6	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.5	0.2	0.5	0.1	0.1	0.3	0.0	3.3	0.1	0.2	0.1	0.1	0.0	0.0	0.8	0.5	4.1	0.0	0.4	0.0	0.8	9.6	0.2	0.0	0.4	1.7	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.7	0.9	0.1	1.0	0.6	0.2	1.0	0.0	1.7	1.0	0.8	0.2	0.0	0.2	0.6	0.0	0.1	14.4	19.1	25.8	11.8	8.9	3.4	0.7	9.2	2.7	4.7	0.0	0.3	0.0	1.1	0.2	1.1	0.6	0.0	2.7	2.3	1.8	0.0	0.0	0.0	0.7	233.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.0	1.1	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.0	0.0	1.2	1.6	0.3	0.7	0.5	0.0	0.6
HIST3H3	"H3.4, H3/g, H3FT, H3t"	ENSG00000168148	"Histone cluster 3 H3"	Q16695	1	228424845-228425325	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	194	"testis: 107.8"	"Cell type enhanced"	"Detected in some"	29	"Early spermatids: 2.8;Late spermatids: 13.2;Spermatocytes: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;MCF7: 1.3;THP-1: 1.8"									"CAB001386, CAB003812, HPA042570"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056"	"unprognostic (4.45e-1)"				"unprognostic (4.66e-2)"			"unprognostic (1.36e-1)"		"unprognostic (3.78e-3)"	"unprognostic (1.75e-2)"		"unprognostic (4.04e-2)"	"unprognostic (1.39e-2)"			"unprognostic (2.26e-2)"	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	107.8	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	1.8	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.2	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0
HIST3H2A	MGC3165	ENSG00000181218	"Histone cluster 3 H2A"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 35.8;lymphoid tissue: 62.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 18.7;SCLC-21H: 15.8;U-266/70: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	2.5	20.5	4.3	7.0	8.3	11.1	5.8	35.8	8.1	9.9	3.8	2.4	2.0	7.7	5.0	4.4	7.0	4.2	3.8	4.9	5.4	4.6	1.6	1.0	2.5	5.1	5.6	5.3	8.3	4.5	3.5	5.0	3.4	6.5	7.0	2.8	13.9	6.6	3.9	1.0	6.4	4.2	1.5	5.2	6.6	4.7	3.5	4.8	62.3	1.9	5.6	9.3	2.9	9.3	3.4	3.4	5.1	7.1	6.8	11.7	4.3	3.6	1.9	2.6	3.5	2.1	2.2	3.1	1.8	1.7	5.2	3.6	1.9	3.0	1.6	2.2	0.4	0.0	8.9	1.8	0.8	1.2	2.6	18.7	2.6	2.5	0.0	5.0	1.8	5.2	4.8	5.3	1.0	2.2	2.1	2.2	3.4	9.0	0.0	0.0	5.1	2.3	0.0	3.9	2.1	4.8	0.0	0.0	13.6	0.8	2.2	15.8	11.1	6.3	5.6	12.1	0.4	9.9	1.3	0.8	0.0	0.0	7.0	1.6	18.8	13.4	0.0	1.8	1.8	1.3	5.1	1.7	0.0	7.1	3.1	5.1	3.4	6.8	5.3	3.4	2.0	5.3	5.2	0.7	6.8	7.1	0.6	11.7	4.3	4.3	8.3	35.8	5.9	5.4	4.6	5.6	5.3	6.5	4.8	0.0	0.3	7.5	21.8	1.1	18.2	5.5	5.1	18.7	13.6	3.5	45.2	11.8	6.6	3.3	0.6	1.0	6.0	23.3	2.7	9.5	3.1	30.8	13.9	0.0	23.0	39.7	35.1	1.3	8.0	1.1	19.2	14.3	3.3	25.2	26.6	24.1	9.7	17.3	8.1	1.1	6.4	0.0	4.6	0.5	2.7	5.1	45.0	41.5	17.4	32.1
HIST3H2BB		ENSG00000196890	"Histone cluster 3 H2B family member b"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 56.0"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 6.0;Cone photoreceptor cells: 5.9;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 18.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	2.0	4.7	1.2	12.1	3.1	2.8	1.3	12.8	3.2	8.9	1.3	1.1	0.6	2.1	1.4	2.0	4.1	6.2	1.7	2.2	1.5	2.2	1.3	0.9	2.1	5.4	1.2	1.5	1.6	1.7	1.7	2.0	1.5	4.1	2.2	1.5	3.4	2.0	2.0	1.8	4.8	1.7	1.2	6.2	4.5	2.4	2.1	0.7	56.0	1.7	5.9	11.8	2.0	7.9	1.5	1.1	3.4	1.5	1.1	0.9	0.5	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.5	1.0	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.3	0.4	0.1	0.4	0.3	0.2	0.0	0.0	0.8	0.0	0.2	1.5	0.5	1.0	0.4	0.3	0.1	3.7	0.1	0.1	0.0	0.0	0.5	0.1	18.5	4.4	0.0	0.2	0.1	0.1	1.7	1.0	0.5	0.5	0.5	0.7	1.3	0.8	0.9	0.2	1.5	0.9	0.7	3.4	1.1	1.5	1.1	0.7	0.5	1.2	3.1	12.8	3.1	1.5	2.2	1.2	1.5	4.1	0.7	6.0	0.0	0.0	1.2	0.1	3.8	0.8	0.0	4.0	0.0	0.0	5.9	0.2	1.7	0.0	0.0	0.0	0.2	23.3	0.0	0.1	0.0	0.5	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.7	2.9	0.0	0.3	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.3	0.8	2.5	0.4	0.5
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487061-228495766	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 42.3;U-266/70: 76.8"	"Low region specificity"	"Detected in all"							HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	15.7	30.3	25.6	12.5	28.1	12.3	10.3	33.2	54.7	11.4	10.7	15.5	12.5	14.7	12.9	12.2	18.0	14.2	14.5	17.7	25.2	24.9	16.2	20.4	11.5	9.8	20.2	29.3	20.2	19.4	22.3	16.4	8.8	22.7	15.0	6.6	12.3	30.3	12.6	55.5	15.5	13.2	8.6	16.3	19.0	14.2	9.5	11.4	11.1	27.9	19.4	11.2	10.0	13.1	2.0	1.7	8.7	2.1	1.0	2.3	0.6	9.4	7.1	5.0	10.5	5.5	3.6	9.7	7.9	4.9	5.0	3.8	3.6	6.6	21.6	16.6	9.0	4.1	7.6	6.3	6.7	1.9	9.8	8.1	6.5	5.3	4.7	15.0	7.4	12.8	6.3	12.1	3.8	5.2	6.1	4.4	16.5	10.4	42.3	3.6	5.3	11.8	6.6	11.2	6.7	7.3	10.1	4.6	20.3	3.6	6.0	11.1	11.2	8.1	16.8	21.4	1.7	11.8	17.8	10.1	6.2	6.4	6.7	7.5	76.8	23.0	11.8	16.7	7.8	10.4	0.0	1.1	8.7	1.3	2.1	1.5	1.2	1.5	2.3	1.4	2.0	1.4	1.2	0.3	1.0	1.4	1.7	1.3	0.6	25.6	28.1	33.2	47.3	25.2	24.9	20.2	29.3	22.7	11.4	23.8	13.3	36.1	41.5	32.2	84.0	56.1	38.2	8.1	18.2	38.4	17.7	14.3	96.2	13.8	0.5	22.6	33.3	0.0	20.8	20.1	31.6	30.3	44.9	56.2	24.8	52.4	38.4	29.4	29.7	2.5	22.7	23.8	37.1	6.4	26.7	103.2	20.8	20.4	24.4	99.3	37.8	19.4	38.1	4.4	22.0	48.3	14.8	41.5	27.6	24.7
RHOU	"ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, WRCH-1, WRCH1"	ENSG00000116574	"Ras homolog family member U"	Q7L0Q8	1	228735077-228746669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.8"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 61.6;Extravillous trophoblasts: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.8;MOLT-4: 18.4;RT4: 17.7;THP-1: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049592	Approved					NA	NA					"HPA049592: AB_2680827"	"unprognostic (7.90e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.26e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (3.56e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-2)"	15.3	8.7	21.4	6.0	27.8	7.6	15.9	3.2	23.4	15.9	15.2	58.8	11.0	24.0	9.0	8.5	6.9	16.4	25.5	8.0	28.2	13.8	3.9	26.6	8.4	5.7	32.1	16.5	16.5	19.1	21.1	4.7	17.9	24.5	13.4	10.9	9.5	12.1	12.1	21.0	3.9	26.2	9.3	37.3	10.4	14.5	8.8	30.5	1.1	12.6	1.7	1.7	12.7	8.9	0.0	1.6	1.3	1.8	0.5	3.1	0.5	0.4	1.0	3.3	0.2	0.7	0.4	41.8	0.2	0.4	0.2	0.1	4.4	6.1	0.0	2.4	0.5	0.2	0.2	1.2	0.0	0.2	6.4	2.3	0.0	0.3	1.3	4.7	3.2	0.4	0.2	0.3	0.1	0.2	0.0	0.0	1.6	0.0	0.0	0.2	1.0	18.4	3.4	1.0	5.5	0.4	0.1	1.0	0.5	0.1	17.7	1.2	3.7	0.3	2.8	0.0	7.5	0.0	12.2	0.3	0.0	0.5	0.0	0.0	1.0	4.1	0.0	0.0	8.3	2.1	0.0	1.2	1.3	1.6	1.8	3.1	0.0	1.2	2.2	1.6	0.0	0.2	0.9	0.1	0.5	0.7	1.5	0.0	0.5	21.4	27.8	3.2	23.4	28.2	13.8	32.1	16.5	24.5	30.5	14.9	16.0	0.0	3.2	4.0	4.3	61.6	25.5	25.4	26.1	1.8	0.0	15.8	0.0	3.5	0.4	35.0	51.9	0.0	7.6	76.5	24.5	24.5	0.0	32.6	17.7	7.9	2.9	29.4	28.1	1.9	1.7	19.2	15.1	1.0	8.2	6.0	5.0	24.6	1.1	0.6	0.9	0.0	10.0	0.7	2.2	2.9	28.4	3.3	7.5	10.5
TMEM78	FLJ40168	ENSG00000177800	"Transmembrane protein 78"	Q5T7P6	1	229249636-229251810	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;bone marrow: 2.5"	"Cell type enriched"	"Detected in single"	5	"Melanocytes: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"											HPA042351	Uncertain					NA	NA					"HPA042351: AB_10961259"	"unprognostic (2.45e-2)"		"unprognostic (3.07e-1)"		"unprognostic (1.23e-1)"			"unprognostic (1.51e-1)"		"unprognostic (3.33e-1)"		"unprognostic (9.45e-2)"		"unprognostic (5.59e-2)"	"unprognostic (1.29e-1)"			0.1	0.4	0.5	0.2	0.5	2.5	0.4	0.7	0.7	0.1	0.1			0.1	0.5	0.6	0.1	0.3	0.2	0.1	0.4	0.3	0.1	0.6	0.0	0.7	0.3		0.2	0.7	0.5	0.2	0.0		0.4	0.3		0.7	0.0	1.8	1.2	0.2	0.0	0.3	0.6	0.1	0.7			0.3		0.2	0.1	0.1	1.3	2.6	5.3	0.5	1.3	0.9	0.1	0.4	1.3	0.8	2.1	0.2	0.0	0.6	0.4	0.0	0.1	0.1	0.2	1.9	0.5	0.5	0.4	0.2	1.0	0.0	0.0	0.3	0.6	0.6	0.8	1.8	0.3	0.0	0.6	0.5	0.2	0.0	0.1	0.0	0.5	0.1	0.5	0.3	0.7	0.0	0.3	0.6	1.5	0.6	0.4	0.6	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.5	0.2	0.0	1.1	0.5	0.1	0.0	0.6	0.5	0.5	0.3	0.9	0.6	0.8	0.5	0.6	0.8	5.3	0.5	0.7	0.7	0.3	0.5	0.8	0.6	0.5	0.1	1.3	0.9	0.8	2.6	1.3	0.5	2.6	0.4	0.1											0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2
RAB4A	"HRES-1/RAB4, RAB4"	ENSG00000168118	"RAB4A, member RAS oncogene family"	P20338	1	229271062-229305894	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 21.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 21.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.21e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.72e-2)"	12.0	13.6	25.8	11.0	23.4	6.4	19.8	26.6	27.0	20.6	17.2	19.7	15.7	16.9	13.1	14.4	18.2	15.9	17.9	36.9	23.2	26.6	15.9	29.6	11.0	10.8	32.0	15.6	16.8	27.8	12.4	11.2	11.4	24.2	35.5	19.6	14.7	38.2	22.5	30.2	16.8	13.1	18.6	26.4	7.7	24.6	13.1	18.9	12.2	20.2	16.8	12.2	17.9	15.7	2.0	4.6	21.0	4.2	1.4	2.2	2.3	4.9	6.7	11.3	7.8	16.2	18.1	9.4	7.5	9.0	4.6	4.4	12.4	8.3	0.0	12.6	10.1	3.8	5.4	7.5	10.6	6.5	6.2	14.9	6.6	6.1	19.3	10.5	13.4	5.4	13.9	15.3	3.2	4.5	13.7	10.3	7.3	6.9	0.0	8.0	6.3	6.7	9.0	10.1	30.5	9.3	2.2	1.8	3.4	24.3	11.9	9.7	12.7	6.2	9.5	12.9	6.2	9.0	24.0	7.1	0.0	3.7	7.3	10.3	6.0	5.5	0.0	3.2	11.5	10.7	12.5	3.6	21.0	1.6	4.2	1.5	1.9	2.1	2.0	4.6	2.0	1.3	1.7	0.9	1.4	2.7	2.5	2.2	2.3	25.8	23.4	26.6	27.0	23.2	26.6	32.0	15.6	24.2	18.9	14.9	16.6	52.0	123.2	121.7	24.1	77.5	127.4	34.8	28.4	41.8	45.2	64.0	96.2	83.1	115.6	50.1	61.9	23.3	101.1	74.2	51.3	127.5	25.3	90.4	60.2	28.6	46.7	30.1	63.0	135.2	43.1	72.8	60.8	76.7	78.3	14.7	75.6	107.2	78.8	105.4	52.5	45.3	54.5	65.7	26.9	107.1	48.5	50.4	103.0	118.8
SPHAR		ENSG00000213029	"S-phase response (cyclin related)"	Q15513	1	229304857-229305504	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	31	"brain: 3.1"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 2: 1.4;Club cells: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Daudi: 2.0"															NA	NA																							0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCSAP	"C1orf96, CSAP, FLJ41471"	ENSG00000154429	"Centriole, cilia and spindle associated protein"	Q6IQ19	1	229321005-229343294	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.6;placenta: 28.7"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 92.0;Syncytiotrophoblasts: 85.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028402, HPA043443"	Enhanced	Supported				NA	NA					"HPA028402: AB_10603681, HPA043443: AB_2678485"	"unprognostic (4.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.50e-13)"	"unprognostic (9.67e-2)"	"unprognostic (4.93e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.03e-1)"	3.4	3.9	19.3	4.9	20.5	13.3	6.8	29.9	39.6	3.7	3.1	9.8	1.4	3.8	3.7	3.0	4.1	2.3	3.7	3.1	14.1	8.9	2.2	3.8	4.8	4.6	9.8	20.7	6.9	3.0	4.3	5.7	28.7	8.9	4.7	3.7	4.9	4.7	3.8	3.0	13.3	3.4	3.0	10.7	5.3	3.4	2.7	11.3	8.5	2.8	0.4	4.2	3.7	2.8	1.0	1.9	5.8	3.2	0.5	2.0	0.4	6.6	3.6	4.8	8.8	3.3	3.0	39.3	4.8	2.4	5.5	5.3	4.4	4.1	4.2	3.6	4.2	4.5	5.2	10.2	3.6	5.6	7.7	9.9	4.4	3.6	3.2	2.0	7.1	8.7	1.1	2.9	4.3	5.5	4.4	3.9	9.8	5.9	6.4	4.4	2.2	20.1	7.6	4.4	5.0	5.3	5.9	12.3	2.8	2.6	4.1	9.8	13.2	9.0	5.5	4.6	4.2	4.3	10.0	2.5	4.8	7.4	6.5	7.4	5.9	9.1	3.1	5.7	7.2	5.6	5.8	1.5	3.1	0.9	3.0	2.0	0.5	1.1	1.3	1.3	1.0	1.1	0.9	2.4	0.5	3.2	1.9	1.4	0.4	19.3	20.5	29.9	22.1	14.1	8.9	9.8	20.7	8.9	11.3	8.9	1.4	0.9	5.3	7.2	92.0	3.3	0.0	1.4	2.3	1.8	39.3	12.5	5.0	1.4	30.4	1.5	0.7	23.3	0.3	30.8	4.0	6.4	0.0	2.6	9.8	17.5	2.4	1.8	13.2	17.3	0.0	17.3	5.0	1.8	2.5	11.3	0.5	0.0	2.5	0.0	42.1	0.0	3.9	0.5	0.9	14.3	85.1	4.4	1.5	5.4
ACTA1	"ACTA, NEM3"	ENSG00000143632	"Actin, alpha 1, skeletal muscle"	P68133	1	229431245-229434098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 1935.3;tongue: 523.6"	"Cell type enriched"	"Detected in some"	448	"Cardiomyocytes: 1758.3"	"Group enriched"	"Detected in many"	18	"head and neck cancer: 133.1;prostate cancer: 34.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	22	"BEWO: 104.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000045, HPA041264, HPA041271"	Enhanced					NA	NA		6100000000			"CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.07e-4)"	"unprognostic (5.75e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.56e-3)"	"unprognostic (9.40e-4)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.01e-1)"	29.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	0.2	0.2	0.0	0.8	0.2	0.2	48.6	30.0	0.2	0.2	122.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.0	2.7	0.2	0.0	40.4	0.2	1935.3	0.5	0.2	1.2	0.4	0.2	0.2	0.2	0.0	0.0	5.3	523.6	39.9	0.2	0.1	4.4	14.7	20.5	15.5	5.1	9.7	20.8	0.0	0.0	0.0	0.0	0.0	0.0	104.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.5	0.0	0.1	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	8.9	9.3	20.5	7.6	15.5	5.7	4.4	6.4	7.4	14.7	4.3	5.0	7.7	12.1	5.1	14.0	4.7	9.7	20.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	1758.3	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.5	0.0	0.4	0.0	0.0	0.0	1.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440260-229508341	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	20.6	20.0	17.4	16.3	21.6	16.2	25.4	29.8	24.0	19.6	17.7	27.2	15.5	13.2	23.0	18.4	18.5	22.2	13.5	22.7	17.6	17.0	19.5	15.6	19.8	27.8	20.9	20.3	27.3	17.8	33.3	23.3	23.0	20.6	19.1	18.3	15.5	17.8	21.2	28.6	21.8	16.2	20.9	19.4	19.1	17.1	19.4	20.9	38.0	21.7	18.0	22.8	20.2	17.9	9.0	10.5	7.5	13.6	7.6	10.9	7.3	14.3	11.6	18.2	9.4	13.1	14.1	35.5	11.9	12.2	17.8	16.2	13.7	14.2	20.9	10.4	11.8	7.9	19.1	25.1	12.6	19.1	12.6	31.2	12.6	12.0	10.3	10.5	25.5	10.3	11.0	9.5	12.8	15.3	12.4	14.8	18.0	28.4	10.1	13.9	6.5	18.8	10.9	27.2	20.2	10.6	18.4	18.9	20.5	10.1	12.7	15.6	19.4	17.8	11.2	13.0	9.3	17.4	20.3	12.9	8.1	9.9	14.0	17.7	9.7	12.0	22.5	9.2	14.9	16.8	7.5	8.2	6.1	8.8	8.2	10.9	9.0	9.3	9.7	10.5	7.1	9.6	10.0	2.9	7.6	13.6	6.0	8.6	7.3	17.4	21.6	29.8	23.4	17.6	17.0	20.9	20.3	20.6	20.9	8.9	17.6	3.7	5.2	8.0	16.0	17.3	7.6	9.4	10.3	14.0	7.9	18.2	5.0	7.2	1.1	8.7	2.9	0.0	7.4	11.1	10.6	5.8	7.0	9.5	8.5	15.9	9.8	12.3	12.3	1.9	11.5	7.1	6.8	9.0	7.1	11.6	6.2	6.5	11.3	6.8	11.9	0.0	9.9	12.3	16.7	9.4	15.3	7.0	9.5	5.5
ABCB10	"EST20237, M-ABC2, MTABC2"	ENSG00000135776	"ATP binding cassette subfamily B member 10"	Q9NRK6	1	229516582-229558695	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Erythroid cells: 140.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044063, CAB044065, HPA055175"	Uncertain					NA	NA					"CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727"	"unprognostic (1.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.06e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.37e-2)"	13.2	6.4	5.5	6.7	6.0	37.1	14.0	15.1	6.1	7.9	18.8	5.4	3.7	12.6	9.9	6.9	10.7	6.1	11.9	8.3	5.5	5.4	10.9	24.7	9.8	15.5	5.2	3.8	6.3	8.2	9.0	4.2	11.4	4.9	9.9	8.6	5.3	7.1	5.9	13.9	6.0	30.1	14.7	5.0	15.0	7.8	4.0	4.2	9.4	9.6	8.3	12.1	10.0	9.1	2.4	3.2	2.9	2.7	1.3	4.1	1.3	10.4	6.2	5.2	4.2	8.9	7.7	22.7	9.7	7.3	8.8	8.0	6.4	8.0	11.5	8.9	8.8	3.6	9.1	11.1	8.0	8.9	7.8	14.1	12.6	5.6	8.1	6.4	42.4	7.1	5.3	6.9	5.3	6.2	5.3	9.4	20.7	26.9	26.6	9.0	3.3	10.7	24.3	6.9	12.2	5.3	9.8	10.3	12.2	7.1	6.8	3.8	5.8	7.5	8.4	11.8	3.3	6.5	14.8	7.2	9.5	6.0	5.9	13.1	6.5	4.8	10.0	5.0	7.4	6.0	1.7	2.4	2.9	2.8	2.7	3.6	1.8	3.3	4.1	2.8	2.4	3.0	4.0	0.4	1.3	1.9	3.2	2.7	1.3	5.5	6.0	15.1	6.1	5.5	5.4	5.2	3.8	4.9	4.2	8.9	1.3	0.8	2.5	2.9	5.8	11.8	2.5	9.4	5.7	0.0	11.8	5.1	1.7	4.1	0.0	4.5	8.0	140.2	4.5	9.3	4.8	7.1	5.7	15.3	8.1	9.5	9.8	5.5	11.0	0.2	4.6	6.4	8.5	15.4	12.8	2.9	4.3	10.5	4.2	4.5	4.5	6.5	5.2	2.9	2.9	4.4	3.0	3.9	10.5	3.5
TAF5L	PAF65B	ENSG00000135801	"TATA-box binding protein associated factor 5 like"	O75529	1	229593111-229626047	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067941			Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA067941: AB_2685929"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.17e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	19.5	8.3	13.0	14.4	12.8	23.0	25.6	13.5	14.7	12.1	15.3	14.7	9.9	12.7	15.8	10.6	15.0	14.1	16.3	12.9	10.5	9.0	9.5	18.6	13.6	15.7	12.1	8.0	12.2	10.4	12.7	11.6	25.0	12.9	15.7	15.8	9.2	13.3	12.3	24.9	10.1	17.0	16.5	12.8	15.6	13.8	8.5	10.5	15.9	13.5	11.9	15.3	17.1	13.2	1.1	1.6	0.2	1.3	2.1	2.6	0.8	16.5	9.6	13.8	11.5	9.5	10.0	35.8	11.2	13.5	14.1	13.2	12.9	13.6	18.7	12.0	12.1	9.2	14.2	15.2	13.8	13.6	13.9	21.8	14.6	9.8	8.1	10.7	19.3	17.0	11.1	13.5	13.9	12.0	5.5	13.7	19.8	19.4	17.3	13.2	8.0	21.8	10.4	19.5	18.7	7.6	19.4	15.5	19.2	9.8	15.4	13.9	16.9	9.6	13.3	15.4	5.3	15.8	20.2	11.8	11.8	14.4	15.5	23.6	9.2	7.0	21.4	8.9	11.7	18.5	0.0	1.1	0.2	2.1	1.2	2.6	1.1	2.2	1.7	1.6	1.0	2.2	1.9	0.2	2.1	1.3	0.7	1.9	0.8	13.0	12.8	13.5	14.7	10.5	9.0	12.1	8.0	12.9	10.5	3.0	6.5	2.2	3.8	5.0	5.7	6.3	7.6	4.0	9.1	3.5	11.8	9.7	1.7	3.6	2.1	6.3	9.1	0.0	7.2	29.3	4.8	5.8	0.0	12.1	8.4	6.4	11.5	6.7	6.9	2.9	4.4	6.8	5.0	10.0	10.6	3.2	5.6	7.0	3.9	2.8	8.3	12.9	6.2	6.5	2.2	4.5	8.7	5.1	8.3	7.0
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.1	7.2	9.6	4.6	3.8	22.1	5.9	3.6	9.1	6.9	11.0	5.8	15.2	6.8	4.1	4.8	10.2	17.8	7.2	8.4	7.4	17.0	9.5	9.3	6.4	4.3	13.8	8.2	3.7	5.3	9.0	7.1	2.3	4.3	9.0	20.0	7.1	5.6	5.8	15.4	6.8	24.2	13.1	7.4	17.3	10.3	15.2	4.1	9.3	10.8	13.3	6.9	7.3	5.8	2.6	8.2	7.9	4.7	7.5	9.5	9.5	16.7	7.9	7.6	22.9	4.0	10.4	13.6	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2	0.0	0.6	1.9	4.7	9.0	6.8	2.4	2.5	0.0	2.3	5.2	27.5	4.2	0.0	2.3	0.3	5.5	0.9	0.0	2.4	8.6	2.7	4.3	0.0	2.9	2.5	3.2	6.3	4.3	1.8	0.8	2.0	2.4	5.0	2.8	1.8	2.7	2.3	0.0	3.2	1.6	17.2	0.0	3.0	5.2	2.9	8.0	2.7	0.0	3.0	3.1
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282124	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 140.3"	"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 114.0;Extravillous trophoblasts: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 90.9"					"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	19.5	25.6	11.1	19.6	10.1	6.9	20.4	7.7	12.5	11.7	12.7	9.1	10.5	11.3	13.7	11.5	11.5	13.2	17.0	13.9	12.5	8.5	17.5	140.3	13.2	20.4	8.4	9.0	24.8	35.9	4.3	7.3	16.6	12.6	10.8	7.5	10.5	11.1	9.6	42.2	8.4	11.3	14.6	13.6	9.5	18.0	12.7	8.2	28.4	10.7	10.7	7.0	14.9	13.1	6.7	13.5	3.5	10.1	2.7	5.3	6.3	16.2	21.7	12.8	15.1	24.6	21.0	26.4	30.7	19.1	12.5	12.0	9.3	30.9	4.1	22.9	16.2	29.2	31.7	8.4	25.8	10.5	41.0	11.0	12.5	48.5	10.4	13.4	4.7	24.6	30.0	12.8	16.7	6.7	27.5	14.6	23.2	15.5	6.3	13.8	4.4	24.6	4.8	17.5	10.9	20.7	27.5	18.3	12.6	12.3	19.3	4.0	15.1	31.1	1.6	18.7	7.1	9.9	9.0	34.6	12.3	23.7	27.7	24.3	21.0	12.0	9.2	31.6	9.6	90.9	1.1	10.1	3.5	4.7	9.6	3.6	3.8	2.9	4.7	7.9	6.7	2.8	5.3	3.2	2.7	9.6	13.5	3.4	6.3	11.1	10.1	7.7	11.8	12.5	8.5	8.4	9.0	12.6	8.2	14.9	14.7	24.2	16.5	13.6	27.5	13.9	22.9	9.4	15.9	22.7	31.4	5.3	5.0	41.3	43.0	13.8	16.1	0.0	114.0	106.1	24.4	21.9	12.7	80.2	23.0	27.0	16.1	15.4	38.3	19.2	33.1	18.8	23.6	47.7	17.9	11.2	87.4	17.6	27.6	18.9	69.7	12.9	11.3	3.6	10.6	6.9	13.8	15.2	15.3	14.0
PGBD5	"DKFZp761A0620, FLJ11413"	ENSG00000177614	"PiggyBac transposable element derived 5"	Q8N414	1	230314482-230426371	"Disease related genes, Predicted intracellular proteins"	Transposition	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 23.0;Cone photoreceptor cells: 19.6;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;GAMG: 9.2;NTERA-2: 18.3;RH-30: 10.0;SCLC-21H: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065010			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065010: AB_2685402"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (8.78e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.51e-1)"	0.8	10.8	16.0	0.8	14.1	0.6	0.7	17.9	27.0	21.9	1.5	6.0	0.1	1.0	5.8	0.5	1.8	5.6	2.2	13.3	20.0	8.0	1.5	2.8	1.8	0.9	7.1	8.9	0.9	21.6	0.9	4.0	2.6	8.0	1.4	1.3	1.0	3.2	1.2	2.8	0.9	1.0	3.0	5.0	2.6	1.6	5.8	4.6	0.5	6.0	0.6	5.1	1.6	1.5	0.8	0.6	1.5	0.6	0.6	0.6	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	4.0	0.0	18.0	1.7	0.1	9.2	3.4	1.4	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.1	0.9	0.1	3.6	18.3	0.0	0.1	0.0	10.0	2.8	2.1	0.0	25.3	4.7	0.6	0.0	0.2	0.4	0.2	6.1	0.0	0.0	1.5	0.0	1.4	7.7	5.8	0.0	0.0	1.5	0.3	1.5	0.6	1.2	0.6	0.6	0.5	0.4	0.5	0.4	0.4	0.8	0.6	0.6	1.2	0.6	0.6	0.6	0.4	0.2	16.0	14.1	17.9	23.8	20.0	8.0	7.1	8.9	8.0	4.6	0.0	3.4	0.0	0.6	0.1	23.0	5.5	0.0	1.4	0.0	0.0	19.6	0.0	0.0	6.1	0.6	0.1	0.0	0.0	5.1	0.1	0.4	1.3	10.4	4.0	8.7	20.6	8.7	0.0	3.7	0.4	0.0	0.6	1.7	0.0	0.0	2.4	4.9	0.0	0.0	0.6	9.3	0.0	0.7	0.7	1.5	0.0	0.2	0.0	0.0	0.9
COG2	LDLC	ENSG00000135775	"Component of oligomeric golgi complex 2"	Q14746	1	230642489-230693982	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076994			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA076994: AB_2686823"	"unprognostic (2.21e-1)"	"unprognostic (7.35e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.62e-2)"	11.6	27.5	11.4	12.7	12.5	8.0	13.2	24.9	13.7	14.1	18.5	15.4	13.4	13.3	14.3	14.6	10.9	14.5	13.9	17.7	11.4	8.6	17.3	12.7	11.0	14.7	14.5	9.6	12.7	17.0	49.1	17.6	11.1	12.3	13.0	23.0	14.0	14.6	13.6	25.5	13.5	18.0	11.9	11.1	18.5	15.8	13.9	13.4	21.6	16.8	10.7	17.2	13.7	15.9	11.6	13.8	15.0	20.2	16.2	18.1	13.4	8.1	9.6	11.6	11.2	11.6	9.1	16.9	7.1	11.0	11.8	10.4	12.9	12.6	25.2	11.1	9.6	7.6	12.4	10.8	12.7	11.3	20.3	21.5	8.8	9.5	13.6	14.3	22.8	13.9	12.2	14.1	7.4	10.8	7.6	9.7	15.7	15.2	14.3	9.4	6.5	20.5	11.4	16.6	25.0	18.0	17.8	18.6	29.7	12.2	12.2	12.0	16.4	8.3	15.3	16.0	5.4	18.3	22.4	8.3	5.7	5.3	7.0	13.7	17.5	14.5	20.1	9.5	9.4	12.0	10.9	11.8	15.0	13.1	15.0	15.2	11.6	12.5	12.5	13.8	11.0	18.1	15.7	0.5	16.2	20.2	6.9	9.9	13.4	11.4	12.5	24.9	13.7	11.4	8.6	14.5	9.6	12.3	13.4	20.8	17.9	15.6	5.5	4.6	15.6	24.8	17.8	41.5	18.2	12.2	27.5	10.7	23.2	15.3	5.4	7.7	14.3	0.0	20.3	9.8	8.2	6.6	22.0	11.3	12.0	23.8	17.9	9.8	23.4	3.3	10.6	9.9	6.8	13.6	32.6	20.0	15.1	7.0	13.8	17.9	44.0	12.9	9.2	19.0	22.0	4.3	7.7	14.6	22.2	5.2
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230702523-230714297	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 309.0"	"Group enriched"	"Detected in many"	12	"Cholangiocytes: 828.0;Hepatocytes: 2051.9"	"Group enriched"	"Detected in all"	10	"glioma: 275.3;liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 111.1;THP-1: 42.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	110000000000			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	2.8	3.2	23.6	1.9	25.0	1.4	1.6	17.1	37.0	3.8	2.1	24.2	0.0	1.9	1.7	1.8	2.0	2.3	22.5	30.9	18.0	11.9	9.3	309.0	1.6	1.5	19.5	15.0	1.8	2.3	1.8	2.6	1.5	23.8	2.5	2.2	0.0	1.5	1.9	7.8	1.4	2.2	2.6	29.8	1.4	2.4	2.0	15.9	0.0	1.9	0.5	1.4	3.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	111.1	0.3	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	42.4	0.0	0.0	0.2	0.0	0.2	0.6	7.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	25.0	17.1	20.0	18.0	11.9	19.5	15.0	23.8	15.9	0.0	1.7	34.4	0.9	0.6	4.5	43.1	828.0	0.0	0.0	3.5	33.4	0.1	21.6	119.6	56.8	0.5	0.0	116.8	8.6	0.1	2.8	19.4	0.0	2051.9	1.8	3.2	0.0	34.4	50.3	31.9	3.7	0.0	8.5	1.0	0.0	89.3	18.7	0.0	3.2	123.3	42.2	12.9	6.4	0.4	0.4	0.0	0.6	4.5	0.0	1.3
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.6;lung: 19.8;stomach 1: 35.8"	"Group enriched"	"Detected in many"	10	"Alveolar cells type 1: 23.8;Mucus-secreting cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Group enriched"	"Detected in some"	6	"OE19: 11.9;SCLC-21H: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483, HPA062050"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: "	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.2	0.7	0.4	7.0	0.3	0.0	0.2	0.3	0.5	0.4	10.4	0.4	0.2	3.9	0.2	0.2	0.7	1.5	12.7	0.2	0.5	0.2	0.2	0.2	19.8	0.2	0.6	0.2	0.3	0.2	0.0	0.6	0.2	0.2	0.8	13.7	0.2	8.1	0.2	1.3	0.0	17.6	0.2	1.1	0.2	35.8	0.2	0.2	0.2	0.2	1.0	7.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	0.0	0.6	11.9	0.0	0.4	0.0	0.0	0.0	0.1	17.1	0.0	0.0	0.5	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.4	0.5	0.2	0.6	0.2	0.2	0.2	23.8	4.8	0.0	0.5	0.0	0.0	3.3	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.2	4.5	0.0	3.5	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.1	0.0	2.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.4	0.2	1.1	3.5	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	1.0
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 178.6;Smooth muscle cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	22.6	8.8	25.7	6.6	30.4	2.9	18.6	5.2	31.9	23.4	12.9	66.2	3.5	7.4	17.4	10.2	10.2	13.8	20.4	26.9	27.5	19.4	8.2	6.7	41.9	8.3	44.9	16.2	18.2	17.2	17.1	3.4	19.3	37.4	11.8	7.7	9.1	12.0	21.5	39.0	17.3	7.8	29.2	57.4	10.6	13.0	4.4	36.7	1.5	14.8	6.8	5.7	12.9	10.9	2.8	2.3	10.6	3.6	4.2	3.9	6.6	7.0	5.4	14.8	10.0	28.3	20.8	25.4	13.0	21.0	6.8	6.9	17.2	4.0	8.4	8.3	44.9	3.4	4.6	7.8	2.8	5.1	27.7	7.3	1.3	5.1	5.7	12.1	4.3	1.3	24.9	4.5	2.6	3.0	14.8	4.3	5.4	2.7	2.9	4.7	4.8	3.4	2.1	17.2	15.9	4.4	8.0	10.5	1.9	5.4	8.5	8.5	13.7	6.6	8.8	4.6	8.3	11.2	3.8	3.2	11.1	11.2	2.5	7.7	5.3	2.4	2.5	2.9	2.7	31.0	10.6	1.7	0.5	2.8	3.6	3.5	2.8	1.9	1.1	2.3	1.9	3.9	3.2	1.4	4.2	1.7	0.3	0.8	6.6	25.7	30.4	5.2	26.8	27.5	19.4	44.9	16.2	37.4	36.7	178.6	21.0	0.8	9.8	23.1	1.9	33.8	28.1	6.7	20.5	10.4	9.8	14.6	1.7	37.4	9.1	10.2	1.6	0.0	22.6	26.6	56.3	16.9	2.3	3.9	9.4	23.8	5.2	11.1	2.2	7.3	12.4	2.8	62.4	4.6	9.7	11.2	26.6	3.5	8.5	4.8	4.4	32.3	73.1	5.7	4.2	25.3	10.8	0.7	6.0	16.2
TTC13	FLJ22584	ENSG00000143643	"Tetratricopeptide repeat domain 13"	Q8NBP0	1	230906243-230978875	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018022, HPA051558"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018022: AB_2211524, HPA051558: AB_2681534"	"unprognostic (2.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.10e-2)"	"prognostic favorable (7.66e-4)"	"unprognostic (2.60e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.60e-11)"	"unprognostic (4.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.54e-3)"	10.5	7.1	8.9	16.6	26.7	13.1	9.6	11.2	12.4	7.3	13.6	12.5	8.6	10.5	9.3	9.2	8.5	9.2	8.9	7.0	9.9	7.9	6.9	9.0	12.2	23.4	13.3	9.3	8.2	13.7	13.5	15.5	9.9	12.6	8.1	21.6	7.9	9.6	9.5	15.6	12.8	15.6	8.4	14.7	21.3	15.6	3.9	13.7	18.4	9.8	6.2	18.9	8.0	9.1	4.2	10.8	7.6	7.7	11.9	10.0	5.1	7.6	7.8	7.7	14.9	7.2	4.7	15.8	11.2	8.8	6.3	7.1	11.4	8.3	14.1	10.3	6.7	6.3	12.3	5.0	4.1	4.2	15.7	15.4	4.2	8.3	7.7	7.6	8.6	3.9	4.1	7.3	5.9	5.5	6.3	11.1	6.1	4.4	8.2	5.8	3.9	4.5	8.2	8.7	25.5	9.7	7.4	11.0	19.6	6.6	5.3	10.6	9.2	8.5	8.8	14.9	3.5	9.4	11.2	5.6	7.5	1.0	10.0	19.7	10.2	16.7	4.3	7.3	5.5	12.2	7.6	7.6	6.8	10.0	5.8	6.8	4.2	7.0	8.2	10.8	3.9	5.7	6.8	2.9	11.9	7.7	7.4	5.4	5.1	8.9	26.7	11.2	12.4	9.9	7.9	13.3	9.3	12.6	13.7	6.0	9.0	9.9	1.2	3.0	4.0	2.5	0.0	0.0	4.5	1.8	5.9	3.7	1.7	4.4	1.4	4.5	2.6	0.0	7.5	4.4	2.8	1.5	9.2	5.9	4.6	11.1	5.8	2.5	7.0	1.7	2.6	7.1	1.7	1.0	10.7	4.0	3.5	8.6	6.3	1.1	10.0	6.5	3.9	2.3	2.4	2.4	1.4	12.8	7.0	1.0
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000595	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	8.2	16.3	22.0	10.1	31.0	10.0	16.1	17.1	24.3	11.0	20.0	16.5	13.9	13.8	8.1	20.6	13.6	12.3	17.0	24.2	23.8	21.8	21.0	20.9	12.5	11.0	22.7	17.7	9.8	14.9	18.4	25.8	9.4	22.0	14.0	21.6	15.4	16.9	13.4	15.7	14.6	15.6	10.7	27.1	10.5	13.7	24.6	18.2	11.0	18.4	16.8	11.9	12.7	9.3	15.3	13.9	7.3	17.7	12.5	14.0	8.3	20.0	21.8	10.9	13.0	15.9	13.9	10.2	9.4	17.5	17.4	20.1	8.0	15.7	5.8	11.8	10.9	10.7	16.5	20.5	12.8	20.7	14.7	28.8	17.9	15.8	10.8	16.2	26.3	14.6	15.0	13.5	9.4	10.9	11.3	11.6	18.0	26.3	15.9	11.4	7.0	10.7	8.0	14.0	21.2	14.8	12.7	16.2	16.4	23.2	16.5	11.4	17.3	11.3	13.4	27.8	2.7	24.0	23.5	6.4	6.9	4.4	12.6	22.6	24.6	21.6	14.4	18.9	23.0	18.8	6.4	7.6	7.3	9.8	10.8	13.3	15.3	11.0	11.7	9.1	10.1	13.8	12.7	1.9	12.5	17.7	13.9	14.0	8.3	22.0	31.0	17.1	24.3	23.8	21.8	22.7	17.7	22.0	18.2	14.9	24.8	20.9	19.1	11.4	19.4	26.9	7.6	17.4	18.2	27.9	2.0	32.5	51.4	20.9	26.0	11.9	11.7	46.7	35.3	12.7	17.5	14.6	16.2	17.9	21.8	36.5	7.5	12.3	11.5	14.7	8.6	14.3	23.6	9.0	15.0	28.4	17.4	10.5	15.6	24.2	13.2	0.0	14.4	92.9	16.8	13.2	13.0	7.9	27.4	16.2
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 39.6;placenta: 48.3"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 143.5;Extravillous trophoblasts: 248.1;Rod photoreceptor cells: 96.4;Syncytiotrophoblasts: 232.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 52.2;SK-MEL-30: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA059052: AB_2683890, HPA059578: AB_2684070"	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	39.6	12.9	8.0	3.7	8.5	3.9	32.8	3.9	5.4	5.1	3.6	4.9	2.0	1.6	5.7	2.1	3.4	2.7	4.6	4.7	7.9	11.2	8.7	5.7	10.5	6.7	14.0	2.3	4.7	15.0	4.0	4.2	48.3	13.1	4.7	2.4	12.0	3.5	3.9	4.2	14.1	1.8	3.5	10.9	9.6	3.1	2.8	8.3	0.8	3.9	5.0	3.6	4.3	9.7	1.2	0.0	4.3	0.7	0.3	3.0	0.8	0.3	4.8	2.2	4.7	5.5	1.1	52.2	2.7	2.0	1.0	1.8	7.3	4.3	0.0	0.6	1.7	6.0	2.9	4.2	0.6	0.8	14.5	10.2	2.3	0.1	0.3	21.2	1.7	12.6	18.4	9.5	0.0	4.8	0.0	2.6	5.3	18.0	3.0	0.9	1.7	1.1	3.0	3.3	4.3	1.5	5.7	7.3	5.5	3.6	5.1	2.0	5.8	0.9	0.4	27.3	5.2	0.2	10.1	0.4	8.2	0.0	0.1	5.0	6.6	7.9	4.0	2.4	3.4	16.1	4.3	0.7	0.0	0.6	0.1	1.1	1.2	0.8	1.5	0.0	0.6	1.3	3.0	0.0	0.3	0.2	0.0	0.0	0.8	8.0	8.5	3.9	5.4	7.9	11.2	14.0	2.3	13.1	8.3	0.0	1.6	2.7	15.8	26.8	32.0	3.0	2.5	0.0	1.2	0.0	72.6	143.5	3.3	2.1	1.1	20.1	0.0	0.0	2.9	248.1	6.4	12.7	4.6	10.6	41.7	7.9	0.0	5.5	13.1	1.8	2.6	3.0	20.3	0.0	0.4	22.8	4.3	0.0	1.4	4.4	96.4	0.0	2.1	3.8	8.9	28.7	232.7	2.2	0.9	13.3
TRIM67	TNL	ENSG00000119283	"Tripartite motif containing 67"	Q6ZTA4	1	231162112-231221556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 14.4"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 65.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;HMC-1: 1.6;HSkMC: 1.4;SCLC-21H: 7.2;SH-SY5Y: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034776	Uncertain					NA	NA					"HPA034776: AB_10603997"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.93e-10)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.10e-3)"	0.3	0.7	1.3	0.2	1.3	0.1	0.1	13.3	14.4	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.3	1.2	1.9	0.2	0.1	0.1	0.2	1.5	0.0	0.2	0.2	0.1	1.9	0.4	1.9	0.1	0.2	1.7	0.2	0.1	0.1	0.4	0.3	0.2	0.9	0.2	0.2	0.5	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.0	0.0	7.2	1.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	13.3	1.9	1.2	1.9	1.5	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
AL109810.2		ENSG00000235710			1	231184098-231187627	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	6	"brain: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"A549: 1.4"															NA	NA																							0.0	0.0		0.0		0.0	0.0		1.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf131	DKFZp547B1713	ENSG00000143633	"Chromosome 1 open reading frame 131"	Q8NDD1	1	231223763-231241187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028452, HPA029920"	Enhanced					NA	NA					"HPA028452: AB_10610979, HPA029920: AB_10600423"	"unprognostic (5.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (2.64e-9)"	"unprognostic (8.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (9.84e-4)"	11.0	14.1	11.7	14.1	15.1	11.9	11.1	15.8	13.8	8.4	20.2	11.3	14.1	24.5	10.4	9.4	14.4	11.8	11.4	9.3	12.4	8.5	12.1	16.5	9.8	16.7	14.2	12.1	10.9	12.8	7.4	16.6	13.5	13.0	10.5	17.7	6.8	14.3	7.2	20.5	10.7	24.9	10.4	11.2	15.2	15.7	7.3	13.2	18.4	10.5	13.1	16.7	11.2	10.3	24.9	22.1	28.4	21.0	25.2	23.5	12.7	10.7	10.6	8.0	11.5	8.8	8.8	26.5	8.0	5.8	10.6	7.2	16.6	10.0	23.5	14.7	6.2	5.1	16.1	15.5	6.5	9.9	12.5	24.2	10.5	6.9	17.8	9.2	18.5	14.6	7.3	10.2	8.0	9.7	4.7	8.7	12.6	21.3	7.9	7.9	11.4	20.3	17.3	16.4	30.6	8.6	18.9	10.7	24.9	10.0	7.9	9.2	14.1	13.3	8.9	9.9	4.0	15.4	24.0	5.7	7.0	9.1	11.8	13.8	12.7	20.0	19.3	7.0	14.6	15.5	20.5	21.0	28.4	14.7	20.5	17.0	24.9	19.2	19.6	19.7	22.6	19.5	18.6	12.4	25.2	20.1	22.1	23.5	12.7	11.7	15.1	15.8	13.8	12.4	8.5	14.2	12.1	13.0	13.2	20.8	18.4	33.7	11.9	8.5	19.4	14.9	50.9	16.0	17.0	24.4	11.8	56.7	33.2	26.8	2.2	24.0	28.6	0.0	31.7	49.1	17.5	14.0	16.2	41.2	25.9	22.3	20.3	19.6	23.7	2.1	27.6	20.7	11.8	22.6	33.2	19.7	25.6	35.1	21.2	15.3	15.6	12.9	13.3	17.2	31.3	10.0	32.5	29.7	39.9	10.4
GNPAT	"DAP-AT, DAPAT, DHAPAT"	ENSG00000116906	"Glyceronephosphate O-acyltransferase"	O15228	1	231241207-231277973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.87e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.29e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-1)"	14.7	20.1	18.3	17.9	17.0	9.6	34.6	18.9	17.8	12.6	18.6	14.7	16.6	18.9	13.9	16.0	14.5	18.4	13.5	39.3	16.9	13.9	16.7	19.5	20.3	24.4	17.1	15.0	15.3	26.7	14.3	15.0	12.3	16.5	15.3	16.3	10.8	20.6	18.0	61.1	14.9	19.1	24.7	17.7	13.5	18.0	26.5	15.0	16.2	13.6	20.2	15.9	14.4	13.6	23.7	23.8	23.4	30.3	16.4	23.9	18.5	14.8	16.6	23.6	17.8	19.4	28.8	15.9	12.6	14.3	13.4	15.4	21.2	18.6	21.4	15.9	18.8	14.1	16.1	15.6	17.1	19.8	24.2	14.3	15.4	16.3	30.5	19.8	26.2	12.3	20.0	21.0	13.8	15.6	17.5	31.3	21.5	22.5	20.6	27.7	4.8	23.3	15.2	37.8	42.2	19.1	25.7	31.6	25.0	16.7	11.1	15.7	22.4	21.1	11.9	18.3	9.8	20.8	41.7	16.3	13.6	12.8	19.6	31.2	26.7	33.9	24.7	19.6	22.2	25.2	17.7	24.1	23.4	16.5	24.0	19.0	23.2	21.6	21.6	23.8	23.7	19.1	17.4	9.5	16.4	30.3	11.3	23.9	18.5	18.3	17.0	18.9	17.8	16.9	13.9	17.1	15.0	16.5	15.0	23.8	14.4	37.4	17.0	11.9	22.4	48.8	28.1	29.4	17.0	26.2	37.3	21.3	14.9	34.5	55.1	21.5	15.8	0.0	37.7	16.2	18.4	21.6	11.5	23.2	24.4	11.1	27.1	16.0	21.2	86.2	23.6	22.5	11.8	25.2	19.8	22.6	34.7	35.1	25.1	22.8	23.3	19.4	22.5	39.6	31.0	12.2	10.4	23.2	31.5	16.0
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	12.1	9.3	10.4	11.2	9.6	22.1	10.3	14.8	12.8	8.6	8.6	9.9	9.5	8.8	9.3	7.6	11.1	8.5	7.7	9.0	9.2	10.3	9.2	11.2	9.5	12.6	9.1	9.9	11.2	11.2	17.1	11.9	14.4	11.9	8.7	7.3	6.7	9.5	9.9	26.7	12.2	11.4	6.8	9.0	13.0	10.1	6.7	9.3	16.9	12.9	9.2	13.3	7.7	9.9	1.8	2.1	6.0	3.8	2.0	3.5	1.2	7.4	8.2	5.0	5.1	13.1	10.7	12.2	9.1	7.7	6.9	6.5	7.7	7.5	8.4	8.1	9.0	6.2	12.2	7.2	9.8	7.6	10.9	17.6	5.1	10.4	4.9	7.4	8.9	14.2	10.7	10.8	10.1	9.7	8.1	8.4	8.8	9.3	20.2	10.9	3.8	8.3	5.5	7.6	9.3	7.0	5.5	7.8	10.8	8.6	8.6	6.7	7.2	9.2	12.1	8.9	4.1	11.6	13.0	11.4	9.3	6.6	12.4	15.9	15.2	8.7	9.2	10.7	8.1	11.7	4.5	1.8	3.3	1.3	2.3	1.6	1.2	1.7	1.5	1.3	1.8	2.0	3.5	6.0	2.0	3.8	2.1	1.5	1.2	10.4	9.6	14.8	12.8	9.2	10.3	9.1	9.9	11.9	9.3	8.9	9.8	9.0	4.6	16.5	3.9	6.7	12.7	2.7	9.1	8.7	5.9	3.6	1.7	2.9	0.8	9.2	6.3	23.3	3.1	2.5	5.3	4.9	2.3	8.2	4.8	3.2	4.6	8.6	12.3	0.4	3.7	6.4	3.3	2.8	4.5	5.7	4.0	0.0	5.3	4.1	11.6	0.0	3.8	4.9	4.7	12.9	7.8	7.7	3.8	6.5
SPRTN	"C1orf124, DKFZP547N043, DVC1, Spartan"	ENSG00000010072	"SprT-like N-terminal domain"	Q9H040	1	231337104-231355023	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025073	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025073: AB_1847695"	"unprognostic (2.63e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.35e-2)"	8.0	8.3	7.5	7.7	9.4	16.2	9.0	7.3	10.0	8.4	7.1	12.4	8.2	6.4	8.5	7.2	11.2	7.3	7.3	8.4	7.7	7.1	8.1	9.6	6.1	9.4	9.9	7.1	7.2	6.3	9.0	12.7	12.5	10.9	6.6	6.3	7.1	8.7	7.2	18.5	9.3	7.0	8.1	10.1	9.2	7.3	23.3	9.3	16.1	8.3	10.9	9.6	7.8	7.6	6.7	6.5	13.8	9.1	8.6	10.1	5.0	11.2	9.8	9.0	9.8	8.4	6.0	10.8	10.3	9.0	11.9	10.3	11.1	10.0	10.2	11.1	8.4	4.7	16.8	12.7	10.2	12.8	8.5	22.0	6.3	9.5	7.7	9.0	10.6	9.4	8.1	11.0	12.8	10.5	5.4	11.8	9.2	15.5	10.1	11.7	6.1	11.3	6.2	8.8	13.0	8.4	10.0	11.9	12.1	10.2	8.4	11.3	10.9	10.8	8.6	11.6	4.2	15.5	16.3	8.7	10.3	10.5	14.6	16.3	7.8	8.1	13.9	8.0	9.4	17.3	9.3	6.6	13.0	7.7	9.1	8.7	6.7	7.8	9.1	6.5	5.2	9.3	10.1	13.8	8.6	6.5	6.1	8.1	5.0	7.5	9.4	7.3	10.0	7.7	7.1	9.9	7.1	10.9	9.3	14.9	3.4	13.7	9.7	28.4	22.3	3.9	2.5	16.0	10.3	3.5	80.5	10.5	8.3	7.5	16.8	14.6	9.0	0.0	8.3	9.5	11.2	7.3	26.4	6.4	8.2	14.3	11.5	10.4	6.1	7.8	8.3	10.3	6.8	13.6	6.4	12.4	8.8	5.9	7.4	6.2	58.4	12.9	12.0	47.2	18.5	24.8	12.7	20.3	6.6	14.5
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231425044	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 14.9;skeletal muscle: 46.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved					NA	NA					"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavorable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	4.9	4.2	4.4	1.4	4.5	0.8	3.5	3.6	4.3	3.0	3.3			3.9	3.1	2.6	3.5	2.3	2.9	7.0	4.4	3.5	5.2	7.2	1.6	1.6	4.1		4.1	4.4	5.5	2.1	4.4		2.6	2.8		2.3	3.5	46.9	5.6	3.9	2.8	4.1	3.0	2.0	1.3			2.8		1.8	2.5	2.7	0.6	0.7	14.9	1.4	0.7	1.1	0.3	13.5	13.0	4.2	8.0	11.0	7.6	4.6	6.7	9.8	9.3	12.8	9.5	10.8	4.1	11.7	9.5	7.1	6.8	5.9	7.8	16.5	5.8	14.8	2.0	5.4	8.1	7.8	9.6	2.7	6.0	7.2	6.3	7.8	13.6	12.1	4.4	9.2	7.7	8.8	2.6	2.3	3.6	5.0	8.2	7.3	5.0	5.8	5.0	11.8	4.8	4.2	11.3	8.3	10.9	22.0	2.8	5.8	27.5	14.3	10.9	6.0	10.9	12.5	19.1	11.6	3.7	15.2	3.6	15.2	4.1	0.6	2.5	0.7	0.9	0.5	0.6	0.8	0.6	0.7	0.6	0.9	1.1	14.9	0.7	1.4	0.6	0.6	0.3											17.9	21.0	17.1	13.9	52.0	29.6	107.6	71.4	9.4	10.3	17.4	35.3	14.4	29.9	33.2	0.9	34.6	39.6	0.0	31.0	19.9	31.2	15.1	9.3	63.5	14.7	58.8	12.2	28.8	20.9	3.4	15.0	24.1	25.3	8.2	24.3	55.9	37.0	28.6	21.5	37.2	42.8	19.4	30.9	8.6	21.6	50.3	8.7	18.1	19.3	17.0
TSNAX	TRAX	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528653-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		100000	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	27.4	29.9	23.9	17.1	26.7	12.0	23.4	28.0	33.1	19.7	16.2	21.9	17.2	15.8	20.0	24.6	18.0	16.4	16.7	22.7	25.1	23.9	29.1	23.0	18.4	22.6	22.1	22.1	18.6	14.6	32.3	36.0	18.3	28.5	21.3	18.0	19.6	17.5	19.9	52.5	20.6	14.8	18.9	28.2	24.0	15.5	17.5	24.4	24.5	26.7	25.4	22.0	19.1	17.3	10.0	11.7	54.6	17.5	18.7	13.5	11.0	11.0	9.1	13.9	11.4	10.3	12.7	15.8	12.6	19.1	16.2	14.0	7.8	15.6	15.6	21.3	13.7	6.0	12.1	11.0	11.4	21.1	13.9	19.2	15.0	9.4	10.3	14.2	24.7	31.9	15.5	12.6	15.6	12.1	10.2	11.7	11.4	24.2	11.1	21.9	4.5	15.9	12.1	20.5	9.3	11.1	15.8	15.3	21.1	18.1	12.8	13.3	25.6	13.1	16.7	42.4	5.9	24.3	42.0	10.9	11.2	10.2	22.4	22.6	18.9	24.9	17.4	18.3	19.6	30.6	54.6	11.2	29.2	11.4	13.5	10.8	10.0	12.3	11.2	11.7	9.9	13.2	12.7	11.4	18.7	17.5	6.8	13.5	11.0	23.9	26.7	28.0	33.1	25.1	23.9	22.1	22.1	28.5	24.4	26.8	32.9	25.4	17.9	38.9	58.2	20.9	38.2	26.8	17.0	40.1	27.5	39.1	46.4	25.0	7.5	33.3	20.5	46.7	27.1	39.0	28.8	14.4	75.1	26.0	42.6	62.0	27.7	27.6	51.1	7.5	31.1	45.0	25.3	37.9	29.8	64.5	23.0	23.4	33.9	36.6	45.9	38.8	35.6	28.1	70.9	44.9	30.3	35.8	22.4	12.2
DISC1		ENSG00000162946	"Disrupted in schizophrenia 1"	Q9NRI5	1	231626815-232041272	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 105.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 12.4;TIME: 9.7;WM-115: 9.9"					"Low region specificity"	"Detected in all"			HPA048911			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	5.3	3.3	9.1	6.4	10.6	5.3	7.6	2.5	7.6	4.9	3.1	11.6	0.0	2.6	4.2	1.6	3.1	2.9	5.6	19.2	9.2	5.9	2.7	3.1	3.9	11.3	10.5	4.8	9.6	2.1	2.7	2.8	14.3	9.2	3.9	2.9	13.1	4.0	2.4	3.2	2.9	3.1	3.4	10.2	6.1	2.4	2.2	9.3	4.2	4.1	2.5	3.9	4.5	7.2	0.5	3.3	2.6	2.9	0.7	1.6	0.7	0.0	0.5	4.5	0.1	0.1	0.4	3.3	1.7	4.1	4.8	4.0	1.6	1.0	0.1	5.4	1.5	1.1	0.0	0.4	0.1	4.2	2.8	1.9	2.4	0.4	4.4	0.6	4.0	6.0	2.5	0.8	1.5	1.3	3.2	4.2	3.1	0.0	1.8	5.2	0.4	1.1	6.1	2.3	0.0	1.7	3.0	1.3	0.5	0.2	0.0	0.8	2.5	1.6	0.0	2.7	1.2	0.0	12.4	9.7	2.5	2.6	1.2	1.0	1.1	0.8	0.0	1.9	6.2	9.9	0.3	2.7	0.1	0.9	2.9	0.5	0.1	1.4	0.3	3.3	0.5	1.6	0.5	2.6	0.7	1.2	1.9	0.5	0.7	9.1	10.6	2.5	6.3	9.2	5.9	10.5	4.8	9.2	9.3	0.0	1.4	0.0	0.5	0.8	10.7	4.6	0.0	1.4	1.2	3.5	7.9	6.0	0.0	0.6	12.9	5.3	0.0	0.0	1.0	0.6	3.3	0.4	6.9	0.0	9.3	0.0	0.0	9.8	13.5	17.3	0.9	8.9	3.3	0.0	0.0	2.5	1.4	0.0	1.4	0.0	105.2	0.0	1.3	0.4	1.1	1.0	2.1	3.1	0.2	0.5
SIPA1L2	KIAA1389	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232561558	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 54.1;Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 33.8;NTERA-2: 27.1;WM-115: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Golgi apparatus"		No	NA			"Nuclear bodies"	"Nuclear membrane, Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: AB_2672165"	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	4.1	1.1	3.6	2.9	3.3	2.1	3.4	0.3	7.6	3.2	8.9			1.6	1.9	1.0	8.7	1.2	4.4	16.2	3.1	3.9	1.6	2.4	6.5	0.8	6.5		6.7	1.4	3.9	3.2	10.0		2.9	10.5		3.3	2.3	2.5	3.3	3.3	3.7	3.0	4.5	2.0	3.4			3.4		1.1	4.7	5.7	0.0	1.2	4.3	1.2	2.0	2.4	0.2	0.0	3.6	33.8	0.2	0.2	0.0	14.6	0.6	1.2	1.5	1.1	1.4	0.0	2.8	6.8	12.7	1.4	0.8	6.9	1.1	1.4	0.0	6.4	0.0	3.3	0.0	3.1	0.4	3.6	1.9	4.7	0.3	3.0	0.0	7.8	12.4	0.0	0.0	0.8	1.5	3.6	0.3	27.1	0.1	5.4	0.0	0.0	1.7	4.3	5.3	1.8	5.9	11.3	0.3	4.6	8.1	0.7	0.4	2.7	4.0	0.0	8.7	1.4	3.2	0.0	0.0	5.0	3.1	22.9	0.0	0.6	0.0	0.2	1.2	2.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	4.3	2.0	0.9	1.2	0.0	0.2											6.0	2.6	0.5	7.6	7.8	24.4	54.1	12.7	5.3	5.7	3.5	49.1	4.0	0.0	5.3	9.5	18.6	16.4	0.0	0.5	6.1	12.6	14.3	1.1	3.0	8.9	4.8	6.9	1.3	12.9	7.6	0.9	11.0	13.5	5.4	30.2	10.8	1.2	35.1	1.8	0.2	35.3	0.0	19.8	3.4	26.0	6.5	12.4	1.0	21.2	15.9
MAP10	"KIAA1383, MTR120"	ENSG00000212916	"Microtubule associated protein 10"	Q9P2G4	1	232804892-232808407	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 9.4;Cone photoreceptor cells: 21.6;Spermatocytes: 8.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.8;NB-4: 7.8;REH: 6.4;THP-1: 11.9;U-937: 8.1"					"Low region specificity"	"Detected in all"			HPA052496	Approved					NA	NA					"HPA052496: AB_2681852"	"unprognostic (2.70e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.60e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.73e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.98e-2)"	1.0	1.6	1.6	1.1	2.9	0.2	2.2	1.7	3.7	2.0	0.9			1.6	1.5	3.8	0.7	1.6	1.4	3.4	1.8	2.0	1.2	3.4	1.2	3.3	1.5		3.1	3.5	0.8	1.4	1.0		1.0	0.7		1.6	0.9	3.1	0.3	1.9	1.5	1.2	1.5	1.7	4.1			2.9		2.5	1.6	0.8	2.0	5.1	7.6	5.0	2.1	2.5	1.4	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.9	0.7	0.3	0.4	0.0	4.8	0.0	2.4	1.8	0.0	0.0	0.0	1.1	0.8	1.8	0.0	0.2	0.3	0.0	2.1	3.0	0.0	3.0	0.3	0.3	0.0	0.3	3.7	0.0	1.2	0.0	1.7	2.1	7.8	7.8	0.0	2.0	0.0	6.4	0.0	2.1	1.7	1.9	4.0	3.3	0.0	0.4	0.0	1.2	0.7	11.9	0.9	0.0	2.1	0.2	1.4	2.3	0.0	0.0	1.9	8.1	0.2	7.6	3.3	2.9	1.0	2.3	1.1	1.2	1.6	0.4	4.4	2.0	2.4	1.7	0.1	2.1	5.0	5.1	2.5	1.4											0.0	1.4	0.8	0.2	0.3	9.4	3.3	5.1	0.0	2.3	0.0	21.6	0.5	0.0	2.1	2.4	1.5	0.9	0.0	2.6	0.6	0.5	0.2	1.1	1.0	1.3	0.0	0.0	0.0	2.7	1.1	0.6	1.1	0.0	3.6	0.9	3.0	1.4	0.0	0.7	0.0	7.1	0.0	0.6	8.0	5.1	0.3	0.2	0.8	0.8	0.1
NTPCR	"C1orf57, HCR-NTPase, MGC13186"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	5.4	9.8	13.2	5.8	14.9	2.5	8.7	14.5	15.9	9.9	8.0	11.1	4.1	5.1	9.6	9.5	8.0	11.3	9.6	10.3	13.3	13.1	8.4	6.1	7.4	6.5	13.7	10.8	12.9	13.4	16.9	8.0	6.3	18.5	8.8	10.3	10.8	10.1	10.0	26.8	9.9	6.8	9.9	12.6	6.3	5.8	11.2	11.0	5.7	13.6	11.1	6.5	7.1	7.4	2.4	1.5	3.3	1.8	1.6	4.3	1.3	2.5	6.2	7.1	3.5	5.3	7.0	0.1	1.7	5.5	5.3	7.2	4.4	3.0	3.9	3.8	3.4	3.0	3.4	4.7	6.3	5.8	2.9	8.9	1.2	3.9	5.6	5.5	2.1	2.4	9.3	12.3	5.1	5.2	5.3	4.3	7.5	3.4	6.1	6.2	1.8	5.5	5.6	7.0	5.1	7.4	3.6	4.6	5.7	7.8	3.1	6.2	10.3	2.4	2.1	2.5	5.6	5.2	4.8	3.2	4.4	3.6	4.8	4.7	6.9	5.6	4.5	5.2	5.2	6.3	1.1	1.6	0.8	2.1	1.8	2.5	1.6	3.0	1.3	1.5	2.4	4.3	3.5	3.3	1.6	1.6	0.6	3.5	1.3	13.2	14.9	14.5	15.9	13.3	13.1	13.7	10.8	18.5	11.0	17.9	19.7	13.4	32.1	17.2	15.2	58.9	28.1	12.0	11.4	24.4	25.5	55.1	79.6	53.6	28.3	24.0	38.0	0.0	56.9	49.7	26.7	31.6	16.1	32.1	37.9	9.5	24.8	26.4	19.2	21.4	18.7	22.0	21.9	33.3	46.4	34.1	37.9	21.0	28.7	60.8	20.0	12.9	24.7	60.2	34.9	20.8	23.5	17.5	61.5	31.6
PCNX2	"FLJ11383, KIAA0435, PCNXL2"	ENSG00000135749	"Pecanex homolog 2"	A6NKB5	1	232983435-233295713	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 29.6"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 8.9;Ciliated cells: 8.1;Club cells: 12.5;Collecting duct cells: 12.2;Distal tubular cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013815, HPA014427"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013815: AB_2236561, HPA014427: AB_1855081"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.27e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	4.7	4.7	11.4	7.5	16.8	4.2	7.7	29.6	23.1	4.9	3.9	6.3	4.2	3.4	6.6	14.0	5.2	9.0	8.1	2.3	11.9	8.2	5.4	1.2	4.7	9.4	8.0	13.1	11.4	5.2	8.6	18.6	2.4	14.3	6.2	4.8	6.0	6.0	8.1	5.6	6.3	5.6	5.2	5.8	5.3	5.8	5.5	5.5	4.0	7.9	3.4	8.8	6.0	5.7	1.5	1.8	0.9	0.9	0.8	3.1	1.1	3.8	9.4	5.1	0.1	8.4	9.2	1.5	2.3	6.8	2.4	4.3	3.0	4.7	8.1	5.5	6.3	9.0	6.4	2.3	6.7	5.7	6.8	6.9	0.1	4.8	0.0	3.8	2.6	1.6	7.0	5.9	4.8	19.1	8.3	4.5	6.1	0.0	4.3	2.4	2.3	7.4	0.2	16.5	3.3	5.7	0.1	1.4	1.1	4.4	6.0	8.8	7.3	3.4	1.5	1.4	3.0	3.4	0.7	1.7	6.8	4.4	7.7	7.6	5.2	5.4	0.1	6.2	3.0	7.8	0.9	0.9	0.4	3.1	0.5	2.4	1.5	2.5	2.9	1.8	1.3	1.1	2.1	0.7	0.8	0.7	0.6	2.7	1.1	11.4	16.8	29.6	23.1	11.9	8.2	8.0	13.1	14.3	5.5	8.9	5.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.5	12.2	0.0	0.3	6.6	5.1	0.0	0.0	0.0	0.0	2.9	1.1	0.0	0.0	1.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.0	0.0	4.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.6	3.2	2.0	3.4	2.2	1.3	2.2	10.0	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1.0	1.2	1.3	6.0	1.0	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5.0	0.2	0.1	7.4	12.7	0.2	0.0	0.0	0.0	6.4	0.2	0.0	0.3	0.5	7.0	6.5	0.7	5.2	0.1	2.4	4.0	9.5	3.9	0.8	13.8	18.3	0.1	7.1	0.0	0.5	12.1	2.9	0.1	5.2	0.2	7.4	1.4	0.4	5.8	0.1	2.4	0.0	1.6	3.8	4.3	9.1	8.7	5.6	0.0	0.0	13.3	8.8	3.1	9.4	2.5	4.3	0.2	0.0	1.0	3.7	3.9	0.0	0.0	1.2	0.0	7.4	2.3	2.9	0.0	1.2	3.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.8	0.5	0.0	0.0	0.1	5.0	0.0	0.2	0.2	0.1	2.0	2.2	10.0	3.3	1.3	2.1	0.9	1.7	1.2	0.6	32.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.0	0.0	0.0	3.3	9.7	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	7.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614004-233672512	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 75.3"	"Cell type enriched"	"Detected in single"	98	"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in single"	98	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 236.2"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	1.9	3.3	15.2	2.2	12.7	0.3	4.5	75.3	22.8	5.5	11.5	7.9	5.1	12.5	4.5	22.9	12.0	8.4	9.3	20.8	10.3	5.2	7.2	10.8	3.4	0.8	8.9	11.1	3.8	4.4	2.5	11.3	5.0	22.3	4.6	10.6	2.6	7.2	9.3	0.5	8.7	9.6	3.2	12.3	0.8	28.0	0.7	7.8	0.0	5.6	1.6	3.2	4.3	6.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	10.3	5.6	0.0	0.0	0.0	0.0	15.8	2.8	0.0	0.0	0.0	0.0	17.0	0.0	6.7	2.0	2.3	15.0	2.8	4.9	0.0	0.0	4.9	0.0	21.0	0.0	0.1	0.0	0.5	1.2	5.3	0.0	3.9	0.3	0.0	5.7	2.4	4.5	0.0	3.8	3.7	0.0	3.4	12.1	12.8	0.0	0.8	1.1	4.9	8.6	19.8	3.9	10.3	4.5	0.0	0.3	1.3	0.0	0.0	0.0	8.4	0.0	0.3	45.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	15.2	12.7	75.3	17.1	10.3	5.2	8.9	11.1	22.3	7.8	8.9	15.6	0.0	117.0	56.2	1.2	37.7	5.1	28.1	33.0	17.4	3.9	0.2	1.7	19.6	0.9	0.7	34.8	0.0	42.5	13.5	15.3	169.9	0.0	8.2	0.6	189.1	28.2	0.0	0.8	0.0	1.4	0.8	10.1	0.0	45.4	65.8	61.4	22.8	0.0	11.3	5.0	0.0	3.4	0.4	0.7	41.7	0.7	1.5	21.1	247.4
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904933-234324516	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in some"	9	"Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	49	"plasmacytoid DC: 7.1"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 7.1"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.8	3.5	4.6	1.3	26.0	0.7	6.8	25.1	16.7	1.4	0.8	0.5	0.0	0.8	1.0	2.5	1.6	1.7	0.8	0.6	5.4	4.6	1.6	0.6	1.2	2.4	4.8	6.6	0.6	3.6	4.6	2.8	0.7	4.1	2.0	0.8	0.0	6.6	1.1	1.1	0.8	0.9	1.1	4.8	1.0	2.5	1.1	4.3	0.5	1.9	0.3	1.9	0.8	0.6	0.0	7.1	0.0	0.1	0.0	0.0	0.0	1.4	3.9	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.3	0.0	3.6	0.0	49.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.4	0.0	0.0	0.0	3.6	0.0	2.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	4.6	26.0	25.1	11.6	5.4	4.6	4.8	6.6	4.1	4.3	0.0	0.0	0.0	2.4	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.6	0.0	0.0	0.0	3.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.0
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234384049	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028588	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.12e-4)"	11.0	17.8	26.4	14.4	33.9	9.4	16.6	14.3	27.5	9.7	17.7	5.7	12.9	26.4	8.4	20.3	15.5	9.4	14.2	19.1	19.3	15.7	21.4	21.4	13.6	16.2	16.3	16.1	9.1	16.7	7.6	9.5	8.7	13.4	13.3	15.6	6.0	13.6	11.6	52.7	8.7	19.7	10.6	11.4	12.5	14.4	5.8	13.3	13.1	13.6	20.2	12.0	11.6	14.6	27.5	33.3	19.7	31.3	18.3	36.6	20.2	17.8	22.9	8.3	9.4	8.7	17.3	26.4	13.1	8.0	13.8	13.0	17.6	23.9	17.8	24.4	7.5	25.9	22.8	12.9	16.2	11.0	22.1	55.1	8.0	26.0	46.6	33.6	19.6	15.6	11.4	21.8	18.1	14.0	12.1	17.0	19.8	38.8	16.1	14.9	9.5	18.6	38.1	20.4	40.3	10.9	11.1	10.0	35.0	17.2	16.9	14.8	10.8	12.7	22.6	40.4	5.5	20.0	33.9	12.8	16.4	13.6	21.9	39.2	19.2	37.2	21.8	12.5	31.2	29.2	19.7	31.3	9.7	18.5	28.5	18.2	27.5	29.9	23.0	33.3	18.0	31.3	23.1	8.1	18.3	23.8	22.5	36.6	20.2	26.4	33.9	14.3	27.5	19.3	15.7	16.3	16.1	13.4	13.3	8.9	20.0	38.5	39.3	50.8	13.8	71.2	22.9	53.5	26.1	45.4	3.9	44.1	87.9	47.5	2.9	23.3	63.5	23.3	59.9	71.2	34.2	56.7	21.9	46.9	75.0	11.1	21.4	22.1	35.3	3.4	24.2	49.2	28.7	43.3	52.3	20.6	56.3	40.3	26.5	86.4	13.3	19.4	24.5	17.2	25.3	51.3	36.5	30.0	65.5	64.8
TARBP1	"TRM3, TRMT3, TRP-185"	ENSG00000059588	"TAR (HIV-1) RNA binding protein 1"	Q13395	1	234391313-234479103	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020810, HPA024632"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB020810: , HPA024632: AB_1857770"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.14e-10)"	"unprognostic (5.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.27e-2)"	7.2	6.7	10.3	10.5	19.4	12.0	11.4	22.5	22.9	6.5	7.3	10.5	3.0	7.8	7.2	9.8	10.7	10.0	11.3	6.6	7.1	6.8	7.0	4.7	7.6	11.9	6.6	18.2	5.7	12.7	12.9	12.1	10.1	13.0	9.5	11.4	8.7	12.8	5.8	11.0	10.1	8.9	5.7	8.0	8.7	10.2	5.6	6.4	8.7	10.1	6.2	13.6	5.5	7.7	1.2	4.0	0.0	0.3	0.9	1.9	0.2	11.5	8.1	5.4	6.2	8.9	12.3	11.1	4.9	3.8	6.5	4.8	3.8	7.6	10.0	5.3	3.7	5.6	7.6	6.1	6.2	6.3	9.8	9.4	5.5	8.5	5.6	2.8	24.2	4.9	5.1	5.7	4.7	2.6	5.1	6.6	13.6	6.9	6.5	4.5	2.4	10.0	11.9	11.3	12.5	3.3	17.6	3.1	9.9	4.4	6.8	5.7	6.8	6.8	8.9	7.5	3.7	5.7	24.8	4.4	6.0	0.7	6.6	9.9	17.4	11.4	4.4	3.9	11.4	8.9	0.0	0.3	0.0	0.6	0.3	0.9	1.2	0.4	0.4	0.4	0.3	1.9	1.1	0.0	0.9	0.1	4.0	0.0	0.2	10.3	19.4	22.5	22.9	7.1	6.8	6.6	18.2	13.0	6.4	38.7	17.7	11.9	3.5	5.6	29.8	5.2	10.2	30.8	14.8	7.0	35.3	16.9	1.7	4.3	12.6	9.2	4.2	0.0	5.0	12.3	8.0	4.6	3.5	7.6	7.8	54.0	11.1	11.1	5.3	1.5	5.2	9.1	10.1	2.8	11.2	8.2	7.1	3.5	5.6	3.3	17.9	0.0	7.6	3.5	5.1	7.2	10.0	11.8	17.6	4.6
IRF2BP2	IRF-2BP2	ENSG00000168264	"Interferon regulatory factor 2 binding protein 2"	Q7Z5L9	1	234604269-234609525	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 396.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 75.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027815, HPA062269"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027815: AB_10609994, HPA062269: AB_2684732"	"unprognostic (1.15e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	17.9	14.5	11.3	21.1	12.9	48.0	29.9	16.5	17.6	19.8	19.3	13.8	10.9	13.9	20.3	13.1	17.3	17.1	31.6	19.6	12.7	11.5	12.3	20.4	35.0	30.3	11.1	10.6	25.3	22.6	15.9	10.8	11.1	13.9	18.5	18.1	16.8	19.6	12.9	18.8	25.2	20.0	11.6	15.0	16.2	17.0	23.9	11.3	28.6	21.1	14.6	19.5	17.4	19.4	4.0	17.4	8.9	4.5	2.8	5.1	2.3	7.5	11.7	8.4	12.9	17.7	14.1	10.1	6.1	5.2	3.7	4.1	6.7	9.4	0.0	14.4	5.8	12.3	10.5	4.5	8.0	5.7	12.4	10.6	7.3	9.2	19.8	14.4	26.9	25.7	16.5	18.6	8.1	15.3	21.0	9.1	6.9	6.3	15.6	9.3	2.2	6.8	28.7	7.6	17.8	4.5	13.4	3.9	17.9	7.0	6.3	16.9	11.9	9.8	13.1	19.1	8.7	12.6	75.3	10.2	13.1	5.5	9.7	11.4	34.7	9.0	2.5	6.5	24.6	17.7	8.9	4.5	7.6	4.1	3.4	4.2	4.0	5.0	4.8	4.5	3.9	5.1	4.3	2.3	2.8	1.8	17.4	3.7	2.3	11.3	12.9	16.5	17.6	12.7	11.5	11.1	10.6	13.9	11.3	125.0	159.6	51.3	373.3	289.5	29.7	48.7	129.9	73.6	138.8	48.8	9.8	34.2	11.6	50.2	20.2	107.9	65.6	70.0	43.0	37.5	72.0	119.8	103.0	148.0	75.7	55.6	139.8	102.5	119.4	18.0	64.5	110.8	104.6	13.6	101.3	95.4	59.9	66.6	76.4	35.8	18.6	77.6	123.6	20.5	17.0	346.3	66.4	45.8	141.3	396.8
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109336-235128936	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	27.2	35.0	46.3	15.3	60.2	32.7	52.8	40.0	66.2	36.1	25.5	28.4	29.0	24.4	34.5	39.0	28.0	40.0	27.9	33.9	47.1	48.7	41.2	35.2	24.2	33.6	42.5	40.5	50.9	63.6	38.6	25.4	27.1	48.2	34.0	28.2	23.5	47.8	30.7	33.4	33.0	21.3	33.8	54.5	19.0	27.2	16.3	23.0	18.0	58.7	28.4	21.9	36.2	28.9	15.9	20.9	16.4	13.8	9.8	22.6	14.2	35.9	19.0	25.0	21.0	19.7	39.8	38.8	25.9	22.4	24.4	17.8	24.5	25.4	43.8	34.5	22.4	6.9	28.8	27.7	25.1	32.2	10.5	59.2	26.7	25.4	46.3	33.0	59.8	16.1	35.5	34.5	24.4	33.7	33.2	26.4	17.2	56.0	16.2	26.7	10.5	25.4	27.1	56.2	24.0	10.3	31.1	19.1	56.7	27.4	25.9	32.9	77.1	20.1	28.2	55.1	10.7	43.6	65.8	23.3	21.5	13.0	27.1	54.9	38.4	36.1	32.1	25.2	28.7	36.3	16.4	12.4	4.1	13.9	12.9	17.1	15.9	18.1	17.3	15.1	12.7	22.6	17.6	3.9	9.8	13.8	20.9	15.5	14.2	46.3	60.2	40.0	66.2	47.1	48.7	42.5	40.5	48.2	23.0	128.1	138.6	191.4	199.9	237.5	49.8	120.5	135.0	99.0	162.7	47.1	27.5	147.0	135.9	142.1	230.8	135.2	112.6	46.7	180.7	308.9	116.9	237.5	153.6	148.6	144.2	47.7	154.1	102.5	169.4	269.0	143.5	148.5	141.7	101.0	251.0	122.3	199.7	133.3	144.2	188.2	47.6	103.5	156.9	79.9	69.4	250.1	166.8	109.0	224.1	238.8
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161457	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	15.8	10.5	17.2	16.4	18.1	30.6	14.8	15.5	22.3	11.0	13.5	10.6	7.0	16.7	10.9	15.2	15.4	9.9	11.3	15.2	13.4	11.6	19.4	14.2	11.5	20.0	16.9	9.9	13.9	13.5	6.6	24.9	14.7	20.9	13.5	12.6	7.6	18.3	11.2	22.2	17.9	17.6	10.9	17.9	14.6	13.1	28.8	17.3	17.5	14.7	10.9	17.1	14.1	16.0	34.2	27.2	38.0	19.2	25.3	35.5	22.7	12.0	9.1	9.5	12.1	7.2	13.0	23.6	12.8	8.9	11.5	11.1	12.3	13.8	20.8	13.9	7.7	9.2	18.1	11.3	11.7	11.1	18.8	18.4	15.6	6.5	8.5	14.4	24.6	15.3	11.4	13.5	10.7	7.4	10.6	9.2	20.8	22.1	10.7	14.5	6.9	21.4	21.2	27.6	16.6	6.5	20.1	10.5	24.0	11.9	9.2	11.8	21.5	17.7	11.3	28.9	6.9	24.6	26.8	9.6	11.7	10.2	16.1	25.6	13.0	21.0	22.0	13.7	16.5	18.2	38.0	16.9	20.4	23.7	19.2	28.2	34.2	27.3	30.4	17.2	26.3	26.0	29.9	8.2	25.3	19.1	27.2	35.5	22.7	17.2	18.1	15.5	22.3	13.4	11.6	16.9	9.9	20.9	17.3	17.9	10.9	5.1	5.4	2.9	3.3	2.6	5.1	16.0	11.4	3.5	9.8	5.2	5.0	5.6	5.6	3.5	3.6	0.0	5.4	3.7	3.5	4.5	22.0	3.0	2.9	0.0	7.5	5.5	6.8	4.4	3.7	4.3	3.3	9.0	2.6	4.1	7.1	2.9	5.3	7.9	4.9	0.0	5.2	6.1	5.3	3.3	5.1	11.4	3.7	5.7
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	15.3	13.8	14.9	19.0	22.5	34.1	15.9	32.8	17.6	19.7	13.4	19.2	18.2	9.1	18.7	18.1	12.0	15.0	15.2	10.6	15.2	14.5	13.1	14.0	15.5	22.3	26.9	13.9	21.8	16.8	23.8	25.7	14.7	20.3	17.9	10.7	12.0	16.7	17.0	12.3	12.3	14.2	14.6	19.8	19.8	14.7	19.5	23.4	33.7	20.2	8.2	18.9	18.2	18.6	17.1	11.7	35.9	11.8	16.6	17.0	6.0	12.2	9.2	16.2	12.5	11.9	12.5	13.3	14.0	12.3	9.7	9.5	9.5	13.1	14.4	16.3	10.5	6.9	10.9	13.1	5.9	14.1	18.5	14.2	11.6	11.1	7.9	9.1	12.4	17.1	8.4	8.0	11.9	10.2	12.7	13.1	9.2	15.0	20.7	9.1	5.5	18.5	11.3	14.8	8.8	6.1	6.9	11.5	12.0	10.6	10.3	13.2	18.3	17.8	14.8	13.8	4.9	15.6	20.1	18.0	12.0	9.1	14.6	13.6	20.2	16.0	14.4	8.2	9.1	16.0	24.6	7.1	19.5	16.1	7.6	14.7	15.6	17.0	13.7	6.8	17.1	16.9	14.4	35.9	16.6	11.8	11.7	13.6	6.0	14.9	22.5	32.8	17.6	15.2	14.5	26.9	13.9	20.3	23.4	95.3	99.9	54.7	68.9	110.4	111.2	62.2	35.7	91.0	101.2	29.6	113.9	55.7	16.6	62.0	329.6	108.9	41.9	46.7	41.8	58.1	114.7	81.5	105.3	23.1	39.4	106.5	86.4	65.7	52.4	349.2	93.7	99.4	79.2	108.2	45.8	77.7	57.3	49.9	72.9	15.0	150.5	45.3	129.6	212.6	167.8	93.1	131.0	129.6	39.6	111.5
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 164.1;Late spermatids: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029472	Enhanced					NA	NA					"HPA029472: AB_10696206"	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.5	24.8	26.8	16.2	25.7	6.8	33.4	30.1	28.7	24.9	23.1	19.9	21.8	19.8	22.8	30.3	24.1	20.9	19.2	21.8	25.4	25.8	26.4	20.0	18.9	18.3	24.4	22.0	23.5	16.0	19.0	29.3	24.2	25.8	29.0	23.2	15.9	27.8	21.9	26.8	19.0	20.6	24.9	28.3	20.4	20.1	42.5	25.6	22.6	27.9	21.2	20.0	26.9	17.9	28.5	22.2	33.9	35.9	22.1	31.3	26.0	16.6	9.0	22.7	17.0	17.7	25.6	8.9	14.9	20.8	9.8	13.9	7.0	26.6	11.3	21.6	16.3	16.0	13.6	12.0	15.3	13.1	11.5	22.4	9.6	8.6	11.8	20.0	11.8	8.2	16.6	27.6	13.3	18.0	17.4	17.4	19.1	22.9	10.2	12.9	9.8	14.6	14.1	19.4	44.2	4.7	9.0	7.1	12.8	27.4	9.0	18.2	25.2	11.1	25.6	21.3	8.7	31.9	18.8	14.7	11.8	8.9	19.9	13.9	17.8	21.5	13.8	14.9	13.3	21.1	26.6	22.8	33.9	24.8	26.8	24.9	28.5	31.3	26.4	22.2	23.4	29.2	26.5	20.6	22.1	35.9	18.4	30.0	26.0	26.8	25.7	30.1	28.7	25.4	25.8	24.4	22.0	25.8	25.6	29.8	37.5	16.7	58.0	35.4	29.3	20.4	20.4	17.4	15.9	19.2	41.2	26.1	61.3	31.7	164.1	29.1	23.6	0.0	25.0	30.3	35.7	57.0	23.2	12.4	23.9	46.1	16.7	28.3	22.2	214.2	33.1	33.8	64.1	33.3	21.8	38.1	25.9	24.1	32.9	45.5	48.9	25.8	42.4	62.3	46.6	35.5	39.4	32.6	20.4	46.7
TBCE	"HRD, KCS, KCS1, pac2"	ENSG00000285053	"Tubulin folding cofactor E"		1	235328570-235448952	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA026552, HPA026557"	Approved					NA	NA					"HPA026552: AB_1857797, HPA026557: AB_1857798"																		5.8	4.3	6.5	5.3	6.2	5.4	4.7	7.5	8.7	5.0	5.3	4.5	5.0	4.7	6.8	3.5	5.7	4.6	3.7	4.5	5.6		6.0	3.8	3.8	6.6	5.8	5.1	9.4	3.1	3.4	7.2	6.7	6.2	6.7	5.3	3.3	6.5	5.0	4.7	4.5	4.8	5.9	5.5	4.6	5.7	6.6	6.2	5.2	6.8	4.8	6.6	6.5	1.7	4.3	5.1	7.1	6.5	3.6	6.4	4.5	5.3	3.4	7.1	7.8	2.1	3.4	3.5	2.4	2.6	8.7	4.6	1.4	4.9	4.4	7.2	2.0	3.3	2.4	4.6	4.3	6.0	5.5	6.6	3.0	2.8	2.3	0.9	5.2	5.7	1.2	1.5	4.7	5.4	1.8	3.1	4.1	5.1	3.1	5.2	4.2	5.7	2.4	6.9	2.5	1.7	4.5	3.8	2.7	3.1	2.9	10.6	7.6	4.8	3.6	2.5	1.6	7.1	6.9	2.2	3.4	7.1	2.4	2.8	3.6	6.6	6.5	6.2	2.7	5.5	7.1	5.2	5.7	5.7	6.5	6.0	4.3	5.1	6.0	5.1	3.6	5.9	4.9	1.5	3.6	5.3	3.9	6.4	4.5											0.0	5.1	5.4	4.6	2.7	8.6	0.0	7.6	5.3	4.5	7.0	3.9	0.0	0.0	2.6	6.3	3.3	4.2	0.0	1.4	0.0	3.1	2.3	3.5	5.8	0.0	6.4	3.4	0.6	4.3	5.3	10.0	6.6	8.5	10.0	5.0	7.8	2.4	5.3	7.1	0.6	11.3	0.0	5.6	13.5	8.1	2.5	0.0	5.3	8.1	3.9
TBCE	"HRD, KCS, KCS1, pac2"	ENSG00000284770	"Tubulin folding cofactor E"	Q15813	1	235367360-235452443	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Dwarfism, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	141	"Cardiomyocytes: 14.1"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA026552, HPA026557"	Approved					NA	NA					"HPA026552: AB_1857797, HPA026557: AB_1857798"																		5.2	6.6	4.0	4.3	5.9	3.4	3.1	9.4	6.9	3.8	5.6	5.6	3.6	6.2	7.3	3.4	8.5	2.5	5.8	9.2	4.3		6.7	7.2	3.5	4.0	3.0	4.5	4.1	10.5	2.6	8.7	4.9	11.0	4.5	3.7	6.2	7.8	2.7	15.5	6.5	4.6	3.6	4.4	3.1	5.6	5.0	3.8	3.6	10.7	5.7	5.0	6.0	3.0	1.8	5.3	1.5	6.0	2.0	2.4	1.8	12.0	14.6	11.3	7.5	7.8	8.8	12.7	13.7	5.2	11.7	14.7	12.9	10.3	9.3	25.9	4.5	10.1	8.1	9.9	6.7	9.9	15.8	19.0	9.1	9.3	11.5	11.4	15.2	7.1	9.4	6.1	9.3	9.7	7.3	5.8	15.8	33.5	6.1	11.5	5.9	9.0	7.4	19.6	25.9	3.3	8.9	15.9	19.1	11.4	8.7	9.4	8.9	9.9	10.0	12.9	7.9	17.6	15.9	9.5	10.8	8.3	14.3	13.6	10.0	18.4	10.7	10.0	10.8	16.0	0.6	3.7	1.5	2.0	6.0	2.3	0.8	1.8	2.4	5.3	1.8	1.2	2.0	0.3	2.0	3.2	1.9	1.2	1.8											0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235449923-235504481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 35.7"	"Cell type enriched"	"Detected in many"	7	"Cone photoreceptor cells: 237.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012502, HPA050662"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012502: AB_1845228, HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	5.0	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8.0	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3.0	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7.0	5.0	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	9.9	6.5	7.2	10.7	11.7	9.9	17.4	8.7	7.9	6.6	6.1	5.0	8.9	5.2	11.5	9.9	4.3	12.6	14.0	10.2	8.2	10.2	9.7	3.3	8.3	5.7	7.4	10.7	3.7	7.1	6.6	6.8	16.5	5.0	10.1	14.1	8.0	7.0	6.2	4.7	6.7	3.9	10.3	6.3	3.7	7.4	12.0	13.2	4.2	11.8	9.3	11.9	15.1	5.7	7.5	3.1	11.0	10.9	9.9	5.8	9.6	9.8	11.6	10.2	8.4	3.2	3.8	7.7	13.4	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1.0	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3.0	3.2	4.7	3.9	8.9	5.3	6.4	25.1	27.7	18.9	5.4	2.5	5.3	4.5	5.2	237.6	17.0	0.0	5.8	13.0	6.7	7.3	0.0	6.1	5.6	8.1	23.5	5.7	4.4	3.5	27.0	8.6	4.3	3.1	4.5	9.8	7.9	1.7	9.0	4.6	7.8	7.6	4.3	15.2	0.8	17.3	0.0	14.4	16.6	34.1	26.0	18.8	5.3	5.2	31.0
GNG4		ENSG00000168243	"G protein subunit gamma 4"	P50150	1	235547687-235650754	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;ovary: 25.1;pituitary gland: 18.8"	"Cell type enhanced"	"Detected in many"	15	"Glandular cells: 31.6;Intestinal endocrine cells: 41.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 29.0;SCLC-21H: 30.7;SH-SY5Y: 43.2;U-2197: 12.9"	"Region enriched"	"Detected in many"	6	"olfactory region: 574.6"	"Region enhanced"	"Detected in all"		"olfactory region: 427.7"							NA	NA						"unprognostic (1.50e-3)"	"unprognostic (8.33e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.56e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.01e-3)"	1.9	9.4	16.8	2.0	21.5	0.9	1.1	8.6	24.1	1.8	3.4	6.5	0.5	2.5	8.3	1.1	8.4	1.6	1.2	0.9	10.2	20.8	1.3	0.8	0.9	4.7	6.3	7.7	25.1	4.5	0.8	18.8	4.2	11.2	17.1	3.0	1.7	1.4	1.4	0.8	1.1	4.8	5.8	7.1	0.9	3.6	2.1	2.8	3.1	0.9	0.0	3.9	1.2	1.1	1.3	0.8	3.8	0.6	1.0	0.8	0.3	6.8	0.4	5.1	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	2.1	1.7	0.8	5.4	0.2	1.3	3.5	2.0	0.0	0.1	2.6	0.1	0.0	2.3	0.4	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	1.3	0.2	29.0	0.0	0.0	0.0	2.7	0.1	0.0	0.2	30.7	43.2	0.2	0.1	0.6	0.3	0.0	1.0	0.0	0.3	0.9	12.9	0.9	1.0	0.0	0.0	0.9	0.0	8.5	3.8	0.6	0.6	0.5	0.5	0.4	1.0	0.8	0.5	0.2	1.3	0.6	0.6	2.3	1.0	0.5	0.8	0.6	0.3	16.8	21.5	8.6	21.7	10.2	20.8	6.3	7.7	11.2	2.8	0.0	0.0	0.0	1.6	0.5	2.3	0.4	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	1.0	0.4	3.1	0.0	7.4	5.8	0.5	31.6	0.0	0.0	0.8	1.6	41.2	0.0	0.0	0.6	0.3	0.6	0.0	1.8	11.8	0.5	2.6	0.6	0.4	2.6	1.0	0.0	0.5	1.2	2.1	0.0	5.3	0.0	1.5	0.9
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.8"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 236.3;Rod photoreceptor cells: 167.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.0;monocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	10.3	5.2	6.4	9.0	8.8	31.3	10.6	10.5	7.1	8.8	5.3	3.8	3.4	3.4	6.8	4.3	6.6	5.6	5.8	4.7	4.3	2.4	5.0	6.1	10.9	7.8	4.2	6.0	6.2	5.0	9.1	12.6	5.5	5.3	6.0	5.0	9.6	8.2	4.8	3.9	11.7	6.3	9.8	9.2	11.3	8.4	6.4	6.3	38.8	8.5	4.0	7.6	9.3	10.6	1.6	1.7	13.0	5.9	1.7	1.0	0.7	3.8	0.9	0.4	0.9	6.0	6.9	0.6	1.4	5.7	1.5	1.4	0.0	1.0	0.5	0.6	3.1	3.6	1.8	0.5	0.7	1.3	13.7	1.2	1.2	0.8	0.3	1.1	1.8	1.7	2.3	3.6	1.9	4.7	2.2	1.2	0.6	0.1	0.8	1.2	0.2	2.3	3.9	0.1	0.7	0.4	0.1	0.5	0.0	4.4	4.2	2.5	0.5	1.5	0.0	12.7	0.5	0.5	44.9	2.6	1.1	0.5	1.3	1.2	0.9	0.0	0.0	1.9	17.2	3.2	0.4	3.1	5.7	0.6	3.5	1.0	1.1	0.3	0.7	1.7	1.6	0.2	0.5	13.0	1.7	5.9	0.2	0.2	0.7	6.4	8.8	10.5	7.1	4.3	2.4	4.2	6.0	5.3	6.3	17.9	50.4	48.0	71.9	63.1	61.8	9.2	10.2	24.1	39.8	10.4	88.4	5.4	10.0	5.6	9.9	41.7	11.5	0.0	10.7	4.0	23.9	49.0	106.6	14.5	28.2	49.3	9.2	15.4	73.1	13.4	25.9	70.4	114.7	236.3	11.3	23.7	24.4	14.2	20.5	9.0	167.4	12.9	28.6	79.6	22.6	57.0	7.3	65.4	6.3	82.9
NID1	"entactin, NID"	ENSG00000116962	"Nidogen 1"	P14543	1	235975830-236065162	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ito cells: 249.8;Leydig cells: 164.3;Peritubular cells: 118.1;Sertoli cells: 239.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 5.4;intermediate monocyte: 11.3;myeloid DC: 4.5;non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 4.5;monocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 178.5;ASC TERT1: 83.3;HHSteC: 33.7;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010044	Approved				"Secreted to extracellular matrix"	NA	NA		90000000			"CAB010044: AB_2153287"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.38e-8)"	"unprognostic (3.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.72e-3)"	49.4	12.7	1.6	14.7	4.0	0.7	80.5	1.7	2.2	38.8	29.3	1.9	10.4	6.9	29.4	25.5	23.8	27.4	24.3	40.5	1.6	1.1	18.3	36.7	18.8	24.5	3.3	1.4	29.4	6.3	4.6	3.6	74.6	3.8	19.2	7.3	19.9	6.3	15.3	18.3	7.9	18.5	36.1	3.9	31.0	23.0	19.6	1.7	1.4	12.2	6.2	3.8	41.9	30.0	0.0	4.5	0.3	11.3	0.1	0.0	1.8	0.1	0.5	6.1	0.0	178.5	83.3	11.6	13.8	11.5	8.6	5.7	3.2	4.3	0.0	2.7	20.6	2.3	0.4	4.0	0.0	5.1	0.0	6.6	0.8	0.7	4.9	33.7	0.0	0.0	70.4	0.6	4.2	0.1	3.4	18.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	6.3	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	5.2	0.1	0.0	1.1	2.4	0.0	5.5	15.6	7.5	5.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	11.5	0.2	5.4	0.0	0.0	11.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.1	7.1	0.0	0.0	1.8	1.6	4.0	1.7	2.0	1.6	1.1	3.3	1.4	3.8	1.7	3.0	1.0	9.3	1.1	5.4	0.2	20.7	7.6	0.0	3.4	0.0	0.0	13.2	0.0	0.4	1.1	27.8	0.0	0.0	0.8	8.4	71.4	3.5	1.1	58.6	6.8	3.2	0.0	249.8	23.4	2.4	164.3	6.1	16.9	1.0	0.0	2.1	4.3	0.0	118.1	7.1	0.0	239.3	48.4	0.7	0.2	4.5	13.2	1.9	0.0	2.5
GPR137B	TM7SF1	ENSG00000077585	"G protein-coupled receptor 137B"	O60478	1	236142505-236221865	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 130.8;Muller glia cells: 234.3;Rod photoreceptor cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.3;SK-MEL-30: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026422	Approved					NA	NA					"HPA026422: AB_1849338"	"unprognostic (1.59e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	12.6	6.0	26.3	11.6	32.0	4.5	11.3	12.1	23.2	16.3	7.8	18.4	5.6	7.6	14.9	31.8	7.5	5.1	15.8	19.7	24.1	16.3	51.2	16.7	12.7	18.8	23.4	16.7	10.2	3.3	2.0	3.1	22.4	18.9	8.7	8.8	31.1	5.5	12.2	1.7	13.2	6.8	12.7	26.5	16.2	8.4	3.1	20.0	3.8	11.9	1.7	12.7	19.0	10.4	0.5	1.2	11.7	6.8	0.1	2.7	0.4	1.7	2.4	2.0	1.8	27.3	15.5	0.6	3.9	8.7	2.4	3.3	0.5	2.1	0.2	6.3	4.1	5.4	1.4	2.6	2.4	2.3	1.7	5.1	1.0	0.3	0.4	3.8	1.3	9.7	10.0	8.2	1.8	0.9	7.6	3.8	2.4	0.1	0.0	4.0	2.0	1.1	0.5	1.0	0.7	0.9	1.9	3.2	0.7	3.5	6.3	1.5	3.0	1.4	5.4	67.0	1.6	7.0	2.3	3.3	3.6	2.5	8.5	3.8	0.3	2.1	0.2	2.2	0.9	5.5	11.7	0.9	9.2	0.9	4.0	0.5	0.5	0.7	2.7	1.2	0.3	0.4	0.9	0.2	0.1	6.8	0.3	1.8	0.4	26.3	32.0	12.1	17.6	24.1	16.3	23.4	16.7	18.9	20.0	0.0	1.7	13.7	19.2	22.9	31.8	21.6	5.1	0.0	0.0	12.2	33.4	32.4	14.9	10.9	0.0	5.1	0.8	0.0	9.1	8.0	22.8	18.1	20.7	3.9	78.6	49.3	8.2	13.5	52.0	0.0	8.3	34.3	65.8	130.8	3.6	234.3	10.4	2.9	5.6	77.4	135.9	0.0	10.3	0.1	0.2	17.3	34.1	17.5	2.3	23.0
ERO1B	"ERO1-L(beta), Ero1beta, ERO1LB"	ENSG00000086619	"Endoplasmic reticulum oxidoreductase 1 beta"	Q86YB8	1	236215555-236281985	"Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pancreas: 160.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 96.2;Spermatocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028085	Enhanced				"Intracellular and membrane"	NA	NA					"HPA028085: AB_10601214"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (7.53e-5)"	"unprognostic (1.73e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.90e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.09e-3)"	2.7	2.5	3.2	4.3	4.8	2.6	6.9	7.4	4.0	2.4	3.3	2.0	5.7	4.4	2.5	10.1	1.4	2.1	4.1	2.9	3.3	2.7	3.7	11.6	2.5	3.5	4.0	1.7	3.4	160.4	5.4	8.5	2.2	3.9	2.7	1.4	1.4	9.0	3.2	1.9	1.7	2.7	2.2	3.0	4.1	17.7	10.9	4.1	4.1	12.5	0.8	2.7	2.4	2.3	2.9	7.2	12.9	1.9	1.3	2.8	0.9	1.9	2.3	3.8	3.3	3.1	2.0	4.6	2.9	2.8	2.1	1.8	0.6	2.1	5.2	8.1	4.6	7.9	0.9	1.8	2.6	3.0	5.3	11.4	1.5	0.3	2.0	8.2	2.1	0.9	3.6	5.7	3.7	7.1	4.6	2.5	4.9	0.8	13.3	2.8	1.0	0.9	0.9	1.5	0.2	0.7	10.9	2.7	1.3	4.2	4.5	8.0	4.7	9.5	3.3	7.7	2.1	7.7	9.5	2.3	3.2	2.7	3.2	3.9	9.3	0.6	3.0	4.4	3.1	4.9	12.9	1.9	3.2	2.8	1.9	2.5	1.9	1.5	1.9	1.9	2.9	2.3	2.2	3.9	1.3	0.8	7.2	1.4	0.9	3.2	4.8	7.4	4.0	3.3	2.7	4.0	1.7	3.9	4.1	8.9	10.3	14.8	16.9	0.0	17.4	0.0	30.6	2.7	5.7	15.7	13.7	11.3	1.7	4.0	96.2	5.8	0.3	0.0	14.8	3.6	2.8	16.1	4.7	24.1	5.9	23.8	14.0	13.5	15.6	13.2	17.8	7.4	0.0	3.6	1.5	10.4	15.9	0.0	10.6	7.1	50.0	0.0	0.0	84.9	13.2	0.0	18.9	11.5	0.4	8.4
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 22.7;granulocytes: 20.9;Syncytiotrophoblasts: 18.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	6	"basophil: 24.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 24.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 37.6;RT4: 30.4"	"Group enriched"	"Detected in some"	5	"olfactory region: 0.7;thalamus: 0.8"	"Low region specificity"	"Detected in many"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.9	0.4	0.5	2.4	0.5	0.2	5.8	0.3	0.4	1.1	1.1	0.1	13.7	0.2	0.9	13.0	7.2	1.0	1.3	2.2	0.4	0.4	2.5	0.6	1.7	1.2	0.5	0.0	0.7	5.5	0.0	0.4	6.4	0.1	11.3	0.2	1.7	3.6	16.6	0.3	5.7	0.7	3.6	0.4	2.9	6.4	4.0	0.2	4.5	6.4	5.3	6.8	15.6	9.9	0.1	0.3	24.6	0.2	2.9	4.0	1.1	0.0	1.8	0.1	0.0	0.0	0.0	7.7	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.1	2.0	4.2	3.0	4.5	0.7	6.0	3.6	0.0	0.0	0.6	0.0	0.1	37.6	0.0	1.3	0.5	0.4	0.0	0.0	0.9	0.2	0.0	0.0	0.3	0.1	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	30.4	0.2	0.1	0.0	0.6	0.1	0.2	7.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.6	0.2	0.0	2.1	0.2	2.7	0.1	3.2	4.0	0.3	0.1	0.3	2.1	0.2	2.9	0.1	0.0	2.9	1.1	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.0	0.1	0.2	0.0	2.2	0.8	6.8	6.2	0.0	2.8	5.1	1.4	6.8	0.0	0.0	22.7	3.3	1.2	4.8	1.8	0.0	0.0	0.8	12.0	2.0	3.1	20.9	0.0	3.1	0.0	0.0	4.3	2.7	5.8	0.3	0.7	11.8	6.4	0.0	0.4	1.0	0.0	0.4	0.2	0.0	0.0	1.7	3.1	3.4	4.5	18.9	5.0	0.0	5.8
LGALS8	PCTA-1	ENSG00000116977	"Galectin 8"	O00214	1	236518000-236552981	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012734, HPA030491"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012734: AB_2668720, HPA030491: AB_10602345"	"unprognostic (2.03e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.21e-2)"	27.8	14.0	15.0	17.0	30.5	28.9	18.6	21.7	22.6	14.1	14.8	9.5	10.7	15.5	13.6	19.2	18.5	12.4	17.2	36.0	16.2	14.8	18.5	34.1	21.0	28.2	13.7	17.0	18.3	18.8	22.5	22.7	43.1	25.2	19.8	14.9	10.0	22.4	17.5	7.7	25.3	18.1	15.3	18.1	41.3	13.6	39.9	14.6	19.9	16.8	13.0	16.4	20.7	14.6	4.4	12.7	38.5	14.2	5.3	8.9	9.3	17.7	9.3	1.3	7.0	16.6	14.1	20.6	13.2	15.1	16.5	19.2	12.6	21.7	0.5	12.9	10.9	9.7	19.9	3.7	18.9	15.5	10.3	2.8	12.0	8.1	22.4	20.9	15.9	28.4	13.0	15.1	14.8	5.0	15.9	18.2	9.2	14.2	9.0	11.9	10.9	7.5	3.1	4.8	1.5	7.0	9.1	0.3	1.1	11.7	28.9	4.5	9.3	8.5	28.0	4.7	0.8	20.8	12.6	13.3	0.3	8.2	9.9	16.5	3.4	2.6	0.4	17.1	22.3	10.5	38.5	14.2	7.2	5.4	12.9	7.4	4.4	7.8	5.8	12.7	2.9	5.2	5.4	6.7	5.3	8.7	5.8	8.9	9.3	15.0	30.5	21.7	22.6	16.2	14.8	13.7	17.0	25.2	14.6	71.5	57.4	15.2	26.4	28.8	24.1	47.0	28.1	68.3	67.1	14.0	23.6	53.8	5.0	47.7	244.5	34.9	23.1	0.0	34.4	48.3	22.6	20.5	104.2	22.4	48.8	36.5	17.4	38.6	85.5	157.7	21.9	34.0	6.8	4.6	17.8	6.5	38.3	26.2	13.1	10.3	18.2	25.8	20.0	24.6	8.7	32.4	147.4	34.6	14.5	18.7
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604504	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		120000	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	14.1	11.0	9.2	14.7	11.3	15.2	13.8	15.0	13.9	10.7	10.6	8.6	8.3	7.6	15.9	9.4	14.7	12.5	8.1	9.4	10.0	5.8	9.9	13.2	10.6	16.5	12.9	6.9	15.8	17.2	13.5	12.8	10.5	11.6	11.1	10.8	8.2	12.6	9.5	12.7	14.5	11.6	13.1	6.6	16.1	11.5	20.3	13.2	18.3	12.0	12.8	17.9	12.7	12.8	9.9	5.9	1.8	4.5	6.4	10.0	2.4	14.5	17.5	9.2	13.9	12.9	14.5	20.6	11.8	7.6	13.6	12.2	17.6	12.4	23.9	13.3	10.8	8.4	17.7	20.9	12.6	18.5	12.0	24.0	17.0	12.5	15.0	11.6	30.3	11.0	11.8	11.4	20.5	17.8	6.6	15.5	11.1	38.4	8.1	13.5	7.8	14.3	8.3	36.7	18.7	7.2	16.0	13.3	22.4	8.7	14.7	8.6	19.2	14.3	10.2	12.2	6.4	12.1	11.4	14.7	13.7	12.9	17.6	29.1	15.4	19.2	28.3	12.2	17.0	20.3	1.8	3.6	1.1	7.3	4.5	6.6	9.9	7.2	7.9	4.3	8.1	10.0	9.4	0.5	6.4	4.3	5.9	5.9	2.4	9.2	11.3	15.0	13.9	10.0	5.8	12.9	6.9	11.6	13.2	3.0	10.9	8.8	9.3	17.5	11.2	3.5	12.7	12.0	14.8	5.2	17.7	7.0	3.3	7.4	5.7	10.0	2.7	0.0	7.1	8.9	9.9	7.4	31.3	8.9	6.6	6.4	4.1	11.1	10.0	0.9	13.0	7.4	1.7	6.4	5.5	4.4	10.4	2.9	9.6	3.5	10.4	0.0	9.2	21.3	30.8	14.8	4.1	10.2	8.3	9.1
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236686454-236764631	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4"	"Cell type enriched"	"Detected in some"	88	"Cardiomyocytes: 1655.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.1;HSkMC: 12.2;hTEC/SVTERT24-B: 7.6;WM-115: 2.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 59.7"	"Low region specificity"	"Detected in many"			"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		69000000	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0.0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0.0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0.0	3.5	75.4	4.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	3.1	0.0	0.0	0.1	0.0	0.0	0.7	12.2	0.0	7.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.5	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3	0.0	1.1	0.0	0.3	0.2	0.7	1655.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	18.7	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.6	1.1	0.0	1.4	1.9	2.0	0.1	0.0	0.0	0.0	0.1
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795281-236903981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 84.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA044474: AB_10966696, HPA054915: AB_2732589"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (8.10e-2)"	14.5	11.4	9.9	13.2	13.5	7.6	13.6	14.8	14.4	16.9	16.4	16.2	16.0	7.5	18.1	27.3	10.4	18.4	16.3	21.9	9.4	9.8	21.2	9.5	11.7	14.3	12.6	12.8	24.7	20.8	27.4	12.4	17.5	13.0	14.0	8.9	17.7	11.1	17.3	27.0	15.4	11.7	23.3	12.1	13.9	14.9	20.1	12.1	20.8	22.4	11.1	13.2	18.4	14.4	3.3	1.6	3.0	2.0	2.3	5.8	2.1	9.9	6.7	8.3	6.8	15.4	14.2	9.8	8.8	7.8	9.7	10.1	6.4	7.7	22.3	8.1	9.8	5.2	6.9	10.7	7.8	11.6	10.3	9.2	13.1	9.0	11.7	10.3	20.7	8.2	20.2	4.9	12.8	12.3	7.6	12.8	12.1	18.8	10.5	8.1	6.9	10.8	6.7	11.1	8.2	3.6	11.8	14.7	14.3	7.0	11.6	6.8	18.9	9.9	7.2	8.8	6.1	10.3	8.5	16.6	16.0	6.1	12.2	11.3	22.7	7.0	13.0	10.4	13.1	15.8	2.7	1.6	3.0	3.2	2.0	5.8	2.7	4.2	4.5	1.5	3.3	5.0	4.0	0.1	2.3	1.5	1.6	2.9	2.1	9.9	13.5	14.8	14.4	9.4	9.8	12.6	12.8	13.0	12.1	53.6	31.2	20.1	6.8	7.2	0.0	84.0	20.4	20.1	13.6	38.4	0.0	19.3	1.7	11.9	5.3	12.8	6.3	0.0	12.8	7.8	17.5	8.3	29.0	9.6	12.6	0.0	8.1	15.4	16.5	4.2	22.2	10.4	10.1	10.8	7.3	0.0	11.7	10.5	31.1	5.7	0.0	6.5	15.5	14.9	19.7	4.4	18.9	11.7	12.1	4.8
MT1HL1	MT1P2	ENSG00000244020	"Metallothionein 1H like 1"	P0DM35	1	237004103-237004418	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 10.5;liver: 4.3"	"Group enriched"	"Detected in some"	5	"Distal tubular cells: 6.6;Hepatocytes: 7.3;Paneth cells: 8.6;Proximal tubular cells: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;U-2 OS: 1.7;U-266/84: 3.5;U-87 MG: 1.2"															NA	NA										"unprognostic (5.79e-2)"					"unprognostic (2.78e-1)"				"unprognostic (2.65e-1)"		"unprognostic (3.77e-2)"		0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	10.5	0.1	0.0	1.7	4.3	0.1	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.7	0.1	0.2	0.6	0.8	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.5	0.0	3.5	0.0	1.2	0.0	0.0	0.8	0.2	0.2	0.2	0.2	0.4	0.1	0.8	0.9	0.6	0.2	0.8	0.5	0.0	0.1	0.2	0.0	1.6	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.5	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	8.6	0.0	14.0	0.0	0.0	1.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell type enriched"	"Detected in many"	30	"Cardiomyocytes: 1960.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.3	0.6	0.0	0.0	7.8	10.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	2.7	4.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0	0.0	0.3	0.0	0.0	0.3	65.2	1960.0	0.0	1.4	2.3	1.8	9.8	0.0	0.0	0.0	15.8	1.5	0.0	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.1	1.6	3.4	1.3	0.0	10.2	1.1	0.0	8.5	0.0	0.0	1.5	0.3	0.0	0.0	0.0	4.7	0.0	18.6	3.2	0.9	0.0	0.0	0.0	0.0	0.0
ZP4	ZPB	ENSG00000116996	"Zona pellucida glycoprotein 4"	Q12836	1	237877864-237890922	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 8.5"					"Not detected"	"Not detected"			HPA008547	Supported				"Secreted in female reproductive system"	NA	NA					"HPA008547: AB_1080766"						"unprognostic (7.12e-2)"			"unprognostic (2.70e-1)"						"unprognostic (4.59e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		2.3	0.0	0.0	0.0	1.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTRNR2L11		ENSG00000270188	"MT-RNR2-like 11"	S4R3Y5	1	237943724-237945275	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 64.8;skeletal muscle: 46.5"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1023.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 64.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 66.8;Hep G2: 42.8"														"Secreted to blood"	NA	NA										"unprognostic (1.07e-1)"					"unprognostic (9.70e-2)"			"unprognostic (4.49e-2)"	"unprognostic (5.26e-2)"				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2.0	7.0	1.4	3.7	2.9	2.0	3.1	2.0	2.0	0.2	12.4	4.2	2.3	11.1	7.2	3.0	2.8	2.2	2.6	2.0	3.3	0.0	2.0	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2.0	3.5	0.7	3.3	2.0	4.3	4.0	3.0	0.8	2.0	7.4	0.3	2.0	2.0	5.9	3.4	64.8	7.0	2.9	3.1	8.2	7.1	16.9	7.9	22.1	6.8	1.7	6.3	12.0	0.9	0.7	0.9	7.1	10.4	12.3	7.7	2.3	1.3	21.8	0.2	1.6	0.6	5.3	11.8	12.3	66.8	42.8	2.2	3.4	9.9	6.8	2.3	0.8	3.0	15.5	1.0	8.0	8.6	7.4	2.0	6.1	3.4	11.7	2.1	8.9	3.1	6.5	6.4	5.0	4.6	9.9	3.0	5.3	4.7	5.5	8.7	8.1	6.7	10.8	19.3	8.9	6.3	7.2	3.4	5.6	1.8	5.0	4.9	12.1	2.1	14.8	7.0	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2.0	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3.0	0.0	0.0	0.0	22.2	3.5	0.0	1023.1	0.0	0.0	0.0	12.2	0.0	0.1	39.7	0.0	0.0	2.2	0.0	0.0	0.0	0.1	2.4	23.0	0.0	1.3	0.1	0.0	0.0	1.3	0.3	0.0	0.0	2.4	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.1	0.3	0.2	3.4	0.0	0.0	0.0	20.9
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.8"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 17.2;Early spermatids: 14.2;Exocrine glandular cells: 14.9;Paneth cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 8.7"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Group enriched"	"Detected in many"	18	"monocytes: 1.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 10.2;SH-SY5Y: 32.5;U-266/70: 13.5;U-266/84: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.8	0.0	2.1	1.4	1.8	0.0	0.8	0.8	8.7	0.8	5.9	0.8	0.8	0.8	1.4	0.8	6.6	0.3	0.8	0.8	2.5	1.8	0.8	0.8	1.5	0.8	0.8	1.1	4.3	8.7	0.2	0.8	0.8	0.8	3.8	2.2	39.8	13.7	2.5	0.8	0.7	1.2	3.3	0.8	1.0	4.8	1.7	0.8	1.3	1.3	0.8	1.6	7.1	0.8	0.0	0.0	0.0	1.2	0.0	2.3	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.5	0.3	2.3	1.6	0.0	2.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.6	5.6	0.5	0.8	0.0	0.0	2.9	2.7	5.1	0.0	0.7	10.2	0.4	0.5	0.0	32.5	0.0	0.1	0.1	2.7	1.1	0.0	0.0	1.3	0.5	0.1	0.3	13.5	9.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	1.2	0.7	0.0	0.5	0.4	0.0	0.0	2.3	0.7	0.0	0.0	0.7	0.0	0.5	0.2	2.1	1.8	0.8	8.7	2.5	1.8	0.8	1.1	0.8	0.8	0.0	3.0	0.0	1.4	0.0	17.2	0.8	0.0	2.7	1.2	0.0	0.0	2.6	1.7	0.3	14.2	1.1	2.6	0.0	14.9	0.8	0.5	2.3	1.1	0.0	0.4	0.0	3.4	1.3	0.0	2.6	0.0	0.0	6.8	0.0	2.4	0.2	3.7	23.2	0.4	0.7	0.4	0.0	0.3	5.2	2.0	0.0	0.5	0.0	6.6	0.1
FMN2		ENSG00000155816	"Formin 2"	Q9NZ56	1	240014348-240475189	"Disease related genes, Predicted intracellular proteins"	"DNA damage, Protein transport, Stress response, Transport"	"Actin-binding, Developmental protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 41.0;parathyroid gland: 26.6"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 28.2;Cone photoreceptor cells: 47.1;Horizontal cells: 117.6"	"Group enriched"	"Detected in some"	8	"glioma: 5.9;testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 27.0;BJ hTERT+: 14.3;fHDF/TERT166: 26.6;LHCN-M2: 29.3;U-138 MG: 19.4;WM-115: 30.2"	"Low region specificity"	"Detected in all"							HPA050649			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA050649: AB_2681202"	"unprognostic (1.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.11e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.40e-3)"	1.2	7.3	17.1	1.3	14.5	0.9	1.3	17.2	41.0	1.1	3.2	9.4	0.0	1.4	2.5	2.1	2.1	3.7	2.0	0.9	16.2	11.8	2.9	0.9	1.4	0.9	9.9	15.5	3.9	2.1	26.6	5.6	1.2	12.2	2.9	3.0	1.4	1.3	3.6	0.9	1.0	1.3	2.7	12.3	1.2	1.2	3.4	12.3	0.0	1.3	0.0	1.0	1.2	0.4	0.5	0.4	0.6	0.3	0.4	2.3	0.0	0.0	0.8	2.9	0.0	7.4	5.6	0.0	27.0	14.3	10.7	5.8	0.0	0.0	0.0	0.0	26.6	0.5	0.0	0.4	0.0	10.5	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	3.5	0.7	6.8	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.1	0.0	0.0	0.0	4.5	4.0	0.0	0.1	0.1	0.1	1.1	0.0	0.1	19.4	0.1	7.3	7.0	0.0	0.0	0.0	3.8	0.0	30.2	0.6	0.3	0.1	0.3	0.2	0.2	0.1	0.9	0.1	0.1	0.5	2.3	1.4	0.5	0.4	0.1	0.4	0.3	0.0	17.1	14.5	17.2	19.3	16.2	11.8	9.9	15.5	12.2	12.3	0.0	0.0	0.0	0.0	0.1	28.2	1.2	0.0	0.0	0.0	1.8	47.1	0.0	0.0	0.0	9.1	0.3	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	117.6	11.6	0.6	1.2	2.4	0.3	0.2	1.7	0.0	0.2	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.3	1.6	4.4	0.0	0.5	0.0	0.0	0.0
GREM2	"CKTSF1B2, DAND3, FLJ21195, Prdc"	ENSG00000180875	"Gremlin 2, DAN family BMP antagonist"	Q9H772	1	240489573-240612149	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Heparin-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 90.3;parathyroid gland: 31.4"	"Cell type enriched"	"Detected in many"	14	"Syncytiotrophoblasts: 249.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2;memory CD4 T-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 26.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009920	Approved				"Secreted to blood"	NA	NA					"CAB009920: AB_2279266"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.07e-8)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-2)"	0.6	0.9	3.0	9.5	4.5	0.0	2.2	0.7	5.1	0.8	14.2	0.5	0.9	6.5	8.2	1.9	10.7	1.3	90.3	0.2	2.1	3.6	1.1	21.9	1.3	0.6	1.4	4.8	4.2	0.3	31.4	5.2	5.2	3.0	2.8	12.8	1.7	7.5	1.1	6.5	2.3	11.7	3.8	1.8	1.7	6.4	0.5	0.9	0.0	0.7	3.0	4.1	2.2	0.7	0.0	0.0	0.5	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	1.6	2.1	0.0	5.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.0	2.5	1.1	0.0	0.0	3.3	0.4	0.7	0.3	0.9	0.0	0.0	2.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	2.5	1.3	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.2	3.0	4.5	0.7	5.1	2.1	3.6	1.4	4.8	3.0	0.9	0.0	0.0	0.0	0.0	4.1	17.3	0.3	0.0	1.4	0.0	0.0	11.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.3	0.0	10.5	1.5	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.1	0.0	4.2	0.0	6.1	0.0	2.2	0.4	0.4	3.1	249.2	0.0	0.0	0.1
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775515-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.5;brain: 38.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 19.9;Horizontal cells: 58.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.2;HaCaT: 6.9;hTERT-HME1: 8.4;RH-30: 7.4;SH-SY5Y: 6.5;U-2 OS: 7.4;U-251 MG: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.7	11.5	9.1	0.8	18.3	0.7	0.9	27.6	38.1	0.9	0.8	1.6	1.7	1.0	1.0	0.8	0.9	0.7	1.3	0.7	11.5	8.3	4.2	0.8	0.9	1.1	3.6	8.9	1.3	1.4	0.7	2.8	0.7	4.7	0.8	0.9	1.3	0.7	1.4	0.7	0.9	0.9	0.7	1.4	1.0	4.6	7.8	1.8	0.0	0.7	0.0	1.0	0.7	0.1	0.7	3.6	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.9	0.0	2.7	5.3	7.2	0.5	0.0	0.0	0.0	0.4	3.7	4.0	6.9	0.0	0.1	3.6	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.4	0.5	0.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.9	0.3	0.2	0.0	7.4	0.0	0.0	0.0	6.0	6.5	0.4	0.3	0.3	0.2	0.0	0.0	2.8	0.0	7.4	0.4	8.0	0.0	4.3	0.0	1.1	0.0	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	9.1	18.3	27.6	20.7	11.5	8.3	3.6	8.9	4.7	1.8	0.0	0.0	0.8	0.0	0.0	19.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	58.8	6.9	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	2.0	0.0	0.0	6.4	9.3	0.0	0.0	0.0	0.0	0.0
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.3	24.6	23.3	21.0	22.9	27.1	37.0	36.4	28.5	41.1	25.8	35.1	18.3	18.6	24.1	27.8	18.0	41.8	35.6	27.0	35.8	21.3	11.5	17.5	26.0	30.0	20.6	40.8	15.9	19.6	16.9	23.0	26.0	14.4	25.2	41.2	53.1	24.1	29.9	14.6	35.1	27.3	24.8	42.8	52.8	29.1	25.5	83.6	39.6	24.9	30.0	26.0	30.6	36.3	23.2	16.8	27.7	27.7	24.8	18.5	23.8	32.6	60.5	21.6	23.1	22.6	20.6	46.9	26.5	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7	35.7	27.5	27.0	18.6	17.7	23.0	151.3	33.1	30.8	22.7	22.7	13.7	91.1	66.3	49.6	161.2	17.9	46.4	23.3	39.2	43.6	21.6	16.1	18.5	73.1	45.3	33.4	17.2	11.6	12.6	20.1	22.2	26.8	23.6	29.7	35.6	28.0	29.4	35.1	25.1	58.8	32.6	38.8	21.7	82.8	44.5	16.3	138.9	12.9	60.7	16.3
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;liver: 58.6;placenta: 26.0"	"Cell type enhanced"	"Detected in many"	23	"Hepatocytes: 43.2;Proximal tubular cells: 45.1;Syncytiotrophoblasts: 150.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	79	"classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	97	"B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.4;RPMI-8226: 7.8;RPTEC TERT1: 20.0;SK-BR-3: 10.4;U-698: 8.3"	"Region enriched"	"Detected in single"	4	"thalamus: 1.3"	"Not detected"	"Not detected"			"HPA031115, HPA056942"	Enhanced					NA	NA					"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	3.7	0.6	0.5	3.3	0.6	0.3	2.4	0.2	0.9	0.3	0.4	0.2	0.0	0.0	2.7	0.1	0.3	0.4	0.5	0.4	0.8	0.4	14.2	58.6	6.5	3.2	0.3	0.3	0.4	0.3	0.0	0.4	26.0	0.3	0.4	0.3	0.3	0.5	0.0	0.2	0.3	1.0	0.1	0.5	8.0	0.4	0.6	0.1	0.7	0.4	0.1	4.5	1.4	0.3	20.3	11.1	0.1	14.7	0.0	0.0	2.8	0.1	1.6	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.4	0.0	0.2	5.4	0.4	0.0	0.1	2.2	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.2	0.7	0.1	0.1	0.5	0.0	0.4	0.1	0.8	0.0	0.2	0.0	2.3	0.9	0.8	0.4	1.4	0.1	7.8	20.0	4.1	0.3	0.1	0.0	10.4	0.0	2.1	4.0	1.7	0.0	0.0	0.1	0.1	1.4	0.3	0.5	8.3	0.2	2.0	1.6	0.0	5.2	0.1	0.0	14.7	0.0	16.1	0.0	0.0	5.3	20.3	0.0	0.0	0.1	0.0	14.7	11.1	0.0	2.8	0.5	0.6	0.2	0.9	0.8	0.4	0.3	0.3	0.3	0.1	0.0	0.3	22.3	0.0	0.9	0.0	0.4	2.5	0.0	0.0	0.0	0.0	3.0	5.0	2.2	3.5	0.0	0.0	0.0	0.2	1.6	0.5	0.3	0.0	43.2	7.1	0.0	0.0	1.3	17.4	0.4	0.0	18.4	0.0	3.6	0.0	0.0	2.5	0.0	0.0	45.1	0.0	0.0	0.0	0.5	0.1	1.3	150.6	0.0	0.0	0.0
OPN3	"ECPN, encephalopsin, ERO, NMO-1, PPP1R116"	ENSG00000054277	"Opsin 3"	Q9H1Y3	1	241590102-241677376	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 211.3;Syncytiotrophoblasts: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 35.8"	"Low region specificity"	"Detected in all"							"CAB013682, HPA064443"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013682: , HPA064443: AB_2685267"	"unprognostic (2.41e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.96e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.13e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.44e-3)"	5.3	4.2	5.1	4.5	8.8	1.7	6.4	1.9	22.1	4.4	9.0	2.4	1.0	2.6	6.2	6.7	7.9	6.7	4.6	3.5	5.2	4.9	6.2	18.1	11.8	8.4	5.0	11.1	6.8	4.2	1.8	6.9	26.4	3.4	2.3	8.0	1.4	4.1	2.3	2.6	4.1	4.4	2.9	3.2	7.8	5.6	4.7	1.7	12.5	9.3	1.7	7.1	6.2	5.1	2.5	12.1	0.9	1.4	0.5	0.5	0.6	2.1	7.0	5.1	0.4	18.8	35.8	3.9	3.7	2.8	2.7	2.7	0.5	5.8	0.3	0.2	4.5	3.0	12.2	1.6	2.6	2.7	7.6	0.4	0.0	1.6	4.3	9.5	1.7	4.0	18.1	7.4	1.6	4.1	18.2	5.4	6.3	3.5	1.0	4.3	1.1	0.6	2.2	13.9	8.9	3.8	2.9	0.3	6.7	18.3	3.1	1.4	5.2	2.4	7.4	2.0	10.8	0.4	6.8	6.5	0.6	0.5	1.0	3.9	2.5	3.9	0.3	2.0	5.7	7.8	0.0	1.1	0.9	0.1	1.4	0.1	2.2	0.2	0.2	2.7	2.5	0.3	0.5	0.3	0.5	1.2	12.1	0.2	0.6	5.1	8.8	1.9	22.1	5.2	4.9	5.0	11.1	3.4	1.7	6.0	4.8	15.9	11.0	13.1	2.3	0.6	15.3	1.4	3.4	12.2	0.0	62.4	11.6	13.0	80.4	5.8	7.3	0.0	8.9	211.3	7.6	6.9	2.3	20.3	25.1	0.0	4.1	6.7	25.6	64.2	10.3	41.2	27.0	30.7	9.0	2.1	20.4	8.2	15.6	15.4	2.1	0.0	9.0	7.7	9.1	10.8	143.5	2.6	8.2	11.6
CHML	REP-2	ENSG00000203668	"CHM like, Rab escort protein 2"	P26374	1	241628853-241640254	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029627, HPA029628, HPA062967"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (9.23e-5)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.09e-1)"	6.5	3.8	6.0	5.7	10.5	10.8	7.7	3.6	18.0	6.0	6.4	3.1	1.4	3.8	7.6	5.0	6.1	7.2	5.6	5.1	5.3	5.1	6.5	21.1	12.5	10.0	4.9	13.1	13.3	5.6	8.5	8.2	30.7	4.2	3.7	6.1	2.0	5.8	3.0	7.1	6.5	6.5	5.6	3.7	9.3	5.6	9.9	2.2	14.8	11.0	2.2	5.1	5.2	6.6	1.6	2.9	3.0	1.3	0.5	1.4	0.2	17.6	5.5	8.6	6.8	2.6	7.8	16.8	7.0	3.5	6.1	4.2	10.0	3.3	4.8	10.7	4.6	5.0	3.6	12.0	7.6	11.4	9.3	11.0	6.4	22.4	7.0	5.2	15.2	8.3	6.5	3.4	8.1	8.4	4.3	4.7	13.2	17.2	6.0	7.2	6.9	10.0	10.2	11.4	6.7	17.8	15.3	10.6	16.3	6.1	11.0	11.0	18.2	8.8	6.8	7.6	8.8	7.9	9.9	9.6	12.5	24.3	6.3	13.2	7.0	17.2	5.2	12.2	9.2	19.3	3.0	0.9	0.6	0.5	1.3	0.8	1.3	0.3	0.4	0.8	1.6	1.4	1.1	0.1	0.5	0.8	2.9	0.1	0.2	6.0	10.5	3.6	18.0	5.3	5.1	4.9	13.1	4.2	2.2	44.7	6.5	11.1	3.4	7.6	2.6	16.1	2.5	1.4	9.1	0.0	0.0	19.5	5.0	11.7	10.8	6.8	4.2	0.0	17.8	19.9	5.1	3.9	3.5	1.9	6.4	4.8	6.4	3.1	10.7	16.3	9.8	20.4	16.9	13.6	4.0	2.9	18.3	2.8	17.0	2.1	4.3	12.9	10.3	5.9	12.3	6.4	16.8	4.4	4.3	4.2
WDR64	FLJ32978	ENSG00000162843	"WD repeat domain 64"	B1ANS9	1	241652278-241802133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 17.8"	"Group enriched"	"Detected in some"	78	"Early spermatids: 168.8;Late spermatids: 96.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.1;JURKAT: 1.0;U-266/84: 1.3"	"Not detected"	"Not detected"							HPA046186	Uncertain					NA	NA					"HPA046186: AB_10960064"	"unprognostic (6.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.56e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.2	0.5	0.1	0.1	0.2	0.1	1.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.3	0.1	0.1	0.2	0.2	17.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	1.7	0.3	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	168.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	96.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.7	0.0	0.0	0.0
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	2.1	1.0	0.9	10.3	1.0	15.6	1.0	0.3	1.3	1.3	3.1	0.3	0.1	2.9	0.7	0.8	6.2	0.4	1.3	1.5	0.7	0.6	0.9	1.3	1.5	5.6	0.6	0.3	1.3	1.3	1.8	0.4	4.6	0.7	0.7	3.9	0.3	1.4	0.1	1.0	1.7	4.2	1.0	0.6	5.7	1.5	14.8	0.1	31.3	0.6	4.0	8.1	1.6	2.0	1.4	0.6	2.9	0.7	0.9	3.3	1.0	15.1	10.1	16.7	11.0	1.0	2.7	14.1	20.2	6.8	18.1	19.8	12.6	8.6	16.6	9.9	4.7	9.5	15.1	21.1	8.4	21.5	25.6	18.5	15.4	10.8	6.4	0.3	21.9	11.5	0.6	0.4	18.0	4.9	2.2	5.6	16.3	30.8	21.9	14.4	7.0	23.6	12.4	22.8	18.5	10.0	17.1	15.6	17.7	3.7	9.6	18.7	23.7	13.2	10.7	7.1	8.2	9.9	13.6	2.0	17.6	15.5	16.5	27.2	16.1	21.3	26.7	6.1	17.9	20.9	2.9	0.7	0.0	1.1	0.0	0.0	1.4	1.1	1.1	0.6	1.3	0.6	0.2	0.3	0.9	0.0	0.1	3.3	1.0	0.9	1.0	0.3	1.3	0.7	0.6	0.6	0.3	0.7	0.1	0.0	0.0	0.0	0.1	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.7	0.0	0.0	0.0	0.0	14.1	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	9.8	6.9	0.1	3.3	0.7	0.6	0.1
BECN2	BECN1P1	ENSG00000196289	"Beclin 2"	A8MW95	1	241957767-241959062	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 2.6"					"Not detected"	"Not detected"									NA	NA							"unprognostic (5.50e-1)"		"unprognostic (2.97e-1)"				"unprognostic (2.59e-1)"		"unprognostic (7.16e-3)"				"unprognostic (7.95e-2)"	"unprognostic (8.19e-2)"		"unprognostic (9.27e-5)"	0.2	0.0		0.0		0.0	0.0		0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0			0.0	0.0	0.0		0.7		0.0	0.0		0.0	0.0	0.0	0.2	0.7	0.0		0.0	0.5	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAP1LC3C	ATG8J	ENSG00000197769	"Microtubule associated protein 1 light chain 3 gamma"	Q9BXW4	1	241995490-241999073	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.9"	"Cell type enhanced"	"Detected in single"	17	"granulocytes: 1.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SuSa: 26.1"					"Low region specificity"	"Detected in all"			HPA072670			Supported	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA072670: AB_2686546"	"unprognostic (2.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.44e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.73e-2)"	12.2	0.8	0.5	1.4	0.7	0.1	13.4	0.5	0.9	0.3	4.4	0.2	0.7	0.4	0.5	1.9	8.9	3.5	1.5	1.8	0.3	0.1	0.7	0.4	9.0	5.4	0.5	0.3	4.4	0.4	0.5	2.0	17.9	0.6	0.7	0.5	4.7	7.8	0.2	5.7	5.5	2.6	0.9	0.9	1.4	4.3	1.2	0.5	0.1	2.3	7.1	5.0	6.5	3.5	1.0	0.8	2.6	2.5	0.4	0.5	0.1	0.1	0.0	5.2	0.0	0.2	5.0	3.3	0.1	0.0	0.2	0.2	0.4	0.0	0.0	3.0	1.4	0.3	0.0	0.1	0.1	0.1	0.0	0.9	0.2	0.2	0.1	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.1	1.6	0.1	0.0	0.0	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	26.1	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.6	0.4	0.4	1.2	0.3	0.6	0.3	0.5	0.2	1.0	0.2	0.4	1.2	0.4	2.5	0.8	0.1	0.1	0.5	0.7	0.5	0.9	0.3	0.1	0.5	0.3	0.6	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524696	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 54.8;retina: 37.7"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 54.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol		No	No			Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	1.1	5.4	5.0	0.4	3.7	0.4	1.6	54.8	7.6	2.2	0.8	7.7	0.0	0.4	3.5	0.9	1.6	1.8	0.8	0.8	4.4	4.6	1.5	0.5	0.8	3.3	5.4	2.5	6.6	3.1	1.4	7.2	1.5	12.7	2.7	0.6	37.7	2.2	9.3	0.8	0.6	0.5	2.9	6.0	2.2	0.8	4.2	6.2	0.0	1.0	0.0	1.5	0.4	1.0	0.4	0.2	1.0	0.2	0.3	0.4	0.0	0.0	4.0	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.3	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.4	0.3	0.4	1.0	0.3	0.2	0.2	0.2	0.0	5.0	3.7	54.8	5.5	4.4	4.6	5.4	2.5	12.7	6.2	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	4.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.5	0.0	0.7	0.5	0.2	0.1	0.2	0.0	0.0	0.0
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Group enriched"	"Detected in many"	37	"Early spermatids: 1512.0;Late spermatids: 3749.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"		Yes	No			Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453"	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.2	11.1	8.2	15.9	2.9	16.1	9.6	12.1	11.5	3.2	5.9	4.5	9.9	13.7	4.1	3.0	11.3	6.9	17.3	10.0	6.5	4.7	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.6	16.9	27.7	28.2	2.7	11.3	4.7	15.3	1.3	5.0	4.4	16.6	1.2	14.5	9.0	9.4	1.5	2.5	1.0	19.1	25.7	8.2	0.7	7.7	10.8	2.8	11.2	31.1	22.6	6.7	12.1	18.5	4.6	5.9	9.0	12.0	7.5	51.9	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0	17.9	16.6	13.7	4.2	13.5	41.1	19.0	7.6	25.4	11.4	12.2	5.9	3.1	0.0	18.9	1512.0	31.0	0.7	0.0	6.1	6.7	26.8	3.3	22.0	6.8	31.5	42.9	10.4	18.4	34.9	3749.4	40.9	70.8	21.9	31.5	1.9	11.4	19.1	0.0	33.2	2.1	18.3	25.8	15.7	71.0	23.8	10.0	1.6	7.0	1.6	3.1
SDCCAG8	"BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7"	ENSG00000054282	"Serologically defined colon cancer antigen 8"	Q86SQ7	1	243256034-243500092	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025737, HPA044477, HPA072495"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA025737: AB_2671761, HPA044477: AB_2678955, HPA072495: AB_2686527"	"unprognostic (4.12e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.68e-3)"	"unprognostic (4.69e-2)"	13.5	12.6	17.2	10.0	17.7	7.9	13.0	12.3	17.6	11.4	10.5	22.5	10.4	7.5	13.3	17.7	11.6	17.9	17.6	12.8	16.8	13.5	15.2	7.9	14.8	10.4	17.4	12.0	19.9	17.3	18.0	32.4	11.4	14.2	15.5	8.3	10.7	16.8	13.1	15.1	10.2	9.3	11.3	18.9	15.0	11.0	8.0	20.9	17.4	32.7	7.2	10.4	11.8	10.7	9.8	9.9	9.3	10.7	12.5	8.6	5.2	5.5	4.7	0.7	3.5	5.2	3.0	5.7	3.5	3.0	0.6	1.3	4.5	9.9	2.1	5.8	3.0	0.5	1.9	0.6	4.2	1.4	3.6	5.6	1.8	3.5	2.0	3.3	1.8	4.6	6.1	4.0	3.1	6.6	5.8	4.3	3.8	2.6	3.3	2.5	1.5	0.7	4.3	0.6	6.2	7.9	2.9	0.8	1.8	6.2	3.6	4.8	4.8	4.1	2.1	7.9	0.8	3.7	2.8	4.2	6.0	1.4	1.8	1.9	4.5	2.2	1.0	2.8	3.8	26.3	9.3	10.7	9.0	6.0	10.5	3.8	7.5	6.4	7.8	9.9	9.8	8.6	6.5	6.9	12.5	5.7	7.9	5.0	5.2	17.2	17.7	12.3	17.6	16.8	13.5	17.4	12.0	14.2	20.9	38.7	84.7	13.8	32.4	33.1	69.9	24.6	38.2	72.3	44.3	38.4	82.5	40.2	64.6	55.3	13.0	36.0	15.4	0.0	26.3	74.3	34.9	29.8	47.5	24.3	104.6	62.0	30.7	43.6	40.6	25.5	48.9	49.4	33.7	31.5	16.5	60.3	40.6	23.4	41.8	25.3	72.7	38.8	19.5	47.6	11.3	43.0	22.0	14.9	22.0	20.9
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 71.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (9.27e-4)"	15.4	17.0	16.0	7.8	15.2	2.2	11.0	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10.0	11.8	12.1	9.8	15.5	13.6	12.8	4.0	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17.0	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5.0	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.6	2.4	15.0	0.0	11.1	12.7	8.0	13.3	12.3	8.7	7.7	0.1	9.7	0.0	0.0	17.0	7.5	0.3	8.3	5.3	11.5	6.0	6.5	0.3	0.0	0.0	5.8	0.1	2.6	6.6	0.0	10.8	9.8	18.9	17.7	3.9	0.0	0.1	3.9	0.0	5.1	1.1	6.4	0.0	3.7	2.7	9.1	0.1	2.9	0.9	19.3	25.4	0.1	0.0	24.0	9.1	0.0	8.1	13.9	15.5	11.9	0.1	11.1	1.3	0.4	2.8	11.3	1.3	12.9	1.2	0.9	0.5	2.3	0.3	3.6	1.0	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16.0	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8	3.0	2.1	8.6	11.6	2.2	41.5	5.5	5.1	0.0	4.5	26.2	31.4	9.5	0.0	10.4	71.8	31.5	0.0	0.0	1.5	6.5	7.3	18.3	4.7	0.2	2.7	39.7	0.0	44.8	8.8	51.9	25.3	9.5	6.8	10.0	0.0	20.1	1.0	0.0	33.2	4.4	33.7	19.4	22.9	12.2	11.5	1.5	10.4	13.8	0.0	7.2
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 114.4;skeletal muscle: 40.3"	"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 114.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024656, HPA074019"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024656: , HPA074019: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favorable (6.78e-6)"	4.1	3.4	20.1	7.3	14.7	13.4	4.7	114.4	26.0	4.1	4.7	5.4	8.1	6.9	3.5	10.3	3.0	4.6	3.8	7.4	24.8	6.3	6.4	10.0	5.1	8.8	7.1	19.1	4.0	13.0	3.1	2.7	4.9	11.7	5.5	5.8	4.6	5.2	6.7	40.3	4.1	6.2	5.9	7.5	10.0	5.8	11.4	4.6	16.4	4.4	2.8	8.1	6.5	9.3	2.4	2.2	5.8	1.5	0.3	1.4	0.2	11.7	4.2	16.2	0.6	2.1	2.2	11.3	6.6	4.9	10.7	6.5	3.2	9.5	8.9	0.6	12.7	3.4	1.2	10.3	3.3	13.4	3.1	9.1	1.5	1.4	1.5	3.3	1.8	4.7	1.8	2.8	6.4	4.0	12.9	11.5	9.9	1.1	3.8	12.6	0.1	15.3	7.5	8.3	3.6	1.9	4.5	11.0	2.5	6.7	4.1	23.9	23.3	2.7	0.1	7.3	7.1	0.2	13.6	17.1	5.5	6.7	3.4	13.9	1.6	0.2	3.5	5.5	5.8	11.1	0.2	0.7	2.9	0.3	0.7	0.4	1.6	0.7	0.5	0.9	2.4	1.4	0.9	5.8	0.3	1.5	2.2	0.5	0.2	20.1	14.7	114.4	24.1	24.8	6.3	7.1	19.1	11.7	4.6	8.9	21.0	6.4	3.0	10.0	5.1	19.9	12.7	10.7	11.4	17.4	11.8	1.2	0.0	4.0	2.6	13.2	6.2	0.0	4.5	1.7	2.8	5.0	5.8	37.6	5.2	6.4	18.6	13.5	24.1	2.2	2.0	13.3	3.3	2.8	18.3	48.1	7.3	7.0	4.6	10.1	24.2	12.9	8.1	10.0	6.6	17.2	0.8	3.2	12.8	3.1
C1orf100		ENSG00000173728	"Chromosome 1 open reading frame 100"	Q5SVJ3	1	244352635-244389663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 65.3"	"Group enriched"	"Detected in some"	119	"Early spermatids: 1095.9;Late spermatids: 535.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	51	"K-562: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031179, HPA031180"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA031179: AB_10599995, HPA031180: AB_10599026"	"unprognostic (9.84e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.37e-2)"	"unprognostic (9.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-5)"	"unprognostic (1.85e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1095.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	535.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.9	1.6	0.0	0.0	0.0	0.0	0.0
ADSS		ENSG00000035687	"Adenylosuccinate synthase"	P30520	1	244408494-244452134	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		620000	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.4	17.8	23.2	23.8	31.2	29.2	26.3	18.3	26.3	20.9	20.9	35.9	27.1	21.1	18.9	23.3	27.7	18.3	15.8	9.8	24.9	23.4	25.1	19.3	19.2	21.2	42.5	16.6	20.9	21.2	26.6	17.7	21.0	34.9	19.8	22.7	13.1	25.0	21.7	11.0	26.5	23.2	22.9	29.3	24.9	24.7	48.9	36.7	26.7	26.3	17.9	24.8	26.5	21.8	10.9	13.6	24.6	21.3	15.5	16.0	11.9	25.7	14.2	12.4	10.9	14.6	20.9	22.9	26.0	21.9	18.7	14.2	18.7	24.9	23.0	17.3	20.0	8.0	19.5	13.5	17.0	21.0	17.0	24.0	15.3	14.2	14.1	17.5	36.2	19.8	14.3	20.6	17.4	17.6	21.8	66.6	12.7	26.5	17.1	18.5	6.1	23.2	24.3	33.0	24.6	15.7	21.5	11.8	24.8	31.0	16.0	16.9	14.8	22.1	20.6	26.0	13.8	14.3	19.3	29.1	17.3	9.5	20.0	27.0	20.8	27.2	17.4	14.3	42.5	25.5	24.6	15.8	13.0	15.0	20.5	16.0	10.9	13.7	12.8	13.6	8.6	11.8	13.3	11.9	15.5	21.3	5.5	14.7	11.9	23.2	31.2	18.3	26.3	24.9	23.4	42.5	16.6	34.9	36.7	44.7	30.5	40.0	44.7	90.9	12.4	5.8	35.7	127.2	85.3	57.6	5.9	47.0	74.6	41.2	102.9	33.7	30.0	0.0	44.0	83.0	35.8	40.9	28.9	29.6	33.8	9.5	17.3	37.4	38.1	103.8	17.5	51.2	40.5	37.9	29.4	34.0	38.5	21.0	15.9	57.5	7.2	12.9	34.0	104.8	68.7	86.1	45.2	60.6	38.1	62.8
CATSPERE	"C1orf101, MGC33370"	ENSG00000179397	"Catsper channel auxiliary subunit epsilon"	Q5SY80	1	244454377-244641177	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 26.9"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.7;hTERT-RPE1: 2.6"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.22e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.39e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.37e-4)"	"unprognostic (4.43e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.85e-2)"	0.9	1.1	1.3	0.5	3.2	1.1	1.2	1.7	2.7	1.2	0.5	4.6	0.4	0.5	1.6	4.1	0.6	2.1	0.9	0.5	3.1	1.3	1.4	1.5	1.0	1.8	1.2	1.3	1.4	2.4	2.6	2.2	0.9	3.2	1.0	0.5	1.3	0.9	1.1	1.0	0.7	0.7	1.5	2.8	0.9	0.7	26.9	0.7	0.5	1.6	0.0	0.6	1.0	0.8	0.8	0.9	0.8	0.1	0.1	0.8	0.1	0.3	0.0	0.6	0.0	1.3	2.7	0.2	1.5	1.5	0.2	0.2	0.0	0.7	0.5	1.8	1.7	0.0	0.7	0.4	0.2	0.5	0.0	1.5	0.0	0.4	0.1	0.9	0.0	1.4	2.2	0.7	0.2	0.0	2.6	0.7	0.7	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.0	0.2	1.4	0.0	0.0	0.8	0.0	1.6	1.0	0.7	0.0	0.3	0.4	0.1	0.8	1.8	0.1	0.0	0.0	1.0	0.9	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.7	0.0	0.2	0.8	0.1	0.3	0.0	0.6	0.8	0.1	0.0	0.1	0.1	0.9	0.2	0.1	1.3	3.2	1.7	2.7	3.1	1.3	1.2	1.3	3.2	0.7	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	2.3	1.8	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
DESI2	"C1orf121, CGI-146, FAM152A, FLJ21998, PNAS-4, PPPDE1"	ENSG00000121644	"Desumoylating isopeptidase 2"	Q9BSY9	1	244652935-244709033	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 160.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049950			Approved	Vesicles		NA	NA			Vesicles		"HPA049950: AB_2680969"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (4.52e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.49e-2)"	16.4	13.3	6.4	16.1	12.9	10.5	19.9	17.4	6.5	18.5	19.4	7.6	14.6	10.9	27.7	12.8	14.7	12.4	12.7	27.6	6.5	5.8	9.6	13.5	28.4	11.5	7.7	3.2	16.3	10.0	14.8	11.8	20.4	6.9	14.9	13.1	17.8	12.1	14.8	16.2	11.6	17.5	23.2	6.6	14.3	14.9	49.2	7.4	16.8	25.8	14.5	14.7	16.8	14.4	8.0	4.8	9.1	4.0	3.9	5.6	1.2	24.5	9.2	18.1	15.6	20.8	21.8	22.7	14.3	25.0	14.3	13.2	16.3	11.7	43.8	19.6	17.8	8.3	10.8	22.1	16.2	19.7	14.9	16.2	11.1	6.9	12.2	18.2	19.0	13.4	15.1	22.1	19.0	24.0	13.8	20.0	19.9	16.7	24.4	21.4	4.3	17.4	10.2	41.0	23.3	22.4	12.4	27.4	16.6	10.9	10.3	16.0	21.5	20.3	10.1	17.8	15.2	10.5	14.5	21.7	16.3	17.0	22.0	24.8	24.8	31.9	25.8	13.1	20.6	29.6	4.6	3.0	9.1	4.0	3.9	4.2	8.0	4.2	5.6	4.8	4.7	5.5	5.4	2.5	3.9	4.0	4.2	5.2	1.2	6.4	12.9	17.4	6.5	6.5	5.8	7.7	3.2	6.9	7.4	80.4	41.8	24.3	26.4	49.1	34.2	21.2	28.1	13.4	25.0	17.4	19.6	25.5	18.3	18.2	124.1	27.0	18.6	0.0	29.2	33.3	29.2	39.4	6.9	20.2	21.2	38.1	15.0	23.4	25.4	74.9	32.2	17.4	15.1	26.2	17.8	21.8	26.3	25.9	48.8	13.5	25.0	38.8	32.4	160.4	90.2	36.1	36.2	20.2	25.5	51.9
AL451007.3		ENSG00000284188			1	244729898-244730962	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"testis: 12.4"	"Cell type enriched"	"Detected in single"	33	"Distal tubular cells: 3.3"									"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;NTERA-2: 1.2;SCLC-21H: 1.6"															NA	NA																							0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3		0.6	0.0	0.0	0.0	0.8	0.4	0.0	0.0	1.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.2	1.6	1.5	0.2	0.2	12.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"COX20, cytochrome c oxidase assembly factor"	Q5RI15	1	244835322-244845057	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	13.1	37.9	30.2	17.5	28.9	12.5	14.9	22.0	25.8	11.8	20.5	11.8	9.3	18.2	17.5	16.9	20.6	11.4	16.2	35.4	22.8	27.7	36.7	23.6	11.1	13.4	32.1	18.3	26.7	15.1	14.3	15.1	15.0	19.2	20.2	11.8	27.9	11.3	15.5	33.3	8.1	19.4	42.5	22.0	10.1	17.9	21.1	17.0	10.4	17.5	20.2	10.7	23.0	16.5	18.2	16.3	11.6	18.4	12.2	22.5	10.5	36.7	9.2	9.3	29.0	6.4	4.8	21.9	15.5	10.3	8.9	8.0	26.2	25.7	5.6	19.7	10.4	17.3	9.6	4.9	12.4	12.0	15.6	3.4	10.8	13.5	24.1	8.6	26.4	16.6	4.3	6.0	13.1	9.2	12.8	10.1	6.3	22.2	23.3	18.3	9.1	14.2	11.8	24.6	26.6	19.2	10.5	11.5	34.0	16.5	8.7	5.4	14.9	19.4	10.2	20.1	9.8	18.9	7.6	19.6	19.8	26.0	17.2	33.2	37.0	50.7	11.9	25.2	29.5	18.9	5.7	8.8	11.6	15.4	18.4	15.1	18.2	18.3	16.8	15.0	16.0	11.0	16.9	1.7	12.2	17.8	16.3	22.5	10.5	30.2	28.9	22.0	25.8	22.8	27.7	32.1	18.3	19.2	17.0	17.9	46.2	77.5	98.6	75.7	105.2	57.3	178.3	52.2	58.0	181.5	43.2	203.1	351.5	126.1	26.1	56.2	109.3	93.5	164.5	133.4	54.1	70.8	70.6	249.2	109.9	84.2	59.4	39.3	60.1	57.2	64.5	84.0	69.2	129.8	72.2	94.2	142.7	87.5	75.3	253.1	99.4	64.7	95.9	66.9	97.5	66.0	221.2	70.2	105.2	80.4
HNRNPU	"C1orf199, FLJ30202, FLJ37978, hnRNPU, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm		NA	NA		840000	Nucleoplasm		"CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	55.6	57.5	55.3	55.3	68.1	87.3	60.9	80.2	61.7	53.4	47.9	57.7	49.6	38.9	61.4	74.9	53.3	55.9	48.0	47.4	53.3	51.5	68.5	61.2	45.1	52.2	60.5	51.8	76.0	51.7	85.9	48.6	55.4	47.2	56.5	51.1	43.9	49.0	54.3	69.7	43.9	50.3	58.0	55.4	62.3	49.4	47.8	64.5	121.5	61.7	41.5	64.3	57.5	97.9	17.3	25.1	17.0	11.7	15.1	21.7	7.3	47.9	38.6	51.3	40.2	26.9	23.3	50.4	34.4	22.2	31.6	28.2	36.9	32.0	75.9	32.3	29.0	30.3	37.8	68.6	39.0	50.3	31.9	46.0	65.4	34.2	56.3	28.3	74.8	39.8	26.2	23.6	34.4	36.6	28.4	32.3	47.9	85.1	28.2	42.6	34.3	79.6	77.8	89.0	36.0	35.2	79.9	64.0	41.2	50.9	35.4	42.9	42.3	54.2	35.9	41.6	39.1	49.4	84.4	38.9	31.7	46.7	33.7	60.7	46.6	50.8	74.0	26.0	64.2	45.3	14.1	11.7	15.5	15.3	10.1	16.2	17.3	18.6	18.4	12.4	17.0	21.7	18.3	17.0	15.1	11.0	25.1	15.8	7.3	55.3	68.1	80.2	50.4	53.3	51.5	60.5	51.8	47.2	64.5	303.7	307.6	169.4	272.6	241.0	145.0	162.6	101.9	311.8	396.9	183.2	172.8	181.9	82.9	177.3	334.5	193.4	127.0	0.0	156.7	227.3	175.2	162.2	346.3	111.1	161.8	133.5	190.1	114.8	193.9	392.9	142.4	255.5	116.4	215.6	139.7	150.4	156.6	124.3	134.0	103.9	204.8	142.3	205.0	166.3	161.8	209.2	211.3	200.3	159.5	244.9
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 161.9;Early spermatids: 83.3;Late spermatids: 104.3;Spermatocytes: 117.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 34.8;THP-1: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (4.88e-2)"	11.0	12.5	16.7	5.6	18.6	10.8	14.7	20.1	15.5	11.6	7.3	23.6	13.9	3.0	18.7	19.5	9.6	32.1	13.1	13.7	18.0	14.3	12.5	6.5	11.2	7.8	22.3	12.3	10.6	12.1	14.6	20.6	14.7	16.3	9.2	11.3	11.8	7.4	16.0	15.5	6.1	6.5	13.2	20.9	6.4	10.5	24.4	21.9	5.4	23.7	13.5	9.1	11.5	16.0	3.6	10.8	4.9	1.8	2.9	0.8	1.2	3.1	4.0	9.1	2.3	3.3	7.8	11.1	4.0	4.3	5.2	4.8	10.2	8.6	11.0	8.7	5.0	5.5	2.5	3.6	2.3	3.2	1.1	2.2	5.3	15.9	4.5	7.0	5.4	34.8	6.7	4.9	7.0	6.6	6.2	7.9	0.3	20.3	9.0	4.4	3.3	1.1	14.9	11.6	4.5	3.0	20.8	1.4	2.9	13.2	5.4	7.2	9.7	7.0	2.7	5.8	10.7	2.6	30.7	1.2	6.4	2.4	3.5	14.5	3.1	5.1	7.3	5.1	15.6	5.1	1.2	1.7	2.8	0.5	1.8	0.8	3.6	0.7	0.4	5.5	3.3	0.6	0.6	4.9	2.9	1.3	10.8	0.8	1.2	16.7	18.6	20.1	15.5	18.0	14.3	22.3	12.3	16.3	21.9	3.0	12.6	4.7	9.1	4.5	12.5	54.7	0.0	161.9	21.6	22.7	13.7	12.8	43.1	5.7	83.3	11.4	2.6	0.0	9.5	40.1	10.4	6.8	0.0	6.8	9.8	4.8	18.1	8.0	14.2	104.3	8.3	9.8	6.8	6.4	6.3	12.5	5.9	5.8	6.0	14.4	20.0	6.5	11.8	117.5	31.9	2.6	28.6	6.2	6.0	8.8
KIF26B	FLJ10157	ENSG00000162849	"Kinesin family member 26B"	Q2KJY2	1	245154985-245709431	"Predicted intracellular proteins"		"Developmental protein, Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 7.0;Cone photoreceptor cells: 3.9;Exocrine glandular cells: 4.4;Pancreatic endocrine cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 6.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 10.6;REH: 18.9;SH-SY5Y: 10.3;U-937: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027709, HPA028478, HPA028561, HPA028562"	Enhanced		Approved	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane, Microtubules"		"HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417"	"unprognostic (3.66e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.30e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-4)"	"unprognostic (7.22e-3)"	0.7	3.9	7.1	3.0	6.3	0.7	2.1	10.2	9.7	5.2	1.7	8.7	6.0	1.2	3.7	2.9	1.3	2.1	4.2	1.3	5.6	7.2	3.2	1.1	2.7	1.7	7.8	4.6	1.2	1.8	1.4	1.4	7.6	9.6	3.7	0.8	1.1	1.2	7.7	0.9	2.7	1.1	2.3	4.9	1.1	2.9	2.9	3.7	1.3	3.4	1.2	1.4	4.0	0.8	0.0	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	2.6	0.5	0.8	1.9	2.1	1.5	0.1	0.1	3.2	0.0	0.0	3.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.3	10.6	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	18.9	0.1	0.0	1.9	0.0	2.6	10.3	0.0	0.0	0.0	1.8	0.0	1.0	0.3	2.0	0.1	0.0	0.8	0.0	0.0	0.1	0.3	9.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	7.1	6.3	10.2	9.7	5.6	7.2	7.8	4.6	9.6	3.7	0.0	0.3	0.0	0.1	0.8	0.8	2.2	0.0	2.7	0.0	7.0	3.9	1.8	0.0	1.8	1.7	0.0	0.0	0.0	4.4	2.0	0.9	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.6	0.4	3.3	1.0	0.0	0.3	5.5	0.0	0.0	0.0	0.1	0.0	0.4	0.5	1.0	1.1	2.1	0.0	0.0	0.0
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 108.5;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 95.1;K-562: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	6.0	12.0	9.9	9.7	16.2	7.6	10.6	25.9	14.7	8.9	6.5	6.4	3.7	4.5	8.7	21.8	6.1	10.0	7.7	5.8	10.3	12.0	8.9	5.5	9.2	6.3	12.0	10.2	8.0	7.2	6.7	11.9	4.6	15.3	6.8	8.3	9.5	5.3	5.9	9.5	6.7	5.2	7.6	6.8	5.3	6.1	10.5	8.1	7.5	18.8	3.6	9.3	8.3	6.6	11.3	5.9	8.3	3.4	19.4	12.9	8.7	4.7	2.9	4.2	3.6	4.8	6.6	4.2	6.7	5.0	7.9	17.8	3.7	5.5	7.7	5.4	6.2	4.9	3.1	3.8	7.5	26.5	4.0	3.9	4.5	4.3	4.5	9.0	4.6	95.1	17.7	1.8	10.4	6.7	6.0	5.4	5.5	35.9	2.7	7.7	1.6	8.7	8.8	3.7	6.6	4.7	8.1	5.1	11.2	5.7	6.9	10.0	4.8	3.1	0.4	6.1	4.7	3.9	7.8	4.1	3.8	2.6	2.7	7.9	13.6	3.7	4.0	7.3	6.3	4.4	8.1	3.4	8.3	10.5	3.0	10.8	11.3	11.1	12.8	5.9	11.1	12.3	12.9	2.4	19.4	3.3	3.8	11.8	8.7	9.9	16.2	25.9	14.7	10.3	12.0	12.0	10.2	15.3	8.1	6.0	27.8	5.3	13.2	10.9	5.8	7.7	2.5	44.2	13.6	12.2	21.6	7.8	13.3	20.6	46.2	11.7	4.2	0.0	28.1	33.5	15.4	5.4	108.5	4.2	10.3	9.5	24.1	9.2	3.8	74.1	10.3	6.0	11.8	1.8	8.3	9.1	16.5	2.9	16.3	14.6	13.9	0.0	15.1	17.3	24.7	10.0	6.1	13.6	9.2	6.4
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540560-246566324	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	10.6	23.1	4.2	7.2	8.4	15.5	9.0	8.4	9.9	7.0	8.9	6.5	9.4	8.2	9.5	7.2	9.5	6.9	8.5	11.3	4.3	5.5	15.5	42.3	5.9	8.7	4.8	5.7	6.5	19.7	5.6	7.8	10.5	7.6	8.9	9.6	5.9	13.6	8.9	21.4	8.7	10.3	6.8	6.5	9.0	9.6	8.7	5.7	13.0	15.6	7.3	12.0	9.1	6.5	10.6	11.0	1.2	7.5	12.6	10.4	4.5	12.6	12.2	4.7	8.4	5.9	8.5	16.6	9.3	9.6	10.6	9.8	14.8	12.3	22.7	14.6	9.4	6.9	11.0	11.4	9.9	14.7	8.8	4.4	11.5	7.5	13.0	9.8	20.2	10.4	8.4	11.9	9.1	10.3	5.8	8.2	8.1	33.1	7.8	9.1	5.9	10.2	9.1	21.1	22.2	12.5	10.2	9.4	27.5	9.6	14.0	10.5	21.3	9.0	16.4	30.8	5.5	11.9	19.5	6.0	7.4	9.0	10.4	24.3	22.6	37.7	17.9	9.1	20.0	9.3	0.2	4.7	1.2	8.4	4.8	10.4	10.6	7.5	8.8	11.0	10.4	9.6	8.2	1.0	12.6	7.5	9.5	10.3	4.5	4.2	8.4	8.4	9.9	4.3	5.5	4.8	5.7	7.6	5.7	6.0	6.5	9.3	11.9	47.4	3.0	15.1	2.5	8.1	17.0	15.7	9.8	20.8	24.9	11.2	1.0	11.7	6.8	0.0	13.3	23.0	10.8	10.8	13.9	32.0	10.9	0.0	10.9	6.2	9.7	1.9	6.1	7.6	5.0	5.4	12.1	4.5	9.1	8.6	4.2	28.3	3.6	12.9	16.0	7.2	22.3	39.3	17.6	8.7	19.0	9.2
CNST	"C1orf71, FLJ32001, PPP1R64"	ENSG00000162852	"Consortin, connexin sorting protein"	Q6PJW8	1	246566444-246668584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007225, HPA007226"	Approved		Supported	Vesicles		NA	NA		4600000	Vesicles		"HPA007225: AB_1848869, HPA007226: AB_2667782"	"unprognostic (1.55e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.26e-1)"	15.5	21.7	10.2	13.7	22.3	21.8	12.8	25.1	22.4	10.6	14.6	8.1	10.2	11.0	14.7	9.4	18.6	10.0	9.7	11.1	9.5	17.6	9.9	25.1	12.4	16.4	11.2	14.1	12.1	11.0	15.2	17.4	11.9	13.7	9.7	13.4	11.6	9.4	9.6	35.5	11.6	15.5	18.4	7.6	12.3	9.6	17.2	9.3	24.6	15.4	10.2	18.6	14.9	11.0	21.1	6.6	21.6	11.1	7.8	19.3	9.0	4.3	5.7	4.2	3.7	6.9	8.1	8.5	14.1	13.9	14.3	10.9	5.5	5.7	12.6	6.3	13.9	4.2	4.5	6.5	4.8	19.5	7.0	2.2	14.8	5.2	4.1	10.1	7.3	28.7	7.6	4.6	13.8	14.8	7.1	4.4	6.8	18.7	5.6	8.0	3.1	8.0	3.4	13.8	6.0	5.0	7.9	7.6	10.3	5.4	12.6	9.7	11.6	6.0	3.5	17.4	5.1	6.5	6.5	6.2	17.8	4.3	7.3	9.5	17.1	21.7	12.8	4.4	11.0	17.1	21.6	4.7	12.9	8.8	5.0	9.6	19.4	15.0	8.1	4.6	21.1	19.3	10.3	6.2	7.8	11.1	6.6	18.1	9.0	10.2	22.3	25.1	22.4	9.5	17.6	11.2	14.1	13.7	9.3	11.9	15.0	6.5	13.5	22.0	28.1	10.4	7.6	32.1	25.0	3.5	13.7	3.1	6.6	5.9	36.0	31.6	39.9	0.0	5.2	5.0	12.2	17.4	38.3	18.1	8.5	15.9	14.5	28.3	13.3	30.0	8.9	11.1	13.5	7.2	16.1	12.2	7.1	17.5	7.4	4.1	21.8	12.9	18.4	12.1	11.9	23.5	7.8	18.4	10.1	17.0
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724047-246768137	"Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 95.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 1022.4;Spermatocytes: 461.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	17	"basophil: 95.3"	"Lineage enriched"	"Detected in all"	22	"granulocytes: 95.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 53.5"	"Low region specificity"	"Detected in all"							"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA		2100000	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	14.1	25.8	15.7	6.4	17.5	13.4	11.3	11.3	20.5	10.9	11.7	24.7	8.5	15.1	12.0	8.5	4.8	14.4	9.7	15.8	15.6	19.8	23.0	67.3	9.3	7.3	26.1	15.0	10.6	12.7	15.0	12.7	14.1	21.7	18.1	12.2	7.3	7.4	16.7	23.9	10.7	15.3	10.8	62.1	5.1	12.4	65.1	17.5	8.5	18.2	7.3	4.8	25.0	13.2	1.4	2.3	95.3	3.2	4.2	3.0	2.1	13.1	12.8	9.4	5.6	11.3	14.2	0.1	10.3	14.4	17.4	14.6	7.8	37.0	7.0	13.5	11.8	9.7	4.3	7.9	3.0	17.9	9.7	2.9	11.8	11.7	15.6	10.6	22.9	10.2	9.5	1.4	11.8	1.2	16.5	18.6	14.7	14.7	0.0	17.3	3.1	23.8	29.1	14.1	7.1	10.2	20.1	12.1	0.0	53.5	30.9	10.7	12.0	13.9	0.6	9.1	5.2	10.4	23.9	12.1	8.1	7.2	19.6	26.5	34.7	11.9	4.1	13.8	31.3	10.6	95.3	3.2	5.5	2.5	2.8	3.0	1.4	0.7	2.1	1.3	1.1	1.0	3.0	0.8	4.2	1.8	2.3	0.5	2.1	15.7	17.5	11.3	20.5	15.6	19.8	26.1	15.0	21.7	17.5	6.0	11.5	8.0	36.7	26.8	29.6	33.1	50.9	52.2	17.0	144.8	17.7	28.0	26.6	57.2	1022.4	20.2	47.9	0.0	61.3	13.6	42.0	76.7	57.5	163.4	83.3	6.4	43.0	21.5	44.3	154.3	44.0	20.4	45.5	15.4	25.1	52.2	56.6	28.1	44.6	51.6	30.6	19.4	27.8	461.4	68.6	59.8	70.7	16.7	53.2	149.1
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931978	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 114.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Group enriched"	"Detected in many"	5	"B-cells: 5.0;granulocytes: 8.4;T-cells: 2.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	20.2	13.7	10.4	11.0	17.4	17.3	14.3	23.3	12.9	12.2	12.6	7.5	10.3	8.3	13.8	8.2	10.7	14.7	8.9	14.9	10.1	6.8	13.4	13.1	9.7	9.5	11.6	8.3	23.3	12.3	19.2	17.6	10.7	10.9	10.1	8.1	7.4	10.7	11.5	15.6	11.3	10.3	10.1	11.4	12.5	12.7	33.9	11.3	17.9	15.3	8.8	9.7	14.5	20.9	5.0	1.1	8.4	0.9	0.7	2.9	0.7	23.9	12.2	10.8	9.5	10.7	10.7	22.9	17.4	8.5	12.7	10.5	11.9	9.1	23.7	19.0	9.0	7.5	20.7	17.2	8.9	21.5	16.8	7.2	15.0	13.3	10.4	8.0	21.7	11.8	10.2	7.9	16.4	16.8	5.9	9.2	8.9	41.6	11.6	12.1	5.5	16.1	9.8	25.1	14.4	13.3	19.8	17.5	18.4	7.8	12.1	13.6	19.8	22.8	8.7	9.3	8.3	11.1	13.5	12.0	13.1	15.1	18.4	32.7	21.1	29.5	26.5	10.6	13.8	12.7	0.7	0.6	1.7	1.7	0.3	1.3	5.0	1.9	1.6	0.8	1.3	2.9	1.5	8.4	0.7	0.9	1.1	2.9	0.7	10.4	17.4	23.3	12.9	10.1	6.8	11.6	8.3	10.9	11.3	32.8	25.4	17.3	13.4	26.7	19.8	17.1	7.6	21.4	27.3	5.2	7.9	12.0	3.3	11.2	54.5	16.3	12.2	0.0	10.5	9.1	14.6	17.6	11.5	12.5	8.0	17.5	20.7	19.0	15.5	17.5	33.4	16.8	3.3	11.8	12.5	8.9	13.9	10.5	36.7	7.6	15.4	32.3	23.7	114.9	37.5	26.8	11.3	13.8	11.2	22.6
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.3;testis: 8.3"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 2.0;Extravillous trophoblasts: 3.7;Mucus-secreting cells: 2.0;Spermatocytes: 3.1;Spermatogonia: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 5.1"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.2"	"Low cell line specificity"	"Detected in many"											HPA024743	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.3	0.3	0.6	3.2	2.1	3.3	1.5	1.6	1.0	0.6	1.0	0.0	0.0	0.4	0.6	0.0	1.3	0.3	0.2	0.3	5.1	0.4	0.7	0.2	0.9	1.1	0.5	0.9	0.6	1.7	0.0	0.6	2.5	0.3	0.4	1.5	0.1	1.1	0.1	0.2	0.5	2.3	1.4	0.7	0.4	0.6	8.3	0.0	8.3	0.3	0.0	2.2	0.4	0.7	0.1	0.1	3.2	0.2	0.2	0.2	0.0	6.6	0.8	4.1	10.3	0.1	0.1	10.8	2.2	0.1	3.1	4.3	6.9	0.4	5.5	4.4	1.2	3.8	2.0	11.6	0.6	3.6	0.0	4.0	3.5	1.5	4.2	0.0	0.0	1.4	0.2	0.0	3.6	2.9	0.9	1.2	7.0	4.7	0.0	3.3	2.6	7.4	3.9	7.7	6.7	4.3	4.1	9.5	0.0	0.7	3.7	3.7	6.3	3.4	2.7	1.2	4.2	2.9	4.9	0.5	0.5	6.0	3.1	0.0	0.7	1.8	0.1	0.0	0.0	2.2	0.7	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	3.2	0.2	0.1	0.1	0.0	0.0	0.6	2.1	1.6	1.0	5.1	0.4	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	3.7	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.1	2.7	0.1	0.9	0.0	1.4	0.1
ZNF670	MGC12466	ENSG00000277462	"Zinc finger protein 670"	Q9BS34	1	247036784-247078755	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 21.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003142	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003142: AB_1859404"	"unprognostic (2.11e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.05e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-2)"	3.5	2.2	3.1	2.9	5.5	0.7	6.2	12.0	6.1	4.1	2.6	3.2	0.0	2.8	5.7	3.4	1.9	3.7	3.8	2.5	4.5		3.9	3.0	4.0	3.4	1.8	1.3	5.5	2.8	3.1	1.3	1.4	4.0	3.4	3.5	2.5	1.9	3.1	1.6	2.6	2.4	4.3	2.9	3.1	3.3	4.8	2.7	5.4	3.7	3.0	4.7	4.2	1.0	6.6	4.1	1.7	2.3	2.8	6.5	2.3	3.8	2.7	7.8	9.6	2.0	3.4	18.1	4.9	3.3	5.9	5.9	3.2	4.1	6.2	8.2	3.0	3.2	3.2	8.6	3.8	11.2	4.6	1.1	5.5	1.8	4.9	1.7	6.8	3.4	1.9	4.0	3.8	7.4	0.9	3.8	4.9	7.9	2.7	5.9	1.5	8.0	3.3	14.5	8.6	4.9	8.3	9.7	5.8	3.5	8.4	9.0	8.2	6.9	2.7	3.8	4.6	2.8	14.3	2.4	3.6	4.1	2.6	5.4	5.2	9.9	12.7	1.3	4.9	4.5	0.0	2.0	1.7	4.4	2.3	2.3	6.6	4.1	4.6	4.1	5.9	6.5	4.9	0.2	2.8	1.4	2.3	3.0	2.3											3.0	1.7	0.0	8.6	21.5	4.3	0.6	7.6	6.7	4.5	5.2	0.0	2.2	5.0	4.6	5.2	4.4	0.4	0.0	2.5	6.7	2.3	3.8	0.0	2.8	2.1	6.4	0.0	4.9	1.9	1.0	1.7	1.6	6.8	2.8	2.7	2.0	2.7	1.5	1.4	2.8	1.4	0.0	4.4	1.6	3.3	9.8	0.7	0.0	1.1	3.7
ZNF669	FLJ12606	ENSG00000188295	"Zinc finger protein 669"	Q96BR6	1	247099962-247104372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 28.5;Rod photoreceptor cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044043	Uncertain					NA	NA					"HPA044043: AB_10964039"	"unprognostic (1.88e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.59e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.81e-2)"	10.6	5.3	4.7	7.1	6.5	17.4	9.6	11.0	9.2	8.8	6.2	8.2	3.0	4.9	9.7	5.8	5.5	7.3	5.2	4.5	5.2	5.5	7.7	4.8	6.2	11.1	4.9	3.9	8.6	8.3	5.8	9.1	5.0	8.2	6.5	6.4	5.2	7.0	6.0	5.0	6.2	7.0	6.6	5.2	10.5	6.6	9.6	4.4	24.1	8.8	4.3	9.4	6.9	5.2	8.2	5.5	11.1	3.3	5.6	8.5	3.4	3.3	2.3	7.7	8.8	4.5	4.0	7.8	4.7	5.0	7.0	6.8	5.6	3.5	4.7	7.4	3.3	4.8	4.2	7.4	5.8	7.4	2.4	1.8	0.3	5.4	4.0	3.6	4.1	5.6	3.7	6.1	5.4	3.9	3.2	3.9	12.1	8.1	3.3	6.9	2.9	11.2	4.5	17.9	6.8	4.8	8.9	7.5	3.4	4.9	9.5	8.3	14.7	6.3	3.3	2.4	9.0	6.5	16.0	4.2	4.7	5.3	4.4	9.0	8.4	15.1	9.6	1.3	2.3	4.7	11.1	3.3	9.9	6.1	2.1	8.0	8.2	7.4	5.8	4.1	7.2	8.5	8.0	8.1	5.6	3.0	5.5	7.6	3.4	4.7	6.5	11.0	9.2	5.2	5.5	4.9	3.9	8.2	4.4	3.0	8.8	12.7	4.8	8.7	28.5	1.4	12.7	10.7	4.5	1.8	11.8	3.2	6.6	4.3	9.2	5.8	1.9	0.0	6.7	3.6	3.2	2.5	14.0	2.5	4.4	15.9	7.5	6.2	5.4	5.3	6.6	9.1	11.8	1.8	2.1	9.8	6.5	0.0	3.5	2.6	29.5	0.0	2.5	7.0	9.2	7.4	1.9	13.3	1.9	3.3
ZNF124	"HZF-16, HZF16"	ENSG00000196418	"Zinc finger protein 124"	Q15973	1	247121975-247172016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.7;salivary gland: 23.4"	"Group enriched"	"Detected in many"	31	"Early spermatids: 319.1;Late spermatids: 835.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031127	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA031127: AB_10602685"	"unprognostic (3.97e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.03e-4)"	1.9	1.1	1.2	1.9	1.0	2.8	2.1	1.9	1.4	1.6	3.9			3.5	4.1	2.3	1.7	1.7	1.8	1.5	1.5	1.7	3.4	1.9	2.8	3.0	1.8		3.1	3.9	0.5	0.8	2.2		2.3	4.0		23.4	1.2	1.1	2.2	4.2	1.8	2.1	5.2	2.6	2.8			2.4		3.4	3.1	1.8	10.6	12.6	10.0	14.7	9.9	12.3	6.3	3.6	2.8	7.9	10.4	3.0	1.9	19.9	3.8	2.3	4.0	4.1	4.2	3.3	7.4	4.5	3.0	2.7	4.0	9.4	3.0	5.7	0.4	2.6	6.5	3.3	8.9	2.9	11.6	7.5	2.3	2.4	3.9	3.8	1.9	5.7	8.7	9.1	5.2	5.0	3.2	11.9	7.5	20.5	7.1	6.5	12.6	6.4	5.2	3.8	11.0	12.4	12.6	5.6	4.4	3.8	9.9	3.2	18.6	6.5	3.0	4.5	3.3	6.8	4.5	5.5	10.9	1.2	11.9	6.3	6.2	8.8	10.0	7.0	9.9	10.1	10.6	9.1	8.5	12.6	6.7	12.3	11.8	2.0	9.9	14.7	9.9	6.7	6.3											14.9	9.9	3.7	3.6	3.2	3.3	4.4	5.1	4.0	7.9	3.5	3.9	3.1	1.7	4.3	319.1	8.8	6.6	0.0	4.3	5.7	2.7	4.0	10.5	0.8	7.2	0.0	7.5	2.5	18.7	835.8	11.2	14.2	6.8	5.4	5.6	2.1	3.7	10.7	11.3	4.9	5.2	6.5	3.3	7.4	12.8	1.4	1.1	4.3	8.0	5.7
ZNF496	"MGC15548, ZKSCAN17, ZSCAN49"	ENSG00000162714	"Zinc finger protein 496"	Q96IT1	1	247297412-247331846	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055834			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA055834: "	"unprognostic (1.88e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.55e-1)"	10.1	6.2	6.9	6.4	8.2	6.3	8.7	11.4	13.5	17.8	10.8	15.1	4.7	4.1	16.1	11.4	7.2	16.8	8.7	9.6	6.3	5.8	8.1	4.7	8.7	6.8	6.3	6.2	21.7	20.4	12.7	7.0	10.6	7.3	10.1	6.3	14.5	8.1	12.3	16.6	5.9	6.7	13.0	7.1	9.6	9.2	21.1	7.8	22.4	14.1	7.0	7.5	12.8	8.5	1.5	2.7	0.3	1.0	2.7	5.5	1.8	12.0	11.1	11.7	14.3	4.7	12.0	14.8	5.7	14.1	12.7	11.5	6.0	11.3	3.4	9.8	9.2	4.8	10.4	12.0	10.9	12.8	9.3	2.9	11.2	7.8	6.8	12.7	13.6	5.8	12.7	11.5	9.9	23.9	14.2	15.0	16.4	19.8	8.8	7.8	7.7	13.4	9.4	23.6	5.3	16.6	12.8	12.9	4.6	7.8	14.6	10.1	22.2	7.6	8.6	11.3	11.2	9.0	16.9	10.3	9.3	13.2	4.1	17.6	9.8	7.8	9.9	3.9	0.9	10.0	0.0	1.0	0.3	2.1	0.7	3.4	0.8	0.9	2.3	2.7	1.5	1.9	5.5	0.3	2.7	1.0	1.6	0.3	1.8	6.9	8.2	11.4	13.5	6.3	5.8	6.3	6.2	7.3	7.8	0.0	2.7	1.5	3.6	3.3	6.8	7.6	2.5	4.0	5.7	1.8	2.0	4.1	1.7	3.8	8.3	5.7	1.0	0.0	5.0	5.0	6.6	4.8	3.5	1.8	5.0	3.2	4.7	7.4	4.7	28.7	5.2	2.0	3.3	3.6	2.0	1.5	4.4	2.9	6.7	2.4	6.9	6.5	6.6	14.0	8.3	3.0	3.5	1.7	3.4	3.9
NLRP3	"AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, FCAS, FCU, MWS, NALP3, PYPAF1"	ENSG00000162711	"NLR family pyrin domain containing 3"	Q96P20	1	247416156-247449108	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	Activator	"Amyloidosis, Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 40.3;bone marrow: 38.2"	"Group enriched"	"Detected in some"	11	"Hofbauer cells: 15.0;Kupffer cells: 26.7;Macrophages: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 40.3"	"Group enriched"	"Detected in many"	20	"dendritic cells: 13.4;granulocytes: 40.3;monocytes: 12.5"	"Cell line enhanced"	"Detected in some"		"NB-4: 7.2;THP-1: 41.6;U-937: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012878	Uncertain				"Intracellular and membrane"	NA	NA					"HPA012878: AB_1846752"	"unprognostic (3.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.84e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.17e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.10e-2)"	7.4	1.4	2.8	8.3	3.3	38.2	3.2	0.7	3.7	1.8	1.5	6.9	1.5	0.8	4.5	0.9	2.4	3.0	8.9	2.0	3.0	3.1	1.3	1.8	8.2	8.9	3.3	0.8	1.3	1.4	1.1	1.2	3.0	5.2	1.0	1.7	2.4	1.5	0.7	0.9	0.8	2.5	4.1	4.9	8.5	1.6	0.6	3.3	1.0	1.0	3.2	2.8	3.3	0.9	0.0	13.4	40.3	12.5	0.0	1.1	3.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	1.3	1.6	0.2	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.2	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.6	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.0	4.0	10.4	1.2	40.3	12.5	0.1	0.2	7.7	0.6	0.0	1.1	0.4	13.4	0.0	0.4	0.2	3.0	0.0	3.6	0.6	0.0	3.9	2.8	3.3	0.7	3.7	3.0	3.1	3.3	0.8	5.2	3.3	0.0	0.3	0.5	0.0	0.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.8	0.0	2.3	0.0	15.0	0.0	0.0	0.6	26.7	0.0	0.0	42.3	0.0	1.0	0.0	0.5	0.1	0.0	0.4	0.0	0.2	0.0	0.5	0.5	0.2	0.5	1.1	2.5	0.0	0.0
OR2B11		ENSG00000177535	"Olfactory receptor family 2 subfamily B member 11"	Q5JQS5	1	247449118-247458105	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.1"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 14.7;Club cells: 9.1;granulocytes: 3.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"THP-1: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047459	Uncertain					NA	NA					"HPA047459: AB_10963692"					"unprognostic (1.83e-1)"													1.5	0.1	0.1	1.2	0.1	3.1	0.1	0.0	0.2	0.3	0.1			0.0	0.0	0.1	0.1	0.7	1.0	0.2	0.1	0.1	0.0	0.1	0.4	0.3	0.1		0.1	1.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.2			0.3		0.0	0.3	0.0	0.0	0.0	0.5	1.5	0.0	0.3	0.0	0.1	0.2	0.6	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	5.2	0.6	0.1	0.4	0.1	0.1	0.1	0.1	0.4	0.9	0.6	0.1	0.5	0.8	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0											0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	14.7	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 48.3;brain: 17.6"	"Cell type enriched"	"Detected in some"	27	"granulocytes: 214.1"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	10	"cerebellum: 17.6"	"Cell type enriched"	"Detected in single"	439	"basophil: 48.3"	"Lineage enriched"	"Detected in single"	439	"granulocytes: 48.3"	"Group enriched"	"Detected in some"	73	"HEL: 28.5;HMC-1: 113.3"					"Low region specificity"	"Detected in single"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	3.7	0.3	0.4	1.1	0.4	2.4	1.6	17.6	0.4	3.8	2.1	0.2	0.0	2.2	2.4	2.2	1.9	0.6	2.7	1.3	0.4	0.5	0.5	0.4	5.6	1.1	0.5	0.0	0.3	0.5	0.1	0.4	0.3	1.7	9.5	2.4	0.4	1.0	0.9	0.5	1.2	2.5	6.6	0.9	0.5	1.4	5.3	0.0	1.4	0.4	2.4	1.5	3.4	9.4	0.1	0.0	48.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	113.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	48.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	17.6	0.4	0.4	0.5	0.5	0.0	1.7	0.0	0.0	7.9	0.0	0.0	0.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	6.7	0.1	0.0	0.0	0.0	0.0	0.3	1.3	214.1	0.0	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.9	1.6	0.5	0.0	0.0	0.0	0.0
OR2C3	"OR2C4, OR2C5P, OST742"	ENSG00000196242	"Olfactory receptor family 2 subfamily C member 3"	Q8N628	1	247524677-247536440	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.2;testis: 4.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 1.6;granulocytes: 1.1;Late spermatids: 2.1;Spermatocytes: 2.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	12	"basophil: 4.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.3;granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8"									HPA058578			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA058578: AB_2683761"									"unprognostic (1.96e-1)"			"unprognostic (7.29e-2)"		"unprognostic (3.45e-2)"	"unprognostic (1.03e-1)"			0.2	0.4	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.9	0.1			0.0	0.2	0.9	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1		0.3	0.2	1.3	0.1	0.4		0.7	0.0		0.1	0.0	0.5	0.1	0.1	0.4	0.1	0.1	0.1	4.6			0.1		0.0	0.2	0.1	0.0	1.3	4.2	0.0	0.1	0.1	0.0	0.5	0.3	0.6	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.3	1.8	0.6	0.2	0.0	1.1	0.3	0.0	0.1	0.0	0.7	0.5	0.1	0.2	0.1	0.1	0.2	0.5	0.5	0.0	0.1	0.0	0.4	0.1	0.5	1.2	0.7	0.1	0.0	0.4	0.2	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.5	0.6	0.6	0.3	0.7	0.4	1.2	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.5	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0
GCSAML-AS1		ENSG00000284824	"GCSAML antisense RNA 1"	Q8N628	1	247524679-247532613	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 4.5"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.1;hTERT-HME1: 1.0;SK-MEL-30: 1.2"									HPA058578			Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA058578: AB_2683761"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.5			0.0		0.0	0.0		0.0	0.8	0.6	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0
OR2G2		ENSG00000177489	"Olfactory receptor family 2 subfamily G member 2"	Q8NGZ5	1	247588360-247589313	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	46	"granulocytes: 4.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.3"					"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0			0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2G3		ENSG00000177476	"Olfactory receptor family 2 subfamily G member 3"	Q8NGZ4	1	247605586-247606515	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13G1		ENSG00000197437	"Olfactory receptor family 13 subfamily G member 1"	Q8NGZ3	1	247670812-247679739	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.9;NB-4: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"olfactory region: 0.1"							NA	NA																							0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6F1	OST731	ENSG00000169214	"Olfactory receptor family 6 subfamily F member 1"	Q8NGZ6	1	247711436-247716646	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	13	"testis: 4.6"	"Group enriched"	"Detected in some"	63	"Early spermatids: 13.9;Late spermatids: 14.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	57	"GAMG: 6.4"	"Not detected"	"Not detected"													NA	NA																	"unprognostic (5.75e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
AC118470.1		ENSG00000239395			1	247711813-247723764	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	44	"testis: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	89	"GAMG: 8.9"															NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	6.3			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14A2	"OR5AX1, OR5AX1P"	ENSG00000241128	"Olfactory receptor family 14 subfamily A member 2"	Q96R54	1	247722957-247724043	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	12	"testis: 7.4"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 11.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	109	"GAMG: 10.9"									HPA052685	Uncertain					NA	NA					"HPA052685: AB_2681914"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4			0.0		0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
OR14K1	OR5AY1	ENSG00000153230	"Olfactory receptor family 14 subfamily K member 1"	Q8NGZ2	1	247738615-247739559	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"testis: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"GAMG: 11.0"					"Not detected"	"Not detected"			HPA016643	Uncertain					NA	NA					"HPA016643: AB_1854788"										"unprognostic (1.62e-1)"		"unprognostic (1.63e-1)"						0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.2	0.2			0.0	0.3	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.5	0.2		0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	1.9			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1C1	"HSTPCR27, TPCR27"	ENSG00000221888	"Olfactory receptor family 1 subfamily C member 1"	Q15619	1	247754846-247760556	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 1.4;testis: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"																	NA	NA															"unprognostic (3.40e-1)"		"unprognostic (3.58e-1)"			"unprognostic (3.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0			0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0		0.2	0.0	0.0	0.0	0.0		0.1	0.1		0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	5.7			0.1		0.0	0.1	0.0	0.7	0.5	1.4	0.6	0.4	0.6	0.3	0.7	1.4	0.6	0.7	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.6	0.8	0.4	0.1	1.0	0.6	0.2	0.0	0.0	0.1	0.1	0.5	0.3	0.4	0.0	0.8	0.7	0.0	0.4	0.5	0.0	0.3	0.0	0.1	0.4	0.7	0.0	0.8	0.2	0.2	0.3	0.6	0.7	0.1	0.4	0.0	0.1	0.3	0.4	0.1	0.1	0.2	0.1	1.4	0.5	0.5	0.9	1.0	1.1	0.4	0.7	0.0	0.1	0.3	0.6	0.3	1.5	1.3	0.2	0.4	0.3	0.6	0.3	0.4	0.5	0.2	0.4	0.7	0.4	0.6	1.4	0.4	0.6	0.5	0.4	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14A16	OR5AT1	ENSG00000196772	"Olfactory receptor family 14 subfamily A member 16"	Q8NHC5	1	247814660-247824119	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.9"					"Not detected"	"Not detected"									NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR11L1		ENSG00000197591	"Olfactory receptor family 11 subfamily L member 1"	Q8NGX0	1	247840928-247841896	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8			2.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857199-247878205	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2"	"Cell type enriched"	"Detected in many"	16	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.0;HEL: 21.4;K-562: 11.8;PC-3: 20.7;U-2 OS: 16.8;WM-115: 21.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023637	Uncertain					NA	NA		310000			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.7	0.8	1.3	1.0	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0.0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1.0	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0.0	15.2	0.0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	1.0	8.0	0.0	0.0	0.0	0.8	21.4	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	11.8	0.1	0.0	0.0	0.0	0.1	1.4	0.0	20.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	2.1	0.0	0.0	16.8	0.0	0.0	3.6	0.0	0.0	0.0	6.1	21.8	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1.0	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1	3.0	4.0	1.7	0.6	0.9	2.3	0.4	0.0	6.7	10.3	1.8	11.8	2.4	0.0	0.1	3.1	0.8	0.0	186.9	0.0	3.3	1.5	2.9	8.1	0.0	2.0	0.0	1.2	1.8	2.6	0.5	0.9	1.6	1.7	0.0	0.4	1.5	0.2	0.0	0.7	0.0	3.5	0.0	0.8	2.8	10.9	0.6	4.1	1.3	0.8	0.9
OR2W3	"OR2W3P, OR2W8P, OST718"	ENSG00000238243	"Olfactory receptor family 2 subfamily W member 3"	Q7Z3T1	1	247895587-247896531	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"bone marrow: 13.8;thyroid gland: 8.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 13.1;PC-3: 13.2;U-2 OS: 8.6;U-937: 6.2;WM-115: 9.4"									HPA045594	Uncertain					NA	NA					"HPA045594: AB_10960280"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.57e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-2)"		"unprognostic (2.79e-6)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (9.05e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.3	1.6	13.8	0.2	0.0	2.2	0.4	0.7			0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	1.7	0.0	0.1	0.5	0.0	1.1		0.0	0.2	0.0	0.3	1.6		0.5	0.6		0.0	0.0	0.0	0.3	0.2	0.4	0.4	0.8	0.1	1.1			8.2		0.0	0.3	0.2	0.6	1.4	1.0	0.6	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	3.9	0.0	0.0	0.0	0.3	13.1	0.0	0.0	0.0	1.7	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.1	0.5	0.0	13.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	8.6	0.0	0.0	1.5	0.0	0.0	0.0	6.2	9.4	0.0	0.2	1.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.6	0.2	0.0	0.8	0.0	0.5	0.0	0.0	1.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T8	OR2T8P	ENSG00000177462	"Olfactory receptor family 2 subfamily T member 8"	A6NH00	1	247920252-247921956	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;thyroid gland: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.0;HaCaT: 1.1;HEL: 2.6;PC-3: 1.9;U-2 OS: 1.2;U-937: 2.4"															NA	NA						"unprognostic (7.26e-2)"									"unprognostic (4.16e-1)"		"unprognostic (2.88e-1)"			"unprognostic (1.06e-1)"	"unprognostic (2.83e-2)"		0.1	0.0	0.3	0.1	1.1	2.4	0.2	0.0	0.7	0.2	0.1			0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.6		0.0	0.0	0.0	0.0	0.3		0.5	0.4		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	1.4			3.8		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	1.1	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OR2AJ1	"OR2AJ1P, OR2AJ1Q"	ENSG00000177275	"Olfactory receptor family 2 subfamily AJ member 1"	Q8NGZ0	1	247924889-247935339	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.5;thyroid gland: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.5"															NA	NA																							0.0	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.6	0.2	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.1			1.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2L8		ENSG00000279263	"Olfactory receptor family 2 subfamily L member 8 (gene/pseudogene)"	Q8NGY9	1	247948858-247949796	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.7	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.5			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.3		0.0	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2AK2	OR2AK1P	ENSG00000187080	"Olfactory receptor family 2 subfamily AK member 2"	Q8NG84	1	247965233-247966386	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"bone marrow: 2.5;testis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"PC-3: 1.5"									HPA052544	Uncertain					NA	NA					"HPA052544: AB_2681865"																		0.0	0.2	0.0	0.0	0.3	2.5	0.0	0.1	0.2	0.4	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3			0.2		0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2L5	"OR2L11, OR2L5P"	ENSG00000197454	"Olfactory receptor family 2 subfamily L member 5"	Q8NG80	1	248013660-248024276	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"PC-3: 1.2"															NA	NA																							0.1	0.1	0.3	0.2	0.6	1.7	0.0	0.7	0.6	0.5	0.1			0.0	0.1	0.5	0.0	0.2	0.2	0.0	0.5	0.5	0.0	0.0	0.1	0.3	0.5		0.0	0.0	0.0	0.3	0.2		0.4	0.0		0.0	0.2	0.6	0.5	0.0	0.1	0.5	0.6	0.0	0.5			0.3		0.5	0.2	0.0	0.6	0.2	0.7	0.3	0.1	0.4	0.0	0.1	0.4	0.0	0.1	0.4	0.3	0.6	0.5	0.1	0.0	0.1	0.4	0.5	0.1	0.1	0.6	0.4	0.4	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.6	0.0	0.2	0.5	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.5	0.0	0.3	0.1	0.1	0.1	0.0	1.2	0.4	0.2	0.2	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.7	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2L2	"HSHTPCRH07, HTPCRH07, OR2L12, OR2L4P"	ENSG00000203663	"Olfactory receptor family 2 subfamily L member 2"	Q8NH16	1	248030070-248042305	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.1;testis: 3.3"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 10.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 10.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																	NA	NA										"unprognostic (3.37e-2)"				"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"					"unprognostic (2.96e-2)"			0.3	0.4	1.1	0.4	1.1	2.7	0.0	0.4	0.9	0.1	0.1			0.9	0.2	0.1	0.3	0.1	0.4	0.0	1.6	1.2	0.2	1.7	0.2	0.3	1.7		0.0	0.0	0.0	0.3	0.0		0.3	0.1		0.1	0.0	2.2	0.6	1.0	0.0	4.1	0.7	0.9	3.3			0.2		0.0	0.0	0.0	1.7	0.8	2.7	0.8	1.2	1.0	0.2	1.0	0.7	0.9	1.0	0.2	0.1	2.3	0.6	0.0	0.0	0.0	0.6	1.2	1.2	1.2	0.1	0.9	0.8	0.0	0.0	0.3	1.2	0.3	1.0	1.8	0.7	0.0	0.7	1.2	0.0	0.1	0.1	0.0	1.0	0.1	1.0	0.5	2.9	0.1	0.6	0.4	1.4	1.2	1.0	1.4	1.2	1.4	0.8	0.2	1.6	1.3	2.2	1.3	0.7	0.5	1.4	0.9	0.7	1.4	0.9	1.9	1.9	1.4	2.2	1.3	1.1	1.3	1.0	1.3	2.5	0.8	0.6	1.0	0.4	0.8	0.7	0.6	0.5	0.2	1.7	0.8	0.9	2.7	1.2	0.6	0.8	0.4	0.2											17.9	10.8	0.0	0.0	0.0	0.0	0.0	0.0	18.7	13.6	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
OR2L3		ENSG00000198128	"Olfactory receptor family 2 subfamily L member 3"	Q8NG85	1	248046836-248063407	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.0;prostate: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.8;Karpas-707: 1.9"															NA	NA																							0.3	0.2	0.4	1.0	0.4	3.0	0.6	1.3	0.5	0.4	0.0			0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.8		0.0	0.0	0.0	0.9	0.2		4.1	0.0		0.1	0.1	0.0	0.3	0.1	0.0	1.5	0.8	0.0	0.2			0.4		0.0	0.3	0.0	0.1	0.0	0.5	0.2	0.1	0.3	0.0	0.5	0.4	0.8	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.0	0.9	0.3	0.0	0.0	0.1	0.3	0.3	0.0	1.8	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.2	1.9	0.0	0.8	0.4	0.5	0.5	0.2	0.7	0.1	0.8	0.2	0.1	0.5	0.2	0.1	0.4	0.0	0.0	0.5	0.1	1.0	0.0	0.8	0.5	0.3	0.4	1.0	0.5	0.7	1.1	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2L13	OR2L14	ENSG00000196071	"Olfactory receptor family 2 subfamily L member 13"	Q8N349	1	248095184-248101103	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.2;brain: 7.3"	"Cell type enhanced"	"Detected in single"	20	"Early spermatids: 1.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	13	"B-cells: 1.0;granulocytes: 3.2;T-cells: 1.5"	"Group enriched"	"Detected in some"	9	"ASC diff: 1.1;GAMG: 2.5;WM-115: 2.9"															NA	NA						"unprognostic (1.39e-2)"				"unprognostic (1.53e-1)"				"unprognostic (9.89e-2)"	"unprognostic (3.66e-1)"		"unprognostic (7.01e-2)"			"unprognostic (2.44e-2)"	"unprognostic (1.14e-1)"		0.0	2.0	2.1	0.0	2.4	0.2	0.6	0.7	7.3	0.1	0.1			0.0	0.0	1.2	0.0	1.0	0.0	0.0	2.5	3.2	0.0	0.0	0.0	0.2	3.5		0.2	0.0	0.0	0.2	0.1		1.8	0.1		0.0	0.6	0.0	0.0	0.0	0.1	4.5	1.1	0.0	1.2			0.9		0.1	0.1	0.0	1.0	0.1	3.2	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	3.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.6	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
OR2M5	OR2M5P	ENSG00000162727	"Olfactory receptor family 2 subfamily M member 5"	A3KFT3	1	248145148-248146086	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.1			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2M2	"OR2M2Q, OST423"	ENSG00000198601	"Olfactory receptor family 2 subfamily M member 2"	Q96R28	1	248174821-248181067	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2M3	"OR2M3P, OR2M6, OST003"	ENSG00000228198	"Olfactory receptor family 2 subfamily M member 3"	Q8NG83	1	248197265-248212925	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	23	"Club cells: 2.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																	NA	NA																							0.5	0.5	0.9	0.5	0.9	3.6	0.5	0.6	1.2	1.5	1.2			0.7	0.6	2.0	0.5	0.5	0.6	0.5	1.0	1.1	1.6	1.6	0.5	0.8	1.1		1.0	0.7	0.0	0.7	0.3		0.5	1.4		1.4	0.0	0.8	2.4	0.6	0.0	0.7	0.8	0.8	1.6			0.9		0.0	0.7	0.5	1.7	1.4	3.3	1.9	0.9	1.4	0.5	2.8	1.6	2.5	2.6	1.0	1.1	2.4	2.2	0.3	0.3	0.6	6.2	3.7	3.3	2.4	0.5	3.6	2.6	1.1	0.8	0.9	3.2	2.2	1.7	5.2	2.0	0.4	2.2	2.1	0.9	1.1	0.6	0.8	1.7	0.5	2.3	3.7	6.6	0.7	2.4	1.8	2.5	3.9	2.4	1.4	2.1	2.8	3.0	1.0	2.2	2.7	2.3	2.9	1.5	1.7	3.1	2.9	2.0	3.1	2.9	3.6	2.9	1.9	4.2	2.6	2.5	2.4	2.0	2.6	3.3	1.6	0.8	1.4	1.9	1.2	1.0	1.1	0.9	0.6	1.7	1.2	1.2	3.2	0.9	1.3	1.4	0.9	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2M4	"HSHTPCRX18, HTPCRX18, OST710, TPCR100"	ENSG00000171180	"Olfactory receptor family 2 subfamily M member 4"	Q96R27	1	248231417-248244679	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"							"Not detected"	"Not detected"			HPA051308	Uncertain					NA	NA					"HPA051308: AB_2681435"																		0.4	0.1	0.5	0.0	0.6	2.6	0.5	0.4	1.3	0.3	0.2			0.2	0.3	1.1	0.1	0.5	0.5	0.1	0.7	1.3	0.1	1.5	0.1	0.2	1.1		0.8	1.4	0.6	0.3	0.0		0.2	0.0		0.7	0.0	0.1	1.0	0.2	0.0	1.0	0.2	0.2	0.4			0.4		0.0	0.2	0.2	1.0	0.6	2.1	0.6	1.3	0.7	0.3	0.7	0.2	0.5	0.7	1.2	2.3	0.4	0.4	0.2	0.1	0.0	0.8	0.4	0.7	0.3	0.3	0.9	0.4	0.5	0.7	0.1	0.1	0.3	1.0	1.6	0.7	0.1	1.2	0.7	1.6	0.1	0.3	0.2	0.4	0.8	0.5	0.9	1.8	0.2	0.9	0.3	1.0	0.9	0.2	0.8	1.9	0.4	0.8	0.2	1.4	1.3	1.0	0.4	0.5	0.8	0.5	0.6	0.1	1.7	0.8	0.8	0.9	0.3	1.3	0.7	0.4	0.6	1.0	1.0	1.9	0.6	0.4	0.6	0.5	0.4	0.5	0.5	0.4	0.1	1.0	0.5	0.7	2.1	1.3	0.6	0.6	0.4	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T33		ENSG00000177212	"Olfactory receptor family 2 subfamily T member 33"	Q8NG76	1	248269917-248277976	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.2;thyroid gland: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.1"															NA	NA															"unprognostic (5.79e-2)"						"unprognostic (2.22e-1)"		0.1	0.2	0.4	0.2	1.0	2.2	0.1	0.0	0.8	0.5	0.1			0.5	0.0	0.5	0.1	0.2	0.3	0.0	0.2	1.1	0.1	0.2	0.0	0.2	0.8		0.5	0.0	0.0	0.1	0.1		0.5	0.0		1.5	0.0	0.7	0.3	0.6	0.0	0.1	0.3	0.7	1.7			2.4		0.1	0.6	0.0	0.6	0.9	1.3	0.3	0.4	0.7	0.0	0.6	0.0	0.3	0.4	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.4	2.1	0.5	0.0	1.2	0.6	0.0	0.0	0.0	0.6	0.1	1.6	0.7	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.3	0.9	0.0	0.6	0.5	0.7	0.4	0.5	1.8	0.3	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.3	0.8	0.1	0.4	0.6	0.7	0.9	1.8	0.1	0.8	0.3	0.8	0.2	1.2	0.5	1.3	0.2	0.3	0.5	0.3	0.3	0.6	0.4	0.4	0.2	0.6	0.7	0.7	0.7	0.4	0.3	0.9	0.2	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T12		ENSG00000177201	"Olfactory receptor family 2 subfamily T member 12"	Q8NG77	1	248290139-248303424	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;epididymis: 2.9;liver: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.7;U-2197: 3.6"															NA	NA																							0.1	0.1	0.1	0.2	0.3	0.9	0.2	0.1	0.4	0.4	0.2			0.1	0.3	2.9	0.1	0.3	0.0	0.1	0.4	0.4	0.1	4.7	0.2	0.2	0.4		0.2	0.1	0.0	0.2	0.0		0.1	0.4		0.1	0.0	0.2	0.7	0.3	0.0	0.2	0.2	0.2	0.7			0.6		0.2	0.2	0.2	1.3	0.6	2.4	0.4	1.0	0.8	0.1	1.0	0.3	0.4	0.8	0.1	0.2	0.8	0.1	0.1	0.1	0.2	0.7	0.6	1.1	0.5	0.1	0.5	0.3	0.2	0.3	0.2	0.9	0.3	0.9	4.7	0.7	0.1	0.9	1.2	0.2	0.2	0.3	0.0	0.3	0.1	0.6	0.4	2.1	0.1	0.9	1.4	0.8	1.3	0.4	0.3	0.5	0.6	0.7	0.2	1.1	0.7	0.8	0.6	0.9	0.3	1.0	0.7	0.9	1.2	1.0	0.9	3.6	0.6	0.9	0.9	0.5	0.6	0.5	0.8	2.4	0.4	0.3	0.8	0.3	0.6	0.8	0.6	0.6	0.2	1.3	0.8	0.8	1.1	1.0	0.4	0.6	0.3	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2M7		ENSG00000177186	"Olfactory receptor family 2 subfamily M member 7"	Q8NG81	1	248323630-248324568	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14C36	OR5BF1	ENSG00000177174	"Olfactory receptor family 14 subfamily C member 36"	Q8NHC7	1	248348775-248349713	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"prostate: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"HeLa: 2.3"															NA	NA																							0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		1.7	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T4	OR2T4Q	ENSG00000196944	"Olfactory receptor family 2 subfamily T member 4"	Q8NH00	1	248361581-248362627	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;cervix, uterine: 1.1;prostate: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.4"															NA	NA																							0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	1.1	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T6	"OR2T6P, OR2T9, OST703"	ENSG00000198104	"Olfactory receptor family 2 subfamily T member 6"	Q8NHC8	1	248375746-248391811	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.6;HBF TERT88: 1.2"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.0	0.8	0.5	0.0			0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.0	0.4		0.3	0.0	0.0	0.0	0.1		0.3	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.7			0.0		0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.6	0.3	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.3	0.1	0.2	0.1	0.0	0.3	0.4	0.0	0.1	0.1	0.7	0.3	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.5	0.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T1	OR1-25	ENSG00000175143	"Olfactory receptor family 2 subfamily T member 1"	O43869	1	248403048-248408020	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA063064	Uncertain					NA	NA					"HPA063064: AB_2684935"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T2	OR2T2P	ENSG00000196240	"Olfactory receptor family 2 subfamily T member 2"	Q6IF00	1	248445512-248455725	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"kidney: 14.1"	"Cell type enriched"	"Detected in single"	14	"Proximal tubular cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enriched"	"Detected in single"	22	"Karpas-707: 3.2"															NA	NA																							0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	1.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T3		ENSG00000196539	"Olfactory receptor family 2 subfamily T member 3"	Q8NH03	1	248473351-248474307	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.1		1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0			0.0		0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T5		ENSG00000203661	"Olfactory receptor family 2 subfamily T member 5"	Q6IEZ7	1	248488589-248491113	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.7	0.0		1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2G6		ENSG00000188558	"Olfactory receptor family 2 subfamily G member 6"	Q5TZ20	1	248508073-248527337	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2"	"Group enriched"	"Detected in some"	19	"Alveolar cells type 2: 2.6;Ciliated cells: 2.7;Club cells: 1.2;granulocytes: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.2"															NA	NA																							0.2	0.2	0.2	0.2	0.2	3.2	0.2	0.2	0.2	0.3	0.2			0.6	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2		0.2	1.1	0.0	0.2	0.1		0.8	0.0		0.6	0.0	0.3	0.9	0.3	0.0	0.2	0.5	1.1	1.9			0.2		0.3	0.4	0.2	1.4	0.7	1.8	0.8	0.6	0.6	0.1	0.7	0.5	0.6	0.7	0.1	0.4	1.0	1.0	0.1	0.1	0.2	0.7	0.9	0.8	1.1	0.0	0.6	0.8	0.3	0.1	0.4	0.9	0.7	0.8	1.3	0.4	0.0	1.0	0.9	0.1	0.4	0.1	0.4	0.5	0.3	0.9	0.7	3.2	0.1	0.6	0.7	0.8	1.2	0.3	0.7	0.9	0.6	0.4	0.2	1.4	0.6	0.8	0.8	0.7	0.7	0.6	2.0	0.9	2.4	0.9	1.2	1.2	0.8	1.3	0.9	1.0	0.5	0.9	0.7	1.7	0.5	0.5	0.5	0.3	0.4	0.4	0.4	0.4	0.2	1.4	0.5	0.6	1.8	0.6	0.8	0.7	0.3	0.1											0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T29		ENSG00000182783	"Olfactory receptor family 2 subfamily T member 29"	Q8NH02	1	248556912-248562772	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.5;kidney: 2.7;prostate: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.5"	"Cell line enriched"	"Detected in single"	33	"Karpas-707: 3.2"															NA	NA																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	0.0		0.0	0.1	0.0	0.0	0.0		1.6	0.0		0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2			0.3		0.1	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T34		ENSG00000183310	"Olfactory receptor family 2 subfamily T member 34"	Q8NGX1	1	248573801-248574757	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.4"	"Cell line enriched"	"Detected in single"	15	"Karpas-707: 1.5"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.4		0.3	0.0		0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T10		ENSG00000184022	"Olfactory receptor family 2 subfamily T member 10"	Q8NGZ9	1	248590487-248597700	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"kidney: 11.2"	"Cell type enriched"	"Detected in single"	59	"Proximal tubular cells: 5.9"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.4"	"Group enriched"	"Detected in some"	7	"BJ hTERT+: 3.1;Karpas-707: 2.4"									HPA052019	Uncertain					NA	NA					"HPA052019: AB_2681696"													"unprognostic (8.58e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.4	0.0		0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1			0.0		0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T11	OR2T11Q	ENSG00000279301	"Olfactory receptor family 2 subfamily T member 11 (gene/pseudogene)"	Q8NH01	1	248623557-248635091	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;bone marrow: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"															NA	NA																							0.1	0.0		0.0		1.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.6	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.2	0.5	0.1	0.0		0.0	0.2	0.5			0.0		0.0	0.0		1.1	0.4	1.4	0.3	0.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.3	0.7	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.2	0.4	0.0	0.2	0.3	0.0	0.6	0.0	0.4	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	1.1	0.0	0.1	1.4	0.3	0.2	0.4	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T35		ENSG00000177151	"Olfactory receptor family 2 subfamily T member 35"	Q8NGX2	1	248636356-248645278	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"Daudi: 1.1"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.0			0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0		0.0	0.1	0.0	0.0	0.6		0.3	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T27		ENSG00000187701	"Olfactory receptor family 2 subfamily T member 27"	Q8NH04	1	248649838-248655528	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14I1	"OR5BU1, OR5BU1P"	ENSG00000189181	"Olfactory receptor family 14 subfamily I member 1"	A6ND48	1	248681369-248682304	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 7.4"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.1"															NA	NA																	"unprognostic (3.68e-1)"	"unprognostic (1.63e-1)"					0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	7.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYPD8		ENSG00000259823	"LY6/PLAUR domain containing 8"	Q6UX82	1	248718649-248755739	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 60.0;lymphoid tissue: 40.9"	"Cell type enriched"	"Detected in some"	7	"Paneth cells: 701.4"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 15.2"					"Group enriched"	"Detected in some"	6	"classical monocyte: 1.0;intermediate monocyte: 1.1;MAIT T-cell: 1.7;neutrophil: 2.3;plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;THP-1: 2.5"					"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA						"unprognostic (6.69e-3)"		"unprognostic (3.53e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-4)"	"unprognostic (8.62e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.89e-1)"		"unprognostic (1.07e-1)"	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.1	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.8	0.0	0.0	0.0	0.0	0.0	8.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.1	2.3	1.1	0.0	1.7	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.1	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	3.4	0.0	57.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	30.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	104.6	0.0	0.0	701.4	0.0	1.7	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	16.3	0.0
SH3BP5L	KIAA1720	ENSG00000175137	"SH3 binding domain protein 5 like"	Q7L8J4	1	248810446-248826633	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038067, HPA038068"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA038067: AB_2675814, HPA038068: AB_10670651"	"unprognostic (2.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.99e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.66e-2)"	4.1	5.0	5.3	4.0	4.8	3.0	3.3	10.3	8.7	4.1	4.9			6.2	4.9	2.5	7.2	4.7	3.3	6.5	5.5	4.0	4.1	4.5	3.9	4.2	4.2		3.9	4.2	5.9	2.4	5.0		3.9	2.9		5.1	5.7	13.6	8.0	5.6	4.3	5.0	5.4	4.3	3.6			3.6		4.0	4.1	3.7	1.1	1.2	6.2	1.8	0.4	1.5	1.0	10.0	6.3	8.4	9.6	12.0	8.1	11.0	22.7	7.8	13.3	10.1	6.1	8.9	5.0	13.8	19.0	3.3	10.8	7.9	9.7	6.4	11.5	2.8	8.2	6.8	4.9	7.3	8.9	9.9	6.6	10.5	14.7	5.6	9.4	8.8	9.5	14.0	5.3	8.9	3.3	8.4	6.1	14.7	11.2	16.2	9.6	5.9	10.2	9.1	4.5	9.7	13.4	7.0	8.7	7.5	6.6	9.4	18.4	12.1	16.4	7.0	6.6	34.5	13.2	14.7	4.5	12.2	10.3	6.9	5.5	1.8	5.4	1.1	1.0	1.1	0.5	1.5	0.9	1.2	1.1	0.5	0.4	6.2	0.4	0.4	0.8	0.2	1.0											0.0	1.3	3.0	1.7	4.0	8.1	8.9	2.5	0.0	0.0	10.4	0.0	7.5	1.7	7.2	1.1	3.1	12.6	0.0	5.1	4.0	5.1	3.0	0.0	7.4	5.2	7.9	7.5	4.3	5.7	0.4	4.0	3.7	3.3	5.4	7.2	3.7	8.3	8.7	5.3	5.8	3.3	0.0	3.3	8.0	6.0	4.1	9.5	5.2	5.2	2.7
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	11.3	12.5	11.1	16.4	13.6	15.1	12.1	18.6	15.3	10.2	13.0	17.3	15.0	13.8	12.1	10.7	15.9	11.3	13.3	20.1	11.4	10.2	14.8	27.5	13.6	16.7	14.1	7.5	12.0	14.1	20.4	14.1	16.1	12.4	18.7	11.1	15.1	24.1	14.8	46.6	13.3	16.8	11.3	11.2	16.0	12.7	12.4	14.5	28.1	21.7	21.0	17.3	14.5	10.4	14.5	20.8	9.6	13.4	10.5	8.0	10.3	10.2	11.7	9.6	10.7	5.4	3.8	18.1	9.8	5.3	6.9	7.6	6.4	10.8	11.6	10.1	6.4	5.4	10.1	5.2	7.2	4.6	16.8	2.9	17.7	10.8	8.6	7.0	7.7	13.7	4.2	6.0	9.2	6.6	5.7	6.5	8.0	21.5	9.7	4.9	7.4	13.6	7.7	11.0	11.8	19.9	25.7	9.1	9.1	7.2	8.5	14.1	12.4	8.7	13.3	8.6	6.0	7.7	15.8	5.5	9.8	5.8	6.5	19.8	29.1	10.9	6.8	9.1	13.6	8.0	7.6	13.3	9.6	8.0	13.4	6.7	10.8	5.7	7.9	20.8	14.5	6.3	5.6	8.1	10.5	12.4	11.7	6.5	10.3	11.1	13.6	18.6	15.3	11.4	10.2	14.1	7.5	12.4	14.5	3.0	17.5	21.4	22.4	11.6	21.0	16.9	7.6	5.3	4.5	15.7	11.8	28.2	18.3	16.4	6.2	12.1	18.8	0.0	9.4	16.4	10.8	20.5	28.7	14.8	15.4	9.5	17.3	5.5	15.2	8.9	5.2	14.1	11.8	12.6	16.6	19.2	12.1	17.3	5.3	13.5	30.2	6.5	9.9	22.9	13.6	12.8	59.6	13.8	15.2	19.9
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.7	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	1.9	7.0	6.5	6.2	3.4	8.9	4.4	7.1	10.9	1.6	2.8	7.9	5.7	2.4	8.0	4.8	12.8	4.7	4.3	8.0	14.6	4.4	2.1	3.4	4.0	16.3	8.8	12.4	11.1	13.7	2.8	12.0	9.0	3.6	8.5	6.3	4.5	7.8	8.4	1.7	9.5	13.0	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.8	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7	8.9	7.5	8.0	10.6	8.5	14.0	3.0	10.2	8.1	2.3	10.4	21.6	10.2	5.0	6.3	8.0	6.3	8.8	23.3	3.4	9.1	6.6	13.7	5.7	5.9	5.7	11.1	7.9	1.8	6.9	5.8	9.5	5.4	15.1	6.4	9.4	8.4	6.1	5.8	6.7	3.1	13.8	0.0	4.9	31.1	15.6	6.9	5.1	10.2	11.7	8.5
PGBD2		ENSG00000185220	"PiggyBac transposable element derived 2"	Q6P3X8	1	248906196-248919946	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3;Syncytiotrophoblasts: 23.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA029888, HPA029889, HPA029890"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002"	"unprognostic (1.06e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.05e-4)"	5.8	7.0	5.0	11.1	6.8	5.7	9.5	10.5	7.7	7.6	7.7	11.9	10.2	8.9	8.6	8.2	11.1	6.8	8.6	4.5	5.1	4.6	7.2	11.8	5.7	10.4	7.4	5.4	10.2	14.7	8.3	5.6	12.7	7.8	9.9	9.9	6.0	10.0	12.8	2.9	12.3	11.9	8.4	5.6	17.3	7.9	13.9	8.6	5.5	12.5	3.9	12.2	7.5	18.2	12.7	8.0	13.9	9.1	7.8	10.9	5.7	4.5	6.2	9.9	5.7	8.8	5.8	12.0	4.4	3.9	7.7	7.3	4.6	6.2	12.0	5.7	4.3	4.4	7.4	5.9	5.5	8.9	7.1	2.8	11.5	9.7	7.0	5.0	5.9	11.3	5.2	5.9	9.1	5.1	6.3	4.4	5.8	18.2	10.5	5.5	8.2	3.3	6.9	9.1	15.5	7.3	14.2	3.1	3.9	4.6	5.9	3.7	6.5	6.3	9.2	7.1	7.0	4.1	11.6	5.3	5.2	5.2	4.6	4.8	10.1	10.0	5.4	5.6	13.2	4.7	13.9	8.8	13.2	9.8	6.2	9.4	12.7	8.6	9.1	8.0	12.6	8.7	10.9	6.5	7.8	9.1	3.8	5.8	5.7	5.0	6.8	10.5	7.7	5.1	4.6	7.4	5.4	7.8	8.6	0.0	9.9	5.0	2.5	4.6	3.0	2.0	2.5	4.0	7.9	5.2	2.0	9.6	1.7	3.8	2.8	4.5	6.4	23.3	2.6	3.5	3.8	2.0	2.3	3.2	2.7	1.6	1.2	3.7	1.5	1.9	2.8	3.1	6.8	3.6	4.3	2.7	1.9	6.5	1.8	2.1	2.5	0.0	3.6	13.0	10.4	5.6	23.2	6.4	4.4	2.1
